Original gene set ID	Original gene set description	Nominal P value	False discovery rate	Reconstituted gene set Z score gene 1	Reconstituted gene set Z score gene 2	Reconstituted gene set Z score gene 3	Reconstituted gene set Z score gene 4	Reconstituted gene set Z score gene 5	Reconstituted gene set Z score gene 6	Reconstituted gene set Z score gene 7	Reconstituted gene set Z score gene 8	Reconstituted gene set Z score gene 9	Reconstituted gene set Z score gene 10
MP:0000180	abnormal circulating cholesterol level	3.59e-08	<= 0.05	ABCG5 (7.0)	ABCG8 (7.0)	APOC1 (5.6)	APOA5 (5.2)	TM6SF2 (5.0)	NPC1L1 (5.0)	APOB (4.7)	APOC4 (4.5)	FADS1 (4.2)	FADS2 (4.1)
MP:0000609	abnormal liver physiology	1.46e-06	<= 0.05	APOA5 (6.3)	APOC4 (6.0)	PLG (5.1)	APOB (5.0)	ABCG5 (4.6)	HP (4.5)	ABCG8 (4.3)	APOC1 (4.2)	ANGPTL3 (4.2)	SLC22A1 (3.7)
MP:0005179	decreased circulating cholesterol level	1.54e-06	<= 0.05	ABCG5 (7.8)	APOB (7.3)	NPC1L1 (7.2)	TM6SF2 (6.9)	ABCG8 (6.8)	APOA5 (5.4)	PLG (4.9)	APOC1 (4.6)	APOC4 (3.8)	HP (3.5)
GO:0055088	lipid homeostasis	2.07e-06	<= 0.05	ABCG8 (5.5)	NPC1L1 (5.0)	ABCG5 (4.8)	TM6SF2 (4.2)	APOC1 (3.5)	HNF1A (3.5)	APOB (3.3)	APOA5 (3.2)	APOC4 (3.1)	CYP7A1 (3.1)
GO:0044264	cellular polysaccharide metabolic process	2.57e-06	<= 0.05	LPA (2.9)	ZNF180 (2.8)	NT5DC1 (2.7)	SORT1 (2.7)	ZNF101 (2.6)	AMIGO1 (2.5)	SYPL2 (2.4)	CYB561D1 (2.0)	ENSG00000254235 (2.0)	ZHX3 (1.8)
MP:0001552	increased circulating triglyceride level	2.94e-06	<= 0.05	ABCG8 (5.2)	APOA5 (5.1)	ABCG5 (5.1)	GPAM (5.1)	MOSC1 (4.9)	NPC1L1 (4.7)	APOB (4.6)	TM6SF2 (4.6)	HP (4.0)	APOC1 (3.9)
MP:0000599	enlarged liver	4.40e-06	<= 0.05	ABCG8 (5.7)	APOA5 (4.8)	RHD (4.4)	APOC4 (4.0)	TM6SF2 (3.6)	LPA (3.6)	SLC22A1 (3.5)	CYP7A1 (3.4)	ABCG5 (3.3)	RHCE (3.2)
GO:0005976	polysaccharide metabolic process	4.46e-06	<= 0.05	LPA (2.9)	SORT1 (2.9)	ENSG00000228044 (2.8)	NT5DC1 (2.7)	ST3GAL4 (2.5)	ZNF180 (2.3)	CILP2 (2.2)	CYB561D1 (2.1)	AMIGO1 (2.1)	SYPL2 (2.0)
ENSG00000158796	DEDD PPI subnetwork	6.15e-06	<= 0.05	BLOC1S3 (3.0)	ABCG8 (2.7)	FRK (2.6)	ABCG5 (2.4)	ZNF180 (2.3)	TRAFD1 (2.2)	MAU2 (2.0)	TOP1 (2.0)	COL4A3BP (2.0)	PVRL2 (1.9)
MP:0002118	abnormal lipid homeostasis	6.29e-06	<= 0.05	GPAM (5.5)	APOC1 (5.1)	APOA5 (5.1)	MOSC1 (4.9)	ABCG8 (4.9)	ABCG5 (4.8)	HP (4.7)	TM6SF2 (4.6)	APOB (4.2)	APOC4 (4.1)
MP:0003406	failure of zygotic cell division	6.76e-06	<= 0.05	PSRC1 (3.3)	ATXN2 (3.2)	MAPKAPK5 (3.0)	LPIN3 (2.9)	APOC1 (2.8)	APOB (2.7)	ATXN7L2 (2.6)	BRAP (2.5)	GRINA (2.5)	ERP29 (2.1)
ENSG00000125686	MED1 PPI subnetwork	8.34e-06	<= 0.05	GEMIN7 (3.1)	BUD13 (3.1)	ATXN2 (2.9)	C12orf51 (2.5)	DHX38 (2.2)	ATXN7L2 (2.1)	SMARCA4 (2.1)	LDLR (1.7)	ENSG00000226648 (1.6)	MAPKAPK5 (1.5)
MP:0000182	increased circulating LDL cholesterol level	1.07e-05	<= 0.05	APOC1 (5.5)	NPC1L1 (4.5)	TM6SF2 (4.0)	ABCG5 (3.6)	TIMD4 (3.5)	APOA5 (3.2)	APOE (3.0)	GPAM (2.9)	FADS1 (2.8)	ABCG8 (2.7)
ENSG00000131910	NR0B2 PPI subnetwork	1.08e-05	<= 0.05	CYP7A1 (3.5)	ABCG8 (3.5)	ST3GAL4 (3.2)	APOC1 (2.6)	HNF1A (2.5)	MOSC1 (2.5)	APOA5 (2.3)	TM6SF2 (2.1)	GCNT4 (2.1)	ENSG00000254235 (2.0)
MP:0003982	increased cholesterol level	1.14e-05	<= 0.05	APOC4 (5.2)	APOA5 (4.7)	FADS2 (4.6)	FADS1 (4.3)	APOE (4.2)	CYP7A1 (4.1)	HMGCR (3.9)	ABCG5 (3.2)	APOC1 (3.0)	ABCG8 (3.0)
MP:0002727	decreased circulating insulin level	1.24e-05	<= 0.05	KIAA1324 (2.5)	TRIB1 (2.5)	APOC1 (2.4)	PPP1R37 (2.3)	MAFB (2.1)	GPAM (2.1)	APOB (2.0)	ZHX3 (1.9)	CETP (1.8)	TOP1 (1.8)
GO:0042632	cholesterol homeostasis	1.48e-05	<= 0.05	ABCG8 (5.7)	NPC1L1 (5.3)	ABCG5 (4.9)	TM6SF2 (4.4)	APOB (3.5)	APOC1 (3.4)	APOC4 (3.2)	HNF1A (3.0)	APOA5 (3.0)	TIMD4 (2.7)
GO:0055092	sterol homeostasis	1.48e-05	<= 0.05	ABCG8 (5.7)	NPC1L1 (5.3)	ABCG5 (4.9)	TM6SF2 (4.4)	APOB (3.5)	APOC1 (3.4)	APOC4 (3.2)	HNF1A (3.0)	APOA5 (3.0)	TIMD4 (2.7)
GO:0046527	glucosyltransferase activity	1.51e-05	<= 0.05	PVR (3.5)	ATP13A1 (3.3)	PVRL2 (2.9)	HP (2.6)	ANKRD31 (2.6)	CLPTM1 (2.4)	NAA25 (2.4)	SORT1 (2.4)	MOSC1 (2.2)	ENSG00000254235 (2.0)
REACTOME_LIPOPROTEIN_METABOLISM	REACTOME_LIPOPROTEIN_METABOLISM	1.66e-05	<= 0.05	APOB (9.0)	APOC1 (7.8)	ABCG5 (6.9)	NPC1L1 (6.4)	APOA5 (5.9)	PLG (5.8)	TM6SF2 (5.4)	APOC4 (4.8)	APOE (4.4)	ANGPTL3 (4.4)
GO:0042803	protein homodimerization activity	1.71e-05	<= 0.05	APOC1 (2.8)	KANK2 (2.6)	ALDH2 (2.5)	ST3GAL4 (2.5)	NPC1L1 (2.3)	APOB (2.3)	FADS1 (2.2)	SH2B3 (2.2)	HP (2.2)	RHD (2.1)
GO:0042304	regulation of fatty acid biosynthetic process	1.75e-05	<= 0.05	FADS2 (2.7)	HNF1A (2.7)	PCSK9 (2.6)	FADS1 (2.4)	LPIN3 (2.2)	NPC1L1 (2.1)	ABCG5 (2.0)	TM6SF2 (1.9)	CYP7A1 (1.9)	CBLC (1.7)
MP:0000208	decreased hematocrit	1.81e-05	<= 0.05	RHCE (10.2)	RHD (9.7)	ITGB3 (3.4)	GMPR (3.3)	GRINA (2.7)	CETP (2.5)	C12orf51 (2.3)	BCL3 (2.3)	TIMD4 (2.2)	APOC1 (2.2)
ENSG00000108984	MAP2K6 PPI subnetwork	1.84e-05	<= 0.05	CETP (3.3)	OASL (2.7)	BRAP (2.3)	TRIB1 (2.1)	ACAD10 (2.1)	MYLIP (2.0)	TIMD4 (2.0)	ENSG00000254235 (1.9)	TSSK6 (1.9)	ALDH2 (1.7)
KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM	1.86e-05	<= 0.05	MOSC1 (3.5)	TM6SF2 (3.3)	ABCG8 (2.5)	CETP (2.2)	GRINA (2.1)	LPAR2 (2.0)	ABCG5 (2.0)	NPC1L1 (2.0)	PLEKHH2 (1.9)	FADS1 (1.8)
MP:0001764	abnormal homeostasis	2.04e-05	<= 0.05	SLC22A1 (4.0)	ABCG5 (4.0)	LPA (3.4)	HP (3.4)	TM6SF2 (3.1)	TRIB1 (2.8)	NPC1L1 (2.7)	TRAPPC6A (2.7)	MOSC1 (2.3)	APOB (2.3)
MP:0002702	decreased circulating free fatty acid level	2.15e-05	<= 0.05	MOSC1 (5.9)	APOB (4.4)	HP (4.3)	GPAM (3.9)	APOA5 (3.6)	APOC4 (3.5)	PLG (3.2)	APOC1 (3.2)	TM6SF2 (2.7)	TRIB1 (2.6)
MP:0002599	increased mean platelet volume	2.18e-05	<= 0.05	ABCG8 (6.8)	ITGB3 (4.9)	ABCG5 (4.8)	CETP (4.2)	TM6SF2 (4.1)	RHCE (3.5)	NPC1L1 (3.5)	GMPR (2.9)	TIMD4 (2.9)	RHD (2.8)
GO:0003706	ligand-regulated transcription factor activity	2.46e-05	<= 0.05	PPP1R37 (4.9)	BCL3 (3.4)	ENSG00000254235 (2.0)	PLEC (2.0)	BLOC1S3 (2.0)	BCAM (2.0)	ATXN2 (1.9)	CLPTM1 (1.9)	KANK2 (1.9)	ST3GAL4 (1.8)
GO:0015918	sterol transport	2.68e-05	<= 0.05	ABCG8 (4.6)	ABCG5 (4.1)	NPC1L1 (3.6)	TM6SF2 (3.3)	TIMD4 (3.3)	APOC1 (3.2)	APOB (2.9)	MOSC1 (2.8)	APOA5 (2.7)	APOE (2.6)
GO:0033692	cellular polysaccharide biosynthetic process	2.69e-05	<= 0.05	ZNF101 (2.5)	ENSG00000254235 (2.5)	CYB561D1 (2.4)	SORT1 (2.4)	AMIGO1 (2.3)	LPA (2.3)	NT5DC1 (2.3)	ZNF180 (2.3)	SYPL2 (2.0)	ENSG00000228044 (1.9)
MP:0000639	abnormal adrenal gland morphology	2.82e-05	<= 0.05	APOC1 (4.8)	FADS2 (4.2)	FADS1 (3.9)	GPAM (2.8)	C11orf9 (2.8)	PVRL2 (2.6)	HMGCR (2.6)	GCNT4 (2.2)	COL4A3BP (2.0)	GOT2P1 (1.8)
GO:0005625	soluble fraction	2.94e-05	<= 0.05	SARS (4.0)	MOSC1 (3.0)	GRINA (2.8)	GPAM (2.5)	TM6SF2 (2.2)	NPC1L1 (2.2)	ERP29 (2.2)	HP (2.2)	ALDH2 (2.1)	FADS2 (2.1)
ENSG00000100288	CHKB PPI subnetwork	3.12e-05	<= 0.05	CYP7A1 (3.6)	APOA5 (3.6)	ANGPTL3 (3.5)	LPA (3.4)	PLG (3.4)	SLC22A1 (3.1)	NKPD1 (2.8)	APOC1 (2.7)	HAPLN4 (2.5)	C11orf9 (2.4)
MP:0009289	decreased epididymal fat pad weight	3.26e-05	<= 0.05	SORT1 (3.7)	APOC4 (3.5)	HP (3.5)	ZHX3 (3.4)	MOSC1 (3.3)	GPAM (2.7)	MAFB (2.4)	PLG (2.1)	SYPL2 (2.1)	APOC1 (2.1)
GO:0032368	regulation of lipid transport	3.27e-05	<= 0.05	ABCG8 (4.0)	TIMD4 (3.8)	NPC1L1 (3.8)	ABCG5 (3.7)	TM6SF2 (3.2)	CBLC (2.8)	GEMIN7 (2.7)	APOC1 (2.6)	MOSC1 (2.6)	APOE (2.5)
ENSG00000113889	KNG1 PPI subnetwork	3.30e-05	<= 0.05	ANGPTL3 (6.6)	APOC4 (5.1)	PLG (5.1)	HP (4.6)	LPA (4.0)	ITGB3 (3.6)	APOA5 (3.5)	CYP7A1 (3.0)	PCSK9 (2.9)	SLC22A1 (2.8)
GO:0030301	cholesterol transport	3.40e-05	<= 0.05	ABCG8 (4.5)	ABCG5 (4.1)	NPC1L1 (3.7)	TIMD4 (3.4)	TM6SF2 (3.3)	APOC1 (3.1)	APOB (2.9)	MOSC1 (2.7)	APOA5 (2.7)	APOE (2.5)
GO:0032370	positive regulation of lipid transport	3.79e-05	<= 0.05	GEMIN7 (2.9)	TIMD4 (2.7)	APOC1 (2.6)	CBLC (2.5)	C12orf43 (2.4)	MYLIP (2.3)	CETP (2.3)	PMFBP1 (2.1)	ST3GAL4 (2.0)	MAFB (1.9)
MP:0005668	decreased circulating leptin level	4.26e-05	<= 0.05	GPAM (4.6)	MOSC1 (3.4)	SORT1 (3.4)	HP (3.0)	APOC1 (2.9)	ST3GAL4 (2.8)	ALDH2 (2.6)	PPP1R37 (2.2)	HLX (2.2)	BCL3 (2.1)
GO:0006869	lipid transport	4.44e-05	<= 0.05	ABCG8 (3.9)	TM6SF2 (3.9)	ABCG5 (3.6)	NPC1L1 (3.4)	LPIN3 (2.5)	APOB (2.4)	APOA5 (2.4)	APOC1 (2.4)	GPAM (2.3)	MOSC1 (2.3)
ENSG00000186350	RXRA PPI subnetwork	4.55e-05	<= 0.05	BCL3 (3.2)	TRIB1 (3.1)	ATXN2 (2.9)	PPP1R37 (2.8)	RELB (2.5)	MARK4 (2.5)	ABCG5 (2.4)	CARM1 (2.2)	CLPTM1 (2.2)	MAFB (2.0)
GO:0032376	positive regulation of cholesterol transport	4.63e-05	<= 0.05	APOC1 (3.6)	GEMIN7 (3.4)	MYLIP (3.1)	TIMD4 (2.9)	APOE (2.5)	ENSG00000238078 (2.4)	ENSG00000254235 (2.3)	CETP (2.1)	MOSC1 (2.1)	ALDH2 (2.0)
GO:0032373	positive regulation of sterol transport	4.63e-05	<= 0.05	APOC1 (3.6)	GEMIN7 (3.4)	MYLIP (3.1)	TIMD4 (2.9)	APOE (2.5)	ENSG00000238078 (2.4)	ENSG00000254235 (2.3)	CETP (2.1)	MOSC1 (2.1)	ALDH2 (2.0)
MP:0001786	skin edema	4.79e-05	<= 0.05	ITGB3 (4.5)	NYNRIN (3.1)	GRINA (2.8)	CETP (2.6)	MAFB (2.3)	MYLIP (2.1)	BCL3 (2.1)	TM6SF2 (2.0)	SLC44A2 (1.9)	C12orf51 (1.7)
ENSG00000197561	ELANE PPI subnetwork	5.21e-05	<= 0.05	HP (8.3)	PLG (3.9)	TIMD4 (3.5)	APOA5 (3.2)	ANGPTL3 (3.1)	APOC1 (3.1)	SLC22A1 (2.9)	CETP (2.6)	RHD (2.6)	APOB (2.4)
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	5.29e-05	<= 0.05	APOB (7.3)	NPC1L1 (7.1)	ABCG5 (7.1)	APOC1 (6.0)	TM6SF2 (5.8)	ABCG8 (5.7)	APOA5 (4.7)	PLG (4.1)	GPAM (3.9)	APOC4 (3.9)
MP:0000691	enlarged spleen	5.55e-05	<= 0.05	RHCE (4.7)	RHD (4.6)	BCL3 (3.4)	RELB (3.3)	GMIP (3.3)	PARP10 (3.1)	SH2B3 (2.1)	SLC44A2 (2.1)	MAFB (1.8)	TIMD4 (1.8)
ENSG00000168092	PAFAH1B2 PPI subnetwork	6.15e-05	<= 0.05	GEMIN7 (2.7)	TOMM40 (2.5)	CBLC (2.4)	RHD (2.2)	TMEM116 (2.1)	SMARCA4 (2.0)	PTPN11 (1.9)	ABO (1.9)	NYNRIN (1.8)	MARK4 (1.8)
MP:0005559	increased circulating glucose level	6.30e-05	<= 0.05	NPC1L1 (3.6)	GPAM (2.7)	MOSC1 (2.2)	KIAA1324 (2.0)	HP (1.9)	ABCG8 (1.8)	PCSK9 (1.8)	LPIN3 (1.7)	BCL3 (1.7)	LDLR (1.7)
GO:0005506	iron ion binding	6.44e-05	<= 0.05	SLC22A1 (5.5)	CYP7A1 (5.0)	HP (4.9)	LPA (4.7)	FADS1 (4.5)	PLG (4.0)	APOA5 (4.0)	ANGPTL3 (4.0)	RHCE (3.9)	ABCG5 (3.7)
MP:0005311	abnormal circulating amino acid level	6.67e-05	<= 0.05	PLG (5.4)	SLC22A1 (5.0)	APOA5 (4.9)	LPA (4.7)	ANGPTL3 (4.5)	APOC4 (4.5)	TM6SF2 (4.2)	CYP7A1 (4.0)	HP (3.7)	ABCG8 (3.6)
MP:0002941	increased circulating alanine transaminase level	6.90e-05	<= 0.05	APOA5 (5.1)	SLC22A1 (4.8)	TM6SF2 (4.3)	ABCG5 (4.0)	APOC4 (3.9)	CYP7A1 (3.4)	LPIN3 (3.3)	PLG (3.3)	HP (3.2)	LPA (3.2)
GO:0052689	carboxylic ester hydrolase activity	7.06e-05	<= 0.05	APOC1 (3.7)	TM6SF2 (3.5)	CETP (3.4)	APOC4 (3.3)	SLC22A1 (3.2)	NKPD1 (3.0)	MOSC1 (3.0)	CYP7A1 (3.0)	APOA5 (2.8)	GPAM (2.8)
MP:0005278	abnormal cholesterol homeostasis	7.16e-05	<= 0.05	NPC1L1 (8.1)	ABCG5 (7.6)	FADS1 (7.5)	HMGCR (7.4)	FADS2 (7.0)	APOB (6.8)	ABCG8 (5.9)	LDLR (5.9)	APOC1 (5.8)	PCSK9 (4.8)
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	7.48e-05	<= 0.05	HMGCR (8.0)	LDLR (7.9)	FADS2 (7.7)	FADS1 (7.6)	PCSK9 (5.6)	GPAM (5.5)	ABCG5 (4.8)	APOC1 (4.6)	TM6SF2 (4.2)	ABCG8 (4.1)
GO:0009395	phospholipid catabolic process	7.59e-05	<= 0.05	NKPD1 (6.4)	DNAH11 (3.0)	CETP (2.9)	TSSK6 (2.6)	APOE (2.3)	LPIN3 (1.8)	CYB561D1 (1.8)	APOC4 (1.6)	PLEKHH2 (1.5)	ENSG00000235545 (1.5)
MP:0003983	decreased cholesterol level	7.99e-05	<= 0.05	HMGCR (7.0)	LDLR (7.0)	FADS1 (5.7)	FADS2 (5.6)	TM6SF2 (4.9)	ABCG8 (4.7)	ABCG5 (4.4)	NPC1L1 (4.3)	CYP7A1 (3.9)	PCSK9 (3.5)
MP:0001711	abnormal placenta morphology	8.36e-05	<= 0.05	CBLC (2.9)	MOSC1 (2.7)	APOB (2.7)	PTPN11 (2.5)	TRIB1 (2.4)	APOA5 (2.4)	LDLR (2.4)	DHODH (2.4)	HP (2.3)	ANGPTL3 (2.1)
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	8.38e-05	<= 0.05	PLG (6.0)	APOA5 (5.5)	ANGPTL3 (5.4)	APOC4 (5.4)	SLC22A1 (4.6)	APOB (4.3)	HP (3.9)	LPA (3.9)	ABO (3.1)	HNF1A (2.9)
ENSG00000171564	FGB PPI subnetwork	8.50e-05	<= 0.05	PLG (7.2)	APOB (6.7)	ANGPTL3 (6.6)	APOA5 (6.1)	APOC4 (5.3)	APOC1 (4.6)	HP (4.4)	SLC22A1 (2.9)	CYP7A1 (2.7)	ABCG5 (2.7)
ENSG00000124151	NCOA3 PPI subnetwork	9.61e-05	<= 0.05	TRIB1 (3.5)	MAU2 (2.4)	SH2B3 (2.4)	UBXN2B (2.1)	ATXN2 (2.0)	C12orf51 (2.0)	LPIN3 (2.0)	PLEC (1.8)	APOA5 (1.7)	CYP7A1 (1.7)
ENSG00000146674	IGFBP3 PPI subnetwork	9.71e-05	<= 0.05	LPA (3.9)	CYP7A1 (3.9)	APOA5 (3.8)	HP (3.8)	SLC22A1 (3.6)	APOC4 (3.4)	ANGPTL3 (3.1)	APOE (2.8)	APOB (2.6)	PLG (2.6)
GO:0010876	lipid localization	1.01e-04	<= 0.05	ABCG8 (3.7)	TM6SF2 (3.6)	ABCG5 (3.3)	NPC1L1 (3.2)	MOSC1 (2.9)	GPAM (2.9)	APOC1 (2.6)	NKPD1 (2.5)	APOB (2.3)	APOA5 (2.3)
MP:0002644	decreased circulating triglyceride level	1.02e-04	<= 0.05	NPC1L1 (5.2)	APOB (5.1)	MOSC1 (5.0)	APOC1 (4.8)	HP (4.5)	GPAM (4.2)	TM6SF2 (4.0)	ABCG5 (3.8)	APOA5 (3.2)	ABCG8 (3.2)
ENSG00000173281	PPP1R3B PPI subnetwork	1.08e-04	<= 0.05	ZNF180 (3.9)	DHODH (3.5)	LPA (3.4)	SYPL2 (3.1)	MOSC1 (2.6)	CLPTM1 (2.4)	MARK4 (2.1)	SORT1 (2.1)	TSSK6 (2.0)	SLC44A2 (1.9)
GO:0030169	low-density lipoprotein particle binding	1.08e-04	<= 0.05	TIMD4 (4.4)	HMGCR (4.3)	CETP (4.3)	LPA (4.1)	APOA5 (3.9)	PCSK9 (3.7)	FADS2 (3.4)	APOC4 (3.4)	APOC1 (3.2)	PLG (3.2)
MP:0010182	decreased susceptibility to weight gain	1.10e-04	<= 0.05	APOB (4.1)	APOA5 (4.0)	PCSK9 (3.9)	HMGCR (3.8)	HP (3.6)	LPA (3.0)	FADS2 (2.9)	SLC44A2 (2.8)	APOC1 (2.7)	DNAH11 (2.7)
GO:0038024	cargo receptor activity	1.17e-04	<= 0.05	TIMD4 (6.1)	HP (3.8)	MAFB (2.9)	CETP (2.7)	APOB (2.6)	ABCG5 (2.5)	ABCG8 (2.4)	APOA5 (2.3)	CILP2 (2.2)	NPC1L1 (2.1)
ENSG00000175899	A2M PPI subnetwork	1.18e-04	<= 0.05	APOC4 (4.5)	HP (4.2)	ANGPTL3 (4.2)	APOB (4.1)	APOA5 (4.0)	APOC1 (3.8)	PLG (3.3)	SLC22A1 (3.3)	ABCG5 (2.9)	MOSC1 (2.6)
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR:ACTIVATED_RECEPTOR_ALPHA_PPARALPHA	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PEROXISOME_PROLIFERATOR:ACTIVATED_RECEPTOR_ALPHA_PPARALPHA	1.21e-04	<= 0.05	LDLR (5.2)	FADS2 (5.2)	GPAM (3.8)	APOB (3.7)	HMGCR (3.6)	FADS1 (3.5)	HP (3.0)	APOC4 (3.0)	ANGPTL3 (2.8)	PCSK9 (2.8)
MP:0005637	abnormal iron homeostasis	1.28e-04	<= 0.05	RHD (6.8)	RHCE (5.1)	HP (4.7)	TM6SF2 (2.7)	TIMD4 (2.4)	ALDH2 (2.3)	TMED4 (2.3)	APOC1 (2.2)	CYP7A1 (2.1)	GPAM (2.1)
REACTOME_METABOLISM_OF_CARBOHYDRATES	REACTOME_METABOLISM_OF_CARBOHYDRATES	1.32e-04	<= 0.05	TM6SF2 (4.4)	ABCG5 (3.6)	DOCK7 (3.4)	NPC1L1 (3.3)	SYPL2 (3.2)	MOSC1 (3.1)	DHODH (3.0)	SORT1 (2.9)	GPAM (2.7)	ABCG8 (2.6)
MP:0002981	increased liver weight	1.34e-04	<= 0.05	ABCG8 (6.9)	TM6SF2 (5.2)	APOA5 (5.0)	APOC4 (5.0)	SLC22A1 (4.6)	FADS1 (4.5)	ABCG5 (4.5)	PLG (4.4)	CYP7A1 (4.0)	LPA (3.7)
MP:0005145	increased circulating VLDL cholesterol level	1.40e-04	<= 0.05	APOC1 (5.6)	MOSC1 (3.9)	GPAM (3.7)	ALDH2 (3.5)	APOC4 (3.2)	TIMD4 (3.0)	HP (2.7)	FADS2 (2.6)	FADS1 (2.4)	DNM2 (2.3)
ENSG00000164344	KLKB1 PPI subnetwork	1.41e-04	<= 0.05	ANGPTL3 (7.5)	LPA (6.8)	PLG (6.2)	APOA5 (6.2)	APOC4 (5.9)	SLC22A1 (4.9)	CYP7A1 (3.8)	HP (3.6)	APOE (3.5)	APOC1 (2.6)
GO:0032371	regulation of sterol transport	1.43e-04	<= 0.05	ABCG8 (4.8)	ABCG5 (4.4)	TIMD4 (4.0)	NPC1L1 (3.8)	TM6SF2 (3.5)	APOC1 (3.3)	GEMIN7 (3.1)	MOSC1 (3.0)	APOB (2.9)	APOE (2.6)
GO:0032374	regulation of cholesterol transport	1.43e-04	<= 0.05	ABCG8 (4.8)	ABCG5 (4.4)	TIMD4 (4.0)	NPC1L1 (3.8)	TM6SF2 (3.5)	APOC1 (3.3)	GEMIN7 (3.1)	MOSC1 (3.0)	APOB (2.9)	APOE (2.6)
GO:0070328	triglyceride homeostasis	1.45e-04	<= 0.05	ABCG8 (4.9)	TM6SF2 (3.9)	ABCG5 (3.8)	NPC1L1 (3.3)	TIMD4 (3.2)	CYP7A1 (3.0)	HNF1A (3.0)	APOC4 (2.7)	APOC1 (2.7)	LPIN3 (2.6)
ENSG00000110330	BIRC2 PPI subnetwork	1.52e-04	<= 0.05	RELB (4.6)	TRAFD1 (2.7)	USP24 (2.7)	PARP10 (2.4)	LPAR2 (2.1)	TRAPPC6A (2.0)	SLC22A1 (1.9)	C1orf63 (1.9)	BCL3 (1.9)	COL4A3BP (1.8)
KEGG_INSULIN_SIGNALING_PATHWAY	KEGG_INSULIN_SIGNALING_PATHWAY	1.56e-04	<= 0.05	GPAM (4.0)	SORT1 (3.5)	DNM2 (3.3)	MOSC1 (3.1)	SLC44A2 (2.6)	PTPN11 (2.5)	SYPL2 (2.5)	USP24 (2.4)	GMIP (2.1)	MARK4 (2.1)
ENSG00000144908	ALDH1L1 PPI subnetwork	1.69e-04	<= 0.05	PLG (3.8)	ANGPTL3 (3.4)	APOC4 (2.9)	APOA5 (2.5)	OGDH (2.4)	ILF3 (2.4)	DDX56 (2.3)	CYP7A1 (2.2)	TOMM40 (2.1)	APOB (2.0)
REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	1.79e-04	<= 0.05	FADS2 (5.3)	LDLR (5.2)	APOB (4.0)	GPAM (4.0)	HMGCR (3.7)	FADS1 (3.7)	HP (3.1)	APOC4 (3.0)	ANGPTL3 (3.0)	PCSK9 (2.8)
ENSG00000167711	SERPINF2 PPI subnetwork	1.80e-04	<= 0.05	HP (5.9)	ANGPTL3 (5.2)	PLG (4.4)	APOC4 (4.1)	CEACAM19 (4.0)	APOA5 (3.3)	LPA (2.6)	NKPD1 (2.6)	MOSC1 (2.1)	PCSK9 (2.1)
REACTOME_HDL:MEDIATED_LIPID_TRANSPORT	REACTOME_HDL:MEDIATED_LIPID_TRANSPORT	1.84e-04	<= 0.05	APOC1 (8.8)	APOB (6.9)	APOE (6.6)	ABCG5 (4.6)	APOA5 (4.4)	TIMD4 (4.3)	NPC1L1 (4.3)	PLG (4.3)	MYLIP (4.0)	ANGPTL3 (3.8)
ENSG00000175354	PTPN2 PPI subnetwork	1.96e-04	<= 0.05	PARP10 (3.1)	PLCG1 (2.8)	C1orf63 (2.3)	BCL3 (2.3)	TMEM50A (2.1)	CBLC (2.1)	PBX4 (1.8)	APOE (1.8)	C12orf47 (1.7)	ZHX3 (1.7)
ENSG00000206346	DOM3Z PPI subnetwork	1.98e-04	<= 0.05	SUGP1 (4.3)	MAU2 (3.7)	DDX56 (2.8)	ATP13A1 (2.6)	PARP10 (2.5)	GRINA (2.1)	ENSG00000226648 (2.1)	ABO (2.0)	GOT2P1 (2.0)	PLEC (1.9)
ENSG00000206266	ENSG00000206266 PPI subnetwork	1.98e-04	<= 0.05	SUGP1 (4.3)	MAU2 (3.7)	DDX56 (2.8)	ATP13A1 (2.6)	PARP10 (2.5)	GRINA (2.1)	ENSG00000226648 (2.1)	ABO (2.0)	GOT2P1 (2.0)	PLEC (1.9)
ENSG00000204348	DOM3Z PPI subnetwork	1.98e-04	<= 0.05	SUGP1 (4.3)	MAU2 (3.7)	DDX56 (2.8)	ATP13A1 (2.6)	PARP10 (2.5)	GRINA (2.1)	ENSG00000226648 (2.1)	ABO (2.0)	GOT2P1 (2.0)	PLEC (1.9)
GO:0034185	apolipoprotein binding	2.01e-04	<= 0.05	ANGPTL3 (4.6)	APOA5 (4.5)	APOC4 (4.1)	APOB (3.8)	LPA (3.4)	ABCG5 (3.1)	PCSK9 (2.9)	NPC1L1 (2.8)	APOE (2.7)	APOC1 (2.7)
GO:0046890	regulation of lipid biosynthetic process	2.01e-04	<= 0.05	ST3GAL4 (3.6)	FADS2 (2.8)	GPAM (2.8)	HNF1A (2.8)	FADS1 (2.5)	LDLR (2.4)	NPC1L1 (2.4)	CYP7A1 (2.1)	ABCG8 (2.0)	ENSG00000226645 (2.0)
MP:0004773	abnormal bile composition	2.06e-04	<= 0.05	ABCG5 (9.0)	ABCG8 (8.1)	APOA5 (6.0)	APOB (5.7)	NPC1L1 (5.6)	APOC4 (5.5)	TM6SF2 (5.2)	CYP7A1 (3.9)	PLG (3.8)	SLC22A1 (2.7)
GO:0004879	ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity	2.10e-04	<= 0.05	TRIB1 (3.0)	ABCG8 (2.9)	ABCG5 (2.5)	TM6SF2 (2.4)	ST3GAL4 (2.4)	CYP7A1 (2.3)	GCNT4 (2.2)	PPP1R37 (2.1)	HNF1A (2.1)	FRK (2.0)
GO:0005496	steroid binding	2.13e-04	<= 0.05	APOB (6.0)	APOC1 (4.9)	ABCG5 (4.6)	TM6SF2 (4.1)	ANGPTL3 (4.0)	APOA5 (4.0)	APOC4 (3.9)	PLG (3.8)	ABCG8 (3.2)	KIAA1324 (2.9)
GO:0009746	response to hexose stimulus	2.18e-04	<= 0.05	HNF1A (2.7)	ENSG00000254235 (2.6)	PCSK9 (2.5)	ABCG5 (2.3)	KIAA1324 (2.0)	ABCG8 (1.9)	COL4A3BP (1.8)	TM6SF2 (1.6)	GPAM (1.6)	FRK (1.6)
MP:0005659	decreased susceptibility to diet-induced obesity	2.21e-04	<= 0.05	MOSC1 (4.6)	TRIB1 (3.8)	TM6SF2 (3.8)	ABCG5 (3.6)	ABCG8 (3.1)	GCNT4 (2.5)	HP (2.5)	SORT1 (2.3)	APOA5 (2.3)	PLEC (2.2)
ENSG00000106633	GCK PPI subnetwork	2.29e-04	<= 0.05	ENSG00000254235 (4.4)	C12orf43 (3.7)	ZNF259 (2.3)	APOA5 (2.3)	QTRT1 (2.3)	LPA (2.1)	ENSG00000238078 (1.9)	ANKRD31 (1.9)	MOSC1 (1.8)	HNF1A (1.8)
MP:0005319	abnormal enzyme/ coenzyme level	2.33e-04	<= 0.05	HP (4.0)	SLC22A1 (3.6)	LDLR (3.2)	LPA (3.2)	ST3GAL4 (3.1)	FADS1 (3.1)	NPC1L1 (3.0)	ABCG8 (2.9)	PLG (2.8)	FADS2 (2.6)
GO:0045723	positive regulation of fatty acid biosynthetic process	2.36e-04	<= 0.05	CEACAM19 (3.2)	HNF1A (3.0)	ENSG00000254235 (2.4)	C12orf47 (1.8)	PCSK9 (1.8)	CBLC (1.6)	TSSK6 (1.6)	TXNL4B (1.6)	HAPLN4 (1.6)	MOSC1 (1.6)
GO:0034637	cellular carbohydrate biosynthetic process	2.43e-04	<= 0.05	LPA (3.1)	SORT1 (2.7)	ENSG00000254235 (2.6)	SYPL2 (2.6)	GPAM (2.4)	NT5DC1 (2.4)	ZNF180 (2.3)	DHODH (2.2)	MOSC1 (2.1)	SLC22A1 (1.8)
GO:0043691	reverse cholesterol transport	2.45e-04	<= 0.05	APOC1 (3.9)	HAVCR1 (3.5)	APOB (3.4)	TIMD4 (3.3)	APOA5 (3.0)	ABCG5 (2.9)	APOE (2.8)	APOC4 (2.7)	MYLIP (2.6)	HNF1A (2.5)
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	2.55e-04	<= 0.05	TM6SF2 (3.5)	ABCG8 (3.5)	ABCG5 (3.1)	TRIB1 (2.9)	HNF1A (2.6)	CYP7A1 (2.4)	NPC1L1 (2.4)	APOA5 (2.2)	APOB (2.1)	GCNT4 (2.1)
GO:0005319	lipid transporter activity	2.56e-04	<= 0.05	ABCG5 (7.2)	APOB (6.2)	ABCG8 (5.6)	TM6SF2 (5.5)	APOC1 (5.5)	APOA5 (5.3)	APOC4 (4.5)	NPC1L1 (4.4)	PLG (4.4)	ANGPTL3 (3.4)
GO:0007568	aging	2.60e-04	<= 0.05	FADS2 (2.9)	ENSG00000235545 (2.7)	LDLR (2.1)	FADS1 (2.0)	GCNT4 (1.9)	KANK2 (1.9)	GRINA (1.8)	BLOC1S3 (1.7)	ACAD10 (1.6)	GOT2P1 (1.5)
REACTOME_INNATE_IMMUNE_SYSTEM	REACTOME_INNATE_IMMUNE_SYSTEM	2.61e-04	<= 0.05	OASL (6.9)	PARP10 (4.7)	RELB (4.0)	BCL3 (3.6)	TRAFD1 (3.4)	HP (3.2)	LPA (2.8)	TRIB1 (2.2)	GMIP (2.1)	ANGPTL3 (2.1)
GO:0034358	plasma lipoprotein particle	2.67e-04	<= 0.05	APOC1 (9.0)	APOA5 (7.8)	PLG (7.3)	APOB (7.1)	APOC4 (7.0)	APOE (5.7)	HP (5.2)	ANGPTL3 (4.8)	LPA (4.6)	ABCG5 (4.5)
GO:0032994	protein-lipid complex	2.67e-04	<= 0.05	APOC1 (9.0)	APOA5 (7.8)	PLG (7.3)	APOB (7.1)	APOC4 (7.0)	APOE (5.7)	HP (5.2)	ANGPTL3 (4.8)	LPA (4.6)	ABCG5 (4.5)
ENSG00000143379	SETDB1 PPI subnetwork	2.82e-04	<= 0.05	BUD13 (3.7)	C19orf52 (2.6)	ZNF180 (2.5)	MARK4 (2.3)	ILF3 (2.0)	SMARCA4 (2.0)	GATAD2A (2.0)	MYLIP (1.9)	TMEM57 (1.8)	ATXN2 (1.6)
GO:0034362	low-density lipoprotein particle	2.83e-04	<= 0.05	APOC1 (9.0)	PCSK9 (4.6)	PLG (4.4)	APOE (4.3)	HMGCR (4.0)	APOA5 (3.9)	LPA (3.7)	APOC4 (3.7)	LPAR2 (2.8)	ABCG5 (2.7)
GO:0019217	regulation of fatty acid metabolic process	2.83e-04	<= 0.05	PCSK9 (2.6)	MOSC1 (2.5)	AMIGO1 (2.1)	ACAD10 (2.0)	GMPR (2.0)	FADS1 (1.9)	GPAM (1.9)	SYPL2 (1.8)	FADS2 (1.8)	TXNL4B (1.8)
MP:0002874	decreased hemoglobin content	2.87e-04	<= 0.05	RHD (10.0)	RHCE (9.6)	GMPR (3.7)	CETP (3.5)	TIMD4 (3.3)	ITGB3 (3.1)	MAFB (2.8)	PVR (2.4)	ENSG00000226645 (2.1)	C12orf51 (2.1)
MP:0002551	abnormal blood coagulation	2.98e-04	<= 0.05	ITGB3 (6.5)	PLG (5.9)	ANGPTL3 (5.6)	HP (5.4)	APOA5 (5.2)	APOC4 (4.7)	GMPR (4.5)	SLC22A1 (3.9)	APOB (3.9)	LPA (3.6)
ENSG00000109680	TBC1D19 PPI subnetwork	2.99e-04	<= 0.05	APOB (6.7)	ANGPTL3 (5.4)	APOE (4.5)	APOC4 (4.3)	APOC1 (4.0)	APOA5 (4.0)	PLG (3.9)	HP (3.7)	PCSK9 (3.1)	ABCG5 (2.9)
ENSG00000185324	CDK10 PPI subnetwork	3.08e-04	<= 0.05	MYLIP (2.9)	NYNRIN (2.8)	ZNF180 (2.0)	TRIB1 (1.8)	TIMD4 (1.8)	ZNF101 (1.7)	DHODH (1.5)	ENSG00000254235 (1.5)	PVRL2 (1.5)	MAFB (1.5)
ENSG00000160282	FTCD PPI subnetwork	3.11e-04	<= 0.05	CLPTM1 (3.3)	SARS (3.3)	PLG (3.1)	GOT2P1 (2.9)	CARM1 (2.8)	ILF3 (2.6)	ANGPTL3 (2.6)	OGDH (2.5)	APOA5 (2.5)	TOMM40 (2.4)
GO:0008202	steroid metabolic process	3.14e-04	<= 0.05	FADS2 (5.9)	LDLR (5.5)	CYP7A1 (5.4)	HMGCR (5.3)	FADS1 (5.3)	PCSK9 (4.9)	LPA (3.9)	NPC1L1 (3.8)	SLC22A1 (3.7)	TM6SF2 (3.5)
ENSG00000198734	F5 PPI subnetwork	3.16e-04	<= 0.05	HP (7.1)	PLG (4.7)	APOA5 (4.3)	APOB (4.1)	ITGB3 (4.0)	APOC4 (3.5)	ANGPTL3 (3.0)	APOC1 (2.8)	SLC22A1 (2.7)	TIMD4 (2.5)
GO:0097006	regulation of plasma lipoprotein particle levels	3.25e-04	<= 0.05	TIMD4 (3.9)	APOC1 (3.8)	APOE (3.6)	NPC1L1 (3.3)	MOSC1 (3.1)	ABCG5 (2.9)	APOB (2.8)	HAVCR1 (2.7)	CETP (2.4)	APOC4 (2.3)
GO:0016829	lyase activity	3.45e-04	<= 0.05	GPAM (4.0)	MOSC1 (4.0)	DHODH (3.6)	FADS2 (3.3)	APOA5 (3.3)	PLG (3.1)	FADS1 (3.0)	LPA (2.9)	ALDH2 (2.9)	RHD (2.8)
MP:0005292	improved glucose tolerance	3.53e-04	<= 0.05	MOSC1 (3.6)	GPAM (2.9)	SORT1 (2.6)	ZHX3 (2.3)	TRIB1 (2.2)	HLX (2.2)	APOA5 (2.1)	HP (2.1)	NPC1L1 (2.1)	ENSG00000254235 (2.1)
REACTOME_HEXOSE_TRANSPORT	REACTOME_HEXOSE_TRANSPORT	3.56e-04	<= 0.05	DOCK7 (3.5)	NAA25 (2.7)	BUD13 (2.6)	DDX56 (2.5)	ABCG5 (2.5)	TM6SF2 (2.4)	USP1 (2.3)	DHODH (2.3)	POC5 (2.3)	LPA (2.2)
GO:0045923	positive regulation of fatty acid metabolic process	3.64e-04	<= 0.05	ENSG00000254235 (2.5)	MOSC1 (2.5)	HNF1A (2.1)	ENSG00000235545 (1.6)	TIMD4 (1.6)	GPAM (1.6)	CBLC (1.5)	PCSK9 (1.5)	ABCG8 (1.5)	APOC4 (1.5)
GO:0034284	response to monosaccharide stimulus	3.72e-04	<= 0.05	HNF1A (2.8)	PCSK9 (2.4)	ENSG00000254235 (2.4)	KIAA1324 (2.2)	ABCG5 (2.2)	ABCG8 (1.9)	COL4A3BP (1.8)	GPAM (1.6)	TM6SF2 (1.6)	ANKRD31 (1.5)
MP:0005178	increased circulating cholesterol level	3.81e-04	<= 0.05	MOSC1 (5.0)	APOB (4.8)	APOA5 (4.3)	APOC1 (4.3)	APOC4 (3.6)	GPAM (3.6)	HP (3.1)	ABCG5 (3.0)	TIMD4 (2.9)	APOE (2.8)
GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	3.82e-04	<= 0.05	SLC22A1 (6.2)	LPA (6.0)	CYP7A1 (5.3)	FADS2 (4.6)	FADS1 (4.5)	ABCG5 (4.3)	PLG (4.3)	ANGPTL3 (4.3)	APOC4 (4.2)	HMGCR (4.1)
ENSG00000100448	CTSG PPI subnetwork	3.84e-04	<= 0.05	ITGB3 (6.7)	HP (6.4)	TIMD4 (5.1)	CETP (4.7)	APOC1 (3.8)	APOE (3.5)	ANGPTL3 (3.4)	PLG (3.4)	MAFB (3.2)	RHD (3.2)
GO:0031406	carboxylic acid binding	3.96e-04	<= 0.05	MOSC1 (4.6)	PLG (4.3)	APOA5 (4.3)	ANGPTL3 (4.3)	APOC1 (3.6)	APOC4 (3.6)	APOB (3.6)	TM6SF2 (3.6)	ABCG8 (3.3)	ABCG5 (3.3)
MP:0001783	decreased white adipose tissue amount	3.97e-04	<= 0.05	MOSC1 (3.9)	APOC1 (3.2)	GPAM (3.0)	HP (2.3)	PMFBP1 (2.2)	TOP1 (2.1)	SORT1 (2.1)	ST3GAL4 (1.8)	TRIB1 (1.5)	LDLR (1.5)
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	3.98e-04	<= 0.05	PLG (8.5)	ANGPTL3 (8.3)	APOC4 (7.9)	HP (7.7)	APOA5 (7.3)	APOC1 (6.1)	SLC22A1 (5.5)	LPA (5.4)	APOB (4.8)	APOE (4.4)
MP:0002628	hepatic steatosis	3.99e-04	<= 0.05	APOA5 (5.1)	APOC4 (4.6)	HP (3.9)	ABCG5 (3.9)	APOC1 (3.7)	APOB (3.6)	TM6SF2 (3.6)	GPAM (3.5)	PLG (3.3)	ANGPTL3 (2.9)
GO:0005796	Golgi lumen	4.02e-04	<= 0.05	APOC4 (4.3)	SLC22A1 (4.2)	PLG (4.1)	ANGPTL3 (4.0)	LPA (4.0)	ABO (3.9)	APOA5 (3.8)	APOB (2.7)	HNF1A (2.7)	PCSK9 (2.6)
GO:0008289	lipid binding	4.02e-04	<= 0.05	ABCG5 (5.7)	APOB (4.9)	ABCG8 (4.3)	TM6SF2 (4.2)	APOC1 (3.6)	APOA5 (3.6)	NPC1L1 (3.4)	APOC4 (3.3)	MOSC1 (3.3)	PLG (2.8)
GO:0031099	regeneration	4.03e-04	<= 0.05	HAPLN4 (2.7)	GCNT4 (2.4)	ENSG00000228044 (2.1)	APOB (1.9)	GOT2P1 (1.8)	PSRC1 (1.8)	APOA5 (1.7)	APOC1 (1.7)	APOC4 (1.7)	CEACAM19 (1.7)
MP:0003887	increased hepatocyte apoptosis	4.04e-04	<= 0.05	APOB (3.8)	TRIB1 (3.1)	PCSK9 (3.0)	APOE (2.7)	HMGCR (2.4)	APOC1 (2.3)	PLG (2.3)	FADS1 (2.2)	GATAD2A (2.1)	BLOC1S3 (2.1)
MP:0003179	decreased platelet cell number	4.07e-04	<= 0.05	ITGB3 (8.7)	CETP (4.5)	GMPR (3.6)	RHCE (3.1)	TIMD4 (2.8)	RHD (2.6)	MAFB (2.4)	SLC44A2 (2.4)	BCL3 (2.3)	PARP10 (2.2)
ENSG00000151835	SACS PPI subnetwork	4.07e-04	<= 0.05	APOB (4.3)	PLG (3.7)	APOA5 (3.6)	ANGPTL3 (3.5)	APOC4 (3.1)	HP (3.1)	APOC1 (2.8)	LPA (2.6)	NPC1L1 (2.4)	ABCG5 (2.2)
MP:0002078	abnormal glucose homeostasis	4.08e-04	<= 0.05	GPAM (5.8)	MOSC1 (4.6)	TIMD4 (2.8)	CETP (2.6)	APOA5 (2.3)	SORT1 (2.1)	SYPL2 (2.1)	AMIGO1 (2.0)	HP (2.0)	COL4A3BP (1.9)
REACTOME_GAMMA:CARBOXYLATION_TRANSPORT_AND_AMINO:TERMINAL_CLEAVAGE_OF_PROTEINS	REACTOME_GAMMA:CARBOXYLATION_TRANSPORT_AND_AMINO:TERMINAL_CLEAVAGE_OF_PROTEINS	4.23e-04	<= 0.05	PLG (6.7)	APOA5 (6.0)	APOC4 (5.9)	ANGPTL3 (5.9)	LPA (5.1)	SLC22A1 (4.9)	HP (4.3)	APOB (4.3)	APOC1 (3.9)	ABO (3.4)
ENSG00000088926	F11 PPI subnetwork	4.28e-04	<= 0.05	PLG (8.3)	ANGPTL3 (7.3)	ITGB3 (6.6)	APOC4 (6.1)	APOA5 (5.9)	LPA (5.0)	HP (4.7)	SLC22A1 (4.4)	APOB (4.2)	CETP (3.9)
GO:0004252	serine-type endopeptidase activity	4.36e-04	<= 0.05	HP (4.4)	SLC22A1 (4.2)	CBLC (3.8)	APOC4 (3.7)	PLG (3.6)	APOA5 (3.6)	ANGPTL3 (3.0)	CEACAM19 (3.0)	CYP7A1 (2.9)	LPA (2.6)
MP:0002647	decreased intestinal cholesterol absorption	4.53e-04	<= 0.05	ABCG5 (5.9)	APOA5 (4.1)	ABCG8 (4.0)	APOC4 (3.9)	TM6SF2 (3.8)	NPC1L1 (3.0)	PLG (2.9)	GPAM (2.9)	APOB (2.7)	HP (2.3)
GO:0046906	tetrapyrrole binding	4.63e-04	<= 0.05	SLC22A1 (6.8)	LPA (5.8)	CYP7A1 (5.2)	APOA5 (4.7)	ANGPTL3 (4.5)	ABCG5 (4.4)	PLG (4.4)	APOC4 (4.2)	ABCG8 (4.1)	ALDH2 (3.7)
GO:0000271	polysaccharide biosynthetic process	4.68e-04	<= 0.05	ENSG00000254235 (2.5)	CYB561D1 (2.5)	ST3GAL4 (2.4)	NT5DC1 (2.2)	LPA (2.2)	ZNF180 (2.2)	ENSG00000228044 (2.1)	AMIGO1 (2.1)	SORT1 (2.1)	TMEM57 (2.1)
ENSG00000211949	ENSG00000211949 PPI subnetwork	4.85e-04	<= 0.05	APOE (6.4)	APOC1 (4.9)	TIMD4 (4.1)	APOB (4.1)	HP (3.5)	BCAM (3.5)	PLG (3.3)	APOC4 (2.9)	ANGPTL3 (2.8)	APOA5 (2.7)
KEGG_PRION_DISEASES	KEGG_PRION_DISEASES	4.90e-04	<= 0.05	LPA (5.5)	TIMD4 (5.1)	SLC22A1 (4.5)	APOE (4.5)	APOC4 (4.3)	PLG (4.0)	HP (3.9)	APOC1 (3.8)	ANGPTL3 (3.5)	APOA5 (3.4)
ENSG00000100522	GNPNAT1 PPI subnetwork	4.95e-04	<= 0.05	C19orf52 (3.7)	SYPL2 (2.8)	CYP7A1 (2.7)	AMIGO1 (2.3)	MAU2 (2.2)	NKPD1 (2.1)	CYB561D1 (2.0)	DHODH (2.0)	CBLC (1.9)	ENSG00000226645 (1.8)
ENSG00000180210	F2 PPI subnetwork	5.03e-04	<= 0.05	PLG (7.4)	ANGPTL3 (7.4)	HP (6.1)	APOA5 (6.0)	APOC4 (5.7)	ITGB3 (5.4)	APOB (5.4)	APOC1 (4.8)	SLC22A1 (4.8)	LPA (4.6)
GO:0008203	cholesterol metabolic process	5.06e-04	<= 0.05	HMGCR (8.2)	LDLR (7.8)	FADS2 (7.6)	FADS1 (7.2)	PCSK9 (6.8)	CYP7A1 (3.6)	NPC1L1 (3.5)	LPA (3.3)	TMEM57 (2.8)	NKPD1 (2.7)
GO:0015248	sterol transporter activity	5.09e-04	<= 0.05	APOC1 (9.0)	ABCG5 (8.6)	ABCG8 (7.6)	APOB (7.5)	APOA5 (5.5)	NPC1L1 (5.4)	APOC4 (4.3)	TM6SF2 (4.3)	TIMD4 (4.2)	APOE (3.9)
ENSG00000215756	ENSG00000215756 PPI subnetwork	5.10e-04	<= 0.05	APOC4 (6.0)	APOB (5.9)	APOA5 (5.8)	APOC1 (5.6)	PLG (5.4)	ABCG5 (4.8)	NPC1L1 (4.6)	ANGPTL3 (4.6)	HP (4.3)	APOE (4.2)
ENSG00000118137	APOA1 PPI subnetwork	5.10e-04	<= 0.05	APOC4 (6.0)	APOB (5.9)	APOA5 (5.8)	APOC1 (5.6)	PLG (5.4)	ABCG5 (4.8)	NPC1L1 (4.6)	ANGPTL3 (4.6)	HP (4.3)	APOE (4.2)
MP:0008478	increased spleen white pulp amount	5.21e-04	<= 0.05	HP (2.7)	SLC22A1 (2.3)	KANK2 (2.1)	PLG (2.0)	APOC4 (2.0)	ANGPTL3 (1.9)	LPA (1.8)	SLC44A2 (1.7)	ZNF101 (1.6)	ALDH2 (1.6)
GO:0017127	cholesterol transporter activity	5.21e-04	<= 0.05	APOC1 (8.8)	ABCG5 (8.7)	APOB (8.1)	ABCG8 (7.5)	NPC1L1 (6.2)	APOA5 (5.5)	TM6SF2 (4.6)	TIMD4 (4.6)	APOC4 (4.2)	MYLIP (3.8)
MP:0004774	abnormal bile salt level	5.22e-04	<= 0.05	APOC4 (6.0)	ABCG8 (5.6)	ABCG5 (5.1)	APOA5 (4.9)	TM6SF2 (4.6)	ANGPTL3 (4.4)	PLG (3.3)	CYP7A1 (2.6)	SLC22A1 (2.6)	APOB (2.5)
GO:0008610	lipid biosynthetic process	5.24e-04	<= 0.05	FADS2 (6.4)	FADS1 (6.0)	HMGCR (5.6)	LDLR (5.4)	PCSK9 (4.3)	CYP7A1 (3.9)	GPAM (3.1)	NKPD1 (3.1)	TRAPPC6A (2.6)	ST3GAL4 (2.2)
MP:0001860	liver inflammation	5.28e-04	<= 0.05	RELB (4.8)	BCL3 (4.8)	APOA5 (3.3)	APOC4 (3.1)	LPA (2.9)	GMIP (2.9)	APOC1 (2.9)	PLG (2.7)	HAVCR1 (2.6)	SH2B3 (2.5)
GO:0042598	vesicular fraction	5.35e-04	<= 0.05	FADS2 (5.9)	HMGCR (5.6)	CYP7A1 (5.6)	FADS1 (5.5)	SLC22A1 (5.3)	LDLR (5.0)	LPA (4.7)	APOC4 (4.6)	ANGPTL3 (4.5)	PLG (4.4)
ENSG00000197461	PDGFA PPI subnetwork	5.41e-04	<= 0.05	ITGB3 (4.5)	APOE (3.4)	ZHX3 (2.3)	ENSG00000226645 (2.2)	C17orf57 (2.0)	KANK2 (1.9)	GCNT4 (1.9)	CETP (1.7)	HNF1A (1.7)	CEACAM19 (1.6)
REACTOME_FACILITATIVE_NA:INDEPENDENT_GLUCOSE_TRANSPORTERS	REACTOME_FACILITATIVE_NA:INDEPENDENT_GLUCOSE_TRANSPORTERS	5.41e-04	<= 0.05	TMED4 (3.3)	TM6SF2 (2.8)	APOB (2.6)	GCNT4 (2.5)	ABCG5 (2.4)	ABCG8 (2.2)	NPC1L1 (1.9)	AMIGO1 (1.7)	TSSK6 (1.7)	MYLIP (1.6)
ENSG00000155660	PDIA4 PPI subnetwork	5.42e-04	<= 0.05	ABCG5 (3.8)	ERP29 (3.8)	PCSK9 (3.6)	NPC1L1 (3.3)	TM6SF2 (3.3)	HMGCR (3.0)	TMED4 (2.7)	BRAP (2.2)	C12orf43 (2.1)	HP (2.0)
GO:0004623	phospholipase A2 activity	5.46e-04	<= 0.05	NKPD1 (4.5)	CETP (3.8)	APOC1 (3.7)	TIMD4 (3.5)	APOE (3.1)	LPIN3 (2.7)	MOSC1 (2.5)	CEACAM19 (2.1)	TSSK6 (1.8)	TMEM116 (1.7)
MP:0011108	partial embryonic lethality during organogenesis	5.46e-04	<= 0.05	PVRL2 (4.3)	NYNRIN (2.9)	TRIB1 (2.6)	HNF1A (2.6)	BCAM (2.6)	APOB (2.5)	PVR (2.5)	ATXN2 (2.3)	KANK2 (2.1)	C11orf9 (2.1)
GO:0009743	response to carbohydrate stimulus	5.50e-04	<= 0.05	HNF1A (2.8)	PCSK9 (2.6)	ABCG5 (2.6)	ABCG8 (2.4)	ANKRD31 (2.3)	NPC1L1 (2.2)	KIAA1324 (2.1)	GPAM (2.0)	TM6SF2 (2.0)	COL4A3BP (1.8)
ENSG00000068976	PYGM PPI subnetwork	5.55e-04	<= 0.05	CLPTM1 (3.1)	OGDH (3.0)	DNM2 (2.8)	PPP1R37 (2.4)	SLC44A2 (2.4)	SYPL2 (2.4)	GOT2P1 (2.2)	TRAPPC6A (2.0)	SUGP1 (2.0)	ST3GAL4 (2.0)
MP:0005048	thrombosis	5.58e-04	<= 0.05	ITGB3 (5.1)	ANGPTL3 (4.9)	APOB (3.8)	RHD (3.8)	PLG (3.7)	RHCE (3.7)	APOA5 (3.6)	GMPR (3.2)	HP (3.1)	SLC22A1 (3.0)
GO:0020037	heme binding	5.59e-04	<= 0.05	SLC22A1 (7.2)	LPA (6.0)	CYP7A1 (5.4)	ABCG5 (4.8)	APOA5 (4.7)	APOC4 (4.4)	PLG (4.3)	ABCG8 (4.3)	ANGPTL3 (4.2)	HP (3.7)
ENSG00000125730	C3 PPI subnetwork	5.71e-04	<= 0.05	HP (6.7)	APOC4 (5.6)	LPA (5.5)	ANGPTL3 (5.4)	APOA5 (4.6)	PLG (4.4)	SLC22A1 (4.0)	TIMD4 (3.6)	APOC1 (3.4)	CYP7A1 (3.3)
GO:0046982	protein heterodimerization activity	5.71e-04	<= 0.05	MARK4 (2.3)	APOB (2.2)	NPC1L1 (2.1)	GRINA (2.0)	CLPTM1 (2.0)	ITGB3 (1.9)	ABCG8 (1.9)	MAFB (1.9)	PPP1R37 (1.9)	HLX (1.9)
GO:0005792	microsome	5.72e-04	<= 0.05	FADS2 (6.0)	HMGCR (5.7)	CYP7A1 (5.6)	FADS1 (5.5)	SLC22A1 (5.3)	LDLR (5.1)	LPA (4.7)	APOC4 (4.6)	ANGPTL3 (4.4)	PLG (4.4)
ENSG00000135100	HNF1A PPI subnetwork	5.79e-04	<= 0.05	PARP10 (2.8)	CBLC (2.7)	BCL3 (2.4)	GMIP (2.4)	USP24 (2.1)	PPP1R37 (2.1)	MAU2 (2.0)	PLEKHH2 (1.8)	PLCG1 (1.7)	PLEC (1.7)
ENSG00000005339	CREBBP PPI subnetwork	5.87e-04	<= 0.05	TRIB1 (4.4)	ATXN2 (3.2)	PARP10 (3.1)	BCL3 (2.8)	HLX (2.7)	CARM1 (2.5)	SH2B3 (2.5)	GRINA (2.4)	BUD13 (2.4)	NYNRIN (2.2)
GO:0002020	protease binding	5.88e-04	<= 0.05	HNF1A (3.3)	APOB (3.0)	HP (2.8)	APOA5 (2.8)	ADAM1 (2.7)	BCL3 (2.4)	GRINA (2.0)	RELB (2.0)	ZNF101 (1.9)	ST3GAL4 (1.8)
MP:0002743	glomerulonephritis	5.92e-04	<= 0.20	MAFB (4.4)	BCL3 (3.1)	TRIB1 (2.8)	RELB (2.6)	TIMD4 (2.6)	TOP1 (2.5)	APOE (2.4)	GCNT4 (2.1)	GMIP (2.1)	LPIN3 (1.9)
ENSG00000198646	NCOA6 PPI subnetwork	5.93e-04	<= 0.20	PLEC (3.5)	TRIB1 (3.2)	ATXN7L2 (2.8)	C12orf51 (2.4)	GRINA (2.4)	GMIP (2.3)	ZHX3 (2.1)	RELB (2.1)	GEMIN7 (2.1)	GOT2P1 (2.1)
KEGG_LYSINE_DEGRADATION	KEGG_LYSINE_DEGRADATION	5.99e-04	<= 0.20	PLG (3.5)	ANGPTL3 (3.5)	ACAD10 (3.4)	MOSC1 (3.1)	GPAM (2.9)	CYP7A1 (2.8)	LPA (2.6)	OGDH (2.5)	APOC4 (2.4)	ATXN2 (2.4)
GO:0019842	vitamin binding	6.10e-04	<= 0.20	PLG (5.3)	ANGPTL3 (5.3)	APOA5 (5.2)	TM6SF2 (4.6)	APOC4 (4.4)	MOSC1 (3.9)	CYP7A1 (3.7)	SLC22A1 (3.6)	ABCG8 (3.3)	ABCG5 (3.3)
MP:0005621	abnormal cell physiology	6.24e-04	<= 0.20	OASL (3.9)	YIPF2 (2.8)	PARP10 (2.4)	DHX38 (2.4)	CLPTM1 (2.3)	BCL3 (2.2)	TMEM50A (2.2)	ATP13A1 (2.1)	SLC44A2 (2.0)	LDLR (2.0)
MP:0005309	increased circulating ammonia level	6.27e-04	<= 0.20	TM6SF2 (7.3)	ABCG5 (6.3)	ABCG8 (5.1)	NPC1L1 (5.0)	PLG (4.6)	APOA5 (4.3)	HP (4.2)	APOC4 (4.1)	APOB (4.1)	ANGPTL3 (2.9)
REACTOME_CHYLOMICRON:MEDIATED_LIPID_TRANSPORT	REACTOME_CHYLOMICRON:MEDIATED_LIPID_TRANSPORT	6.42e-04	<= 0.20	APOB (10.9)	NPC1L1 (7.9)	ABCG5 (7.7)	APOC1 (6.6)	TM6SF2 (6.0)	PLG (5.2)	APOA5 (5.1)	ABCG8 (4.4)	APOC4 (4.3)	ANGPTL3 (3.7)
GO:0071814	protein-lipid complex binding	6.44e-04	<= 0.20	APOC1 (6.7)	APOB (6.2)	APOA5 (4.7)	PLG (4.7)	TIMD4 (4.5)	CETP (4.5)	APOC4 (4.3)	ANGPTL3 (3.9)	HP (3.6)	PCSK9 (3.5)
GO:0071813	lipoprotein particle binding	6.44e-04	<= 0.20	APOC1 (6.7)	APOB (6.2)	APOA5 (4.7)	PLG (4.7)	TIMD4 (4.5)	CETP (4.5)	APOC4 (4.3)	ANGPTL3 (3.9)	HP (3.6)	PCSK9 (3.5)
ENSG00000019991	HGF PPI subnetwork	6.57e-04	<= 0.20	MYLIP (4.1)	LPA (3.8)	APOA5 (3.6)	CBLC (3.2)	ENSG00000254235 (3.1)	CYP7A1 (3.1)	HLX (3.1)	C1orf63 (3.0)	SLC22A1 (2.8)	ABCG5 (2.6)
MP:0009763	increased sensitivity to induced morbidity/mortality	6.60e-04	<= 0.20	HP (5.0)	TIMD4 (3.6)	LPA (3.2)	MAFB (3.2)	SLC22A1 (2.9)	APOC4 (2.7)	ANGPTL3 (2.7)	CETP (2.5)	APOA5 (2.5)	GPAM (2.5)
GO:0032870	cellular response to hormone stimulus	6.70e-04	<= 0.20	TMEM57 (2.5)	ST3GAL4 (2.1)	COL4A3BP (2.0)	HNF1A (1.9)	PPP1R37 (1.8)	GCNT4 (1.8)	NPC1L1 (1.7)	ABCG8 (1.7)	ATXN7L2 (1.6)	ATXN2 (1.6)
GO:0019216	regulation of lipid metabolic process	6.71e-04	<= 0.20	GPAM (3.8)	MOSC1 (2.8)	APOC1 (2.3)	ST3GAL4 (2.3)	BLOC1S3 (2.0)	ENSG00000228044 (1.9)	TMEM57 (1.9)	ALDH2 (1.8)	FADS1 (1.8)	COL4A3BP (1.7)
MP:0000603	pale liver	6.78e-04	<= 0.20	RHD (3.3)	RHCE (2.7)	LPAR2 (2.7)	GRINA (2.6)	GPAM (2.4)	PARP10 (2.3)	MOSC1 (2.0)	SLC44A2 (1.9)	TIMD4 (1.9)	ACAD10 (1.8)
GO:0046470	phosphatidylcholine metabolic process	6.82e-04	<= 0.20	NPC1L1 (3.0)	LPA (3.0)	HAVCR1 (2.9)	C17orf57 (2.8)	TIMD4 (2.7)	APOC4 (2.7)	APOA5 (2.7)	ENSG00000235545 (2.6)	CYP7A1 (2.5)	APOE (2.4)
GO:0032934	sterol binding	6.93e-04	<= 0.20	APOC1 (6.7)	APOB (6.5)	APOE (4.4)	ABCG5 (4.2)	APOC4 (4.1)	APOA5 (4.1)	TIMD4 (3.7)	HP (3.3)	MOSC1 (3.3)	NPC1L1 (3.3)
ENSG00000204319	ENSG00000204319 PPI subnetwork	6.94e-04	<= 0.20	HP (4.9)	APOC1 (4.5)	PLG (4.3)	ANGPTL3 (4.1)	APOC4 (4.0)	APOA5 (3.9)	APOB (3.3)	LPA (3.1)	CYP7A1 (2.7)	MOSC1 (2.6)
MP:0008808	decreased spleen iron level	6.99e-04	<= 0.20	RHD (7.1)	RHCE (5.2)	HP (4.8)	APOA5 (3.3)	APOC1 (3.3)	SLC22A1 (3.2)	APOC4 (3.2)	TIMD4 (2.8)	PCSK9 (2.6)	LPA (2.5)
GO:0034381	plasma lipoprotein particle clearance	7.01e-04	<= 0.20	APOC1 (3.2)	NPC1L1 (3.1)	HNF1A (3.0)	PCSK9 (2.9)	APOB (2.8)	APOE (2.7)	TIMD4 (2.5)	GCNT4 (2.5)	GPAM (2.4)	HAVCR1 (2.4)
ENSG00000109819	PPARGC1A PPI subnetwork	7.04e-04	<= 0.20	MAU2 (2.8)	PLEC (2.7)	USP24 (2.7)	ZHX3 (2.4)	DHX38 (2.1)	ATXN2 (2.0)	GOT2P1 (2.0)	GMIP (1.9)	TOP1 (1.8)	SMARCA4 (1.7)
GO:0071495	cellular response to endogenous stimulus	7.12e-04	<= 0.20	C11orf9 (2.3)	TMEM57 (2.2)	COL4A3BP (2.0)	PPP1R37 (2.0)	NPC1L1 (2.0)	HNF1A (1.9)	ATXN7L2 (1.8)	SH2B3 (1.7)	KANK2 (1.7)	GPAM (1.6)
GO:0030669	clathrin-coated endocytic vesicle membrane	7.15e-04	<= 0.20	HMGCR (3.5)	FADS1 (3.1)	FADS2 (2.3)	CEACAM19 (2.2)	DOCK7 (2.1)	ZHX3 (2.0)	PVRL2 (2.0)	PPP1R37 (2.0)	C11orf9 (2.0)	GRINA (1.9)
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS	7.15e-04	<= 0.20	APOC4 (9.0)	APOA5 (7.7)	ANGPTL3 (7.7)	CYP7A1 (7.5)	PLG (7.3)	SLC22A1 (5.5)	ABCG5 (5.1)	ABCG8 (4.4)	LPA (4.1)	HP (3.4)
REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS	7.30e-04	<= 0.20	C11orf9 (3.3)	HNF1A (3.2)	PCSK9 (3.0)	CYP7A1 (3.0)	ABO (2.8)	NPC1L1 (2.6)	KIAA1324 (2.4)	LPA (2.2)	TM6SF2 (2.2)	ABCG8 (2.2)
MP:0005023	abnormal wound healing	7.37e-04	<= 0.20	ANGPTL3 (5.2)	HP (5.0)	PLG (4.5)	APOA5 (4.1)	APOB (3.5)	APOC4 (3.3)	ABCG5 (3.3)	SLC22A1 (3.1)	APOC1 (2.7)	PCSK9 (2.5)
GO:0016125	sterol metabolic process	7.42e-04	<= 0.20	HMGCR (8.1)	LDLR (7.9)	FADS2 (7.8)	FADS1 (7.3)	PCSK9 (6.7)	CYP7A1 (3.7)	NPC1L1 (3.4)	LPA (3.2)	NKPD1 (2.6)	TMEM57 (2.5)
GO:0042439	ethanolamine-containing compound metabolic process	7.48e-04	<= 0.20	LPA (3.6)	ENSG00000235545 (3.1)	HAVCR1 (3.1)	TSSK6 (3.0)	APOC4 (2.5)	TM6SF2 (2.5)	CYP7A1 (2.4)	SLC22A1 (2.3)	TIMD4 (2.2)	NPC1L1 (2.2)
ENSG00000057593	F7 PPI subnetwork	7.49e-04	<= 0.20	PLG (4.9)	ANGPTL3 (4.4)	APOA5 (4.3)	APOC4 (4.2)	HP (3.7)	APOB (3.5)	LPA (3.4)	APOC1 (3.1)	CYP7A1 (2.9)	SLC22A1 (2.8)
GO:0090181	regulation of cholesterol metabolic process	7.51e-04	<= 0.20	ENSG00000238078 (4.1)	ABCG8 (2.9)	TMEM57 (2.7)	CYP7A1 (2.5)	FADS2 (2.4)	APOC1 (2.3)	FRK (2.0)	TRAPPC6A (2.0)	NT5DC1 (1.9)	UBXN2B (1.7)
GO:0045334	clathrin-coated endocytic vesicle	7.53e-04	<= 0.20	HMGCR (3.1)	CLPTM1 (2.8)	FADS1 (2.5)	PLCG1 (2.4)	PPP1R37 (2.4)	FADS2 (2.4)	OGDH (2.2)	CEACAM19 (2.0)	C11orf9 (1.9)	BRAP (1.8)
GO:0005543	phospholipid binding	7.63e-04	<= 0.20	ABCG5 (4.9)	NPC1L1 (3.6)	APOB (3.6)	ABCG8 (3.4)	COL4A3BP (2.9)	HLX (2.6)	APOC1 (2.4)	MAFB (2.3)	MYLIP (2.2)	APOC4 (2.2)
MP:0005334	abnormal fat pad morphology	7.65e-04	<= 0.20	GPAM (4.3)	PCSK9 (2.7)	MOSC1 (2.7)	FADS1 (2.6)	HAPLN4 (2.5)	COL4A3BP (2.5)	FADS2 (2.3)	SH2B3 (2.3)	SYPL2 (2.1)	HLX (2.1)
MP:0006271	abnormal involution of the mammary gland	7.68e-04	<= 0.20	LPA (3.0)	BCL3 (2.3)	ENSG00000238078 (2.3)	SLC22A1 (2.3)	HP (2.2)	PVR (2.2)	ENSG00000254235 (2.1)	PLEKHH2 (1.9)	AP1M2 (1.8)	CEACAM19 (1.8)
ENSG00000186832	KRT16 PPI subnetwork	7.72e-04	<= 0.20	APOB (4.7)	APOE (4.4)	HP (4.0)	PLG (4.0)	ANGPTL3 (3.9)	APOC4 (3.9)	APOA5 (3.7)	APOC1 (3.5)	NPC1L1 (3.1)	PCSK9 (2.3)
GO:0016540	protein autoprocessing	7.75e-04	<= 0.20	HNF1A (2.7)	CBLC (2.6)	GEMIN7 (2.6)	AP1M2 (2.1)	NPC1L1 (1.9)	ZNF180 (1.8)	HAPLN4 (1.8)	ENSG00000238078 (1.7)	LPAR2 (1.6)	RHCE (1.6)
ENSG00000180879	SSR4 PPI subnetwork	7.82e-04	<= 0.20	ATP13A1 (3.8)	TOMM40 (3.6)	QTRT1 (2.7)	POLK (2.7)	CETP (2.6)	NT5DC1 (2.1)	TIMD4 (1.9)	ERP29 (1.9)	YIPF2 (1.8)	LPA (1.8)
MP:0001577	anemia	7.87e-04	<= 0.20	RHCE (7.6)	RHD (7.6)	GMPR (3.7)	ITGB3 (3.2)	BCL3 (2.6)	RELB (2.5)	SH2B3 (2.5)	HLX (2.3)	TRIB1 (2.1)	C12orf51 (2.0)
ENSG00000169598	DFFB PPI subnetwork	7.99e-04	<= 0.20	CBLC (2.9)	GEMIN7 (2.2)	ABO (2.2)	GCNT4 (2.0)	CETP (2.0)	CYB561D1 (1.9)	TMEM57 (1.8)	ABCG5 (1.7)	ABCG8 (1.7)	PSRC1 (1.7)
MP:0003333	liver fibrosis	8.06e-04	<= 0.20	BCL3 (3.7)	ANGPTL3 (3.4)	SLC22A1 (3.2)	PCSK9 (3.1)	CEACAM19 (3.0)	APOA5 (2.7)	LPA (2.5)	PVR (2.5)	HP (2.3)	APOC4 (2.3)
MP:0004777	abnormal phospholipid level	8.18e-04	<= 0.20	ABCG8 (6.5)	APOC1 (5.3)	APOC4 (3.8)	MYLIP (3.7)	GPAM (3.5)	HP (3.4)	COL4A3BP (3.2)	APOA5 (3.1)	FADS1 (3.0)	CYP7A1 (2.9)
ENSG00000141101	NOB1 PPI subnetwork	8.22e-04	<= 0.20	QTRT1 (4.6)	DDX56 (4.4)	NAA25 (4.2)	ZNF259 (3.8)	TOMM40 (3.5)	DHODH (3.2)	DHX38 (2.6)	ATP13A1 (2.5)	C12orf43 (2.4)	ILF3 (2.3)
ENSG00000164733	CTSB PPI subnetwork	8.34e-04	<= 0.20	MAFB (4.7)	APOC1 (4.3)	APOE (3.3)	HLX (2.9)	HP (2.8)	HAVCR1 (2.3)	ENSG00000238078 (2.1)	ANGPTL3 (2.0)	ALDH2 (1.9)	RHD (1.7)
GO:0005355	glucose transmembrane transporter activity	8.46e-04	<= 0.20	TMED4 (3.5)	GOT2P1 (3.5)	NPC1L1 (3.2)	TM6SF2 (3.0)	APOB (2.7)	ABCG5 (2.6)	GCNT4 (2.4)	TSSK6 (2.2)	HNF1A (2.0)	PBX4 (1.8)
KEGG_PPAR_SIGNALING_PATHWAY	KEGG_PPAR_SIGNALING_PATHWAY	8.60e-04	<= 0.20	MOSC1 (5.7)	APOC1 (4.9)	GPAM (4.8)	APOA5 (4.7)	APOC4 (4.3)	TM6SF2 (4.2)	HP (4.2)	PLG (4.2)	APOB (4.1)	ABCG5 (3.9)
MP:0002640	reticulocytosis	8.69e-04	<= 0.20	RHCE (11.7)	RHD (11.1)	GMPR (4.1)	C12orf51 (3.8)	KANK2 (2.5)	TMEM57 (1.9)	ABCG8 (1.9)	CETP (1.8)	GRINA (1.7)	FADS2 (1.7)
ENSG00000000971	CFH PPI subnetwork	8.80e-04	<= 0.20	HP (5.7)	ANGPTL3 (4.8)	PLG (4.6)	LPA (4.3)	APOC4 (4.1)	DHODH (3.6)	APOA5 (3.5)	ST3GAL4 (2.6)	APOC1 (2.5)	RHD (2.5)
GO:0009749	response to glucose stimulus	8.81e-04	<= 0.20	HNF1A (3.0)	PCSK9 (2.5)	ENSG00000254235 (2.4)	KIAA1324 (2.0)	ANKRD31 (2.0)	ABCG5 (1.6)	GPAM (1.6)	ABCG8 (1.5)	COL4A3BP (1.4)	MOSC1 (1.4)
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	9.01e-04	<= 0.20	APOC4 (9.2)	CYP7A1 (7.6)	APOA5 (7.5)	ANGPTL3 (7.3)	PLG (7.1)	LPA (6.5)	SLC22A1 (6.4)	ABCG5 (4.7)	HP (4.2)	ABCG8 (4.0)
GO:0017171	serine hydrolase activity	9.01e-04	<= 0.20	HP (4.1)	SLC22A1 (4.0)	APOC4 (3.5)	APOA5 (3.5)	PLG (3.5)	CBLC (3.3)	ANGPTL3 (2.9)	CYP7A1 (2.9)	CEACAM19 (2.8)	NKPD1 (2.8)
ENSG00000122861	PLAU PPI subnetwork	9.11e-04	<= 0.20	ANGPTL3 (3.4)	APOE (3.3)	APOC1 (3.3)	HP (3.0)	PVRL2 (2.9)	APOA5 (2.7)	PLG (2.5)	APOB (2.3)	PVR (2.1)	CEACAM19 (1.8)
KEGG_ARGININE_AND_PROLINE_METABOLISM	KEGG_ARGININE_AND_PROLINE_METABOLISM	9.22e-04	<= 0.20	ABCG8 (4.9)	TM6SF2 (4.6)	PLG (4.5)	ABCG5 (4.2)	ANGPTL3 (3.7)	PCSK9 (3.0)	APOA5 (3.0)	HP (2.9)	APOC4 (2.8)	CYP7A1 (2.6)
MP:0011109	partial lethality throughout fetal growth and development	9.27e-04	<= 0.20	PVRL2 (3.4)	ATXN2 (3.4)	KANK2 (3.2)	PLEC (2.6)	MYLIP (2.6)	NYNRIN (2.5)	BCAM (2.2)	MAFB (2.1)	C12orf51 (2.1)	ITGB3 (2.0)
ENSG00000170486	KRT72 PPI subnetwork	9.28e-04	<= 0.20	APOB (8.4)	APOC1 (6.4)	PLG (5.5)	ANGPTL3 (4.8)	APOA5 (4.4)	APOE (4.1)	ABCG5 (4.0)	APOC4 (3.9)	HP (3.7)	NPC1L1 (3.3)
GO:0031100	organ regeneration	9.38e-04	<= 0.20	DNAH11 (2.4)	ENSG00000254235 (2.3)	GCNT4 (2.2)	APOB (2.0)	CETP (2.0)	GOT2P1 (1.8)	HAVCR1 (1.7)	MOSC1 (1.7)	TRAPPC6A (1.7)	HP (1.7)
MP:0000607	abnormal hepatocyte morphology	9.52e-04	<= 0.20	APOA5 (4.4)	APOC4 (3.6)	ANGPTL3 (3.1)	HP (3.1)	SLC22A1 (2.9)	PLG (2.7)	APOB (2.6)	APOC1 (2.5)	ABCG5 (2.4)	ABCG8 (2.4)
GO:0019200	carbohydrate kinase activity	9.60e-04	<= 0.20	DHODH (3.0)	GOT2P1 (2.9)	MOSC1 (2.6)	TRAPPC6A (2.6)	TM6SF2 (2.5)	ST3GAL4 (2.3)	CYP7A1 (2.2)	NPC1L1 (2.1)	PBX4 (2.0)	ACAD10 (2.0)
REACTOME_GLUCOSE_TRANSPORT	REACTOME_GLUCOSE_TRANSPORT	9.79e-04	<= 0.20	DOCK7 (3.7)	NAA25 (2.8)	DDX56 (2.6)	LPA (2.6)	BUD13 (2.6)	DHODH (2.4)	POC5 (2.4)	USP1 (2.3)	USP24 (2.2)	MOSC1 (2.0)
ENSG00000067048	DDX3Y PPI subnetwork	9.88e-04	<= 0.20	QTRT1 (5.5)	DDX56 (5.1)	NAA25 (4.2)	ATP13A1 (3.8)	ZNF259 (3.7)	DHX38 (3.1)	TOMM40 (3.1)	ILF3 (3.0)	DHODH (2.9)	TOP1 (2.8)
GO:0052548	regulation of endopeptidase activity	9.93e-04	<= 0.20	POLK (2.9)	GOT2P1 (2.7)	HP (2.4)	PCSK9 (2.1)	SLC22A1 (2.1)	C17orf57 (2.1)	APOA5 (2.0)	PLG (1.8)	PSMA5 (1.7)	ANGPTL3 (1.7)
ENSG00000126218	F10 PPI subnetwork	9.93e-04	<= 0.20	APOA5 (6.2)	ANGPTL3 (6.1)	PLG (6.0)	HP (5.5)	APOB (5.0)	APOC4 (5.0)	SLC22A1 (4.8)	APOC1 (4.0)	PCSK9 (3.5)	ABCG5 (2.9)
MP:0005318	decreased triglyceride level	1.02e-03	<= 0.20	GPAM (5.0)	MOSC1 (3.9)	HP (3.4)	LPA (3.0)	ACAD10 (2.8)	SH2B3 (2.6)	TMEM57 (2.3)	SORT1 (2.0)	MAFB (2.0)	SYPL2 (1.9)
MP:0004255	abnormal spongiotrophoblast layer morphology	1.03e-03	<= 0.20	DNM2 (3.1)	BCL3 (2.7)	LDLR (2.5)	PCSK9 (2.1)	PLEC (2.1)	NYNRIN (2.0)	ST3GAL4 (1.9)	ENSG00000254235 (1.8)	SLC22A1 (1.7)	GATAD2A (1.6)
GO:0003707	steroid hormone receptor activity	1.03e-03	<= 0.20	TM6SF2 (3.4)	ABCG8 (3.3)	ABCG5 (3.2)	HNF1A (2.8)	CYP7A1 (2.6)	TRIB1 (2.5)	GCNT4 (2.3)	NPC1L1 (2.1)	APOB (2.0)	PPP1R37 (2.0)
GO:0034375	high-density lipoprotein particle remodeling	1.04e-03	<= 0.20	APOC1 (4.2)	APOA5 (3.6)	APOB (3.6)	APOC4 (3.4)	APOE (3.3)	ABCG5 (3.0)	TIMD4 (3.0)	HNF1A (2.8)	PLG (2.7)	ANGPTL3 (2.5)
GO:0048029	monosaccharide binding	1.05e-03	<= 0.20	LPA (4.7)	TRAPPC6A (3.0)	GPAM (2.7)	MOSC1 (2.7)	APOA5 (2.6)	DHODH (2.4)	ERP29 (2.4)	ENSG00000254235 (2.4)	ATP13A1 (2.2)	CYP7A1 (2.2)
GO:0019825	oxygen binding	1.05e-03	<= 0.20	SLC22A1 (5.9)	ABCG5 (5.0)	ANGPTL3 (4.9)	PLG (4.9)	APOA5 (4.4)	LPA (4.3)	APOC4 (4.0)	TM6SF2 (3.8)	APOC1 (3.8)	RHCE (3.8)
GO:0031348	negative regulation of defense response	1.06e-03	<= 0.20	ANKRD31 (3.0)	ADAM1 (2.4)	PARP10 (2.3)	ALDH2 (2.3)	APOC1 (1.7)	SH2B3 (1.7)	GEMIN7 (1.7)	OASL (1.6)	HLX (1.5)	MYLIP (1.5)
ENSG00000084774	CAD PPI subnetwork	1.07e-03	<= 0.20	RELB (5.2)	BCL3 (4.3)	CARM1 (2.5)	CEACAM19 (2.4)	CLPTM1 (2.2)	ATP13A1 (2.2)	MAU2 (2.1)	DNM2 (2.0)	SH2B3 (2.0)	PLEC (1.9)
MP:0004772	abnormal bile secretion	1.08e-03	<= 0.20	ABCG8 (10.7)	APOA5 (6.6)	APOC4 (5.9)	TM6SF2 (5.1)	APOB (4.6)	NPC1L1 (4.4)	CYP7A1 (4.2)	ABCG5 (4.1)	PLG (4.1)	ANGPTL3 (3.6)
MP:0010180	increased susceptibility to weight loss	1.10e-03	<= 0.20	FADS1 (3.7)	ABCG5 (3.5)	CYP7A1 (3.4)	ABCG8 (3.1)	HMGCR (3.0)	LDLR (2.8)	SLC22A1 (2.8)	APOC4 (2.2)	ALDH2 (2.2)	GCNT4 (2.0)
GO:0008236	serine-type peptidase activity	1.10e-03	<= 0.20	HP (4.2)	SLC22A1 (3.8)	APOA5 (3.5)	APOC4 (3.5)	PLG (3.4)	CBLC (3.3)	CYP7A1 (2.9)	ANGPTL3 (2.8)	CEACAM19 (2.7)	NKPD1 (2.6)
MP:0002642	anisocytosis	1.11e-03	<= 0.20	RHD (12.8)	RHCE (12.6)	GMPR (4.0)	C12orf51 (2.9)	BLOC1S3 (2.4)	CETP (2.2)	NT5DC1 (1.9)	MAFB (1.8)	ACAD10 (1.7)	TIMD4 (1.6)
ENSG00000170927	PKHD1 PPI subnetwork	1.14e-03	<= 0.20	APOB (6.2)	ANGPTL3 (5.1)	APOE (4.5)	APOC4 (4.3)	PLG (3.9)	APOA5 (3.7)	APOC1 (3.6)	HP (3.4)	ABCG5 (2.9)	PCSK9 (2.5)
GO:0045834	positive regulation of lipid metabolic process	1.14e-03	<= 0.20	ENSG00000228044 (2.6)	GPAM (2.6)	APOC1 (2.2)	ST3GAL4 (2.1)	ALDH2 (2.1)	POLK (2.1)	MYLIP (2.0)	TMEM57 (2.0)	TIMD4 (1.9)	CETP (1.9)
ENSG00000164438	TLX3 PPI subnetwork	1.14e-03	<= 0.20	TXNL4B (3.5)	OASL (3.0)	TIMD4 (2.9)	CETP (2.8)	SH2B3 (1.9)	BUD13 (1.8)	BLOC1S3 (1.8)	SUGP1 (1.7)	DHX38 (1.6)	MYLIP (1.5)
ENSG00000163736	PPBP PPI subnetwork	1.15e-03	<= 0.20	ANGPTL3 (3.2)	APOC4 (3.1)	PLG (3.1)	HP (3.0)	LPA (2.7)	APOA5 (2.7)	CYP7A1 (2.6)	MOSC1 (2.5)	ST3GAL4 (2.4)	PVRL2 (2.0)
MP:0003949	abnormal circulating lipid level	1.15e-03	<= 0.20	ABCG8 (7.6)	TM6SF2 (7.1)	ABCG5 (6.5)	NPC1L1 (4.9)	APOB (4.4)	APOA5 (4.3)	PLG (4.3)	APOC1 (3.5)	APOC4 (3.4)	ANGPTL3 (3.2)
GO:0015149	hexose transmembrane transporter activity	1.15e-03	<= 0.20	TMED4 (3.6)	NPC1L1 (3.2)	GOT2P1 (3.1)	TM6SF2 (2.6)	APOB (2.6)	GCNT4 (2.4)	ABCG5 (2.3)	TSSK6 (2.1)	ITGB3 (1.8)	PBX4 (1.8)
ENSG00000171557	FGG PPI subnetwork	1.15e-03	<= 0.20	ANGPTL3 (6.5)	HP (6.3)	PLG (5.7)	APOB (5.5)	APOA5 (4.7)	APOC4 (4.5)	APOC1 (4.3)	ITGB3 (4.1)	APOE (2.7)	PCSK9 (2.7)
MP:0009549	decreased platelet aggregation	1.16e-03	<= 0.20	ITGB3 (8.9)	GMPR (4.2)	TIMD4 (3.3)	FADS1 (2.9)	APOC1 (2.7)	APOE (2.7)	ABCG8 (2.7)	APOB (2.4)	APOC4 (2.4)	APOA5 (2.3)
MP:0005146	decreased circulating VLDL cholesterol level	1.16e-03	<= 0.20	NPC1L1 (9.1)	TM6SF2 (7.7)	ABCG5 (7.7)	APOB (7.7)	ABCG8 (5.5)	APOA5 (5.0)	APOC1 (4.7)	GPAM (3.7)	PLG (3.7)	HP (3.5)
ENSG00000154415	PPP1R3A PPI subnetwork	1.19e-03	<= 0.20	USP24 (3.4)	DNM2 (3.1)	GMIP (2.9)	SORT1 (2.8)	PLEC (2.5)	SYPL2 (2.4)	COL4A3BP (2.3)	ZNF180 (2.1)	SLC44A2 (2.1)	DNAH11 (2.1)
GO:0032411	positive regulation of transporter activity	1.20e-03	<= 0.20	C17orf57 (2.9)	ENSG00000228044 (2.5)	AMIGO1 (2.2)	ENSG00000254235 (2.0)	DNAH11 (2.0)	CETP (1.8)	OGDH (1.7)	PLEKHH2 (1.6)	NKPD1 (1.6)	ANKRD31 (1.6)
ENSG00000211896	ENSG00000211896 PPI subnetwork	1.20e-03	<= 0.20	APOE (4.5)	APOC1 (3.9)	TIMD4 (3.7)	MAFB (2.9)	NKPD1 (2.2)	LPA (2.2)	SLC22A1 (1.9)	PCSK9 (1.8)	GPAM (1.8)	HP (1.8)
REACTOME_GLUCOSE_METABOLISM	REACTOME_GLUCOSE_METABOLISM	1.21e-03	<= 0.20	SYPL2 (4.4)	GPAM (3.2)	GOT2P1 (2.8)	HP (2.8)	MOSC1 (2.8)	SORT1 (2.6)	DHODH (2.5)	LPA (2.4)	DOCK7 (2.3)	PLG (2.2)
ENSG00000158874	APOA2 PPI subnetwork	1.21e-03	<= 0.20	APOC1 (6.2)	APOB (6.1)	NPC1L1 (4.8)	ABCG5 (4.5)	APOA5 (4.2)	APOC4 (4.0)	APOE (4.0)	PLG (3.8)	HP (3.6)	ANGPTL3 (3.3)
GO:0052547	regulation of peptidase activity	1.22e-03	<= 0.20	POLK (2.6)	GOT2P1 (2.5)	HP (2.4)	PCSK9 (2.2)	SLC22A1 (2.0)	APOA5 (1.9)	CEACAM19 (1.8)	ST3GAL4 (1.7)	C17orf57 (1.7)	PLG (1.7)
MP:0000186	decreased circulating HDL cholesterol level	1.24e-03	<= 0.20	APOB (8.0)	NPC1L1 (7.7)	ABCG5 (6.8)	TM6SF2 (5.9)	APOC1 (5.1)	APOA5 (4.6)	GPAM (4.4)	ABCG8 (4.0)	PLG (3.8)	APOC4 (3.7)
GO:0034361	very-low-density lipoprotein particle	1.24e-03	<= 0.20	APOB (8.7)	APOC1 (8.2)	PLG (7.3)	APOA5 (6.4)	APOC4 (5.6)	HP (5.4)	APOE (5.1)	ANGPTL3 (4.7)	ABCG5 (4.5)	NPC1L1 (3.9)
GO:0034385	triglyceride-rich lipoprotein particle	1.24e-03	<= 0.20	APOB (8.7)	APOC1 (8.2)	PLG (7.3)	APOA5 (6.4)	APOC4 (5.6)	HP (5.4)	APOE (5.1)	ANGPTL3 (4.7)	ABCG5 (4.5)	NPC1L1 (3.9)
ENSG00000103479	RBL2 PPI subnetwork	1.24e-03	<= 0.20	FEN1 (3.3)	USP1 (2.9)	MAPKAPK5 (2.7)	DHODH (2.4)	TOMM40 (2.1)	TMED4 (2.0)	DDX56 (2.0)	BUD13 (1.9)	ENSG00000226645 (1.8)	PSRC1 (1.8)
MP:0001547	abnormal lipid level	1.24e-03	<= 0.20	APOC1 (5.5)	GPAM (4.3)	MOSC1 (4.1)	APOE (3.6)	APOC4 (3.5)	FADS2 (3.2)	FADS1 (3.2)	SORT1 (3.1)	APOA5 (2.9)	LDLR (2.4)
ENSG00000141141	DDX52 PPI subnetwork	1.29e-03	<= 0.20	DDX56 (4.8)	NAA25 (4.5)	ZNF259 (4.5)	TOMM40 (3.8)	QTRT1 (3.6)	C12orf43 (3.0)	DHX38 (2.7)	DHODH (2.5)	TOP1 (2.4)	SUGP1 (2.0)
MP:0002089	abnormal postnatal growth/weight/body size	1.29e-03	<= 0.20	PPP1R37 (2.8)	NYNRIN (2.8)	NPC1L1 (2.7)	CLPTM1 (2.3)	PLCG1 (2.3)	CILP2 (2.3)	MARK4 (2.2)	GATAD2A (2.1)	CELSR2 (2.0)	HNF1A (1.6)
ENSG00000116353	MECR PPI subnetwork	1.30e-03	<= 0.20	ABCG8 (5.0)	TM6SF2 (4.1)	SLC22A1 (3.8)	GPAM (3.7)	ABCG5 (3.6)	CYP7A1 (3.6)	NPC1L1 (3.0)	APOB (2.9)	FRK (2.4)	APOA5 (2.3)
GO:0033344	cholesterol efflux	1.31e-03	<= 0.20	ABCG8 (4.4)	ABCG5 (4.2)	NPC1L1 (3.7)	TIMD4 (3.6)	APOC1 (3.6)	APOE (3.6)	APOB (3.3)	TM6SF2 (2.9)	APOA5 (2.4)	MYLIP (2.3)
ENSG00000117601	SERPINC1 PPI subnetwork	1.31e-03	<= 0.20	APOC4 (8.3)	PLG (7.6)	APOA5 (6.9)	ANGPTL3 (6.8)	HP (5.3)	CYP7A1 (4.8)	SLC22A1 (4.7)	APOB (4.3)	LPA (4.2)	APOC1 (4.1)
ENSG00000138750	NUP54 PPI subnetwork	1.32e-03	<= 0.20	NAA25 (3.4)	GATAD2A (2.9)	FEN1 (2.9)	USP1 (2.7)	ILF3 (2.7)	POC5 (2.6)	DDX56 (2.5)	ENSG00000226648 (2.1)	BUD13 (2.0)	CARM1 (1.9)
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	1.32e-03	<= 0.20	PLG (7.9)	ANGPTL3 (7.7)	APOC4 (6.7)	HP (6.6)	ITGB3 (5.9)	APOA5 (5.9)	APOB (4.7)	SLC22A1 (4.4)	APOC1 (3.9)	LPA (3.8)
MP:0001570	abnormal circulating enzyme level	1.33e-03	<= 0.20	RHD (3.0)	APOA5 (2.9)	RHCE (2.7)	ENSG00000254235 (2.5)	ERP29 (2.3)	BCAM (2.3)	LPA (2.3)	ABCG5 (2.1)	ENSG00000238078 (2.1)	MYLIP (2.1)
GO:0071825	protein-lipid complex subunit organization	1.36e-03	<= 0.20	APOC1 (4.1)	APOE (3.8)	ABCG5 (3.7)	NPC1L1 (3.5)	APOB (3.4)	HAVCR1 (3.3)	TIMD4 (3.2)	MOSC1 (2.8)	ABCG8 (2.7)	APOA5 (2.7)
GO:0071827	plasma lipoprotein particle organization	1.36e-03	<= 0.20	APOC1 (4.1)	APOE (3.8)	ABCG5 (3.7)	NPC1L1 (3.5)	APOB (3.4)	HAVCR1 (3.3)	TIMD4 (3.2)	MOSC1 (2.8)	ABCG8 (2.7)	APOA5 (2.7)
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY	1.37e-03	<= 0.20	RELB (4.6)	GPAM (4.3)	BCL3 (4.0)	MOSC1 (3.3)	SORT1 (2.5)	GRINA (2.3)	SYPL2 (2.2)	ABCG8 (2.2)	HP (2.1)	MAPKAPK5 (2.0)
ENSG00000181031	RPH3AL PPI subnetwork	1.38e-03	<= 0.20	TIMD4 (3.4)	KIAA1324 (3.3)	OASL (3.3)	CETP (3.1)	TMEM57 (2.4)	SUGP1 (2.3)	LPAR2 (2.2)	YIPF2 (2.1)	C1orf63 (2.1)	C19orf52 (1.9)
GO:0032451	demethylase activity	1.39e-03	<= 0.20	SLC22A1 (4.1)	LPA (3.7)	ABCG8 (3.6)	CYP7A1 (3.0)	APOA5 (2.9)	NPC1L1 (2.9)	ABCG5 (2.7)	TRAFD1 (2.5)	C12orf47 (2.4)	TMEM57 (2.4)
GO:0016051	carbohydrate biosynthetic process	1.40e-03	<= 0.20	LPA (2.5)	SORT1 (2.5)	SYPL2 (2.4)	NT5DC1 (2.4)	ST3GAL4 (2.3)	DHODH (2.3)	GPAM (2.3)	ZNF180 (2.3)	ENSG00000254235 (2.2)	MOSC1 (1.9)
GO:0034364	high-density lipoprotein particle	1.42e-03	<= 0.20	APOA5 (8.8)	PLG (8.3)	APOC4 (8.0)	APOC1 (8.0)	APOB (7.9)	LPA (6.1)	ANGPTL3 (5.8)	SLC22A1 (5.2)	HP (4.9)	ABCG5 (4.7)
GO:0015485	cholesterol binding	1.42e-03	<= 0.20	APOC1 (7.2)	APOB (6.9)	APOE (4.7)	NPC1L1 (4.6)	TIMD4 (4.3)	APOA5 (4.2)	ABCG5 (4.1)	APOC4 (4.1)	PLG (3.4)	HP (3.3)
ENSG00000032742	IFT88 PPI subnetwork	1.42e-03	<= 0.20	PPP1R37 (4.1)	GOT2P1 (3.4)	CLPTM1 (3.1)	CILP2 (2.4)	UBXN2B (2.2)	GRINA (2.1)	NT5DC1 (2.0)	CELSR2 (2.0)	CEACAM19 (1.9)	PBX4 (1.8)
MP:0005343	increased circulating aspartate transaminase level	1.42e-03	<= 0.20	NPC1L1 (3.6)	TM6SF2 (3.4)	ABCG5 (3.4)	APOC1 (3.1)	APOA5 (3.0)	FADS1 (2.9)	ABCG8 (2.6)	APOB (2.5)	SLC22A1 (2.4)	CBLC (2.3)
ENSG00000213923	CSNK1E PPI subnetwork	1.43e-03	<= 0.20	QTRT1 (4.0)	ZNF259 (3.8)	NAA25 (3.5)	DDX56 (3.1)	ILF3 (2.9)	ATP13A1 (2.8)	TOMM40 (2.8)	DHX38 (2.7)	CARM1 (2.7)	TOP1 (2.6)
GO:0006644	phospholipid metabolic process	1.44e-03	<= 0.20	BLOC1S3 (3.5)	NKPD1 (3.5)	LPAR2 (3.2)	ATP13A1 (2.7)	TSSK6 (2.4)	HMGCR (2.3)	SLC44A2 (2.3)	GCNT4 (2.3)	UBXN2B (2.0)	SORT1 (2.0)
GO:0016747	transferase activity, transferring acyl groups other than amino-acyl groups	1.46e-03	<= 0.20	HMGCR (4.2)	FADS1 (4.1)	FADS2 (3.8)	GPAM (3.6)	ABCG5 (3.5)	TM6SF2 (3.1)	ABCG8 (2.8)	MOSC1 (2.7)	COL4A3BP (2.7)	UBXN2B (2.6)
ENSG00000186951	PPARA PPI subnetwork	1.49e-03	<= 0.20	C12orf51 (3.4)	TOP1 (3.2)	ZHX3 (2.4)	SMARCA4 (2.2)	ATXN2 (2.0)	APOA5 (2.0)	MAFB (1.8)	TM6SF2 (1.8)	APOB (1.8)	ABCG8 (1.7)
MP:0011427	mesangial cell hyperplasia	1.55e-03	<= 0.20	C11orf9 (3.9)	BCAM (3.5)	PLEKHH2 (3.5)	PVR (2.5)	PVRL2 (2.3)	TRIB1 (2.1)	APOA5 (1.9)	ATXN7L2 (1.9)	BCL3 (1.7)	TMED4 (1.7)
ENSG00000105671	DDX49 PPI subnetwork	1.56e-03	<= 0.20	DDX56 (4.4)	NAA25 (4.4)	ZNF259 (4.0)	QTRT1 (3.6)	TOMM40 (3.3)	DHODH (2.6)	DHX38 (2.4)	C12orf43 (2.4)	HMGCR (2.1)	PSMA5 (2.1)
MP:0004952	increased spleen weight	1.56e-03	<= 0.20	RHCE (8.4)	RHD (8.2)	TIMD4 (5.3)	CETP (4.3)	MAFB (3.9)	GMIP (2.9)	GRINA (2.8)	TRIB1 (2.7)	BCL3 (2.2)	PARP10 (2.1)
GO:0016053	organic acid biosynthetic process	1.60e-03	<= 0.20	CYP7A1 (4.7)	FADS2 (3.4)	PCSK9 (3.0)	FADS1 (2.9)	APOC4 (2.8)	TM6SF2 (2.8)	ANGPTL3 (2.8)	ALDH2 (2.7)	LPA (2.7)	ABCG8 (2.6)
GO:0046394	carboxylic acid biosynthetic process	1.60e-03	<= 0.20	CYP7A1 (4.7)	FADS2 (3.4)	PCSK9 (3.0)	FADS1 (2.9)	APOC4 (2.8)	TM6SF2 (2.8)	ANGPTL3 (2.8)	ALDH2 (2.7)	LPA (2.7)	ABCG8 (2.6)
MP:0001914	hemorrhage	1.61e-03	<= 0.20	ITGB3 (3.7)	KANK2 (3.4)	NYNRIN (3.2)	PVRL2 (2.9)	HLX (2.8)	APOB (2.6)	SLC44A2 (2.5)	BCAM (2.0)	HP (1.9)	PVR (1.9)
GO:0008395	steroid hydroxylase activity	1.61e-03	<= 0.20	APOC4 (5.0)	ABCG5 (5.0)	SLC22A1 (4.6)	LPA (4.0)	TM6SF2 (3.8)	ABCG8 (3.8)	APOA5 (3.6)	CYP7A1 (3.6)	ST3GAL4 (3.0)	APOC1 (3.0)
MP:0003566	abnormal cell adhesion	1.62e-03	<= 0.20	ITGB3 (4.5)	CLPTM1 (3.4)	PLEC (2.7)	KANK2 (2.7)	PVRL2 (2.3)	OGDH (2.1)	GMPR (2.0)	PVR (2.0)	LDLR (1.8)	BCAM (1.8)
ENSG00000123240	OPTN PPI subnetwork	1.64e-03	<= 0.20	ATP13A1 (3.2)	MAU2 (2.7)	PARP10 (2.6)	MAPKAPK5 (2.2)	ACAD10 (2.2)	TMEM50A (2.1)	NT5DC1 (2.1)	TRAFD1 (2.1)	GMIP (2.1)	C12orf51 (2.0)
ENSG00000084674	APOB PPI subnetwork	1.66e-03	<= 0.20	APOB (5.9)	APOC1 (4.5)	PLG (3.4)	ERP29 (3.4)	PCSK9 (3.3)	ANGPTL3 (3.0)	HP (3.0)	NPC1L1 (2.9)	APOA5 (2.6)	APOC4 (2.5)
GO:0004620	phospholipase activity	1.67e-03	<= 0.20	CETP (4.4)	NKPD1 (4.4)	APOE (3.7)	TIMD4 (3.3)	APOC1 (3.1)	MAFB (2.8)	LPIN3 (2.7)	MOSC1 (2.5)	SORT1 (2.4)	ABCG8 (1.9)
ENSG00000101361	NOP56 PPI subnetwork	1.69e-03	<= 0.20	NAA25 (4.8)	ZNF259 (4.8)	DDX56 (4.5)	QTRT1 (4.0)	TOMM40 (3.9)	ILF3 (3.0)	ATP13A1 (3.0)	DHX38 (2.8)	TOP1 (2.6)	DHODH (2.5)
ENSG00000162409	PRKAA2 PPI subnetwork	1.69e-03	<= 0.20	BRAP (3.0)	SARS (2.8)	CARM1 (2.7)	PTPN11 (2.4)	GPAM (2.4)	C12orf51 (2.4)	MOSC1 (2.4)	OGDH (2.2)	MAPKAPK5 (2.2)	TRIB1 (2.1)
MP:0005317	increased triglyceride level	1.70e-03	<= 0.20	APOC1 (5.8)	GPAM (4.4)	MOSC1 (3.7)	TIMD4 (3.0)	HP (2.8)	SORT1 (2.4)	ALDH2 (2.1)	MYLIP (2.0)	PPP1R37 (2.0)	CETP (1.9)
ENSG00000160285	LSS PPI subnetwork	1.71e-03	<= 0.20	HMGCR (13.2)	LDLR (11.3)	FADS1 (9.4)	FADS2 (8.8)	PCSK9 (7.4)	SLC22A1 (3.6)	NPC1L1 (3.4)	CYP7A1 (3.0)	PLG (2.5)	TM6SF2 (2.2)
MP:0004151	decreased circulating iron level	1.73e-03	<= 0.20	TIMD4 (4.2)	MAFB (3.3)	CETP (3.1)	HNF1A (3.0)	HP (2.7)	RHD (2.7)	BCL3 (2.5)	APOE (2.2)	GCNT4 (2.1)	APOC1 (1.9)
ENSG00000115414	FN1 PPI subnetwork	1.74e-03	<= 0.20	CILP2 (3.5)	APOE (3.5)	APOC4 (2.7)	APOC1 (2.6)	ABCG5 (2.6)	APOB (2.4)	ST3GAL4 (2.4)	ITGB3 (2.4)	PLEC (2.3)	HP (2.2)
MP:0001852	conjunctivitis	1.74e-03	<= 0.20	HP (3.9)	LPA (2.7)	CYB561D1 (2.5)	HLX (2.4)	CETP (2.3)	ENSG00000238078 (2.1)	APOA5 (1.9)	ANGPTL3 (1.8)	KANK2 (1.8)	BCL3 (1.8)
REACTOME_INTRINSIC_PATHWAY	REACTOME_INTRINSIC_PATHWAY	1.75e-03	<= 0.20	PLG (7.0)	ITGB3 (6.4)	ANGPTL3 (6.4)	APOC4 (6.1)	APOA5 (5.1)	LPA (4.9)	SLC22A1 (4.5)	HP (4.4)	CETP (4.2)	GMPR (3.5)
MP:0000183	decreased circulating LDL cholesterol level	1.75e-03	<= 0.20	NPC1L1 (9.2)	APOB (7.1)	ABCG5 (6.4)	TM6SF2 (6.4)	APOC1 (5.9)	GPAM (4.7)	PCSK9 (4.1)	ABCG8 (4.0)	HP (3.8)	PLG (3.8)
GO:0018214	protein carboxylation	1.76e-03	<= 0.20	LPA (4.3)	ABO (4.1)	HNF1A (3.6)	ANGPTL3 (3.6)	SLC22A1 (3.4)	APOC4 (3.3)	APOA5 (3.2)	ENSG00000254235 (3.0)	PLG (3.0)	CEACAM19 (2.6)
GO:0017187	peptidyl-glutamic acid carboxylation	1.76e-03	<= 0.20	LPA (4.3)	ABO (4.1)	HNF1A (3.6)	ANGPTL3 (3.6)	SLC22A1 (3.4)	APOC4 (3.3)	APOA5 (3.2)	ENSG00000254235 (3.0)	PLG (3.0)	CEACAM19 (2.6)
ENSG00000215755	ENSG00000215755 PPI subnetwork	1.76e-03	<= 0.20	APOB (5.7)	NPC1L1 (5.0)	APOC1 (4.9)	ABCG5 (4.2)	APOA5 (4.1)	APOC4 (3.4)	PLG (3.3)	HP (3.2)	APOE (3.1)	ANGPTL3 (3.0)
ENSG00000110245	APOC3 PPI subnetwork	1.76e-03	<= 0.20	APOB (5.7)	NPC1L1 (5.0)	APOC1 (4.9)	ABCG5 (4.2)	APOA5 (4.1)	APOC4 (3.4)	PLG (3.3)	HP (3.2)	APOE (3.1)	ANGPTL3 (3.0)
ENSG00000084676	NCOA1 PPI subnetwork	1.77e-03	<= 0.20	TRIB1 (4.8)	UBXN2B (3.8)	BCL3 (2.9)	ATXN2 (2.8)	PLEC (2.8)	CYP7A1 (2.8)	C12orf51 (2.5)	ABCG5 (2.4)	ABCG8 (2.3)	MAU2 (2.2)
MP:0003303	peritoneal inflammation	1.78e-03	<= 0.20	SH2B3 (2.4)	RELB (2.4)	CETP (2.4)	ENSG00000228044 (2.1)	HLX (2.0)	BCL3 (2.0)	FRK (1.9)	CYP7A1 (1.8)	TRIB1 (1.8)	ITGB3 (1.8)
ENSG00000100181	ENSG00000100181 PPI subnetwork	1.80e-03	<= 0.20	QTRT1 (4.0)	ZNF259 (3.7)	DDX56 (3.4)	NAA25 (3.3)	CARM1 (2.9)	ATP13A1 (2.9)	DHX38 (2.9)	TOMM40 (2.8)	ILF3 (2.7)	TOP1 (2.6)
GO:0051183	vitamin transporter activity	1.80e-03	<= 0.20	TM6SF2 (4.5)	APOB (4.4)	ABCG8 (4.0)	ABCG5 (3.4)	ANGPTL3 (3.3)	APOC4 (3.3)	GPAM (3.2)	PLG (2.6)	APOA5 (2.6)	NPC1L1 (2.6)
MP:0005339	increased susceptibility to atherosclerosis	1.83e-03	<= 0.20	NPC1L1 (8.2)	APOB (7.7)	APOC1 (6.5)	ABCG5 (5.9)	TM6SF2 (4.8)	FADS1 (4.3)	FADS2 (4.3)	APOA5 (4.0)	HMGCR (3.6)	ABCG8 (3.3)
ENSG00000064692	SNCAIP PPI subnetwork	1.83e-03	<= 0.20	CYP7A1 (2.2)	ANGPTL3 (2.1)	APOA5 (2.1)	GCNT4 (2.0)	ENSG00000226645 (1.9)	RHD (1.8)	SLC22A1 (1.8)	FADS2 (1.8)	PCSK9 (1.8)	SLC44A2 (1.8)
MP:0008735	increased susceptibility to endotoxin shock	1.85e-03	<= 0.20	OASL (5.0)	PARP10 (4.2)	TRIB1 (4.1)	MAFB (3.4)	TIMD4 (2.9)	PLEKHH2 (2.4)	BCL3 (2.3)	HP (2.3)	ITGB3 (2.2)	CETP (2.1)
GO:0046930	pore complex	1.86e-03	<= 0.20	ANGPTL3 (3.5)	LPA (3.2)	PLG (2.9)	DDX56 (2.9)	POC5 (2.8)	NAA25 (2.7)	CARM1 (2.4)	USP24 (2.4)	DHODH (2.3)	USP1 (2.3)
GO:0016853	isomerase activity	1.86e-03	<= 0.20	HMGCR (4.0)	FADS2 (3.8)	FADS1 (3.4)	TRAPPC6A (3.3)	NT5DC1 (3.3)	DHODH (3.2)	QTRT1 (3.1)	PCSK9 (3.1)	ERP29 (3.0)	TOMM40 (2.9)
GO:0016052	carbohydrate catabolic process	1.87e-03	<= 0.20	GOT2P1 (2.5)	ERP29 (2.4)	SORT1 (2.2)	SYPL2 (2.1)	TMED4 (2.1)	TRAPPC6A (2.0)	PMFBP1 (1.9)	ACAD10 (1.8)	OGDH (1.7)	CEACAM19 (1.7)
ENSG00000181827	RFX7 PPI subnetwork	1.87e-03	<= 0.20	APOB (5.0)	BCAM (4.1)	APOE (3.9)	PLG (3.9)	HP (3.7)	APOC1 (3.6)	APOC4 (3.3)	APOA5 (3.2)	ANGPTL3 (3.1)	PCSK9 (2.5)
KEGG_ABC_TRANSPORTERS	KEGG_ABC_TRANSPORTERS	1.87e-03	<= 0.20	ABCG8 (6.3)	ABCG5 (4.3)	TM6SF2 (3.8)	CYP7A1 (3.5)	ATP13A1 (2.8)	PARP10 (2.7)	APOC4 (2.6)	SLC22A1 (2.5)	APOA5 (2.5)	APOB (2.4)
ENSG00000186395	KRT10 PPI subnetwork	1.89e-03	<= 0.20	KANK2 (2.7)	NYNRIN (2.5)	SLC22A1 (2.1)	OGDH (2.0)	PCSK9 (1.9)	PLEC (1.8)	ANGPTL3 (1.7)	GMPR (1.6)	APOC1 (1.5)	BCAM (1.5)
ENSG00000089154	GCN1L1 PPI subnetwork	1.89e-03	<= 0.20	DDX56 (4.2)	NAA25 (3.7)	SARS (3.2)	TOMM40 (3.2)	USP24 (3.1)	DHX38 (2.9)	SMARCA4 (2.6)	PSMA5 (2.6)	POC5 (2.5)	ZNF259 (2.3)
MP:0005642	decreased mean corpuscular hemoglobin concentration	1.91e-03	<= 0.20	RHD (8.6)	RHCE (7.3)	ENSG00000254235 (3.2)	GMPR (3.1)	TIMD4 (2.9)	FRK (2.6)	SYPL2 (1.9)	LPA (1.9)	MYLIP (1.9)	CYP7A1 (1.8)
MP:0009356	decreased liver triglyceride level	1.92e-03	<= 0.20	GPAM (4.2)	MOSC1 (3.7)	SORT1 (3.5)	LDLR (3.3)	HP (3.0)	ALDH2 (2.6)	FADS2 (2.5)	PPP1R37 (2.4)	FADS1 (2.4)	APOC1 (2.3)
MP:0000598	abnormal liver morphology	1.94e-03	<= 0.20	APOC4 (4.7)	APOA5 (4.6)	SLC22A1 (4.0)	LPA (3.9)	CYP7A1 (3.7)	COL4A3BP (3.6)	HP (3.5)	PCSK9 (3.5)	APOC1 (3.3)	ANGPTL3 (3.0)
GO:0009991	response to extracellular stimulus	1.94e-03	<= 0.20	TM6SF2 (3.0)	ABCG8 (2.8)	NPC1L1 (2.7)	ABCG5 (2.3)	FADS2 (2.2)	CYP7A1 (2.1)	ALDH2 (2.0)	PCSK9 (2.0)	TRAPPC6A (1.9)	ACAD10 (1.9)
ENSG00000165140	FBP1 PPI subnetwork	1.94e-03	<= 0.20	GRINA (3.2)	CYP7A1 (3.2)	PLG (3.2)	APOC4 (2.7)	UBXN2B (2.6)	ANGPTL3 (2.4)	LPA (2.3)	HNF1A (2.2)	MOSC1 (2.1)	APOA5 (1.9)
REACTOME_COMPLEMENT_CASCADE	REACTOME_COMPLEMENT_CASCADE	1.96e-03	<= 0.20	APOC4 (7.0)	LPA (6.5)	PLG (6.1)	ANGPTL3 (6.0)	HP (5.9)	TIMD4 (5.9)	SLC22A1 (5.8)	APOA5 (5.7)	APOC1 (5.5)	APOE (4.4)
KEGG_LINOLEIC_ACID_METABOLISM	KEGG_LINOLEIC_ACID_METABOLISM	1.96e-03	<= 0.20	ABCG5 (7.3)	SLC22A1 (6.7)	ABCG8 (5.6)	LPA (5.5)	APOC4 (4.7)	TM6SF2 (4.4)	NPC1L1 (4.0)	ANGPTL3 (3.5)	APOA5 (3.4)	HP (3.4)
GO:0045540	regulation of cholesterol biosynthetic process	1.97e-03	<= 0.20	ENSG00000238078 (4.4)	ABCG8 (3.5)	FADS2 (2.9)	APOC1 (2.6)	CYP7A1 (2.5)	HMGCR (2.4)	ENSG00000235545 (2.2)	FADS1 (2.2)	ABCG5 (2.2)	TMEM57 (1.9)
ENSG00000136108	CKAP2 PPI subnetwork	1.97e-03	<= 0.20	APOB (6.9)	ANGPTL3 (6.4)	PLG (4.9)	APOC4 (4.7)	APOA5 (4.4)	APOE (4.2)	APOC1 (4.2)	HP (3.9)	PCSK9 (3.2)	ABCG5 (2.9)
GO:0061008	hepaticobiliary system development	1.98e-03	<= 0.20	CYP7A1 (3.9)	PCSK9 (3.0)	HNF1A (2.9)	ABCG5 (2.6)	ABCG8 (2.4)	COL4A3BP (2.3)	ANGPTL3 (1.9)	TRAPPC6A (1.9)	APOA5 (1.9)	APOB (1.9)
ENSG00000136110	LECT1 PPI subnetwork	1.98e-03	<= 0.20	APOE (7.6)	APOB (6.6)	TIMD4 (5.5)	APOC1 (4.7)	APOA5 (4.0)	ANGPTL3 (3.6)	APOC4 (3.6)	NPC1L1 (3.5)	HP (3.4)	ABCG5 (3.4)
GO:0044403	symbiosis, encompassing mutualism through parasitism	1.99e-03	<= 0.20	OASL (2.3)	TIMD4 (2.1)	CETP (2.1)	SLC22A1 (2.0)	GRINA (1.8)	TRAFD1 (1.8)	HP (1.8)	PARP10 (1.8)	GCNT4 (1.8)	LPA (1.7)
GO:0015145	monosaccharide transmembrane transporter activity	1.99e-03	<= 0.20	TMED4 (3.8)	NPC1L1 (3.3)	GOT2P1 (3.2)	TM6SF2 (2.8)	APOB (2.6)	ABCG5 (2.3)	GCNT4 (2.3)	TSSK6 (2.2)	PMFBP1 (1.8)	PBX4 (1.8)
GO:0044283	small molecule biosynthetic process	2.01e-03	<= 0.20	CYP7A1 (4.5)	FADS2 (3.3)	TM6SF2 (3.1)	LPA (2.9)	FADS1 (2.8)	ALDH2 (2.7)	SLC22A1 (2.7)	GPAM (2.6)	PCSK9 (2.5)	ABCG8 (2.5)
ENSG00000197081	IGF2R PPI subnetwork	2.01e-03	<= 0.20	GRINA (3.2)	LPAR2 (2.4)	UBXN2B (1.9)	MAFB (1.8)	MYLIP (1.8)	CEACAM19 (1.7)	USP24 (1.7)	DNM2 (1.6)	C11orf9 (1.6)	APOC1 (1.5)
ENSG00000198780	FAM169A PPI subnetwork	2.01e-03	<= 0.20	APOE (7.6)	APOB (6.1)	APOC1 (4.7)	TIMD4 (4.6)	NPC1L1 (3.9)	APOA5 (3.6)	HP (3.5)	MAFB (3.5)	APOC4 (3.4)	ANGPTL3 (3.3)
GO:0016746	transferase activity, transferring acyl groups	2.01e-03	<= 0.20	HMGCR (5.3)	FADS1 (4.6)	FADS2 (4.5)	GPAM (3.7)	TM6SF2 (3.1)	MOSC1 (2.9)	ABCG5 (2.9)	LDLR (2.8)	ABCG8 (2.6)	NKPD1 (2.5)
GO:0004175	endopeptidase activity	2.02e-03	<= 0.20	CBLC (3.4)	PVRL2 (2.9)	SLC22A1 (2.8)	HP (2.6)	CEACAM19 (2.4)	CYP7A1 (2.3)	APOC4 (2.3)	TM6SF2 (2.3)	NKPD1 (2.2)	APOA5 (2.0)
ENSG00000167751	KLK2 PPI subnetwork	2.02e-03	<= 0.20	PLG (4.4)	APOA5 (4.3)	APOC1 (3.7)	SLC22A1 (3.4)	HP (3.2)	PVRL2 (3.2)	ANGPTL3 (2.9)	APOB (2.9)	APOC4 (2.8)	HNF1A (2.6)
GO:0051119	sugar transmembrane transporter activity	2.03e-03	<= 0.20	TMED4 (3.5)	TM6SF2 (2.5)	GOT2P1 (2.3)	APOB (2.0)	CLPTM1 (1.9)	BLOC1S3 (1.9)	SLC44A2 (1.9)	ATP13A1 (1.8)	NPC1L1 (1.7)	LDLR (1.7)
MP:0002310	decreased susceptibility to hepatic steatosis	2.04e-03	<= 0.20	TM6SF2 (4.0)	TRIB1 (3.4)	NPC1L1 (2.9)	MAU2 (2.7)	BRAP (2.6)	HP (2.5)	ABCG5 (2.5)	GPAM (2.5)	MAFB (2.4)	AMIGO1 (2.4)
MP:0000221	decreased leukocyte cell number	2.04e-03	<= 0.20	BCL3 (3.5)	PARP10 (2.9)	CYP7A1 (2.9)	SLC22A1 (2.9)	LPA (2.8)	RELB (2.8)	OASL (2.5)	ZNF101 (2.4)	PVR (2.2)	ABCG8 (2.2)
MP:0000465	gastrointestinal hemorrhage	2.05e-03	<= 0.20	ALDH2 (3.3)	NYNRIN (3.2)	ITGB3 (2.9)	HP (2.8)	CETP (2.5)	APOC4 (2.3)	MAFB (2.2)	APOA5 (2.0)	GMIP (2.0)	APOE (2.0)
MP:0010026	decreased liver cholesterol level	2.06e-03	<= 0.20	LDLR (8.5)	HMGCR (7.3)	FADS1 (6.4)	FADS2 (6.2)	PCSK9 (3.7)	SORT1 (2.9)	TIMD4 (2.8)	LPA (2.6)	NPC1L1 (2.5)	GRINA (2.3)
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	2.08e-03	<= 0.20	GPAM (3.9)	TM6SF2 (3.2)	NT5DC1 (3.1)	MOSC1 (3.0)	DHODH (3.0)	ABCG8 (2.7)	ALDH2 (2.2)	ACAD10 (2.2)	CYP7A1 (2.0)	ABCG5 (1.9)
REACTOME_METABOLISM_OF_WATER:SOLUBLE_VITAMINS_AND_COFACTORS	REACTOME_METABOLISM_OF_WATER:SOLUBLE_VITAMINS_AND_COFACTORS	2.08e-03	<= 0.20	GPAM (3.9)	TM6SF2 (3.2)	NT5DC1 (3.1)	MOSC1 (3.0)	DHODH (3.0)	ABCG8 (2.7)	ALDH2 (2.2)	ACAD10 (2.2)	CYP7A1 (2.0)	ABCG5 (1.9)
ENSG00000169896	ITGAM PPI subnetwork	2.08e-03	<= 0.20	HP (5.5)	CETP (5.3)	ITGB3 (4.0)	TIMD4 (4.0)	APOE (3.5)	RHD (3.3)	ENSG00000228044 (3.1)	APOC1 (2.9)	APOA5 (2.8)	RELB (2.4)
ENSG00000213512	GBP7 PPI subnetwork	2.08e-03	<= 0.20	TRAPPC6A (2.6)	GEMIN7 (2.5)	PVRL2 (2.2)	MYLIP (2.1)	GCNT4 (2.1)	FRK (2.1)	ZNF180 (1.8)	ENSG00000228044 (1.7)	ILF3 (1.6)	FADS2 (1.6)
ENSG00000127948	POR PPI subnetwork	2.08e-03	<= 0.20	LPA (6.0)	SLC22A1 (5.6)	ABCG5 (4.7)	APOA5 (4.2)	APOC4 (3.9)	ABCG8 (3.6)	HP (3.2)	APOC1 (2.9)	TM6SF2 (2.9)	PLG (2.7)
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS	2.09e-03	<= 0.20	APOC4 (8.3)	LPA (7.5)	CYP7A1 (7.1)	APOA5 (6.6)	PLG (5.4)	SLC22A1 (5.4)	ANGPTL3 (5.2)	HP (4.1)	ABCG5 (3.9)	APOC1 (3.4)
ENSG00000206340	C4A PPI subnetwork	2.10e-03	<= 0.20	APOB (6.7)	APOA5 (4.5)	PLG (4.3)	HP (4.1)	APOC1 (3.7)	ANGPTL3 (3.6)	APOC4 (3.5)	ABCG5 (3.5)	NPC1L1 (3.4)	TM6SF2 (2.9)
MP:0003909	increased eating behavior	2.10e-03	<= 0.20	GPAM (5.2)	NPC1L1 (4.2)	MOSC1 (4.1)	HP (2.8)	TM6SF2 (2.7)	KIAA1324 (2.6)	APOC1 (2.6)	ALDH2 (2.3)	APOB (2.0)	PMFBP1 (2.0)
ENSG00000002330	BAD PPI subnetwork	2.11e-03	<= 0.20	SH2B3 (2.5)	TRIB1 (2.2)	MARK4 (2.2)	LDLR (2.1)	GATAD2A (1.9)	DNM2 (1.8)	GRINA (1.7)	C11orf9 (1.7)	AP1M2 (1.6)	UBXN2B (1.6)
ENSG00000172602	RND1 PPI subnetwork	2.13e-03	<= 0.20	DOCK7 (2.3)	ZNF180 (2.0)	PPP1R37 (1.9)	HAPLN4 (1.9)	ABCG8 (1.8)	AP1M2 (1.8)	SLC44A2 (1.7)	ENSG00000254235 (1.7)	PVRL2 (1.7)	LPIN3 (1.5)
GO:0031983	vesicle lumen	2.13e-03	<= 0.20	ANGPTL3 (6.2)	HP (5.7)	PLG (5.3)	ITGB3 (5.3)	APOB (4.5)	APOA5 (4.2)	APOC4 (4.0)	APOE (3.9)	APOC1 (3.5)	LPA (2.3)
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	2.15e-03	<= 0.20	PLG (5.5)	ANGPTL3 (5.0)	SLC22A1 (4.9)	APOA5 (4.8)	LPA (4.1)	APOC4 (4.0)	CYP7A1 (4.0)	ABCG8 (3.3)	PSMA5 (3.2)	ALDH2 (3.2)
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS	2.16e-03	<= 0.20	APOC4 (9.1)	CYP7A1 (7.0)	APOA5 (6.9)	LPA (6.4)	PLG (6.2)	ANGPTL3 (6.0)	SLC22A1 (5.8)	HP (4.2)	ABCG5 (3.7)	ABCG8 (3.4)
ENSG00000107623	GDF10 PPI subnetwork	2.20e-03	<= 0.20	APOB (6.3)	ANGPTL3 (5.8)	APOE (4.4)	PLG (4.4)	APOC1 (4.2)	APOC4 (4.2)	APOA5 (4.1)	HP (3.8)	ABCG5 (2.8)	PCSK9 (2.6)
ENSG00000136250	AOAH PPI subnetwork	2.20e-03	<= 0.20	APOB (5.1)	BCAM (4.1)	PLG (4.0)	APOE (3.9)	HP (3.7)	APOC1 (3.5)	APOA5 (3.3)	APOC4 (3.2)	ANGPTL3 (3.1)	PCSK9 (2.9)
GO:0019637	organophosphate metabolic process	2.21e-03	<= 0.20	BLOC1S3 (3.4)	LPAR2 (3.2)	NKPD1 (2.9)	TSSK6 (2.7)	ATP13A1 (2.4)	GCNT4 (2.3)	MOSC1 (2.2)	HMGCR (2.1)	SORT1 (2.0)	SLC44A2 (2.0)
GO:0016763	transferase activity, transferring pentosyl groups	2.23e-03	<= 0.20	PARP10 (5.8)	OASL (5.3)	TRAFD1 (2.9)	DHODH (2.5)	UBXN2B (2.1)	TRIB1 (2.0)	POLK (1.3)	HNF1A (1.3)	CARM1 (1.3)	TOP1 (1.3)
GO:0001889	liver development	2.24e-03	<= 0.20	CYP7A1 (4.0)	PCSK9 (3.1)	HNF1A (3.0)	ABCG5 (2.6)	ABCG8 (2.4)	C19orf52 (2.0)	GEMIN7 (2.0)	TRAPPC6A (1.9)	APOB (1.9)	ANGPTL3 (1.9)
GO:0004867	serine-type endopeptidase inhibitor activity	2.26e-03	<= 0.20	PLG (5.2)	HP (5.2)	APOB (5.2)	APOA5 (5.1)	APOC4 (3.9)	APOC1 (3.8)	ANGPTL3 (3.8)	PCSK9 (3.2)	SLC22A1 (3.2)	ABCG5 (2.7)
ENSG00000125124	BBS2 PPI subnetwork	2.26e-03	<= 0.20	PLG (3.2)	BCAM (3.0)	DYNC2LI1 (2.7)	SLC22A1 (2.6)	ANGPTL3 (2.5)	DHODH (2.4)	BCL3 (2.3)	LPAR2 (2.1)	HP (2.0)	PLEC (1.9)
ENSG00000173039	RELA PPI subnetwork	2.28e-03	<= 0.20	BCL3 (4.6)	TRIB1 (4.5)	RELB (4.1)	BUD13 (2.5)	TRAFD1 (2.4)	MYLIP (2.3)	PARP10 (2.1)	LDLR (2.0)	GRINA (1.9)	C12orf51 (1.9)
ENSG00000154582	TCEB1 PPI subnetwork	2.29e-03	<= 0.20	BUD13 (3.5)	PLG (2.7)	DHX38 (2.6)	ANGPTL3 (2.5)	ZNF259 (2.4)	BCL3 (2.3)	SUGP1 (2.3)	GEMIN7 (2.1)	APOB (2.1)	HP (2.0)
REACTOME_HEMOSTASIS	REACTOME_HEMOSTASIS	2.30e-03	<= 0.20	ITGB3 (7.9)	HP (2.7)	CETP (2.6)	GMPR (2.6)	PLG (2.5)	SH2B3 (2.5)	ANGPTL3 (2.3)	APOB (2.2)	APOE (2.1)	APOC4 (2.1)
MP:0000418	focal hair loss	2.31e-03	<= 0.20	HMGCR (3.2)	FADS1 (3.0)	FADS2 (2.9)	LDLR (2.6)	SLC44A2 (2.2)	BLOC1S3 (2.1)	BCAM (2.0)	APOC4 (1.9)	PLCG1 (1.9)	ABCG5 (1.9)
GO:0045178	basal part of cell	2.31e-03	<= 0.20	PLEC (3.3)	CYP7A1 (3.1)	POLK (2.6)	CBLC (2.5)	DOCK7 (2.5)	LDLR (2.3)	TSSK6 (2.1)	TMEM116 (2.1)	ABCG8 (2.0)	BCAM (2.0)
ENSG00000182446	NPLOC4 PPI subnetwork	2.34e-03	<= 0.20	BRAP (3.3)	ATXN2 (3.0)	SUGP1 (2.9)	TMEM57 (2.6)	DHX38 (2.2)	ATP13A1 (2.1)	SARS (2.0)	YIPF2 (2.0)	LDLR (2.0)	LPAR2 (1.9)
GO:0006639	acylglycerol metabolic process	2.35e-03	<= 0.20	GPAM (4.7)	MOSC1 (4.3)	NPC1L1 (4.0)	FADS1 (4.0)	PCSK9 (3.9)	FADS2 (3.6)	HMGCR (3.3)	TM6SF2 (3.3)	LDLR (3.0)	APOC1 (2.5)
MP:0001634	internal hemorrhage	2.36e-03	<= 0.20	ITGB3 (4.9)	NYNRIN (3.6)	ANGPTL3 (2.9)	ST3GAL4 (2.8)	HP (2.8)	HLX (2.5)	C12orf51 (2.2)	LPA (2.1)	PLG (2.0)	GMPR (2.0)
ENSG00000092439	TRPM7 PPI subnetwork	2.37e-03	<= 0.20	CETP (3.3)	TIMD4 (2.8)	OASL (2.7)	C1orf63 (2.4)	SORT1 (2.0)	DNAH11 (2.0)	MOSC1 (1.8)	HNF1A (1.7)	PLEKHH2 (1.6)	TMEM57 (1.6)
ENSG00000110244	APOA4 PPI subnetwork	2.37e-03	<= 0.20	APOB (7.0)	NPC1L1 (4.8)	ABCG5 (4.6)	PLG (4.3)	APOA5 (4.2)	ANGPTL3 (3.7)	APOC1 (3.5)	APOC4 (3.5)	TM6SF2 (3.4)	HP (2.8)
MP:0002875	decreased erythrocyte cell number	2.39e-03	<= 0.20	RHCE (8.4)	RHD (8.0)	CETP (3.7)	GMPR (3.5)	ITGB3 (3.0)	TIMD4 (3.0)	C12orf51 (2.9)	ENSG00000238078 (1.8)	SLC44A2 (1.8)	ATXN2 (1.7)
ENSG00000118690	ARMC2 PPI subnetwork	2.40e-03	<= 0.20	APOB (5.0)	BCAM (4.2)	PLG (3.9)	APOE (3.7)	HP (3.7)	APOC1 (3.5)	APOC4 (3.3)	APOA5 (3.2)	PCSK9 (3.1)	ANGPTL3 (3.0)
ENSG00000068971	PPP2R5B PPI subnetwork	2.40e-03	<= 0.20	SARS (3.6)	BRAP (3.0)	BLOC1S3 (2.4)	C17orf57 (2.2)	TRAPPC6A (2.0)	CLPTM1 (1.8)	GOT2P1 (1.7)	PCSK9 (1.7)	ILF3 (1.6)	NKPD1 (1.5)
MP:0010377	abnormal gut flora balance	2.41e-03	<= 0.20	ABCG5 (3.0)	HP (3.0)	CEACAM19 (2.8)	PARP10 (2.5)	TM6SF2 (2.3)	NPC1L1 (2.3)	ALDH2 (2.2)	ABCG8 (2.1)	CBLC (2.1)	GMIP (2.0)
ENSG00000138757	G3BP2 PPI subnetwork	2.42e-03	<= 0.20	TIMD4 (3.5)	CETP (3.3)	C1orf63 (2.7)	OASL (2.5)	TOP1 (2.4)	SMARCA4 (2.4)	FADS2 (2.1)	ILF3 (2.0)	GATAD2A (1.9)	RELB (1.9)
ENSG00000167971	CASKIN1 PPI subnetwork	2.42e-03	<= 0.20	AP1M2 (2.4)	ENSG00000228044 (2.4)	PSRC1 (2.4)	ILF3 (2.4)	C11orf9 (2.3)	MAU2 (2.2)	ATXN2 (2.1)	LDLR (2.0)	DNM2 (1.9)	CARM1 (1.7)
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA:HYDROXYCHOLESTEROL	REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA:HYDROXYCHOLESTEROL	2.43e-03	<= 0.20	APOC4 (10.3)	APOA5 (8.5)	CYP7A1 (8.0)	PLG (6.8)	ANGPTL3 (6.7)	SLC22A1 (5.9)	LPA (5.5)	ABCG8 (4.8)	ABCG5 (4.8)	APOC1 (4.2)
MP:0005416	abnormal circulating protein level	2.44e-03	<= 0.20	APOC1 (4.4)	PLG (4.3)	APOA5 (4.1)	SLC22A1 (4.1)	ANGPTL3 (3.9)	HP (3.9)	APOB (3.4)	APOC4 (3.2)	NPC1L1 (2.5)	TM6SF2 (2.5)
ENSG00000106804	C5 PPI subnetwork	2.44e-03	<= 0.20	APOC4 (7.8)	LPA (7.7)	PLG (7.7)	HP (7.3)	ANGPTL3 (7.0)	APOA5 (6.6)	SLC22A1 (5.5)	APOC1 (5.4)	PCSK9 (4.0)	APOB (3.8)
ENSG00000188488	SERPINA5 PPI subnetwork	2.45e-03	<= 0.20	PLG (7.2)	ANGPTL3 (6.4)	APOC4 (5.6)	APOA5 (5.4)	APOB (5.3)	HP (4.3)	APOC1 (3.5)	PCSK9 (2.9)	HNF1A (2.8)	SLC22A1 (2.7)
MP:0001556	increased circulating HDL cholesterol level	2.46e-03	<= 0.20	APOC1 (5.0)	FADS2 (4.7)	FADS1 (4.6)	GPAM (4.5)	MOSC1 (4.4)	HMGCR (3.9)	PCSK9 (2.9)	HP (2.3)	HNF1A (2.3)	NPC1L1 (2.2)
GO:0006638	neutral lipid metabolic process	2.47e-03	<= 0.20	GPAM (4.7)	MOSC1 (4.4)	NPC1L1 (4.1)	FADS1 (4.0)	PCSK9 (3.9)	FADS2 (3.6)	HMGCR (3.3)	TM6SF2 (3.3)	LDLR (3.0)	APOC1 (2.5)
ENSG00000180530	NRIP1 PPI subnetwork	2.49e-03	<= 0.20	PPP1R37 (4.1)	KANK2 (2.2)	ATXN2 (2.0)	SH2B3 (2.0)	YIPF2 (1.9)	MYLIP (1.9)	NYNRIN (1.8)	APOC1 (1.5)	ST3GAL4 (1.5)	AMIGO1 (1.5)
REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	2.50e-03	<= 0.20	TIMD4 (5.7)	APOE (5.3)	APOC1 (4.9)	APOC4 (4.5)	HP (4.2)	LPA (4.2)	SLC22A1 (4.0)	APOA5 (3.5)	ANGPTL3 (3.4)	PLG (3.3)
ENSG00000166285	ENSG00000166285 PPI subnetwork	2.50e-03	<= 0.20	APOB (8.5)	APOA5 (5.7)	PLG (5.4)	HP (5.2)	ANGPTL3 (4.6)	APOC4 (4.4)	APOC1 (4.2)	ABCG5 (4.0)	NPC1L1 (3.8)	APOE (3.7)
ENSG00000204359	CFB PPI subnetwork	2.50e-03	<= 0.20	APOB (8.5)	APOA5 (5.7)	PLG (5.4)	HP (5.2)	ANGPTL3 (4.6)	APOC4 (4.4)	APOC1 (4.2)	ABCG5 (4.0)	NPC1L1 (3.8)	APOE (3.7)
GO:0004709	MAP kinase kinase kinase activity	2.51e-03	<= 0.20	NT5DC1 (3.3)	FRK (2.7)	NKPD1 (2.6)	TRIB1 (2.4)	BCL3 (2.4)	ZHX3 (2.3)	CYB561D1 (2.1)	POLK (1.9)	LPIN3 (1.8)	SH2B3 (1.8)
ENSG00000034971	MYOC PPI subnetwork	2.52e-03	<= 0.20	APOE (4.1)	KANK2 (3.3)	APOC1 (3.1)	PCSK9 (2.2)	GPAM (2.2)	C1orf63 (1.9)	CYB561D1 (1.8)	UBXN2B (1.7)	TIMD4 (1.5)	PLEC (1.5)
ENSG00000206218	ENSG00000206218 PPI subnetwork	2.52e-03	<= 0.20	ABCG5 (3.1)	MYLIP (2.8)	TRIB1 (2.1)	TM6SF2 (2.0)	ABCG8 (2.0)	ZHX3 (2.0)	HNF1A (1.9)	NPC1L1 (1.9)	C12orf43 (1.8)	PSMA5 (1.7)
ENSG00000206289	RXRB PPI subnetwork	2.52e-03	<= 0.20	ABCG5 (3.1)	MYLIP (2.8)	TRIB1 (2.1)	TM6SF2 (2.0)	ABCG8 (2.0)	ZHX3 (2.0)	HNF1A (1.9)	NPC1L1 (1.9)	C12orf43 (1.8)	PSMA5 (1.7)
ENSG00000204231	RXRB PPI subnetwork	2.52e-03	<= 0.20	ABCG5 (3.1)	MYLIP (2.8)	TRIB1 (2.1)	TM6SF2 (2.0)	ABCG8 (2.0)	ZHX3 (2.0)	HNF1A (1.9)	NPC1L1 (1.9)	C12orf43 (1.8)	PSMA5 (1.7)
ENSG00000119335	SET PPI subnetwork	2.52e-03	<= 0.20	CARM1 (2.4)	BUD13 (2.2)	PLEC (2.1)	PSRC1 (2.1)	ILF3 (1.9)	NCAN (1.9)	BRAP (1.9)	GATAD2A (1.7)	TXNL4B (1.7)	TOP1 (1.6)
GO:0016840	carbon-nitrogen lyase activity	2.58e-03	<= 0.20	LPA (6.7)	APOA5 (5.6)	APOC4 (4.9)	SLC22A1 (4.8)	PLG (4.8)	ANGPTL3 (4.1)	CEACAM19 (3.8)	APOC1 (3.1)	ABCG5 (3.0)	MOSC1 (2.9)
MP:0002891	increased insulin sensitivity	2.60e-03	<= 0.20	PPP1R37 (3.1)	ATXN7L2 (2.8)	TRIB1 (2.7)	ZHX3 (2.3)	SORT1 (2.2)	SYPL2 (2.2)	AMIGO1 (2.1)	ZNF101 (2.0)	HAVCR1 (1.9)	BCL3 (1.8)
MP:0009831	abnormal sperm midpiece morphology	2.61e-03	<= 0.20	TSSK6 (3.0)	PMFBP1 (3.0)	BRAP (2.5)	PVR (2.3)	GCNT4 (2.2)	ZNF180 (2.2)	ANKRD31 (2.1)	YIPF2 (1.9)	TIMD4 (1.7)	BCAM (1.6)
ENSG00000215754	ENSG00000215754 PPI subnetwork	2.61e-03	<= 0.20	APOB (8.1)	APOC1 (5.8)	ABCG5 (5.1)	PLG (4.9)	NPC1L1 (4.9)	APOA5 (4.9)	ANGPTL3 (4.2)	APOC4 (3.9)	HP (3.4)	TM6SF2 (3.2)
REACTOME_ABC:FAMILY_PROTEINS_MEDIATED_TRANSPORT	REACTOME_ABC:FAMILY_PROTEINS_MEDIATED_TRANSPORT	2.62e-03	<= 0.20	ABCG8 (6.3)	ABCG5 (5.3)	TM6SF2 (4.0)	APOB (4.0)	NPC1L1 (3.8)	NT5DC1 (3.3)	CYP7A1 (2.8)	CLPTM1 (2.3)	C17orf57 (2.2)	APOA5 (2.2)
ENSG00000163586	FABP1 PPI subnetwork	2.62e-03	<= 0.20	PLG (5.4)	ANGPTL3 (5.2)	APOA5 (5.2)	APOB (5.0)	APOC4 (4.8)	APOC1 (3.5)	HP (3.5)	CYP7A1 (3.4)	GOT2P1 (3.2)	SLC22A1 (2.3)
MP:0000490	abnormal crypts of Lieberkuhn morphology	2.62e-03	<= 0.20	GEMIN7 (2.6)	ABO (2.4)	HLX (2.4)	CEACAM19 (2.4)	GCNT4 (2.1)	TIMD4 (2.0)	UBXN2B (1.9)	KIAA1324 (1.7)	BCL3 (1.7)	LPAR2 (1.7)
KEGG_TRYPTOPHAN_METABOLISM	KEGG_TRYPTOPHAN_METABOLISM	2.63e-03	<= 0.20	SLC22A1 (4.2)	APOA5 (4.1)	PLG (4.0)	CYP7A1 (3.7)	LPA (3.7)	MOSC1 (3.6)	TM6SF2 (3.6)	ANGPTL3 (3.4)	APOC4 (2.9)	ACAD10 (2.8)
ENSG00000038358	EDC4 PPI subnetwork	2.66e-03	<= 0.20	MAU2 (4.2)	BRAP (3.1)	TRIB1 (2.8)	COL4A3BP (2.8)	TXNL4B (2.7)	DNM2 (2.5)	C12orf43 (2.4)	ACAD10 (2.4)	TRAFD1 (2.3)	ENSG00000254235 (2.3)
REACTOME_PHASE_1_:_FUNCTIONALIZATION_OF_COMPOUNDS	REACTOME_PHASE_1_:_FUNCTIONALIZATION_OF_COMPOUNDS	2.69e-03	<= 0.20	LPA (6.8)	SLC22A1 (6.7)	CYP7A1 (5.9)	APOC4 (5.5)	ABCG5 (5.3)	TM6SF2 (4.9)	APOA5 (4.7)	ANGPTL3 (4.6)	ABCG8 (4.5)	ALDH2 (4.2)
ENSG00000120158	RCL1 PPI subnetwork	2.70e-03	<= 0.20	DDX56 (4.9)	QTRT1 (4.6)	ZNF259 (4.5)	NAA25 (4.1)	C12orf43 (3.1)	DHODH (3.1)	TOMM40 (3.1)	DHX38 (2.3)	ATP13A1 (2.2)	SUGP1 (2.1)
ENSG00000197766	CFD PPI subnetwork	2.73e-03	<= 0.20	APOB (7.7)	PLG (5.9)	APOA5 (5.8)	HP (4.7)	ANGPTL3 (4.7)	APOC4 (4.5)	APOC1 (4.0)	ABCG5 (3.2)	APOE (3.0)	NPC1L1 (3.0)
GO:0033293	monocarboxylic acid binding	2.75e-03	<= 0.20	MOSC1 (5.3)	GPAM (4.2)	APOB (4.0)	APOC1 (3.7)	APOE (3.5)	ACAD10 (3.4)	APOA5 (3.1)	ALDH2 (2.8)	TM6SF2 (2.8)	PCSK9 (2.7)
ENSG00000186153	WWOX PPI subnetwork	2.76e-03	<= 0.20	SMARCA4 (3.9)	DHX38 (3.0)	MAU2 (2.8)	GMIP (2.6)	ILF3 (2.6)	CARM1 (2.6)	GRINA (2.3)	CLPTM1 (2.3)	GATAD2A (2.3)	PPP1R37 (2.1)
ENSG00000130164	LDLR PPI subnetwork	2.77e-03	<= 0.20	ERP29 (5.3)	HMGCR (4.2)	TMED4 (4.1)	NPC1L1 (3.1)	ITGB3 (3.0)	PCSK9 (2.9)	APOC1 (2.9)	FADS1 (2.5)	YIPF2 (2.4)	FADS2 (1.9)
GO:0005996	monosaccharide metabolic process	2.79e-03	<= 0.20	SYPL2 (2.6)	ACAD10 (2.4)	NT5DC1 (2.2)	LPA (2.2)	ENSG00000254235 (2.1)	SORT1 (2.1)	DHODH (2.1)	SLC22A1 (2.1)	GOT2P1 (1.9)	TRAPPC6A (1.8)
REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	2.80e-03	<= 0.20	FADS2 (6.5)	GPAM (6.0)	LDLR (5.8)	FADS1 (5.7)	HMGCR (5.1)	MOSC1 (4.0)	PCSK9 (3.6)	APOB (3.2)	HP (3.1)	ALDH2 (2.8)
MP:0006298	abnormal platelet activation	2.82e-03	<= 0.20	ITGB3 (8.1)	ABCG8 (5.5)	CETP (4.0)	TIMD4 (3.2)	GMPR (3.0)	GMIP (2.4)	LPA (2.3)	MAFB (2.2)	SLC44A2 (1.7)	NPC1L1 (1.6)
MP:0003111	abnormal cell nucleus morphology	2.84e-03	<= 0.20	FEN1 (5.0)	USP1 (4.0)	PSRC1 (3.7)	NKPD1 (2.4)	ILF3 (1.9)	SUGP1 (1.8)	RHCE (1.8)	PVR (1.7)	ENSG00000228044 (1.7)	UBXN2B (1.5)
ENSG00000156453	PCDH1 PPI subnetwork	2.85e-03	<= 0.20	APOB (6.8)	APOA5 (4.5)	PLG (4.3)	ANGPTL3 (3.9)	HP (3.9)	APOC4 (3.5)	ABCG5 (3.5)	APOC1 (3.4)	NPC1L1 (3.2)	TM6SF2 (2.6)
ENSG00000131187	F12 PPI subnetwork	2.87e-03	<= 0.20	ANGPTL3 (7.3)	PLG (6.0)	APOC4 (6.0)	HP (5.5)	APOA5 (4.8)	SLC22A1 (4.4)	APOE (3.9)	APOC1 (3.7)	ITGB3 (3.6)	CYP7A1 (3.5)
GO:0033762	response to glucagon stimulus	2.88e-03	<= 0.20	CYP7A1 (2.6)	ITGB3 (2.5)	PCSK9 (2.3)	ENSG00000254235 (2.3)	ST3GAL4 (2.3)	TM6SF2 (2.1)	LPA (2.1)	PMFBP1 (2.0)	ABCG8 (2.0)	GCNT4 (1.8)
MP:0001585	hemolytic anemia	2.90e-03	<= 0.20	RHD (9.2)	RHCE (8.1)	C12orf51 (4.1)	ABCG8 (3.6)	GRINA (2.6)	CYP7A1 (2.4)	GMPR (2.2)	LPA (2.1)	APOC4 (2.0)	APOA5 (1.8)
GO:0006641	triglyceride metabolic process	2.93e-03	<= 0.20	GPAM (4.9)	MOSC1 (4.2)	NPC1L1 (4.2)	FADS1 (4.1)	PCSK9 (4.0)	FADS2 (3.8)	HMGCR (3.4)	TM6SF2 (3.3)	LDLR (3.2)	APOC1 (2.5)
MP:0005365	abnormal bile salt homeostasis	2.93e-03	<= 0.20	ABCG5 (3.8)	APOA5 (3.7)	APOC4 (3.4)	ABCG8 (2.9)	HNF1A (2.8)	APOC1 (2.7)	TM6SF2 (2.7)	CETP (2.3)	APOE (2.2)	PLG (2.1)
ENSG00000103363	TCEB2 PPI subnetwork	2.96e-03	<= 0.20	BUD13 (3.4)	DHX38 (2.7)	SUGP1 (2.5)	PLG (2.5)	APOB (2.2)	ANGPTL3 (2.1)	HP (2.1)	BCL3 (2.1)	DOCK7 (2.0)	APOA5 (1.8)
GO:0046486	glycerolipid metabolic process	2.99e-03	<= 0.20	MOSC1 (3.7)	GPAM (3.7)	NPC1L1 (3.4)	BLOC1S3 (3.4)	TM6SF2 (2.8)	FADS1 (2.8)	HMGCR (2.6)	FADS2 (2.4)	CYP7A1 (2.4)	PCSK9 (2.1)
ENSG00000185010	F8 PPI subnetwork	3.00e-03	<= 0.20	PLG (4.7)	ANGPTL3 (4.5)	APOC4 (4.5)	APOA5 (4.5)	APOB (4.0)	HP (3.9)	SLC22A1 (3.9)	APOC1 (3.1)	ERP29 (2.8)	LPA (2.3)
REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	3.02e-03	<= 0.20	TIMD4 (5.5)	APOE (5.1)	APOC4 (4.7)	SLC22A1 (4.6)	LPA (4.3)	APOC1 (4.2)	APOA5 (3.9)	PLG (3.8)	ANGPTL3 (3.7)	HP (2.9)
GO:0090207	regulation of triglyceride metabolic process	3.02e-03	<= 0.20	TM6SF2 (3.3)	NPC1L1 (2.9)	GCNT4 (2.8)	ABCG5 (2.6)	ABCG8 (2.5)	APOC1 (2.3)	MOSC1 (2.3)	GPAM (2.1)	ANKRD31 (2.0)	ENSG00000226648 (1.8)
ENSG00000086061	DNAJA1 PPI subnetwork	3.03e-03	<= 0.20	RELB (4.4)	BCL3 (3.5)	PLEC (2.8)	PLG (2.7)	ANGPTL3 (2.7)	PVR (2.4)	APOC4 (2.3)	OGDH (2.1)	HLX (2.0)	MYLIP (2.0)
GO:0016863	intramolecular oxidoreductase activity, transposing C=C bonds	3.03e-03	<= 0.20	HMGCR (7.1)	FADS2 (6.1)	FADS1 (6.0)	LDLR (5.5)	MOSC1 (3.4)	TRAPPC6A (2.9)	PCSK9 (2.7)	CYP7A1 (2.7)	APOA5 (2.5)	APOC1 (2.1)
ENSG00000141076	CIRH1A PPI subnetwork	3.03e-03	<= 0.20	ZNF259 (4.7)	DDX56 (4.7)	NAA25 (4.4)	QTRT1 (3.9)	TOMM40 (3.5)	DHODH (2.8)	ATP13A1 (2.5)	DHX38 (2.5)	GATAD2A (2.2)	C12orf43 (2.1)
ENSG00000126934	MAP2K2 PPI subnetwork	3.06e-03	<= 0.20	CARM1 (2.9)	DNM2 (2.9)	APOB (2.8)	PLG (2.6)	HP (2.5)	ANGPTL3 (2.3)	PLEC (2.3)	UBXN2B (2.1)	SYPL2 (1.9)	PTPN11 (1.9)
ENSG00000163631	ALB PPI subnetwork	3.07e-03	<= 0.20	PLG (8.3)	ANGPTL3 (6.6)	APOB (5.9)	APOA5 (5.7)	APOC1 (5.4)	APOC4 (5.3)	HP (4.6)	SLC22A1 (3.1)	PCSK9 (2.8)	ABCG5 (2.3)
REACTOME_METABOLISM_OF_POLYAMINES	REACTOME_METABOLISM_OF_POLYAMINES	3.08e-03	<= 0.20	QTRT1 (3.8)	GMPR (2.5)	SLC44A2 (2.4)	APOE (2.4)	HNF1A (2.3)	TOMM40 (2.3)	TSSK6 (2.0)	DHODH (1.9)	CARM1 (1.7)	MAFB (1.6)
ENSG00000113580	NR3C1 PPI subnetwork	3.08e-03	<= 0.20	ATXN2 (3.0)	SMARCA4 (2.7)	CARM1 (2.6)	TRAFD1 (2.6)	TRIB1 (2.5)	CYP7A1 (2.4)	APOB (2.4)	BCL3 (2.4)	PBX4 (2.3)	PLCG1 (2.2)
GO:0032369	negative regulation of lipid transport	3.08e-03	<= 0.20	ABCG8 (5.0)	C17orf57 (4.4)	ABCG5 (3.7)	NPC1L1 (3.4)	TM6SF2 (3.4)	APOB (2.7)	GEMIN7 (2.6)	APOE (2.5)	CYB561D1 (2.2)	LPIN3 (2.2)
GO:0031667	response to nutrient levels	3.09e-03	<= 0.20	TM6SF2 (3.0)	NPC1L1 (2.9)	ABCG8 (2.7)	FADS2 (2.4)	ABCG5 (2.1)	ACAD10 (2.0)	PCSK9 (2.0)	CYP7A1 (1.9)	TRAPPC6A (1.8)	KIAA1324 (1.7)
ENSG00000106617	PRKAG2 PPI subnetwork	3.10e-03	<= 0.20	LDLR (3.9)	FADS1 (3.2)	GPAM (3.0)	FADS2 (2.8)	CYP7A1 (2.7)	PLG (2.6)	TM6SF2 (2.4)	SARS (2.3)	ACAD10 (2.3)	C12orf51 (2.2)
ENSG00000154134	ROBO3 PPI subnetwork	3.11e-03	<= 0.20	APOE (7.8)	APOB (6.2)	TIMD4 (4.9)	APOC1 (4.8)	NPC1L1 (4.0)	APOA5 (3.6)	MAFB (3.6)	HP (3.5)	ABCG5 (3.5)	PLG (3.3)
ENSG00000164695	CHMP4C PPI subnetwork	3.13e-03	<= 0.20	MARK4 (2.6)	MAU2 (2.6)	ATP13A1 (2.4)	BLOC1S3 (2.2)	ENSG00000226648 (2.2)	SUGP1 (1.9)	DYNC2LI1 (1.9)	ABO (1.8)	APOB (1.8)	GCNT4 (1.6)
GO:0016298	lipase activity	3.13e-03	<= 0.20	NKPD1 (4.2)	CETP (4.0)	APOE (3.2)	APOC1 (3.0)	MAFB (2.9)	MOSC1 (2.7)	TIMD4 (2.5)	SORT1 (2.3)	ABCG8 (2.3)	APOC4 (2.0)
ENSG00000137561	TTPA PPI subnetwork	3.14e-03	<= 0.20	APOB (6.2)	PLG (6.1)	ANGPTL3 (5.4)	APOA5 (5.0)	APOC4 (4.1)	APOC1 (3.3)	HP (3.1)	GOT2P1 (2.6)	PCSK9 (2.4)	SLC22A1 (2.3)
GO:0070988	demethylation	3.16e-03	<= 0.20	NPC1L1 (3.8)	LPA (3.6)	ABCG8 (3.5)	ABCG5 (3.2)	SLC22A1 (3.1)	TM6SF2 (2.6)	BLOC1S3 (2.2)	GCNT4 (2.1)	C17orf57 (2.0)	CYP7A1 (1.8)
GO:0043434	response to peptide hormone stimulus	3.18e-03	<= 0.20	COL4A3BP (3.3)	SORT1 (2.7)	MOSC1 (2.5)	ENSG00000254235 (2.5)	GPAM (2.3)	KIAA1324 (2.1)	NPC1L1 (2.0)	HAPLN4 (2.0)	TM6SF2 (1.9)	CYP7A1 (1.9)
MP:0003038	decreased infarction size	3.19e-03	<= 0.20	MAFB (2.9)	APOC1 (2.4)	TSSK6 (2.4)	SLC22A1 (2.4)	ENSG00000226648 (2.2)	HP (2.1)	PMFBP1 (2.1)	HLX (2.0)	TMEM57 (2.0)	ITGB3 (1.9)
KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	KEGG_ALPHA_LINOLENIC_ACID_METABOLISM	3.19e-03	<= 0.20	FADS1 (4.7)	NKPD1 (3.8)	ABCG8 (2.7)	ABCG5 (2.2)	TMEM57 (2.2)	GCNT4 (2.2)	HMGCR (2.1)	BLOC1S3 (2.0)	LDLR (2.0)	TIMD4 (2.0)
ENSG00000183508	FAM46C PPI subnetwork	3.21e-03	<= 0.20	CBLC (4.3)	CLPTM1 (3.0)	BLOC1S3 (2.8)	QTRT1 (2.6)	AP1M2 (2.5)	PLCG1 (2.3)	C12orf43 (2.2)	HNF1A (2.1)	TXNL4B (2.1)	DNM2 (2.1)
MP:0002404	increased intestinal adenoma incidence	3.24e-03	<= 0.20	ANKRD31 (2.8)	SLC44A2 (2.3)	FEN1 (2.1)	PARP10 (2.1)	DNM2 (2.0)	ATP13A1 (2.0)	FADS2 (1.9)	TM6SF2 (1.7)	ENSG00000226648 (1.7)	ENSG00000254235 (1.7)
ENSG00000065154	OAT PPI subnetwork	3.25e-03	<= 0.20	C19orf52 (3.1)	CLPTM1 (2.9)	SUGP1 (2.5)	TOMM40 (2.3)	DDX56 (2.2)	PSMA5 (2.1)	HAPLN4 (2.0)	QTRT1 (2.0)	ENSG00000226645 (2.0)	ZNF101 (1.9)
ENSG00000038002	AGA PPI subnetwork	3.25e-03	<= 0.20	APOB (7.4)	PLG (5.4)	APOA5 (5.3)	HP (4.5)	ANGPTL3 (4.3)	APOC4 (4.2)	APOC1 (3.7)	APOE (3.1)	ABCG5 (3.1)	NPC1L1 (3.1)
MP:0009355	increased liver triglyceride level	3.25e-03	<= 0.20	FADS1 (5.5)	APOB (4.4)	GPAM (4.4)	MOSC1 (4.1)	TM6SF2 (3.6)	NPC1L1 (3.6)	ABCG5 (3.5)	HMGCR (3.4)	HP (3.0)	APOA5 (2.9)
ENSG00000125998	FAM83C PPI subnetwork	3.26e-03	<= 0.20	APOE (7.6)	APOB (6.2)	TIMD4 (4.6)	APOC1 (4.6)	NPC1L1 (3.8)	APOA5 (3.6)	MAFB (3.5)	APOC4 (3.4)	HP (3.4)	ABCG5 (3.2)
ENSG00000128708	HAT1 PPI subnetwork	3.26e-03	<= 0.20	PSMA5 (2.7)	NAA25 (2.7)	TOMM40 (2.6)	DHX38 (2.4)	ENSG00000254235 (2.2)	TXNL4B (2.1)	DDX56 (2.0)	QTRT1 (1.9)	SMARCA4 (1.8)	FEN1 (1.8)
MP:0000240	extramedullary hematopoiesis	3.28e-03	<= 0.20	RHD (5.9)	RHCE (5.1)	BCL3 (4.6)	RELB (4.0)	PARP10 (3.7)	GMIP (3.6)	SH2B3 (2.8)	GRINA (2.7)	DNM2 (2.2)	MAFB (2.0)
MP:0000229	abnormal megakaryocyte differentiation	3.28e-03	<= 0.20	ABCG8 (7.8)	ITGB3 (6.0)	RHD (5.6)	RHCE (4.5)	CETP (4.5)	GMPR (3.7)	TIMD4 (2.6)	TM6SF2 (2.5)	FADS2 (1.8)	CYP7A1 (1.7)
ENSG00000136986	DERL1 PPI subnetwork	3.29e-03	<= 0.20	PLG (3.2)	APOC4 (3.1)	ANGPTL3 (3.1)	LPA (2.7)	HP (2.4)	APOC1 (2.3)	CYP7A1 (2.2)	APOA5 (1.8)	ITGB3 (1.8)	APOB (1.7)
GO:0006730	one-carbon metabolic process	3.29e-03	<= 0.20	QTRT1 (2.7)	DHODH (2.5)	ZNF180 (2.3)	LPA (2.2)	UBXN2B (2.1)	ILF3 (2.1)	ATXN7L2 (2.0)	C12orf51 (1.9)	ENSG00000238078 (1.9)	SLC22A1 (1.7)
ENSG00000165630	PRPF18 PPI subnetwork	3.31e-03	<= 0.20	DHX38 (4.0)	SMARCA4 (2.5)	TOP1 (2.4)	ATP13A1 (2.3)	USP1 (2.3)	MAU2 (2.2)	ZNF180 (2.0)	SUGP1 (2.0)	POC5 (1.9)	DDX56 (1.9)
MP:0001935	decreased litter size	3.33e-03	<= 0.20	APOB (2.6)	PLEKHH2 (2.4)	TRIB1 (2.4)	KANK2 (2.3)	PCSK9 (2.3)	ALDH2 (1.9)	APOE (1.8)	CYP7A1 (1.8)	GMPR (1.7)	NYNRIN (1.7)
GO:0070279	vitamin B6 binding	3.33e-03	<= 0.20	APOA5 (5.2)	PLG (4.9)	ANGPTL3 (4.6)	SLC22A1 (4.2)	APOC4 (4.0)	MOSC1 (3.9)	LPA (3.8)	TM6SF2 (3.7)	ALDH2 (3.5)	ABCG5 (3.4)
GO:0030170	pyridoxal phosphate binding	3.33e-03	<= 0.20	APOA5 (5.2)	PLG (4.9)	ANGPTL3 (4.6)	SLC22A1 (4.2)	APOC4 (4.0)	MOSC1 (3.9)	LPA (3.8)	TM6SF2 (3.7)	ALDH2 (3.5)	ABCG5 (3.4)
MP:0002447	abnormal erythrocyte morphology	3.35e-03	<= 0.20	RHCE (11.7)	RHD (11.6)	GMPR (4.5)	C12orf51 (4.0)	SLC44A2 (2.2)	MAU2 (2.2)	FADS2 (2.1)	KANK2 (2.0)	TMEM57 (1.9)	DNM2 (1.8)
ENSG00000215320	ENSG00000215320 PPI subnetwork	3.40e-03	<= 0.20	PARP10 (3.1)	USP24 (2.6)	CBLC (2.4)	BCL3 (2.3)	GMIP (2.2)	MAU2 (2.1)	MAFB (1.8)	OASL (1.8)	PPP1R37 (1.8)	HNF1A (1.7)
GO:0001701	in utero embryonic development	3.42e-03	<= 0.20	PVRL2 (2.3)	ATXN2 (2.1)	ATXN7L2 (2.1)	KANK2 (1.9)	SLC44A2 (1.9)	CEACAM19 (1.8)	PPP1R37 (1.7)	NYNRIN (1.6)	CARM1 (1.6)	TRIB1 (1.4)
GO:0008757	S-adenosylmethionine-dependent methyltransferase activity	3.47e-03	<= 0.20	QTRT1 (3.7)	DHODH (3.1)	NAA25 (2.7)	C12orf43 (2.4)	C12orf51 (2.3)	ILF3 (2.2)	MAPKAPK5 (2.1)	C19orf52 (2.0)	ATP13A1 (1.9)	ATXN2 (1.9)
MP:0004111	abnormal coronary artery morphology	3.50e-03	<= 0.20	MAFB (3.0)	MYLIP (2.8)	FRK (2.3)	TMEM57 (2.3)	TRIB1 (2.3)	SYPL2 (1.8)	PVR (1.7)	BCL3 (1.7)	TOP1 (1.6)	TMED4 (1.6)
GO:0044042	glucan metabolic process	3.50e-03	<= 0.20	SYPL2 (3.3)	LPA (3.3)	NT5DC1 (3.1)	SORT1 (2.6)	CYP7A1 (2.4)	ENSG00000254235 (2.3)	ZNF180 (2.2)	MOSC1 (2.2)	GPAM (2.2)	ZNF101 (2.1)
GO:0006073	cellular glucan metabolic process	3.50e-03	<= 0.20	SYPL2 (3.3)	LPA (3.3)	NT5DC1 (3.1)	SORT1 (2.6)	CYP7A1 (2.4)	ENSG00000254235 (2.3)	ZNF180 (2.2)	MOSC1 (2.2)	GPAM (2.2)	ZNF101 (2.1)
ENSG00000132394	EEFSEC PPI subnetwork	3.51e-03	<= 0.20	SARS (3.6)	PTPN11 (2.9)	BRAP (2.9)	ILF3 (2.4)	CLPTM1 (2.4)	BLOC1S3 (2.2)	C12orf43 (2.1)	OGDH (2.1)	CARM1 (2.0)	C12orf47 (1.9)
GO:0016811	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	3.51e-03	<= 0.20	ACAD10 (3.0)	SLC22A1 (2.9)	HNF1A (2.6)	NT5DC1 (2.5)	NPC1L1 (2.4)	TM6SF2 (2.4)	ATXN7L2 (2.2)	LPA (1.9)	C11orf9 (1.9)	ABCG5 (1.9)
ENSG00000182010	RTKN2 PPI subnetwork	3.54e-03	<= 0.20	APOB (5.1)	BCAM (4.1)	PLG (3.8)	APOE (3.8)	HP (3.7)	APOC1 (3.3)	APOA5 (3.2)	APOC4 (3.2)	ANGPTL3 (3.0)	PCSK9 (2.7)
GO:0044106	cellular amine metabolic process	3.54e-03	<= 0.20	CYP7A1 (3.1)	DHODH (3.1)	NT5DC1 (2.9)	LPA (2.9)	ABCG8 (2.9)	ANGPTL3 (2.7)	SLC22A1 (2.7)	TM6SF2 (2.5)	SARS (2.5)	ALDH2 (2.2)
ENSG00000091831	ESR1 PPI subnetwork	3.55e-03	<= 0.20	ATXN2 (3.3)	BCL3 (2.8)	PPP1R37 (2.8)	TRIB1 (2.7)	ZHX3 (2.5)	PLEC (2.4)	SMARCA4 (2.4)	DHX38 (2.3)	DNM2 (2.2)	MAU2 (2.2)
GO:0072593	reactive oxygen species metabolic process	3.56e-03	<= 0.20	ALDH2 (3.4)	GOT2P1 (2.6)	C17orf57 (2.3)	TRAPPC6A (2.1)	RHD (1.9)	AP1M2 (1.9)	RHCE (1.6)	ACAD10 (1.5)	PCSK9 (1.5)	CEACAM19 (1.5)
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	3.59e-03	<= 0.20	ITGB3 (8.2)	APOB (3.8)	HP (3.4)	APOC1 (3.3)	CETP (3.3)	PLG (3.0)	APOC4 (2.9)	APOA5 (2.8)	ANGPTL3 (2.8)	APOE (2.7)
ENSG00000017427	IGF1 PPI subnetwork	3.62e-03	<= 0.20	MYLIP (4.7)	LPA (3.8)	HLX (3.2)	APOE (3.2)	C1orf63 (3.2)	APOA5 (2.9)	ABCG5 (2.6)	ATXN7L2 (2.3)	SLC22A1 (2.3)	APOC4 (2.2)
ENSG00000105926	MPP6 PPI subnetwork	3.64e-03	<= 0.20	QTRT1 (4.4)	SUGP1 (3.2)	DDX56 (2.9)	ATP13A1 (2.5)	C19orf52 (2.3)	ILF3 (2.2)	DHODH (2.2)	MAU2 (2.1)	APOE (2.1)	UBXN2B (2.0)
ENSG00000007402	CACNA2D2 PPI subnetwork	3.66e-03	<= 0.20	APOB (6.4)	ANGPTL3 (6.0)	PLG (4.3)	APOE (4.2)	APOC4 (4.1)	APOA5 (3.9)	APOC1 (3.9)	HP (3.5)	PCSK9 (2.8)	ABCG5 (2.7)
MP:0005251	blepharitis	3.66e-03	<= 0.20	LPAR2 (3.0)	SLC44A2 (2.5)	BCL3 (2.5)	GMIP (2.3)	DNM2 (2.2)	QTRT1 (2.2)	KANK2 (2.0)	GCNT4 (1.9)	SH2B3 (1.9)	PPP1R37 (1.8)
GO:0051259	protein oligomerization	3.66e-03	<= 0.20	NT5DC1 (2.6)	ACAD10 (2.2)	HAPLN4 (1.9)	C12orf43 (1.8)	SLC22A1 (1.7)	MOSC1 (1.7)	GMPR (1.7)	TRAPPC6A (1.6)	PARP10 (1.6)	C19orf52 (1.5)
ENSG00000185479	KRT6B PPI subnetwork	3.67e-03	<= 0.20	APOB (7.5)	PLG (5.3)	APOA5 (5.2)	ANGPTL3 (4.4)	HP (4.4)	APOC4 (4.2)	APOC1 (3.7)	ABCG5 (3.3)	NPC1L1 (3.0)	APOE (2.8)
ENSG00000033800	PIAS1 PPI subnetwork	3.71e-03	<= 0.20	TRAFD1 (3.2)	BCL3 (2.4)	CETP (2.0)	ABCG8 (1.8)	ALDH2 (1.7)	GOT2P1 (1.7)	OASL (1.7)	PARP10 (1.6)	ENSG00000228044 (1.6)	GATAD2A (1.6)
ENSG00000115548	KDM3A PPI subnetwork	3.72e-03	<= 0.20	SARS (4.3)	OGDH (3.1)	CLPTM1 (3.1)	PTPN11 (3.1)	C12orf43 (2.8)	BRAP (2.7)	GATAD2A (2.3)	CARM1 (2.1)	DNAH11 (1.9)	ILF3 (1.8)
ENSG00000175536	LIPT2 PPI subnetwork	3.72e-03	<= 0.20	USP24 (3.1)	QTRT1 (2.4)	NAA25 (2.2)	GMPR (2.1)	ENSG00000254235 (1.9)	SMARCA4 (1.7)	DHX38 (1.7)	CYP7A1 (1.7)	GEMIN7 (1.6)	ATP13A1 (1.6)
ENSG00000141378	PTRH2 PPI subnetwork	3.74e-03	<= 0.20	DNM2 (3.8)	GATAD2A (3.2)	CARM1 (3.0)	QTRT1 (2.7)	MAU2 (2.6)	TOMM40 (2.4)	CLPTM1 (2.4)	PPP1R37 (2.3)	SUGP1 (2.2)	TMEM57 (2.0)
MP:0008809	increased spleen iron level	3.74e-03	<= 0.20	RHCE (10.8)	RHD (10.7)	TIMD4 (5.9)	CETP (5.0)	GMPR (2.2)	HP (2.2)	APOC1 (2.2)	SLC44A2 (1.6)	GEMIN7 (1.6)	APOE (1.6)
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	3.78e-03	<= 0.20	ERP29 (4.8)	ATP13A1 (3.3)	TMED4 (2.9)	NKPD1 (2.7)	TMEM50A (2.3)	TRAPPC6A (2.3)	CETP (2.0)	GCNT4 (1.9)	PMFBP1 (1.8)	COL4A3BP (1.7)
ENSG00000049618	ARID1B PPI subnetwork	3.79e-03	<= 0.20	CARM1 (3.5)	GRINA (3.1)	TRAFD1 (2.9)	SMARCA4 (2.7)	CLPTM1 (2.7)	PPP1R37 (2.6)	ATXN2 (2.3)	PCSK9 (2.2)	NYNRIN (2.1)	MAU2 (2.1)
ENSG00000150527	CTAGE5 PPI subnetwork	3.79e-03	<= 0.20	APOB (7.3)	PLG (5.3)	APOA5 (5.3)	ANGPTL3 (4.4)	HP (4.4)	APOC4 (4.3)	APOC1 (3.9)	ABCG5 (3.3)	APOE (3.0)	NPC1L1 (2.9)
ENSG00000148965	SAA4 PPI subnetwork	3.80e-03	<= 0.20	APOB (5.9)	APOE (4.9)	PLG (4.7)	HP (4.2)	APOA5 (3.9)	APOC4 (3.9)	APOC1 (3.9)	ANGPTL3 (3.5)	BCAM (3.2)	PCSK9 (3.0)
GO:0001530	lipopolysaccharide binding	3.81e-03	<= 0.20	HP (3.7)	MAFB (3.7)	MYLIP (2.6)	LDLR (2.2)	NKPD1 (2.1)	FADS1 (2.1)	APOC1 (2.1)	ALDH2 (1.9)	APOE (1.9)	TRIB1 (1.8)
ENSG00000067225	PKM2 PPI subnetwork	3.81e-03	<= 0.20	SARS (4.5)	PLEC (2.5)	SMARCA4 (2.1)	FADS2 (2.1)	NAA25 (2.0)	NT5DC1 (1.9)	OGDH (1.8)	FADS1 (1.8)	GRINA (1.8)	PSMA5 (1.8)
GO:0051635	bacterial cell surface binding	3.83e-03	<= 0.20	HP (8.5)	LPA (4.6)	APOC4 (4.2)	APOA5 (4.2)	TIMD4 (3.8)	CETP (3.7)	PLG (3.6)	DHODH (3.2)	MOSC1 (3.2)	ABCG5 (2.9)
MP:0008553	increased circulating tumor necrosis factor level	3.86e-03	<= 0.20	BCL3 (4.8)	MAFB (4.5)	TRIB1 (4.4)	CETP (4.2)	TIMD4 (4.2)	RELB (3.7)	GMIP (3.4)	PARP10 (2.4)	PVR (2.3)	LPAR2 (2.2)
GO:0008374	O-acyltransferase activity	3.89e-03	<= 0.20	MOSC1 (4.8)	TM6SF2 (4.6)	NPC1L1 (4.0)	GPAM (3.9)	FADS1 (2.9)	ABCG5 (2.8)	FADS2 (2.6)	APOB (2.3)	LPAR2 (2.2)	GRINA (2.1)
ENSG00000166949	SMAD3 PPI subnetwork	3.89e-03	<= 0.20	GATAD2A (4.2)	TRIB1 (3.4)	BUD13 (3.0)	PLEC (2.8)	PLCG1 (2.5)	CARM1 (2.5)	NYNRIN (2.4)	ATXN7L2 (2.4)	ATXN2 (2.3)	KANK2 (2.3)
ENSG00000100311	PDGFB PPI subnetwork	3.90e-03	<= 0.20	C1orf63 (4.0)	MYLIP (2.8)	PLEC (2.6)	HLX (2.5)	CBLC (2.5)	C17orf57 (2.3)	SLC44A2 (2.0)	HAVCR1 (2.0)	ADAM1 (2.0)	APOE (1.7)
GO:0045725	positive regulation of glycogen biosynthetic process	3.91e-03	<= 0.20	LPA (2.0)	ENSG00000226645 (1.8)	ENSG00000228044 (1.7)	GPAM (1.7)	KANK2 (1.6)	MYLIP (1.6)	HNF1A (1.5)	TMEM116 (1.2)	ZNF180 (1.2)	PPP1R37 (1.2)
ENSG00000122194	PLG PPI subnetwork	3.91e-03	<= 0.20	ANGPTL3 (5.3)	PLG (4.8)	APOC4 (4.5)	APOA5 (4.4)	HP (4.1)	SLC22A1 (3.9)	APOB (3.7)	PVRL2 (3.0)	APOC1 (2.9)	APOE (2.8)
ENSG00000119938	PPP1R3C PPI subnetwork	3.92e-03	<= 0.20	SYPL2 (3.7)	LPA (3.0)	ZNF180 (3.0)	DHODH (2.8)	SORT1 (2.6)	CLPTM1 (2.4)	DOCK7 (2.2)	SLC44A2 (2.1)	NT5DC1 (2.1)	MOSC1 (2.0)
ENSG00000012963	UBR7 PPI subnetwork	3.94e-03	<= 0.20	ATXN7L2 (4.6)	DNM2 (3.5)	QTRT1 (2.8)	PSMA5 (2.5)	ABO (2.5)	C19orf52 (2.3)	SYPL2 (2.2)	MAFB (2.1)	C17orf57 (2.1)	ATP13A1 (2.0)
GO:0042157	lipoprotein metabolic process	3.97e-03	<= 0.20	NPC1L1 (3.0)	HNF1A (2.8)	ABCG5 (2.5)	ADAM1 (2.4)	CEACAM19 (2.4)	C17orf57 (2.3)	ERP29 (2.3)	TM6SF2 (2.2)	APOC1 (2.2)	TMED4 (2.1)
GO:0060205	cytoplasmic membrane-bounded vesicle lumen	3.98e-03	<= 0.20	ANGPTL3 (6.3)	HP (5.6)	ITGB3 (5.4)	PLG (5.3)	APOB (4.4)	APOA5 (4.1)	APOC4 (4.1)	APOE (4.0)	APOC1 (3.5)	LPA (2.7)
ENSG00000112651	MRPL2 PPI subnetwork	3.98e-03	<= 0.20	NAA25 (4.5)	DDX56 (4.3)	TOMM40 (3.8)	ZNF259 (3.8)	QTRT1 (3.7)	DHODH (3.0)	C12orf43 (2.5)	TOP1 (2.3)	BRAP (2.2)	DHX38 (2.2)
MP:0003657	abnormal erythrocyte osmotic lysis	4.06e-03	<= 0.20	RHD (12.0)	RHCE (11.4)	GMPR (3.8)	C12orf51 (3.5)	ABCG8 (3.0)	APOA5 (2.4)	CYP7A1 (2.2)	ADAM1 (1.9)	NPC1L1 (1.9)	GRINA (1.8)
MP:0004185	abnormal adipocyte glucose uptake	4.06e-03	<= 0.20	GPAM (3.2)	SYPL2 (3.2)	PLCG1 (3.0)	ATXN7L2 (2.6)	PLEC (2.6)	ENSG00000254235 (2.3)	CETP (2.3)	GATAD2A (2.3)	DNM2 (2.2)	PTPN11 (2.1)
MP:0005560	decreased circulating glucose level	4.08e-03	<= 0.20	APOA5 (4.0)	APOC4 (3.7)	GPAM (3.2)	KIAA1324 (3.0)	HP (2.9)	MOSC1 (2.8)	APOC1 (2.4)	LPA (2.3)	TM6SF2 (2.2)	ANGPTL3 (2.1)
GO:0071383	cellular response to steroid hormone stimulus	4.08e-03	<= 0.20	HNF1A (3.7)	ABCG8 (3.3)	LPIN3 (2.7)	CYP7A1 (2.5)	ABO (2.3)	GCNT4 (2.1)	TM6SF2 (2.0)	FRK (2.0)	TMEM57 (1.7)	ABCG5 (1.7)
GO:0016042	lipid catabolic process	4.12e-03	<= 0.20	NKPD1 (4.9)	ACAD10 (3.7)	MOSC1 (3.1)	GCNT4 (2.7)	ABCG8 (2.6)	TM6SF2 (2.5)	GPAM (2.5)	LPA (2.3)	APOC4 (2.3)	SLC22A1 (2.2)
GO:0005977	glycogen metabolic process	4.17e-03	<= 0.20	LPA (3.5)	SYPL2 (3.3)	NT5DC1 (3.1)	ENSG00000254235 (2.5)	SORT1 (2.5)	CYP7A1 (2.5)	ZNF180 (2.3)	GPAM (2.2)	ZHX3 (2.1)	ZNF101 (2.1)
MP:0002575	increased circulating ketone body level	4.17e-03	<= 0.20	ACAD10 (3.8)	MOSC1 (3.7)	GPAM (3.4)	APOA5 (2.8)	HNF1A (2.6)	NPC1L1 (2.4)	ZHX3 (2.3)	ABCG8 (1.8)	HP (1.7)	ABCG5 (1.7)
GO:0008206	bile acid metabolic process	4.21e-03	<= 0.20	CYP7A1 (6.5)	APOC4 (4.3)	ANGPTL3 (4.1)	LPA (4.1)	SLC22A1 (3.8)	ABCG8 (3.7)	ABCG5 (3.3)	APOA5 (3.2)	TM6SF2 (2.7)	NKPD1 (2.7)
GO:0044419	interspecies interaction between organisms	4.21e-03	<= 0.20	PARP10 (3.3)	OASL (2.9)	TRAFD1 (2.7)	GRINA (2.4)	MAU2 (2.3)	NAA25 (2.3)	TOP1 (2.0)	ADAM1 (1.8)	BUD13 (1.8)	PTPN11 (1.7)
ENSG00000084754	HADHA PPI subnetwork	4.25e-03	<= 0.20	SYPL2 (3.3)	ACAD10 (3.0)	OGDH (2.5)	GMPR (2.4)	TMEM50A (2.3)	PLEC (2.0)	RHD (1.9)	RELB (1.8)	LPAR2 (1.7)	LPIN3 (1.7)
GO:0050997	quaternary ammonium group binding	4.27e-03	<= 0.20	PLG (7.8)	APOC4 (6.7)	ANGPTL3 (6.3)	APOB (5.6)	APOA5 (5.1)	LPA (4.5)	HP (4.4)	ABCG5 (3.9)	TIMD4 (3.7)	APOE (3.6)
GO:0051184	cofactor transporter activity	4.32e-03	<= 0.20	TM6SF2 (4.7)	ABCG8 (4.1)	ABCG5 (3.1)	NPC1L1 (2.8)	GRINA (2.4)	APOB (2.4)	HAVCR1 (2.3)	DNAH11 (2.2)	TMEM116 (2.1)	NT5DC1 (2.0)
MP:0005325	abnormal renal glomerulus morphology	4.32e-03	<= 0.20	PVRL2 (4.3)	BCAM (4.0)	NYNRIN (2.5)	TRIB1 (2.5)	PVR (2.4)	TMED4 (2.2)	APOE (2.0)	MAFB (1.9)	BCL3 (1.7)	HLX (1.6)
ENSG00000213044	ENSG00000213044 PPI subnetwork	4.33e-03	<= 0.20	APOB (8.4)	APOC1 (5.9)	PLG (5.8)	APOA5 (5.6)	ANGPTL3 (5.0)	HP (5.0)	APOC4 (4.4)	ABCG5 (4.2)	NPC1L1 (3.9)	APOE (3.5)
ENSG00000143569	UBAP2L PPI subnetwork	4.35e-03	<= 0.20	PPP1R37 (3.3)	C17orf57 (3.3)	GRINA (3.2)	CARM1 (2.6)	UBXN2B (2.2)	MARK4 (2.1)	BLOC1S3 (1.9)	PTPN11 (1.9)	CEACAM19 (1.7)	OGDH (1.7)
GO:0018904	organic ether metabolic process	4.38e-03	<= 0.20	GPAM (4.5)	MOSC1 (4.2)	PCSK9 (3.6)	FADS1 (3.6)	NPC1L1 (3.6)	FADS2 (3.5)	HMGCR (3.5)	TM6SF2 (3.2)	LDLR (3.0)	CYP7A1 (2.5)
ENSG00000131095	GFAP PPI subnetwork	4.40e-03	<= 0.20	ITGB3 (2.2)	MOSC1 (2.1)	C11orf9 (1.9)	PLEC (1.8)	LPA (1.6)	POLK (1.6)	ENSG00000238078 (1.5)	CELSR2 (1.5)	HAPLN4 (1.5)	SYPL2 (1.4)
REACTOME_CYTOCHROME_P450_:_ARRANGED_BY_SUBSTRATE_TYPE	REACTOME_CYTOCHROME_P450_:_ARRANGED_BY_SUBSTRATE_TYPE	4.42e-03	<= 0.20	SLC22A1 (8.0)	LPA (7.3)	CYP7A1 (6.0)	APOC4 (5.6)	ABCG5 (5.3)	TM6SF2 (5.3)	APOA5 (5.1)	ABCG8 (4.6)	ANGPTL3 (4.5)	PLG (4.3)
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	4.45e-03	<= 0.20	PLG (4.5)	ANGPTL3 (4.0)	ABCG5 (3.3)	SLC22A1 (3.3)	CYP7A1 (3.1)	APOC4 (3.1)	ABCG8 (3.0)	TM6SF2 (2.6)	APOA5 (2.6)	HP (2.4)
GO:0006694	steroid biosynthetic process	4.46e-03	<= 0.20	FADS2 (7.3)	HMGCR (7.0)	LDLR (6.9)	FADS1 (6.6)	PCSK9 (5.7)	CYP7A1 (4.7)	ST3GAL4 (3.4)	TRAPPC6A (3.0)	SLC22A1 (2.1)	APOC4 (2.1)
MP:0008770	decreased survivor rate	4.48e-03	<= 0.20	PCSK9 (4.5)	LDLR (3.3)	MYLIP (2.8)	USP24 (2.7)	HLX (2.6)	OASL (2.5)	FADS1 (2.5)	PLEC (2.3)	KANK2 (2.2)	GMPR (2.2)
GO:0051248	negative regulation of protein metabolic process	4.49e-03	<= 0.20	PSMA5 (2.9)	TMEM57 (2.4)	TRAFD1 (1.9)	GRINA (1.8)	NAA25 (1.7)	ENSG00000238078 (1.6)	GCNT4 (1.6)	TRIB1 (1.4)	PARP10 (1.4)	DDX56 (1.4)
ENSG00000204983	PRSS1 PPI subnetwork	4.49e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.0)	ANGPTL3 (5.0)	HP (4.4)	APOC4 (4.1)	APOC1 (4.0)	ABCG5 (3.7)	NPC1L1 (3.6)	APOE (3.3)
ENSG00000211592	ENSG00000211592 PPI subnetwork	4.50e-03	<= 0.20	APOE (5.4)	TIMD4 (4.6)	MAFB (4.0)	APOC1 (2.8)	CETP (2.4)	ALDH2 (2.3)	DOCK7 (1.9)	GPAM (1.9)	GCNT4 (1.8)	RHD (1.6)
GO:0034774	secretory granule lumen	4.55e-03	<= 0.20	ANGPTL3 (6.5)	HP (5.7)	PLG (5.4)	ITGB3 (5.3)	APOE (4.2)	APOA5 (4.2)	APOB (4.1)	APOC4 (4.1)	APOC1 (3.7)	LPA (2.9)
ENSG00000004455	AK2 PPI subnetwork	4.63e-03	<= 0.20	NYNRIN (3.4)	MARK4 (2.8)	ZNF180 (2.6)	RHCE (2.3)	PSMA5 (2.0)	ZNF101 (1.9)	GRINA (1.8)	MYLIP (1.8)	TM6SF2 (1.8)	CELSR2 (1.7)
ENSG00000089199	CHGB PPI subnetwork	4.63e-03	<= 0.20	C17orf57 (3.0)	C12orf51 (2.8)	GPAM (2.8)	ATXN7L2 (2.7)	MARK4 (2.7)	SMARCA4 (2.4)	PLEC (2.4)	ACAD10 (2.4)	HAPLN4 (2.2)	MAPKAPK5 (2.1)
ENSG00000075643	MOCOS PPI subnetwork	4.64e-03	<= 0.20	APOE (7.7)	APOB (5.8)	TIMD4 (4.8)	APOC1 (4.5)	MAFB (3.6)	APOA5 (3.5)	NPC1L1 (3.5)	HP (3.4)	APOC4 (3.4)	PLG (3.3)
ENSG00000100902	PSMA6 PPI subnetwork	4.65e-03	<= 0.20	PSMA5 (5.0)	NAA25 (3.5)	DDX56 (3.3)	TOMM40 (3.0)	ZNF259 (2.6)	SARS (2.3)	SUGP1 (2.3)	NT5DC1 (2.0)	TRAFD1 (1.9)	QTRT1 (1.8)
MP:0002356	abnormal spleen red pulp morphology	4.67e-03	<= 0.20	RHCE (3.3)	HLX (3.0)	MAFB (2.6)	PLEKHH2 (2.4)	RHD (2.4)	ATP13A1 (2.1)	ZNF101 (2.0)	YIPF2 (1.8)	GMPR (1.8)	MYLIP (1.8)
ENSG00000154262	ABCA6 PPI subnetwork	4.67e-03	<= 0.20	APOE (7.8)	APOB (6.2)	APOC1 (4.7)	TIMD4 (4.5)	NPC1L1 (3.9)	MAFB (3.6)	APOA5 (3.4)	HP (3.4)	APOC4 (3.0)	ABCG5 (3.0)
MP:0000512	intestinal ulcer	4.68e-03	<= 0.20	SLC22A1 (5.5)	FADS1 (4.4)	APOC4 (3.2)	LPA (3.1)	APOA5 (3.0)	ANGPTL3 (2.7)	C17orf57 (2.7)	HP (2.6)	NYNRIN (2.6)	LDLR (2.5)
KEGG_STEROID_HORMONE_BIOSYNTHESIS	KEGG_STEROID_HORMONE_BIOSYNTHESIS	4.70e-03	<= 0.20	CYP7A1 (6.1)	ABCG5 (5.9)	SLC22A1 (5.5)	ABCG8 (5.2)	APOC4 (5.2)	LPA (4.7)	APOA5 (4.2)	ANGPTL3 (3.8)	TM6SF2 (3.5)	ST3GAL4 (3.1)
MP:0000187	abnormal triglyceride level	4.72e-03	<= 0.20	PCSK9 (5.7)	NPC1L1 (5.2)	FADS2 (5.1)	ABCG5 (5.0)	FADS1 (5.0)	HMGCR (4.9)	APOC1 (4.8)	GPAM (3.9)	LDLR (3.6)	TM6SF2 (3.3)
MP:0005294	abnormal heart ventricle morphology	4.76e-03	<= 0.20	PVR (3.1)	BCAM (2.7)	PVRL2 (2.5)	HP (1.9)	ENSG00000226648 (1.9)	CEACAM19 (1.8)	NYNRIN (1.6)	KANK2 (1.4)	GPAM (1.4)	SLC22A1 (1.3)
ENSG00000109272	PF4V1 PPI subnetwork	4.77e-03	<= 0.20	APOB (7.8)	PLG (5.4)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.7)	ABCG5 (3.6)	APOE (3.2)
ENSG00000205813	ENSG00000205813 PPI subnetwork	4.77e-03	<= 0.20	APOB (7.8)	PLG (5.4)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.7)	ABCG5 (3.6)	APOE (3.2)
MP:0005342	abnormal intestinal lipid absorption	4.77e-03	<= 0.20	ABCG8 (6.6)	TM6SF2 (6.0)	ABCG5 (5.4)	NPC1L1 (5.3)	APOB (3.1)	HAPLN4 (2.1)	GCNT4 (2.1)	CBLC (2.0)	KIAA1324 (2.0)	C11orf9 (1.9)
GO:0065005	protein-lipid complex assembly	4.79e-03	<= 0.20	NPC1L1 (5.2)	APOB (4.0)	ABCG5 (3.9)	APOC1 (3.5)	HAVCR1 (3.3)	APOE (3.2)	TM6SF2 (3.0)	APOA5 (2.8)	ABCG8 (2.4)	APOC4 (2.1)
GO:0034377	plasma lipoprotein particle assembly	4.79e-03	<= 0.20	NPC1L1 (5.2)	APOB (4.0)	ABCG5 (3.9)	APOC1 (3.5)	HAVCR1 (3.3)	APOE (3.2)	TM6SF2 (3.0)	APOA5 (2.8)	ABCG8 (2.4)	APOC4 (2.1)
ENSG00000171401	KRT13 PPI subnetwork	4.79e-03	<= 0.20	APOB (8.1)	PLG (5.5)	APOA5 (5.2)	ANGPTL3 (4.9)	HP (4.5)	APOC1 (4.3)	APOC4 (4.2)	NPC1L1 (3.9)	ABCG5 (3.8)	APOE (3.2)
ENSG00000197530	MIB2 PPI subnetwork	4.80e-03	<= 0.20	TIMD4 (3.6)	OASL (3.5)	CETP (3.3)	HNF1A (2.3)	SYPL2 (2.0)	BRAP (1.9)	PLG (1.8)	LPA (1.7)	GOT2P1 (1.7)	HAPLN4 (1.6)
GO:0016209	antioxidant activity	4.81e-03	<= 0.20	ALDH2 (4.0)	MOSC1 (4.0)	RHD (3.4)	HP (2.9)	PSMA5 (2.3)	APOC1 (2.3)	HLX (2.1)	NYNRIN (2.0)	RHCE (1.9)	AP1M2 (1.8)
ENSG00000160220	ENSG00000160220 PPI subnetwork	4.82e-03	<= 0.20	ZNF259 (4.7)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (3.6)	TOMM40 (3.6)	DHODH (2.9)	DHX38 (2.5)	ATP13A1 (2.5)	BRAP (2.3)	C12orf43 (2.1)
ENSG00000183336	BOLA2 PPI subnetwork	4.83e-03	<= 0.20	LPIN3 (2.5)	GOT2P1 (2.5)	NT5DC1 (2.5)	DOCK7 (2.5)	FADS2 (1.7)	TOP1 (1.6)	TOMM40 (1.6)	ABO (1.6)	SH2B3 (1.5)	PBX4 (1.5)
ENSG00000169627	BOLA2B PPI subnetwork	4.83e-03	<= 0.20	LPIN3 (2.5)	GOT2P1 (2.5)	NT5DC1 (2.5)	DOCK7 (2.5)	FADS2 (1.7)	TOP1 (1.6)	TOMM40 (1.6)	ABO (1.6)	SH2B3 (1.5)	PBX4 (1.5)
ENSG00000168454	TXNDC2 PPI subnetwork	4.84e-03	<= 0.20	APOE (7.4)	APOB (6.4)	TIMD4 (5.3)	APOC1 (4.5)	APOA5 (3.9)	NPC1L1 (3.8)	ABCG5 (3.6)	APOC4 (3.5)	MAFB (3.4)	PLG (3.4)
ENSG00000167768	KRT1 PPI subnetwork	4.93e-03	<= 0.20	APOC4 (3.5)	PLG (3.5)	ANGPTL3 (3.2)	HP (2.9)	APOA5 (2.8)	SLC22A1 (2.7)	LPA (2.5)	CEACAM19 (2.5)	CBLC (2.4)	APOC1 (2.3)
MP:0004259	small placenta	4.93e-03	<= 0.20	LDLR (3.4)	PCSK9 (3.2)	APOB (3.1)	FADS2 (2.5)	HMGCR (2.4)	DNM2 (2.3)	APOA5 (2.3)	HP (2.1)	C11orf9 (2.1)	AP1M2 (2.1)
ENSG00000008083	JARID2 PPI subnetwork	4.95e-03	<= 0.20	OASL (3.2)	TIMD4 (2.9)	CETP (2.5)	C11orf9 (2.3)	NPC1L1 (2.3)	GMPR (2.2)	HNF1A (2.1)	LPAR2 (2.0)	ABCG8 (1.6)	PVRL2 (1.6)
MP:0008705	increased interleukin-6 secretion	4.96e-03	<= 0.20	OASL (4.0)	GMIP (3.4)	ALDH2 (3.1)	MOSC1 (2.9)	TRIB1 (2.9)	BCL3 (2.7)	COL4A3BP (2.3)	RELB (2.2)	GRINA (2.2)	HP (2.2)
ENSG00000168907	PLA2G4F PPI subnetwork	4.97e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.8)	ABCG5 (3.6)	APOE (3.3)
ENSG00000103742	IGDCC4 PPI subnetwork	4.98e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.4)	APOC4 (4.0)	APOC1 (3.9)	NPC1L1 (3.8)	ABCG5 (3.7)	APOE (3.1)
ENSG00000047849	MAP4 PPI subnetwork	5.00e-03	<= 0.20	PSRC1 (2.7)	DNAH11 (2.5)	GRINA (2.3)	POC5 (2.3)	ENSG00000235545 (2.2)	GMIP (2.0)	OGDH (2.0)	BRAP (1.9)	ZHX3 (1.9)	ENSG00000226648 (1.9)
ENSG00000142515	KLK3 PPI subnetwork	5.01e-03	<= 0.20	HP (3.7)	APOC1 (3.7)	APOA5 (3.6)	RHD (3.3)	PCSK9 (3.2)	LPA (2.8)	ANGPTL3 (2.5)	APOE (2.5)	TIMD4 (2.4)	APOC4 (2.2)
GO:0004866	endopeptidase inhibitor activity	5.03e-03	<= 0.20	HP (5.7)	APOB (5.4)	PLG (5.2)	APOA5 (4.9)	APOC1 (4.5)	APOC4 (4.2)	ANGPTL3 (4.0)	SLC22A1 (3.3)	PCSK9 (3.2)	LPA (2.7)
MP:0002086	abnormal extraembryonic tissue morphology	5.04e-03	<= 0.20	PVRL2 (2.5)	DOCK7 (2.4)	C17orf57 (2.3)	GATAD2A (2.3)	ITGB3 (2.1)	LDLR (2.0)	ATXN2 (2.0)	DNM2 (2.0)	COL4A3BP (1.9)	KANK2 (1.9)
MP:0003103	liver degeneration	5.10e-03	<= 0.20	OASL (4.2)	PARP10 (3.9)	PLG (3.8)	APOC4 (3.4)	APOA5 (3.2)	RHD (3.2)	BCL3 (2.8)	ANGPTL3 (2.8)	LPA (2.6)	TIMD4 (2.5)
ENSG00000170871	KIAA0232 PPI subnetwork	5.12e-03	<= 0.20	APOB (8.6)	PLG (5.9)	APOA5 (5.6)	ANGPTL3 (5.0)	HP (4.9)	APOC4 (4.5)	APOC1 (4.3)	NPC1L1 (3.9)	ABCG5 (3.8)	APOE (3.4)
GO:0004497	monooxygenase activity	5.14e-03	<= 0.20	SLC22A1 (6.4)	LPA (6.1)	CYP7A1 (5.6)	ABCG5 (4.9)	APOC4 (4.9)	ANGPTL3 (4.7)	PLG (4.6)	TM6SF2 (4.2)	ABCG8 (4.0)	APOA5 (3.8)
MP:0005266	abnormal metabolism	5.17e-03	<= 0.20	ABCG8 (6.2)	HP (3.8)	NPC1L1 (3.6)	KIAA1324 (3.5)	TM6SF2 (3.2)	ABCG5 (3.2)	LPIN3 (3.1)	APOB (2.7)	APOC4 (2.7)	MOSC1 (2.6)
ENSG00000124006	OBSL1 PPI subnetwork	5.20e-03	<= 0.20	APOB (7.8)	PLG (5.5)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.2)	APOC1 (4.0)	ABCG5 (3.7)	NPC1L1 (3.6)	APOE (3.2)
GO:0015718	monocarboxylic acid transport	5.22e-03	<= 0.20	TM6SF2 (3.6)	ABCG8 (3.1)	CYP7A1 (2.7)	APOA5 (2.3)	APOC4 (2.2)	DNAH11 (2.0)	ABCG5 (1.9)	GPAM (1.8)	CYB561D1 (1.8)	MOSC1 (1.7)
GO:0046463	acylglycerol biosynthetic process	5.23e-03	<= 0.20	FADS1 (4.9)	FADS2 (4.8)	GPAM (4.6)	PCSK9 (4.4)	HMGCR (4.0)	MOSC1 (3.9)	LDLR (3.4)	NPC1L1 (2.5)	TM6SF2 (2.4)	BLOC1S3 (2.2)
GO:0046460	neutral lipid biosynthetic process	5.23e-03	<= 0.20	FADS1 (4.9)	FADS2 (4.8)	GPAM (4.6)	PCSK9 (4.4)	HMGCR (4.0)	MOSC1 (3.9)	LDLR (3.4)	NPC1L1 (2.5)	TM6SF2 (2.4)	BLOC1S3 (2.2)
ENSG00000156587	UBE2L6 PPI subnetwork	5.24e-03	<= 0.20	GRINA (2.8)	OGDH (2.5)	CARM1 (2.5)	GOT2P1 (2.4)	OASL (2.4)	TRAFD1 (2.3)	PPP1R37 (2.2)	COL4A3BP (2.1)	C19orf52 (2.0)	PARP10 (1.8)
GO:0043498	cell surface binding	5.24e-03	<= 0.20	HP (8.8)	PLG (5.8)	ANGPTL3 (5.6)	APOC4 (5.1)	APOB (5.0)	APOA5 (4.9)	MOSC1 (3.4)	LPA (3.2)	PCSK9 (2.8)	TIMD4 (2.7)
GO:0051260	protein homooligomerization	5.24e-03	<= 0.20	LPA (2.4)	TRAPPC6A (2.4)	ACAD10 (2.3)	ALDH2 (1.9)	CYP7A1 (1.9)	TMEM116 (1.9)	SLC22A1 (1.8)	TMEM57 (1.8)	CILP2 (1.8)	MOSC1 (1.7)
GO:0016709	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen	5.26e-03	<= 0.20	LPA (5.9)	SLC22A1 (5.9)	PLG (5.7)	APOC4 (5.6)	ABCG5 (5.4)	CYP7A1 (5.3)	ANGPTL3 (4.7)	APOA5 (4.6)	ABCG8 (4.0)	TM6SF2 (3.8)
GO:0007584	response to nutrient	5.28e-03	<= 0.20	FADS2 (3.0)	ATXN7L2 (2.8)	CYP7A1 (2.7)	TM6SF2 (2.6)	NPC1L1 (2.4)	ABCG8 (2.4)	PCSK9 (2.3)	ENSG00000235545 (2.3)	FADS1 (2.0)	LDLR (1.9)
ENSG00000188994	ZNF292 PPI subnetwork	5.29e-03	<= 0.20	APOB (7.7)	PLG (5.4)	APOA5 (5.0)	ANGPTL3 (4.7)	HP (4.3)	APOC4 (4.1)	APOC1 (4.1)	ABCG5 (3.7)	NPC1L1 (3.6)	APOE (3.2)
GO:0006112	energy reserve metabolic process	5.33e-03	<= 0.20	SORT1 (3.3)	HAPLN4 (3.1)	ENSG00000238078 (2.9)	GPAM (2.9)	CYP7A1 (2.8)	ENSG00000254235 (2.5)	MOSC1 (2.5)	KIAA1324 (2.4)	AMIGO1 (2.4)	LPA (2.1)
ENSG00000047457	CP PPI subnetwork	5.40e-03	<= 0.20	RHD (3.5)	HP (3.4)	TIMD4 (3.2)	ALDH2 (2.9)	CYP7A1 (2.6)	APOE (2.6)	CETP (2.5)	APOC4 (2.4)	DOCK7 (2.2)	APOA5 (2.0)
MP:0008470	abnormal spleen B cell follicle morphology	5.40e-03	<= 0.20	RELB (5.7)	GRINA (4.6)	CLPTM1 (3.5)	PVRL2 (3.3)	HAVCR1 (3.1)	TIMD4 (2.8)	GMIP (2.4)	CETP (2.2)	BCAM (2.0)	PLEC (1.8)
ENSG00000072778	ACADVL PPI subnetwork	5.41e-03	<= 0.20	BCAM (2.8)	ANGPTL3 (2.7)	APOC1 (2.0)	OGDH (2.0)	APOE (1.9)	PLEC (1.9)	ALDH2 (1.9)	RHD (1.8)	BRAP (1.8)	GMPR (1.8)
GO:0015144	carbohydrate transmembrane transporter activity	5.41e-03	<= 0.20	TMED4 (3.4)	TM6SF2 (2.7)	APOB (2.4)	ATP13A1 (2.3)	CLPTM1 (2.3)	TSSK6 (2.2)	TMEM50A (2.0)	SORT1 (2.0)	HAPLN4 (1.9)	NPC1L1 (1.8)
ENSG00000198911	SREBF2 PPI subnetwork	5.42e-03	<= 0.20	LDLR (7.7)	HMGCR (7.2)	FADS2 (5.4)	FADS1 (4.9)	PCSK9 (4.1)	ABO (2.5)	CARM1 (2.4)	UBXN2B (2.3)	HNF1A (2.3)	SH2B3 (2.0)
GO:0061135	endopeptidase regulator activity	5.45e-03	<= 0.20	HP (5.7)	APOB (5.4)	PLG (5.1)	APOA5 (4.8)	APOC1 (4.5)	APOC4 (4.1)	ANGPTL3 (3.9)	PCSK9 (3.4)	SLC22A1 (3.4)	LPA (2.6)
ENSG00000133805	AMPD3 PPI subnetwork	5.55e-03	<= 0.20	APOB (7.8)	PLG (5.6)	APOA5 (5.1)	ANGPTL3 (4.8)	HP (4.3)	APOC4 (4.1)	APOC1 (4.0)	NPC1L1 (3.6)	ABCG5 (3.6)	APOE (3.1)
GO:0043176	amine binding	5.57e-03	<= 0.20	PLG (4.7)	ANGPTL3 (4.7)	APOC4 (4.4)	ABCG5 (4.0)	ABCG8 (3.6)	SLC22A1 (3.5)	APOA5 (3.3)	LPA (3.3)	HP (3.2)	APOC1 (2.8)
ENSG00000105197	TIMM50 PPI subnetwork	5.57e-03	<= 0.20	RELB (8.0)	BCL3 (4.9)	HAVCR1 (2.8)	PVR (2.5)	CLPTM1 (2.5)	CEACAM19 (2.0)	GCNT4 (1.9)	GRINA (1.9)	LPAR2 (1.9)	CARM1 (1.8)
REACTOME_COMMON_PATHWAY	REACTOME_COMMON_PATHWAY	5.59e-03	<= 0.20	PLG (7.8)	ANGPTL3 (7.8)	HP (7.7)	APOB (6.4)	APOC4 (6.3)	APOA5 (5.9)	APOC1 (4.1)	ITGB3 (3.8)	PCSK9 (3.6)	SLC22A1 (3.5)
GO:0051213	dioxygenase activity	5.59e-03	<= 0.20	APOA5 (3.2)	SLC22A1 (2.2)	BLOC1S3 (2.1)	TRAFD1 (1.9)	PVR (1.9)	POC5 (1.8)	LPA (1.8)	CYP7A1 (1.7)	ATXN7L2 (1.7)	HAPLN4 (1.7)
GO:0006576	cellular biogenic amine metabolic process	5.60e-03	<= 0.20	LPA (3.1)	ENSG00000254235 (2.9)	TSSK6 (2.9)	CYP7A1 (2.7)	SLC22A1 (2.5)	TM6SF2 (2.3)	APOA5 (2.2)	APOC4 (2.2)	HNF1A (2.1)	ANGPTL3 (2.1)
GO:0031093	platelet alpha granule lumen	5.64e-03	<= 0.20	ANGPTL3 (6.5)	HP (5.7)	PLG (5.4)	ITGB3 (5.3)	APOE (4.2)	APOB (4.1)	APOA5 (4.1)	APOC4 (4.0)	APOC1 (3.7)	LPA (2.6)
GO:0016702	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	5.64e-03	<= 0.20	APOA5 (3.3)	SLC22A1 (2.2)	BLOC1S3 (1.9)	TRAFD1 (1.9)	LPA (1.9)	PVR (1.8)	POC5 (1.8)	CYP7A1 (1.7)	ATXN7L2 (1.7)	HP (1.7)
ENSG00000184588	PDE4B PPI subnetwork	5.65e-03	<= 0.20	APOE (5.3)	TIMD4 (3.7)	APOC4 (3.5)	APOB (3.4)	APOA5 (3.4)	ANGPTL3 (2.9)	PLG (2.9)	APOC1 (2.8)	PCSK9 (2.7)	MAFB (2.7)
ENSG00000183520	UTP11L PPI subnetwork	5.68e-03	<= 0.20	DDX56 (4.4)	ZNF259 (4.2)	QTRT1 (3.9)	NAA25 (3.9)	TOMM40 (3.6)	DHODH (3.0)	C12orf43 (2.4)	ATP13A1 (2.4)	DHX38 (2.1)	BRAP (2.1)
MP:0005332	abnormal amino acid level	5.69e-03	<= 0.20	APOC4 (4.5)	APOA5 (4.1)	SLC22A1 (4.0)	ANGPTL3 (4.0)	LPA (4.0)	PLG (3.9)	TM6SF2 (3.8)	CYP7A1 (3.0)	ABCG8 (2.8)	NT5DC1 (2.6)
ENSG00000104823	ECH1 PPI subnetwork	5.80e-03	<= 0.20	TRAPPC6A (3.0)	ZNF180 (2.9)	GEMIN7 (2.5)	USP24 (2.3)	PVRL2 (2.3)	BLOC1S3 (2.2)	CETP (2.0)	MARK4 (1.9)	QTRT1 (1.8)	ENSG00000228044 (1.8)
GO:0003714	transcription corepressor activity	5.86e-03	<= 0.20	ATXN2 (2.6)	TRIB1 (2.6)	GATAD2A (2.4)	PPP1R37 (2.3)	MARK4 (2.2)	ATXN7L2 (2.2)	BCL3 (2.1)	SARS (2.1)	NYNRIN (2.0)	ZNF101 (2.0)
MP:0001255	decreased body height	5.86e-03	<= 0.20	CBLC (2.3)	PLEKHH2 (2.2)	CILP2 (2.0)	MAFB (2.0)	APOE (2.0)	ST3GAL4 (2.0)	TIMD4 (2.0)	CLPTM1 (1.8)	NKPD1 (1.8)	TMEM57 (1.8)
MP:0001853	heart inflammation	5.87e-03	<= 0.20	APOE (2.8)	BCL3 (2.6)	PARP10 (2.5)	TRAFD1 (2.4)	CLPTM1 (2.0)	RELB (1.9)	ENSG00000226645 (1.8)	SYPL2 (1.7)	TIMD4 (1.5)	FRK (1.5)
MP:0008249	abnormal common lymphocyte progenitor cell morphology	5.89e-03	<= 0.20	KANK2 (3.7)	CETP (3.5)	TIMD4 (3.3)	LPA (2.6)	C19orf52 (2.5)	CEACAM19 (2.2)	MAU2 (1.9)	NT5DC1 (1.9)	PLCG1 (1.8)	TMEM57 (1.8)
ENSG00000179409	GEMIN4 PPI subnetwork	5.94e-03	<= 0.20	QTRT1 (3.6)	TOMM40 (3.2)	RELB (2.4)	C12orf43 (2.4)	PSMA5 (2.3)	GEMIN7 (2.3)	CARM1 (2.0)	SARS (2.0)	ILF3 (1.9)	ATXN7L2 (1.9)
GO:0006006	glucose metabolic process	5.95e-03	<= 0.20	SYPL2 (2.8)	GOT2P1 (2.8)	GPAM (2.6)	LPA (2.4)	ENSG00000254235 (2.4)	ACAD10 (2.4)	HAPLN4 (2.2)	OGDH (2.2)	MOSC1 (2.1)	SORT1 (2.1)
ENSG00000132361	KIAA0664 PPI subnetwork	5.99e-03	<= 0.20	DDX56 (4.3)	NAA25 (3.7)	ZNF259 (3.5)	SARS (3.4)	TOMM40 (3.4)	QTRT1 (3.0)	DHX38 (2.6)	SUGP1 (2.6)	TOP1 (2.5)	PSMA5 (2.5)
ENSG00000067596	DHX8 PPI subnetwork	6.00e-03	<= 0.20	SUGP1 (3.8)	DHX38 (3.7)	MAU2 (3.4)	ZNF259 (2.7)	BUD13 (2.7)	BRAP (2.5)	SMARCA4 (2.4)	POC5 (2.3)	QTRT1 (2.1)	TOP1 (2.0)
ENSG00000101680	LAMA1 PPI subnetwork	6.01e-03	<= 0.20	BCAM (3.8)	KANK2 (3.4)	PVRL2 (2.5)	TMED4 (2.5)	C17orf57 (2.4)	SLC44A2 (2.4)	CBLC (2.2)	APOC4 (2.1)	ST3GAL4 (2.1)	PLEC (2.1)
ENSG00000110169	HPX PPI subnetwork	6.02e-03	<= 0.20	APOB (7.8)	PLG (5.0)	APOA5 (4.8)	ANGPTL3 (4.3)	HP (3.9)	APOC1 (3.7)	APOC4 (3.6)	NPC1L1 (3.6)	ABCG5 (3.6)	APOE (3.1)
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	6.08e-03	<= 0.20	ABCG8 (6.9)	ABCG5 (6.8)	APOB (4.8)	NPC1L1 (4.6)	TM6SF2 (3.8)	NT5DC1 (2.8)	APOA5 (2.7)	CYP7A1 (2.3)	C17orf57 (2.2)	APOC1 (2.1)
MP:0003229	abnormal vitelline vasculature morphology	6.09e-03	<= 0.20	PVR (2.6)	SH2B3 (2.6)	NYNRIN (2.4)	CLPTM1 (2.4)	DNM2 (2.3)	GATAD2A (2.2)	PVRL2 (2.2)	SLC44A2 (2.0)	ATXN2 (2.0)	CETP (2.0)
GO:0019903	protein phosphatase binding	6.11e-03	<= 0.20	DNM2 (3.2)	PPP1R37 (2.6)	COL4A3BP (2.2)	PVRL2 (2.1)	CLPTM1 (2.1)	SLC44A2 (2.1)	BRAP (2.0)	C11orf9 (1.8)	ENSG00000235545 (1.7)	BCAM (1.6)
MP:0010025	decreased total body fat amount	6.17e-03	<= 0.20	GPAM (3.5)	SYPL2 (3.2)	TM6SF2 (2.7)	HP (2.5)	HAPLN4 (2.4)	DNAH11 (2.3)	KANK2 (2.3)	BCL3 (2.3)	MOSC1 (2.2)	ZHX3 (2.0)
MP:0011097	complete embryonic lethality before turning of embryo	6.19e-03	<= 0.20	DOCK7 (3.8)	LDLR (3.1)	FADS1 (2.7)	ALDH2 (2.5)	TMEM57 (2.2)	DNM2 (2.2)	GOT2P1 (2.1)	TOP1 (2.0)	USP24 (1.8)	ZNF259 (1.7)
MP:0000414	alopecia	6.25e-03	<= 0.20	PLEC (4.0)	CBLC (3.7)	HMGCR (3.4)	AP1M2 (2.9)	MAFB (2.9)	LDLR (2.8)	APOC1 (2.6)	CELSR2 (2.3)	TRIB1 (2.1)	YIPF2 (2.0)
ENSG00000055957	ITIH1 PPI subnetwork	6.28e-03	<= 0.20	APOB (7.7)	PLG (5.0)	APOA5 (4.7)	ANGPTL3 (4.3)	HP (3.9)	APOC1 (3.8)	NPC1L1 (3.8)	APOC4 (3.6)	ABCG5 (3.4)	APOE (3.2)
GO:0016701	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen	6.28e-03	<= 0.20	APOA5 (3.4)	SLC22A1 (2.1)	BLOC1S3 (2.1)	PVR (1.9)	TRAFD1 (1.9)	POC5 (1.8)	CYP7A1 (1.8)	LPA (1.8)	HP (1.7)	ATXN7L2 (1.6)
ENSG00000197451	HNRNPAB PPI subnetwork	6.30e-03	<= 0.20	SYPL2 (3.6)	BCAM (2.9)	CARM1 (2.5)	OGDH (2.2)	ACAD10 (1.8)	TMEM50A (1.5)	NT5DC1 (1.5)	C1orf63 (1.4)	LPA (1.3)	C17orf57 (1.2)
GO:0019318	hexose metabolic process	6.34e-03	<= 0.20	SYPL2 (2.7)	ENSG00000254235 (2.6)	ACAD10 (2.4)	GOT2P1 (2.4)	SORT1 (2.3)	GPAM (2.3)	NT5DC1 (2.2)	LPA (2.1)	DHODH (2.1)	TRAPPC6A (2.1)
ENSG00000181929	PRKAG1 PPI subnetwork	6.35e-03	<= 0.20	GPAM (4.0)	PLG (3.1)	SARS (2.9)	BCAM (2.6)	CYP7A1 (2.4)	DOCK7 (2.3)	HAPLN4 (2.2)	SORT1 (2.0)	MOSC1 (2.0)	LDLR (2.0)
REACTOME_PLATELET_DEGRANULATION	REACTOME_PLATELET_DEGRANULATION	6.40e-03	<= 0.20	ITGB3 (7.9)	HP (5.3)	ANGPTL3 (5.1)	PLG (4.4)	APOB (4.0)	APOE (3.9)	APOC1 (3.2)	APOC4 (3.2)	APOA5 (3.2)	GMPR (2.8)
ENSG00000102103	PQBP1 PPI subnetwork	6.41e-03	<= 0.20	GATAD2A (2.8)	BUD13 (2.7)	CARM1 (2.7)	GEMIN7 (2.6)	MAU2 (2.5)	GMIP (2.4)	MARK4 (2.2)	SMARCA4 (2.1)	ENSG00000254235 (2.0)	FADS2 (2.0)
MP:0005344	increased circulating bilirubin level	6.44e-03	<= 0.20	RHD (9.2)	RHCE (8.0)	GMPR (3.4)	C12orf51 (3.1)	CYP7A1 (2.9)	KANK2 (2.7)	APOA5 (2.5)	APOC4 (2.2)	ANGPTL3 (2.0)	SLC22A1 (2.0)
ENSG00000133937	GSC PPI subnetwork	6.48e-03	<= 0.20	KANK2 (2.8)	PCSK9 (2.4)	ABO (2.3)	ENSG00000226648 (2.3)	PLCG1 (1.9)	TRIB1 (1.8)	ATXN7L2 (1.7)	KIAA1324 (1.6)	CILP2 (1.6)	NKPD1 (1.6)
GO:0005788	endoplasmic reticulum lumen	6.53e-03	<= 0.20	ERP29 (5.4)	TMED4 (4.5)	YIPF2 (3.6)	APOB (2.6)	ABCG5 (2.4)	NPC1L1 (2.3)	TM6SF2 (2.2)	CLPTM1 (2.2)	PVR (2.2)	PLG (2.1)
GO:0008329	pattern recognition receptor activity	6.56e-03	<= 0.20	MAFB (5.4)	TIMD4 (4.1)	HP (3.7)	MYLIP (2.8)	HLX (2.7)	ABCG5 (2.1)	APOC1 (2.1)	CEACAM19 (1.9)	UBXN2B (1.9)	ALDH2 (1.7)
ENSG00000185245	GP1BA PPI subnetwork	6.57e-03	<= 0.20	ITGB3 (9.3)	HP (4.4)	PLG (4.2)	ANGPTL3 (3.7)	APOC4 (3.2)	CETP (3.0)	CYP7A1 (2.9)	RHD (2.6)	APOA5 (2.4)	TIMD4 (2.3)
MP:0003717	pallor	6.58e-03	<= 0.20	RHD (5.6)	RHCE (5.1)	KANK2 (3.7)	USP24 (2.6)	C12orf51 (2.3)	GMPR (2.1)	ATXN2 (1.7)	DNM2 (1.7)	ITGB3 (1.7)	PTPN11 (1.6)
ENSG00000003436	TFPI PPI subnetwork	6.58e-03	<= 0.20	HP (5.1)	DNAH11 (2.5)	PVRL2 (2.3)	ITGB3 (2.2)	NPC1L1 (2.1)	ENSG00000226645 (2.0)	MOSC1 (1.8)	SLC22A1 (1.7)	CYP7A1 (1.7)	PBX4 (1.6)
MP:0010027	increased liver cholesterol level	6.62e-03	<= 0.20	FADS1 (6.9)	FADS2 (6.6)	HMGCR (5.9)	PCSK9 (5.8)	APOC1 (4.2)	APOB (4.0)	NPC1L1 (3.7)	TM6SF2 (3.6)	LDLR (3.5)	GPAM (3.4)
ENSG00000115718	PROC PPI subnetwork	6.70e-03	<= 0.20	HP (5.2)	APOA5 (4.0)	PLG (3.8)	ANGPTL3 (3.6)	TIMD4 (3.5)	SLC22A1 (3.5)	ITGB3 (3.4)	APOB (3.3)	PVR (2.7)	PVRL2 (2.6)
ENSG00000197263	OR8D2 PPI subnetwork	6.70e-03	<= 0.20	APOB (5.0)	PLG (4.5)	ANGPTL3 (4.4)	APOC1 (4.2)	APOA5 (3.8)	APOC4 (3.7)	HP (3.7)	APOE (3.2)	PCSK9 (2.9)	C11orf9 (2.4)
GO:0016846	carbon-sulfur lyase activity	6.71e-03	<= 0.20	TM6SF2 (4.5)	APOA5 (3.7)	ABCG5 (3.3)	NPC1L1 (3.1)	ALDH2 (3.1)	ENSG00000235545 (2.7)	SLC22A1 (2.6)	APOC4 (2.6)	PCSK9 (2.5)	ABCG8 (2.4)
ENSG00000087191	PSMC5 PPI subnetwork	6.73e-03	<= 0.20	PSMA5 (6.0)	NT5DC1 (3.0)	NAA25 (2.9)	SARS (2.6)	DHX38 (2.5)	TRAFD1 (2.5)	BRAP (2.2)	SUGP1 (2.2)	DDX56 (2.2)	TOMM40 (2.1)
ENSG00000070423	RNF126 PPI subnetwork	6.74e-03	<= 0.20	USP24 (3.4)	GMPR (2.9)	TMEM57 (2.3)	GRINA (2.3)	CLPTM1 (2.2)	ATP13A1 (1.9)	UBXN2B (1.9)	C12orf51 (1.8)	MAU2 (1.7)	SLC44A2 (1.7)
ENSG00000145692	BHMT PPI subnetwork	6.76e-03	<= 0.20	PLG (6.3)	ANGPTL3 (5.5)	APOB (5.5)	APOC4 (5.4)	APOA5 (5.0)	HP (3.6)	APOC1 (3.3)	CYP7A1 (3.2)	UBXN2B (2.9)	GOT2P1 (2.6)
ENSG00000197249	SERPINA1 PPI subnetwork	6.78e-03	<= 0.20	HP (4.1)	MOSC1 (3.1)	RHD (3.0)	CEACAM19 (2.8)	FRK (2.0)	APOA5 (2.0)	HAPLN4 (1.9)	APOC4 (1.9)	DNAH11 (1.8)	RHCE (1.6)
GO:0051170	nuclear import	6.80e-03	<= 0.20	ENSG00000254235 (2.8)	ENSG00000235545 (2.2)	USP24 (2.2)	GATAD2A (2.0)	MYLIP (1.8)	NAA25 (1.8)	BLOC1S3 (1.7)	OASL (1.7)	TRAFD1 (1.7)	PTPN11 (1.5)
KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG	6.81e-03	<= 0.20	HNF1A (4.4)	C11orf9 (3.6)	PCSK9 (3.5)	ABO (3.4)	KIAA1324 (3.1)	CYP7A1 (3.1)	NPC1L1 (2.5)	HAPLN4 (2.4)	TM6SF2 (2.4)	ABCG8 (2.3)
ENSG00000013364	MVP PPI subnetwork	6.81e-03	<= 0.20	PLG (6.1)	APOB (5.7)	ANGPTL3 (5.4)	APOC4 (4.9)	APOA5 (4.8)	HP (3.4)	CYP7A1 (3.1)	APOC1 (2.8)	UBXN2B (2.7)	GOT2P1 (2.6)
GO:0034383	low-density lipoprotein particle clearance	6.83e-03	<= 0.20	NPC1L1 (3.8)	GCNT4 (3.2)	ABCG5 (2.3)	GPAM (2.2)	MOSC1 (2.2)	ABCG8 (2.1)	HMGCR (2.1)	TIMD4 (2.0)	TM6SF2 (2.0)	DNAH11 (1.9)
GO:0000272	polysaccharide catabolic process	6.84e-03	<= 0.20	SYPL2 (2.8)	SORT1 (2.7)	PMFBP1 (2.6)	CEACAM19 (2.5)	ENSG00000228044 (2.4)	ENSG00000235545 (2.1)	ST3GAL4 (1.9)	HP (1.8)	TMED4 (1.8)	AMIGO1 (1.8)
ENSG00000177425	PAWR PPI subnetwork	6.85e-03	<= 0.20	PVRL2 (3.5)	ANGPTL3 (3.2)	PLG (3.0)	NPC1L1 (2.9)	APOB (2.7)	ABCG5 (2.7)	PVR (2.3)	HP (2.2)	FRK (2.2)	TM6SF2 (2.1)
ENSG00000157326	DHRS4 PPI subnetwork	6.88e-03	<= 0.20	SARS (3.8)	BRAP (3.0)	CLPTM1 (2.7)	PTPN11 (2.7)	ILF3 (2.3)	CARM1 (2.2)	OGDH (2.2)	C12orf43 (2.1)	GATAD2A (2.0)	BLOC1S3 (2.0)
REACTOME_CLASSICAL_ANTIBODY:MEDIATED_COMPLEMENT_ACTIVATION	REACTOME_CLASSICAL_ANTIBODY:MEDIATED_COMPLEMENT_ACTIVATION	6.91e-03	<= 0.20	TIMD4 (5.5)	APOE (5.5)	APOC1 (3.7)	MAFB (3.1)	SLC22A1 (2.8)	CETP (2.4)	ANGPTL3 (2.2)	HP (2.0)	PLG (2.0)	LPA (2.0)
REACTOME_XENOBIOTICS	REACTOME_XENOBIOTICS	6.95e-03	<= 0.20	SLC22A1 (11.2)	LPA (7.8)	ABCG5 (7.8)	TM6SF2 (6.8)	ABCG8 (6.1)	APOA5 (5.8)	NPC1L1 (5.7)	APOC4 (5.5)	ANGPTL3 (4.9)	PLG (4.4)
GO:0042974	retinoic acid receptor binding	6.98e-03	<= 0.20	APOC1 (3.1)	TM6SF2 (2.3)	DNM2 (2.3)	ABCG5 (2.0)	LPIN3 (2.0)	HNF1A (1.9)	TIMD4 (1.9)	ATXN2 (1.7)	PLEC (1.7)	MAPKAPK5 (1.7)
MP:0005289	increased oxygen consumption	6.99e-03	<= 0.20	MOSC1 (5.8)	GPAM (4.2)	TM6SF2 (3.3)	APOA5 (2.8)	SORT1 (2.8)	ALDH2 (2.5)	HP (2.4)	ZNF101 (2.3)	NPC1L1 (2.3)	LPA (2.2)
ENSG00000132693	CRP PPI subnetwork	7.01e-03	<= 0.20	LPA (5.5)	APOC4 (5.3)	ANGPTL3 (5.1)	TIMD4 (4.4)	PLG (4.4)	APOA5 (4.3)	HP (4.2)	APOC1 (4.1)	SLC22A1 (3.8)	APOE (3.6)
GO:0005542	folic acid binding	7.03e-03	<= 0.20	CYP7A1 (4.0)	MOSC1 (3.8)	SLC22A1 (3.7)	LPA (3.5)	APOA5 (3.0)	APOC4 (3.0)	ENSG00000226645 (2.8)	ANGPTL3 (2.7)	TIMD4 (2.6)	GCNT4 (2.5)
MP:0001200	thick skin	7.04e-03	<= 0.20	HMGCR (3.8)	CBLC (3.5)	PPP1R37 (2.9)	NPC1L1 (2.8)	BCL3 (2.8)	GCNT4 (2.7)	C11orf9 (2.3)	YIPF2 (2.2)	TRIB1 (2.1)	FRK (2.1)
ENSG00000124120	TTPAL PPI subnetwork	7.05e-03	<= 0.20	APOB (7.2)	NPC1L1 (4.1)	APOC1 (3.9)	APOE (3.5)	ABCG5 (3.4)	HP (3.1)	PCSK9 (2.9)	PLG (2.8)	APOA5 (2.7)	TM6SF2 (2.7)
GO:0072378	blood coagulation, fibrin clot formation	7.11e-03	<= 0.20	ITGB3 (4.8)	ANGPTL3 (3.1)	LPA (3.0)	APOC4 (2.9)	PLG (2.9)	ENSG00000226648 (2.6)	GMPR (2.6)	CETP (2.5)	APOA5 (2.5)	CYP7A1 (2.4)
ENSG00000125810	CD93 PPI subnetwork	7.15e-03	<= 0.20	PLG (4.0)	APOC4 (3.5)	APOE (3.5)	SLC22A1 (3.2)	APOA5 (3.1)	APOC1 (3.0)	BCAM (2.7)	LPA (2.6)	CETP (2.4)	C17orf57 (2.3)
KEGG_STARCH_AND_SUCROSE_METABOLISM	KEGG_STARCH_AND_SUCROSE_METABOLISM	7.17e-03	<= 0.20	ABCG5 (4.8)	ABCG8 (4.3)	TM6SF2 (4.3)	CYP7A1 (3.8)	MOSC1 (2.8)	SLC22A1 (2.6)	HP (2.5)	HAPLN4 (2.4)	SYPL2 (2.3)	LPA (2.3)
ENSG00000186847	KRT14 PPI subnetwork	7.21e-03	<= 0.20	TIMD4 (2.8)	GMPR (2.8)	ANGPTL3 (2.7)	CETP (2.6)	OASL (2.6)	PMFBP1 (2.4)	ENSG00000228044 (2.3)	PLG (2.2)	DNAH11 (2.1)	CEACAM19 (2.1)
ENSG00000125775	SDCBP2 PPI subnetwork	7.22e-03	<= 0.20	UBXN2B (3.3)	PBX4 (2.7)	AP1M2 (2.6)	PLEKHH2 (2.5)	PVR (2.2)	APOE (2.2)	HAVCR1 (2.0)	YIPF2 (1.9)	GOT2P1 (1.9)	TMEM50A (1.9)
ENSG00000140463	BBS4 PPI subnetwork	7.27e-03	<= 0.20	BCAM (3.4)	PLEC (2.5)	PLG (2.4)	DYNC2LI1 (2.3)	ANGPTL3 (2.2)	KANK2 (2.2)	SLC22A1 (2.2)	OGDH (2.1)	SUGP1 (2.0)	CEACAM19 (2.0)
GO:0016741	transferase activity, transferring one-carbon groups	7.45e-03	<= 0.20	DHODH (4.2)	QTRT1 (4.0)	C12orf43 (3.4)	TXNL4B (2.7)	DDX56 (2.7)	NAA25 (2.2)	ZNF259 (1.9)	UBXN2B (1.9)	ATP13A1 (1.8)	ACAD10 (1.7)
MP:0001201	translucent skin	7.48e-03	<= 0.20	CELSR2 (4.3)	SYPL2 (2.6)	ENSG00000238078 (2.2)	ZNF180 (2.1)	BCAM (1.8)	CEACAM19 (1.8)	ENSG00000254235 (1.7)	NYNRIN (1.6)	MARK4 (1.6)	PLEC (1.5)
ENSG00000110107	PRPF19 PPI subnetwork	7.48e-03	<= 0.20	SUGP1 (3.5)	DHX38 (3.3)	MAU2 (2.8)	DDX56 (2.7)	BUD13 (2.7)	BRAP (2.4)	ZNF259 (2.3)	ILF3 (2.2)	SMARCA4 (2.2)	TRAFD1 (2.1)
GO:0016769	transferase activity, transferring nitrogenous groups	7.52e-03	<= 0.20	SLC22A1 (4.4)	APOA5 (4.1)	PLG (4.1)	ANGPTL3 (3.8)	LPA (3.6)	ALDH2 (3.5)	APOC4 (3.5)	TM6SF2 (3.3)	SARS (2.9)	CYP7A1 (2.8)
GO:0019432	triglyceride biosynthetic process	7.57e-03	<= 0.20	FADS2 (5.0)	FADS1 (4.9)	GPAM (4.8)	PCSK9 (4.4)	HMGCR (4.2)	LDLR (3.7)	MOSC1 (3.7)	NPC1L1 (2.7)	TM6SF2 (2.5)	NKPD1 (2.2)
ENSG00000172594	SMPDL3A PPI subnetwork	7.60e-03	<= 0.20	APOE (6.7)	APOB (6.5)	TIMD4 (4.8)	APOC1 (4.4)	APOA5 (3.9)	ABCG5 (3.7)	APOC4 (3.7)	NPC1L1 (3.6)	PLG (3.5)	ANGPTL3 (3.3)
ENSG00000116030	SUMO1 PPI subnetwork	7.60e-03	<= 0.20	SARS (4.0)	NAA25 (2.9)	HMGCR (2.8)	USP24 (2.5)	TOP1 (2.4)	GATAD2A (2.3)	ILF3 (2.2)	ENSG00000238078 (2.2)	LDLR (2.2)	USP1 (2.1)
MP:0002419	abnormal innate immunity	7.65e-03	<= 0.20	TRIB1 (5.3)	HP (3.6)	MAFB (3.5)	BCL3 (3.4)	PVR (3.2)	HLX (2.6)	ALDH2 (2.6)	GMIP (2.5)	GRINA (2.3)	SLC22A1 (2.2)
ENSG00000169371	SNUPN PPI subnetwork	7.67e-03	<= 0.20	ZNF180 (3.4)	BUD13 (3.2)	POC5 (2.3)	C12orf47 (2.1)	ENSG00000238078 (2.0)	DHODH (1.9)	ENSG00000228044 (1.8)	AMIGO1 (1.8)	USP1 (1.8)	C12orf43 (1.8)
GO:0031091	platelet alpha granule	7.69e-03	<= 0.20	ITGB3 (7.5)	HP (5.7)	ANGPTL3 (5.5)	PLG (4.7)	APOC4 (3.7)	APOE (3.7)	APOA5 (3.6)	APOB (3.5)	APOC1 (3.4)	GMPR (3.1)
MP:0000493	rectal prolapse	7.69e-03	<= 0.20	PLEC (3.3)	BCL3 (2.5)	APOC4 (2.3)	ANGPTL3 (2.0)	CLPTM1 (2.0)	LDLR (2.0)	NYNRIN (2.0)	PPP1R37 (1.8)	SH2B3 (1.8)	PLEKHH2 (1.7)
MP:0011091	complete prenatal lethality	7.75e-03	<= 0.20	PCSK9 (2.4)	CLPTM1 (2.2)	MAFB (2.0)	ALDH2 (2.0)	APOE (2.0)	C11orf9 (2.0)	HMGCR (1.8)	PVRL2 (1.8)	ATP13A1 (1.7)	ENSG00000226648 (1.7)
MP:0009766	increased sensitivity to xenobiotic induced morbidity/mortality	7.82e-03	<= 0.20	LPA (3.9)	SLC22A1 (3.6)	CYP7A1 (3.3)	PBX4 (2.6)	ANGPTL3 (2.5)	MOSC1 (2.3)	APOC4 (2.3)	PLG (2.2)	PARP10 (2.2)	TRIB1 (2.0)
MP:0001622	abnormal vasculogenesis	7.84e-03	<= 0.20	MAFB (2.4)	TOP1 (2.3)	HLX (2.3)	APOE (2.0)	ENSG00000235545 (1.9)	NYNRIN (1.9)	MYLIP (1.8)	SH2B3 (1.7)	ATXN2 (1.7)	BCAM (1.6)
ENSG00000132703	APCS PPI subnetwork	7.87e-03	<= 0.20	HP (4.9)	APOC4 (4.4)	APOE (4.4)	PLG (4.2)	APOC1 (4.1)	ANGPTL3 (4.1)	SLC22A1 (3.9)	LPA (3.8)	APOA5 (3.6)	TIMD4 (3.1)
ENSG00000120800	UTP20 PPI subnetwork	7.91e-03	<= 0.20	ZNF259 (4.9)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (4.2)	TOMM40 (4.1)	DHODH (4.0)	DHX38 (2.4)	ATP13A1 (2.2)	SUGP1 (2.2)	MAPKAPK5 (2.0)
GO:0030414	peptidase inhibitor activity	7.92e-03	<= 0.20	HP (5.6)	APOB (5.5)	PLG (5.1)	APOA5 (4.7)	APOC1 (4.4)	APOC4 (4.0)	ANGPTL3 (3.7)	PCSK9 (3.1)	SLC22A1 (3.0)	GPAM (2.6)
GO:0016725	oxidoreductase activity, acting on CH or CH2 groups	7.92e-03	<= 0.20	SLC22A1 (7.2)	ABCG5 (6.6)	LPA (6.4)	CYP7A1 (5.8)	APOC4 (5.5)	APOA5 (5.1)	ABCG8 (5.1)	TM6SF2 (5.0)	HP (4.8)	NPC1L1 (4.4)
ENSG00000130939	UBE4B PPI subnetwork	7.95e-03	<= 0.20	DHX38 (2.7)	HMGCR (2.3)	TMEM57 (2.1)	FADS2 (2.0)	CARM1 (2.0)	GOT2P1 (1.9)	ZNF101 (1.8)	TRAFD1 (1.7)	BUD13 (1.6)	QTRT1 (1.6)
ENSG00000185950	IRS2 PPI subnetwork	7.95e-03	<= 0.20	DNM2 (4.3)	MARK4 (3.1)	TOP1 (2.9)	CARM1 (2.8)	SMARCA4 (2.8)	GMIP (2.7)	ZHX3 (2.6)	C12orf51 (2.5)	COL4A3BP (2.3)	BCL3 (2.3)
MP:0001696	failure to gastrulate	7.95e-03	<= 0.20	ATXN7L2 (3.1)	C17orf57 (2.7)	ENSG00000254235 (2.3)	ATXN2 (2.2)	PVR (2.2)	DOCK7 (2.1)	C1orf63 (1.8)	MAPKAPK5 (1.7)	RHCE (1.7)	ZNF180 (1.6)
ENSG00000064703	DDX20 PPI subnetwork	8.04e-03	<= 0.20	TOMM40 (3.6)	PSMA5 (2.6)	C12orf43 (2.5)	DHX38 (2.5)	QTRT1 (2.2)	DDX56 (2.1)	ZNF259 (2.1)	ATXN2 (2.1)	ZNF180 (1.9)	NAA25 (1.8)
ENSG00000150990	DHX37 PPI subnetwork	8.06e-03	<= 0.20	ZNF259 (4.6)	DDX56 (4.4)	NAA25 (3.9)	DHODH (3.6)	QTRT1 (3.6)	TOMM40 (3.5)	DHX38 (2.3)	SUGP1 (2.1)	ATP13A1 (2.0)	TOP1 (1.9)
GO:0072376	protein activation cascade	8.10e-03	<= 0.20	LPA (7.0)	TIMD4 (4.9)	APOC4 (4.6)	SLC22A1 (4.5)	CETP (4.0)	ANGPTL3 (3.9)	APOA5 (3.6)	PLG (3.4)	HP (3.3)	APOE (2.8)
ENSG00000117984	CTSD PPI subnetwork	8.11e-03	<= 0.20	APOE (4.8)	MAFB (3.5)	CETP (3.5)	APOC1 (2.6)	GRINA (2.6)	PLCG1 (2.5)	TRAPPC6A (2.4)	TIMD4 (2.4)	CEACAM19 (2.4)	BCAM (2.3)
ENSG00000125755	SYMPK PPI subnetwork	8.12e-03	<= 0.20	GRINA (3.3)	ENSG00000228044 (2.4)	UBXN2B (2.3)	OGDH (2.2)	ENSG00000235545 (2.2)	DYNC2LI1 (1.9)	DHX38 (1.8)	CYP7A1 (1.8)	ATP13A1 (1.6)	HNF1A (1.5)
MP:0003205	testicular atrophy	8.13e-03	<= 0.20	TMEM116 (3.0)	ITGB3 (2.6)	UBXN2B (2.5)	ZHX3 (2.4)	PCSK9 (2.0)	USP1 (2.0)	FEN1 (1.9)	CELSR2 (1.9)	BCAM (1.7)	PBX4 (1.7)
ENSG00000160255	ITGB2 PPI subnetwork	8.19e-03	<= 0.20	SH2B3 (3.1)	HP (3.1)	GMIP (3.0)	APOB (2.8)	HLX (2.8)	ANGPTL3 (2.7)	PLG (2.6)	CETP (2.6)	SLC44A2 (2.4)	APOE (2.3)
MP:0005264	glomerulosclerosis	8.21e-03	<= 0.20	BCAM (3.5)	PVRL2 (3.5)	MAFB (3.4)	PLEKHH2 (2.1)	CETP (2.0)	CEACAM19 (2.0)	C17orf57 (1.8)	HLX (1.6)	KANK2 (1.6)	NT5DC1 (1.5)
GO:0045017	glycerolipid biosynthetic process	8.24e-03	<= 0.20	FADS1 (3.3)	GPAM (3.3)	FADS2 (3.2)	MOSC1 (3.1)	HMGCR (2.9)	BLOC1S3 (2.7)	NPC1L1 (2.3)	PCSK9 (2.3)	LDLR (2.1)	TM6SF2 (2.1)
MP:0000420	ruffled hair	8.27e-03	<= 0.20	BCL3 (2.9)	CBLC (2.7)	LDLR (2.7)	PLEC (2.0)	YIPF2 (1.9)	NPC1L1 (1.8)	AP1M2 (1.8)	SLC44A2 (1.8)	CYB561D1 (1.7)	SH2B3 (1.7)
GO:0050728	negative regulation of inflammatory response	8.32e-03	<= 0.20	ANKRD31 (3.2)	ALDH2 (2.0)	DNAH11 (1.8)	SH2B3 (1.7)	APOC1 (1.5)	POLK (1.5)	TRIB1 (1.5)	HLX (1.5)	TIMD4 (1.4)	ADAM1 (1.3)
GO:0006633	fatty acid biosynthetic process	8.33e-03	<= 0.20	FADS2 (4.7)	FADS1 (4.6)	NKPD1 (3.9)	PCSK9 (3.5)	HMGCR (3.3)	LDLR (3.0)	ALDH2 (2.4)	TRAPPC6A (2.4)	CYB561D1 (2.3)	GMPR (2.3)
ENSG00000102878	HSF4 PPI subnetwork	8.34e-03	<= 0.20	PARP10 (3.0)	MAU2 (2.9)	USP24 (2.7)	MARK4 (2.5)	ZNF180 (2.2)	GMIP (2.1)	BCL3 (2.1)	SMARCA4 (2.1)	DHX38 (2.1)	ATXN2 (1.9)
MP:0005459	decreased percent body fat	8.35e-03	<= 0.20	TRIB1 (3.4)	MOSC1 (2.5)	SORT1 (2.3)	GPAM (2.3)	ST3GAL4 (2.2)	HLX (2.1)	LPA (2.0)	GCNT4 (1.9)	ZHX3 (1.9)	NPC1L1 (1.9)
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	8.36e-03	<= 0.20	TIMD4 (3.5)	APOC1 (2.8)	ANGPTL3 (2.7)	APOE (2.7)	C19orf52 (2.0)	APOC4 (1.9)	MYLIP (1.9)	HP (1.9)	MAFB (1.8)	PLG (1.6)
MP:0004993	decreased bone resorption	8.44e-03	<= 0.20	GMIP (2.6)	FRK (2.4)	ENSG00000228044 (2.3)	DNM2 (2.2)	MYLIP (2.0)	MAU2 (1.9)	PARP10 (1.6)	ITGB3 (1.5)	CLPTM1 (1.5)	HLX (1.5)
MP:0001798	impaired macrophage phagocytosis	8.53e-03	<= 0.20	TIMD4 (5.5)	MAFB (5.1)	CETP (4.8)	APOE (3.2)	APOC1 (2.9)	HP (1.9)	PLEC (1.9)	UBXN2B (1.8)	TMEM116 (1.7)	ALDH2 (1.7)
GO:0006662	glycerol ether metabolic process	8.55e-03	<= 0.20	GPAM (4.4)	MOSC1 (4.3)	PCSK9 (3.6)	FADS1 (3.5)	NPC1L1 (3.4)	FADS2 (3.3)	HMGCR (3.2)	TM6SF2 (3.0)	LDLR (2.7)	HP (2.2)
GO:0005044	scavenger receptor activity	8.56e-03	<= 0.20	TIMD4 (7.3)	CETP (3.9)	MAFB (3.6)	ABCG8 (2.8)	ABCG5 (2.8)	NPC1L1 (2.3)	HP (2.3)	CILP2 (2.3)	TM6SF2 (2.0)	MYLIP (2.0)
GO:0045120	pronucleus	8.62e-03	<= 0.20	PSRC1 (3.4)	POC5 (2.7)	USP1 (2.7)	BUD13 (2.4)	CEACAM19 (2.4)	FEN1 (2.0)	GEMIN7 (1.8)	TMED4 (1.7)	RHD (1.6)	MAU2 (1.6)
ENSG00000140848	CPNE2 PPI subnetwork	8.67e-03	<= 0.20	TOMM40 (3.7)	CLPTM1 (3.0)	GEMIN7 (2.8)	TMEM57 (2.6)	ZNF180 (2.4)	DNM2 (2.3)	GOT2P1 (2.2)	ADAM1 (2.2)	PSRC1 (2.1)	KANK2 (2.0)
MP:0005584	abnormal enzyme/coenzyme activity	8.71e-03	<= 0.20	GPAM (3.5)	APOC1 (2.6)	HP (2.6)	TM6SF2 (2.4)	PVR (2.2)	GOT2P1 (2.1)	SLC22A1 (2.0)	ALDH2 (2.0)	USP24 (1.5)	ABCG8 (1.5)
MP:0005166	decreased susceptibility to injury	8.73e-03	<= 0.20	HP (3.1)	BCL3 (2.7)	C17orf57 (2.4)	PLEKHH2 (2.0)	NPC1L1 (1.8)	ENSG00000228044 (1.8)	CBLC (1.7)	SLC22A1 (1.7)	ABCG5 (1.6)	LPA (1.5)
MP:0008537	increased susceptibility to induced colitis	8.73e-03	<= 0.20	KIAA1324 (3.3)	BCL3 (3.2)	OASL (2.6)	ABCG5 (2.3)	PARP10 (2.3)	ALDH2 (2.2)	HLX (2.2)	TM6SF2 (1.9)	PLEKHH2 (1.9)	ABCG8 (1.8)
ENSG00000169100	SLC25A6 PPI subnetwork	8.75e-03	<= 0.20	HAVCR1 (3.5)	GOT2P1 (3.1)	C19orf52 (2.3)	DHODH (1.9)	LPAR2 (1.7)	TOMM40 (1.7)	KIAA1324 (1.6)	PSMA5 (1.6)	NAA25 (1.6)	ZNF259 (1.5)
GO:0008170	N-methyltransferase activity	8.75e-03	<= 0.20	QTRT1 (3.4)	DHODH (3.1)	C12orf51 (2.9)	ATXN2 (2.8)	ATP13A1 (2.6)	NAA25 (2.4)	LPA (2.3)	C19orf52 (2.2)	MAU2 (2.1)	ILF3 (2.1)
REACTOME_GLYCOLYSIS	REACTOME_GLYCOLYSIS	8.75e-03	<= 0.20	NPC1L1 (2.9)	GOT2P1 (2.5)	PCSK9 (2.0)	SYPL2 (1.9)	FADS2 (1.9)	TM6SF2 (1.8)	CELSR2 (1.7)	CEACAM19 (1.6)	HP (1.5)	ABCG5 (1.5)
ENSG00000086189	DIMT1 PPI subnetwork	8.76e-03	<= 0.20	DDX56 (4.9)	ZNF259 (4.4)	NAA25 (4.1)	QTRT1 (3.6)	TOMM40 (3.4)	DHX38 (3.3)	ATP13A1 (3.3)	C12orf43 (2.6)	DHODH (2.4)	USP24 (2.3)
ENSG00000164338	UTP15 PPI subnetwork	8.77e-03	<= 0.20	ZNF259 (4.6)	DDX56 (4.5)	NAA25 (4.3)	QTRT1 (3.5)	TOMM40 (3.0)	DHODH (2.7)	DHX38 (2.3)	ATP13A1 (2.3)	BRAP (2.2)	SUGP1 (2.2)
MP:0008479	decreased spleen white pulp amount	8.77e-03	<= 0.20	HLX (2.3)	SH2B3 (2.3)	BCL3 (2.2)	ZNF101 (2.1)	GRINA (2.1)	ZNF259 (1.8)	RHCE (1.7)	ATP13A1 (1.7)	GMPR (1.6)	PARP10 (1.6)
MP:0001846	increased inflammatory response	8.79e-03	<= 0.20	BCL3 (4.0)	TIMD4 (3.5)	RELB (3.4)	MAFB (3.0)	PLEC (2.9)	GMIP (2.9)	CETP (2.7)	SH2B3 (2.5)	LPAR2 (2.5)	TRIB1 (2.3)
ENSG00000213764	ENSG00000213764 PPI subnetwork	8.86e-03	<= 0.20	TRAPPC6A (2.7)	TMEM50A (2.6)	QTRT1 (2.3)	LPA (2.3)	FADS2 (2.2)	LDLR (2.0)	GEMIN7 (1.9)	CYB561D1 (1.9)	CLPTM1 (1.9)	HAVCR1 (1.8)
ENSG00000196459	TRAPPC2 PPI subnetwork	8.86e-03	<= 0.20	TRAPPC6A (2.7)	TMEM50A (2.6)	QTRT1 (2.3)	LPA (2.3)	FADS2 (2.2)	LDLR (2.0)	GEMIN7 (1.9)	CYB561D1 (1.9)	CLPTM1 (1.9)	HAVCR1 (1.8)
ENSG00000145833	DDX46 PPI subnetwork	8.87e-03	<= 0.20	CARM1 (4.4)	SMARCA4 (4.2)	SUGP1 (3.1)	BUD13 (2.9)	MARK4 (2.8)	GATAD2A (2.8)	BRAP (2.5)	DNM2 (2.4)	MAU2 (2.4)	ABO (2.2)
GO:0060416	response to growth hormone stimulus	8.87e-03	<= 0.20	ABO (3.1)	CYP7A1 (2.8)	HNF1A (2.7)	ABCG8 (2.6)	PBX4 (2.4)	ENSG00000254235 (2.3)	LPA (2.1)	TRAFD1 (2.1)	ABCG5 (2.1)	TM6SF2 (1.9)
KEGG_ARACHIDONIC_ACID_METABOLISM	KEGG_ARACHIDONIC_ACID_METABOLISM	8.88e-03	<= 0.20	ABCG5 (4.3)	ALDH2 (4.2)	ABCG8 (3.7)	LPA (3.2)	TM6SF2 (2.8)	ANGPTL3 (2.4)	HP (2.3)	SLC22A1 (2.3)	APOC4 (2.3)	NKPD1 (2.2)
GO:0044275	cellular carbohydrate catabolic process	8.93e-03	<= 0.20	GOT2P1 (2.5)	SYPL2 (2.1)	OGDH (1.9)	ACAD10 (1.9)	HAPLN4 (1.9)	TM6SF2 (1.8)	PCSK9 (1.7)	ENSG00000254235 (1.7)	SORT1 (1.7)	DHODH (1.7)
MP:0001698	decreased embryo size	8.96e-03	<= 0.20	PVRL2 (2.9)	ATXN2 (2.8)	PTPN11 (2.5)	LDLR (2.4)	GATAD2A (2.2)	DOCK7 (2.2)	NYNRIN (2.1)	SMARCA4 (1.9)	USP24 (1.9)	TOP1 (1.8)
ENSG00000115461	IGFBP5 PPI subnetwork	9.01e-03	<= 0.20	APOA5 (3.1)	APOB (2.9)	LPA (2.9)	HP (2.9)	APOE (2.6)	SLC22A1 (2.6)	PVR (2.3)	APOC4 (2.3)	PLG (2.2)	CYP7A1 (2.0)
ENSG00000167721	TSR1 PPI subnetwork	9.01e-03	<= 0.20	DDX56 (5.0)	ZNF259 (4.5)	NAA25 (4.5)	QTRT1 (3.6)	TOMM40 (3.1)	DHX38 (2.9)	DHODH (2.8)	ATP13A1 (2.7)	MAPKAPK5 (2.7)	C12orf43 (2.2)
REACTOME_GLUCONEOGENESIS	REACTOME_GLUCONEOGENESIS	9.07e-03	<= 0.20	SYPL2 (3.6)	PLG (3.1)	TM6SF2 (2.7)	FADS2 (2.7)	SARS (2.5)	FADS1 (2.5)	APOA5 (2.3)	ALDH2 (2.2)	SLC22A1 (2.1)	HAPLN4 (2.1)
ENSG00000127445	PIN1 PPI subnetwork	9.09e-03	<= 0.20	PSRC1 (3.0)	GRINA (2.8)	RHD (2.8)	MARK4 (2.8)	C12orf51 (2.4)	BUD13 (2.4)	FEN1 (2.1)	ILF3 (2.0)	BCL3 (1.9)	RHCE (1.7)
ENSG00000133935	C14orf1 PPI subnetwork	9.12e-03	<= 0.20	LDLR (9.1)	HMGCR (8.9)	FADS2 (7.9)	FADS1 (6.6)	PCSK9 (5.6)	GEMIN7 (2.9)	TRAPPC6A (2.9)	CYP7A1 (2.3)	BUD13 (2.1)	TOMM40 (1.7)
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2	9.14e-03	<= 0.20	ITGB3 (7.8)	HP (5.1)	ANGPTL3 (5.0)	PLG (4.3)	APOE (3.9)	APOB (3.9)	APOC1 (3.3)	APOC4 (3.0)	APOA5 (3.0)	TIMD4 (3.0)
GO:0051241	negative regulation of multicellular organismal process	9.17e-03	<= 0.20	OASL (2.6)	ALDH2 (2.0)	TIMD4 (2.0)	SH2B3 (1.9)	ANGPTL3 (1.9)	HP (1.9)	APOC4 (1.7)	CETP (1.6)	SLC22A1 (1.6)	APOB (1.6)
MP:0000488	abnormal intestinal epithelium morphology	9.21e-03	<= 0.20	TIMD4 (3.7)	BCL3 (2.4)	HLX (2.0)	PLEKHH2 (2.0)	TOP1 (1.9)	MOSC1 (1.7)	NYNRIN (1.7)	KANK2 (1.7)	PLEC (1.7)	PBX4 (1.6)
ENSG00000030582	GRN PPI subnetwork	9.21e-03	<= 0.20	HP (2.7)	RHD (2.6)	PVRL2 (2.4)	ERP29 (1.9)	NPC1L1 (1.8)	CEACAM19 (1.8)	NYNRIN (1.8)	ITGB3 (1.7)	PVR (1.6)	RHCE (1.6)
ENSG00000168310	IRF2 PPI subnetwork	9.22e-03	<= 0.20	PARP10 (4.7)	OASL (3.9)	RELB (3.8)	BCL3 (3.6)	SH2B3 (2.8)	TRAFD1 (2.7)	GRINA (2.6)	TOP1 (2.3)	ILF3 (2.2)	C1orf63 (1.9)
GO:0008831	dTDP-4-dehydrorhamnose reductase activity	9.34e-03	<= 0.20	HMGCR (4.6)	LDLR (3.6)	FADS2 (3.5)	FADS1 (3.1)	PCSK9 (2.9)	NT5DC1 (2.9)	TMEM50A (2.5)	TRAPPC6A (2.0)	BLOC1S3 (2.0)	YIPF2 (1.9)
MP:0008875	abnormal xenobiotic pharmacokinetics	9.36e-03	<= 0.20	SLC22A1 (6.0)	APOA5 (5.6)	CYP7A1 (5.6)	ABCG8 (5.4)	APOC4 (5.1)	ABCG5 (4.9)	LPA (4.4)	ANGPTL3 (4.3)	TM6SF2 (4.2)	PLG (4.2)
MP:0000681	abnormal thyroid gland morphology	9.37e-03	<= 0.20	HAVCR1 (3.6)	MYLIP (2.8)	HAPLN4 (2.2)	MAFB (1.9)	BCAM (1.8)	HLX (1.8)	GRINA (1.7)	ENSG00000254235 (1.6)	APOE (1.5)	ABCG5 (1.5)
GO:0016229	steroid dehydrogenase activity	9.38e-03	<= 0.20	SLC22A1 (4.6)	APOC1 (3.9)	FADS2 (3.8)	LPA (3.5)	FADS1 (3.4)	HMGCR (3.4)	CYP7A1 (3.1)	APOC4 (3.0)	APOA5 (2.9)	PLG (2.4)
GO:0019902	phosphatase binding	9.41e-03	<= 0.20	DNM2 (3.4)	PPP1R37 (3.1)	PVRL2 (2.9)	C11orf9 (2.6)	BCAM (2.3)	SLC44A2 (2.1)	CLPTM1 (2.1)	MARK4 (1.9)	COL4A3BP (1.8)	KANK2 (1.8)
GO:0019439	aromatic compound catabolic process	9.41e-03	<= 0.20	CYP7A1 (5.5)	SLC22A1 (4.2)	LPA (4.1)	APOA5 (3.4)	ANGPTL3 (3.2)	APOC4 (3.0)	ENSG00000254235 (2.8)	PLG (2.6)	ENSG00000228044 (2.5)	CEACAM19 (2.4)
ENSG00000083520	DIS3 PPI subnetwork	9.46e-03	<= 0.20	DDX56 (4.9)	NAA25 (4.0)	C12orf43 (3.9)	ZNF259 (3.8)	QTRT1 (3.6)	DHODH (3.5)	TOMM40 (3.1)	DHX38 (2.9)	USP24 (2.7)	BRAP (2.2)
MP:0010875	increased bone volume	9.49e-03	<= 0.20	TRIB1 (2.4)	CETP (2.4)	PLEKHH2 (2.4)	ATXN7L2 (2.0)	LPA (1.9)	DNAH11 (1.8)	MAFB (1.7)	SH2B3 (1.7)	ABCG5 (1.6)	PARP10 (1.4)
ENSG00000197616	MYH6 PPI subnetwork	9.50e-03	<= 0.20	SYPL2 (3.2)	GMPR (2.7)	OGDH (2.5)	BCAM (2.1)	C12orf47 (2.1)	C1orf63 (2.1)	TMEM50A (1.9)	ACAD10 (1.8)	LPIN3 (1.6)	NKPD1 (1.5)
ENSG00000077348	EXOSC5 PPI subnetwork	9.54e-03	<= 0.20	DDX56 (5.0)	ZNF259 (3.6)	C12orf43 (3.2)	NAA25 (3.2)	SUGP1 (3.0)	USP24 (2.7)	DHODH (2.6)	DHX38 (2.3)	QTRT1 (2.3)	TOMM40 (2.1)
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	9.57e-03	<= 0.20	ANGPTL3 (3.8)	PLG (3.0)	UBXN2B (2.7)	SLC22A1 (2.5)	ALDH2 (2.3)	CYB561D1 (2.3)	GEMIN7 (2.3)	TM6SF2 (2.1)	LPA (2.0)	CYP7A1 (1.9)
ENSG00000074800	ENO1 PPI subnetwork	9.60e-03	<= 0.20	UBXN2B (4.0)	ANGPTL3 (3.1)	APOC4 (3.0)	CYP7A1 (3.0)	MOSC1 (2.8)	C19orf52 (2.4)	PLEC (2.1)	ENSG00000238078 (2.1)	SLC22A1 (1.6)	PSMA5 (1.5)
MP:0002357	abnormal spleen white pulp morphology	9.64e-03	<= 0.20	GRINA (4.7)	FADS1 (3.7)	RELB (2.5)	BCL3 (2.5)	PARP10 (2.1)	MAFB (1.8)	TRIB1 (1.8)	UBXN2B (1.8)	SLC22A1 (1.7)	TOMM40 (1.7)
ENSG00000112936	C7 PPI subnetwork	9.70e-03	<= 0.20	LPA (8.2)	APOC4 (7.6)	ANGPTL3 (7.6)	HP (6.4)	APOA5 (6.3)	SLC22A1 (6.3)	PLG (6.2)	APOC1 (3.7)	ABCG5 (3.4)	APOB (3.1)
MP:0009674	decreased birth weight	9.79e-03	<= 0.20	LDLR (3.0)	NYNRIN (2.8)	MARK4 (2.6)	LPAR2 (2.5)	TOP1 (2.4)	FADS1 (2.3)	FADS2 (2.2)	HMGCR (2.0)	TRIB1 (1.8)	CELSR2 (1.8)
MP:0008657	increased interleukin-1 beta secretion	9.81e-03	<= 0.20	PVR (2.9)	BCL3 (2.8)	CEACAM19 (2.7)	DNAH11 (2.2)	TRIB1 (2.0)	DHX38 (1.8)	MAPKAPK5 (1.7)	C12orf47 (1.7)	TMEM50A (1.7)	GCNT4 (1.6)
MP:0002079	increased circulating insulin level	9.89e-03	<= 0.20	GPAM (6.2)	MOSC1 (4.4)	NPC1L1 (2.7)	KIAA1324 (2.7)	ENSG00000254235 (2.4)	APOA5 (2.3)	TM6SF2 (2.2)	ABCG5 (2.1)	GCNT4 (1.9)	TIMD4 (1.7)
ENSG00000112249	ASCC3 PPI subnetwork	9.91e-03	<= 0.20	ATXN2 (2.9)	MAPKAPK5 (2.5)	BRAP (2.3)	ANKRD31 (2.0)	DHX38 (2.0)	PCSK9 (1.9)	SMARCA4 (1.8)	CLPTM1 (1.8)	TRAFD1 (1.8)	SLC44A2 (1.8)
ENSG00000182326	C1S PPI subnetwork	9.91e-03	<= 0.20	APOE (5.9)	TIMD4 (4.9)	APOC1 (3.6)	MAFB (3.6)	CETP (2.3)	HP (2.2)	SLC22A1 (1.7)	KANK2 (1.5)	C19orf52 (1.4)	ENSG00000235545 (1.4)
GO:0046965	retinoid X receptor binding	9.95e-03	<= 0.20	APOC1 (3.3)	DNM2 (2.8)	TM6SF2 (2.6)	ABCG5 (2.3)	CETP (2.2)	TIMD4 (2.0)	MAPKAPK5 (1.9)	LPIN3 (1.9)	APOB (1.8)	PLEC (1.6)
MP:0002665	decreased circulating corticosterone level	9.95e-03	<= 0.20	FADS2 (3.9)	FADS1 (3.9)	GPAM (2.9)	ABO (2.9)	CYP7A1 (2.5)	HMGCR (2.3)	ST3GAL4 (2.2)	LPIN3 (1.9)	TSSK6 (1.9)	APOC1 (1.9)
MP:0009413	skeletal muscle fiber atrophy	9.97e-03	<= 0.20	SYPL2 (3.7)	APOC4 (2.5)	CYP7A1 (2.4)	UBXN2B (2.4)	KANK2 (2.2)	ANGPTL3 (1.9)	C11orf9 (1.8)	NCAN (1.7)	GOT2P1 (1.7)	GMPR (1.6)
ENSG00000145192	AHSG PPI subnetwork	0.01	<= 0.20	ANGPTL3 (6.6)	PLG (6.4)	APOC4 (5.1)	APOA5 (4.7)	APOB (4.4)	APOC1 (3.6)	HP (3.4)	CYP7A1 (2.8)	SLC22A1 (2.3)	PCSK9 (2.3)
ENSG00000197471	SPN PPI subnetwork	0.01	<= 0.20	SH2B3 (3.0)	PBX4 (2.9)	ST3GAL4 (2.5)	OASL (2.4)	RELB (2.4)	TIMD4 (2.2)	PVR (2.2)	OGDH (2.1)	GATAD2A (1.9)	PLEC (1.9)
ENSG00000180733	ENSG00000180733 PPI subnetwork	0.01	<= 0.20	SARS (4.3)	BCL3 (3.2)	MAFB (2.9)	HLX (2.6)	RELB (2.4)	TRAFD1 (2.3)	TXNL4B (2.0)	MAPKAPK5 (1.7)	GRINA (1.7)	PLEKHH2 (1.5)
ENSG00000005961	ITGA2B PPI subnetwork	0.01	<= 0.20	HP (6.2)	APOB (5.2)	ITGB3 (5.0)	PLG (4.3)	ANGPTL3 (4.2)	APOA5 (3.3)	APOC1 (3.3)	APOC4 (3.3)	CILP2 (2.6)	APOE (2.6)
ENSG00000103319	EEF2K PPI subnetwork	0.01	<= 0.20	PTPN11 (2.5)	NAA25 (2.4)	BRAP (2.3)	GATAD2A (2.3)	C12orf43 (2.3)	NKPD1 (2.0)	APOB (2.0)	ADAM1 (2.0)	MAPKAPK5 (1.7)	AP1M2 (1.7)
GO:0035264	multicellular organism growth	0.01	<= 0.20	AMIGO1 (3.1)	C12orf51 (2.5)	ZNF180 (2.3)	ENSG00000235545 (2.3)	USP24 (2.3)	ANKRD31 (1.9)	KIAA1324 (1.7)	ENSG00000228044 (1.6)	SLC44A2 (1.6)	GEMIN7 (1.4)
GO:0005504	fatty acid binding	0.01	<= 0.20	MOSC1 (5.0)	APOB (4.2)	APOE (3.7)	APOC1 (3.6)	APOA5 (3.6)	ACAD10 (3.1)	ALDH2 (2.9)	PLG (2.9)	GPAM (2.9)	HNF1A (2.5)
GO:0045087	innate immune response	0.01	<= 0.20	OASL (6.1)	PARP10 (5.3)	TRAFD1 (3.9)	LPA (2.5)	CYB561D1 (2.4)	TIMD4 (2.3)	BCL3 (1.8)	ADAM1 (1.7)	GMIP (1.6)	HP (1.6)
ENSG00000030110	BAK1 PPI subnetwork	0.01	<= 0.20	POLK (3.2)	CBLC (2.8)	TRAPPC6A (2.7)	GATAD2A (2.4)	MARK4 (2.4)	ERP29 (2.3)	TOP1 (2.1)	PLCG1 (2.1)	GEMIN7 (2.0)	C12orf43 (1.8)
ENSG00000104368	PLAT PPI subnetwork	0.01	<= 0.20	ANGPTL3 (4.4)	APOB (3.8)	APOC4 (3.6)	APOE (3.6)	HP (3.5)	PVRL2 (3.4)	APOA5 (3.3)	PLG (3.2)	APOC1 (3.2)	CYP7A1 (3.0)
ENSG00000107223	EDF1 PPI subnetwork	0.01	<= 0.20	GCNT4 (2.5)	TIMD4 (2.5)	MOSC1 (2.4)	APOC1 (2.1)	HNF1A (2.0)	PMFBP1 (1.9)	HAVCR1 (1.8)	ST3GAL4 (1.7)	COL4A3BP (1.7)	ZNF180 (1.6)
MP:0005015	increased T cell number	0.01	<= 0.20	RELB (3.5)	ZNF101 (2.9)	TIMD4 (2.8)	CETP (2.8)	BCL3 (2.7)	GMIP (2.5)	TRIB1 (2.5)	MAFB (2.4)	PBX4 (2.2)	TRAFD1 (1.8)
MP:0005331	insulin resistance	0.01	<= 0.20	GPAM (5.5)	MOSC1 (3.4)	NPC1L1 (3.2)	PCSK9 (2.6)	APOC1 (2.5)	USP24 (2.3)	PLEC (2.1)	SYPL2 (2.0)	GCNT4 (1.9)	TM6SF2 (1.8)
ENSG00000206274	ENSG00000206274 PPI subnetwork	0.01	<= 0.20	SARS (4.5)	OGDH (3.2)	CLPTM1 (3.1)	SYPL2 (2.8)	DNAH11 (2.3)	DNM2 (2.2)	C17orf57 (2.2)	GOT2P1 (2.0)	ZNF259 (2.0)	PLEC (2.0)
ENSG00000206383	HSPA1L PPI subnetwork	0.01	<= 0.20	SARS (4.5)	OGDH (3.2)	CLPTM1 (3.1)	SYPL2 (2.8)	DNAH11 (2.3)	DNM2 (2.2)	C17orf57 (2.2)	GOT2P1 (2.0)	ZNF259 (2.0)	PLEC (2.0)
ENSG00000196415	PRTN3 PPI subnetwork	0.01	<= 0.20	HP (4.2)	ALDH2 (2.8)	BCL3 (2.8)	PVR (2.7)	RELB (2.3)	HLX (2.1)	ENSG00000228044 (2.1)	GMIP (1.9)	APOC1 (1.6)	MAFB (1.5)
ENSG00000104549	SQLE PPI subnetwork	0.01	<= 0.20	HMGCR (10.9)	LDLR (9.9)	FADS2 (8.3)	FADS1 (8.1)	PCSK9 (7.3)	CYP7A1 (3.7)	SLC22A1 (3.7)	NPC1L1 (3.4)	PLG (3.1)	TM6SF2 (3.0)
GO:0006606	protein import into nucleus	0.01	<= 0.20	ENSG00000254235 (2.8)	ENSG00000235545 (2.2)	USP24 (2.1)	GATAD2A (2.0)	MYLIP (1.7)	BLOC1S3 (1.7)	OASL (1.6)	NAA25 (1.6)	TRAFD1 (1.6)	PLCG1 (1.5)
REACTOME_REGULATION_OF_IFNA_SIGNALING	REACTOME_REGULATION_OF_IFNA_SIGNALING	0.01	<= 0.20	OASL (6.9)	TRAFD1 (5.0)	PARP10 (4.6)	BCL3 (3.6)	ATP13A1 (2.2)	CYP7A1 (2.1)	TMEM50A (2.1)	GOT2P1 (2.0)	NAA25 (1.9)	ZNF101 (1.8)
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	0.01	<= 0.20	ITGB3 (4.4)	APOB (4.0)	APOC1 (3.4)	HP (3.3)	ANGPTL3 (3.2)	APOA5 (3.0)	PLG (3.0)	APOC4 (2.8)	APOE (2.5)	SH2B3 (2.5)
MP:0008873	increased physiological sensitivity to xenobiotic	0.01	<= 0.20	CYP7A1 (4.0)	SLC22A1 (3.7)	ABCG8 (3.5)	TM6SF2 (3.4)	ABCG5 (2.9)	LPA (2.7)	ENSG00000254235 (2.5)	HP (2.4)	ALDH2 (2.3)	APOA5 (2.2)
ENSG00000122484	RPAP2 PPI subnetwork	0.01	<= 0.20	ZNF259 (4.4)	C12orf43 (3.7)	NAA25 (3.5)	DDX56 (3.2)	DHX38 (3.1)	QTRT1 (3.0)	ENSG00000226645 (2.8)	TOMM40 (2.8)	DHODH (2.7)	SUGP1 (2.1)
GO:0034504	protein localization to nucleus	0.01	<= 0.20	ENSG00000254235 (3.1)	USP24 (2.4)	MYLIP (2.3)	GATAD2A (2.1)	ZNF101 (2.0)	POLK (1.7)	OASL (1.6)	TRAFD1 (1.6)	ENSG00000238078 (1.6)	BLOC1S3 (1.5)
GO:0006094	gluconeogenesis	0.01	<= 0.20	HAPLN4 (2.6)	TM6SF2 (2.5)	ENSG00000254235 (2.3)	MOSC1 (2.3)	TSSK6 (2.2)	LPA (2.2)	ACAD10 (2.2)	CEACAM19 (2.1)	GOT2P1 (2.1)	SYPL2 (2.0)
REACTOME_BIOLOGICAL_OXIDATIONS	REACTOME_BIOLOGICAL_OXIDATIONS	0.01	<= 0.20	SLC22A1 (6.5)	CYP7A1 (6.1)	LPA (5.9)	TM6SF2 (5.5)	ABCG5 (5.3)	APOC4 (5.2)	ANGPTL3 (4.7)	ABCG8 (4.7)	APOA5 (4.2)	ALDH2 (4.2)
ENSG00000162645	GBP2 PPI subnetwork	0.01	<= 0.20	GEMIN7 (3.1)	TRAPPC6A (2.8)	APOE (2.1)	PVRL2 (2.1)	ZNF180 (2.0)	C11orf9 (1.7)	GCNT4 (1.6)	ENSG00000254235 (1.5)	DOCK7 (1.5)	FRK (1.4)
ENSG00000135047	CTSL1 PPI subnetwork	0.01	<= 0.20	MAFB (4.8)	GCNT4 (2.0)	ANGPTL3 (2.0)	APOE (1.9)	CYP7A1 (1.9)	GRINA (1.8)	ALDH2 (1.8)	TIMD4 (1.7)	MYLIP (1.7)	HLX (1.7)
ENSG00000103942	HOMER2 PPI subnetwork	0.01	<= 0.20	PLG (6.2)	ANGPTL3 (5.7)	APOB (4.8)	APOA5 (4.4)	APOC4 (4.1)	HP (3.5)	APOC1 (3.3)	SLC22A1 (2.6)	C12orf47 (2.2)	GPAM (2.2)
MP:0004229	abnormal embryonic erythropoiesis	0.01	<= 0.20	RHD (5.7)	RHCE (4.6)	FADS2 (3.7)	BCL3 (3.1)	GMPR (3.0)	FADS1 (2.7)	ITGB3 (2.6)	LDLR (2.5)	TRAPPC6A (2.5)	HMGCR (2.3)
MP:0003727	abnormal retinal layer morphology	0.01	<= 0.20	MYLIP (4.4)	GEMIN7 (2.5)	SH2B3 (2.4)	MOSC1 (2.3)	APOC4 (2.2)	ABO (2.0)	PVRL2 (1.8)	CYP7A1 (1.6)	PPP1R37 (1.6)	BCAM (1.6)
ENSG00000086619	ERO1LB PPI subnetwork	0.01	<= 0.20	DDX56 (4.3)	NAA25 (4.1)	QTRT1 (3.9)	ZNF259 (3.9)	TOMM40 (3.6)	DHODH (3.1)	TOP1 (2.7)	ATP13A1 (2.5)	PSMA5 (2.1)	HMGCR (2.1)
ENSG00000173372	C1QA PPI subnetwork	0.01	<= 0.20	HP (3.8)	APOE (3.2)	PLG (3.1)	ANGPTL3 (3.0)	SLC22A1 (3.0)	APOC4 (2.6)	APOA5 (2.3)	TIMD4 (2.3)	APOC1 (1.9)	LPA (1.9)
ENSG00000130203	APOE PPI subnetwork	0.01	<= 0.20	APOB (6.7)	APOC1 (5.0)	NPC1L1 (3.4)	APOA5 (3.3)	ABCG5 (3.1)	PLG (3.0)	ANGPTL3 (2.8)	HP (2.6)	APOE (2.5)	FADS1 (2.4)
ENSG00000126768	TIMM17B PPI subnetwork	0.01	<= 0.20	DHODH (3.7)	TRAPPC6A (3.3)	TOMM40 (3.2)	CYP7A1 (3.0)	SARS (2.8)	ANGPTL3 (2.6)	DNM2 (2.5)	ILF3 (2.4)	APOC4 (2.3)	GCNT4 (2.3)
MP:0009548	abnormal platelet aggregation	0.01	<= 0.20	ITGB3 (6.7)	CETP (2.9)	ENSG00000238078 (2.3)	MOSC1 (2.0)	GMPR (2.0)	SLC22A1 (1.8)	PLG (1.7)	PLEKHH2 (1.7)	APOB (1.7)	ENSG00000228044 (1.6)
MP:0008813	decreased common myeloid progenitor cell number	0.01	<= 0.20	RHD (2.8)	ITGB3 (2.8)	KANK2 (2.4)	CETP (2.3)	LPA (2.0)	C12orf51 (1.9)	RHCE (1.9)	TOP1 (1.8)	ATXN2 (1.7)	RELB (1.6)
ENSG00000128272	ATF4 PPI subnetwork	0.01	<= 0.20	TRIB1 (5.4)	SARS (4.4)	MAFB (2.8)	BCL3 (2.7)	MAPKAPK5 (2.5)	PVR (2.3)	POC5 (2.3)	TXNL4B (2.2)	HLX (2.1)	APOB (1.8)
ENSG00000118785	SPP1 PPI subnetwork	0.01	<= 0.20	APOE (3.1)	PTPN11 (2.4)	PVR (2.3)	ITGB3 (2.3)	CARM1 (2.0)	C17orf57 (1.9)	APOC1 (1.8)	GMPR (1.8)	APOC4 (1.7)	PLG (1.7)
MP:0004756	abnormal proximal convoluted tubule morphology	0.01	<= 0.20	RHD (4.6)	RHCE (3.9)	GMPR (2.8)	HNF1A (2.7)	GPAM (2.2)	POLK (2.1)	PLG (2.0)	GRINA (2.0)	DHODH (2.0)	DOCK7 (1.9)
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	0.01	<= 0.20	SLC44A2 (4.2)	ITGB3 (3.7)	APOE (3.4)	BCAM (2.8)	APOC1 (2.7)	APOB (2.5)	C17orf57 (2.4)	CETP (2.2)	GMIP (2.2)	PLEC (2.1)
ENSG00000171560	FGA PPI subnetwork	0.01	<= 0.20	ANGPTL3 (5.7)	PLG (5.5)	APOA5 (4.5)	HP (4.3)	APOC4 (4.1)	APOB (4.1)	APOC1 (3.5)	PCSK9 (2.8)	GPAM (2.2)	ITGB3 (1.8)
ENSG00000115415	STAT1 PPI subnetwork	0.01	<= 0.20	PARP10 (4.8)	BCL3 (4.2)	TRAFD1 (4.1)	RELB (3.6)	OASL (3.5)	HLX (3.0)	TRIB1 (2.5)	SH2B3 (2.4)	TMEM50A (2.4)	MAU2 (2.2)
GO:0009925	basal plasma membrane	0.01	<= 0.20	PLEC (3.2)	CYP7A1 (3.1)	DOCK7 (2.5)	CBLC (2.5)	BCAM (2.4)	ABCG8 (2.4)	C17orf57 (2.1)	TSSK6 (2.1)	TMEM116 (2.0)	ABCG5 (2.0)
GO:0016866	intramolecular transferase activity	0.01	<= 0.20	ZNF259 (3.8)	DHODH (3.5)	TOMM40 (2.7)	C12orf43 (2.6)	GPAM (2.5)	QTRT1 (2.4)	DDX56 (2.3)	BUD13 (2.3)	NAA25 (2.3)	NT5DC1 (2.3)
MP:0008617	increased circulating interleukin-12 level	0.01	<= 0.20	OASL (4.8)	PARP10 (4.0)	TRAFD1 (3.7)	TIMD4 (3.1)	CETP (2.4)	GMIP (2.1)	ATP13A1 (2.0)	NPC1L1 (1.9)	YIPF2 (1.7)	ENSG00000254235 (1.6)
ENSG00000165271	NOL6 PPI subnetwork	0.01	<= 0.20	ZNF259 (5.0)	NAA25 (4.7)	DDX56 (4.6)	QTRT1 (4.4)	DHODH (3.9)	TOMM40 (3.8)	ATP13A1 (2.6)	DHX38 (2.5)	C12orf43 (2.5)	BRAP (2.5)
ENSG00000148498	PARD3 PPI subnetwork	0.01	<= 0.20	CBLC (4.0)	MARK4 (3.2)	AP1M2 (2.8)	PSRC1 (2.4)	LPAR2 (2.4)	KANK2 (1.9)	UBXN2B (1.8)	COL4A3BP (1.8)	CELSR2 (1.7)	DNM2 (1.7)
ENSG00000196365	LONP1 PPI subnetwork	0.01	<= 0.20	C12orf47 (3.4)	DDX56 (2.6)	TOMM40 (2.4)	SARS (2.1)	CYP7A1 (2.1)	ATP13A1 (2.0)	DOCK7 (1.8)	AP1M2 (1.8)	PSMA5 (1.7)	BLOC1S3 (1.5)
GO:0034369	plasma lipoprotein particle remodeling	0.01	<= 0.20	APOC1 (4.1)	APOE (3.5)	APOB (3.4)	TIMD4 (3.4)	ABCG5 (3.4)	APOC4 (3.3)	APOA5 (3.1)	PLG (2.6)	MOSC1 (2.6)	HP (2.3)
GO:0034367	macromolecular complex remodeling	0.01	<= 0.20	APOC1 (4.1)	APOE (3.5)	APOB (3.4)	TIMD4 (3.4)	ABCG5 (3.4)	APOC4 (3.3)	APOA5 (3.1)	PLG (2.6)	MOSC1 (2.6)	HP (2.3)
GO:0034368	protein-lipid complex remodeling	0.01	<= 0.20	APOC1 (4.1)	APOE (3.5)	APOB (3.4)	TIMD4 (3.4)	ABCG5 (3.4)	APOC4 (3.3)	APOA5 (3.1)	PLG (2.6)	MOSC1 (2.6)	HP (2.3)
ENSG00000106462	EZH2 PPI subnetwork	0.01	<= 0.20	TOP1 (2.8)	SMARCA4 (2.8)	ATXN2 (2.5)	MARK4 (2.4)	ATP13A1 (2.4)	ILF3 (2.4)	PSRC1 (2.3)	NYNRIN (2.3)	DNM2 (2.3)	TRAFD1 (2.2)
GO:0000932	cytoplasmic mRNA processing body	0.01	<= 0.20	PARP10 (3.7)	TXNL4B (3.1)	OASL (2.9)	USP24 (2.6)	GEMIN7 (2.4)	ATXN2 (2.4)	UBXN2B (2.2)	ENSG00000228044 (2.1)	DHX38 (2.1)	GATAD2A (1.9)
MP:0009789	decreased susceptibility to bacterial infection induced morbidity/mortality	0.01	<= 0.20	HP (5.0)	BCL3 (3.0)	RELB (2.9)	FRK (2.5)	MAFB (2.3)	CEACAM19 (2.2)	HLX (2.1)	PLG (1.9)	SLC22A1 (1.8)	ANGPTL3 (1.8)
GO:0032787	monocarboxylic acid metabolic process	0.01	<= 0.20	CYP7A1 (4.1)	ACAD10 (3.7)	FADS2 (3.2)	GPAM (3.1)	SLC22A1 (3.0)	ALDH2 (2.9)	FADS1 (2.9)	APOC4 (2.7)	LPA (2.7)	TRAPPC6A (2.6)
GO:0016712	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	0.01	<= 0.20	SLC22A1 (8.7)	LPA (6.2)	ABCG5 (6.1)	ABCG8 (5.5)	TM6SF2 (5.3)	CYP7A1 (5.0)	APOC4 (4.4)	APOA5 (4.1)	NPC1L1 (3.8)	ANGPTL3 (3.7)
ENSG00000160310	PRMT2 PPI subnetwork	0.01	<= 0.20	PPP1R37 (3.4)	ZHX3 (3.1)	ATXN2 (2.8)	CLPTM1 (2.6)	GRINA (2.5)	CELSR2 (2.4)	TOMM40 (2.2)	MARK4 (2.2)	C12orf51 (2.0)	ABO (1.9)
GO:0005537	mannose binding	0.01	<= 0.20	LPA (6.0)	CETP (4.8)	TIMD4 (4.4)	APOA5 (4.1)	SLC22A1 (4.0)	APOC4 (3.2)	PLG (3.2)	ERP29 (3.0)	DHODH (2.5)	ATP13A1 (2.3)
ENSG00000132196	HSD17B7 PPI subnetwork	0.01	<= 0.20	HMGCR (15.1)	LDLR (13.0)	FADS1 (10.7)	FADS2 (9.7)	PCSK9 (8.4)	CYP7A1 (3.8)	NPC1L1 (3.4)	SLC22A1 (3.3)	PLG (3.0)	GPAM (2.0)
GO:0018200	peptidyl-glutamic acid modification	0.01	<= 0.20	HNF1A (3.9)	ABO (3.9)	LPA (3.5)	ANGPTL3 (2.8)	SLC22A1 (2.8)	APOC4 (2.7)	ADAM1 (2.7)	DNAH11 (2.5)	PLG (2.5)	APOA5 (2.4)
MP:0005439	decreased glycogen level	0.01	<= 0.20	GPAM (5.7)	MOSC1 (4.6)	APOA5 (3.3)	HP (3.2)	SYPL2 (3.1)	CYP7A1 (3.0)	NT5DC1 (2.7)	LPA (2.0)	APOC4 (1.9)	PPP1R37 (1.8)
GO:0061134	peptidase regulator activity	0.01	<= 0.20	HP (5.4)	APOB (5.1)	PLG (4.7)	APOA5 (4.4)	APOC1 (4.2)	APOC4 (3.7)	ANGPTL3 (3.5)	PCSK9 (3.3)	SLC22A1 (3.1)	GPAM (2.4)
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	0.01	<= 0.20	ITGB3 (5.6)	APOB (4.9)	ANGPTL3 (4.2)	APOC1 (4.1)	HAVCR1 (3.7)	HP (3.6)	PLG (3.6)	APOA5 (3.3)	APOC4 (3.0)	PCSK9 (2.5)
ENSG00000132471	WBP2 PPI subnetwork	0.01	<= 0.20	PPP1R37 (3.4)	USP24 (2.9)	ZNF180 (2.4)	DYNC2LI1 (2.4)	BCAM (2.3)	GATAD2A (2.2)	CLPTM1 (2.1)	YIPF2 (1.8)	SUGP1 (1.8)	ATXN2 (1.7)
ENSG00000159352	PSMD4 PPI subnetwork	0.01	<= 0.20	PSMA5 (5.2)	NAA25 (3.1)	TOMM40 (2.6)	SARS (2.6)	DDX56 (2.5)	OGDH (2.2)	NT5DC1 (2.1)	ZNF259 (2.0)	PTPN11 (1.9)	TRAFD1 (1.9)
ENSG00000143013	LMO4 PPI subnetwork	0.01	<= 0.20	CARM1 (3.0)	NYNRIN (2.3)	KANK2 (2.1)	C12orf51 (2.0)	MAFB (1.9)	ENSG00000226648 (1.6)	TIMD4 (1.6)	ZHX3 (1.4)	ENSG00000254235 (1.4)	POC5 (1.4)
KEGG_STEROID_BIOSYNTHESIS	KEGG_STEROID_BIOSYNTHESIS	0.01	<= 0.20	HMGCR (16.5)	LDLR (14.5)	FADS1 (13.1)	FADS2 (11.9)	PCSK9 (8.7)	NPC1L1 (3.8)	TRAPPC6A (2.4)	CYP7A1 (2.4)	GPAM (2.2)	NKPD1 (1.8)
GO:0006520	cellular amino acid metabolic process	0.01	<= 0.20	DHODH (3.2)	NT5DC1 (3.2)	SARS (2.9)	CYP7A1 (2.8)	ABCG8 (2.8)	SLC22A1 (2.6)	ANGPTL3 (2.5)	LPA (2.5)	QTRT1 (2.3)	ALDH2 (2.2)
ENSG00000156127	BATF PPI subnetwork	0.01	<= 0.20	TRIB1 (6.4)	BCL3 (3.5)	SARS (3.4)	MAFB (3.2)	PARP10 (2.7)	HLX (2.5)	MAPKAPK5 (2.3)	POC5 (2.0)	TRAFD1 (1.9)	GRINA (1.7)
MP:0000530	abnormal kidney blood vessel morphology	0.01	<= 0.20	PLEKHH2 (3.5)	HLX (3.4)	NYNRIN (3.1)	BCAM (3.1)	C11orf9 (2.6)	NPC1L1 (2.2)	ABCG5 (2.2)	PVRL2 (2.2)	APOB (2.1)	TM6SF2 (1.9)
GO:0071702	organic substance transport	0.01	<= 0.20	ABCG8 (4.7)	TM6SF2 (4.2)	ABCG5 (3.5)	NPC1L1 (3.4)	GCNT4 (2.9)	MOSC1 (2.3)	HAPLN4 (1.8)	APOB (1.8)	SORT1 (1.8)	APOA5 (1.8)
GO:0042991	transcription factor import into nucleus	0.01	<= 0.20	ENSG00000235545 (3.0)	LPAR2 (2.5)	MYLIP (2.4)	ABO (2.3)	OASL (2.3)	ZNF101 (2.1)	GCNT4 (1.9)	PARP10 (1.8)	ENSG00000226645 (1.8)	SH2B3 (1.6)
ENSG00000101266	CSNK2A1 PPI subnetwork	0.01	<= 0.20	TOP1 (4.2)	CARM1 (4.1)	SMARCA4 (4.1)	ILF3 (3.6)	TOMM40 (3.5)	TRIB1 (2.7)	DHX38 (2.5)	QTRT1 (2.5)	GATAD2A (2.4)	C12orf43 (2.4)
ENSG00000112159	MDN1 PPI subnetwork	0.01	<= 0.20	ZNF259 (4.8)	TOMM40 (4.8)	NAA25 (4.7)	DDX56 (4.5)	QTRT1 (3.4)	SUGP1 (3.1)	PSMA5 (3.1)	DHX38 (3.0)	DHODH (2.5)	ATP13A1 (2.3)
GO:0008209	androgen metabolic process	0.01	<= 0.20	CYP7A1 (3.5)	ST3GAL4 (3.3)	LPA (3.0)	NKPD1 (2.7)	FRK (2.6)	LPIN3 (2.4)	ENSG00000228044 (2.2)	ABCG8 (2.0)	PMFBP1 (2.0)	CYB561D1 (2.0)
ENSG00000067177	PHKA1 PPI subnetwork	0.01	<= 0.20	SYPL2 (3.4)	TXNL4B (2.6)	ZHX3 (2.4)	ZNF180 (2.3)	GPAM (2.2)	GMPR (2.1)	OGDH (2.0)	SORT1 (2.0)	DHODH (1.7)	PBX4 (1.6)
ENSG00000041357	PSMA4 PPI subnetwork	0.01	<= 0.20	PSMA5 (5.3)	NAA25 (3.4)	DDX56 (3.3)	TOMM40 (3.0)	ZNF259 (2.6)	SARS (2.3)	SUGP1 (1.8)	HMGCR (1.8)	QTRT1 (1.8)	TRAFD1 (1.6)
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.01	<= 0.20	OASL (10.1)	PARP10 (5.7)	RELB (4.4)	TRAFD1 (4.3)	BCL3 (3.1)	CYP7A1 (2.2)	ZNF101 (2.2)	ZNF180 (2.2)	PVR (2.2)	CYB561D1 (2.0)
ENSG00000143815	LBR PPI subnetwork	0.01	<= 0.20	HMGCR (10.8)	LDLR (8.7)	FADS1 (8.5)	FADS2 (7.7)	PCSK9 (5.9)	GRINA (2.5)	TOP1 (2.3)	NPC1L1 (2.0)	ENSG00000226645 (1.8)	ADAM1 (1.8)
ENSG00000064835	POU1F1 PPI subnetwork	0.01	<= 0.20	ABCG8 (4.3)	CYP7A1 (3.9)	ABCG5 (3.8)	ENSG00000254235 (3.4)	MOSC1 (3.3)	SLC22A1 (3.3)	TM6SF2 (3.1)	APOA5 (3.0)	TRIB1 (2.9)	LPA (2.7)
ENSG00000169251	NMD3 PPI subnetwork	0.01	<= 0.20	ZNF259 (4.9)	DHODH (3.6)	SUGP1 (3.5)	QTRT1 (3.4)	NAA25 (3.4)	DDX56 (3.4)	DHX38 (3.2)	TOMM40 (3.0)	ATP13A1 (3.0)	ENSG00000226645 (2.2)
MP:0003918	decreased kidney weight	0.01	<= 0.20	AMIGO1 (2.5)	CBLC (2.4)	BCAM (2.2)	HNF1A (2.2)	ATXN7L2 (2.1)	TM6SF2 (2.0)	SLC44A2 (1.9)	NPC1L1 (1.8)	CYB561D1 (1.8)	CILP2 (1.8)
ENSG00000140264	SERF2 PPI subnetwork	0.01	<= 0.20	ANGPTL3 (3.8)	NYNRIN (3.3)	FRK (2.6)	ATXN2 (2.0)	C11orf9 (1.9)	TOP1 (1.9)	PPP1R37 (1.8)	KANK2 (1.8)	APOB (1.8)	PLG (1.7)
GO:0016860	intramolecular oxidoreductase activity	0.01	<= 0.20	ERP29 (3.4)	HMGCR (3.4)	FADS2 (3.3)	FADS1 (3.2)	TRAPPC6A (2.7)	PCSK9 (2.7)	TMED4 (2.5)	LDLR (2.4)	DHODH (2.4)	PMFBP1 (2.1)
GO:0043178	alcohol binding	0.01	<= 0.20	APOC4 (4.5)	PLG (3.9)	TIMD4 (3.4)	LPA (3.3)	ANGPTL3 (3.2)	HP (2.9)	APOB (2.8)	MOSC1 (2.7)	SLC22A1 (2.6)	ABCG5 (2.5)
ENSG00000149131	SERPING1 PPI subnetwork	0.01	<= 0.20	APOC4 (6.2)	ANGPTL3 (5.8)	SLC22A1 (5.8)	LPA (5.2)	APOA5 (5.2)	HP (5.0)	PLG (4.9)	CYP7A1 (4.6)	BCL3 (2.5)	MOSC1 (2.4)
ENSG00000165704	HPRT1 PPI subnetwork	0.01	<= 0.20	RHD (2.5)	ANGPTL3 (2.4)	UBXN2B (2.3)	TXNL4B (2.3)	GEMIN7 (2.3)	MAU2 (2.3)	PLG (2.2)	LPA (2.1)	HNF1A (1.8)	TMEM50A (1.7)
ENSG00000145907	G3BP1 PPI subnetwork	0.01	<= 0.20	GATAD2A (4.0)	SMARCA4 (2.8)	ABO (2.8)	PBX4 (2.8)	PLEC (2.7)	BUD13 (2.7)	GMIP (2.4)	C19orf52 (2.1)	TOP1 (2.0)	SH2B3 (1.9)
ENSG00000146587	RBAK PPI subnetwork	0.01	<= 0.20	C19orf52 (2.5)	GRINA (2.3)	ZNF180 (2.2)	OASL (2.2)	PARP10 (2.1)	OGDH (2.1)	BRAP (2.1)	QTRT1 (2.1)	YIPF2 (2.1)	SUGP1 (1.9)
MP:0011098	complete embryonic lethality during organogenesis	0.01	<= 0.20	ATXN2 (2.8)	KANK2 (2.8)	HLX (2.5)	GATAD2A (2.4)	PVR (2.0)	SMARCA4 (2.0)	PVRL2 (2.0)	NYNRIN (2.0)	DNM2 (2.0)	USP24 (1.9)
GO:0050892	intestinal absorption	0.01	<= 0.20	NPC1L1 (7.4)	ABCG8 (6.3)	TM6SF2 (5.6)	ABCG5 (5.2)	APOB (3.5)	GCNT4 (2.5)	CBLC (2.3)	FRK (2.2)	TMED4 (2.1)	HNF1A (1.8)
MP:0002591	decreased mean corpuscular volume	0.01	<= 0.20	RHCE (12.3)	RHD (11.2)	GMPR (4.4)	C12orf51 (2.9)	APOC1 (2.2)	PCSK9 (2.1)	HP (2.0)	GRINA (1.9)	TIMD4 (1.9)	FADS2 (1.7)
ENSG00000023734	STRAP PPI subnetwork	0.01	<= 0.20	ZNF180 (3.4)	MAPKAPK5 (3.4)	GEMIN7 (2.9)	POC5 (2.9)	PLEC (2.1)	C19orf52 (2.1)	SH2B3 (2.0)	PVR (1.9)	NAA25 (1.8)	ATXN7L2 (1.7)
ENSG00000186979	ENSG00000186979 PPI subnetwork	0.01	<= 0.20	DDX56 (2.3)	PLG (2.2)	USP24 (2.1)	ZHX3 (1.9)	ATP13A1 (1.9)	APOA5 (1.8)	NAA25 (1.7)	TMED4 (1.7)	QTRT1 (1.6)	ANGPTL3 (1.6)
MP:0000218	increased leukocyte cell number	0.01	<= 0.20	GMIP (3.9)	BCL3 (3.6)	RELB (3.4)	TIMD4 (3.1)	CETP (3.0)	RHD (2.7)	RHCE (2.4)	HLX (2.3)	ITGB3 (2.1)	SH2B3 (2.0)
MP:0001511	disheveled coat	0.01	<= 0.20	LDLR (3.6)	GRINA (3.1)	BCL3 (2.9)	HMGCR (2.9)	TRAPPC6A (2.8)	CETP (2.7)	CBLC (2.6)	PCSK9 (2.5)	PLEC (2.5)	FADS1 (2.1)
GO:0051701	interaction with host	0.01	<= 0.20	GCNT4 (3.0)	OASL (2.7)	PARP10 (2.1)	GRINA (2.0)	LPA (2.0)	PPP1R37 (1.9)	ENSG00000254235 (1.9)	HAVCR1 (1.9)	TRAFD1 (1.9)	SLC44A2 (1.8)
GO:0016645	oxidoreductase activity, acting on the CH-NH group of donors	0.01	<= 0.20	PLG (4.2)	ANGPTL3 (3.7)	CYP7A1 (3.2)	APOC4 (3.2)	SLC22A1 (2.9)	ALDH2 (2.7)	DHODH (2.7)	APOA5 (2.5)	SARS (2.3)	ACAD10 (2.1)
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	0.01	<= 0.20	POC5 (3.1)	DOCK7 (3.0)	DDX56 (3.0)	NAA25 (3.0)	USP1 (2.7)	BUD13 (2.6)	USP24 (2.6)	MAPKAPK5 (2.1)	ILF3 (2.0)	DHX38 (2.0)
MP:0002417	abnormal megakaryocyte morphology	0.01	<= 0.20	ABCG8 (5.2)	MARK4 (3.1)	GMPR (2.8)	RHCE (2.8)	RHD (2.7)	ITGB3 (2.5)	C17orf57 (2.1)	NPC1L1 (2.1)	SH2B3 (1.9)	HLX (1.6)
GO:0004806	triglyceride lipase activity	0.01	<= 0.20	MOSC1 (3.9)	GPAM (3.2)	PMFBP1 (2.1)	KIAA1324 (2.0)	NPC1L1 (2.0)	APOC1 (1.9)	TM6SF2 (1.8)	APOC4 (1.6)	CYP7A1 (1.4)	HP (1.4)
ENSG00000148843	PDCD11 PPI subnetwork	0.01	<= 0.20	ZNF259 (5.1)	NAA25 (5.0)	DDX56 (4.5)	QTRT1 (4.1)	TOMM40 (3.7)	DHODH (3.1)	C12orf43 (2.7)	DHX38 (2.6)	TOP1 (2.3)	MAPKAPK5 (2.3)
ENSG00000050820	BCAR1 PPI subnetwork	0.01	<= 0.20	DNM2 (3.3)	GATAD2A (3.1)	PLEC (2.9)	SLC44A2 (2.9)	APOE (2.9)	LPAR2 (2.6)	CBLC (2.5)	PPP1R37 (2.4)	ENSG00000226645 (2.4)	KANK2 (2.3)
MP:0001780	decreased brown adipose tissue amount	0.01	<= 0.20	MOSC1 (5.0)	GPAM (4.2)	APOC1 (3.2)	SORT1 (3.0)	SYPL2 (2.4)	ST3GAL4 (2.3)	LDLR (2.3)	MAU2 (2.1)	PPP1R37 (1.9)	NT5DC1 (1.8)
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	0.01	> 0.20	PLG (6.0)	ANGPTL3 (5.8)	SLC22A1 (5.2)	APOA5 (5.1)	CYP7A1 (4.6)	APOC4 (4.1)	LPA (4.1)	MOSC1 (3.5)	TM6SF2 (3.4)	SARS (3.2)
MP:0001195	flaky skin	0.01	> 0.20	NKPD1 (4.1)	ENSG00000254235 (3.3)	HMGCR (2.9)	MAFB (2.9)	LDLR (2.4)	CELSR2 (2.2)	CEACAM19 (2.0)	APOC4 (2.0)	FADS1 (1.9)	TRIB1 (1.9)
GO:0010874	regulation of cholesterol efflux	0.01	> 0.20	TIMD4 (4.8)	GEMIN7 (3.5)	APOC1 (3.2)	ENSG00000238078 (3.2)	MYLIP (2.8)	APOE (2.2)	NKPD1 (2.1)	ST3GAL4 (1.8)	GPAM (1.8)	CETP (1.8)
GO:0051059	NF-kappaB binding	0.01	> 0.20	RELB (4.5)	ENSG00000226645 (2.7)	BCL3 (2.3)	PARP10 (2.2)	ZNF259 (2.1)	GMIP (2.0)	GRINA (2.0)	GCNT4 (2.0)	BRAP (1.9)	BUD13 (1.7)
ENSG00000188536	HBA2 PPI subnetwork	0.01	> 0.20	APOB (5.2)	PLG (4.7)	ANGPTL3 (4.5)	APOA5 (4.2)	RHCE (3.9)	APOC4 (3.8)	APOC1 (3.7)	RHD (3.2)	HP (2.9)	PCSK9 (2.8)
ENSG00000206172	HBA1 PPI subnetwork	0.01	> 0.20	APOB (5.2)	PLG (4.7)	ANGPTL3 (4.5)	APOA5 (4.2)	RHCE (3.9)	APOC4 (3.8)	APOC1 (3.7)	RHD (3.2)	HP (2.9)	PCSK9 (2.8)
GO:0006631	fatty acid metabolic process	0.01	> 0.20	ACAD10 (4.2)	FADS2 (3.4)	FADS1 (3.2)	NKPD1 (3.0)	GPAM (3.0)	ALDH2 (2.7)	MOSC1 (2.7)	TRAPPC6A (2.6)	CYP7A1 (2.2)	HMGCR (2.2)
ENSG00000151576	QTRTD1 PPI subnetwork	0.01	> 0.20	APOB (4.6)	ANGPTL3 (3.3)	PLG (3.2)	NPC1L1 (3.2)	APOA5 (2.8)	APOC1 (2.8)	APOC4 (2.7)	ABCG5 (2.7)	GMPR (2.4)	HP (2.3)
ENSG00000133104	SPG20 PPI subnetwork	0.01	> 0.20	DYNC2LI1 (3.5)	GATAD2A (2.4)	MARK4 (2.3)	CYP7A1 (2.3)	UBXN2B (2.2)	TMEM57 (2.0)	BLOC1S3 (1.8)	ENSG00000228044 (1.7)	DOCK7 (1.7)	USP1 (1.7)
ENSG00000211662	ENSG00000211662 PPI subnetwork	0.01	> 0.20	APOC1 (3.0)	HP (2.9)	SLC22A1 (2.9)	APOE (2.8)	APOB (2.5)	ENSG00000228044 (2.3)	USP24 (2.3)	PLG (2.3)	CYP7A1 (2.2)	APOC4 (2.0)
ENSG00000185057	ENSG00000185057 PPI subnetwork	0.01	> 0.20	DDX56 (4.9)	QTRT1 (4.5)	ZNF259 (4.4)	NAA25 (4.0)	TOMM40 (3.5)	DHODH (3.2)	C12orf43 (2.8)	SUGP1 (2.4)	ATP13A1 (2.2)	DHX38 (2.2)
ENSG00000178607	ERN1 PPI subnetwork	0.01	> 0.20	ERP29 (4.1)	BRAP (4.0)	ST3GAL4 (2.7)	C12orf47 (2.7)	YIPF2 (2.3)	ATXN2 (2.2)	MAPKAPK5 (2.2)	PPP1R37 (2.2)	DNM2 (2.1)	TRAFD1 (2.0)
GO:0010884	positive regulation of lipid storage	0.01	> 0.20	ABCG8 (3.5)	GCNT4 (2.6)	MOSC1 (2.6)	BLOC1S3 (2.4)	ABCG5 (2.3)	C12orf43 (2.2)	APOC1 (2.2)	GPAM (2.1)	GEMIN7 (2.1)	CYB561D1 (2.0)
ENSG00000187741	FANCA PPI subnetwork	0.01	> 0.20	OASL (4.6)	TRAFD1 (3.1)	ZNF101 (2.7)	USP1 (2.6)	FEN1 (2.2)	ATP13A1 (2.0)	TOP1 (1.9)	PARP10 (1.8)	POC5 (1.7)	MAFB (1.7)
ENSG00000137642	SORL1 PPI subnetwork	0.01	> 0.20	AP1M2 (3.3)	KIAA1324 (2.8)	HNF1A (2.7)	DNM2 (2.3)	CETP (1.8)	DHX38 (1.7)	FRK (1.7)	TMED4 (1.6)	C12orf47 (1.6)	CBLC (1.5)
ENSG00000137801	THBS1 PPI subnetwork	0.01	> 0.20	ANGPTL3 (4.5)	APOC4 (4.2)	PLG (3.7)	HP (3.3)	ITGB3 (3.2)	APOE (3.1)	APOA5 (3.1)	CYP7A1 (2.7)	APOC1 (2.6)	KANK2 (2.3)
GO:0031907	microbody lumen	0.01	> 0.20	PLG (5.0)	SLC22A1 (4.7)	MOSC1 (4.3)	APOA5 (4.2)	ANGPTL3 (4.1)	APOC4 (3.9)	FADS2 (3.3)	TM6SF2 (3.2)	GPAM (3.1)	CYP7A1 (2.9)
GO:0005782	peroxisomal matrix	0.01	> 0.20	PLG (5.0)	SLC22A1 (4.7)	MOSC1 (4.3)	APOA5 (4.2)	ANGPTL3 (4.1)	APOC4 (3.9)	FADS2 (3.3)	TM6SF2 (3.2)	GPAM (3.1)	CYP7A1 (2.9)
ENSG00000149357	LAMTOR1 PPI subnetwork	0.01	> 0.20	ACAD10 (4.6)	NT5DC1 (3.3)	OGDH (2.6)	HNF1A (2.6)	TMED4 (2.4)	TRAPPC6A (2.3)	GMPR (2.0)	C1orf63 (1.8)	GCNT4 (1.7)	CETP (1.6)
MP:0010383	increased adenoma incidence	0.01	> 0.20	PTPN11 (3.0)	ADAM1 (2.8)	C12orf51 (2.5)	DOCK7 (2.3)	KANK2 (2.3)	POC5 (2.2)	TMEM116 (2.1)	ENSG00000226648 (2.0)	C12orf43 (1.9)	ZNF180 (1.8)
GO:0010575	positive regulation vascular endothelial growth factor production	0.01	> 0.20	ENSG00000228044 (2.4)	ST3GAL4 (2.4)	PMFBP1 (2.4)	TMEM116 (1.9)	ATXN7L2 (1.8)	DOCK7 (1.7)	ENSG00000226648 (1.6)	ENSG00000235545 (1.5)	TSSK6 (1.4)	POLK (1.4)
ENSG00000141510	TP53 PPI subnetwork	0.01	> 0.20	TRIB1 (3.5)	FEN1 (2.8)	USP1 (2.7)	PSRC1 (2.6)	ILF3 (2.0)	BUD13 (1.7)	TOP1 (1.7)	BCL3 (1.5)	GRINA (1.5)	MYLIP (1.4)
ENSG00000137656	BUD13 PPI subnetwork	0.01	> 0.20	BUD13 (4.3)	BRAP (3.6)	SUGP1 (3.4)	BLOC1S3 (2.3)	ZNF259 (2.3)	POC5 (2.3)	C19orf52 (2.3)	DHX38 (2.3)	ZNF180 (2.3)	USP1 (2.2)
ENSG00000147140	NONO PPI subnetwork	0.01	> 0.20	ILF3 (3.4)	TOP1 (3.3)	SMARCA4 (2.4)	USP1 (2.1)	DOCK7 (2.1)	DHX38 (2.0)	NAA25 (1.8)	QTRT1 (1.8)	PLEC (1.7)	NT5DC1 (1.6)
GO:0048037	cofactor binding	0.01	> 0.20	ALDH2 (4.5)	ACAD10 (3.8)	MOSC1 (3.7)	PLG (3.6)	SLC22A1 (3.4)	FADS2 (3.3)	FADS1 (3.2)	GPAM (3.2)	ANGPTL3 (2.8)	LPA (2.4)
MP:0005293	impaired glucose tolerance	0.01	> 0.20	KIAA1324 (4.5)	GPAM (3.3)	MOSC1 (2.7)	AMIGO1 (2.1)	TRIB1 (2.0)	TMEM57 (1.9)	GCNT4 (1.9)	NPC1L1 (1.8)	LDLR (1.7)	PVR (1.7)
ENSG00000165556	CDX2 PPI subnetwork	0.01	> 0.20	PCSK9 (5.1)	HMGCR (4.9)	LDLR (4.4)	FADS1 (3.7)	FADS2 (3.3)	HAVCR1 (2.8)	ABO (2.7)	ENSG00000226645 (2.5)	HNF1A (2.5)	NPC1L1 (2.1)
GO:0071496	cellular response to external stimulus	0.01	> 0.20	TXNL4B (2.5)	BLOC1S3 (2.4)	POLK (2.2)	ABO (2.1)	CEACAM19 (1.9)	LPIN3 (1.9)	PCSK9 (1.7)	AP1M2 (1.7)	BRAP (1.6)	GCNT4 (1.5)
KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM	0.01	> 0.20	APOA5 (4.3)	SLC22A1 (4.0)	APOC4 (3.8)	PLG (3.6)	LPA (3.2)	CYP7A1 (3.0)	ALDH2 (2.6)	DHODH (2.5)	GOT2P1 (2.5)	ANGPTL3 (2.2)
ENSG00000140379	BCL2A1 PPI subnetwork	0.01	> 0.20	RELB (3.0)	PPP1R37 (2.9)	TRAPPC6A (2.8)	CBLC (2.6)	GEMIN7 (2.5)	GATAD2A (2.3)	LPAR2 (1.8)	CLPTM1 (1.8)	C12orf43 (1.8)	BRAP (1.8)
GO:0019218	regulation of steroid metabolic process	0.01	> 0.20	ST3GAL4 (3.8)	FADS2 (2.7)	FADS1 (2.3)	APOC1 (2.3)	GPAM (2.2)	LDLR (2.1)	TRAPPC6A (2.0)	TMEM50A (1.9)	BLOC1S3 (1.8)	ENSG00000226645 (1.8)
GO:0016597	amino acid binding	0.01	> 0.20	ANGPTL3 (5.0)	PLG (4.6)	ABCG8 (4.2)	SLC22A1 (4.1)	APOC4 (4.1)	ABCG5 (3.7)	CYP7A1 (3.7)	APOA5 (3.7)	LPA (3.3)	TM6SF2 (3.2)
ENSG00000177600	RPLP2 PPI subnetwork	0.01	> 0.20	DDX56 (3.1)	NAA25 (3.1)	ZNF259 (3.0)	TOMM40 (2.6)	PVR (2.3)	C12orf43 (2.1)	QTRT1 (2.1)	GATAD2A (2.0)	ILF3 (1.8)	TOP1 (1.8)
MP:0003436	decreased susceptibility to induced arthritis	0.01	> 0.20	GMIP (3.3)	MAFB (3.0)	HLX (2.7)	BCL3 (2.6)	CYP7A1 (2.4)	HP (2.3)	SH2B3 (2.2)	MYLIP (2.1)	RELB (2.0)	TRIB1 (1.8)
ENSG00000174175	SELP PPI subnetwork	0.01	> 0.20	ITGB3 (6.5)	TIMD4 (3.8)	ZNF101 (3.3)	CETP (3.3)	GMPR (2.3)	GMIP (2.3)	ATP13A1 (2.3)	BLOC1S3 (2.0)	DYNC2LI1 (1.9)	CLPTM1 (1.9)
GO:0033993	response to lipid	0.01	> 0.20	PCSK9 (2.8)	FADS2 (2.5)	HMGCR (2.4)	FADS1 (2.3)	GPAM (2.1)	BLOC1S3 (2.0)	ENSG00000238078 (2.0)	LDLR (2.0)	ATXN7L2 (2.0)	ABCG8 (1.9)
KEGG_RETINOL_METABOLISM	KEGG_RETINOL_METABOLISM	0.01	> 0.20	LPA (7.1)	ABCG5 (7.1)	SLC22A1 (6.9)	CYP7A1 (6.2)	ABCG8 (5.9)	TM6SF2 (5.8)	APOC4 (5.5)	APOA5 (4.7)	ANGPTL3 (4.0)	NPC1L1 (3.5)
GO:0044242	cellular lipid catabolic process	0.01	> 0.20	NKPD1 (4.9)	ACAD10 (3.9)	MOSC1 (3.4)	GPAM (3.0)	NT5DC1 (2.7)	ALDH2 (2.5)	TM6SF2 (2.2)	ABCG8 (2.2)	ENSG00000238078 (2.1)	APOC4 (1.9)
ENSG00000161955	TNFSF13 PPI subnetwork	0.01	> 0.20	COL4A3BP (2.2)	PVR (2.0)	CYB561D1 (1.9)	NT5DC1 (1.9)	ENSG00000226648 (1.8)	ZNF101 (1.8)	PLEKHH2 (1.7)	AMIGO1 (1.5)	PBX4 (1.5)	HAVCR1 (1.4)
MP:0005282	decreased fatty acid level	0.01	> 0.20	GPAM (4.7)	FADS1 (4.6)	MOSC1 (4.2)	FADS2 (4.1)	APOC1 (3.2)	HMGCR (2.8)	HP (2.8)	LDLR (2.7)	APOC4 (2.6)	NCAN (2.3)
ENSG00000112773	FAM46A PPI subnetwork	0.01	> 0.20	YIPF2 (3.7)	AP1M2 (3.1)	CARM1 (2.9)	SMARCA4 (2.8)	C19orf52 (2.5)	LPIN3 (2.4)	PPP1R37 (2.3)	CLPTM1 (2.3)	SUGP1 (2.2)	DNM2 (2.1)
GO:0051346	negative regulation of hydrolase activity	0.01	> 0.20	HP (2.7)	APOB (2.5)	APOA5 (2.4)	CEACAM19 (2.4)	APOC4 (2.3)	PLG (2.2)	ANGPTL3 (2.1)	ABCG5 (2.1)	SLC22A1 (1.9)	HNF1A (1.9)
MP:0001770	abnormal iron level	0.01	> 0.20	RHD (4.6)	RHCE (4.4)	HP (3.0)	GMPR (2.8)	ABCG5 (2.2)	ABCG8 (2.0)	CYP7A1 (1.8)	PARP10 (1.5)	ENSG00000228044 (1.5)	BCL3 (1.4)
MP:0002723	abnormal immune serum protein physiology	0.01	> 0.20	APOC1 (4.1)	RELB (3.3)	HP (3.0)	BCL3 (2.7)	C17orf57 (2.6)	SH2B3 (2.4)	SLC44A2 (2.3)	ITGB3 (2.1)	GMIP (2.1)	SLC22A1 (2.1)
ENSG00000107796	ACTA2 PPI subnetwork	0.01	> 0.20	SYPL2 (4.8)	ITGB3 (3.9)	NPC1L1 (3.0)	UBXN2B (2.8)	ANGPTL3 (2.3)	C12orf51 (2.2)	TOP1 (1.9)	TM6SF2 (1.9)	USP24 (1.8)	APOB (1.7)
MP:0001559	hyperglycemia	0.01	> 0.20	GPAM (4.9)	MOSC1 (3.5)	C11orf9 (2.4)	RHCE (2.1)	SORT1 (2.1)	CETP (1.8)	LPIN3 (1.7)	TMEM57 (1.7)	GCNT4 (1.7)	TIMD4 (1.7)
ENSG00000206300	ENSG00000206300 PPI subnetwork	0.01	> 0.20	TOMM40 (3.4)	ZNF259 (3.3)	SMARCA4 (3.2)	ILF3 (3.2)	CARM1 (2.9)	TOP1 (2.8)	DHX38 (2.6)	SARS (2.6)	QTRT1 (2.6)	GATAD2A (2.5)
ENSG00000206406	CSNK2B PPI subnetwork	0.01	> 0.20	TOMM40 (3.4)	ZNF259 (3.3)	SMARCA4 (3.2)	ILF3 (3.2)	CARM1 (2.9)	TOP1 (2.8)	DHX38 (2.6)	SARS (2.6)	QTRT1 (2.6)	GATAD2A (2.5)
ENSG00000204435	CSNK2B PPI subnetwork	0.01	> 0.20	TOMM40 (3.4)	ZNF259 (3.3)	SMARCA4 (3.2)	ILF3 (3.2)	CARM1 (2.9)	TOP1 (2.8)	DHX38 (2.6)	SARS (2.6)	QTRT1 (2.6)	GATAD2A (2.5)
ENSG00000139726	DENR PPI subnetwork	0.01	> 0.20	PSMA5 (2.5)	ADAM1 (2.3)	ANGPTL3 (2.2)	APOC1 (2.0)	BRAP (2.0)	ILF3 (2.0)	PLG (1.9)	C12orf43 (1.8)	PTPN11 (1.7)	SUGP1 (1.7)
ENSG00000115761	NOL10 PPI subnetwork	0.01	> 0.20	ZNF259 (4.6)	DDX56 (4.5)	QTRT1 (3.9)	NAA25 (3.9)	TOMM40 (3.3)	DHODH (3.1)	ATP13A1 (2.6)	DHX38 (2.5)	SUGP1 (2.3)	GATAD2A (2.3)
MP:0010375	increased kidney iron level	0.01	> 0.20	RHD (11.7)	RHCE (11.0)	APOC4 (3.9)	PLG (3.9)	GMPR (3.8)	ANGPTL3 (3.4)	APOC1 (2.9)	APOA5 (2.9)	C12orf51 (2.6)	SLC22A1 (2.3)
MP:0005606	increased bleeding time	0.01	> 0.20	ITGB3 (9.6)	GMPR (4.4)	HP (2.9)	ABCG8 (2.9)	APOC4 (2.7)	FADS1 (2.7)	CYP7A1 (2.6)	ANGPTL3 (2.3)	APOA5 (2.2)	PLG (2.2)
ENSG00000039537	C6 PPI subnetwork	0.01	> 0.20	PLG (8.3)	ANGPTL3 (7.5)	APOC4 (7.1)	APOA5 (6.5)	LPA (6.5)	HP (5.4)	SLC22A1 (5.4)	APOC1 (4.4)	APOB (3.8)	ABCG5 (3.4)
ENSG00000073578	SDHA PPI subnetwork	0.01	> 0.20	GEMIN7 (2.3)	ATXN7L2 (2.2)	BRAP (1.9)	OGDH (1.8)	LPIN3 (1.7)	RELB (1.6)	RHCE (1.6)	ZNF259 (1.5)	BUD13 (1.5)	GOT2P1 (1.4)
GO:0070330	aromatase activity	0.01	> 0.20	SLC22A1 (8.3)	LPA (5.7)	ABCG8 (5.4)	ABCG5 (5.4)	TM6SF2 (4.9)	CYP7A1 (4.2)	NPC1L1 (3.6)	APOA5 (3.4)	ANGPTL3 (3.3)	APOC4 (3.2)
ENSG00000164342	TLR3 PPI subnetwork	0.01	> 0.20	PARP10 (5.0)	OASL (4.8)	FRK (2.8)	TRAFD1 (2.6)	BCL3 (2.6)	GMIP (2.5)	LPAR2 (2.1)	RELB (2.0)	MAU2 (1.9)	PTPN11 (1.8)
GO:0071375	cellular response to peptide hormone stimulus	0.01	> 0.20	COL4A3BP (2.9)	PTPN11 (2.9)	SORT1 (2.4)	TMEM57 (2.0)	ENSG00000254235 (2.0)	USP24 (1.9)	MOSC1 (1.8)	GPAM (1.7)	BRAP (1.6)	GRINA (1.6)
GO:0008198	ferrous iron binding	0.01	> 0.20	RHCE (6.2)	RHD (6.1)	GMPR (3.2)	APOC1 (2.9)	APOC4 (2.8)	APOE (2.2)	GEMIN7 (2.2)	ZNF180 (2.1)	C12orf51 (2.0)	ABCG5 (2.0)
GO:0002443	leukocyte mediated immunity	0.02	> 0.20	LPA (2.6)	SLC22A1 (2.6)	TIMD4 (2.3)	GMIP (1.9)	APOE (1.8)	CYB561D1 (1.7)	APOC4 (1.7)	GEMIN7 (1.7)	HP (1.7)	PARP10 (1.6)
MP:0001915	intracranial hemorrhage	0.02	> 0.20	PLEC (2.5)	NYNRIN (2.4)	SH2B3 (2.3)	LPA (2.3)	PLG (2.2)	APOA5 (2.2)	APOC4 (2.1)	BCAM (1.9)	KANK2 (1.9)	APOC1 (1.9)
ENSG00000163743	RCHY1 PPI subnetwork	0.02	> 0.20	PPP1R37 (2.6)	ITGB3 (2.4)	PBX4 (2.4)	MYLIP (2.2)	GMPR (2.0)	RHD (1.9)	DNAH11 (1.9)	FADS2 (1.8)	BCAM (1.6)	FRK (1.4)
GO:0070875	positive regulation of glycogen metabolic process	0.02	> 0.20	LPA (2.4)	MYLIP (1.6)	ENSG00000226645 (1.6)	PPP1R37 (1.6)	ENSG00000228044 (1.5)	GPAM (1.5)	ZHX3 (1.4)	PBX4 (1.3)	ZNF180 (1.3)	TMEM116 (1.2)
ENSG00000182636	NDN PPI subnetwork	0.02	> 0.20	YIPF2 (3.3)	LDLR (3.2)	FADS1 (2.9)	HMGCR (2.7)	ATP13A1 (2.5)	FADS2 (2.3)	CLPTM1 (2.3)	GOT2P1 (2.1)	ERP29 (2.0)	PVRL2 (2.0)
GO:0019915	lipid storage	0.02	> 0.20	APOE (3.1)	APOC1 (2.9)	MOSC1 (2.9)	ENSG00000238078 (2.7)	COL4A3BP (2.5)	GPAM (2.5)	ABCG8 (2.2)	CETP (2.0)	NKPD1 (1.9)	ABCG5 (1.9)
GO:0032414	positive regulation of ion transmembrane transporter activity	0.02	> 0.20	C17orf57 (3.0)	DNAH11 (2.4)	ENSG00000228044 (2.4)	NKPD1 (2.2)	OGDH (2.1)	AMIGO1 (1.9)	CYB561D1 (1.9)	ZNF180 (1.8)	ENSG00000226648 (1.8)	PLEKHH2 (1.7)
ENSG00000172216	CEBPB PPI subnetwork	0.02	> 0.20	BCL3 (3.7)	CARM1 (3.6)	TRIB1 (3.5)	RELB (3.5)	GRINA (3.2)	ATXN2 (3.2)	GMIP (2.4)	HLX (2.0)	SARS (2.0)	PLEC (1.9)
GO:0009064	glutamine family amino acid metabolic process	0.02	> 0.20	ABCG8 (3.4)	CYP7A1 (3.2)	LPA (2.8)	ANGPTL3 (2.6)	TM6SF2 (2.6)	DHODH (2.5)	ABCG5 (2.2)	SLC22A1 (2.2)	ACAD10 (2.1)	PLG (2.0)
MP:0000496	abnormal small intestine morphology	0.02	> 0.20	HLX (3.2)	NPC1L1 (2.8)	HNF1A (2.7)	ZNF101 (2.5)	MAFB (2.4)	PBX4 (2.3)	LPAR2 (2.3)	CBLC (2.0)	TM6SF2 (1.8)	GATAD2A (1.8)
GO:0046504	glycerol ether biosynthetic process	0.02	> 0.20	GPAM (4.7)	FADS1 (4.6)	FADS2 (4.6)	PCSK9 (4.2)	HMGCR (4.0)	MOSC1 (3.9)	LDLR (3.1)	NPC1L1 (2.1)	TM6SF2 (2.1)	SORT1 (2.0)
ENSG00000156482	RPL30 PPI subnetwork	0.02	> 0.20	NAA25 (3.5)	ZNF259 (3.3)	DDX56 (3.2)	TOMM40 (3.1)	QTRT1 (2.8)	GATAD2A (2.6)	TOP1 (2.0)	SARS (2.0)	PVR (2.0)	ATP13A1 (2.0)
MP:0002712	increased circulating glucagon level	0.02	> 0.20	APOC4 (3.2)	APOB (3.1)	APOA5 (3.1)	ABCG5 (3.1)	NPC1L1 (3.0)	CYP7A1 (3.0)	ABCG8 (2.9)	GCNT4 (2.7)	ZHX3 (2.5)	HAVCR1 (2.5)
MP:0000245	abnormal erythropoiesis	0.02	> 0.20	RHD (9.4)	RHCE (8.8)	GMPR (3.1)	C12orf51 (2.9)	TMEM57 (2.9)	BCL3 (2.5)	TOP1 (2.3)	SH2B3 (2.1)	GRINA (1.9)	DNM2 (1.7)
ENSG00000163806	SPDYA PPI subnetwork	0.02	> 0.20	GATAD2A (3.3)	PTPN11 (2.4)	KANK2 (2.3)	OGDH (2.0)	SYPL2 (1.9)	SORT1 (1.7)	LPA (1.6)	DNM2 (1.6)	PLEC (1.6)	SLC44A2 (1.5)
ENSG00000001630	CYP51A1 PPI subnetwork	0.02	> 0.20	HMGCR (12.0)	LDLR (11.6)	FADS1 (8.9)	FADS2 (8.2)	PCSK9 (6.8)	TM6SF2 (2.4)	CYP7A1 (2.4)	NPC1L1 (2.3)	ATP13A1 (2.3)	TMED4 (2.1)
MP:0009767	decreased sensitivity to xenobiotic induced morbidity/mortality	0.02	> 0.20	ABCG5 (3.7)	ABCG8 (3.2)	CETP (2.9)	NPC1L1 (2.7)	SLC22A1 (2.4)	APOA5 (2.2)	TM6SF2 (2.1)	LPA (2.0)	APOC4 (1.9)	PARP10 (1.8)
ENSG00000002834	LASP1 PPI subnetwork	0.02	> 0.20	PLG (5.6)	APOB (5.2)	ANGPTL3 (4.9)	APOA5 (4.6)	APOC4 (4.4)	HP (3.1)	APOC1 (2.4)	GOT2P1 (2.3)	UBXN2B (2.2)	ABCG5 (2.2)
ENSG00000143514	TP53BP2 PPI subnetwork	0.02	> 0.20	LPAR2 (2.7)	MARK4 (2.7)	CARM1 (2.4)	C11orf9 (2.3)	CETP (2.3)	AP1M2 (2.2)	TIMD4 (2.2)	GATAD2A (2.1)	OASL (2.0)	GRINA (1.9)
MP:0001274	curly vibrissae	0.02	> 0.20	AP1M2 (3.0)	MARK4 (2.4)	NYNRIN (2.0)	CBLC (1.8)	DNM2 (1.6)	LPIN3 (1.6)	ENSG00000254235 (1.5)	ABO (1.5)	BCAM (1.4)	SLC22A1 (1.4)
MP:0005508	abnormal skeleton morphology	0.02	> 0.20	CILP2 (4.0)	TRIB1 (3.0)	MAFB (2.5)	PLEKHH2 (2.4)	LDLR (2.3)	NYNRIN (2.2)	TMEM57 (1.9)	APOE (1.9)	MYLIP (1.9)	KANK2 (1.8)
ENSG00000133958	UNC79 PPI subnetwork	0.02	> 0.20	ANGPTL3 (3.6)	KANK2 (2.8)	DYNC2LI1 (2.7)	APOC4 (2.1)	APOB (2.0)	APOC1 (1.9)	ZNF180 (1.9)	APOA5 (1.8)	MARK4 (1.8)	SLC22A1 (1.7)
ENSG00000125835	SNRPB PPI subnetwork	0.02	> 0.20	ILF3 (3.9)	C1orf63 (3.1)	TOP1 (3.0)	DHX38 (2.9)	BUD13 (2.8)	SMARCA4 (2.8)	USP1 (2.6)	PSMA5 (2.1)	PTPN11 (1.9)	FEN1 (1.9)
ENSG00000161618	ALDH16A1 PPI subnetwork	0.02	> 0.20	PLG (6.2)	APOB (5.6)	APOA5 (5.4)	ANGPTL3 (5.3)	APOC4 (5.3)	HP (3.6)	APOC1 (3.1)	CYP7A1 (3.0)	UBXN2B (2.5)	ABCG5 (2.1)
ENSG00000167508	MVD PPI subnetwork	0.02	> 0.20	DDX56 (4.4)	NAA25 (4.4)	ZNF259 (4.1)	QTRT1 (3.9)	TOMM40 (3.9)	DHODH (3.1)	SARS (2.6)	SUGP1 (2.4)	TOP1 (2.3)	C12orf43 (2.3)
GO:0003854	3-beta-hydroxy-delta5-steroid dehydrogenase activity	0.02	> 0.20	HMGCR (4.3)	FADS2 (3.6)	FADS1 (3.4)	LDLR (3.3)	PCSK9 (3.1)	ENSG00000254235 (2.3)	NT5DC1 (2.2)	TRAPPC6A (2.1)	BLOC1S3 (2.0)	GMPR (1.9)
MP:0009788	increased susceptibility to bacterial infection induced morbidity/mortality	0.02	> 0.20	HP (4.4)	OASL (4.2)	PARP10 (3.2)	BCL3 (3.1)	RELB (2.7)	TRAFD1 (2.6)	CYP7A1 (2.3)	HLX (2.1)	ENSG00000228044 (1.9)	TIMD4 (1.7)
GO:0014070	response to organic cyclic compound	0.02	> 0.20	ENSG00000235545 (3.0)	LDLR (2.0)	FADS2 (1.9)	ANKRD31 (1.9)	PCSK9 (1.8)	CYP7A1 (1.7)	TRIB1 (1.7)	MAFB (1.6)	POLK (1.5)	ALDH2 (1.4)
ENSG00000115641	FHL2 PPI subnetwork	0.02	> 0.20	SYPL2 (3.4)	UBXN2B (2.7)	BCAM (2.5)	ABO (2.3)	PLEC (2.1)	GOT2P1 (2.1)	SH2B3 (2.1)	BUD13 (2.0)	ENSG00000238078 (1.9)	ACAD10 (1.9)
MP:0010701	fusion of atlas and odontoid process	0.02	> 0.20	BCAM (3.5)	NYNRIN (2.7)	ENSG00000235545 (2.0)	C11orf9 (2.0)	ENSG00000254235 (1.8)	PVRL2 (1.7)	ST3GAL4 (1.6)	MARK4 (1.5)	PLEC (1.5)	SLC44A2 (1.5)
GO:0004857	enzyme inhibitor activity	0.02	> 0.20	APOB (5.6)	HP (5.3)	PLG (4.7)	APOA5 (4.3)	APOC4 (4.1)	APOC1 (4.1)	ANGPTL3 (3.2)	PCSK9 (2.7)	APOE (2.7)	ABCG5 (2.6)
ENSG00000127993	RBM48 PPI subnetwork	0.02	> 0.20	TXNL4B (2.7)	ALDH2 (2.6)	C11orf9 (2.4)	PSMA5 (2.1)	POLK (1.9)	LPA (1.9)	MAFB (1.7)	GEMIN7 (1.7)	TRAFD1 (1.6)	FEN1 (1.6)
ENSG00000082701	GSK3B PPI subnetwork	0.02	> 0.20	TRIB1 (2.9)	PLEC (2.9)	DNM2 (2.9)	ILF3 (2.5)	LDLR (2.4)	DOCK7 (2.4)	GATAD2A (2.4)	MARK4 (2.2)	PTPN11 (2.1)	ZHX3 (1.9)
ENSG00000092208	GEMIN2 PPI subnetwork	0.02	> 0.20	PSMA5 (3.2)	QTRT1 (3.1)	TOMM40 (3.0)	ILF3 (2.6)	BUD13 (2.2)	ZNF180 (2.1)	DDX56 (2.1)	USP1 (1.9)	ATXN7L2 (1.8)	ATP13A1 (1.7)
ENSG00000205572	SERF1B PPI subnetwork	0.02	> 0.20	ILF3 (3.5)	DHX38 (2.9)	SUGP1 (2.9)	QTRT1 (2.7)	DDX56 (2.5)	PLCG1 (2.5)	SMARCA4 (2.4)	BUD13 (2.3)	MAU2 (2.2)	ADAM1 (2.2)
ENSG00000172058	SERF1A PPI subnetwork	0.02	> 0.20	ILF3 (3.5)	DHX38 (2.9)	SUGP1 (2.9)	QTRT1 (2.7)	DDX56 (2.5)	PLCG1 (2.5)	SMARCA4 (2.4)	BUD13 (2.3)	MAU2 (2.2)	ADAM1 (2.2)
ENSG00000078061	ARAF PPI subnetwork	0.02	> 0.20	AP1M2 (3.1)	CARM1 (3.1)	PLEC (3.0)	CBLC (2.8)	LPIN3 (2.5)	TOP1 (2.4)	PPP1R37 (2.2)	KANK2 (2.1)	SMARCA4 (2.1)	DNM2 (2.1)
ENSG00000054267	ARID4B PPI subnetwork	0.02	> 0.20	RELB (3.6)	PVRL2 (2.6)	OASL (2.6)	BCL3 (2.4)	CEACAM19 (2.2)	TRAFD1 (2.2)	POLK (2.1)	PARP10 (2.1)	GRINA (2.1)	ST3GAL4 (2.1)
ENSG00000171914	TLN2 PPI subnetwork	0.02	> 0.20	NPC1L1 (3.3)	APOB (2.6)	APOA5 (2.4)	FRK (2.3)	APOC1 (2.2)	LPIN3 (2.1)	ZNF101 (2.1)	LPAR2 (2.0)	HAPLN4 (2.0)	ABCG5 (2.0)
MP:0000928	incomplete cephalic closure	0.02	> 0.20	NYNRIN (3.0)	CARM1 (2.7)	ENSG00000226648 (2.4)	MAFB (2.3)	APOB (2.2)	SLC44A2 (2.2)	ABO (2.1)	MARK4 (2.1)	DYNC2LI1 (1.9)	GEMIN7 (1.9)
ENSG00000154162	CDH12 PPI subnetwork	0.02	> 0.20	BCAM (3.6)	APOB (3.3)	PLG (3.2)	HP (3.0)	APOC4 (2.7)	APOA5 (2.5)	SLC22A1 (2.5)	APOC1 (2.4)	PCSK9 (2.2)	TIMD4 (2.1)
ENSG00000212981	ENSG00000212981 PPI subnetwork	0.02	> 0.20	NAA25 (4.6)	DDX56 (4.1)	ZNF259 (3.5)	QTRT1 (3.3)	TOMM40 (2.7)	DHX38 (2.5)	DHODH (2.5)	C12orf43 (2.5)	PTPN11 (2.1)	SUGP1 (2.1)
MP:0005108	abnormal ulna morphology	0.02	> 0.20	DNAH11 (2.4)	ANKRD31 (2.2)	PLEC (2.2)	PCSK9 (2.1)	NYNRIN (2.0)	ZHX3 (1.7)	NPC1L1 (1.5)	KANK2 (1.4)	PLEKHH2 (1.4)	PLCG1 (1.3)
GO:0015908	fatty acid transport	0.02	> 0.20	NKPD1 (2.9)	TM6SF2 (2.7)	CYB561D1 (2.6)	ACAD10 (2.1)	AMIGO1 (2.0)	ABCG8 (2.0)	OGDH (1.9)	LPIN3 (1.8)	MOSC1 (1.6)	ABCG5 (1.5)
MP:0002344	abnormal lymph node B cell domain morphology	0.02	> 0.20	RELB (6.7)	BCL3 (4.4)	UBXN2B (4.0)	GRINA (3.7)	CEACAM19 (3.2)	TRIB1 (2.7)	PARP10 (2.7)	ST3GAL4 (2.5)	MAFB (2.5)	GOT2P1 (2.2)
ENSG00000100284	TOM1 PPI subnetwork	0.02	> 0.20	BLOC1S3 (2.2)	DNM2 (1.9)	DOCK7 (1.9)	C11orf9 (1.9)	ADAM1 (1.8)	COL4A3BP (1.7)	GRINA (1.7)	FRK (1.6)	C17orf57 (1.5)	TRAFD1 (1.5)
ENSG00000169047	IRS1 PPI subnetwork	0.02	> 0.20	DNM2 (2.4)	SMARCA4 (2.2)	CBLC (2.2)	SLC44A2 (2.2)	ENSG00000226645 (2.1)	GMIP (2.1)	AP1M2 (2.1)	PTPN11 (2.0)	ATXN2 (1.9)	ST3GAL4 (1.9)
MP:0004567	decreased myocardial fiber number	0.02	> 0.20	KANK2 (3.6)	BCAM (2.4)	MYLIP (1.9)	PLEC (1.8)	CYB561D1 (1.7)	ITGB3 (1.7)	AP1M2 (1.6)	SORT1 (1.6)	CBLC (1.5)	PVRL2 (1.5)
ENSG00000214078	CPNE1 PPI subnetwork	0.02	> 0.20	GOT2P1 (2.6)	CEACAM19 (2.4)	NT5DC1 (2.3)	PLEC (2.2)	C12orf51 (2.1)	ZNF180 (2.1)	C17orf57 (2.1)	PVRL2 (2.1)	PVR (1.9)	PTPN11 (1.8)
ENSG00000103035	PSMD7 PPI subnetwork	0.02	> 0.20	PSMA5 (5.3)	TRAFD1 (3.1)	NAA25 (2.8)	NT5DC1 (2.5)	DDX56 (2.0)	TOMM40 (1.8)	BRAP (1.6)	SUGP1 (1.5)	CLPTM1 (1.3)	ABCG8 (1.3)
ENSG00000168610	STAT3 PPI subnetwork	0.02	> 0.20	BCL3 (5.1)	TRIB1 (4.4)	PARP10 (3.2)	RELB (2.7)	HLX (2.5)	POLK (2.4)	TMEM50A (2.2)	COL4A3BP (2.2)	PLCG1 (2.2)	MYLIP (2.1)
MP:0003068	enlarged kidney	0.02	> 0.20	DYNC2LI1 (3.7)	C11orf9 (3.2)	BCAM (2.9)	FADS1 (2.8)	PLEKHH2 (2.7)	NYNRIN (2.3)	KANK2 (1.9)	SLC22A1 (1.9)	TRAPPC6A (1.8)	QTRT1 (1.8)
GO:0033365	protein localization to organelle	0.02	> 0.20	USP24 (2.2)	GOT2P1 (1.9)	ZNF101 (1.8)	BLOC1S3 (1.7)	AMIGO1 (1.7)	POLK (1.6)	MAU2 (1.5)	PTPN11 (1.5)	GATAD2A (1.5)	YIPF2 (1.4)
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	0.02	> 0.20	ANGPTL3 (2.6)	PLG (2.4)	MOSC1 (2.3)	ATP13A1 (2.2)	CLPTM1 (2.2)	SLC22A1 (2.2)	APOC4 (2.1)	SORT1 (2.0)	HP (2.0)	APOC1 (1.9)
ENSG00000166888	STAT6 PPI subnetwork	0.02	> 0.20	RELB (5.5)	BCL3 (5.2)	PARP10 (4.0)	GMIP (3.5)	TRAFD1 (3.0)	DNM2 (2.7)	TMEM50A (2.5)	SH2B3 (2.3)	COL4A3BP (2.3)	BUD13 (2.2)
ENSG00000101040	ZMYND8 PPI subnetwork	0.02	> 0.20	USP24 (3.3)	MARK4 (2.7)	GMIP (2.5)	DHX38 (2.5)	PARP10 (2.5)	PPP1R37 (2.2)	MAFB (2.2)	SMARCA4 (2.1)	BCL3 (2.0)	POLK (1.9)
ENSG00000212645	ENSG00000212645 PPI subnetwork	0.02	> 0.20	ERP29 (3.9)	BRAP (3.1)	ST3GAL4 (2.6)	YIPF2 (2.5)	PPP1R37 (2.4)	DNM2 (2.3)	C12orf47 (2.3)	LPAR2 (2.0)	CBLC (1.9)	CLPTM1 (1.7)
GO:0032332	positive regulation of chondrocyte differentiation	0.02	> 0.20	LPIN3 (2.7)	GOT2P1 (2.1)	CEACAM19 (2.0)	PMFBP1 (1.9)	ZHX3 (1.6)	PLEKHH2 (1.4)	TMED4 (1.3)	ENSG00000228044 (1.3)	CILP2 (1.3)	ANKRD31 (1.2)
ENSG00000114767	RRP9 PPI subnetwork	0.02	> 0.20	ZNF259 (4.7)	DDX56 (4.3)	NAA25 (4.0)	QTRT1 (3.7)	TOMM40 (3.4)	DHODH (2.7)	TOP1 (2.3)	ATP13A1 (2.0)	DHX38 (1.8)	C12orf43 (1.8)
ENSG00000124610	HIST1H1A PPI subnetwork	0.02	> 0.20	TSSK6 (2.5)	GCNT4 (2.4)	MYLIP (2.1)	PSRC1 (2.1)	NPC1L1 (1.7)	POLK (1.7)	PLG (1.6)	ANGPTL3 (1.5)	TXNL4B (1.4)	C11orf9 (1.4)
GO:0034339	regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor	0.02	> 0.20	GCNT4 (3.2)	HNF1A (2.8)	PPP1R37 (2.5)	ABCG8 (2.4)	LPIN3 (2.0)	TSSK6 (2.0)	TM6SF2 (1.9)	NPC1L1 (1.7)	ABO (1.7)	ST3GAL4 (1.7)
ENSG00000136169	SETDB2 PPI subnetwork	0.02	> 0.20	PLG (3.2)	APOB (3.2)	BCAM (3.1)	HP (3.1)	APOC1 (2.7)	APOC4 (2.6)	TIMD4 (2.5)	SLC22A1 (2.4)	APOA5 (2.3)	APOE (2.3)
ENSG00000126461	SCAF1 PPI subnetwork	0.02	> 0.20	APOB (6.0)	APOC1 (4.5)	HP (4.2)	PLG (4.1)	APOE (4.0)	ANGPTL3 (3.5)	APOA5 (3.5)	PCSK9 (3.3)	APOC4 (2.9)	SLC22A1 (2.8)
ENSG00000132825	PPP1R3D PPI subnetwork	0.02	> 0.20	CBLC (5.5)	AP1M2 (3.7)	PVRL2 (2.3)	CELSR2 (1.9)	ZNF180 (1.9)	MARK4 (1.8)	ST3GAL4 (1.7)	DHODH (1.7)	MOSC1 (1.6)	PTPN11 (1.6)
GO:0055102	lipase inhibitor activity	0.02	> 0.20	APOB (5.4)	HP (4.2)	PLG (4.0)	APOC4 (3.5)	APOE (3.2)	APOA5 (3.2)	ANGPTL3 (2.9)	APOC1 (2.5)	PVR (2.3)	CYP7A1 (2.3)
ENSG00000025800	KPNA6 PPI subnetwork	0.02	> 0.20	TOMM40 (4.2)	FEN1 (2.9)	GATAD2A (2.8)	QTRT1 (2.8)	TOP1 (2.8)	DHODH (2.7)	NAA25 (2.7)	CARM1 (2.5)	DHX38 (2.4)	DDX56 (2.3)
MP:0002643	poikilocytosis	0.02	> 0.20	RHD (11.5)	RHCE (11.1)	C12orf51 (2.8)	GMPR (2.7)	FADS1 (2.0)	ZNF180 (1.9)	APOC1 (1.9)	PPP1R37 (1.8)	ADAM1 (1.8)	FADS2 (1.8)
MP:0005479	decreased circulating triiodothyronine level	0.02	> 0.20	C17orf57 (3.6)	HAVCR1 (3.5)	MYLIP (3.1)	COL4A3BP (3.0)	POLK (2.4)	TRIB1 (2.4)	MAFB (2.3)	MOSC1 (1.9)	C11orf9 (1.8)	CYP7A1 (1.7)
MP:0000601	small liver	0.02	> 0.20	RHD (3.0)	C12orf51 (2.9)	USP24 (2.8)	RHCE (2.7)	TRIB1 (2.7)	BCL3 (2.2)	TOP1 (1.9)	GCNT4 (1.8)	SMARCA4 (1.7)	ATXN2 (1.7)
MP:0001152	Leydig cell hyperplasia	0.02	> 0.20	ST3GAL4 (3.9)	TSSK6 (2.3)	HNF1A (1.8)	LPIN3 (1.8)	C12orf47 (1.8)	ZNF180 (1.7)	NYNRIN (1.5)	ATXN7L2 (1.5)	ABO (1.4)	DHODH (1.4)
MP:0001533	abnormal skeleton physiology	0.02	> 0.20	CILP2 (5.7)	MAFB (2.9)	ITGB3 (2.5)	TMEM57 (2.2)	CLPTM1 (2.2)	FRK (2.1)	PPP1R37 (1.9)	ST3GAL4 (1.7)	APOC1 (1.7)	MYLIP (1.7)
GO:0030246	carbohydrate binding	0.02	> 0.20	HP (4.8)	CILP2 (4.2)	LPA (3.2)	MAFB (2.7)	MOSC1 (2.6)	PLG (2.4)	APOC4 (2.4)	TIMD4 (2.3)	SLC22A1 (2.3)	APOA5 (2.2)
MP:0005220	abnormal exocrine pancreas morphology	0.02	> 0.20	LPA (3.1)	APOA5 (2.6)	ALDH2 (2.5)	PPP1R37 (2.2)	ENSG00000226648 (2.0)	KANK2 (1.9)	APOC4 (1.7)	TMEM57 (1.7)	NYNRIN (1.6)	ANGPTL3 (1.6)
MP:0002810	microcytic anemia	0.02	> 0.20	RHD (9.5)	RHCE (7.7)	TIMD4 (3.6)	GMPR (3.1)	MAFB (2.9)	CETP (2.5)	BCL3 (1.9)	HP (1.9)	C12orf51 (1.8)	TMEM57 (1.6)
GO:0009607	response to biotic stimulus	0.02	> 0.20	OASL (5.3)	PARP10 (4.0)	TRAFD1 (3.1)	ENSG00000235545 (2.4)	GRINA (2.2)	ADAM1 (2.0)	MAFB (2.0)	HP (1.7)	TXNL4B (1.5)	BCL3 (1.5)
MP:0002451	abnormal macrophage physiology	0.02	> 0.20	BCL3 (4.0)	MAFB (4.0)	RELB (3.8)	PARP10 (3.0)	GMIP (2.9)	TRIB1 (2.2)	MYLIP (2.2)	HLX (2.1)	OASL (2.1)	PVR (2.0)
GO:0051707	response to other organism	0.02	> 0.20	OASL (5.3)	PARP10 (4.1)	TRAFD1 (3.2)	ENSG00000235545 (2.8)	GRINA (2.1)	MAFB (2.0)	ADAM1 (1.7)	HP (1.7)	BCL3 (1.5)	GMIP (1.5)
GO:0005529	GO:0005529	0.02	> 0.20	LPA (3.8)	HP (3.5)	MOSC1 (2.8)	ERP29 (2.7)	APOA5 (2.7)	SORT1 (2.2)	DHODH (2.2)	TM6SF2 (2.1)	ABCG5 (2.0)	APOC4 (2.0)
GO:0009755	hormone-mediated signaling pathway	0.02	> 0.20	HNF1A (3.3)	GCNT4 (2.3)	ST3GAL4 (2.2)	ABCG8 (2.1)	CYP7A1 (2.0)	TM6SF2 (2.0)	NPC1L1 (2.0)	FRK (2.0)	PPP1R37 (1.9)	ATXN7L2 (1.8)
GO:0042737	drug catabolic process	0.02	> 0.20	LPA (6.6)	SLC22A1 (6.5)	TM6SF2 (4.5)	ABCG8 (4.0)	ABCG5 (3.8)	NPC1L1 (3.5)	GCNT4 (3.4)	CYP7A1 (2.2)	APOA5 (2.0)	APOC4 (2.0)
ENSG00000148296	SURF6 PPI subnetwork	0.02	> 0.20	TOMM40 (3.8)	ZNF259 (3.4)	QTRT1 (3.4)	NAA25 (2.7)	DDX56 (2.2)	ANKRD31 (2.1)	C12orf43 (2.0)	ILF3 (1.9)	DHODH (1.7)	ZNF180 (1.6)
MP:0005666	abnormal adipose tissue physiology	0.02	> 0.20	MAFB (2.9)	GPAM (2.8)	SYPL2 (2.6)	TIMD4 (2.4)	TRIB1 (2.3)	BLOC1S3 (2.1)	ATXN7L2 (1.8)	ACAD10 (1.7)	AMIGO1 (1.7)	MOSC1 (1.7)
MP:0008807	increased liver iron level	0.02	> 0.20	RHD (11.5)	RHCE (10.3)	HP (4.1)	GMPR (2.9)	TIMD4 (2.0)	C12orf51 (1.8)	CETP (1.8)	APOA5 (1.6)	APOC1 (1.6)	APOC4 (1.5)
ENSG00000120210	INSL6 PPI subnetwork	0.02	> 0.20	PARP10 (3.0)	PLEKHH2 (2.9)	LPAR2 (2.7)	OASL (2.5)	BCL3 (2.5)	NT5DC1 (2.4)	GMIP (2.2)	TRIB1 (2.2)	COL4A3BP (2.2)	PLCG1 (2.1)
GO:0045833	negative regulation of lipid metabolic process	0.02	> 0.20	TRAPPC6A (2.1)	ENSG00000228044 (2.0)	GPAM (1.9)	NPC1L1 (1.8)	PPP1R37 (1.6)	CETP (1.5)	APOC1 (1.5)	C12orf47 (1.5)	TXNL4B (1.4)	FADS1 (1.4)
GO:0006699	bile acid biosynthetic process	0.02	> 0.20	CYP7A1 (5.8)	LPA (4.5)	APOC4 (4.2)	SLC22A1 (3.5)	ANGPTL3 (3.5)	APOA5 (3.0)	ABCG8 (2.8)	PLG (2.4)	UBXN2B (2.2)	ABCG5 (2.1)
ENSG00000131018	SYNE1 PPI subnetwork	0.02	> 0.20	TIMD4 (3.9)	OASL (3.4)	CETP (3.4)	GMPR (2.6)	DNAH11 (2.5)	KANK2 (2.3)	BLOC1S3 (2.2)	NKPD1 (1.9)	GOT2P1 (1.8)	BCAM (1.7)
ENSG00000152582	SPEF2 PPI subnetwork	0.02	> 0.20	APOE (5.9)	APOB (4.7)	ANGPTL3 (3.4)	HAVCR1 (3.3)	TIMD4 (3.0)	APOC4 (3.0)	APOC1 (3.0)	MAFB (2.9)	APOA5 (2.9)	PLG (2.7)
ENSG00000011260	UTP18 PPI subnetwork	0.02	> 0.20	ZNF259 (4.8)	DDX56 (4.4)	NAA25 (4.2)	QTRT1 (4.0)	TOMM40 (3.3)	C12orf43 (3.0)	DHODH (2.9)	SARS (2.3)	SUGP1 (2.2)	ATP13A1 (2.1)
ENSG00000072832	CRMP1 PPI subnetwork	0.02	> 0.20	APOE (2.5)	FADS2 (2.0)	C11orf9 (1.9)	KIAA1324 (1.8)	DYNC2LI1 (1.8)	APOC1 (1.7)	TRAPPC6A (1.7)	ZNF180 (1.7)	TOMM40 (1.5)	GCNT4 (1.5)
MP:0004001	decreased hepatocyte proliferation	0.02	> 0.20	TRIB1 (3.0)	ABCG5 (2.8)	APOB (2.7)	GCNT4 (2.0)	POLK (2.0)	ANGPTL3 (1.8)	PMFBP1 (1.7)	ENSG00000254235 (1.6)	HP (1.6)	APOA5 (1.6)
MP:0000189	hypoglycemia	0.02	> 0.20	MOSC1 (3.8)	GPAM (3.5)	ACAD10 (2.8)	OGDH (2.3)	APOA5 (2.2)	APOC4 (2.0)	PLG (1.9)	ENSG00000226645 (1.8)	GOT2P1 (1.8)	SLC22A1 (1.8)
KEGG_PYRUVATE_METABOLISM	KEGG_PYRUVATE_METABOLISM	0.02	> 0.20	FADS2 (5.1)	FADS1 (4.8)	GPAM (4.7)	ALDH2 (3.6)	PCSK9 (3.5)	MOSC1 (3.5)	ACAD10 (3.3)	LDLR (3.0)	HMGCR (2.6)	OGDH (2.6)
ENSG00000130208	APOC1 PPI subnetwork	0.02	> 0.20	APOB (5.0)	APOC4 (3.4)	PLG (3.3)	APOA5 (3.2)	NPC1L1 (3.1)	ANGPTL3 (3.0)	APOC1 (2.7)	APOE (2.6)	ABCG5 (2.4)	HP (2.4)
ENSG00000007264	MATK PPI subnetwork	0.02	> 0.20	ITGB3 (3.5)	PLEC (2.7)	GMIP (2.4)	SLC44A2 (2.4)	ST3GAL4 (2.3)	OGDH (2.2)	MAFB (1.9)	LPAR2 (1.8)	BCAM (1.8)	C17orf57 (1.7)
ENSG00000137975	CLCA2 PPI subnetwork	0.02	> 0.20	APOB (7.8)	APOC1 (4.0)	PLG (4.0)	APOA5 (3.8)	ABCG5 (3.7)	NPC1L1 (3.6)	GMPR (3.0)	HP (3.0)	GPAM (2.8)	APOC4 (2.8)
ENSG00000105220	GPI PPI subnetwork	0.02	> 0.20	OGDH (3.6)	CYP7A1 (2.2)	TOMM40 (2.2)	TMED4 (2.1)	ZNF180 (2.1)	SARS (1.9)	GRINA (1.7)	CLPTM1 (1.7)	ABCG8 (1.5)	GOT2P1 (1.5)
GO:0071396	cellular response to lipid	0.02	> 0.20	HMGCR (2.8)	ENSG00000254235 (2.7)	PCSK9 (2.6)	ABCG8 (2.4)	FADS2 (2.1)	APOC4 (2.0)	BLOC1S3 (2.0)	FADS1 (1.9)	ABCG5 (1.9)	HLX (1.9)
ENSG00000125991	ERGIC3 PPI subnetwork	0.02	> 0.20	YIPF2 (2.5)	TMEM57 (2.4)	C12orf43 (2.4)	POC5 (2.3)	ERP29 (2.3)	KIAA1324 (2.3)	DHODH (2.2)	CLPTM1 (1.9)	ANKRD31 (1.8)	CYP7A1 (1.8)
GO:0044448	cell cortex part	0.02	> 0.20	RHD (3.3)	RHCE (2.8)	GMPR (2.5)	DNM2 (2.3)	ENSG00000238078 (2.3)	C12orf51 (2.1)	KANK2 (2.1)	OGDH (1.9)	LPIN3 (1.9)	PLCG1 (1.8)
ENSG00000125538	IL1B PPI subnetwork	0.02	> 0.20	BCL3 (4.9)	RELB (4.3)	TRIB1 (4.3)	HLX (3.2)	HP (2.5)	ST3GAL4 (2.3)	ENSG00000235545 (1.8)	ENSG00000228044 (1.5)	RHD (1.4)	OASL (1.4)
ENSG00000118922	KLF12 PPI subnetwork	0.02	> 0.20	PSRC1 (2.5)	ENSG00000228044 (2.1)	USP1 (2.1)	DOCK7 (2.0)	POC5 (2.0)	ILF3 (1.9)	ENSG00000226648 (1.9)	C12orf51 (1.9)	BRAP (1.8)	CYB561D1 (1.8)
ENSG00000081019	RSBN1 PPI subnetwork	0.02	> 0.20	C19orf52 (2.7)	SUGP1 (2.1)	QTRT1 (2.1)	PARP10 (2.1)	BRAP (1.9)	OASL (1.9)	GRINA (1.8)	CLPTM1 (1.8)	YIPF2 (1.8)	DHX38 (1.7)
REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE	0.02	> 0.20	RELB (4.4)	BCL3 (4.2)	TRIB1 (3.8)	OASL (3.4)	SH2B3 (3.2)	PVR (3.1)	GMIP (2.9)	MAFB (2.7)	HLX (2.5)	PARP10 (2.1)
ENSG00000172780	RAB43 PPI subnetwork	0.02	> 0.20	DHX38 (3.6)	BUD13 (3.4)	BRAP (3.3)	SUGP1 (3.3)	ZNF259 (2.8)	SMARCA4 (2.5)	MAU2 (2.3)	ZNF180 (2.2)	POC5 (1.7)	SARS (1.7)
KEGG_FOLATE_BIOSYNTHESIS	KEGG_FOLATE_BIOSYNTHESIS	0.02	> 0.20	TM6SF2 (2.8)	ST3GAL4 (2.6)	ABO (2.5)	HNF1A (2.3)	MOSC1 (2.2)	CBLC (1.8)	ABCG8 (1.8)	NT5DC1 (1.7)	SLC22A1 (1.6)	ZNF259 (1.5)
ENSG00000103671	TRIP4 PPI subnetwork	0.02	> 0.20	ATXN2 (2.6)	C12orf51 (2.4)	BCL3 (2.2)	PLEC (2.2)	ANKRD31 (1.9)	RELB (1.8)	NT5DC1 (1.7)	TRIB1 (1.7)	GCNT4 (1.6)	UBXN2B (1.6)
REACTOME_APOPTOSIS	REACTOME_APOPTOSIS	0.02	> 0.20	TRAFD1 (4.5)	PSMA5 (4.2)	PARP10 (2.5)	RELB (2.0)	TMEM50A (1.8)	NT5DC1 (1.7)	DDX56 (1.6)	SUGP1 (1.6)	TOMM40 (1.5)	CBLC (1.5)
GO:0009250	glucan biosynthetic process	0.02	> 0.20	ENSG00000254235 (3.4)	SYPL2 (3.3)	LPA (2.9)	NT5DC1 (2.7)	ZNF101 (2.2)	SORT1 (2.2)	GPAM (2.1)	CYP7A1 (1.9)	AMIGO1 (1.7)	MOSC1 (1.6)
GO:0005978	glycogen biosynthetic process	0.02	> 0.20	ENSG00000254235 (3.4)	SYPL2 (3.3)	LPA (2.9)	NT5DC1 (2.7)	ZNF101 (2.2)	SORT1 (2.2)	GPAM (2.1)	CYP7A1 (1.9)	AMIGO1 (1.7)	MOSC1 (1.6)
GO:0000790	nuclear chromatin	0.02	> 0.20	CARM1 (2.7)	ATXN2 (2.7)	MAFB (2.5)	ATXN7L2 (2.5)	BUD13 (2.3)	TOP1 (2.2)	ILF3 (2.2)	MARK4 (2.2)	MAPKAPK5 (2.1)	NYNRIN (1.9)
ENSG00000173369	C1QB PPI subnetwork	0.02	> 0.20	TIMD4 (3.7)	APOE (3.2)	MAFB (3.2)	SLC22A1 (2.9)	APOC1 (2.0)	APOC4 (1.8)	CILP2 (1.8)	ANGPTL3 (1.8)	CETP (1.8)	HP (1.7)
ENSG00000136628	EPRS PPI subnetwork	0.02	> 0.20	SARS (3.9)	NAA25 (3.5)	DDX56 (3.4)	HMGCR (3.4)	ZNF259 (3.2)	RELB (2.6)	PSMA5 (2.5)	ATP13A1 (2.3)	LDLR (2.1)	CLPTM1 (2.1)
ENSG00000122779	TRIM24 PPI subnetwork	0.02	> 0.20	CELSR2 (3.1)	KIAA1324 (2.9)	CYP7A1 (2.9)	FRK (2.5)	ZNF180 (2.5)	PSRC1 (2.4)	POLK (2.1)	PLCG1 (2.0)	ABCG8 (2.0)	DYNC2LI1 (1.8)
MP:0001718	abnormal visceral yolk sac morphology	0.02	> 0.20	APOB (4.1)	C11orf9 (3.3)	HNF1A (3.2)	APOA5 (2.8)	NPC1L1 (2.5)	SH2B3 (2.2)	KANK2 (2.0)	HP (2.0)	ATXN2 (1.8)	PLG (1.7)
ENSG00000198336	MYL4 PPI subnetwork	0.02	> 0.20	APOB (7.5)	APOC1 (4.1)	PLG (3.9)	NPC1L1 (3.7)	ABCG5 (3.7)	APOA5 (3.6)	GPAM (2.8)	APOC4 (2.8)	HP (2.7)	ANGPTL3 (2.6)
ENSG00000107611	CUBN PPI subnetwork	0.02	> 0.20	APOB (7.1)	ANGPTL3 (6.1)	PLG (5.6)	APOC4 (3.6)	NPC1L1 (3.6)	APOA5 (3.6)	HP (3.3)	C11orf9 (3.3)	APOC1 (3.1)	ABCG5 (2.9)
ENSG00000115594	IL1R1 PPI subnetwork	0.02	> 0.20	UBXN2B (2.8)	BCL3 (2.8)	ENSG00000254235 (2.7)	PARP10 (2.6)	ST3GAL4 (2.2)	OASL (2.2)	ENSG00000235545 (2.1)	BLOC1S3 (1.9)	GCNT4 (1.6)	ABCG5 (1.5)
REACTOME_REGULATION_OF_BETA:CELL_DEVELOPMENT	REACTOME_REGULATION_OF_BETA:CELL_DEVELOPMENT	0.02	> 0.20	ABO (3.8)	KIAA1324 (3.5)	HNF1A (3.2)	CYP7A1 (2.9)	C11orf9 (2.8)	PCSK9 (2.6)	ABCG8 (2.5)	NPC1L1 (2.5)	TM6SF2 (2.3)	HAPLN4 (1.9)
GO:0002252	immune effector process	0.02	> 0.20	PARP10 (3.2)	LPA (3.0)	OASL (3.0)	TIMD4 (2.8)	GMIP (2.6)	GEMIN7 (2.1)	CYB561D1 (2.0)	SLC22A1 (1.9)	CETP (1.9)	TRAFD1 (1.8)
ENSG00000015171	ZMYND11 PPI subnetwork	0.02	> 0.20	ZNF180 (2.9)	GRINA (2.8)	PARP10 (2.0)	OASL (1.7)	C19orf52 (1.6)	QTRT1 (1.6)	ATXN2 (1.6)	AMIGO1 (1.5)	SORT1 (1.5)	BRAP (1.4)
GO:0010951	negative regulation of endopeptidase activity	0.02	> 0.20	CEACAM19 (3.0)	HP (2.7)	GOT2P1 (2.4)	APOA5 (2.2)	HNF1A (2.2)	PLG (2.1)	PCSK9 (2.1)	SLC22A1 (2.0)	APOB (1.9)	ANGPTL3 (1.9)
ENSG00000110987	BCL7A PPI subnetwork	0.02	> 0.20	RELB (5.8)	BCL3 (4.9)	CARM1 (4.5)	MAU2 (2.9)	GRINA (2.8)	CLPTM1 (2.7)	GMIP (2.5)	TRAFD1 (2.2)	C12orf43 (2.1)	MARK4 (2.0)
ENSG00000111707	SUDS3 PPI subnetwork	0.02	> 0.20	BUD13 (3.5)	BRAP (3.3)	MAU2 (2.7)	C19orf52 (2.2)	ILF3 (2.2)	SUGP1 (2.1)	MARK4 (2.1)	ATXN2 (2.0)	CARM1 (2.0)	C12orf51 (1.9)
ENSG00000215301	DDX3X PPI subnetwork	0.02	> 0.20	SMARCA4 (3.5)	ILF3 (3.2)	DHX38 (3.0)	NAA25 (2.9)	TOP1 (2.9)	GATAD2A (2.4)	USP1 (2.4)	DDX56 (2.3)	ATP13A1 (2.3)	OASL (2.3)
ENSG00000131370	SH3BP5 PPI subnetwork	0.02	> 0.20	ANGPTL3 (3.4)	PLG (3.0)	APOA5 (2.8)	TMEM57 (2.6)	APOC1 (2.2)	ABO (2.1)	LPA (2.0)	APOC4 (2.0)	ST3GAL4 (2.0)	CYP7A1 (1.9)
GO:0030162	regulation of proteolysis	0.02	> 0.20	ENSG00000228044 (3.3)	GEMIN7 (2.5)	DYNC2LI1 (2.2)	CLPTM1 (1.8)	ENSG00000235545 (1.8)	BLOC1S3 (1.5)	APOC1 (1.4)	SLC22A1 (1.3)	APOA5 (1.3)	ZNF180 (1.2)
GO:0016810	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds	0.02	> 0.20	TM6SF2 (3.1)	NPC1L1 (3.0)	HP (2.9)	SLC22A1 (2.8)	ABCG5 (2.7)	ABCG8 (2.7)	HNF1A (2.5)	LPA (2.4)	LPIN3 (2.3)	ATXN7L2 (2.3)
GO:0016064	immunoglobulin mediated immune response	0.02	> 0.20	LPA (3.6)	SLC22A1 (3.4)	TIMD4 (3.1)	APOC4 (2.6)	APOE (2.5)	DHODH (2.2)	ANGPTL3 (2.2)	CETP (2.0)	APOA5 (1.9)	DYNC2LI1 (1.8)
GO:0030194	positive regulation of blood coagulation	0.02	> 0.20	ANGPTL3 (3.7)	PCSK9 (3.4)	APOC4 (3.2)	APOA5 (2.9)	PLG (2.7)	HP (2.6)	SLC22A1 (2.1)	LPA (2.1)	APOB (1.9)	ADAM1 (1.8)
MP:0001654	hepatic necrosis	0.02	> 0.20	LPA (5.4)	SLC22A1 (4.9)	APOA5 (4.1)	ANGPTL3 (3.9)	APOC4 (3.8)	CETP (3.5)	ITGB3 (3.2)	PLG (3.2)	CYP7A1 (3.1)	BCL3 (2.4)
ENSG00000155380	SLC16A1 PPI subnetwork	0.02	> 0.20	ACAD10 (4.1)	TMED4 (3.2)	HNF1A (2.9)	NT5DC1 (2.6)	TMEM50A (2.2)	TRAPPC6A (2.1)	CETP (2.0)	GMPR (1.9)	PLEKHH2 (1.9)	KANK2 (1.8)
GO:0006695	cholesterol biosynthetic process	0.02	> 0.20	HMGCR (10.2)	LDLR (9.4)	FADS2 (8.5)	PCSK9 (8.3)	FADS1 (8.1)	CYP7A1 (2.9)	NKPD1 (2.7)	NPC1L1 (2.5)	TRAPPC6A (2.5)	TMEM57 (2.2)
GO:0017144	drug metabolic process	0.02	> 0.20	CYP7A1 (5.3)	SLC22A1 (5.2)	LPA (5.1)	ABCG8 (4.5)	TM6SF2 (4.5)	ABCG5 (3.9)	GCNT4 (3.1)	NPC1L1 (2.9)	APOC4 (2.6)	APOA5 (2.3)
GO:0019724	B cell mediated immunity	0.02	> 0.20	LPA (3.5)	SLC22A1 (3.3)	TIMD4 (3.1)	APOC4 (2.5)	APOE (2.5)	ANGPTL3 (2.2)	DHODH (2.1)	CETP (2.0)	APOA5 (1.9)	HP (1.7)
GO:0010466	negative regulation of peptidase activity	0.02	> 0.20	CEACAM19 (3.6)	GOT2P1 (2.6)	HP (2.6)	HNF1A (2.1)	APOA5 (2.1)	SLC22A1 (2.0)	PCSK9 (1.9)	PLG (1.9)	ANGPTL3 (1.7)	APOB (1.7)
ENSG00000143575	HAX1 PPI subnetwork	0.02	> 0.20	ABCG8 (2.7)	ABCG5 (2.3)	C1orf63 (2.1)	ALDH2 (2.0)	ERP29 (2.0)	PBX4 (2.0)	KANK2 (2.0)	TRAPPC6A (1.9)	APOC4 (1.9)	TM6SF2 (1.8)
ENSG00000108821	COL1A1 PPI subnetwork	0.02	> 0.20	ITGB3 (5.7)	ST3GAL4 (2.9)	CETP (2.9)	APOE (2.9)	TIMD4 (2.0)	KANK2 (1.9)	MAFB (1.6)	C17orf57 (1.5)	CBLC (1.5)	GMPR (1.4)
ENSG00000117318	ID3 PPI subnetwork	0.02	> 0.20	LPIN3 (2.2)	MYLIP (2.2)	SYPL2 (2.0)	GCNT4 (2.0)	CLPTM1 (1.9)	BCL3 (1.9)	TRIB1 (1.8)	LDLR (1.6)	ATXN2 (1.6)	ATXN7L2 (1.6)
ENSG00000164220	F2RL2 PPI subnetwork	0.02	> 0.20	ANGPTL3 (2.9)	KANK2 (2.6)	ZHX3 (2.3)	ENSG00000238078 (2.2)	MOSC1 (2.2)	APOA5 (2.1)	APOC4 (2.0)	POC5 (1.9)	ITGB3 (1.9)	LPIN3 (1.8)
ENSG00000124299	PEPD PPI subnetwork	0.02	> 0.20	USP24 (3.0)	QTRT1 (2.5)	DHX38 (2.2)	SMARCA4 (2.1)	NAA25 (2.0)	GMPR (1.9)	ILF3 (1.8)	CYP7A1 (1.8)	ENSG00000254235 (1.7)	CELSR2 (1.7)
ENSG00000158711	ELK4 PPI subnetwork	0.02	> 0.20	TRIB1 (3.1)	NCAN (2.7)	HLX (2.6)	KANK2 (2.2)	ENSG00000226648 (2.1)	CEACAM19 (2.0)	BCL3 (2.0)	CYB561D1 (1.9)	PLEC (1.8)	PLCG1 (1.7)
ENSG00000112578	BYSL PPI subnetwork	0.02	> 0.20	DDX56 (4.5)	ZNF259 (4.4)	NAA25 (4.3)	QTRT1 (3.7)	TOMM40 (3.5)	DHX38 (3.1)	ATP13A1 (2.5)	DHODH (2.4)	SUGP1 (2.2)	C12orf43 (1.9)
ENSG00000089157	RPLP0 PPI subnetwork	0.02	> 0.20	NAA25 (4.2)	DDX56 (3.3)	ILF3 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	TOMM40 (2.6)	TOP1 (2.5)	DHX38 (2.2)	PTPN11 (2.1)	CARM1 (2.0)
ENSG00000104946	TBC1D17 PPI subnetwork	0.02	> 0.20	TMEM57 (3.6)	GMPR (2.9)	C12orf51 (2.4)	LPAR2 (2.4)	NYNRIN (2.3)	MARK4 (2.2)	PVRL2 (2.2)	BCAM (2.2)	DDX56 (2.1)	OGDH (2.1)
ENSG00000171735	CAMTA1 PPI subnetwork	0.02	> 0.20	APOB (7.7)	APOC1 (4.1)	PLG (3.8)	NPC1L1 (3.7)	ABCG5 (3.6)	APOA5 (3.6)	HP (2.8)	GMPR (2.7)	APOC4 (2.6)	ANGPTL3 (2.6)
GO:0046889	positive regulation of lipid biosynthetic process	0.02	> 0.20	MYLIP (2.7)	COL4A3BP (2.6)	ENSG00000238078 (2.3)	HNF1A (2.2)	TMEM57 (2.1)	ST3GAL4 (2.0)	ENSG00000228044 (1.8)	POC5 (1.8)	POLK (1.7)	GPAM (1.6)
ENSG00000170458	CD14 PPI subnetwork	0.02	> 0.20	HP (5.2)	PARP10 (3.9)	OASL (3.0)	MYLIP (2.7)	LPIN3 (2.0)	APOA5 (1.8)	PLG (1.8)	GMIP (1.7)	SH2B3 (1.7)	FADS2 (1.6)
ENSG00000197343	ZNF655 PPI subnetwork	0.02	> 0.20	TIMD4 (3.7)	CETP (3.3)	OASL (3.3)	C1orf63 (1.9)	HNF1A (1.7)	TSSK6 (1.5)	ANKRD31 (1.5)	DNAH11 (1.3)	TMEM57 (1.3)	MOSC1 (1.3)
ENSG00000198373	WWP2 PPI subnetwork	0.02	> 0.20	CETP (3.7)	GRINA (3.1)	AP1M2 (2.7)	TIMD4 (2.3)	SLC44A2 (2.2)	HNF1A (1.9)	BCAM (1.8)	OASL (1.8)	HAVCR1 (1.7)	SYPL2 (1.7)
ENSG00000204898	ENSG00000204898 PPI subnetwork	0.02	> 0.20	CETP (4.4)	HP (3.7)	PLEC (3.0)	TIMD4 (2.6)	C12orf47 (2.5)	LPA (2.5)	ENSG00000226648 (2.4)	PVRL2 (2.1)	GMIP (2.1)	DOCK7 (2.0)
ENSG00000079385	CEACAM1 PPI subnetwork	0.02	> 0.20	CETP (4.4)	HP (3.7)	PLEC (3.0)	TIMD4 (2.6)	C12orf47 (2.5)	LPA (2.5)	ENSG00000226648 (2.4)	PVRL2 (2.1)	GMIP (2.1)	DOCK7 (2.0)
GO:0016638	oxidoreductase activity, acting on the CH-NH2 group of donors	0.02	> 0.20	PLG (4.4)	ANGPTL3 (3.9)	SLC22A1 (3.1)	MOSC1 (3.0)	HP (2.6)	ATXN7L2 (2.5)	TM6SF2 (2.3)	APOC4 (2.2)	GPAM (2.1)	SYPL2 (1.8)
GO:0006956	complement activation	0.02	> 0.20	LPA (7.1)	TIMD4 (5.1)	SLC22A1 (4.3)	APOC4 (4.2)	CETP (3.4)	ANGPTL3 (3.3)	APOA5 (3.1)	HP (3.0)	APOE (3.0)	DHODH (2.8)
ENSG00000079246	XRCC5 PPI subnetwork	0.02	> 0.20	SMARCA4 (3.1)	FEN1 (2.9)	ILF3 (2.7)	TOP1 (2.4)	PLCG1 (2.3)	USP1 (2.2)	POLK (2.1)	DHX38 (2.0)	ACAD10 (2.0)	NAA25 (1.7)
MP:0002412	increased susceptibility to bacterial infection	0.02	> 0.20	HP (5.5)	MAFB (3.8)	TIMD4 (3.6)	BCL3 (3.0)	RELB (2.3)	GMIP (2.3)	OASL (2.2)	PARP10 (2.2)	CETP (2.2)	HLX (2.0)
MP:0004948	abnormal neuronal precursor proliferation	0.02	> 0.20	ENSG00000254235 (2.7)	PLCG1 (2.5)	PSRC1 (2.1)	APOA5 (2.0)	C12orf51 (1.8)	BRAP (1.8)	SLC22A1 (1.7)	PPP1R37 (1.5)	ABO (1.5)	APOC4 (1.4)
GO:0032259	methylation	0.02	> 0.20	QTRT1 (2.5)	ZNF180 (2.5)	ENSG00000238078 (2.3)	C19orf52 (2.3)	DHODH (2.1)	MAPKAPK5 (1.9)	ILF3 (1.9)	ATXN7L2 (1.7)	ENSG00000254235 (1.7)	BUD13 (1.6)
ENSG00000106355	LSM5 PPI subnetwork	0.02	> 0.20	DHX38 (4.2)	MAU2 (3.3)	ATP13A1 (3.2)	SMARCA4 (2.6)	ILF3 (2.5)	BUD13 (2.5)	DDX56 (2.4)	SUGP1 (2.3)	TOMM40 (2.2)	TXNL4B (2.2)
ENSG00000188313	PLSCR1 PPI subnetwork	0.02	> 0.20	ACAD10 (2.7)	ATXN2 (2.7)	PVRL2 (2.6)	ABO (2.5)	CEACAM19 (2.3)	BCAM (2.1)	TMED4 (2.1)	PPP1R37 (2.0)	GRINA (2.0)	C11orf9 (2.0)
MP:0005438	abnormal glycogen homeostasis	0.02	> 0.20	GRINA (2.7)	SYPL2 (2.5)	PPP1R37 (2.1)	ATP13A1 (2.1)	DNM2 (2.1)	BCAM (2.0)	PARP10 (1.9)	PLEC (1.9)	BLOC1S3 (1.8)	ZNF180 (1.8)
ENSG00000104938	CLEC4M PPI subnetwork	0.02	> 0.20	HNF1A (3.7)	ERP29 (2.6)	CETP (2.3)	NT5DC1 (2.3)	ACAD10 (2.1)	TRAPPC6A (1.9)	CBLC (1.7)	PCSK9 (1.6)	BRAP (1.6)	PTPN11 (1.6)
GO:0051262	protein tetramerization	0.02	> 0.20	NT5DC1 (3.4)	NKPD1 (2.8)	LPA (2.4)	CYP7A1 (2.4)	TRAPPC6A (2.4)	ANKRD31 (2.3)	ACAD10 (2.3)	GOT2P1 (2.2)	DHODH (2.1)	SLC22A1 (2.1)
MP:0011099	complete lethality throughout fetal growth and development	0.02	> 0.20	NYNRIN (3.8)	HLX (3.6)	USP24 (2.5)	C12orf51 (2.5)	PLEC (2.3)	BCAM (2.3)	ATXN2 (2.2)	KANK2 (2.0)	PTPN11 (1.9)	TRIB1 (1.8)
GO:0006725	cellular aromatic compound metabolic process	0.02	> 0.20	LPA (3.7)	CYP7A1 (3.7)	SLC22A1 (3.4)	ENSG00000254235 (2.7)	ANKRD31 (2.5)	ABCG8 (2.5)	DHODH (2.4)	TM6SF2 (2.3)	TRAPPC6A (2.1)	ABCG5 (2.1)
ENSG00000128709	HOXD9 PPI subnetwork	0.02	> 0.20	DHODH (2.3)	ITGB3 (1.8)	MAU2 (1.8)	GCNT4 (1.7)	ZHX3 (1.7)	DHX38 (1.7)	LPIN3 (1.6)	MAPKAPK5 (1.6)	LDLR (1.6)	PVRL2 (1.6)
GO:0042493	response to drug	0.02	> 0.20	ABCG8 (3.6)	TM6SF2 (2.9)	ABCG5 (2.8)	SLC22A1 (2.5)	TMED4 (2.4)	NPC1L1 (2.2)	FADS2 (2.2)	LPA (2.0)	PCSK9 (1.8)	LDLR (1.7)
ENSG00000146109	ABT1 PPI subnetwork	0.02	> 0.20	NAA25 (4.4)	DDX56 (4.0)	ZNF259 (3.9)	TOMM40 (3.7)	QTRT1 (3.5)	DHODH (3.2)	C12orf43 (2.6)	DHX38 (2.5)	TOP1 (2.4)	MAPKAPK5 (2.2)
GO:0008483	transaminase activity	0.02	> 0.20	SLC22A1 (4.8)	APOA5 (4.5)	PLG (4.3)	LPA (3.9)	ANGPTL3 (3.6)	ALDH2 (3.6)	APOC4 (3.5)	SARS (2.9)	CYP7A1 (2.6)	TM6SF2 (2.5)
ENSG00000182367	ENSG00000182367 PPI subnetwork	0.02	> 0.20	DHX38 (3.6)	USP1 (2.3)	SMARCA4 (2.2)	TOP1 (2.2)	MAU2 (2.2)	PLCG1 (2.1)	ILF3 (2.1)	BUD13 (2.1)	ATP13A1 (2.1)	TRAFD1 (1.9)
ENSG00000181104	F2R PPI subnetwork	0.02	> 0.20	HP (4.4)	APOC4 (2.8)	ANGPTL3 (2.6)	KANK2 (2.3)	APOA5 (2.2)	RHD (2.2)	HLX (2.1)	ST3GAL4 (1.9)	PLG (1.8)	CEACAM19 (1.8)
ENSG00000135372	NAT10 PPI subnetwork	0.02	> 0.20	ZNF259 (5.1)	NAA25 (4.5)	DDX56 (4.2)	QTRT1 (4.1)	TOMM40 (3.9)	DHODH (3.2)	DHX38 (2.8)	SUGP1 (2.7)	ATP13A1 (2.6)	C12orf43 (2.6)
MP:0005152	pancytopenia	0.02	> 0.20	ST3GAL4 (2.9)	DOCK7 (2.7)	UBXN2B (2.5)	DNAH11 (2.5)	CEACAM19 (2.4)	RHD (2.2)	RHCE (2.2)	SLC44A2 (2.1)	NYNRIN (2.1)	POC5 (2.1)
MP:0008596	increased circulating interleukin-6 level	0.02	> 0.20	TRIB1 (3.8)	PARP10 (3.7)	CETP (3.1)	OASL (3.0)	BCL3 (2.8)	HLX (2.4)	GMIP (2.4)	SH2B3 (2.3)	TRAFD1 (2.1)	FADS2 (2.0)
ENSG00000164251	F2RL1 PPI subnetwork	0.02	> 0.20	HP (5.6)	MOSC1 (3.1)	ANGPTL3 (2.9)	RHD (2.9)	APOC4 (2.5)	APOA5 (2.4)	AP1M2 (2.3)	PBX4 (2.2)	CBLC (2.1)	CYP7A1 (2.0)
GO:0071371	cellular response to gonadotropin stimulus	0.02	> 0.20	DNAH11 (3.2)	C11orf9 (3.1)	ABO (2.6)	ST3GAL4 (2.5)	FADS2 (2.1)	HMGCR (2.0)	TMED4 (2.0)	ENSG00000238078 (1.9)	GOT2P1 (1.8)	LDLR (1.7)
ENSG00000007908	SELE PPI subnetwork	0.02	> 0.20	PLEC (4.3)	ITGB3 (3.5)	KANK2 (2.8)	ADAM1 (2.6)	DNM2 (2.6)	DHX38 (2.5)	ENSG00000226648 (2.4)	PVR (2.4)	SLC44A2 (2.2)	ZHX3 (2.2)
ENSG00000143373	ZNF687 PPI subnetwork	0.02	> 0.20	C19orf52 (2.6)	QTRT1 (2.2)	DHX38 (2.1)	ZNF180 (2.1)	OASL (2.0)	SUGP1 (2.0)	BRAP (2.0)	PARP10 (2.0)	SORT1 (1.6)	TRAFD1 (1.5)
MP:0004056	abnormal myocardium compact layer morphology	0.02	> 0.20	C11orf9 (3.6)	TMEM57 (3.3)	APOB (3.0)	COL4A3BP (2.6)	ABCG8 (2.5)	GPAM (2.3)	TMED4 (2.1)	ALDH2 (2.1)	C17orf57 (2.1)	PVRL2 (2.0)
MP:0001683	absent mesoderm	0.02	> 0.20	ENSG00000254235 (2.6)	PVR (2.4)	DOCK7 (2.3)	LDLR (2.2)	TMEM57 (2.1)	NYNRIN (1.7)	ATXN7L2 (1.7)	KIAA1324 (1.7)	HMGCR (1.6)	TMEM50A (1.5)
ENSG00000116962	NID1 PPI subnetwork	0.02	> 0.20	BCAM (3.7)	PVR (2.6)	APOE (2.6)	HAVCR1 (2.3)	CBLC (2.2)	AP1M2 (2.1)	FRK (2.0)	ERP29 (2.0)	C17orf57 (1.9)	APOC1 (1.8)
MP:0002816	colitis	0.02	> 0.20	CYP7A1 (2.6)	HLX (2.3)	OASL (2.3)	LPA (2.2)	BCL3 (2.2)	GMIP (2.1)	PLEC (2.1)	SH2B3 (2.0)	PBX4 (1.9)	APOC4 (1.8)
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	0.02	> 0.20	ITGB3 (9.5)	CETP (3.5)	APOE (3.0)	ANGPTL3 (2.9)	SH2B3 (2.8)	HP (2.7)	PLG (2.6)	APOB (2.3)	TIMD4 (2.3)	APOC1 (2.3)
ENSG00000211660	ENSG00000211660 PPI subnetwork	0.02	> 0.20	APOE (6.6)	TIMD4 (5.2)	MAFB (4.5)	APOC1 (3.3)	CETP (2.5)	CARM1 (1.6)	GPAM (1.6)	LPA (1.5)	HAVCR1 (1.5)	C19orf52 (1.4)
ENSG00000211653	ENSG00000211653 PPI subnetwork	0.02	> 0.20	APOE (6.6)	TIMD4 (5.2)	MAFB (4.5)	APOC1 (3.3)	CETP (2.5)	CARM1 (1.6)	GPAM (1.6)	LPA (1.5)	HAVCR1 (1.5)	C19orf52 (1.4)
ENSG00000058729	RIOK2 PPI subnetwork	0.02	> 0.20	DDX56 (4.3)	NAA25 (4.3)	QTRT1 (4.3)	ZNF259 (4.2)	TOMM40 (3.0)	DHODH (2.8)	DHX38 (2.7)	ILF3 (2.7)	ATP13A1 (2.6)	C12orf43 (2.3)
ENSG00000139197	PEX5 PPI subnetwork	0.02	> 0.20	NT5DC1 (2.6)	SLC22A1 (2.0)	ALDH2 (2.0)	MYLIP (2.0)	AMIGO1 (2.0)	LPA (1.9)	DYNC2LI1 (1.9)	GRINA (1.9)	APOC4 (1.7)	ACAD10 (1.5)
ENSG00000064012	CASP8 PPI subnetwork	0.02	> 0.20	RELB (3.5)	BCL3 (2.9)	ST3GAL4 (2.6)	TRAFD1 (2.5)	CEACAM19 (2.5)	PVRL2 (2.4)	GRINA (2.3)	OASL (2.3)	PARP10 (2.0)	POLK (1.9)
REACTOME_TOLL_RECEPTOR_CASCADES	REACTOME_TOLL_RECEPTOR_CASCADES	0.02	> 0.20	OASL (4.2)	RELB (3.9)	BCL3 (3.7)	TRIB1 (3.6)	SH2B3 (3.5)	GMIP (2.9)	PARP10 (2.8)	MAFB (2.5)	PVR (2.4)	TRAFD1 (2.2)
GO:0071941	nitrogen cycle metabolic process	0.02	> 0.20	TM6SF2 (5.1)	ABCG8 (5.0)	NPC1L1 (4.8)	ABCG5 (4.8)	C17orf57 (3.8)	CYP7A1 (3.0)	ZHX3 (2.6)	APOC4 (2.6)	TMED4 (2.5)	SLC22A1 (2.4)
ENSG00000123329	ARHGAP9 PPI subnetwork	0.02	> 0.20	PLEKHH2 (3.8)	PARP10 (2.9)	OASL (2.6)	TRIB1 (2.5)	BCL3 (2.5)	TRAFD1 (2.3)	PPP1R37 (2.3)	LPAR2 (2.2)	COL4A3BP (2.2)	NT5DC1 (2.0)
GO:0030128	clathrin coat of endocytic vesicle	0.02	> 0.20	ZHX3 (3.1)	CLPTM1 (2.6)	PPP1R37 (2.6)	GRINA (2.2)	USP24 (2.1)	TMEM50A (1.9)	POLK (1.8)	PVRL2 (1.8)	ZNF180 (1.8)	CBLC (1.7)
MP:0003702	abnormal chromosome morphology	0.02	> 0.20	UBXN2B (4.3)	PSRC1 (3.9)	USP1 (3.4)	FEN1 (3.0)	ENSG00000226648 (2.3)	DOCK7 (1.9)	HNF1A (1.6)	ENSG00000254235 (1.5)	ERP29 (1.5)	POC5 (1.5)
ENSG00000173566	NUDT18 PPI subnetwork	0.02	> 0.20	NT5DC1 (2.8)	UBXN2B (2.4)	MAU2 (2.3)	CARM1 (2.1)	GMPR (1.9)	APOA5 (1.9)	TXNL4B (1.9)	LPA (1.8)	PMFBP1 (1.6)	KIAA1324 (1.5)
GO:0030145	manganese ion binding	0.02	> 0.20	PMFBP1 (3.4)	ENSG00000228044 (2.4)	TXNL4B (2.2)	ANKRD31 (2.1)	HP (1.9)	GPAM (1.9)	MOSC1 (1.8)	USP24 (1.7)	ENSG00000226648 (1.7)	BCL3 (1.6)
GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	0.02	> 0.20	POLK (3.7)	TRAFD1 (2.5)	GOT2P1 (2.4)	BLOC1S3 (2.2)	C17orf57 (2.2)	OASL (2.1)	ST3GAL4 (2.1)	GEMIN7 (1.8)	PARP10 (1.7)	TRAPPC6A (1.7)
GO:2001056	positive regulation of cysteine-type endopeptidase activity	0.02	> 0.20	POLK (3.7)	TRAFD1 (2.5)	GOT2P1 (2.4)	BLOC1S3 (2.2)	C17orf57 (2.2)	OASL (2.1)	ST3GAL4 (2.1)	GEMIN7 (1.8)	PARP10 (1.7)	TRAPPC6A (1.7)
ENSG00000109606	DHX15 PPI subnetwork	0.02	> 0.20	DDX56 (4.7)	ZNF259 (4.6)	NAA25 (4.2)	TOMM40 (3.8)	QTRT1 (3.7)	DHX38 (3.0)	SMARCA4 (2.9)	SUGP1 (2.7)	C12orf43 (2.6)	ATP13A1 (2.6)
MP:0001722	pale yolk sac	0.02	> 0.20	KANK2 (3.4)	GATAD2A (3.3)	ATXN2 (3.3)	RHCE (2.8)	RHD (2.5)	C12orf51 (2.4)	SH2B3 (2.4)	MARK4 (2.2)	APOB (2.1)	BCAM (2.0)
ENSG00000100105	PATZ1 PPI subnetwork	0.02	> 0.20	TIMD4 (3.7)	OASL (3.6)	CETP (3.4)	PLEKHH2 (2.1)	TMEM57 (2.1)	HNF1A (1.9)	C1orf63 (1.8)	ENSG00000226648 (1.5)	TMEM116 (1.4)	TXNL4B (1.4)
ENSG00000177156	TALDO1 PPI subnetwork	0.02	> 0.20	ERP29 (3.0)	FRK (2.7)	OGDH (2.0)	ZNF101 (1.8)	GOT2P1 (1.7)	TM6SF2 (1.6)	SMARCA4 (1.6)	GRINA (1.5)	PARP10 (1.4)	COL4A3BP (1.4)
ENSG00000204221	WDR46 PPI subnetwork	0.02	> 0.20	ZNF259 (4.9)	DDX56 (4.5)	NAA25 (4.3)	QTRT1 (4.0)	TOMM40 (3.6)	DHODH (3.1)	DHX38 (2.6)	C12orf43 (2.5)	BRAP (2.4)	SUGP1 (2.3)
ENSG00000206284	WDR46 PPI subnetwork	0.02	> 0.20	ZNF259 (4.9)	DDX56 (4.5)	NAA25 (4.3)	QTRT1 (4.0)	TOMM40 (3.6)	DHODH (3.1)	DHX38 (2.6)	C12orf43 (2.5)	BRAP (2.4)	SUGP1 (2.3)
ENSG00000052749	RRP12 PPI subnetwork	0.02	> 0.20	NAA25 (5.0)	ZNF259 (4.7)	DDX56 (4.7)	TOMM40 (3.6)	QTRT1 (3.6)	DHODH (2.5)	DHX38 (2.3)	C12orf43 (2.2)	ATP13A1 (2.1)	PVR (2.0)
GO:0032933	SREBP-mediated signaling pathway	0.02	> 0.20	LDLR (5.3)	FADS2 (5.1)	HMGCR (5.0)	FADS1 (4.5)	PCSK9 (4.1)	TMEM57 (3.1)	PPP1R37 (2.6)	ENSG00000226648 (2.2)	C17orf57 (2.2)	POLK (2.1)
ENSG00000132464	ENAM PPI subnetwork	0.02	> 0.20	PLG (3.3)	APOB (3.3)	CILP2 (3.2)	ERP29 (3.1)	ANGPTL3 (3.0)	TMEM50A (2.6)	HP (2.5)	APOC1 (2.4)	SLC22A1 (2.3)	CLPTM1 (2.3)
ENSG00000179588	ZFPM1 PPI subnetwork	0.02	> 0.20	C11orf9 (3.0)	NYNRIN (2.9)	GMPR (2.7)	ABO (2.2)	RHCE (2.1)	RHD (2.0)	MARK4 (1.9)	PVRL2 (1.9)	MAU2 (1.8)	YIPF2 (1.8)
MP:0003674	oxidative stress	0.02	> 0.20	APOC1 (3.4)	RHCE (2.7)	ALDH2 (2.4)	TRAPPC6A (2.4)	NT5DC1 (2.2)	ANGPTL3 (2.2)	HP (2.2)	PLG (2.1)	RHD (2.0)	BLOC1S3 (2.0)
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	0.02	> 0.20	GPAM (3.5)	MOSC1 (3.4)	GEMIN7 (2.6)	C12orf51 (2.4)	HP (2.4)	MAPKAPK5 (2.3)	SH2B3 (2.3)	TIMD4 (2.1)	ATXN2 (1.8)	GRINA (1.8)
ENSG00000187837	HIST1H1C PPI subnetwork	0.02	> 0.20	C1orf63 (2.8)	PSRC1 (2.7)	USP1 (2.5)	ILF3 (2.4)	TOP1 (2.3)	ERP29 (2.0)	ACAD10 (1.9)	TMEM50A (1.8)	USP24 (1.8)	SMARCA4 (1.7)
ENSG00000115234	SNX17 PPI subnetwork	0.02	> 0.20	HMGCR (4.7)	FADS1 (4.1)	FADS2 (3.8)	ITGB3 (3.2)	C17orf57 (2.4)	TMEM57 (2.3)	MAFB (2.2)	ZHX3 (2.0)	ZNF101 (1.9)	PCSK9 (1.9)
ENSG00000179715	FAM113B PPI subnetwork	0.02	> 0.20	APOB (7.7)	APOC1 (3.9)	PLG (3.9)	NPC1L1 (3.7)	APOA5 (3.6)	ABCG5 (3.6)	HP (2.8)	GMPR (2.7)	GPAM (2.7)	APOC4 (2.6)
ENSG00000125482	TTF1 PPI subnetwork	0.02	> 0.20	MAPKAPK5 (3.4)	DHX38 (2.7)	ZNF259 (2.7)	TXNL4B (2.6)	C12orf43 (2.5)	DYNC2LI1 (2.5)	GEMIN7 (2.2)	DDX56 (2.1)	ATXN2 (2.0)	NAA25 (1.9)
ENSG00000132780	NASP PPI subnetwork	0.02	> 0.20	DNAH11 (2.3)	GEMIN7 (2.2)	ZHX3 (2.1)	ABO (1.7)	TRIB1 (1.7)	C19orf52 (1.7)	MYLIP (1.7)	C11orf9 (1.6)	TMEM50A (1.6)	PMFBP1 (1.4)
MP:0001190	reddish skin	0.02	> 0.20	CBLC (5.4)	BCL3 (5.1)	GRINA (3.0)	AP1M2 (2.8)	RELB (2.4)	CEACAM19 (2.3)	TRIB1 (2.2)	NPC1L1 (2.0)	GMIP (1.9)	PARP10 (1.8)
ENSG00000136205	TNS3 PPI subnetwork	0.02	> 0.20	TIMD4 (3.4)	APOE (2.5)	MAFB (2.1)	FADS2 (2.1)	BCAM (2.0)	PSRC1 (1.9)	ALDH2 (1.8)	DOCK7 (1.8)	AMIGO1 (1.7)	CYP7A1 (1.7)
ENSG00000102974	CTCF PPI subnetwork	0.02	> 0.20	USP1 (2.9)	PLEC (2.6)	GOT2P1 (2.2)	ENSG00000228044 (1.9)	MYLIP (1.9)	USP24 (1.8)	ATXN2 (1.8)	SH2B3 (1.7)	GATAD2A (1.7)	ILF3 (1.6)
ENSG00000196540	ENSG00000196540 PPI subnetwork	0.02	> 0.20	APOB (7.6)	APOC1 (4.1)	PLG (3.8)	NPC1L1 (3.7)	APOA5 (3.6)	ABCG5 (3.6)	GMPR (2.8)	HP (2.8)	APOC4 (2.7)	GPAM (2.6)
MP:0002752	abnormal somatic nervous system morphology	0.02	> 0.20	PVR (2.5)	CELSR2 (2.3)	TMED4 (1.9)	TRIB1 (1.9)	TSSK6 (1.8)	ENSG00000254235 (1.7)	FADS1 (1.7)	TIMD4 (1.7)	ABCG5 (1.5)	HLX (1.5)
ENSG00000113460	BRIX1 PPI subnetwork	0.02	> 0.20	NAA25 (4.9)	ZNF259 (4.8)	TOMM40 (4.0)	DDX56 (3.8)	QTRT1 (3.8)	DHODH (2.9)	C12orf43 (2.6)	DHX38 (2.4)	ATP13A1 (2.1)	ILF3 (1.8)
ENSG00000160185	UBASH3A PPI subnetwork	0.02	> 0.20	PARP10 (3.2)	PLEKHH2 (3.1)	OASL (2.6)	LPAR2 (2.5)	BCL3 (2.4)	COL4A3BP (2.4)	TRIB1 (2.4)	PPP1R37 (2.2)	ABCG8 (2.0)	NT5DC1 (2.0)
MP:0003888	liver hemorrhage	0.02	> 0.20	CETP (3.7)	HP (2.8)	HLX (2.3)	LPA (2.1)	LPIN3 (2.1)	UBXN2B (2.1)	PLG (2.0)	PVRL2 (1.8)	APOA5 (1.7)	C12orf51 (1.6)
ENSG00000074211	PPP2R2C PPI subnetwork	0.02	> 0.20	NAA25 (2.8)	CEACAM19 (2.2)	TOMM40 (2.2)	PSMA5 (2.2)	QTRT1 (2.0)	C12orf51 (1.8)	CLPTM1 (1.8)	NKPD1 (1.7)	ZNF259 (1.6)	ENSG00000254235 (1.6)
GO:0050820	positive regulation of coagulation	0.02	> 0.20	ANGPTL3 (3.3)	PCSK9 (3.2)	APOC4 (3.1)	APOA5 (2.9)	PLG (2.5)	ADAM1 (2.4)	HP (2.3)	SLC22A1 (2.3)	LPA (2.1)	ABO (2.1)
MP:0005562	decreased mean corpuscular hemoglobin	0.02	> 0.20	RHCE (10.0)	RHD (9.0)	GMPR (2.6)	TIMD4 (2.4)	DNAH11 (2.0)	CETP (1.9)	BLOC1S3 (1.9)	FADS2 (1.9)	ERP29 (1.8)	ATXN7L2 (1.7)
GO:0016411	acylglycerol O-acyltransferase activity	0.02	> 0.20	GPAM (5.2)	TM6SF2 (5.0)	MOSC1 (4.6)	NPC1L1 (3.8)	ENSG00000254235 (3.7)	LPAR2 (2.9)	GRINA (2.9)	FADS1 (2.5)	FADS2 (2.3)	SORT1 (2.2)
ENSG00000184083	FAM120C PPI subnetwork	0.02	> 0.20	C19orf52 (2.3)	SUGP1 (2.3)	DHX38 (2.2)	PARP10 (2.2)	QTRT1 (1.9)	BRAP (1.9)	OASL (1.9)	ZNF180 (1.9)	GRINA (1.8)	SORT1 (1.7)
REACTOME_TRYPTOPHAN_CATABOLISM	REACTOME_TRYPTOPHAN_CATABOLISM	0.02	> 0.20	APOA5 (5.6)	SLC22A1 (5.5)	CYP7A1 (4.5)	ENSG00000254235 (4.1)	PLG (4.0)	LPA (4.0)	APOC4 (3.4)	ANGPTL3 (3.3)	ENSG00000228044 (2.0)	TM6SF2 (2.0)
GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	0.02	> 0.20	ERP29 (3.2)	PVR (3.1)	POC5 (2.1)	DHODH (2.0)	BUD13 (2.0)	BLOC1S3 (1.9)	PVRL2 (1.7)	C12orf47 (1.6)	TRAPPC6A (1.6)	ADAM1 (1.5)
ENSG00000211619	ENSG00000211619 PPI subnetwork	0.02	> 0.20	APOE (2.4)	NPC1L1 (2.3)	APOB (2.2)	MAFB (2.2)	GCNT4 (1.9)	APOC4 (1.9)	ABCG5 (1.8)	GPAM (1.7)	ZNF180 (1.7)	FRK (1.7)
GO:0033273	response to vitamin	0.02	> 0.20	ENSG00000235545 (2.5)	FADS2 (2.3)	ATXN7L2 (2.2)	ABO (1.9)	AP1M2 (1.8)	YIPF2 (1.8)	TSSK6 (1.7)	CYP7A1 (1.7)	TMED4 (1.7)	ALDH2 (1.7)
GO:0008144	drug binding	0.02	> 0.20	GMPR (2.4)	ALDH2 (2.4)	C12orf47 (2.3)	APOB (2.3)	HMGCR (2.0)	ST3GAL4 (2.0)	C1orf63 (1.9)	ABCG5 (1.9)	FADS2 (1.7)	KIAA1324 (1.6)
ENSG00000087269	NOP14 PPI subnetwork	0.02	> 0.20	DDX56 (4.8)	ZNF259 (4.8)	NAA25 (4.2)	QTRT1 (3.8)	TOMM40 (3.4)	DHODH (3.1)	DHX38 (2.2)	ATP13A1 (2.1)	TOP1 (2.1)	C12orf43 (2.0)
ENSG00000168090	COPS6 PPI subnetwork	0.02	> 0.20	PPP1R37 (2.5)	SARS (2.2)	CLPTM1 (2.2)	MYLIP (2.0)	CEACAM19 (1.8)	ALDH2 (1.8)	GRINA (1.7)	YIPF2 (1.7)	USP1 (1.6)	NKPD1 (1.6)
GO:0051050	positive regulation of transport	0.02	> 0.20	KIAA1324 (2.9)	ENSG00000235545 (2.2)	YIPF2 (2.2)	ENSG00000228044 (1.9)	AMIGO1 (1.9)	GPAM (1.8)	NPC1L1 (1.7)	AP1M2 (1.7)	PLEKHH2 (1.5)	ENSG00000238078 (1.4)
GO:0051055	negative regulation of lipid biosynthetic process	0.02	> 0.20	TRAPPC6A (2.4)	NPC1L1 (2.4)	BLOC1S3 (2.0)	HNF1A (1.8)	C12orf47 (1.7)	HMGCR (1.6)	FADS1 (1.5)	GCNT4 (1.5)	PPP1R37 (1.4)	TM6SF2 (1.4)
MP:0005076	abnormal cell differentiation	0.02	> 0.20	BCL3 (3.5)	TRIB1 (3.0)	MAFB (2.8)	MYLIP (2.5)	ANKRD31 (2.2)	PLEC (2.2)	TOP1 (2.2)	PPP1R37 (2.1)	ALDH2 (1.9)	C12orf51 (1.8)
MP:0005440	increased glycogen level	0.02	> 0.20	APOA5 (4.4)	APOC4 (4.0)	PLG (4.0)	APOB (3.9)	LPA (3.3)	MOSC1 (3.2)	HP (3.1)	CYP7A1 (2.8)	ANGPTL3 (2.7)	SORT1 (2.7)
ENSG00000023445	BIRC3 PPI subnetwork	0.02	> 0.20	RELB (4.9)	PARP10 (3.5)	ST3GAL4 (3.0)	LPAR2 (2.3)	TRAFD1 (2.3)	BCL3 (2.3)	NT5DC1 (2.1)	SLC22A1 (1.8)	ENSG00000238078 (1.8)	C19orf52 (1.7)
ENSG00000115541	HSPE1 PPI subnetwork	0.02	> 0.20	FADS2 (3.7)	TRAPPC6A (3.2)	NT5DC1 (3.1)	FADS1 (2.6)	LDLR (2.3)	FRK (1.9)	OASL (1.9)	PCSK9 (1.8)	PVRL2 (1.8)	KANK2 (1.8)
ENSG00000066926	FECH PPI subnetwork	0.02	> 0.20	NT5DC1 (3.9)	ACAD10 (2.9)	NAA25 (2.6)	ERP29 (2.2)	TOMM40 (2.2)	MAPKAPK5 (1.9)	BRAP (1.9)	BUD13 (1.8)	TMED4 (1.7)	RHD (1.6)
ENSG00000169306	IL1RAPL1 PPI subnetwork	0.02	> 0.20	ST3GAL4 (2.8)	AP1M2 (2.7)	HNF1A (2.5)	DNM2 (2.3)	KIAA1324 (2.2)	NYNRIN (1.9)	ITGB3 (1.8)	CETP (1.8)	PLEC (1.7)	CBLC (1.7)
ENSG00000123609	NMI PPI subnetwork	0.02	> 0.20	PARP10 (5.5)	TRAPPC6A (2.9)	TRAFD1 (2.6)	OASL (2.6)	BLOC1S3 (2.3)	GEMIN7 (2.2)	TMEM50A (2.2)	ENSG00000254235 (2.0)	APOE (1.8)	HAPLN4 (1.8)
ENSG00000153879	CEBPG PPI subnetwork	0.02	> 0.20	SARS (4.2)	TRIB1 (4.1)	BCL3 (3.3)	MAFB (3.1)	PVR (3.0)	HLX (2.4)	ABCG8 (2.3)	ST3GAL4 (2.1)	PVRL2 (2.1)	POC5 (2.0)
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	0.02	> 0.20	OASL (9.4)	TRAFD1 (4.3)	PARP10 (4.2)	RELB (3.7)	BCL3 (3.2)	PVR (3.1)	CYP7A1 (2.5)	GOT2P1 (2.1)	GEMIN7 (2.0)	C12orf43 (1.9)
ENSG00000120693	SMAD9 PPI subnetwork	0.02	> 0.20	PLEC (2.7)	CLPTM1 (2.6)	ATP13A1 (2.3)	MAFB (2.2)	PPP1R37 (2.1)	MAU2 (2.1)	TRIB1 (2.1)	CYB561D1 (2.0)	YIPF2 (1.9)	DNM2 (1.8)
GO:0050817	coagulation	0.02	> 0.20	ITGB3 (7.1)	GMPR (3.2)	CETP (2.1)	ANGPTL3 (1.9)	PTPN11 (1.8)	TMEM50A (1.8)	C11orf9 (1.8)	TIMD4 (1.7)	PLG (1.5)	ZNF101 (1.5)
GO:0016126	sterol biosynthetic process	0.02	> 0.20	HMGCR (9.8)	LDLR (9.4)	FADS2 (8.4)	FADS1 (8.1)	PCSK9 (8.0)	CYP7A1 (2.9)	NPC1L1 (2.4)	TRAPPC6A (2.3)	NKPD1 (2.1)	TMEM57 (1.9)
ENSG00000196498	NCOR2 PPI subnetwork	0.02	> 0.20	TRIB1 (3.6)	MAU2 (2.7)	ZHX3 (2.6)	PARP10 (2.5)	BCL3 (2.3)	DHX38 (2.3)	PLEC (2.0)	GMIP (1.9)	ATXN2 (1.6)	RELB (1.6)
GO:0010565	regulation of cellular ketone metabolic process	0.02	> 0.20	ENSG00000254235 (2.6)	PSMA5 (2.5)	TXNL4B (2.3)	NT5DC1 (2.2)	GPAM (2.2)	PCSK9 (1.9)	OGDH (1.8)	TRAFD1 (1.7)	ZNF180 (1.7)	NAA25 (1.6)
GO:0006575	cellular modified amino acid metabolic process	0.02	> 0.20	MOSC1 (2.7)	TM6SF2 (2.6)	ABCG8 (2.4)	AMIGO1 (2.3)	LPA (2.3)	SLC22A1 (2.1)	CYP7A1 (1.9)	NT5DC1 (1.9)	ABCG5 (1.9)	SYPL2 (1.8)
MP:0008577	increased circulating interferon-gamma level	0.02	> 0.20	PARP10 (6.3)	OASL (6.3)	TRAFD1 (4.7)	BCL3 (3.7)	TRIB1 (2.8)	RELB (2.7)	GRINA (2.2)	GMIP (2.2)	POLK (1.8)	CEACAM19 (1.7)
ENSG00000205246	RPSAP58 PPI subnetwork	0.02	> 0.20	NAA25 (5.1)	ZNF259 (3.6)	PSMA5 (3.4)	TOMM40 (3.4)	DDX56 (3.3)	QTRT1 (3.1)	SARS (2.9)	DHODH (2.5)	BRAP (2.1)	NT5DC1 (2.0)
GO:0034614	cellular response to reactive oxygen species	0.02	> 0.20	DNAH11 (3.6)	GOT2P1 (3.0)	ACAD10 (2.5)	ALDH2 (2.4)	PBX4 (2.4)	C17orf57 (2.4)	RHD (2.0)	MOSC1 (1.9)	RHCE (1.8)	C12orf51 (1.7)
ENSG00000129255	MPDU1 PPI subnetwork	0.02	> 0.20	ANKRD31 (2.9)	PMFBP1 (2.2)	LDLR (2.1)	PLEKHH2 (1.7)	DHODH (1.7)	FADS2 (1.6)	FADS1 (1.6)	TMEM116 (1.5)	HMGCR (1.4)	CILP2 (1.4)
KEGG_PEROXISOME	KEGG_PEROXISOME	0.02	> 0.20	MOSC1 (3.7)	GPAM (3.7)	ANGPTL3 (3.5)	PLG (3.4)	ACAD10 (3.3)	TRAPPC6A (3.3)	APOC4 (2.8)	NT5DC1 (2.7)	ALDH2 (2.7)	HP (2.7)
MP:0002429	abnormal blood cell morphology/development	0.02	> 0.20	BCL3 (4.2)	GMIP (2.8)	ENSG00000228044 (2.6)	PMFBP1 (2.3)	TRIB1 (2.0)	ILF3 (2.0)	MAFB (2.0)	C12orf51 (1.8)	HAVCR1 (1.8)	ENSG00000226648 (1.7)
ENSG00000164692	COL1A2 PPI subnetwork	0.02	> 0.20	ITGB3 (9.5)	CETP (3.8)	CILP2 (2.9)	APOE (2.7)	GMPR (2.4)	MAFB (2.1)	ALDH2 (2.0)	TIMD4 (2.0)	ST3GAL4 (1.7)	ABCG8 (1.7)
ENSG00000083093	PALB2 PPI subnetwork	0.02	> 0.20	APOB (8.2)	APOC1 (4.6)	PLG (4.0)	ABCG5 (3.7)	NPC1L1 (3.6)	APOA5 (3.6)	HP (3.0)	GPAM (2.7)	ANGPTL3 (2.7)	APOC4 (2.6)
ENSG00000171105	INSR PPI subnetwork	0.02	> 0.20	TRIB1 (2.7)	HLX (2.4)	SLC44A2 (2.3)	USP24 (2.3)	COL4A3BP (2.1)	SH2B3 (2.1)	MARK4 (2.1)	PVRL2 (1.9)	SORT1 (1.7)	GMIP (1.7)
ENSG00000092098	RNF31 PPI subnetwork	0.02	> 0.20	PARP10 (6.2)	OASL (4.1)	TRAFD1 (4.0)	BCL3 (2.9)	RHD (2.9)	GRINA (2.7)	RHCE (2.6)	CYB561D1 (2.5)	ABO (2.4)	RELB (2.3)
ENSG00000116717	GADD45A PPI subnetwork	0.02	> 0.20	PSRC1 (3.0)	TRIB1 (2.7)	TXNL4B (2.3)	MYLIP (2.1)	HLX (2.0)	POLK (1.9)	GCNT4 (1.9)	BUD13 (1.8)	PLEC (1.8)	ZHX3 (1.8)
MP:0001881	abnormal mammary gland physiology	0.02	> 0.20	PLEKHH2 (3.1)	C11orf9 (2.3)	HNF1A (2.2)	PARP10 (2.0)	ENSG00000238078 (2.0)	GPAM (1.8)	ENSG00000228044 (1.7)	RHD (1.6)	CYP7A1 (1.6)	AMIGO1 (1.5)
ENSG00000126749	ENSG00000126749 PPI subnetwork	0.02	> 0.20	ZNF259 (4.3)	DDX56 (4.3)	NAA25 (4.2)	QTRT1 (3.3)	TOMM40 (3.1)	C12orf43 (2.8)	DHODH (2.8)	DHX38 (2.4)	SUGP1 (2.1)	ATXN7L2 (2.0)
ENSG00000124383	MPHOSPH10 PPI subnetwork	0.02	> 0.20	ZNF259 (5.0)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (3.8)	TOMM40 (3.3)	DHODH (3.0)	DHX38 (2.6)	ATP13A1 (2.2)	SUGP1 (2.1)	BRAP (2.0)
ENSG00000206403	ABHD16A PPI subnetwork	0.02	> 0.20	ERP29 (3.6)	TMEM50A (3.5)	ATP13A1 (2.6)	C1orf63 (2.5)	MAU2 (2.5)	TMEM57 (2.3)	QTRT1 (2.1)	OASL (1.9)	YIPF2 (1.9)	SUGP1 (1.8)
ENSG00000204427	ABHD16A PPI subnetwork	0.02	> 0.20	ERP29 (3.6)	TMEM50A (3.5)	ATP13A1 (2.6)	C1orf63 (2.5)	MAU2 (2.5)	TMEM57 (2.3)	QTRT1 (2.1)	OASL (1.9)	YIPF2 (1.9)	SUGP1 (1.8)
ENSG00000096467	ENSG00000096467 PPI subnetwork	0.02	> 0.20	ERP29 (3.6)	TMEM50A (3.5)	ATP13A1 (2.6)	C1orf63 (2.5)	MAU2 (2.5)	TMEM57 (2.3)	QTRT1 (2.1)	OASL (1.9)	YIPF2 (1.9)	SUGP1 (1.8)
MP:0001713	decreased trophoblast giant cell number	0.02	> 0.20	GOT2P1 (2.1)	CARM1 (2.0)	APOA5 (1.9)	ABCG8 (1.7)	DNM2 (1.7)	ANGPTL3 (1.7)	LDLR (1.6)	RHCE (1.5)	AP1M2 (1.4)	HLX (1.4)
ENSG00000164167	LSM6 PPI subnetwork	0.02	> 0.20	SUGP1 (4.2)	DHX38 (4.2)	MAU2 (3.5)	SMARCA4 (3.5)	DDX56 (3.3)	ATP13A1 (3.1)	QTRT1 (2.8)	CARM1 (2.5)	TOP1 (2.5)	BUD13 (2.5)
GO:0006027	glycosaminoglycan catabolic process	0.02	> 0.20	CEACAM19 (4.4)	PMFBP1 (4.0)	ENSG00000228044 (3.8)	NKPD1 (3.8)	CETP (3.2)	TMED4 (2.9)	TIMD4 (2.2)	GCNT4 (2.2)	ERP29 (2.0)	PBX4 (2.0)
GO:0042993	positive regulation of transcription factor import into nucleus	0.02	> 0.20	ENSG00000235545 (2.8)	ENSG00000238078 (2.8)	OASL (2.8)	GCNT4 (2.5)	SH2B3 (2.2)	FRK (2.2)	MYLIP (2.1)	CYB561D1 (2.1)	PARP10 (2.0)	ENSG00000228044 (1.9)
REACTOME_SIGNALING_BY_SCF:KIT	REACTOME_SIGNALING_BY_SCF:KIT	0.02	> 0.20	DNM2 (2.9)	ZHX3 (2.2)	PARP10 (2.2)	MARK4 (2.2)	COL4A3BP (2.0)	PTPN11 (2.0)	HLX (1.8)	MYLIP (1.8)	PLEC (1.8)	GMIP (1.5)
MP:0003311	aminoaciduria	0.02	> 0.20	HAVCR1 (5.5)	TM6SF2 (4.6)	ALDH2 (3.1)	TMEM116 (2.8)	NPC1L1 (2.5)	FRK (2.2)	ANGPTL3 (2.2)	SLC22A1 (2.1)	AP1M2 (2.1)	MOSC1 (1.9)
ENSG00000082781	ITGB5 PPI subnetwork	0.02	> 0.20	ITGB3 (3.5)	KANK2 (3.3)	PLEC (3.1)	PVR (2.6)	PVRL2 (2.6)	APOE (2.5)	SH2B3 (2.0)	FRK (1.7)	PPP1R37 (1.7)	MAFB (1.7)
ENSG00000179801	ENSG00000179801 PPI subnetwork	0.02	> 0.20	DDX56 (2.3)	PLG (2.3)	TMED4 (2.2)	APOA5 (1.8)	GOT2P1 (1.6)	ZHX3 (1.6)	NAA25 (1.6)	PLEKHH2 (1.5)	USP24 (1.5)	APOB (1.4)
ENSG00000146729	GBAS PPI subnetwork	0.02	> 0.20	AP1M2 (3.3)	ILF3 (2.9)	LPAR2 (2.6)	BCAM (2.4)	PVRL2 (2.2)	KANK2 (2.0)	TOMM40 (1.9)	CARM1 (1.7)	TOP1 (1.6)	SMARCA4 (1.6)
ENSG00000107447	DNTT PPI subnetwork	0.02	> 0.20	TIMD4 (3.3)	ALDH2 (2.9)	APOE (2.8)	BCL3 (2.3)	MAFB (2.2)	ENSG00000226645 (2.0)	ZNF180 (1.9)	AMIGO1 (1.9)	CETP (1.8)	FADS1 (1.8)
ENSG00000182752	PAPPA PPI subnetwork	0.02	> 0.20	HP (2.9)	NYNRIN (2.3)	GMPR (2.1)	RHD (2.1)	DNAH11 (2.1)	CYP7A1 (2.0)	LPA (1.9)	APOC4 (1.8)	APOC1 (1.8)	PCSK9 (1.7)
GO:0016830	carbon-carbon lyase activity	0.02	> 0.20	FADS2 (3.9)	FADS1 (3.6)	GPAM (3.5)	PLG (3.3)	DHODH (3.3)	HMGCR (3.3)	TRAPPC6A (3.1)	SARS (2.7)	PCSK9 (2.5)	ANGPTL3 (2.3)
ENSG00000164934	DCAF13 PPI subnetwork	0.02	> 0.20	ZNF259 (4.7)	DDX56 (4.5)	NAA25 (4.1)	QTRT1 (3.8)	TOMM40 (3.1)	DHODH (2.8)	SUGP1 (2.4)	DHX38 (2.2)	ATP13A1 (2.1)	TOP1 (2.1)
ENSG00000123685	BATF3 PPI subnetwork	0.02	> 0.20	TRIB1 (6.0)	SARS (3.9)	BCL3 (3.5)	PVR (2.7)	MAFB (2.7)	ABCG8 (2.5)	KIAA1324 (2.1)	MAPKAPK5 (2.0)	ABCG5 (1.8)	LDLR (1.7)
GO:0003712	transcription cofactor activity	0.02	> 0.20	ATXN2 (3.1)	BUD13 (2.7)	NYNRIN (2.6)	MAPKAPK5 (2.5)	TMEM57 (2.5)	TRIB1 (2.5)	SMARCA4 (2.4)	CARM1 (2.4)	ATXN7L2 (2.2)	MAU2 (2.2)
GO:0042311	vasodilation	0.02	> 0.20	NPC1L1 (2.4)	LPIN3 (2.1)	C12orf47 (2.0)	ANKRD31 (1.9)	ERP29 (1.9)	ENSG00000235545 (1.7)	ST3GAL4 (1.6)	TXNL4B (1.6)	ENSG00000228044 (1.6)	FRK (1.5)
MP:0001282	short vibrissae	0.02	> 0.20	MAFB (2.2)	NYNRIN (2.2)	NKPD1 (2.1)	ABO (2.0)	ERP29 (1.7)	ENSG00000254235 (1.7)	BCAM (1.7)	PLEC (1.6)	GEMIN7 (1.6)	SYPL2 (1.5)
MP:0001926	female infertility	0.02	> 0.20	FADS1 (3.2)	LDLR (3.1)	FADS2 (2.3)	CYP7A1 (2.2)	PCSK9 (2.2)	NYNRIN (2.0)	MOSC1 (1.9)	PLCG1 (1.9)	KIAA1324 (1.8)	ABCG8 (1.8)
MP:0000281	abnormal interventricular septum morphology	0.02	> 0.20	MYLIP (3.9)	MAFB (2.7)	BCAM (2.1)	TRIB1 (2.0)	ATXN7L2 (1.7)	MARK4 (1.7)	TIMD4 (1.7)	TMEM57 (1.6)	GRINA (1.5)	HLX (1.5)
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.02	> 0.20	OASL (5.7)	RELB (3.9)	BCL3 (3.7)	TRAFD1 (3.3)	PARP10 (3.2)	GMIP (2.4)	MYLIP (1.9)	MAU2 (1.9)	PVR (1.8)	SH2B3 (1.8)
ENSG00000111615	KRR1 PPI subnetwork	0.02	> 0.20	ZNF259 (4.8)	DDX56 (4.5)	QTRT1 (4.4)	NAA25 (4.4)	TOMM40 (3.7)	DHODH (3.3)	DHX38 (2.6)	TOP1 (2.5)	C12orf43 (2.4)	SUGP1 (2.4)
MP:0005533	increased body temperature	0.02	> 0.20	MOSC1 (3.5)	TM6SF2 (3.2)	APOC1 (3.1)	ALDH2 (2.8)	SYPL2 (2.7)	HP (2.6)	OASL (2.4)	PVR (2.2)	CETP (2.1)	TIMD4 (2.1)
GO:0042990	regulation of transcription factor import into nucleus	0.02	> 0.20	ENSG00000235545 (2.9)	LPAR2 (2.6)	OASL (2.4)	ABO (2.2)	ZNF101 (2.0)	MYLIP (2.0)	PARP10 (1.8)	SH2B3 (1.7)	GCNT4 (1.7)	RELB (1.6)
GO:0007249	I-kappaB kinase/NF-kappaB cascade	0.02	> 0.20	PARP10 (3.4)	RELB (2.6)	SH2B3 (2.4)	ST3GAL4 (2.3)	TRAFD1 (2.3)	ZNF101 (2.2)	GRINA (2.1)	BCL3 (2.0)	CYB561D1 (2.0)	GEMIN7 (1.9)
ENSG00000125485	DDX31 PPI subnetwork	0.02	> 0.20	ZNF259 (4.9)	NAA25 (4.2)	TOMM40 (4.0)	DDX56 (3.7)	QTRT1 (3.4)	DHX38 (3.0)	DHODH (2.6)	MAPKAPK5 (2.4)	C12orf43 (2.3)	ATP13A1 (2.3)
ENSG00000170484	KRT74 PPI subnetwork	0.02	> 0.20	PLEKHH2 (3.3)	PARP10 (2.9)	LPAR2 (2.7)	OASL (2.6)	NT5DC1 (2.4)	BCL3 (2.3)	PLCG1 (2.2)	COL4A3BP (2.2)	GMIP (2.0)	TRIB1 (2.0)
GO:0016363	nuclear matrix	0.02	> 0.20	TOP1 (4.0)	USP1 (3.1)	ZNF180 (2.8)	ILF3 (2.6)	DNM2 (2.6)	PSRC1 (2.2)	SUGP1 (2.1)	FEN1 (2.1)	BUD13 (2.0)	SMARCA4 (1.9)
ENSG00000010244	ZNF207 PPI subnetwork	0.02	> 0.20	ILF3 (3.4)	ATXN2 (3.3)	SUGP1 (3.2)	PPP1R37 (2.9)	BUD13 (2.4)	C1orf63 (2.3)	SMARCA4 (2.2)	ATXN7L2 (2.1)	MAU2 (2.0)	TOP1 (1.9)
GO:0051289	protein homotetramerization	0.02	> 0.20	TRAPPC6A (3.7)	LPA (3.3)	CYP7A1 (2.6)	ACAD10 (2.6)	GOT2P1 (2.6)	DNAH11 (2.5)	UBXN2B (2.3)	DHODH (2.2)	NT5DC1 (2.1)	SLC22A1 (1.9)
MP:0002060	abnormal skin morphology	0.02	> 0.20	CBLC (4.2)	GCNT4 (2.8)	PLEC (2.5)	C17orf57 (2.3)	AP1M2 (2.0)	LDLR (1.9)	ABCG8 (1.9)	MAFB (1.7)	CYB561D1 (1.7)	DYNC2LI1 (1.6)
REACTOME_ENDOGENOUS_STEROLS	REACTOME_ENDOGENOUS_STEROLS	0.02	> 0.20	ST3GAL4 (4.8)	APOC4 (4.4)	CYP7A1 (3.9)	APOA5 (3.2)	APOC1 (2.9)	PLG (2.8)	LPA (2.8)	SLC22A1 (2.6)	HMGCR (2.3)	FADS2 (2.2)
GO:0000062	fatty-acyl-CoA binding	0.02	> 0.20	ACAD10 (5.0)	MOSC1 (3.7)	TRAPPC6A (2.4)	C19orf52 (2.4)	ALDH2 (2.3)	GPAM (2.0)	APOA5 (1.9)	ABCG8 (1.9)	OGDH (1.9)	LPA (1.8)
ENSG00000122180	MYOG PPI subnetwork	0.02	> 0.20	KANK2 (3.2)	NYNRIN (2.5)	CARM1 (2.3)	MAPKAPK5 (2.2)	HLX (1.9)	CYB561D1 (1.7)	ATXN7L2 (1.6)	SYPL2 (1.5)	UBXN2B (1.5)	ENSG00000254235 (1.5)
MP:0004794	increased anti-nuclear antigen antibody level	0.02	> 0.20	RELB (4.7)	BCL3 (3.8)	MAFB (3.1)	TRIB1 (2.5)	COL4A3BP (2.5)	PARP10 (2.3)	GMIP (2.3)	TIMD4 (2.1)	CETP (2.1)	ENSG00000238078 (1.8)
ENSG00000107807	TLX1 PPI subnetwork	0.02	> 0.20	GCNT4 (2.4)	PTPN11 (2.2)	ZHX3 (2.2)	SH2B3 (1.8)	ENSG00000226648 (1.7)	BRAP (1.6)	KANK2 (1.6)	MAPKAPK5 (1.6)	NKPD1 (1.5)	DYNC2LI1 (1.5)
GO:0009103	lipopolysaccharide biosynthetic process	0.02	> 0.20	ENSG00000228044 (3.4)	ENSG00000226648 (2.8)	BRAP (2.3)	CYB561D1 (1.6)	ST3GAL4 (1.6)	PPP1R37 (1.5)	ABO (1.5)	CARM1 (1.5)	DNM2 (1.5)	SH2B3 (1.4)
MP:0003091	abnormal cell migration	0.02	> 0.20	PLEC (3.5)	RELB (3.5)	BCL3 (3.1)	CLPTM1 (3.1)	TRIB1 (2.7)	ITGB3 (2.3)	PVRL2 (2.3)	HLX (2.3)	CETP (2.0)	KANK2 (1.8)
GO:0032862	activation of Rho GTPase activity	0.02	> 0.20	CEACAM19 (3.3)	ENSG00000238078 (3.2)	AP1M2 (3.1)	LPIN3 (2.6)	HNF1A (2.4)	CETP (2.2)	ENSG00000228044 (2.1)	CBLC (1.7)	ENSG00000226645 (1.7)	C11orf9 (1.6)
ENSG00000162909	CAPN2 PPI subnetwork	0.03	> 0.20	ANGPTL3 (3.4)	SH2B3 (3.2)	PLG (2.9)	FRK (2.4)	PVR (2.1)	C17orf57 (2.1)	GRINA (2.0)	LPA (1.9)	ALDH2 (1.9)	SLC44A2 (1.7)
GO:0042562	hormone binding	0.03	> 0.20	KIAA1324 (3.7)	GPAM (2.7)	LPA (2.6)	PLG (2.3)	C12orf47 (2.2)	MYLIP (2.2)	ALDH2 (2.2)	MOSC1 (2.2)	SLC22A1 (2.1)	ANGPTL3 (2.0)
ENSG00000109072	SEBOX PPI subnetwork	0.03	> 0.20	APOB (3.7)	PLG (3.4)	ANGPTL3 (3.1)	PVR (2.9)	APOA5 (2.9)	APOC1 (2.7)	PLEKHH2 (2.7)	HP (2.7)	SLC22A1 (2.4)	APOC4 (2.0)
MP:0002413	abnormal megakaryocyte progenitor cell morphology	0.03	> 0.20	ABCG8 (4.1)	SH2B3 (3.2)	GMPR (3.0)	ITGB3 (2.8)	RHCE (2.4)	BCL3 (2.2)	NYNRIN (2.2)	FADS2 (2.1)	SLC44A2 (2.1)	HAPLN4 (1.6)
GO:0043401	steroid hormone mediated signaling pathway	0.03	> 0.20	HNF1A (3.7)	GCNT4 (3.0)	ABCG8 (2.7)	TM6SF2 (2.5)	PPP1R37 (2.3)	ENSG00000226648 (2.0)	CYP7A1 (2.0)	GOT2P1 (1.8)	AMIGO1 (1.8)	ABCG5 (1.7)
MP:0001882	abnormal lactation	0.03	> 0.20	KIAA1324 (3.1)	NPC1L1 (3.1)	LPA (2.7)	GPAM (2.3)	CYP7A1 (1.9)	CELSR2 (1.8)	APOC1 (1.8)	HLX (1.7)	PLEKHH2 (1.7)	MAFB (1.7)
ENSG00000167363	FN3K PPI subnetwork	0.03	> 0.20	PLEKHH2 (3.2)	PARP10 (3.0)	LPAR2 (2.7)	OASL (2.6)	BCL3 (2.3)	NT5DC1 (2.3)	PLCG1 (2.1)	COL4A3BP (2.1)	TRIB1 (2.1)	GMIP (2.0)
MP:0002652	thin myocardium	0.03	> 0.20	C11orf9 (3.3)	KANK2 (3.2)	MAPKAPK5 (2.4)	USP24 (2.4)	PVRL2 (2.3)	UBXN2B (2.3)	DOCK7 (2.2)	ATXN2 (2.1)	TIMD4 (2.0)	C12orf51 (2.0)
MP:0005419	hypoalbuminemia	0.03	> 0.20	TM6SF2 (3.1)	SH2B3 (2.9)	ACAD10 (2.8)	BCL3 (2.7)	NT5DC1 (2.6)	ABCG8 (2.5)	PVRL2 (2.3)	APOE (2.0)	CLPTM1 (1.9)	TRAPPC6A (1.9)
GO:0017038	protein import	0.03	> 0.20	NAA25 (2.2)	MYLIP (1.9)	AMIGO1 (1.7)	ENSG00000226645 (1.7)	PTPN11 (1.6)	ENSG00000254235 (1.6)	USP24 (1.6)	BLOC1S3 (1.5)	ENSG00000238078 (1.5)	GATAD2A (1.5)
GO:0032496	response to lipopolysaccharide	0.03	> 0.20	ENSG00000228044 (2.9)	PVR (2.7)	MAFB (2.3)	BCL3 (2.3)	DNAH11 (2.2)	GRINA (2.2)	TRIB1 (2.1)	HLX (2.0)	HP (1.9)	PARP10 (1.7)
ENSG00000145819	ARHGAP26 PPI subnetwork	0.03	> 0.20	CETP (3.5)	TIMD4 (3.5)	OASL (3.4)	SLC44A2 (3.0)	LPAR2 (2.0)	CILP2 (1.8)	SYPL2 (1.7)	ATP13A1 (1.6)	MOSC1 (1.6)	HNF1A (1.5)
ENSG00000196517	SLC6A9 PPI subnetwork	0.03	> 0.20	BCAM (2.7)	TIMD4 (2.4)	PCSK9 (2.3)	KANK2 (2.1)	RPH3A (2.1)	CYP7A1 (2.1)	NYNRIN (1.9)	LPA (1.6)	HP (1.6)	DOCK7 (1.5)
GO:0006702	androgen biosynthetic process	0.03	> 0.20	ST3GAL4 (3.3)	DNAH11 (2.5)	CYP7A1 (2.3)	ABO (2.2)	ABCG8 (2.2)	FADS2 (2.1)	TSSK6 (2.1)	FRK (2.1)	FADS1 (1.8)	HNF1A (1.7)
GO:0001678	cellular glucose homeostasis	0.03	> 0.20	ENSG00000254235 (4.8)	ST3GAL4 (2.7)	GEMIN7 (2.6)	PCSK9 (2.1)	ENSG00000238078 (1.6)	KIAA1324 (1.6)	UBXN2B (1.5)	ADAM1 (1.4)	PPP1R37 (1.4)	HNF1A (1.4)
ENSG00000152147	GEMIN6 PPI subnetwork	0.03	> 0.20	ZNF180 (3.8)	TOMM40 (2.8)	C12orf47 (2.7)	POC5 (2.2)	C12orf43 (2.0)	BLOC1S3 (2.0)	GEMIN7 (1.8)	BUD13 (1.7)	ABO (1.6)	TRAPPC6A (1.6)
ENSG00000102007	PLP2 PPI subnetwork	0.03	> 0.20	ST3GAL4 (2.7)	TMEM116 (2.5)	PVR (2.3)	TMEM50A (2.2)	ADAM1 (2.1)	CYB561D1 (1.9)	DOCK7 (1.7)	PLEC (1.7)	BRAP (1.7)	MAU2 (1.6)
MP:0003725	increased autoantibody level	0.03	> 0.20	MAFB (2.8)	TRAFD1 (2.6)	RELB (2.4)	APOC1 (2.4)	PARP10 (2.1)	SLC22A1 (2.1)	TRIB1 (2.0)	GMIP (1.9)	ZNF101 (1.9)	HAVCR1 (1.7)
MP:0006356	abnormal third branchial arch artery morphology	0.03	> 0.20	PVR (3.1)	TMEM116 (2.3)	PLCG1 (2.2)	TMEM57 (1.7)	TSSK6 (1.5)	KANK2 (1.5)	ENSG00000235545 (1.5)	HLX (1.5)	PVRL2 (1.5)	SH2B3 (1.4)
ENSG00000157456	CCNB2 PPI subnetwork	0.03	> 0.20	USP1 (3.9)	FEN1 (3.5)	PSRC1 (2.8)	POC5 (2.1)	TOMM40 (1.9)	SMARCA4 (1.8)	ILF3 (1.8)	DHX38 (1.8)	ENSG00000226648 (1.6)	PTPN11 (1.5)
GO:0034698	response to gonadotropin stimulus	0.03	> 0.20	DNAH11 (4.3)	ST3GAL4 (2.7)	C11orf9 (2.3)	SLC44A2 (2.1)	FADS2 (2.1)	ATXN7L2 (2.0)	ABO (2.0)	HMGCR (1.9)	PMFBP1 (1.8)	CEACAM19 (1.7)
GO:0010885	regulation of cholesterol storage	0.03	> 0.20	ABCG8 (3.0)	TIMD4 (2.9)	APOC1 (2.9)	APOE (2.7)	MYLIP (2.5)	ATXN7L2 (2.5)	TMEM116 (2.5)	GEMIN7 (2.4)	LPIN3 (2.2)	GCNT4 (2.1)
ENSG00000108592	FTSJ3 PPI subnetwork	0.03	> 0.20	ZNF259 (4.9)	NAA25 (4.6)	QTRT1 (3.9)	DDX56 (3.6)	TOMM40 (3.6)	DHX38 (2.8)	DHODH (2.7)	ATP13A1 (2.5)	MAPKAPK5 (2.2)	C12orf43 (2.2)
GO:0061041	regulation of wound healing	0.03	> 0.20	ITGB3 (4.1)	ANGPTL3 (3.0)	PVR (2.8)	HNF1A (2.7)	CYP7A1 (2.5)	PCSK9 (2.4)	GMPR (2.3)	CEACAM19 (2.2)	APOC4 (2.1)	PLG (2.0)
GO:0007596	blood coagulation	0.03	> 0.20	ITGB3 (7.2)	GMPR (3.2)	CETP (2.1)	ANGPTL3 (1.9)	PTPN11 (1.8)	C11orf9 (1.7)	TMEM50A (1.7)	TIMD4 (1.6)	ZNF101 (1.6)	PLG (1.5)
MP:0001716	abnormal placenta labyrinth morphology	0.03	> 0.20	DNM2 (2.7)	AP1M2 (2.5)	PVRL2 (2.4)	APOB (2.4)	LDLR (2.3)	PLEC (2.1)	APOE (1.9)	APOC1 (1.9)	GPAM (1.9)	PCSK9 (1.9)
GO:0044438	microbody part	0.03	> 0.20	MOSC1 (4.4)	GPAM (4.2)	FADS2 (3.5)	PLG (3.3)	ANGPTL3 (3.0)	APOA5 (2.7)	SLC22A1 (2.7)	APOC4 (2.7)	CYP7A1 (2.6)	ABCG8 (2.6)
GO:0044439	peroxisomal part	0.03	> 0.20	MOSC1 (4.4)	GPAM (4.2)	FADS2 (3.5)	PLG (3.3)	ANGPTL3 (3.0)	APOA5 (2.7)	SLC22A1 (2.7)	APOC4 (2.7)	CYP7A1 (2.6)	ABCG8 (2.6)
MP:0009643	abnormal urine homeostasis	0.03	> 0.20	PLG (4.6)	ANGPTL3 (3.7)	TM6SF2 (3.1)	AP1M2 (2.9)	TMEM116 (2.8)	SLC22A1 (2.6)	GRINA (2.0)	CEACAM19 (1.9)	SYPL2 (1.9)	ENSG00000228044 (1.8)
ENSG00000112304	ACOT13 PPI subnetwork	0.03	> 0.20	SYPL2 (3.4)	ACAD10 (2.9)	GMPR (2.2)	TMEM50A (2.1)	OGDH (2.0)	PLCG1 (1.7)	DDX56 (1.5)	C1orf63 (1.4)	TMED4 (1.4)	LPIN3 (1.4)
GO:0006595	polyamine metabolic process	0.03	> 0.20	QTRT1 (3.9)	TSSK6 (2.9)	HNF1A (2.8)	C19orf52 (2.3)	SLC44A2 (2.2)	ZNF101 (2.1)	GMPR (1.9)	ATP13A1 (1.9)	UBXN2B (1.9)	DHODH (1.7)
GO:0033764	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	0.03	> 0.20	APOC1 (3.9)	SLC22A1 (3.7)	FADS2 (3.4)	FADS1 (3.4)	HMGCR (3.1)	CBLC (2.7)	APOC4 (2.2)	LDLR (2.1)	TRAPPC6A (2.1)	ALDH2 (2.0)
MP:0004955	increased thymus weight	0.03	> 0.20	ZNF101 (4.2)	HLX (2.2)	PBX4 (2.0)	TRIB1 (1.9)	ENSG00000238078 (1.8)	ANKRD31 (1.5)	BCL3 (1.4)	GCNT4 (1.4)	FEN1 (1.4)	USP1 (1.4)
GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	0.03	> 0.20	POLK (3.4)	TRAFD1 (2.8)	BLOC1S3 (2.7)	GOT2P1 (2.7)	OASL (2.5)	ST3GAL4 (2.1)	PARP10 (1.8)	FRK (1.7)	C12orf43 (1.6)	TRAPPC6A (1.5)
ENSG00000143772	ITPKB PPI subnetwork	0.03	> 0.20	ATP13A1 (2.6)	MAPKAPK5 (2.5)	TOMM40 (2.5)	DHODH (2.4)	ANKRD31 (2.1)	ZNF180 (2.1)	CARM1 (2.0)	HNF1A (2.0)	PCSK9 (1.9)	SMARCA4 (1.8)
ENSG00000174177	CTU2 PPI subnetwork	0.03	> 0.20	HMGCR (6.9)	LDLR (4.7)	APOA5 (2.9)	FADS1 (2.5)	FADS2 (2.5)	ATXN7L2 (2.2)	CYP7A1 (2.1)	PLG (1.9)	LPA (1.8)	ABCG5 (1.8)
ENSG00000059378	PARP12 PPI subnetwork	0.03	> 0.20	ZNF180 (3.1)	GMIP (2.6)	USP24 (2.5)	MAU2 (2.3)	PLCG1 (2.0)	BCL3 (1.9)	DHX38 (1.9)	ZHX3 (1.9)	PSRC1 (1.9)	LPAR2 (1.7)
GO:0000989	transcription factor binding transcription factor activity	0.03	> 0.20	ATXN2 (3.0)	TRIB1 (2.6)	BUD13 (2.6)	NYNRIN (2.6)	CARM1 (2.5)	ATXN7L2 (2.5)	MAPKAPK5 (2.4)	TMEM57 (2.4)	SMARCA4 (2.3)	MAU2 (2.1)
REACTOME_SIGNALING_BY_TGF_BETA	REACTOME_SIGNALING_BY_TGF_BETA	0.03	> 0.20	SH2B3 (3.5)	TMEM57 (2.5)	KANK2 (2.2)	GATAD2A (2.1)	PLEC (1.8)	MAPKAPK5 (1.8)	MARK4 (1.8)	TMEM50A (1.7)	CYP7A1 (1.6)	SLC44A2 (1.6)
ENSG00000185736	ADARB2 PPI subnetwork	0.03	> 0.20	C19orf52 (2.4)	SUGP1 (2.2)	QTRT1 (2.2)	DHX38 (2.1)	PARP10 (2.0)	OASL (2.0)	BRAP (2.0)	ZNF180 (1.8)	YIPF2 (1.8)	GRINA (1.7)
GO:0002449	lymphocyte mediated immunity	0.03	> 0.20	SLC22A1 (3.1)	LPA (2.5)	TIMD4 (2.4)	APOE (2.3)	APOC4 (2.0)	ANGPTL3 (1.7)	POLK (1.6)	APOA5 (1.6)	PARP10 (1.6)	GEMIN7 (1.5)
MP:0000604	amyloidosis	0.03	> 0.20	APOC1 (5.1)	APOE (5.1)	PLG (3.5)	APOB (3.4)	APOA5 (3.1)	ANGPTL3 (2.9)	HP (2.8)	APOC4 (2.7)	SLC22A1 (2.6)	MAFB (2.4)
ENSG00000089737	DDX24 PPI subnetwork	0.03	> 0.20	ZNF259 (4.9)	DDX56 (4.0)	NAA25 (4.0)	QTRT1 (4.0)	TOMM40 (3.9)	DHODH (3.0)	C12orf43 (2.9)	DHX38 (2.9)	ATP13A1 (2.8)	USP24 (2.3)
ENSG00000123416	TUBA1B PPI subnetwork	0.03	> 0.20	OGDH (3.1)	PLEC (2.9)	SARS (2.5)	GRINA (2.0)	CLPTM1 (1.8)	C17orf57 (1.8)	CARM1 (1.8)	C12orf51 (1.7)	NAA25 (1.7)	ATP13A1 (1.7)
GO:0051240	positive regulation of multicellular organismal process	0.03	> 0.20	HLX (2.3)	ENSG00000235545 (2.1)	GEMIN7 (1.9)	MAFB (1.6)	PVR (1.6)	ZNF101 (1.6)	OASL (1.6)	ALDH2 (1.5)	C17orf57 (1.5)	SLC44A2 (1.4)
ENSG00000178105	DDX10 PPI subnetwork	0.03	> 0.20	DDX56 (4.4)	NAA25 (4.0)	ZNF259 (4.0)	QTRT1 (3.7)	TOMM40 (3.4)	DHODH (2.9)	C12orf43 (2.9)	DHX38 (2.7)	SUGP1 (2.6)	TOP1 (2.3)
GO:0031434	mitogen-activated protein kinase kinase binding	0.03	> 0.20	PPP1R37 (3.0)	MAU2 (2.7)	DNM2 (2.5)	C11orf9 (2.3)	RPH3A (2.3)	SORT1 (2.0)	LPAR2 (1.9)	GEMIN7 (1.7)	HLX (1.7)	CLPTM1 (1.6)
GO:0032403	protein complex binding	0.03	> 0.20	PLEC (3.0)	APOE (2.9)	CYP7A1 (2.7)	APOC4 (2.3)	CLPTM1 (2.2)	CELSR2 (2.2)	MAFB (2.1)	MARK4 (2.0)	SLC44A2 (2.0)	SH2B3 (1.9)
ENSG00000184481	FOXO4 PPI subnetwork	0.03	> 0.20	PPP1R37 (2.0)	UBXN2B (1.8)	PLEC (1.7)	GATAD2A (1.6)	PLCG1 (1.6)	SLC44A2 (1.5)	ABO (1.5)	ENSG00000254235 (1.4)	GCNT4 (1.4)	BCL3 (1.4)
GO:0009055	electron carrier activity	0.03	> 0.20	SLC22A1 (6.2)	LPA (4.8)	ALDH2 (4.6)	ANGPTL3 (4.4)	APOC4 (4.3)	PLG (4.1)	ABCG5 (3.6)	APOA5 (3.5)	ABCG8 (3.4)	CYP7A1 (3.3)
ENSG00000166598	HSP90B1 PPI subnetwork	0.03	> 0.20	ERP29 (3.7)	CELSR2 (2.2)	BCAM (2.2)	PCSK9 (1.9)	TMED4 (1.8)	YIPF2 (1.7)	HMGCR (1.7)	PLCG1 (1.6)	GRINA (1.6)	CARM1 (1.6)
ENSG00000081479	LRP2 PPI subnetwork	0.03	> 0.20	PLG (5.0)	APOC1 (4.9)	ANGPTL3 (4.8)	APOC4 (4.0)	HP (3.3)	APOA5 (3.1)	APOB (2.7)	APOE (2.5)	C11orf9 (2.3)	GPAM (2.1)
ENSG00000177971	IMP3 PPI subnetwork	0.03	> 0.20	ZNF259 (4.8)	DDX56 (4.1)	NAA25 (3.9)	QTRT1 (3.8)	TOMM40 (3.1)	DHODH (2.7)	SUGP1 (2.3)	ATP13A1 (2.3)	DHX38 (2.3)	TOP1 (2.2)
ENSG00000071462	WBSCR22 PPI subnetwork	0.03	> 0.20	DDX56 (4.9)	QTRT1 (4.4)	NAA25 (4.2)	ZNF259 (4.2)	DHODH (3.2)	TOMM40 (3.2)	C12orf43 (2.8)	ATP13A1 (2.6)	ATXN7L2 (2.3)	PTPN11 (2.2)
GO:0010950	positive regulation of endopeptidase activity	0.03	> 0.20	POLK (3.4)	TRAFD1 (2.4)	OASL (2.2)	C17orf57 (2.2)	GOT2P1 (2.2)	PARP10 (2.0)	BLOC1S3 (2.0)	ST3GAL4 (1.8)	GEMIN7 (1.7)	TRAPPC6A (1.7)
REACTOME_ASSOCIATION_OF_TRICCCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	REACTOME_ASSOCIATION_OF_TRICCCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	0.03	> 0.20	NT5DC1 (2.7)	LPIN3 (2.6)	ZHX3 (2.4)	QTRT1 (2.1)	DHX38 (2.1)	ENSG00000238078 (1.9)	ZNF259 (1.8)	DDX56 (1.7)	MAPKAPK5 (1.7)	PSMA5 (1.7)
ENSG00000182953	ENSG00000182953 PPI subnetwork	0.03	> 0.20	QTRT1 (4.4)	DDX56 (3.8)	NAA25 (3.6)	ZNF259 (3.6)	TOMM40 (3.3)	DHX38 (3.2)	DHODH (3.2)	C12orf43 (2.6)	ILF3 (2.5)	ATP13A1 (2.2)
ENSG00000120156	TEK PPI subnetwork	0.03	> 0.20	COL4A3BP (3.1)	DNM2 (2.1)	TMEM57 (1.9)	HLX (1.9)	ZHX3 (1.8)	TRAFD1 (1.8)	PARP10 (1.7)	ITGB3 (1.7)	USP24 (1.6)	DNAH11 (1.6)
ENSG00000165029	ABCA1 PPI subnetwork	0.03	> 0.20	PLCG1 (3.2)	ZHX3 (3.0)	PPP1R37 (2.8)	COL4A3BP (2.5)	KANK2 (2.5)	MAPKAPK5 (2.5)	APOB (2.3)	ITGB3 (2.2)	GATAD2A (2.0)	APOE (1.9)
ENSG00000212860	ENSG00000212860 PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000212866	HSPA1B PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000215292	ENSG00000215292 PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000204388	HSPA1B PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000204389	HSPA1A PPI subnetwork	0.03	> 0.20	OGDH (3.2)	RELB (3.2)	PLEC (3.0)	BCL3 (2.8)	AP1M2 (2.4)	CARM1 (2.1)	TOMM40 (2.0)	GRINA (1.9)	NAA25 (1.9)	ILF3 (1.8)
ENSG00000165733	BMS1 PPI subnetwork	0.03	> 0.20	ZNF259 (5.4)	DDX56 (4.9)	NAA25 (4.6)	QTRT1 (4.1)	TOMM40 (3.6)	DHODH (3.4)	C12orf43 (2.5)	SUGP1 (2.4)	DHX38 (2.4)	ATP13A1 (2.3)
GO:0019319	hexose biosynthetic process	0.03	> 0.20	TM6SF2 (2.4)	LPA (2.2)	MOSC1 (2.2)	HAPLN4 (2.2)	HNF1A (2.1)	ABCG8 (2.0)	ENSG00000254235 (1.9)	ACAD10 (1.9)	APOA5 (1.9)	SYPL2 (1.9)
GO:0030299	intestinal cholesterol absorption	0.03	> 0.20	NPC1L1 (7.8)	ABCG8 (6.3)	ABCG5 (5.2)	TM6SF2 (4.7)	APOB (3.8)	APOA5 (2.2)	CBLC (2.0)	FRK (2.0)	GCNT4 (2.0)	MOSC1 (1.7)
ENSG00000163513	TGFBR2 PPI subnetwork	0.03	> 0.20	SH2B3 (3.5)	MYLIP (3.2)	KANK2 (3.2)	GATAD2A (3.0)	NYNRIN (2.8)	PVR (2.4)	CETP (2.0)	DNM2 (1.6)	PLEC (1.6)	PLCG1 (1.5)
ENSG00000100714	MTHFD1 PPI subnetwork	0.03	> 0.20	SARS (4.6)	NAA25 (2.7)	ACAD10 (2.2)	FADS2 (1.9)	QTRT1 (1.8)	DDX56 (1.8)	ILF3 (1.8)	LDLR (1.8)	ATP13A1 (1.7)	HMGCR (1.6)
ENSG00000197283	SYNGAP1 PPI subnetwork	0.03	> 0.20	PPP1R37 (3.0)	PLCG1 (2.8)	CELSR2 (2.6)	RPH3A (2.3)	NCAN (2.0)	MAPKAPK5 (2.0)	AMIGO1 (2.0)	DNAH11 (1.9)	MARK4 (1.8)	CETP (1.8)
ENSG00000164168	TMEM184C PPI subnetwork	0.03	> 0.20	C1orf63 (2.6)	ZHX3 (2.4)	CYP7A1 (2.3)	ATXN7L2 (2.2)	ST3GAL4 (1.7)	GRINA (1.6)	DNM2 (1.6)	C12orf43 (1.5)	ENSG00000254235 (1.4)	OGDH (1.4)
ENSG00000197586	ENTPD6 PPI subnetwork	0.03	> 0.20	LDLR (4.7)	HMGCR (4.1)	C17orf57 (2.4)	CYB561D1 (2.3)	NPC1L1 (2.2)	FADS1 (2.2)	DNAH11 (2.1)	TXNL4B (1.9)	TMED4 (1.8)	FADS2 (1.8)
ENSG00000130985	UBA1 PPI subnetwork	0.03	> 0.20	SARS (4.7)	ATXN2 (2.5)	RHD (2.4)	NYNRIN (2.3)	FEN1 (1.9)	DDX56 (1.8)	GRINA (1.7)	GMPR (1.7)	RHCE (1.6)	MAPKAPK5 (1.5)
ENSG00000135900	MRPL44 PPI subnetwork	0.03	> 0.20	ACAD10 (4.7)	TMED4 (2.4)	NT5DC1 (2.4)	HNF1A (2.2)	OGDH (2.2)	ATXN7L2 (2.1)	TRAPPC6A (1.8)	TMEM50A (1.7)	PLEKHH2 (1.7)	ERP29 (1.6)
GO:0002455	humoral immune response mediated by circulating immunoglobulin	0.03	> 0.20	LPA (5.1)	SLC22A1 (4.3)	TIMD4 (4.1)	APOC4 (3.5)	ANGPTL3 (3.2)	HP (2.9)	CETP (2.7)	PLG (2.6)	APOE (2.6)	APOA5 (2.5)
MP:0000367	abnormal coat/ hair morphology	0.03	> 0.20	LDLR (4.5)	HMGCR (3.8)	PCSK9 (3.4)	FADS1 (2.2)	CYB561D1 (2.1)	BLOC1S3 (2.0)	AP1M2 (1.9)	FADS2 (1.8)	NYNRIN (1.8)	ENSG00000238078 (1.6)
ENSG00000099860	GADD45B PPI subnetwork	0.03	> 0.20	TRIB1 (3.2)	PSRC1 (2.5)	MOSC1 (2.0)	HLX (2.0)	RHCE (1.9)	ZHX3 (1.6)	POLK (1.6)	MYLIP (1.6)	BCL3 (1.5)	PPP1R37 (1.5)
GO:0007599	hemostasis	0.03	> 0.20	ITGB3 (7.1)	GMPR (3.1)	CETP (2.2)	ANGPTL3 (1.9)	PTPN11 (1.8)	TMEM50A (1.6)	C11orf9 (1.6)	ZNF101 (1.6)	TIMD4 (1.6)	PLG (1.5)
GO:0046718	viral entry into host cell	0.03	> 0.20	CETP (3.7)	ENSG00000228044 (3.0)	GCNT4 (2.8)	SLC44A2 (2.7)	PVR (2.4)	NKPD1 (2.3)	TIMD4 (2.2)	GEMIN7 (2.0)	CBLC (2.0)	LPA (1.9)
ENSG00000179348	GATA2 PPI subnetwork	0.03	> 0.20	RHD (3.5)	SH2B3 (3.4)	RHCE (2.9)	GMPR (2.6)	MAFB (2.2)	MARK4 (2.1)	BCL3 (2.0)	TMEM57 (1.7)	USP24 (1.7)	TRIB1 (1.6)
ENSG00000167244	IGF2 PPI subnetwork	0.03	> 0.20	APOB (4.0)	BCAM (3.2)	APOC4 (2.9)	APOA5 (2.8)	TMED4 (2.4)	ANGPTL3 (2.2)	ABCG5 (2.2)	APOE (2.1)	SLC22A1 (2.0)	MYLIP (2.0)
ENSG00000086758	HUWE1 PPI subnetwork	0.03	> 0.20	ATP13A1 (3.4)	SMARCA4 (3.0)	TOMM40 (3.0)	CLPTM1 (2.9)	BRAP (2.9)	PSMA5 (2.9)	SARS (2.9)	DHX38 (2.6)	DDX56 (2.5)	NAA25 (2.4)
GO:0006953	acute-phase response	0.03	> 0.20	ENSG00000228044 (3.5)	HP (2.9)	SLC22A1 (2.8)	ENSG00000235545 (2.5)	APOA5 (2.5)	LPA (2.3)	ABCG5 (2.0)	APOC4 (1.9)	PLG (1.8)	TIMD4 (1.8)
GO:0030193	regulation of blood coagulation	0.03	> 0.20	ITGB3 (4.2)	ANGPTL3 (3.4)	CYP7A1 (2.9)	GMPR (2.8)	APOC4 (2.7)	PCSK9 (2.6)	PLG (2.4)	PVR (2.3)	SLC22A1 (2.3)	PMFBP1 (2.3)
ENSG00000211973	ENSG00000211973 PPI subnetwork	0.03	> 0.20	APOE (6.1)	TIMD4 (5.8)	MAFB (4.2)	APOC1 (3.0)	CETP (2.3)	MYLIP (1.8)	LPIN3 (1.7)	GPAM (1.6)	ADAM1 (1.3)	SLC22A1 (1.1)
ENSG00000211979	ENSG00000211979 PPI subnetwork	0.03	> 0.20	APOE (6.1)	TIMD4 (5.8)	MAFB (4.2)	APOC1 (3.0)	CETP (2.3)	MYLIP (1.8)	LPIN3 (1.7)	GPAM (1.6)	ADAM1 (1.3)	SLC22A1 (1.1)
GO:0008168	methyltransferase activity	0.03	> 0.20	DHODH (4.2)	QTRT1 (3.9)	C12orf43 (3.6)	TXNL4B (2.9)	DDX56 (2.6)	NAA25 (2.2)	ZNF259 (2.0)	UBXN2B (1.9)	ATP13A1 (1.7)	BUD13 (1.6)
ENSG00000106006	HOXA6 PPI subnetwork	0.03	> 0.20	ATXN2 (4.3)	ANKRD31 (2.6)	C12orf51 (2.5)	CARM1 (2.4)	ATXN7L2 (2.4)	MARK4 (2.3)	HNF1A (2.2)	MAU2 (2.2)	GOT2P1 (2.0)	GATAD2A (1.9)
MP:0002418	increased susceptibility to viral infection	0.03	> 0.20	OASL (9.3)	PARP10 (7.5)	TRAFD1 (5.2)	RELB (2.3)	GMIP (2.3)	BCL3 (2.1)	ATP13A1 (1.7)	POLK (1.4)	SH2B3 (1.3)	QTRT1 (1.1)
ENSG00000108651	UTP6 PPI subnetwork	0.03	> 0.20	MAU2 (4.0)	PARP10 (3.1)	USP24 (2.5)	MARK4 (2.4)	GMIP (2.3)	SMARCA4 (2.3)	BCL3 (2.1)	DHX38 (1.9)	ZNF180 (1.9)	MAFB (1.8)
GO:0001540	beta-amyloid binding	0.03	> 0.20	RPH3A (2.8)	APOB (2.5)	APOE (2.5)	ABCG5 (2.5)	APOC1 (2.5)	AMIGO1 (1.9)	TM6SF2 (1.9)	CELSR2 (1.8)	NPC1L1 (1.8)	CEACAM19 (1.8)
GO:0009617	response to bacterium	0.03	> 0.20	HP (2.4)	PMFBP1 (2.0)	HLX (2.0)	MAFB (2.0)	BCL3 (1.9)	ADAM1 (1.8)	PVR (1.8)	CEACAM19 (1.8)	ENSG00000228044 (1.7)	DNAH11 (1.7)
MP:0009399	increased skeletal muscle fiber size	0.03	> 0.20	SYPL2 (5.2)	KANK2 (3.3)	CLPTM1 (2.7)	COL4A3BP (2.6)	CEACAM19 (2.2)	GRINA (2.1)	LPIN3 (2.1)	PLEC (2.0)	ATP13A1 (1.9)	OGDH (1.8)
ENSG00000105974	CAV1 PPI subnetwork	0.03	> 0.20	PLEC (3.8)	BCAM (3.7)	CLPTM1 (3.2)	SLC44A2 (3.2)	PVRL2 (2.6)	GRINA (2.5)	BCL3 (2.3)	DNM2 (2.0)	OGDH (1.9)	APOE (1.7)
MP:0002972	abnormal cardiac muscle contractility	0.03	> 0.20	SYPL2 (3.0)	RELB (2.9)	BCAM (2.0)	ACAD10 (1.9)	BCL3 (1.9)	PVR (1.8)	PTPN11 (1.7)	GMPR (1.7)	CETP (1.6)	HP (1.5)
GO:0048545	response to steroid hormone stimulus	0.03	> 0.20	KIAA1324 (2.5)	TM6SF2 (2.3)	ABCG5 (2.3)	LPA (2.0)	TMED4 (1.7)	PVRL2 (1.7)	ABCG8 (1.6)	HAPLN4 (1.6)	ENSG00000226648 (1.6)	SLC22A1 (1.6)
ENSG00000148248	SURF4 PPI subnetwork	0.03	> 0.20	HMGCR (3.3)	TMEM50A (3.3)	TMED4 (3.2)	ATP13A1 (2.9)	LDLR (2.4)	TMEM57 (2.3)	YIPF2 (2.1)	ABCG8 (2.1)	FADS1 (2.1)	CYB561D1 (2.1)
ENSG00000101343	CRNKL1 PPI subnetwork	0.03	> 0.20	SUGP1 (4.1)	DHX38 (3.9)	BUD13 (3.6)	MAU2 (2.8)	BRAP (2.8)	C12orf43 (2.7)	SMARCA4 (2.7)	ZNF180 (2.6)	DDX56 (2.5)	TRAFD1 (2.2)
ENSG00000185591	SP1 PPI subnetwork	0.03	> 0.20	TRIB1 (4.2)	ATXN2 (3.4)	RELB (3.0)	SH2B3 (2.8)	PLEC (2.6)	BCL3 (2.6)	LDLR (2.4)	MAFB (2.2)	TOP1 (2.0)	MARK4 (2.0)
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450	0.03	> 0.20	ABCG5 (6.3)	SLC22A1 (5.7)	LPA (5.6)	ABCG8 (5.2)	APOC4 (5.0)	CYP7A1 (5.0)	TM6SF2 (4.7)	ANGPTL3 (4.4)	ALDH2 (4.2)	APOA5 (3.8)
GO:0043531	ADP binding	0.03	> 0.20	POLK (3.8)	ERP29 (3.1)	FADS1 (2.6)	ACAD10 (2.5)	GMPR (2.0)	PARP10 (2.0)	OGDH (1.9)	FADS2 (1.9)	ENSG00000238078 (1.9)	HAPLN4 (1.7)
GO:0050662	coenzyme binding	0.03	> 0.20	ACAD10 (4.3)	ALDH2 (4.1)	FADS2 (3.5)	FADS1 (3.4)	MOSC1 (3.3)	SLC22A1 (2.9)	TRAPPC6A (2.8)	GPAM (2.8)	PLG (2.6)	NT5DC1 (2.6)
GO:0044282	small molecule catabolic process	0.03	> 0.20	ACAD10 (4.2)	LPA (3.5)	MOSC1 (3.0)	SLC22A1 (3.0)	ALDH2 (2.9)	CYP7A1 (2.6)	TRAPPC6A (2.6)	ANGPTL3 (2.5)	NT5DC1 (2.5)	DHODH (2.3)
ENSG00000163714	U2SURP PPI subnetwork	0.03	> 0.20	NAA25 (2.6)	CYB561D1 (2.2)	ATXN2 (2.0)	DDX56 (1.9)	PSMA5 (1.7)	ATP13A1 (1.7)	C12orf43 (1.7)	NT5DC1 (1.7)	DHX38 (1.6)	ATXN7L2 (1.6)
ENSG00000136938	ANP32B PPI subnetwork	0.03	> 0.20	DOCK7 (3.1)	AP1M2 (2.9)	BCAM (2.7)	TOMM40 (2.7)	PVRL2 (2.3)	OGDH (2.3)	NAA25 (2.0)	ILF3 (1.9)	NT5DC1 (1.8)	CARM1 (1.8)
ENSG00000168884	TNIP2 PPI subnetwork	0.03	> 0.20	RELB (9.9)	BCL3 (5.5)	C12orf43 (2.6)	SH2B3 (2.1)	DHX38 (2.1)	GRINA (2.0)	PVR (2.0)	MAU2 (1.9)	ACAD10 (1.8)	ST3GAL4 (1.8)
ENSG00000105202	FBL PPI subnetwork	0.03	> 0.20	NAA25 (4.8)	ZNF259 (4.6)	DDX56 (4.6)	TOMM40 (4.1)	QTRT1 (3.8)	DHODH (2.8)	DHX38 (2.6)	ATP13A1 (2.5)	SUGP1 (2.5)	TOP1 (2.4)
ENSG00000065183	WDR3 PPI subnetwork	0.03	> 0.20	ZNF259 (4.7)	DDX56 (4.4)	NAA25 (4.0)	QTRT1 (3.8)	TOMM40 (3.5)	DHODH (2.9)	ATP13A1 (2.2)	DHX38 (2.1)	C12orf43 (2.0)	TOP1 (1.9)
MP:0003304	large intestinal inflammation	0.03	> 0.20	BCL3 (6.0)	RELB (5.6)	GRINA (4.4)	PARP10 (3.0)	GMIP (2.6)	PLEC (2.4)	SH2B3 (2.1)	SLC44A2 (2.1)	POLK (2.0)	HP (1.9)
ENSG00000101255	TRIB3 PPI subnetwork	0.03	> 0.20	PARP10 (3.2)	GMIP (3.0)	MAU2 (2.7)	DHX38 (2.2)	BCL3 (2.2)	PPP1R37 (2.2)	ZNF180 (2.0)	TRAFD1 (2.0)	OASL (1.9)	USP24 (1.9)
GO:0046164	alcohol catabolic process	0.03	> 0.20	GOT2P1 (2.6)	ENSG00000254235 (2.3)	FRK (1.9)	PCSK9 (1.9)	ACAD10 (1.9)	LPIN3 (1.8)	TSSK6 (1.7)	GPAM (1.7)	TRAPPC6A (1.7)	FADS2 (1.6)
MP:0008752	abnormal tumor necrosis factor level	0.03	> 0.20	PARP10 (5.0)	MAFB (4.0)	BCL3 (3.6)	RELB (3.3)	TRIB1 (3.1)	APOE (3.1)	PMFBP1 (2.5)	APOC1 (2.3)	SH2B3 (1.9)	OASL (1.9)
ENSG00000187498	COL4A1 PPI subnetwork	0.03	> 0.20	APOE (3.1)	C17orf57 (3.1)	CETP (2.7)	KANK2 (2.3)	ITGB3 (1.7)	PLEC (1.5)	PCSK9 (1.5)	ATXN7L2 (1.5)	ANGPTL3 (1.4)	HP (1.3)
ENSG00000087088	BAX PPI subnetwork	0.03	> 0.20	PPP1R37 (3.0)	LPIN3 (2.8)	TRAPPC6A (2.3)	MARK4 (2.1)	POLK (1.9)	CBLC (1.9)	C12orf43 (1.7)	CLPTM1 (1.7)	GRINA (1.7)	TXNL4B (1.7)
ENSG00000108559	NUP88 PPI subnetwork	0.03	> 0.20	USP1 (3.2)	POC5 (2.9)	NAA25 (2.7)	BUD13 (2.6)	ZNF180 (2.5)	FEN1 (2.2)	CARM1 (2.1)	MAPKAPK5 (2.0)	DOCK7 (1.9)	DDX56 (1.9)
GO:0032354	response to follicle-stimulating hormone stimulus	0.03	> 0.20	ST3GAL4 (3.5)	DNAH11 (2.8)	HMGCR (2.7)	FADS2 (2.4)	LDLR (2.4)	ABCG8 (2.2)	FADS1 (2.2)	TMED4 (2.0)	GCNT4 (1.9)	CYP7A1 (1.6)
GO:0006778	porphyrin-containing compound metabolic process	0.03	> 0.20	RHCE (7.3)	RHD (7.0)	ADAM1 (3.1)	C12orf51 (2.6)	GMPR (2.5)	ACAD10 (2.2)	TRAPPC6A (2.0)	NT5DC1 (1.9)	BLOC1S3 (1.8)	BRAP (1.5)
GO:0033013	tetrapyrrole metabolic process	0.03	> 0.20	RHCE (7.3)	RHD (7.0)	ADAM1 (3.1)	C12orf51 (2.6)	GMPR (2.5)	ACAD10 (2.2)	TRAPPC6A (2.0)	NT5DC1 (1.9)	BLOC1S3 (1.8)	BRAP (1.5)
MP:0009346	decreased trabecular bone thickness	0.03	> 0.20	PVRL2 (2.9)	MAFB (2.7)	TRIB1 (2.6)	ENSG00000238078 (2.4)	BCL3 (2.1)	ADAM1 (2.0)	TMEM57 (1.9)	FRK (1.9)	ENSG00000228044 (1.9)	BCAM (1.8)
GO:0016878	acid-thiol ligase activity	0.03	> 0.20	HMGCR (5.1)	FADS2 (4.7)	LDLR (4.2)	ACAD10 (4.1)	FADS1 (3.9)	PCSK9 (3.9)	GPAM (3.4)	MOSC1 (3.0)	TRAPPC6A (2.9)	CYP7A1 (2.7)
ENSG00000167004	PDIA3 PPI subnetwork	0.03	> 0.20	PCSK9 (3.0)	ERP29 (2.5)	CBLC (2.4)	BCAM (2.2)	ST3GAL4 (2.1)	PARP10 (2.0)	HMGCR (1.9)	ENSG00000228044 (1.9)	TRAFD1 (1.8)	PVR (1.8)
ENSG00000141551	CSNK1D PPI subnetwork	0.03	> 0.20	DDX56 (3.9)	ZNF259 (3.9)	QTRT1 (3.8)	NAA25 (3.5)	CARM1 (2.9)	ATP13A1 (2.9)	ILF3 (2.9)	TOMM40 (2.8)	DHX38 (2.4)	PTPN11 (2.3)
MP:0004500	increased incidence of ionizing radiation-induced tumors	0.03	> 0.20	TRIB1 (2.8)	PVR (2.5)	POLK (2.5)	DYNC2LI1 (2.4)	MYLIP (2.4)	UBXN2B (2.1)	RHCE (2.0)	ATXN7L2 (1.9)	CYP7A1 (1.8)	USP1 (1.7)
ENSG00000108270	AATF PPI subnetwork	0.03	> 0.20	ZNF259 (4.6)	DDX56 (4.0)	NAA25 (3.9)	DHODH (3.7)	QTRT1 (3.6)	TOMM40 (3.4)	C12orf43 (2.7)	DHX38 (2.2)	TOP1 (2.0)	ATP13A1 (1.9)
ENSG00000007816	ENSG00000007816 PPI subnetwork	0.03	> 0.20	ZNF259 (4.8)	DDX56 (4.8)	NAA25 (4.5)	QTRT1 (4.3)	TOMM40 (3.8)	DHODH (3.2)	DHX38 (2.5)	ATP13A1 (2.5)	BRAP (2.3)	GATAD2A (2.3)
ENSG00000182809	CRIP2 PPI subnetwork	0.03	> 0.20	SYPL2 (4.2)	GMPR (2.7)	OGDH (2.2)	ACAD10 (2.2)	C11orf9 (2.1)	TMEM50A (1.9)	BCAM (1.6)	PSMA5 (1.5)	PVRL2 (1.3)	FADS2 (1.3)
GO:0042579	microbody	0.03	> 0.20	MOSC1 (4.8)	GPAM (4.3)	FADS2 (4.1)	PLG (3.4)	ACAD10 (3.4)	TRAPPC6A (3.4)	HMGCR (3.2)	FADS1 (3.1)	NT5DC1 (3.0)	ANGPTL3 (3.0)
GO:0005777	peroxisome	0.03	> 0.20	MOSC1 (4.8)	GPAM (4.3)	FADS2 (4.1)	PLG (3.4)	ACAD10 (3.4)	TRAPPC6A (3.4)	HMGCR (3.2)	FADS1 (3.1)	NT5DC1 (3.0)	ANGPTL3 (3.0)
ENSG00000131043	C20orf4 PPI subnetwork	0.03	> 0.20	DHX38 (4.3)	SUGP1 (3.2)	MAU2 (2.8)	SMARCA4 (2.7)	BRAP (2.5)	ATP13A1 (2.5)	QTRT1 (2.4)	DDX56 (2.1)	DNM2 (2.0)	BUD13 (2.0)
GO:0000305	response to oxygen radical	0.03	> 0.20	GOT2P1 (2.9)	RHCE (2.7)	ENSG00000235545 (2.5)	RHD (2.5)	PBX4 (2.3)	C12orf51 (2.0)	TRAPPC6A (1.8)	TMEM116 (1.7)	PMFBP1 (1.6)	LPAR2 (1.6)
GO:0000303	response to superoxide	0.03	> 0.20	GOT2P1 (2.9)	RHCE (2.7)	ENSG00000235545 (2.5)	RHD (2.5)	PBX4 (2.3)	C12orf51 (2.0)	TRAPPC6A (1.8)	TMEM116 (1.7)	PMFBP1 (1.6)	LPAR2 (1.6)
ENSG00000115232	ITGA4 PPI subnetwork	0.03	> 0.20	SLC44A2 (3.4)	APOE (3.4)	ITGB3 (2.7)	TIMD4 (2.6)	GMIP (2.4)	SH2B3 (2.4)	APOC1 (2.1)	RHD (2.0)	ST3GAL4 (1.9)	MAFB (1.8)
GO:0030228	lipoprotein particle receptor activity	0.03	> 0.20	FADS1 (4.9)	HMGCR (4.9)	FADS2 (4.7)	TIMD4 (3.1)	ADAM1 (2.8)	PCSK9 (2.7)	CEACAM19 (2.4)	CETP (2.1)	SORT1 (2.1)	ACAD10 (2.1)
REACTOME_MYD88:INDEPENDENT_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	REACTOME_MYD88:INDEPENDENT_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.03	> 0.20	RELB (4.7)	BCL3 (3.6)	SH2B3 (3.5)	TRIB1 (3.4)	PVR (3.4)	OASL (3.2)	PARP10 (2.8)	HLX (2.6)	GMIP (2.4)	GRINA (1.9)
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM	0.03	> 0.20	RHCE (10.2)	RHD (9.7)	NT5DC1 (2.4)	DHODH (2.4)	MAFB (2.3)	ADAM1 (2.2)	ANGPTL3 (2.2)	ALDH2 (2.1)	GMPR (2.0)	C12orf51 (1.9)
ENSG00000150347	ARID5B PPI subnetwork	0.03	> 0.20	C19orf52 (2.6)	BRAP (2.3)	PARP10 (2.3)	SUGP1 (2.2)	DHX38 (2.2)	OASL (2.0)	QTRT1 (2.0)	ZNF180 (1.9)	GRINA (1.9)	YIPF2 (1.8)
GO:0042558	pteridine-containing compound metabolic process	0.03	> 0.20	CYP7A1 (3.1)	GOT2P1 (2.6)	HNF1A (2.6)	DHODH (2.4)	ABCG8 (2.4)	TXNL4B (2.2)	NT5DC1 (2.2)	ENSG00000254235 (2.1)	UBXN2B (2.1)	ENSG00000238078 (2.0)
GO:0016922	ligand-dependent nuclear receptor binding	0.03	> 0.20	C12orf51 (3.2)	UBXN2B (2.6)	ATXN2 (2.4)	ZHX3 (2.1)	HNF1A (2.1)	PLCG1 (1.9)	MAPKAPK5 (1.7)	MAU2 (1.7)	USP24 (1.7)	COL4A3BP (1.7)
ENSG00000142507	PSMB6 PPI subnetwork	0.03	> 0.20	PSMA5 (6.0)	TRAFD1 (3.0)	TOMM40 (2.6)	NAA25 (2.3)	NT5DC1 (2.2)	DDX56 (1.9)	SUGP1 (1.6)	SARS (1.6)	DHX38 (1.5)	CLPTM1 (1.4)
ENSG00000197818	SLC9A8 PPI subnetwork	0.03	> 0.20	APOB (8.2)	APOC1 (4.5)	PLG (4.0)	ABCG5 (3.9)	NPC1L1 (3.8)	APOA5 (3.7)	HP (2.8)	APOC4 (2.7)	APOE (2.6)	ANGPTL3 (2.6)
MP:0008254	increased megakaryocyte cell number	0.03	> 0.20	ABCG8 (4.4)	GMPR (4.1)	ITGB3 (3.2)	RHCE (2.9)	RHD (2.9)	GRINA (2.4)	SH2B3 (2.0)	TM6SF2 (1.9)	TMEM57 (1.9)	USP24 (1.8)
ENSG00000173486	FKBP2 PPI subnetwork	0.03	> 0.20	APOE (3.2)	CARM1 (2.3)	TIMD4 (2.3)	CETP (2.3)	SLC44A2 (2.2)	USP24 (2.1)	GMIP (1.9)	C12orf51 (1.8)	C19orf52 (1.7)	KANK2 (1.6)
ENSG00000196290	NIF3L1 PPI subnetwork	0.03	> 0.20	GEMIN7 (2.8)	ZNF180 (2.6)	GMPR (2.4)	HAVCR1 (2.4)	TXNL4B (2.1)	SLC22A1 (2.0)	MAU2 (1.9)	TRAFD1 (1.9)	KIAA1324 (1.7)	CARM1 (1.5)
GO:0050810	regulation of steroid biosynthetic process	0.03	> 0.20	ST3GAL4 (4.4)	ENSG00000226645 (3.1)	FADS2 (2.9)	LDLR (2.7)	HMGCR (2.6)	FADS1 (2.4)	BLOC1S3 (2.4)	ABCG8 (2.2)	COL4A3BP (1.9)	GPAM (1.9)
GO:0050818	regulation of coagulation	0.03	> 0.20	ITGB3 (3.7)	ANGPTL3 (3.1)	GMPR (2.9)	PCSK9 (2.8)	CYP7A1 (2.6)	PVR (2.6)	APOC4 (2.5)	ENSG00000228044 (2.4)	SLC22A1 (2.3)	PLG (2.2)
ENSG00000008853	RHOBTB2 PPI subnetwork	0.03	> 0.20	CLPTM1 (2.4)	GMIP (2.3)	PPP1R37 (2.2)	ENSG00000235545 (2.1)	SLC44A2 (2.1)	OGDH (2.1)	DNM2 (2.0)	GRINA (1.9)	COL4A3BP (1.9)	CARM1 (1.8)
REACTOME_CHOLESTEROL_BIOSYNTHESIS	REACTOME_CHOLESTEROL_BIOSYNTHESIS	0.03	> 0.20	HMGCR (17.8)	LDLR (16.0)	FADS1 (13.3)	FADS2 (12.7)	PCSK9 (10.2)	TRAPPC6A (2.8)	CYP7A1 (2.5)	NPC1L1 (2.5)	NKPD1 (2.0)	GPAM (2.0)
ENSG00000088247	KHSRP PPI subnetwork	0.03	> 0.20	DHX38 (2.6)	TRAPPC6A (2.5)	C1orf63 (2.2)	BUD13 (2.1)	ENSG00000254235 (2.1)	ABCG8 (1.9)	C19orf52 (1.8)	ILF3 (1.8)	SUGP1 (1.8)	CYP7A1 (1.6)
GO:0008653	lipopolysaccharide metabolic process	0.03	> 0.20	ENSG00000228044 (3.5)	ENSG00000226648 (2.7)	BRAP (2.3)	CYB561D1 (1.7)	PPP1R37 (1.6)	ST3GAL4 (1.5)	DNM2 (1.5)	CILP2 (1.5)	ABO (1.4)	CARM1 (1.4)
ENSG00000136718	IMP4 PPI subnetwork	0.03	> 0.20	ZNF259 (4.6)	DDX56 (4.3)	NAA25 (4.0)	QTRT1 (3.8)	TOMM40 (3.1)	DHODH (2.7)	TOP1 (2.1)	SUGP1 (2.0)	DHX38 (2.0)	ATP13A1 (1.9)
ENSG00000172531	PPP1CA PPI subnetwork	0.03	> 0.20	PSRC1 (3.0)	BLOC1S3 (2.8)	DNM2 (2.5)	MARK4 (2.5)	USP1 (2.2)	SORT1 (2.2)	ATXN2 (1.9)	PTPN11 (1.9)	KANK2 (1.8)	SYPL2 (1.7)
MP:0004187	cardia bifida	0.03	> 0.20	PVRL2 (3.3)	MARK4 (2.9)	PVR (2.8)	LPAR2 (2.5)	C11orf9 (2.4)	HNF1A (2.1)	ADAM1 (1.8)	CLPTM1 (1.7)	GRINA (1.7)	ENSG00000226648 (1.6)
ENSG00000151552	QDPR PPI subnetwork	0.03	> 0.20	TIMD4 (5.7)	APOE (5.4)	MAFB (3.7)	APOC1 (2.9)	CETP (2.7)	ALDH2 (2.1)	ANGPTL3 (2.1)	GPAM (2.0)	APOC4 (1.9)	PLG (1.9)
MP:0003667	hemangiosarcoma	0.03	> 0.20	POLK (2.7)	TMEM50A (2.2)	MOSC1 (1.8)	LPIN3 (1.8)	PTPN11 (1.7)	ENSG00000228044 (1.7)	C12orf51 (1.6)	HAVCR1 (1.6)	CYP7A1 (1.5)	GCNT4 (1.5)
ENSG00000116830	TTF2 PPI subnetwork	0.03	> 0.20	MAPKAPK5 (3.1)	PSRC1 (2.8)	FEN1 (2.5)	BUD13 (2.3)	ATXN2 (2.1)	CETP (2.0)	USP1 (1.9)	ADAM1 (1.9)	POC5 (1.9)	C1orf63 (1.6)
GO:0015721	bile acid and bile salt transport	0.03	> 0.20	CYP7A1 (6.7)	APOC4 (4.5)	ANGPTL3 (4.0)	APOA5 (3.5)	SLC22A1 (3.3)	ABCG8 (3.2)	LPA (2.9)	PLG (2.6)	GOT2P1 (2.5)	TM6SF2 (2.4)
ENSG00000073009	IKBKG PPI subnetwork	0.03	> 0.20	RELB (4.5)	SARS (3.1)	USP24 (2.7)	BCL3 (2.5)	PARP10 (2.5)	NAA25 (2.2)	PLEC (2.2)	OGDH (2.2)	HAVCR1 (2.2)	PTPN11 (2.0)
GO:0005126	cytokine receptor binding	0.03	> 0.20	RELB (3.4)	BCL3 (3.3)	TIMD4 (3.1)	OASL (2.5)	CETP (2.3)	PVR (2.1)	CYP7A1 (1.8)	PVRL2 (1.8)	SH2B3 (1.8)	ZNF101 (1.6)
ENSG00000151224	MAT1A PPI subnetwork	0.03	> 0.20	TOMM40 (4.3)	NAA25 (4.2)	SARS (3.6)	ZNF259 (3.5)	DDX56 (3.4)	PSMA5 (3.4)	CLPTM1 (3.2)	DHX38 (2.5)	ATP13A1 (2.1)	QTRT1 (2.1)
ENSG00000134597	RBMX2 PPI subnetwork	0.03	> 0.20	BUD13 (4.3)	SUGP1 (3.9)	BRAP (3.1)	DHX38 (2.9)	ZNF259 (2.9)	POC5 (2.4)	MAU2 (1.9)	DDX56 (1.9)	C12orf43 (1.8)	ZNF180 (1.7)
MP:0003402	decreased liver weight	0.03	> 0.20	LDLR (3.9)	POLK (3.3)	PCSK9 (2.2)	HMGCR (2.2)	KIAA1324 (2.0)	SLC44A2 (1.9)	ZHX3 (1.8)	ATXN7L2 (1.6)	GCNT4 (1.6)	C11orf9 (1.6)
GO:0008158	hedgehog receptor activity	0.03	> 0.20	LDLR (6.6)	FADS2 (5.8)	FADS1 (5.4)	PCSK9 (3.9)	HMGCR (3.0)	ST3GAL4 (2.9)	CYP7A1 (2.6)	TM6SF2 (2.4)	ATP13A1 (2.3)	ABCG8 (2.3)
MP:0001859	kidney inflammation	0.03	> 0.20	TM6SF2 (3.5)	GCNT4 (3.1)	HNF1A (3.0)	FRK (2.9)	TRIB1 (2.9)	NPC1L1 (2.8)	TMEM116 (2.3)	ABCG5 (2.3)	MAFB (2.0)	ADAM1 (1.9)
MP:0003331	hepatocellular carcinoma	0.03	> 0.20	APOA5 (3.0)	C17orf57 (2.8)	LPIN3 (2.8)	LPA (2.6)	ANGPTL3 (2.6)	TMEM57 (2.6)	SLC22A1 (2.4)	CYP7A1 (2.4)	APOC4 (2.3)	PLG (2.1)
MP:0009264	failure of eyelid fusion	0.03	> 0.20	DOCK7 (3.3)	AMIGO1 (2.8)	TRIB1 (2.6)	ENSG00000235545 (2.2)	CBLC (2.2)	NYNRIN (1.9)	MARK4 (1.9)	CEACAM19 (1.9)	ENSG00000238078 (1.8)	LDLR (1.7)
ENSG00000005844	ITGAL PPI subnetwork	0.03	> 0.20	APOE (3.4)	SH2B3 (3.0)	SLC44A2 (2.9)	RELB (2.5)	GMIP (2.3)	C19orf52 (1.9)	CYB561D1 (1.9)	TMEM116 (1.8)	CETP (1.7)	APOC1 (1.6)
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	0.03	> 0.20	RELB (4.6)	OASL (4.4)	PARP10 (3.8)	BCL3 (3.6)	SH2B3 (3.2)	TRIB1 (3.1)	PVR (3.0)	TRAFD1 (2.7)	GMIP (2.5)	HLX (2.3)
REACTOME_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_3_TLR3_CASCADE	0.03	> 0.20	RELB (4.6)	OASL (4.4)	PARP10 (3.8)	BCL3 (3.6)	SH2B3 (3.2)	TRIB1 (3.1)	PVR (3.0)	TRAFD1 (2.7)	GMIP (2.5)	HLX (2.3)
GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.03	> 0.20	SLC22A1 (3.2)	TIMD4 (3.1)	LPA (2.6)	APOE (2.3)	CETP (2.2)	PARP10 (2.0)	APOC4 (1.9)	RELB (1.8)	GMIP (1.7)	BCL3 (1.6)
GO:0032101	regulation of response to external stimulus	0.03	> 0.20	ENSG00000228044 (3.4)	TIMD4 (2.2)	GCNT4 (2.2)	CETP (2.2)	HLX (2.1)	APOE (1.8)	PVR (1.7)	ITGB3 (1.6)	SLC22A1 (1.6)	SH2B3 (1.6)
REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	REACTOME_TRIGLYCERIDE_BIOSYNTHESIS	0.03	> 0.20	FADS1 (7.8)	HMGCR (7.5)	FADS2 (7.1)	GPAM (6.8)	LDLR (6.5)	PCSK9 (4.3)	MOSC1 (4.1)	NPC1L1 (3.0)	SORT1 (2.7)	GRINA (2.4)
ENSG00000099194	SCD PPI subnetwork	0.03	> 0.20	FADS2 (5.7)	FADS1 (5.0)	LDLR (4.5)	HMGCR (3.9)	TM6SF2 (3.3)	NPC1L1 (3.1)	SLC22A1 (2.4)	PCSK9 (2.1)	C11orf9 (2.1)	GPAM (2.0)
GO:0019841	retinol binding	0.03	> 0.20	ABCG5 (5.0)	TM6SF2 (4.3)	APOB (4.3)	APOA5 (3.2)	ABCG8 (3.0)	NYNRIN (2.8)	APOC4 (2.7)	NKPD1 (2.6)	NPC1L1 (2.5)	LPAR2 (2.4)
GO:0008235	metalloexopeptidase activity	0.03	> 0.20	NPC1L1 (2.2)	PMFBP1 (2.2)	KIAA1324 (2.1)	ENSG00000226648 (2.0)	TM6SF2 (1.9)	APOB (1.9)	HAPLN4 (1.8)	PLG (1.7)	FRK (1.6)	ADAM1 (1.5)
ENSG00000173702	MUC13 PPI subnetwork	0.03	> 0.20	ST3GAL4 (2.9)	AP1M2 (2.9)	DNM2 (2.7)	SH2B3 (2.1)	KIAA1324 (2.0)	HNF1A (2.0)	NYNRIN (1.9)	ITGB3 (1.6)	PLEC (1.5)	FRK (1.5)
KEGG_BUTANOATE_METABOLISM	KEGG_BUTANOATE_METABOLISM	0.03	> 0.20	ACAD10 (5.1)	MOSC1 (4.5)	FADS2 (4.4)	HMGCR (4.2)	FADS1 (4.0)	PCSK9 (3.4)	CYP7A1 (3.1)	PLG (3.0)	LDLR (3.0)	ALDH2 (2.9)
ENSG00000167088	SNRPD1 PPI subnetwork	0.03	> 0.20	ILF3 (3.7)	DHX38 (3.3)	BUD13 (3.1)	C1orf63 (3.0)	TOP1 (2.8)	USP1 (2.7)	SMARCA4 (2.7)	FEN1 (2.7)	SUGP1 (2.7)	QTRT1 (2.5)
ENSG00000134987	WDR36 PPI subnetwork	0.03	> 0.20	DDX56 (4.8)	ZNF259 (4.7)	QTRT1 (4.1)	NAA25 (4.0)	TOMM40 (4.0)	DHODH (3.5)	DHX38 (2.9)	ATP13A1 (2.6)	GATAD2A (2.2)	C12orf43 (2.2)
ENSG00000124571	XPO5 PPI subnetwork	0.03	> 0.20	NAA25 (3.6)	DDX56 (3.3)	TOMM40 (2.6)	ATP13A1 (2.4)	QTRT1 (2.1)	DHX38 (2.1)	ENSG00000226648 (2.0)	PSMA5 (1.9)	SMARCA4 (1.9)	POC5 (1.8)
ENSG00000143799	PARP1 PPI subnetwork	0.03	> 0.20	FEN1 (3.7)	DHX38 (3.1)	RELB (2.7)	USP1 (2.5)	RHD (2.3)	ENSG00000226648 (2.1)	PLCG1 (2.0)	KANK2 (1.8)	SMARCA4 (1.7)	ILF3 (1.6)
GO:0005938	cell cortex	0.03	> 0.20	KANK2 (2.5)	RHD (2.4)	DNM2 (2.4)	PLCG1 (2.0)	RHCE (2.0)	ITGB3 (1.9)	LPIN3 (1.8)	ENSG00000238078 (1.8)	OGDH (1.7)	HAVCR1 (1.7)
MP:0003135	increased erythroid progenitor cell number	0.03	> 0.20	RHCE (9.2)	RHD (8.6)	GMPR (3.4)	C12orf51 (2.8)	C19orf52 (2.3)	SLC44A2 (2.2)	DNM2 (2.2)	ADAM1 (1.8)	SH2B3 (1.7)	ILF3 (1.6)
ENSG00000163110	PDLIM5 PPI subnetwork	0.03	> 0.20	TIMD4 (3.3)	CETP (3.2)	PLEKHH2 (2.9)	SH2B3 (2.3)	GMPR (2.3)	RHD (2.0)	DNAH11 (1.8)	SYPL2 (1.7)	C11orf9 (1.7)	FADS1 (1.6)
ENSG00000159251	ACTC1 PPI subnetwork	0.03	> 0.20	KANK2 (3.2)	C1orf63 (3.0)	OGDH (2.8)	PLEC (2.6)	PVR (2.1)	ITGB3 (2.1)	C17orf57 (2.0)	NPC1L1 (2.0)	PVRL2 (1.9)	ANGPTL3 (1.8)
ENSG00000172071	EIF2AK3 PPI subnetwork	0.03	> 0.20	PARP10 (3.1)	USP24 (2.7)	BCL3 (2.1)	ZNF180 (2.1)	MARK4 (1.9)	MAU2 (1.9)	POLK (1.9)	MAFB (1.8)	SMARCA4 (1.8)	MYLIP (1.8)
ENSG00000127526	SLC35E1 PPI subnetwork	0.03	> 0.20	CLPTM1 (3.5)	BLOC1S3 (3.0)	ERP29 (2.7)	ATP13A1 (2.5)	SARS (2.3)	TMEM57 (2.3)	CBLC (2.2)	NT5DC1 (2.2)	OGDH (2.2)	YIPF2 (2.1)
ENSG00000148143	ZNF462 PPI subnetwork	0.03	> 0.20	C19orf52 (2.3)	PARP10 (2.2)	DHX38 (2.2)	BRAP (2.0)	QTRT1 (2.0)	SUGP1 (1.9)	OASL (1.9)	GRINA (1.8)	YIPF2 (1.8)	SORT1 (1.8)
ENSG00000004799	PDK4 PPI subnetwork	0.03	> 0.20	ACAD10 (3.0)	OGDH (2.8)	USP24 (2.8)	CLPTM1 (2.4)	GPAM (2.3)	C12orf43 (2.2)	MOSC1 (1.9)	HAVCR1 (1.8)	ABCG8 (1.8)	NAA25 (1.7)
ENSG00000145332	KLHL8 PPI subnetwork	0.03	> 0.20	ATXN7L2 (2.7)	QTRT1 (2.2)	ENSG00000226645 (2.0)	YIPF2 (1.9)	APOA5 (1.9)	TMEM50A (1.8)	ENSG00000238078 (1.7)	C19orf52 (1.7)	ERP29 (1.7)	SARS (1.6)
GO:0046627	negative regulation of insulin receptor signaling pathway	0.03	> 0.20	ST3GAL4 (2.2)	ENSG00000226645 (2.0)	BCL3 (1.8)	TRIB1 (1.7)	GCNT4 (1.7)	TMED4 (1.6)	TOP1 (1.5)	AP1M2 (1.4)	TSSK6 (1.4)	PBX4 (1.4)
MP:0000628	abnormal mammary gland development	0.03	> 0.20	CELSR2 (3.3)	KIAA1324 (2.7)	CYP7A1 (2.2)	POLK (2.2)	SLC22A1 (1.8)	BCL3 (1.8)	PTPN11 (1.8)	ANKRD31 (1.8)	UBXN2B (1.8)	APOC4 (1.7)
REACTOME_ACTIVATED_TLR4_SIGNALLING	REACTOME_ACTIVATED_TLR4_SIGNALLING	0.03	> 0.20	RELB (4.6)	BCL3 (4.2)	TRIB1 (3.9)	OASL (3.4)	SH2B3 (3.1)	PVR (2.9)	HLX (2.8)	GMIP (2.5)	PARP10 (2.5)	MAFB (1.9)
ENSG00000171791	BCL2 PPI subnetwork	0.03	> 0.20	GRINA (3.3)	RELB (3.0)	TRAPPC6A (2.7)	TMEM50A (2.4)	PVR (2.1)	CLPTM1 (2.1)	BRAP (2.1)	PVRL2 (1.9)	C1orf63 (1.8)	TRIB1 (1.8)
REACTOME_REGULATION_OF_INSULIN:LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN:LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	REACTOME_REGULATION_OF_INSULIN:LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN:LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	0.03	> 0.20	APOC4 (4.2)	APOA5 (4.0)	SLC22A1 (3.7)	HP (3.7)	APOB (3.0)	LPA (3.0)	PLG (2.8)	BCAM (2.7)	ANGPTL3 (2.6)	ABCG5 (2.5)
ENSG00000169957	ZNF768 PPI subnetwork	0.03	> 0.20	C19orf52 (2.5)	SUGP1 (2.3)	BRAP (2.0)	OASL (2.0)	PARP10 (2.0)	ENSG00000228044 (2.0)	DHX38 (1.8)	SORT1 (1.8)	QTRT1 (1.7)	GRINA (1.6)
REACTOME_RIG:IMDA5_MEDIATED_INDUCTION_OF_IFN:ALPHABETA_PATHWAYS	REACTOME_RIG:IMDA5_MEDIATED_INDUCTION_OF_IFN:ALPHABETA_PATHWAYS	0.03	> 0.20	OASL (10.7)	PARP10 (7.4)	RELB (5.8)	TRAFD1 (4.9)	BCL3 (4.1)	ZNF101 (2.2)	CYP7A1 (2.0)	MAU2 (1.7)	GMIP (1.6)	CYB561D1 (1.6)
MP:0003606	kidney failure	0.03	> 0.20	BCAM (4.9)	PLEKHH2 (2.8)	POLK (2.5)	C11orf9 (2.3)	GRINA (2.1)	NYNRIN (2.1)	PVR (2.0)	CELSR2 (1.9)	ZHX3 (1.7)	TMED4 (1.7)
MP:0003957	abnormal nitric oxide homeostasis	0.03	> 0.20	PARP10 (3.8)	TRIB1 (3.6)	TRAFD1 (3.3)	BCL3 (3.0)	RELB (2.8)	HP (2.6)	MAFB (2.6)	GRINA (2.5)	PVR (2.4)	SYPL2 (2.1)
GO:0015645	fatty acid ligase activity	0.03	> 0.20	APOC4 (3.8)	MOSC1 (3.3)	PLG (3.1)	HMGCR (3.1)	FADS1 (2.8)	CYP7A1 (2.8)	APOA5 (2.7)	APOC1 (2.5)	GPAM (2.3)	FADS2 (2.3)
ENSG00000174718	C12orf35 PPI subnetwork	0.03	> 0.20	APOB (5.8)	APOC1 (4.1)	NPC1L1 (2.8)	GPAM (2.8)	APOA5 (2.7)	PLG (2.6)	ITGB3 (2.5)	HP (2.4)	ABCG5 (2.4)	HAVCR1 (2.3)
ENSG00000140284	SLC27A2 PPI subnetwork	0.03	> 0.20	HMGCR (10.2)	LDLR (8.2)	FADS1 (7.1)	FADS2 (7.1)	PCSK9 (6.6)	GRINA (2.3)	GPAM (2.2)	NKPD1 (2.0)	MOSC1 (1.8)	TMEM50A (1.6)
MP:0000596	abnormal liver development	0.03	> 0.20	TRIB1 (3.6)	C11orf9 (3.1)	DOCK7 (2.3)	KANK2 (2.3)	MAPKAPK5 (2.3)	PVR (2.1)	LDLR (2.0)	ENSG00000238078 (1.9)	HNF1A (1.9)	HLX (1.8)
MP:0005464	abnormal platelet physiology	0.03	> 0.20	ITGB3 (9.1)	GMPR (4.9)	FADS1 (2.2)	PTPN11 (1.8)	ABCG5 (1.7)	ST3GAL4 (1.7)	POLK (1.6)	NYNRIN (1.5)	ENSG00000238078 (1.4)	GCNT4 (1.4)
GO:0031528	microvillus membrane	0.03	> 0.20	APOB (3.2)	HNF1A (3.2)	TMED4 (3.0)	C11orf9 (2.4)	BCAM (1.9)	DNAH11 (1.8)	NPC1L1 (1.8)	LDLR (1.7)	OGDH (1.6)	TM6SF2 (1.6)
MP:0004947	skin inflammation	0.03	> 0.20	BCL3 (4.5)	PARP10 (3.7)	GMIP (3.4)	GRINA (2.8)	DNM2 (2.7)	ST3GAL4 (2.7)	TRAFD1 (2.3)	PLEC (2.2)	GCNT4 (2.1)	CYB561D1 (1.8)
ENSG00000052802	MSMO1 PPI subnetwork	0.03	> 0.20	HMGCR (12.8)	LDLR (12.2)	FADS1 (9.9)	FADS2 (9.3)	PCSK9 (7.2)	CYP7A1 (2.7)	NPC1L1 (2.6)	GPAM (2.4)	CLPTM1 (2.3)	TMEM50A (2.1)
ENSG00000176165	FOXG1 PPI subnetwork	0.03	> 0.20	ATXN2 (2.6)	PLCG1 (2.4)	MYLIP (2.1)	LPIN3 (2.0)	MAFB (1.9)	TRIB1 (1.9)	KANK2 (1.8)	ANKRD31 (1.6)	PVRL2 (1.5)	ENSG00000238078 (1.4)
ENSG00000215612	HMX1 PPI subnetwork	0.03	> 0.20	ZNF180 (3.9)	GEMIN7 (2.6)	PPP1R37 (2.5)	PLCG1 (2.2)	HAPLN4 (2.0)	TRAPPC6A (2.0)	SARS (1.9)	ERP29 (1.8)	ALDH2 (1.8)	ZNF101 (1.7)
ENSG00000137500	CCDC90B PPI subnetwork	0.03	> 0.20	HAVCR1 (2.4)	ALDH2 (2.3)	BLOC1S3 (2.2)	KANK2 (2.1)	GEMIN7 (2.0)	TMEM57 (1.9)	TRAPPC6A (1.9)	GMPR (1.7)	GCNT4 (1.7)	NCAN (1.7)
ENSG00000184895	SRY PPI subnetwork	0.03	> 0.20	BCAM (2.8)	NKPD1 (2.6)	SYPL2 (2.2)	NYNRIN (2.1)	PPP1R37 (1.9)	PLEKHH2 (1.9)	GEMIN7 (1.8)	YIPF2 (1.8)	POLK (1.6)	PVRL2 (1.6)
ENSG00000162407	PPAP2B PPI subnetwork	0.03	> 0.20	USP24 (2.9)	PARP10 (2.8)	MARK4 (2.7)	GMIP (2.7)	MAU2 (2.4)	DHX38 (2.3)	POLK (2.1)	ATXN2 (2.1)	BCL3 (2.0)	SMARCA4 (2.0)
GO:0010952	positive regulation of peptidase activity	0.03	> 0.20	POLK (3.1)	TRAFD1 (2.3)	ST3GAL4 (2.2)	OASL (2.1)	PARP10 (2.0)	C17orf57 (1.8)	MAPKAPK5 (1.8)	BLOC1S3 (1.7)	ENSG00000238078 (1.7)	FRK (1.7)
MP:0001664	abnormal digestion	0.03	> 0.20	GRINA (2.4)	SYPL2 (2.2)	ATP13A1 (2.1)	NPC1L1 (2.1)	UBXN2B (2.1)	HLX (2.1)	MOSC1 (2.0)	TMEM57 (1.9)	AMIGO1 (1.8)	CYP7A1 (1.8)
GO:0004553	hydrolase activity, hydrolyzing O-glycosyl compounds	0.03	> 0.20	ERP29 (4.4)	TMED4 (3.7)	ATP13A1 (3.2)	SORT1 (3.1)	TRAPPC6A (2.9)	TM6SF2 (2.4)	NPC1L1 (2.4)	NKPD1 (2.1)	GCNT4 (2.1)	APOE (1.8)
ENSG00000118046	STK11 PPI subnetwork	0.03	> 0.20	DNM2 (3.8)	MAU2 (3.7)	LPAR2 (2.6)	CARM1 (2.4)	GMIP (2.1)	SLC44A2 (2.0)	C19orf52 (2.0)	ILF3 (2.0)	ATP13A1 (1.9)	CELSR2 (1.9)
ENSG00000136869	TLR4 PPI subnetwork	0.03	> 0.20	RELB (4.4)	BCL3 (3.4)	PVR (3.2)	SH2B3 (2.7)	MAFB (2.6)	TRIB1 (2.0)	GMIP (1.9)	OASL (1.8)	DNM2 (1.6)	BRAP (1.6)
KEGG_DRUG_METABOLISM_CYTOCHROME_P450	KEGG_DRUG_METABOLISM_CYTOCHROME_P450	0.03	> 0.20	ABCG5 (6.3)	SLC22A1 (5.7)	LPA (5.7)	CYP7A1 (5.5)	ABCG8 (5.2)	APOC4 (5.1)	TM6SF2 (4.7)	ANGPTL3 (4.5)	APOA5 (3.8)	ALDH2 (3.7)
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM	0.03	> 0.20	GPAM (5.1)	HMGCR (3.7)	C19orf52 (2.2)	LDLR (2.2)	DHODH (2.2)	USP24 (2.1)	PCSK9 (2.0)	FADS2 (2.0)	NT5DC1 (2.0)	MOSC1 (1.6)
ENSG00000177200	CHD9 PPI subnetwork	0.03	> 0.20	ZNF180 (2.5)	BRAP (2.3)	TOP1 (2.2)	GEMIN7 (2.2)	BUD13 (2.2)	C1orf63 (2.2)	TXNL4B (2.1)	C17orf57 (1.9)	TMEM57 (1.7)	DHX38 (1.7)
ENSG00000163938	GNL3 PPI subnetwork	0.03	> 0.20	QTRT1 (4.5)	ZNF259 (4.3)	TOMM40 (4.2)	NAA25 (4.0)	DDX56 (3.7)	ATP13A1 (2.7)	C12orf43 (2.6)	DHODH (2.6)	DHX38 (2.3)	SUGP1 (2.2)
ENSG00000164924	YWHAZ PPI subnetwork	0.03	> 0.20	PLEC (4.1)	SMARCA4 (3.9)	SARS (3.3)	OGDH (2.9)	PTPN11 (2.5)	ATXN2 (2.2)	ILF3 (2.1)	PSMA5 (2.0)	DNM2 (1.9)	HMGCR (1.7)
ENSG00000111652	COPS7A PPI subnetwork	0.03	> 0.20	NT5DC1 (2.3)	ATXN7L2 (2.0)	ITGB3 (2.0)	DYNC2LI1 (2.0)	UBXN2B (1.9)	RHD (1.8)	ZNF259 (1.8)	QTRT1 (1.7)	NYNRIN (1.6)	PBX4 (1.6)
GO:0010878	cholesterol storage	0.03	> 0.20	APOC1 (3.0)	TMEM116 (2.9)	ATXN7L2 (2.7)	APOE (2.7)	TIMD4 (2.6)	ABCG8 (2.6)	MOSC1 (2.2)	MYLIP (2.1)	LPIN3 (2.0)	ENSG00000238078 (2.0)
GO:0008643	carbohydrate transport	0.03	> 0.20	GCNT4 (2.8)	NPC1L1 (2.7)	ABCG8 (2.4)	TMED4 (2.4)	POC5 (2.3)	SORT1 (2.1)	TM6SF2 (2.1)	AMIGO1 (2.0)	KIAA1324 (1.9)	ABCG5 (1.8)
ENSG00000124782	RREB1 PPI subnetwork	0.03	> 0.20	GRINA (2.4)	C19orf52 (2.3)	QTRT1 (2.2)	ZNF180 (2.2)	OASL (2.2)	PARP10 (2.2)	SUGP1 (2.0)	YIPF2 (1.9)	BRAP (1.9)	ATP13A1 (1.7)
MP:0004816	abnormal class switch recombination	0.03	> 0.20	RELB (6.0)	BCL3 (3.6)	GMIP (3.1)	GCNT4 (2.1)	GRINA (1.7)	SH2B3 (1.7)	TIMD4 (1.6)	NT5DC1 (1.5)	ZNF101 (1.5)	TRIB1 (1.5)
ENSG00000101210	EEF1A2 PPI subnetwork	0.03	> 0.20	RELB (4.1)	BCL3 (3.4)	COL4A3BP (2.3)	BUD13 (2.3)	ENSG00000226645 (2.0)	SMARCA4 (1.8)	CARM1 (1.7)	DHX38 (1.7)	C1orf63 (1.6)	C19orf52 (1.6)
MP:0009657	failure of chorioallantoic fusion	0.03	> 0.20	CLPTM1 (2.6)	HAVCR1 (2.5)	APOE (2.3)	PPP1R37 (2.3)	ATXN2 (2.0)	BCAM (2.0)	GATAD2A (1.9)	CETP (1.8)	DOCK7 (1.7)	APOC1 (1.7)
MP:0008412	increased cellular sensitivity to oxidative stress	0.03	> 0.20	RHCE (6.9)	RHD (4.2)	TRAPPC6A (3.3)	TMEM57 (2.2)	C12orf51 (2.0)	ABCG5 (2.0)	PSMA5 (1.9)	ALDH2 (1.9)	ZHX3 (1.9)	DHODH (1.9)
GO:0022600	digestive system process	0.04	> 0.20	NPC1L1 (6.2)	TM6SF2 (4.4)	ABCG5 (3.8)	ABCG8 (3.7)	KIAA1324 (3.6)	C17orf57 (2.7)	APOB (2.7)	ABO (2.2)	CBLC (2.1)	TMED4 (1.9)
GO:0070325	lipoprotein particle receptor binding	0.04	> 0.20	APOB (7.7)	ABCG5 (5.9)	NPC1L1 (5.5)	APOC1 (5.1)	PLG (4.1)	APOC4 (3.3)	HP (3.3)	APOA5 (3.2)	ANGPTL3 (2.9)	ABCG8 (2.5)
REACTOME_PLATELET_SENSITIZATION_BY_LDL	REACTOME_PLATELET_SENSITIZATION_BY_LDL	0.04	> 0.20	ABCG5 (3.0)	HP (2.7)	ABCG8 (2.4)	MOSC1 (2.3)	GPAM (2.2)	PVR (1.9)	ENSG00000226645 (1.9)	CLPTM1 (1.8)	MAPKAPK5 (1.8)	NPC1L1 (1.7)
ENSG00000137309	HMGA1 PPI subnetwork	0.04	> 0.20	MAPKAPK5 (3.1)	BUD13 (2.9)	POC5 (2.9)	USP1 (2.5)	NAA25 (2.5)	DOCK7 (2.5)	ILF3 (2.3)	RELB (2.2)	TOP1 (2.2)	PSRC1 (2.0)
ENSG00000180138	CSNK1A1L PPI subnetwork	0.04	> 0.20	NYNRIN (3.1)	ENSG00000226648 (2.4)	LPIN3 (1.8)	CARM1 (1.7)	PLCG1 (1.7)	TRIB1 (1.7)	NPC1L1 (1.6)	MARK4 (1.5)	ENSG00000235545 (1.5)	PBX4 (1.5)
MP:0010279	increased gastrointestinal tumor incidence	0.04	> 0.20	ZNF180 (3.0)	BCAM (2.4)	CLPTM1 (2.3)	BLOC1S3 (2.2)	FEN1 (2.0)	PARP10 (1.8)	DYNC2LI1 (1.8)	FADS2 (1.8)	AP1M2 (1.8)	POC5 (1.8)
GO:0070201	regulation of establishment of protein localization	0.04	> 0.20	ZNF101 (2.2)	ST3GAL4 (1.7)	ENSG00000238078 (1.7)	PLEKHH2 (1.7)	GEMIN7 (1.7)	HLX (1.6)	AP1M2 (1.6)	SH2B3 (1.5)	PVRL2 (1.5)	OASL (1.4)
MP:0001879	abnormal lymphatic vessel morphology	0.04	> 0.20	CETP (5.1)	HLX (3.2)	BCAM (3.0)	ITGB3 (2.4)	SLC44A2 (1.9)	PVRL2 (1.8)	MAFB (1.5)	LPA (1.5)	DNAH11 (1.4)	CILP2 (1.4)
ENSG00000164751	PEX2 PPI subnetwork	0.04	> 0.20	CYP7A1 (3.0)	FADS2 (2.9)	GPAM (2.9)	LDLR (2.9)	CEACAM19 (2.8)	HMGCR (2.5)	PCSK9 (2.4)	TSSK6 (2.3)	MOSC1 (2.3)	C19orf52 (2.2)
ENSG00000115233	PSMD14 PPI subnetwork	0.04	> 0.20	PSMA5 (5.4)	TRAFD1 (3.2)	NAA25 (2.6)	OGDH (2.4)	NT5DC1 (2.3)	TOMM40 (2.2)	DDX56 (1.9)	SARS (1.7)	SMARCA4 (1.7)	CLPTM1 (1.7)
GO:0005720	nuclear heterochromatin	0.04	> 0.20	NYNRIN (3.9)	ENSG00000254235 (2.8)	HAVCR1 (2.2)	ZNF180 (2.1)	USP1 (2.0)	TOP1 (2.0)	PVRL2 (1.9)	CYP7A1 (1.8)	ILF3 (1.6)	NT5DC1 (1.6)
ENSG00000160808	MYL3 PPI subnetwork	0.04	> 0.20	ADAM1 (3.6)	ANKRD31 (2.6)	BRAP (2.5)	ENSG00000238078 (2.4)	TRAFD1 (2.2)	FADS2 (2.1)	C12orf51 (2.1)	SYPL2 (2.0)	TOP1 (1.9)	KANK2 (1.8)
MP:0000600	liver hypoplasia	0.04	> 0.20	BCL3 (3.6)	C11orf9 (3.5)	RHD (2.1)	TRIB1 (1.9)	RELB (1.9)	KANK2 (1.8)	MAU2 (1.7)	UBXN2B (1.6)	ST3GAL4 (1.6)	RHCE (1.5)
ENSG00000044574	HSPA5 PPI subnetwork	0.04	> 0.20	PSMA5 (3.8)	TRAFD1 (3.1)	SMARCA4 (2.6)	SARS (2.6)	NAA25 (2.3)	CLPTM1 (2.2)	OGDH (2.2)	TOP1 (2.1)	ERP29 (1.9)	TOMM40 (1.9)
GO:0005635	nuclear envelope	0.04	> 0.20	LDLR (3.3)	NAA25 (3.1)	USP24 (2.6)	DOCK7 (2.5)	USP1 (2.4)	DDX56 (2.3)	POC5 (2.1)	PLEC (2.1)	FEN1 (1.9)	FADS1 (1.8)
GO:0004467	long-chain fatty acid-CoA ligase activity	0.04	> 0.20	HMGCR (3.8)	FADS1 (3.7)	APOC4 (3.3)	PLG (3.1)	PCSK9 (3.0)	LDLR (2.8)	FADS2 (2.7)	HP (2.3)	APOA5 (2.3)	MOSC1 (2.2)
ENSG00000115816	CEBPZ PPI subnetwork	0.04	> 0.20	ZNF259 (5.0)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (3.6)	QTRT1 (3.3)	DHODH (3.1)	DHX38 (3.1)	ATP13A1 (2.8)	C12orf43 (2.6)	SUGP1 (2.5)
GO:0006958	complement activation, classical pathway	0.04	> 0.20	LPA (5.5)	SLC22A1 (4.4)	TIMD4 (4.2)	APOC4 (3.7)	ANGPTL3 (3.4)	HP (3.0)	APOE (2.9)	APOA5 (2.8)	PCSK9 (2.8)	PLG (2.7)
ENSG00000100354	TNRC6B PPI subnetwork	0.04	> 0.20	TMED4 (3.3)	NPC1L1 (3.3)	FADS1 (3.2)	PCSK9 (3.2)	HMGCR (2.7)	FADS2 (2.6)	USP24 (2.2)	LDLR (2.2)	GATAD2A (2.0)	UBXN2B (2.0)
ENSG00000158691	ZSCAN12 PPI subnetwork	0.04	> 0.20	C19orf52 (2.4)	PARP10 (2.4)	QTRT1 (2.2)	OASL (2.2)	SUGP1 (2.1)	DHX38 (2.1)	GRINA (1.9)	YIPF2 (1.9)	BRAP (1.7)	SORT1 (1.6)
ENSG00000205560	CPT1B PPI subnetwork	0.04	> 0.20	CYP7A1 (3.0)	HAPLN4 (2.9)	LPA (2.5)	SLC22A1 (2.5)	C11orf9 (2.4)	RHD (2.3)	ALDH2 (2.0)	ITGB3 (1.9)	C12orf47 (1.8)	RHCE (1.8)
ENSG00000173511	VEGFB PPI subnetwork	0.04	> 0.20	MYLIP (4.3)	C1orf63 (3.6)	HLX (3.0)	C17orf57 (2.4)	ENSG00000226648 (2.2)	ADAM1 (2.1)	ATXN7L2 (1.8)	DNAH11 (1.8)	SLC44A2 (1.6)	ENSG00000254235 (1.6)
MP:0004796	increased anti-histone antibody level	0.04	> 0.20	ZNF101 (3.2)	TIMD4 (2.9)	MAFB (2.4)	CETP (2.3)	TRIB1 (2.3)	ENSG00000226648 (2.2)	POLK (2.1)	GRINA (2.1)	ENSG00000238078 (2.0)	KANK2 (2.0)
MP:0001545	abnormal hematopoietic system physiology	0.04	> 0.20	RHD (3.8)	RHCE (3.7)	USP24 (2.2)	ENSG00000228044 (2.2)	APOC1 (2.2)	POLK (2.1)	C17orf57 (2.1)	GMIP (2.0)	C1orf63 (1.9)	LPA (1.8)
ENSG00000136045	PWP1 PPI subnetwork	0.04	> 0.20	ZNF259 (4.9)	TOMM40 (4.1)	QTRT1 (3.9)	NAA25 (3.8)	DDX56 (3.6)	ATP13A1 (2.6)	ILF3 (2.5)	CARM1 (2.1)	DHODH (2.1)	SMARCA4 (2.0)
GO:0032452	histone demethylase activity	0.04	> 0.20	LPA (2.6)	C12orf47 (2.5)	TMEM57 (2.5)	TOP1 (2.5)	C12orf51 (2.4)	ATXN7L2 (2.3)	BUD13 (2.3)	ERP29 (2.2)	TRAFD1 (2.2)	GCNT4 (2.1)
GO:0015914	phospholipid transport	0.04	> 0.20	C17orf57 (4.3)	ABCG5 (3.9)	COL4A3BP (3.0)	MYLIP (2.8)	NPC1L1 (2.5)	APOB (2.3)	APOC1 (2.2)	TM6SF2 (2.1)	PMFBP1 (2.1)	TIMD4 (1.9)
GO:0046503	glycerolipid catabolic process	0.04	> 0.20	MOSC1 (3.9)	NPC1L1 (3.8)	GPAM (3.7)	TM6SF2 (3.0)	ABCG5 (2.8)	APOB (2.4)	PMFBP1 (2.3)	APOC1 (2.3)	APOC4 (2.3)	HP (2.3)
REACTOME_GRB2SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS	REACTOME_GRB2SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS	0.04	> 0.20	ITGB3 (5.5)	APOB (5.2)	APOC1 (4.3)	ANGPTL3 (4.0)	PLG (3.8)	HP (3.7)	HAVCR1 (3.7)	APOA5 (3.3)	APOC4 (2.8)	APOE (2.8)
GO:0002250	adaptive immune response	0.04	> 0.20	TIMD4 (3.2)	SLC22A1 (3.1)	LPA (2.6)	CETP (2.3)	APOE (2.2)	PARP10 (2.0)	ZNF101 (2.0)	RELB (1.9)	APOC4 (1.8)	BCL3 (1.7)
ENSG00000042832	TG PPI subnetwork	0.04	> 0.20	ERP29 (4.3)	HP (2.9)	TMED4 (2.3)	PLG (2.1)	APOC4 (2.0)	ADAM1 (2.0)	APOA5 (1.9)	ANGPTL3 (1.9)	BCAM (1.8)	MAFB (1.8)
ENSG00000130826	DKC1 PPI subnetwork	0.04	> 0.20	DDX56 (4.9)	NAA25 (4.3)	QTRT1 (4.3)	TOMM40 (4.2)	ZNF259 (4.0)	DHODH (3.2)	TOP1 (3.0)	SUGP1 (2.7)	DHX38 (2.7)	ATP13A1 (2.3)
ENSG00000145912	NHP2 PPI subnetwork	0.04	> 0.20	QTRT1 (4.8)	ZNF259 (4.3)	DDX56 (4.1)	C12orf43 (3.7)	C19orf52 (3.4)	TOMM40 (3.2)	SUGP1 (3.0)	DHX38 (2.4)	ATP13A1 (2.4)	DHODH (2.3)
ENSG00000137285	TUBB2B PPI subnetwork	0.04	> 0.20	RELB (3.7)	TXNL4B (2.8)	SARS (2.5)	HP (2.4)	PLG (2.3)	DNM2 (2.3)	ZNF259 (2.1)	LDLR (2.1)	SUGP1 (2.0)	BCL3 (2.0)
MP:0004090	abnormal sarcomere morphology	0.04	> 0.20	SYPL2 (6.0)	GMPR (2.9)	BCAM (2.0)	ENSG00000228044 (1.8)	TRAPPC6A (1.8)	HNF1A (1.6)	OGDH (1.6)	LPAR2 (1.6)	C17orf57 (1.5)	PVRL2 (1.4)
MP:0000372	irregular coat pigmentation	0.04	> 0.20	GMPR (2.8)	MYLIP (2.7)	NKPD1 (2.3)	PLEKHH2 (1.9)	PCSK9 (1.8)	BLOC1S3 (1.6)	HMGCR (1.6)	FRK (1.6)	TMEM50A (1.5)	HAVCR1 (1.5)
GO:0006959	humoral immune response	0.04	> 0.20	LPA (5.7)	TIMD4 (4.4)	SLC22A1 (3.7)	CETP (3.4)	APOC4 (3.1)	HP (2.7)	DHODH (2.5)	ANGPTL3 (2.1)	APOE (2.1)	APOA5 (2.0)
GO:0000988	protein binding transcription factor activity	0.04	> 0.20	ATXN2 (3.0)	TRIB1 (2.6)	BUD13 (2.6)	NYNRIN (2.5)	CARM1 (2.5)	ATXN7L2 (2.4)	TMEM57 (2.4)	MAPKAPK5 (2.4)	SMARCA4 (2.2)	MAU2 (2.0)
GO:0016798	hydrolase activity, acting on glycosyl bonds	0.04	> 0.20	ERP29 (4.2)	TMED4 (3.5)	ATP13A1 (3.1)	TRAPPC6A (2.8)	SORT1 (2.7)	NKPD1 (2.5)	TM6SF2 (2.4)	NPC1L1 (2.2)	NT5DC1 (2.0)	HNF1A (2.0)
GO:0071222	cellular response to lipopolysaccharide	0.04	> 0.20	PVR (3.6)	LPIN3 (2.5)	PARP10 (2.5)	OASL (2.3)	GRINA (2.2)	DNAH11 (1.8)	CEACAM19 (1.8)	ENSG00000226645 (1.6)	UBXN2B (1.6)	MAFB (1.6)
REACTOME_BMAL1CLOCKNPAS2_ACTIVATES_GENE_EXPRESSION	REACTOME_BMAL1CLOCKNPAS2_ACTIVATES_GENE_EXPRESSION	0.04	> 0.20	ZHX3 (4.1)	TRIB1 (3.5)	C12orf51 (2.4)	GPAM (2.3)	LPIN3 (2.0)	LDLR (2.0)	CILP2 (1.7)	MAFB (1.6)	CYP7A1 (1.5)	USP24 (1.4)
GO:0002237	response to molecule of bacterial origin	0.04	> 0.20	PVR (2.7)	ENSG00000228044 (2.6)	MAFB (2.4)	TRIB1 (2.4)	BCL3 (2.3)	DNAH11 (2.2)	GRINA (2.1)	HLX (2.1)	PARP10 (1.8)	HP (1.8)
GO:0006954	inflammatory response	0.04	> 0.20	TIMD4 (3.1)	MAFB (2.8)	ENSG00000228044 (2.8)	PMFBP1 (2.1)	BCL3 (2.0)	HP (1.9)	HLX (1.7)	C17orf57 (1.7)	SLC22A1 (1.7)	ST3GAL4 (1.6)
GO:0015929	hexosaminidase activity	0.04	> 0.20	ERP29 (4.9)	NKPD1 (3.5)	TRAPPC6A (2.9)	TMED4 (2.6)	ATP13A1 (2.5)	GCNT4 (2.4)	ABCG8 (1.9)	ENSG00000238078 (1.8)	CEACAM19 (1.6)	SORT1 (1.6)
MP:0005027	increased susceptibility to parasitic infection	0.04	> 0.20	RELB (3.2)	BCL3 (2.8)	CETP (2.3)	TIMD4 (2.2)	HLX (1.7)	SLC22A1 (1.5)	PVR (1.4)	PBX4 (1.4)	TRAFD1 (1.3)	PLCG1 (1.3)
MP:0008428	abnormal spatial working memory	0.04	> 0.20	HMGCR (3.7)	FADS1 (3.2)	NCAN (2.9)	APOC1 (2.8)	ABCG5 (2.7)	ENSG00000238078 (2.4)	CELSR2 (2.3)	RPH3A (2.2)	ABCG8 (2.2)	FADS2 (2.0)
ENSG00000077150	NFKB2 PPI subnetwork	0.04	> 0.20	RELB (4.3)	BCL3 (3.7)	PLEC (2.3)	ILF3 (2.1)	SARS (2.0)	NAA25 (1.9)	PVR (1.7)	CLPTM1 (1.7)	USP24 (1.6)	GRINA (1.6)
MP:0005031	abnormal trophoblast layer morphology	0.04	> 0.20	CBLC (2.6)	PTPN11 (2.5)	OGDH (1.9)	PLEC (1.8)	LDLR (1.8)	DHX38 (1.7)	C12orf51 (1.7)	DNM2 (1.7)	ATXN7L2 (1.5)	ABO (1.5)
MP:0006042	increased apoptosis	0.04	> 0.20	ATP13A1 (3.1)	DHX38 (2.8)	GATAD2A (2.6)	SMARCA4 (2.4)	MAU2 (2.3)	TOP1 (2.3)	CARM1 (1.9)	USP1 (1.9)	FEN1 (1.8)	TMEM57 (1.8)
GO:0006897	endocytosis	0.04	> 0.20	TIMD4 (2.6)	DNM2 (2.5)	CETP (2.5)	GRINA (2.5)	MAFB (2.5)	CLPTM1 (2.2)	SH2B3 (2.1)	C12orf51 (2.1)	PPP1R37 (2.0)	ERP29 (1.8)
GO:0010324	membrane invagination	0.04	> 0.20	TIMD4 (2.6)	DNM2 (2.5)	CETP (2.5)	GRINA (2.5)	MAFB (2.5)	CLPTM1 (2.2)	SH2B3 (2.1)	C12orf51 (2.1)	PPP1R37 (2.0)	ERP29 (1.8)
ENSG00000175866	BAIAP2 PPI subnetwork	0.04	> 0.20	CBLC (3.2)	CARM1 (3.1)	ZHX3 (2.6)	PPP1R37 (2.5)	HNF1A (2.5)	AP1M2 (2.4)	MARK4 (2.4)	TSSK6 (2.3)	C11orf9 (2.3)	DNM2 (2.2)
ENSG00000116560	SFPQ PPI subnetwork	0.04	> 0.20	SMARCA4 (3.3)	C1orf63 (3.2)	DHX38 (3.1)	RELB (3.0)	TOP1 (2.9)	ILF3 (2.9)	CLPTM1 (2.7)	BCL3 (2.7)	NT5DC1 (1.9)	DOCK7 (1.7)
GO:0051271	negative regulation of cellular component movement	0.04	> 0.20	PVRL2 (3.0)	CEACAM19 (2.8)	GCNT4 (2.5)	KANK2 (2.5)	ENSG00000254235 (2.4)	CILP2 (2.2)	HLX (2.0)	BCAM (1.8)	PLEKHH2 (1.7)	ENSG00000226645 (1.6)
GO:0006805	xenobiotic metabolic process	0.04	> 0.20	CYP7A1 (5.4)	LPA (4.6)	SLC22A1 (4.3)	ABCG8 (4.1)	TM6SF2 (4.0)	ABCG5 (3.2)	ALDH2 (3.0)	ANGPTL3 (2.8)	APOC4 (2.7)	FRK (2.5)
ENSG00000100380	ST13 PPI subnetwork	0.04	> 0.20	ST3GAL4 (2.9)	HP (2.5)	PLG (2.4)	APOC4 (2.3)	APOC1 (2.3)	CELSR2 (2.1)	ANGPTL3 (2.0)	BRAP (2.0)	PARP10 (2.0)	OASL (1.7)
ENSG00000103502	CDIPT PPI subnetwork	0.04	> 0.20	ABCG8 (3.7)	TMED4 (3.5)	YIPF2 (3.4)	TMEM50A (3.4)	SLC22A1 (3.0)	TM6SF2 (2.6)	ABCG5 (2.3)	CEACAM19 (1.9)	NKPD1 (1.8)	TMEM57 (1.8)
GO:0031418	L-ascorbic acid binding	0.04	> 0.20	PVR (3.1)	ERP29 (2.7)	MYLIP (2.0)	DHODH (1.7)	CETP (1.7)	ZNF180 (1.6)	GOT2P1 (1.6)	ATP13A1 (1.5)	DYNC2LI1 (1.5)	TMED4 (1.5)
KEGG_VEGF_SIGNALING_PATHWAY	KEGG_VEGF_SIGNALING_PATHWAY	0.04	> 0.20	GATAD2A (3.4)	DNM2 (3.0)	MARK4 (2.6)	MYLIP (2.3)	GMIP (2.1)	CYB561D1 (2.0)	SH2B3 (2.0)	PLEC (2.0)	TMEM57 (2.0)	TMEM116 (1.6)
GO:0071466	cellular response to xenobiotic stimulus	0.04	> 0.20	CYP7A1 (5.4)	LPA (4.6)	SLC22A1 (4.2)	ABCG8 (4.0)	TM6SF2 (4.0)	ABCG5 (3.2)	ALDH2 (3.0)	ANGPTL3 (2.8)	APOC4 (2.7)	FRK (2.5)
GO:0009410	response to xenobiotic stimulus	0.04	> 0.20	CYP7A1 (5.4)	LPA (4.6)	SLC22A1 (4.2)	ABCG8 (4.0)	TM6SF2 (4.0)	ABCG5 (3.2)	ALDH2 (3.0)	ANGPTL3 (2.8)	APOC4 (2.7)	FRK (2.5)
ENSG00000119616	FCF1 PPI subnetwork	0.04	> 0.20	DDX56 (4.4)	ZNF259 (4.1)	NAA25 (3.9)	QTRT1 (3.8)	C12orf43 (3.5)	DHODH (3.0)	TOMM40 (2.7)	BRAP (2.0)	SARS (1.9)	PVR (1.8)
GO:0040029	regulation of gene expression, epigenetic	0.04	> 0.20	MAPKAPK5 (2.5)	USP24 (2.2)	MAU2 (2.0)	BUD13 (1.9)	DOCK7 (1.9)	ATXN2 (1.9)	NT5DC1 (1.7)	ZNF180 (1.7)	C17orf57 (1.6)	ILF3 (1.5)
ENSG00000143627	PKLR PPI subnetwork	0.04	> 0.20	SARS (4.0)	PSMA5 (2.7)	OGDH (2.2)	NT5DC1 (2.1)	TOMM40 (2.1)	ALDH2 (2.0)	GPAM (2.0)	FRK (1.9)	NAA25 (1.8)	SYPL2 (1.7)
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	0.04	> 0.20	SYPL2 (5.3)	MOSC1 (3.0)	SORT1 (2.9)	HP (2.9)	DOCK7 (2.7)	GPAM (2.6)	GMPR (2.6)	NT5DC1 (2.2)	LPAR2 (2.1)	DHODH (2.1)
ENSG00000147383	NSDHL PPI subnetwork	0.04	> 0.20	HMGCR (16.7)	LDLR (14.7)	FADS1 (12.2)	FADS2 (10.7)	PCSK9 (9.2)	CYP7A1 (4.0)	GPAM (2.3)	TRAPPC6A (2.1)	NPC1L1 (2.0)	GCNT4 (1.5)
ENSG00000039987	BEST2 PPI subnetwork	0.04	> 0.20	ATP13A1 (4.5)	HNF1A (2.9)	MAPKAPK5 (2.7)	DDX56 (2.6)	PTPN11 (2.3)	BRAP (2.2)	TOMM40 (2.2)	MAU2 (2.2)	GATAD2A (2.1)	DHODH (2.0)
ENSG00000151276	MAGI1 PPI subnetwork	0.04	> 0.20	PVRL2 (3.3)	FRK (3.2)	BCAM (2.8)	AP1M2 (2.7)	SYPL2 (2.5)	CARM1 (2.1)	GCNT4 (1.8)	CELSR2 (1.8)	OGDH (1.7)	HAVCR1 (1.7)
ENSG00000197621	ENSG00000197621 PPI subnetwork	0.04	> 0.20	HP (3.7)	APOB (3.1)	FRK (2.7)	NPC1L1 (2.5)	HAVCR1 (2.3)	GMPR (2.3)	APOE (2.1)	APOA5 (2.1)	CELSR2 (2.1)	BRAP (2.0)
MP:0001712	abnormal placenta development	0.04	> 0.20	MYLIP (2.5)	AP1M2 (2.1)	HLX (1.9)	CBLC (1.9)	LPAR2 (1.8)	DHX38 (1.7)	ATXN7L2 (1.7)	LPIN3 (1.7)	DNM2 (1.7)	PVRL2 (1.5)
ENSG00000110958	PTGES3 PPI subnetwork	0.04	> 0.20	PARP10 (2.9)	TRIB1 (2.5)	CYP7A1 (2.2)	GOT2P1 (2.0)	AP1M2 (2.0)	ENSG00000254235 (2.0)	YIPF2 (1.9)	GRINA (1.9)	HAPLN4 (1.8)	ZNF101 (1.7)
MP:0002962	increased urine protein level	0.04	> 0.20	BCAM (4.5)	PVR (3.2)	PVRL2 (2.7)	NT5DC1 (2.6)	C11orf9 (2.2)	PLEKHH2 (2.2)	POLK (2.0)	PLEC (2.0)	MAFB (1.6)	CEACAM19 (1.6)
GO:0032677	regulation of interleukin-8 production	0.04	> 0.20	HP (2.2)	PVR (1.9)	HLX (1.8)	ENSG00000228044 (1.7)	ST3GAL4 (1.7)	ZNF180 (1.7)	TIMD4 (1.6)	SH2B3 (1.6)	DNAH11 (1.6)	FRK (1.5)
ENSG00000102900	NUP93 PPI subnetwork	0.04	> 0.20	POC5 (3.2)	DDX56 (2.9)	CARM1 (2.9)	NAA25 (2.8)	USP1 (2.8)	TOMM40 (2.7)	USP24 (2.3)	MAPKAPK5 (2.2)	FEN1 (1.9)	ENSG00000226648 (1.9)
GO:0031347	regulation of defense response	0.04	> 0.20	PARP10 (3.3)	OASL (3.1)	ENSG00000228044 (2.9)	SH2B3 (2.6)	BCL3 (2.3)	TRAFD1 (2.2)	ZNF101 (2.1)	GMIP (2.0)	TIMD4 (2.0)	RELB (1.9)
GO:0016485	protein processing	0.04	> 0.20	ENSG00000254235 (3.1)	KIAA1324 (3.0)	CEACAM19 (2.9)	TMED4 (2.5)	ENSG00000238078 (2.3)	YIPF2 (2.0)	DYNC2LI1 (1.8)	GCNT4 (1.7)	CYB561D1 (1.6)	ENSG00000228044 (1.4)
ENSG00000138363	ATIC PPI subnetwork	0.04	> 0.20	FADS1 (3.4)	FADS2 (3.1)	C19orf52 (2.4)	ST3GAL4 (2.3)	NT5DC1 (2.2)	FRK (2.2)	SARS (2.1)	ENSG00000238078 (2.1)	C12orf47 (2.0)	GMIP (1.9)
ENSG00000064547	LPAR2 PPI subnetwork	0.04	> 0.20	USP24 (2.9)	PARP10 (2.6)	POLK (2.2)	BCL3 (2.1)	MARK4 (2.1)	MAU2 (2.1)	SMARCA4 (2.0)	ZNF180 (1.9)	ATXN2 (1.9)	PPP1R37 (1.8)
MP:0011101	partial prenatal lethality	0.04	> 0.20	LDLR (2.7)	OGDH (2.6)	PLEKHH2 (2.6)	BCAM (2.4)	CILP2 (2.4)	HMGCR (2.2)	NYNRIN (2.1)	PCSK9 (2.1)	KANK2 (1.9)	GATAD2A (1.7)
ENSG00000072694	FCGR2B PPI subnetwork	0.04	> 0.20	PLG (2.7)	APOA5 (2.3)	LPA (2.3)	APOC4 (2.2)	HP (2.2)	ANGPTL3 (2.0)	GMIP (2.0)	SLC22A1 (2.0)	SLC44A2 (1.5)	MOSC1 (1.5)
GO:0010745	negative regulation of macrophage derived foam cell differentiation	0.04	> 0.20	TIMD4 (4.4)	APOE (2.6)	ENSG00000238078 (2.6)	GEMIN7 (2.5)	C17orf57 (2.3)	MYLIP (2.3)	MOSC1 (2.2)	APOC1 (2.2)	PBX4 (2.2)	CETP (1.9)
GO:0042301	phosphate ion binding	0.04	> 0.20	TM6SF2 (3.8)	LPA (3.8)	ABCG5 (3.8)	NPC1L1 (3.6)	ABCG8 (2.6)	TMEM50A (2.5)	HAPLN4 (2.4)	PLG (2.3)	GCNT4 (2.2)	ALDH2 (2.2)
GO:0019835	cytolysis	0.04	> 0.20	LPA (5.1)	SLC22A1 (3.3)	APOC4 (2.8)	ZNF101 (2.2)	ANGPTL3 (2.2)	APOA5 (2.2)	ABCG5 (2.1)	DHODH (2.0)	TMEM116 (2.0)	PLG (1.9)
ENSG00000185637	ENSG00000185637 PPI subnetwork	0.04	> 0.20	PSMA5 (3.6)	SMARCA4 (2.6)	SARS (2.3)	TOMM40 (2.0)	NAA25 (2.0)	SUGP1 (1.9)	C11orf9 (1.8)	ANGPTL3 (1.8)	FEN1 (1.6)	DDX56 (1.6)
ENSG00000171150	SOCS5 PPI subnetwork	0.04	> 0.20	BCL3 (4.4)	PARP10 (2.8)	GMIP (2.8)	PLEKHH2 (2.8)	HLX (2.6)	RELB (2.6)	TRIB1 (2.2)	CETP (2.0)	ZNF101 (2.0)	PBX4 (1.9)
ENSG00000211677	ENSG00000211677 PPI subnetwork	0.04	> 0.20	APOE (5.2)	TIMD4 (4.3)	APOC1 (3.7)	MAFB (3.2)	CETP (2.6)	GPAM (2.1)	KANK2 (1.9)	PCSK9 (1.9)	DYNC2LI1 (1.9)	SLC22A1 (1.9)
ENSG00000211679	ENSG00000211679 PPI subnetwork	0.04	> 0.20	APOE (5.2)	TIMD4 (4.3)	APOC1 (3.7)	MAFB (3.2)	CETP (2.6)	GPAM (2.1)	KANK2 (1.9)	PCSK9 (1.9)	DYNC2LI1 (1.9)	SLC22A1 (1.9)
MP:0004502	decreased incidence of chemically-induced tumors	0.04	> 0.20	PVRL2 (3.9)	BCL3 (3.2)	HLX (2.5)	PVR (2.1)	HP (2.0)	SLC22A1 (1.9)	RELB (1.8)	TRAPPC6A (1.7)	PLEKHH2 (1.7)	C11orf9 (1.6)
ENSG00000074370	ATP2A3 PPI subnetwork	0.04	> 0.20	FRK (3.4)	AP1M2 (3.1)	CBLC (2.9)	HNF1A (2.7)	C12orf47 (2.0)	DHX38 (1.9)	ENSG00000238078 (1.8)	NT5DC1 (1.6)	MYLIP (1.6)	KIAA1324 (1.5)
GO:0009251	glucan catabolic process	0.04	> 0.20	SYPL2 (3.3)	ENSG00000235545 (2.8)	AMIGO1 (2.5)	SORT1 (2.5)	ST3GAL4 (2.3)	ABCG8 (2.0)	ABCG5 (2.0)	ZHX3 (1.9)	ZNF101 (1.9)	HAPLN4 (1.8)
GO:0044247	cellular polysaccharide catabolic process	0.04	> 0.20	SYPL2 (3.3)	ENSG00000235545 (2.8)	AMIGO1 (2.5)	SORT1 (2.5)	ST3GAL4 (2.3)	ABCG8 (2.0)	ABCG5 (2.0)	ZHX3 (1.9)	ZNF101 (1.9)	HAPLN4 (1.8)
ENSG00000140795	MYLK3 PPI subnetwork	0.04	> 0.20	APOB (7.1)	APOC1 (3.9)	PLG (3.6)	NPC1L1 (3.4)	ABCG5 (3.4)	APOA5 (3.2)	HP (2.5)	ANGPTL3 (2.4)	APOC4 (2.4)	GPAM (2.3)
GO:0042730	fibrinolysis	0.04	> 0.20	ANGPTL3 (4.1)	APOC4 (3.3)	PLG (3.1)	SLC22A1 (2.8)	CEACAM19 (2.8)	APOA5 (2.8)	ENSG00000228044 (2.7)	PCSK9 (2.6)	HP (2.6)	CYP7A1 (2.6)
ENSG00000124788	ATXN1 PPI subnetwork	0.04	> 0.20	TRAFD1 (2.8)	GRINA (2.7)	FADS2 (2.7)	LDLR (2.7)	FADS1 (2.5)	RPH3A (2.5)	C12orf51 (2.5)	BUD13 (2.5)	CLPTM1 (2.4)	ATXN7L2 (2.3)
MP:0000523	cortical renal glomerulopathies	0.04	> 0.20	POLK (2.8)	MOSC1 (2.7)	ALDH2 (2.3)	KANK2 (2.3)	GRINA (1.9)	GPAM (1.8)	GCNT4 (1.8)	PLEKHH2 (1.6)	BLOC1S3 (1.4)	TSSK6 (1.4)
ENSG00000101182	PSMA7 PPI subnetwork	0.04	> 0.20	PSMA5 (5.2)	NAA25 (3.3)	DDX56 (3.0)	TOMM40 (2.5)	SARS (2.4)	TRAFD1 (2.3)	NT5DC1 (2.2)	HMGCR (2.1)	ZNF259 (2.1)	SUGP1 (1.9)
ENSG00000078401	EDN1 PPI subnetwork	0.04	> 0.20	RHCE (3.3)	CETP (3.1)	KANK2 (2.7)	RHD (2.7)	ATXN7L2 (2.4)	APOE (1.6)	ANKRD31 (1.6)	ENSG00000228044 (1.6)	SUGP1 (1.6)	ZNF259 (1.4)
MP:0006043	decreased apoptosis	0.04	> 0.20	PARP10 (3.6)	MAFB (2.2)	ADAM1 (2.2)	TRAFD1 (2.1)	POLK (2.1)	SH2B3 (2.0)	HLX (1.9)	FRK (1.8)	TRAPPC6A (1.7)	SARS (1.5)
ENSG00000105972	ENSG00000105972 PPI subnetwork	0.04	> 0.20	GRINA (3.3)	YIPF2 (2.3)	TXNL4B (2.2)	PSRC1 (2.1)	QTRT1 (2.1)	CARM1 (2.1)	DNM2 (2.0)	SLC22A1 (2.0)	UBXN2B (1.9)	CLPTM1 (1.8)
GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	0.04	> 0.20	PPP1R37 (3.4)	YIPF2 (2.9)	SARS (2.6)	BLOC1S3 (2.6)	ERP29 (2.3)	LPAR2 (2.0)	DNAH11 (1.9)	ENSG00000226648 (1.7)	FRK (1.6)	CARM1 (1.6)
ENSG00000164077	MON1A PPI subnetwork	0.04	> 0.20	ITGB3 (4.2)	RHD (3.6)	ZNF259 (3.3)	CLPTM1 (2.6)	GEMIN7 (2.5)	SARS (2.3)	RHCE (2.3)	C12orf43 (2.3)	C12orf51 (2.2)	BRAP (2.0)
KEGG_THYROID_CANCER	KEGG_THYROID_CANCER	0.04	> 0.20	PLEC (3.0)	MAFB (2.0)	ENSG00000238078 (2.0)	AMIGO1 (1.9)	CARM1 (1.9)	CELSR2 (1.8)	DNM2 (1.8)	GRINA (1.8)	LPIN3 (1.7)	AP1M2 (1.7)
ENSG00000161204	ABCF3 PPI subnetwork	0.04	> 0.20	NAA25 (3.6)	BRAP (2.8)	GPAM (2.7)	NT5DC1 (2.2)	ILF3 (2.2)	OGDH (2.2)	TMEM116 (2.1)	SARS (2.1)	POC5 (2.1)	CYP7A1 (2.0)
ENSG00000196700	ZNF512B PPI subnetwork	0.04	> 0.20	DHX38 (3.5)	ANKRD31 (2.3)	BCAM (2.2)	C12orf47 (2.1)	PLCG1 (2.1)	ATXN2 (2.1)	BRAP (2.0)	DOCK7 (1.9)	SMARCA4 (1.9)	PPP1R37 (1.8)
ENSG00000182973	CNOT10 PPI subnetwork	0.04	> 0.20	BLOC1S3 (3.3)	TMEM116 (3.1)	BRAP (2.8)	TMEM50A (2.4)	ST3GAL4 (2.1)	TOMM40 (1.9)	GCNT4 (1.8)	ATP13A1 (1.8)	TRAPPC6A (1.8)	CLPTM1 (1.7)
ENSG00000125733	TRIP10 PPI subnetwork	0.04	> 0.20	ATXN2 (2.7)	LPIN3 (2.6)	GOT2P1 (2.5)	C12orf51 (2.3)	ENSG00000238078 (2.2)	DOCK7 (2.1)	UBXN2B (2.0)	NT5DC1 (1.8)	SLC44A2 (1.8)	AP1M2 (1.6)
ENSG00000196504	PRPF40A PPI subnetwork	0.04	> 0.20	DHX38 (4.1)	ATXN2 (3.9)	SMARCA4 (3.7)	ILF3 (3.3)	BRAP (3.1)	TOP1 (2.9)	NAA25 (2.5)	DNM2 (2.5)	ATP13A1 (2.4)	BUD13 (2.3)
ENSG00000144158	ENSG00000144158 PPI subnetwork	0.04	> 0.20	SUGP1 (4.6)	DHX38 (4.4)	BUD13 (3.2)	MAU2 (3.0)	SMARCA4 (3.0)	DDX56 (2.5)	BRAP (2.4)	ZNF259 (2.4)	ILF3 (2.2)	QTRT1 (2.1)
MP:0008706	decreased interleukin-6 secretion	0.04	> 0.20	BCL3 (4.0)	PARP10 (3.9)	RELB (3.7)	OASL (3.5)	MAFB (3.0)	CETP (2.5)	TRIB1 (2.4)	GMIP (2.2)	TRAFD1 (2.0)	PVR (1.7)
ENSG00000211893	ENSG00000211893 PPI subnetwork	0.04	> 0.20	APOB (5.8)	APOE (4.7)	APOA5 (4.4)	PLG (3.9)	APOC4 (3.5)	PCSK9 (3.5)	HP (3.3)	APOC1 (3.3)	ANGPTL3 (3.0)	NPC1L1 (2.8)
ENSG00000130803	ZNF317 PPI subnetwork	0.04	> 0.20	DHX38 (2.1)	PARP10 (2.0)	SUGP1 (2.0)	OASL (2.0)	C19orf52 (1.9)	QTRT1 (1.9)	GRINA (1.9)	SORT1 (1.7)	AMIGO1 (1.7)	YIPF2 (1.6)
GO:0019430	removal of superoxide radicals	0.04	> 0.20	RHCE (2.6)	RHD (2.6)	TMEM116 (2.4)	GOT2P1 (2.2)	PBX4 (2.1)	ANKRD31 (2.1)	TXNL4B (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.8)	LPAR2 (1.7)
GO:0071450	cellular response to oxygen radical	0.04	> 0.20	RHCE (2.6)	RHD (2.6)	TMEM116 (2.4)	GOT2P1 (2.2)	PBX4 (2.1)	ANKRD31 (2.1)	TXNL4B (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.8)	LPAR2 (1.7)
GO:0071451	cellular response to superoxide	0.04	> 0.20	RHCE (2.6)	RHD (2.6)	TMEM116 (2.4)	GOT2P1 (2.2)	PBX4 (2.1)	ANKRD31 (2.1)	TXNL4B (1.9)	PMFBP1 (1.8)	ENSG00000235545 (1.8)	LPAR2 (1.7)
ENSG00000075673	ATP12A PPI subnetwork	0.04	> 0.20	ACAD10 (4.0)	NT5DC1 (3.0)	HNF1A (2.4)	C1orf63 (2.0)	TRAPPC6A (1.8)	TMED4 (1.7)	GMPR (1.7)	PCSK9 (1.6)	CETP (1.5)	KIAA1324 (1.5)
ENSG00000140678	ITGAX PPI subnetwork	0.04	> 0.20	APOB (6.5)	HP (5.9)	ANGPTL3 (4.5)	APOA5 (4.4)	APOC1 (4.4)	PLG (4.4)	APOE (4.3)	APOC4 (3.4)	HAVCR1 (3.1)	ENSG00000235545 (2.2)
ENSG00000173545	ZNF622 PPI subnetwork	0.04	> 0.20	ZNF259 (5.4)	NAA25 (4.5)	DDX56 (3.8)	QTRT1 (3.7)	TOMM40 (3.5)	DHODH (3.0)	MAPKAPK5 (2.8)	ENSG00000226645 (2.4)	SUGP1 (2.2)	C12orf43 (2.1)
MP:0008410	increased cellular sensitivity to ultraviolet irradiation	0.04	> 0.20	MAU2 (2.6)	SUGP1 (2.4)	POC5 (2.2)	MYLIP (1.9)	GCNT4 (1.9)	MAPKAPK5 (1.8)	UBXN2B (1.8)	TRAPPC6A (1.7)	POLK (1.7)	NYNRIN (1.7)
ENSG00000106628	POLD2 PPI subnetwork	0.04	> 0.20	FEN1 (4.6)	USP1 (3.6)	SLC22A1 (2.2)	PLG (2.1)	APOC4 (2.1)	ANGPTL3 (2.1)	LPA (2.0)	ENSG00000235545 (2.0)	GOT2P1 (1.7)	TXNL4B (1.5)
ENSG00000153046	CDYL PPI subnetwork	0.04	> 0.20	C19orf52 (2.7)	TMEM57 (2.6)	MYLIP (2.4)	CARM1 (2.2)	MARK4 (2.1)	GATAD2A (1.7)	BUD13 (1.7)	GRINA (1.6)	ST3GAL4 (1.5)	USP24 (1.5)
ENSG00000163785	RYK PPI subnetwork	0.04	> 0.20	CBLC (2.6)	TRAPPC6A (2.4)	C1orf63 (2.2)	HNF1A (2.2)	ANKRD31 (2.1)	ERP29 (2.1)	AP1M2 (2.0)	ATXN2 (1.7)	SORT1 (1.6)	MYLIP (1.5)
ENSG00000148719	DNAJB12 PPI subnetwork	0.04	> 0.20	ACAD10 (4.3)	NT5DC1 (2.9)	HNF1A (2.8)	TMED4 (2.7)	OGDH (2.1)	TRAPPC6A (2.0)	GMPR (2.0)	TIMD4 (1.9)	PLEKHH2 (1.9)	CETP (1.8)
ENSG00000126562	WNK4 PPI subnetwork	0.04	> 0.20	CBLC (3.9)	USP24 (3.5)	AP1M2 (3.0)	PARP10 (2.9)	GMIP (2.3)	ATXN2 (2.2)	SMARCA4 (1.9)	BCL3 (1.9)	MAU2 (1.8)	PBX4 (1.8)
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU:RICH_ELEMENTS	REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU:RICH_ELEMENTS	0.04	> 0.20	PSMA5 (5.2)	TRAFD1 (3.1)	NAA25 (2.9)	TOMM40 (2.8)	NT5DC1 (2.6)	DDX56 (2.2)	TMEM50A (2.1)	PARP10 (1.8)	SMARCA4 (1.8)	SUGP1 (1.7)
MP:0008561	decreased tumor necrosis factor secretion	0.04	> 0.20	MAFB (3.7)	CETP (3.2)	RELB (3.0)	BCL3 (3.0)	TIMD4 (2.6)	GMIP (2.3)	SH2B3 (2.2)	OASL (2.1)	APOE (1.9)	APOC1 (1.8)
MP:0003542	abnormal vascular endothelial cell development	0.04	> 0.20	SH2B3 (4.3)	SLC44A2 (2.4)	ZHX3 (2.4)	NCAN (2.2)	HLX (2.1)	ENSG00000226648 (2.0)	OGDH (2.0)	TMEM57 (2.0)	ITGB3 (1.9)	MAFB (1.8)
GO:0016877	ligase activity, forming carbon-sulfur bonds	0.04	> 0.20	HMGCR (5.8)	FADS1 (5.1)	FADS2 (5.0)	LDLR (4.7)	GPAM (4.4)	PCSK9 (4.3)	MOSC1 (3.5)	ACAD10 (3.0)	APOC1 (2.2)	PLG (2.1)
ENSG00000163879	DNALI1 PPI subnetwork	0.04	> 0.20	TXNL4B (3.2)	BLOC1S3 (3.0)	GEMIN7 (2.5)	TRAPPC6A (2.3)	TOP1 (2.3)	BRAP (2.2)	TRAFD1 (2.0)	ZNF180 (2.0)	FRK (1.9)	C19orf52 (1.8)
ENSG00000119285	HEATR1 PPI subnetwork	0.04	> 0.20	ZNF259 (5.2)	DDX56 (4.8)	NAA25 (4.5)	TOMM40 (4.1)	QTRT1 (3.9)	DHODH (3.5)	DHX38 (2.6)	ATP13A1 (2.6)	SUGP1 (2.3)	GATAD2A (2.0)
ENSG00000173406	DAB1 PPI subnetwork	0.04	> 0.20	HMGCR (3.1)	C11orf9 (2.8)	GATAD2A (2.6)	SORT1 (2.4)	SLC44A2 (2.4)	PLEC (2.2)	FADS2 (2.2)	FADS1 (2.2)	ENSG00000228044 (2.1)	PCSK9 (2.1)
ENSG00000149177	PTPRJ PPI subnetwork	0.04	> 0.20	HAVCR1 (3.3)	ENSG00000226648 (3.1)	LPIN3 (2.9)	ZHX3 (2.5)	MAFB (2.3)	C11orf9 (2.0)	APOE (1.9)	DDX56 (1.9)	PLEC (1.8)	PLCG1 (1.8)
ENSG00000133027	PEMT PPI subnetwork	0.04	> 0.20	TMEM50A (3.4)	TMED4 (3.1)	CLPTM1 (2.9)	TM6SF2 (2.9)	ERP29 (2.7)	SLC22A1 (2.5)	NPC1L1 (2.5)	TMEM57 (2.4)	YIPF2 (2.2)	LPA (2.2)
ENSG00000113407	TARS PPI subnetwork	0.04	> 0.20	SARS (4.3)	SUGP1 (3.3)	BRAP (3.0)	PSMA5 (2.9)	DDX56 (2.7)	ZNF259 (2.4)	NAA25 (2.4)	TOMM40 (2.3)	CBLC (2.1)	NT5DC1 (2.0)
ENSG00000110799	VWF PPI subnetwork	0.04	> 0.20	ITGB3 (8.4)	CETP (4.4)	GMPR (3.1)	TIMD4 (2.8)	ERP29 (2.5)	YIPF2 (2.2)	MOSC1 (2.0)	RHD (1.8)	CYP7A1 (1.7)	TMED4 (1.6)
GO:0001666	response to hypoxia	0.04	> 0.20	DNAH11 (2.6)	POLK (1.9)	PVR (1.8)	CETP (1.5)	FRK (1.4)	LPIN3 (1.4)	NT5DC1 (1.4)	ENSG00000238078 (1.3)	RHD (1.3)	RHCE (1.2)
ENSG00000100726	TELO2 PPI subnetwork	0.04	> 0.20	C19orf52 (2.5)	GPAM (2.4)	ENSG00000226645 (2.0)	SUGP1 (2.0)	TRAPPC6A (1.9)	DHX38 (1.9)	USP24 (1.8)	DHODH (1.7)	YIPF2 (1.6)	MAU2 (1.6)
MP:0000611	jaundice	0.04	> 0.20	RHCE (10.1)	RHD (10.0)	GMPR (3.6)	C12orf51 (3.3)	ACAD10 (2.2)	ABO (1.9)	CYP7A1 (1.8)	USP24 (1.6)	KANK2 (1.4)	ENSG00000228044 (1.4)
MP:0001869	pancreas inflammation	0.04	> 0.20	LPA (3.5)	GEMIN7 (2.5)	C17orf57 (2.4)	PLEKHH2 (1.9)	SLC22A1 (1.9)	BCL3 (1.9)	RELB (1.8)	SH2B3 (1.8)	TIMD4 (1.8)	APOA5 (1.7)
ENSG00000111859	NEDD9 PPI subnetwork	0.04	> 0.20	SH2B3 (3.1)	SLC44A2 (2.8)	DNM2 (2.7)	ABO (2.6)	PLEC (2.4)	GMIP (2.2)	MAPKAPK5 (2.2)	PLCG1 (2.1)	GATAD2A (2.0)	KANK2 (2.0)
ENSG00000165156	ZHX1 PPI subnetwork	0.04	> 0.20	ILF3 (2.3)	TOP1 (2.3)	ITGB3 (2.2)	FADS2 (2.2)	GMPR (2.2)	BUD13 (2.1)	UBXN2B (1.9)	TXNL4B (1.9)	GRINA (1.8)	PSMA5 (1.8)
ENSG00000196497	IPO4 PPI subnetwork	0.04	> 0.20	NAA25 (3.6)	PSMA5 (3.4)	DDX56 (3.3)	TOMM40 (2.9)	SARS (2.8)	NT5DC1 (2.5)	SUGP1 (2.1)	SMARCA4 (2.1)	ZNF259 (2.1)	OGDH (1.9)
GO:0030863	cortical cytoskeleton	0.04	> 0.20	RHD (4.7)	RHCE (4.6)	GMPR (3.6)	C12orf51 (2.9)	ENSG00000238078 (2.5)	KANK2 (2.1)	ITGB3 (1.9)	PMFBP1 (1.9)	BCAM (1.8)	PLCG1 (1.8)
ENSG00000150337	FCGR1A PPI subnetwork	0.04	> 0.20	PLG (5.9)	ANGPTL3 (5.5)	APOC4 (5.2)	HP (4.5)	APOA5 (4.2)	LPA (3.4)	SLC22A1 (2.9)	ABCG5 (2.6)	MAFB (2.0)	DHODH (1.9)
ENSG00000080824	HSP90AA1 PPI subnetwork	0.04	> 0.20	BCL3 (3.4)	RELB (3.2)	OGDH (2.8)	GOT2P1 (2.7)	SARS (2.6)	GRINA (2.5)	PLEC (2.4)	NAA25 (2.2)	TOMM40 (2.2)	DHX38 (2.0)
ENSG00000105063	PPP6R1 PPI subnetwork	0.04	> 0.20	TOMM40 (3.2)	RELB (2.9)	NAA25 (2.3)	C19orf52 (2.2)	ATP13A1 (2.1)	PPP1R37 (2.1)	POC5 (2.1)	NT5DC1 (2.0)	USP24 (1.9)	PTPN11 (1.9)
ENSG00000157106	SMG1 PPI subnetwork	0.04	> 0.20	USP24 (4.3)	DHODH (3.7)	CARM1 (3.1)	C12orf51 (2.7)	SMARCA4 (2.2)	SUGP1 (2.1)	PVRL2 (2.1)	MAU2 (1.9)	NYNRIN (1.8)	ILF3 (1.8)
MP:0005564	increased hemoglobin content	0.04	> 0.20	RHCE (3.6)	RHD (3.3)	CETP (2.2)	SLC44A2 (2.1)	FRK (2.0)	ANGPTL3 (1.8)	ABO (1.8)	PCSK9 (1.6)	MAU2 (1.5)	ENSG00000226648 (1.4)
GO:0006720	isoprenoid metabolic process	0.04	> 0.20	PCSK9 (5.1)	FADS2 (4.6)	FADS1 (4.5)	LDLR (4.4)	HMGCR (4.4)	CYP7A1 (3.7)	LPA (3.2)	NPC1L1 (3.1)	TM6SF2 (2.6)	ABCG8 (2.5)
ENSG00000088205	DDX18 PPI subnetwork	0.04	> 0.20	ZNF259 (5.1)	NAA25 (4.7)	DDX56 (4.4)	TOMM40 (4.3)	DHODH (3.7)	QTRT1 (3.6)	DHX38 (2.9)	ATP13A1 (2.5)	SARS (2.3)	C12orf43 (2.1)
MP:0011405	tubulointerstitial nephritis	0.04	> 0.20	BCAM (4.6)	GRINA (3.3)	TMED4 (2.8)	NPC1L1 (2.6)	GMPR (2.6)	HNF1A (2.6)	ABCG5 (2.6)	PVR (2.3)	NT5DC1 (2.2)	NYNRIN (2.2)
MP:0004808	abnormal hematopoietic stem cell morphology	0.04	> 0.20	KANK2 (3.1)	TIMD4 (2.8)	TRIB1 (2.7)	UBXN2B (2.7)	ATXN2 (2.6)	HNF1A (2.5)	PARP10 (2.0)	GRINA (2.0)	CETP (1.9)	C12orf51 (1.9)
ENSG00000185627	PSMD13 PPI subnetwork	0.04	> 0.20	PSMA5 (5.3)	NAA25 (2.8)	SARS (2.7)	NT5DC1 (2.6)	TOMM40 (2.6)	TRAFD1 (2.1)	ENSG00000254235 (1.8)	SMARCA4 (1.7)	DDX56 (1.6)	PTPN11 (1.4)
ENSG00000113387	SUB1 PPI subnetwork	0.04	> 0.20	BUD13 (3.0)	C12orf47 (2.5)	TMED4 (2.1)	TOP1 (1.9)	PLEC (1.7)	MARK4 (1.6)	ATXN7L2 (1.6)	OGDH (1.5)	POC5 (1.5)	TRIB1 (1.5)
MP:0008734	decreased susceptibility to endotoxin shock	0.04	> 0.20	BCL3 (4.8)	RELB (4.3)	PVR (3.2)	MAFB (3.1)	HP (2.7)	TIMD4 (2.7)	CETP (2.5)	ST3GAL4 (2.3)	TRIB1 (2.2)	ENSG00000228044 (1.9)
GO:0044241	lipid digestion	0.04	> 0.20	NPC1L1 (7.2)	ABCG8 (5.3)	ABCG5 (4.2)	TM6SF2 (4.0)	APOB (2.9)	GCNT4 (2.0)	APOA5 (1.8)	FRK (1.7)	ADAM1 (1.6)	CBLC (1.5)
ENSG00000206324	AGPAT1 PPI subnetwork	0.04	> 0.20	HMGCR (3.7)	USP24 (3.1)	TMEM57 (2.6)	LDLR (2.5)	CYP7A1 (2.3)	SARS (2.3)	OGDH (2.3)	BRAP (2.2)	NAA25 (2.2)	FADS1 (2.0)
ENSG00000206255	ENSG00000206255 PPI subnetwork	0.04	> 0.20	HMGCR (3.7)	USP24 (3.1)	TMEM57 (2.6)	LDLR (2.5)	CYP7A1 (2.3)	SARS (2.3)	OGDH (2.3)	BRAP (2.2)	NAA25 (2.2)	FADS1 (2.0)
ENSG00000204310	AGPAT1 PPI subnetwork	0.04	> 0.20	HMGCR (3.7)	USP24 (3.1)	TMEM57 (2.6)	LDLR (2.5)	CYP7A1 (2.3)	SARS (2.3)	OGDH (2.3)	BRAP (2.2)	NAA25 (2.2)	FADS1 (2.0)
MP:0002358	abnormal spleen periarteriolar lymphoid sheath morphology	0.04	> 0.20	RELB (4.2)	ZNF101 (3.5)	BCL3 (3.1)	GMIP (2.7)	CYB561D1 (2.0)	GRINA (1.8)	TIMD4 (1.8)	SLC44A2 (1.8)	ITGB3 (1.8)	PLCG1 (1.7)
GO:0016893	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	0.04	> 0.20	ZNF180 (3.0)	C12orf43 (2.4)	LPA (2.2)	CETP (1.8)	BUD13 (1.7)	DHODH (1.7)	GEMIN7 (1.6)	FEN1 (1.6)	DDX56 (1.6)	LPAR2 (1.6)
MP:0003849	greasy coat	0.04	> 0.20	APOA5 (4.0)	LPA (4.0)	APOC4 (3.7)	ENSG00000254235 (3.5)	TRAPPC6A (2.1)	PLG (2.0)	SLC22A1 (2.0)	AMIGO1 (1.8)	BLOC1S3 (1.7)	HP (1.5)
MP:0005558	decreased creatinine clearance	0.04	> 0.20	PLG (4.4)	ANGPTL3 (3.2)	ANKRD31 (2.9)	APOA5 (2.6)	ENSG00000228044 (2.3)	BCAM (2.3)	GRINA (2.3)	APOC4 (2.2)	ZHX3 (2.2)	TXNL4B (1.9)
ENSG00000103342	GSPT1 PPI subnetwork	0.04	> 0.20	TXNL4B (3.3)	TOP1 (3.2)	BRAP (3.1)	GATAD2A (2.7)	PTPN11 (2.2)	C12orf43 (2.2)	ACAD10 (2.2)	RELB (2.1)	TRAFD1 (2.0)	NCAN (2.0)
MP:0001601	abnormal myelopoiesis	0.04	> 0.20	GMIP (3.2)	RHCE (3.1)	BCL3 (2.5)	HLX (2.4)	RHD (2.3)	HP (2.3)	TRIB1 (2.2)	PARP10 (1.9)	GOT2P1 (1.8)	TIMD4 (1.6)
GO:0007569	cell aging	0.04	> 0.20	POLK (2.8)	CARM1 (2.1)	GOT2P1 (1.9)	BLOC1S3 (1.9)	TRAPPC6A (1.6)	ENSG00000226648 (1.6)	CEACAM19 (1.5)	PLEC (1.5)	PARP10 (1.5)	KANK2 (1.4)
ENSG00000105248	CCDC94 PPI subnetwork	0.04	> 0.20	DHX38 (3.4)	ZNF259 (3.4)	BUD13 (3.1)	SARS (2.5)	POC5 (2.5)	SUGP1 (2.4)	QTRT1 (2.4)	BRAP (2.4)	SMARCA4 (2.0)	USP24 (1.9)
ENSG00000078808	SDF4 PPI subnetwork	0.04	> 0.20	ACAD10 (3.9)	NT5DC1 (3.2)	TMED4 (2.6)	HNF1A (2.1)	GMPR (1.9)	TRAPPC6A (1.9)	PLEKHH2 (1.8)	TIMD4 (1.6)	PCSK9 (1.6)	GCNT4 (1.6)
GO:0031593	polyubiquitin binding	0.05	> 0.20	GRINA (3.6)	HAVCR1 (2.4)	NT5DC1 (2.3)	GMPR (2.3)	YIPF2 (2.2)	CARM1 (2.1)	MAU2 (2.0)	SLC22A1 (1.8)	SUGP1 (1.7)	LPAR2 (1.6)
ENSG00000113595	TRIM23 PPI subnetwork	0.05	> 0.20	MYLIP (2.9)	GCNT4 (2.5)	CBLC (2.4)	BLOC1S3 (2.3)	GEMIN7 (2.2)	TRAPPC6A (2.0)	C17orf57 (2.0)	ZNF180 (2.0)	TMEM57 (1.7)	NKPD1 (1.4)
ENSG00000123838	C4BPA PPI subnetwork	0.05	> 0.20	APOC4 (3.1)	APOA5 (3.1)	ANGPTL3 (3.0)	ABCG5 (2.4)	ENSG00000254235 (2.4)	C11orf9 (2.2)	ABCG8 (2.2)	FRK (2.1)	NKPD1 (1.8)	ZNF259 (1.7)
ENSG00000160049	DFFA PPI subnetwork	0.05	> 0.20	CYB561D1 (2.5)	CBLC (2.4)	UBXN2B (2.1)	ST3GAL4 (1.9)	ABO (1.6)	TM6SF2 (1.5)	C1orf63 (1.5)	ENSG00000254235 (1.4)	DNM2 (1.3)	ABCG8 (1.3)
MP:0000219	increased neutrophil cell number	0.05	> 0.20	GMIP (4.3)	BCL3 (4.3)	RELB (3.0)	ITGB3 (2.6)	SLC44A2 (2.6)	DNM2 (2.0)	SH2B3 (2.0)	CETP (1.9)	PLEC (1.9)	ST3GAL4 (1.9)
ENSG00000105373	GLTSCR2 PPI subnetwork	0.05	> 0.20	NAA25 (3.4)	USP24 (2.9)	DHODH (2.8)	ZNF259 (2.6)	DHX38 (2.2)	DDX56 (2.0)	GCNT4 (2.0)	ABCG5 (2.0)	POC5 (1.9)	NPC1L1 (1.7)
ENSG00000160094	ZNF362 PPI subnetwork	0.05	> 0.20	DHX38 (2.5)	C19orf52 (2.4)	SUGP1 (2.2)	QTRT1 (2.2)	PARP10 (2.1)	BRAP (1.9)	OASL (1.9)	YIPF2 (1.9)	AMIGO1 (1.8)	OGDH (1.7)
GO:0046777	protein autophosphorylation	0.05	> 0.20	SLC44A2 (2.6)	CEACAM19 (2.3)	PTPN11 (2.2)	C12orf51 (2.2)	C1orf63 (2.1)	ENSG00000228044 (2.0)	MARK4 (1.9)	LPIN3 (1.8)	BLOC1S3 (1.7)	ENSG00000238078 (1.6)
ENSG00000070061	IKBKAP PPI subnetwork	0.05	> 0.20	GEMIN7 (3.1)	ENSG00000226645 (2.0)	MAPKAPK5 (2.0)	MYLIP (1.9)	BRAP (1.8)	ENSG00000235545 (1.7)	RELB (1.6)	BUD13 (1.6)	ATXN7L2 (1.5)	TXNL4B (1.5)
ENSG00000171403	KRT9 PPI subnetwork	0.05	> 0.20	POLK (3.1)	DYNC2LI1 (2.3)	CEACAM19 (2.2)	ANGPTL3 (2.0)	APOC1 (2.0)	ALDH2 (1.8)	APOC4 (1.8)	PBX4 (1.8)	PLG (1.7)	HMGCR (1.6)
GO:0009310	amine catabolic process	0.05	> 0.20	LPA (3.2)	SLC22A1 (2.9)	ANGPTL3 (2.9)	CYP7A1 (2.9)	ACAD10 (2.6)	DHODH (2.5)	ENSG00000254235 (2.5)	MOSC1 (2.4)	QTRT1 (2.4)	PLG (2.3)
MP:0003057	abnormal epicardium morphology	0.05	> 0.20	KANK2 (3.5)	RHD (3.2)	TIMD4 (2.9)	CETP (2.6)	MAFB (2.4)	C12orf51 (2.2)	C11orf9 (2.0)	BCAM (1.9)	C1orf63 (1.8)	TMEM50A (1.8)
GO:0008654	phospholipid biosynthetic process	0.05	> 0.20	ATP13A1 (2.6)	TSSK6 (2.4)	FADS2 (2.3)	TMED4 (2.2)	HMGCR (2.1)	CLPTM1 (2.1)	LPAR2 (2.0)	GCNT4 (1.9)	ERP29 (1.9)	YIPF2 (1.9)
MP:0006058	decreased cerebral infarction size	0.05	> 0.20	TRIB1 (4.0)	PLEKHH2 (3.3)	APOC1 (3.3)	MAFB (3.0)	ENSG00000254235 (2.9)	PVR (2.7)	FRK (2.3)	CELSR2 (2.1)	NCAN (1.8)	HLX (1.8)
MP:0009832	abnormal sperm mitochondrial sheath morphology	0.05	> 0.20	C11orf9 (3.1)	TSSK6 (3.0)	NT5DC1 (2.8)	FRK (2.3)	HLX (1.9)	PVR (1.8)	NPC1L1 (1.7)	APOE (1.7)	FADS1 (1.6)	ENSG00000228044 (1.6)
MP:0005032	abnormal ectoplacental cone morphology	0.05	> 0.20	PPP1R37 (3.7)	ZNF180 (3.1)	LPAR2 (2.3)	LPIN3 (2.1)	PVRL2 (2.1)	ENSG00000238078 (2.0)	PSRC1 (1.9)	PVR (1.9)	ST3GAL4 (1.8)	QTRT1 (1.7)
GO:0016407	acetyltransferase activity	0.05	> 0.20	C19orf52 (2.6)	FADS2 (2.6)	CARM1 (2.4)	HMGCR (2.4)	COL4A3BP (2.3)	FADS1 (2.2)	PCSK9 (2.1)	ENSG00000254235 (2.1)	LDLR (2.1)	UBXN2B (2.0)
ENSG00000118520	ARG1 PPI subnetwork	0.05	> 0.20	NAA25 (3.3)	HP (2.8)	PVRL2 (2.3)	PVR (2.2)	CEACAM19 (2.2)	SARS (2.0)	OGDH (1.9)	RHCE (1.9)	TMEM57 (1.6)	AMIGO1 (1.5)
ENSG00000102309	PIN4 PPI subnetwork	0.05	> 0.20	CARM1 (3.3)	TMEM57 (2.2)	ILF3 (2.1)	C12orf51 (2.0)	SMARCA4 (1.8)	GMPR (1.8)	CYB561D1 (1.8)	NKPD1 (1.8)	ALDH2 (1.5)	BRAP (1.5)
ENSG00000214528	ENSG00000214528 PPI subnetwork	0.05	> 0.20	DNAH11 (2.7)	SYPL2 (2.6)	ANKRD31 (2.5)	ATXN7L2 (2.5)	ENSG00000228044 (2.1)	ATXN2 (2.1)	HLX (2.0)	PMFBP1 (1.9)	KANK2 (1.9)	PCSK9 (1.7)
GO:0051604	protein maturation	0.05	> 0.20	TMED4 (3.0)	ENSG00000254235 (2.8)	KIAA1324 (2.8)	YIPF2 (2.4)	CEACAM19 (2.2)	DYNC2LI1 (2.1)	ENSG00000238078 (1.9)	CYB561D1 (1.8)	ERP29 (1.6)	ENSG00000228044 (1.4)
GO:0006957	complement activation, alternative pathway	0.05	> 0.20	LPA (6.8)	APOC4 (4.3)	SLC22A1 (4.1)	ANGPTL3 (3.9)	TIMD4 (3.7)	HP (3.5)	APOA5 (3.1)	PLG (3.0)	PBX4 (2.5)	DHODH (2.4)
GO:0032637	interleukin-8 production	0.05	> 0.20	HP (2.1)	ST3GAL4 (1.8)	HLX (1.8)	BLOC1S3 (1.8)	PVR (1.7)	ENSG00000228044 (1.7)	TIMD4 (1.6)	DNAH11 (1.5)	FRK (1.4)	ZNF180 (1.4)
ENSG00000131459	GFPT2 PPI subnetwork	0.05	> 0.20	NAA25 (3.6)	SARS (3.3)	GPAM (3.1)	OGDH (3.1)	SMARCA4 (2.8)	DDX56 (2.5)	PSMA5 (2.4)	DHODH (2.3)	SLC22A1 (2.3)	TOMM40 (2.2)
GO:0004521	endoribonuclease activity	0.05	> 0.20	ZNF180 (3.3)	DHODH (2.7)	CEACAM19 (2.1)	C12orf43 (2.0)	FEN1 (1.8)	LPA (1.7)	DDX56 (1.6)	BUD13 (1.6)	CARM1 (1.6)	ENSG00000235545 (1.5)
GO:0005980	glycogen catabolic process	0.05	> 0.20	SYPL2 (3.3)	ENSG00000235545 (2.7)	SORT1 (2.4)	AMIGO1 (2.3)	ST3GAL4 (2.3)	ZHX3 (1.9)	C17orf57 (1.9)	ABCG8 (1.9)	ZNF101 (1.8)	GMPR (1.8)
MP:0009243	hairpin sperm flagellum	0.05	> 0.20	TSSK6 (2.8)	ENSG00000228044 (2.5)	FRK (2.0)	CYP7A1 (2.0)	C12orf47 (1.9)	HLX (1.7)	ST3GAL4 (1.7)	PMFBP1 (1.7)	PCSK9 (1.7)	TMEM57 (1.5)
ENSG00000012048	BRCA1 PPI subnetwork	0.05	> 0.20	FEN1 (4.0)	USP1 (3.8)	SMARCA4 (2.4)	BUD13 (2.2)	USP24 (2.1)	TOP1 (2.0)	PTPN11 (2.0)	CARM1 (1.9)	ILF3 (1.9)	GEMIN7 (1.7)
ENSG00000131791	PRKAB2 PPI subnetwork	0.05	> 0.20	C12orf51 (2.6)	ILF3 (2.5)	OGDH (2.4)	CARM1 (1.8)	SARS (1.8)	ZNF180 (1.6)	DNM2 (1.5)	HAPLN4 (1.5)	CILP2 (1.4)	LDLR (1.4)
ENSG00000104980	TIMM44 PPI subnetwork	0.05	> 0.20	DNM2 (3.1)	SARS (2.7)	DHODH (2.7)	ANGPTL3 (2.5)	CYP7A1 (2.4)	ILF3 (2.3)	ACAD10 (2.3)	TOMM40 (2.2)	QTRT1 (2.1)	LPA (2.1)
GO:0046365	monosaccharide catabolic process	0.05	> 0.20	GOT2P1 (2.5)	ENSG00000254235 (2.2)	PCSK9 (2.0)	ACAD10 (2.0)	LPIN3 (1.9)	FRK (1.9)	TRAPPC6A (1.8)	NT5DC1 (1.6)	TSSK6 (1.6)	ERP29 (1.6)
MP:0003961	decreased lean body mass	0.05	> 0.20	HMGCR (4.2)	FADS2 (3.2)	TMEM57 (3.0)	GPAM (3.0)	NPC1L1 (2.8)	FADS1 (2.4)	LDLR (2.3)	PCSK9 (2.3)	LPIN3 (2.0)	USP24 (2.0)
MP:0000602	enlarged liver sinusoidal spaces	0.05	> 0.20	RHCE (3.6)	RHD (3.5)	LPA (3.2)	POLK (2.6)	SLC22A1 (2.5)	CETP (2.3)	C12orf51 (2.3)	APOC4 (2.1)	COL4A3BP (1.8)	TMEM57 (1.8)
ENSG00000065243	PKN2 PPI subnetwork	0.05	> 0.20	CETP (3.7)	TIMD4 (3.2)	TMEM57 (2.8)	OASL (2.5)	TMEM50A (2.2)	C1orf63 (2.2)	HNF1A (1.9)	SLC44A2 (1.8)	ANKRD31 (1.7)	FADS2 (1.7)
ENSG00000171566	PLRG1 PPI subnetwork	0.05	> 0.20	DHX38 (4.5)	SUGP1 (4.0)	SMARCA4 (3.3)	BUD13 (3.3)	MAU2 (3.1)	DDX56 (2.7)	ZNF259 (2.5)	C19orf52 (2.4)	SARS (2.1)	ILF3 (2.1)
ENSG00000129988	LBP PPI subnetwork	0.05	> 0.20	HP (6.7)	APOB (4.4)	APOC4 (3.2)	ABCG5 (3.1)	PLG (2.9)	APOC1 (2.9)	ADAM1 (2.7)	ANGPTL3 (2.7)	NPC1L1 (2.7)	MAFB (2.6)
ENSG00000174744	BRMS1 PPI subnetwork	0.05	> 0.20	OASL (6.2)	PARP10 (3.1)	TRAFD1 (2.7)	USP1 (2.2)	TMED4 (1.9)	CYP7A1 (1.9)	PCSK9 (1.8)	HNF1A (1.8)	KANK2 (1.7)	ENSG00000235545 (1.7)
MP:0004929	decreased epididymis weight	0.05	> 0.20	FRK (3.7)	FADS2 (2.2)	TRAPPC6A (2.1)	ANGPTL3 (2.0)	ST3GAL4 (2.0)	CETP (1.8)	LDLR (1.7)	LPIN3 (1.7)	MYLIP (1.6)	HMGCR (1.4)
MP:0009429	decreased embryo weight	0.05	> 0.20	UBXN2B (3.7)	PPP1R37 (3.1)	ST3GAL4 (2.4)	ZNF180 (2.1)	TRIB1 (2.1)	PVRL2 (2.1)	CLPTM1 (1.8)	LPIN3 (1.8)	MAU2 (1.6)	NYNRIN (1.6)
KEGG_TYROSINE_METABOLISM	KEGG_TYROSINE_METABOLISM	0.05	> 0.20	APOC4 (4.9)	APOA5 (4.4)	PLG (3.8)	ANGPTL3 (3.5)	SLC22A1 (3.4)	HP (3.4)	ABCG5 (3.4)	LPA (3.3)	ALDH2 (2.9)	MOSC1 (2.8)
GO:0010608	posttranscriptional regulation of gene expression	0.05	> 0.20	ADAM1 (2.6)	MYLIP (2.6)	BRAP (2.5)	ILF3 (2.3)	MAPKAPK5 (2.2)	PTPN11 (2.0)	USP24 (1.9)	ZNF259 (1.8)	C12orf43 (1.8)	DOCK7 (1.8)
ENSG00000122257	RBBP6 PPI subnetwork	0.05	> 0.20	TIMD4 (3.6)	CETP (3.2)	OASL (2.6)	NKPD1 (2.4)	GATAD2A (2.2)	YIPF2 (1.9)	NPC1L1 (1.9)	HNF1A (1.7)	TXNL4B (1.5)	PTPN11 (1.5)
GO:0071219	cellular response to molecule of bacterial origin	0.05	> 0.20	PVR (3.4)	PARP10 (2.3)	OASL (2.3)	DNAH11 (2.2)	LPIN3 (2.2)	GRINA (2.1)	CEACAM19 (1.9)	UBXN2B (1.8)	MAFB (1.7)	AMIGO1 (1.6)
GO:0034399	nuclear periphery	0.05	> 0.20	TOP1 (3.9)	USP1 (3.3)	ZNF180 (2.9)	DNM2 (2.8)	ILF3 (2.7)	FEN1 (2.4)	PSRC1 (2.2)	SMARCA4 (2.1)	SUGP1 (2.0)	BUD13 (2.0)
ENSG00000128602	SMO PPI subnetwork	0.05	> 0.20	PARP10 (2.7)	GMIP (2.6)	MAU2 (2.4)	PPP1R37 (2.3)	BCL3 (2.2)	USP24 (2.1)	ATXN2 (2.0)	MYLIP (2.0)	SMARCA4 (1.9)	MAFB (1.9)
ENSG00000183735	TBK1 PPI subnetwork	0.05	> 0.20	PARP10 (5.3)	OASL (4.5)	RELB (4.2)	GRINA (3.6)	TRAFD1 (3.2)	BCL3 (2.6)	FRK (2.4)	ILF3 (1.9)	CLPTM1 (1.8)	NAA25 (1.8)
GO:0071900	regulation of protein serine/threonine kinase activity	0.05	> 0.20	ENSG00000226645 (3.8)	TRIB1 (3.1)	HLX (2.5)	PVR (2.1)	MYLIP (1.8)	SLC44A2 (1.7)	GCNT4 (1.7)	ENSG00000226648 (1.7)	LPAR2 (1.6)	KANK2 (1.5)
ENSG00000111725	PRKAB1 PPI subnetwork	0.05	> 0.20	SARS (4.0)	PSMA5 (3.9)	TOMM40 (3.5)	ILF3 (3.2)	NAA25 (2.9)	SMARCA4 (2.7)	NT5DC1 (2.2)	OGDH (2.1)	DOCK7 (2.0)	FADS1 (2.0)
GO:0042593	glucose homeostasis	0.05	> 0.20	ST3GAL4 (2.6)	ENSG00000254235 (2.4)	GPAM (2.1)	PCSK9 (2.1)	MOSC1 (2.1)	HNF1A (2.1)	ADAM1 (2.0)	LPA (1.6)	KIAA1324 (1.5)	ACAD10 (1.5)
GO:0033500	carbohydrate homeostasis	0.05	> 0.20	ST3GAL4 (2.6)	ENSG00000254235 (2.4)	GPAM (2.1)	PCSK9 (2.1)	MOSC1 (2.1)	HNF1A (2.1)	ADAM1 (2.0)	LPA (1.6)	KIAA1324 (1.5)	ACAD10 (1.5)
ENSG00000196353	CPNE4 PPI subnetwork	0.05	> 0.20	ZNF180 (2.8)	GOT2P1 (2.6)	PLEC (2.3)	C12orf51 (2.2)	C17orf57 (2.1)	ENSG00000235545 (1.9)	NT5DC1 (1.9)	PBX4 (1.9)	DNM2 (1.9)	PTPN11 (1.9)
ENSG00000131759	RARA PPI subnetwork	0.05	> 0.20	C12orf51 (3.1)	ATXN2 (2.7)	MAU2 (2.4)	TRIB1 (2.3)	ABO (2.2)	SMARCA4 (2.2)	PPP1R37 (2.1)	ZHX3 (2.0)	BCL3 (2.0)	MAPKAPK5 (1.9)
ENSG00000055044	NOP58 PPI subnetwork	0.05	> 0.20	ZNF259 (5.0)	DDX56 (5.0)	NAA25 (4.7)	QTRT1 (3.8)	TOMM40 (3.8)	C12orf43 (3.1)	DHODH (3.1)	SUGP1 (2.4)	TOP1 (2.4)	DHX38 (2.3)
ENSG00000144852	NR1I2 PPI subnetwork	0.05	> 0.20	PPP1R37 (2.4)	KIAA1324 (2.3)	TM6SF2 (2.3)	MAFB (2.2)	MAU2 (2.1)	SLC22A1 (1.8)	GOT2P1 (1.8)	ABCG5 (1.8)	APOA5 (1.7)	PLEC (1.7)
ENSG00000111145	ELK3 PPI subnetwork	0.05	> 0.20	TMEM57 (2.5)	PLCG1 (2.0)	GATAD2A (2.0)	ENSG00000254235 (2.0)	C19orf52 (1.8)	CARM1 (1.8)	POC5 (1.7)	PPP1R37 (1.7)	ATXN7L2 (1.6)	ZHX3 (1.6)
ENSG00000141646	SMAD4 PPI subnetwork	0.05	> 0.20	KANK2 (3.3)	ATXN2 (3.2)	GATAD2A (2.8)	MAU2 (2.5)	CARM1 (2.3)	MYLIP (2.3)	BUD13 (2.1)	SMARCA4 (2.0)	DHX38 (1.9)	ATXN7L2 (1.8)
ENSG00000132432	SEC61G PPI subnetwork	0.05	> 0.20	HMGCR (5.3)	LDLR (4.9)	FADS1 (3.4)	FADS2 (3.3)	PCSK9 (3.2)	TMEM57 (2.9)	ATP13A1 (2.8)	TMEM50A (2.3)	SUGP1 (2.3)	POLK (2.1)
GO:0046128	purine ribonucleoside metabolic process	0.05	> 0.20	DHODH (3.1)	TXNL4B (2.7)	PCSK9 (2.5)	TRAPPC6A (2.3)	CYP7A1 (2.1)	LPA (2.1)	FADS2 (1.9)	C12orf47 (1.8)	LDLR (1.6)	ENSG00000254235 (1.5)
ENSG00000102241	HTATSF1 PPI subnetwork	0.05	> 0.20	SUGP1 (3.5)	ILF3 (3.0)	DHX38 (2.8)	TOP1 (2.7)	MAU2 (2.6)	SMARCA4 (2.2)	BUD13 (2.2)	ENSG00000226645 (2.1)	PSMA5 (2.0)	ATP13A1 (1.9)
ENSG00000183751	TBL3 PPI subnetwork	0.05	> 0.20	ZNF259 (4.6)	DDX56 (4.3)	QTRT1 (4.0)	NAA25 (3.8)	TOMM40 (3.6)	DHODH (2.6)	C12orf43 (2.3)	DHX38 (2.2)	SUGP1 (2.2)	GATAD2A (2.0)
ENSG00000174483	BBS1 PPI subnetwork	0.05	> 0.20	UBXN2B (3.3)	BCAM (2.6)	DYNC2LI1 (2.4)	PLEC (2.3)	KANK2 (2.3)	ABCG5 (2.3)	SUGP1 (2.2)	SLC22A1 (2.0)	OGDH (2.0)	TM6SF2 (1.8)
ENSG00000129965	INS-IGF2 PPI subnetwork	0.05	> 0.20	USP24 (3.1)	APOE (2.9)	HAVCR1 (2.7)	C11orf9 (2.5)	PLEKHH2 (2.0)	KANK2 (1.9)	PLCG1 (1.6)	CELSR2 (1.6)	MYLIP (1.6)	TMED4 (1.5)
GO:0002064	epithelial cell development	0.05	> 0.20	DNAH11 (2.9)	ENSG00000238078 (2.5)	AP1M2 (2.5)	CILP2 (2.3)	CELSR2 (2.3)	PVRL2 (2.2)	GOT2P1 (2.2)	TSSK6 (2.0)	ENSG00000235545 (2.0)	BCAM (1.9)
ENSG00000175387	SMAD2 PPI subnetwork	0.05	> 0.20	KANK2 (3.1)	ATXN2 (3.0)	MARK4 (2.9)	DHX38 (2.7)	GATAD2A (2.5)	PTPN11 (2.5)	SH2B3 (2.4)	PLCG1 (2.4)	CLPTM1 (2.4)	SMARCA4 (2.3)
ENSG00000142192	APP PPI subnetwork	0.05	> 0.20	APOE (3.5)	CELSR2 (2.6)	PLEKHH2 (2.3)	APOC1 (2.2)	CLPTM1 (2.1)	BCAM (2.0)	PVRL2 (2.0)	ABCG5 (1.9)	RPH3A (1.9)	GRINA (1.7)
ENSG00000166930	MS4A5 PPI subnetwork	0.05	> 0.20	ST3GAL4 (2.9)	AP1M2 (2.8)	DNM2 (2.4)	KIAA1324 (2.3)	HNF1A (2.3)	PLEC (1.9)	ITGB3 (1.7)	SH2B3 (1.6)	C12orf47 (1.6)	CBLC (1.5)
ENSG00000132382	MYBBP1A PPI subnetwork	0.05	> 0.20	NAA25 (3.6)	SMARCA4 (3.2)	TOMM40 (2.7)	ILF3 (2.7)	C12orf43 (2.5)	TRIB1 (2.4)	DHX38 (2.3)	ANKRD31 (2.3)	USP1 (2.3)	ADAM1 (2.2)
GO:0009119	ribonucleoside metabolic process	0.05	> 0.20	TXNL4B (2.7)	DHODH (2.5)	LPA (2.3)	FADS2 (1.7)	TRAPPC6A (1.7)	PCSK9 (1.7)	GOT2P1 (1.6)	MOSC1 (1.6)	LDLR (1.5)	DDX56 (1.5)
ENSG00000143171	RXRG PPI subnetwork	0.05	> 0.20	TRIB1 (3.7)	PLEC (3.3)	ABCG5 (1.7)	AMIGO1 (1.7)	HNF1A (1.7)	ACAD10 (1.5)	LDLR (1.5)	NYNRIN (1.5)	TM6SF2 (1.4)	MARK4 (1.4)
ENSG00000182359	KBTBD3 PPI subnetwork	0.05	> 0.20	ACAD10 (3.8)	NT5DC1 (3.2)	HNF1A (2.4)	TRAPPC6A (1.7)	CETP (1.6)	C1orf63 (1.6)	PCSK9 (1.6)	GMPR (1.5)	TMED4 (1.5)	ATP13A1 (1.5)
GO:0071548	response to dexamethasone stimulus	0.05	> 0.20	RHCE (3.9)	RHD (3.2)	ABCG8 (2.7)	ABCG5 (2.5)	TXNL4B (2.0)	ENSG00000226645 (1.9)	DNAH11 (1.9)	TMEM57 (1.9)	C19orf52 (1.8)	CEACAM19 (1.7)
ENSG00000164305	CASP3 PPI subnetwork	0.05	> 0.20	PTPN11 (3.4)	GATAD2A (2.6)	POLK (2.5)	ST3GAL4 (2.2)	UBXN2B (1.9)	BCL3 (1.9)	DHX38 (1.7)	OGDH (1.5)	TRAFD1 (1.5)	ILF3 (1.5)
GO:0006305	DNA alkylation	0.05	> 0.20	ENSG00000238078 (3.5)	ANKRD31 (3.3)	MAU2 (2.1)	LPAR2 (2.1)	YIPF2 (2.0)	C17orf57 (1.9)	COL4A3BP (1.8)	ACAD10 (1.8)	ATP13A1 (1.7)	SUGP1 (1.7)
GO:0006306	DNA methylation	0.05	> 0.20	ENSG00000238078 (3.5)	ANKRD31 (3.3)	MAU2 (2.1)	LPAR2 (2.1)	YIPF2 (2.0)	C17orf57 (1.9)	COL4A3BP (1.8)	ACAD10 (1.8)	ATP13A1 (1.7)	SUGP1 (1.7)
ENSG00000186416	NKRF PPI subnetwork	0.05	> 0.20	RELB (4.0)	BCL3 (3.9)	PARP10 (3.3)	USP24 (2.9)	GMIP (2.9)	MAU2 (2.9)	DHX38 (2.5)	MARK4 (2.1)	SMARCA4 (2.1)	ATXN2 (2.0)
MP:0001874	acanthosis	0.05	> 0.20	CBLC (4.2)	BCL3 (3.2)	RELB (3.0)	AP1M2 (2.5)	MAFB (2.4)	GEMIN7 (2.1)	PARP10 (2.1)	PMFBP1 (2.0)	GMIP (1.8)	PLEC (1.7)
ENSG00000100079	LGALS2 PPI subnetwork	0.05	> 0.20	NPC1L1 (5.0)	C11orf9 (3.5)	PCSK9 (3.1)	KIAA1324 (2.5)	HNF1A (2.5)	PLEC (2.4)	NT5DC1 (2.3)	DNAH11 (1.9)	TMEM50A (1.9)	LDLR (1.9)
ENSG00000165916	PSMC3 PPI subnetwork	0.05	> 0.20	PSMA5 (5.4)	NAA25 (3.0)	TOMM40 (2.7)	DDX56 (2.6)	NT5DC1 (2.6)	SARS (2.5)	TRAFD1 (2.2)	ENSG00000254235 (2.0)	SMARCA4 (1.9)	ZNF259 (1.8)
ENSG00000183048	SLC25A10 PPI subnetwork	0.05	> 0.20	HAVCR1 (2.9)	TRAFD1 (2.8)	CEACAM19 (2.4)	ADAM1 (2.4)	ANKRD31 (1.9)	DYNC2LI1 (1.9)	ATXN2 (1.8)	ITGB3 (1.7)	PVR (1.5)	RHD (1.5)
ENSG00000138495	COX17 PPI subnetwork	0.05	> 0.20	GEMIN7 (2.5)	FADS2 (2.2)	FADS1 (2.1)	TRAPPC6A (2.1)	BLOC1S3 (2.0)	ZNF180 (2.0)	ITGB3 (1.9)	RHD (1.8)	GRINA (1.6)	HMGCR (1.6)
ENSG00000142534	RPS11 PPI subnetwork	0.05	> 0.20	NAA25 (3.9)	DDX56 (3.5)	DHX38 (3.0)	C12orf43 (2.9)	SARS (2.8)	ZNF259 (2.7)	QTRT1 (2.7)	TOMM40 (2.6)	SUGP1 (2.4)	PTPN11 (2.1)
GO:0031063	regulation of histone deacetylation	0.05	> 0.20	TMEM57 (4.5)	FADS2 (3.0)	GCNT4 (2.4)	FADS1 (2.2)	PPP1R37 (2.1)	PCSK9 (2.0)	POLK (1.9)	GATAD2A (1.8)	PLCG1 (1.7)	BLOC1S3 (1.6)
MP:0001192	scaly skin	0.05	> 0.20	HMGCR (3.0)	CBLC (2.8)	CEACAM19 (2.7)	MAFB (2.6)	NKPD1 (2.4)	GRINA (2.2)	TRIB1 (2.1)	CYB561D1 (2.0)	AP1M2 (2.0)	NPC1L1 (2.0)
ENSG00000104856	RELB PPI subnetwork	0.05	> 0.20	RELB (4.2)	CARM1 (3.1)	BCL3 (2.8)	ILF3 (2.5)	GRINA (2.5)	SMARCA4 (2.3)	CLPTM1 (2.2)	C12orf43 (2.1)	NT5DC1 (2.1)	USP24 (1.4)
GO:0009074	aromatic amino acid family catabolic process	0.05	> 0.20	CYP7A1 (3.9)	SLC22A1 (3.9)	ENSG00000254235 (3.9)	LPA (3.3)	APOA5 (3.3)	ANGPTL3 (3.2)	PLG (2.6)	APOC4 (2.6)	ENSG00000228044 (1.9)	CEACAM19 (1.8)
ENSG00000160208	RRP1B PPI subnetwork	0.05	> 0.20	ZNF259 (5.1)	NAA25 (4.2)	TOMM40 (4.0)	DDX56 (3.5)	QTRT1 (3.4)	DHODH (3.1)	DHX38 (3.1)	ATP13A1 (2.6)	C12orf43 (2.5)	MAPKAPK5 (2.3)
ENSG00000196943	C14orf21 PPI subnetwork	0.05	> 0.20	ZNF259 (4.6)	NAA25 (4.4)	DDX56 (4.2)	QTRT1 (3.7)	TOMM40 (3.5)	DHODH (3.2)	TOP1 (2.5)	C12orf43 (2.3)	PVR (2.2)	DHX38 (1.8)
ENSG00000100030	MAPK1 PPI subnetwork	0.05	> 0.20	TRIB1 (5.1)	PLEC (3.1)	LDLR (2.8)	SH2B3 (2.3)	DNM2 (2.2)	PLCG1 (1.9)	PVR (1.9)	BCL3 (1.8)	ATXN2 (1.8)	PPP1R37 (1.7)
ENSG00000122406	RPL5 PPI subnetwork	0.05	> 0.20	NAA25 (4.3)	ZNF259 (3.8)	DDX56 (3.6)	TOMM40 (2.8)	QTRT1 (2.8)	SARS (2.7)	DHX38 (2.3)	SUGP1 (2.3)	C12orf43 (2.2)	BRAP (2.1)
ENSG00000005189	ENSG00000005189 PPI subnetwork	0.05	> 0.20	SYPL2 (5.1)	ZHX3 (2.7)	GMPR (2.3)	NKPD1 (2.1)	FADS1 (1.9)	CILP2 (1.9)	ENSG00000235545 (1.7)	ALDH2 (1.7)	C19orf52 (1.6)	MAU2 (1.5)
GO:0051181	cofactor transport	0.05	> 0.20	DNAH11 (3.0)	ABCG8 (2.9)	TMED4 (2.7)	TM6SF2 (2.5)	HAVCR1 (2.1)	TMEM116 (2.0)	CEACAM19 (1.8)	LPAR2 (1.8)	ABCG5 (1.6)	NPC1L1 (1.6)
GO:0051427	hormone receptor binding	0.05	> 0.20	DNM2 (2.6)	DHX38 (2.3)	MAPKAPK5 (2.3)	TRAFD1 (2.2)	ATXN2 (2.1)	BUD13 (1.8)	MAFB (1.7)	COL4A3BP (1.5)	USP24 (1.5)	SMARCA4 (1.4)
ENSG00000131721	RHOXF2 PPI subnetwork	0.05	> 0.20	PPP1R37 (4.5)	NYNRIN (3.3)	YIPF2 (3.0)	CLPTM1 (2.6)	SARS (2.3)	AP1M2 (2.3)	SUGP1 (2.2)	ANKRD31 (2.1)	CARM1 (2.1)	ILF3 (1.9)
GO:0016323	basolateral plasma membrane	0.05	> 0.20	PLEC (3.8)	BCAM (3.5)	AP1M2 (2.8)	ANGPTL3 (2.6)	TMEM116 (2.6)	PLG (2.5)	SLC22A1 (2.2)	CBLC (1.8)	ENSG00000226648 (1.7)	DNM2 (1.7)
REACTOME_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME	REACTOME_MYD88_DEPENDENT_CASCADE_INITIATED_ON_ENDOSOME	0.05	> 0.20	RELB (4.2)	TRIB1 (3.7)	SH2B3 (3.6)	OASL (3.4)	BCL3 (3.1)	HLX (2.5)	PARP10 (2.3)	PVR (2.2)	CARM1 (2.0)	GMIP (1.9)
REACTOME_TOLL_LIKE_RECEPTOR_78_TLR78_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_78_TLR78_CASCADE	0.05	> 0.20	RELB (4.2)	TRIB1 (3.7)	SH2B3 (3.6)	OASL (3.4)	BCL3 (3.1)	HLX (2.5)	PARP10 (2.3)	PVR (2.2)	CARM1 (2.0)	GMIP (1.9)
GO:0008009	chemokine activity	0.05	> 0.20	TIMD4 (4.7)	RELB (3.6)	MAFB (3.2)	OASL (2.9)	BCL3 (2.8)	CETP (2.8)	PVRL2 (2.5)	GRINA (1.8)	ENSG00000228044 (1.6)	PARP10 (1.4)
ENSG00000099341	PSMD8 PPI subnetwork	0.05	> 0.20	PSMA5 (5.5)	TOMM40 (2.7)	NT5DC1 (2.6)	NAA25 (2.5)	SARS (2.3)	TRAFD1 (2.2)	ENSG00000254235 (1.8)	QTRT1 (1.7)	SMARCA4 (1.6)	CYP7A1 (1.5)
GO:0019239	deaminase activity	0.05	> 0.20	OASL (3.9)	PARP10 (3.3)	SYPL2 (3.2)	NPC1L1 (3.2)	ABCG5 (3.2)	LPIN3 (3.0)	TM6SF2 (2.8)	TRAFD1 (2.7)	ABCG8 (2.1)	TSSK6 (2.0)
GO:0033619	membrane protein proteolysis	0.05	> 0.20	ST3GAL4 (3.3)	CLPTM1 (2.5)	ENSG00000254235 (2.4)	TMEM50A (2.3)	GCNT4 (1.9)	SLC44A2 (1.9)	CYB561D1 (1.8)	ENSG00000228044 (1.7)	ZNF101 (1.7)	NYNRIN (1.7)
MP:0005244	hemopericardium	0.05	> 0.20	PVRL2 (4.4)	C11orf9 (4.1)	NYNRIN (2.5)	BCAM (2.4)	PVR (2.2)	C17orf57 (2.0)	PLEKHH2 (1.5)	ENSG00000226648 (1.5)	CBLC (1.4)	KANK2 (1.4)
ENSG00000168542	COL3A1 PPI subnetwork	0.05	> 0.20	FRK (3.1)	ST3GAL4 (2.6)	PARP10 (2.4)	CILP2 (2.1)	CBLC (2.0)	PPP1R37 (2.0)	KANK2 (1.9)	ZNF180 (1.8)	ENSG00000238078 (1.8)	PTPN11 (1.8)
MP:0000511	abnormal intestinal mucosa morphology	0.05	> 0.20	HLX (2.7)	NYNRIN (2.6)	GRINA (2.5)	C11orf9 (2.2)	HNF1A (2.0)	LPAR2 (1.9)	TM6SF2 (1.9)	MOSC1 (1.8)	UBXN2B (1.8)	ENSG00000238078 (1.7)
GO:0004386	helicase activity	0.05	> 0.20	DHX38 (4.3)	SUGP1 (4.0)	OASL (3.5)	MAPKAPK5 (3.0)	ATP13A1 (2.7)	ILF3 (2.7)	DHODH (2.6)	SMARCA4 (2.6)	NAA25 (2.6)	DDX56 (2.5)
MP:0002109	abnormal limb morphology	0.05	> 0.20	BCAM (3.8)	CILP2 (3.2)	MAFB (2.8)	LDLR (2.7)	PCSK9 (2.4)	ZHX3 (2.3)	PLEKHH2 (2.1)	PLEC (2.1)	SLC44A2 (2.1)	NYNRIN (2.0)
GO:0005041	low-density lipoprotein receptor activity	0.05	> 0.20	HMGCR (4.4)	TIMD4 (3.5)	FADS2 (3.4)	FADS1 (3.3)	PCSK9 (3.0)	CEACAM19 (2.6)	CETP (2.5)	PVRL2 (2.4)	SORT1 (2.3)	ENSG00000228044 (2.2)
MP:0011423	kidney cortex atrophy	0.05	> 0.20	TMED4 (2.8)	HAVCR1 (2.6)	APOB (2.4)	C11orf9 (2.3)	HNF1A (2.3)	TRIB1 (1.9)	DNAH11 (1.8)	NYNRIN (1.8)	ABCG5 (1.8)	NPC1L1 (1.8)
ENSG00000166582	CENPV PPI subnetwork	0.05	> 0.20	SUGP1 (2.3)	DHX38 (2.1)	C19orf52 (2.1)	BRAP (2.0)	YIPF2 (2.0)	QTRT1 (2.0)	PARP10 (1.9)	OASL (1.8)	AMIGO1 (1.8)	SORT1 (1.7)
ENSG00000066044	ELAVL1 PPI subnetwork	0.05	> 0.20	ILF3 (5.2)	QTRT1 (4.4)	SMARCA4 (4.2)	CARM1 (4.2)	ATP13A1 (2.9)	MAU2 (2.8)	GATAD2A (2.7)	DNM2 (2.6)	AP1M2 (2.4)	DDX56 (2.3)
ENSG00000166025	AMOTL1 PPI subnetwork	0.05	> 0.20	USP24 (2.6)	MAU2 (2.2)	SMARCA4 (2.0)	ATXN2 (2.0)	ZNF180 (1.9)	DHX38 (1.9)	CARM1 (1.8)	MAPKAPK5 (1.8)	DOCK7 (1.6)	SUGP1 (1.6)
ENSG00000099942	CRKL PPI subnetwork	0.05	> 0.20	SLC44A2 (3.5)	TIMD4 (2.7)	PLEKHH2 (2.6)	CETP (2.4)	SH2B3 (2.2)	USP24 (2.1)	GMIP (2.1)	DNM2 (2.0)	LPAR2 (2.0)	MAU2 (2.0)
GO:0042800	histone methyltransferase activity (H3-K4 specific)	0.05	> 0.20	C12orf51 (3.9)	BRAP (3.1)	BUD13 (2.7)	C19orf52 (2.6)	ATXN2 (2.5)	ATXN7L2 (2.0)	C12orf43 (1.9)	PLEC (1.9)	GOT2P1 (1.6)	QTRT1 (1.6)
MP:0004130	abnormal muscle cell glucose uptake	0.05	> 0.20	SYPL2 (4.3)	GPAM (4.0)	SORT1 (3.5)	PLEKHH2 (2.9)	BLOC1S3 (2.6)	MOSC1 (2.5)	AMIGO1 (2.4)	DNM2 (2.2)	CYB561D1 (2.2)	PPP1R37 (2.1)
REACTOME_INTERLEUKIN:6_SIGNALING	REACTOME_INTERLEUKIN:6_SIGNALING	0.05	> 0.20	BCL3 (6.8)	TRAFD1 (3.2)	PARP10 (2.8)	RELB (2.6)	PVR (2.4)	TRIB1 (2.4)	USP24 (2.3)	ZNF101 (2.2)	ENSG00000228044 (1.8)	CYB561D1 (1.7)
MP:0005657	abnormal neural plate morphology	0.05	> 0.20	CARM1 (3.4)	GRINA (2.6)	GATAD2A (2.4)	CLPTM1 (2.3)	ATXN7L2 (2.3)	UBXN2B (2.3)	NYNRIN (2.2)	ENSG00000235545 (2.2)	OASL (2.1)	PLCG1 (2.1)
ENSG00000197122	SRC PPI subnetwork	0.05	> 0.20	PLEC (3.6)	SH2B3 (2.7)	SORT1 (2.4)	DNM2 (2.4)	GMIP (2.4)	SMARCA4 (2.2)	ITGB3 (2.2)	C11orf9 (2.0)	MARK4 (1.9)	MAFB (1.8)
REACTOME_METABOLISM_OF_RNA	REACTOME_METABOLISM_OF_RNA	0.05	> 0.20	PSMA5 (3.3)	NAA25 (3.1)	DHX38 (2.4)	DDX56 (2.4)	TOMM40 (2.4)	TRAFD1 (2.1)	BUD13 (2.0)	ILF3 (1.9)	POC5 (1.9)	ZNF259 (1.8)
ENSG00000134398	ERN2 PPI subnetwork	0.05	> 0.20	ATP13A1 (4.3)	LDLR (3.8)	YIPF2 (3.7)	ERP29 (3.6)	FADS1 (2.9)	TMEM57 (2.9)	TMEM50A (2.8)	TMED4 (2.6)	CLPTM1 (2.6)	QTRT1 (2.5)
KEGG_GLYCEROLIPID_METABOLISM	KEGG_GLYCEROLIPID_METABOLISM	0.05	> 0.20	MOSC1 (4.4)	TM6SF2 (3.9)	GPAM (2.6)	ENSG00000226645 (1.9)	KIAA1324 (1.9)	GCNT4 (1.8)	NPC1L1 (1.8)	FADS1 (1.8)	COL4A3BP (1.7)	APOA5 (1.6)
GO:0051180	vitamin transport	0.05	> 0.20	LPAR2 (2.6)	TM6SF2 (2.6)	ABCG8 (2.5)	TMED4 (2.5)	TMEM116 (2.0)	GCNT4 (2.0)	POLK (2.0)	ANGPTL3 (1.8)	HAVCR1 (1.7)	HAPLN4 (1.5)
MP:0004953	decreased spleen weight	0.05	> 0.20	RHCE (2.4)	RELB (2.3)	POLK (1.9)	ATXN7L2 (1.8)	SLC44A2 (1.8)	RHD (1.7)	ANGPTL3 (1.6)	NPC1L1 (1.6)	APOB (1.5)	FRK (1.4)
ENSG00000129354	AP1M2 PPI subnetwork	0.05	> 0.20	CLPTM1 (3.6)	SH2B3 (3.0)	GATAD2A (2.6)	FADS2 (2.5)	MAU2 (2.3)	FADS1 (2.2)	SMARCA4 (2.2)	GRINA (2.0)	DNM2 (1.9)	ZNF101 (1.9)
ENSG00000132182	NUP210 PPI subnetwork	0.05	> 0.20	USP1 (3.6)	NAA25 (3.5)	POC5 (3.3)	DDX56 (2.7)	DOCK7 (2.6)	ILF3 (2.5)	FEN1 (2.4)	ENSG00000226648 (2.1)	PSRC1 (2.0)	BUD13 (1.9)
MP:0003131	increased erythrocyte cell number	0.05	> 0.20	RHCE (4.0)	RHD (3.5)	BCL3 (3.5)	POLK (2.4)	HLX (2.3)	TOP1 (2.3)	HP (2.3)	C12orf47 (2.2)	TRIB1 (2.1)	SH2B3 (2.0)
MP:0011320	abnormal glomerular capillary morphology	0.05	> 0.20	BCAM (4.6)	PVRL2 (4.0)	C11orf9 (3.8)	PLEKHH2 (3.4)	PPP1R37 (2.3)	NYNRIN (2.1)	CELSR2 (2.0)	AP1M2 (1.6)	DYNC2LI1 (1.6)	CLPTM1 (1.5)
REACTOME_ANDROGEN_BIOSYNTHESIS	REACTOME_ANDROGEN_BIOSYNTHESIS	0.05	> 0.20	ENSG00000254235 (3.7)	CYP7A1 (2.6)	LPA (2.6)	DNAH11 (2.3)	FADS2 (2.2)	ST3GAL4 (2.2)	FADS1 (2.0)	APOA5 (1.9)	FRK (1.8)	KIAA1324 (1.8)
ENSG00000095015	MAP3K1 PPI subnetwork	0.05	> 0.20	TOMM40 (3.1)	SARS (2.7)	PARP10 (2.1)	NAA25 (2.1)	ILF3 (1.9)	PLEC (1.9)	SMARCA4 (1.9)	DOCK7 (1.9)	DDX56 (1.8)	ANKRD31 (1.6)
REACTOME_CIRCADIAN_CLOCK	REACTOME_CIRCADIAN_CLOCK	0.05	> 0.20	ZHX3 (3.9)	TRIB1 (3.4)	LPIN3 (2.1)	C12orf51 (2.0)	GPAM (1.9)	ATXN2 (1.8)	CILP2 (1.6)	TMEM57 (1.5)	MYLIP (1.5)	LDLR (1.5)
MP:0009764	decreased sensitivity to induced morbidity/mortality	0.05	> 0.20	OASL (3.0)	SH2B3 (2.9)	PVR (2.2)	ST3GAL4 (2.2)	PARP10 (2.1)	APOE (1.9)	HLX (1.9)	ITGB3 (1.9)	ALDH2 (1.8)	BCL3 (1.8)
MP:0008525	decreased cranium height	0.05	> 0.20	NYNRIN (2.9)	CILP2 (2.0)	PLEKHH2 (2.0)	KANK2 (1.8)	MAPKAPK5 (1.8)	CLPTM1 (1.8)	ABO (1.8)	DOCK7 (1.6)	PLCG1 (1.5)	PPP1R37 (1.4)
ENSG00000116001	TIA1 PPI subnetwork	0.05	> 0.20	SMARCA4 (4.8)	DHX38 (4.6)	ILF3 (4.4)	SUGP1 (3.9)	CARM1 (3.1)	TOP1 (2.8)	ATP13A1 (2.7)	QTRT1 (2.7)	TOMM40 (2.6)	NAA25 (2.4)
ENSG00000134376	CRB1 PPI subnetwork	0.05	> 0.20	NYNRIN (3.1)	UBXN2B (2.3)	BCAM (2.0)	PLCG1 (2.0)	SLC22A1 (2.0)	APOE (1.9)	PARP10 (1.6)	LPIN3 (1.6)	PTPN11 (1.5)	ZHX3 (1.5)
ENSG00000162772	ATF3 PPI subnetwork	0.05	> 0.20	TRIB1 (5.8)	BCL3 (4.7)	PVR (3.7)	RELB (3.6)	SARS (3.3)	TRAFD1 (2.4)	ATXN2 (2.3)	MAPKAPK5 (2.1)	POLK (1.9)	PLEC (1.8)
GO:0000975	regulatory region DNA binding	0.05	> 0.20	TRIB1 (4.1)	HLX (2.7)	BCL3 (2.4)	ATXN2 (2.1)	CARM1 (1.9)	MYLIP (1.8)	MAFB (1.8)	SH2B3 (1.7)	PARP10 (1.7)	KANK2 (1.7)
GO:0001067	regulatory region nucleic acid binding	0.05	> 0.20	TRIB1 (4.1)	HLX (2.7)	BCL3 (2.4)	ATXN2 (2.1)	CARM1 (1.9)	MYLIP (1.8)	MAFB (1.8)	SH2B3 (1.7)	PARP10 (1.7)	KANK2 (1.7)
GO:0008093	cytoskeletal adaptor activity	0.05	> 0.20	ST3GAL4 (2.9)	PLEC (2.7)	PBX4 (2.3)	HLX (2.1)	GMPR (2.0)	PPP1R37 (2.0)	UBXN2B (2.0)	PMFBP1 (1.9)	RHD (1.9)	C11orf9 (1.8)
ENSG00000092820	EZR PPI subnetwork	0.05	> 0.20	PVR (2.7)	TIMD4 (2.7)	PLEC (2.6)	RELB (2.5)	GATAD2A (2.3)	C11orf9 (2.1)	BCL3 (2.1)	SLC44A2 (2.1)	ZNF101 (1.7)	LDLR (1.6)
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	0.05	> 0.20	OASL (9.3)	PARP10 (6.4)	TRAFD1 (5.0)	RELB (3.0)	BCL3 (2.6)	CYP7A1 (2.5)	GOT2P1 (2.3)	TMEM50A (2.0)	BLOC1S3 (2.0)	GEMIN7 (2.0)
GO:0050996	positive regulation of lipid catabolic process	0.05	> 0.20	APOC4 (2.7)	APOB (2.4)	ABCG8 (2.4)	PLG (2.3)	ABCG5 (2.1)	MOSC1 (2.0)	TM6SF2 (1.9)	ANGPTL3 (1.8)	C17orf57 (1.6)	APOA5 (1.6)
GO:0010907	positive regulation of glucose metabolic process	0.05	> 0.20	GOT2P1 (2.1)	TSSK6 (2.0)	ZHX3 (1.9)	TMEM116 (1.9)	HNF1A (1.9)	CYP7A1 (1.8)	AMIGO1 (1.8)	FRK (1.7)	LPA (1.6)	GPAM (1.6)
KEGG_APOPTOSIS	KEGG_APOPTOSIS	0.05	> 0.20	RELB (5.3)	BCL3 (4.8)	ST3GAL4 (2.7)	GMIP (2.5)	TRAFD1 (2.2)	SH2B3 (2.2)	PARP10 (2.1)	POLK (2.0)	GRINA (1.7)	PTPN11 (1.7)
ENSG00000107643	MAPK8 PPI subnetwork	0.05	> 0.20	TRIB1 (6.2)	POLK (3.7)	SH2B3 (3.6)	BCL3 (2.6)	PLEC (2.6)	PVR (2.5)	LDLR (2.0)	RELB (1.9)	PLCG1 (1.8)	GRINA (1.8)
MP:0009114	decreased pancreatic beta cell mass	0.05	> 0.20	TRIB1 (2.5)	DNAH11 (2.4)	KIAA1324 (2.4)	PLEKHH2 (2.1)	ENSG00000226645 (1.8)	MYLIP (1.8)	OASL (1.6)	GCNT4 (1.6)	LPIN3 (1.5)	LDLR (1.5)
GO:0007597	blood coagulation, intrinsic pathway	0.05	> 0.20	ITGB3 (5.2)	ANGPTL3 (3.5)	PLG (3.1)	APOC4 (2.9)	LPA (2.8)	GMPR (2.8)	CETP (2.7)	APOA5 (2.5)	SLC22A1 (2.5)	HP (2.1)
MP:0001289	persistence of hyaloid vascular system	0.05	> 0.20	BCAM (3.8)	NYNRIN (2.6)	PVRL2 (2.5)	PVR (2.3)	NCAN (2.0)	HLX (1.9)	CYP7A1 (1.7)	C11orf9 (1.7)	POLK (1.7)	PLCG1 (1.4)
ENSG00000108924	HLF PPI subnetwork	0.05	> 0.20	SARS (3.2)	TRIB1 (3.2)	MAPKAPK5 (2.6)	POC5 (2.3)	GCNT4 (2.2)	BCL3 (2.0)	TRAFD1 (1.8)	MYLIP (1.6)	RELB (1.6)	MAFB (1.6)
MP:0001873	stomach inflammation	0.05	> 0.20	KIAA1324 (4.0)	BCL3 (2.8)	CBLC (2.5)	SLC44A2 (2.5)	PLEC (2.4)	GRINA (2.3)	PLEKHH2 (2.0)	DNM2 (2.0)	C17orf57 (1.9)	GEMIN7 (1.8)
MP:0010724	thick interventricular septum	0.05	> 0.20	NPC1L1 (2.6)	TM6SF2 (2.2)	MYLIP (2.2)	GMPR (2.2)	C11orf9 (2.0)	ATXN7L2 (1.9)	C12orf47 (1.9)	ABO (1.8)	ATXN2 (1.8)	BLOC1S3 (1.5)
GO:0035770	ribonucleoprotein granule	0.05	> 0.20	TRAFD1 (3.0)	OASL (2.5)	PARP10 (2.1)	ANKRD31 (2.0)	COL4A3BP (2.0)	TXNL4B (1.9)	GATAD2A (1.8)	MAPKAPK5 (1.8)	ENSG00000238078 (1.8)	ENSG00000228044 (1.7)
REACTOME_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	REACTOME_MYD88_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.05	> 0.20	RELB (4.3)	TRIB1 (3.9)	SH2B3 (3.3)	BCL3 (3.1)	PVR (2.8)	HLX (2.7)	CARM1 (2.1)	GMIP (1.9)	MAFB (1.8)	BUD13 (1.7)
REACTOME_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_5_TLR5_CASCADE	0.05	> 0.20	RELB (4.3)	TRIB1 (3.9)	SH2B3 (3.3)	BCL3 (3.1)	PVR (2.8)	HLX (2.7)	CARM1 (2.1)	GMIP (1.9)	MAFB (1.8)	BUD13 (1.7)
REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_10_TLR10_CASCADE	0.05	> 0.20	RELB (4.3)	TRIB1 (3.9)	SH2B3 (3.3)	BCL3 (3.1)	PVR (2.8)	HLX (2.7)	CARM1 (2.1)	GMIP (1.9)	MAFB (1.8)	BUD13 (1.7)
MP:0004883	abnormal vascular wound healing	0.05	> 0.20	APOB (2.6)	ABCG5 (2.6)	GPAM (2.6)	CELSR2 (2.6)	KIAA1324 (2.0)	TRIB1 (2.0)	BCAM (1.9)	LDLR (1.8)	APOA5 (1.7)	ABCG8 (1.7)
MP:0010090	increased circulating creatine kinase level	0.05	> 0.20	SYPL2 (3.6)	LPIN3 (3.1)	KANK2 (2.5)	GEMIN7 (2.3)	AMIGO1 (2.3)	CEACAM19 (2.3)	TMEM50A (2.2)	SLC44A2 (2.1)	MOSC1 (2.0)	GPAM (1.9)
MP:0005262	coloboma	0.05	> 0.20	DYNC2LI1 (3.9)	ZNF180 (2.1)	DNAH11 (2.1)	PLEKHH2 (2.1)	ENSG00000226648 (2.0)	TMEM116 (2.0)	ENSG00000228044 (2.0)	ABO (1.9)	ZHX3 (1.6)	FRK (1.5)
GO:0004622	lysophospholipase activity	0.05	> 0.20	TIMD4 (4.1)	NKPD1 (3.3)	CETP (3.1)	SORT1 (2.5)	MAFB (2.4)	PLEKHH2 (2.1)	MYLIP (2.1)	ABCG8 (2.0)	HLX (2.0)	UBXN2B (1.9)
ENSG00000120949	TNFRSF8 PPI subnetwork	0.05	> 0.20	PARP10 (3.0)	USP24 (2.8)	MAU2 (2.8)	GMIP (2.8)	ZNF180 (2.6)	BCL3 (2.6)	RELB (2.0)	ATXN2 (2.0)	PSRC1 (1.8)	SMARCA4 (1.8)
MP:0008565	decreased interferon-beta secretion	0.05	> 0.20	OASL (12.0)	PARP10 (8.1)	TRAFD1 (5.8)	BCL3 (3.0)	RELB (2.7)	ATP13A1 (2.5)	FRK (1.8)	GRINA (1.5)	C1orf63 (1.5)	CYB561D1 (1.5)
ENSG00000138722	MMRN1 PPI subnetwork	0.05	> 0.20	ILF3 (2.9)	HMGCR (2.7)	TOMM40 (2.5)	SMARCA4 (2.4)	FADS1 (2.2)	TMEM57 (2.1)	OGDH (2.0)	LDLR (1.9)	TMEM50A (1.8)	FADS2 (1.7)
GO:0022618	ribonucleoprotein complex assembly	0.05	> 0.20	C12orf43 (3.1)	BRAP (3.0)	QTRT1 (2.7)	ZNF259 (2.7)	SUGP1 (2.7)	DHX38 (2.2)	BUD13 (2.1)	NAA25 (2.0)	DDX56 (2.0)	GOT2P1 (1.8)
ENSG00000136156	ITM2B PPI subnetwork	0.05	> 0.20	DNM2 (3.1)	COL4A3BP (2.7)	GMIP (2.4)	USP24 (2.4)	PLEC (2.2)	POLK (2.1)	BCL3 (1.8)	ALDH2 (1.8)	DNAH11 (1.8)	SLC44A2 (1.8)
GO:0002039	p53 binding	0.05	> 0.20	ATXN2 (3.5)	DHX38 (3.3)	BRAP (2.5)	ILF3 (2.5)	SMARCA4 (2.3)	USP24 (2.1)	TMEM57 (2.1)	CARM1 (2.0)	ATP13A1 (1.7)	GATAD2A (1.7)
MP:0003355	decreased ovulation rate	0.05	> 0.20	MAFB (2.7)	TRIB1 (2.7)	BCL3 (2.6)	MOSC1 (2.1)	CELSR2 (1.8)	HP (1.8)	HLX (1.8)	C11orf9 (1.8)	BCAM (1.7)	C17orf57 (1.6)
MP:0003917	increased kidney weight	0.05	> 0.20	GPAM (3.7)	PLEKHH2 (2.9)	MOSC1 (2.8)	SLC22A1 (2.7)	APOC4 (2.5)	APOA5 (2.5)	PLG (2.5)	CEACAM19 (2.3)	ALDH2 (2.2)	APOB (2.2)
ENSG00000139515	PDX1 PPI subnetwork	0.05	> 0.20	PARP10 (3.0)	LPAR2 (2.7)	OASL (2.5)	ENSG00000228044 (2.4)	ABCG5 (2.4)	C12orf43 (2.2)	ABCG8 (2.2)	COL4A3BP (2.1)	TRAFD1 (2.0)	PLEKHH2 (1.9)
MP:0002376	abnormal dendritic cell physiology	0.05	> 0.20	RELB (3.8)	SH2B3 (2.8)	BCL3 (2.7)	TRAFD1 (2.7)	PARP10 (2.6)	OASL (2.5)	HLX (2.3)	GMIP (2.1)	TRIB1 (1.5)	TIMD4 (1.5)
GO:0006706	steroid catabolic process	0.05	> 0.20	LPA (6.6)	SLC22A1 (4.7)	CYP7A1 (3.4)	ENSG00000228044 (3.0)	APOC4 (3.0)	ENSG00000254235 (2.9)	ABCG8 (2.8)	ABCG5 (2.5)	ANGPTL3 (2.4)	APOA5 (2.4)
ENSG00000117707	PROX1 PPI subnetwork	0.05	> 0.20	HAVCR1 (2.6)	ZHX3 (2.5)	UBXN2B (2.1)	GCNT4 (1.7)	PMFBP1 (1.6)	ABCG8 (1.5)	MOSC1 (1.4)	DNAH11 (1.4)	ABO (1.3)	ENSG00000226648 (1.2)
ENSG00000138756	BMP2K PPI subnetwork	0.05	> 0.20	CARM1 (3.6)	DNM2 (3.4)	NKPD1 (2.8)	SMARCA4 (2.7)	GCNT4 (2.7)	BRAP (2.4)	PTPN11 (2.3)	ZNF259 (1.8)	ATXN2 (1.7)	DHX38 (1.6)
GO:0006536	glutamate metabolic process	0.05	> 0.20	ANGPTL3 (3.2)	ABCG8 (3.1)	TM6SF2 (3.0)	SLC22A1 (3.0)	LPA (3.0)	DNAH11 (2.8)	ABO (2.6)	PMFBP1 (2.4)	APOC4 (2.4)	PLG (2.2)
ENSG00000158486	DNAH3 PPI subnetwork	0.05	> 0.20	GPAM (3.1)	LDLR (2.5)	CETP (2.5)	MOSC1 (2.0)	FADS2 (1.9)	PCSK9 (1.9)	AMIGO1 (1.9)	HAVCR1 (1.8)	PTPN11 (1.8)	ENSG00000228044 (1.7)
GO:0032269	negative regulation of cellular protein metabolic process	0.05	> 0.20	PSMA5 (3.0)	TMEM57 (2.7)	NAA25 (2.1)	TRAFD1 (2.1)	DDX56 (1.7)	GRINA (1.5)	TRIB1 (1.5)	C12orf43 (1.4)	GCNT4 (1.3)	ZNF259 (1.3)
REACTOME_ASSEMBLY_OF_THE_PRE:REPLICATIVE_COMPLEX	REACTOME_ASSEMBLY_OF_THE_PRE:REPLICATIVE_COMPLEX	0.05	> 0.20	PSMA5 (5.5)	FEN1 (3.2)	NT5DC1 (3.0)	TRAFD1 (2.7)	NAA25 (2.1)	SUGP1 (1.9)	TOMM40 (1.9)	PARP10 (1.6)	DDX56 (1.5)	USP1 (1.5)
ENSG00000109929	SC5DL PPI subnetwork	0.05	> 0.20	HMGCR (13.2)	LDLR (10.9)	FADS1 (9.4)	FADS2 (8.4)	PCSK9 (7.1)	NPC1L1 (3.8)	CYP7A1 (2.9)	TM6SF2 (2.1)	GPAM (2.1)	C12orf47 (1.9)
ENSG00000100393	EP300 PPI subnetwork	0.05	> 0.20	TRIB1 (4.5)	HLX (2.9)	MAFB (2.5)	ATXN2 (2.3)	PARP10 (2.1)	KANK2 (2.1)	BCL3 (2.0)	BUD13 (1.8)	DHX38 (1.8)	MAU2 (1.7)
GO:0071826	ribonucleoprotein complex subunit organization	0.05	> 0.20	C12orf43 (3.3)	BRAP (3.2)	SUGP1 (2.7)	QTRT1 (2.7)	ZNF259 (2.6)	DHX38 (2.2)	NAA25 (2.1)	PTPN11 (2.0)	GOT2P1 (1.9)	DDX56 (1.9)
MP:0003921	abnormal heart left ventricle morphology	0.05	> 0.20	PVRL2 (2.8)	CBLC (2.4)	BCAM (1.9)	BCL3 (1.5)	APOB (1.4)	C17orf57 (1.4)	KANK2 (1.4)	ACAD10 (1.3)	C11orf9 (1.3)	NYNRIN (1.3)
GO:0032868	response to insulin stimulus	0.05	> 0.20	COL4A3BP (3.3)	SORT1 (2.7)	MOSC1 (2.6)	TMEM57 (2.2)	GPAM (2.1)	ENSG00000238078 (2.0)	HAPLN4 (1.9)	ENSG00000254235 (1.9)	PTPN11 (1.7)	GRINA (1.6)
ENSG00000173692	PSMD1 PPI subnetwork	0.05	> 0.20	PSMA5 (4.8)	NAA25 (2.8)	TRAFD1 (2.7)	SARS (2.6)	NT5DC1 (2.5)	TOMM40 (1.9)	DDX56 (1.8)	BRAP (1.7)	TOP1 (1.7)	SMARCA4 (1.6)
GO:0005764	lysosome	0.05	> 0.20	ERP29 (5.1)	APOE (3.5)	TMEM50A (3.2)	COL4A3BP (2.8)	GRINA (2.8)	SORT1 (2.6)	TMED4 (2.5)	ATP13A1 (2.4)	MAFB (2.3)	CLPTM1 (2.1)
GO:0000323	lytic vacuole	0.05	> 0.20	ERP29 (5.1)	APOE (3.5)	TMEM50A (3.2)	COL4A3BP (2.8)	GRINA (2.8)	SORT1 (2.6)	TMED4 (2.5)	ATP13A1 (2.4)	MAFB (2.3)	CLPTM1 (2.1)
MP:0000322	increased granulocyte number	0.05	> 0.20	RELB (4.5)	BCL3 (4.4)	GMIP (2.9)	PARP10 (2.8)	HLX (2.7)	TRAFD1 (2.3)	MAFB (2.1)	TRIB1 (2.1)	SH2B3 (1.9)	GRINA (1.6)
GO:0035162	embryonic hemopoiesis	0.05	> 0.20	RHCE (4.2)	RHD (4.0)	CYB561D1 (2.0)	DNAH11 (2.0)	ENSG00000238078 (1.9)	ENSG00000254235 (1.9)	BRAP (1.8)	ITGB3 (1.8)	ZNF259 (1.7)	GMPR (1.7)
MP:0010300	increased skin tumor incidence	0.05	> 0.20	PBX4 (2.6)	MARK4 (2.2)	SLC44A2 (2.0)	ZNF101 (1.9)	ALDH2 (1.7)	LPIN3 (1.7)	TMEM116 (1.7)	SORT1 (1.7)	FADS2 (1.6)	POLK (1.6)
ENSG00000090487	SPG21 PPI subnetwork	0.06	> 0.20	PVR (2.3)	TRAPPC6A (2.1)	APOE (2.1)	ENSG00000254235 (2.1)	BLOC1S3 (2.0)	C12orf47 (1.8)	CETP (1.8)	GEMIN7 (1.8)	ENSG00000228044 (1.8)	APOC1 (1.7)
GO:0042379	chemokine receptor binding	0.06	> 0.20	TIMD4 (4.2)	RELB (3.8)	MAFB (3.3)	BCL3 (3.1)	OASL (3.0)	PVRL2 (2.8)	CETP (2.6)	GRINA (1.8)	ENSG00000228044 (1.7)	TRAFD1 (1.5)
ENSG00000198300	ZIM2 PPI subnetwork	0.06	> 0.20	APOC1 (3.3)	ITGB3 (3.2)	APOB (2.5)	GMPR (2.4)	LPIN3 (2.2)	HAVCR1 (2.2)	TMEM50A (2.2)	C1orf63 (2.1)	MAPKAPK5 (2.1)	TMEM57 (1.9)
GO:0030864	cortical actin cytoskeleton	0.06	> 0.20	RHD (4.0)	RHCE (3.0)	C12orf51 (2.6)	PLCG1 (2.3)	KANK2 (2.3)	ZNF101 (2.1)	PLEC (1.8)	CETP (1.7)	AP1M2 (1.7)	ENSG00000238078 (1.6)
GO:0042036	negative regulation of cytokine biosynthetic process	0.06	> 0.20	ENSG00000238078 (2.7)	ENSG00000254235 (2.7)	ENSG00000228044 (2.6)	CEACAM19 (2.5)	C12orf47 (1.7)	ENSG00000226645 (1.5)	TMED4 (1.5)	ST3GAL4 (1.3)	ZNF101 (1.3)	ZNF180 (1.2)
ENSG00000143995	MEIS1 PPI subnetwork	0.06	> 0.20	SYPL2 (2.7)	DNAH11 (2.6)	ANKRD31 (2.5)	ATXN7L2 (2.3)	ENSG00000228044 (2.1)	PMFBP1 (2.0)	ATXN2 (2.0)	KANK2 (1.9)	HLX (1.8)	PCSK9 (1.8)
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	KEGG_GLYCOLYSIS_GLUCONEOGENESIS	0.06	> 0.20	ALDH2 (3.2)	LPA (3.1)	PLG (3.1)	CYP7A1 (3.0)	MOSC1 (2.7)	SLC22A1 (2.5)	APOC4 (2.2)	ANGPTL3 (2.2)	HP (2.1)	GPAM (2.0)
ENSG00000078304	PPP2R5C PPI subnetwork	0.06	> 0.20	MYLIP (2.7)	CEACAM19 (2.6)	ENSG00000226645 (2.6)	MARK4 (2.3)	TRIB1 (2.1)	PSRC1 (2.1)	CBLC (1.9)	LPAR2 (1.8)	PVRL2 (1.7)	UBXN2B (1.7)
MP:0008008	early cellular replicative senescence	0.06	> 0.20	DOCK7 (3.0)	MARK4 (2.8)	UBXN2B (2.7)	BRAP (2.4)	ATXN7L2 (2.0)	ANKRD31 (1.9)	USP24 (1.9)	DHX38 (1.9)	PBX4 (1.9)	TMEM116 (1.9)
GO:0000187	activation of MAPK activity	0.06	> 0.20	LPAR2 (2.9)	ABO (2.8)	ENSG00000226645 (2.2)	ENSG00000228044 (2.0)	SLC44A2 (1.9)	ST3GAL4 (1.8)	GCNT4 (1.7)	GMIP (1.7)	TSSK6 (1.5)	MAU2 (1.4)
GO:0050880	regulation of blood vessel size	0.06	> 0.20	C12orf47 (2.4)	LPIN3 (1.8)	TSSK6 (1.8)	CETP (1.7)	ENSG00000228044 (1.7)	FRK (1.6)	ABO (1.5)	GMPR (1.5)	HAPLN4 (1.4)	NPC1L1 (1.4)
ENSG00000115274	INO80B PPI subnetwork	0.06	> 0.20	DHX38 (2.6)	BUD13 (2.1)	PCSK9 (2.1)	BRAP (2.0)	USP24 (2.0)	PLCG1 (1.9)	ATXN7L2 (1.9)	C12orf43 (1.8)	ZNF180 (1.7)	KANK2 (1.7)
GO:0008527	taste receptor activity	0.06	> 0.20	GCNT4 (2.9)	ABO (2.6)	ENSG00000228044 (2.5)	TSSK6 (1.9)	DNAH11 (1.9)	ENSG00000235545 (1.8)	ENSG00000226645 (1.6)	ANKRD31 (1.5)	NPC1L1 (1.4)	C11orf9 (1.2)
ENSG00000169429	IL8 PPI subnetwork	0.06	> 0.20	RELB (6.8)	BCL3 (4.4)	TRIB1 (3.8)	OASL (3.0)	ITGB3 (2.6)	MAFB (2.5)	GRINA (2.1)	PVR (2.0)	LPAR2 (1.7)	APOE (1.7)
ENSG00000143748	NVL PPI subnetwork	0.06	> 0.20	ZNF259 (5.1)	NAA25 (4.9)	DDX56 (4.2)	TOMM40 (3.7)	QTRT1 (3.2)	DHODH (3.1)	DHX38 (2.8)	MAPKAPK5 (2.5)	C12orf43 (2.4)	ENSG00000226645 (2.4)
MP:0011090	partial perinatal lethality	0.06	> 0.20	HAVCR1 (2.9)	BCAM (2.8)	TRIB1 (2.5)	PVR (2.3)	PVRL2 (2.3)	MYLIP (2.1)	HLX (1.9)	ENSG00000238078 (1.9)	KANK2 (1.9)	USP24 (1.8)
ENSG00000178363	CALML3 PPI subnetwork	0.06	> 0.20	SYPL2 (3.9)	GMPR (2.3)	GPAM (2.0)	RPH3A (1.9)	OGDH (1.8)	NCAN (1.7)	MOSC1 (1.6)	SORT1 (1.6)	PLEC (1.5)	ADAM1 (1.4)
ENSG00000115866	DARS PPI subnetwork	0.06	> 0.20	SARS (7.4)	NAA25 (3.1)	PSMA5 (2.9)	FADS2 (2.7)	SMARCA4 (2.7)	SUGP1 (2.6)	ZNF259 (2.6)	HMGCR (2.5)	QTRT1 (2.2)	FADS1 (2.1)
ENSG00000204390	HSPA1L PPI subnetwork	0.06	> 0.20	RELB (5.3)	BCL3 (4.6)	PLEC (3.0)	ILF3 (2.4)	PVR (2.4)	TOMM40 (2.2)	PARP10 (1.9)	ZNF259 (1.8)	GRINA (1.8)	ATP13A1 (1.7)
ENSG00000164107	HAND2 PPI subnetwork	0.06	> 0.20	MARK4 (2.6)	GRINA (2.6)	DNM2 (2.4)	OGDH (2.3)	C11orf9 (2.3)	CARM1 (2.3)	KANK2 (2.1)	ATXN7L2 (1.8)	ENSG00000238078 (1.8)	HLX (1.5)
ENSG00000163347	CLDN1 PPI subnetwork	0.06	> 0.20	CBLC (4.5)	AP1M2 (4.3)	PVRL2 (3.4)	BCAM (3.0)	ATXN2 (2.7)	FRK (2.1)	ITGB3 (2.0)	KANK2 (2.0)	YIPF2 (1.9)	GPAM (1.8)
ENSG00000163528	CHCHD4 PPI subnetwork	0.06	> 0.20	MOSC1 (2.6)	ANGPTL3 (2.1)	GPAM (1.9)	GMIP (1.8)	ENSG00000238078 (1.8)	TOMM40 (1.8)	PBX4 (1.8)	CYP7A1 (1.7)	TRAPPC6A (1.6)	ENSG00000226648 (1.6)
MP:0008560	increased tumor necrosis factor secretion	0.06	> 0.20	CETP (4.0)	GMIP (3.6)	MAFB (3.6)	TRIB1 (3.4)	OASL (3.2)	RELB (3.0)	BCL3 (2.8)	PARP10 (2.5)	TIMD4 (2.4)	GRINA (2.3)
ENSG00000128322	IGLL1 PPI subnetwork	0.06	> 0.20	BCAM (3.2)	ALDH2 (2.8)	CILP2 (2.6)	RPH3A (2.1)	TIMD4 (2.0)	NYNRIN (1.9)	RHD (1.9)	SLC22A1 (1.8)	CLPTM1 (1.8)	DOCK7 (1.7)
GO:0043603	cellular amide metabolic process	0.06	> 0.20	TM6SF2 (5.0)	ABCG5 (4.3)	ABCG8 (4.3)	NPC1L1 (3.7)	CYP7A1 (2.5)	PBX4 (2.5)	APOC4 (2.3)	SLC22A1 (2.3)	ANKRD31 (2.2)	ZHX3 (2.2)
GO:0005158	insulin receptor binding	0.06	> 0.20	GPAM (2.5)	CELSR2 (2.3)	CYP7A1 (2.2)	C11orf9 (2.2)	APOC4 (1.9)	ANGPTL3 (1.8)	NAA25 (1.6)	SH2B3 (1.6)	KANK2 (1.5)	BRAP (1.4)
ENSG00000081377	CDC14B PPI subnetwork	0.06	> 0.20	PSRC1 (3.4)	DNM2 (3.3)	MAU2 (3.2)	ILF3 (2.5)	LDLR (2.0)	C12orf51 (1.9)	RELB (1.8)	AP1M2 (1.8)	PLEC (1.8)	RHCE (1.8)
GO:0043499	eukaryotic cell surface binding	0.06	> 0.20	APOB (5.9)	HP (5.9)	ANGPTL3 (4.6)	PLG (4.4)	APOA5 (4.0)	APOC4 (3.5)	APOC1 (2.8)	MOSC1 (2.6)	ITGB3 (2.5)	PVR (2.5)
GO:0042605	peptide antigen binding	0.06	> 0.20	PARP10 (3.8)	NPC1L1 (3.4)	TM6SF2 (3.3)	CETP (2.9)	TRAFD1 (2.3)	CELSR2 (2.2)	LPA (2.1)	FADS1 (2.0)	HMGCR (2.0)	HAPLN4 (1.9)
ENSG00000119812	FAM98A PPI subnetwork	0.06	> 0.20	MAPKAPK5 (3.2)	ATXN2 (3.0)	SMARCA4 (2.9)	BRAP (2.8)	C12orf51 (2.4)	C12orf43 (2.4)	TRAFD1 (2.3)	CLPTM1 (2.3)	NAA25 (2.2)	OGDH (2.0)
GO:0050308	sugar-phosphatase activity	0.06	> 0.20	NPC1L1 (3.6)	SORT1 (2.9)	TM6SF2 (2.4)	PLG (2.2)	ACAD10 (2.2)	LPA (2.0)	AP1M2 (1.9)	TRIB1 (1.9)	ENSG00000228044 (1.8)	MAFB (1.8)
GO:0019203	carbohydrate phosphatase activity	0.06	> 0.20	NPC1L1 (3.6)	SORT1 (2.9)	TM6SF2 (2.4)	PLG (2.2)	ACAD10 (2.2)	LPA (2.0)	AP1M2 (1.9)	TRIB1 (1.9)	ENSG00000228044 (1.8)	MAFB (1.8)
ENSG00000196136	SERPINA3 PPI subnetwork	0.06	> 0.20	ENSG00000228044 (4.1)	HP (2.8)	CEACAM19 (2.4)	MOSC1 (1.7)	RHD (1.6)	SLC22A1 (1.5)	ACAD10 (1.5)	ANKRD31 (1.3)	APOC4 (1.2)	ENSG00000226648 (1.2)
GO:0042278	purine nucleoside metabolic process	0.06	> 0.20	DHODH (3.1)	TXNL4B (2.9)	TRAPPC6A (2.8)	PCSK9 (2.4)	CYP7A1 (2.2)	LPA (2.0)	C12orf47 (1.9)	FADS2 (1.8)	ENSG00000254235 (1.7)	NT5DC1 (1.6)
ENSG00000120688	WBP4 PPI subnetwork	0.06	> 0.20	ILF3 (4.6)	SUGP1 (3.9)	SMARCA4 (3.6)	DHX38 (3.3)	C1orf63 (2.8)	MAU2 (2.7)	TOP1 (2.7)	ATP13A1 (2.5)	USP1 (2.5)	CLPTM1 (2.3)
MP:0005554	decreased circulating creatinine level	0.06	> 0.20	TMEM116 (2.8)	PMFBP1 (2.5)	ABCG5 (2.2)	TRIB1 (2.2)	HAVCR1 (2.1)	TM6SF2 (2.0)	PBX4 (1.9)	TIMD4 (1.8)	DYNC2LI1 (1.8)	C19orf52 (1.8)
MP:0008843	absent subcutaneous adipose tissue	0.06	> 0.20	TRIB1 (2.7)	PLEC (2.4)	MOSC1 (2.3)	PCSK9 (2.3)	ACAD10 (2.2)	KANK2 (2.1)	CYB561D1 (2.1)	ENSG00000226648 (1.8)	CBLC (1.8)	SUGP1 (1.7)
ENSG00000170632	ARMC10 PPI subnetwork	0.06	> 0.20	ACAD10 (3.9)	NT5DC1 (3.0)	HNF1A (2.1)	C1orf63 (1.9)	TRAPPC6A (1.8)	GMPR (1.7)	PCSK9 (1.6)	CETP (1.6)	SORT1 (1.5)	TIMD4 (1.4)
ENSG00000134070	IRAK2 PPI subnetwork	0.06	> 0.20	ACAD10 (3.3)	HNF1A (2.4)	NT5DC1 (2.2)	CETP (2.0)	PLEKHH2 (2.0)	CBLC (1.9)	TMEM50A (1.7)	TRAPPC6A (1.7)	ATXN7L2 (1.7)	ERP29 (1.6)
ENSG00000132153	DHX30 PPI subnetwork	0.06	> 0.20	OGDH (2.0)	DHX38 (2.0)	NT5DC1 (2.0)	QTRT1 (1.9)	PLCG1 (1.8)	ATXN7L2 (1.8)	ATP13A1 (1.8)	DNAH11 (1.7)	BUD13 (1.7)	ABO (1.7)
MP:0004003	abnormal vascular endothelial cell physiology	0.06	> 0.20	SH2B3 (2.4)	BCAM (2.3)	ALDH2 (2.0)	ITGB3 (1.9)	CILP2 (1.7)	PVR (1.6)	CYP7A1 (1.5)	TRIB1 (1.5)	NCAN (1.4)	ENSG00000228044 (1.3)
MP:0002928	abnormal bile duct morphology	0.06	> 0.20	DYNC2LI1 (4.0)	HAVCR1 (2.9)	BCL3 (2.3)	CYB561D1 (2.3)	PLEKHH2 (1.9)	ZHX3 (1.7)	HNF1A (1.6)	ENSG00000254235 (1.6)	FRK (1.6)	CEACAM19 (1.5)
GO:0034434	sterol esterification	0.06	> 0.20	APOC1 (3.9)	APOE (3.3)	APOB (3.3)	NPC1L1 (3.1)	HAVCR1 (3.0)	ENSG00000228044 (2.9)	APOA5 (2.5)	HNF1A (2.4)	ABCG5 (2.1)	APOC4 (2.1)
GO:0034435	cholesterol esterification	0.06	> 0.20	APOC1 (3.9)	APOE (3.3)	APOB (3.3)	NPC1L1 (3.1)	HAVCR1 (3.0)	ENSG00000228044 (2.9)	APOA5 (2.5)	HNF1A (2.4)	ABCG5 (2.1)	APOC4 (2.1)
GO:0034433	steroid esterification	0.06	> 0.20	APOC1 (3.9)	APOE (3.3)	APOB (3.3)	NPC1L1 (3.1)	HAVCR1 (3.0)	ENSG00000228044 (2.9)	APOA5 (2.5)	HNF1A (2.4)	ABCG5 (2.1)	APOC4 (2.1)
ENSG00000172115	CYCS PPI subnetwork	0.06	> 0.20	TRAPPC6A (2.6)	BUD13 (2.5)	DNM2 (2.4)	BRAP (2.4)	ALDH2 (2.0)	PSMA5 (1.9)	SH2B3 (1.8)	RELB (1.7)	OGDH (1.7)	ENSG00000226645 (1.6)
ENSG00000165527	ARF6 PPI subnetwork	0.06	> 0.20	SARS (4.4)	SMARCA4 (4.1)	ILF3 (3.4)	ATP13A1 (3.4)	DOCK7 (3.1)	CLPTM1 (2.8)	DNM2 (2.7)	OGDH (2.3)	ERP29 (2.3)	PSMA5 (2.2)
MP:0008127	decreased dendritic cell number	0.06	> 0.20	RELB (4.9)	BCL3 (4.0)	TRAFD1 (3.1)	SH2B3 (2.5)	PARP10 (2.1)	HAVCR1 (2.1)	ATXN7L2 (2.1)	PVRL2 (2.1)	HLX (2.1)	GEMIN7 (2.0)
ENSG00000175197	DDIT3 PPI subnetwork	0.06	> 0.20	TRIB1 (6.8)	SARS (3.3)	PVR (3.0)	BCL3 (2.7)	ENSG00000226645 (2.3)	HLX (1.9)	MAFB (1.8)	TSSK6 (1.7)	YIPF2 (1.6)	LDLR (1.6)
REACTOME_INTERFERON_ALPHABETA_SIGNALING	REACTOME_INTERFERON_ALPHABETA_SIGNALING	0.06	> 0.20	OASL (14.4)	PARP10 (9.0)	TRAFD1 (5.7)	GMPR (2.1)	BCL3 (1.8)	TMEM50A (1.7)	ATP13A1 (1.7)	RELB (1.3)	ENSG00000228044 (1.2)	TRIB1 (1.2)
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	0.06	> 0.20	ZHX3 (3.9)	PLEC (2.8)	MARK4 (2.5)	ITGB3 (2.5)	MYLIP (2.3)	SH2B3 (2.3)	DNM2 (2.2)	COL4A3BP (2.0)	CLPTM1 (2.0)	OGDH (2.0)
ENSG00000114354	TFG PPI subnetwork	0.06	> 0.20	PARP10 (2.5)	BLOC1S3 (2.4)	OASL (2.3)	LDLR (2.1)	KANK2 (2.1)	LPAR2 (1.9)	FADS1 (1.9)	FADS2 (1.9)	TSSK6 (1.9)	GEMIN7 (1.8)
MP:0001231	abnormal epidermis stratum basale morphology	0.06	> 0.20	CBLC (4.6)	PLEC (3.4)	ABCG8 (2.5)	MAFB (2.4)	AP1M2 (2.3)	ENSG00000254235 (2.1)	CELSR2 (2.0)	BCAM (1.9)	RELB (1.9)	LDLR (1.7)
GO:0004197	cysteine-type endopeptidase activity	0.06	> 0.20	APOE (4.0)	NKPD1 (2.6)	MAFB (2.5)	CEACAM19 (2.2)	ENSG00000254235 (2.0)	USP24 (2.0)	CBLC (1.9)	TMEM50A (1.8)	TMEM57 (1.8)	ERP29 (1.7)
MP:0011402	renal cast	0.06	> 0.20	PLEKHH2 (3.2)	BCAM (2.9)	FRK (2.4)	GRINA (2.3)	MAFB (2.3)	ENSG00000228044 (1.7)	NT5DC1 (1.6)	BCL3 (1.6)	CEACAM19 (1.6)	ACAD10 (1.6)
MP:0008074	increased CD4-positive T cell number	0.06	> 0.20	BCL3 (3.7)	RELB (3.5)	CETP (3.3)	ZNF101 (2.8)	TIMD4 (2.8)	GMIP (2.4)	MAFB (2.4)	APOC1 (2.2)	SLC44A2 (2.2)	TRIB1 (1.9)
GO:0042107	cytokine metabolic process	0.06	> 0.20	ENSG00000228044 (3.0)	TIMD4 (1.9)	ENSG00000226645 (1.7)	CYB561D1 (1.7)	GMIP (1.6)	ENSG00000235545 (1.6)	DNAH11 (1.6)	ST3GAL4 (1.6)	PARP10 (1.6)	BCL3 (1.5)
ENSG00000172915	NBEA PPI subnetwork	0.06	> 0.20	MYLIP (3.1)	NKPD1 (3.0)	SH2B3 (3.0)	MAFB (2.7)	LPIN3 (2.7)	TIMD4 (2.1)	NYNRIN (2.0)	BLOC1S3 (1.7)	GPAM (1.7)	ZNF180 (1.7)
ENSG00000090104	RGS1 PPI subnetwork	0.06	> 0.20	YIPF2 (3.3)	DNM2 (3.1)	C19orf52 (3.0)	ITGB3 (2.7)	ATP13A1 (2.5)	SUGP1 (2.3)	SMARCA4 (2.2)	MAU2 (2.1)	TSSK6 (2.0)	QTRT1 (2.0)
ENSG00000107566	ERLIN1 PPI subnetwork	0.06	> 0.20	RELB (8.8)	BCL3 (6.0)	SH2B3 (2.9)	CYB561D1 (2.2)	CLPTM1 (2.0)	BLOC1S3 (1.8)	PLEC (1.6)	PVR (1.6)	MYLIP (1.5)	MAU2 (1.5)
GO:0016628	oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor	0.06	> 0.20	FADS2 (8.2)	FADS1 (7.5)	HMGCR (6.8)	LDLR (5.7)	PCSK9 (4.9)	TRAPPC6A (4.3)	APOC1 (3.3)	MOSC1 (2.5)	LPA (2.3)	CYP7A1 (2.3)
ENSG00000079459	FDFT1 PPI subnetwork	0.06	> 0.20	HMGCR (11.3)	LDLR (10.2)	FADS1 (7.8)	FADS2 (5.8)	PCSK9 (5.5)	GEMIN7 (2.7)	TMEM50A (2.4)	BLOC1S3 (2.4)	CILP2 (2.3)	GPAM (2.0)
ENSG00000141434	MEP1B PPI subnetwork	0.06	> 0.20	TM6SF2 (4.9)	NPC1L1 (3.8)	ABCG5 (3.4)	KIAA1324 (3.3)	ABCG8 (2.9)	PLEKHH2 (2.9)	PARP10 (2.6)	OASL (2.2)	MAPKAPK5 (2.1)	APOB (1.9)
ENSG00000152104	PTPN14 PPI subnetwork	0.06	> 0.20	CETP (3.7)	TIMD4 (3.4)	PVRL2 (2.8)	AP1M2 (2.7)	OASL (2.5)	ATP13A1 (2.3)	LPAR2 (2.1)	C11orf9 (2.0)	PLEKHH2 (1.9)	SORT1 (1.7)
MP:0008944	decreased sensitivity to induced cell death	0.06	> 0.20	TRIB1 (2.9)	PARP10 (2.4)	OASL (2.4)	C17orf57 (2.1)	C1orf63 (1.8)	NYNRIN (1.8)	SH2B3 (1.8)	PVR (1.7)	LPAR2 (1.5)	ENSG00000254235 (1.5)
MP:0010209	abnormal circulating chemokine level	0.06	> 0.20	BCL3 (5.2)	RELB (2.9)	TIMD4 (2.8)	MAFB (2.5)	ENSG00000228044 (2.1)	CETP (2.0)	C11orf9 (1.9)	HP (1.8)	FRK (1.6)	ST3GAL4 (1.6)
MP:0000714	increased thymocyte number	0.06	> 0.20	RELB (2.2)	CYB561D1 (2.2)	TRAPPC6A (2.0)	PLCG1 (2.0)	BCL3 (1.9)	MAU2 (1.7)	PBX4 (1.7)	TMEM50A (1.5)	GMIP (1.5)	ZNF101 (1.5)
ENSG00000105976	MET PPI subnetwork	0.06	> 0.20	DNM2 (3.2)	TOP1 (3.1)	CETP (2.5)	GRINA (2.1)	DNAH11 (2.1)	DOCK7 (2.0)	ITGB3 (1.9)	KANK2 (1.9)	NCAN (1.9)	C12orf51 (1.9)
ENSG00000117133	RPF1 PPI subnetwork	0.06	> 0.20	ZNF259 (4.8)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (3.8)	QTRT1 (3.7)	DHX38 (3.0)	DHODH (2.8)	C12orf43 (2.3)	ATP13A1 (2.3)	ENSG00000226645 (2.2)
GO:0019840	isoprenoid binding	0.06	> 0.20	TM6SF2 (3.9)	ABCG5 (3.8)	APOB (3.6)	C11orf9 (2.8)	APOC4 (2.7)	NYNRIN (2.6)	APOA5 (2.5)	ABCG8 (2.3)	CYP7A1 (2.3)	LPAR2 (2.2)
GO:0060759	regulation of response to cytokine stimulus	0.06	> 0.20	ZNF101 (3.4)	GRINA (2.7)	CEACAM19 (2.7)	OASL (2.6)	PARP10 (2.6)	C17orf57 (2.5)	ENSG00000238078 (2.5)	TRAFD1 (2.0)	MAU2 (1.9)	NKPD1 (1.9)
ENSG00000118271	TTR PPI subnetwork	0.06	> 0.20	APOB (3.0)	PLG (2.7)	APOC4 (2.6)	APOA5 (2.5)	ANGPTL3 (2.4)	APOC1 (2.3)	C11orf9 (2.2)	HP (2.2)	GPAM (2.0)	CYP7A1 (2.0)
GO:0090077	foam cell differentiation	0.06	> 0.20	TIMD4 (4.2)	MOSC1 (2.7)	APOE (2.6)	ENSG00000228044 (2.5)	APOC1 (2.3)	GEMIN7 (2.0)	GOT2P1 (2.0)	ST3GAL4 (1.8)	GPAM (1.7)	ITGB3 (1.7)
GO:0010742	macrophage derived foam cell differentiation	0.06	> 0.20	TIMD4 (4.2)	MOSC1 (2.7)	APOE (2.6)	ENSG00000228044 (2.5)	APOC1 (2.3)	GEMIN7 (2.0)	GOT2P1 (2.0)	ST3GAL4 (1.8)	GPAM (1.7)	ITGB3 (1.7)
ENSG00000173575	CHD2 PPI subnetwork	0.06	> 0.20	C19orf52 (2.8)	BRAP (2.4)	SUGP1 (2.2)	DHX38 (2.1)	SMARCA4 (2.1)	ILF3 (2.1)	BUD13 (1.9)	ZNF180 (1.9)	PARP10 (1.8)	ATP13A1 (1.7)
ENSG00000114491	UMPS PPI subnetwork	0.06	> 0.20	NT5DC1 (2.7)	ATP13A1 (2.3)	ZNF180 (2.1)	DHODH (2.0)	LPA (1.9)	USP24 (1.9)	CETP (1.8)	QTRT1 (1.8)	GATAD2A (1.7)	CEACAM19 (1.6)
GO:0005149	interleukin-1 receptor binding	0.06	> 0.20	OASL (2.9)	NKPD1 (2.8)	PARP10 (2.5)	BCL3 (2.3)	ST3GAL4 (2.0)	GCNT4 (1.9)	ENSG00000254235 (1.7)	GMIP (1.6)	NYNRIN (1.6)	SMARCA4 (1.5)
ENSG00000198327	HIST1H4F PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197061	HIST1H4C PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000188987	HIST1H4D PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000158406	HIST1H4H PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000198518	HIST1H4E PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000124529	HIST1H4B PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197914	HIST1H4K PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000198558	HIST1H4L PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000183941	HIST2H4A PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000198339	HIST1H4I PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000182217	HIST2H4B PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197837	HIST4H4 PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000197238	HIST1H4J PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
ENSG00000196176	HIST1H4A PPI subnetwork	0.06	> 0.20	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.7)	TOMM40 (2.6)	DHODH (2.3)	DDX56 (2.3)	DHX38 (2.2)	QTRT1 (2.2)	FEN1 (2.1)	NAA25 (1.8)
MP:0009283	decreased gonadal fat pad weight	0.06	> 0.20	MOSC1 (4.3)	HAPLN4 (2.9)	GPAM (2.7)	ALDH2 (2.5)	HLX (2.4)	LPA (2.3)	TXNL4B (2.2)	SORT1 (2.1)	TM6SF2 (1.9)	CETP (1.9)
GO:0071407	cellular response to organic cyclic compound	0.06	> 0.20	NKPD1 (2.8)	LPIN3 (2.6)	PBX4 (2.5)	ENSG00000254235 (2.4)	GEMIN7 (2.3)	TRAPPC6A (2.0)	LPA (1.6)	BLOC1S3 (1.6)	CYB561D1 (1.5)	SLC44A2 (1.5)
GO:0090311	regulation of protein deacetylation	0.06	> 0.20	TMEM57 (4.6)	FADS2 (2.6)	GCNT4 (2.1)	FADS1 (2.0)	PPP1R37 (1.8)	PCSK9 (1.8)	GOT2P1 (1.6)	POLK (1.6)	DNM2 (1.5)	BRAP (1.5)
REACTOME_TRAF6_MEDIATED_NF:KB_ACTIVATION	REACTOME_TRAF6_MEDIATED_NF:KB_ACTIVATION	0.06	> 0.20	RELB (8.8)	OASL (7.0)	PARP10 (5.6)	BCL3 (4.9)	CYB561D1 (2.8)	TRAFD1 (2.5)	GRINA (2.0)	PVR (1.7)	MYLIP (1.7)	CLPTM1 (1.6)
ENSG00000122870	BICC1 PPI subnetwork	0.06	> 0.20	MAPKAPK5 (2.8)	ATP13A1 (2.8)	LPA (2.7)	TOMM40 (2.4)	USP24 (2.2)	MAU2 (2.2)	CEACAM19 (2.1)	ANKRD31 (2.1)	DHODH (2.0)	CETP (2.0)
ENSG00000171552	BCL2L1 PPI subnetwork	0.06	> 0.20	RELB (3.6)	TRAPPC6A (3.4)	TMEM50A (2.8)	GRINA (2.6)	CLPTM1 (2.4)	C12orf47 (2.3)	TRAFD1 (2.0)	GMIP (2.0)	C12orf43 (1.9)	ENSG00000238078 (1.9)
MP:0002397	abnormal bone marrow morphology	0.06	> 0.20	RHD (5.6)	RHCE (4.9)	CILP2 (3.2)	GMIP (2.8)	GRINA (2.4)	C12orf47 (2.2)	C12orf51 (2.1)	RELB (2.1)	MAPKAPK5 (2.1)	PLEC (2.1)
GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	0.06	> 0.20	POLK (3.2)	ENSG00000238078 (2.7)	C17orf57 (2.6)	TRAPPC6A (2.3)	OASL (2.1)	ITGB3 (2.0)	TRAFD1 (1.9)	PARP10 (1.7)	GOT2P1 (1.7)	GEMIN7 (1.7)
ENSG00000104375	STK3 PPI subnetwork	0.06	> 0.20	CEACAM19 (2.8)	UBXN2B (2.7)	PARP10 (2.7)	NT5DC1 (2.6)	TRAFD1 (2.4)	LPIN3 (1.9)	C1orf63 (1.7)	DHX38 (1.6)	ANKRD31 (1.6)	NKPD1 (1.6)
ENSG00000005175	RPAP3 PPI subnetwork	0.06	> 0.20	CARM1 (3.5)	TRAPPC6A (3.0)	GATAD2A (2.7)	TOMM40 (2.7)	ILF3 (2.6)	DNM2 (2.6)	QTRT1 (2.5)	CLPTM1 (2.4)	MARK4 (2.2)	BLOC1S3 (2.1)
KEGG_ACUTE_MYELOID_LEUKEMIA	KEGG_ACUTE_MYELOID_LEUKEMIA	0.06	> 0.20	DNM2 (4.0)	GATAD2A (2.5)	GMIP (2.5)	GEMIN7 (2.4)	BCL3 (2.4)	RELB (2.3)	BLOC1S3 (2.2)	GRINA (2.1)	HLX (2.1)	SLC44A2 (2.0)
GO:0016279	protein-lysine N-methyltransferase activity	0.06	> 0.20	C12orf51 (4.2)	ATXN2 (3.3)	C12orf43 (2.4)	MAU2 (2.4)	GOT2P1 (2.0)	BUD13 (1.8)	ATXN7L2 (1.8)	SMARCA4 (1.7)	USP24 (1.7)	BRAP (1.7)
GO:0016278	lysine N-methyltransferase activity	0.06	> 0.20	C12orf51 (4.2)	ATXN2 (3.3)	C12orf43 (2.4)	MAU2 (2.4)	GOT2P1 (2.0)	BUD13 (1.8)	ATXN7L2 (1.8)	SMARCA4 (1.7)	USP24 (1.7)	BRAP (1.7)
MP:0005201	abnormal retinal pigment epithelium morphology	0.06	> 0.20	DOCK7 (2.9)	ST3GAL4 (2.6)	PMFBP1 (2.3)	MAFB (2.2)	FADS1 (1.9)	GMPR (1.7)	GPAM (1.6)	HMGCR (1.5)	DYNC2LI1 (1.5)	APOE (1.3)
ENSG00000100316	RPL3 PPI subnetwork	0.06	> 0.20	ZNF259 (3.9)	NAA25 (3.3)	C12orf43 (2.9)	DDX56 (2.8)	DHX38 (2.6)	SARS (2.5)	TOMM40 (2.3)	SUGP1 (2.2)	TOP1 (2.2)	ATP13A1 (2.1)
GO:0042402	cellular biogenic amine catabolic process	0.06	> 0.20	ENSG00000254235 (4.6)	SLC22A1 (3.0)	LPA (2.7)	DNAH11 (2.5)	APOA5 (1.9)	CYP7A1 (1.8)	TM6SF2 (1.7)	HNF1A (1.5)	ATXN7L2 (1.4)	FRK (1.4)
MP:0002135	abnormal kidney morphology	0.06	> 0.20	BCAM (3.1)	PLEKHH2 (3.1)	NYNRIN (3.1)	TMEM116 (2.8)	KANK2 (2.4)	PVRL2 (2.4)	ENSG00000228044 (1.9)	AP1M2 (1.8)	PVR (1.6)	HLX (1.5)
ENSG00000083544	TDRD3 PPI subnetwork	0.06	> 0.20	ATP13A1 (4.2)	HNF1A (2.9)	DDX56 (2.8)	PTPN11 (2.6)	MAPKAPK5 (2.5)	DHODH (2.3)	BRAP (2.3)	CEACAM19 (2.2)	TOMM40 (2.1)	ANKRD31 (2.1)
ENSG00000117528	ABCD3 PPI subnetwork	0.06	> 0.20	C19orf52 (3.1)	SORT1 (2.7)	LPA (2.3)	GPAM (2.3)	ENSG00000226648 (2.3)	GRINA (2.0)	SLC44A2 (1.9)	MOSC1 (1.9)	ALDH2 (1.8)	SLC22A1 (1.8)
GO:0051341	regulation of oxidoreductase activity	0.06	> 0.20	ENSG00000235545 (4.1)	ENSG00000228044 (2.0)	GOT2P1 (2.0)	ATXN7L2 (1.9)	TXNL4B (1.8)	ZNF101 (1.8)	AMIGO1 (1.6)	FRK (1.5)	PVR (1.5)	HNF1A (1.4)
ENSG00000142867	BCL10 PPI subnetwork	0.06	> 0.20	BCL3 (3.1)	RELB (3.1)	MYLIP (2.4)	PLEC (2.2)	UBXN2B (2.2)	ZNF180 (2.1)	PARP10 (1.9)	ZNF101 (1.9)	ANKRD31 (1.9)	HLX (1.8)
ENSG00000106344	RBM28 PPI subnetwork	0.06	> 0.20	ZNF259 (5.2)	NAA25 (4.9)	TOMM40 (4.0)	QTRT1 (4.0)	DDX56 (3.9)	C12orf43 (3.1)	DHODH (2.9)	DHX38 (2.7)	ATP13A1 (2.5)	MAPKAPK5 (2.3)
ENSG00000089234	BRAP PPI subnetwork	0.06	> 0.20	ZNF259 (3.7)	TOMM40 (3.1)	TOP1 (2.9)	NAA25 (2.8)	DDX56 (2.3)	DHX38 (2.2)	USP24 (2.2)	SMARCA4 (2.1)	C12orf51 (2.0)	RHCE (1.9)
ENSG00000107816	LZTS2 PPI subnetwork	0.06	> 0.20	RHD (3.3)	ITGB3 (2.2)	PPP1R37 (2.2)	FRK (1.9)	MARK4 (1.8)	GMPR (1.7)	ENSG00000226648 (1.7)	PVRL2 (1.6)	TRAPPC6A (1.6)	ENSG00000228044 (1.6)
ENSG00000069399	BCL3 PPI subnetwork	0.06	> 0.20	RELB (5.0)	BCL3 (4.3)	TRIB1 (3.4)	BUD13 (2.6)	PSMA5 (2.5)	PLEC (2.3)	GRINA (2.2)	ATXN2 (1.8)	LDLR (1.8)	C12orf51 (1.7)
ENSG00000082641	NFE2L1 PPI subnetwork	0.06	> 0.20	TRIB1 (9.5)	BCL3 (2.9)	TSSK6 (2.3)	LDLR (2.1)	BLOC1S3 (2.0)	ENSG00000238078 (1.9)	GRINA (1.9)	MAFB (1.9)	PVR (1.6)	LPIN3 (1.6)
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE	0.06	> 0.20	RELB (4.1)	SH2B3 (3.7)	TRIB1 (3.5)	OASL (3.2)	BCL3 (2.9)	HLX (2.4)	PARP10 (2.2)	MAPKAPK5 (2.2)	BUD13 (1.9)	CARM1 (1.9)
ENSG00000101945	SUV39H1 PPI subnetwork	0.06	> 0.20	SMARCA4 (2.9)	C12orf51 (2.7)	MAU2 (2.6)	PLCG1 (2.2)	TOP1 (1.9)	ATP13A1 (1.8)	NT5DC1 (1.8)	ZHX3 (1.7)	MARK4 (1.6)	CEACAM19 (1.6)
ENSG00000168546	GFRA2 PPI subnetwork	0.06	> 0.20	OASL (2.8)	TMEM57 (2.0)	HNF1A (1.9)	PLEKHH2 (1.9)	TIMD4 (1.6)	CETP (1.5)	POLK (1.5)	C1orf63 (1.5)	ENSG00000228044 (1.5)	DNAH11 (1.5)
ENSG00000120694	HSPH1 PPI subnetwork	0.06	> 0.20	PSMA5 (3.4)	SARS (3.2)	SMARCA4 (3.2)	OGDH (3.1)	NAA25 (2.4)	CARM1 (2.4)	SUGP1 (2.3)	GOT2P1 (2.0)	ATP13A1 (2.0)	PTPN11 (2.0)
ENSG00000136695	IL36RN PPI subnetwork	0.06	> 0.20	NYNRIN (2.9)	ENSG00000254235 (2.3)	CYB561D1 (2.1)	GCNT4 (2.0)	MAU2 (2.0)	ABO (1.9)	KANK2 (1.9)	NPC1L1 (1.8)	SYPL2 (1.8)	GEMIN7 (1.8)
ENSG00000074696	PTPLAD1 PPI subnetwork	0.06	> 0.20	GRINA (2.5)	POC5 (2.4)	HLX (1.8)	BCL3 (1.8)	MAPKAPK5 (1.8)	TMEM57 (1.7)	ENSG00000228044 (1.7)	POLK (1.7)	BRAP (1.6)	RHD (1.5)
MP:0000733	abnormal muscle development	0.06	> 0.20	SYPL2 (5.1)	POLK (3.0)	PVR (2.7)	TRIB1 (2.0)	PLEC (2.0)	CYP7A1 (1.8)	ATXN7L2 (1.7)	KANK2 (1.6)	LPIN3 (1.5)	COL4A3BP (1.3)
KEGG_GALACTOSE_METABOLISM	KEGG_GALACTOSE_METABOLISM	0.06	> 0.20	DOCK7 (2.9)	TM6SF2 (2.7)	NPC1L1 (2.5)	TRAPPC6A (2.5)	CYP7A1 (2.1)	GOT2P1 (2.0)	ABCG5 (2.0)	NT5DC1 (1.8)	DHODH (1.6)	ABCG8 (1.6)
ENSG00000175467	SART1 PPI subnetwork	0.06	> 0.20	C19orf52 (3.6)	QTRT1 (3.5)	DHX38 (3.1)	SMARCA4 (3.1)	BRAP (3.1)	MAU2 (3.1)	CARM1 (3.1)	TOP1 (2.8)	BUD13 (2.6)	ILF3 (2.5)
ENSG00000164609	SLU7 PPI subnetwork	0.06	> 0.20	DHX38 (4.1)	SUGP1 (3.6)	BRAP (2.7)	BUD13 (2.5)	POC5 (2.4)	MAU2 (2.2)	ZNF259 (2.2)	TOP1 (2.1)	SMARCA4 (2.1)	ZNF180 (2.0)
ENSG00000198104	OR2T6 PPI subnetwork	0.06	> 0.20	APOB (5.8)	APOE (4.4)	PLG (4.3)	APOA5 (4.1)	ANGPTL3 (3.9)	APOC1 (3.7)	APOC4 (3.5)	PCSK9 (3.4)	HP (3.1)	NPC1L1 (2.6)
ENSG00000161638	ITGA5 PPI subnetwork	0.06	> 0.20	ITGB3 (4.7)	APOE (4.4)	BCAM (3.2)	SLC22A1 (2.6)	PLEC (2.4)	PLG (2.3)	APOC1 (2.3)	CLPTM1 (2.3)	HP (2.3)	APOC4 (2.0)
MP:0002421	abnormal cell-mediated immunity	0.06	> 0.20	APOC1 (4.2)	HLX (3.9)	BCL3 (3.7)	CETP (3.0)	GRINA (2.8)	SH2B3 (2.6)	PARP10 (2.0)	BRAP (2.0)	ST3GAL4 (1.8)	ALDH2 (1.8)
ENSG00000198835	GJC2 PPI subnetwork	0.06	> 0.20	APOB (5.9)	APOE (4.5)	PLG (4.3)	APOA5 (4.1)	ANGPTL3 (4.0)	APOC1 (3.8)	APOC4 (3.5)	PCSK9 (3.4)	HP (3.2)	NPC1L1 (2.5)
MP:0010373	myeloid hyperplasia	0.06	> 0.20	BCL3 (3.4)	RELB (3.0)	SH2B3 (2.5)	UBXN2B (2.4)	C12orf51 (2.1)	ENSG00000254235 (2.1)	MAPKAPK5 (2.0)	BUD13 (2.0)	ST3GAL4 (1.9)	USP24 (1.7)
MP:0000039	abnormal otic capsule morphology	0.06	> 0.20	CILP2 (3.3)	CEACAM19 (2.2)	KIAA1324 (1.9)	MYLIP (1.8)	ENSG00000226648 (1.8)	CETP (1.7)	PLEKHH2 (1.5)	DYNC2LI1 (1.5)	TRIB1 (1.3)	HLX (1.3)
ENSG00000131236	CAP1 PPI subnetwork	0.06	> 0.20	USP24 (3.4)	NAA25 (2.5)	OGDH (2.5)	SMARCA4 (2.3)	CLPTM1 (2.2)	TOMM40 (2.0)	CARM1 (1.8)	TOP1 (1.6)	NT5DC1 (1.6)	DDX56 (1.6)
ENSG00000143546	S100A8 PPI subnetwork	0.06	> 0.20	BLOC1S3 (2.4)	AP1M2 (2.2)	GMIP (2.2)	GEMIN7 (2.2)	CLPTM1 (2.1)	HP (1.9)	TOMM40 (1.8)	TRAPPC6A (1.7)	PCSK9 (1.7)	PLEKHH2 (1.5)
GO:0019320	hexose catabolic process	0.06	> 0.20	GOT2P1 (2.6)	PCSK9 (2.2)	ENSG00000254235 (2.0)	ACAD10 (1.9)	TRAPPC6A (1.9)	LPIN3 (1.8)	FRK (1.8)	TSSK6 (1.6)	FADS2 (1.6)	ERP29 (1.6)
MP:0001785	edema	0.06	> 0.20	BCAM (4.0)	NYNRIN (3.7)	PVRL2 (3.3)	HLX (2.8)	SLC44A2 (2.1)	SH2B3 (2.0)	KANK2 (1.9)	ATXN7L2 (1.8)	C11orf9 (1.7)	CETP (1.7)
ENSG00000113360	DROSHA PPI subnetwork	0.06	> 0.20	PARP10 (3.1)	MAU2 (3.0)	GMIP (2.7)	USP24 (2.6)	ZNF180 (2.3)	MARK4 (2.1)	POLK (2.0)	ATXN2 (2.0)	BCL3 (2.0)	SMARCA4 (1.9)
ENSG00000138834	MAPK8IP3 PPI subnetwork	0.06	> 0.20	PARP10 (3.6)	OASL (3.3)	ZNF180 (3.2)	HAPLN4 (2.7)	PLEKHH2 (2.7)	PLCG1 (2.6)	MARK4 (2.3)	LPAR2 (2.2)	GMIP (2.1)	C11orf9 (1.9)
GO:0044269	glycerol ether catabolic process	0.06	> 0.20	MOSC1 (4.5)	GPAM (4.0)	NPC1L1 (3.9)	TM6SF2 (2.9)	ABCG5 (2.7)	APOB (2.6)	HP (2.4)	APOC1 (2.4)	APOC4 (2.2)	PMFBP1 (2.0)
GO:0046461	neutral lipid catabolic process	0.06	> 0.20	MOSC1 (4.5)	GPAM (4.0)	NPC1L1 (3.9)	TM6SF2 (2.9)	ABCG5 (2.7)	APOB (2.6)	HP (2.4)	APOC1 (2.4)	APOC4 (2.2)	PMFBP1 (2.0)
GO:0046464	acylglycerol catabolic process	0.06	> 0.20	MOSC1 (4.5)	GPAM (4.0)	NPC1L1 (3.9)	TM6SF2 (2.9)	ABCG5 (2.7)	APOB (2.6)	HP (2.4)	APOC1 (2.4)	APOC4 (2.2)	PMFBP1 (2.0)
ENSG00000096171	VARS PPI subnetwork	0.06	> 0.20	SUGP1 (3.3)	SARS (3.2)	SMARCA4 (2.4)	ZNF180 (2.0)	ZNF101 (2.0)	NAA25 (2.0)	RHCE (1.9)	RHD (1.9)	CLPTM1 (1.9)	GPAM (1.8)
ENSG00000204394	VARS PPI subnetwork	0.06	> 0.20	SUGP1 (3.3)	SARS (3.2)	SMARCA4 (2.4)	ZNF180 (2.0)	ZNF101 (2.0)	NAA25 (2.0)	RHCE (1.9)	RHD (1.9)	CLPTM1 (1.9)	GPAM (1.8)
GO:0010883	regulation of lipid storage	0.06	> 0.20	MOSC1 (3.0)	TIMD4 (2.7)	CETP (2.6)	APOC1 (2.5)	GPAM (2.4)	ABCG8 (2.4)	GCNT4 (2.3)	GEMIN7 (2.1)	ENSG00000238078 (2.0)	APOE (2.0)
REACTOME_AMYLOIDS	REACTOME_AMYLOIDS	0.06	> 0.20	NPC1L1 (4.1)	APOB (3.5)	ABCG5 (3.1)	HP (2.8)	GMPR (2.7)	APOA5 (2.6)	MYLIP (2.2)	PLG (2.2)	PCSK9 (2.0)	ABCG8 (1.9)
ENSG00000123908	EIF2C2 PPI subnetwork	0.06	> 0.20	ATXN2 (2.7)	C12orf43 (2.4)	TMED4 (2.4)	COL4A3BP (2.3)	MAPKAPK5 (2.0)	ENSG00000235545 (1.9)	TMEM116 (1.6)	USP24 (1.6)	AMIGO1 (1.6)	C12orf51 (1.6)
ENSG00000183785	TUBA8 PPI subnetwork	0.06	> 0.20	ENSG00000228044 (3.0)	GOT2P1 (2.6)	ADAM1 (2.5)	ZNF101 (2.0)	PMFBP1 (1.9)	GEMIN7 (1.7)	BRAP (1.6)	DYNC2LI1 (1.6)	C11orf9 (1.6)	CARM1 (1.6)
GO:0048569	post-embryonic organ development	0.06	> 0.20	DNAH11 (3.7)	GEMIN7 (3.0)	MAFB (2.8)	ENSG00000226648 (2.6)	POLK (2.5)	HNF1A (2.5)	LPAR2 (2.4)	PPP1R37 (2.3)	TRAPPC6A (2.3)	FRK (2.1)
MP:0008641	increased circulating interleukin-1 beta level	0.06	> 0.20	BCL3 (3.2)	HMGCR (3.2)	TRIB1 (3.1)	MAFB (2.9)	GMIP (2.5)	TIMD4 (2.4)	ENSG00000228044 (2.3)	SH2B3 (1.8)	TOP1 (1.7)	CETP (1.7)
ENSG00000145715	RASA1 PPI subnetwork	0.06	> 0.20	SH2B3 (2.9)	SLC44A2 (2.5)	CETP (2.4)	MARK4 (2.3)	DNM2 (2.1)	PLEC (2.0)	GMIP (2.0)	MAFB (1.9)	GATAD2A (1.9)	HAVCR1 (1.8)
ENSG00000172340	SUCLG2 PPI subnetwork	0.06	> 0.20	TXNL4B (3.1)	GMPR (2.8)	C11orf9 (2.3)	DHX38 (2.2)	PMFBP1 (2.1)	PPP1R37 (2.0)	ENSG00000228044 (1.9)	UBXN2B (1.7)	ENSG00000238078 (1.6)	NKPD1 (1.5)
ENSG00000147050	KDM6A PPI subnetwork	0.06	> 0.20	C19orf52 (3.0)	TXNL4B (2.8)	PLCG1 (2.2)	BRAP (2.0)	BUD13 (2.0)	SUGP1 (1.9)	CLPTM1 (1.8)	TMED4 (1.8)	APOA5 (1.6)	MOSC1 (1.5)
ENSG00000117154	IGSF21 PPI subnetwork	0.06	> 0.20	PVRL2 (3.6)	PVR (2.9)	C17orf57 (2.5)	NYNRIN (2.5)	TRAPPC6A (2.3)	ATXN7L2 (1.9)	MARK4 (1.8)	GEMIN7 (1.8)	RPH3A (1.7)	ENSG00000238078 (1.7)
GO:0045926	negative regulation of growth	0.06	> 0.20	TXNL4B (2.4)	AMIGO1 (2.2)	GCNT4 (2.1)	TMED4 (2.0)	CILP2 (1.9)	MYLIP (1.9)	POLK (1.9)	C19orf52 (1.8)	HLX (1.6)	PVR (1.5)
GO:0001816	cytokine production	0.06	> 0.20	OASL (3.1)	PARP10 (2.7)	SH2B3 (2.5)	POLK (2.1)	TIMD4 (2.1)	RELB (2.1)	GMIP (2.0)	ZNF101 (2.0)	CYB561D1 (1.8)	BCL3 (1.7)
REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION	0.06	> 0.20	SARS (6.6)	ALDH2 (3.0)	HAPLN4 (2.9)	GPAM (2.5)	TM6SF2 (2.1)	ABCG5 (1.9)	C19orf52 (1.8)	ABCG8 (1.8)	ENSG00000254235 (1.6)	APOA5 (1.5)
ENSG00000128829	EIF2AK4 PPI subnetwork	0.06	> 0.20	DDX56 (4.4)	QTRT1 (4.1)	NAA25 (3.8)	ZNF259 (3.6)	C12orf43 (3.0)	ILF3 (2.9)	PLCG1 (2.7)	DHX38 (2.6)	TOP1 (2.3)	TOMM40 (2.2)
ENSG00000145425	RPS3A PPI subnetwork	0.06	> 0.20	DDX56 (3.9)	NAA25 (3.3)	TOMM40 (3.1)	ILF3 (2.8)	ZNF259 (2.7)	QTRT1 (2.7)	SARS (2.7)	SMARCA4 (2.6)	DHX38 (2.4)	SUGP1 (2.4)
ENSG00000105640	RPL18A PPI subnetwork	0.06	> 0.20	ZNF259 (3.8)	DDX56 (3.6)	NAA25 (3.3)	QTRT1 (3.0)	TOMM40 (2.7)	DHX38 (2.5)	C12orf43 (2.5)	SUGP1 (2.5)	DHODH (2.4)	ATP13A1 (2.1)
ENSG00000168918	INPP5D PPI subnetwork	0.06	> 0.20	ACAD10 (3.2)	C17orf57 (2.6)	HNF1A (2.5)	ITGB3 (2.1)	ERP29 (2.0)	PLEKHH2 (1.9)	ENSG00000226648 (1.9)	OGDH (1.9)	TIMD4 (1.8)	MAFB (1.7)
ENSG00000080345	RIF1 PPI subnetwork	0.06	> 0.20	PSMA5 (2.8)	TXNL4B (2.7)	TOMM40 (2.7)	GEMIN7 (2.6)	DYNC2LI1 (2.1)	PPP1R37 (2.1)	DHX38 (1.9)	CLPTM1 (1.9)	ATXN7L2 (1.8)	C12orf47 (1.7)
ENSG00000173542	MOB1B PPI subnetwork	0.06	> 0.20	PSRC1 (3.0)	BLOC1S3 (2.3)	POC5 (2.2)	RHCE (2.0)	GMPR (1.7)	DOCK7 (1.6)	ENSG00000254235 (1.5)	GEMIN7 (1.5)	USP1 (1.5)	ILF3 (1.2)
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	0.06	> 0.20	TOMM40 (3.0)	DHODH (2.9)	PVR (2.6)	TXNL4B (2.6)	DDX56 (2.1)	POC5 (2.0)	GRINA (1.9)	COL4A3BP (1.9)	TRAPPC6A (1.8)	TMEM50A (1.7)
ENSG00000145431	PDGFC PPI subnetwork	0.06	> 0.20	MYLIP (4.6)	C1orf63 (4.1)	HLX (3.0)	C17orf57 (2.4)	ENSG00000238078 (2.0)	LPIN3 (2.0)	SLC44A2 (1.9)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	GMIP (1.7)
ENSG00000170962	PDGFD PPI subnetwork	0.06	> 0.20	MYLIP (4.6)	C1orf63 (4.1)	HLX (3.0)	C17orf57 (2.4)	ENSG00000238078 (2.0)	LPIN3 (2.0)	SLC44A2 (1.9)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	GMIP (1.7)
REACTOME_SULFUR_AMINO_ACID_METABOLISM	REACTOME_SULFUR_AMINO_ACID_METABOLISM	0.06	> 0.20	SLC22A1 (3.5)	APOA5 (3.4)	PLG (3.4)	APOC4 (3.0)	ALDH2 (2.9)	ANGPTL3 (2.5)	HP (2.4)	CYP7A1 (2.4)	SARS (2.3)	C1orf63 (2.2)
ENSG00000138468	SENP7 PPI subnetwork	0.06	> 0.20	PSRC1 (3.2)	PARP10 (2.8)	USP24 (2.8)	MAU2 (2.7)	DHX38 (2.4)	GMIP (2.4)	BCL3 (2.2)	MARK4 (2.1)	ZNF180 (1.9)	SMARCA4 (1.9)
ENSG00000135213	POM121C PPI subnetwork	0.06	> 0.20	POC5 (3.8)	NAA25 (2.7)	USP1 (2.6)	POLK (2.4)	BUD13 (2.3)	FEN1 (2.2)	DOCK7 (2.2)	KIAA1324 (2.0)	ILF3 (1.9)	DDX56 (1.8)
ENSG00000136636	KCTD3 PPI subnetwork	0.06	> 0.20	GPAM (2.7)	LDLR (2.5)	ENSG00000228044 (2.3)	FADS2 (2.3)	HAVCR1 (1.9)	FADS1 (1.9)	PCSK9 (1.8)	CETP (1.8)	C12orf51 (1.7)	SLC22A1 (1.6)
GO:0007595	lactation	0.06	> 0.20	DNAH11 (3.0)	GOT2P1 (2.7)	ATXN7L2 (2.7)	KIAA1324 (2.5)	ANKRD31 (2.4)	GEMIN7 (2.0)	DHODH (1.9)	BLOC1S3 (1.8)	PMFBP1 (1.7)	TRAPPC6A (1.5)
GO:0005507	copper ion binding	0.06	> 0.20	APOB (3.1)	CILP2 (2.5)	HP (2.3)	BCAM (2.0)	PBX4 (1.8)	TRAPPC6A (1.7)	RHCE (1.7)	APOA5 (1.7)	ENSG00000254235 (1.5)	PLG (1.5)
GO:0030195	negative regulation of blood coagulation	0.06	> 0.20	ANGPTL3 (4.3)	ITGB3 (3.4)	PLG (3.2)	APOC4 (3.1)	ENSG00000228044 (3.1)	PCSK9 (3.0)	CEACAM19 (2.9)	SLC22A1 (2.9)	CYP7A1 (2.6)	GMPR (2.5)
MP:0008499	increased IgG1 level	0.06	> 0.20	RELB (4.6)	BCL3 (4.3)	TRIB1 (2.6)	PBX4 (2.2)	GCNT4 (2.0)	GMIP (1.9)	POLK (1.8)	C17orf57 (1.8)	TIMD4 (1.8)	PARP10 (1.7)
GO:0045940	positive regulation of steroid metabolic process	0.06	> 0.20	ENSG00000228044 (3.1)	MYLIP (3.0)	APOC1 (2.6)	COL4A3BP (2.4)	TMEM57 (2.3)	POC5 (2.2)	APOB (2.0)	SLC44A2 (1.9)	APOE (1.9)	ST3GAL4 (1.7)
GO:0051186	cofactor metabolic process	0.06	> 0.20	ACAD10 (4.2)	NT5DC1 (3.4)	TRAPPC6A (3.3)	DHODH (2.8)	OGDH (2.6)	GPAM (2.6)	PCSK9 (2.5)	FADS1 (2.5)	FADS2 (2.5)	MOSC1 (2.4)
ENSG00000124228	DDX27 PPI subnetwork	0.06	> 0.20	NAA25 (4.8)	ZNF259 (4.6)	TOMM40 (4.2)	DDX56 (4.0)	QTRT1 (4.0)	DHODH (3.3)	DHX38 (3.0)	ATP13A1 (2.7)	C12orf43 (2.7)	USP24 (2.1)
ENSG00000163814	CDCP1 PPI subnetwork	0.06	> 0.20	CBLC (3.1)	TMED4 (2.5)	ALDH2 (2.5)	BCAM (2.3)	NYNRIN (2.2)	ANGPTL3 (2.1)	APOC4 (2.1)	AP1M2 (2.1)	MARK4 (2.0)	ENSG00000238078 (2.0)
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	0.06	> 0.20	RELB (4.4)	SH2B3 (3.5)	TRIB1 (3.4)	PVR (3.3)	BCL3 (3.2)	HLX (2.8)	GMIP (1.9)	GRINA (1.5)	ENSG00000228044 (1.5)	MAFB (1.4)
GO:0009063	cellular amino acid catabolic process	0.06	> 0.20	CYP7A1 (3.2)	ANGPTL3 (3.1)	LPA (3.0)	SLC22A1 (2.8)	ACAD10 (2.7)	MOSC1 (2.5)	DHODH (2.4)	PLG (2.4)	ENSG00000254235 (2.4)	UBXN2B (2.4)
MP:0000416	sparse hair	0.06	> 0.20	CBLC (4.8)	AP1M2 (4.4)	CELSR2 (2.6)	NPC1L1 (2.4)	BCAM (2.1)	CYB561D1 (2.0)	PLEC (1.8)	MARK4 (1.6)	ZNF180 (1.6)	C17orf57 (1.5)
ENSG00000214265	SNURF PPI subnetwork	0.06	> 0.20	PSMA5 (3.5)	TOMM40 (3.1)	ZNF180 (2.8)	BLOC1S3 (2.7)	BUD13 (2.3)	USP1 (1.7)	C12orf47 (1.7)	GEMIN7 (1.6)	PARP10 (1.5)	OASL (1.4)
ENSG00000105281	SLC1A5 PPI subnetwork	0.06	> 0.20	CEACAM19 (2.4)	TMEM50A (2.2)	TRAPPC6A (1.8)	PBX4 (1.8)	FRK (1.7)	ITGB3 (1.7)	PARP10 (1.7)	C1orf63 (1.6)	ZNF101 (1.5)	C11orf9 (1.5)
MP:0002957	intestinal adenocarcinoma	0.06	> 0.20	POLK (2.1)	ANKRD31 (2.1)	FEN1 (1.9)	MAPKAPK5 (1.9)	SLC44A2 (1.9)	PLEKHH2 (1.8)	ENSG00000228044 (1.8)	DNM2 (1.5)	BCL3 (1.5)	PPP1R37 (1.4)
REACTOME_INTERLEUKIN:7_SIGNALING	REACTOME_INTERLEUKIN:7_SIGNALING	0.06	> 0.20	BCL3 (2.6)	DNAH11 (2.3)	DNM2 (2.3)	USP24 (2.2)	GRINA (2.0)	CETP (2.0)	PARP10 (1.9)	C12orf47 (1.8)	COL4A3BP (1.7)	HAVCR1 (1.6)
GO:0010212	response to ionizing radiation	0.06	> 0.20	POLK (3.5)	ZNF101 (2.6)	ENSG00000228044 (2.6)	UBXN2B (2.3)	ZNF180 (2.0)	FRK (1.9)	C17orf57 (1.9)	C12orf43 (1.9)	TRAPPC6A (1.7)	PSRC1 (1.6)
GO:0019838	growth factor binding	0.06	> 0.20	SLC44A2 (3.4)	BCAM (3.3)	APOE (2.9)	CILP2 (2.6)	PVRL2 (2.4)	HLX (2.4)	KANK2 (2.2)	KIAA1324 (1.9)	CELSR2 (1.8)	PLEC (1.6)
ENSG00000149923	PPP4C PPI subnetwork	0.07	> 0.20	RELB (3.0)	CLPTM1 (2.2)	SARS (2.1)	PSMA5 (2.0)	SMARCA4 (1.9)	DHX38 (1.8)	ILF3 (1.7)	USP24 (1.7)	NAA25 (1.7)	NT5DC1 (1.5)
ENSG00000108344	PSMD3 PPI subnetwork	0.07	> 0.20	PSMA5 (5.7)	NAA25 (2.8)	NT5DC1 (2.8)	DDX56 (2.5)	TRAFD1 (2.2)	TOMM40 (2.0)	ENSG00000254235 (1.7)	SARS (1.6)	ZNF259 (1.5)	SMARCA4 (1.4)
ENSG00000105401	CDC37 PPI subnetwork	0.07	> 0.20	GRINA (2.1)	UBXN2B (2.1)	PTPN11 (1.8)	TXNL4B (1.8)	ENSG00000238078 (1.7)	C1orf63 (1.7)	POLK (1.6)	PVR (1.6)	BRAP (1.5)	GEMIN7 (1.5)
ENSG00000198062	POTEH PPI subnetwork	0.07	> 0.20	ACAD10 (4.0)	NT5DC1 (3.0)	HNF1A (2.4)	TRAPPC6A (1.7)	C1orf63 (1.7)	PCSK9 (1.7)	CETP (1.6)	GMPR (1.5)	SORT1 (1.5)	TIMD4 (1.5)
MP:0001919	abnormal reproductive system physiology	0.07	> 0.20	TRIB1 (2.7)	FRK (2.5)	ZNF101 (2.2)	LDLR (2.1)	FADS1 (2.0)	ENSG00000228044 (2.0)	CELSR2 (2.0)	ANKRD31 (1.9)	HMGCR (1.9)	PLEKHH2 (1.7)
GO:2000146	negative regulation of cell motility	0.07	> 0.20	CEACAM19 (2.7)	PVRL2 (2.6)	KANK2 (2.4)	CILP2 (2.4)	ENSG00000254235 (2.3)	GCNT4 (2.1)	HLX (2.0)	ENSG00000226645 (1.7)	BCAM (1.6)	PLEKHH2 (1.6)
GO:0046395	carboxylic acid catabolic process	0.07	> 0.20	ACAD10 (4.2)	LPA (3.8)	SLC22A1 (3.2)	ANGPTL3 (3.1)	MOSC1 (2.8)	CYP7A1 (2.7)	APOA5 (2.5)	ALDH2 (2.5)	PLG (2.5)	APOC4 (2.4)
GO:0016054	organic acid catabolic process	0.07	> 0.20	ACAD10 (4.2)	LPA (3.8)	SLC22A1 (3.2)	ANGPTL3 (3.1)	MOSC1 (2.8)	CYP7A1 (2.7)	APOA5 (2.5)	ALDH2 (2.5)	PLG (2.5)	APOC4 (2.4)
ENSG00000135341	MAP3K7 PPI subnetwork	0.07	> 0.20	PARP10 (3.2)	TRAFD1 (3.1)	FRK (3.1)	TRIB1 (2.5)	PTPN11 (2.4)	C1orf63 (2.2)	BCL3 (2.1)	OASL (2.0)	HLX (2.0)	PVR (1.9)
ENSG00000100926	TM9SF1 PPI subnetwork	0.07	> 0.20	ACAD10 (3.9)	NT5DC1 (3.2)	HNF1A (2.3)	GMPR (1.8)	TRAPPC6A (1.7)	C1orf63 (1.7)	PCSK9 (1.6)	CETP (1.6)	TMED4 (1.5)	SORT1 (1.5)
GO:0004708	MAP kinase kinase activity	0.07	> 0.20	MOSC1 (2.5)	CARM1 (2.5)	CYB561D1 (2.4)	GEMIN7 (2.4)	SH2B3 (2.3)	CEACAM19 (2.3)	HAPLN4 (2.0)	ERP29 (1.9)	C19orf52 (1.9)	ZNF180 (1.8)
ENSG00000120885	CLU PPI subnetwork	0.07	> 0.20	TIMD4 (3.8)	HP (2.7)	APOC4 (2.6)	GPAM (2.6)	SLC22A1 (2.4)	ANGPTL3 (2.3)	LPA (2.2)	CETP (2.0)	ALDH2 (2.0)	PLG (2.0)
GO:0035257	nuclear hormone receptor binding	0.07	> 0.20	DNM2 (2.5)	ATXN2 (2.5)	TRAFD1 (2.0)	MAFB (2.0)	DHX38 (1.9)	MAPKAPK5 (1.9)	BUD13 (1.8)	C12orf51 (1.6)	TOP1 (1.6)	TIMD4 (1.4)
ENSG00000147649	MTDH PPI subnetwork	0.07	> 0.20	ACAD10 (4.2)	NT5DC1 (2.7)	HNF1A (2.5)	TMED4 (2.2)	GCNT4 (1.9)	GMPR (1.8)	C1orf63 (1.8)	CETP (1.8)	TIMD4 (1.7)	OGDH (1.6)
ENSG00000164587	RPS14 PPI subnetwork	0.07	> 0.20	DDX56 (2.8)	NAA25 (2.6)	ZNF259 (2.5)	QTRT1 (2.5)	SUGP1 (2.3)	ILF3 (2.3)	DHX38 (2.1)	C12orf43 (2.0)	PTPN11 (1.9)	SARS (1.8)
GO:0019865	immunoglobulin binding	0.07	> 0.20	PLG (3.1)	ANGPTL3 (2.9)	HP (2.5)	MAFB (2.4)	APOC4 (2.4)	GMPR (2.2)	ALDH2 (1.9)	LPA (1.9)	SLC22A1 (1.9)	CYP7A1 (1.7)
ENSG00000198788	MUC2 PPI subnetwork	0.07	> 0.20	AP1M2 (3.0)	HNF1A (2.6)	KIAA1324 (2.4)	DNM2 (2.4)	ST3GAL4 (2.1)	CBLC (1.8)	FRK (1.8)	ENSG00000235545 (1.6)	CETP (1.6)	ITGB3 (1.4)
GO:0071260	cellular response to mechanical stimulus	0.07	> 0.20	GCNT4 (2.6)	ANKRD31 (2.6)	TXNL4B (2.2)	ST3GAL4 (2.0)	UBXN2B (2.0)	TRAFD1 (2.0)	C12orf43 (1.8)	SH2B3 (1.8)	FRK (1.7)	PARP10 (1.7)
ENSG00000125352	RNF113A PPI subnetwork	0.07	> 0.20	BRAP (3.2)	BUD13 (3.0)	SUGP1 (2.8)	DHX38 (2.3)	POC5 (2.2)	ZNF259 (2.1)	QTRT1 (2.1)	MAU2 (2.0)	SMARCA4 (1.8)	TM6SF2 (1.7)
ENSG00000009844	VTA1 PPI subnetwork	0.07	> 0.20	TRAPPC6A (3.9)	POC5 (2.7)	UBXN2B (2.7)	TOMM40 (2.5)	RHD (2.2)	BCAM (2.1)	GRINA (2.1)	RHCE (2.1)	ENSG00000238078 (2.0)	C12orf43 (2.0)
MP:0001870	salivary gland inflammation	0.07	> 0.20	BCL3 (3.3)	CETP (2.5)	TIMD4 (2.3)	CARM1 (2.2)	GRINA (2.2)	MAFB (2.1)	PBX4 (2.1)	CLPTM1 (2.0)	GOT2P1 (2.0)	RELB (2.0)
ENSG00000196781	TLE1 PPI subnetwork	0.07	> 0.20	ENSG00000238078 (2.3)	PPP1R37 (2.2)	PVRL2 (2.2)	KIAA1324 (2.0)	ALDH2 (1.9)	TOP1 (1.9)	GRINA (1.8)	TXNL4B (1.7)	KANK2 (1.7)	ILF3 (1.7)
GO:0044212	transcription regulatory region DNA binding	0.07	> 0.20	TRIB1 (4.0)	HLX (2.5)	ATXN2 (2.2)	BCL3 (2.0)	CARM1 (1.8)	MAFB (1.8)	PLEC (1.8)	KANK2 (1.7)	GATAD2A (1.7)	ATXN7L2 (1.7)
ENSG00000165409	TSHR PPI subnetwork	0.07	> 0.20	BLOC1S3 (2.5)	USP24 (1.9)	DNM2 (1.8)	BCL3 (1.7)	C17orf57 (1.6)	HAVCR1 (1.5)	PCSK9 (1.5)	PPP1R37 (1.5)	KIAA1324 (1.4)	YIPF2 (1.4)
MP:0002680	decreased corpora lutea number	0.07	> 0.20	LPA (2.4)	ENSG00000235545 (2.2)	APOC4 (2.1)	C12orf51 (1.8)	TRAPPC6A (1.8)	CETP (1.7)	C17orf57 (1.7)	ITGB3 (1.7)	APOA5 (1.6)	HLX (1.5)
ENSG00000089351	GRAMD1A PPI subnetwork	0.07	> 0.20	CARM1 (3.3)	ILF3 (2.7)	DNM2 (2.7)	C12orf51 (2.6)	ATXN2 (2.3)	ATP13A1 (2.2)	ENSG00000228044 (2.1)	SMARCA4 (2.0)	QTRT1 (1.8)	ATXN7L2 (1.7)
ENSG00000160469	BRSK1 PPI subnetwork	0.07	> 0.20	DDX56 (4.6)	QTRT1 (4.0)	NAA25 (3.9)	ZNF259 (3.7)	DHODH (3.6)	C12orf43 (3.1)	TOMM40 (2.6)	HMGCR (2.4)	DHX38 (2.4)	SUGP1 (2.3)
GO:0008033	tRNA processing	0.07	> 0.20	QTRT1 (3.9)	DHODH (3.8)	C12orf43 (3.1)	NAA25 (2.8)	C19orf52 (2.7)	TXNL4B (2.7)	ZNF259 (2.7)	DDX56 (2.6)	ATXN7L2 (2.5)	ZNF180 (2.3)
ENSG00000100109	TFIP11 PPI subnetwork	0.07	> 0.20	MAU2 (4.0)	SUGP1 (3.8)	DHX38 (3.8)	SMARCA4 (2.8)	ATP13A1 (2.8)	BUD13 (2.6)	QTRT1 (2.5)	ILF3 (2.5)	DDX56 (2.3)	TOP1 (2.3)
ENSG00000106245	BUD31 PPI subnetwork	0.07	> 0.20	SUGP1 (4.2)	DHX38 (4.0)	BUD13 (3.2)	MAU2 (2.6)	DDX56 (2.6)	BRAP (2.4)	SMARCA4 (2.4)	C19orf52 (2.3)	ILF3 (2.2)	ZNF259 (2.1)
ENSG00000163510	CWC22 PPI subnetwork	0.07	> 0.20	SUGP1 (4.0)	DHX38 (4.0)	BUD13 (3.4)	MAU2 (2.9)	SMARCA4 (2.5)	ZNF259 (2.4)	BRAP (2.4)	DDX56 (2.4)	TOP1 (2.1)	ILF3 (2.1)
ENSG00000089048	ESF1 PPI subnetwork	0.07	> 0.20	DDX56 (4.2)	ZNF259 (4.1)	NAA25 (3.8)	TOMM40 (3.7)	QTRT1 (3.3)	DHODH (2.5)	SUGP1 (2.4)	DHX38 (2.0)	TOP1 (2.0)	GATAD2A (1.9)
MP:0000422	delayed hair appearance	0.07	> 0.20	RHD (4.6)	RHCE (3.6)	APOC1 (3.6)	MAFB (2.8)	APOE (2.7)	CETP (2.2)	TIMD4 (2.1)	PLG (2.0)	BCAM (2.0)	ABCG5 (2.0)
GO:0042054	histone methyltransferase activity	0.07	> 0.20	C12orf51 (4.2)	ATXN2 (3.3)	MAU2 (2.6)	C12orf43 (2.3)	SMARCA4 (2.3)	QTRT1 (2.2)	ATXN7L2 (2.1)	BUD13 (2.1)	ATP13A1 (2.0)	ILF3 (1.8)
MP:0010264	increased hepatoma incidence	0.07	> 0.20	PSRC1 (3.6)	POLK (2.4)	ABCG8 (2.0)	HLX (1.9)	FEN1 (1.8)	ABCG5 (1.8)	ENSG00000228044 (1.7)	C1orf63 (1.6)	APOA5 (1.6)	DNAH11 (1.5)
ENSG00000040199	PHLPP2 PPI subnetwork	0.07	> 0.20	QTRT1 (3.5)	TRIB1 (3.2)	ATP13A1 (2.6)	TOMM40 (2.6)	SARS (2.4)	DHX38 (2.2)	UBXN2B (2.0)	ZNF259 (1.7)	LPIN3 (1.7)	DDX56 (1.7)
ENSG00000160062	ZBTB8A PPI subnetwork	0.07	> 0.20	GRINA (2.7)	ATXN7L2 (2.4)	LPAR2 (2.3)	ATP13A1 (2.2)	BRAP (2.2)	C19orf52 (2.1)	ABCG8 (2.1)	FRK (2.0)	PARP10 (1.9)	SUGP1 (1.8)
ENSG00000163530	DPPA2 PPI subnetwork	0.07	> 0.20	GRINA (2.7)	ATXN7L2 (2.3)	ENSG00000254235 (2.3)	ZNF180 (2.2)	CLPTM1 (2.0)	TMED4 (2.0)	LDLR (1.9)	ABO (1.9)	C12orf43 (1.8)	HAPLN4 (1.7)
ENSG00000130338	TULP4 PPI subnetwork	0.07	> 0.20	ATP13A1 (3.8)	MAPKAPK5 (2.7)	PTPN11 (2.6)	DDX56 (2.4)	USP24 (2.4)	HNF1A (2.4)	CEACAM19 (2.3)	LPA (2.3)	BRAP (2.2)	TOMM40 (2.0)
ENSG00000111605	CPSF6 PPI subnetwork	0.07	> 0.20	BUD13 (3.3)	PCSK9 (2.7)	TRAPPC6A (2.4)	ACAD10 (2.2)	HNF1A (2.1)	OGDH (2.1)	ILF3 (2.1)	NT5DC1 (1.9)	ABO (1.8)	CARM1 (1.7)
MP:0003396	abnormal embryonic hematopoiesis	0.07	> 0.20	GMPR (4.1)	SH2B3 (3.4)	ITGB3 (2.7)	HLX (2.5)	ENSG00000226648 (2.5)	PLCG1 (2.4)	RHD (2.4)	FADS2 (2.3)	NYNRIN (2.0)	SLC44A2 (1.9)
ENSG00000171094	ALK PPI subnetwork	0.07	> 0.20	PLEKHH2 (3.8)	PARP10 (2.9)	COL4A3BP (2.8)	OASL (2.8)	LPAR2 (2.6)	TRIB1 (2.3)	ABCG5 (2.2)	C12orf43 (2.1)	BCL3 (2.1)	PSRC1 (2.1)
GO:0008234	cysteine-type peptidase activity	0.07	> 0.20	USP24 (3.2)	ZNF180 (3.0)	APOE (2.6)	OASL (2.4)	TMEM57 (2.4)	BRAP (2.3)	ADAM1 (2.0)	MAU2 (2.0)	CEACAM19 (1.9)	NKPD1 (1.9)
ENSG00000134759	ELP2 PPI subnetwork	0.07	> 0.20	TMEM50A (3.9)	TRAFD1 (3.1)	MYLIP (2.6)	SUGP1 (2.3)	TOP1 (2.1)	GEMIN7 (2.1)	DHX38 (2.1)	SMARCA4 (2.0)	ILF3 (2.0)	COL4A3BP (1.9)
MP:0008563	decreased interferon-alpha secretion	0.07	> 0.20	OASL (12.6)	PARP10 (8.5)	TRAFD1 (5.0)	BCL3 (3.0)	RELB (2.0)	SH2B3 (1.5)	ATP13A1 (1.4)	CYB561D1 (1.4)	RHCE (1.3)	C1orf63 (1.2)
REACTOME_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_2_TLR2_CASCADE	0.07	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
REACTOME_MYD88MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	REACTOME_MYD88MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	0.07	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
REACTOME_TOLL_LIKE_RECEPTOR_TLR1TLR2_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_TLR1TLR2_CASCADE	0.07	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
REACTOME_TOLL_LIKE_RECEPTOR_TLR6TLR2_CASCADE	REACTOME_TOLL_LIKE_RECEPTOR_TLR6TLR2_CASCADE	0.07	> 0.20	RELB (4.3)	TRIB1 (4.0)	BCL3 (3.7)	SH2B3 (3.1)	HLX (3.0)	PVR (2.7)	GMIP (2.1)	MAFB (2.0)	CARM1 (2.0)	BUD13 (1.8)
ENSG00000163810	TGM4 PPI subnetwork	0.07	> 0.20	APOB (5.6)	ANGPTL3 (4.3)	PLG (4.2)	APOE (3.9)	APOC1 (3.4)	HP (3.2)	APOC4 (3.2)	APOA5 (3.1)	PCSK9 (2.6)	GPAM (2.1)
ENSG00000138326	RPS24 PPI subnetwork	0.07	> 0.20	NAA25 (4.1)	DDX56 (3.6)	ZNF259 (3.6)	QTRT1 (3.2)	TOMM40 (2.7)	C12orf43 (2.7)	SARS (2.5)	TOP1 (2.3)	DHX38 (2.3)	ADAM1 (2.1)
ENSG00000143942	CHAC2 PPI subnetwork	0.07	> 0.20	CLPTM1 (5.4)	BCAM (3.3)	OGDH (3.3)	DNM2 (2.9)	GRINA (2.3)	PLEC (2.2)	CELSR2 (2.1)	GATAD2A (2.0)	PPP1R37 (2.0)	UBXN2B (2.0)
ENSG00000196914	ARHGEF12 PPI subnetwork	0.07	> 0.20	CELSR2 (3.7)	KANK2 (3.4)	ENSG00000238078 (3.4)	LPIN3 (3.3)	DOCK7 (2.6)	PTPN11 (2.4)	PLEC (2.4)	ENSG00000235545 (2.1)	HLX (2.0)	AP1M2 (1.9)
REACTOME_FATTY_ACYL:COA_BIOSYNTHESIS	REACTOME_FATTY_ACYL:COA_BIOSYNTHESIS	0.07	> 0.20	HMGCR (9.6)	FADS1 (9.4)	FADS2 (8.5)	LDLR (8.3)	GPAM (5.8)	PCSK9 (5.7)	MOSC1 (3.3)	BLOC1S3 (2.1)	SORT1 (2.0)	APOC1 (1.9)
ENSG00000163737	PF4 PPI subnetwork	0.07	> 0.20	ITGB3 (4.5)	FADS1 (3.6)	HMGCR (3.6)	PCSK9 (3.3)	FADS2 (3.3)	PVR (3.2)	OASL (2.9)	SLC22A1 (2.6)	TRIB1 (1.9)	CYP7A1 (1.8)
MP:0009431	decreased fetal weight	0.07	> 0.20	LPAR2 (3.0)	FRK (2.5)	MYLIP (2.4)	LDLR (1.9)	MAU2 (1.8)	AMIGO1 (1.8)	GPAM (1.7)	YIPF2 (1.6)	PLEKHH2 (1.6)	COL4A3BP (1.6)
ENSG00000049323	LTBP1 PPI subnetwork	0.07	> 0.20	GRINA (2.7)	ITGB3 (2.7)	CEACAM19 (2.1)	APOE (2.1)	SH2B3 (1.9)	APOB (1.9)	CARM1 (1.8)	KANK2 (1.7)	LPA (1.7)	MAFB (1.6)
GO:0071378	cellular response to growth hormone stimulus	0.07	> 0.20	HNF1A (2.7)	PBX4 (2.5)	TRAFD1 (1.9)	KIAA1324 (1.8)	PLEKHH2 (1.6)	USP24 (1.6)	DNM2 (1.5)	ENSG00000228044 (1.4)	BRAP (1.4)	ZHX3 (1.4)
GO:0060396	growth hormone receptor signaling pathway	0.07	> 0.20	HNF1A (2.7)	PBX4 (2.5)	TRAFD1 (1.9)	KIAA1324 (1.8)	PLEKHH2 (1.6)	USP24 (1.6)	DNM2 (1.5)	ENSG00000228044 (1.4)	BRAP (1.4)	ZHX3 (1.4)
MP:0004938	dilated vasculature	0.07	> 0.20	SMARCA4 (2.8)	C12orf51 (2.7)	ENSG00000226648 (2.2)	DNM2 (2.0)	APOC4 (2.0)	PLG (2.0)	CARM1 (1.9)	ITGB3 (1.7)	MAU2 (1.7)	SLC44A2 (1.6)
ENSG00000111641	NOP2 PPI subnetwork	0.07	> 0.20	ZNF259 (5.1)	NAA25 (4.5)	TOMM40 (4.2)	DDX56 (4.0)	QTRT1 (3.6)	DHX38 (3.2)	C12orf43 (2.9)	ATP13A1 (2.8)	MAPKAPK5 (2.5)	DHODH (2.5)
ENSG00000163029	SMC6 PPI subnetwork	0.07	> 0.20	PARP10 (3.7)	PLEKHH2 (2.9)	OASL (2.6)	LPAR2 (2.4)	ABCG8 (2.3)	DNM2 (2.0)	TRAFD1 (1.8)	POLK (1.8)	TMEM116 (1.8)	ZNF101 (1.8)
GO:0015923	mannosidase activity	0.07	> 0.20	ERP29 (3.4)	TRAPPC6A (2.8)	ATP13A1 (2.7)	TMEM50A (2.1)	YIPF2 (2.1)	TMED4 (1.9)	TMEM57 (1.8)	ENSG00000235545 (1.5)	C17orf57 (1.5)	TRIB1 (1.5)
ENSG00000184343	SRPK3 PPI subnetwork	0.07	> 0.20	C1orf63 (3.7)	POC5 (2.7)	SARS (2.5)	PSMA5 (2.1)	LPIN3 (1.9)	PLEKHH2 (1.9)	GEMIN7 (1.8)	MYLIP (1.7)	USP1 (1.7)	CEACAM19 (1.6)
MP:0005478	decreased circulating thyroxine level	0.07	> 0.20	GOT2P1 (2.8)	C17orf57 (2.7)	MOSC1 (1.9)	NCAN (1.7)	GPAM (1.7)	TXNL4B (1.4)	APOA5 (1.4)	C11orf9 (1.4)	CETP (1.4)	COL4A3BP (1.4)
GO:0030141	secretory granule	0.07	> 0.20	KIAA1324 (4.7)	HP (4.4)	ITGB3 (4.1)	TSSK6 (2.3)	MOSC1 (2.2)	APOB (2.0)	ERP29 (2.0)	APOA5 (1.8)	AP1M2 (1.7)	GMPR (1.7)
ENSG00000076555	ACACB PPI subnetwork	0.07	> 0.20	SARS (3.3)	GPAM (3.1)	NAA25 (3.0)	ATP13A1 (2.7)	TOMM40 (2.6)	ILF3 (2.5)	USP24 (2.3)	DDX56 (2.2)	PSMA5 (2.1)	OGDH (2.0)
GO:0008063	Toll signaling pathway	0.07	> 0.20	SH2B3 (2.6)	TRIB1 (2.3)	ENSG00000228044 (2.2)	BLOC1S3 (2.2)	CYB561D1 (2.1)	LPAR2 (2.0)	GMIP (2.0)	BCL3 (2.0)	PVR (1.9)	RELB (1.9)
ENSG00000100201	DDX17 PPI subnetwork	0.07	> 0.20	PPP1R37 (2.7)	C1orf63 (2.6)	UBXN2B (2.5)	NYNRIN (2.4)	ILF3 (2.4)	MAU2 (2.1)	SMARCA4 (1.8)	NCAN (1.8)	TOP1 (1.8)	CLPTM1 (1.7)
ENSG00000072210	ALDH3A2 PPI subnetwork	0.07	> 0.20	ACAD10 (3.8)	NT5DC1 (2.7)	HNF1A (2.3)	C1orf63 (1.8)	PCSK9 (1.7)	TRAPPC6A (1.7)	SORT1 (1.7)	TIMD4 (1.7)	CETP (1.6)	GMPR (1.6)
ENSG00000105438	KDELR1 PPI subnetwork	0.07	> 0.20	HMGCR (5.0)	FADS1 (4.9)	LDLR (4.0)	PCSK9 (3.1)	TMED4 (2.9)	FADS2 (2.7)	YIPF2 (2.4)	BLOC1S3 (2.2)	DYNC2LI1 (2.1)	SORT1 (2.1)
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	0.07	> 0.20	BCL3 (4.9)	TRAFD1 (4.0)	PARP10 (3.6)	HLX (3.0)	GRINA (2.2)	LDLR (2.1)	TRIB1 (2.1)	ALDH2 (1.8)	AMIGO1 (1.7)	ENSG00000228044 (1.6)
GO:0070482	response to oxygen levels	0.07	> 0.20	LPIN3 (2.3)	DNAH11 (2.2)	PVR (2.2)	POLK (2.0)	FRK (1.4)	NT5DC1 (1.3)	BLOC1S3 (1.3)	CETP (1.3)	CEACAM19 (1.2)	TRIB1 (1.2)
MP:0006094	increased fat cell size	0.07	> 0.20	GPAM (4.1)	MOSC1 (2.8)	COL4A3BP (1.7)	TSSK6 (1.7)	APOB (1.7)	TMED4 (1.7)	TIMD4 (1.6)	PPP1R37 (1.5)	ABCG5 (1.4)	OASL (1.4)
GO:0043414	macromolecule methylation	0.07	> 0.20	C19orf52 (2.8)	ENSG00000238078 (2.7)	QTRT1 (2.5)	ZNF180 (2.4)	MAPKAPK5 (2.3)	C12orf51 (2.1)	DNAH11 (2.0)	ILF3 (2.0)	DHODH (1.8)	BUD13 (1.8)
ENSG00000119630	PGF PPI subnetwork	0.07	> 0.20	MYLIP (4.7)	HLX (4.1)	C1orf63 (3.7)	C17orf57 (2.3)	DNAH11 (1.7)	ATXN7L2 (1.7)	SLC44A2 (1.7)	ENSG00000226648 (1.7)	LPA (1.5)	MAFB (1.5)
ENSG00000198301	SDAD1 PPI subnetwork	0.07	> 0.20	ZNF259 (5.3)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (3.8)	QTRT1 (3.4)	DHODH (2.9)	MAPKAPK5 (2.8)	C12orf43 (2.7)	DHX38 (2.7)	ADAM1 (2.3)
MP:0006085	myocardial necrosis	0.07	> 0.20	RHD (4.2)	PLEC (2.9)	RHCE (2.8)	KANK2 (2.5)	MAFB (2.2)	TIMD4 (2.1)	SYPL2 (2.1)	BCAM (1.8)	GMPR (1.8)	ENSG00000235545 (1.7)
ENSG00000214485	ENSG00000214485 PPI subnetwork	0.07	> 0.20	DDX56 (4.7)	NAA25 (4.7)	ZNF259 (4.6)	TOMM40 (3.6)	QTRT1 (3.5)	DHODH (3.2)	DHX38 (2.8)	ATP13A1 (2.6)	ILF3 (2.6)	SUGP1 (2.5)
GO:0050727	regulation of inflammatory response	0.07	> 0.20	ENSG00000228044 (3.4)	DNAH11 (2.4)	ANKRD31 (2.1)	ALDH2 (2.1)	TIMD4 (2.0)	BCL3 (1.7)	PVR (1.6)	PARP10 (1.6)	SH2B3 (1.5)	PMFBP1 (1.5)
MP:0010067	increased red blood cell distribution width	0.07	> 0.20	RHCE (8.7)	RHD (6.6)	GMPR (3.4)	BRAP (3.0)	C12orf51 (1.9)	PLCG1 (1.8)	CETP (1.7)	KANK2 (1.7)	HNF1A (1.7)	LPIN3 (1.7)
GO:0030336	negative regulation of cell migration	0.07	> 0.20	CEACAM19 (2.9)	PVRL2 (2.6)	KANK2 (2.6)	CILP2 (2.3)	ENSG00000254235 (2.3)	HLX (2.1)	GCNT4 (1.9)	PLEKHH2 (1.7)	BCAM (1.6)	DNAH11 (1.6)
GO:0019433	triglyceride catabolic process	0.07	> 0.20	MOSC1 (4.3)	GPAM (4.0)	NPC1L1 (4.0)	TM6SF2 (3.2)	ABCG5 (2.6)	HP (2.2)	PMFBP1 (2.1)	APOC1 (2.0)	ABCG8 (1.9)	APOC4 (1.9)
ENSG00000076924	XAB2 PPI subnetwork	0.07	> 0.20	BUD13 (3.9)	SUGP1 (3.7)	DHX38 (3.4)	ZNF259 (3.1)	BRAP (3.0)	POC5 (2.6)	C12orf43 (2.6)	DDX56 (2.5)	SARS (2.3)	ZNF180 (2.1)
GO:0060338	regulation of type I interferon-mediated signaling pathway	0.07	> 0.20	OASL (3.1)	GOT2P1 (2.9)	TRAFD1 (2.8)	ZNF101 (2.7)	PARP10 (2.6)	ENSG00000235545 (2.2)	ATP13A1 (2.1)	MAU2 (1.9)	C19orf52 (1.9)	CYP7A1 (1.6)
MP:0002773	decreased circulating luteinizing hormone level	0.07	> 0.20	KIAA1324 (3.8)	MYLIP (2.9)	MOSC1 (2.8)	PMFBP1 (2.1)	TM6SF2 (2.0)	PBX4 (1.8)	C12orf51 (1.8)	GCNT4 (1.7)	GPAM (1.7)	KANK2 (1.7)
ENSG00000141867	BRD4 PPI subnetwork	0.07	> 0.20	BRAP (3.2)	USP1 (3.1)	FEN1 (3.0)	FRK (2.5)	ATXN2 (1.9)	ANKRD31 (1.9)	ENSG00000226645 (1.8)	MAPKAPK5 (1.8)	C12orf43 (1.7)	ERP29 (1.7)
MP:0002189	abnormal myocardial trabeculae morphology	0.07	> 0.20	C17orf57 (3.0)	MAFB (2.7)	ATXN2 (2.4)	ACAD10 (2.3)	MOSC1 (2.3)	KANK2 (2.1)	COL4A3BP (1.8)	DOCK7 (1.7)	C11orf9 (1.6)	GPAM (1.6)
ENSG00000126226	PCID2 PPI subnetwork	0.07	> 0.20	DHX38 (4.6)	SUGP1 (3.2)	SMARCA4 (3.0)	BUD13 (2.8)	TOP1 (2.8)	ILF3 (2.5)	DDX56 (2.5)	MAU2 (2.4)	TOMM40 (2.0)	FEN1 (1.8)
ENSG00000167840	ZNF232 PPI subnetwork	0.07	> 0.20	APOB (5.8)	APOE (4.4)	PLG (4.0)	APOA5 (4.0)	APOC4 (3.6)	HP (3.4)	PCSK9 (3.3)	APOC1 (3.2)	ANGPTL3 (3.0)	TIMD4 (2.8)
ENSG00000068438	FTSJ1 PPI subnetwork	0.07	> 0.20	PSMA5 (3.9)	TOMM40 (3.4)	QTRT1 (2.4)	DDX56 (2.2)	SARS (2.0)	ZNF259 (1.8)	ERP29 (1.7)	GEMIN7 (1.7)	DHODH (1.6)	TMEM50A (1.6)
ENSG00000067606	PRKCZ PPI subnetwork	0.07	> 0.20	DNM2 (3.0)	UBXN2B (2.7)	TMEM50A (2.3)	PTPN11 (2.3)	AP1M2 (2.2)	MARK4 (2.0)	GMIP (2.0)	CYB561D1 (2.0)	C11orf9 (1.9)	CELSR2 (1.8)
MP:0005026	decreased susceptibility to parasitic infection	0.07	> 0.20	RHD (5.0)	RHCE (4.7)	SLC22A1 (2.3)	PARP10 (2.2)	CYP7A1 (2.2)	MAFB (2.1)	TIMD4 (1.8)	APOC1 (1.7)	PLG (1.6)	RELB (1.6)
ENSG00000132646	PCNA PPI subnetwork	0.07	> 0.20	FEN1 (5.6)	USP1 (4.1)	POC5 (2.6)	PSRC1 (2.5)	SMARCA4 (2.0)	POLK (1.7)	BUD13 (1.6)	FADS1 (1.5)	ZNF180 (1.5)	KANK2 (1.4)
MP:0005123	increased circulating growth hormone level	0.07	> 0.20	GPAM (3.1)	KIAA1324 (2.3)	ADAM1 (2.1)	GEMIN7 (2.1)	C11orf9 (1.9)	ENSG00000254235 (1.9)	PCSK9 (1.8)	TIMD4 (1.8)	NPC1L1 (1.8)	PTPN11 (1.7)
GO:0004181	metallocarboxypeptidase activity	0.07	> 0.20	KIAA1324 (2.3)	FRK (2.2)	CILP2 (1.8)	C11orf9 (1.7)	DYNC2LI1 (1.6)	ENSG00000226648 (1.6)	MYLIP (1.6)	APOB (1.5)	PMFBP1 (1.5)	UBXN2B (1.5)
ENSG00000080608	KIAA0020 PPI subnetwork	0.07	> 0.20	NAA25 (4.8)	ZNF259 (4.3)	DDX56 (4.0)	TOMM40 (3.8)	QTRT1 (3.1)	ATP13A1 (2.8)	DHODH (2.5)	USP24 (2.4)	DHX38 (2.4)	SUGP1 (2.2)
MP:0005326	abnormal podocyte morphology	0.07	> 0.20	BCAM (3.6)	PVRL2 (3.6)	ST3GAL4 (3.4)	PLEKHH2 (3.3)	NT5DC1 (2.3)	C11orf9 (2.2)	TMED4 (1.7)	UBXN2B (1.6)	PCSK9 (1.6)	C17orf57 (1.5)
MP:0002781	increased circulating testosterone level	0.07	> 0.20	BCAM (2.9)	KIAA1324 (2.6)	GPAM (2.2)	PVRL2 (2.1)	ST3GAL4 (1.9)	FADS2 (1.6)	GOT2P1 (1.6)	LPIN3 (1.5)	TXNL4B (1.5)	ABCG5 (1.4)
ENSG00000113658	SMAD5 PPI subnetwork	0.07	> 0.20	ZNF180 (2.7)	KANK2 (2.1)	MARK4 (2.0)	ALDH2 (1.9)	MAPKAPK5 (1.9)	PVRL2 (1.9)	ATXN2 (1.9)	PTPN11 (1.8)	CLPTM1 (1.8)	PLEC (1.8)
ENSG00000119414	PPP6C PPI subnetwork	0.07	> 0.20	DHX38 (2.6)	NAA25 (2.3)	TOMM40 (2.2)	RELB (2.2)	PLG (2.0)	ANGPTL3 (2.0)	DDX56 (2.0)	ATP13A1 (1.8)	C19orf52 (1.8)	LDLR (1.7)
ENSG00000166716	ZNF592 PPI subnetwork	0.07	> 0.20	C19orf52 (2.3)	QTRT1 (2.2)	PARP10 (2.1)	BRAP (2.0)	DHX38 (2.0)	AMIGO1 (1.9)	SUGP1 (1.9)	OASL (1.9)	YIPF2 (1.9)	GRINA (1.8)
GO:0004869	cysteine-type endopeptidase inhibitor activity	0.07	> 0.20	PLG (3.9)	HP (3.6)	ANGPTL3 (3.3)	APOC4 (3.2)	APOB (3.1)	APOA5 (3.1)	SLC22A1 (3.1)	APOC1 (2.9)	LPA (2.8)	ALDH2 (1.9)
ENSG00000108561	C1QBP PPI subnetwork	0.07	> 0.20	RELB (3.3)	ILF3 (2.8)	BCL3 (2.1)	CLPTM1 (2.0)	PPP1R37 (1.9)	PTPN11 (1.8)	NT5DC1 (1.8)	ENSG00000238078 (1.8)	MYLIP (1.7)	SARS (1.7)
ENSG00000188157	AGRN PPI subnetwork	0.07	> 0.20	RHD (2.6)	NKPD1 (2.4)	PPP1R37 (2.3)	AMIGO1 (2.2)	ITGB3 (2.1)	ABO (2.0)	MOSC1 (1.9)	NCAN (1.9)	ANKRD31 (1.9)	ENSG00000254235 (1.9)
ENSG00000091127	PUS7 PPI subnetwork	0.07	> 0.20	DDX56 (3.5)	TOMM40 (3.4)	GPAM (3.2)	DHODH (2.9)	PTPN11 (2.7)	ADAM1 (2.5)	ATP13A1 (2.4)	NAA25 (2.3)	QTRT1 (2.3)	PPP1R37 (2.2)
ENSG00000125347	IRF1 PPI subnetwork	0.07	> 0.20	PARP10 (4.9)	RELB (3.9)	OASL (3.7)	BCL3 (3.4)	TRAFD1 (2.8)	SH2B3 (2.7)	GRINA (2.1)	C12orf51 (1.9)	CEACAM19 (1.9)	USP24 (1.5)
ENSG00000184047	DIABLO PPI subnetwork	0.07	> 0.20	RELB (5.7)	PBX4 (3.4)	BCL3 (2.8)	TRAFD1 (2.7)	ST3GAL4 (2.6)	PARP10 (2.5)	ZNF180 (2.2)	ZNF259 (1.9)	UBXN2B (1.8)	LPAR2 (1.7)
GO:0043574	peroxisomal transport	0.07	> 0.20	NT5DC1 (3.6)	C19orf52 (3.0)	AMIGO1 (2.5)	YIPF2 (2.4)	CYP7A1 (1.9)	ACAD10 (1.8)	TMEM116 (1.6)	TSSK6 (1.6)	ABO (1.5)	GOT2P1 (1.4)
ENSG00000102030	NAA10 PPI subnetwork	0.07	> 0.20	DDX56 (3.1)	TOMM40 (2.5)	ALDH2 (2.3)	TOP1 (2.2)	GOT2P1 (2.2)	C19orf52 (2.1)	ATP13A1 (2.0)	LPA (1.9)	GATAD2A (1.8)	ILF3 (1.7)
ENSG00000181656	GPR88 PPI subnetwork	0.07	> 0.20	ATXN2 (4.4)	PPP1R37 (3.8)	DHX38 (3.2)	CARM1 (3.1)	SUGP1 (3.1)	ILF3 (3.1)	SMARCA4 (3.0)	CLPTM1 (2.9)	BRAP (2.8)	BUD13 (2.8)
MP:0009278	abnormal bone marrow cell physiology	0.07	> 0.20	CETP (3.6)	TRIB1 (3.5)	BCL3 (3.4)	TIMD4 (3.2)	RHCE (2.5)	MAFB (2.3)	PLEKHH2 (1.9)	KIAA1324 (1.9)	FEN1 (1.7)	AP1M2 (1.7)
ENSG00000212695	ENSG00000212695 PPI subnetwork	0.07	> 0.20	ZNF259 (4.3)	DDX56 (4.2)	NAA25 (3.9)	QTRT1 (3.5)	DHODH (3.1)	DHX38 (2.9)	TOMM40 (2.6)	C12orf43 (2.4)	ATP13A1 (2.2)	SUGP1 (2.1)
GO:0004519	endonuclease activity	0.07	> 0.20	ZNF180 (2.6)	DHODH (2.6)	FEN1 (2.1)	C12orf43 (2.0)	POC5 (1.8)	BUD13 (1.6)	NT5DC1 (1.6)	CEACAM19 (1.5)	DDX56 (1.5)	ZHX3 (1.5)
GO:0009792	embryo development ending in birth or egg hatching	0.07	> 0.20	ATXN7L2 (3.2)	PVRL2 (2.4)	NYNRIN (2.0)	ATXN2 (1.9)	CARM1 (1.8)	ENSG00000254235 (1.7)	BCAM (1.6)	PPP1R37 (1.4)	CILP2 (1.4)	HLX (1.4)
ENSG00000164605	ENSG00000164605 PPI subnetwork	0.07	> 0.20	ATP13A1 (3.0)	MAPKAPK5 (2.8)	TOMM40 (2.4)	LPA (2.3)	HNF1A (2.3)	DHODH (2.1)	CEACAM19 (2.0)	USP24 (1.9)	DDX56 (1.8)	BRAP (1.8)
GO:0034142	toll-like receptor 4 signaling pathway	0.07	> 0.20	SH2B3 (2.6)	ENSG00000228044 (2.5)	TRIB1 (2.3)	RELB (2.2)	CYB561D1 (2.1)	ENSG00000226645 (2.0)	BLOC1S3 (2.0)	BCL3 (2.0)	GMIP (1.8)	OASL (1.8)
ENSG00000170581	STAT2 PPI subnetwork	0.07	> 0.20	TMEM50A (4.5)	BCL3 (4.0)	C1orf63 (3.4)	TRAFD1 (3.2)	MAU2 (3.0)	DNM2 (2.7)	CARM1 (2.4)	ATXN2 (2.4)	RELB (2.3)	TRIB1 (2.1)
GO:0005913	cell-cell adherens junction	0.07	> 0.20	BCAM (4.8)	PVRL2 (3.9)	AP1M2 (3.6)	PLEC (3.3)	CBLC (3.3)	CELSR2 (2.8)	KANK2 (2.5)	LPIN3 (2.1)	DNM2 (1.8)	SORT1 (1.7)
ENSG00000100888	CHD8 PPI subnetwork	0.07	> 0.20	DHX38 (2.7)	C19orf52 (2.7)	QTRT1 (2.5)	BUD13 (2.4)	BLOC1S3 (2.0)	ANKRD31 (1.9)	PCSK9 (1.8)	ILF3 (1.8)	OGDH (1.8)	ZNF180 (1.6)
MP:0001146	abnormal testis morphology	0.07	> 0.20	FADS1 (3.1)	ABCG8 (3.0)	C11orf9 (2.9)	ST3GAL4 (2.9)	ABCG5 (2.7)	PVRL2 (2.5)	TSSK6 (2.4)	C12orf47 (2.0)	UBXN2B (1.9)	CYP7A1 (1.9)
ENSG00000185507	IRF7 PPI subnetwork	0.07	> 0.20	PARP10 (4.0)	PLEKHH2 (3.0)	BCL3 (2.7)	LPAR2 (2.6)	COL4A3BP (2.2)	ZNF180 (2.2)	NT5DC1 (2.1)	C12orf51 (2.0)	PMFBP1 (2.0)	ATXN7L2 (1.9)
ENSG00000100504	PYGL PPI subnetwork	0.07	> 0.20	SYPL2 (2.9)	GMPR (2.5)	PBX4 (2.2)	SORT1 (2.0)	CARM1 (1.8)	POLK (1.7)	SLC44A2 (1.7)	MARK4 (1.7)	ITGB3 (1.6)	ENSG00000238078 (1.6)
ENSG00000165731	RET PPI subnetwork	0.07	> 0.20	C11orf9 (2.6)	ABO (2.3)	PBX4 (2.2)	GATAD2A (2.1)	TMEM57 (2.1)	SH2B3 (2.0)	PVRL2 (2.0)	HAVCR1 (1.8)	KANK2 (1.7)	DOCK7 (1.7)
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	0.07	> 0.20	FADS1 (3.7)	LDLR (3.6)	FADS2 (3.4)	HMGCR (3.1)	ABCG8 (3.0)	ST3GAL4 (2.9)	APOC1 (2.7)	TM6SF2 (2.6)	GCNT4 (2.1)	PLG (2.1)
KEGG_OTHER_GLYCAN_DEGRADATION	KEGG_OTHER_GLYCAN_DEGRADATION	0.07	> 0.20	ERP29 (4.7)	TRAPPC6A (2.9)	NT5DC1 (2.8)	ATP13A1 (2.8)	TMED4 (2.4)	SORT1 (1.9)	HNF1A (1.7)	COL4A3BP (1.7)	PCSK9 (1.7)	CEACAM19 (1.7)
GO:0070035	purine NTP-dependent helicase activity	0.07	> 0.20	OASL (4.1)	SUGP1 (4.1)	DHX38 (3.9)	DHODH (2.7)	ILF3 (2.7)	ATP13A1 (2.6)	NAA25 (2.4)	ZNF259 (2.3)	DDX56 (2.3)	SMARCA4 (2.1)
GO:0008026	ATP-dependent helicase activity	0.07	> 0.20	OASL (4.1)	SUGP1 (4.1)	DHX38 (3.9)	DHODH (2.7)	ILF3 (2.7)	ATP13A1 (2.6)	NAA25 (2.4)	ZNF259 (2.3)	DDX56 (2.3)	SMARCA4 (2.1)
ENSG00000073282	TP63 PPI subnetwork	0.07	> 0.20	BCAM (4.9)	C11orf9 (4.4)	PVRL2 (3.3)	MARK4 (3.1)	ENSG00000226645 (3.0)	CELSR2 (2.5)	NYNRIN (2.4)	TOP1 (2.3)	HP (1.9)	C1orf63 (1.8)
MP:0004933	abnormal epididymis epithelium morphology	0.07	> 0.20	ST3GAL4 (3.0)	YIPF2 (2.4)	FRK (2.1)	ITGB3 (2.1)	TMED4 (2.0)	ABO (2.0)	HMGCR (2.0)	CYP7A1 (1.9)	FADS1 (1.6)	APOC1 (1.5)
ENSG00000100056	DGCR14 PPI subnetwork	0.07	> 0.20	BRAP (3.4)	COL4A3BP (2.6)	C12orf51 (2.5)	TMEM57 (2.3)	POC5 (2.1)	DHX38 (2.1)	NAA25 (2.1)	ANKRD31 (1.8)	SH2B3 (1.7)	TMEM116 (1.5)
GO:0051917	regulation of fibrinolysis	0.07	> 0.20	ANGPTL3 (5.0)	APOC4 (4.2)	PLG (4.2)	PCSK9 (3.8)	APOA5 (3.7)	HP (3.0)	LPA (2.9)	SLC22A1 (2.9)	CEACAM19 (2.7)	HNF1A (2.6)
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR78_OR_9_ACTIVATION	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR78_OR_9_ACTIVATION	0.07	> 0.20	RELB (4.2)	TRIB1 (3.7)	SH2B3 (3.4)	BCL3 (3.1)	HLX (2.5)	PVR (2.3)	CARM1 (2.1)	GMIP (1.8)	OASL (1.7)	BUD13 (1.7)
GO:0016779	nucleotidyltransferase activity	0.07	> 0.20	OASL (3.7)	DDX56 (3.4)	ZNF259 (3.1)	PARP10 (2.8)	DHODH (2.7)	GEMIN7 (2.4)	MAPKAPK5 (2.2)	C12orf43 (2.1)	USP1 (2.1)	FEN1 (2.1)
MP:0002088	abnormal embryonic growth/weight/body size	0.07	> 0.20	APOE (2.3)	MAFB (2.3)	NYNRIN (2.0)	SLC22A1 (1.9)	ANKRD31 (1.9)	BCAM (1.8)	GRINA (1.7)	UBXN2B (1.7)	PLCG1 (1.6)	ENSG00000226648 (1.6)
ENSG00000103343	ZNF174 PPI subnetwork	0.07	> 0.20	C19orf52 (2.3)	GRINA (2.1)	OASL (2.1)	QTRT1 (2.1)	SUGP1 (2.0)	ZNF180 (1.9)	YIPF2 (1.9)	PARP10 (1.9)	BRAP (1.8)	AMIGO1 (1.7)
ENSG00000146007	ZMAT2 PPI subnetwork	0.07	> 0.20	SUGP1 (3.4)	DHX38 (3.1)	SMARCA4 (2.9)	BUD13 (2.9)	ILF3 (2.9)	CARM1 (2.8)	ATP13A1 (2.6)	MAU2 (2.3)	FEN1 (2.1)	TOMM40 (2.1)
ENSG00000072952	MRVI1 PPI subnetwork	0.07	> 0.20	ACAD10 (3.9)	NT5DC1 (3.0)	HNF1A (2.3)	C1orf63 (1.8)	PCSK9 (1.7)	TRAPPC6A (1.7)	CETP (1.5)	ATP13A1 (1.4)	TMED4 (1.4)	TIMD4 (1.4)
ENSG00000134871	COL4A2 PPI subnetwork	0.07	> 0.20	APOE (3.0)	CETP (2.0)	C17orf57 (1.9)	KANK2 (1.9)	ATP13A1 (1.5)	GCNT4 (1.5)	CILP2 (1.5)	TXNL4B (1.5)	MYLIP (1.4)	PCSK9 (1.3)
MP:0004950	abnormal brain vasculature morphology	0.07	> 0.20	GCNT4 (3.8)	ITGB3 (3.1)	PLEC (2.5)	POLK (2.4)	TIMD4 (2.1)	LPA (2.0)	GEMIN7 (1.9)	DNAH11 (1.8)	CETP (1.7)	LDLR (1.6)
ENSG00000198478	SH3BGRL2 PPI subnetwork	0.07	> 0.20	ST3GAL4 (3.3)	DNM2 (2.7)	AP1M2 (2.5)	KIAA1324 (2.5)	HNF1A (2.4)	SH2B3 (1.9)	CBLC (1.8)	NYNRIN (1.7)	PLEC (1.6)	DOCK7 (1.6)
ENSG00000213639	PPP1CB PPI subnetwork	0.07	> 0.20	GATAD2A (3.0)	KANK2 (2.4)	UBXN2B (2.4)	PLEC (2.4)	GCNT4 (2.3)	GOT2P1 (2.1)	DNM2 (2.1)	TMEM50A (1.9)	CARM1 (1.8)	DYNC2LI1 (1.6)
MP:0008554	decreased circulating tumor necrosis factor level	0.07	> 0.20	MAFB (4.3)	RELB (4.2)	BCL3 (4.2)	GMIP (3.1)	HP (2.5)	TRIB1 (2.5)	TIMD4 (2.1)	ZNF101 (1.9)	FRK (1.9)	OASL (1.9)
ENSG00000004948	CALCR PPI subnetwork	0.07	> 0.20	RPH3A (2.4)	PLEC (2.1)	LPA (2.1)	APOC4 (2.0)	ABCG5 (2.0)	PVRL2 (1.9)	AMIGO1 (1.9)	ZNF180 (1.8)	PSRC1 (1.8)	KANK2 (1.6)
GO:0005501	retinoid binding	0.07	> 0.20	TM6SF2 (3.8)	ABCG5 (3.7)	APOB (3.6)	C11orf9 (3.0)	APOC4 (2.6)	NYNRIN (2.6)	APOA5 (2.4)	LPAR2 (2.4)	CYP7A1 (2.3)	ABCG8 (2.1)
GO:0006304	DNA modification	0.07	> 0.20	ANKRD31 (2.9)	ENSG00000238078 (2.8)	C17orf57 (2.4)	MAPKAPK5 (2.0)	SUGP1 (2.0)	ACAD10 (2.0)	DHODH (1.7)	MAU2 (1.5)	YIPF2 (1.5)	FRK (1.4)
MP:0001790	abnormal immune system physiology	0.07	> 0.20	BCL3 (5.4)	RELB (3.8)	GMIP (3.1)	TIMD4 (2.5)	CETP (2.3)	HLX (2.0)	MAFB (1.8)	C17orf57 (1.6)	PARP10 (1.5)	TRAFD1 (1.4)
MP:0004618	thoracic vertebral transformation	0.07	> 0.20	UBXN2B (2.1)	HLX (1.7)	NYNRIN (1.6)	HNF1A (1.6)	ATXN7L2 (1.4)	ATXN2 (1.1)	OASL (1.1)	HAVCR1 (1.1)	BCAM (1.1)	DYNC2LI1 (1.1)
KEGG_FATTY_ACID_METABOLISM	KEGG_FATTY_ACID_METABOLISM	0.07	> 0.20	ACAD10 (4.3)	MOSC1 (4.1)	APOC4 (4.1)	GPAM (4.0)	APOA5 (3.8)	LPA (3.7)	ALDH2 (3.5)	CYP7A1 (3.3)	PLG (3.2)	ANGPTL3 (3.2)
ENSG00000103994	ZFP106 PPI subnetwork	0.07	> 0.20	C19orf52 (2.3)	ATP13A1 (2.1)	SUGP1 (2.1)	DHX38 (1.9)	TRAFD1 (1.8)	BRAP (1.8)	OGDH (1.7)	QTRT1 (1.7)	ATXN2 (1.6)	YIPF2 (1.5)
ENSG00000142655	PEX14 PPI subnetwork	0.07	> 0.20	NT5DC1 (3.2)	ACAD10 (2.8)	DYNC2LI1 (2.2)	RHCE (2.1)	TMEM57 (2.0)	TMEM116 (2.0)	ENSG00000226645 (1.9)	GPAM (1.8)	DOCK7 (1.8)	MYLIP (1.8)
ENSG00000204103	MAFB PPI subnetwork	0.07	> 0.20	TRIB1 (5.9)	COL4A3BP (2.8)	MAFB (2.6)	AMIGO1 (1.8)	NPC1L1 (1.7)	C12orf43 (1.7)	ACAD10 (1.6)	MAU2 (1.6)	HNF1A (1.5)	PVR (1.5)
MP:0008255	decreased megakaryocyte cell number	0.07	> 0.20	BCL3 (3.8)	ITGB3 (2.8)	CETP (2.4)	SLC44A2 (2.0)	ABCG8 (1.8)	CEACAM19 (1.8)	MARK4 (1.8)	ABCG5 (1.6)	CYB561D1 (1.5)	PCSK9 (1.4)
GO:0008305	integrin complex	0.07	> 0.20	ITGB3 (3.3)	SLC44A2 (2.7)	C17orf57 (2.4)	CEACAM19 (2.2)	MAFB (2.1)	GMIP (2.0)	ST3GAL4 (1.9)	ENSG00000238078 (1.8)	PLEC (1.8)	SH2B3 (1.8)
MP:0008024	absent lymph nodes	0.07	> 0.20	BCL3 (4.9)	CILP2 (3.9)	GMIP (3.4)	CETP (3.3)	NT5DC1 (2.9)	SH2B3 (2.1)	RELB (1.9)	GEMIN7 (1.9)	CLPTM1 (1.9)	CYB561D1 (1.8)
ENSG00000133477	FAM83F PPI subnetwork	0.07	> 0.20	ACAD10 (4.0)	NT5DC1 (3.1)	HNF1A (2.2)	TRAPPC6A (1.7)	CETP (1.7)	C1orf63 (1.6)	GMPR (1.6)	SORT1 (1.5)	TIMD4 (1.5)	TMED4 (1.4)
ENSG00000159189	C1QC PPI subnetwork	0.07	> 0.20	TIMD4 (4.9)	APOE (4.4)	MAFB (3.4)	CETP (2.6)	APOC1 (2.2)	CLPTM1 (1.6)	HP (1.6)	BCL3 (1.6)	ALDH2 (1.5)	GCNT4 (1.5)
MP:0004889	increased energy expenditure	0.07	> 0.20	ST3GAL4 (3.3)	MYLIP (3.0)	MOSC1 (2.6)	GPAM (2.6)	HP (2.6)	SORT1 (2.4)	ZHX3 (2.0)	LPIN3 (1.8)	MAU2 (1.8)	AMIGO1 (1.7)
ENSG00000175166	PSMD2 PPI subnetwork	0.07	> 0.20	PSMA5 (5.2)	NAA25 (2.8)	TOMM40 (2.6)	SARS (2.6)	DDX56 (2.4)	NT5DC1 (2.4)	ZNF259 (1.9)	TRAFD1 (1.9)	SMARCA4 (1.8)	BRAP (1.7)
MP:0011102	partial embryonic lethality	0.07	> 0.20	FADS2 (3.4)	FADS1 (3.3)	LDLR (3.2)	ENSG00000226648 (2.9)	PCSK9 (2.9)	HMGCR (2.8)	NYNRIN (2.5)	PLCG1 (2.3)	COL4A3BP (2.1)	GMPR (1.9)
ENSG00000100906	NFKBIA PPI subnetwork	0.07	> 0.20	RELB (3.9)	BCL3 (3.7)	CARM1 (2.3)	GRINA (2.2)	GMIP (2.1)	CLPTM1 (2.1)	MYLIP (2.1)	DNM2 (2.0)	PTPN11 (1.9)	PLEC (1.8)
MP:0004274	abnormal embryonic/fetal subventricular zone morphology	0.07	> 0.20	DHX38 (2.5)	MAU2 (2.2)	UBXN2B (2.0)	ENSG00000235545 (1.8)	PPP1R37 (1.8)	ATXN7L2 (1.8)	NCAN (1.7)	ENSG00000228044 (1.7)	CYP7A1 (1.7)	POLK (1.6)
GO:0010269	response to selenium ion	0.08	> 0.20	ABCG8 (4.3)	ABCG5 (4.1)	NPC1L1 (3.9)	TM6SF2 (3.6)	GCNT4 (3.0)	ANKRD31 (2.3)	ENSG00000235545 (2.2)	C17orf57 (2.1)	HP (1.9)	ZHX3 (1.8)
ENSG00000087245	MMP2 PPI subnetwork	0.08	> 0.20	MAFB (3.2)	APOE (3.1)	KANK2 (2.4)	TRIB1 (2.1)	CILP2 (2.0)	BCL3 (2.0)	APOC1 (1.9)	LPA (1.7)	CLPTM1 (1.5)	FRK (1.5)
GO:0001882	nucleoside binding	0.08	> 0.20	NPC1L1 (4.4)	TM6SF2 (2.8)	ABCG5 (2.5)	ABCG8 (2.4)	PVRL2 (2.0)	ALDH2 (2.0)	GCNT4 (1.9)	LPIN3 (1.9)	ZNF180 (1.9)	ZHX3 (1.8)
GO:0019748	secondary metabolic process	0.08	> 0.20	ST3GAL4 (2.2)	PMFBP1 (2.0)	CYP7A1 (2.0)	TM6SF2 (1.8)	C12orf47 (1.6)	FRK (1.6)	GOT2P1 (1.6)	ENSG00000228044 (1.5)	ABCG5 (1.4)	GMPR (1.4)
GO:0006656	phosphatidylcholine biosynthetic process	0.08	> 0.20	NPC1L1 (3.9)	ENSG00000235545 (3.5)	C17orf57 (2.7)	TM6SF2 (2.5)	APOA5 (2.3)	APOB (2.3)	ABCG5 (2.2)	HAVCR1 (2.0)	AP1M2 (2.0)	PMFBP1 (1.9)
ENSG00000134882	UBAC2 PPI subnetwork	0.08	> 0.20	ACAD10 (4.3)	NT5DC1 (3.2)	HNF1A (3.0)	TMED4 (2.4)	C1orf63 (2.2)	TRAPPC6A (1.9)	PLEKHH2 (1.9)	ATXN7L2 (1.8)	TIMD4 (1.7)	GCNT4 (1.6)
ENSG00000186575	NF2 PPI subnetwork	0.08	> 0.20	LPAR2 (3.7)	DNM2 (3.3)	ST3GAL4 (2.8)	PBX4 (2.5)	PTPN11 (2.3)	LDLR (2.2)	DOCK7 (2.0)	GMIP (2.0)	DHX38 (2.0)	PLEC (2.0)
ENSG00000119698	PPP4R4 PPI subnetwork	0.08	> 0.20	ATP13A1 (4.3)	DDX56 (2.9)	MAPKAPK5 (2.7)	TOMM40 (2.6)	BRAP (2.6)	PTPN11 (2.5)	HNF1A (2.4)	LPA (2.3)	CEACAM19 (2.2)	DHODH (2.1)
ENSG00000181856	SLC2A4 PPI subnetwork	0.08	> 0.20	ENSG00000228044 (2.5)	PTPN11 (2.3)	PVR (2.1)	C12orf43 (1.9)	BCAM (1.9)	KANK2 (1.9)	SYPL2 (1.8)	OASL (1.7)	TRAFD1 (1.7)	DNAH11 (1.7)
ENSG00000205517	RGL3 PPI subnetwork	0.08	> 0.20	COL4A3BP (2.6)	PTPN11 (2.5)	ILF3 (2.3)	MAPKAPK5 (2.2)	TOMM40 (2.1)	NAA25 (2.1)	GATAD2A (2.1)	ATP13A1 (2.0)	GMPR (1.6)	TSSK6 (1.5)
MP:0005658	increased susceptibility to diet-induced obesity	0.08	> 0.20	ABCG5 (3.9)	NPC1L1 (3.7)	ABCG8 (3.0)	KIAA1324 (3.0)	GPAM (2.6)	APOB (2.6)	TM6SF2 (2.4)	CELSR2 (1.9)	APOA5 (1.8)	LPIN3 (1.7)
GO:0042612	MHC class I protein complex	0.08	> 0.20	PARP10 (3.2)	PVR (2.7)	POLK (2.0)	TMEM50A (1.9)	APOA5 (1.9)	PVRL2 (1.8)	SLC22A1 (1.7)	APOE (1.7)	SH2B3 (1.5)	ANKRD31 (1.4)
ENSG00000115484	CCT4 PPI subnetwork	0.08	> 0.20	NAA25 (4.2)	PSMA5 (3.0)	DDX56 (2.8)	SARS (2.4)	USP24 (2.4)	BRAP (2.1)	SMARCA4 (2.0)	C12orf43 (2.0)	MAPKAPK5 (2.0)	ZNF259 (2.0)
GO:0090312	positive regulation of protein deacetylation	0.08	> 0.20	TMEM57 (3.7)	FADS2 (3.0)	BLOC1S3 (2.8)	FADS1 (2.3)	ENSG00000228044 (2.2)	POLK (2.2)	PCSK9 (1.9)	PARP10 (1.8)	BRAP (1.8)	POC5 (1.8)
ENSG00000135698	MPHOSPH6 PPI subnetwork	0.08	> 0.20	ILF3 (2.9)	QTRT1 (2.9)	DNM2 (2.8)	SUGP1 (2.5)	AP1M2 (2.2)	DOCK7 (2.2)	SARS (2.1)	POC5 (2.0)	TMEM57 (2.0)	MAU2 (2.0)
MP:0002191	abnormal artery morphology	0.08	> 0.20	MAFB (3.3)	PLCG1 (2.8)	CETP (2.7)	HLX (2.6)	SLC44A2 (2.4)	PVR (2.2)	PVRL2 (2.2)	KANK2 (2.1)	PLEKHH2 (2.0)	BCAM (1.9)
GO:0010894	negative regulation of steroid biosynthetic process	0.08	> 0.20	TRAPPC6A (2.9)	HMGCR (2.3)	ST3GAL4 (2.3)	TMEM50A (2.1)	LDLR (1.8)	ZNF101 (1.8)	PPP1R37 (1.8)	NPC1L1 (1.7)	FADS1 (1.7)	FADS2 (1.6)
GO:0045939	negative regulation of steroid metabolic process	0.08	> 0.20	TRAPPC6A (2.9)	HMGCR (2.3)	ST3GAL4 (2.3)	TMEM50A (2.1)	LDLR (1.8)	ZNF101 (1.8)	PPP1R37 (1.8)	NPC1L1 (1.7)	FADS1 (1.7)	FADS2 (1.6)
ENSG00000164270	HTR4 PPI subnetwork	0.08	> 0.20	MARK4 (3.1)	SMARCA4 (2.9)	TOP1 (2.5)	NT5DC1 (2.0)	ATXN2 (2.0)	DNM2 (1.9)	GATAD2A (1.9)	BUD13 (1.8)	C19orf52 (1.7)	ILF3 (1.6)
ENSG00000143418	CERS2 PPI subnetwork	0.08	> 0.20	HMGCR (6.7)	LDLR (6.6)	FADS1 (4.8)	PCSK9 (3.8)	FADS2 (3.6)	APOA5 (3.4)	HP (2.9)	LPA (2.9)	MOSC1 (2.5)	PLG (2.3)
GO:0006525	arginine metabolic process	0.08	> 0.20	ABCG8 (3.7)	ENSG00000226645 (3.6)	C17orf57 (3.6)	TM6SF2 (3.2)	ABCG5 (2.8)	CEACAM19 (2.7)	CYP7A1 (2.7)	ZHX3 (2.6)	PCSK9 (2.2)	HP (2.1)
ENSG00000173876	TUBB8 PPI subnetwork	0.08	> 0.20	ACAD10 (3.8)	NT5DC1 (3.2)	HNF1A (2.4)	C1orf63 (2.1)	TMED4 (2.0)	PCSK9 (1.9)	TRAPPC6A (1.8)	KIAA1324 (1.7)	CETP (1.6)	SORT1 (1.6)
ENSG00000180185	FAHD1 PPI subnetwork	0.08	> 0.20	ACAD10 (4.1)	TMED4 (3.2)	HNF1A (3.2)	NT5DC1 (2.5)	CETP (2.2)	TRAPPC6A (2.2)	TMEM50A (2.1)	CBLC (1.9)	ERP29 (1.8)	PCSK9 (1.6)
GO:0046915	transition metal ion transmembrane transporter activity	0.08	> 0.20	RHCE (2.7)	RHD (2.3)	NPC1L1 (2.3)	AP1M2 (2.2)	MAFB (2.2)	YIPF2 (1.7)	TMED4 (1.7)	TMEM116 (1.7)	ATP13A1 (1.6)	SLC44A2 (1.6)
ENSG00000163554	SPTA1 PPI subnetwork	0.08	> 0.20	DNM2 (2.7)	PLEC (2.5)	C12orf51 (2.3)	SYPL2 (1.9)	C17orf57 (1.9)	GMIP (1.8)	HAVCR1 (1.8)	OGDH (1.7)	GOT2P1 (1.7)	PMFBP1 (1.6)
MP:0001243	abnormal dermal layer morphology	0.08	> 0.20	ST3GAL4 (2.5)	PLEC (2.1)	SLC44A2 (1.9)	APOE (1.7)	CYB561D1 (1.6)	SYPL2 (1.5)	MAFB (1.5)	MYLIP (1.4)	C1orf63 (1.4)	C12orf51 (1.4)
GO:0001871	pattern binding	0.08	> 0.20	CILP2 (5.2)	HP (4.4)	MAFB (3.0)	PLG (2.7)	ANGPTL3 (2.2)	TIMD4 (2.1)	APOC4 (2.0)	LPA (1.9)	APOE (1.9)	MOSC1 (1.8)
GO:0030247	polysaccharide binding	0.08	> 0.20	CILP2 (5.2)	HP (4.4)	MAFB (3.0)	PLG (2.7)	ANGPTL3 (2.2)	TIMD4 (2.1)	APOC4 (2.0)	LPA (1.9)	APOE (1.9)	MOSC1 (1.8)
ENSG00000124198	ARFGEF2 PPI subnetwork	0.08	> 0.20	NAA25 (4.3)	DHX38 (3.6)	ZNF259 (3.3)	DDX56 (3.2)	USP24 (2.8)	OGDH (2.7)	TOP1 (2.4)	TOMM40 (2.0)	DOCK7 (1.9)	ATP13A1 (1.9)
GO:0003018	vascular process in circulatory system	0.08	> 0.20	C12orf47 (2.2)	FRK (2.1)	CETP (1.8)	ABO (1.7)	HAPLN4 (1.7)	NPC1L1 (1.6)	LPIN3 (1.6)	HLX (1.5)	ENSG00000228044 (1.5)	ITGB3 (1.3)
ENSG00000155329	ZCCHC10 PPI subnetwork	0.08	> 0.20	TOP1 (2.9)	C1orf63 (2.9)	C17orf57 (2.2)	ZNF180 (2.2)	SMARCA4 (1.9)	ATXN7L2 (1.8)	CARM1 (1.8)	BLOC1S3 (1.7)	BRAP (1.6)	SLC44A2 (1.5)
ENSG00000179562	GCC1 PPI subnetwork	0.08	> 0.20	PPP1R37 (2.8)	CELSR2 (2.7)	ENSG00000254235 (2.7)	ATXN2 (2.3)	MARK4 (2.3)	C12orf43 (2.2)	C17orf57 (2.1)	ATXN7L2 (1.9)	HAVCR1 (1.9)	GEMIN7 (1.7)
GO:0006909	phagocytosis	0.08	> 0.20	HP (3.0)	MAFB (2.9)	TIMD4 (2.6)	ALDH2 (2.4)	CILP2 (2.2)	DHODH (2.2)	LPA (2.1)	HAVCR1 (2.0)	ANKRD31 (1.8)	C17orf57 (1.6)
GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB cascade	0.08	> 0.20	PARP10 (3.1)	ST3GAL4 (3.0)	SH2B3 (2.4)	CYB561D1 (2.2)	TRAFD1 (2.1)	GRINA (2.1)	BLOC1S3 (1.9)	RELB (1.9)	C19orf52 (1.9)	ZNF101 (1.8)
GO:0008652	cellular amino acid biosynthetic process	0.08	> 0.20	CYP7A1 (3.4)	TM6SF2 (3.2)	ABCG8 (3.1)	SARS (3.0)	ANGPTL3 (2.8)	PLG (2.3)	APOC4 (2.1)	DHODH (2.1)	LPA (2.0)	APOA5 (2.0)
ENSG00000169136	ATF5 PPI subnetwork	0.08	> 0.20	SARS (4.3)	HLX (3.8)	PVRL2 (2.4)	BCL3 (2.3)	PVR (2.3)	RPH3A (2.0)	MAFB (1.8)	YIPF2 (1.6)	POC5 (1.5)	ZNF259 (1.4)
MP:0004201	fetal growth retardation	0.08	> 0.20	LDLR (3.8)	HMGCR (2.8)	C17orf57 (2.1)	PCSK9 (1.9)	PVRL2 (1.8)	NYNRIN (1.8)	C11orf9 (1.8)	CARM1 (1.8)	NKPD1 (1.7)	ENSG00000228044 (1.7)
GO:0040013	negative regulation of locomotion	0.08	> 0.20	CEACAM19 (3.0)	PVRL2 (2.6)	GCNT4 (2.5)	ENSG00000226645 (2.3)	PLEKHH2 (2.3)	ANKRD31 (2.3)	HLX (2.2)	CILP2 (2.0)	ENSG00000254235 (1.9)	KANK2 (1.9)
ENSG00000008128	CDK11A PPI subnetwork	0.08	> 0.20	UBXN2B (3.4)	SMARCA4 (2.2)	C12orf47 (2.1)	GRINA (2.0)	PARP10 (1.9)	BCL3 (1.9)	TRAPPC6A (1.8)	COL4A3BP (1.8)	C1orf63 (1.7)	BUD13 (1.7)
ENSG00000114270	COL7A1 PPI subnetwork	0.08	> 0.20	CBLC (4.3)	BCAM (4.3)	AP1M2 (3.0)	CELSR2 (2.3)	PLEC (2.3)	C17orf57 (2.2)	HAVCR1 (2.2)	PLEKHH2 (2.0)	FRK (1.9)	ITGB3 (1.9)
ENSG00000211460	TSN PPI subnetwork	0.08	> 0.20	POC5 (2.7)	MYLIP (2.6)	GRINA (2.6)	BRAP (2.4)	MAPKAPK5 (2.2)	GMPR (2.1)	ZNF101 (2.1)	C12orf43 (2.0)	GEMIN7 (2.0)	TXNL4B (2.0)
GO:0005024	transforming growth factor beta-activated receptor activity	0.08	> 0.20	NYNRIN (2.8)	CEACAM19 (2.1)	TMED4 (2.0)	PLEC (2.0)	ZNF101 (1.8)	PVRL2 (1.8)	PVR (1.7)	BCAM (1.7)	AMIGO1 (1.5)	SLC44A2 (1.5)
GO:0007257	activation of JUN kinase activity	0.08	> 0.20	ENSG00000226645 (3.2)	GCNT4 (2.6)	LPAR2 (2.6)	ENSG00000235545 (2.5)	ST3GAL4 (2.3)	PPP1R37 (2.0)	ATXN7L2 (2.0)	ABO (1.5)	OGDH (1.5)	ZHX3 (1.5)
ENSG00000099917	MED15 PPI subnetwork	0.08	> 0.20	ATXN7L2 (2.8)	BUD13 (2.8)	GEMIN7 (2.7)	MAPKAPK5 (2.6)	LDLR (2.4)	C12orf51 (2.3)	ATXN2 (2.1)	FADS2 (2.1)	ENSG00000226648 (2.0)	HMGCR (1.9)
ENSG00000105329	TGFB1 PPI subnetwork	0.08	> 0.20	CILP2 (5.1)	KANK2 (2.5)	ITGB3 (2.3)	BCAM (1.8)	MAFB (1.8)	SLC22A1 (1.8)	LPA (1.7)	SLC44A2 (1.7)	PVR (1.7)	ALDH2 (1.5)
ENSG00000213585	VDAC1 PPI subnetwork	0.08	> 0.20	OGDH (3.5)	GMPR (3.0)	ENSG00000226648 (2.4)	ENSG00000238078 (2.1)	NT5DC1 (2.1)	C11orf9 (2.1)	FADS2 (2.1)	SYPL2 (2.1)	PLCG1 (2.0)	C1orf63 (2.0)
MP:0002971	abnormal brown adipose tissue morphology	0.08	> 0.20	SORT1 (3.1)	MOSC1 (2.6)	SYPL2 (2.4)	APOC1 (2.3)	GPAM (2.2)	MAFB (2.2)	ST3GAL4 (2.0)	GCNT4 (1.9)	ACAD10 (1.8)	FADS1 (1.7)
ENSG00000072201	LNX1 PPI subnetwork	0.08	> 0.20	LPAR2 (2.4)	MAU2 (2.3)	TRAPPC6A (2.1)	MYLIP (2.0)	TRAFD1 (1.9)	C1orf63 (1.9)	TXNL4B (1.9)	POC5 (1.8)	PPP1R37 (1.8)	TOMM40 (1.7)
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_PROINFLAMMATORY_CYTOKINES	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_PROINFLAMMATORY_CYTOKINES	0.08	> 0.20	RELB (4.4)	SH2B3 (3.3)	TRIB1 (3.1)	BCL3 (3.0)	PVR (2.7)	HLX (2.6)	GMIP (1.8)	ENSG00000228044 (1.7)	GRINA (1.6)	PARP10 (1.6)
ENSG00000179776	CDH5 PPI subnetwork	0.08	> 0.20	NYNRIN (2.3)	KANK2 (2.2)	PVRL2 (2.2)	C11orf9 (2.1)	SH2B3 (1.9)	PLEC (1.9)	DHX38 (1.8)	PLG (1.8)	APOB (1.8)	PVR (1.7)
MP:0001792	impaired wound healing	0.08	> 0.20	ANGPTL3 (3.4)	AP1M2 (2.8)	HP (2.5)	CBLC (2.5)	APOB (2.1)	ABCG5 (2.0)	APOA5 (2.0)	BCL3 (1.8)	KANK2 (1.7)	APOC4 (1.7)
GO:0009982	pseudouridine synthase activity	0.08	> 0.20	DHODH (4.2)	QTRT1 (4.0)	ZNF259 (3.8)	NAA25 (3.7)	BUD13 (3.4)	DDX56 (3.0)	TOMM40 (2.9)	C12orf43 (2.7)	ACAD10 (2.4)	ATXN7L2 (1.8)
MP:0009642	abnormal blood homeostasis	0.08	> 0.20	APOB (4.6)	PLG (4.6)	HP (4.2)	APOA5 (3.7)	APOC4 (3.1)	ANGPTL3 (3.0)	ABCG5 (3.0)	TM6SF2 (2.3)	GPAM (2.3)	SLC22A1 (2.0)
MP:0001071	abnormal facial nerve morphology	0.08	> 0.20	HLX (2.7)	BCAM (2.1)	MYLIP (1.7)	BLOC1S3 (1.6)	DYNC2LI1 (1.4)	TOP1 (1.4)	TSSK6 (1.4)	SORT1 (1.4)	ZHX3 (1.3)	ANKRD31 (1.3)
ENSG00000134365	CFHR4 PPI subnetwork	0.08	> 0.20	TIMD4 (3.0)	OASL (2.9)	CETP (2.7)	PLEKHH2 (1.9)	C1orf63 (1.8)	DNAH11 (1.8)	TMEM57 (1.7)	ENSG00000228044 (1.5)	HNF1A (1.4)	SYPL2 (1.4)
MP:0005097	polychromatophilia	0.08	> 0.20	RHCE (11.3)	RHD (11.1)	GMPR (4.6)	KANK2 (2.8)	FRK (2.0)	PBX4 (1.8)	TMEM50A (1.7)	C12orf51 (1.6)	DHODH (1.5)	ENSG00000226645 (1.5)
MP:0004779	abnormal production of surfactant	0.08	> 0.20	TMEM116 (3.3)	ERP29 (3.0)	APOA5 (2.6)	BCAM (2.4)	HLX (2.2)	APOC1 (1.9)	KIAA1324 (1.9)	SLC22A1 (1.8)	SORT1 (1.8)	DNAH11 (1.6)
ENSG00000034693	PEX3 PPI subnetwork	0.08	> 0.20	CLPTM1 (4.2)	GPAM (2.9)	NT5DC1 (2.8)	MARK4 (2.5)	AMIGO1 (2.2)	ABCG8 (2.1)	DHODH (2.1)	MOSC1 (1.9)	YIPF2 (1.8)	PPP1R37 (1.7)
MP:0002080	prenatal lethality	0.08	> 0.20	LDLR (2.5)	MYLIP (2.4)	HMGCR (2.4)	PCSK9 (2.3)	SLC44A2 (2.1)	USP24 (1.9)	MARK4 (1.9)	FADS2 (1.8)	BCL3 (1.8)	NYNRIN (1.8)
ENSG00000184863	RBM33 PPI subnetwork	0.08	> 0.20	ATXN2 (3.1)	MAPKAPK5 (2.9)	SMARCA4 (2.9)	BRAP (2.7)	NAA25 (2.5)	TRAFD1 (2.4)	C12orf43 (2.3)	CLPTM1 (2.2)	ANKRD31 (2.1)	C12orf51 (2.1)
GO:0012507	ER to Golgi transport vesicle membrane	0.08	> 0.20	FADS2 (4.2)	YIPF2 (3.5)	LDLR (3.4)	HMGCR (3.1)	FADS1 (2.9)	ABCG8 (2.3)	NPC1L1 (1.9)	TMED4 (1.7)	LPIN3 (1.7)	ENSG00000228044 (1.6)
ENSG00000125868	DSTN PPI subnetwork	0.08	> 0.20	NPC1L1 (3.9)	C11orf9 (3.5)	HNF1A (2.8)	TM6SF2 (2.4)	APOB (2.3)	OGDH (2.1)	PCSK9 (2.1)	NT5DC1 (1.9)	ADAM1 (1.8)	C1orf63 (1.7)
ENSG00000168298	HIST1H1E PPI subnetwork	0.08	> 0.20	C19orf52 (2.5)	POLK (2.4)	PCSK9 (2.2)	TSSK6 (2.2)	ACAD10 (1.8)	PSRC1 (1.8)	CYB561D1 (1.6)	NKPD1 (1.5)	USP1 (1.4)	ENSG00000226648 (1.4)
ENSG00000108256	NUFIP2 PPI subnetwork	0.08	> 0.20	BRAP (3.1)	ATXN2 (3.0)	MAPKAPK5 (3.0)	SMARCA4 (2.9)	TRAFD1 (2.8)	C12orf51 (2.6)	C12orf43 (2.4)	ANKRD31 (2.2)	SUGP1 (2.1)	CLPTM1 (2.1)
GO:0042089	cytokine biosynthetic process	0.08	> 0.20	ENSG00000228044 (2.5)	ENSG00000226645 (2.2)	TIMD4 (1.9)	ENSG00000235545 (1.8)	GMIP (1.7)	CYB561D1 (1.6)	PARP10 (1.6)	BCL3 (1.6)	HLX (1.6)	OASL (1.5)
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL	0.08	> 0.20	BLOC1S3 (3.1)	CLPTM1 (2.6)	DNM2 (2.3)	GRINA (2.2)	ZNF180 (2.1)	PLEC (2.1)	PPP1R37 (2.0)	MARK4 (2.0)	MAU2 (1.9)	POLK (1.8)
MP:0003227	abnormal vascular branching morphogenesis	0.08	> 0.20	BCAM (3.2)	NYNRIN (2.6)	HLX (2.4)	SH2B3 (2.2)	CETP (2.2)	SLC44A2 (2.2)	GATAD2A (2.1)	ITGB3 (2.0)	PVRL2 (1.8)	PLEC (1.8)
MP:0001554	increased circulating free fatty acid level	0.08	> 0.20	MOSC1 (3.7)	APOA5 (3.0)	GPAM (2.9)	TIMD4 (2.4)	SORT1 (2.4)	ABCG8 (2.1)	FRK (2.1)	HP (2.0)	CETP (1.7)	APOC1 (1.7)
ENSG00000108679	LGALS3BP PPI subnetwork	0.08	> 0.20	PLEC (2.3)	ATP13A1 (2.2)	OASL (2.1)	KANK2 (2.1)	FRK (1.8)	APOE (1.8)	DHODH (1.7)	C19orf52 (1.6)	BCL3 (1.5)	PVR (1.5)
ENSG00000053372	MRTO4 PPI subnetwork	0.08	> 0.20	ZNF259 (5.2)	NAA25 (4.7)	DDX56 (4.5)	TOMM40 (3.9)	QTRT1 (3.0)	DHX38 (2.7)	DHODH (2.6)	ATP13A1 (2.5)	ENSG00000226645 (2.2)	MAPKAPK5 (2.2)
ENSG00000184979	USP18 PPI subnetwork	0.08	> 0.20	OASL (3.2)	TIMD4 (2.8)	PLEKHH2 (2.1)	CETP (2.0)	C1orf63 (1.7)	TMEM57 (1.5)	DNAH11 (1.5)	SYPL2 (1.4)	BCAM (1.4)	ENSG00000228044 (1.3)
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	0.08	> 0.20	HMGCR (14.2)	LDLR (13.4)	FADS2 (11.5)	FADS1 (11.0)	PCSK9 (8.8)	TRAPPC6A (2.0)	NKPD1 (1.8)	CYP7A1 (1.7)	LPAR2 (1.6)	GPAM (1.5)
ENSG00000102882	MAPK3 PPI subnetwork	0.08	> 0.20	TRIB1 (3.8)	LDLR (2.8)	GRINA (2.8)	RPH3A (2.6)	PLEC (2.5)	SH2B3 (2.4)	BCL3 (2.2)	PVR (2.0)	RELB (1.8)	DNM2 (1.7)
MP:0003070	increased vascular permeability	0.08	> 0.20	PLEC (3.0)	ST3GAL4 (2.7)	APOE (2.4)	LPIN3 (2.3)	CETP (2.2)	KANK2 (2.2)	GATAD2A (1.8)	C11orf9 (1.8)	PVRL2 (1.8)	NCAN (1.7)
ENSG00000129170	CSRP3 PPI subnetwork	0.08	> 0.20	SYPL2 (6.1)	GMPR (3.2)	OGDH (2.0)	ACAD10 (1.9)	LPIN3 (1.6)	RHCE (1.6)	PLEC (1.5)	RHD (1.5)	TMEM50A (1.5)	FADS1 (1.4)
GO:0050926	regulation of positive chemotaxis	0.08	> 0.20	ABO (3.4)	DNAH11 (2.9)	TMEM116 (2.0)	GCNT4 (1.8)	YIPF2 (1.7)	CYB561D1 (1.7)	ENSG00000226648 (1.5)	PPP1R37 (1.5)	PLEKHH2 (1.5)	CYP7A1 (1.4)
MP:0006396	decreased long bone epiphyseal plate size	0.08	> 0.20	HNF1A (2.8)	CILP2 (2.0)	PLEKHH2 (1.8)	KIAA1324 (1.7)	PVRL2 (1.7)	CELSR2 (1.7)	APOE (1.6)	MYLIP (1.6)	SLC22A1 (1.5)	MAFB (1.5)
MP:0009402	decreased skeletal muscle fiber diameter	0.08	> 0.20	SYPL2 (3.5)	TRIB1 (2.5)	TMEM50A (2.4)	PVR (2.2)	ZHX3 (2.2)	KANK2 (1.9)	AMIGO1 (1.8)	NYNRIN (1.8)	OGDH (1.7)	GMPR (1.6)
ENSG00000031823	RANBP3 PPI subnetwork	0.08	> 0.20	TMEM50A (3.2)	QTRT1 (2.6)	BRAP (2.4)	C12orf43 (2.3)	TOMM40 (2.2)	ZNF180 (2.1)	CLPTM1 (2.1)	TXNL4B (2.0)	LPIN3 (1.9)	ILF3 (1.9)
ENSG00000141068	KSR1 PPI subnetwork	0.08	> 0.20	DNM2 (4.3)	CARM1 (3.8)	PLEC (3.4)	LPAR2 (3.1)	ZHX3 (2.7)	C11orf9 (2.4)	CBLC (2.4)	AP1M2 (2.2)	SMARCA4 (2.2)	C12orf43 (2.0)
GO:0050819	negative regulation of coagulation	0.08	> 0.20	ANGPTL3 (3.9)	ENSG00000228044 (3.7)	PCSK9 (3.2)	ITGB3 (2.9)	PLG (2.9)	APOC4 (2.9)	SLC22A1 (2.9)	GMPR (2.6)	PVR (2.4)	CYP7A1 (2.3)
ENSG00000151846	PABPC3 PPI subnetwork	0.08	> 0.20	SMARCA4 (2.3)	ILF3 (2.2)	DDX56 (2.2)	QTRT1 (2.1)	SARS (2.1)	TOMM40 (2.1)	TOP1 (1.8)	NAA25 (1.8)	DHX38 (1.7)	SUGP1 (1.7)
ENSG00000170889	RPS9 PPI subnetwork	0.08	> 0.20	QTRT1 (4.1)	DDX56 (3.8)	NAA25 (3.6)	ZNF259 (2.8)	C12orf43 (2.5)	ATP13A1 (2.5)	PTPN11 (2.5)	ILF3 (2.5)	SARS (2.4)	TOMM40 (2.3)
GO:0046209	nitric oxide metabolic process	0.08	> 0.20	AMIGO1 (2.0)	PVR (1.9)	GCNT4 (1.9)	TXNL4B (1.7)	C17orf57 (1.6)	BCL3 (1.6)	TMEM116 (1.6)	ENSG00000228044 (1.6)	MAFB (1.5)	PLCG1 (1.4)
MP:0001861	lung inflammation	0.08	> 0.20	RELB (3.8)	BCL3 (3.8)	MAFB (3.6)	GMIP (3.4)	PVR (2.1)	TRIB1 (2.1)	SH2B3 (2.1)	GRINA (1.9)	PARP10 (1.8)	TIMD4 (1.7)
ENSG00000166333	ILK PPI subnetwork	0.08	> 0.20	FADS2 (3.6)	ITGB3 (2.7)	FADS1 (2.7)	DNM2 (2.6)	DHX38 (2.5)	LDLR (2.4)	DDX56 (2.4)	GATAD2A (2.2)	DOCK7 (2.2)	HMGCR (2.2)
ENSG00000163811	WDR43 PPI subnetwork	0.08	> 0.20	ZNF259 (4.3)	QTRT1 (4.2)	DDX56 (4.0)	TOMM40 (3.8)	NAA25 (3.3)	DHODH (3.3)	C12orf43 (3.1)	PVR (2.2)	DHX38 (2.1)	SARS (2.0)
MP:0004615	cervical vertebral transformation	0.08	> 0.20	NYNRIN (2.5)	HLX (2.3)	UBXN2B (2.2)	TRIB1 (1.8)	DOCK7 (1.7)	ENSG00000254235 (1.3)	BCAM (1.3)	PMFBP1 (1.3)	ATXN7L2 (1.2)	PLEKHH2 (1.2)
ENSG00000109320	NFKB1 PPI subnetwork	0.08	> 0.20	RELB (4.7)	BCL3 (4.6)	GRINA (3.4)	TRIB1 (2.8)	PVR (2.1)	GEMIN7 (2.0)	PSMA5 (1.9)	GMIP (1.6)	PLEC (1.6)	C12orf51 (1.6)
ENSG00000065618	COL17A1 PPI subnetwork	0.08	> 0.20	PLEC (4.3)	CBLC (4.3)	BCAM (4.2)	PVRL2 (3.1)	AP1M2 (2.9)	ST3GAL4 (1.9)	CELSR2 (1.9)	DOCK7 (1.7)	ALDH2 (1.4)	PVR (1.4)
GO:0043009	chordate embryonic development	0.08	> 0.20	ATXN7L2 (3.2)	PVRL2 (2.4)	NYNRIN (2.0)	ATXN2 (1.9)	CARM1 (1.9)	ENSG00000254235 (1.8)	BCAM (1.6)	PPP1R37 (1.5)	HLX (1.5)	CILP2 (1.4)
ENSG00000113810	SMC4 PPI subnetwork	0.08	> 0.20	USP1 (2.6)	C12orf43 (2.6)	ILF3 (2.5)	PSRC1 (2.4)	FEN1 (2.4)	C12orf47 (2.2)	DHX38 (2.2)	DDX56 (2.0)	ATP13A1 (1.9)	QTRT1 (1.9)
MP:0002020	increased tumor incidence	0.08	> 0.20	FEN1 (3.3)	TMEM57 (2.2)	USP1 (2.0)	C17orf57 (2.0)	DNM2 (1.9)	C12orf51 (1.8)	RELB (1.8)	BCL3 (1.8)	KANK2 (1.8)	PSRC1 (1.7)
ENSG00000162692	VCAM1 PPI subnetwork	0.08	> 0.20	TIMD4 (6.1)	CETP (5.8)	RHD (2.4)	PBX4 (2.4)	GMIP (1.9)	ST3GAL4 (1.9)	HP (1.8)	TRAPPC6A (1.7)	PTPN11 (1.7)	C19orf52 (1.5)
GO:0034599	cellular response to oxidative stress	0.08	> 0.20	GOT2P1 (3.2)	C17orf57 (2.8)	ACAD10 (2.8)	RHD (2.5)	RHCE (2.3)	DNAH11 (2.2)	PBX4 (2.1)	ALDH2 (2.0)	TMEM116 (1.6)	TRIB1 (1.5)
ENSG00000150630	VEGFC PPI subnetwork	0.08	> 0.20	MYLIP (4.1)	HLX (3.8)	C1orf63 (3.5)	PVRL2 (2.1)	SLC44A2 (2.0)	ENSG00000238078 (2.0)	C17orf57 (2.0)	ADAM1 (1.9)	CBLC (1.8)	ENSG00000226648 (1.6)
ENSG00000125695	STRADA PPI subnetwork	0.08	> 0.20	ILF3 (3.8)	DNM2 (3.1)	C19orf52 (2.9)	CARM1 (2.7)	TOP1 (2.5)	BRAP (2.3)	ZHX3 (2.1)	MAU2 (2.1)	SLC44A2 (2.0)	GMPR (1.8)
ENSG00000070756	PABPC1 PPI subnetwork	0.08	> 0.20	SMARCA4 (3.3)	ILF3 (3.3)	DHX38 (3.2)	ATP13A1 (3.0)	TOP1 (2.9)	SARS (2.6)	DDX56 (2.4)	NAA25 (2.4)	GATAD2A (2.4)	SUGP1 (2.3)
MP:0001144	vagina atresia	0.08	> 0.20	OASL (3.7)	BCAM (3.6)	NYNRIN (3.1)	PMFBP1 (3.0)	HAVCR1 (2.9)	MYLIP (2.6)	MAFB (2.6)	NKPD1 (2.5)	PVRL2 (2.3)	AP1M2 (2.2)
MP:0008414	abnormal spatial reference memory	0.08	> 0.20	GCNT4 (3.2)	APOC1 (3.1)	RPH3A (2.5)	TMEM116 (2.5)	ABCG8 (2.2)	ABCG5 (2.1)	ENSG00000226645 (2.1)	APOA5 (1.9)	ZNF180 (1.9)	LPA (1.8)
GO:0016127	sterol catabolic process	0.08	> 0.20	ENSG00000254235 (7.4)	LPA (5.5)	NKPD1 (2.5)	ADAM1 (2.1)	SLC22A1 (2.0)	APOC4 (1.9)	ENSG00000228044 (1.7)	CYP7A1 (1.7)	ST3GAL4 (1.7)	ENSG00000238078 (1.6)
GO:0006707	cholesterol catabolic process	0.08	> 0.20	ENSG00000254235 (7.4)	LPA (5.5)	NKPD1 (2.5)	ADAM1 (2.1)	SLC22A1 (2.0)	APOC4 (1.9)	ENSG00000228044 (1.7)	CYP7A1 (1.7)	ST3GAL4 (1.7)	ENSG00000238078 (1.6)
ENSG00000205420	KRT6A PPI subnetwork	0.08	> 0.20	CELSR2 (3.0)	ENSG00000228044 (2.3)	PLG (2.0)	APOC1 (1.9)	ANGPTL3 (1.9)	LPA (1.9)	GMPR (1.8)	PMFBP1 (1.7)	ALDH2 (1.7)	HP (1.6)
MP:0002495	increased IgA level	0.08	> 0.20	RELB (5.6)	GMIP (3.9)	BCL3 (3.5)	CETP (2.9)	SH2B3 (2.5)	MAFB (1.9)	PARP10 (1.8)	RHD (1.7)	SLC22A1 (1.6)	POLK (1.5)
MP:0000321	increased bone marrow cell number	0.08	> 0.20	RHD (4.0)	RHCE (3.7)	HLX (3.2)	BCL3 (3.2)	HP (3.0)	PARP10 (2.2)	GMIP (2.1)	TRIB1 (2.1)	RELB (1.7)	MAFB (1.5)
GO:0030532	small nuclear ribonucleoprotein complex	0.08	> 0.20	DHX38 (3.7)	C12orf47 (2.4)	SUGP1 (2.3)	DDX56 (2.2)	TOMM40 (2.2)	ATP13A1 (2.1)	POC5 (2.1)	FEN1 (1.9)	BUD13 (1.9)	USP1 (1.9)
ENSG00000104833	TUBB4A PPI subnetwork	0.08	> 0.20	RELB (6.3)	BCL3 (3.8)	GRINA (2.3)	CLPTM1 (2.2)	PVR (2.2)	NAA25 (1.9)	TRAFD1 (1.8)	SMARCA4 (1.7)	SARS (1.6)	PBX4 (1.6)
ENSG00000196954	CASP4 PPI subnetwork	0.08	> 0.20	TRAFD1 (2.5)	DOCK7 (2.5)	FRK (2.4)	ENSG00000228044 (2.1)	C17orf57 (1.8)	TMEM50A (1.7)	HMGCR (1.7)	ATP13A1 (1.6)	BLOC1S3 (1.6)	POLK (1.5)
ENSG00000128739	SNRPN PPI subnetwork	0.08	> 0.20	TOMM40 (3.7)	ZNF180 (3.3)	PSMA5 (3.2)	BLOC1S3 (2.6)	BUD13 (2.0)	TRAPPC6A (1.9)	USP1 (1.9)	GEMIN7 (1.7)	PARP10 (1.7)	DHX38 (1.7)
ENSG00000010438	PRSS3 PPI subnetwork	0.08	> 0.20	APOC4 (2.7)	ANGPTL3 (2.6)	PLG (2.5)	DYNC2LI1 (2.3)	APOA5 (2.2)	ADAM1 (2.1)	ENSG00000228044 (2.0)	HP (1.9)	APOC1 (1.9)	ABO (1.9)
ENSG00000121966	CXCR4 PPI subnetwork	0.08	> 0.20	BCL3 (4.5)	PARP10 (3.5)	TRAFD1 (3.4)	GMIP (3.1)	HLX (2.6)	CETP (2.3)	HP (2.2)	GRINA (2.0)	OASL (1.8)	RELB (1.8)
GO:0030134	ER to Golgi transport vesicle	0.08	> 0.20	FADS2 (3.9)	YIPF2 (3.5)	LDLR (3.3)	HMGCR (2.9)	FADS1 (2.8)	TMED4 (2.1)	ABCG8 (2.0)	ENSG00000228044 (1.7)	NPC1L1 (1.7)	LPIN3 (1.5)
ENSG00000198053	SIRPA PPI subnetwork	0.08	> 0.20	USP24 (3.0)	DNM2 (2.7)	COL4A3BP (2.7)	PLEC (2.6)	GMIP (2.6)	OGDH (1.9)	BCL3 (1.9)	CELSR2 (1.7)	MAU2 (1.7)	SORT1 (1.7)
MP:0010831	partial lethality	0.08	> 0.20	HP (3.5)	MOSC1 (2.4)	SORT1 (2.3)	TXNL4B (2.2)	CBLC (2.1)	OGDH (2.0)	APOB (1.9)	TMEM116 (1.8)	LPAR2 (1.8)	GOT2P1 (1.6)
ENSG00000172795	DCP2 PPI subnetwork	0.08	> 0.20	DHODH (4.1)	DHX38 (3.9)	ZNF259 (3.5)	DDX56 (3.5)	ATP13A1 (3.4)	USP24 (3.1)	NAA25 (2.9)	SUGP1 (2.7)	TXNL4B (2.6)	QTRT1 (2.1)
ENSG00000004975	DVL2 PPI subnetwork	0.08	> 0.20	BUD13 (2.5)	CARM1 (2.0)	GRINA (2.0)	LPAR2 (2.0)	MARK4 (1.9)	PVRL2 (1.7)	TXNL4B (1.5)	CELSR2 (1.5)	ATXN7L2 (1.4)	UBXN2B (1.4)
ENSG00000198841	KTI12 PPI subnetwork	0.08	> 0.20	RHD (2.3)	RHCE (2.1)	PCSK9 (2.0)	UBXN2B (1.8)	ENSG00000254235 (1.8)	TXNL4B (1.8)	HNF1A (1.6)	NT5DC1 (1.5)	SUGP1 (1.4)	PLCG1 (1.4)
ENSG00000100342	APOL1 PPI subnetwork	0.08	> 0.20	HP (3.6)	APOB (3.2)	GMPR (2.5)	FRK (2.2)	APOE (2.2)	NPC1L1 (2.1)	BRAP (2.0)	TRIB1 (1.9)	APOA5 (1.9)	CELSR2 (1.8)
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	0.08	> 0.20	KIAA1324 (3.9)	HAPLN4 (2.9)	GPAM (2.7)	NPC1L1 (2.4)	MOSC1 (2.4)	COL4A3BP (2.1)	SORT1 (2.1)	HLX (2.0)	TMEM50A (1.9)	TM6SF2 (1.9)
ENSG00000157514	TSC22D3 PPI subnetwork	0.08	> 0.20	TRIB1 (5.6)	RELB (5.4)	ENSG00000238078 (2.5)	MAPKAPK5 (2.3)	BCL3 (2.3)	PBX4 (2.2)	PARP10 (2.1)	LPAR2 (1.8)	BUD13 (1.7)	GEMIN7 (1.6)
MP:0005596	increased susceptibility to type I hypersensitivity reaction	0.08	> 0.20	KANK2 (2.5)	MAFB (2.3)	PLEKHH2 (2.0)	ALDH2 (1.8)	MOSC1 (1.6)	KIAA1324 (1.6)	POLK (1.6)	PLCG1 (1.6)	OGDH (1.5)	TRIB1 (1.4)
ENSG00000166233	ARIH1 PPI subnetwork	0.08	> 0.20	ZNF259 (2.9)	DDX56 (2.9)	ADAM1 (2.7)	SUGP1 (2.6)	USP24 (2.5)	DHODH (2.4)	C12orf43 (2.4)	OASL (2.4)	TOMM40 (2.4)	NAA25 (2.3)
ENSG00000160213	CSTB PPI subnetwork	0.08	> 0.20	APOE (4.0)	GRINA (3.2)	RHD (3.1)	MAFB (2.3)	RHCE (2.2)	UBXN2B (2.1)	PLCG1 (1.9)	SARS (1.9)	GOT2P1 (1.9)	ALDH2 (1.8)
ENSG00000189403	HMGB1 PPI subnetwork	0.08	> 0.20	PCSK9 (3.1)	BCL3 (2.5)	FADS1 (2.5)	TRIB1 (2.3)	CELSR2 (2.0)	CARM1 (1.9)	FADS2 (1.8)	LDLR (1.7)	C12orf47 (1.7)	ENSG00000238078 (1.6)
MP:0001314	corneal opacity	0.08	> 0.20	MAFB (3.8)	APOC1 (2.9)	AMIGO1 (2.7)	CETP (2.6)	ENSG00000238078 (2.0)	PLCG1 (1.9)	ENSG00000226648 (1.9)	MYLIP (1.9)	APOE (1.8)	HAVCR1 (1.7)
ENSG00000147065	MSN PPI subnetwork	0.08	> 0.20	RELB (3.4)	SH2B3 (2.6)	GMIP (2.4)	TIMD4 (2.3)	PVR (2.1)	LDLR (2.1)	LPAR2 (2.0)	BCL3 (2.0)	SLC44A2 (1.9)	ST3GAL4 (1.8)
GO:0008633	activation of pro-apoptotic gene products	0.08	> 0.20	C12orf43 (2.6)	HAVCR1 (2.5)	TXNL4B (2.4)	BRAP (2.4)	LPIN3 (2.4)	CYB561D1 (2.2)	LPAR2 (2.1)	BLOC1S3 (2.0)	FRK (2.0)	PARP10 (1.9)
ENSG00000198824	CHAMP1 PPI subnetwork	0.08	> 0.20	SMARCA4 (4.2)	C1orf63 (3.0)	DOCK7 (2.6)	ILF3 (2.5)	GATAD2A (2.4)	PPP1R37 (2.2)	BUD13 (2.2)	TOP1 (2.1)	SUGP1 (2.0)	TMEM57 (2.0)
ENSG00000141506	PIK3R5 PPI subnetwork	0.08	> 0.20	HLX (3.7)	C1orf63 (2.9)	SLC44A2 (2.8)	DOCK7 (2.8)	MYLIP (2.4)	PVRL2 (2.2)	GMIP (2.2)	DNM2 (1.9)	PLEC (1.8)	SH2B3 (1.7)
MP:0000521	abnormal kidney cortex morphology	0.08	> 0.20	NYNRIN (3.5)	AMIGO1 (2.7)	BCAM (2.4)	C17orf57 (2.2)	APOB (1.9)	TMEM116 (1.9)	SYPL2 (1.8)	TMED4 (1.8)	ATXN7L2 (1.7)	ALDH2 (1.7)
ENSG00000072518	MARK2 PPI subnetwork	0.08	> 0.20	DNM2 (4.1)	MARK4 (4.0)	LPAR2 (2.6)	TSSK6 (2.5)	GMIP (2.1)	ABO (1.9)	ATXN7L2 (1.9)	C1orf63 (1.9)	CARM1 (1.9)	UBXN2B (1.8)
ENSG00000114062	UBE3A PPI subnetwork	0.08	> 0.20	POLK (2.5)	ATXN2 (2.1)	CARM1 (1.9)	LPA (1.9)	GOT2P1 (1.8)	COL4A3BP (1.8)	KIAA1324 (1.7)	C19orf52 (1.6)	LPAR2 (1.6)	MARK4 (1.5)
ENSG00000170276	ENSG00000170276 PPI subnetwork	0.08	> 0.20	ADAM1 (3.3)	PTPN11 (2.8)	C1orf63 (2.6)	SYPL2 (2.5)	TRAFD1 (2.5)	OGDH (2.2)	ATXN7L2 (1.9)	BRAP (1.9)	CEACAM19 (1.9)	DNM2 (1.8)
ENSG00000139687	RB1 PPI subnetwork	0.08	> 0.20	FEN1 (3.1)	USP1 (3.0)	TOP1 (2.6)	MAFB (2.6)	TRIB1 (2.0)	MAU2 (2.0)	MYLIP (1.9)	BUD13 (1.6)	KANK2 (1.6)	PSRC1 (1.5)
GO:0050776	regulation of immune response	0.09	> 0.20	TIMD4 (3.4)	ZNF101 (3.1)	GMIP (2.8)	LPA (2.2)	CETP (2.1)	PARP10 (2.1)	CYB561D1 (2.1)	MAFB (2.0)	SH2B3 (2.0)	POLK (1.8)
ENSG00000178035	IMPDH2 PPI subnetwork	0.09	> 0.20	CBLC (2.2)	PLEC (2.2)	TRAPPC6A (2.1)	KANK2 (2.0)	FRK (1.9)	NT5DC1 (1.8)	PCSK9 (1.8)	TOMM40 (1.7)	ENSG00000226645 (1.7)	PVRL2 (1.6)
ENSG00000173113	TRMT112 PPI subnetwork	0.09	> 0.20	C19orf52 (4.2)	NKPD1 (3.8)	MAU2 (3.2)	NT5DC1 (2.5)	PCSK9 (2.2)	RHD (2.1)	HAVCR1 (2.0)	KANK2 (1.8)	DNM2 (1.7)	SUGP1 (1.7)
ENSG00000148942	SLC5A12 PPI subnetwork	0.09	> 0.20	TIMD4 (3.1)	OASL (3.1)	CETP (2.9)	PLEKHH2 (2.0)	TMEM57 (1.7)	DNAH11 (1.6)	TSSK6 (1.5)	C1orf63 (1.5)	HNF1A (1.4)	CEACAM19 (1.4)
MP:0001263	weight loss	0.09	> 0.20	PVR (4.2)	BCL3 (3.9)	HP (2.8)	SLC22A1 (2.6)	RELB (2.5)	OASL (2.5)	LPA (2.4)	TRIB1 (2.3)	ANGPTL3 (2.1)	TXNL4B (2.0)
GO:0072663	establishment of protein localization to peroxisome	0.09	> 0.20	NT5DC1 (3.8)	C19orf52 (3.1)	YIPF2 (2.5)	AMIGO1 (2.5)	CYP7A1 (2.0)	ACAD10 (1.9)	GOT2P1 (1.8)	TMED4 (1.5)	LPA (1.4)	BRAP (1.4)
GO:0006625	protein targeting to peroxisome	0.09	> 0.20	NT5DC1 (3.8)	C19orf52 (3.1)	YIPF2 (2.5)	AMIGO1 (2.5)	CYP7A1 (2.0)	ACAD10 (1.9)	GOT2P1 (1.8)	TMED4 (1.5)	LPA (1.4)	BRAP (1.4)
GO:0072662	protein localization to peroxisome	0.09	> 0.20	NT5DC1 (3.8)	C19orf52 (3.1)	YIPF2 (2.5)	AMIGO1 (2.5)	CYP7A1 (2.0)	ACAD10 (1.9)	GOT2P1 (1.8)	TMED4 (1.5)	LPA (1.4)	BRAP (1.4)
ENSG00000163636	PSMD6 PPI subnetwork	0.09	> 0.20	PSMA5 (5.5)	TOMM40 (3.0)	TRAFD1 (2.5)	NAA25 (2.5)	NT5DC1 (2.4)	ENSG00000254235 (2.0)	DDX56 (1.6)	PTPN11 (1.5)	QTRT1 (1.4)	PARP10 (1.4)
GO:0030203	glycosaminoglycan metabolic process	0.09	> 0.20	TMED4 (2.9)	ST3GAL4 (2.7)	TMEM50A (2.1)	ERP29 (2.1)	TMEM57 (2.0)	CILP2 (1.9)	ENSG00000228044 (1.9)	CEACAM19 (1.7)	NKPD1 (1.6)	YIPF2 (1.6)
GO:0009895	negative regulation of catabolic process	0.09	> 0.20	ENSG00000228044 (2.6)	GPAM (1.8)	ST3GAL4 (1.7)	ZHX3 (1.7)	ENSG00000226648 (1.6)	PBX4 (1.5)	ENSG00000238078 (1.4)	POC5 (1.3)	APOA5 (1.3)	KANK2 (1.2)
ENSG00000170727	BOP1 PPI subnetwork	0.09	> 0.20	ZNF259 (4.9)	NAA25 (4.6)	TOMM40 (4.2)	DDX56 (3.9)	DHX38 (3.5)	QTRT1 (3.4)	DHODH (3.4)	ATP13A1 (2.9)	C12orf43 (2.7)	PTPN11 (2.6)
GO:0016861	intramolecular oxidoreductase activity, interconverting aldoses and ketoses	0.09	> 0.20	TRAPPC6A (3.5)	PMFBP1 (2.2)	QTRT1 (2.2)	NT5DC1 (1.8)	GRINA (1.7)	PARP10 (1.7)	PLCG1 (1.7)	C12orf43 (1.7)	CETP (1.6)	BLOC1S3 (1.6)
MP:0003231	abnormal placenta vasculature	0.09	> 0.20	DOCK7 (3.3)	BCAM (2.3)	NYNRIN (2.2)	KANK2 (2.2)	PVRL2 (2.1)	C12orf51 (2.0)	BCL3 (1.8)	CBLC (1.8)	ZHX3 (1.8)	APOE (1.8)
ENSG00000106105	GARS PPI subnetwork	0.09	> 0.20	SARS (3.1)	ZNF101 (2.3)	NT5DC1 (2.3)	NAA25 (2.1)	FADS1 (2.0)	PLEC (1.9)	PMFBP1 (1.8)	QTRT1 (1.8)	PCSK9 (1.7)	UBXN2B (1.7)
ENSG00000188976	NOC2L PPI subnetwork	0.09	> 0.20	NAA25 (5.0)	ZNF259 (4.8)	TOMM40 (4.2)	QTRT1 (4.1)	DDX56 (4.0)	DHODH (3.1)	C12orf43 (3.0)	TOP1 (2.5)	DHX38 (2.4)	BRAP (2.3)
ENSG00000178053	MLF1 PPI subnetwork	0.09	> 0.20	TXNL4B (3.3)	C19orf52 (3.1)	QTRT1 (2.4)	SUGP1 (2.2)	UBXN2B (2.2)	ENSG00000226645 (2.2)	AMIGO1 (2.1)	YIPF2 (2.1)	MYLIP (2.0)	BRAP (2.0)
ENSG00000143226	FCGR2A PPI subnetwork	0.09	> 0.20	ITGB3 (4.8)	LPA (3.4)	MAFB (2.7)	CETP (2.6)	TIMD4 (2.5)	ANGPTL3 (2.5)	PLG (2.5)	HP (2.5)	APOC4 (2.5)	ABCG5 (2.1)
ENSG00000141447	OSBPL1A PPI subnetwork	0.09	> 0.20	USP24 (3.1)	PARP10 (3.0)	MAU2 (2.9)	GMIP (2.5)	BCL3 (2.4)	ATXN2 (2.2)	MARK4 (2.2)	SMARCA4 (2.0)	DHX38 (1.8)	C12orf51 (1.8)
ENSG00000143867	OSR1 PPI subnetwork	0.09	> 0.20	USP24 (3.1)	PARP10 (3.0)	MAU2 (2.9)	GMIP (2.5)	BCL3 (2.4)	ATXN2 (2.2)	MARK4 (2.2)	SMARCA4 (2.0)	DHX38 (1.8)	C12orf51 (1.8)
GO:0004549	tRNA-specific ribonuclease activity	0.09	> 0.20	ZNF180 (3.4)	DHODH (3.2)	GEMIN7 (2.8)	POC5 (2.7)	C12orf43 (2.7)	QTRT1 (1.8)	TOMM40 (1.7)	PSMA5 (1.7)	NAA25 (1.7)	BLOC1S3 (1.6)
MP:0011204	abnormal visceral yolk sac blood island morphology	0.09	> 0.20	HLX (3.0)	ENSG00000228044 (2.1)	ANKRD31 (1.7)	NYNRIN (1.7)	ACAD10 (1.6)	OGDH (1.6)	ZNF180 (1.5)	GEMIN7 (1.5)	NT5DC1 (1.4)	BCAM (1.3)
ENSG00000113712	CSNK1A1 PPI subnetwork	0.09	> 0.20	GATAD2A (3.2)	DNM2 (2.4)	LPAR2 (2.0)	TRIB1 (2.0)	PVRL2 (1.9)	MARK4 (1.8)	ENSG00000226645 (1.8)	NYNRIN (1.8)	UBXN2B (1.7)	PPP1R37 (1.6)
GO:0004091	carboxylesterase activity	0.09	> 0.20	TM6SF2 (4.6)	SLC22A1 (4.3)	CYP7A1 (3.7)	ABCG8 (3.5)	ABCG5 (3.5)	ANGPTL3 (3.0)	APOC4 (2.1)	APOA5 (2.1)	AMIGO1 (2.1)	PMFBP1 (2.0)
ENSG00000172936	MYD88 PPI subnetwork	0.09	> 0.20	OASL (3.8)	PARP10 (3.2)	GMIP (3.0)	SH2B3 (2.9)	BCL3 (2.1)	POLK (2.0)	MAFB (1.9)	RELB (1.8)	TMEM50A (1.7)	CYB561D1 (1.6)
MP:0006267	abnormal intercalated disc morphology	0.09	> 0.20	SYPL2 (3.4)	DNM2 (2.0)	BLOC1S3 (1.7)	KANK2 (1.7)	GMPR (1.6)	LDLR (1.5)	OGDH (1.4)	FADS1 (1.4)	ERP29 (1.4)	TRAFD1 (1.4)
ENSG00000175826	CTDNEP1 PPI subnetwork	0.09	> 0.20	BUD13 (2.6)	GEMIN7 (2.6)	USP24 (2.6)	CARM1 (2.5)	MAU2 (2.2)	NAA25 (2.1)	MAPKAPK5 (2.1)	C12orf43 (2.0)	TRAFD1 (1.9)	ZNF259 (1.9)
GO:0010181	FMN binding	0.09	> 0.20	PLG (3.6)	SLC22A1 (3.3)	ANGPTL3 (3.0)	LPA (2.9)	DHODH (2.7)	LPIN3 (2.6)	BLOC1S3 (2.6)	GRINA (2.3)	HP (2.3)	APOA5 (2.3)
GO:0004540	ribonuclease activity	0.09	> 0.20	DHODH (3.3)	ZNF180 (2.4)	OASL (2.3)	C12orf43 (2.3)	QTRT1 (2.3)	DDX56 (2.1)	POC5 (2.0)	SUGP1 (1.8)	NT5DC1 (1.7)	TMEM50A (1.7)
MP:0004231	abnormal calcium ion homeostasis	0.09	> 0.20	CYB561D1 (2.5)	CBLC (2.4)	AMIGO1 (2.4)	BCAM (2.3)	NYNRIN (2.1)	SYPL2 (2.1)	ENSG00000228044 (2.0)	HAVCR1 (2.0)	PVRL2 (1.9)	SLC44A2 (1.9)
MP:0000552	abnormal radius morphology	0.09	> 0.20	PLEKHH2 (2.3)	PCSK9 (1.9)	KANK2 (1.8)	NYNRIN (1.6)	ENSG00000228044 (1.5)	SYPL2 (1.5)	ANKRD31 (1.5)	LDLR (1.4)	PLEC (1.3)	TMEM116 (1.3)
GO:0044058	regulation of digestive system process	0.09	> 0.20	NPC1L1 (5.5)	ABCG8 (4.6)	ABCG5 (4.6)	TM6SF2 (4.4)	APOB (2.9)	C17orf57 (2.8)	ADAM1 (2.6)	HAPLN4 (2.2)	MOSC1 (1.9)	LPIN3 (1.6)
GO:0050661	NADP binding	0.09	> 0.20	FADS2 (4.0)	ALDH2 (3.7)	FADS1 (3.3)	ACAD10 (3.3)	LPIN3 (2.9)	KIAA1324 (2.8)	NT5DC1 (2.6)	PCSK9 (2.3)	SLC22A1 (2.2)	CYP7A1 (2.2)
ENSG00000198677	TTC37 PPI subnetwork	0.09	> 0.20	DHX38 (3.5)	USP24 (3.3)	DDX56 (3.3)	NAA25 (2.8)	DHODH (2.6)	TOMM40 (2.5)	PTPN11 (2.3)	BRAP (2.2)	ATP13A1 (2.2)	ZNF259 (2.2)
ENSG00000185104	FAF1 PPI subnetwork	0.09	> 0.20	TMEM57 (3.0)	SUGP1 (2.3)	BRAP (2.2)	USP24 (2.0)	RELB (1.9)	GATAD2A (1.8)	BLOC1S3 (1.7)	COL4A3BP (1.7)	CEACAM19 (1.7)	MAU2 (1.6)
MP:0010420	muscular ventricular septal defect	0.09	> 0.20	ST3GAL4 (2.7)	NYNRIN (2.6)	GPAM (2.3)	GMPR (1.9)	MYLIP (1.8)	KANK2 (1.7)	NPC1L1 (1.5)	TM6SF2 (1.4)	SLC22A1 (1.3)	USP24 (1.3)
REACTOME_METABOLISM_OF_NON:CODING_RNA	REACTOME_METABOLISM_OF_NON:CODING_RNA	0.09	> 0.20	POC5 (3.3)	NAA25 (3.1)	BUD13 (2.8)	USP1 (2.6)	DDX56 (2.6)	PSMA5 (2.2)	MAPKAPK5 (2.0)	TOMM40 (2.0)	ILF3 (2.0)	FEN1 (2.0)
REACTOME_SNRNP_ASSEMBLY	REACTOME_SNRNP_ASSEMBLY	0.09	> 0.20	POC5 (3.3)	NAA25 (3.1)	BUD13 (2.8)	USP1 (2.6)	DDX56 (2.6)	PSMA5 (2.2)	MAPKAPK5 (2.0)	TOMM40 (2.0)	ILF3 (2.0)	FEN1 (2.0)
ENSG00000109805	NCAPG PPI subnetwork	0.09	> 0.20	PSRC1 (3.8)	POC5 (2.4)	ANKRD31 (2.3)	BLOC1S3 (2.2)	FEN1 (2.1)	ENSG00000228044 (1.7)	TRIB1 (1.7)	PMFBP1 (1.4)	NT5DC1 (1.4)	AP1M2 (1.2)
ENSG00000149100	EIF3M PPI subnetwork	0.09	> 0.20	C19orf52 (3.2)	BRAP (3.0)	MAPKAPK5 (2.6)	C12orf47 (2.5)	C12orf43 (2.4)	BUD13 (2.3)	SH2B3 (2.1)	PTPN11 (2.0)	C1orf63 (2.0)	SARS (1.9)
ENSG00000112992	NNT PPI subnetwork	0.09	> 0.20	ACAD10 (3.9)	NT5DC1 (3.0)	HNF1A (2.3)	C1orf63 (1.7)	CETP (1.6)	TMED4 (1.6)	TRAPPC6A (1.6)	PCSK9 (1.6)	SORT1 (1.5)	ATP13A1 (1.4)
MP:0008803	abnormal placental labyrinth vasculature morphology	0.09	> 0.20	AP1M2 (3.4)	DNM2 (2.9)	PVRL2 (2.3)	KANK2 (2.1)	C12orf51 (2.0)	CARM1 (2.0)	HLX (1.9)	CBLC (1.8)	MAU2 (1.8)	PLEC (1.7)
MP:0001845	abnormal inflammatory response	0.09	> 0.20	HLX (3.7)	MAFB (3.1)	HP (3.1)	BCL3 (2.7)	GMIP (2.1)	MYLIP (1.9)	RELB (1.9)	ENSG00000228044 (1.8)	CILP2 (1.6)	TRIB1 (1.4)
ENSG00000198836	OPA1 PPI subnetwork	0.09	> 0.20	ACAD10 (3.0)	TRAPPC6A (2.6)	TMEM50A (2.6)	NT5DC1 (2.6)	HNF1A (2.5)	TMED4 (2.4)	ERP29 (1.9)	POLK (1.9)	ATXN7L2 (1.7)	SORT1 (1.5)
GO:0006509	membrane protein ectodomain proteolysis	0.09	> 0.20	ST3GAL4 (3.2)	CLPTM1 (2.5)	ENSG00000254235 (2.4)	TMEM50A (2.1)	SLC44A2 (1.9)	ENSG00000228044 (1.6)	ZNF101 (1.5)	NYNRIN (1.5)	CYB561D1 (1.4)	TMED4 (1.4)
MP:0001715	placental labyrinth hypoplasia	0.09	> 0.20	MOSC1 (2.3)	RELB (2.1)	QTRT1 (1.7)	CBLC (1.7)	LPIN3 (1.6)	CARM1 (1.6)	HP (1.6)	RHCE (1.5)	APOC4 (1.5)	TRIB1 (1.5)
ENSG00000147955	SIGMAR1 PPI subnetwork	0.09	> 0.20	HMGCR (13.6)	LDLR (11.5)	FADS1 (10.4)	FADS2 (9.4)	PCSK9 (7.2)	TRAPPC6A (2.9)	ERP29 (2.3)	NPC1L1 (2.0)	GPAM (1.8)	CYP7A1 (1.7)
MP:0006270	abnormal mammary gland growth during lactation	0.09	> 0.20	LPA (2.8)	SLC22A1 (2.4)	ALDH2 (1.7)	APOC4 (1.7)	APOA5 (1.6)	GRINA (1.5)	NPC1L1 (1.5)	ENSG00000226648 (1.4)	CEACAM19 (1.3)	RELB (1.2)
GO:0046626	regulation of insulin receptor signaling pathway	0.09	> 0.20	ENSG00000226645 (3.5)	GCNT4 (2.2)	TRIB1 (1.8)	MOSC1 (1.7)	BCL3 (1.5)	C11orf9 (1.5)	PLEKHH2 (1.5)	TMED4 (1.3)	TSSK6 (1.3)	ZNF259 (1.2)
MP:0004214	abnormal long bone diaphysis morphology	0.09	> 0.20	CILP2 (4.2)	NYNRIN (3.2)	CBLC (2.8)	BCAM (2.5)	APOE (2.2)	PLEC (2.0)	ENSG00000238078 (2.0)	ENSG00000228044 (2.0)	PLEKHH2 (2.0)	TRIB1 (1.9)
MP:0011348	abnormal renal glomerulus basement membrane morphology	0.09	> 0.20	BCAM (4.3)	PLEKHH2 (3.1)	NT5DC1 (2.9)	KANK2 (2.8)	CELSR2 (2.7)	ABO (1.8)	TMED4 (1.7)	POLK (1.6)	PVRL2 (1.6)	CYP7A1 (1.5)
MP:0002416	abnormal proerythroblast morphology	0.09	> 0.20	RHD (5.0)	RHCE (4.5)	BCL3 (3.1)	CILP2 (2.9)	GRINA (2.6)	SH2B3 (2.5)	USP24 (2.4)	GMIP (2.2)	TIMD4 (2.1)	LPAR2 (1.9)
MP:0003356	impaired luteinization	0.09	> 0.20	FADS1 (4.1)	LDLR (2.7)	MOSC1 (2.2)	POLK (2.0)	HMGCR (1.9)	ANKRD31 (1.8)	PARP10 (1.8)	ITGB3 (1.7)	LPIN3 (1.5)	GPAM (1.5)
ENSG00000133657	ATP13A3 PPI subnetwork	0.09	> 0.20	ATP13A1 (4.1)	BRAP (3.0)	MAPKAPK5 (2.9)	DDX56 (2.7)	HNF1A (2.6)	TOMM40 (2.3)	DHODH (2.2)	C12orf51 (2.1)	ANKRD31 (2.1)	CETP (2.1)
GO:0051223	regulation of protein transport	0.09	> 0.20	ZNF101 (2.4)	ST3GAL4 (1.7)	GEMIN7 (1.6)	OASL (1.5)	PBX4 (1.5)	HLX (1.5)	LPAR2 (1.4)	PLEKHH2 (1.3)	RELB (1.3)	ENSG00000226648 (1.3)
ENSG00000112182	BACH2 PPI subnetwork	0.09	> 0.20	DOCK7 (3.2)	TRIB1 (3.2)	ACAD10 (2.4)	CETP (2.4)	LDLR (2.2)	ENSG00000228044 (1.9)	ATXN2 (1.9)	TMEM57 (1.9)	DNAH11 (1.8)	CILP2 (1.8)
KEGG_PROSTATE_CANCER	KEGG_PROSTATE_CANCER	0.09	> 0.20	MYLIP (2.5)	RELB (2.4)	KIAA1324 (2.1)	TMEM50A (2.0)	ITGB3 (1.8)	PTPN11 (1.8)	MOSC1 (1.7)	MARK4 (1.6)	GATAD2A (1.5)	PLEC (1.5)
MP:0004564	enlarged myocardial fiber	0.09	> 0.20	MOSC1 (2.3)	ACAD10 (2.1)	ALDH2 (2.1)	NPC1L1 (2.0)	TM6SF2 (2.0)	DOCK7 (1.5)	GPAM (1.5)	NCAN (1.4)	DHX38 (1.4)	ERP29 (1.3)
ENSG00000111602	TIMELESS PPI subnetwork	0.09	> 0.20	FEN1 (5.9)	USP1 (3.9)	ILF3 (2.2)	TMEM57 (2.2)	DHX38 (2.0)	MAFB (1.7)	ENSG00000228044 (1.5)	KANK2 (1.5)	ZHX3 (1.5)	CYP7A1 (1.4)
GO:0046364	monosaccharide biosynthetic process	0.09	> 0.20	LPA (2.5)	MOSC1 (2.5)	GPAM (2.1)	TM6SF2 (2.1)	DHODH (1.9)	HAPLN4 (1.8)	ACAD10 (1.8)	SLC22A1 (1.7)	SYPL2 (1.7)	NT5DC1 (1.7)
GO:0009309	amine biosynthetic process	0.09	> 0.20	TM6SF2 (3.2)	CYP7A1 (3.1)	ANGPTL3 (2.6)	ABCG8 (2.5)	HNF1A (2.3)	SARS (2.3)	QTRT1 (2.1)	PLG (2.0)	GOT2P1 (1.9)	APOC4 (1.9)
GO:0006568	tryptophan metabolic process	0.09	> 0.20	ENSG00000254235 (5.9)	CYP7A1 (3.3)	SLC22A1 (3.1)	LPA (3.0)	ENSG00000228044 (2.7)	APOA5 (2.3)	CYB561D1 (2.1)	ANGPTL3 (1.6)	ATXN7L2 (1.4)	APOC4 (1.4)
GO:0043488	regulation of mRNA stability	0.09	> 0.20	ENSG00000238078 (3.7)	ADAM1 (3.2)	ENSG00000235545 (2.3)	ENSG00000226645 (2.0)	NT5DC1 (2.0)	TOP1 (1.8)	ILF3 (1.8)	TRIB1 (1.7)	ENSG00000226648 (1.5)	KANK2 (1.5)
ENSG00000140332	TLE3 PPI subnetwork	0.09	> 0.20	BUD13 (3.1)	PPP1R37 (2.4)	ABO (2.3)	MAU2 (2.2)	SUGP1 (2.2)	BLOC1S3 (1.9)	MARK4 (1.8)	FADS2 (1.7)	NYNRIN (1.7)	C19orf52 (1.7)
ENSG00000101608	MYL12A PPI subnetwork	0.09	> 0.20	MYLIP (2.5)	C1orf63 (2.4)	PVRL2 (2.1)	GMPR (2.0)	C19orf52 (2.0)	PVR (2.0)	POLK (2.0)	ITGB3 (1.8)	KANK2 (1.7)	PLEC (1.6)
GO:0031016	pancreas development	0.09	> 0.20	HNF1A (2.8)	C11orf9 (2.6)	ANKRD31 (2.4)	KIAA1324 (2.2)	ABO (1.9)	PLEKHH2 (1.7)	DNAH11 (1.7)	CYP7A1 (1.5)	NPC1L1 (1.5)	DYNC2LI1 (1.4)
GO:0045922	negative regulation of fatty acid metabolic process	0.09	> 0.20	FADS1 (2.9)	FADS2 (2.7)	NPC1L1 (2.4)	PCSK9 (2.4)	ZNF180 (2.1)	LPIN3 (2.0)	HMGCR (1.9)	TM6SF2 (1.9)	LDLR (1.8)	TRAPPC6A (1.7)
GO:0035150	regulation of tube size	0.09	> 0.20	C12orf47 (2.3)	LPIN3 (1.7)	TSSK6 (1.7)	CETP (1.7)	FRK (1.7)	ENSG00000228044 (1.6)	ABO (1.5)	HAPLN4 (1.5)	NPC1L1 (1.4)	GMPR (1.4)
ENSG00000075426	FOSL2 PPI subnetwork	0.09	> 0.20	TRIB1 (7.8)	SARS (3.1)	MAPKAPK5 (2.5)	POLK (2.2)	BCL3 (2.0)	POC5 (1.9)	MYLIP (1.8)	BLOC1S3 (1.8)	MAFB (1.6)	ATXN2 (1.4)
ENSG00000138385	SSB PPI subnetwork	0.09	> 0.20	QTRT1 (2.6)	POLK (2.4)	TOP1 (2.2)	BLOC1S3 (2.1)	NAA25 (2.0)	PTPN11 (2.0)	UBXN2B (1.8)	GCNT4 (1.8)	PVR (1.8)	RELB (1.8)
GO:0052192	movement in environment of other organism involved in symbiotic interaction	0.09	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0030260	entry into host cell	0.09	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0051828	entry into other organism involved in symbiotic interaction	0.09	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0051806	entry into cell of other organism involved in symbiotic interaction	0.09	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0044409	entry into host	0.09	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0052126	movement in host environment	0.09	> 0.20	CETP (3.4)	GCNT4 (2.9)	SLC44A2 (2.7)	NKPD1 (2.4)	PVR (2.4)	LPA (2.2)	ENSG00000228044 (2.2)	TIMD4 (2.1)	ENSG00000254235 (2.1)	GOT2P1 (1.9)
GO:0046218	indolalkylamine catabolic process	0.09	> 0.20	ENSG00000254235 (5.5)	CYP7A1 (3.7)	SLC22A1 (3.4)	LPA (3.0)	ENSG00000228044 (2.8)	APOA5 (2.6)	CYB561D1 (1.8)	ST3GAL4 (1.7)	ANGPTL3 (1.7)	APOC4 (1.6)
GO:0006569	tryptophan catabolic process	0.09	> 0.20	ENSG00000254235 (5.5)	CYP7A1 (3.7)	SLC22A1 (3.4)	LPA (3.0)	ENSG00000228044 (2.8)	APOA5 (2.6)	CYB561D1 (1.8)	ST3GAL4 (1.7)	ANGPTL3 (1.7)	APOC4 (1.6)
GO:0042436	indole-containing compound catabolic process	0.09	> 0.20	ENSG00000254235 (5.5)	CYP7A1 (3.7)	SLC22A1 (3.4)	LPA (3.0)	ENSG00000228044 (2.8)	APOA5 (2.6)	CYB561D1 (1.8)	ST3GAL4 (1.7)	ANGPTL3 (1.7)	APOC4 (1.6)
GO:0004177	aminopeptidase activity	0.09	> 0.20	NPC1L1 (5.1)	TM6SF2 (3.1)	ERP29 (2.6)	HAVCR1 (2.1)	PMFBP1 (1.9)	ENSG00000254235 (1.9)	MAPKAPK5 (1.8)	ABCG5 (1.7)	ACAD10 (1.7)	C12orf43 (1.7)
ENSG00000112964	GHR PPI subnetwork	0.09	> 0.20	BCL3 (3.4)	COL4A3BP (2.3)	PVR (2.1)	C17orf57 (2.0)	HLX (1.7)	CYP7A1 (1.6)	ZNF101 (1.5)	CETP (1.5)	ZHX3 (1.4)	SH2B3 (1.4)
ENSG00000196455	PIK3R4 PPI subnetwork	0.09	> 0.20	HLX (2.9)	DNM2 (2.5)	DOCK7 (2.3)	GMIP (2.2)	SLC44A2 (2.2)	C1orf63 (2.1)	ENSG00000226645 (2.1)	SH2B3 (2.0)	PVRL2 (1.9)	PLEC (1.9)
GO:0048557	embryonic digestive tract morphogenesis	0.09	> 0.20	PLEKHH2 (4.0)	ENSG00000228044 (3.5)	ENSG00000254235 (3.0)	ENSG00000226648 (2.9)	LPAR2 (2.4)	ENSG00000235545 (2.3)	C11orf9 (2.1)	CBLC (2.1)	BLOC1S3 (2.1)	PBX4 (2.1)
MP:0001046	abnormal enteric neuron morphology	0.09	> 0.20	HLX (2.8)	CELSR2 (2.3)	ZNF101 (2.2)	TRIB1 (2.2)	MYLIP (2.0)	CYP7A1 (1.9)	AMIGO1 (1.8)	ENSG00000254235 (1.8)	ABO (1.7)	KIAA1324 (1.6)
REACTOME_REGULATION_OF_DNA_REPLICATION	REACTOME_REGULATION_OF_DNA_REPLICATION	0.09	> 0.20	PSMA5 (5.1)	FEN1 (3.6)	NT5DC1 (2.8)	TRAFD1 (2.5)	TOMM40 (2.0)	NAA25 (1.9)	USP1 (1.8)	SUGP1 (1.7)	DDX56 (1.3)	PARP10 (1.3)
GO:0042813	Wnt-activated receptor activity	0.09	> 0.20	CILP2 (4.7)	BCAM (2.8)	CELSR2 (2.6)	PVRL2 (2.5)	AMIGO1 (2.2)	LPAR2 (2.1)	DYNC2LI1 (1.7)	YIPF2 (1.6)	KIAA1324 (1.5)	PLEKHH2 (1.3)
ENSG00000138685	FGF2 PPI subnetwork	0.09	> 0.20	HAVCR1 (3.0)	PLEKHH2 (2.8)	APOE (2.2)	CETP (2.1)	PPP1R37 (1.9)	ENSG00000238078 (1.9)	MAFB (1.8)	TIMD4 (1.8)	C17orf57 (1.8)	BCAM (1.7)
GO:0034446	substrate adhesion-dependent cell spreading	0.09	> 0.20	PLEKHH2 (3.4)	LPIN3 (2.7)	KANK2 (2.5)	AP1M2 (2.1)	GCNT4 (1.9)	NYNRIN (1.9)	HNF1A (1.7)	PMFBP1 (1.7)	BCAM (1.7)	TSSK6 (1.6)
MP:0000689	abnormal spleen morphology	0.09	> 0.20	RHD (3.5)	RHCE (3.2)	RELB (3.1)	MAFB (2.9)	BCL3 (2.9)	CETP (2.7)	GMIP (2.5)	ZNF101 (2.2)	TIMD4 (2.1)	SLC44A2 (1.9)
ENSG00000107968	MAP3K8 PPI subnetwork	0.09	> 0.20	RELB (5.2)	BCL3 (3.5)	PVR (3.4)	PLEC (2.3)	GRINA (2.1)	MYLIP (1.9)	C1orf63 (1.8)	C12orf43 (1.6)	TRAFD1 (1.6)	PARP10 (1.5)
GO:0000792	heterochromatin	0.09	> 0.20	NYNRIN (3.3)	ILF3 (2.8)	USP1 (2.7)	TOP1 (2.5)	CARM1 (2.3)	FEN1 (2.3)	ATXN2 (1.9)	PSRC1 (1.8)	LPAR2 (1.8)	KANK2 (1.8)
MP:0008057	abnormal DNA replication	0.09	> 0.20	POLK (2.4)	MYLIP (2.4)	USP1 (2.3)	PPP1R37 (2.1)	BCL3 (2.0)	NT5DC1 (1.9)	AMIGO1 (1.7)	PMFBP1 (1.7)	KANK2 (1.5)	SH2B3 (1.4)
KEGG_LYSOSOME	KEGG_LYSOSOME	0.09	> 0.20	ERP29 (5.8)	APOE (4.0)	ATP13A1 (3.4)	SORT1 (3.4)	GRINA (3.2)	TMEM50A (3.1)	TMED4 (2.9)	CLPTM1 (2.8)	COL4A3BP (2.4)	APOC1 (2.2)
ENSG00000198517	MAFK PPI subnetwork	0.09	> 0.20	TRIB1 (5.1)	SARS (4.9)	PVR (2.9)	BCL3 (2.8)	RELB (2.6)	POC5 (2.5)	MAPKAPK5 (2.5)	LDLR (2.4)	TXNL4B (1.9)	LPAR2 (1.8)
MP:0001242	hyperkeratosis	0.09	> 0.20	HMGCR (4.0)	LDLR (3.4)	PCSK9 (3.0)	FADS1 (2.9)	CBLC (2.9)	AP1M2 (2.8)	CELSR2 (2.7)	FADS2 (2.2)	NKPD1 (2.0)	APOC1 (1.6)
MP:0009403	increased variability of skeletal muscle fiber size	0.09	> 0.20	SYPL2 (5.6)	PVR (2.7)	BCAM (2.3)	PLEC (2.1)	CYP7A1 (2.1)	MAU2 (1.7)	CYB561D1 (1.6)	AMIGO1 (1.5)	APOC4 (1.5)	KANK2 (1.5)
MP:0000109	abnormal parietal bone morphology	0.09	> 0.20	NYNRIN (3.2)	CILP2 (2.6)	ST3GAL4 (2.0)	MYLIP (2.0)	NCAN (1.8)	MAU2 (1.6)	PVRL2 (1.5)	ALDH2 (1.5)	BCL3 (1.4)	SLC44A2 (1.4)
GO:0006096	glycolysis	0.09	> 0.20	GOT2P1 (3.5)	PCSK9 (1.9)	TSSK6 (1.7)	HAPLN4 (1.7)	PMFBP1 (1.6)	ACAD10 (1.6)	ENSG00000254235 (1.4)	ENSG00000228044 (1.3)	DHODH (1.2)	GMPR (1.2)
ENSG00000153234	NR4A2 PPI subnetwork	0.09	> 0.20	SMARCA4 (2.4)	C19orf52 (2.3)	OGDH (2.3)	POLK (2.0)	SUGP1 (2.0)	DNM2 (2.0)	UBXN2B (1.9)	MAU2 (1.7)	PSMA5 (1.7)	BUD13 (1.7)
ENSG00000092853	CLSPN PPI subnetwork	0.09	> 0.20	FEN1 (6.2)	USP1 (4.3)	NT5DC1 (2.3)	MAU2 (2.1)	TMEM116 (1.5)	ENSG00000228044 (1.5)	HAVCR1 (1.5)	DHODH (1.4)	FRK (1.2)	ZNF180 (1.2)
ENSG00000100320	RBFOX2 PPI subnetwork	0.09	> 0.20	NYNRIN (3.1)	BCAM (2.9)	MYLIP (2.2)	ABO (2.0)	PLEKHH2 (1.7)	C12orf47 (1.6)	KANK2 (1.6)	TRAFD1 (1.6)	MAPKAPK5 (1.6)	KIAA1324 (1.5)
ENSG00000165197	FIGF PPI subnetwork	0.09	> 0.20	MYLIP (4.2)	HLX (3.6)	C1orf63 (3.2)	C17orf57 (2.6)	SLC44A2 (2.2)	ENSG00000238078 (2.1)	ADAM1 (2.0)	PVRL2 (1.8)	LPIN3 (1.6)	ATXN7L2 (1.6)
ENSG00000108010	GLRX3 PPI subnetwork	0.09	> 0.20	ABCG5 (2.6)	PLCG1 (2.1)	ENSG00000235545 (1.8)	ABCG8 (1.8)	TRAFD1 (1.7)	HAVCR1 (1.7)	LPA (1.7)	LPIN3 (1.6)	FADS1 (1.6)	TM6SF2 (1.5)
ENSG00000127022	CANX PPI subnetwork	0.09	> 0.20	TMED4 (3.3)	ERP29 (3.1)	APOB (2.6)	CLPTM1 (2.4)	HNF1A (2.3)	BCAM (2.2)	HP (2.2)	YIPF2 (2.0)	APOC1 (1.9)	ABCG5 (1.9)
GO:0071214	cellular response to abiotic stimulus	0.09	> 0.20	C12orf43 (2.4)	TRAFD1 (2.2)	ZNF101 (2.1)	HAVCR1 (2.0)	FRK (1.8)	UBXN2B (1.7)	LPIN3 (1.7)	POLK (1.6)	BLOC1S3 (1.5)	GEMIN7 (1.5)
ENSG00000087152	ATXN7L3 PPI subnetwork	0.09	> 0.20	ATXN7L2 (3.1)	ZNF259 (2.3)	LDLR (2.1)	C17orf57 (1.7)	ANKRD31 (1.7)	YIPF2 (1.5)	TSSK6 (1.4)	ENSG00000226645 (1.4)	C11orf9 (1.4)	ACAD10 (1.3)
ENSG00000172352	CDY1B PPI subnetwork	0.09	> 0.20	TMEM57 (3.2)	MYLIP (2.2)	TSSK6 (2.0)	C19orf52 (1.8)	POLK (1.8)	GRINA (1.7)	BUD13 (1.6)	CYP7A1 (1.6)	TOMM40 (1.5)	TMEM116 (1.4)
ENSG00000172288	CDY1 PPI subnetwork	0.09	> 0.20	TMEM57 (3.2)	MYLIP (2.2)	TSSK6 (2.0)	C19orf52 (1.8)	POLK (1.8)	GRINA (1.7)	BUD13 (1.6)	CYP7A1 (1.6)	TOMM40 (1.5)	TMEM116 (1.4)
ENSG00000114942	EEF1B2 PPI subnetwork	0.09	> 0.20	SARS (3.4)	OGDH (2.6)	MAPKAPK5 (2.4)	TXNL4B (1.9)	GRINA (1.9)	CYP7A1 (1.8)	ZNF101 (1.7)	ERP29 (1.5)	DHX38 (1.5)	GMPR (1.5)
ENSG00000113456	RAD1 PPI subnetwork	0.09	> 0.20	FEN1 (3.8)	USP1 (3.1)	CLPTM1 (2.5)	POC5 (2.4)	ERP29 (2.2)	YIPF2 (2.1)	GATAD2A (1.9)	TMED4 (1.9)	PPP1R37 (1.9)	ENSG00000228044 (1.9)
ENSG00000072958	AP1M1 PPI subnetwork	0.09	> 0.20	CLPTM1 (2.4)	CARM1 (2.4)	ERP29 (2.2)	YIPF2 (2.0)	ADAM1 (1.9)	COL4A3BP (1.8)	BRAP (1.8)	PTPN11 (1.7)	FRK (1.6)	SMARCA4 (1.6)
MP:0003448	altered tumor morphology	0.09	> 0.20	TRIB1 (4.2)	UBXN2B (2.8)	GCNT4 (2.7)	SLC44A2 (2.5)	NYNRIN (2.5)	PBX4 (2.1)	LPIN3 (2.1)	ALDH2 (2.0)	COL4A3BP (2.0)	BCL3 (1.8)
ENSG00000120690	ELF1 PPI subnetwork	0.09	> 0.20	BCL3 (3.1)	GMIP (2.9)	DHX38 (2.9)	USP24 (2.8)	PARP10 (2.5)	RELB (2.2)	MAU2 (2.0)	ATXN2 (1.8)	POLK (1.8)	SMARCA4 (1.6)
REACTOME_ER:PHAGOSOME_PATHWAY	REACTOME_ER:PHAGOSOME_PATHWAY	0.09	> 0.20	PSMA5 (5.3)	TRAFD1 (3.9)	PARP10 (3.5)	NAA25 (2.0)	NT5DC1 (1.6)	TMEM50A (1.5)	TOMM40 (1.5)	RELB (1.4)	TMED4 (1.2)	DDX56 (1.2)
ENSG00000010278	CD9 PPI subnetwork	0.09	> 0.20	PVRL2 (3.1)	PLEC (2.9)	ERP29 (2.5)	PVR (2.4)	ST3GAL4 (2.2)	TIMD4 (2.1)	BCAM (2.0)	APOE (1.9)	CLPTM1 (1.6)	KANK2 (1.6)
GO:0009084	glutamine family amino acid biosynthetic process	0.09	> 0.20	CYP7A1 (3.6)	TM6SF2 (3.1)	ABCG8 (3.0)	ABO (2.8)	ANGPTL3 (2.7)	PCSK9 (2.1)	APOC4 (2.0)	PLG (2.0)	DHODH (1.9)	ZHX3 (1.8)
GO:0033197	response to vitamin E	0.09	> 0.20	DNAH11 (6.1)	CEACAM19 (2.9)	GCNT4 (2.9)	FADS1 (2.5)	MOSC1 (2.5)	HMGCR (2.0)	FADS2 (1.9)	ENSG00000238078 (1.9)	LDLR (1.8)	TSSK6 (1.7)
GO:0043086	negative regulation of catalytic activity	0.09	> 0.20	PSMA5 (1.9)	CELSR2 (1.8)	HP (1.6)	TRIB1 (1.6)	APOC4 (1.4)	PCSK9 (1.4)	GPAM (1.4)	PLG (1.4)	APOB (1.3)	ITGB3 (1.3)
ENSG00000204569	PPP1R10 PPI subnetwork	0.09	> 0.20	QTRT1 (2.8)	BRAP (2.6)	SUGP1 (2.4)	YIPF2 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	OASL (2.2)	C19orf52 (2.1)	ENSG00000228044 (1.9)	GRINA (1.9)
ENSG00000206407	ENSG00000206407 PPI subnetwork	0.09	> 0.20	QTRT1 (2.8)	BRAP (2.6)	SUGP1 (2.4)	YIPF2 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	OASL (2.2)	C19orf52 (2.1)	ENSG00000228044 (1.9)	GRINA (1.9)
ENSG00000206489	PPP1R10 PPI subnetwork	0.09	> 0.20	QTRT1 (2.8)	BRAP (2.6)	SUGP1 (2.4)	YIPF2 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	OASL (2.2)	C19orf52 (2.1)	ENSG00000228044 (1.9)	GRINA (1.9)
GO:0010743	regulation of macrophage derived foam cell differentiation	0.09	> 0.20	TIMD4 (4.4)	MOSC1 (2.5)	APOE (2.4)	GEMIN7 (2.3)	APOC1 (2.1)	ENSG00000228044 (1.8)	ITGB3 (1.7)	HP (1.7)	GPAM (1.7)	CETP (1.6)
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	KEGG_DRUG_METABOLISM_OTHER_ENZYMES	0.09	> 0.20	SLC22A1 (6.6)	CYP7A1 (5.4)	ABCG5 (5.3)	LPA (4.6)	ABCG8 (4.5)	APOC4 (4.4)	ANGPTL3 (4.2)	PLG (3.7)	TM6SF2 (3.7)	APOA5 (3.6)
GO:0016859	cis-trans isomerase activity	0.09	> 0.20	YIPF2 (3.7)	ERP29 (3.2)	TOMM40 (2.6)	QTRT1 (2.5)	TMED4 (2.1)	TXNL4B (2.0)	CLPTM1 (1.8)	OGDH (1.8)	ST3GAL4 (1.7)	DYNC2LI1 (1.7)
MP:0001270	distended abdomen	0.09	> 0.20	GCNT4 (2.5)	HLX (2.4)	MAFB (2.1)	PLCG1 (2.0)	CILP2 (1.9)	TMEM57 (1.9)	KANK2 (1.7)	PLEKHH2 (1.6)	MYLIP (1.6)	YIPF2 (1.4)
GO:0004859	phospholipase inhibitor activity	0.09	> 0.20	HP (2.9)	ALDH2 (2.9)	APOE (2.8)	CYP7A1 (2.7)	COL4A3BP (2.4)	APOC4 (2.3)	PVR (2.2)	PLG (2.1)	PLEC (1.9)	GEMIN7 (1.8)
GO:0048872	homeostasis of number of cells	0.09	> 0.20	RHD (4.8)	RHCE (4.8)	C12orf51 (1.8)	MAFB (1.7)	SH2B3 (1.4)	DNM2 (1.3)	SLC44A2 (1.3)	GRINA (1.3)	TIMD4 (1.3)	TMEM57 (1.2)
MP:0005006	abnormal osteoblast physiology	0.09	> 0.20	CILP2 (4.9)	MAFB (2.2)	BCAM (2.2)	TMEM116 (2.1)	ANGPTL3 (1.9)	ITGB3 (1.8)	APOC1 (1.8)	MYLIP (1.7)	TMEM57 (1.5)	ANKRD31 (1.5)
ENSG00000172379	ARNT2 PPI subnetwork	0.09	> 0.20	USP24 (3.0)	MAFB (2.8)	GMIP (2.6)	BCL3 (2.6)	PARP10 (2.5)	MAU2 (2.4)	PLEKHH2 (2.1)	SMARCA4 (2.0)	DHX38 (1.8)	POLK (1.8)
ENSG00000171824	EXOSC10 PPI subnetwork	0.09	> 0.20	DHX38 (3.1)	DHODH (2.8)	DDX56 (2.7)	ATP13A1 (2.7)	TOP1 (2.7)	TOMM40 (2.7)	USP1 (2.4)	SUGP1 (2.3)	ZNF259 (2.1)	UBXN2B (2.0)
MP:0011093	complete embryonic lethality at implantation	0.09	> 0.20	C12orf47 (3.5)	BUD13 (2.8)	TMED4 (2.5)	FRK (2.4)	GOT2P1 (2.2)	OGDH (1.9)	POC5 (1.9)	ERP29 (1.8)	USP1 (1.5)	FEN1 (1.4)
ENSG00000174444	RPL4 PPI subnetwork	0.09	> 0.20	DDX56 (3.7)	NAA25 (3.7)	ZNF259 (3.3)	TOMM40 (3.1)	QTRT1 (2.9)	ILF3 (2.4)	TOP1 (2.2)	SUGP1 (2.1)	DHX38 (2.0)	DHODH (2.0)
MP:0001633	poor circulation	0.09	> 0.20	HNF1A (2.3)	PVRL2 (2.2)	DHODH (1.8)	LPIN3 (1.8)	MYLIP (1.7)	SLC22A1 (1.7)	DNM2 (1.6)	ENSG00000238078 (1.6)	SORT1 (1.4)	SH2B3 (1.4)
ENSG00000091536	MYO15A PPI subnetwork	0.09	> 0.20	SYPL2 (3.3)	NT5DC1 (2.2)	ENSG00000235545 (2.1)	PPP1R37 (2.0)	DYNC2LI1 (1.9)	HAVCR1 (1.9)	KANK2 (1.6)	PVR (1.5)	DOCK7 (1.4)	C1orf63 (1.4)
ENSG00000090659	CD209 PPI subnetwork	0.09	> 0.20	ATP13A1 (4.1)	MAPKAPK5 (2.7)	DDX56 (2.6)	BRAP (2.6)	HNF1A (2.6)	PTPN11 (2.3)	CETP (2.3)	TOMM40 (2.3)	CEACAM19 (2.2)	ANKRD31 (2.0)
GO:0015749	monosaccharide transport	0.09	> 0.20	GCNT4 (3.5)	NPC1L1 (3.1)	DOCK7 (2.9)	ABCG8 (2.2)	KIAA1324 (2.1)	ABCG5 (2.0)	POC5 (2.0)	ENSG00000235545 (2.0)	SORT1 (1.9)	TMED4 (1.9)
GO:0031625	ubiquitin protein ligase binding	0.09	> 0.20	MYLIP (3.7)	BRAP (3.6)	GRINA (2.9)	TMEM57 (2.6)	ALDH2 (2.2)	GATAD2A (1.9)	MAFB (1.8)	TRIB1 (1.8)	SH2B3 (1.7)	POC5 (1.5)
ENSG00000173120	KDM2A PPI subnetwork	0.09	> 0.20	PARP10 (3.1)	MAU2 (2.5)	MYLIP (2.3)	MARK4 (2.1)	GMIP (2.0)	POLK (1.9)	USP24 (1.9)	ZHX3 (1.9)	MAFB (1.7)	BCL3 (1.7)
GO:2000191	regulation of fatty acid transport	0.09	> 0.20	C12orf43 (2.1)	CBLC (2.1)	PPP1R37 (1.7)	ATXN7L2 (1.7)	ST3GAL4 (1.3)	MAFB (1.3)	PMFBP1 (1.3)	BLOC1S3 (1.3)	CLPTM1 (1.2)	PVR (1.2)
ENSG00000123064	DDX54 PPI subnetwork	0.09	> 0.20	ZNF259 (5.2)	NAA25 (4.7)	DDX56 (4.3)	TOMM40 (4.0)	QTRT1 (3.7)	DHODH (3.3)	DHX38 (2.7)	ATP13A1 (2.4)	SUGP1 (2.3)	USP24 (2.1)
ENSG00000104835	FBXO17 PPI subnetwork	0.09	> 0.20	PSMA5 (3.4)	NAA25 (3.2)	ENSG00000235545 (2.7)	CARM1 (2.5)	TOP1 (2.3)	TRAFD1 (2.2)	HMGCR (2.1)	ABCG5 (2.0)	SUGP1 (2.0)	TOMM40 (1.9)
ENSG00000121058	COIL PPI subnetwork	0.09	> 0.20	POLK (2.8)	C12orf43 (2.0)	C19orf52 (2.0)	RPH3A (1.8)	TOMM40 (1.8)	SARS (1.8)	ILF3 (1.7)	TSSK6 (1.6)	DHODH (1.6)	SUGP1 (1.5)
ENSG00000112312	GMNN PPI subnetwork	0.09	> 0.20	FEN1 (3.4)	USP1 (2.8)	KANK2 (2.0)	ANKRD31 (1.9)	TMEM116 (1.9)	HLX (1.9)	GCNT4 (1.6)	ENSG00000235545 (1.6)	POLK (1.4)	ATXN7L2 (1.3)
ENSG00000183034	OTOP2 PPI subnetwork	0.09	> 0.20	NPC1L1 (3.1)	FADS1 (3.1)	HMGCR (2.9)	FADS2 (2.6)	NYNRIN (2.5)	USP24 (2.2)	GATAD2A (1.9)	TM6SF2 (1.9)	GOT2P1 (1.8)	COL4A3BP (1.7)
ENSG00000100767	PAPLN PPI subnetwork	0.09	> 0.20	MYLIP (3.0)	BUD13 (2.4)	PLEKHH2 (1.9)	HNF1A (1.5)	DOCK7 (1.4)	HLX (1.3)	PVRL2 (1.3)	ZHX3 (1.3)	TRIB1 (1.3)	SARS (1.2)
GO:0005539	glycosaminoglycan binding	0.09	> 0.20	CILP2 (5.3)	HP (4.2)	PLG (3.0)	MAFB (2.7)	ANGPTL3 (2.3)	APOC4 (2.2)	TIMD4 (2.1)	LPA (2.0)	APOE (1.9)	MOSC1 (1.8)
REACTOME_ISG15_ANTIVIRAL_MECHANISM	REACTOME_ISG15_ANTIVIRAL_MECHANISM	0.09	> 0.20	OASL (11.7)	PARP10 (6.3)	TRAFD1 (3.5)	USP24 (2.5)	NAA25 (2.5)	DOCK7 (2.2)	GMPR (1.9)	ILF3 (1.8)	ATP13A1 (1.7)	USP1 (1.6)
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN:STIMULATED_GENES	REACTOME_ANTIVIRAL_MECHANISM_BY_IFN:STIMULATED_GENES	0.09	> 0.20	OASL (11.7)	PARP10 (6.3)	TRAFD1 (3.5)	USP24 (2.5)	NAA25 (2.5)	DOCK7 (2.2)	GMPR (1.9)	ILF3 (1.8)	ATP13A1 (1.7)	USP1 (1.6)
REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	REACTOME_TRANSPORT_OF_ORGANIC_ANIONS	0.09	> 0.20	CYP7A1 (4.5)	APOA5 (3.9)	HP (3.9)	PLG (3.8)	SLC22A1 (3.7)	ANGPTL3 (3.4)	APOC4 (3.2)	LPA (2.6)	APOC1 (2.5)	HAVCR1 (2.3)
ENSG00000085721	RRN3 PPI subnetwork	0.09	> 0.20	ZNF259 (3.4)	C12orf43 (3.3)	HMGCR (3.0)	DDX56 (2.9)	DYNC2LI1 (2.8)	GEMIN7 (2.8)	DHODH (2.7)	TXNL4B (2.6)	QTRT1 (2.5)	NAA25 (1.9)
ENSG00000003402	CFLAR PPI subnetwork	0.09	> 0.20	RELB (5.4)	PVR (3.3)	PARP10 (3.0)	TRAFD1 (2.7)	BLOC1S3 (2.6)	BCL3 (2.5)	ST3GAL4 (2.3)	ZNF180 (2.3)	FRK (2.3)	BUD13 (2.2)
MP:0005013	increased lymphocyte cell number	0.09	> 0.20	RELB (5.7)	BCL3 (3.5)	CETP (3.1)	RHD (2.7)	GMIP (2.6)	SH2B3 (2.5)	RHCE (2.4)	APOE (2.0)	TRIB1 (1.8)	GRINA (1.6)
ENSG00000172164	SNTB1 PPI subnetwork	0.09	> 0.20	KANK2 (3.8)	SYPL2 (3.5)	PPP1R37 (3.4)	PLCG1 (2.1)	BCAM (2.1)	ATXN7L2 (2.0)	PBX4 (1.9)	SLC44A2 (1.8)	NKPD1 (1.8)	ZHX3 (1.7)
ENSG00000139343	SNRPF PPI subnetwork	0.09	> 0.20	BUD13 (3.5)	ILF3 (3.4)	C1orf63 (3.0)	DHX38 (2.9)	TOP1 (2.9)	SUGP1 (2.8)	SMARCA4 (2.6)	QTRT1 (2.5)	USP1 (2.4)	FEN1 (2.1)
ENSG00000111845	PAK1IP1 PPI subnetwork	0.10	> 0.20	ZNF259 (5.3)	DDX56 (4.7)	NAA25 (4.2)	QTRT1 (4.1)	TOMM40 (3.9)	DHODH (3.6)	ENSG00000226645 (2.6)	C12orf43 (2.4)	SUGP1 (2.3)	TOP1 (2.2)
GO:0043491	protein kinase B signaling cascade	0.10	> 0.20	TIMD4 (2.7)	CETP (2.4)	ZNF180 (2.2)	PVRL2 (2.2)	SORT1 (2.1)	NKPD1 (2.0)	CILP2 (1.8)	CLPTM1 (1.7)	BCAM (1.7)	SLC44A2 (1.5)
ENSG00000145781	COMMD10 PPI subnetwork	0.10	> 0.20	RELB (4.4)	GEMIN7 (3.3)	BCL3 (3.2)	TRAPPC6A (3.0)	CYB561D1 (2.2)	CLPTM1 (2.2)	GRINA (2.1)	PPP1R37 (2.0)	C12orf43 (1.8)	MAPKAPK5 (1.7)
GO:0030132	clathrin coat of coated pit	0.10	> 0.20	CLPTM1 (2.9)	GRINA (2.8)	SARS (2.6)	ZHX3 (2.4)	C1orf63 (2.2)	ENSG00000235545 (1.9)	TMEM50A (1.9)	CEACAM19 (1.8)	GEMIN7 (1.8)	PVRL2 (1.8)
ENSG00000147403	RPL10 PPI subnetwork	0.10	> 0.20	NAA25 (3.7)	DDX56 (3.5)	QTRT1 (3.4)	ZNF259 (3.0)	DHODH (2.5)	TOP1 (2.4)	ILF3 (2.2)	C12orf43 (2.1)	GATAD2A (2.1)	TOMM40 (2.1)
ENSG00000112186	CAP2 PPI subnetwork	0.10	> 0.20	USP24 (3.4)	NAA25 (2.8)	SARS (2.4)	SMARCA4 (2.4)	CLPTM1 (2.3)	OGDH (2.2)	GPAM (2.0)	DDX56 (1.9)	TOMM40 (1.7)	TOP1 (1.7)
MP:0002655	abnormal keratinocyte morphology	0.10	> 0.20	PLEC (4.0)	CBLC (3.9)	ENSG00000235545 (2.8)	RELB (2.4)	MAFB (2.0)	BCAM (2.0)	BCL3 (1.9)	LDLR (1.7)	LPAR2 (1.7)	AP1M2 (1.6)
ENSG00000156304	SCAF4 PPI subnetwork	0.10	> 0.20	SUGP1 (3.6)	ILF3 (3.5)	BUD13 (2.9)	SMARCA4 (2.9)	C1orf63 (2.6)	DHX38 (2.5)	MAU2 (2.1)	USP1 (2.0)	ST3GAL4 (1.9)	FEN1 (1.9)
REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR	0.10	> 0.20	RELB (4.1)	CLPTM1 (3.5)	TMEM50A (2.4)	GMIP (2.1)	GRINA (2.0)	TMED4 (1.9)	CYB561D1 (1.9)	TRAPPC6A (1.9)	PLEC (1.9)	LDLR (1.9)
ENSG00000144867	SRPRB PPI subnetwork	0.10	> 0.20	LDLR (6.6)	FADS1 (5.6)	FADS2 (4.4)	HMGCR (4.2)	PCSK9 (3.3)	TRAPPC6A (2.2)	YIPF2 (2.1)	C12orf47 (1.9)	ATP13A1 (1.5)	SORT1 (1.5)
ENSG00000114737	CISH PPI subnetwork	0.10	> 0.20	PARP10 (3.2)	USP24 (2.5)	TRAFD1 (2.2)	CYB561D1 (2.1)	BCL3 (2.0)	TMEM50A (1.8)	ALDH2 (1.6)	OASL (1.6)	PLEKHH2 (1.3)	ZHX3 (1.3)
GO:0016627	oxidoreductase activity, acting on the CH-CH group of donors	0.10	> 0.20	ALDH2 (4.3)	FADS2 (4.1)	ACAD10 (4.0)	GPAM (3.6)	TRAPPC6A (3.4)	FADS1 (3.4)	MOSC1 (3.1)	HMGCR (2.4)	LPA (2.4)	NT5DC1 (2.3)
MP:0004969	pale kidney	0.10	> 0.20	TRIB1 (3.5)	FRK (3.0)	PLEKHH2 (2.5)	PVR (2.3)	C17orf57 (2.3)	KANK2 (2.2)	NT5DC1 (2.1)	ENSG00000235545 (1.8)	MAU2 (1.6)	ENSG00000226645 (1.6)
ENSG00000132005	RFX1 PPI subnetwork	0.10	> 0.20	ATXN2 (3.0)	ZHX3 (2.6)	GMPR (2.3)	KANK2 (2.2)	CARM1 (2.1)	C12orf51 (2.1)	ZNF101 (2.0)	BCL3 (1.9)	KIAA1324 (1.9)	NYNRIN (1.8)
ENSG00000117500	TMED5 PPI subnetwork	0.10	> 0.20	HMGCR (3.6)	FADS1 (3.6)	FADS2 (3.4)	LDLR (3.3)	TMED4 (3.2)	TMEM50A (2.5)	DNAH11 (2.0)	TMEM57 (1.9)	TXNL4B (1.9)	GCNT4 (1.9)
ENSG00000156697	UTP14A PPI subnetwork	0.10	> 0.20	DHODH (3.2)	QTRT1 (3.1)	ATXN7L2 (2.7)	TOMM40 (2.7)	ZNF259 (2.6)	NAA25 (2.6)	HAVCR1 (2.4)	DDX56 (2.4)	DHX38 (1.8)	MAPKAPK5 (1.8)
GO:0005925	focal adhesion	0.10	> 0.20	PLEC (4.1)	ITGB3 (3.6)	KANK2 (2.6)	PVRL2 (2.3)	GMIP (2.3)	BCAM (2.0)	C11orf9 (1.9)	SH2B3 (1.9)	DNM2 (1.9)	GPAM (1.7)
ENSG00000132170	PPARG PPI subnetwork	0.10	> 0.20	C12orf51 (3.4)	TOP1 (2.6)	TRIB1 (2.6)	ABCG8 (2.6)	ABCG5 (2.3)	APOB (2.3)	MAPKAPK5 (2.2)	DOCK7 (1.8)	ALDH2 (1.7)	ATXN2 (1.7)
MP:0003572	abnormal uterus development	0.10	> 0.20	DYNC2LI1 (2.6)	HAVCR1 (2.1)	BCAM (1.9)	NCAN (1.7)	ITGB3 (1.7)	ST3GAL4 (1.4)	C12orf47 (1.3)	GMPR (1.2)	CELSR2 (1.1)	AP1M2 (1.0)
ENSG00000171311	EXOSC1 PPI subnetwork	0.10	> 0.20	USP24 (4.2)	DDX56 (3.4)	DHODH (3.1)	SUGP1 (2.9)	DHX38 (2.9)	NAA25 (2.4)	POC5 (2.3)	TOMM40 (2.2)	ZNF259 (2.1)	POLK (2.0)
GO:0045599	negative regulation of fat cell differentiation	0.10	> 0.20	ENSG00000238078 (2.3)	ENSG00000254235 (1.9)	TMEM116 (1.6)	SH2B3 (1.6)	LDLR (1.6)	GCNT4 (1.5)	FADS1 (1.4)	ZNF180 (1.4)	ITGB3 (1.3)	HMGCR (1.3)
ENSG00000034152	MAP2K3 PPI subnetwork	0.10	> 0.20	ATXN7L2 (2.3)	MARK4 (2.3)	PLEC (2.1)	MOSC1 (2.1)	PPP1R37 (1.9)	TRIB1 (1.9)	KANK2 (1.6)	SORT1 (1.6)	PBX4 (1.6)	GRINA (1.5)
GO:0005773	vacuole	0.10	> 0.20	ERP29 (5.0)	APOE (3.3)	TMEM50A (3.2)	GRINA (3.1)	COL4A3BP (2.7)	SORT1 (2.7)	TMED4 (2.7)	ATP13A1 (2.6)	CLPTM1 (2.4)	YIPF2 (2.2)
ENSG00000121741	ZMYM2 PPI subnetwork	0.10	> 0.20	TOP1 (3.2)	SMARCA4 (2.7)	ILF3 (2.5)	DHX38 (2.3)	KANK2 (2.2)	TRAFD1 (2.1)	GATAD2A (1.9)	MYLIP (1.9)	C1orf63 (1.8)	TMEM57 (1.8)
ENSG00000151322	NPAS3 PPI subnetwork	0.10	> 0.20	OASL (2.9)	TIMD4 (2.7)	CETP (2.7)	PLEKHH2 (2.1)	TMEM57 (1.8)	DNAH11 (1.6)	SYPL2 (1.6)	C1orf63 (1.4)	SLC44A2 (1.4)	ENSG00000228044 (1.3)
ENSG00000127884	ECHS1 PPI subnetwork	0.10	> 0.20	TMEM50A (2.5)	MYLIP (2.0)	GRINA (1.8)	C1orf63 (1.7)	POC5 (1.7)	GMIP (1.6)	RHD (1.5)	RELB (1.4)	USP1 (1.4)	C12orf47 (1.4)
GO:0005902	microvillus	0.10	> 0.20	HNF1A (3.3)	TM6SF2 (2.9)	NPC1L1 (2.7)	C11orf9 (2.7)	APOB (2.5)	APOE (2.3)	KIAA1324 (2.0)	AP1M2 (2.0)	CBLC (2.0)	BCAM (1.9)
MP:0001721	absent visceral yolk sac blood islands	0.10	> 0.20	HLX (2.8)	RHD (2.6)	PLCG1 (2.6)	MAFB (2.6)	ENSG00000226648 (2.5)	APOE (2.3)	TMEM57 (2.2)	MYLIP (2.2)	CETP (2.1)	HNF1A (2.1)
REACTOME_DESTABILIZATION_OF_MRNA_BY_BUTYRATE_RESPONSE_FACTOR_1_BRF1	REACTOME_DESTABILIZATION_OF_MRNA_BY_BUTYRATE_RESPONSE_FACTOR_1_BRF1	0.10	> 0.20	TOMM40 (3.6)	DHODH (3.1)	GRINA (2.6)	TXNL4B (2.3)	C12orf43 (2.3)	TRAPPC6A (2.2)	ZNF259 (1.9)	TMEM50A (1.8)	BCL3 (1.8)	DDX56 (1.8)
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.10	> 0.20	RPH3A (2.0)	GOT2P1 (2.0)	AMIGO1 (1.9)	HAPLN4 (1.8)	CBLC (1.7)	GEMIN7 (1.6)	SYPL2 (1.6)	GRINA (1.6)	TRAFD1 (1.6)	BRAP (1.5)
REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	0.10	> 0.20	ZNF180 (8.6)	ZNF101 (4.0)	BLOC1S3 (2.0)	POC5 (1.7)	BRAP (1.7)	TXNL4B (1.6)	MAU2 (1.5)	BUD13 (1.3)	POLK (1.3)	C19orf52 (1.2)
MP:0000939	decreased motor neuron number	0.10	> 0.20	TRIB1 (2.5)	ABO (2.4)	CELSR2 (2.1)	TIMD4 (2.1)	BCAM (1.9)	CILP2 (1.9)	TMEM116 (1.7)	SH2B3 (1.7)	PMFBP1 (1.5)	DYNC2LI1 (1.4)
ENSG00000163956	LRPAP1 PPI subnetwork	0.10	> 0.20	FADS1 (3.2)	PCSK9 (2.9)	FADS2 (2.8)	DOCK7 (2.6)	HMGCR (2.5)	DNAH11 (2.5)	ATXN2 (2.3)	USP24 (2.2)	ITGB3 (2.1)	SARS (2.0)
ENSG00000164050	PLXNB1 PPI subnetwork	0.10	> 0.20	HAVCR1 (3.3)	PVR (2.5)	BCL3 (2.3)	PVRL2 (2.1)	PLEC (2.1)	DOCK7 (2.1)	TRIB1 (2.0)	LDLR (1.9)	C12orf51 (1.9)	CELSR2 (1.8)
ENSG00000182093	WRB PPI subnetwork	0.10	> 0.20	C12orf51 (4.7)	UBXN2B (3.1)	ATXN2 (3.1)	ZHX3 (2.9)	ENSG00000254235 (2.3)	OGDH (2.2)	USP24 (2.2)	CYP7A1 (2.0)	SMARCA4 (1.8)	GOT2P1 (1.7)
ENSG00000073536	NLE1 PPI subnetwork	0.10	> 0.20	ZNF259 (5.1)	NAA25 (4.7)	DDX56 (4.1)	TOMM40 (3.7)	QTRT1 (3.5)	MAPKAPK5 (3.0)	DHX38 (2.8)	DHODH (2.8)	C12orf43 (2.6)	SUGP1 (2.4)
GO:0003823	antigen binding	0.10	> 0.20	LPA (3.6)	TM6SF2 (2.8)	CETP (2.7)	ALDH2 (2.2)	NPC1L1 (2.1)	RPH3A (2.0)	HMGCR (1.9)	ABCG8 (1.9)	MAFB (1.7)	PARP10 (1.5)
ENSG00000166401	SERPINB8 PPI subnetwork	0.10	> 0.20	APOA5 (3.0)	HP (2.8)	APOB (2.7)	HNF1A (2.5)	KANK2 (2.4)	NPC1L1 (2.3)	PLG (2.2)	APOC4 (2.2)	SYPL2 (2.1)	ST3GAL4 (1.9)
ENSG00000123975	CKS2 PPI subnetwork	0.10	> 0.20	TMEM57 (2.6)	CARM1 (2.6)	GRINA (2.3)	FEN1 (2.2)	DOCK7 (2.2)	LPIN3 (2.2)	GMPR (2.2)	RHCE (1.8)	BCAM (1.7)	CLPTM1 (1.6)
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	0.10	> 0.20	FADS2 (10.3)	FADS1 (9.9)	HMGCR (7.2)	LDLR (6.8)	PCSK9 (4.7)	GPAM (3.8)	MOSC1 (3.2)	DOCK7 (2.4)	APOC1 (2.4)	ALDH2 (2.2)
MP:0002177	abnormal outer ear morphology	0.10	> 0.20	AP1M2 (2.6)	GCNT4 (2.6)	HAVCR1 (2.1)	CBLC (2.0)	CEACAM19 (2.0)	MYLIP (1.9)	DNAH11 (1.9)	PLCG1 (1.7)	DOCK7 (1.4)	CILP2 (1.3)
ENSG00000072062	PRKACA PPI subnetwork	0.10	> 0.20	HLX (2.6)	RELB (2.1)	RPH3A (2.0)	PLEC (1.9)	NCAN (1.9)	BCAM (1.9)	SH2B3 (1.8)	DNM2 (1.8)	GPAM (1.8)	PTPN11 (1.8)
ENSG00000184967	NOC4L PPI subnetwork	0.10	> 0.20	DDX56 (4.8)	ZNF259 (4.5)	NAA25 (3.7)	TOMM40 (3.4)	QTRT1 (3.4)	DHODH (2.7)	MAPKAPK5 (2.1)	DHX38 (2.1)	BRAP (2.0)	SUGP1 (2.0)
GO:0043122	regulation of I-kappaB kinase/NF-kappaB cascade	0.10	> 0.20	PARP10 (2.9)	ST3GAL4 (2.8)	SH2B3 (2.6)	CYB561D1 (2.5)	GRINA (2.2)	RELB (2.1)	GEMIN7 (1.8)	TRAFD1 (1.7)	OASL (1.7)	BLOC1S3 (1.6)
ENSG00000206088	ENSG00000206088 PPI subnetwork	0.10	> 0.20	TRIB1 (2.6)	MYLIP (2.5)	CELSR2 (2.5)	BCL3 (2.4)	SMARCA4 (2.2)	POLK (2.0)	GATAD2A (1.9)	PARP10 (1.9)	BUD13 (1.9)	RELB (1.8)
ENSG00000170522	ELOVL6 PPI subnetwork	0.10	> 0.20	TMEM50A (4.2)	HMGCR (3.6)	FADS2 (3.2)	ATP13A1 (3.2)	CLPTM1 (3.2)	LDLR (3.2)	TMED4 (2.9)	FADS1 (2.8)	PCSK9 (2.5)	POC5 (2.1)
ENSG00000119888	EPCAM PPI subnetwork	0.10	> 0.20	NPC1L1 (5.0)	AP1M2 (4.2)	ABCG5 (2.9)	TM6SF2 (2.7)	KIAA1324 (2.7)	FRK (2.4)	ST3GAL4 (2.3)	HNF1A (2.2)	CBLC (2.0)	DNM2 (1.9)
ENSG00000126070	EIF2C3 PPI subnetwork	0.10	> 0.20	FADS1 (3.2)	NPC1L1 (3.1)	HMGCR (3.0)	FADS2 (2.8)	GATAD2A (2.1)	LDLR (2.0)	NYNRIN (2.0)	USP24 (1.9)	TM6SF2 (1.8)	GEMIN7 (1.8)
ENSG00000162928	PEX13 PPI subnetwork	0.10	> 0.20	NT5DC1 (3.3)	C19orf52 (3.3)	YIPF2 (2.6)	TRAPPC6A (2.3)	COL4A3BP (2.1)	DYNC2LI1 (2.0)	FRK (1.9)	UBXN2B (1.7)	ENSG00000226648 (1.7)	AMIGO1 (1.6)
GO:0045088	regulation of innate immune response	0.10	> 0.20	PARP10 (3.2)	OASL (3.1)	TRAFD1 (2.8)	ZNF101 (2.7)	CYB561D1 (2.6)	ENSG00000228044 (2.2)	SH2B3 (2.1)	BCL3 (2.1)	RELB (1.9)	POLK (1.8)
GO:0019048	virus-host interaction	0.10	> 0.20	GCNT4 (2.7)	ENSG00000254235 (2.1)	OASL (2.1)	PPP1R37 (1.9)	ERP29 (1.9)	CYB561D1 (1.9)	PTPN11 (1.8)	CETP (1.8)	PARP10 (1.8)	NAA25 (1.8)
ENSG00000109618	SEPSECS PPI subnetwork	0.10	> 0.20	ATP13A1 (3.9)	MAPKAPK5 (2.8)	BRAP (2.7)	HNF1A (2.7)	DDX56 (2.7)	PTPN11 (2.3)	TOMM40 (2.3)	CEACAM19 (2.3)	DHODH (2.1)	LPA (2.0)
GO:0004303	estradiol 17-beta-dehydrogenase activity	0.10	> 0.20	APOC1 (3.8)	SLC22A1 (3.4)	APOC4 (3.2)	CBLC (2.7)	ANGPTL3 (2.5)	APOA5 (2.4)	ALDH2 (2.4)	ABCG5 (2.2)	LPA (2.0)	PMFBP1 (2.0)
ENSG00000166165	CKB PPI subnetwork	0.10	> 0.20	RELB (2.9)	C12orf43 (2.6)	BUD13 (2.4)	HAVCR1 (2.2)	SYPL2 (2.0)	ILF3 (1.8)	DHX38 (1.8)	GEMIN7 (1.7)	QTRT1 (1.7)	ANKRD31 (1.5)
GO:0055037	recycling endosome	0.10	> 0.20	TMEM116 (2.6)	PTPN11 (2.4)	SLC44A2 (2.2)	HMGCR (2.2)	CYB561D1 (2.2)	BLOC1S3 (1.9)	FADS2 (1.8)	DNM2 (1.6)	FADS1 (1.6)	COL4A3BP (1.5)
ENSG00000204209	DAXX PPI subnetwork	0.10	> 0.20	OASL (4.2)	TRAFD1 (4.2)	PARP10 (2.9)	SH2B3 (2.1)	POLK (2.0)	PLCG1 (2.0)	BRAP (2.0)	USP24 (1.9)	DHX38 (1.7)	USP1 (1.7)
ENSG00000206279	DAXX PPI subnetwork	0.10	> 0.20	OASL (4.2)	TRAFD1 (4.2)	PARP10 (2.9)	SH2B3 (2.1)	POLK (2.0)	PLCG1 (2.0)	BRAP (2.0)	USP24 (1.9)	DHX38 (1.7)	USP1 (1.7)
ENSG00000206206	DAXX PPI subnetwork	0.10	> 0.20	OASL (4.2)	TRAFD1 (4.2)	PARP10 (2.9)	SH2B3 (2.1)	POLK (2.0)	PLCG1 (2.0)	BRAP (2.0)	USP24 (1.9)	DHX38 (1.7)	USP1 (1.7)
MP:0003449	abnormal intestinal goblet cell morphology	0.10	> 0.20	KIAA1324 (3.8)	NYNRIN (2.7)	MOSC1 (2.4)	PLCG1 (2.2)	HNF1A (2.1)	TMED4 (2.0)	C11orf9 (2.0)	BCAM (1.7)	PLEC (1.7)	PLEKHH2 (1.7)
MP:0006264	decreased systemic arterial systolic blood pressure	0.10	> 0.20	C12orf47 (2.7)	HLX (2.6)	PLG (2.4)	ANGPTL3 (2.0)	HNF1A (1.6)	SLC22A1 (1.6)	ZHX3 (1.6)	TRIB1 (1.5)	BCAM (1.5)	HP (1.5)
ENSG00000157873	TNFRSF14 PPI subnetwork	0.10	> 0.20	PSMA5 (3.3)	TOMM40 (3.1)	ERP29 (2.3)	ATP13A1 (2.3)	QTRT1 (2.1)	TOP1 (1.9)	DHODH (1.9)	ILF3 (1.8)	PBX4 (1.7)	DDX56 (1.6)
ENSG00000009790	TRAF3IP3 PPI subnetwork	0.10	> 0.20	ZNF180 (3.4)	PARP10 (2.8)	MARK4 (2.6)	CBLC (2.5)	BCL3 (2.1)	GMIP (1.8)	OASL (1.7)	SMARCA4 (1.6)	PBX4 (1.6)	MAFB (1.6)
GO:0016887	ATPase activity	0.10	> 0.20	DHX38 (3.9)	ATP13A1 (3.5)	SMARCA4 (3.0)	SUGP1 (2.9)	USP24 (2.6)	NAA25 (2.5)	MAU2 (2.2)	DOCK7 (2.2)	ILF3 (2.1)	COL4A3BP (2.1)
GO:2000116	regulation of cysteine-type endopeptidase activity	0.10	> 0.20	POLK (3.2)	ENSG00000238078 (2.7)	C17orf57 (2.4)	TRAPPC6A (2.3)	OASL (2.1)	ITGB3 (2.0)	TRAFD1 (1.9)	GOT2P1 (1.7)	GEMIN7 (1.7)	ST3GAL4 (1.6)
ENSG00000173726	TOMM20 PPI subnetwork	0.10	> 0.20	TM6SF2 (3.7)	APOB (3.6)	ABCG5 (3.3)	ZNF259 (3.0)	ABCG8 (2.9)	APOA5 (2.7)	APOC4 (2.4)	TMED4 (2.3)	GCNT4 (2.3)	NPC1L1 (2.1)
ENSG00000179218	CALR PPI subnetwork	0.10	> 0.20	ITGB3 (3.1)	ERP29 (2.7)	RPH3A (2.6)	TMED4 (2.5)	PCSK9 (2.2)	HAPLN4 (2.2)	HP (2.1)	BCAM (2.0)	ZNF101 (1.9)	APOA5 (1.8)
REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE:REPLICATIVE_COMPLEX	REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE:REPLICATIVE_COMPLEX	0.10	> 0.20	FEN1 (3.8)	LPAR2 (3.0)	USP1 (2.7)	TMEM116 (2.3)	ENSG00000226645 (2.0)	GOT2P1 (1.8)	KANK2 (1.5)	NT5DC1 (1.5)	GMPR (1.5)	LPIN3 (1.4)
REACTOME_TRAF3:DEPENDENT_IRF_ACTIVATION_PATHWAY	REACTOME_TRAF3:DEPENDENT_IRF_ACTIVATION_PATHWAY	0.10	> 0.20	OASL (13.0)	PARP10 (8.2)	TRAFD1 (4.0)	RELB (3.1)	CYB561D1 (2.4)	BLOC1S3 (2.3)	GEMIN7 (2.0)	BCL3 (1.8)	GMIP (1.6)	PVRL2 (1.4)
GO:0001892	embryonic placenta development	0.10	> 0.20	CBLC (2.4)	ATXN2 (2.1)	UBXN2B (1.9)	C12orf51 (1.9)	ENSG00000226645 (1.7)	TRIB1 (1.6)	PVRL2 (1.6)	ADAM1 (1.5)	SLC44A2 (1.5)	ENSG00000228044 (1.4)
ENSG00000151702	FLI1 PPI subnetwork	0.10	> 0.20	RHCE (5.8)	RHD (5.2)	GMPR (3.7)	ABO (2.2)	PTPN11 (1.9)	TRAPPC6A (1.9)	ENSG00000228044 (1.7)	TOMM40 (1.3)	CEACAM19 (1.3)	FEN1 (1.3)
ENSG00000173110	HSPA6 PPI subnetwork	0.10	> 0.20	RELB (3.0)	BCL3 (2.5)	PVR (2.3)	MYLIP (2.2)	TXNL4B (1.9)	SARS (1.7)	PLEC (1.6)	GRINA (1.5)	CLPTM1 (1.5)	TRAFD1 (1.4)
GO:0006007	glucose catabolic process	0.10	> 0.20	GOT2P1 (3.0)	ACAD10 (2.1)	PCSK9 (1.9)	TRAPPC6A (1.8)	TSSK6 (1.7)	FADS2 (1.6)	FADS1 (1.5)	FRK (1.4)	GPAM (1.4)	GMPR (1.4)
ENSG00000173917	HOXB2 PPI subnetwork	0.10	> 0.20	ANKRD31 (3.0)	C12orf51 (2.9)	POC5 (2.2)	CEACAM19 (2.1)	COL4A3BP (1.9)	HLX (1.9)	DNAH11 (1.9)	MAU2 (1.9)	ENSG00000238078 (1.8)	PLEC (1.8)
GO:0010817	regulation of hormone levels	0.10	> 0.20	KIAA1324 (3.8)	NPC1L1 (2.0)	CYP7A1 (2.0)	ABCG8 (1.9)	ABO (1.7)	ABCG5 (1.7)	ENSG00000228044 (1.7)	CYB561D1 (1.6)	TM6SF2 (1.5)	MOSC1 (1.5)
ENSG00000149269	PAK1 PPI subnetwork	0.10	> 0.20	SH2B3 (3.3)	ENSG00000238078 (2.3)	PLEC (2.3)	CEACAM19 (2.2)	GATAD2A (2.1)	DNM2 (2.0)	LPIN3 (1.9)	DHX38 (1.9)	GCNT4 (1.8)	PPP1R37 (1.8)
ENSG00000116670	MAD2L2 PPI subnetwork	0.10	> 0.20	CLPTM1 (2.5)	PPP1R37 (2.3)	CBLC (2.3)	ABO (2.1)	BUD13 (2.0)	CETP (2.0)	TIMD4 (1.9)	C12orf51 (1.9)	KANK2 (1.8)	PSRC1 (1.8)
MP:0002733	abnormal thermal nociception	0.10	> 0.20	APOC1 (3.5)	PCSK9 (2.7)	GCNT4 (2.7)	ABCG5 (2.3)	TM6SF2 (2.2)	NPC1L1 (2.2)	GEMIN7 (2.0)	PVRL2 (1.8)	BCAM (1.8)	LPAR2 (1.8)
ENSG00000106443	PHF14 PPI subnetwork	0.10	> 0.20	ATP13A1 (4.2)	MAPKAPK5 (2.8)	HNF1A (2.7)	PTPN11 (2.5)	DHODH (2.4)	CEACAM19 (2.3)	DDX56 (2.3)	BRAP (2.2)	TOMM40 (2.2)	ANKRD31 (2.0)
ENSG00000169710	FASN PPI subnetwork	0.10	> 0.20	PLEC (3.6)	HMGCR (2.5)	GRINA (2.4)	PCSK9 (2.2)	C1orf63 (1.9)	ILF3 (1.9)	OGDH (1.9)	CLPTM1 (1.8)	LPAR2 (1.6)	UBXN2B (1.6)
GO:0050918	positive chemotaxis	0.10	> 0.20	ABO (2.9)	CYP7A1 (2.2)	TMEM116 (1.5)	PLEKHH2 (1.5)	GCNT4 (1.4)	DNAH11 (1.4)	HLX (1.3)	CETP (1.3)	ENSG00000228044 (1.3)	C12orf51 (1.2)
ENSG00000187899	ENSG00000187899 PPI subnetwork	0.10	> 0.20	DDX56 (4.4)	QTRT1 (3.8)	ZNF259 (3.8)	NAA25 (3.7)	DHODH (3.3)	TOMM40 (3.1)	C12orf43 (2.8)	DHX38 (2.2)	BRAP (2.0)	SARS (2.0)
ENSG00000167930	ITFG3 PPI subnetwork	0.10	> 0.20	ACAD10 (3.6)	NT5DC1 (2.9)	HNF1A (2.3)	PCSK9 (1.8)	TRAPPC6A (1.7)	C1orf63 (1.6)	GMPR (1.6)	SORT1 (1.5)	TIMD4 (1.5)	CETP (1.4)
ENSG00000106125	FAM188B PPI subnetwork	0.10	> 0.20	FADS2 (6.6)	LDLR (5.9)	FADS1 (5.3)	HMGCR (5.3)	PCSK9 (3.6)	HAVCR1 (2.3)	PBX4 (1.8)	ENSG00000226648 (1.7)	ERP29 (1.7)	PVRL2 (1.6)
GO:0051384	response to glucocorticoid stimulus	0.10	> 0.20	LPA (3.0)	ABCG5 (2.5)	SLC22A1 (2.5)	APOC4 (2.1)	APOA5 (2.1)	ABCG8 (2.0)	HP (1.9)	ATXN7L2 (1.8)	PLG (1.7)	HAPLN4 (1.7)
GO:0071216	cellular response to biotic stimulus	0.10	> 0.20	PVR (3.3)	PARP10 (2.2)	GRINA (2.2)	OASL (2.1)	LPIN3 (2.1)	DNAH11 (1.9)	CEACAM19 (1.7)	MYLIP (1.7)	UBXN2B (1.7)	AMIGO1 (1.5)
GO:0002065	columnar/cuboidal epithelial cell differentiation	0.10	> 0.20	GCNT4 (3.6)	C11orf9 (3.1)	KIAA1324 (2.7)	GOT2P1 (2.6)	ENSG00000235545 (2.4)	ABCG8 (2.3)	CBLC (2.1)	ANKRD31 (2.0)	LPAR2 (1.8)	ENSG00000254235 (1.6)
ENSG00000116489	CAPZA1 PPI subnetwork	0.10	> 0.20	SH2B3 (3.5)	TMEM50A (2.9)	DNM2 (2.3)	POLK (2.2)	CYB561D1 (1.9)	MARK4 (1.8)	GMPR (1.8)	NPC1L1 (1.8)	PVR (1.8)	GEMIN7 (1.7)
KEGG_BASE_EXCISION_REPAIR	KEGG_BASE_EXCISION_REPAIR	0.10	> 0.20	FEN1 (4.0)	USP1 (3.4)	ZNF180 (2.2)	DHODH (2.0)	ABO (1.8)	BUD13 (1.8)	ILF3 (1.8)	TRAPPC6A (1.7)	C12orf47 (1.7)	MAPKAPK5 (1.7)
MP:0005185	decreased circulating progesterone level	0.10	> 0.20	KIAA1324 (3.6)	APOB (3.2)	GPAM (2.8)	ST3GAL4 (2.4)	LPIN3 (1.9)	ABCG8 (1.7)	HNF1A (1.6)	MOSC1 (1.5)	ABO (1.4)	ABCG5 (1.4)
ENSG00000197170	PSMD12 PPI subnetwork	0.10	> 0.20	PSMA5 (5.7)	NAA25 (2.8)	TOMM40 (2.7)	TRAFD1 (2.7)	NT5DC1 (2.1)	DDX56 (1.9)	TOP1 (1.8)	HMGCR (1.4)	ENSG00000254235 (1.4)	CLPTM1 (1.3)
ENSG00000132507	EIF5A PPI subnetwork	0.10	> 0.20	GMPR (3.2)	SARS (2.8)	ZNF259 (2.4)	PVR (2.0)	ATP13A1 (2.0)	TOMM40 (1.9)	DDX56 (1.8)	PMFBP1 (1.6)	TRIB1 (1.5)	HMGCR (1.5)
GO:0042312	regulation of vasodilation	0.10	> 0.20	LPIN3 (3.5)	NPC1L1 (2.3)	ANKRD31 (2.2)	TMEM116 (1.8)	ENSG00000226648 (1.7)	ENSG00000226645 (1.7)	POLK (1.7)	PMFBP1 (1.5)	C12orf47 (1.5)	GCNT4 (1.4)
MP:0005290	decreased oxygen consumption	0.10	> 0.20	MOSC1 (3.2)	CETP (2.8)	SORT1 (2.5)	PPP1R37 (2.4)	CELSR2 (2.2)	GEMIN7 (2.1)	SYPL2 (1.9)	ALDH2 (1.8)	HAPLN4 (1.8)	AMIGO1 (1.8)
MP:0008140	podocyte foot process effacement	0.10	> 0.20	BCAM (4.4)	PVRL2 (3.8)	NT5DC1 (3.0)	ENSG00000238078 (2.7)	PLEKHH2 (2.1)	C11orf9 (2.1)	ANKRD31 (2.0)	FRK (2.0)	HNF1A (1.7)	OGDH (1.6)
ENSG00000134243	SORT1 PPI subnetwork	0.10	> 0.20	TOMM40 (2.2)	SARS (2.2)	TOP1 (2.2)	GRINA (2.1)	GOT2P1 (2.1)	PSMA5 (2.0)	DHX38 (1.9)	CELSR2 (1.9)	GCNT4 (1.8)	ILF3 (1.8)
MP:0005232	abnormal mesenteric lymph node morphology	0.10	> 0.20	BCL3 (4.6)	RELB (3.8)	GRINA (3.8)	NPC1L1 (2.8)	PARP10 (2.7)	ABO (2.6)	PLEC (2.5)	TM6SF2 (2.4)	GMIP (2.2)	SH2B3 (2.2)
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	0.10	> 0.20	GMPR (2.7)	PSRC1 (2.6)	OASL (2.4)	PVRL2 (2.2)	ITGB3 (2.1)	TRAFD1 (1.9)	KANK2 (1.9)	C11orf9 (1.8)	SH2B3 (1.8)	RHCE (1.7)
KEGG_ONE_CARBON_POOL_BY_FOLATE	KEGG_ONE_CARBON_POOL_BY_FOLATE	0.10	> 0.20	SARS (3.7)	CYP7A1 (3.4)	DHODH (3.0)	LPA (2.5)	SLC22A1 (2.5)	PLG (2.5)	GOT2P1 (2.4)	APOC4 (2.2)	QTRT1 (2.1)	CEACAM19 (2.1)
GO:0000981	sequence-specific DNA binding RNA polymerase II transcription factor activity	0.10	> 0.20	TRIB1 (4.9)	KANK2 (2.5)	NYNRIN (2.1)	HNF1A (2.1)	SH2B3 (1.8)	ALDH2 (1.8)	MAFB (1.7)	ATXN2 (1.7)	PVRL2 (1.6)	BCL3 (1.6)
MP:0003806	abnormal nucleotide metabolism	0.10	> 0.20	ABCG5 (3.5)	TM6SF2 (3.3)	C17orf57 (2.9)	ABCG8 (2.7)	LPA (2.7)	SLC22A1 (2.6)	ACAD10 (2.3)	ALDH2 (2.3)	PBX4 (2.2)	NPC1L1 (2.2)
ENSG00000136574	GATA4 PPI subnetwork	0.10	> 0.20	NYNRIN (4.6)	CARM1 (2.2)	COL4A3BP (2.2)	TRIB1 (2.1)	ENSG00000238078 (2.1)	HLX (2.1)	ATXN7L2 (1.8)	CETP (1.8)	CEACAM19 (1.7)	SH2B3 (1.6)
GO:0051568	histone H3-K4 methylation	0.10	> 0.20	C12orf51 (3.2)	ANKRD31 (2.8)	ZNF180 (2.7)	MAU2 (2.7)	C19orf52 (2.7)	ATXN2 (1.8)	C1orf63 (1.8)	BUD13 (1.7)	ATXN7L2 (1.7)	USP24 (1.6)
ENSG00000128881	TTBK2 PPI subnetwork	0.10	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.4)	DNAH11 (2.1)	C1orf63 (1.8)	TMEM57 (1.7)	CEACAM19 (1.6)	SYPL2 (1.5)	HNF1A (1.5)	MOSC1 (1.4)
GO:0000302	response to reactive oxygen species	0.10	> 0.20	ACAD10 (2.7)	DNAH11 (2.5)	ALDH2 (2.4)	GOT2P1 (2.3)	C12orf47 (2.2)	TRIB1 (2.1)	CEACAM19 (2.0)	RHD (1.6)	PVR (1.6)	MOSC1 (1.5)
ENSG00000104812	GYS1 PPI subnetwork	0.10	> 0.20	PTPN11 (3.3)	C19orf52 (2.8)	ZHX3 (2.7)	BRAP (2.7)	MAU2 (2.4)	C12orf43 (2.3)	GPAM (1.9)	COL4A3BP (1.8)	MYLIP (1.7)	HP (1.7)
ENSG00000102780	DGKH PPI subnetwork	0.10	> 0.20	GPAM (2.9)	C12orf51 (2.5)	CETP (2.4)	ENSG00000228044 (2.4)	LDLR (2.3)	MOSC1 (2.0)	HAVCR1 (1.8)	PCSK9 (1.8)	KANK2 (1.8)	PTPN11 (1.6)
ENSG00000136271	DDX56 PPI subnetwork	0.10	> 0.20	ZNF259 (4.8)	TOMM40 (4.1)	NAA25 (4.1)	DDX56 (4.1)	QTRT1 (3.4)	DHODH (3.0)	DHX38 (2.8)	C12orf43 (2.8)	SUGP1 (2.7)	MAPKAPK5 (2.0)
GO:0009791	post-embryonic development	0.10	> 0.20	DNAH11 (4.9)	UBXN2B (2.3)	ENSG00000228044 (2.2)	PMFBP1 (1.9)	TRAPPC6A (1.8)	TSSK6 (1.7)	ST3GAL4 (1.6)	GCNT4 (1.6)	C11orf9 (1.5)	MARK4 (1.5)
ENSG00000162298	SYVN1 PPI subnetwork	0.10	> 0.20	LDLR (3.4)	TMEM57 (2.0)	OGDH (2.0)	FADS2 (1.9)	FADS1 (1.8)	BRAP (1.7)	TMED4 (1.7)	PCSK9 (1.4)	PVR (1.4)	PSMA5 (1.4)
GO:0016458	gene silencing	0.10	> 0.20	GCNT4 (2.6)	MAPKAPK5 (2.5)	DOCK7 (2.2)	ACAD10 (1.8)	ATXN2 (1.7)	GATAD2A (1.7)	C12orf51 (1.7)	TXNL4B (1.6)	BUD13 (1.5)	C19orf52 (1.4)
ENSG00000206233	ENSG00000206233 PPI subnetwork	0.10	> 0.20	PARP10 (5.1)	YIPF2 (2.7)	ERP29 (2.5)	CLPTM1 (1.8)	ST3GAL4 (1.7)	HAPLN4 (1.5)	LPIN3 (1.5)	PPP1R37 (1.5)	CBLC (1.5)	MYLIP (1.5)
ENSG00000206297	TAP1 PPI subnetwork	0.10	> 0.20	PARP10 (5.1)	YIPF2 (2.7)	ERP29 (2.5)	CLPTM1 (1.8)	ST3GAL4 (1.7)	HAPLN4 (1.5)	LPIN3 (1.5)	PPP1R37 (1.5)	CBLC (1.5)	MYLIP (1.5)
ENSG00000168394	TAP1 PPI subnetwork	0.10	> 0.20	PARP10 (5.1)	YIPF2 (2.7)	ERP29 (2.5)	CLPTM1 (1.8)	ST3GAL4 (1.7)	HAPLN4 (1.5)	LPIN3 (1.5)	PPP1R37 (1.5)	CBLC (1.5)	MYLIP (1.5)
REACTOME_DNA_REPLICATION_PRE:INITIATION	REACTOME_DNA_REPLICATION_PRE:INITIATION	0.10	> 0.20	PSMA5 (4.9)	FEN1 (4.6)	USP1 (2.8)	NT5DC1 (2.8)	TRAFD1 (2.1)	NAA25 (1.9)	ENSG00000235545 (1.6)	TOMM40 (1.4)	ZNF180 (1.4)	DDX56 (1.4)
REACTOME_MG1_TRANSITION	REACTOME_MG1_TRANSITION	0.10	> 0.20	PSMA5 (4.9)	FEN1 (4.6)	USP1 (2.8)	NT5DC1 (2.8)	TRAFD1 (2.1)	NAA25 (1.9)	ENSG00000235545 (1.6)	TOMM40 (1.4)	ZNF180 (1.4)	DDX56 (1.4)
ENSG00000163823	CCR1 PPI subnetwork	0.10	> 0.20	OASL (4.5)	RELB (2.9)	PARP10 (2.8)	PVR (2.8)	MAFB (2.8)	BCL3 (2.8)	TRAFD1 (2.2)	TMEM50A (1.9)	AMIGO1 (1.9)	PSMA5 (1.4)
MP:0004045	abnormal cell cycle checkpoint function	0.10	> 0.20	PSRC1 (3.2)	FEN1 (2.6)	USP1 (2.2)	UBXN2B (2.2)	ENSG00000226645 (2.0)	POLK (1.9)	ATXN7L2 (1.8)	C1orf63 (1.7)	ILF3 (1.6)	BLOC1S3 (1.4)
GO:0004675	transmembrane receptor protein serine/threonine kinase activity	0.10	> 0.20	CEACAM19 (2.3)	NYNRIN (2.3)	PVRL2 (2.1)	TMED4 (2.0)	MAFB (1.8)	PLEC (1.8)	PVR (1.7)	BCAM (1.7)	SLC44A2 (1.6)	ZNF101 (1.5)
ENSG00000161217	PCYT1A PPI subnetwork	0.10	> 0.20	ENSG00000254235 (2.9)	NT5DC1 (2.8)	RHCE (2.1)	NAA25 (2.1)	BRAP (2.0)	C12orf43 (2.0)	SYPL2 (1.9)	LPAR2 (1.9)	RHD (1.8)	FRK (1.7)
ENSG00000168264	IRF2BP2 PPI subnetwork	0.10	> 0.20	COL4A3BP (3.3)	POLK (2.8)	ATXN2 (2.6)	C12orf51 (2.5)	MAPKAPK5 (2.4)	FRK (2.3)	POC5 (2.2)	MYLIP (2.1)	MAU2 (1.9)	C1orf63 (1.8)
MP:0002073	abnormal hair growth	0.10	> 0.20	AP1M2 (3.3)	PCSK9 (2.1)	CELSR2 (2.1)	BCAM (2.0)	APOC1 (1.9)	LPA (1.8)	PLEKHH2 (1.8)	NYNRIN (1.7)	AMIGO1 (1.6)	ABO (1.5)
GO:0001890	placenta development	0.10	> 0.20	ENSG00000226645 (2.7)	CBLC (2.7)	AP1M2 (2.1)	UBXN2B (2.0)	ATXN7L2 (1.8)	PVRL2 (1.8)	ENSG00000228044 (1.7)	C12orf51 (1.6)	CYP7A1 (1.5)	SLC22A1 (1.3)
REACTOME_VIRAL_DSRNATLR3TRIF_COMPLEX_ACTIVATES_RIP1	REACTOME_VIRAL_DSRNATLR3TRIF_COMPLEX_ACTIVATES_RIP1	0.10	> 0.20	RELB (8.5)	BCL3 (5.7)	OASL (4.5)	PARP10 (4.0)	TRAFD1 (3.1)	GMIP (2.7)	PVR (2.2)	ST3GAL4 (2.0)	ATP13A1 (1.6)	C12orf43 (1.4)
GO:0051098	regulation of binding	0.10	> 0.20	GATAD2A (2.7)	MAFB (2.5)	MARK4 (2.4)	MYLIP (2.3)	GRINA (2.1)	TMEM57 (2.0)	OASL (1.6)	ENSG00000238078 (1.6)	PLCG1 (1.5)	NYNRIN (1.4)
GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	0.10	> 0.20	FADS1 (4.1)	ALDH2 (4.0)	FADS2 (3.9)	SLC22A1 (3.2)	TRAPPC6A (2.7)	CYP7A1 (2.4)	ANGPTL3 (2.3)	APOC4 (2.3)	PLG (2.2)	APOC1 (2.1)
GO:0008645	hexose transport	0.10	> 0.20	GCNT4 (3.4)	NPC1L1 (3.0)	DOCK7 (3.0)	ABCG8 (2.3)	KIAA1324 (2.1)	ABCG5 (2.0)	SORT1 (2.0)	POC5 (2.0)	DNAH11 (1.9)	TMED4 (1.8)
GO:0015758	glucose transport	0.10	> 0.20	GCNT4 (3.4)	NPC1L1 (3.0)	DOCK7 (3.0)	ABCG8 (2.3)	KIAA1324 (2.1)	ABCG5 (2.0)	SORT1 (2.0)	POC5 (2.0)	DNAH11 (1.9)	TMED4 (1.8)
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	0.10	> 0.20	RELB (2.7)	HLX (2.5)	BLOC1S3 (2.4)	BCL3 (2.2)	C19orf52 (1.9)	ENSG00000228044 (1.9)	SH2B3 (1.9)	CYB561D1 (1.8)	ZNF101 (1.7)	NT5DC1 (1.7)
GO:0018024	histone-lysine N-methyltransferase activity	0.10	> 0.20	C12orf51 (4.4)	ATXN2 (3.4)	MAU2 (2.6)	C12orf43 (2.2)	BRAP (1.8)	BUD13 (1.8)	ATXN7L2 (1.8)	SMARCA4 (1.7)	USP24 (1.7)	GOT2P1 (1.6)
GO:0014037	Schwann cell differentiation	0.10	> 0.20	ENSG00000226645 (3.2)	DNAH11 (3.1)	ST3GAL4 (2.2)	ENSG00000254235 (2.0)	GCNT4 (1.9)	AMIGO1 (1.8)	ENSG00000226648 (1.8)	CYP7A1 (1.7)	ZHX3 (1.6)	PLEC (1.6)
ENSG00000140009	ESR2 PPI subnetwork	0.10	> 0.20	ATXN2 (3.5)	PLCG1 (3.4)	SLC44A2 (2.9)	PPP1R37 (2.8)	MAPKAPK5 (2.7)	MYLIP (2.5)	ZHX3 (2.4)	KANK2 (2.3)	KIAA1324 (2.3)	SMARCA4 (2.3)
GO:0051188	cofactor biosynthetic process	0.10	> 0.20	NT5DC1 (3.6)	RHCE (3.3)	RHD (3.1)	ACAD10 (3.0)	DHODH (2.8)	GPAM (2.6)	TRAPPC6A (2.5)	FADS1 (2.5)	PCSK9 (2.4)	C19orf52 (2.4)
MP:0005312	pericardial effusion	0.10	> 0.20	ATXN2 (3.3)	C12orf51 (3.1)	KANK2 (2.9)	USP24 (2.7)	HMGCR (2.4)	PTPN11 (2.3)	LDLR (1.9)	UBXN2B (1.8)	ACAD10 (1.7)	RHD (1.6)
ENSG00000186868	MAPT PPI subnetwork	0.10	> 0.20	TMEM50A (3.1)	RPH3A (2.5)	COL4A3BP (2.2)	GATAD2A (2.0)	C1orf63 (2.0)	SMARCA4 (1.9)	CLPTM1 (1.9)	GRINA (1.8)	ENSG00000238078 (1.8)	DNM2 (1.7)
MP:0000291	enlarged pericardium	0.10	> 0.20	SLC44A2 (2.9)	PVRL2 (2.3)	ENSG00000235545 (2.3)	KANK2 (2.2)	BCAM (2.0)	CBLC (2.0)	ATXN2 (2.0)	GRINA (1.9)	GPAM (1.8)	LDLR (1.7)
ENSG00000131788	PIAS3 PPI subnetwork	0.10	> 0.20	PARP10 (3.0)	OASL (3.0)	BCL3 (2.7)	KIAA1324 (2.5)	ATXN2 (2.1)	KANK2 (2.1)	USP24 (2.0)	PLEC (1.9)	ENSG00000226648 (1.8)	COL4A3BP (1.7)
ENSG00000106123	EPHB6 PPI subnetwork	0.10	> 0.20	MAU2 (3.0)	GMIP (2.6)	USP24 (2.6)	PARP10 (2.6)	ATXN2 (2.3)	BCL3 (2.3)	MARK4 (2.2)	ZNF180 (2.1)	MAFB (2.1)	POLK (1.9)
ENSG00000140939	NOL3 PPI subnetwork	0.10	> 0.20	BLOC1S3 (3.1)	GEMIN7 (2.9)	TRAPPC6A (2.9)	PPP1R37 (2.7)	LPAR2 (2.2)	ST3GAL4 (2.1)	ZNF180 (2.0)	PVRL2 (2.0)	CBLC (1.8)	PARP10 (1.7)
REACTOME_ANTIGEN_PROCESSING:CROSS_PRESENTATION	REACTOME_ANTIGEN_PROCESSING:CROSS_PRESENTATION	0.10	> 0.20	PSMA5 (5.1)	TRAFD1 (4.0)	PARP10 (3.5)	NAA25 (2.2)	NT5DC1 (1.6)	TMED4 (1.6)	TMEM50A (1.5)	RELB (1.5)	TOMM40 (1.5)	DDX56 (1.2)
MP:0000008	increased white adipose tissue amount	0.10	> 0.20	ST3GAL4 (3.0)	GPAM (2.9)	KIAA1324 (2.8)	MOSC1 (2.5)	APOC1 (1.9)	DYNC2LI1 (1.8)	GOT2P1 (1.7)	C12orf47 (1.6)	DNAH11 (1.5)	OASL (1.4)
GO:0004190	aspartic-type endopeptidase activity	0.10	> 0.20	CLPTM1 (4.1)	GRINA (2.8)	MAU2 (2.8)	TMED4 (2.8)	TMEM50A (2.6)	TMEM57 (2.3)	C17orf57 (2.0)	GCNT4 (2.0)	PVRL2 (1.9)	ATP13A1 (1.9)
GO:0070001	aspartic-type peptidase activity	0.10	> 0.20	CLPTM1 (4.1)	GRINA (2.8)	MAU2 (2.8)	TMED4 (2.8)	TMEM50A (2.6)	TMEM57 (2.3)	C17orf57 (2.0)	GCNT4 (2.0)	PVRL2 (1.9)	ATP13A1 (1.9)
ENSG00000205571	SMN2 PPI subnetwork	0.10	> 0.20	GEMIN7 (3.5)	PSMA5 (3.1)	USP1 (2.2)	TOMM40 (1.9)	QTRT1 (1.9)	TRAPPC6A (1.9)	FEN1 (1.9)	C12orf43 (1.7)	ILF3 (1.7)	ZNF180 (1.7)
ENSG00000172062	SMN1 PPI subnetwork	0.10	> 0.20	GEMIN7 (3.5)	PSMA5 (3.1)	USP1 (2.2)	TOMM40 (1.9)	QTRT1 (1.9)	TRAPPC6A (1.9)	FEN1 (1.9)	C12orf43 (1.7)	ILF3 (1.7)	ZNF180 (1.7)
GO:0070542	response to fatty acid	0.10	> 0.20	KIAA1324 (2.1)	FADS2 (2.1)	UBXN2B (2.1)	CYP7A1 (1.9)	TSSK6 (1.8)	PCSK9 (1.7)	GPAM (1.7)	HMGCR (1.6)	NPC1L1 (1.6)	FADS1 (1.6)
ENSG00000117480	FAAH PPI subnetwork	0.10	> 0.20	ACAD10 (3.7)	NT5DC1 (2.9)	HNF1A (2.1)	C1orf63 (1.9)	SORT1 (1.8)	CETP (1.8)	TIMD4 (1.7)	PLEC (1.6)	TRAPPC6A (1.6)	OGDH (1.5)
ENSG00000176406	RIMS2 PPI subnetwork	0.10	> 0.20	TMEM50A (3.0)	KIAA1324 (2.7)	GEMIN7 (2.6)	YIPF2 (2.3)	PBX4 (2.3)	GATAD2A (2.2)	C19orf52 (2.1)	TMEM57 (2.0)	APOC1 (2.0)	PVRL2 (1.9)
GO:0070301	cellular response to hydrogen peroxide	0.11	> 0.20	DNAH11 (3.7)	GOT2P1 (2.9)	PBX4 (2.5)	MOSC1 (2.2)	C17orf57 (2.1)	RHD (1.9)	ALDH2 (1.8)	RHCE (1.8)	GPAM (1.7)	ACAD10 (1.6)
ENSG00000123405	NFE2 PPI subnetwork	0.11	> 0.20	PVR (2.8)	TMEM57 (2.5)	TRIB1 (2.3)	PVRL2 (2.2)	ALDH2 (2.1)	C11orf9 (2.1)	SH2B3 (2.1)	LDLR (1.9)	BCL3 (1.9)	ENSG00000226645 (1.7)
GO:0006916	anti-apoptosis	0.11	> 0.20	GRINA (2.8)	ENSG00000238078 (2.7)	TRIB1 (2.3)	HAVCR1 (2.1)	PVR (1.7)	BCL3 (1.6)	KIAA1324 (1.4)	FRK (1.4)	ST3GAL4 (1.3)	MAFB (1.3)
ENSG00000100294	MCAT PPI subnetwork	0.11	> 0.20	BRAP (3.0)	ATXN2 (2.9)	MAPKAPK5 (2.8)	SMARCA4 (2.8)	TRAFD1 (2.6)	C12orf51 (2.4)	C12orf43 (2.2)	OGDH (2.1)	NAA25 (2.1)	ANKRD31 (2.0)
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	0.11	> 0.20	OASL (10.1)	PARP10 (7.4)	TRAFD1 (5.3)	BCL3 (3.5)	RELB (3.4)	GMIP (1.8)	SH2B3 (1.8)	NAA25 (1.7)	GRINA (1.7)	HLX (1.5)
REACTOME_METABOLISM_OF_PORPHYRINS	REACTOME_METABOLISM_OF_PORPHYRINS	0.11	> 0.20	RHCE (11.8)	RHD (11.7)	GMPR (2.9)	C12orf51 (2.4)	MAFB (2.4)	ALDH2 (2.3)	CETP (2.3)	NT5DC1 (2.1)	DHODH (1.9)	APOC1 (1.8)
MP:0003059	decreased insulin secretion	0.11	> 0.20	KIAA1324 (5.3)	FRK (3.3)	GCNT4 (2.4)	COL4A3BP (2.2)	PLEKHH2 (2.1)	HAPLN4 (2.1)	TMEM57 (1.8)	TRIB1 (1.7)	LDLR (1.5)	POLK (1.4)
REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS	0.11	> 0.20	NAA25 (3.8)	POC5 (3.3)	DDX56 (3.2)	USP1 (3.1)	ILF3 (2.4)	FEN1 (2.4)	DOCK7 (2.3)	USP24 (2.3)	BUD13 (2.1)	TOMM40 (2.0)
GO:0008134	transcription factor binding	0.11	> 0.20	TRIB1 (3.2)	ATXN2 (2.8)	KANK2 (2.5)	ATXN7L2 (2.4)	HLX (2.3)	DHX38 (2.2)	MARK4 (2.0)	MAFB (2.0)	PLEC (1.9)	PLCG1 (1.8)
ENSG00000109111	SUPT6H PPI subnetwork	0.11	> 0.20	SARS (3.2)	BRAP (2.9)	CARM1 (2.8)	DNM2 (2.5)	DHX38 (2.4)	CYP7A1 (2.4)	SUGP1 (2.4)	ZNF259 (2.3)	C17orf57 (2.2)	TRAPPC6A (2.0)
ENSG00000203747	FCGR3A PPI subnetwork	0.11	> 0.20	TIMD4 (2.6)	ITGB3 (2.5)	SLC22A1 (1.9)	CETP (1.8)	APOE (1.7)	PLCG1 (1.6)	APOC4 (1.6)	APOA5 (1.4)	HP (1.4)	SLC44A2 (1.3)
MP:0005033	abnormal trophoblast giant cells	0.11	> 0.20	DNM2 (2.3)	CLPTM1 (2.2)	MAFB (2.0)	BUD13 (1.9)	DHX38 (1.8)	PLEC (1.8)	ACAD10 (1.6)	LPIN3 (1.6)	PPP1R37 (1.5)	MARK4 (1.4)
GO:0031300	intrinsic to organelle membrane	0.11	> 0.20	CLPTM1 (4.4)	TMED4 (3.3)	ATP13A1 (3.1)	YIPF2 (3.0)	AMIGO1 (2.7)	TMEM50A (2.5)	CYB561D1 (2.5)	ERP29 (2.5)	GRINA (2.4)	TMEM57 (2.0)
ENSG00000106799	TGFBR1 PPI subnetwork	0.11	> 0.20	MYLIP (3.3)	SH2B3 (3.1)	DYNC2LI1 (2.6)	GATAD2A (2.2)	PVR (2.1)	POLK (2.0)	BLOC1S3 (2.0)	TRIB1 (1.8)	GCNT4 (1.8)	PTPN11 (1.6)
ENSG00000119866	BCL11A PPI subnetwork	0.11	> 0.20	MAU2 (2.7)	PARP10 (2.7)	USP24 (2.7)	ATXN2 (2.5)	GMIP (2.2)	BCL3 (2.2)	MARK4 (2.1)	SMARCA4 (2.1)	ZHX3 (1.9)	DHX38 (1.8)
GO:0003993	acid phosphatase activity	0.11	> 0.20	CLPTM1 (2.6)	RHCE (2.4)	YIPF2 (2.3)	PMFBP1 (2.3)	ANKRD31 (2.3)	C12orf51 (2.1)	HNF1A (2.0)	RHD (2.0)	AMIGO1 (1.6)	APOC1 (1.6)
ENSG00000173889	PHC3 PPI subnetwork	0.11	> 0.20	CELSR2 (2.8)	MARK4 (2.2)	ST3GAL4 (2.1)	CYB561D1 (2.0)	TRAFD1 (1.8)	SH2B3 (1.7)	LPIN3 (1.7)	HP (1.6)	TMEM57 (1.6)	PLG (1.5)
ENSG00000128594	LRRC4 PPI subnetwork	0.11	> 0.20	NPC1L1 (3.4)	FADS1 (2.9)	HMGCR (2.8)	FADS2 (2.8)	PCSK9 (2.6)	TMED4 (2.1)	NYNRIN (2.1)	GEMIN7 (2.0)	TM6SF2 (1.9)	GOT2P1 (1.9)
GO:0015030	Cajal body	0.11	> 0.20	BUD13 (4.8)	ZNF259 (4.3)	DDX56 (2.8)	FEN1 (2.5)	C12orf47 (2.5)	USP1 (2.4)	DHODH (2.3)	NAA25 (2.1)	ZNF180 (2.1)	POC5 (2.0)
MP:0003720	abnormal neural tube closure	0.11	> 0.20	NYNRIN (2.6)	PVRL2 (2.4)	ATXN7L2 (2.3)	FADS2 (2.3)	BCAM (2.1)	HMGCR (2.1)	ZHX3 (2.0)	LDLR (2.0)	SLC44A2 (2.0)	DYNC2LI1 (1.8)
MP:0003721	increased tumor growth/size	0.11	> 0.20	RELB (4.3)	BCL3 (3.5)	ITGB3 (3.0)	SLC44A2 (2.6)	OASL (2.1)	TRAFD1 (2.0)	LDLR (2.0)	PVR (1.8)	ST3GAL4 (1.8)	PARP10 (1.7)
REACTOME_INTERFERON_SIGNALING	REACTOME_INTERFERON_SIGNALING	0.11	> 0.20	OASL (12.3)	PARP10 (8.4)	TRAFD1 (6.1)	NAA25 (2.1)	RELB (2.0)	BCL3 (1.9)	GMPR (1.9)	POLK (1.6)	ADAM1 (1.5)	PSMA5 (1.5)
ENSG00000007392	LUC7L PPI subnetwork	0.11	> 0.20	DHX38 (4.5)	ILF3 (4.1)	SMARCA4 (3.9)	SUGP1 (3.9)	TOP1 (3.2)	DDX56 (2.9)	BUD13 (2.4)	DOCK7 (2.0)	ATP13A1 (2.0)	NAA25 (1.9)
ENSG00000077942	FBLN1 PPI subnetwork	0.11	> 0.20	CILP2 (3.8)	BCAM (2.3)	C17orf57 (2.0)	ZNF101 (1.7)	CEACAM19 (1.6)	LPA (1.6)	ITGB3 (1.6)	ALDH2 (1.5)	HAVCR1 (1.5)	RHCE (1.4)
GO:0001085	RNA polymerase II transcription factor binding	0.11	> 0.20	RHD (5.3)	RHCE (3.9)	FADS2 (3.3)	ITGB3 (3.2)	GMPR (3.0)	TMEM57 (2.5)	FADS1 (2.0)	C1orf63 (1.9)	UBXN2B (1.8)	SH2B3 (1.8)
ENSG00000164244	PRRC1 PPI subnetwork	0.11	> 0.20	SMARCA4 (4.4)	C1orf63 (2.9)	BUD13 (2.7)	DOCK7 (2.6)	ILF3 (2.5)	GATAD2A (2.4)	TMEM57 (2.2)	CARM1 (2.2)	SUGP1 (2.1)	MAU2 (2.0)
GO:0009066	aspartate family amino acid metabolic process	0.11	> 0.20	ENSG00000254235 (3.0)	QTRT1 (2.6)	NT5DC1 (2.6)	CYP7A1 (2.0)	TXNL4B (2.0)	ACAD10 (1.9)	DHODH (1.9)	DYNC2LI1 (1.9)	GOT2P1 (1.9)	SLC22A1 (1.8)
GO:0031018	endocrine pancreas development	0.11	> 0.20	ANKRD31 (2.4)	HNF1A (2.1)	ABO (2.0)	KIAA1324 (1.9)	DNAH11 (1.8)	CEACAM19 (1.7)	FRK (1.5)	CYP7A1 (1.5)	C11orf9 (1.5)	UBXN2B (1.4)
MP:0002970	abnormal white adipose tissue morphology	0.11	> 0.20	MOSC1 (4.5)	SORT1 (2.7)	TM6SF2 (2.4)	SYPL2 (2.3)	CETP (2.1)	GPAM (2.1)	APOC1 (2.0)	ABCG5 (1.8)	APOB (1.7)	NPC1L1 (1.7)
MP:0008597	decreased circulating interleukin-6 level	0.11	> 0.20	MAFB (4.6)	RELB (2.9)	BCL3 (2.9)	C11orf9 (2.5)	APOE (2.5)	GMIP (2.4)	TIMD4 (2.4)	TRIB1 (2.1)	FRK (1.9)	HLX (1.8)
ENSG00000138297	TIMM23 PPI subnetwork	0.11	> 0.20	DHODH (3.2)	TOMM40 (2.7)	GEMIN7 (2.7)	TRAPPC6A (2.3)	C19orf52 (2.2)	QTRT1 (2.1)	ANGPTL3 (2.0)	POC5 (2.0)	DDX56 (1.9)	CYP7A1 (1.9)
ENSG00000149016	TUT1 PPI subnetwork	0.11	> 0.20	SMARCA4 (4.3)	C1orf63 (2.9)	DOCK7 (2.8)	ILF3 (2.7)	BUD13 (2.6)	GATAD2A (2.5)	TOP1 (2.1)	CARM1 (2.1)	TMEM57 (2.1)	MAU2 (1.9)
ENSG00000103426	CORO7 PPI subnetwork	0.11	> 0.20	DHODH (3.9)	DNM2 (2.8)	CYP7A1 (2.8)	LPA (2.5)	APOC4 (2.3)	ANGPTL3 (2.3)	TRAPPC6A (2.1)	ILF3 (2.0)	GOT2P1 (1.9)	PMFBP1 (1.8)
MP:0001656	focal hepatic necrosis	0.11	> 0.20	RHD (5.3)	APOB (4.6)	HP (4.6)	PLG (4.6)	APOC1 (4.4)	APOA5 (4.0)	ANGPTL3 (3.8)	RHCE (3.8)	APOC4 (3.2)	APOE (2.9)
ENSG00000137486	ARRB1 PPI subnetwork	0.11	> 0.20	GMIP (3.1)	DNM2 (2.8)	TOP1 (2.3)	PTPN11 (2.2)	CARM1 (2.1)	COL4A3BP (2.1)	SH2B3 (2.0)	DHX38 (2.0)	C1orf63 (1.9)	CLPTM1 (1.8)
GO:0044445	cytosolic part	0.11	> 0.20	NKPD1 (2.1)	DNAH11 (2.1)	RHCE (1.9)	GMPR (1.8)	GEMIN7 (1.6)	POLK (1.6)	MOSC1 (1.5)	PLEKHH2 (1.5)	BRAP (1.3)	SARS (1.3)
GO:0070306	lens fiber cell differentiation	0.11	> 0.20	ABO (2.8)	TMEM57 (1.7)	PLEC (1.7)	CILP2 (1.4)	C17orf57 (1.4)	CEACAM19 (1.3)	PBX4 (1.1)	CLPTM1 (1.0)	PVR (0.9)	GOT2P1 (0.9)
GO:0048020	CCR chemokine receptor binding	0.11	> 0.20	CETP (4.0)	RELB (3.3)	OASL (2.9)	TIMD4 (2.9)	BCL3 (2.8)	ZNF101 (2.4)	GRINA (2.0)	MAFB (2.0)	TM6SF2 (2.0)	PVR (1.9)
REACTOME_PHASE_II_CONJUGATION	REACTOME_PHASE_II_CONJUGATION	0.11	> 0.20	SLC22A1 (5.1)	CYP7A1 (4.9)	TM6SF2 (4.7)	ABCG5 (3.8)	ABCG8 (3.6)	APOC4 (3.5)	ANGPTL3 (3.5)	LPA (3.2)	APOA5 (2.8)	ALDH2 (2.8)
ENSG00000138378	STAT4 PPI subnetwork	0.11	> 0.20	HLX (3.6)	COL4A3BP (3.4)	BCL3 (3.2)	ENSG00000238078 (2.6)	ALDH2 (2.5)	DNM2 (2.4)	TRAFD1 (2.3)	PARP10 (2.3)	TRIB1 (2.0)	GMIP (2.0)
GO:0046165	alcohol biosynthetic process	0.11	> 0.20	TSSK6 (2.6)	LPA (2.3)	MOSC1 (2.3)	TM6SF2 (2.2)	DHODH (1.9)	SORT1 (1.9)	PMFBP1 (1.8)	GPAM (1.8)	ENSG00000254235 (1.7)	OGDH (1.5)
GO:0006721	terpenoid metabolic process	0.11	> 0.20	LPA (4.0)	ABCG8 (3.9)	TM6SF2 (3.7)	CYP7A1 (3.6)	ABCG5 (3.2)	NPC1L1 (3.1)	SLC22A1 (3.0)	APOC4 (2.3)	APOA5 (2.3)	NKPD1 (2.1)
GO:0016408	C-acyltransferase activity	0.11	> 0.20	HMGCR (6.4)	LDLR (5.1)	NKPD1 (4.5)	FADS2 (4.4)	FADS1 (4.3)	PCSK9 (2.4)	TRAPPC6A (2.4)	ENSG00000235545 (1.8)	ACAD10 (1.8)	OGDH (1.8)
ENSG00000135968	GCC2 PPI subnetwork	0.11	> 0.20	MAPKAPK5 (3.0)	HNF1A (2.5)	BRAP (2.4)	CEACAM19 (2.3)	TOMM40 (2.3)	ATP13A1 (2.2)	MAU2 (2.1)	ADAM1 (2.0)	DHODH (1.9)	CETP (1.9)
ENSG00000115590	IL1R2 PPI subnetwork	0.11	> 0.20	ST3GAL4 (2.9)	UBXN2B (2.6)	OASL (2.2)	ENSG00000254235 (1.8)	PARP10 (1.8)	ABCG5 (1.8)	ABCG8 (1.7)	TRAFD1 (1.6)	HLX (1.6)	ENSG00000235545 (1.6)
ENSG00000105610	KLF1 PPI subnetwork	0.11	> 0.20	CARM1 (6.4)	SMARCA4 (3.9)	MAU2 (3.5)	MARK4 (3.5)	ATXN2 (3.4)	GATAD2A (3.1)	MAPKAPK5 (2.6)	NYNRIN (2.4)	ILF3 (2.2)	BRAP (2.2)
MP:0011353	expanded mesangial matrix	0.11	> 0.20	BCAM (3.1)	PLEKHH2 (3.0)	PVRL2 (2.5)	APOC1 (2.1)	TMEM50A (2.1)	C1orf63 (2.0)	MAFB (1.8)	PLG (1.8)	KANK2 (1.7)	FADS1 (1.7)
ENSG00000133124	IRS4 PPI subnetwork	0.11	> 0.20	CETP (2.7)	PVRL2 (2.5)	TIMD4 (2.3)	DNAH11 (2.2)	PLEKHH2 (2.1)	SLC44A2 (2.0)	ATP13A1 (1.8)	ERP29 (1.7)	ZHX3 (1.7)	PLCG1 (1.6)
ENSG00000188739	RBM34 PPI subnetwork	0.11	> 0.20	ZNF259 (4.8)	NAA25 (4.7)	TOMM40 (3.7)	DDX56 (3.6)	QTRT1 (3.0)	TOP1 (3.0)	DHODH (2.9)	DHX38 (2.5)	MAPKAPK5 (2.0)	ATP13A1 (2.0)
MP:0002925	abnormal cardiovascular development	0.11	> 0.20	MYLIP (2.7)	C19orf52 (2.5)	BCAM (2.3)	ENSG00000238078 (2.0)	DYNC2LI1 (1.9)	HLX (1.8)	CETP (1.8)	ABCG5 (1.7)	SYPL2 (1.7)	PPP1R37 (1.7)
GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	0.11	> 0.20	PLG (3.4)	MOSC1 (3.3)	APOC4 (3.3)	CYP7A1 (3.3)	GPAM (3.2)	ANGPTL3 (3.1)	ALDH2 (2.8)	TRAPPC6A (2.8)	SLC22A1 (2.8)	LPA (2.6)
ENSG00000137462	TLR2 PPI subnetwork	0.11	> 0.20	ERP29 (2.8)	MAFB (2.3)	BCL3 (2.3)	HP (2.0)	CYP7A1 (1.9)	CLPTM1 (1.7)	PARP10 (1.7)	DOCK7 (1.5)	BLOC1S3 (1.5)	MYLIP (1.5)
ENSG00000171490	RSL1D1 PPI subnetwork	0.11	> 0.20	DDX56 (4.6)	ZNF259 (4.5)	NAA25 (4.1)	QTRT1 (4.0)	TOMM40 (3.5)	DHODH (3.0)	C12orf43 (2.7)	ILF3 (2.5)	GATAD2A (2.4)	SUGP1 (2.3)
MP:0003567	abnormal fetal cardiomyocyte proliferation	0.11	> 0.20	NYNRIN (3.4)	BCAM (2.5)	C11orf9 (2.3)	ATXN7L2 (2.2)	PVR (1.9)	GPAM (1.7)	GCNT4 (1.7)	TMED4 (1.7)	HP (1.7)	NT5DC1 (1.7)
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	0.11	> 0.20	ANGPTL3 (4.4)	PLG (3.5)	DHODH (3.3)	SLC22A1 (3.2)	APOC4 (2.9)	LPA (2.4)	CYP7A1 (2.4)	ALDH2 (2.4)	FADS1 (2.4)	C12orf47 (2.2)
ENSG00000197858	GPAA1 PPI subnetwork	0.11	> 0.20	ATP13A1 (3.2)	CLPTM1 (3.2)	NT5DC1 (3.0)	ERP29 (2.9)	TMED4 (2.3)	RHCE (2.2)	GRINA (2.2)	CYB561D1 (2.1)	SORT1 (2.0)	RHD (1.9)
GO:0000038	very long-chain fatty acid metabolic process	0.11	> 0.20	NKPD1 (3.2)	FADS2 (3.1)	CYB561D1 (2.3)	MOSC1 (1.7)	HMGCR (1.7)	DNM2 (1.6)	ABCG8 (1.5)	AMIGO1 (1.5)	GMPR (1.5)	FADS1 (1.4)
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	REACTOME_GLYCOSPHINGOLIPID_METABOLISM	0.11	> 0.20	NKPD1 (4.7)	ERP29 (4.6)	HNF1A (3.7)	TMED4 (3.0)	COL4A3BP (2.5)	TM6SF2 (2.4)	TMEM50A (2.4)	ATP13A1 (2.3)	HAPLN4 (2.3)	APOE (2.3)
GO:0005667	transcription factor complex	0.11	> 0.20	ATXN2 (2.7)	MAPKAPK5 (2.7)	ATXN7L2 (2.6)	KANK2 (2.6)	CARM1 (2.4)	TRIB1 (2.0)	BUD13 (1.9)	HLX (1.8)	ALDH2 (1.7)	PLCG1 (1.6)
GO:0042277	peptide binding	0.11	> 0.20	KIAA1324 (3.7)	YIPF2 (3.0)	ERP29 (2.9)	NPC1L1 (2.7)	TM6SF2 (2.4)	ABCG8 (2.1)	TOP1 (2.1)	ATP13A1 (1.9)	GPAM (1.9)	CETP (1.9)
ENSG00000130479	MAP1S PPI subnetwork	0.11	> 0.20	SMARCA4 (4.0)	C1orf63 (3.1)	DOCK7 (2.9)	ILF3 (2.5)	BUD13 (2.5)	TOP1 (2.2)	NAA25 (2.0)	TMEM57 (2.0)	GATAD2A (1.8)	SUGP1 (1.8)
ENSG00000160691	SHC1 PPI subnetwork	0.11	> 0.20	SLC44A2 (3.6)	GMIP (3.6)	DNM2 (2.8)	CETP (2.5)	SH2B3 (2.5)	PLEC (2.4)	TIMD4 (2.3)	PVRL2 (2.2)	ADAM1 (2.0)	APOE (2.0)
ENSG00000135387	CAPRIN1 PPI subnetwork	0.11	> 0.20	C1orf63 (3.7)	GATAD2A (3.0)	BUD13 (2.7)	CARM1 (2.7)	GEMIN7 (2.6)	TRAPPC6A (2.5)	ILF3 (2.4)	DHX38 (2.3)	NT5DC1 (2.2)	TOP1 (2.1)
ENSG00000132356	PRKAA1 PPI subnetwork	0.11	> 0.20	GPAM (3.0)	SYPL2 (2.3)	CYB561D1 (2.3)	SORT1 (2.2)	ATXN7L2 (2.2)	SARS (2.1)	ACAD10 (2.0)	PLG (1.8)	HMGCR (1.7)	AMIGO1 (1.6)
GO:0016646	oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor	0.11	> 0.20	SARS (3.3)	DHODH (2.9)	TRAPPC6A (2.6)	PVRL2 (2.3)	FADS2 (2.2)	PLG (2.2)	FADS1 (2.2)	ENSG00000238078 (2.2)	APOC4 (2.0)	CYP7A1 (1.9)
ENSG00000106258	CYP3A5 PPI subnetwork	0.11	> 0.20	HMGCR (12.7)	LDLR (12.7)	FADS1 (9.6)	FADS2 (8.7)	PCSK9 (7.5)	GPAM (2.3)	SORT1 (2.0)	TRAPPC6A (1.8)	YIPF2 (1.6)	ATP13A1 (1.5)
ENSG00000021461	CYP3A43 PPI subnetwork	0.11	> 0.20	HMGCR (12.7)	LDLR (12.7)	FADS1 (9.6)	FADS2 (8.7)	PCSK9 (7.5)	GPAM (2.3)	SORT1 (2.0)	TRAPPC6A (1.8)	YIPF2 (1.6)	ATP13A1 (1.5)
MP:0005088	increased acute inflammation	0.11	> 0.20	SH2B3 (3.7)	PMFBP1 (3.1)	TRIB1 (2.8)	GMIP (2.3)	POLK (2.0)	BCL3 (1.8)	C11orf9 (1.5)	APOE (1.4)	RELB (1.4)	LDLR (1.3)
ENSG00000151849	CENPJ PPI subnetwork	0.11	> 0.20	RHD (3.9)	RHCE (3.8)	GRINA (3.2)	NYNRIN (2.3)	AMIGO1 (2.1)	GMPR (1.9)	ANKRD31 (1.7)	ABO (1.6)	ITGB3 (1.6)	PPP1R37 (1.6)
ENSG00000196549	MME PPI subnetwork	0.11	> 0.20	ACAD10 (2.6)	ABO (2.2)	TMED4 (2.1)	TRIB1 (2.0)	ERP29 (1.7)	CBLC (1.7)	TM6SF2 (1.5)	PVRL2 (1.4)	COL4A3BP (1.4)	BRAP (1.3)
ENSG00000134954	ETS1 PPI subnetwork	0.11	> 0.20	TRIB1 (2.9)	MYLIP (2.7)	KIAA1324 (2.4)	MAFB (2.0)	ATXN2 (1.9)	GMIP (1.8)	BCL3 (1.8)	SH2B3 (1.7)	USP24 (1.6)	PARP10 (1.6)
MP:0008670	decreased interleukin-12b secretion	0.11	> 0.20	MAFB (4.1)	RELB (3.9)	BCL3 (3.5)	SH2B3 (2.6)	OASL (2.6)	PARP10 (2.5)	GMIP (2.3)	PMFBP1 (2.0)	TRIB1 (1.7)	FRK (1.6)
GO:0002262	myeloid cell homeostasis	0.11	> 0.20	ENSG00000254235 (2.9)	DNAH11 (2.6)	TRAFD1 (2.1)	TXNL4B (2.0)	ERP29 (1.7)	C17orf57 (1.7)	LPAR2 (1.6)	C12orf43 (1.5)	CYB561D1 (1.4)	PPP1R37 (1.4)
ENSG00000143702	CEP170 PPI subnetwork	0.11	> 0.20	ST3GAL4 (2.9)	AP1M2 (2.9)	DNM2 (2.5)	KIAA1324 (2.3)	HNF1A (2.2)	PLEC (2.0)	ITGB3 (2.0)	NYNRIN (1.9)	CETP (1.6)	C12orf47 (1.6)
ENSG00000123576	ESX1 PPI subnetwork	0.11	> 0.20	COL4A3BP (3.7)	ITGB3 (2.5)	ALDH2 (2.5)	ABCG8 (2.2)	HAVCR1 (2.1)	GOT2P1 (1.6)	ATXN2 (1.6)	CEACAM19 (1.5)	MAFB (1.5)	HAPLN4 (1.5)
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	0.11	> 0.20	PARP10 (5.0)	YIPF2 (3.2)	TMED4 (2.6)	TRAFD1 (1.7)	CEACAM19 (1.7)	HNF1A (1.6)	CBLC (1.5)	RELB (1.4)	NPC1L1 (1.4)	ERP29 (1.4)
ENSG00000168477	TNXB PPI subnetwork	0.11	> 0.20	PTPN11 (2.9)	FRK (2.7)	ZNF180 (2.6)	PARP10 (2.6)	DOCK7 (2.4)	ENSG00000254235 (2.2)	ADAM1 (1.9)	ALDH2 (1.7)	TOMM40 (1.6)	C17orf57 (1.5)
MP:0001212	skin lesions	0.11	> 0.20	MAFB (3.2)	APOC1 (2.8)	BCL3 (2.6)	GRINA (2.6)	PARP10 (2.5)	CYB561D1 (2.0)	HLX (1.8)	ENSG00000235545 (1.7)	GMIP (1.7)	UBXN2B (1.5)
ENSG00000161057	PSMC2 PPI subnetwork	0.11	> 0.20	PSMA5 (5.8)	TOMM40 (3.5)	NT5DC1 (2.6)	TRAFD1 (2.3)	DDX56 (2.3)	NAA25 (2.3)	SARS (1.8)	SMARCA4 (1.7)	SUGP1 (1.7)	ZNF259 (1.6)
MP:0002411	decreased susceptibility to bacterial infection	0.11	> 0.20	MAFB (3.2)	GMIP (2.7)	FRK (2.6)	C11orf9 (2.3)	APOE (2.1)	PARP10 (2.0)	BCL3 (1.7)	OASL (1.6)	CBLC (1.4)	RELB (1.4)
MP:0000410	waved hair	0.11	> 0.20	PVR (1.8)	CELSR2 (1.5)	ANKRD31 (1.4)	POLK (1.4)	AP1M2 (1.3)	CYB561D1 (1.3)	NKPD1 (1.2)	BLOC1S3 (1.2)	ZNF180 (1.2)	MARK4 (1.1)
GO:0015924	mannosyl-oligosaccharide mannosidase activity	0.11	> 0.20	ERP29 (3.0)	TMEM57 (2.2)	C17orf57 (2.1)	YIPF2 (2.1)	TRAPPC6A (2.1)	TMEM50A (1.8)	ENSG00000235545 (1.7)	ENSG00000254235 (1.5)	CYB561D1 (1.4)	C1orf63 (1.4)
ENSG00000185386	MAPK11 PPI subnetwork	0.11	> 0.20	TRIB1 (6.8)	POLK (2.6)	SH2B3 (2.2)	HLX (1.7)	MYLIP (1.7)	ATXN7L2 (1.7)	PVR (1.5)	SYPL2 (1.4)	NPC1L1 (1.3)	POC5 (1.2)
KEGG_PROPANOATE_METABOLISM	KEGG_PROPANOATE_METABOLISM	0.11	> 0.20	ACAD10 (5.1)	ALDH2 (4.0)	MOSC1 (4.0)	GPAM (3.9)	FADS2 (3.8)	FADS1 (3.6)	TRAPPC6A (2.9)	NT5DC1 (2.8)	PCSK9 (2.8)	OGDH (2.8)
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON:LYMPHOID_CELL	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON:LYMPHOID_CELL	0.11	> 0.20	TIMD4 (3.6)	APOE (2.9)	SLC44A2 (2.9)	CETP (1.9)	RHD (1.8)	RELB (1.7)	PVR (1.5)	PLCG1 (1.4)	C19orf52 (1.3)	BCAM (1.3)
GO:0050660	flavin adenine dinucleotide binding	0.11	> 0.20	ALDH2 (4.5)	ACAD10 (3.8)	MOSC1 (3.3)	PLG (3.1)	HP (3.1)	GPAM (2.8)	LPIN3 (2.5)	SLC22A1 (2.5)	ANGPTL3 (2.1)	FADS2 (2.1)
ENSG00000071539	TRIP13 PPI subnetwork	0.11	> 0.20	NYNRIN (2.8)	ABCG8 (2.1)	LPIN3 (2.0)	TM6SF2 (2.0)	HNF1A (2.0)	CBLC (1.8)	ACAD10 (1.8)	TMEM116 (1.7)	CEACAM19 (1.6)	TMEM57 (1.3)
ENSG00000164776	PHKG1 PPI subnetwork	0.11	> 0.20	CILP2 (3.4)	SYPL2 (2.8)	ZNF180 (2.4)	SORT1 (2.3)	GPAM (2.2)	GMPR (2.1)	NCAN (2.0)	KIAA1324 (1.9)	TXNL4B (1.6)	ZHX3 (1.6)
GO:0000387	spliceosomal snRNP assembly	0.11	> 0.20	C12orf43 (2.9)	C19orf52 (2.6)	ENSG00000238078 (2.6)	GOT2P1 (2.6)	ZNF259 (2.5)	ZNF180 (2.3)	QTRT1 (2.0)	NKPD1 (2.0)	TOMM40 (1.8)	BUD13 (1.8)
GO:0019900	kinase binding	0.11	> 0.20	RELB (2.7)	PLCG1 (2.5)	GMIP (2.3)	PTPN11 (2.3)	POLK (2.2)	TRIB1 (2.1)	C11orf9 (2.0)	COL4A3BP (2.0)	DNM2 (2.0)	NCAN (1.9)
GO:0043168	anion binding	0.11	> 0.20	TM6SF2 (4.0)	NPC1L1 (3.9)	ABCG5 (3.6)	LPA (2.6)	HAPLN4 (2.6)	ABCG8 (2.4)	BCAM (2.4)	GCNT4 (2.2)	APOB (1.8)	PLG (1.8)
ENSG00000126767	ELK1 PPI subnetwork	0.11	> 0.20	SH2B3 (3.0)	HLX (2.6)	GEMIN7 (2.6)	BCL3 (2.2)	PBX4 (2.1)	CEACAM19 (2.0)	TRIB1 (2.0)	ENSG00000238078 (1.8)	ALDH2 (1.8)	KANK2 (1.7)
ENSG00000005469	CROT PPI subnetwork	0.11	> 0.20	APOC1 (3.3)	APOB (2.7)	GMPR (2.6)	ITGB3 (2.5)	GPAM (2.1)	TMEM50A (2.1)	HAVCR1 (2.0)	BRAP (2.0)	TMEM57 (2.0)	LPIN3 (1.8)
GO:0005520	insulin-like growth factor binding	0.11	> 0.20	CILP2 (4.1)	APOE (2.5)	KANK2 (2.3)	PPP1R37 (2.0)	PVRL2 (1.9)	BCAM (1.9)	ADAM1 (1.6)	YIPF2 (1.5)	TMED4 (1.4)	APOB (1.3)
ENSG00000134588	USP26 PPI subnetwork	0.11	> 0.20	ILF3 (3.0)	HMGCR (2.6)	TOMM40 (2.6)	SMARCA4 (2.6)	FADS1 (2.2)	LDLR (1.9)	TMEM57 (1.9)	OGDH (1.9)	C1orf63 (1.7)	TMEM50A (1.6)
GO:0006400	tRNA modification	0.11	> 0.20	QTRT1 (3.6)	NAA25 (3.3)	C12orf43 (3.3)	DHODH (3.3)	ZNF259 (2.7)	MAPKAPK5 (2.6)	TOMM40 (2.4)	TXNL4B (2.4)	C19orf52 (2.3)	ATP13A1 (2.1)
ENSG00000091136	LAMB1 PPI subnetwork	0.11	> 0.20	BCAM (4.2)	KANK2 (3.3)	SLC44A2 (2.8)	PLEC (2.5)	PVRL2 (2.3)	PLEKHH2 (2.3)	OGDH (2.2)	ST3GAL4 (2.1)	CBLC (1.9)	HNF1A (1.8)
ENSG00000085063	CD59 PPI subnetwork	0.11	> 0.20	LPA (5.2)	SLC22A1 (4.7)	APOC4 (4.3)	PLG (4.1)	ANGPTL3 (3.9)	APOA5 (3.5)	ITGB3 (3.5)	ABCG5 (3.0)	ADAM1 (2.6)	HP (2.5)
GO:0002526	acute inflammatory response	0.11	> 0.20	ENSG00000228044 (3.2)	HP (3.1)	FRK (2.5)	LPA (2.4)	TIMD4 (2.4)	SLC22A1 (2.2)	ST3GAL4 (2.1)	ENSG00000235545 (2.1)	APOA5 (2.0)	ANGPTL3 (1.9)
ENSG00000090061	CCNK PPI subnetwork	0.11	> 0.20	GCNT4 (2.8)	TRAPPC6A (2.6)	BUD13 (2.5)	PARP10 (1.7)	SUGP1 (1.5)	OGDH (1.4)	CARM1 (1.4)	GMPR (1.4)	MARK4 (1.4)	CELSR2 (1.3)
MP:0002446	abnormal macrophage morphology	0.11	> 0.20	TIMD4 (4.5)	APOC1 (3.7)	CETP (3.7)	HP (2.6)	SLC44A2 (2.5)	RELB (2.5)	APOE (2.3)	CYB561D1 (2.1)	SORT1 (2.1)	ACAD10 (1.9)
GO:0050994	regulation of lipid catabolic process	0.11	> 0.20	MOSC1 (3.2)	GPAM (2.7)	APOC4 (2.7)	ABCG8 (2.2)	APOB (2.1)	PLG (1.8)	APOA5 (1.8)	COL4A3BP (1.8)	TM6SF2 (1.7)	AMIGO1 (1.6)
ENSG00000180176	TH PPI subnetwork	0.11	> 0.20	GRINA (3.5)	CARM1 (3.4)	ATXN2 (2.1)	GOT2P1 (2.1)	ENSG00000238078 (2.1)	MARK4 (2.0)	GMPR (1.9)	BCAM (1.7)	SLC44A2 (1.7)	NT5DC1 (1.7)
GO:0071902	positive regulation of protein serine/threonine kinase activity	0.11	> 0.20	SLC44A2 (2.6)	ENSG00000228044 (2.3)	HLX (2.1)	LPAR2 (2.1)	PTPN11 (2.0)	ABO (1.9)	ENSG00000226645 (1.7)	AMIGO1 (1.7)	ST3GAL4 (1.7)	GCNT4 (1.5)
ENSG00000077157	PPP1R12B PPI subnetwork	0.11	> 0.20	SYPL2 (3.5)	ENSG00000238078 (2.7)	ANKRD31 (2.6)	PTPN11 (2.1)	GOT2P1 (1.8)	CYP7A1 (1.6)	DYNC2LI1 (1.5)	SLC44A2 (1.5)	TMEM50A (1.4)	C12orf47 (1.3)
GO:0042770	signal transduction in response to DNA damage	0.11	> 0.20	NT5DC1 (2.6)	PSMA5 (2.5)	TRAFD1 (2.5)	ENSG00000238078 (1.9)	NAA25 (1.9)	BUD13 (1.8)	PARP10 (1.8)	BRAP (1.7)	SUGP1 (1.6)	C12orf47 (1.6)
GO:0051702	interaction with symbiont	0.11	> 0.20	CEACAM19 (2.9)	RHD (2.4)	ENSG00000235545 (2.3)	HP (2.2)	ADAM1 (1.6)	ZNF101 (1.6)	ENSG00000226645 (1.6)	PBX4 (1.6)	GOT2P1 (1.5)	BUD13 (1.5)
GO:0070411	I-SMAD binding	0.11	> 0.20	KANK2 (4.0)	ALDH2 (2.3)	PLCG1 (2.1)	ENSG00000226648 (1.9)	ABO (1.6)	PCSK9 (1.6)	ENSG00000228044 (1.6)	MARK4 (1.5)	MAPKAPK5 (1.4)	TMEM50A (1.4)
ENSG00000183765	CHEK2 PPI subnetwork	0.11	> 0.20	USP1 (4.8)	FEN1 (4.2)	PSRC1 (3.6)	PLCG1 (2.3)	ZNF101 (2.0)	POC5 (1.9)	POLK (1.8)	DOCK7 (1.8)	RHCE (1.8)	TOP1 (1.5)
GO:0043274	phospholipase binding	0.11	> 0.20	ITGB3 (2.9)	PPP1R37 (2.9)	PVR (2.8)	ENSG00000228044 (2.5)	GATAD2A (2.3)	COL4A3BP (2.0)	HAVCR1 (1.9)	DNAH11 (1.6)	ENSG00000254235 (1.5)	BCL3 (1.4)
MP:0000693	spleen hyperplasia	0.11	> 0.20	BCL3 (3.7)	GMIP (3.5)	MAFB (2.9)	TRIB1 (2.6)	CETP (2.5)	RELB (2.3)	TIMD4 (2.0)	SH2B3 (2.0)	HLX (1.8)	MYLIP (1.5)
MP:0009321	increased histiocytic sarcoma incidence	0.11	> 0.20	ATXN7L2 (2.6)	FEN1 (2.3)	USP1 (2.1)	C17orf57 (1.8)	MAPKAPK5 (1.6)	GMIP (1.6)	LPIN3 (1.5)	ZHX3 (1.4)	GOT2P1 (1.4)	PTPN11 (1.3)
GO:0005730	nucleolus	0.11	> 0.20	ZNF259 (4.1)	QTRT1 (3.7)	DDX56 (3.6)	NAA25 (3.5)	DHODH (3.5)	TOMM40 (3.3)	C12orf43 (3.2)	DHX38 (2.3)	ILF3 (2.1)	TOP1 (2.1)
GO:0051347	positive regulation of transferase activity	0.11	> 0.20	ENSG00000228044 (4.0)	PTPN11 (2.2)	AMIGO1 (2.1)	HLX (2.1)	PVR (2.1)	SLC44A2 (2.0)	ST3GAL4 (1.9)	POLK (1.7)	ENSG00000235545 (1.6)	SH2B3 (1.6)
GO:0006544	glycine metabolic process	0.11	> 0.20	CYP7A1 (4.1)	SLC22A1 (3.7)	ENSG00000254235 (3.4)	TXNL4B (3.4)	ANGPTL3 (2.9)	UBXN2B (2.9)	GOT2P1 (2.6)	DHODH (2.6)	APOA5 (2.5)	PLG (2.3)
ENSG00000136231	IGF2BP3 PPI subnetwork	0.11	> 0.20	ILF3 (3.3)	DDX56 (2.9)	CARM1 (2.8)	BRAP (2.7)	ATP13A1 (2.6)	MAPKAPK5 (2.5)	GATAD2A (2.4)	TOMM40 (2.4)	TRAFD1 (1.9)	QTRT1 (1.9)
MP:0000702	enlarged lymph nodes	0.11	> 0.20	RELB (4.4)	GMIP (3.0)	TRIB1 (2.7)	BCL3 (2.6)	SH2B3 (2.6)	PARP10 (2.4)	MAFB (1.8)	POLK (1.6)	TIMD4 (1.4)	LPIN3 (1.3)
GO:0043130	ubiquitin binding	0.11	> 0.20	GRINA (3.7)	RELB (2.9)	HAVCR1 (2.1)	MAU2 (1.8)	SARS (1.7)	POC5 (1.7)	PVR (1.6)	ATXN2 (1.6)	PSMA5 (1.4)	BRAP (1.3)
GO:0043487	regulation of RNA stability	0.11	> 0.20	ADAM1 (3.3)	ENSG00000238078 (2.8)	ENSG00000235545 (1.9)	ILF3 (1.8)	QTRT1 (1.7)	KANK2 (1.7)	TOP1 (1.7)	NT5DC1 (1.6)	TRIB1 (1.6)	LPAR2 (1.5)
ENSG00000185338	SOCS1 PPI subnetwork	0.11	> 0.20	GMIP (3.6)	BCL3 (3.3)	HLX (3.2)	RELB (2.6)	TIMD4 (2.6)	SH2B3 (2.6)	PARP10 (2.5)	DNM2 (2.1)	CETP (2.1)	PLEKHH2 (1.9)
ENSG00000142166	IFNAR1 PPI subnetwork	0.11	> 0.20	BCL3 (3.3)	COL4A3BP (2.5)	PARP10 (1.7)	ZNF101 (1.7)	CYP7A1 (1.6)	OASL (1.6)	PVR (1.6)	RELB (1.4)	TIMD4 (1.3)	TRAFD1 (1.3)
ENSG00000170345	FOS PPI subnetwork	0.11	> 0.20	TRIB1 (4.3)	BCL3 (4.1)	MAPKAPK5 (3.0)	GRINA (2.7)	PARP10 (2.4)	RELB (2.4)	OASL (2.3)	HLX (2.3)	ATXN2 (2.2)	CARM1 (2.2)
ENSG00000196305	IARS PPI subnetwork	0.11	> 0.20	SARS (6.4)	RELB (4.0)	NAA25 (2.9)	PSMA5 (2.6)	ZNF259 (2.1)	GOT2P1 (2.0)	DDX56 (1.9)	BCL3 (1.6)	POC5 (1.6)	QTRT1 (1.6)
MP:0009237	kinked sperm flagellum	0.11	> 0.20	TSSK6 (3.6)	CEACAM19 (2.5)	TIMD4 (2.3)	PMFBP1 (2.1)	MARK4 (2.0)	NT5DC1 (1.8)	ENSG00000228044 (1.7)	FADS2 (1.7)	PCSK9 (1.5)	SLC44A2 (1.5)
ENSG00000185634	SHC4 PPI subnetwork	0.11	> 0.20	MYLIP (4.5)	C1orf63 (3.6)	SLC44A2 (3.4)	HLX (2.7)	LPIN3 (2.6)	C17orf57 (2.6)	ENSG00000238078 (2.2)	ADAM1 (2.1)	PVRL2 (2.0)	CBLC (1.9)
REACTOME_ETHANOL_OXIDATION	REACTOME_ETHANOL_OXIDATION	0.11	> 0.20	LPA (5.1)	APOC4 (4.4)	GPAM (3.4)	CYP7A1 (3.0)	ABCG5 (2.8)	HP (2.8)	APOA5 (2.8)	KIAA1324 (2.8)	ALDH2 (2.7)	ANGPTL3 (2.5)
MP:0008874	decreased physiological sensitivity to xenobiotic	0.11	> 0.20	SLC22A1 (3.7)	LPA (3.0)	HLX (3.0)	MAFB (2.6)	POLK (2.6)	CYP7A1 (2.4)	ENSG00000254235 (2.3)	APOA5 (2.1)	ABCG8 (1.9)	BCL3 (1.8)
MP:0000266	abnormal heart morphology	0.11	> 0.20	KANK2 (2.5)	BCAM (2.5)	MAFB (2.3)	ATXN2 (2.3)	PTPN11 (2.1)	ACAD10 (1.6)	APOB (1.6)	PVRL2 (1.5)	GPAM (1.4)	ALDH2 (1.4)
ENSG00000126883	NUP214 PPI subnetwork	0.11	> 0.20	NAA25 (3.7)	POC5 (3.6)	DOCK7 (3.0)	USP1 (2.9)	USP24 (2.7)	MAPKAPK5 (2.5)	ILF3 (2.1)	DDX56 (2.1)	ENSG00000235545 (1.5)	ENSG00000226648 (1.4)
GO:0002576	platelet degranulation	0.11	> 0.20	ITGB3 (6.8)	ANGPTL3 (3.1)	GMPR (2.6)	ADAM1 (2.3)	APOE (2.2)	HP (2.2)	PLG (1.9)	ZNF101 (1.8)	HNF1A (1.8)	APOC4 (1.7)
ENSG00000130227	XPO7 PPI subnetwork	0.11	> 0.20	NAA25 (2.2)	ENSG00000254235 (2.0)	MAPKAPK5 (2.0)	POC5 (1.9)	HLX (1.8)	SLC22A1 (1.8)	GATAD2A (1.7)	USP24 (1.7)	SARS (1.7)	ENSG00000226648 (1.7)
MP:0008019	increased liver tumor incidence	0.11	> 0.20	PBX4 (2.4)	CYP7A1 (2.4)	AMIGO1 (2.0)	DOCK7 (1.9)	APOC4 (1.7)	ABCG8 (1.7)	PSRC1 (1.7)	DNM2 (1.7)	POC5 (1.6)	FEN1 (1.6)
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCTTRIC	REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCTTRIC	0.11	> 0.20	NAA25 (2.3)	GMPR (2.1)	SMARCA4 (2.1)	ITGB3 (1.9)	PSMA5 (1.8)	ZNF259 (1.7)	DDX56 (1.7)	RHD (1.7)	NKPD1 (1.7)	HMGCR (1.6)
GO:0019213	deacetylase activity	0.11	> 0.20	PLCG1 (3.4)	ATXN7L2 (2.5)	HNF1A (2.1)	ACAD10 (2.0)	TXNL4B (2.0)	BUD13 (1.9)	NT5DC1 (1.8)	ANGPTL3 (1.6)	PSRC1 (1.6)	YIPF2 (1.6)
ENSG00000123992	DNPEP PPI subnetwork	0.11	> 0.20	PLCG1 (2.0)	LPIN3 (2.0)	ATXN7L2 (2.0)	FADS2 (1.9)	TRIB1 (1.8)	ZNF101 (1.7)	CBLC (1.6)	APOC1 (1.5)	TRAFD1 (1.5)	HP (1.5)
ENSG00000174720	LARP7 PPI subnetwork	0.11	> 0.20	ZNF259 (5.3)	NAA25 (4.8)	DDX56 (4.0)	TOMM40 (3.5)	QTRT1 (3.0)	TOP1 (2.8)	MAPKAPK5 (2.4)	DHX38 (2.4)	DHODH (2.3)	C12orf43 (2.3)
MP:0000479	abnormal enterocyte morphology	0.11	> 0.20	ABCG8 (2.4)	CBLC (2.3)	HLX (2.1)	FRK (2.0)	TIMD4 (1.9)	C1orf63 (1.8)	KIAA1324 (1.8)	PLEKHH2 (1.7)	ABCG5 (1.6)	ZNF101 (1.6)
MP:0002092	abnormal eye morphology	0.11	> 0.20	TRIB1 (2.5)	GPAM (1.9)	ST3GAL4 (1.7)	LPA (1.7)	MAFB (1.7)	ENSG00000254235 (1.5)	APOE (1.5)	PLEC (1.4)	TMEM116 (1.4)	PLCG1 (1.3)
ENSG00000133895	MEN1 PPI subnetwork	0.11	> 0.20	RELB (4.9)	BCL3 (3.5)	PLEC (2.9)	BUD13 (2.2)	POC5 (2.0)	USP1 (2.0)	C19orf52 (1.7)	KIAA1324 (1.7)	FEN1 (1.5)	MAPKAPK5 (1.5)
ENSG00000121753	BAI2 PPI subnetwork	0.11	> 0.20	LDLR (4.9)	FADS1 (3.1)	COL4A3BP (3.1)	C12orf51 (2.5)	OGDH (2.5)	HNF1A (2.5)	PCSK9 (2.4)	DNAH11 (2.3)	FADS2 (2.2)	SORT1 (2.0)
ENSG00000132603	NIP7 PPI subnetwork	0.12	> 0.20	ZNF259 (4.9)	NAA25 (4.5)	TOMM40 (3.7)	DDX56 (3.6)	QTRT1 (3.5)	DHODH (2.5)	DHX38 (2.4)	ATP13A1 (2.3)	SUGP1 (2.2)	C12orf43 (2.0)
MP:0005169	abnormal male meiosis	0.12	> 0.20	ANKRD31 (4.7)	TMEM116 (2.6)	PBX4 (2.0)	FEN1 (1.8)	SUGP1 (1.7)	BRAP (1.6)	MAU2 (1.6)	LPAR2 (1.4)	ENSG00000238078 (1.4)	LPIN3 (1.2)
GO:0016634	oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor	0.12	> 0.20	RHCE (3.6)	ACAD10 (3.1)	RHD (3.1)	MOSC1 (3.0)	LPA (2.5)	TM6SF2 (2.4)	GPAM (2.3)	APOA5 (2.2)	SLC22A1 (2.1)	ALDH2 (2.0)
GO:0001885	endothelial cell development	0.12	> 0.20	DNAH11 (4.2)	CILP2 (4.1)	ENSG00000226645 (2.2)	ANKRD31 (2.2)	ENSG00000226648 (1.9)	PBX4 (1.8)	BCAM (1.8)	CEACAM19 (1.7)	ABO (1.6)	UBXN2B (1.6)
GO:0051536	iron-sulfur cluster binding	0.12	> 0.20	ACAD10 (3.9)	RHCE (2.9)	NT5DC1 (2.4)	TOMM40 (2.1)	RHD (2.0)	LPIN3 (1.9)	GMPR (1.8)	SARS (1.7)	OASL (1.7)	DHODH (1.7)
GO:0051540	metal cluster binding	0.12	> 0.20	ACAD10 (3.9)	RHCE (2.9)	NT5DC1 (2.4)	TOMM40 (2.1)	RHD (2.0)	LPIN3 (1.9)	GMPR (1.8)	SARS (1.7)	OASL (1.7)	DHODH (1.7)
ENSG00000120509	PDZD11 PPI subnetwork	0.12	> 0.20	AP1M2 (3.4)	DNM2 (3.4)	LPAR2 (2.5)	ZHX3 (2.4)	ATXN7L2 (2.4)	CARM1 (2.4)	CBLC (2.4)	KANK2 (2.3)	GPAM (2.3)	OGDH (2.1)
MP:0003984	embryonic growth retardation	0.12	> 0.20	GATAD2A (3.3)	PVR (2.8)	LDLR (2.7)	HMGCR (2.4)	KANK2 (2.2)	ATXN2 (2.1)	USP24 (2.0)	DOCK7 (2.0)	PTPN11 (1.9)	ENSG00000226648 (1.9)
ENSG00000136286	MYO1G PPI subnetwork	0.12	> 0.20	USP24 (3.5)	DNM2 (3.5)	PLEC (3.2)	COL4A3BP (2.4)	GMIP (2.3)	POLK (2.1)	SORT1 (2.1)	ALDH2 (1.9)	OGDH (1.7)	PTPN11 (1.7)
GO:0010638	positive regulation of organelle organization	0.12	> 0.20	POLK (2.8)	GCNT4 (2.4)	MYLIP (1.9)	ANKRD31 (1.9)	NYNRIN (1.9)	TMEM50A (1.6)	POC5 (1.5)	PLCG1 (1.5)	SH2B3 (1.3)	YIPF2 (1.3)
ENSG00000102226	USP11 PPI subnetwork	0.12	> 0.20	DNM2 (3.4)	SUGP1 (3.4)	BRAP (3.2)	ILF3 (3.2)	MAU2 (3.0)	C19orf52 (2.3)	TRAFD1 (2.3)	DYNC2LI1 (2.1)	MARK4 (2.1)	HAPLN4 (2.0)
GO:2000377	regulation of reactive oxygen species metabolic process	0.12	> 0.20	ENSG00000226645 (3.0)	CEACAM19 (2.7)	ANKRD31 (2.5)	PVR (2.2)	ALDH2 (2.0)	BRAP (1.8)	HNF1A (1.6)	CBLC (1.6)	PCSK9 (1.5)	DYNC2LI1 (1.4)
GO:0010039	response to iron ion	0.12	> 0.20	RHD (3.9)	RHCE (3.8)	GEMIN7 (2.7)	C12orf51 (2.1)	FRK (1.8)	ABO (1.7)	ENSG00000254235 (1.5)	TMEM116 (1.5)	ADAM1 (1.4)	AP1M2 (1.4)
ENSG00000101004	NINL PPI subnetwork	0.12	> 0.20	BRAP (3.1)	ENSG00000226648 (2.3)	MAU2 (2.0)	TSSK6 (2.0)	DHX38 (1.9)	POC5 (1.9)	ITGB3 (1.8)	TRIB1 (1.7)	TRAFD1 (1.7)	C12orf47 (1.6)
ENSG00000101082	SLA2 PPI subnetwork	0.12	> 0.20	APOB (2.9)	APOC1 (2.8)	HAVCR1 (2.5)	TMEM50A (2.4)	ZNF101 (2.4)	LPIN3 (2.3)	ITGB3 (2.3)	PLCG1 (2.3)	LPAR2 (1.8)	C1orf63 (1.8)
GO:0043901	negative regulation of multi-organism process	0.12	> 0.20	DNAH11 (2.6)	HP (2.3)	RHD (2.2)	TIMD4 (1.9)	GEMIN7 (1.9)	ADAM1 (1.8)	TRAFD1 (1.8)	CETP (1.7)	RHCE (1.7)	OASL (1.6)
GO:0031965	nuclear membrane	0.12	> 0.20	LDLR (3.3)	NAA25 (2.7)	DDX56 (2.6)	TMED4 (2.4)	ATP13A1 (2.2)	ERP29 (2.2)	HAVCR1 (2.2)	USP1 (2.0)	PSRC1 (1.8)	DHODH (1.7)
ENSG00000132522	GPS2 PPI subnetwork	0.12	> 0.20	UBXN2B (1.9)	PSRC1 (1.8)	SMARCA4 (1.8)	GMIP (1.7)	ITGB3 (1.6)	GCNT4 (1.6)	SH2B3 (1.6)	SLC44A2 (1.5)	OGDH (1.5)	AP1M2 (1.4)
ENSG00000164985	PSIP1 PPI subnetwork	0.12	> 0.20	DOCK7 (3.2)	NAA25 (3.2)	BUD13 (3.2)	USP24 (3.1)	DDX56 (2.7)	USP1 (2.6)	POC5 (2.6)	ILF3 (2.4)	FEN1 (2.3)	C12orf51 (2.1)
ENSG00000213341	CHUK PPI subnetwork	0.12	> 0.20	RELB (5.3)	BCL3 (4.0)	PARP10 (3.6)	OASL (3.5)	SH2B3 (2.8)	PTPN11 (2.5)	PLEC (2.3)	BCAM (2.2)	PPP1R37 (2.2)	TRIB1 (2.0)
ENSG00000130810	PPAN PPI subnetwork	0.12	> 0.20	ZNF259 (5.3)	NAA25 (4.2)	DDX56 (4.0)	TOMM40 (3.7)	QTRT1 (3.2)	DHODH (2.8)	MAPKAPK5 (2.7)	DHX38 (2.7)	C12orf43 (2.1)	SUGP1 (2.1)
GO:0042743	hydrogen peroxide metabolic process	0.12	> 0.20	GOT2P1 (3.5)	ADAM1 (2.6)	C19orf52 (2.5)	ALDH2 (2.3)	PBX4 (2.2)	TMED4 (2.1)	MOSC1 (1.9)	RHCE (1.9)	C17orf57 (1.9)	SLC22A1 (1.8)
GO:0042440	pigment metabolic process	0.12	> 0.20	RHCE (4.9)	RHD (4.6)	GMPR (2.6)	ADAM1 (2.4)	NT5DC1 (2.3)	DHODH (2.2)	TRAPPC6A (2.1)	ENSG00000235545 (2.0)	ACAD10 (1.5)	PMFBP1 (1.4)
ENSG00000120738	EGR1 PPI subnetwork	0.12	> 0.20	TRIB1 (4.3)	BCL3 (3.4)	UBXN2B (2.7)	CARM1 (2.4)	TOP1 (2.1)	ATXN2 (1.8)	MAFB (1.7)	GRINA (1.7)	ALDH2 (1.6)	BCAM (1.6)
MP:0008058	abnormal DNA repair	0.12	> 0.20	POC5 (4.5)	ZNF180 (2.0)	FEN1 (2.0)	UBXN2B (1.9)	KANK2 (1.7)	GEMIN7 (1.6)	PSRC1 (1.6)	MAPKAPK5 (1.6)	NT5DC1 (1.5)	CBLC (1.5)
GO:0016641	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	0.12	> 0.20	MOSC1 (3.2)	HP (2.2)	ATXN7L2 (2.2)	KANK2 (1.9)	RELB (1.7)	PLG (1.7)	GPAM (1.6)	TRAFD1 (1.6)	NPC1L1 (1.6)	OASL (1.6)
MP:0001510	abnormal coat appearance	0.12	> 0.20	CBLC (3.3)	AP1M2 (3.2)	CEACAM19 (3.2)	GCNT4 (2.0)	TM6SF2 (1.9)	ENSG00000254235 (1.9)	CELSR2 (1.9)	TRAPPC6A (1.8)	YIPF2 (1.7)	ENSG00000238078 (1.6)
GO:0060760	positive regulation of response to cytokine stimulus	0.12	> 0.20	C17orf57 (2.8)	COL4A3BP (2.6)	CEACAM19 (2.5)	POLK (2.5)	ENSG00000235545 (2.0)	ZNF101 (1.8)	GRINA (1.7)	CYB561D1 (1.6)	TM6SF2 (1.3)	HNF1A (1.2)
ENSG00000148082	SHC3 PPI subnetwork	0.12	> 0.20	MYLIP (3.9)	SLC44A2 (3.2)	HLX (3.0)	C1orf63 (2.9)	C17orf57 (2.8)	ABCG8 (2.5)	PVRL2 (2.0)	LPA (1.9)	LPIN3 (1.9)	TIMD4 (1.8)
GO:0001817	regulation of cytokine production	0.12	> 0.20	OASL (3.1)	PARP10 (2.7)	SH2B3 (2.5)	RELB (2.3)	ZNF101 (2.2)	TIMD4 (2.0)	GMIP (2.0)	POLK (1.7)	BCL3 (1.7)	ST3GAL4 (1.6)
ENSG00000163002	NUP35 PPI subnetwork	0.12	> 0.20	NAA25 (3.6)	USP1 (3.4)	POC5 (3.1)	DOCK7 (2.9)	DDX56 (2.5)	BUD13 (2.4)	ILF3 (2.4)	USP24 (2.3)	FEN1 (2.2)	ENSG00000226648 (2.0)
ENSG00000158828	PINK1 PPI subnetwork	0.12	> 0.20	TIMD4 (3.1)	OASL (3.0)	CETP (2.6)	PLEKHH2 (1.8)	TMEM57 (1.7)	C1orf63 (1.7)	DNAH11 (1.5)	BCAM (1.4)	GOT2P1 (1.3)	HNF1A (1.3)
ENSG00000129152	MYOD1 PPI subnetwork	0.12	> 0.20	KANK2 (2.8)	MYLIP (2.4)	MAFB (2.2)	TRIB1 (2.1)	PTPN11 (1.8)	ATXN2 (1.7)	ATXN7L2 (1.7)	ALDH2 (1.7)	BCL3 (1.6)	GCNT4 (1.5)
ENSG00000130560	UBAC1 PPI subnetwork	0.12	> 0.20	RHCE (1.9)	ENSG00000235545 (1.9)	PTPN11 (1.9)	ZNF180 (1.9)	C12orf51 (1.7)	SYPL2 (1.7)	NPC1L1 (1.5)	UBXN2B (1.5)	SH2B3 (1.5)	ERP29 (1.5)
MP:0005181	decreased circulating estradiol level	0.12	> 0.20	MYLIP (2.7)	KANK2 (2.6)	GPAM (2.4)	ST3GAL4 (2.2)	LDLR (1.7)	PMFBP1 (1.5)	GCNT4 (1.5)	ABCG8 (1.4)	TOP1 (1.3)	ENSG00000238078 (1.3)
ENSG00000157077	ZFYVE9 PPI subnetwork	0.12	> 0.20	PTPN11 (3.2)	DNM2 (2.5)	BRAP (2.1)	ADAM1 (2.1)	PARP10 (2.1)	ATXN2 (2.0)	CLPTM1 (2.0)	TMEM50A (1.9)	TRAFD1 (1.9)	MAPKAPK5 (1.8)
ENSG00000095319	NUP188 PPI subnetwork	0.12	> 0.20	NAA25 (3.7)	POC5 (3.5)	USP1 (3.5)	DDX56 (2.6)	DOCK7 (2.5)	USP24 (2.3)	FEN1 (2.3)	BUD13 (2.2)	ILF3 (2.1)	CARM1 (1.9)
GO:0006022	aminoglycan metabolic process	0.12	> 0.20	TMED4 (3.4)	ERP29 (2.6)	NKPD1 (2.6)	ST3GAL4 (2.1)	CEACAM19 (2.0)	TMEM50A (1.9)	PMFBP1 (1.9)	ADAM1 (1.9)	CILP2 (1.8)	ENSG00000228044 (1.8)
ENSG00000168488	ATXN2L PPI subnetwork	0.12	> 0.20	BRAP (2.4)	ENSG00000226648 (2.4)	DNAH11 (2.4)	YIPF2 (2.3)	C19orf52 (2.2)	ATXN2 (2.1)	ANKRD31 (2.0)	ST3GAL4 (2.0)	BLOC1S3 (1.9)	RHD (1.9)
MP:0003383	abnormal gluconeogenesis	0.12	> 0.20	GPAM (4.5)	PVR (2.9)	MAFB (2.4)	HP (2.3)	SORT1 (2.3)	ZHX3 (2.2)	ATXN2 (1.8)	CILP2 (1.8)	ATXN7L2 (1.8)	MOSC1 (1.8)
MP:0003724	increased susceptibility to induced arthritis	0.12	> 0.20	BCL3 (4.4)	CETP (3.7)	TRIB1 (3.1)	ITGB3 (3.0)	MOSC1 (2.8)	HP (2.4)	TRAFD1 (2.4)	CILP2 (2.2)	ENSG00000238078 (2.0)	RELB (1.9)
ENSG00000197747	S100A10 PPI subnetwork	0.12	> 0.20	APOE (2.2)	DNAH11 (2.1)	ANGPTL3 (1.9)	SLC22A1 (1.8)	PLEC (1.8)	KANK2 (1.6)	C12orf47 (1.6)	NT5DC1 (1.3)	APOC4 (1.3)	TRAPPC6A (1.3)
ENSG00000166170	BAG5 PPI subnetwork	0.12	> 0.20	FRK (2.9)	PARP10 (2.7)	ZNF180 (2.6)	PTPN11 (2.2)	DOCK7 (1.8)	TOMM40 (1.7)	SYPL2 (1.6)	ADAM1 (1.6)	C17orf57 (1.5)	PPP1R37 (1.5)
ENSG00000163624	CDS1 PPI subnetwork	0.12	> 0.20	ATP13A1 (3.7)	HNF1A (3.1)	MAPKAPK5 (2.6)	PTPN11 (2.4)	DHODH (2.4)	DDX56 (2.4)	BRAP (2.3)	TOMM40 (2.1)	CEACAM19 (2.1)	ANKRD31 (2.1)
REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS	REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS	0.12	> 0.20	RELB (4.0)	OASL (3.2)	TRAFD1 (3.1)	HAVCR1 (3.0)	PARP10 (2.5)	BCL3 (2.5)	FRK (2.5)	LPAR2 (2.5)	POC5 (1.8)	POLK (1.6)
REACTOME_DEATH_RECEPTOR__SIGNALLING	REACTOME_DEATH_RECEPTOR__SIGNALLING	0.12	> 0.20	RELB (4.0)	OASL (3.2)	TRAFD1 (3.1)	HAVCR1 (3.0)	PARP10 (2.5)	BCL3 (2.5)	FRK (2.5)	LPAR2 (2.5)	POC5 (1.8)	POLK (1.6)
MP:0004762	increased anti-double stranded DNA antibody level	0.12	> 0.20	MAFB (3.5)	CETP (3.4)	GMIP (2.6)	RELB (2.5)	BCL3 (2.1)	ZNF101 (2.1)	TRIB1 (1.7)	GCNT4 (1.7)	TOP1 (1.6)	TIMD4 (1.5)
ENSG00000100138	NHP2L1 PPI subnetwork	0.12	> 0.20	ILF3 (3.9)	DHX38 (3.4)	TOP1 (3.0)	DDX56 (3.0)	TOMM40 (3.0)	QTRT1 (2.9)	DHODH (2.9)	SUGP1 (2.8)	SMARCA4 (2.7)	USP1 (2.6)
ENSG00000109971	HSPA8 PPI subnetwork	0.12	> 0.20	PSMA5 (3.4)	TOMM40 (3.2)	SMARCA4 (3.0)	SARS (2.8)	NAA25 (2.7)	CLPTM1 (2.5)	GATAD2A (2.5)	DDX56 (2.3)	CARM1 (2.1)	ILF3 (2.1)
GO:0008201	heparin binding	0.12	> 0.20	HP (4.8)	CILP2 (4.1)	PLG (3.4)	ANGPTL3 (2.7)	APOC4 (2.4)	CYP7A1 (2.3)	APOC1 (2.2)	APOE (2.1)	MAFB (2.1)	PCSK9 (1.9)
ENSG00000089159	PXN PPI subnetwork	0.12	> 0.20	PLEC (4.7)	ITGB3 (3.0)	SH2B3 (2.3)	KANK2 (2.2)	APOE (2.1)	TOP1 (2.0)	SLC44A2 (1.8)	SMARCA4 (1.8)	GATAD2A (1.8)	DNM2 (1.7)
ENSG00000132964	CDK8 PPI subnetwork	0.12	> 0.20	ATXN2 (3.1)	GEMIN7 (3.0)	C12orf51 (2.7)	ATXN7L2 (2.5)	BUD13 (2.3)	POC5 (2.2)	TMEM57 (2.1)	USP24 (1.8)	DHX38 (1.8)	BRAP (1.7)
MP:0003656	abnormal erythrocyte physiology	0.12	> 0.20	RHD (10.9)	RHCE (9.6)	GMPR (2.8)	C12orf51 (2.5)	TRAPPC6A (2.3)	TXNL4B (2.1)	FADS2 (1.9)	HP (1.8)	BLOC1S3 (1.8)	ZNF180 (1.7)
ENSG00000140464	PML PPI subnetwork	0.12	> 0.20	OASL (4.0)	TRAFD1 (3.5)	ATXN2 (3.5)	TRIB1 (3.2)	BRAP (3.1)	GATAD2A (2.7)	SH2B3 (2.7)	MAU2 (2.4)	PARP10 (2.3)	C12orf51 (1.8)
MP:0000220	increased monocyte cell number	0.12	> 0.20	RELB (4.1)	BCL3 (3.8)	GMIP (3.6)	CETP (3.3)	RHD (3.0)	RHCE (2.6)	SLC44A2 (2.4)	HP (2.2)	TIMD4 (2.2)	ST3GAL4 (1.7)
ENSG00000136111	TBC1D4 PPI subnetwork	0.12	> 0.20	PLEC (3.2)	BLOC1S3 (2.8)	C11orf9 (2.8)	SMARCA4 (2.8)	CARM1 (2.6)	LPAR2 (2.5)	MARK4 (2.5)	C12orf51 (2.4)	AP1M2 (2.4)	UBXN2B (2.3)
ENSG00000173473	SMARCC1 PPI subnetwork	0.12	> 0.20	CARM1 (3.9)	ATXN2 (3.2)	SMARCA4 (2.8)	RHCE (2.4)	C12orf51 (2.3)	ILF3 (2.2)	USP1 (2.1)	NYNRIN (2.0)	MAU2 (2.0)	TRAFD1 (2.0)
ENSG00000140682	TGFB1I1 PPI subnetwork	0.12	> 0.20	SH2B3 (4.1)	GATAD2A (3.0)	HAPLN4 (2.7)	CARM1 (2.4)	HNF1A (2.4)	POLK (2.3)	BRAP (2.0)	GMIP (2.0)	PLEC (1.9)	PMFBP1 (1.9)
GO:0043393	regulation of protein binding	0.12	> 0.20	TMEM57 (3.1)	AMIGO1 (2.7)	TXNL4B (2.0)	SLC44A2 (1.9)	GATAD2A (1.9)	GRINA (1.8)	OASL (1.6)	GCNT4 (1.6)	TMEM116 (1.4)	PLCG1 (1.4)
GO:0015936	coenzyme A metabolic process	0.12	> 0.20	PCSK9 (3.9)	LDLR (3.6)	FADS2 (3.2)	FADS1 (3.0)	HMGCR (2.6)	ENSG00000228044 (2.1)	TRAPPC6A (2.1)	GPAM (2.1)	TMEM57 (1.9)	TMEM116 (1.9)
ENSG00000136352	NKX2-1 PPI subnetwork	0.12	> 0.20	DNM2 (2.6)	SH2B3 (2.5)	ZHX3 (2.4)	ATXN2 (2.3)	C11orf9 (2.1)	ABO (1.9)	BCL3 (1.9)	C12orf51 (1.8)	COL4A3BP (1.8)	PTPN11 (1.7)
GO:0072224	metanephric glomerulus development	0.12	> 0.20	PLEKHH2 (2.6)	DYNC2LI1 (2.0)	DNAH11 (2.0)	AMIGO1 (2.0)	NYNRIN (1.8)	ENSG00000254235 (1.8)	ATXN7L2 (1.6)	BCAM (1.6)	C11orf9 (1.6)	ANKRD31 (1.5)
GO:0042246	tissue regeneration	0.12	> 0.20	ENSG00000226648 (2.5)	PBX4 (2.2)	CEACAM19 (2.1)	ABCG5 (2.1)	SYPL2 (2.1)	LPIN3 (2.0)	CBLC (2.0)	HAPLN4 (2.0)	ENSG00000235545 (1.8)	GOT2P1 (1.7)
ENSG00000105371	ICAM4 PPI subnetwork	0.12	> 0.20	RHD (3.9)	APOC1 (2.8)	RHCE (2.7)	BCAM (2.4)	APOE (2.3)	HP (2.2)	DOCK7 (2.0)	RPH3A (2.0)	ALDH2 (1.9)	APOB (1.7)
MP:0001939	secondary sex reversal	0.12	> 0.20	TSSK6 (3.3)	ST3GAL4 (3.1)	C11orf9 (2.6)	NYNRIN (2.2)	PLEKHH2 (1.7)	LPAR2 (1.6)	NPC1L1 (1.5)	ATXN7L2 (1.4)	ALDH2 (1.3)	NKPD1 (1.3)
MP:0004921	decreased placenta weight	0.12	> 0.20	PVRL2 (2.5)	PCSK9 (2.1)	TRIB1 (2.1)	LPA (2.0)	MYLIP (1.9)	PVR (1.9)	NYNRIN (1.7)	DHODH (1.6)	CBLC (1.6)	ATXN7L2 (1.6)
MP:0008102	lymph node hyperplasia	0.12	> 0.20	RELB (6.1)	BCL3 (4.4)	RHD (3.4)	PARP10 (3.1)	RHCE (2.7)	NT5DC1 (1.8)	GMIP (1.7)	LDLR (1.7)	SH2B3 (1.6)	TIMD4 (1.5)
GO:0005681	spliceosomal complex	0.12	> 0.20	DHX38 (4.2)	BUD13 (3.5)	TOP1 (3.4)	SUGP1 (3.2)	C1orf63 (2.9)	ILF3 (2.8)	USP1 (2.4)	MAPKAPK5 (2.4)	SMARCA4 (2.1)	C12orf43 (2.1)
ENSG00000109906	ZBTB16 PPI subnetwork	0.12	> 0.20	DNM2 (3.1)	POLK (2.4)	YIPF2 (2.3)	PBX4 (2.2)	ACAD10 (2.1)	MAU2 (1.9)	PSRC1 (1.9)	PSMA5 (1.9)	PPP1R37 (1.9)	BCL3 (1.9)
ENSG00000100346	CACNA1I PPI subnetwork	0.12	> 0.20	APOB (5.0)	PLG (4.0)	APOE (3.9)	APOA5 (3.6)	PCSK9 (3.6)	APOC1 (3.4)	ANGPTL3 (3.4)	APOC4 (3.4)	HP (2.8)	GPAM (2.1)
ENSG00000088826	SMOX PPI subnetwork	0.12	> 0.20	ATP13A1 (3.6)	HNF1A (2.9)	MAPKAPK5 (2.9)	DDX56 (2.7)	BRAP (2.3)	ADAM1 (2.2)	PTPN11 (2.2)	DHODH (2.0)	ANKRD31 (2.0)	MAU2 (1.8)
ENSG00000186115	CYP4F2 PPI subnetwork	0.12	> 0.20	HMGCR (10.9)	LDLR (10.3)	FADS1 (7.8)	FADS2 (6.6)	PCSK9 (5.9)	ABO (3.0)	TRAPPC6A (2.5)	ADAM1 (2.1)	C12orf47 (1.8)	TMED4 (1.7)
MP:0011107	partial embryonic lethality before turning of embryo	0.12	> 0.20	C17orf57 (3.0)	SYPL2 (2.1)	ATXN2 (1.7)	PMFBP1 (1.5)	ABCG5 (1.5)	GCNT4 (1.5)	POLK (1.5)	ENSG00000228044 (1.5)	LPA (1.5)	HAVCR1 (1.4)
MP:0005281	increased fatty acid level	0.12	> 0.20	GPAM (4.0)	APOC1 (2.4)	ACAD10 (2.3)	MOSC1 (2.2)	MAFB (2.1)	SYPL2 (1.8)	ABCG5 (1.8)	PARP10 (1.8)	ATXN7L2 (1.8)	HP (1.6)
ENSG00000185551	NR2F2 PPI subnetwork	0.12	> 0.20	PLCG1 (2.7)	MYLIP (2.4)	ATXN2 (2.3)	ZNF180 (2.1)	MAU2 (2.0)	POLK (2.0)	PBX4 (1.7)	USP24 (1.7)	CEACAM19 (1.6)	PLEC (1.5)
MP:0008722	abnormal chemokine secretion	0.12	> 0.20	PVR (3.5)	TRIB1 (3.3)	BCL3 (3.2)	ALDH2 (2.5)	HP (2.4)	MAFB (2.2)	SORT1 (2.1)	CEACAM19 (1.8)	GMIP (1.8)	PMFBP1 (1.6)
MP:0001121	uterus hypoplasia	0.12	> 0.20	KIAA1324 (2.3)	PMFBP1 (2.2)	TXNL4B (2.1)	ENSG00000228044 (1.9)	BCAM (1.8)	CYB561D1 (1.7)	DNAH11 (1.7)	HAVCR1 (1.5)	NT5DC1 (1.5)	TMED4 (1.5)
GO:0070528	protein kinase C signaling cascade	0.12	> 0.20	GCNT4 (2.8)	C17orf57 (2.8)	CEACAM19 (2.6)	ENSG00000226645 (2.5)	ATXN7L2 (2.1)	GOT2P1 (1.8)	ENSG00000235545 (1.8)	C11orf9 (1.6)	NKPD1 (1.3)	ST3GAL4 (1.3)
ENSG00000047315	POLR2B PPI subnetwork	0.12	> 0.20	ILF3 (3.5)	TOP1 (3.2)	DHX38 (3.0)	SUGP1 (2.9)	USP1 (2.7)	SMARCA4 (2.6)	DDX56 (2.6)	BUD13 (2.6)	FEN1 (2.3)	PSMA5 (2.1)
GO:0016891	endoribonuclease activity, producing 5'-phosphomonoesters	0.12	> 0.20	ZNF180 (3.7)	C12orf43 (3.1)	BUD13 (2.3)	DHODH (2.3)	FEN1 (2.0)	QTRT1 (1.8)	C19orf52 (1.8)	LPA (1.7)	CARM1 (1.7)	GEMIN7 (1.7)
REACTOME_SPHINGOLIPID_METABOLISM	REACTOME_SPHINGOLIPID_METABOLISM	0.12	> 0.20	NKPD1 (4.9)	ERP29 (3.7)	HNF1A (3.5)	TMEM50A (3.3)	COL4A3BP (3.3)	TMED4 (2.7)	HAVCR1 (2.7)	ATP13A1 (2.3)	ZHX3 (2.2)	TM6SF2 (2.1)
ENSG00000063438	AHRR PPI subnetwork	0.12	> 0.20	PLEC (2.8)	NT5DC1 (2.2)	TMEM50A (1.9)	TMEM57 (1.9)	POLK (1.8)	OGDH (1.7)	C17orf57 (1.6)	TOP1 (1.6)	SARS (1.4)	DNM2 (1.4)
GO:0005901	caveola	0.12	> 0.20	PLEC (2.6)	CELSR2 (2.4)	USP24 (2.2)	GMPR (2.1)	GRINA (2.1)	TRIB1 (2.0)	PVR (1.8)	BCAM (1.7)	ALDH2 (1.6)	COL4A3BP (1.6)
MP:0003044	impaired basement membrane formation	0.12	> 0.20	PVRL2 (3.2)	BCAM (2.8)	PVR (2.5)	ERP29 (2.4)	TMED4 (2.1)	ATP13A1 (2.1)	CELSR2 (2.1)	APOE (1.8)	CBLC (1.7)	HAVCR1 (1.6)
REACTOME_METAL_ION_SLC_TRANSPORTERS	REACTOME_METAL_ION_SLC_TRANSPORTERS	0.12	> 0.20	YIPF2 (2.8)	ERP29 (2.2)	NPC1L1 (2.1)	RHD (1.8)	ATP13A1 (1.8)	TMED4 (1.8)	AP1M2 (1.7)	SORT1 (1.6)	RHCE (1.5)	TM6SF2 (1.5)
GO:0006605	protein targeting	0.12	> 0.20	PTPN11 (2.1)	ZNF101 (2.1)	ENSG00000238078 (1.9)	GATAD2A (1.7)	GRINA (1.7)	AMIGO1 (1.7)	USP24 (1.6)	ENSG00000235545 (1.6)	ENSG00000254235 (1.6)	NAA25 (1.5)
MP:0011089	complete perinatal lethality	0.12	> 0.20	NYNRIN (2.5)	BCAM (2.5)	CELSR2 (2.4)	PVRL2 (2.1)	MYLIP (1.9)	ENSG00000254235 (1.8)	ATXN2 (1.6)	PLEC (1.6)	DOCK7 (1.6)	CILP2 (1.5)
REACTOME_NF:KB_ACTIVATION_THROUGH_FADDRIP:1_PATHWAY_MEDIATED_BY_CASPASE:8_AND_:10	REACTOME_NF:KB_ACTIVATION_THROUGH_FADDRIP:1_PATHWAY_MEDIATED_BY_CASPASE:8_AND_:10	0.12	> 0.20	OASL (9.3)	PARP10 (6.8)	TRAFD1 (2.9)	CYB561D1 (2.3)	ZNF180 (2.3)	BLOC1S3 (2.3)	FRK (1.8)	ZNF101 (1.4)	ENSG00000235545 (1.4)	C19orf52 (1.4)
MP:0004067	abnormal trabecula carnea morphology	0.12	> 0.20	ABO (2.8)	TMEM116 (2.0)	BLOC1S3 (1.8)	PVR (1.8)	UBXN2B (1.8)	KANK2 (1.6)	HAVCR1 (1.6)	C1orf63 (1.5)	MARK4 (1.5)	ALDH2 (1.4)
GO:0050764	regulation of phagocytosis	0.12	> 0.20	HP (2.8)	CILP2 (2.5)	ANKRD31 (1.7)	MAFB (1.7)	GPAM (1.6)	ERP29 (1.6)	LPA (1.6)	ALDH2 (1.6)	UBXN2B (1.6)	GOT2P1 (1.6)
MP:0008997	increased blood osmolality	0.12	> 0.20	SLC22A1 (2.1)	PLG (2.0)	BCAM (1.9)	ANGPTL3 (1.8)	CELSR2 (1.8)	MOSC1 (1.7)	ABCG5 (1.5)	AMIGO1 (1.5)	AP1M2 (1.5)	NYNRIN (1.3)
GO:0010676	positive regulation of cellular carbohydrate metabolic process	0.12	> 0.20	CYP7A1 (1.9)	GOT2P1 (1.9)	ZHX3 (1.9)	TMEM116 (1.8)	FRK (1.8)	HNF1A (1.8)	GMPR (1.4)	PCSK9 (1.4)	GPAM (1.2)	ENSG00000254235 (1.2)
GO:0045913	positive regulation of carbohydrate metabolic process	0.12	> 0.20	CYP7A1 (1.9)	GOT2P1 (1.9)	ZHX3 (1.9)	TMEM116 (1.8)	FRK (1.8)	HNF1A (1.8)	GMPR (1.4)	PCSK9 (1.4)	GPAM (1.2)	ENSG00000254235 (1.2)
GO:0007565	female pregnancy	0.12	> 0.20	CEACAM19 (3.7)	ENSG00000226645 (2.5)	ATXN7L2 (1.8)	KIAA1324 (1.8)	ENSG00000228044 (1.6)	GCNT4 (1.5)	FRK (1.5)	ENSG00000238078 (1.4)	LPIN3 (1.4)	AP1M2 (1.4)
GO:0070064	proline-rich region binding	0.12	> 0.20	ZHX3 (2.9)	CETP (2.4)	GEMIN7 (2.3)	LPIN3 (2.0)	TRAPPC6A (2.0)	ABO (2.0)	CARM1 (1.9)	PVR (1.8)	ANGPTL3 (1.6)	KANK2 (1.6)
MP:0004616	lumbar vertebral transformation	0.12	> 0.20	ATXN2 (2.0)	PLCG1 (1.9)	HAVCR1 (1.8)	NYNRIN (1.8)	DYNC2LI1 (1.7)	ZHX3 (1.6)	UBXN2B (1.6)	ZNF180 (1.4)	ENSG00000238078 (1.3)	HNF1A (1.2)
ENSG00000135046	ANXA1 PPI subnetwork	0.12	> 0.20	PVR (3.0)	BCL3 (2.5)	DNM2 (2.3)	ALDH2 (2.1)	TMEM50A (2.0)	PARP10 (1.8)	MARK4 (1.8)	SORT1 (1.8)	HAVCR1 (1.7)	NKPD1 (1.7)
MP:0000255	vasculature congestion	0.12	> 0.20	RHD (3.3)	ATXN2 (3.1)	GATAD2A (2.7)	RHCE (2.5)	TRIB1 (2.4)	GEMIN7 (2.0)	GCNT4 (2.0)	ADAM1 (2.0)	MARK4 (1.9)	DNAH11 (1.8)
GO:0016849	phosphorus-oxygen lyase activity	0.12	> 0.20	NYNRIN (3.4)	CETP (2.6)	ITGB3 (2.4)	HLX (2.3)	ABCG8 (1.8)	CYP7A1 (1.8)	BCAM (1.7)	HAVCR1 (1.5)	MYLIP (1.5)	ENSG00000254235 (1.5)
GO:0010470	regulation of gastrulation	0.12	> 0.20	DYNC2LI1 (2.5)	HNF1A (2.2)	LPAR2 (2.2)	FRK (1.6)	KANK2 (1.6)	PMFBP1 (1.5)	AP1M2 (1.4)	TMEM116 (1.3)	TSSK6 (1.3)	ANKRD31 (1.3)
ENSG00000163781	TOPBP1 PPI subnetwork	0.12	> 0.20	PLCG1 (3.1)	FEN1 (2.8)	APOA5 (2.5)	USP1 (2.2)	ENSG00000238078 (2.0)	SMARCA4 (1.9)	DOCK7 (1.8)	APOC4 (1.7)	PTPN11 (1.6)	ENSG00000254235 (1.6)
GO:0031056	regulation of histone modification	0.12	> 0.20	TMEM57 (3.7)	SH2B3 (2.1)	C12orf51 (1.9)	PCSK9 (1.8)	MYLIP (1.8)	FADS1 (1.7)	ABO (1.6)	ZNF180 (1.4)	GOT2P1 (1.4)	ATXN2 (1.3)
GO:0010574	regulation of vascular endothelial growth factor production	0.12	> 0.20	PMFBP1 (2.7)	ST3GAL4 (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.6)	ENSG00000254235 (1.5)	BCL3 (1.4)	ATXN7L2 (1.3)	OASL (1.3)	PVR (1.3)	TXNL4B (1.3)
GO:0010573	vascular endothelial growth factor production	0.12	> 0.20	PMFBP1 (2.7)	ST3GAL4 (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.6)	ENSG00000254235 (1.5)	BCL3 (1.4)	ATXN7L2 (1.3)	OASL (1.3)	PVR (1.3)	TXNL4B (1.3)
MP:0005093	decreased B cell proliferation	0.12	> 0.20	GMIP (5.0)	RELB (4.3)	BCL3 (3.3)	SH2B3 (3.2)	MYLIP (2.5)	MAFB (2.1)	TIMD4 (1.9)	CETP (1.7)	GEMIN7 (1.7)	SLC44A2 (1.7)
ENSG00000123091	RNF11 PPI subnetwork	0.12	> 0.20	MAU2 (3.0)	FRK (2.6)	MAPKAPK5 (2.5)	CARM1 (2.3)	ATXN2 (2.2)	OGDH (2.2)	BRAP (2.1)	ENSG00000226645 (2.1)	USP24 (2.1)	RELB (2.1)
GO:0048536	spleen development	0.12	> 0.20	ENSG00000228044 (2.7)	ABO (2.2)	RHCE (2.1)	ENSG00000226648 (1.9)	RHD (1.8)	GCNT4 (1.7)	DYNC2LI1 (1.6)	PLEKHH2 (1.5)	LPAR2 (1.5)	MAFB (1.4)
ENSG00000178409	BEND3 PPI subnetwork	0.12	> 0.20	C19orf52 (2.3)	YIPF2 (2.1)	BRAP (2.0)	ATP13A1 (2.0)	GRINA (1.9)	SUGP1 (1.9)	DHX38 (1.9)	PARP10 (1.8)	TRAFD1 (1.8)	QTRT1 (1.7)
ENSG00000132467	UTP3 PPI subnetwork	0.12	> 0.20	DDX56 (4.0)	ZNF259 (4.0)	DHODH (3.2)	NAA25 (3.2)	QTRT1 (2.7)	DHX38 (2.2)	C12orf43 (1.9)	TOP1 (1.7)	ATXN7L2 (1.6)	SARS (1.6)
GO:0001954	positive regulation of cell-matrix adhesion	0.12	> 0.20	SLC44A2 (3.7)	GCNT4 (3.1)	CETP (2.9)	PLEKHH2 (2.4)	PBX4 (2.4)	YIPF2 (2.1)	AP1M2 (2.0)	ITGB3 (1.9)	CYP7A1 (1.7)	PVRL2 (1.6)
ENSG00000112658	SRF PPI subnetwork	0.12	> 0.20	SH2B3 (3.7)	PLEC (2.7)	ENSG00000226648 (2.4)	TOP1 (2.3)	TRIB1 (2.1)	LPIN3 (2.1)	KANK2 (2.0)	HLX (1.9)	CEACAM19 (1.9)	NPC1L1 (1.7)
MP:0011096	complete embryonic lethality before somite formation	0.12	> 0.20	FEN1 (3.6)	USP1 (3.3)	PSRC1 (2.9)	PSMA5 (2.1)	ILF3 (2.0)	BUD13 (1.8)	DHX38 (1.7)	SMARCA4 (1.7)	DDX56 (1.6)	CARM1 (1.6)
GO:0005385	zinc ion transmembrane transporter activity	0.12	> 0.20	NPC1L1 (3.5)	AP1M2 (2.5)	YIPF2 (2.3)	ATP13A1 (1.9)	TM6SF2 (1.8)	CYB561D1 (1.5)	RHCE (1.5)	ATXN7L2 (1.5)	APOB (1.4)	ERP29 (1.2)
GO:0030897	HOPS complex	0.12	> 0.20	BRAP (3.6)	ACAD10 (3.1)	TRAFD1 (3.1)	YIPF2 (3.0)	SUGP1 (3.0)	LPIN3 (2.9)	BLOC1S3 (2.6)	LPAR2 (2.3)	C12orf43 (2.2)	AP1M2 (2.2)
MP:0008288	abnormal adrenal cortex morphology	0.12	> 0.20	APOC1 (5.1)	ST3GAL4 (3.6)	PARP10 (2.8)	FADS1 (2.6)	DNAH11 (2.3)	UBXN2B (2.2)	FADS2 (2.0)	YIPF2 (1.8)	OASL (1.8)	GPAM (1.8)
ENSG00000107537	PHYH PPI subnetwork	0.12	> 0.20	NT5DC1 (3.4)	RHD (2.9)	HAPLN4 (2.6)	RHCE (2.5)	ZNF180 (2.2)	OGDH (2.1)	CELSR2 (2.0)	SLC44A2 (1.9)	CETP (1.8)	UBXN2B (1.7)
GO:0032459	regulation of protein oligomerization	0.12	> 0.20	C12orf47 (3.4)	ZNF101 (2.1)	BRAP (2.1)	TMEM116 (2.1)	TXNL4B (1.8)	LPIN3 (1.7)	FRK (1.7)	POLK (1.6)	ANKRD31 (1.5)	C12orf43 (1.5)
MP:0002424	abnormal reticulocyte morphology	0.12	> 0.20	RHD (7.6)	RHCE (6.9)	C12orf51 (2.7)	PTPN11 (2.1)	ENSG00000226645 (2.1)	DHODH (1.8)	TIMD4 (1.6)	CYB561D1 (1.6)	C12orf47 (1.6)	TOP1 (1.4)
ENSG00000081014	AP4E1 PPI subnetwork	0.12	> 0.20	APOC1 (3.5)	ITGB3 (3.0)	APOB (2.8)	C1orf63 (2.4)	GMPR (2.4)	LPIN3 (2.3)	TMEM50A (2.2)	ZNF101 (1.8)	HAVCR1 (1.7)	TOP1 (1.5)
ENSG00000171223	JUNB PPI subnetwork	0.12	> 0.20	TRIB1 (6.3)	BCL3 (4.8)	TRAFD1 (2.2)	ACAD10 (2.1)	MAFB (2.1)	ENSG00000228044 (1.9)	PVR (1.9)	RELB (1.8)	HLX (1.7)	POLK (1.5)
ENSG00000186895	FGF3 PPI subnetwork	0.13	> 0.20	HAVCR1 (4.9)	HAPLN4 (3.9)	PLEKHH2 (3.2)	ZHX3 (2.9)	C11orf9 (2.8)	C17orf57 (2.6)	CBLC (2.5)	NYNRIN (2.2)	CEACAM19 (2.1)	NCAN (1.9)
MP:0008033	impaired lipolysis	0.13	> 0.20	MOSC1 (3.9)	GPAM (3.7)	SORT1 (2.8)	HP (2.5)	APOC1 (1.8)	BCAM (1.8)	GRINA (1.8)	NAA25 (1.8)	COL4A3BP (1.7)	CELSR2 (1.7)
ENSG00000061936	SFSWAP PPI subnetwork	0.13	> 0.20	DHODH (2.9)	MAPKAPK5 (2.5)	ATP13A1 (2.5)	LPA (2.4)	CEACAM19 (2.4)	HNF1A (2.2)	TOMM40 (2.2)	ANKRD31 (2.1)	CETP (1.9)	DDX56 (1.5)
ENSG00000125503	PPP1R12C PPI subnetwork	0.13	> 0.20	USP24 (3.8)	PLEC (3.6)	DNM2 (3.0)	GMIP (2.9)	COL4A3BP (2.4)	POLK (2.3)	SORT1 (2.1)	ALDH2 (2.0)	CYB561D1 (1.8)	PVR (1.8)
GO:0045226	extracellular polysaccharide biosynthetic process	0.13	> 0.20	NT5DC1 (2.7)	BLOC1S3 (2.5)	ENSG00000254235 (2.2)	HMGCR (2.2)	TMEM50A (2.0)	CYB561D1 (2.0)	PCSK9 (2.0)	TRAPPC6A (1.9)	FADS2 (1.8)	YIPF2 (1.8)
GO:0046379	extracellular polysaccharide metabolic process	0.13	> 0.20	NT5DC1 (2.7)	BLOC1S3 (2.5)	ENSG00000254235 (2.2)	HMGCR (2.2)	TMEM50A (2.0)	CYB561D1 (2.0)	PCSK9 (2.0)	TRAPPC6A (1.9)	FADS2 (1.8)	YIPF2 (1.8)
MP:0004057	thin myocardium compact layer	0.13	> 0.20	HLX (2.7)	HNF1A (2.5)	SH2B3 (1.9)	C12orf51 (1.8)	NCAN (1.7)	MAPKAPK5 (1.6)	ALDH2 (1.5)	MYLIP (1.5)	C1orf63 (1.5)	BLOC1S3 (1.4)
GO:0071564	npBAF complex	0.13	> 0.20	CARM1 (5.2)	NYNRIN (3.0)	GRINA (2.8)	SMARCA4 (2.6)	TMEM57 (2.4)	ATXN2 (2.3)	MAU2 (2.2)	SUGP1 (2.2)	MARK4 (2.1)	C12orf51 (2.0)
GO:0001959	regulation of cytokine-mediated signaling pathway	0.13	> 0.20	ZNF101 (3.2)	PARP10 (2.7)	CEACAM19 (2.6)	GRINA (2.6)	OASL (2.6)	ENSG00000238078 (2.4)	C17orf57 (2.2)	TRAFD1 (2.0)	NKPD1 (2.0)	MAU2 (1.9)
ENSG00000071537	SEL1L PPI subnetwork	0.13	> 0.20	ERP29 (3.2)	LDLR (3.2)	CLPTM1 (2.9)	DNM2 (2.6)	YIPF2 (2.6)	TMED4 (2.5)	CYB561D1 (2.4)	ATP13A1 (2.1)	TMEM57 (1.9)	CYP7A1 (1.9)
ENSG00000056345	ENSG00000056345 PPI subnetwork	0.13	> 0.20	ITGB3 (5.4)	APOB (3.1)	APOE (2.7)	KANK2 (2.5)	HP (2.4)	PLEC (2.2)	PLG (2.1)	C17orf57 (1.9)	APOC4 (1.8)	PCSK9 (1.7)
GO:0044454	nuclear chromosome part	0.13	> 0.20	USP1 (4.1)	FEN1 (4.0)	PSRC1 (2.4)	POC5 (2.1)	BUD13 (1.9)	NYNRIN (1.8)	ILF3 (1.8)	ATXN2 (1.6)	TOP1 (1.5)	ATXN7L2 (1.5)
GO:0071013	catalytic step 2 spliceosome	0.13	> 0.20	SUGP1 (4.5)	DHX38 (4.5)	TOP1 (3.5)	ILF3 (3.4)	BUD13 (3.0)	SMARCA4 (2.9)	C1orf63 (2.4)	DDX56 (2.2)	USP1 (2.1)	QTRT1 (1.9)
ENSG00000129214	SHBG PPI subnetwork	0.13	> 0.20	GMPR (3.4)	GRINA (2.5)	ADAM1 (2.4)	BCL3 (2.2)	PLEC (2.2)	CLPTM1 (2.0)	PVRL2 (1.9)	BCAM (1.8)	OGDH (1.8)	CBLC (1.8)
GO:0031269	pseudopodium assembly	0.13	> 0.20	ENSG00000235545 (4.0)	PVRL2 (2.9)	CBLC (2.8)	CETP (2.7)	BLOC1S3 (2.3)	C11orf9 (2.1)	BRAP (2.0)	SLC44A2 (1.8)	SYPL2 (1.8)	ZNF101 (1.6)
ENSG00000099797	TECR PPI subnetwork	0.13	> 0.20	HMGCR (5.9)	LDLR (5.2)	FADS1 (4.8)	FADS2 (4.3)	TMEM50A (3.7)	PCSK9 (3.3)	CLPTM1 (3.1)	ERP29 (3.1)	ATP13A1 (2.6)	BRAP (2.5)
ENSG00000134313	KIDINS220 PPI subnetwork	0.13	> 0.20	SARS (2.8)	ZNF180 (2.0)	SH2B3 (1.9)	ABCG8 (1.9)	AMIGO1 (1.9)	ABCG5 (1.9)	PLG (1.8)	TMEM50A (1.8)	APOC4 (1.7)	SLC44A2 (1.7)
GO:0009069	serine family amino acid metabolic process	0.13	> 0.20	TXNL4B (2.9)	SLC22A1 (2.9)	CYP7A1 (2.8)	GOT2P1 (2.8)	SARS (2.7)	PMFBP1 (2.6)	ANGPTL3 (2.4)	TMEM116 (2.4)	LPA (2.3)	ENSG00000254235 (2.3)
ENSG00000204590	GNL1 PPI subnetwork	0.13	> 0.20	ZNF259 (5.0)	NAA25 (4.4)	DDX56 (4.1)	QTRT1 (3.3)	TOMM40 (3.2)	ATP13A1 (2.9)	SUGP1 (2.9)	DHX38 (2.8)	SARS (2.7)	ENSG00000226645 (2.2)
ENSG00000206412	GNL1 PPI subnetwork	0.13	> 0.20	ZNF259 (5.0)	NAA25 (4.4)	DDX56 (4.1)	QTRT1 (3.3)	TOMM40 (3.2)	ATP13A1 (2.9)	SUGP1 (2.9)	DHX38 (2.8)	SARS (2.7)	ENSG00000226645 (2.2)
ENSG00000206492	GNL1 PPI subnetwork	0.13	> 0.20	ZNF259 (5.0)	NAA25 (4.4)	DDX56 (4.1)	QTRT1 (3.3)	TOMM40 (3.2)	ATP13A1 (2.9)	SUGP1 (2.9)	DHX38 (2.8)	SARS (2.7)	ENSG00000226645 (2.2)
ENSG00000167815	PRDX2 PPI subnetwork	0.13	> 0.20	RHD (2.7)	RHCE (2.3)	COL4A3BP (2.2)	GPAM (2.1)	PSMA5 (2.0)	NT5DC1 (1.9)	CYP7A1 (1.8)	DYNC2LI1 (1.6)	DOCK7 (1.5)	CEACAM19 (1.5)
ENSG00000121057	AKAP1 PPI subnetwork	0.13	> 0.20	KANK2 (2.9)	ADAM1 (2.5)	DYNC2LI1 (2.2)	PTPN11 (2.1)	ITGB3 (1.8)	TRIB1 (1.8)	SH2B3 (1.4)	QTRT1 (1.3)	AMIGO1 (1.3)	GMPR (1.3)
ENSG00000100994	PYGB PPI subnetwork	0.13	> 0.20	SYPL2 (3.3)	SORT1 (2.7)	GMPR (2.4)	ITGB3 (2.2)	DHODH (1.9)	KIAA1324 (1.9)	PMFBP1 (1.8)	ST3GAL4 (1.8)	SLC44A2 (1.8)	AMIGO1 (1.7)
ENSG00000120659	TNFSF11 PPI subnetwork	0.13	> 0.20	RELB (4.4)	TOMM40 (2.0)	SH2B3 (2.0)	TMEM50A (1.7)	PVR (1.6)	BCL3 (1.6)	NPC1L1 (1.6)	BLOC1S3 (1.5)	ENSG00000226645 (1.5)	ENSG00000228044 (1.4)
GO:0003755	peptidyl-prolyl cis-trans isomerase activity	0.13	> 0.20	YIPF2 (3.9)	ERP29 (3.2)	TOMM40 (2.8)	QTRT1 (2.6)	TMED4 (2.3)	TXNL4B (2.2)	OGDH (1.9)	CLPTM1 (1.9)	DYNC2LI1 (1.7)	DHODH (1.6)
MP:0001209	spontaneous skin ulceration	0.13	> 0.20	FADS1 (4.8)	LDLR (3.8)	CBLC (2.9)	GMIP (2.4)	APOC1 (2.2)	HMGCR (1.9)	CYB561D1 (1.8)	AP1M2 (1.8)	APOE (1.7)	BCL3 (1.7)
GO:0070741	response to interleukin-6	0.13	> 0.20	FRK (2.6)	ZNF101 (2.2)	HNF1A (1.9)	TXNL4B (1.9)	CYP7A1 (1.5)	PVR (1.5)	CEACAM19 (1.3)	KIAA1324 (1.3)	ENSG00000235545 (1.3)	ERP29 (1.2)
GO:0031143	pseudopodium	0.13	> 0.20	SYPL2 (5.9)	AP1M2 (3.4)	PVRL2 (3.1)	CBLC (2.9)	GMPR (1.8)	BLOC1S3 (1.8)	SORT1 (1.6)	HNF1A (1.6)	CLPTM1 (1.4)	NPC1L1 (1.4)
ENSG00000131473	ACLY PPI subnetwork	0.13	> 0.20	FADS2 (2.5)	FADS1 (2.3)	C19orf52 (2.1)	LDLR (2.1)	GOT2P1 (2.1)	ILF3 (1.8)	TMEM50A (1.7)	HMGCR (1.7)	GATAD2A (1.7)	TMEM57 (1.6)
MP:0005505	increased platelet cell number	0.13	> 0.20	ITGB3 (2.4)	LPIN3 (2.2)	RHD (2.2)	POLK (2.1)	PCSK9 (1.9)	NT5DC1 (1.8)	CYB561D1 (1.8)	GPAM (1.7)	RELB (1.7)	OASL (1.7)
ENSG00000159388	BTG2 PPI subnetwork	0.13	> 0.20	CETP (3.8)	GCNT4 (3.4)	TMED4 (2.3)	HNF1A (2.2)	DHODH (1.9)	TIMD4 (1.8)	TRAPPC6A (1.7)	PCSK9 (1.7)	PLCG1 (1.5)	ABO (1.4)
ENSG00000087077	TRIP6 PPI subnetwork	0.13	> 0.20	ITGB3 (4.0)	LPIN3 (3.2)	RHCE (2.8)	SLC44A2 (2.3)	LPAR2 (2.2)	PLEC (2.2)	SYPL2 (2.1)	GMIP (2.0)	PLCG1 (2.0)	PLEKHH2 (1.9)
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	0.13	> 0.20	TRAFD1 (2.7)	ST3GAL4 (2.4)	POLK (2.1)	PARP10 (2.0)	GATAD2A (2.0)	TRAPPC6A (1.9)	LPIN3 (1.7)	SH2B3 (1.7)	FEN1 (1.6)	RELB (1.6)
MP:0006262	testis tumor	0.13	> 0.20	ST3GAL4 (3.5)	ABO (2.1)	KANK2 (2.0)	ENSG00000226645 (1.9)	ALDH2 (1.8)	NYNRIN (1.8)	ATXN7L2 (1.6)	FADS2 (1.6)	MARK4 (1.4)	FADS1 (1.4)
ENSG00000171475	WIPF2 PPI subnetwork	0.13	> 0.20	CARM1 (3.7)	PPP1R37 (3.6)	GMIP (3.0)	CLPTM1 (2.8)	GATAD2A (2.7)	MARK4 (2.7)	GRINA (2.4)	DNM2 (2.3)	SMARCA4 (2.0)	ATXN2 (1.9)
GO:0060135	maternal process involved in female pregnancy	0.13	> 0.20	CEACAM19 (3.9)	GCNT4 (3.2)	UBXN2B (3.1)	CYP7A1 (2.9)	DNAH11 (2.5)	ENSG00000226645 (2.0)	ABO (1.9)	KIAA1324 (1.7)	TSSK6 (1.7)	TXNL4B (1.6)
GO:0060711	labyrinthine layer development	0.13	> 0.20	CBLC (3.7)	ENSG00000228044 (2.6)	ENSG00000235545 (2.2)	ENSG00000226645 (2.1)	C12orf51 (2.1)	ZNF101 (2.0)	MYLIP (2.0)	AP1M2 (1.9)	PVRL2 (1.6)	ENSG00000254235 (1.6)
MP:0002279	abnormal diaphragm morphology	0.13	> 0.20	C11orf9 (4.0)	SYPL2 (3.7)	GMPR (2.6)	PLEC (2.1)	PLEKHH2 (1.8)	KANK2 (1.8)	DOCK7 (1.6)	COL4A3BP (1.6)	MOSC1 (1.5)	PVRL2 (1.4)
MP:0000417	short hair	0.13	> 0.20	AP1M2 (3.6)	LDLR (3.1)	HMGCR (3.1)	ENSG00000235545 (2.9)	PCSK9 (2.7)	CELSR2 (2.6)	GCNT4 (2.5)	ABO (2.4)	ENSG00000238078 (2.4)	CBLC (2.3)
GO:0008175	tRNA methyltransferase activity	0.13	> 0.20	QTRT1 (4.9)	NAA25 (3.5)	TOMM40 (2.8)	ATP13A1 (2.7)	C12orf43 (2.7)	DHODH (2.6)	DDX56 (2.5)	MAPKAPK5 (2.3)	YIPF2 (2.3)	ZNF259 (2.1)
ENSG00000131368	MRPS25 PPI subnetwork	0.13	> 0.20	ACAD10 (3.6)	NT5DC1 (3.3)	TMED4 (3.1)	HNF1A (3.1)	TRAPPC6A (1.8)	OGDH (1.7)	C1orf63 (1.7)	PCSK9 (1.5)	GCNT4 (1.5)	CETP (1.5)
ENSG00000025770	NCAPH2 PPI subnetwork	0.13	> 0.20	USP1 (3.2)	FEN1 (3.0)	OGDH (2.5)	SYPL2 (2.5)	ENSG00000226645 (2.4)	ILF3 (2.3)	C12orf47 (2.2)	PSRC1 (1.9)	ABCG8 (1.7)	ZNF180 (1.5)
MP:0000248	macrocytosis	0.13	> 0.20	RHD (6.4)	RHCE (4.1)	FADS1 (2.7)	ZNF180 (2.4)	FADS2 (2.3)	FEN1 (2.0)	GMPR (2.0)	C12orf51 (1.9)	TMEM57 (1.8)	TRAPPC6A (1.8)
ENSG00000083845	RPS5 PPI subnetwork	0.13	> 0.20	QTRT1 (3.6)	DDX56 (3.6)	NAA25 (3.3)	C12orf43 (2.7)	ZNF259 (2.6)	TOMM40 (2.6)	SARS (2.5)	NKPD1 (2.2)	DHX38 (2.1)	ILF3 (2.0)
ENSG00000144381	HSPD1 PPI subnetwork	0.13	> 0.20	TOMM40 (2.4)	PSMA5 (2.3)	OGDH (2.1)	DDX56 (1.9)	SMARCA4 (1.7)	TOP1 (1.7)	NAA25 (1.6)	GMPR (1.5)	DOCK7 (1.4)	HMGCR (1.4)
ENSG00000167670	CHAF1A PPI subnetwork	0.13	> 0.20	FEN1 (3.6)	USP1 (3.3)	SMARCA4 (2.7)	TMEM57 (2.4)	ATP13A1 (2.3)	PTPN11 (2.2)	BRAP (2.1)	ZNF180 (2.1)	MAU2 (2.1)	GATAD2A (1.8)
GO:0000266	mitochondrial fission	0.13	> 0.20	TXNL4B (3.6)	POLK (3.2)	GOT2P1 (2.2)	TMEM57 (2.2)	TRAPPC6A (1.9)	PPP1R37 (1.7)	BRAP (1.7)	GEMIN7 (1.6)	ENSG00000226645 (1.6)	BLOC1S3 (1.4)
ENSG00000082512	TRAF5 PPI subnetwork	0.13	> 0.20	RELB (5.0)	BCL3 (3.5)	ZNF180 (2.6)	PBX4 (2.6)	LPAR2 (2.1)	NT5DC1 (1.9)	PVR (1.9)	AMIGO1 (1.8)	CYB561D1 (1.8)	PARP10 (1.8)
ENSG00000117020	AKT3 PPI subnetwork	0.13	> 0.20	RELB (2.6)	DNM2 (2.5)	MAU2 (2.5)	COL4A3BP (2.2)	KANK2 (1.9)	MOSC1 (1.9)	ZHX3 (1.9)	PARP10 (1.9)	USP24 (1.8)	PTPN11 (1.6)
ENSG00000183684	ALYREF PPI subnetwork	0.13	> 0.20	ILF3 (4.4)	TOP1 (3.9)	QTRT1 (3.3)	SMARCA4 (3.2)	USP1 (3.1)	TOMM40 (2.8)	C1orf63 (2.7)	DHX38 (2.7)	BUD13 (2.7)	SUGP1 (2.7)
ENSG00000137936	BCAR3 PPI subnetwork	0.13	> 0.20	GATAD2A (3.5)	TOMM40 (3.3)	SARS (3.1)	DDX56 (2.9)	SMARCA4 (2.7)	QTRT1 (2.6)	ILF3 (2.5)	C12orf43 (2.3)	FADS2 (2.2)	NAA25 (2.0)
MP:0002192	hydrops fetalis	0.13	> 0.20	HLX (4.4)	NYNRIN (3.1)	PPP1R37 (2.6)	PVRL2 (2.1)	C11orf9 (1.9)	KANK2 (1.7)	ATXN7L2 (1.4)	PLEKHH2 (1.3)	MYLIP (1.2)	TOMM40 (1.2)
ENSG00000116213	WRAP73 PPI subnetwork	0.13	> 0.20	SARS (3.7)	TOMM40 (2.9)	ILF3 (2.5)	FEN1 (2.1)	ZNF259 (1.9)	PSMA5 (1.9)	OGDH (1.9)	DHX38 (1.7)	CLPTM1 (1.7)	HAPLN4 (1.7)
GO:0002224	toll-like receptor signaling pathway	0.13	> 0.20	SH2B3 (3.0)	RELB (2.4)	OASL (2.1)	GMIP (2.1)	TRIB1 (2.1)	BLOC1S3 (2.0)	CYB561D1 (2.0)	PARP10 (1.9)	BCL3 (1.9)	ENSG00000228044 (1.9)
ENSG00000105618	PRPF31 PPI subnetwork	0.13	> 0.20	DHX38 (4.4)	SUGP1 (3.5)	QTRT1 (3.2)	SMARCA4 (2.9)	BUD13 (2.9)	DDX56 (2.8)	ZNF259 (2.3)	MAU2 (2.3)	ILF3 (2.2)	TOP1 (2.1)
GO:0032800	receptor biosynthetic process	0.13	> 0.20	PMFBP1 (2.7)	FRK (2.6)	TIMD4 (2.5)	CEACAM19 (2.3)	ENSG00000238078 (1.9)	NKPD1 (1.8)	CETP (1.8)	ANKRD31 (1.8)	ZNF101 (1.6)	TM6SF2 (1.5)
ENSG00000123159	GIPC1 PPI subnetwork	0.13	> 0.20	CELSR2 (3.8)	PVRL2 (3.3)	SARS (3.0)	NYNRIN (2.8)	MARK4 (2.7)	PLEC (2.6)	BCAM (2.5)	ENSG00000235545 (2.3)	SLC44A2 (2.3)	DNAH11 (2.1)
ENSG00000156299	TIAM1 PPI subnetwork	0.13	> 0.20	PVRL2 (2.7)	LPAR2 (2.6)	MARK4 (2.6)	C11orf9 (2.3)	PLEC (2.3)	NPC1L1 (2.3)	APOC1 (2.2)	TOP1 (2.0)	SH2B3 (2.0)	NYNRIN (2.0)
ENSG00000135097	MSI1 PPI subnetwork	0.13	> 0.20	USP24 (4.0)	BRAP (3.5)	PSMA5 (3.1)	NAA25 (2.8)	ATP13A1 (2.8)	ATXN2 (2.4)	DDX56 (2.4)	CLPTM1 (2.3)	DNM2 (2.3)	QTRT1 (2.2)
ENSG00000173848	NET1 PPI subnetwork	0.13	> 0.20	QTRT1 (3.9)	TOMM40 (2.6)	DDX56 (2.4)	CARM1 (2.4)	DHODH (2.4)	TRIB1 (2.2)	TOP1 (2.1)	OGDH (2.0)	NAA25 (1.9)	GATAD2A (1.9)
ENSG00000101439	CST3 PPI subnetwork	0.13	> 0.20	ERP29 (3.4)	APOE (3.1)	APOC1 (3.0)	RPH3A (2.7)	CELSR2 (2.7)	NCAN (2.3)	TIMD4 (2.2)	BCAM (2.1)	APOC4 (1.9)	HP (1.8)
ENSG00000137154	RPS6 PPI subnetwork	0.13	> 0.20	NAA25 (3.6)	DDX56 (3.3)	C12orf43 (2.9)	QTRT1 (2.8)	ILF3 (2.7)	ZNF259 (2.7)	DHX38 (2.5)	ATP13A1 (2.4)	TOP1 (2.3)	SARS (2.3)
ENSG00000172399	MYOZ2 PPI subnetwork	0.13	> 0.20	SYPL2 (4.1)	GMPR (3.1)	OGDH (2.6)	C1orf63 (2.0)	TMEM50A (1.9)	ACAD10 (1.8)	PLEC (1.6)	BCAM (1.5)	PVRL2 (1.4)	FADS1 (1.4)
ENSG00000198626	RYR2 PPI subnetwork	0.13	> 0.20	ENSG00000238078 (2.3)	SYPL2 (2.2)	ZNF180 (2.0)	CYB561D1 (2.0)	ST3GAL4 (1.9)	GPAM (1.9)	GMPR (1.8)	LPIN3 (1.8)	NKPD1 (1.7)	ADAM1 (1.7)
GO:0005123	death receptor binding	0.13	> 0.20	ZNF180 (2.7)	SH2B3 (2.4)	BRAP (1.9)	BLOC1S3 (1.9)	ZNF101 (1.7)	GMIP (1.5)	PARP10 (1.5)	ENSG00000228044 (1.5)	PMFBP1 (1.5)	BCL3 (1.4)
ENSG00000104695	PPP2CB PPI subnetwork	0.13	> 0.20	PSMA5 (3.7)	TMEM50A (2.2)	TRAFD1 (2.0)	NAA25 (2.0)	ZNF259 (2.0)	MARK4 (2.0)	ENSG00000235545 (1.8)	TOMM40 (1.8)	ENSG00000254235 (1.7)	CARM1 (1.7)
GO:0008299	isoprenoid biosynthetic process	0.13	> 0.20	HMGCR (7.2)	LDLR (7.0)	PCSK9 (6.8)	FADS2 (6.4)	FADS1 (5.9)	CYP7A1 (2.9)	BLOC1S3 (2.1)	LPAR2 (1.8)	ENSG00000226645 (1.7)	GEMIN7 (1.7)
ENSG00000178184	PARD6G PPI subnetwork	0.13	> 0.20	PVRL2 (2.6)	LPAR2 (2.3)	ILF3 (2.0)	PLCG1 (1.9)	C1orf63 (1.9)	BCAM (1.7)	ENSG00000228044 (1.7)	GOT2P1 (1.7)	PSRC1 (1.6)	PVR (1.5)
ENSG00000086205	FOLH1 PPI subnetwork	0.13	> 0.20	ACAD10 (3.9)	TMED4 (3.3)	HNF1A (2.9)	TRAPPC6A (2.7)	CBLC (2.4)	ERP29 (2.4)	NT5DC1 (2.4)	ATXN7L2 (1.7)	PCSK9 (1.6)	BUD13 (1.4)
ENSG00000102678	FGF9 PPI subnetwork	0.13	> 0.20	HAPLN4 (4.4)	PLEKHH2 (3.9)	HAVCR1 (3.7)	C11orf9 (3.1)	ZHX3 (2.7)	NYNRIN (2.4)	CBLC (2.4)	CEACAM19 (2.1)	C17orf57 (2.0)	ENSG00000235545 (1.7)
MP:0000784	forebrain hypoplasia	0.13	> 0.20	PPP1R37 (2.7)	NCAN (2.6)	PLCG1 (2.0)	TMEM116 (2.0)	MARK4 (1.8)	ATXN2 (1.7)	ACAD10 (1.6)	DYNC2LI1 (1.6)	PSRC1 (1.5)	TXNL4B (1.4)
ENSG00000171608	PIK3CD PPI subnetwork	0.13	> 0.20	HLX (3.4)	DNM2 (3.1)	SLC44A2 (3.0)	MYLIP (2.9)	GMIP (2.8)	DOCK7 (2.6)	C1orf63 (2.4)	PLEKHH2 (2.0)	SH2B3 (1.7)	COL4A3BP (1.6)
REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN	0.13	> 0.20	NAA25 (3.7)	POC5 (3.1)	USP1 (3.1)	DDX56 (3.1)	DOCK7 (2.8)	BUD13 (2.6)	ILF3 (2.4)	USP24 (2.3)	FEN1 (2.2)	MAPKAPK5 (1.8)
ENSG00000106348	IMPDH1 PPI subnetwork	0.13	> 0.20	TOMM40 (3.5)	QTRT1 (2.7)	CARM1 (2.6)	SUGP1 (2.5)	TOP1 (2.3)	PSMA5 (2.0)	FADS2 (2.0)	ILF3 (2.0)	SMARCA4 (1.9)	DHODH (1.9)
ENSG00000123384	LRP1 PPI subnetwork	0.13	> 0.20	HP (4.1)	PVRL2 (3.0)	ITGB3 (2.2)	ANGPTL3 (2.2)	CLPTM1 (2.0)	APOC1 (2.0)	YIPF2 (1.8)	PPP1R37 (1.8)	PLG (1.8)	FRK (1.7)
ENSG00000197498	RPF2 PPI subnetwork	0.13	> 0.20	ZNF259 (5.1)	NAA25 (4.6)	DDX56 (4.2)	QTRT1 (3.9)	TOMM40 (3.8)	DHODH (3.2)	DHX38 (2.7)	ATP13A1 (2.6)	C12orf43 (2.4)	MAPKAPK5 (2.4)
GO:0000178	exosome (RNase complex)	0.13	> 0.20	DHODH (3.6)	POC5 (2.7)	DDX56 (2.7)	MAPKAPK5 (2.3)	SUGP1 (2.2)	DHX38 (2.0)	QTRT1 (2.0)	TOMM40 (1.9)	NT5DC1 (1.9)	C12orf43 (1.8)
ENSG00000157557	ETS2 PPI subnetwork	0.13	> 0.20	TRIB1 (3.3)	MAFB (3.2)	PLCG1 (3.2)	MYLIP (2.7)	DHX38 (2.5)	PPP1R37 (2.5)	DOCK7 (2.4)	USP24 (2.2)	GATAD2A (2.1)	HLX (2.1)
ENSG00000185122	HSF1 PPI subnetwork	0.13	> 0.20	PPP1R37 (3.1)	TOMM40 (3.0)	GRINA (2.7)	MARK4 (2.2)	CLPTM1 (2.2)	TRIB1 (2.1)	CARM1 (2.1)	C12orf47 (2.0)	ATXN2 (2.0)	PSMA5 (1.9)
ENSG00000133316	WDR74 PPI subnetwork	0.13	> 0.20	ZNF259 (4.7)	NAA25 (4.6)	TOMM40 (4.0)	DDX56 (3.7)	DHX38 (3.2)	QTRT1 (3.1)	DHODH (2.9)	ATP13A1 (2.7)	C12orf43 (2.2)	MAPKAPK5 (2.2)
MP:0005450	abnormal energy expenditure	0.13	> 0.20	ABO (2.9)	GPAM (2.8)	ZHX3 (2.2)	CILP2 (2.1)	HP (2.1)	PPP1R37 (1.9)	ALDH2 (1.9)	TOP1 (1.7)	SH2B3 (1.7)	GCNT4 (1.6)
GO:0009744	response to sucrose stimulus	0.13	> 0.20	NPC1L1 (4.6)	TM6SF2 (4.1)	FADS2 (3.8)	HAPLN4 (3.5)	ABCG8 (3.5)	ABCG5 (3.4)	ANKRD31 (2.7)	BLOC1S3 (2.5)	CBLC (2.2)	ZHX3 (1.5)
GO:0034285	response to disaccharide stimulus	0.13	> 0.20	NPC1L1 (4.6)	TM6SF2 (4.1)	FADS2 (3.8)	HAPLN4 (3.5)	ABCG8 (3.5)	ABCG5 (3.4)	ANKRD31 (2.7)	BLOC1S3 (2.5)	CBLC (2.2)	ZHX3 (1.5)
GO:0050912	detection of chemical stimulus involved in sensory perception of taste	0.13	> 0.20	GCNT4 (3.1)	ANKRD31 (2.8)	ENSG00000228044 (2.6)	ADAM1 (1.9)	CYP7A1 (1.9)	GOT2P1 (1.8)	OASL (1.8)	ENSG00000235545 (1.6)	PMFBP1 (1.5)	TSSK6 (1.4)
MP:0005087	decreased acute inflammation	0.13	> 0.20	GMIP (3.0)	HLX (2.4)	MAFB (2.4)	SORT1 (1.8)	TMEM116 (1.7)	DHODH (1.6)	SH2B3 (1.6)	CYB561D1 (1.5)	PMFBP1 (1.5)	HP (1.5)
MP:0002833	increased heart weight	0.13	> 0.20	BCAM (3.0)	CEACAM19 (2.2)	OGDH (2.1)	SYPL2 (2.0)	SORT1 (2.0)	GPAM (1.7)	GMPR (1.5)	TMEM116 (1.5)	PVRL2 (1.5)	PLEC (1.3)
ENSG00000100722	ZC3H14 PPI subnetwork	0.13	> 0.20	BRAP (3.8)	NAA25 (3.3)	MAPKAPK5 (3.3)	DDX56 (2.9)	QTRT1 (2.9)	PTPN11 (2.8)	ATXN2 (2.3)	SUGP1 (1.9)	AMIGO1 (1.8)	DHX38 (1.8)
ENSG00000111737	RAB35 PPI subnetwork	0.13	> 0.20	PARP10 (3.7)	ABCG5 (2.8)	TM6SF2 (2.5)	OASL (2.5)	PBX4 (2.2)	ABCG8 (1.9)	ENSG00000228044 (1.9)	PLEKHH2 (1.8)	LPAR2 (1.7)	NT5DC1 (1.6)
REACTOME_STEROID_HORMONES	REACTOME_STEROID_HORMONES	0.13	> 0.20	FADS1 (3.4)	FADS2 (3.2)	APOC1 (3.2)	LDLR (3.2)	ST3GAL4 (2.9)	HMGCR (2.8)	PLG (2.6)	ANGPTL3 (2.4)	CYP7A1 (2.0)	APOA5 (1.9)
GO:0042809	vitamin D receptor binding	0.13	> 0.20	BUD13 (3.0)	ACAD10 (1.8)	ATXN2 (1.7)	CEACAM19 (1.6)	MAU2 (1.6)	TMEM57 (1.6)	PLEC (1.5)	DHX38 (1.4)	MAPKAPK5 (1.4)	GMIP (1.3)
ENSG00000123358	NR4A1 PPI subnetwork	0.13	> 0.20	UBXN2B (2.8)	TRIB1 (2.6)	MYLIP (2.5)	PLEC (2.4)	MARK4 (2.2)	SH2B3 (2.1)	BLOC1S3 (2.0)	OGDH (1.9)	CARM1 (1.9)	DNM2 (1.8)
ENSG00000099804	CDC34 PPI subnetwork	0.13	> 0.20	TRIB1 (2.6)	ENSG00000254235 (2.0)	PVR (2.0)	ZHX3 (1.9)	PTPN11 (1.9)	MAPKAPK5 (1.8)	ENSG00000238078 (1.6)	BRAP (1.6)	GCNT4 (1.4)	ENSG00000235545 (1.2)
ENSG00000122965	RBM19 PPI subnetwork	0.13	> 0.20	QTRT1 (3.7)	DDX56 (3.4)	TOP1 (3.2)	DHODH (3.2)	NAA25 (3.1)	DHX38 (2.9)	TOMM40 (2.8)	ZNF259 (2.8)	USP24 (2.5)	ANKRD31 (2.2)
MP:0008475	intermingled spleen red and white pulp	0.13	> 0.20	RELB (5.6)	RHCE (3.5)	TIMD4 (3.2)	GRINA (3.1)	BCL3 (2.6)	HLX (2.5)	TRIB1 (2.2)	ST3GAL4 (2.2)	LPAR2 (2.2)	GMIP (2.1)
MP:0000495	abnormal colon morphology	0.13	> 0.20	HLX (3.2)	KIAA1324 (3.0)	BCL3 (2.7)	CBLC (2.4)	ABO (2.3)	CYP7A1 (2.3)	PLEC (2.2)	TRIB1 (2.2)	PLEKHH2 (2.1)	RELB (2.1)
GO:0000785	chromatin	0.13	> 0.20	USP1 (3.1)	TSSK6 (2.4)	FEN1 (2.3)	BUD13 (2.1)	TRIB1 (2.0)	GATAD2A (2.0)	SMARCA4 (1.9)	TOP1 (1.9)	PSRC1 (1.7)	TMEM57 (1.7)
ENSG00000160199	PKNOX1 PPI subnetwork	0.13	> 0.20	NYNRIN (3.1)	SYPL2 (3.0)	ENSG00000238078 (2.5)	CARM1 (2.2)	TOMM40 (1.9)	KANK2 (1.8)	SMARCA4 (1.7)	LPIN3 (1.6)	ATXN7L2 (1.6)	ANKRD31 (1.6)
ENSG00000116044	NFE2L2 PPI subnetwork	0.13	> 0.20	TRIB1 (6.4)	LDLR (2.3)	C1orf63 (1.9)	ENSG00000238078 (1.9)	TRAPPC6A (1.9)	SH2B3 (1.7)	HMGCR (1.7)	DOCK7 (1.7)	BCAM (1.6)	MAU2 (1.6)
ENSG00000105429	MEGF8 PPI subnetwork	0.13	> 0.20	FRK (3.5)	PARP10 (2.8)	ZNF180 (2.4)	DOCK7 (2.1)	PTPN11 (1.9)	ABO (1.9)	OASL (1.6)	PPP1R37 (1.5)	USP24 (1.4)	HNF1A (1.4)
ENSG00000075886	TUBA3D PPI subnetwork	0.13	> 0.20	RELB (9.0)	BCL3 (6.2)	MAPKAPK5 (2.5)	PBX4 (2.4)	SH2B3 (2.3)	PVR (2.3)	TRAFD1 (2.2)	OASL (2.1)	PARP10 (2.1)	GMIP (2.0)
ENSG00000198033	TUBA3C PPI subnetwork	0.13	> 0.20	RELB (9.0)	BCL3 (6.2)	MAPKAPK5 (2.5)	PBX4 (2.4)	SH2B3 (2.3)	PVR (2.3)	TRAFD1 (2.2)	OASL (2.1)	PARP10 (2.1)	GMIP (2.0)
GO:0016235	aggresome	0.13	> 0.20	CILP2 (3.2)	BCAM (2.1)	YIPF2 (1.9)	ZNF101 (1.8)	TMEM116 (1.8)	APOE (1.7)	RHCE (1.7)	CYP7A1 (1.6)	ENSG00000226645 (1.6)	TRAFD1 (1.6)
GO:0002221	pattern recognition receptor signaling pathway	0.13	> 0.20	SH2B3 (3.0)	RELB (2.3)	GMIP (2.1)	OASL (2.0)	PARP10 (2.0)	CYB561D1 (1.9)	MAFB (1.9)	TRIB1 (1.8)	BCL3 (1.8)	BLOC1S3 (1.7)
GO:0048771	tissue remodeling	0.13	> 0.20	ENSG00000254235 (2.4)	CILP2 (2.3)	SLC22A1 (2.1)	BCAM (2.0)	PLEKHH2 (1.6)	ENSG00000235545 (1.5)	ST3GAL4 (1.4)	LPA (1.3)	PPP1R37 (1.3)	PVR (1.2)
ENSG00000165119	HNRNPK PPI subnetwork	0.13	> 0.20	TOP1 (3.5)	C1orf63 (3.2)	ILF3 (3.1)	SMARCA4 (3.0)	USP1 (2.5)	DHX38 (2.0)	TOMM40 (2.0)	FEN1 (2.0)	PSMA5 (1.9)	QTRT1 (1.8)
MP:0006354	abnormal fourth branchial arch artery morphology	0.13	> 0.20	PLCG1 (3.1)	PVR (3.0)	CEACAM19 (2.6)	HLX (2.5)	PVRL2 (2.4)	MAFB (1.8)	KANK2 (1.7)	KIAA1324 (1.4)	C19orf52 (1.3)	ABO (1.2)
ENSG00000124587	PEX6 PPI subnetwork	0.13	> 0.20	MYLIP (2.5)	ATXN2 (2.4)	C19orf52 (2.1)	FRK (2.0)	YIPF2 (2.0)	GPAM (1.9)	DOCK7 (1.9)	ENSG00000228044 (1.8)	QTRT1 (1.7)	AMIGO1 (1.6)
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	0.13	> 0.20	ITGB3 (4.0)	APOE (3.5)	MAFB (2.4)	HP (2.2)	APOC1 (1.9)	GMIP (1.7)	NCAN (1.6)	C11orf9 (1.6)	SORT1 (1.4)	TIMD4 (1.4)
GO:0070723	response to cholesterol	0.13	> 0.20	PCSK9 (4.3)	ENSG00000254235 (3.9)	HMGCR (3.7)	LDLR (3.4)	FADS1 (2.8)	FADS2 (2.8)	TXNL4B (2.2)	GPAM (1.9)	TMEM50A (1.8)	UBXN2B (1.6)
ENSG00000101076	HNF4A PPI subnetwork	0.13	> 0.20	ATXN2 (3.0)	APOB (2.3)	CYP7A1 (2.2)	HNF1A (2.1)	GCNT4 (2.1)	HMGCR (1.8)	USP24 (1.7)	C12orf51 (1.7)	BRAP (1.5)	SH2B3 (1.5)
GO:0043560	insulin receptor substrate binding	0.13	> 0.20	COL4A3BP (3.3)	DNM2 (2.2)	TMEM57 (2.0)	ENSG00000238078 (1.9)	ERP29 (1.8)	ENSG00000226645 (1.7)	USP24 (1.6)	PVRL2 (1.5)	C17orf57 (1.5)	TMED4 (1.5)
ENSG00000151090	THRB PPI subnetwork	0.13	> 0.20	ATXN2 (3.7)	C12orf51 (2.5)	DNM2 (2.2)	CARM1 (2.1)	USP24 (2.1)	MAU2 (2.0)	MARK4 (1.9)	PPP1R37 (1.9)	TRIB1 (1.8)	ILF3 (1.8)
REACTOME_DIABETES_PATHWAYS	REACTOME_DIABETES_PATHWAYS	0.13	> 0.20	YIPF2 (3.6)	ERP29 (3.5)	TMED4 (3.3)	SARS (2.9)	DHODH (1.8)	PVR (1.8)	KIAA1324 (1.7)	ATP13A1 (1.5)	SUGP1 (1.4)	GRINA (1.3)
GO:0010035	response to inorganic substance	0.13	> 0.20	RHD (2.6)	HP (2.1)	RHCE (1.9)	TM6SF2 (1.9)	SLC22A1 (1.8)	ABCG5 (1.8)	ADAM1 (1.8)	GOT2P1 (1.8)	ALDH2 (1.7)	ANGPTL3 (1.7)
GO:0002312	B cell activation involved in immune response	0.13	> 0.20	GCNT4 (2.6)	NT5DC1 (2.3)	ZNF101 (2.2)	DYNC2LI1 (1.9)	GOT2P1 (1.6)	HAVCR1 (1.5)	ANKRD31 (1.4)	ZNF180 (1.4)	NKPD1 (1.2)	DNAH11 (1.2)
ENSG00000107338	SHB PPI subnetwork	0.13	> 0.20	PLCG1 (3.6)	ITGB3 (3.6)	HAVCR1 (3.4)	CETP (2.6)	MYLIP (2.3)	DNM2 (2.3)	ZHX3 (2.1)	COL4A3BP (2.1)	GMIP (2.0)	SLC44A2 (1.9)
ENSG00000184985	SORCS2 PPI subnetwork	0.13	> 0.20	PSMA5 (2.4)	TOP1 (2.3)	SARS (2.3)	GOT2P1 (2.3)	TOMM40 (2.2)	DHX38 (2.2)	ILF3 (1.9)	GRINA (1.8)	NPC1L1 (1.7)	MAPKAPK5 (1.7)
ENSG00000121031	ENSG00000121031 PPI subnetwork	0.13	> 0.20	SMARCA4 (3.1)	DHX38 (2.8)	PLEC (2.7)	ILF3 (2.3)	TOP1 (2.1)	OASL (2.0)	OGDH (1.9)	USP1 (1.9)	PARP10 (1.8)	DOCK7 (1.8)
ENSG00000162191	UBXN1 PPI subnetwork	0.13	> 0.20	COL4A3BP (2.7)	CYP7A1 (2.6)	TMEM57 (2.5)	GRINA (2.1)	BLOC1S3 (2.0)	YIPF2 (1.9)	C19orf52 (1.8)	SLC22A1 (1.8)	TMED4 (1.8)	CARM1 (1.6)
ENSG00000162869	PPP1R21 PPI subnetwork	0.13	> 0.20	MAPKAPK5 (3.1)	ATP13A1 (2.7)	TOMM40 (2.3)	LPA (2.1)	ADAM1 (2.0)	HNF1A (2.0)	DHODH (2.0)	USP24 (1.9)	DYNC2LI1 (1.8)	BRAP (1.8)
ENSG00000067842	ATP2B3 PPI subnetwork	0.13	> 0.20	COL4A3BP (3.4)	PPP1R37 (2.2)	SORT1 (2.1)	PMFBP1 (2.1)	TMEM50A (2.0)	SARS (2.0)	NKPD1 (1.9)	CYB561D1 (1.9)	ZHX3 (1.8)	HMGCR (1.8)
ENSG00000173145	NOC3L PPI subnetwork	0.13	> 0.20	ZNF259 (5.0)	NAA25 (4.8)	DDX56 (4.2)	TOMM40 (3.7)	DHODH (3.2)	QTRT1 (3.1)	DHX38 (2.8)	ADAM1 (2.6)	C12orf43 (2.5)	MAPKAPK5 (2.2)
MP:0001211	wrinkled skin	0.13	> 0.20	AP1M2 (4.9)	CBLC (3.9)	CELSR2 (3.1)	CEACAM19 (2.3)	FRK (2.3)	YIPF2 (2.2)	NYNRIN (2.1)	ABCG8 (2.0)	APOA5 (1.9)	ANGPTL3 (1.8)
ENSG00000082146	STRADB PPI subnetwork	0.13	> 0.20	ILF3 (3.4)	MAU2 (2.7)	C19orf52 (2.5)	DNM2 (2.5)	BRAP (2.5)	CARM1 (2.3)	HAPLN4 (2.1)	ATP13A1 (1.9)	SLC44A2 (1.8)	GMPR (1.8)
ENSG00000184451	CCR10 PPI subnetwork	0.13	> 0.20	CETP (6.2)	TIMD4 (6.2)	MAFB (3.3)	ZNF101 (2.7)	RELB (2.7)	GRINA (2.3)	PPP1R37 (2.0)	BCL3 (1.9)	APOE (1.7)	PVRL2 (1.7)
MP:0000790	abnormal stratification in cerebral cortex	0.13	> 0.20	PTPN11 (2.9)	NCAN (2.1)	ENSG00000235545 (2.0)	CYB561D1 (1.8)	LPIN3 (1.8)	GCNT4 (1.8)	PPP1R37 (1.8)	NYNRIN (1.7)	ENSG00000226645 (1.6)	CLPTM1 (1.6)
GO:0034660	ncRNA metabolic process	0.14	> 0.20	QTRT1 (3.8)	NAA25 (3.6)	ZNF259 (3.6)	DDX56 (3.6)	DHODH (3.3)	C12orf43 (3.0)	MAPKAPK5 (2.8)	TOMM40 (2.7)	POC5 (2.6)	C19orf52 (2.2)
ENSG00000063761	ADCK1 PPI subnetwork	0.14	> 0.20	CARM1 (4.5)	ILF3 (2.7)	NKPD1 (2.7)	CEACAM19 (2.6)	GOT2P1 (2.5)	GRINA (2.4)	TSSK6 (2.3)	MARK4 (2.1)	DNM2 (2.1)	SMARCA4 (2.1)
ENSG00000105698	USF2 PPI subnetwork	0.14	> 0.20	MAFB (3.5)	TRIB1 (3.0)	ATXN7L2 (2.3)	CEACAM19 (2.3)	BCL3 (1.8)	PPP1R37 (1.5)	TOP1 (1.5)	CLPTM1 (1.5)	HP (1.4)	TOMM40 (1.4)
ENSG00000164683	HEY1 PPI subnetwork	0.14	> 0.20	SLC44A2 (3.0)	RHCE (2.1)	SH2B3 (1.9)	MYLIP (1.9)	ITGB3 (1.8)	KANK2 (1.8)	LPIN3 (1.7)	ZHX3 (1.7)	GCNT4 (1.5)	TMEM57 (1.5)
MP:0000336	decreased mast cell number	0.14	> 0.20	BCL3 (2.5)	RELB (2.0)	PVR (1.8)	CYB561D1 (1.7)	PMFBP1 (1.5)	ENSG00000228044 (1.4)	GMPR (1.4)	ITGB3 (1.4)	TRAPPC6A (1.3)	TRIB1 (1.3)
GO:0030262	apoptotic nuclear change	0.14	> 0.20	C1orf63 (2.5)	POLK (2.3)	ENSG00000238078 (2.3)	TRAPPC6A (2.1)	ENSG00000226645 (2.1)	ST3GAL4 (1.8)	AMIGO1 (1.7)	C19orf52 (1.6)	LPAR2 (1.5)	ZNF101 (1.3)
ENSG00000114315	HES1 PPI subnetwork	0.14	> 0.20	MYLIP (2.9)	NCAN (2.7)	ALDH2 (2.5)	ZHX3 (2.3)	GPAM (1.8)	PLCG1 (1.8)	MAFB (1.8)	CEACAM19 (1.6)	TM6SF2 (1.5)	TOP1 (1.4)
ENSG00000120833	SOCS2 PPI subnetwork	0.14	> 0.20	BCL3 (5.0)	HLX (3.5)	RELB (3.1)	CETP (2.3)	GMIP (2.2)	TRIB1 (2.1)	TIMD4 (2.1)	ALDH2 (1.9)	GRINA (1.7)	PVRL2 (1.4)
GO:0032813	tumor necrosis factor receptor superfamily binding	0.14	> 0.20	RELB (3.2)	SH2B3 (2.5)	PARP10 (2.4)	HAVCR1 (2.1)	BCL3 (1.8)	TIMD4 (1.8)	CETP (1.7)	GMIP (1.7)	SLC22A1 (1.6)	POLK (1.6)
ENSG00000143621	ILF2 PPI subnetwork	0.14	> 0.20	QTRT1 (4.4)	TOMM40 (3.5)	SUGP1 (2.7)	ILF3 (2.6)	OASL (2.4)	GATAD2A (2.3)	DHODH (2.3)	CARM1 (2.2)	TOP1 (2.2)	SMARCA4 (2.2)
ENSG00000108515	ENO3 PPI subnetwork	0.14	> 0.20	OGDH (3.5)	TOMM40 (2.9)	ERP29 (2.5)	SARS (2.2)	TOP1 (2.2)	ALDH2 (1.9)	SMARCA4 (1.8)	TSSK6 (1.7)	NT5DC1 (1.6)	SYPL2 (1.6)
ENSG00000124795	DEK PPI subnetwork	0.14	> 0.20	BUD13 (3.8)	TSSK6 (2.3)	MYLIP (2.3)	USP1 (2.1)	DOCK7 (1.9)	SMARCA4 (1.7)	C19orf52 (1.6)	NYNRIN (1.6)	FEN1 (1.5)	FADS2 (1.4)
GO:0016813	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines	0.14	> 0.20	HP (3.4)	MOSC1 (2.7)	PLG (2.5)	CBLC (2.3)	AP1M2 (2.0)	ANGPTL3 (2.0)	PMFBP1 (1.9)	SLC44A2 (1.9)	PBX4 (1.9)	ABCG8 (1.7)
ENSG00000153113	CAST PPI subnetwork	0.14	> 0.20	ZHX3 (3.0)	ENSG00000238078 (2.9)	MAFB (2.5)	DNM2 (2.3)	RPH3A (2.2)	NCAN (1.8)	FRK (1.7)	SH2B3 (1.5)	ITGB3 (1.5)	PPP1R37 (1.5)
MP:0005452	abnormal adipose tissue amount	0.14	> 0.20	KIAA1324 (2.7)	PMFBP1 (2.4)	MOSC1 (1.9)	USP24 (1.9)	NPC1L1 (1.8)	GPAM (1.7)	ENSG00000226648 (1.7)	HNF1A (1.6)	TSSK6 (1.5)	MAFB (1.5)
GO:0050830	defense response to Gram-positive bacterium	0.14	> 0.20	HP (2.8)	ENSG00000228044 (2.7)	GOT2P1 (2.4)	C17orf57 (2.3)	DNAH11 (2.2)	ADAM1 (2.0)	PMFBP1 (1.9)	LPA (1.9)	CEACAM19 (1.8)	CYB561D1 (1.6)
MP:0004974	decreased regulatory T cell number	0.14	> 0.20	RELB (4.1)	SH2B3 (2.1)	PBX4 (2.0)	PARP10 (1.9)	GMIP (1.9)	BCL3 (1.8)	CYB561D1 (1.7)	MAFB (1.6)	PLCG1 (1.5)	TRAFD1 (1.2)
ENSG00000153006	SREK1IP1 PPI subnetwork	0.14	> 0.20	C1orf63 (3.1)	ADAM1 (3.0)	COL4A3BP (2.9)	PMFBP1 (2.1)	ERP29 (2.0)	APOE (1.9)	POLK (1.7)	C19orf52 (1.6)	TMEM50A (1.6)	TOP1 (1.6)
GO:0004712	protein serine/threonine/tyrosine kinase activity	0.14	> 0.20	C1orf63 (4.4)	ATXN7L2 (2.9)	CEACAM19 (2.1)	SH2B3 (1.8)	MAU2 (1.8)	ABCG5 (1.8)	DNAH11 (1.7)	SORT1 (1.7)	BRAP (1.7)	PSRC1 (1.6)
ENSG00000072110	ACTN1 PPI subnetwork	0.14	> 0.20	AP1M2 (3.1)	SYPL2 (2.9)	PTPN11 (2.8)	GMPR (2.7)	OGDH (2.7)	PLEC (2.7)	PVRL2 (2.6)	CARM1 (2.4)	GATAD2A (2.3)	ITGB3 (2.3)
MP:0004892	increased adiponectin level	0.14	> 0.20	SH2B3 (2.7)	MOSC1 (2.6)	CETP (2.4)	PLEC (2.3)	ST3GAL4 (2.2)	GPAM (2.2)	OASL (2.2)	TRIB1 (2.2)	LDLR (1.9)	KANK2 (1.8)
GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	0.14	> 0.20	FADS1 (4.2)	ALDH2 (4.0)	FADS2 (3.9)	SLC22A1 (2.7)	TRAPPC6A (2.6)	GPAM (2.1)	APOC1 (2.1)	ABCG5 (2.1)	ACAD10 (2.1)	CYP7A1 (1.8)
MP:0005553	increased circulating creatinine level	0.14	> 0.20	C17orf57 (2.8)	PLG (2.6)	GRINA (2.1)	PLEKHH2 (2.0)	UBXN2B (2.0)	SYPL2 (2.0)	TMEM57 (1.9)	SLC22A1 (1.9)	BCAM (1.8)	FRK (1.8)
GO:0006732	coenzyme metabolic process	0.14	> 0.20	ACAD10 (4.1)	NT5DC1 (3.2)	GPAM (3.2)	FADS2 (3.0)	DHODH (3.0)	PCSK9 (3.0)	OGDH (2.9)	TRAPPC6A (2.8)	FADS1 (2.8)	MOSC1 (2.5)
GO:0006650	glycerophospholipid metabolic process	0.14	> 0.20	BLOC1S3 (3.4)	TSSK6 (2.7)	UBXN2B (2.1)	ATP13A1 (2.1)	HAVCR1 (2.1)	TMEM50A (1.9)	CYB561D1 (1.8)	LPAR2 (1.7)	YIPF2 (1.6)	CLPTM1 (1.5)
MP:0008782	increased B cell apoptosis	0.14	> 0.20	MAFB (3.4)	GMIP (2.8)	TRIB1 (2.6)	MYLIP (2.3)	ALDH2 (2.3)	AP1M2 (2.1)	CETP (2.0)	TIMD4 (1.9)	FRK (1.8)	SH2B3 (1.7)
REACTOME_NF:KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	REACTOME_NF:KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL	0.14	> 0.20	RELB (5.7)	BCL3 (3.1)	GMIP (2.2)	SH2B3 (2.2)	PVR (2.1)	PARP10 (2.0)	BLOC1S3 (1.7)	PCSK9 (1.7)	TRIB1 (1.5)	GRINA (1.5)
ENSG00000133216	EPHB2 PPI subnetwork	0.14	> 0.20	LPAR2 (2.5)	MARK4 (2.5)	PVRL2 (2.4)	PBX4 (2.1)	TRIB1 (2.0)	MAFB (2.0)	YIPF2 (1.9)	PPP1R37 (1.9)	AMIGO1 (1.9)	SLC44A2 (1.8)
ENSG00000116337	AMPD2 PPI subnetwork	0.14	> 0.20	AMIGO1 (3.3)	C19orf52 (3.2)	DNM2 (2.6)	USP24 (2.5)	FRK (2.5)	YIPF2 (2.4)	SUGP1 (2.3)	C12orf47 (2.1)	GEMIN7 (2.0)	NCAN (1.9)
GO:0005905	coated pit	0.14	> 0.20	CLPTM1 (4.2)	GRINA (4.1)	PPP1R37 (3.8)	CEACAM19 (2.6)	SARS (2.3)	DNM2 (2.2)	ERP29 (2.2)	SH2B3 (2.1)	C12orf51 (2.0)	HNF1A (2.0)
ENSG00000152795	HNRPDL PPI subnetwork	0.14	> 0.20	SYPL2 (3.1)	PLCG1 (2.6)	QTRT1 (2.5)	ILF3 (2.2)	TMEM50A (2.2)	OGDH (1.9)	SMARCA4 (1.8)	C1orf63 (1.8)	ACAD10 (1.8)	SUGP1 (1.7)
GO:0005518	collagen binding	0.14	> 0.20	ITGB3 (4.8)	CILP2 (4.4)	KANK2 (2.6)	APOE (2.2)	PLEKHH2 (1.9)	ENSG00000238078 (1.7)	CETP (1.6)	SH2B3 (1.5)	TIMD4 (1.4)	MOSC1 (1.4)
GO:0003950	NAD+ ADP-ribosyltransferase activity	0.14	> 0.20	PARP10 (7.1)	OASL (6.3)	TRAFD1 (4.3)	ENSG00000235545 (2.1)	SYPL2 (1.9)	FRK (1.5)	MYLIP (1.4)	YIPF2 (1.3)	MAPKAPK5 (1.3)	PBX4 (1.3)
ENSG00000204469	PRRC2A PPI subnetwork	0.14	> 0.20	ERP29 (2.4)	C19orf52 (2.3)	QTRT1 (2.2)	CLPTM1 (2.1)	ACAD10 (2.1)	PLEC (2.0)	ATP13A1 (1.9)	ATXN7L2 (1.8)	HP (1.7)	GRINA (1.7)
MP:0002641	anisopoikilocytosis	0.14	> 0.20	RHCE (12.2)	RHD (11.3)	GMPR (3.6)	C12orf51 (2.7)	USP24 (1.9)	APOC1 (1.8)	RPH3A (1.5)	TMEM57 (1.4)	TIMD4 (1.3)	BLOC1S3 (1.2)
GO:0035304	regulation of protein dephosphorylation	0.14	> 0.20	GRINA (2.0)	GOT2P1 (1.8)	RPH3A (1.7)	PPP1R37 (1.6)	ENSG00000228044 (1.6)	GCNT4 (1.6)	SORT1 (1.6)	COL4A3BP (1.5)	AP1M2 (1.4)	ENSG00000238078 (1.4)
ENSG00000120705	ETF1 PPI subnetwork	0.14	> 0.20	NKPD1 (4.1)	GPAM (2.4)	MOSC1 (2.2)	BRAP (2.1)	PTPN11 (2.1)	DHX38 (2.0)	NAA25 (1.9)	DHODH (1.8)	CEACAM19 (1.7)	GATAD2A (1.7)
MP:0001690	failure of somite differentiation	0.14	> 0.20	C17orf57 (5.7)	ATP13A1 (2.4)	GCNT4 (2.4)	NYNRIN (2.3)	ITGB3 (2.2)	ABO (2.2)	HAVCR1 (2.1)	C1orf63 (2.1)	CLPTM1 (1.9)	DNM2 (1.8)
ENSG00000109458	GAB1 PPI subnetwork	0.14	> 0.20	ITGB3 (3.5)	ZHX3 (3.4)	GATAD2A (2.9)	ATXN2 (2.3)	ABO (2.3)	SLC44A2 (2.3)	COL4A3BP (2.2)	SH2B3 (2.1)	PTPN11 (2.0)	DNM2 (1.9)
ENSG00000119953	SMNDC1 PPI subnetwork	0.14	> 0.20	BUD13 (3.2)	DHX38 (3.1)	ZNF259 (2.8)	DDX56 (2.7)	ANKRD31 (2.7)	ILF3 (2.5)	ATP13A1 (2.2)	TOP1 (2.1)	FADS1 (2.1)	NAA25 (2.1)
GO:0031668	cellular response to extracellular stimulus	0.14	> 0.20	BLOC1S3 (2.5)	POLK (2.2)	TXNL4B (2.0)	BRAP (1.9)	CEACAM19 (1.8)	AP1M2 (1.8)	ABO (1.8)	HNF1A (1.7)	TRAPPC6A (1.6)	LPIN3 (1.5)
MP:0002831	absent Peyer's patches	0.14	> 0.20	BCL3 (4.8)	RELB (4.4)	GRINA (3.7)	PLEC (3.2)	GMIP (2.8)	HAVCR1 (2.2)	PARP10 (2.1)	UBXN2B (2.0)	ZNF101 (1.8)	PBX4 (1.7)
MP:0002362	abnormal spleen marginal zone morphology	0.14	> 0.20	TIMD4 (4.7)	RELB (4.5)	CETP (2.9)	GMIP (2.2)	PBX4 (2.2)	ZNF101 (1.8)	MAFB (1.8)	KIAA1324 (1.6)	NPC1L1 (1.6)	BCL3 (1.6)
ENSG00000136153	LMO7 PPI subnetwork	0.14	> 0.20	PLEC (3.8)	CBLC (3.0)	BCAM (2.7)	KANK2 (2.5)	AP1M2 (2.4)	PVRL2 (2.3)	ENSG00000238078 (2.3)	TOP1 (1.8)	PBX4 (1.8)	SYPL2 (1.6)
MP:0010454	abnormal truncus arteriosus septation	0.14	> 0.20	NYNRIN (3.1)	BCAM (2.4)	C11orf9 (2.2)	TRIB1 (2.1)	TRAPPC6A (1.9)	TMED4 (1.9)	DOCK7 (1.8)	PLCG1 (1.7)	ENSG00000238078 (1.7)	MAFB (1.6)
ENSG00000183091	NEB PPI subnetwork	0.14	> 0.20	SYPL2 (7.1)	GMPR (3.4)	TRAPPC6A (2.0)	CYB561D1 (1.8)	KANK2 (1.8)	BLOC1S3 (1.7)	TMEM50A (1.5)	HNF1A (1.5)	TM6SF2 (1.5)	AP1M2 (1.4)
ENSG00000175793	SFN PPI subnetwork	0.14	> 0.20	CBLC (4.7)	AP1M2 (3.1)	BCAM (2.6)	PLEC (2.4)	PVRL2 (2.4)	CELSR2 (2.2)	ATXN2 (2.1)	KANK2 (2.1)	TRIB1 (2.0)	SMARCA4 (1.9)
MP:0011294	renal glomerulus hypertrophy	0.14	> 0.20	MAFB (2.8)	SH2B3 (2.6)	C17orf57 (2.5)	POLK (2.2)	ENSG00000228044 (2.2)	TRIB1 (2.2)	TMEM50A (2.1)	FRK (2.1)	COL4A3BP (2.0)	GOT2P1 (1.9)
MP:0004966	abnormal inner cell mass proliferation	0.14	> 0.20	FEN1 (3.8)	USP1 (3.4)	BUD13 (2.3)	UBXN2B (2.2)	DHX38 (2.0)	ST3GAL4 (1.9)	C19orf52 (1.8)	TOMM40 (1.7)	POC5 (1.7)	BLOC1S3 (1.6)
MP:0001344	blepharoptosis	0.14	> 0.20	NKPD1 (2.3)	DYNC2LI1 (2.2)	SYPL2 (2.1)	FADS2 (1.9)	AMIGO1 (1.7)	CELSR2 (1.7)	GOT2P1 (1.6)	ABCG5 (1.6)	SH2B3 (1.5)	TIMD4 (1.4)
ENSG00000170178	HOXD12 PPI subnetwork	0.14	> 0.20	TRIB1 (4.4)	NPC1L1 (2.5)	PVR (2.3)	POLK (1.9)	BCL3 (1.7)	MAPKAPK5 (1.7)	COL4A3BP (1.7)	C17orf57 (1.7)	LDLR (1.6)	LPIN3 (1.4)
GO:0043296	apical junction complex	0.14	> 0.20	AP1M2 (6.6)	CBLC (4.9)	PVRL2 (4.1)	FRK (3.4)	BCAM (3.4)	PVR (2.2)	DYNC2LI1 (2.1)	LPAR2 (2.0)	PLEKHH2 (1.9)	C11orf9 (1.8)
ENSG00000136891	TEX10 PPI subnetwork	0.14	> 0.20	ZNF259 (5.1)	DDX56 (4.4)	NAA25 (4.1)	QTRT1 (3.6)	DHODH (3.3)	TOMM40 (3.2)	DHX38 (3.2)	C12orf43 (3.0)	SUGP1 (2.4)	ENSG00000226645 (2.4)
MP:0000443	abnormal snout morphology	0.14	> 0.20	CILP2 (2.3)	NPC1L1 (2.0)	MAPKAPK5 (1.9)	ENSG00000235545 (1.8)	AP1M2 (1.8)	CBLC (1.6)	MYLIP (1.4)	NCAN (1.4)	GCNT4 (1.3)	ALDH2 (1.2)
ENSG00000149273	RPS3 PPI subnetwork	0.14	> 0.20	QTRT1 (3.6)	DDX56 (3.5)	NAA25 (3.3)	TOMM40 (3.1)	ZNF259 (3.0)	ILF3 (3.0)	TOP1 (2.5)	DHX38 (2.4)	SUGP1 (2.4)	SARS (2.4)
ENSG00000104365	IKBKB PPI subnetwork	0.14	> 0.20	RELB (5.9)	PARP10 (3.7)	OASL (3.4)	BCL3 (3.1)	SH2B3 (2.1)	ILF3 (2.1)	GMIP (2.0)	TRIB1 (2.0)	TRAFD1 (2.0)	PVR (1.9)
MP:0005065	abnormal neutrophil morphology	0.14	> 0.20	HP (5.3)	TRIB1 (4.3)	ABCG8 (4.0)	HLX (2.6)	MAFB (2.5)	CYP7A1 (2.0)	APOB (2.0)	AMIGO1 (1.9)	SORT1 (1.9)	CYB561D1 (1.8)
MP:0005078	abnormal cytotoxic T cell physiology	0.14	> 0.20	RELB (4.2)	PARP10 (4.0)	HAVCR1 (2.4)	TRAFD1 (2.4)	ST3GAL4 (1.9)	GMIP (1.8)	CETP (1.7)	BCL3 (1.7)	ENSG00000228044 (1.5)	NT5DC1 (1.4)
GO:0033674	positive regulation of kinase activity	0.14	> 0.20	ENSG00000228044 (4.0)	PTPN11 (2.2)	AMIGO1 (2.2)	HLX (2.1)	SLC44A2 (2.1)	PVR (2.1)	ST3GAL4 (1.9)	SH2B3 (1.6)	CYB561D1 (1.5)	POLK (1.5)
MP:0003290	intestinal hypoperistalsis	0.14	> 0.20	KANK2 (3.8)	ITGB3 (3.2)	CETP (3.1)	PLEKHH2 (2.6)	HLX (2.3)	TIMD4 (2.2)	ENSG00000228044 (2.2)	TRIB1 (2.0)	ENSG00000254235 (1.8)	C17orf57 (1.4)
ENSG00000106004	HOXA5 PPI subnetwork	0.14	> 0.20	C11orf9 (2.7)	HLX (2.6)	KANK2 (2.0)	ALDH2 (2.0)	PVRL2 (1.9)	PLCG1 (1.9)	CARM1 (1.7)	NYNRIN (1.6)	ANKRD31 (1.6)	DNAH11 (1.5)
ENSG00000132357	CARD6 PPI subnetwork	0.14	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.4)	C1orf63 (1.9)	TMEM57 (1.6)	DNAH11 (1.6)	SYPL2 (1.5)	PLEKHH2 (1.4)	GOT2P1 (1.4)	HNF1A (1.3)
ENSG00000160712	IL6R PPI subnetwork	0.14	> 0.20	BCL3 (3.5)	COL4A3BP (2.3)	PVR (1.7)	ZNF101 (1.7)	CYP7A1 (1.6)	C17orf57 (1.6)	RELB (1.6)	SLC22A1 (1.5)	CETP (1.3)	BCAM (1.2)
ENSG00000142657	PGD PPI subnetwork	0.14	> 0.20	ZNF259 (4.2)	NAA25 (4.0)	DDX56 (3.2)	TOMM40 (3.2)	SARS (2.7)	OGDH (2.6)	ADAM1 (2.5)	QTRT1 (2.2)	PSMA5 (2.1)	MAPKAPK5 (1.9)
ENSG00000124222	STX16 PPI subnetwork	0.14	> 0.20	CELSR2 (2.7)	C19orf52 (2.6)	GOT2P1 (2.5)	CLPTM1 (2.3)	YIPF2 (2.2)	TXNL4B (2.2)	MAU2 (2.1)	SARS (2.1)	CYB561D1 (2.1)	ATP13A1 (2.0)
ENSG00000005156	LIG3 PPI subnetwork	0.14	> 0.20	GCNT4 (2.7)	SMARCA4 (2.6)	NT5DC1 (2.4)	KANK2 (2.4)	ZHX3 (2.3)	PLCG1 (2.3)	ANKRD31 (2.1)	GPAM (1.9)	SUGP1 (1.6)	LPIN3 (1.5)
MP:0001719	absent vitelline blood vessels	0.14	> 0.20	HLX (3.5)	SH2B3 (3.5)	KANK2 (2.3)	SLC44A2 (2.3)	GATAD2A (2.1)	MYLIP (1.9)	ITGB3 (1.9)	LPA (1.7)	RHCE (1.7)	NYNRIN (1.6)
ENSG00000147168	IL2RG PPI subnetwork	0.14	> 0.20	BCL3 (3.9)	RELB (2.2)	PVR (2.0)	COL4A3BP (1.9)	ZNF101 (1.8)	C17orf57 (1.8)	TRAFD1 (1.8)	PARP10 (1.5)	SLC22A1 (1.4)	TIMD4 (1.4)
REACTOME_GAB1_SIGNALOSOME	REACTOME_GAB1_SIGNALOSOME	0.14	> 0.20	ZHX3 (4.1)	PLEC (2.4)	BRAP (2.2)	DNM2 (2.2)	MAU2 (1.9)	CLPTM1 (1.8)	TRIB1 (1.8)	PTPN11 (1.8)	MARK4 (1.7)	FADS2 (1.7)
ENSG00000087157	PGS1 PPI subnetwork	0.14	> 0.20	HNF1A (3.6)	ATP13A1 (3.5)	DDX56 (2.6)	ANKRD31 (2.4)	PTPN11 (2.2)	USP24 (2.1)	GATAD2A (2.0)	BRAP (1.9)	DHODH (1.9)	MAPKAPK5 (1.8)
MP:0008883	abnormal enterocyte proliferation	0.14	> 0.20	CBLC (3.3)	TM6SF2 (2.7)	ABCG8 (2.3)	PLEC (2.0)	MAPKAPK5 (1.8)	SLC44A2 (1.8)	AMIGO1 (1.7)	ENSG00000226648 (1.7)	APOC4 (1.6)	TMED4 (1.6)
MP:0000295	trabecula carnea hypoplasia	0.14	> 0.20	ENSG00000235545 (2.7)	CARM1 (2.5)	BCAM (2.4)	KANK2 (2.2)	DNM2 (2.2)	NYNRIN (2.1)	SH2B3 (2.0)	BLOC1S3 (2.0)	MARK4 (1.7)	PLG (1.7)
GO:0051591	response to cAMP	0.14	> 0.20	CYP7A1 (3.9)	ENSG00000238078 (3.7)	ABO (3.4)	ATXN7L2 (2.8)	SLC22A1 (2.3)	ST3GAL4 (2.2)	APOC4 (1.8)	LPA (1.7)	PLG (1.7)	ANGPTL3 (1.6)
ENSG00000177791	MYOZ1 PPI subnetwork	0.14	> 0.20	SYPL2 (5.0)	PVR (2.7)	PVRL2 (2.3)	GMPR (2.2)	PLEC (2.1)	ZNF180 (1.7)	CLPTM1 (1.6)	TOMM40 (1.6)	MARK4 (1.5)	HNF1A (1.5)
ENSG00000103653	CSK PPI subnetwork	0.14	> 0.20	ITGB3 (3.1)	PLEC (2.9)	SLC44A2 (2.9)	GMIP (2.9)	SH2B3 (2.9)	CETP (2.7)	TIMD4 (2.1)	ST3GAL4 (2.0)	MAFB (2.0)	KANK2 (1.7)
MP:0004251	failure of heart looping	0.14	> 0.20	ATXN2 (2.8)	PLCG1 (2.4)	NYNRIN (2.4)	KANK2 (2.1)	GATAD2A (1.9)	MARK4 (1.8)	PMFBP1 (1.5)	ENSG00000226648 (1.5)	C12orf51 (1.4)	ADAM1 (1.4)
GO:0003713	transcription coactivator activity	0.14	> 0.20	BUD13 (3.6)	ATXN2 (2.9)	NYNRIN (2.8)	SMARCA4 (2.7)	TMEM57 (2.6)	TRIB1 (2.6)	CARM1 (2.4)	MAU2 (2.4)	C12orf51 (2.0)	MAPKAPK5 (2.0)
ENSG00000095485	CWF19L1 PPI subnetwork	0.14	> 0.20	NT5DC1 (3.4)	ENSG00000226645 (3.2)	ZNF259 (3.0)	DYNC2LI1 (2.5)	SARS (2.1)	ATXN7L2 (2.1)	BRAP (1.9)	FRK (1.8)	YIPF2 (1.6)	TXNL4B (1.6)
MP:0004890	decreased energy expenditure	0.14	> 0.20	CELSR2 (3.2)	APOB (3.0)	CETP (2.9)	ABCG5 (2.6)	C12orf47 (2.3)	TIMD4 (2.2)	APOC1 (2.0)	APOA5 (1.8)	ATXN2 (1.8)	NPC1L1 (1.8)
ENSG00000142675	CNKSR1 PPI subnetwork	0.14	> 0.20	MARK4 (2.2)	DNM2 (2.1)	GATAD2A (2.1)	LPAR2 (2.0)	GRINA (1.8)	KANK2 (1.7)	PVRL2 (1.6)	MAU2 (1.6)	MAPKAPK5 (1.5)	FADS2 (1.5)
MP:0002264	abnormal bronchus morphology	0.14	> 0.20	C17orf57 (3.3)	PVR (2.4)	TMED4 (2.1)	C12orf47 (1.9)	PLCG1 (1.9)	TMEM57 (1.7)	SMARCA4 (1.6)	TRIB1 (1.6)	RELB (1.6)	CEACAM19 (1.5)
ENSG00000155438	MKI67IP PPI subnetwork	0.14	> 0.20	ZNF259 (5.1)	NAA25 (4.3)	DDX56 (4.3)	TOMM40 (3.6)	QTRT1 (3.3)	DHODH (3.1)	DHX38 (2.5)	C12orf43 (2.2)	MAPKAPK5 (2.1)	ENSG00000226645 (1.8)
REACTOME_NEGATIVE_REGULATORS_OF_RIG:IMDA5_SIGNALING	REACTOME_NEGATIVE_REGULATORS_OF_RIG:IMDA5_SIGNALING	0.14	> 0.20	OASL (11.2)	PARP10 (8.6)	TRAFD1 (4.4)	RELB (3.4)	MAU2 (2.1)	ZNF101 (1.8)	BCL3 (1.8)	C19orf52 (1.6)	GMIP (1.6)	ATP13A1 (1.6)
MP:0002371	abnormal thymus cortex morphology	0.14	> 0.20	PBX4 (4.1)	FADS1 (3.7)	ZNF101 (3.5)	RELB (3.4)	PLCG1 (3.3)	BCL3 (3.1)	LDLR (2.7)	LPAR2 (2.2)	HMGCR (2.0)	FRK (2.0)
ENSG00000109534	GAR1 PPI subnetwork	0.14	> 0.20	QTRT1 (4.1)	TOMM40 (4.1)	DDX56 (4.1)	NAA25 (4.0)	ZNF259 (3.9)	DHODH (3.2)	C12orf43 (2.4)	ZNF180 (2.3)	DHX38 (2.3)	TOP1 (2.2)
GO:0042982	amyloid precursor protein metabolic process	0.14	> 0.20	NKPD1 (2.7)	DNAH11 (2.7)	CLPTM1 (2.6)	CYB561D1 (2.5)	CEACAM19 (2.4)	TMEM50A (2.3)	ST3GAL4 (2.0)	TMEM57 (1.9)	SLC44A2 (1.8)	SORT1 (1.8)
ENSG00000116754	SRSF11 PPI subnetwork	0.14	> 0.20	C1orf63 (4.0)	ILF3 (3.7)	BUD13 (3.0)	TOP1 (2.9)	SMARCA4 (2.8)	DHX38 (2.4)	SUGP1 (2.2)	USP1 (2.2)	FEN1 (2.0)	QTRT1 (1.9)
ENSG00000138764	CCNG2 PPI subnetwork	0.14	> 0.20	MYLIP (2.1)	CARM1 (1.9)	LPIN3 (1.6)	APOE (1.6)	MAPKAPK5 (1.6)	RHCE (1.6)	PVRL2 (1.5)	MAFB (1.5)	DNM2 (1.4)	GRINA (1.2)
GO:0003013	circulatory system process	0.14	> 0.20	ABO (3.2)	RHD (1.7)	BCAM (1.7)	C12orf47 (1.7)	C17orf57 (1.7)	RHCE (1.7)	CEACAM19 (1.7)	SORT1 (1.5)	ACAD10 (1.4)	HLX (1.4)
GO:0019955	cytokine binding	0.14	> 0.20	HLX (3.7)	TIMD4 (3.6)	PVR (2.3)	ZNF101 (2.1)	ENSG00000235545 (1.8)	CYB561D1 (1.8)	ANKRD31 (1.7)	CEACAM19 (1.7)	BCL3 (1.5)	GPAM (1.5)
ENSG00000096060	FKBP5 PPI subnetwork	0.14	> 0.20	HAPLN4 (3.0)	FRK (2.6)	RELB (2.2)	MAU2 (2.0)	GMIP (1.8)	C19orf52 (1.8)	POLK (1.7)	CARM1 (1.7)	MYLIP (1.6)	BUD13 (1.4)
REACTOME_PI3KAKT_ACTIVATION	REACTOME_PI3KAKT_ACTIVATION	0.14	> 0.20	ZHX3 (3.1)	ZNF180 (2.6)	MARK4 (1.8)	TRIB1 (1.8)	PTPN11 (1.8)	GRINA (1.8)	MAU2 (1.8)	CLPTM1 (1.7)	DNM2 (1.6)	HLX (1.6)
ENSG00000163909	HEYL PPI subnetwork	0.14	> 0.20	NYNRIN (3.1)	C11orf9 (3.1)	MYLIP (2.8)	KANK2 (2.5)	SH2B3 (2.3)	PTPN11 (2.1)	SLC44A2 (1.7)	C1orf63 (1.7)	ENSG00000238078 (1.6)	DNM2 (1.5)
ENSG00000154767	XPC PPI subnetwork	0.14	> 0.20	SUGP1 (3.4)	PSMA5 (2.9)	TXNL4B (2.5)	NT5DC1 (2.3)	POC5 (2.1)	MAU2 (2.1)	FEN1 (2.0)	TOMM40 (2.0)	CLPTM1 (1.9)	DYNC2LI1 (1.9)
MP:0011094	complete embryonic lethality before implantation	0.14	> 0.20	PSRC1 (3.2)	FEN1 (3.0)	USP1 (2.9)	DHX38 (2.4)	ILF3 (2.4)	USP24 (2.4)	BUD13 (2.4)	SUGP1 (2.3)	ZNF259 (1.9)	DDX56 (1.9)
ENSG00000186676	ENSG00000186676 PPI subnetwork	0.14	> 0.20	SARS (4.4)	PSMA5 (3.9)	ZNF259 (2.8)	TOMM40 (2.5)	HMGCR (2.3)	QTRT1 (2.2)	DHX38 (2.1)	SMARCA4 (2.1)	NAA25 (2.1)	DDX56 (2.0)
GO:0044433	cytoplasmic vesicle part	0.14	> 0.20	ITGB3 (2.6)	SORT1 (2.5)	YIPF2 (2.4)	CLPTM1 (2.4)	APOE (2.4)	RPH3A (2.3)	KIAA1324 (2.2)	ANGPTL3 (2.0)	HP (1.9)	APOB (1.8)
ENSG00000174125	TLR1 PPI subnetwork	0.14	> 0.20	MAFB (3.3)	C1orf63 (1.9)	MYLIP (1.8)	UBXN2B (1.8)	ERP29 (1.7)	POLK (1.6)	PMFBP1 (1.6)	PARP10 (1.5)	SH2B3 (1.5)	LPIN3 (1.5)
GO:0034754	cellular hormone metabolic process	0.14	> 0.20	CYP7A1 (3.8)	ABCG5 (2.7)	LPA (2.6)	NKPD1 (2.6)	ABCG8 (2.5)	ST3GAL4 (2.3)	TM6SF2 (2.3)	SLC22A1 (2.3)	CYB561D1 (2.2)	APOC4 (2.0)
ENSG00000186432	KPNA4 PPI subnetwork	0.14	> 0.20	USP1 (2.8)	FADS2 (2.5)	FADS1 (2.5)	ATXN7L2 (2.4)	PCSK9 (2.3)	TMEM116 (2.2)	C12orf43 (2.1)	FEN1 (2.0)	ST3GAL4 (1.9)	ALDH2 (1.8)
MP:0008519	thin retinal outer plexiform layer	0.14	> 0.20	KIAA1324 (1.8)	FRK (1.7)	MAPKAPK5 (1.7)	GEMIN7 (1.6)	PVRL2 (1.4)	TSSK6 (1.4)	YIPF2 (1.4)	C12orf47 (1.3)	MYLIP (1.3)	HNF1A (1.3)
MP:0002947	hemangioma	0.14	> 0.20	NCAN (2.3)	UBXN2B (2.0)	ABO (1.8)	SLC44A2 (1.8)	DDX56 (1.7)	POLK (1.6)	BCL3 (1.5)	MYLIP (1.5)	GCNT4 (1.4)	ALDH2 (1.3)
ENSG00000123643	SLC36A1 PPI subnetwork	0.14	> 0.20	HMGCR (5.9)	LDLR (5.4)	FADS1 (4.5)	FADS2 (4.4)	TM6SF2 (2.8)	NPC1L1 (2.3)	GPAM (2.1)	ABCG8 (2.0)	TMEM57 (2.0)	GATAD2A (1.9)
REACTOME_SIGNALING_BY_INTERLEUKINS	REACTOME_SIGNALING_BY_INTERLEUKINS	0.14	> 0.20	BCL3 (4.8)	RELB (4.0)	GMIP (3.2)	HLX (2.8)	GRINA (2.4)	DNM2 (2.3)	CYB561D1 (2.1)	PARP10 (2.1)	SH2B3 (1.8)	TRAFD1 (1.7)
MP:0003910	decreased eating behavior	0.14	> 0.20	PLEKHH2 (3.0)	C12orf47 (2.9)	CETP (2.4)	RPH3A (2.4)	ABCG8 (2.1)	ZHX3 (2.1)	ABCG5 (2.1)	ABO (2.1)	CELSR2 (2.0)	FADS1 (1.9)
GO:0005924	cell-substrate adherens junction	0.14	> 0.20	PLEC (4.2)	ITGB3 (3.6)	KANK2 (2.5)	GMIP (2.3)	PVRL2 (2.2)	SH2B3 (1.9)	BCAM (1.9)	DNM2 (1.8)	C11orf9 (1.7)	GPAM (1.5)
MP:0006082	CNS inflammation	0.14	> 0.20	OASL (3.8)	TRAFD1 (3.2)	MAFB (2.2)	COL4A3BP (2.0)	ERP29 (2.0)	APOE (1.9)	PARP10 (1.6)	APOC1 (1.6)	HAVCR1 (1.6)	GCNT4 (1.5)
GO:0050900	leukocyte migration	0.14	> 0.20	TIMD4 (3.2)	MAFB (3.1)	ENSG00000228044 (2.4)	APOE (2.2)	GMIP (2.0)	CETP (1.9)	PVR (1.7)	CEACAM19 (1.7)	ADAM1 (1.6)	ST3GAL4 (1.6)
REACTOME_REV:MEDIATED_NUCLEAR_EXPORT_OF_HIV:1_RNA	REACTOME_REV:MEDIATED_NUCLEAR_EXPORT_OF_HIV:1_RNA	0.14	> 0.20	NAA25 (3.7)	POC5 (3.4)	DDX56 (3.2)	USP1 (3.0)	FEN1 (2.4)	ILF3 (2.4)	USP24 (2.3)	DOCK7 (2.3)	BUD13 (2.2)	DHX38 (2.1)
ENSG00000013275	PSMC4 PPI subnetwork	0.14	> 0.20	PSMA5 (5.0)	NAA25 (3.5)	TOMM40 (2.7)	DDX56 (2.6)	TRAFD1 (2.3)	NT5DC1 (2.2)	SARS (1.9)	SMARCA4 (1.8)	PTPN11 (1.7)	BRAP (1.7)
ENSG00000172766	NAA16 PPI subnetwork	0.14	> 0.20	TOMM40 (3.6)	DDX56 (3.4)	NAA25 (3.3)	ZNF259 (2.8)	SUGP1 (2.7)	OGDH (2.5)	DHX38 (2.5)	PSMA5 (2.4)	SMARCA4 (2.3)	QTRT1 (2.3)
ENSG00000008710	PKD1 PPI subnetwork	0.14	> 0.20	PVRL2 (3.8)	PLEC (3.7)	AP1M2 (2.5)	DOCK7 (2.0)	C11orf9 (2.0)	FADS1 (1.9)	BCAM (1.9)	ITGB3 (1.8)	FADS2 (1.7)	LPIN3 (1.7)
ENSG00000067066	SP100 PPI subnetwork	0.14	> 0.20	ZNF180 (3.4)	ADAM1 (3.1)	C19orf52 (2.9)	ZNF101 (2.7)	FRK (2.5)	PTPN11 (2.4)	TMEM50A (2.2)	NT5DC1 (2.1)	TRAFD1 (1.9)	ENSG00000235545 (1.7)
ENSG00000130522	JUND PPI subnetwork	0.14	> 0.20	TRIB1 (4.7)	BCL3 (4.0)	ATXN2 (2.5)	PVR (2.1)	SARS (2.0)	HLX (1.9)	PARP10 (1.7)	TRAFD1 (1.6)	ALDH2 (1.5)	AMIGO1 (1.5)
MP:0000352	decreased cell proliferation	0.15	> 0.20	USP1 (3.2)	FEN1 (2.6)	TRIB1 (2.2)	DOCK7 (2.2)	PSRC1 (2.0)	KANK2 (2.0)	SMARCA4 (2.0)	CARM1 (1.9)	TOMM40 (1.9)	GATAD2A (1.8)
ENSG00000143033	MTF2 PPI subnetwork	0.15	> 0.20	FRK (2.7)	HLX (2.5)	PVRL2 (1.6)	ATXN2 (1.6)	NT5DC1 (1.5)	USP1 (1.4)	TIMD4 (1.4)	TRIB1 (1.4)	ENSG00000228044 (1.3)	OASL (1.3)
MP:0008713	abnormal cytokine level	0.15	> 0.20	BCL3 (3.6)	TRAFD1 (3.6)	HLX (3.3)	PARP10 (3.1)	MAFB (2.9)	ST3GAL4 (2.3)	ENSG00000228044 (1.8)	MYLIP (1.8)	GRINA (1.7)	PLEKHH2 (1.7)
MP:0008943	increased sensitivity to induced cell death	0.15	> 0.20	SARS (3.3)	SLC44A2 (3.1)	TRAPPC6A (2.5)	CYP7A1 (2.4)	RELB (2.2)	MAPKAPK5 (2.1)	ENSG00000226648 (1.8)	PVR (1.8)	ZHX3 (1.7)	OASL (1.7)
ENSG00000175575	PAAF1 PPI subnetwork	0.15	> 0.20	TOMM40 (4.2)	PSMA5 (4.2)	SUGP1 (2.7)	CLPTM1 (2.6)	FADS2 (2.2)	OGDH (2.2)	DHX38 (2.1)	NT5DC1 (1.9)	NAA25 (1.9)	SARS (1.9)
ENSG00000005882	PDK2 PPI subnetwork	0.15	> 0.20	CLPTM1 (3.7)	SYPL2 (3.5)	TOMM40 (3.1)	GPAM (3.0)	MARK4 (2.8)	OGDH (2.8)	TRAPPC6A (2.1)	PVRL2 (1.8)	CARM1 (1.7)	ZNF180 (1.7)
ENSG00000100596	SPTLC2 PPI subnetwork	0.15	> 0.20	ZNF180 (2.7)	CLPTM1 (2.3)	USP24 (2.3)	C12orf47 (2.2)	MAU2 (2.0)	POLK (1.8)	NKPD1 (1.8)	BCL3 (1.6)	LPAR2 (1.6)	SLC44A2 (1.5)
REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	REACTOME_PIP3_ACTIVATES_AKT_SIGNALING	0.15	> 0.20	ZHX3 (2.8)	ZNF180 (2.3)	CLPTM1 (2.3)	MARK4 (2.0)	TRIB1 (2.0)	UBXN2B (1.7)	TOMM40 (1.7)	MAU2 (1.7)	SARS (1.6)	HLX (1.6)
ENSG00000168066	SF1 PPI subnetwork	0.15	> 0.20	SUGP1 (3.1)	C1orf63 (3.0)	BUD13 (2.9)	DHX38 (2.9)	SMARCA4 (2.8)	CLPTM1 (2.8)	ATXN2 (2.5)	GATAD2A (2.5)	ILF3 (2.5)	MAU2 (2.1)
ENSG00000113569	NUP155 PPI subnetwork	0.15	> 0.20	USP1 (3.0)	BUD13 (3.0)	DOCK7 (3.0)	DDX56 (3.0)	NAA25 (3.0)	POC5 (2.8)	ZNF259 (2.7)	ILF3 (2.5)	CARM1 (2.3)	FEN1 (2.0)
GO:0031663	lipopolysaccharide-mediated signaling pathway	0.15	> 0.20	ENSG00000228044 (3.1)	UBXN2B (2.9)	PARP10 (2.4)	BLOC1S3 (2.4)	PVR (2.2)	GRINA (2.1)	BCL3 (1.6)	PMFBP1 (1.5)	MAU2 (1.5)	LPIN3 (1.5)
ENSG00000085872	CHERP PPI subnetwork	0.15	> 0.20	C1orf63 (3.6)	CARM1 (3.0)	BUD13 (2.7)	SMARCA4 (2.2)	GMIP (2.2)	ATXN2 (1.9)	ENSG00000254235 (1.9)	USP1 (1.8)	DNM2 (1.6)	ILF3 (1.6)
GO:0000299	integral to membrane of membrane fraction	0.15	> 0.20	CLPTM1 (2.5)	GCNT4 (1.8)	DHODH (1.6)	BLOC1S3 (1.6)	GPAM (1.6)	MARK4 (1.4)	CEACAM19 (1.4)	AMIGO1 (1.4)	PLCG1 (1.4)	NKPD1 (1.4)
ENSG00000129460	NGDN PPI subnetwork	0.15	> 0.20	ZNF259 (4.6)	DDX56 (4.2)	NAA25 (3.6)	QTRT1 (3.6)	TOMM40 (3.3)	DHODH (3.2)	C12orf43 (3.2)	SARS (2.2)	GATAD2A (2.0)	BRAP (1.9)
ENSG00000206212	ENSG00000206212 PPI subnetwork	0.15	> 0.20	DDX56 (3.7)	QTRT1 (3.6)	NAA25 (3.1)	ZNF259 (2.9)	TOMM40 (2.8)	SARS (2.4)	DHX38 (2.3)	GATAD2A (2.1)	SUGP1 (2.0)	ATP13A1 (2.0)
ENSG00000182498	ENSG00000182498 PPI subnetwork	0.15	> 0.20	DDX56 (3.7)	QTRT1 (3.6)	NAA25 (3.1)	ZNF259 (2.9)	TOMM40 (2.8)	SARS (2.4)	DHX38 (2.3)	GATAD2A (2.1)	SUGP1 (2.0)	ATP13A1 (2.0)
ENSG00000096150	RPS18 PPI subnetwork	0.15	> 0.20	DDX56 (3.7)	QTRT1 (3.6)	NAA25 (3.1)	ZNF259 (2.9)	TOMM40 (2.8)	SARS (2.4)	DHX38 (2.3)	GATAD2A (2.1)	SUGP1 (2.0)	ATP13A1 (2.0)
ENSG00000168530	MYL1 PPI subnetwork	0.15	> 0.20	ADAM1 (3.0)	SYPL2 (2.5)	ENSG00000238078 (2.4)	KANK2 (2.4)	ITGB3 (2.2)	AP1M2 (2.1)	C12orf51 (2.0)	FADS2 (2.0)	ERP29 (1.9)	ANKRD31 (1.8)
ENSG00000129048	CCRL1 PPI subnetwork	0.15	> 0.20	TIMD4 (4.0)	CETP (3.0)	OASL (3.0)	RELB (2.9)	TM6SF2 (2.0)	NPC1L1 (2.0)	MAFB (1.9)	BCL3 (1.8)	PVRL2 (1.7)	PVR (1.5)
REACTOME_SLC:MEDIATED_TRANSMEMBRANE_TRANSPORT	REACTOME_SLC:MEDIATED_TRANSMEMBRANE_TRANSPORT	0.15	> 0.20	TM6SF2 (3.4)	TMEM116 (3.0)	PLG (3.0)	ANGPTL3 (2.6)	SORT1 (2.5)	ATP13A1 (2.4)	CLPTM1 (2.1)	ABCG8 (2.0)	NPC1L1 (1.8)	NCAN (1.6)
MP:0000692	small spleen	0.15	> 0.20	PBX4 (2.7)	COL4A3BP (2.6)	HLX (2.5)	RHCE (1.9)	POLK (1.9)	CILP2 (1.9)	MYLIP (1.7)	SLC22A1 (1.6)	PLEC (1.6)	SH2B3 (1.5)
ENSG00000163453	IGFBP7 PPI subnetwork	0.15	> 0.20	CILP2 (6.3)	OASL (3.1)	PVR (2.7)	BCAM (2.2)	PVRL2 (2.0)	CETP (1.9)	RELB (1.5)	MYLIP (1.5)	SLC22A1 (1.4)	ANKRD31 (1.4)
MP:0005014	increased B cell number	0.15	> 0.20	RELB (4.0)	TIMD4 (3.5)	CETP (3.2)	BCL3 (3.1)	GMIP (3.0)	MAFB (3.0)	ZNF101 (2.7)	PLCG1 (2.0)	LPIN3 (1.9)	POLK (1.6)
KEGG_CIRCADIAN_RHYTHM_MAMMAL	KEGG_CIRCADIAN_RHYTHM_MAMMAL	0.15	> 0.20	CILP2 (3.1)	TRIB1 (2.7)	GPAM (2.0)	ZHX3 (1.9)	C17orf57 (1.8)	LPIN3 (1.5)	TMEM57 (1.5)	LDLR (1.3)	SH2B3 (1.3)	MAPKAPK5 (1.3)
ENSG00000174697	LEP PPI subnetwork	0.15	> 0.20	BCL3 (4.2)	CETP (2.9)	RELB (2.8)	TIMD4 (2.8)	HLX (2.6)	LPA (2.2)	ALDH2 (2.1)	GMIP (2.0)	APOA5 (1.7)	HP (1.7)
ENSG00000151748	SAV1 PPI subnetwork	0.15	> 0.20	CBLC (5.2)	AP1M2 (4.0)	PVRL2 (3.1)	CELSR2 (2.7)	PSRC1 (2.5)	DHX38 (2.5)	GOT2P1 (2.0)	FRK (2.0)	ST3GAL4 (1.9)	ANKRD31 (1.7)
MP:0005025	abnormal response to infection	0.15	> 0.20	BCL3 (4.4)	PARP10 (3.3)	OASL (2.5)	RELB (2.2)	HLX (2.0)	MAFB (1.9)	TRIB1 (1.7)	TRAFD1 (1.4)	GMIP (1.3)	COL4A3BP (1.3)
ENSG00000111241	FGF6 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000158815	FGF17 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000107831	FGF8 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000162344	FGF19 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000156427	FGF18 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
ENSG00000070388	FGF22 PPI subnetwork	0.15	> 0.20	HAVCR1 (4.8)	HAPLN4 (3.7)	PLEKHH2 (3.4)	C11orf9 (3.2)	ZHX3 (2.8)	C17orf57 (2.5)	CBLC (2.5)	NYNRIN (2.2)	NCAN (1.9)	CEACAM19 (1.9)
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	0.15	> 0.20	TRAPPC6A (3.1)	ST3GAL4 (2.1)	PMFBP1 (2.1)	KIAA1324 (2.0)	NT5DC1 (2.0)	YIPF2 (2.0)	ERP29 (1.9)	BLOC1S3 (1.9)	APOE (1.7)	COL4A3BP (1.6)
ENSG00000138767	CNOT6L PPI subnetwork	0.15	> 0.20	ATP13A1 (4.0)	DDX56 (2.7)	MAPKAPK5 (2.6)	HNF1A (2.4)	BRAP (2.4)	TOMM40 (2.2)	MAU2 (2.1)	TRIB1 (2.0)	PTPN11 (1.9)	DHODH (1.9)
ENSG00000134352	IL6ST PPI subnetwork	0.15	> 0.20	BCL3 (3.8)	COL4A3BP (2.2)	PVR (2.1)	BCAM (2.0)	HLX (1.8)	CYP7A1 (1.7)	SLC22A1 (1.7)	RELB (1.6)	C17orf57 (1.4)	ENSG00000238078 (1.3)
GO:0060068	vagina development	0.15	> 0.20	LPAR2 (2.9)	PPP1R37 (2.8)	BLOC1S3 (2.2)	CYB561D1 (1.9)	LPIN3 (1.7)	POLK (1.5)	QTRT1 (1.5)	NKPD1 (1.4)	HAVCR1 (1.4)	ST3GAL4 (1.4)
ENSG00000170606	HSPA4 PPI subnetwork	0.15	> 0.20	CYP7A1 (2.8)	TOMM40 (2.6)	CLPTM1 (2.5)	GRINA (2.2)	ZNF259 (2.1)	RELB (2.0)	TOP1 (2.0)	ILF3 (1.8)	SARS (1.7)	DHX38 (1.6)
ENSG00000121931	LRIF1 PPI subnetwork	0.15	> 0.20	TOMM40 (2.8)	TXNL4B (2.5)	PSMA5 (2.5)	ZNF180 (2.3)	GEMIN7 (2.1)	ATXN7L2 (2.0)	PPP1R37 (2.0)	CLPTM1 (2.0)	DHX38 (1.9)	PVR (1.8)
REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	0.15	> 0.20	ITGB3 (10.7)	CETP (4.3)	GMPR (3.3)	RHD (2.7)	MAFB (1.8)	APOE (1.7)	ENSG00000228044 (1.7)	ENSG00000238078 (1.7)	TIMD4 (1.7)	ST3GAL4 (1.6)
ENSG00000142252	GEMIN7 PPI subnetwork	0.15	> 0.20	POC5 (3.2)	ZNF180 (2.9)	GEMIN7 (2.4)	QTRT1 (2.2)	C12orf43 (2.2)	TOMM40 (1.9)	BUD13 (1.9)	C12orf47 (1.8)	DHODH (1.6)	FEN1 (1.5)
ENSG00000170677	SOCS6 PPI subnetwork	0.15	> 0.20	BCL3 (3.8)	RELB (2.9)	HLX (2.9)	GMIP (2.4)	TIMD4 (2.1)	GRINA (1.8)	PARP10 (1.7)	TMEM50A (1.7)	TRIB1 (1.6)	SH2B3 (1.5)
GO:0005072	transforming growth factor beta receptor, cytoplasmic mediator activity	0.15	> 0.20	KANK2 (3.0)	MYLIP (1.9)	POC5 (1.7)	ALDH2 (1.6)	MAPKAPK5 (1.5)	BCL3 (1.4)	NYNRIN (1.4)	MAU2 (1.4)	PVR (1.3)	MAFB (1.2)
REACTOME_TERMINATION_OF_O:GLYCAN_BIOSYNTHESIS	REACTOME_TERMINATION_OF_O:GLYCAN_BIOSYNTHESIS	0.15	> 0.20	ST3GAL4 (4.8)	KIAA1324 (3.4)	ABO (1.8)	PMFBP1 (1.6)	AP1M2 (1.6)	PVRL2 (1.6)	FADS1 (1.4)	ITGB3 (1.2)	ENSG00000254235 (1.1)	FADS2 (1.1)
MP:0011346	renal tubule atrophy	0.15	> 0.20	TMED4 (3.2)	PLG (2.8)	BCAM (2.6)	PLEKHH2 (2.3)	NT5DC1 (2.2)	HNF1A (2.0)	C17orf57 (2.0)	ABCG5 (2.0)	ERP29 (1.5)	APOB (1.4)
GO:0051537	2 iron, 2 sulfur cluster binding	0.15	> 0.20	RHD (3.9)	RHCE (3.7)	GMPR (2.5)	APOC4 (2.3)	NT5DC1 (2.0)	ATXN7L2 (1.8)	CYP7A1 (1.7)	OGDH (1.6)	DNAH11 (1.5)	HP (1.5)
GO:0016831	carboxy-lyase activity	0.15	> 0.20	DHODH (3.3)	FADS2 (2.8)	HMGCR (2.7)	PLG (2.5)	SARS (2.3)	GPAM (2.2)	TXNL4B (2.1)	DNAH11 (1.8)	LDLR (1.8)	FADS1 (1.7)
GO:0004716	receptor signaling protein tyrosine kinase activity	0.15	> 0.20	SLC44A2 (2.3)	MAFB (1.9)	GPAM (1.7)	NYNRIN (1.6)	HLX (1.6)	NCAN (1.6)	MYLIP (1.5)	TRIB1 (1.5)	USP24 (1.5)	LPIN3 (1.5)
ENSG00000163346	PBXIP1 PPI subnetwork	0.15	> 0.20	ATXN2 (3.8)	MAPKAPK5 (3.5)	BRAP (3.1)	C12orf51 (3.0)	TRAFD1 (2.6)	C12orf43 (2.5)	ENSG00000226648 (2.2)	SMARCA4 (2.2)	ANKRD31 (2.0)	PCSK9 (1.7)
ENSG00000112062	MAPK14 PPI subnetwork	0.15	> 0.20	TRIB1 (4.3)	PVR (2.6)	GRINA (2.4)	MARK4 (2.4)	CARM1 (2.4)	PTPN11 (2.2)	HLX (2.2)	SH2B3 (2.1)	SARS (2.1)	MAU2 (1.9)
ENSG00000138448	ITGAV PPI subnetwork	0.15	> 0.20	ITGB3 (4.3)	CLPTM1 (3.1)	PVRL2 (2.6)	APOE (2.4)	ST3GAL4 (2.4)	C17orf57 (2.0)	PLEC (2.0)	SLC44A2 (1.9)	USP24 (1.9)	CILP2 (1.8)
ENSG00000009954	BAZ1B PPI subnetwork	0.15	> 0.20	CARM1 (3.6)	SMARCA4 (3.5)	NYNRIN (2.8)	ILF3 (2.6)	ATXN2 (2.1)	FEN1 (2.0)	CELSR2 (1.9)	AP1M2 (1.9)	USP1 (1.8)	C12orf47 (1.8)
GO:0046685	response to arsenic-containing substance	0.15	> 0.20	RHCE (5.4)	RHD (5.0)	FRK (4.1)	POLK (2.2)	HAVCR1 (2.1)	TXNL4B (2.1)	C19orf52 (1.5)	ENSG00000228044 (1.3)	GOT2P1 (1.3)	GEMIN7 (1.3)
ENSG00000143622	RIT1 PPI subnetwork	0.15	> 0.20	NKPD1 (2.3)	MARK4 (2.3)	ABO (2.0)	PMFBP1 (2.0)	PVRL2 (2.0)	PPP1R37 (2.0)	ATXN7L2 (1.8)	BCL3 (1.8)	POLK (1.6)	MYLIP (1.6)
MP:0001729	impaired embryo implantation	0.15	> 0.20	ENSG00000228044 (2.7)	ZHX3 (2.2)	HP (2.0)	C11orf9 (1.9)	DHX38 (1.8)	PVR (1.7)	GPAM (1.6)	HLX (1.6)	ENSG00000254235 (1.5)	PARP10 (1.5)
ENSG00000105723	GSK3A PPI subnetwork	0.15	> 0.20	TRIB1 (3.9)	MARK4 (3.2)	GMIP (2.6)	GRINA (2.4)	SH2B3 (2.2)	PVRL2 (2.2)	MAPKAPK5 (2.2)	MAFB (1.9)	CARM1 (1.8)	UBXN2B (1.7)
GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	0.15	> 0.20	PLEKHH2 (2.1)	KANK2 (2.1)	ATXN7L2 (1.7)	GCNT4 (1.6)	CEACAM19 (1.6)	MARK4 (1.6)	ENSG00000254235 (1.3)	SORT1 (1.3)	ITGB3 (1.3)	ENSG00000226645 (1.3)
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	0.15	> 0.20	ZHX3 (2.8)	NT5DC1 (2.3)	HP (2.3)	TM6SF2 (2.2)	SYPL2 (1.8)	OGDH (1.8)	LPIN3 (1.5)	FADS2 (1.5)	ITGB3 (1.3)	ZNF259 (1.3)
ENSG00000135930	EIF4E2 PPI subnetwork	0.15	> 0.20	CARM1 (3.8)	DNM2 (3.7)	LPAR2 (3.1)	GPAM (2.7)	C11orf9 (2.6)	ZHX3 (2.5)	USP24 (2.4)	GATAD2A (2.2)	PLEC (2.1)	PCSK9 (1.9)
ENSG00000161960	EIF4A1 PPI subnetwork	0.15	> 0.20	TOMM40 (3.5)	PSMA5 (3.3)	NAA25 (3.1)	SARS (2.9)	DDX56 (2.7)	SUGP1 (2.2)	SMARCA4 (2.2)	TOP1 (1.9)	ZNF259 (1.8)	DHX38 (1.7)
GO:0009068	aspartate family amino acid catabolic process	0.15	> 0.20	QTRT1 (2.8)	DYNC2LI1 (2.5)	ENSG00000254235 (2.4)	ACAD10 (2.3)	C19orf52 (2.0)	TMED4 (1.8)	GOT2P1 (1.7)	OGDH (1.6)	NT5DC1 (1.6)	MOSC1 (1.6)
ENSG00000215328	HSPA1A PPI subnetwork	0.15	> 0.20	OGDH (3.4)	AP1M2 (3.0)	PLEC (2.5)	ILF3 (2.3)	SMARCA4 (2.3)	CARM1 (2.1)	SARS (2.0)	POLK (1.9)	TOP1 (1.7)	TOMM40 (1.7)
MP:0010413	complete atrioventricular septal defect	0.15	> 0.20	C11orf9 (3.6)	PVR (2.7)	APOB (2.6)	NYNRIN (2.3)	PVRL2 (2.2)	BCAM (2.2)	ST3GAL4 (2.1)	DOCK7 (1.9)	PLCG1 (1.8)	PPP1R37 (1.5)
GO:0051235	maintenance of location	0.15	> 0.20	TIMD4 (2.5)	CLPTM1 (2.0)	CETP (2.0)	ZNF101 (1.9)	RHD (1.8)	GRINA (1.7)	OGDH (1.6)	C17orf57 (1.5)	RHCE (1.4)	RPH3A (1.4)
GO:0008015	blood circulation	0.15	> 0.20	ABO (3.3)	RHD (1.7)	C12orf47 (1.7)	CEACAM19 (1.7)	RHCE (1.7)	BCAM (1.7)	C17orf57 (1.6)	HLX (1.5)	SORT1 (1.5)	TMEM116 (1.4)
ENSG00000165732	DDX21 PPI subnetwork	0.15	> 0.20	RELB (2.9)	USP1 (2.6)	PVR (2.5)	ILF3 (2.4)	NAA25 (2.4)	SMARCA4 (2.2)	ATP13A1 (2.1)	TRIB1 (2.0)	FEN1 (2.0)	TOMM40 (2.0)
ENSG00000159110	IFNAR2 PPI subnetwork	0.15	> 0.20	BCL3 (3.4)	OASL (3.2)	PARP10 (2.3)	COL4A3BP (2.2)	TRAFD1 (2.0)	CYP7A1 (1.7)	C17orf57 (1.7)	RELB (1.5)	ZNF101 (1.5)	BCAM (1.3)
GO:0007141	male meiosis I	0.15	> 0.20	ANKRD31 (3.8)	TMEM116 (1.7)	GOT2P1 (1.6)	TSSK6 (1.6)	ENSG00000238078 (1.5)	POC5 (1.2)	ENSG00000226645 (1.2)	PLEKHH2 (1.2)	BRAP (1.1)	PBX4 (1.1)
ENSG00000164404	GDF9 PPI subnetwork	0.15	> 0.20	PSRC1 (2.7)	TRAPPC6A (2.7)	ALDH2 (2.3)	CEACAM19 (2.0)	PVRL2 (2.0)	DOCK7 (2.0)	MARK4 (2.0)	GEMIN7 (1.8)	ABO (1.8)	USP1 (1.6)
GO:0006984	ER-nucleus signaling pathway	0.15	> 0.20	FADS2 (3.3)	LDLR (3.2)	GCNT4 (3.1)	HMGCR (2.9)	FADS1 (2.8)	SARS (2.5)	PCSK9 (2.3)	YIPF2 (2.1)	BLOC1S3 (2.0)	ENSG00000238078 (1.9)
GO:0033549	MAP kinase phosphatase activity	0.15	> 0.20	TRIB1 (7.7)	TSSK6 (2.4)	PVR (2.3)	ENSG00000226645 (2.0)	LDLR (1.8)	SYPL2 (1.7)	POLK (1.6)	ENSG00000235545 (1.5)	SH2B3 (1.5)	DNAH11 (1.3)
ENSG00000141696	LEPREL4 PPI subnetwork	0.15	> 0.20	OASL (3.0)	TIMD4 (3.0)	CETP (2.7)	PLEKHH2 (1.8)	TMEM57 (1.8)	DNAH11 (1.7)	C1orf63 (1.7)	TSSK6 (1.4)	POLK (1.4)	SYPL2 (1.3)
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES	0.15	> 0.20	USP1 (3.1)	FEN1 (2.8)	TRAPPC6A (2.4)	BUD13 (2.1)	DDX56 (1.8)	LPIN3 (1.8)	ZNF180 (1.7)	GOT2P1 (1.7)	ERP29 (1.7)	BLOC1S3 (1.6)
REACTOME_BASE_EXCISION_REPAIR	REACTOME_BASE_EXCISION_REPAIR	0.15	> 0.20	USP1 (3.1)	FEN1 (2.8)	TRAPPC6A (2.4)	BUD13 (2.1)	DDX56 (1.8)	LPIN3 (1.8)	ZNF180 (1.7)	GOT2P1 (1.7)	ERP29 (1.7)	BLOC1S3 (1.6)
MP:0001194	dermatitis	0.15	> 0.20	BCL3 (2.9)	TRIB1 (2.8)	NKPD1 (2.8)	GMIP (2.7)	OASL (2.5)	LPAR2 (2.4)	MAFB (2.4)	PARP10 (2.3)	LDLR (2.1)	CYB561D1 (2.0)
MP:0002705	dilated renal tubules	0.15	> 0.20	BCAM (4.6)	PLEKHH2 (3.9)	NYNRIN (2.5)	DYNC2LI1 (2.5)	PLG (2.2)	CELSR2 (2.0)	PVRL2 (1.8)	ENSG00000228044 (1.8)	C17orf57 (1.6)	TMED4 (1.6)
ENSG00000179335	CLK3 PPI subnetwork	0.15	> 0.20	ATXN2 (3.4)	SMARCA4 (2.6)	BRAP (2.6)	NAA25 (2.4)	C12orf43 (2.3)	MAPKAPK5 (2.2)	CLPTM1 (2.2)	C12orf51 (2.1)	ANKRD31 (2.1)	TRAFD1 (1.9)
GO:0031058	positive regulation of histone modification	0.15	> 0.20	TMEM57 (3.2)	PCSK9 (2.3)	SH2B3 (2.1)	FADS2 (2.0)	FADS1 (2.0)	DNM2 (1.9)	C12orf51 (1.9)	MYLIP (1.6)	GOT2P1 (1.6)	ENSG00000228044 (1.4)
ENSG00000102554	KLF5 PPI subnetwork	0.15	> 0.20	BCL3 (3.2)	SH2B3 (3.1)	RELB (2.9)	CARM1 (2.8)	TRIB1 (2.6)	ATXN2 (2.1)	TOP1 (2.0)	BUD13 (1.8)	PLEC (1.6)	ALDH2 (1.6)
ENSG00000113916	BCL6 PPI subnetwork	0.15	> 0.20	BCL3 (3.4)	TRIB1 (3.3)	MAU2 (3.2)	USP24 (3.1)	PARP10 (2.7)	GMIP (2.6)	POLK (2.1)	SMARCA4 (2.1)	MAFB (2.1)	ZNF180 (1.6)
ENSG00000167306	MYO5B PPI subnetwork	0.15	> 0.20	USP24 (3.2)	SMARCA4 (2.7)	COL4A3BP (2.6)	MAPKAPK5 (2.1)	NAA25 (2.0)	C12orf51 (1.9)	POLK (1.8)	PTPN11 (1.6)	ILF3 (1.5)	AP1M2 (1.5)
GO:0042559	pteridine-containing compound biosynthetic process	0.15	> 0.20	TXNL4B (2.6)	DHODH (2.5)	NT5DC1 (2.5)	GOT2P1 (2.4)	HNF1A (2.2)	DNAH11 (2.1)	TRAPPC6A (1.9)	ENSG00000226645 (1.8)	ENSG00000235545 (1.8)	CYP7A1 (1.7)
ENSG00000108590	MED31 PPI subnetwork	0.15	> 0.20	GEMIN7 (3.9)	TXNL4B (3.2)	TRAPPC6A (2.6)	BRAP (2.2)	CLPTM1 (2.1)	MARK4 (2.0)	C12orf47 (1.9)	ATXN7L2 (1.9)	TOMM40 (1.9)	PBX4 (1.8)
ENSG00000133056	PIK3C2B PPI subnetwork	0.15	> 0.20	CBLC (4.9)	DNM2 (2.9)	PVRL2 (2.6)	SLC44A2 (2.5)	AP1M2 (2.5)	PLEC (2.5)	DOCK7 (2.5)	PPP1R37 (2.3)	LPAR2 (2.0)	BCL3 (1.9)
ENSG00000137574	TGS1 PPI subnetwork	0.15	> 0.20	C12orf51 (3.4)	ZHX3 (3.0)	ENSG00000254235 (2.6)	ATXN2 (2.5)	USP24 (2.2)	OGDH (2.1)	USP1 (1.9)	DOCK7 (1.7)	TOP1 (1.5)	NAA25 (1.4)
ENSG00000206267	ENSG00000206267 PPI subnetwork	0.15	> 0.20	TOMM40 (4.3)	DDX56 (4.2)	NAA25 (4.1)	ZNF259 (3.9)	DHODH (3.5)	USP24 (3.5)	QTRT1 (2.7)	DHX38 (2.5)	ATP13A1 (2.4)	SUGP1 (1.9)
ENSG00000204351	SKIV2L PPI subnetwork	0.15	> 0.20	TOMM40 (4.3)	DDX56 (4.2)	NAA25 (4.1)	ZNF259 (3.9)	DHODH (3.5)	USP24 (3.5)	QTRT1 (2.7)	DHX38 (2.5)	ATP13A1 (2.4)	SUGP1 (1.9)
GO:0034138	toll-like receptor 3 signaling pathway	0.15	> 0.20	SH2B3 (2.7)	ENSG00000226645 (2.6)	PARP10 (2.3)	GEMIN7 (2.3)	RELB (2.2)	ENSG00000228044 (2.2)	BLOC1S3 (2.0)	OASL (1.9)	TRIB1 (1.8)	GMIP (1.8)
MP:0002052	decreased tumor incidence	0.15	> 0.20	SLC44A2 (2.8)	HLX (2.1)	TRAFD1 (2.0)	CETP (1.9)	BCL3 (1.8)	C17orf57 (1.7)	GEMIN7 (1.7)	FEN1 (1.6)	PSRC1 (1.6)	NYNRIN (1.5)
MP:0004556	enlarged allantois	0.15	> 0.20	GATAD2A (3.5)	RPH3A (1.9)	LPA (1.8)	APOE (1.7)	TRIB1 (1.7)	C17orf57 (1.7)	HAPLN4 (1.6)	CLPTM1 (1.6)	BLOC1S3 (1.6)	CARM1 (1.5)
GO:0002756	MyD88-independent toll-like receptor signaling pathway	0.15	> 0.20	SH2B3 (2.9)	ENSG00000228044 (2.3)	GEMIN7 (2.2)	ENSG00000226645 (2.2)	PARP10 (2.2)	RELB (1.9)	PVR (1.9)	OASL (1.9)	BLOC1S3 (1.9)	CYB561D1 (1.9)
GO:0051004	regulation of lipoprotein lipase activity	0.15	> 0.20	APOE (2.9)	TSSK6 (2.3)	TM6SF2 (2.0)	APOC4 (1.9)	ABCG5 (1.8)	ENSG00000228044 (1.8)	APOC1 (1.7)	CLPTM1 (1.7)	HP (1.6)	PMFBP1 (1.6)
ENSG00000129691	ASH2L PPI subnetwork	0.15	> 0.20	ATXN2 (4.1)	C12orf51 (2.7)	BUD13 (2.6)	GATAD2A (2.4)	TOP1 (2.2)	SMARCA4 (2.2)	CARM1 (2.2)	ILF3 (2.2)	USP1 (2.2)	C19orf52 (2.1)
ENSG00000114026	OGG1 PPI subnetwork	0.15	> 0.20	ZNF180 (2.5)	SUGP1 (2.3)	MAU2 (2.2)	DYNC2LI1 (2.1)	MAPKAPK5 (2.0)	KIAA1324 (2.0)	BRAP (1.9)	AMIGO1 (1.9)	FEN1 (1.7)	TM6SF2 (1.7)
ENSG00000175054	ATR PPI subnetwork	0.15	> 0.20	FEN1 (5.2)	USP1 (3.7)	TOMM40 (2.7)	SMARCA4 (2.7)	CLPTM1 (1.9)	USP24 (1.8)	ILF3 (1.7)	ENSG00000226648 (1.6)	ZNF180 (1.4)	DNM2 (1.3)
ENSG00000171720	HDAC3 PPI subnetwork	0.15	> 0.20	MAPKAPK5 (2.9)	ATXN2 (2.2)	GATAD2A (2.2)	USP24 (2.2)	MAU2 (2.2)	PTPN11 (2.1)	RELB (1.9)	BCL3 (1.9)	TRIB1 (1.9)	PARP10 (1.7)
MP:0004742	abnormal vestibular system physiology	0.15	> 0.20	PBX4 (3.7)	AP1M2 (2.6)	C12orf47 (2.6)	BCL3 (1.8)	PVRL2 (1.7)	ENSG00000228044 (1.7)	HNF1A (1.7)	TRIB1 (1.6)	ZNF180 (1.4)	LPAR2 (1.4)
GO:0031330	negative regulation of cellular catabolic process	0.15	> 0.20	ENSG00000226648 (2.0)	ST3GAL4 (1.9)	APOE (1.8)	SLC22A1 (1.4)	ZHX3 (1.4)	TMEM57 (1.4)	GRINA (1.2)	ATXN7L2 (1.2)	POC5 (1.1)	MARK4 (1.1)
MP:0000074	abnormal neurocranium morphology	0.15	> 0.20	CILP2 (3.8)	MAFB (3.0)	NYNRIN (2.1)	MYLIP (2.1)	KANK2 (2.0)	PLEC (1.9)	DOCK7 (1.4)	PLEKHH2 (1.4)	ALDH2 (1.4)	LDLR (1.3)
REACTOME_ZINC_TRANSPORTERS	REACTOME_ZINC_TRANSPORTERS	0.15	> 0.20	YIPF2 (3.5)	AP1M2 (2.6)	NPC1L1 (2.5)	ERP29 (2.2)	ATP13A1 (2.2)	ST3GAL4 (1.8)	TMED4 (1.7)	PMFBP1 (1.7)	QTRT1 (1.6)	LPAR2 (1.5)
GO:0032880	regulation of protein localization	0.15	> 0.20	PBX4 (1.8)	ST3GAL4 (1.7)	ZNF101 (1.7)	C17orf57 (1.6)	AP1M2 (1.5)	PLEKHH2 (1.5)	ENSG00000238078 (1.4)	PVRL2 (1.4)	PLCG1 (1.3)	ENSG00000228044 (1.2)
ENSG00000082898	XPO1 PPI subnetwork	0.15	> 0.20	PSRC1 (3.8)	FEN1 (3.4)	POC5 (3.3)	USP1 (2.7)	NAA25 (2.0)	TOP1 (2.0)	HMGCR (1.9)	DHX38 (1.7)	DDX56 (1.7)	ILF3 (1.6)
ENSG00000164597	COG5 PPI subnetwork	0.15	> 0.20	SUGP1 (3.6)	DHX38 (3.2)	MAU2 (3.1)	TRAFD1 (2.3)	DYNC2LI1 (2.3)	DNM2 (2.2)	YIPF2 (2.0)	CETP (2.0)	C12orf43 (1.7)	LPIN3 (1.7)
GO:0010611	regulation of cardiac muscle hypertrophy	0.15	> 0.20	CEACAM19 (3.7)	HNF1A (3.1)	ENSG00000254235 (2.1)	TRAPPC6A (2.1)	DNAH11 (2.0)	HAVCR1 (1.9)	GCNT4 (1.8)	ANKRD31 (1.7)	TXNL4B (1.7)	LPIN3 (1.6)
GO:0001568	blood vessel development	0.15	> 0.20	HLX (2.9)	PVR (2.8)	PVRL2 (2.6)	NYNRIN (2.1)	BCAM (2.1)	SH2B3 (2.0)	KANK2 (1.9)	C17orf57 (1.8)	CEACAM19 (1.7)	MAFB (1.7)
ENSG00000169220	RGS14 PPI subnetwork	0.15	> 0.20	DNM2 (3.9)	USP24 (2.6)	GMIP (2.5)	POLK (2.5)	COL4A3BP (2.4)	TMEM50A (2.1)	MAU2 (2.1)	SORT1 (2.0)	BCL3 (2.0)	SLC44A2 (2.0)
ENSG00000117394	SLC2A1 PPI subnetwork	0.15	> 0.20	LDLR (3.8)	FADS1 (3.6)	FADS2 (3.4)	BRAP (3.3)	PCSK9 (3.2)	HMGCR (3.1)	SARS (2.7)	SORT1 (2.7)	SYPL2 (2.7)	GMPR (2.4)
ENSG00000108654	DDX5 PPI subnetwork	0.15	> 0.20	SMARCA4 (3.6)	ILF3 (3.3)	DDX56 (2.8)	TOP1 (2.7)	GATAD2A (2.7)	CARM1 (2.6)	NAA25 (2.4)	TOMM40 (2.3)	QTRT1 (2.3)	SUGP1 (2.1)
ENSG00000205339	IPO7 PPI subnetwork	0.15	> 0.20	SARS (3.5)	PLEC (3.2)	BRAP (2.7)	DHX38 (2.6)	ATP13A1 (2.6)	USP24 (2.5)	PSMA5 (2.2)	ZNF259 (2.0)	PTPN11 (1.9)	NT5DC1 (1.8)
GO:0005689	U12-type spliceosomal complex	0.15	> 0.20	GEMIN7 (3.1)	C12orf47 (3.0)	DHX38 (3.0)	C12orf43 (2.6)	BUD13 (2.6)	ZNF180 (2.4)	MAPKAPK5 (2.3)	TRAPPC6A (2.1)	ADAM1 (2.1)	ANKRD31 (1.8)
ENSG00000117751	PPP1R8 PPI subnetwork	0.15	> 0.20	BRAP (2.8)	FADS2 (2.7)	ENSG00000238078 (2.1)	USP1 (2.0)	BUD13 (2.0)	CYP7A1 (2.0)	FADS1 (1.9)	TIMD4 (1.7)	SUGP1 (1.7)	CARM1 (1.5)
ENSG00000133704	IPO8 PPI subnetwork	0.15	> 0.20	ATXN2 (2.3)	ENSG00000235545 (1.9)	OGDH (1.9)	ABO (1.8)	GOT2P1 (1.7)	NAA25 (1.7)	TXNL4B (1.7)	PLEC (1.7)	DHODH (1.7)	ITGB3 (1.6)
ENSG00000081237	PTPRC PPI subnetwork	0.15	> 0.20	PLCG1 (2.9)	GMIP (2.7)	SLC44A2 (2.7)	LPA (2.6)	DNM2 (2.0)	ZNF101 (1.9)	APOA5 (1.7)	MAFB (1.7)	LPAR2 (1.6)	TIMD4 (1.6)
GO:0005125	cytokine activity	0.15	> 0.20	TIMD4 (3.2)	RELB (2.5)	BCL3 (2.3)	OASL (2.1)	CYP7A1 (1.9)	CETP (1.9)	PVR (1.8)	SLC22A1 (1.7)	ZNF101 (1.7)	PVRL2 (1.5)
ENSG00000101057	MYBL2 PPI subnetwork	0.15	> 0.20	GATAD2A (3.0)	SMARCA4 (2.8)	USP1 (2.7)	RHD (2.5)	FEN1 (2.3)	KANK2 (2.0)	RHCE (1.9)	PSRC1 (1.9)	ATXN2 (1.7)	GCNT4 (1.5)
GO:0030308	negative regulation of cell growth	0.15	> 0.20	GCNT4 (2.9)	TXNL4B (2.3)	C19orf52 (2.3)	POLK (2.2)	ENSG00000254235 (1.8)	C12orf47 (1.7)	C1orf63 (1.7)	AMIGO1 (1.6)	ANKRD31 (1.6)	TMED4 (1.6)
GO:0004198	calcium-dependent cysteine-type endopeptidase activity	0.15	> 0.20	DNM2 (3.1)	PLEC (2.4)	NYNRIN (2.3)	DNAH11 (2.1)	OASL (2.1)	CBLC (1.8)	LPIN3 (1.8)	PVRL2 (1.7)	ZNF180 (1.7)	PPP1R37 (1.6)
MP:0008476	increased spleen red pulp amount	0.15	> 0.20	RHCE (4.8)	RHD (3.6)	RELB (3.5)	BCL3 (3.1)	PBX4 (2.6)	FADS1 (2.6)	SH2B3 (2.3)	GRINA (2.2)	DNM2 (2.0)	C12orf51 (1.9)
ENSG00000152818	UTRN PPI subnetwork	0.15	> 0.20	ACAD10 (3.2)	HNF1A (3.0)	KANK2 (2.5)	ERP29 (2.2)	NT5DC1 (2.2)	PLCG1 (2.1)	SYPL2 (2.0)	ENSG00000235545 (1.8)	C17orf57 (1.8)	PTPN11 (1.8)
ENSG00000182578	CSF1R PPI subnetwork	0.15	> 0.20	DNM2 (4.0)	GMIP (3.6)	MAFB (3.4)	BCL3 (2.6)	MARK4 (2.4)	TRIB1 (2.3)	ITGB3 (2.2)	CETP (2.2)	ST3GAL4 (2.1)	PPP1R37 (2.0)
MP:0002058	neonatal lethality	0.15	> 0.20	MYLIP (2.9)	ZHX3 (2.5)	SYPL2 (1.8)	PLEKHH2 (1.7)	SORT1 (1.7)	PLCG1 (1.6)	BCAM (1.3)	HAVCR1 (1.3)	CELSR2 (1.3)	KANK2 (1.2)
ENSG00000166747	AP1G1 PPI subnetwork	0.15	> 0.20	CLPTM1 (4.1)	PPP1R37 (3.1)	GRINA (3.0)	SMARCA4 (2.9)	C12orf51 (2.7)	YIPF2 (2.5)	DHX38 (2.2)	COL4A3BP (2.0)	SH2B3 (1.9)	TOP1 (1.8)
GO:0006026	aminoglycan catabolic process	0.15	> 0.20	NKPD1 (4.3)	PMFBP1 (4.0)	CEACAM19 (3.7)	ENSG00000228044 (3.1)	TMED4 (3.1)	ERP29 (2.4)	CETP (2.2)	TIMD4 (1.9)	PBX4 (1.8)	CYB561D1 (1.8)
ENSG00000140650	PMM2 PPI subnetwork	0.15	> 0.20	NAA25 (5.1)	DDX56 (4.2)	TOMM40 (3.7)	ZNF259 (3.3)	SARS (2.8)	QTRT1 (2.4)	PSMA5 (2.3)	PTPN11 (1.9)	SMARCA4 (1.9)	TOP1 (1.8)
GO:0043627	response to estrogen stimulus	0.15	> 0.20	KIAA1324 (2.8)	POLK (2.5)	PVR (1.6)	TMED4 (1.6)	NPC1L1 (1.5)	TMEM57 (1.5)	C11orf9 (1.4)	PVRL2 (1.3)	PLEKHH2 (1.3)	RHD (1.2)
ENSG00000133794	ARNTL PPI subnetwork	0.15	> 0.20	TRIB1 (3.3)	GPAM (2.7)	LDLR (2.4)	TMEM57 (2.3)	TOP1 (2.3)	CYP7A1 (2.1)	SH2B3 (2.0)	ABCG8 (1.9)	BCL3 (1.9)	ZHX3 (1.8)
ENSG00000104852	SNRNP70 PPI subnetwork	0.15	> 0.20	DHX38 (4.3)	TOP1 (3.8)	ILF3 (3.8)	SMARCA4 (3.4)	BUD13 (2.8)	USP1 (2.7)	PTPN11 (2.6)	SUGP1 (2.5)	QTRT1 (2.4)	C1orf63 (2.3)
KEGG_PHENYLALANINE_METABOLISM	KEGG_PHENYLALANINE_METABOLISM	0.15	> 0.20	PLG (4.9)	ANGPTL3 (3.8)	APOA5 (3.7)	MOSC1 (3.6)	ALDH2 (3.3)	SLC22A1 (3.0)	HP (3.0)	APOC4 (3.0)	FRK (2.1)	APOB (1.8)
GO:0001961	positive regulation of cytokine-mediated signaling pathway	0.15	> 0.20	CEACAM19 (2.7)	C17orf57 (2.6)	ENSG00000235545 (1.9)	CYB561D1 (1.9)	GRINA (1.8)	POLK (1.8)	ZNF101 (1.7)	COL4A3BP (1.7)	TM6SF2 (1.5)	HNF1A (1.3)
MP:0002497	increased IgE level	0.16	> 0.20	BCL3 (3.8)	RELB (3.1)	C17orf57 (3.0)	GMIP (2.9)	SH2B3 (2.1)	ZNF101 (1.9)	PARP10 (1.7)	NT5DC1 (1.6)	TIMD4 (1.3)	ENSG00000226645 (1.2)
MP:0004096	abnormal midbrain-hindbrain boundary development	0.16	> 0.20	ABO (3.3)	TSSK6 (2.5)	CARM1 (2.4)	GRINA (1.8)	PLCG1 (1.8)	GEMIN7 (1.7)	NT5DC1 (1.7)	GATAD2A (1.6)	MYLIP (1.3)	TMEM57 (1.3)
KEGG_ADHERENS_JUNCTION	KEGG_ADHERENS_JUNCTION	0.16	> 0.20	PLEC (2.8)	DOCK7 (2.7)	PVRL2 (2.6)	SLC44A2 (2.6)	GATAD2A (2.6)	MARK4 (2.5)	ATXN2 (2.1)	SH2B3 (2.1)	PLCG1 (2.1)	KANK2 (2.0)
ENSG00000129347	KRI1 PPI subnetwork	0.16	> 0.20	ZNF259 (4.6)	DDX56 (4.5)	NAA25 (4.2)	QTRT1 (4.1)	TOMM40 (3.9)	DHODH (3.0)	ILF3 (2.7)	DHX38 (2.7)	ATP13A1 (2.5)	TOP1 (2.4)
ENSG00000105229	PIAS4 PPI subnetwork	0.16	> 0.20	PARP10 (3.9)	BCL3 (2.7)	OASL (2.7)	TRAFD1 (2.6)	MYLIP (2.1)	KANK2 (2.0)	BUD13 (1.7)	C17orf57 (1.7)	ATXN2 (1.6)	DNM2 (1.6)
GO:0033865	nucleoside bisphosphate metabolic process	0.16	> 0.20	ENSG00000228044 (2.9)	LDLR (2.7)	PCSK9 (2.5)	CYP7A1 (2.5)	FADS2 (2.5)	TM6SF2 (2.3)	HMGCR (2.1)	ABCG5 (2.0)	FADS1 (1.8)	ABCG8 (1.6)
GO:0004745	retinol dehydrogenase activity	0.16	> 0.20	SLC22A1 (4.2)	CYP7A1 (3.8)	LPA (3.8)	APOC4 (3.4)	APOA5 (3.3)	MOSC1 (2.3)	TM6SF2 (2.3)	ANGPTL3 (2.1)	PCSK9 (2.1)	ABCG5 (2.1)
GO:0046688	response to copper ion	0.16	> 0.20	PBX4 (2.1)	ZHX3 (2.0)	SLC44A2 (2.0)	SLC22A1 (2.0)	ENSG00000235545 (2.0)	TMEM57 (1.9)	BCAM (1.8)	ENSG00000254235 (1.8)	RHD (1.7)	RHCE (1.5)
ENSG00000175745	NR2F1 PPI subnetwork	0.16	> 0.20	ENSG00000254235 (2.1)	PLEC (2.0)	C12orf51 (1.9)	GCNT4 (1.9)	ZHX3 (1.8)	TOP1 (1.7)	MAFB (1.5)	APOB (1.5)	AMIGO1 (1.5)	ENSG00000235545 (1.5)
ENSG00000100911	PSME2 PPI subnetwork	0.16	> 0.20	PSMA5 (6.4)	TRAFD1 (3.7)	NT5DC1 (2.4)	NAA25 (2.2)	TOMM40 (1.8)	PARP10 (1.7)	SUGP1 (1.6)	DDX56 (1.6)	TMEM50A (1.4)	ABCG8 (1.2)
MP:0011088	partial neonatal lethality	0.16	> 0.20	MAFB (3.0)	LDLR (2.4)	NYNRIN (2.2)	TRIB1 (1.9)	MYLIP (1.8)	HLX (1.7)	FADS2 (1.7)	MARK4 (1.6)	ALDH2 (1.6)	DOCK7 (1.5)
ENSG00000197063	MAFG PPI subnetwork	0.16	> 0.20	TRIB1 (4.2)	BCL3 (2.6)	MAFB (2.5)	RELB (2.4)	TXNL4B (2.4)	HLX (2.4)	GCNT4 (2.4)	POC5 (2.0)	LPAR2 (1.8)	TMEM116 (1.6)
KEGG_ETHER_LIPID_METABOLISM	KEGG_ETHER_LIPID_METABOLISM	0.16	> 0.20	NKPD1 (4.7)	TIMD4 (3.4)	CETP (2.6)	APOE (2.1)	COL4A3BP (2.0)	DOCK7 (1.9)	TMEM116 (1.8)	ST3GAL4 (1.8)	TMEM57 (1.7)	DYNC2LI1 (1.6)
GO:0017091	AU-rich element binding	0.16	> 0.20	MAPKAPK5 (2.9)	ENSG00000226645 (2.6)	TRIB1 (2.5)	NPC1L1 (2.1)	ENSG00000228044 (1.8)	TM6SF2 (1.8)	CBLC (1.6)	C12orf43 (1.6)	BCL3 (1.5)	BUD13 (1.4)
ENSG00000173207	CKS1B PPI subnetwork	0.16	> 0.20	TRIB1 (3.3)	PSRC1 (3.1)	LPA (2.2)	SLC22A1 (2.2)	GCNT4 (1.8)	FEN1 (1.7)	APOA5 (1.7)	HLX (1.7)	NKPD1 (1.6)	BRAP (1.6)
ENSG00000164327	RICTOR PPI subnetwork	0.16	> 0.20	CBLC (4.2)	AP1M2 (3.2)	DHX38 (2.8)	PVRL2 (2.0)	DOCK7 (1.9)	ENSG00000226648 (1.9)	CARM1 (1.9)	DNM2 (1.8)	CELSR2 (1.6)	PSRC1 (1.6)
GO:0046849	bone remodeling	0.16	> 0.20	ENSG00000226645 (2.0)	ENSG00000235545 (1.9)	TMEM116 (1.8)	ENSG00000254235 (1.8)	CILP2 (1.8)	HNF1A (1.7)	ABO (1.6)	C11orf9 (1.5)	MAU2 (1.4)	RHCE (1.1)
GO:0051597	response to methylmercury	0.16	> 0.20	RHCE (6.0)	RHD (5.8)	ANKRD31 (2.3)	DNAH11 (2.1)	C12orf51 (1.9)	GMPR (1.7)	ZNF180 (1.5)	CEACAM19 (1.4)	COL4A3BP (1.3)	BLOC1S3 (1.3)
GO:0009411	response to UV	0.16	> 0.20	ZNF180 (3.5)	BLOC1S3 (3.3)	MAU2 (2.4)	DNAH11 (2.3)	SUGP1 (2.2)	CEACAM19 (2.0)	POLK (1.7)	ENSG00000235545 (1.6)	TRAPPC6A (1.6)	TMEM57 (1.6)
MP:0008872	abnormal physiological response to xenobiotic	0.16	> 0.20	CETP (2.4)	TM6SF2 (2.3)	RPH3A (2.2)	POLK (2.2)	SH2B3 (2.2)	SLC22A1 (2.2)	ABCG8 (2.1)	KIAA1324 (1.8)	BCAM (1.8)	BCL3 (1.8)
GO:0035097	histone methyltransferase complex	0.16	> 0.20	BUD13 (3.2)	ATXN2 (3.2)	QTRT1 (2.6)	C12orf51 (2.5)	C12orf43 (2.5)	OGDH (2.4)	ATXN7L2 (2.1)	ZNF180 (2.1)	ILF3 (1.9)	USP1 (1.9)
GO:0034708	methyltransferase complex	0.16	> 0.20	BUD13 (3.2)	ATXN2 (3.2)	QTRT1 (2.6)	C12orf51 (2.5)	C12orf43 (2.5)	OGDH (2.4)	ATXN7L2 (2.1)	ZNF180 (2.1)	ILF3 (1.9)	USP1 (1.9)
ENSG00000116062	MSH6 PPI subnetwork	0.16	> 0.20	USP1 (3.7)	FEN1 (3.4)	SMARCA4 (2.2)	BUD13 (2.1)	ZNF180 (2.1)	C12orf51 (1.9)	POC5 (1.9)	NYNRIN (1.9)	ILF3 (1.7)	ENSG00000226648 (1.3)
ENSG00000151148	UBE3B PPI subnetwork	0.16	> 0.20	PSMA5 (4.6)	SUGP1 (3.5)	TOMM40 (2.8)	NAA25 (2.7)	DDX56 (2.4)	SARS (2.1)	ZNF180 (2.0)	TXNL4B (1.9)	CLPTM1 (1.9)	C12orf43 (1.7)
GO:0045736	negative regulation of cyclin-dependent protein kinase activity	0.16	> 0.20	ZHX3 (2.8)	ENSG00000254235 (2.6)	ENSG00000226645 (2.5)	BLOC1S3 (2.0)	GCNT4 (1.9)	KANK2 (1.7)	ENSG00000226648 (1.7)	C17orf57 (1.7)	MYLIP (1.5)	ANKRD31 (1.4)
MP:0005670	abnormal white adipose tissue physiology	0.16	> 0.20	MOSC1 (4.3)	GPAM (4.0)	SORT1 (2.8)	HP (2.7)	ST3GAL4 (2.7)	MAU2 (2.1)	ALDH2 (2.0)	MAPKAPK5 (1.9)	SH2B3 (1.7)	LPIN3 (1.7)
MP:0002940	variable body spotting	0.16	> 0.20	HMGCR (3.2)	PCSK9 (3.0)	PLEKHH2 (2.8)	LDLR (2.4)	MYLIP (2.0)	APOE (2.0)	FADS1 (1.9)	KANK2 (1.8)	ENSG00000235545 (1.8)	ST3GAL4 (1.6)
GO:0019751	polyol metabolic process	0.16	> 0.20	TM6SF2 (3.8)	ABCG8 (2.5)	ENSG00000254235 (2.4)	ENSG00000226645 (2.1)	LPAR2 (1.9)	ACAD10 (1.9)	ABCG5 (1.9)	GCNT4 (1.8)	NPC1L1 (1.8)	MOSC1 (1.8)
GO:0046625	sphingolipid binding	0.16	> 0.20	POLK (4.4)	ERP29 (2.7)	ENSG00000226645 (2.6)	C17orf57 (2.5)	NYNRIN (2.1)	SH2B3 (1.8)	HMGCR (1.6)	POC5 (1.5)	SLC44A2 (1.5)	HAVCR1 (1.5)
MP:0003048	abnormal cervical vertebrae morphology	0.16	> 0.20	MYLIP (2.4)	NYNRIN (2.1)	PLEKHH2 (2.0)	DYNC2LI1 (1.7)	PLCG1 (1.6)	TMED4 (1.6)	SYPL2 (1.5)	CILP2 (1.4)	ENSG00000238078 (1.4)	C19orf52 (1.3)
ENSG00000134107	BHLHE40 PPI subnetwork	0.16	> 0.20	BCL3 (3.7)	PARP10 (2.7)	RELB (2.6)	GRINA (2.2)	GMIP (2.1)	PLEC (2.0)	GPAM (1.7)	UBXN2B (1.5)	C17orf57 (1.4)	KIAA1324 (1.4)
ENSG00000007866	TEAD3 PPI subnetwork	0.16	> 0.20	LPAR2 (3.2)	CARM1 (2.9)	DNM2 (2.9)	C11orf9 (2.7)	KANK2 (2.6)	PLEC (2.5)	COL4A3BP (2.5)	PTPN11 (2.4)	ZHX3 (2.4)	GPAM (2.4)
MP:0008484	decreased spleen germinal center size	0.16	> 0.20	RELB (3.4)	CETP (3.1)	GMIP (3.0)	CLPTM1 (2.5)	TIMD4 (2.5)	HAVCR1 (2.3)	PVRL2 (2.2)	ZNF101 (2.1)	APOE (1.8)	ATP13A1 (1.5)
GO:0016888	endodeoxyribonuclease activity, producing 5'-phosphomonoesters	0.16	> 0.20	CETP (3.2)	NKPD1 (3.0)	TIMD4 (2.4)	TMEM116 (2.4)	NT5DC1 (2.0)	HAVCR1 (1.7)	LPIN3 (1.4)	HNF1A (1.4)	TSSK6 (1.4)	MAFB (1.3)
MP:0010378	increased respiratory quotient	0.16	> 0.20	MOSC1 (2.6)	TRIB1 (2.3)	PMFBP1 (1.9)	TMED4 (1.8)	GPAM (1.7)	BLOC1S3 (1.7)	C1orf63 (1.6)	ATXN7L2 (1.6)	SORT1 (1.6)	APOC1 (1.5)
MP:0000751	myopathy	0.16	> 0.20	SYPL2 (5.8)	BCAM (3.5)	CILP2 (2.4)	PLEC (2.3)	SORT1 (1.9)	CELSR2 (1.9)	KANK2 (1.7)	GMPR (1.6)	RPH3A (1.5)	ENSG00000238078 (1.5)
GO:0002758	innate immune response-activating signal transduction	0.16	> 0.20	SH2B3 (3.1)	RELB (2.4)	GMIP (2.4)	PARP10 (2.0)	OASL (1.9)	MAFB (1.9)	BCL3 (1.9)	CYB561D1 (1.9)	TRIB1 (1.8)	MYLIP (1.7)
GO:0032094	response to food	0.16	> 0.20	NPC1L1 (2.5)	ABCG8 (2.4)	ENSG00000228044 (2.2)	KIAA1324 (2.2)	TMED4 (2.1)	ADAM1 (1.9)	GCNT4 (1.6)	ABCG5 (1.6)	AP1M2 (1.6)	TM6SF2 (1.3)
ENSG00000137876	RSL24D1 PPI subnetwork	0.16	> 0.20	ZNF259 (5.2)	NAA25 (4.1)	DDX56 (3.8)	TOMM40 (3.8)	DHODH (3.2)	QTRT1 (3.1)	MAPKAPK5 (2.5)	C12orf43 (2.5)	ENSG00000226645 (2.2)	DHX38 (1.9)
ENSG00000101003	GINS1 PPI subnetwork	0.16	> 0.20	FEN1 (6.7)	USP1 (4.7)	ZNF180 (2.9)	ENSG00000228044 (1.8)	ENSG00000238078 (1.4)	DHODH (1.4)	FADS1 (1.2)	ANKRD31 (1.2)	FRK (1.0)	ILF3 (1.0)
ENSG00000139219	COL2A1 PPI subnetwork	0.16	> 0.20	CILP2 (8.1)	MAFB (3.3)	ITGB3 (3.2)	PLEKHH2 (2.2)	APOE (2.1)	SH2B3 (1.6)	C17orf57 (1.5)	APOC1 (1.5)	BCAM (1.3)	ST3GAL4 (1.3)
ENSG00000173153	ESRRA PPI subnetwork	0.16	> 0.20	SORT1 (3.3)	C12orf51 (3.1)	ZHX3 (2.5)	TOP1 (2.5)	GOT2P1 (2.5)	CELSR2 (1.9)	MAFB (1.9)	DOCK7 (1.8)	ST3GAL4 (1.7)	CETP (1.5)
ENSG00000168906	MAT2A PPI subnetwork	0.16	> 0.20	C19orf52 (3.0)	BRAP (2.8)	TOMM40 (2.4)	ZNF101 (2.1)	DDX56 (2.0)	MAPKAPK5 (2.0)	NAA25 (2.0)	HAPLN4 (1.9)	ENSG00000226645 (1.9)	ADAM1 (1.7)
GO:0034470	ncRNA processing	0.16	> 0.20	QTRT1 (3.7)	DHODH (3.6)	DDX56 (3.6)	NAA25 (3.5)	ZNF259 (3.4)	C12orf43 (3.1)	TOMM40 (2.7)	MAPKAPK5 (2.6)	C19orf52 (2.5)	POC5 (2.4)
ENSG00000141644	MBD1 PPI subnetwork	0.16	> 0.20	KANK2 (3.2)	TRAFD1 (2.7)	MYLIP (2.6)	ENSG00000238078 (2.4)	ATXN2 (2.3)	FRK (2.2)	NKPD1 (2.0)	SH2B3 (1.9)	CETP (1.7)	MARK4 (1.7)
ENSG00000147130	ZMYM3 PPI subnetwork	0.16	> 0.20	SMARCA4 (3.2)	MARK4 (2.8)	TOP1 (2.2)	DNM2 (2.2)	NT5DC1 (2.1)	GATAD2A (1.8)	ATXN2 (1.8)	BUD13 (1.6)	TMEM57 (1.5)	TSSK6 (1.5)
GO:0021602	cranial nerve morphogenesis	0.16	> 0.20	ANKRD31 (3.9)	HAVCR1 (2.5)	PMFBP1 (2.2)	BLOC1S3 (2.2)	TSSK6 (1.9)	FRK (1.6)	GOT2P1 (1.6)	DYNC2LI1 (1.6)	CEACAM19 (1.5)	NKPD1 (1.4)
GO:0009975	cyclase activity	0.16	> 0.20	NYNRIN (3.1)	HLX (2.6)	ITGB3 (2.4)	CETP (2.1)	CYP7A1 (2.0)	ABCG8 (1.7)	ENSG00000254235 (1.6)	BCAM (1.6)	ENSG00000228044 (1.5)	MOSC1 (1.4)
REACTOME_FRS2:MEDIATED_ACTIVATION	REACTOME_FRS2:MEDIATED_ACTIVATION	0.16	> 0.20	CARM1 (2.1)	HLX (2.0)	DNM2 (1.9)	MAPKAPK5 (1.8)	GATAD2A (1.8)	CLPTM1 (1.7)	CYB561D1 (1.7)	SLC44A2 (1.7)	SH2B3 (1.7)	PTPN11 (1.6)
REACTOME_NEPNS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	REACTOME_NEPNS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	0.16	> 0.20	NAA25 (3.7)	POC5 (3.3)	USP1 (3.0)	DDX56 (2.9)	DOCK7 (2.7)	BUD13 (2.5)	USP24 (2.4)	ILF3 (2.2)	MAPKAPK5 (2.1)	FEN1 (2.0)
ENSG00000163283	ALPP PPI subnetwork	0.16	> 0.20	BRAP (2.3)	SORT1 (2.2)	YIPF2 (2.2)	USP24 (2.0)	C19orf52 (1.9)	SUGP1 (1.8)	DHX38 (1.8)	GRINA (1.8)	ATP13A1 (1.8)	TMEM57 (1.7)
ENSG00000084073	ZMPSTE24 PPI subnetwork	0.16	> 0.20	LDLR (4.4)	FADS1 (3.5)	HMGCR (3.2)	FADS2 (3.2)	TMED4 (2.9)	ERP29 (2.4)	PCSK9 (2.2)	TMEM50A (2.2)	HNF1A (1.8)	ATXN7L2 (1.7)
GO:0032182	small conjugating protein binding	0.16	> 0.20	GRINA (3.7)	RELB (2.7)	HAVCR1 (2.4)	MAU2 (2.1)	PARP10 (1.8)	ATXN2 (1.8)	PSMA5 (1.7)	SARS (1.7)	TMEM57 (1.7)	BRAP (1.6)
ENSG00000178177	LCORL PPI subnetwork	0.16	> 0.20	TIMD4 (3.1)	OASL (2.9)	CETP (2.6)	PLEKHH2 (2.0)	C1orf63 (1.7)	TMEM57 (1.7)	SLC44A2 (1.6)	DNAH11 (1.6)	CEACAM19 (1.4)	SYPL2 (1.3)
MP:0003216	absence seizures	0.16	> 0.20	RPH3A (5.1)	HAPLN4 (3.9)	PPP1R37 (2.9)	APOE (2.4)	CLPTM1 (2.0)	APOC1 (1.8)	CYP7A1 (1.8)	GRINA (1.7)	ABCG8 (1.5)	TMEM57 (1.5)
ENSG00000183207	RUVBL2 PPI subnetwork	0.16	> 0.20	ZNF180 (2.8)	SMARCA4 (2.8)	DDX56 (2.3)	PSMA5 (2.3)	TOMM40 (2.2)	SUGP1 (2.0)	DHX38 (2.0)	USP1 (2.0)	QTRT1 (1.8)	BUD13 (1.6)
GO:0050927	positive regulation of positive chemotaxis	0.16	> 0.20	ABO (3.5)	PLEKHH2 (2.2)	TMEM116 (2.1)	DNAH11 (1.9)	YIPF2 (1.8)	CYB561D1 (1.6)	ENSG00000226648 (1.5)	PPP1R37 (1.3)	C19orf52 (1.3)	CYP7A1 (1.3)
GO:0046112	nucleobase biosynthetic process	0.16	> 0.20	DHODH (3.6)	ANKRD31 (2.9)	TXNL4B (2.5)	ENSG00000228044 (2.4)	QTRT1 (2.2)	NKPD1 (1.8)	ENSG00000226648 (1.6)	ENSG00000235545 (1.6)	LPA (1.5)	ACAD10 (1.5)
ENSG00000121671	CRY2 PPI subnetwork	0.16	> 0.20	ZHX3 (2.8)	TMEM57 (2.6)	KANK2 (2.3)	CYP7A1 (2.1)	TMEM116 (1.9)	GPAM (1.9)	ZNF180 (1.6)	ENSG00000254235 (1.5)	CILP2 (1.4)	C12orf43 (1.4)
ENSG00000181467	RAP2B PPI subnetwork	0.16	> 0.20	ACAD10 (4.0)	OGDH (3.1)	TMED4 (2.8)	NT5DC1 (2.7)	HNF1A (2.5)	TRAPPC6A (2.3)	CETP (2.2)	TMEM50A (1.8)	ATXN7L2 (1.7)	GMPR (1.7)
REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS	0.16	> 0.20	NAA25 (3.6)	POC5 (3.4)	DDX56 (3.0)	USP1 (2.8)	DOCK7 (2.6)	BUD13 (2.4)	USP24 (2.4)	ILF3 (2.3)	FEN1 (2.0)	DHX38 (1.8)
MP:0009395	increased nucleated erythrocyte cell number	0.16	> 0.20	RHD (6.9)	RHCE (5.5)	C12orf51 (3.0)	SLC44A2 (3.0)	GMPR (3.0)	TRIB1 (2.9)	ENSG00000238078 (2.3)	KANK2 (2.2)	DNM2 (2.1)	ZNF101 (1.9)
ENSG00000167513	CDT1 PPI subnetwork	0.16	> 0.20	FEN1 (6.6)	USP1 (4.9)	HLX (1.8)	PSRC1 (1.8)	NT5DC1 (1.6)	BUD13 (1.6)	MAU2 (1.3)	MYLIP (1.2)	GMPR (1.2)	FADS1 (1.1)
MP:0001191	abnormal skin condition	0.16	> 0.20	HMGCR (5.2)	LDLR (4.8)	CBLC (3.4)	FADS2 (3.3)	FADS1 (3.2)	PLEC (2.3)	NKPD1 (2.2)	NPC1L1 (2.2)	LPAR2 (2.0)	PCSK9 (2.0)
GO:0050431	transforming growth factor beta binding	0.16	> 0.20	PLEKHH2 (2.3)	KANK2 (1.9)	GPAM (1.9)	SH2B3 (1.8)	ENSG00000235545 (1.8)	PVR (1.7)	NYNRIN (1.6)	BCAM (1.6)	CEACAM19 (1.5)	ALDH2 (1.5)
ENSG00000152464	RPP38 PPI subnetwork	0.16	> 0.20	ZNF180 (3.1)	GEMIN7 (2.4)	POC5 (2.3)	C12orf43 (2.2)	ANKRD31 (1.8)	APOE (1.7)	ITGB3 (1.7)	COL4A3BP (1.7)	C12orf47 (1.7)	SLC44A2 (1.7)
ENSG00000118513	MYB PPI subnetwork	0.16	> 0.20	TOMM40 (2.6)	ATXN2 (2.5)	MAU2 (2.5)	SMARCA4 (2.4)	CARM1 (2.3)	HNF1A (2.2)	MAPKAPK5 (2.0)	C12orf51 (2.0)	CEACAM19 (1.9)	ZHX3 (1.7)
GO:0048486	parasympathetic nervous system development	0.16	> 0.20	TSSK6 (2.4)	BLOC1S3 (2.1)	ENSG00000254235 (2.0)	ENSG00000238078 (1.8)	CEACAM19 (1.8)	TMED4 (1.7)	ENSG00000226648 (1.5)	ENSG00000228044 (1.3)	ZNF101 (1.3)	ANKRD31 (1.3)
GO:0007016	cytoskeletal anchoring at plasma membrane	0.16	> 0.20	RHD (3.6)	RHCE (3.5)	C17orf57 (3.4)	GOT2P1 (3.1)	LPIN3 (2.9)	PLEC (2.6)	OGDH (2.6)	ANKRD31 (2.4)	GEMIN7 (1.8)	PBX4 (1.6)
MP:0000696	abnormal Peyer's patch morphology	0.16	> 0.20	RELB (6.3)	BCL3 (5.5)	GMIP (5.1)	GRINA (3.6)	PBX4 (2.7)	PLEC (2.4)	PARP10 (2.3)	CLPTM1 (2.3)	CETP (1.9)	UBXN2B (1.9)
MP:0002682	decreased mature ovarian follicle number	0.16	> 0.20	FADS1 (4.0)	ANKRD31 (3.9)	PLEKHH2 (2.7)	LDLR (2.1)	CYP7A1 (2.1)	TRAPPC6A (1.9)	MAU2 (1.7)	ENSG00000238078 (1.6)	PCSK9 (1.6)	BRAP (1.5)
ENSG00000173567	GPR113 PPI subnetwork	0.16	> 0.20	TIMD4 (3.1)	OASL (3.0)	CETP (2.5)	PLEKHH2 (1.9)	TMEM57 (1.9)	DNAH11 (1.6)	C1orf63 (1.5)	SLC44A2 (1.5)	POLK (1.3)	CEACAM19 (1.3)
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	0.16	> 0.20	TM6SF2 (3.6)	TMEM116 (3.3)	SORT1 (3.1)	ATP13A1 (3.0)	CLPTM1 (2.8)	ABCG8 (2.4)	ANGPTL3 (2.4)	PLG (2.4)	RHD (2.0)	HAPLN4 (2.0)
GO:0043526	neuroprotection	0.16	> 0.20	TSSK6 (2.7)	GOT2P1 (2.6)	NKPD1 (2.4)	ZNF180 (2.1)	DNAH11 (1.8)	ENSG00000238078 (1.7)	C17orf57 (1.7)	GCNT4 (1.5)	BLOC1S3 (1.4)	PPP1R37 (1.4)
ENSG00000134419	RPS15A PPI subnetwork	0.16	> 0.20	NAA25 (3.6)	DDX56 (3.5)	QTRT1 (3.0)	C12orf43 (2.8)	ZNF259 (2.7)	ILF3 (2.7)	TOMM40 (2.6)	SARS (2.4)	DHX38 (2.3)	TOP1 (2.3)
ENSG00000150455	TIRAP PPI subnetwork	0.16	> 0.20	OASL (3.8)	MAFB (2.5)	PARP10 (2.4)	GMIP (2.0)	UBXN2B (1.8)	TRIB1 (1.8)	ZNF101 (1.8)	BLOC1S3 (1.5)	PMFBP1 (1.5)	ENSG00000238078 (1.3)
GO:0005080	protein kinase C binding	0.16	> 0.20	GRINA (2.9)	RELB (2.7)	PLEC (2.1)	ITGB3 (1.9)	GMIP (1.8)	APOE (1.7)	SMARCA4 (1.7)	CETP (1.7)	FADS1 (1.7)	KANK2 (1.6)
GO:0003085	negative regulation of systemic arterial blood pressure	0.16	> 0.20	ENSG00000235545 (3.6)	AMIGO1 (2.9)	ENSG00000254235 (2.4)	TMEM116 (2.4)	POLK (2.3)	ENSG00000226645 (2.0)	TSSK6 (1.9)	ENSG00000228044 (1.9)	GOT2P1 (1.5)	MAFB (1.4)
ENSG00000106052	TAX1BP1 PPI subnetwork	0.16	> 0.20	LDLR (4.3)	COL4A3BP (2.8)	OGDH (2.3)	FADS1 (2.1)	ZNF180 (1.9)	PCSK9 (1.6)	FRK (1.6)	GRINA (1.6)	RELB (1.6)	SYPL2 (1.5)
MP:0005605	increased bone mass	0.16	> 0.20	MAFB (3.7)	MOSC1 (2.5)	POLK (2.3)	TRIB1 (1.9)	SORT1 (1.8)	CELSR2 (1.8)	PARP10 (1.6)	ENSG00000226648 (1.6)	PLCG1 (1.6)	CILP2 (1.5)
ENSG00000125743	SNRPD2 PPI subnetwork	0.16	> 0.20	ILF3 (3.7)	QTRT1 (3.2)	TOP1 (3.1)	BUD13 (3.0)	SUGP1 (3.0)	DHX38 (2.9)	USP1 (2.7)	SMARCA4 (2.7)	C1orf63 (2.5)	FEN1 (2.4)
ENSG00000176273	SLC35G1 PPI subnetwork	0.16	> 0.20	LDLR (8.6)	FADS1 (7.7)	FADS2 (6.9)	HMGCR (6.6)	PCSK9 (4.2)	ATP13A1 (2.8)	ERP29 (2.6)	TMEM57 (2.5)	SORT1 (2.2)	TMEM50A (2.0)
ENSG00000103152	MPG PPI subnetwork	0.16	> 0.20	PSMA5 (3.1)	CARM1 (3.1)	GOT2P1 (2.5)	NT5DC1 (2.1)	C19orf52 (1.9)	QTRT1 (1.7)	TOMM40 (1.7)	NKPD1 (1.5)	GPAM (1.5)	ILF3 (1.4)
ENSG00000111640	GAPDH PPI subnetwork	0.16	> 0.20	PLEC (2.5)	SARS (2.4)	PSMA5 (2.1)	SMARCA4 (2.1)	TOMM40 (2.1)	DOCK7 (2.0)	NAA25 (2.0)	COL4A3BP (1.9)	HMGCR (1.9)	OGDH (1.7)
GO:0006541	glutamine metabolic process	0.16	> 0.20	ENSG00000254235 (2.9)	ENSG00000238078 (2.9)	CYP7A1 (2.8)	HAPLN4 (2.5)	HAVCR1 (2.2)	CARM1 (1.9)	ADAM1 (1.9)	DYNC2LI1 (1.9)	ACAD10 (1.7)	DNAH11 (1.6)
GO:0045861	negative regulation of proteolysis	0.16	> 0.20	ST3GAL4 (2.3)	PLEKHH2 (2.1)	DYNC2LI1 (2.0)	ENSG00000228044 (1.9)	ATP13A1 (1.8)	TMEM57 (1.6)	CYB561D1 (1.6)	KANK2 (1.3)	PMFBP1 (1.3)	APOE (1.3)
MP:0005534	decreased body temperature	0.16	> 0.20	MOSC1 (2.8)	APOA5 (2.5)	TRIB1 (2.5)	GPAM (2.2)	CETP (2.1)	GCNT4 (2.1)	ANGPTL3 (1.9)	ALDH2 (1.9)	SLC22A1 (1.8)	POLK (1.6)
GO:0005160	transforming growth factor beta receptor binding	0.16	> 0.20	KANK2 (3.9)	PVR (2.9)	C11orf9 (2.7)	MYLIP (2.6)	PLEKHH2 (2.5)	ZNF180 (2.1)	SLC44A2 (1.9)	SH2B3 (1.7)	SORT1 (1.5)	PLCG1 (1.4)
MP:0000434	megacephaly	0.16	> 0.20	NYNRIN (4.5)	KANK2 (2.5)	C11orf9 (2.5)	ENSG00000235545 (2.2)	CBLC (2.2)	PPP1R37 (2.0)	YIPF2 (2.0)	HAPLN4 (1.9)	TM6SF2 (1.8)	CETP (1.7)
ENSG00000136243	NUPL2 PPI subnetwork	0.16	> 0.20	NAA25 (3.8)	USP1 (3.6)	POC5 (2.9)	DOCK7 (2.7)	BUD13 (2.5)	FEN1 (2.3)	ILF3 (2.2)	DDX56 (2.2)	USP24 (2.1)	ENSG00000226648 (1.8)
ENSG00000156709	AIFM1 PPI subnetwork	0.16	> 0.20	C19orf52 (2.5)	TRAFD1 (2.5)	GRINA (2.1)	LPAR2 (2.1)	TRIB1 (2.1)	PARP10 (2.1)	HLX (2.0)	C1orf63 (1.9)	SUGP1 (1.7)	BCL3 (1.7)
ENSG00000123338	NCKAP1L PPI subnetwork	0.16	> 0.20	GMIP (4.5)	ENSG00000235545 (2.8)	DOCK7 (2.6)	C1orf63 (2.5)	SMARCA4 (2.3)	GOT2P1 (1.8)	DNM2 (1.8)	PLEC (1.7)	OGDH (1.6)	ST3GAL4 (1.5)
MP:0001858	intestinal inflammation	0.16	> 0.20	BCL3 (4.0)	ZNF101 (2.6)	GRINA (2.1)	C17orf57 (1.9)	RELB (1.9)	PBX4 (1.9)	TRIB1 (1.8)	PLEC (1.7)	PARP10 (1.7)	CEACAM19 (1.6)
ENSG00000158987	RAPGEF6 PPI subnetwork	0.16	> 0.20	C1orf63 (3.5)	DYNC2LI1 (3.2)	MYLIP (2.8)	BRAP (2.8)	C12orf43 (2.8)	PLEKHH2 (2.7)	BLOC1S3 (2.2)	ZHX3 (2.1)	C17orf57 (1.7)	TRAFD1 (1.6)
ENSG00000147202	DIAPH2 PPI subnetwork	0.16	> 0.20	CARM1 (2.9)	BUD13 (2.6)	ATXN2 (2.4)	ENSG00000254235 (2.3)	UBXN2B (1.8)	C11orf9 (1.7)	OGDH (1.6)	GATAD2A (1.5)	HAVCR1 (1.5)	GRINA (1.5)
MP:0000914	exencephaly	0.16	> 0.20	ATXN2 (2.7)	DYNC2LI1 (2.4)	CARM1 (2.4)	DOCK7 (2.4)	PVRL2 (2.3)	TRIB1 (2.3)	MARK4 (2.1)	NYNRIN (2.0)	PLCG1 (1.8)	KANK2 (1.6)
GO:0045471	response to ethanol	0.16	> 0.20	GPAM (2.4)	ALDH2 (2.2)	LPA (2.1)	ENSG00000235545 (2.0)	ABO (2.0)	GOT2P1 (1.8)	ABCG5 (1.4)	ACAD10 (1.4)	C17orf57 (1.4)	RHCE (1.4)
GO:0070613	regulation of protein processing	0.16	> 0.20	ENSG00000228044 (2.9)	CEACAM19 (2.2)	PCSK9 (2.1)	HAVCR1 (2.0)	HP (1.5)	TXNL4B (1.5)	TMED4 (1.5)	C17orf57 (1.5)	RHCE (1.4)	TMEM116 (1.4)
GO:0042035	regulation of cytokine biosynthetic process	0.16	> 0.20	ENSG00000228044 (2.3)	ENSG00000226645 (1.9)	GMIP (1.7)	BCL3 (1.6)	TIMD4 (1.6)	HLX (1.6)	DNAH11 (1.5)	RELB (1.4)	PVR (1.3)	TRIB1 (1.3)
MP:0002871	albuminuria	0.16	> 0.20	BCAM (4.4)	NT5DC1 (2.4)	PVRL2 (2.0)	TMEM116 (1.9)	POLK (1.9)	TMEM50A (1.9)	OGDH (1.7)	GPAM (1.6)	C17orf57 (1.5)	ST3GAL4 (1.3)
GO:0048534	hemopoietic or lymphoid organ development	0.16	> 0.20	ZNF101 (4.1)	RHCE (3.4)	RHD (3.3)	PBX4 (2.6)	HLX (2.4)	PLCG1 (2.0)	SH2B3 (1.7)	GMIP (1.7)	MAFB (1.6)	SLC44A2 (1.5)
ENSG00000182287	AP1S2 PPI subnetwork	0.16	> 0.20	CLPTM1 (3.1)	YIPF2 (2.9)	GATAD2A (2.5)	CARM1 (2.2)	GMIP (2.2)	ATP13A1 (2.2)	SMARCA4 (2.1)	C12orf51 (2.0)	DNM2 (2.0)	PPP1R37 (1.9)
GO:0031227	intrinsic to endoplasmic reticulum membrane	0.16	> 0.20	CLPTM1 (4.4)	ATP13A1 (4.3)	YIPF2 (3.2)	TMEM50A (3.1)	TMED4 (3.1)	ERP29 (3.1)	CYB561D1 (3.0)	CYP7A1 (2.5)	HMGCR (2.4)	GRINA (2.4)
GO:0007250	activation of NF-kappaB-inducing kinase activity	0.16	> 0.20	ANKRD31 (3.7)	HNF1A (2.6)	PMFBP1 (2.3)	HAVCR1 (2.2)	FRK (1.9)	PCSK9 (1.7)	LPIN3 (1.7)	CBLC (1.6)	DNAH11 (1.6)	GEMIN7 (1.5)
ENSG00000014641	MDH1 PPI subnetwork	0.17	> 0.20	ALDH2 (3.4)	ERP29 (2.9)	DOCK7 (2.7)	SARS (2.6)	UBXN2B (2.4)	GMPR (2.1)	PSMA5 (2.0)	TMED4 (1.9)	RHD (1.9)	GPAM (1.8)
GO:0010627	regulation of intracellular protein kinase cascade	0.17	> 0.20	PVR (2.7)	POLK (2.6)	SH2B3 (2.2)	ST3GAL4 (2.1)	GRINA (2.0)	TRIB1 (1.9)	PARP10 (1.8)	HLX (1.7)	PTPN11 (1.5)	ENSG00000226645 (1.5)
REACTOME_DEFENSINS	REACTOME_DEFENSINS	0.17	> 0.20	PMFBP1 (3.5)	ABCG5 (2.7)	TSSK6 (1.9)	APOB (1.7)	NKPD1 (1.6)	SYPL2 (1.4)	ALDH2 (1.4)	TM6SF2 (1.3)	NPC1L1 (1.1)	HP (1.1)
ENSG00000172301	C17orf79 PPI subnetwork	0.17	> 0.20	TSSK6 (2.8)	BUD13 (2.7)	POLK (2.5)	QTRT1 (2.1)	PPP1R37 (2.0)	GCNT4 (1.6)	GEMIN7 (1.5)	PBX4 (1.5)	ENSG00000226648 (1.4)	FADS2 (1.4)
MP:0000613	abnormal salivary gland morphology	0.17	> 0.20	ATXN7L2 (2.8)	KIAA1324 (2.8)	GOT2P1 (2.4)	RELB (2.3)	SLC22A1 (2.1)	ANKRD31 (2.0)	ADAM1 (1.9)	LDLR (1.7)	TRAFD1 (1.7)	PLEKHH2 (1.6)
ENSG00000147162	OGT PPI subnetwork	0.17	> 0.20	OASL (4.3)	MAU2 (3.0)	BUD13 (3.0)	PLCG1 (2.7)	KANK2 (2.7)	C19orf52 (2.4)	CARM1 (2.4)	BRAP (2.4)	GATAD2A (2.3)	C12orf51 (2.3)
ENSG00000143977	SNRPG PPI subnetwork	0.17	> 0.20	ILF3 (3.8)	BUD13 (3.8)	DHX38 (3.2)	SUGP1 (3.0)	C1orf63 (2.9)	TOP1 (2.8)	QTRT1 (2.4)	DDX56 (2.4)	SMARCA4 (2.4)	USP1 (2.3)
ENSG00000137767	SQRDL PPI subnetwork	0.17	> 0.20	PLEC (3.0)	ATP13A1 (2.8)	ENSG00000226648 (2.2)	ENSG00000235545 (2.0)	FADS2 (1.9)	ATXN2 (1.8)	POLK (1.6)	SLC44A2 (1.6)	NYNRIN (1.6)	ST3GAL4 (1.6)
ENSG00000057294	PKP2 PPI subnetwork	0.17	> 0.20	AP1M2 (3.5)	DNM2 (3.1)	CELSR2 (3.0)	C11orf9 (2.9)	MARK4 (2.7)	PLEC (2.6)	OGDH (2.4)	CBLC (2.4)	LPAR2 (2.4)	PVRL2 (2.2)
ENSG00000108604	SMARCD2 PPI subnetwork	0.17	> 0.20	CARM1 (4.1)	MAU2 (3.1)	SMARCA4 (3.1)	GOT2P1 (2.2)	BCL3 (2.1)	C12orf51 (2.1)	ATXN2 (2.0)	NYNRIN (1.9)	MARK4 (1.7)	NT5DC1 (1.6)
ENSG00000138430	OLA1 PPI subnetwork	0.17	> 0.20	NAA25 (3.6)	SARS (3.5)	HMGCR (3.1)	ZNF259 (3.1)	PSMA5 (2.8)	FADS1 (2.5)	DDX56 (2.1)	MAPKAPK5 (2.1)	FEN1 (1.9)	USP1 (1.9)
ENSG00000197429	IPP PPI subnetwork	0.17	> 0.20	ATXN7L2 (3.2)	ZNF180 (2.5)	BUD13 (2.0)	USP1 (2.0)	UBXN2B (1.9)	BRAP (1.7)	KANK2 (1.7)	TMEM116 (1.6)	DNM2 (1.5)	POC5 (1.5)
ENSG00000206560	ANKRD28 PPI subnetwork	0.17	> 0.20	RELB (7.3)	BCL3 (3.5)	PPP1R37 (2.8)	GRINA (2.4)	CLPTM1 (2.3)	PTPN11 (2.1)	MARK4 (2.1)	SH2B3 (2.0)	GMIP (1.9)	PARP10 (1.8)
ENSG00000142208	AKT1 PPI subnetwork	0.17	> 0.20	BCL3 (2.9)	PTPN11 (2.8)	TRIB1 (2.6)	RELB (2.4)	PLEC (2.0)	SH2B3 (1.9)	DNM2 (1.8)	KANK2 (1.8)	MAU2 (1.7)	GRINA (1.7)
GO:0007586	digestion	0.17	> 0.20	NPC1L1 (6.4)	TM6SF2 (4.7)	ABCG8 (3.9)	KIAA1324 (3.7)	ABCG5 (3.5)	TMED4 (2.0)	GCNT4 (2.0)	FRK (1.9)	APOB (1.8)	ENSG00000226645 (1.8)
GO:0002684	positive regulation of immune system process	0.17	> 0.20	TIMD4 (4.1)	ZNF101 (3.4)	CETP (2.9)	GMIP (2.8)	CYB561D1 (2.1)	MAFB (2.1)	LPA (2.1)	RELB (2.0)	BCL3 (1.7)	PBX4 (1.7)
GO:0007589	body fluid secretion	0.17	> 0.20	KIAA1324 (3.5)	GOT2P1 (2.9)	GEMIN7 (2.2)	LPIN3 (2.2)	PMFBP1 (1.7)	ATXN7L2 (1.7)	NPC1L1 (1.6)	TRAPPC6A (1.6)	HAPLN4 (1.5)	NKPD1 (1.5)
GO:0042987	amyloid precursor protein catabolic process	0.17	> 0.20	CLPTM1 (2.7)	DNAH11 (2.7)	TMEM50A (2.2)	TRAPPC6A (2.0)	TMEM116 (2.0)	SORT1 (1.7)	ANKRD31 (1.6)	TMED4 (1.6)	TMEM57 (1.6)	MAU2 (1.5)
MP:0003141	cardiac fibrosis	0.17	> 0.20	TRIB1 (2.9)	SYPL2 (2.7)	NPC1L1 (2.4)	ABCG8 (2.3)	APOB (2.3)	TM6SF2 (2.2)	PVR (1.6)	ABO (1.6)	PTPN11 (1.5)	BCAM (1.5)
ENSG00000025434	NR1H3 PPI subnetwork	0.17	> 0.20	HNF1A (3.5)	CBLC (2.8)	PVRL2 (2.5)	MAFB (2.2)	NPC1L1 (2.1)	TM6SF2 (2.1)	MARK4 (2.1)	CEACAM19 (2.0)	TRAPPC6A (1.9)	ABCG5 (1.9)
ENSG00000064601	CTSA PPI subnetwork	0.17	> 0.20	OASL (4.7)	ERP29 (3.0)	HNF1A (2.9)	PARP10 (2.8)	TMEM50A (2.5)	C1orf63 (2.5)	ATP13A1 (2.3)	NKPD1 (2.2)	PLCG1 (1.8)	ZHX3 (1.7)
MP:0008751	abnormal interleukin level	0.17	> 0.20	PARP10 (4.9)	OASL (3.1)	RELB (2.8)	MAFB (2.4)	BCL3 (2.4)	SH2B3 (2.2)	APOE (2.2)	TRAFD1 (2.1)	TRIB1 (1.7)	GCNT4 (1.6)
ENSG00000013297	CLDN11 PPI subnetwork	0.17	> 0.20	USP24 (3.8)	PLEC (3.1)	DNM2 (2.8)	COL4A3BP (2.5)	ALDH2 (2.4)	GMIP (2.1)	POLK (2.1)	PVR (1.9)	SORT1 (1.9)	PTPN11 (1.8)
MP:0001126	abnormal ovary morphology	0.17	> 0.20	ST3GAL4 (2.6)	TMEM57 (2.4)	OASL (2.2)	PLEKHH2 (2.1)	LPIN3 (2.0)	KANK2 (1.9)	FRK (1.7)	APOE (1.6)	NYNRIN (1.6)	NKPD1 (1.6)
MP:0003988	disorganized embryonic tissue	0.17	> 0.20	TRIB1 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.0)	ABO (2.0)	TOP1 (1.9)	DOCK7 (1.8)	FEN1 (1.6)	ENSG00000254235 (1.5)	ATXN7L2 (1.5)	ZHX3 (1.5)
ENSG00000111364	DDX55 PPI subnetwork	0.17	> 0.20	ZNF259 (5.2)	NAA25 (4.6)	DDX56 (4.1)	TOMM40 (3.8)	DHODH (2.8)	DHX38 (2.8)	QTRT1 (2.8)	MAPKAPK5 (2.6)	SARS (2.1)	USP24 (2.0)
ENSG00000089902	RCOR1 PPI subnetwork	0.17	> 0.20	SMARCA4 (3.3)	MARK4 (3.2)	PPP1R37 (2.7)	TOP1 (2.6)	CARM1 (2.6)	PLCG1 (2.5)	GATAD2A (2.5)	ATXN2 (2.2)	KANK2 (2.1)	NYNRIN (2.0)
ENSG00000006062	MAP3K14 PPI subnetwork	0.17	> 0.20	ZNF259 (2.8)	NAA25 (2.7)	RELB (2.6)	ILF3 (2.6)	BCL3 (2.3)	SARS (2.2)	TOMM40 (1.9)	TOP1 (1.8)	PVRL2 (1.8)	PVR (1.7)
GO:0051019	mitogen-activated protein kinase binding	0.17	> 0.20	PMFBP1 (3.7)	HAVCR1 (2.8)	TRIB1 (2.6)	POLK (2.5)	C12orf51 (2.4)	GPAM (2.3)	TOP1 (2.0)	DNM2 (1.7)	MYLIP (1.7)	LPIN3 (1.5)
ENSG00000123836	PFKFB2 PPI subnetwork	0.17	> 0.20	ZHX3 (3.5)	DNM2 (3.5)	CARM1 (3.3)	PLEC (3.0)	LPAR2 (3.0)	PTPN11 (2.7)	OGDH (2.7)	GPAM (2.7)	KANK2 (2.4)	USP24 (2.4)
ENSG00000066654	THUMPD1 PPI subnetwork	0.17	> 0.20	ATXN7L2 (3.3)	TMEM50A (2.3)	APOA5 (2.2)	APOC4 (2.0)	SARS (1.8)	C1orf63 (1.8)	PSMA5 (1.7)	ZNF259 (1.7)	BLOC1S3 (1.6)	SLC22A1 (1.6)
ENSG00000100385	IL2RB PPI subnetwork	0.17	> 0.20	BCL3 (3.4)	COL4A3BP (2.1)	RELB (1.8)	TRAFD1 (1.7)	C17orf57 (1.7)	ZNF101 (1.6)	HLX (1.6)	PARP10 (1.6)	CYP7A1 (1.4)	PVR (1.2)
ENSG00000186318	BACE1 PPI subnetwork	0.17	> 0.20	ALDH2 (4.0)	CLPTM1 (4.0)	ERP29 (3.9)	TMED4 (3.1)	GRINA (3.0)	TMEM50A (2.4)	SORT1 (2.2)	NYNRIN (2.0)	TMEM57 (1.9)	GMPR (1.7)
GO:0032365	intracellular lipid transport	0.17	> 0.20	POLK (3.1)	C19orf52 (2.8)	AMIGO1 (2.2)	NKPD1 (2.1)	BRAP (2.0)	ENSG00000238078 (1.9)	ENSG00000235545 (1.9)	ACAD10 (1.9)	FRK (1.9)	TMEM50A (1.7)
MP:0006355	abnormal sixth branchial arch artery morphology	0.17	> 0.20	HLX (3.6)	MYLIP (2.6)	ANKRD31 (1.9)	HNF1A (1.8)	APOE (1.6)	PLCG1 (1.5)	ABO (1.5)	BCAM (1.5)	CETP (1.4)	PVRL2 (1.3)
ENSG00000167526	RPL13 PPI subnetwork	0.17	> 0.20	NAA25 (2.7)	SARS (2.3)	ATP13A1 (2.2)	ZNF259 (2.1)	DHX38 (2.1)	DDX56 (1.9)	GATAD2A (1.8)	TOMM40 (1.8)	ILF3 (1.8)	SUGP1 (1.8)
MP:0000753	paralysis	0.17	> 0.20	HAVCR1 (4.3)	ATP13A1 (2.8)	SYPL2 (2.6)	RPH3A (2.2)	ERP29 (2.1)	TMEM57 (1.8)	NPC1L1 (1.8)	USP24 (1.7)	DOCK7 (1.7)	CELSR2 (1.6)
MP:0008567	decreased interferon-gamma secretion	0.17	> 0.20	PARP10 (3.6)	RELB (2.9)	BCL3 (2.7)	TRAFD1 (2.5)	OASL (2.1)	GMIP (1.9)	HLX (1.9)	MAFB (1.8)	TIMD4 (1.5)	CETP (1.2)
ENSG00000175084	DES PPI subnetwork	0.17	> 0.20	SYPL2 (4.6)	BLOC1S3 (2.1)	GOT2P1 (1.8)	PLEC (1.7)	ST3GAL4 (1.7)	BCAM (1.7)	GMPR (1.4)	C17orf57 (1.4)	PVR (1.3)	CELSR2 (1.3)
ENSG00000103187	COTL1 PPI subnetwork	0.17	> 0.20	ACAD10 (2.6)	C19orf52 (2.6)	C12orf43 (2.4)	TMED4 (2.3)	LPIN3 (2.2)	C12orf47 (2.2)	BRAP (2.1)	ENSG00000238078 (2.0)	GMPR (2.0)	TMEM116 (1.9)
GO:0005903	brush border	0.17	> 0.20	TM6SF2 (6.6)	NPC1L1 (5.5)	AP1M2 (3.9)	ABCG5 (3.9)	APOB (3.6)	TMEM116 (2.9)	ABCG8 (2.5)	PLG (2.4)	KIAA1324 (2.1)	FRK (1.8)
MP:0002813	microcytosis	0.17	> 0.20	RHD (11.8)	RHCE (10.9)	GMPR (4.2)	C12orf51 (2.8)	GRINA (2.3)	ABO (1.9)	ADAM1 (1.7)	RPH3A (1.5)	USP24 (1.5)	ERP29 (1.4)
ENSG00000100764	PSMC1 PPI subnetwork	0.17	> 0.20	PSMA5 (5.6)	NT5DC1 (2.8)	TOMM40 (2.4)	NAA25 (2.0)	TRAFD1 (2.0)	OGDH (1.7)	ENSG00000254235 (1.6)	SARS (1.5)	CLPTM1 (1.4)	DDX56 (1.3)
GO:0005637	nuclear inner membrane	0.17	> 0.20	TMED4 (3.2)	SYPL2 (2.4)	LDLR (2.3)	TMEM50A (1.9)	TRIB1 (1.6)	AMIGO1 (1.5)	C1orf63 (1.5)	COL4A3BP (1.4)	QTRT1 (1.4)	USP1 (1.4)
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	0.17	> 0.20	TIMD4 (3.7)	RELB (3.2)	BCL3 (3.1)	CETP (2.8)	HLX (2.2)	ZNF101 (1.8)	PVR (1.8)	SLC22A1 (1.5)	GMIP (1.2)	PVRL2 (1.2)
ENSG00000125107	CNOT1 PPI subnetwork	0.17	> 0.20	BRAP (2.8)	BUD13 (2.5)	FRK (2.5)	LPIN3 (2.3)	ATXN2 (2.3)	ENSG00000228044 (2.2)	SARS (1.9)	FEN1 (1.8)	ENSG00000254235 (1.7)	TOP1 (1.7)
ENSG00000163166	IWS1 PPI subnetwork	0.17	> 0.20	HNF1A (2.9)	C12orf47 (2.6)	ATP13A1 (2.2)	PTPN11 (2.1)	NT5DC1 (2.1)	BRAP (2.1)	ATXN2 (2.0)	DNM2 (1.9)	MARK4 (1.8)	CARM1 (1.8)
MP:0002633	persistent truncus arteriosis	0.17	> 0.20	TRIB1 (2.9)	ANKRD31 (2.6)	BCAM (2.5)	KANK2 (2.1)	PLCG1 (2.0)	DOCK7 (1.8)	PVR (1.7)	HLX (1.7)	MAFB (1.6)	PVRL2 (1.5)
REACTOME_CASPASE:MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	REACTOME_CASPASE:MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS	0.17	> 0.20	PARP10 (2.8)	FRK (2.6)	ACAD10 (1.9)	C12orf51 (1.9)	PLEC (1.8)	HLX (1.8)	ZNF101 (1.7)	OGDH (1.6)	SH2B3 (1.6)	ANKRD31 (1.4)
GO:0031272	regulation of pseudopodium assembly	0.17	> 0.20	ENSG00000235545 (4.0)	CBLC (2.8)	PVRL2 (2.8)	CETP (2.8)	SLC44A2 (2.2)	C11orf9 (2.1)	BRAP (1.9)	SYPL2 (1.9)	BLOC1S3 (1.7)	HNF1A (1.7)
MP:0000136	abnormal microglial cell morphology	0.17	> 0.20	APOE (3.5)	GMIP (2.5)	BCL3 (2.4)	SORT1 (2.2)	APOC1 (2.2)	GRINA (2.2)	ERP29 (2.1)	HLX (2.1)	TMED4 (2.0)	MAFB (1.9)
MP:0001613	abnormal vasodilation	0.17	> 0.20	HLX (2.9)	HAVCR1 (2.7)	ITGB3 (2.6)	BCAM (2.4)	MOSC1 (2.4)	GPAM (2.3)	C17orf57 (2.1)	HP (2.0)	KIAA1324 (1.8)	MAFB (1.8)
GO:0009595	detection of biotic stimulus	0.17	> 0.20	OASL (3.3)	PARP10 (2.5)	CEACAM19 (2.3)	DNAH11 (2.2)	PMFBP1 (2.0)	TRAFD1 (1.8)	FRK (1.7)	ENSG00000228044 (1.5)	UBXN2B (1.4)	ADAM1 (1.4)
GO:0042346	positive regulation of NF-kappaB import into nucleus	0.17	> 0.20	ENSG00000228044 (2.9)	ENSG00000238078 (2.9)	ENSG00000235545 (2.2)	SH2B3 (2.2)	MYLIP (1.9)	OASL (1.8)	ZNF180 (1.7)	DNAH11 (1.5)	ST3GAL4 (1.4)	LPAR2 (1.3)
ENSG00000151208	DLG5 PPI subnetwork	0.17	> 0.20	UBXN2B (3.6)	CLPTM1 (2.8)	GATAD2A (2.4)	BCAM (2.3)	MYLIP (2.2)	BUD13 (2.2)	GRINA (2.2)	ZHX3 (2.1)	PPP1R37 (2.1)	LPIN3 (1.9)
ENSG00000142273	CBLC PPI subnetwork	0.17	> 0.20	BCL3 (3.6)	HLX (3.4)	RELB (3.1)	CETP (2.7)	GMIP (2.7)	SH2B3 (2.4)	TIMD4 (2.0)	ALDH2 (1.7)	LPA (1.6)	TRIB1 (1.5)
ENSG00000171942	OR10H2 PPI subnetwork	0.17	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.6)	PLEKHH2 (1.9)	TMEM57 (1.9)	DNAH11 (1.8)	C1orf63 (1.6)	POLK (1.4)	SLC44A2 (1.4)	SYPL2 (1.3)
ENSG00000183311	TUBB PPI subnetwork	0.17	> 0.20	PLEC (3.2)	CLPTM1 (2.9)	SMARCA4 (2.7)	RELB (2.7)	SARS (2.7)	PVR (2.6)	BCL3 (2.5)	ATP13A1 (2.2)	NAA25 (2.1)	PSMA5 (2.0)
ENSG00000196230	TUBB PPI subnetwork	0.17	> 0.20	PLEC (3.2)	CLPTM1 (2.9)	SMARCA4 (2.7)	RELB (2.7)	SARS (2.7)	PVR (2.6)	BCL3 (2.5)	ATP13A1 (2.2)	NAA25 (2.1)	PSMA5 (2.0)
ENSG00000137379	ENSG00000137379 PPI subnetwork	0.17	> 0.20	PLEC (3.2)	CLPTM1 (2.9)	SMARCA4 (2.7)	RELB (2.7)	SARS (2.7)	PVR (2.6)	BCL3 (2.5)	ATP13A1 (2.2)	NAA25 (2.1)	PSMA5 (2.0)
GO:0045815	positive regulation of gene expression, epigenetic	0.17	> 0.20	FRK (3.2)	C17orf57 (3.1)	GOT2P1 (2.7)	NT5DC1 (2.4)	TMEM116 (2.1)	ATXN2 (2.0)	ANKRD31 (1.9)	CARM1 (1.8)	TSSK6 (1.7)	MAU2 (1.7)
ENSG00000087086	FTL PPI subnetwork	0.17	> 0.20	GRINA (3.5)	ALDH2 (3.0)	HP (2.6)	ANGPTL3 (2.4)	PLG (2.2)	UBXN2B (2.0)	ACAD10 (1.8)	BCL3 (1.6)	APOB (1.6)	FADS1 (1.5)
ENSG00000115946	PNO1 PPI subnetwork	0.17	> 0.20	DDX56 (4.6)	ZNF259 (4.6)	NAA25 (3.8)	QTRT1 (3.8)	TOMM40 (3.3)	DHODH (2.6)	C12orf43 (2.4)	DHX38 (2.3)	SARS (2.1)	PVR (2.0)
MP:0005330	cardiomyopathy	0.17	> 0.20	ABCG8 (4.3)	ACAD10 (3.0)	SYPL2 (2.6)	NPC1L1 (2.3)	CBLC (2.0)	GMPR (2.0)	TM6SF2 (1.9)	BCAM (1.9)	C1orf63 (1.9)	OGDH (1.6)
ENSG00000086015	MAST2 PPI subnetwork	0.17	> 0.20	DNM2 (3.6)	PLEC (3.3)	ZHX3 (3.3)	CARM1 (3.0)	LPAR2 (2.9)	MAU2 (2.5)	COL4A3BP (2.5)	ATXN7L2 (2.4)	C11orf9 (2.1)	USP24 (2.1)
ENSG00000131153	GINS2 PPI subnetwork	0.17	> 0.20	FEN1 (6.7)	USP1 (4.3)	ZNF180 (1.8)	DHODH (1.7)	ENSG00000228044 (1.5)	ILF3 (1.4)	PSRC1 (1.1)	ERP29 (1.1)	ANKRD31 (1.1)	CYP7A1 (1.0)
REACTOME_CDC6_ASSOCIATION_WITH_THE_ORCORIGIN_COMPLEX	REACTOME_CDC6_ASSOCIATION_WITH_THE_ORCORIGIN_COMPLEX	0.17	> 0.20	FEN1 (3.3)	GOT2P1 (2.4)	USP1 (2.2)	NT5DC1 (2.2)	TMEM116 (2.1)	RHD (1.8)	LPAR2 (1.6)	TXNL4B (1.5)	DHODH (1.5)	ABO (1.3)
MP:0003853	dry skin	0.17	> 0.20	CBLC (4.7)	AP1M2 (4.3)	NKPD1 (4.2)	MOSC1 (2.6)	GPAM (2.5)	HMGCR (2.5)	PLG (2.5)	ENSG00000254235 (2.4)	APOC4 (2.3)	RELB (2.1)
ENSG00000183963	SMTN PPI subnetwork	0.17	> 0.20	OASL (2.9)	TIMD4 (2.9)	CETP (2.2)	SYPL2 (2.1)	C1orf63 (1.7)	TMEM57 (1.7)	DNAH11 (1.6)	ANKRD31 (1.5)	PLEKHH2 (1.4)	TMEM50A (1.4)
ENSG00000116285	ERRFI1 PPI subnetwork	0.17	> 0.20	CBLC (4.5)	AP1M2 (2.8)	PSRC1 (2.5)	DOCK7 (2.4)	PVRL2 (2.4)	BCAM (2.0)	LPIN3 (1.8)	KANK2 (1.7)	PPP1R37 (1.6)	SLC44A2 (1.6)
MP:0000048	abnormal stria vascularis morphology	0.17	> 0.20	APOC1 (2.7)	SORT1 (2.1)	TMEM116 (2.0)	ANKRD31 (1.9)	PTPN11 (1.9)	GMPR (1.8)	MYLIP (1.7)	PMFBP1 (1.7)	NKPD1 (1.7)	HNF1A (1.7)
GO:0010332	response to gamma radiation	0.17	> 0.20	ZNF101 (3.1)	ENSG00000228044 (2.9)	BLOC1S3 (2.4)	UBXN2B (2.3)	ZNF180 (2.1)	GCNT4 (1.9)	CBLC (1.8)	ENSG00000235545 (1.8)	AMIGO1 (1.7)	TRAPPC6A (1.7)
GO:0004518	nuclease activity	0.17	> 0.20	ZNF180 (2.5)	DHODH (2.3)	POC5 (2.3)	FEN1 (2.3)	C12orf43 (2.2)	NT5DC1 (2.0)	DDX56 (2.0)	ZNF259 (2.0)	BUD13 (1.9)	NKPD1 (1.8)
ENSG00000161395	PGAP3 PPI subnetwork	0.17	> 0.20	TMEM50A (3.6)	TMED4 (3.6)	CLPTM1 (3.3)	ERP29 (3.2)	YIPF2 (3.0)	ATP13A1 (3.0)	LPAR2 (2.2)	MAU2 (2.2)	HAVCR1 (2.1)	SORT1 (1.8)
ENSG00000125398	SOX9 PPI subnetwork	0.17	> 0.20	ATXN2 (3.7)	CELSR2 (3.4)	C12orf51 (2.7)	C1orf63 (2.4)	HLX (2.0)	TXNL4B (1.9)	APOE (1.8)	MAFB (1.8)	PLEC (1.7)	NAA25 (1.6)
GO:0010906	regulation of glucose metabolic process	0.17	> 0.20	ENSG00000254235 (4.1)	LPA (2.8)	HNF1A (2.6)	CYP7A1 (2.3)	GPAM (2.2)	PCSK9 (1.9)	KANK2 (1.9)	ZHX3 (1.7)	ZNF180 (1.6)	MOSC1 (1.5)
GO:0051092	positive regulation of NF-kappaB transcription factor activity	0.17	> 0.20	ENSG00000226645 (4.3)	BLOC1S3 (3.8)	RELB (3.2)	ENSG00000228044 (2.5)	ST3GAL4 (2.4)	GMIP (2.4)	BCL3 (2.2)	PARP10 (2.1)	SH2B3 (2.1)	PVR (1.8)
ENSG00000196961	AP2A1 PPI subnetwork	0.17	> 0.20	SMARCA4 (2.8)	C1orf63 (2.7)	KANK2 (2.2)	DNM2 (2.1)	ZNF101 (2.1)	PLEC (2.0)	TOP1 (2.0)	GRINA (2.0)	DOCK7 (1.9)	CETP (1.9)
ENSG00000185043	CIB1 PPI subnetwork	0.17	> 0.20	ITGB3 (3.9)	OASL (3.2)	TRIB1 (2.4)	LPIN3 (2.4)	GCNT4 (2.3)	PLCG1 (2.2)	GMPR (2.2)	POLK (2.1)	ABO (2.0)	ATXN2 (1.9)
ENSG00000107560	RAB11FIP2 PPI subnetwork	0.17	> 0.20	CARM1 (3.7)	AP1M2 (3.4)	LPAR2 (3.4)	DNM2 (3.2)	CBLC (3.2)	COL4A3BP (2.8)	ZHX3 (2.7)	PLEC (2.7)	OGDH (2.5)	MAU2 (2.4)
ENSG00000183405	ENSG00000183405 PPI subnetwork	0.17	> 0.20	DDX56 (4.2)	NAA25 (4.0)	ZNF259 (3.8)	QTRT1 (3.7)	TOMM40 (3.0)	DHODH (3.0)	C12orf43 (2.4)	SUGP1 (2.3)	DHX38 (2.3)	GATAD2A (2.1)
GO:0043236	laminin binding	0.17	> 0.20	PVRL2 (4.3)	BCAM (3.7)	PBX4 (2.5)	PLEC (2.5)	KANK2 (2.3)	CBLC (2.3)	SLC44A2 (2.0)	CLPTM1 (1.9)	ABO (1.8)	ENSG00000254235 (1.8)
MP:0008135	small Peyer's patches	0.17	> 0.20	RELB (6.1)	BCL3 (4.0)	TIMD4 (4.0)	GMIP (3.7)	CETP (2.8)	PARP10 (2.7)	OASL (2.1)	ENSG00000235545 (1.9)	GRINA (1.8)	KIAA1324 (1.4)
MP:0006055	abnormal vascular endothelial cell morphology	0.17	> 0.20	SH2B3 (2.6)	HLX (2.3)	ITGB3 (2.1)	SLC44A2 (2.1)	TRIB1 (1.8)	KANK2 (1.8)	PLEC (1.4)	CETP (1.4)	OGDH (1.2)	C17orf57 (1.2)
ENSG00000107937	GTPBP4 PPI subnetwork	0.17	> 0.20	ZNF259 (4.7)	NAA25 (4.5)	DDX56 (4.3)	TOMM40 (3.9)	QTRT1 (3.3)	DHX38 (2.8)	DHODH (2.6)	ATP13A1 (2.5)	ILF3 (2.4)	TOP1 (2.2)
MP:0002948	abnormal neuron specification	0.17	> 0.20	ANKRD31 (2.8)	HAPLN4 (2.6)	PSRC1 (2.5)	ENSG00000226648 (2.0)	PLEKHH2 (1.7)	PLCG1 (1.6)	DNAH11 (1.5)	PMFBP1 (1.5)	NCAN (1.5)	GEMIN7 (1.5)
ENSG00000163435	ELF3 PPI subnetwork	0.17	> 0.20	OASL (3.9)	PARP10 (2.7)	TRAFD1 (2.3)	TMEM57 (2.2)	SARS (2.2)	GMPR (2.1)	SMARCA4 (1.9)	LPIN3 (1.7)	ATP13A1 (1.7)	ERP29 (1.6)
MP:0005058	abnormal lysosome morphology	0.17	> 0.20	ERP29 (4.9)	TMEM50A (3.0)	SORT1 (3.0)	ATP13A1 (2.8)	COL4A3BP (2.6)	MAFB (2.3)	NT5DC1 (2.2)	CYB561D1 (2.1)	PSRC1 (2.1)	PLCG1 (2.0)
ENSG00000055332	EIF2AK2 PPI subnetwork	0.17	> 0.20	PARP10 (4.1)	TRAFD1 (3.9)	OASL (3.3)	BRAP (2.9)	FRK (2.7)	CYB561D1 (2.4)	ENSG00000228044 (2.2)	RELB (2.1)	C1orf63 (1.9)	C12orf43 (1.9)
MP:0001239	abnormal epidermis stratum granulosum morphology	0.17	> 0.20	NKPD1 (3.7)	CBLC (3.6)	MAFB (2.8)	PLEC (2.6)	AP1M2 (2.4)	TRIB1 (2.1)	CELSR2 (1.9)	ENSG00000254235 (1.8)	BLOC1S3 (1.8)	TOMM40 (1.6)
ENSG00000121653	MAPK8IP1 PPI subnetwork	0.17	> 0.20	RPH3A (2.1)	TRIB1 (2.0)	LDLR (1.8)	PPP1R37 (1.7)	PVR (1.7)	SLC44A2 (1.7)	BCAM (1.6)	SORT1 (1.6)	DNAH11 (1.6)	HAVCR1 (1.5)
MP:0004893	decreased adiponectin level	0.17	> 0.20	TIMD4 (3.3)	ATXN7L2 (3.3)	CETP (3.1)	SORT1 (2.6)	MOSC1 (2.2)	GPAM (1.9)	HP (1.9)	DNM2 (1.9)	NAA25 (1.8)	TOP1 (1.8)
ENSG00000101204	CHRNA4 PPI subnetwork	0.17	> 0.20	ATP13A1 (2.7)	TOMM40 (2.5)	MAPKAPK5 (2.4)	LPA (2.2)	HNF1A (2.0)	PCSK9 (2.0)	ANKRD31 (1.9)	CEACAM19 (1.8)	HAPLN4 (1.7)	USP24 (1.7)
REACTOME_POST:ELONGATION_PROCESSING_OF_INTRONLESS_PRE:MRNA	REACTOME_POST:ELONGATION_PROCESSING_OF_INTRONLESS_PRE:MRNA	0.17	> 0.20	ENSG00000226645 (3.2)	C1orf63 (2.7)	MYLIP (2.3)	ZNF180 (2.2)	C12orf47 (2.1)	ZNF259 (2.1)	TXNL4B (2.0)	UBXN2B (1.9)	FEN1 (1.9)	ENSG00000235545 (1.7)
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE:MRNA	REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE:MRNA	0.17	> 0.20	ENSG00000226645 (3.2)	C1orf63 (2.7)	MYLIP (2.3)	ZNF180 (2.2)	C12orf47 (2.1)	ZNF259 (2.1)	TXNL4B (2.0)	UBXN2B (1.9)	FEN1 (1.9)	ENSG00000235545 (1.7)
GO:0031080	Nup107-160 complex	0.17	> 0.20	POC5 (3.5)	MAPKAPK5 (3.2)	USP1 (2.7)	ENSG00000235545 (2.2)	CARM1 (2.2)	FEN1 (2.1)	NAA25 (2.1)	DOCK7 (2.1)	USP24 (2.1)	MOSC1 (1.9)
GO:0016571	histone methylation	0.17	> 0.20	C12orf51 (3.5)	ZNF180 (2.6)	ATXN7L2 (2.4)	MAU2 (2.3)	ATXN2 (2.2)	C19orf52 (2.2)	QTRT1 (2.0)	BUD13 (2.0)	GOT2P1 (1.8)	USP24 (1.8)
REACTOME_P75NTR_SIGNALS_VIA_NF:KB	REACTOME_P75NTR_SIGNALS_VIA_NF:KB	0.17	> 0.20	RELB (5.9)	BCL3 (3.7)	PVR (2.8)	PARP10 (2.8)	SH2B3 (2.0)	GMIP (1.9)	GATAD2A (1.8)	BLOC1S3 (1.5)	TRIB1 (1.4)	GRINA (1.4)
ENSG00000197157	SND1 PPI subnetwork	0.17	> 0.20	ITGB3 (3.0)	ST3GAL4 (2.6)	ZNF101 (2.0)	NAA25 (2.0)	C12orf47 (1.9)	DHX38 (1.7)	ATXN2 (1.7)	BUD13 (1.6)	SMARCA4 (1.5)	GRINA (1.5)
ENSG00000011052	NME2 PPI subnetwork	0.17	> 0.20	TOMM40 (2.9)	PSMA5 (2.6)	ITGB3 (2.4)	TMEM50A (2.2)	NAA25 (2.1)	C19orf52 (2.1)	PBX4 (2.0)	ZNF180 (2.0)	MYLIP (1.7)	GEMIN7 (1.7)
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE	0.17	> 0.20	ST3GAL4 (3.4)	GCNT4 (2.7)	DOCK7 (2.4)	PVRL2 (2.1)	MARK4 (2.1)	AMIGO1 (2.0)	ENSG00000254235 (1.9)	YIPF2 (1.8)	CETP (1.8)	PSRC1 (1.8)
MP:0001787	pericardial edema	0.17	> 0.20	RHD (2.5)	COL4A3BP (2.4)	HLX (2.2)	PLCG1 (2.2)	ACAD10 (2.1)	UBXN2B (2.1)	C11orf9 (2.0)	GATAD2A (2.0)	DNM2 (1.6)	SH2B3 (1.6)
GO:0014044	Schwann cell development	0.17	> 0.20	ENSG00000226645 (3.7)	DNAH11 (3.1)	PBX4 (2.2)	AMIGO1 (2.1)	ZHX3 (1.8)	KANK2 (1.6)	ENSG00000226648 (1.5)	ZNF101 (1.5)	ST3GAL4 (1.4)	COL4A3BP (1.4)
MP:0003698	abnormal male reproductive system physiology	0.17	> 0.20	KIAA1324 (3.1)	NKPD1 (2.5)	PCSK9 (2.3)	ABCG5 (2.3)	GMPR (2.2)	TRAPPC6A (2.1)	RHCE (2.0)	PARP10 (1.9)	ALDH2 (1.8)	APOB (1.7)
MP:0004499	increased incidence of chemically-induced tumors	0.17	> 0.20	TRIB1 (3.5)	BCL3 (2.8)	NKPD1 (2.8)	PBX4 (2.5)	POLK (2.4)	BRAP (2.1)	C1orf63 (1.8)	MAU2 (1.8)	ENSG00000254235 (1.8)	ALDH2 (1.8)
ENSG00000113302	IL12B PPI subnetwork	0.17	> 0.20	BCL3 (4.7)	RELB (4.5)	HLX (3.3)	TRIB1 (2.9)	TIMD4 (2.1)	GMIP (2.0)	PVR (1.9)	ALDH2 (1.8)	CETP (1.8)	ATXN7L2 (1.6)
MP:0008502	increased IgG3 level	0.17	> 0.20	RELB (4.4)	BCL3 (3.3)	SH2B3 (2.4)	GMIP (2.3)	PBX4 (1.9)	MAFB (1.6)	POLK (1.5)	ALDH2 (1.4)	ZNF101 (1.4)	PVR (1.4)
ENSG00000101966	XIAP PPI subnetwork	0.17	> 0.20	TRAFD1 (3.0)	PARP10 (2.7)	ST3GAL4 (2.6)	UBXN2B (2.5)	NT5DC1 (1.8)	FRK (1.7)	ENSG00000226645 (1.7)	OASL (1.7)	C1orf63 (1.5)	PTPN11 (1.3)
REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE	0.17	> 0.20	DHODH (4.7)	ST3GAL4 (4.4)	ZNF259 (3.4)	QTRT1 (2.9)	ENSG00000226645 (2.5)	TOMM40 (2.5)	DDX56 (2.4)	TRAPPC6A (2.0)	SUGP1 (1.8)	FEN1 (1.7)
GO:0070412	R-SMAD binding	0.17	> 0.20	TRIB1 (4.2)	KANK2 (3.0)	MAPKAPK5 (2.7)	ENSG00000226648 (2.5)	ILF3 (2.4)	ATXN7L2 (2.3)	DOCK7 (2.2)	ENSG00000226645 (2.1)	AMIGO1 (2.0)	PLCG1 (1.7)
MP:0004838	abnormal neural fold elevation formation	0.17	> 0.20	PPP1R37 (2.4)	TOP1 (2.4)	HMGCR (2.3)	TRIB1 (2.3)	CBLC (2.1)	ABCG8 (1.8)	ST3GAL4 (1.6)	BLOC1S3 (1.5)	ENSG00000226648 (1.5)	ALDH2 (1.4)
GO:0009086	methionine biosynthetic process	0.17	> 0.20	DNAH11 (3.2)	ENSG00000254235 (2.7)	DHODH (1.8)	UBXN2B (1.8)	C1orf63 (1.8)	TSSK6 (1.5)	TMED4 (1.5)	ST3GAL4 (1.5)	ANGPTL3 (1.3)	CEACAM19 (1.3)
GO:0016814	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines	0.17	> 0.20	OASL (4.4)	PARP10 (3.6)	SYPL2 (3.2)	NPC1L1 (3.0)	LPIN3 (2.6)	TSSK6 (2.4)	ABCG5 (2.3)	TRAFD1 (2.3)	TM6SF2 (2.1)	ABCG8 (1.6)
ENSG00000065054	SLC9A3R2 PPI subnetwork	0.17	> 0.20	PLEC (2.8)	ST3GAL4 (2.1)	SLC44A2 (2.0)	MAU2 (1.9)	TMEM116 (1.9)	MYLIP (1.9)	GEMIN7 (1.8)	ABO (1.6)	PLG (1.6)	MOSC1 (1.6)
MP:0008029	abnormal paraxial mesoderm morphology	0.18	> 0.20	PLCG1 (3.3)	NYNRIN (2.4)	C17orf57 (2.2)	GATAD2A (2.2)	KANK2 (1.8)	CEACAM19 (1.7)	ALDH2 (1.6)	ATXN2 (1.6)	UBXN2B (1.6)	FADS2 (1.5)
GO:0019867	outer membrane	0.18	> 0.20	FADS1 (3.2)	FADS2 (3.0)	GPAM (2.9)	GMPR (2.8)	MOSC1 (2.8)	ALDH2 (2.6)	PTPN11 (2.1)	PCSK9 (2.0)	LPIN3 (2.0)	GRINA (2.0)
ENSG00000163602	RYBP PPI subnetwork	0.18	> 0.20	PMFBP1 (2.5)	TOP1 (1.9)	ENSG00000238078 (1.8)	C11orf9 (1.7)	TXNL4B (1.6)	BCL3 (1.6)	GATAD2A (1.5)	LDLR (1.5)	HNF1A (1.4)	BUD13 (1.3)
GO:0060333	interferon-gamma-mediated signaling pathway	0.18	> 0.20	TRAFD1 (5.2)	PARP10 (4.9)	OASL (3.7)	ADAM1 (3.4)	C12orf43 (2.1)	ENSG00000228044 (2.0)	CEACAM19 (1.9)	CYB561D1 (1.9)	BCL3 (1.9)	RELB (1.8)
ENSG00000166200	COPS2 PPI subnetwork	0.18	> 0.20	ATXN7L2 (2.1)	PSRC1 (1.9)	POC5 (1.8)	ENSG00000226648 (1.8)	BUD13 (1.7)	QTRT1 (1.7)	DYNC2LI1 (1.6)	NT5DC1 (1.6)	GRINA (1.6)	TIMD4 (1.5)
ENSG00000206181	TCEB3B PPI subnetwork	0.18	> 0.20	FRK (3.1)	LPAR2 (3.0)	YIPF2 (2.5)	ANKRD31 (2.4)	PBX4 (2.3)	HAVCR1 (2.3)	AP1M2 (2.0)	UBXN2B (1.8)	MAU2 (1.8)	SLC44A2 (1.7)
GO:0046949	fatty-acyl-CoA biosynthetic process	0.18	> 0.20	FADS1 (5.4)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.7)	BLOC1S3 (2.8)	NKPD1 (2.3)	MOSC1 (2.1)	DOCK7 (1.8)
GO:0035337	fatty-acyl-CoA metabolic process	0.18	> 0.20	FADS1 (5.4)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.7)	BLOC1S3 (2.8)	NKPD1 (2.3)	MOSC1 (2.1)	DOCK7 (1.8)
ENSG00000169031	COL4A3 PPI subnetwork	0.18	> 0.20	APOE (2.7)	FRK (2.6)	KANK2 (2.5)	PVR (2.1)	CEACAM19 (1.9)	PTPN11 (1.9)	PARP10 (1.8)	HNF1A (1.6)	TMED4 (1.3)	BCAM (1.3)
GO:0001944	vasculature development	0.18	> 0.20	HLX (2.8)	PVR (2.7)	PVRL2 (2.6)	BCAM (2.2)	KANK2 (1.9)	MAFB (1.8)	NYNRIN (1.8)	SH2B3 (1.7)	TRIB1 (1.7)	SLC44A2 (1.6)
ENSG00000115290	GRB14 PPI subnetwork	0.18	> 0.20	C17orf57 (2.9)	AP1M2 (2.2)	APOE (2.1)	CLPTM1 (2.0)	TRIB1 (1.9)	PLCG1 (1.8)	QTRT1 (1.6)	PPP1R37 (1.6)	KANK2 (1.6)	MYLIP (1.6)
GO:0031968	organelle outer membrane	0.18	> 0.20	FADS2 (3.0)	FADS1 (2.9)	GPAM (2.7)	MOSC1 (2.7)	GMPR (2.6)	ALDH2 (2.6)	GRINA (2.1)	AMIGO1 (2.1)	BRAP (2.0)	PARP10 (2.0)
ENSG00000143401	ANP32E PPI subnetwork	0.18	> 0.20	TMED4 (2.9)	QTRT1 (2.6)	TOMM40 (2.4)	DHODH (2.3)	DDX56 (2.3)	POC5 (2.1)	HMGCR (1.9)	BLOC1S3 (1.9)	ATXN2 (1.9)	ZNF180 (1.7)
ENSG00000105953	OGDH PPI subnetwork	0.18	> 0.20	ATP13A1 (3.7)	CLPTM1 (3.5)	OGDH (3.5)	QTRT1 (3.4)	GATAD2A (3.0)	C19orf52 (2.7)	DDX56 (2.3)	TXNL4B (2.3)	YIPF2 (2.3)	BRAP (2.1)
ENSG00000168255	POLR2J3 PPI subnetwork	0.18	> 0.20	GEMIN7 (4.8)	CLPTM1 (3.8)	TOMM40 (2.8)	TRAPPC6A (2.5)	UBXN2B (2.4)	C12orf47 (1.9)	BLOC1S3 (1.6)	TMEM50A (1.6)	GATAD2A (1.6)	TXNL4B (1.5)
ENSG00000197373	ENSG00000197373 PPI subnetwork	0.18	> 0.20	GEMIN7 (4.8)	CLPTM1 (3.8)	TOMM40 (2.8)	TRAPPC6A (2.5)	UBXN2B (2.4)	C12orf47 (1.9)	BLOC1S3 (1.6)	TMEM50A (1.6)	GATAD2A (1.6)	TXNL4B (1.5)
GO:0004861	cyclin-dependent protein kinase inhibitor activity	0.18	> 0.20	MYLIP (2.5)	ENSG00000254235 (2.3)	SORT1 (2.0)	TMED4 (2.0)	ITGB3 (1.8)	SLC44A2 (1.7)	HLX (1.7)	PARP10 (1.6)	C1orf63 (1.6)	MAFB (1.6)
GO:0033687	osteoblast proliferation	0.18	> 0.20	SLC44A2 (4.1)	PLEKHH2 (3.4)	ENSG00000238078 (3.1)	DYNC2LI1 (1.8)	GCNT4 (1.8)	OASL (1.7)	ST3GAL4 (1.7)	YIPF2 (1.6)	HAVCR1 (1.6)	ENSG00000235545 (1.5)
ENSG00000051382	PIK3CB PPI subnetwork	0.18	> 0.20	HLX (3.1)	DOCK7 (3.0)	SLC44A2 (2.5)	MYLIP (2.4)	PVRL2 (2.4)	GMIP (2.3)	C1orf63 (2.3)	PPP1R37 (2.2)	DNM2 (2.1)	COL4A3BP (2.1)
MP:0003814	vascular smooth muscle cell hypoplasia	0.18	> 0.20	PLEC (3.2)	SH2B3 (2.6)	HLX (2.6)	TRIB1 (1.6)	USP24 (1.5)	PCSK9 (1.5)	PLEKHH2 (1.3)	MYLIP (1.3)	BCL3 (1.3)	LDLR (1.2)
ENSG00000138675	FGF5 PPI subnetwork	0.18	> 0.20	HAVCR1 (4.6)	HAPLN4 (3.3)	PLEKHH2 (3.1)	C11orf9 (3.0)	ZHX3 (2.6)	CBLC (2.6)	C17orf57 (2.3)	NCAN (2.3)	NYNRIN (2.0)	CEACAM19 (1.9)
ENSG00000099937	SERPIND1 PPI subnetwork	0.18	> 0.20	RHD (4.0)	HP (3.4)	MOSC1 (2.3)	DYNC2LI1 (2.2)	RHCE (2.2)	APOB (2.2)	PLG (2.1)	CILP2 (2.1)	C12orf51 (2.0)	CYP7A1 (1.8)
ENSG00000159216	RUNX1 PPI subnetwork	0.18	> 0.20	TRIB1 (3.2)	ATXN2 (3.2)	GATAD2A (2.3)	PLCG1 (2.1)	FRK (2.1)	TOP1 (1.9)	HLX (1.9)	C12orf51 (1.8)	SMARCA4 (1.7)	MAFB (1.7)
ENSG00000159377	PSMB4 PPI subnetwork	0.18	> 0.20	PSMA5 (5.9)	TRAFD1 (2.8)	NAA25 (2.5)	NT5DC1 (2.2)	ENSG00000254235 (1.8)	TOMM40 (1.7)	DDX56 (1.6)	SARS (1.3)	PARP10 (1.3)	ZNF101 (1.2)
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	0.18	> 0.20	NAA25 (3.4)	POC5 (3.1)	DDX56 (3.0)	USP24 (2.7)	DOCK7 (2.7)	USP1 (2.7)	BUD13 (2.6)	ILF3 (2.2)	FEN1 (2.0)	MAPKAPK5 (1.9)
ENSG00000108963	DPH1 PPI subnetwork	0.18	> 0.20	DHODH (2.8)	TXNL4B (2.6)	PPP1R37 (2.5)	DDX56 (2.2)	YIPF2 (2.1)	LPAR2 (1.9)	ERP29 (1.7)	COL4A3BP (1.6)	ATXN7L2 (1.5)	C19orf52 (1.5)
MP:0008014	increased lung tumor incidence	0.18	> 0.20	DNM2 (2.6)	TSSK6 (2.6)	FEN1 (2.2)	USP1 (2.1)	PSRC1 (2.0)	SORT1 (1.9)	LPIN3 (1.8)	ACAD10 (1.8)	DHX38 (1.7)	ZNF180 (1.7)
MP:0008973	decreased erythroid progenitor cell number	0.18	> 0.20	TOP1 (2.8)	RHD (2.5)	RHCE (2.5)	C12orf51 (2.2)	TRIB1 (2.1)	SH2B3 (2.1)	TMEM57 (2.0)	HLX (1.9)	ATXN2 (1.8)	OASL (1.7)
MP:0000685	abnormal immune system morphology	0.18	> 0.20	RELB (5.1)	BCL3 (4.0)	CETP (4.0)	TIMD4 (3.3)	GMIP (2.6)	TRAFD1 (2.2)	GRINA (2.0)	GEMIN7 (2.0)	HAVCR1 (1.9)	PARP10 (1.9)
GO:0005381	iron ion transmembrane transporter activity	0.18	> 0.20	C12orf43 (3.2)	TOMM40 (3.1)	LPIN3 (2.5)	ENSG00000226645 (2.2)	ZNF259 (2.1)	PVR (1.9)	BLOC1S3 (1.9)	TMED4 (1.7)	MAPKAPK5 (1.6)	APOE (1.6)
GO:0002920	regulation of humoral immune response	0.18	> 0.20	ENSG00000228044 (4.2)	TIMD4 (3.4)	ENSG00000235545 (2.7)	HAVCR1 (2.4)	DYNC2LI1 (2.2)	ENSG00000238078 (2.1)	GMIP (1.9)	CETP (1.8)	GEMIN7 (1.8)	CEACAM19 (1.8)
ENSG00000141232	TOB1 PPI subnetwork	0.18	> 0.20	DOCK7 (2.7)	MAFB (2.0)	ATXN2 (1.9)	CETP (1.7)	ADAM1 (1.6)	SH2B3 (1.5)	ALDH2 (1.5)	GRINA (1.5)	ENSG00000235545 (1.5)	ABCG8 (1.4)
ENSG00000147905	ZCCHC7 PPI subnetwork	0.18	> 0.20	ZNF180 (2.8)	PLEKHH2 (2.0)	COL4A3BP (2.0)	DHX38 (1.8)	ENSG00000228044 (1.6)	ABCG8 (1.5)	USP24 (1.5)	PPP1R37 (1.5)	POC5 (1.5)	USP1 (1.4)
ENSG00000144648	CCBP2 PPI subnetwork	0.18	> 0.20	OASL (3.6)	RELB (2.7)	CETP (2.6)	MAFB (2.0)	TIMD4 (1.8)	TM6SF2 (1.7)	NPC1L1 (1.7)	BCL3 (1.7)	ZNF101 (1.5)	HLX (1.3)
GO:0045598	regulation of fat cell differentiation	0.18	> 0.20	ENSG00000238078 (2.7)	ENSG00000254235 (2.1)	CILP2 (1.9)	MAFB (1.8)	LDLR (1.6)	MYLIP (1.4)	FADS1 (1.4)	ST3GAL4 (1.2)	SH2B3 (1.1)	PCSK9 (1.1)
ENSG00000186867	QRFPR PPI subnetwork	0.18	> 0.20	OASL (3.2)	TIMD4 (3.0)	CETP (2.4)	PLEKHH2 (2.2)	POLK (1.6)	TMEM57 (1.5)	C1orf63 (1.5)	SYPL2 (1.5)	CEACAM19 (1.4)	DNAH11 (1.4)
ENSG00000018408	WWTR1 PPI subnetwork	0.18	> 0.20	BCAM (3.8)	PPP1R37 (2.5)	NYNRIN (2.3)	NKPD1 (2.1)	KANK2 (2.0)	PLEKHH2 (2.0)	ENSG00000228044 (1.9)	GCNT4 (1.9)	SORT1 (1.7)	TMEM116 (1.6)
ENSG00000138030	KHK PPI subnetwork	0.18	> 0.20	HNF1A (3.4)	TRAPPC6A (3.1)	TXNL4B (2.9)	BUD13 (2.4)	NPC1L1 (2.3)	SUGP1 (2.1)	GEMIN7 (2.0)	ZNF180 (2.0)	APOB (1.7)	YIPF2 (1.6)
ENSG00000012223	LTF PPI subnetwork	0.18	> 0.20	MAFB (5.3)	APOE (3.0)	KIAA1324 (2.6)	LPA (2.3)	APOC1 (2.2)	ALDH2 (2.0)	ADAM1 (1.9)	NPC1L1 (1.9)	DOCK7 (1.9)	TRIB1 (1.9)
GO:0030097	hemopoiesis	0.18	> 0.20	ZNF101 (4.3)	RHCE (3.6)	RHD (3.4)	PBX4 (2.6)	HLX (2.4)	PLCG1 (2.1)	SH2B3 (1.8)	GMIP (1.7)	TRIB1 (1.5)	MAFB (1.5)
ENSG00000196092	PAX5 PPI subnetwork	0.18	> 0.20	MYLIP (3.1)	BUD13 (2.0)	HLX (1.9)	TMEM50A (1.8)	TRIB1 (1.8)	PLCG1 (1.8)	PBX4 (1.8)	C19orf52 (1.7)	KANK2 (1.7)	NCAN (1.6)
GO:0080135	regulation of cellular response to stress	0.18	> 0.20	MAU2 (2.0)	POLK (1.9)	LPAR2 (1.8)	ZNF180 (1.6)	ENSG00000226645 (1.6)	C11orf9 (1.5)	NT5DC1 (1.5)	UBXN2B (1.5)	ST3GAL4 (1.4)	GATAD2A (1.4)
GO:0042623	ATPase activity, coupled	0.18	> 0.20	ATP13A1 (3.6)	DHX38 (3.5)	SUGP1 (3.1)	SMARCA4 (2.8)	MAU2 (2.5)	ILF3 (2.5)	OASL (2.4)	NAA25 (2.4)	USP24 (2.3)	DOCK7 (2.0)
KEGG_BETA_ALANINE_METABOLISM	KEGG_BETA_ALANINE_METABOLISM	0.18	> 0.20	PLG (4.8)	MOSC1 (4.2)	SLC22A1 (3.9)	ANGPTL3 (3.8)	ACAD10 (3.5)	APOA5 (3.1)	ABCG8 (3.0)	LPA (3.0)	APOC4 (2.7)	HP (2.7)
GO:0009266	response to temperature stimulus	0.18	> 0.20	ENSG00000235545 (4.0)	AMIGO1 (2.7)	SYPL2 (1.9)	PVR (1.7)	DNAH11 (1.6)	C12orf51 (1.6)	ACAD10 (1.5)	TRIB1 (1.3)	ENSG00000228044 (1.2)	BCL3 (1.1)
GO:0033017	sarcoplasmic reticulum membrane	0.18	> 0.20	SYPL2 (7.4)	HAVCR1 (2.5)	C17orf57 (2.5)	GMPR (2.3)	CYB561D1 (1.8)	ABO (1.6)	CARM1 (1.6)	OGDH (1.5)	TMED4 (1.4)	C12orf47 (1.4)
ENSG00000108773	KAT2A PPI subnetwork	0.18	> 0.20	ATXN2 (3.5)	PARP10 (2.8)	MAU2 (2.6)	ATXN7L2 (2.5)	MAPKAPK5 (2.5)	C12orf51 (2.4)	BUD13 (2.3)	TRAFD1 (2.1)	CARM1 (2.0)	UBXN2B (2.0)
GO:0060056	mammary gland involution	0.18	> 0.20	PPP1R37 (3.3)	ST3GAL4 (2.7)	C17orf57 (2.6)	CBLC (2.4)	CILP2 (2.2)	LPAR2 (2.1)	C12orf47 (2.0)	LPIN3 (1.9)	ENSG00000228044 (1.8)	SLC44A2 (1.8)
ENSG00000172270	BSG PPI subnetwork	0.18	> 0.20	SYPL2 (3.8)	GMPR (3.4)	CLPTM1 (3.2)	PBX4 (2.5)	DNM2 (2.5)	PLEC (2.4)	OGDH (2.4)	LPAR2 (2.4)	ATXN7L2 (2.3)	C17orf57 (2.3)
ENSG00000135144	DTX1 PPI subnetwork	0.18	> 0.20	PBX4 (2.9)	PARP10 (2.7)	ENSG00000226645 (2.5)	ENSG00000254235 (2.5)	MAFB (2.1)	NKPD1 (2.1)	ABO (2.0)	PLEC (1.8)	TOP1 (1.7)	NYNRIN (1.7)
MP:0004505	decreased renal glomerulus number	0.18	> 0.20	NYNRIN (2.7)	BCAM (2.4)	ENSG00000228044 (2.3)	PLEKHH2 (2.1)	C11orf9 (2.0)	TMEM57 (1.8)	PVRL2 (1.7)	ENSG00000235545 (1.6)	CETP (1.5)	GCNT4 (1.4)
GO:0045766	positive regulation of angiogenesis	0.18	> 0.20	ENSG00000226648 (2.1)	ENSG00000235545 (2.1)	MAFB (1.9)	FRK (1.8)	PVR (1.8)	GCNT4 (1.7)	CEACAM19 (1.6)	ATXN7L2 (1.4)	LPIN3 (1.4)	DOCK7 (1.3)
ENSG00000141380	SS18 PPI subnetwork	0.18	> 0.20	CARM1 (4.2)	SMARCA4 (3.4)	DOCK7 (2.7)	TMEM57 (2.7)	MAPKAPK5 (2.4)	NYNRIN (2.3)	ILF3 (2.2)	MARK4 (2.1)	ZNF101 (2.0)	MAU2 (1.8)
ENSG00000160202	CRYAA PPI subnetwork	0.18	> 0.20	ANGPTL3 (3.2)	APOB (2.7)	PLG (2.6)	PVR (2.1)	CELSR2 (2.0)	APOA5 (1.9)	CEACAM19 (1.9)	ATXN2 (1.9)	APOC4 (1.7)	HP (1.6)
ENSG00000213024	NUP62 PPI subnetwork	0.18	> 0.20	POC5 (2.9)	CARM1 (2.8)	DOCK7 (2.8)	USP1 (2.7)	NAA25 (2.6)	USP24 (2.5)	ILF3 (2.1)	MAPKAPK5 (2.1)	DDX56 (2.0)	BUD13 (2.0)
GO:0035384	thioester biosynthetic process	0.18	> 0.20	FADS1 (5.3)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.5)	BLOC1S3 (2.9)	MOSC1 (2.1)	NKPD1 (2.0)	SORT1 (1.7)
GO:0071616	acyl-CoA biosynthetic process	0.18	> 0.20	FADS1 (5.3)	FADS2 (5.2)	HMGCR (5.0)	LDLR (4.5)	PCSK9 (4.3)	GPAM (3.5)	BLOC1S3 (2.9)	MOSC1 (2.1)	NKPD1 (2.0)	SORT1 (1.7)
GO:0006399	tRNA metabolic process	0.18	> 0.20	QTRT1 (4.0)	DHODH (3.7)	NAA25 (3.4)	DDX56 (3.0)	ZNF259 (3.0)	C12orf43 (2.9)	SARS (2.9)	POC5 (2.4)	NT5DC1 (2.4)	MAPKAPK5 (2.4)
ENSG00000196611	MMP1 PPI subnetwork	0.18	> 0.20	CILP2 (2.7)	BCL3 (2.1)	NCAN (2.1)	PVR (1.9)	PMFBP1 (1.7)	NPC1L1 (1.7)	PVRL2 (1.6)	FRK (1.6)	HAPLN4 (1.5)	TIMD4 (1.3)
MP:0004154	renal tubular necrosis	0.18	> 0.20	RHD (5.2)	RHCE (3.9)	DNAH11 (3.8)	MAFB (2.9)	CETP (2.3)	TIMD4 (2.1)	ABCG5 (2.1)	NPC1L1 (1.7)	C12orf51 (1.7)	GATAD2A (1.6)
GO:0072329	monocarboxylic acid catabolic process	0.18	> 0.20	ACAD10 (4.9)	LPA (3.1)	NT5DC1 (2.8)	MOSC1 (2.5)	SLC22A1 (2.3)	TRAPPC6A (2.0)	GPAM (2.0)	ABCG8 (1.9)	ALDH2 (1.9)	APOC4 (1.8)
ENSG00000084463	WBP11 PPI subnetwork	0.18	> 0.20	SUGP1 (3.0)	C19orf52 (2.9)	CARM1 (2.8)	C1orf63 (2.4)	DHX38 (2.1)	ATXN2 (2.0)	SMARCA4 (1.9)	MAU2 (1.8)	BUD13 (1.8)	C12orf43 (1.6)
REACTOME_P53:INDEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	REACTOME_P53:INDEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	0.18	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.6)	NT5DC1 (2.4)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.6)	DDX56 (1.6)	ZNF259 (1.5)	ABCG8 (1.2)
REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A	REACTOME_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A	0.18	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.6)	NT5DC1 (2.4)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.6)	DDX56 (1.6)	ZNF259 (1.5)	ABCG8 (1.2)
REACTOME_P53:INDEPENDENT_DNA_DAMAGE_RESPONSE	REACTOME_P53:INDEPENDENT_DNA_DAMAGE_RESPONSE	0.18	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.6)	NT5DC1 (2.4)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.6)	DDX56 (1.6)	ZNF259 (1.5)	ABCG8 (1.2)
ENSG00000102145	GATA1 PPI subnetwork	0.18	> 0.20	CARM1 (3.5)	SMARCA4 (3.0)	MARK4 (2.7)	TMEM57 (2.6)	GRINA (2.2)	ATXN2 (2.0)	SH2B3 (1.9)	MAU2 (1.9)	HLX (1.8)	DNM2 (1.7)
GO:0008625	induction of apoptosis via death domain receptors	0.18	> 0.20	ANKRD31 (4.4)	ENSG00000228044 (2.6)	TRAFD1 (2.3)	FRK (2.2)	C12orf43 (2.2)	POLK (1.9)	ADAM1 (1.9)	SH2B3 (1.8)	UBXN2B (1.7)	BLOC1S3 (1.7)
ENSG00000136448	NMT1 PPI subnetwork	0.18	> 0.20	SARS (2.8)	GOT2P1 (2.6)	GATAD2A (2.3)	PPP1R37 (2.2)	MARK4 (2.2)	C11orf9 (2.1)	PLCG1 (2.1)	OGDH (2.1)	CLPTM1 (2.0)	PLEC (2.0)
GO:0008276	protein methyltransferase activity	0.18	> 0.20	C12orf51 (2.9)	DHODH (2.8)	C12orf43 (2.6)	ATXN2 (2.2)	QTRT1 (2.1)	ZNF180 (1.9)	NAA25 (1.9)	C19orf52 (1.8)	BUD13 (1.8)	SMARCA4 (1.7)
MP:0008396	abnormal osteoclast differentiation	0.18	> 0.20	GMIP (3.3)	TRIB1 (3.1)	SH2B3 (2.7)	PARP10 (2.3)	HLX (2.3)	PVR (2.3)	MYLIP (2.2)	BCL3 (2.2)	MAFB (2.1)	RELB (1.9)
ENSG00000047410	TPR PPI subnetwork	0.18	> 0.20	USP1 (2.7)	DHX38 (2.5)	POC5 (2.4)	FEN1 (2.4)	MAPKAPK5 (2.2)	NAA25 (2.2)	DDX56 (2.2)	C12orf51 (2.2)	ZNF180 (1.9)	USP24 (1.7)
MP:0008496	decreased IgG2a level	0.18	> 0.20	RELB (5.9)	CETP (3.5)	BCL3 (2.8)	GMIP (2.7)	TIMD4 (2.6)	ZNF101 (2.2)	SH2B3 (1.9)	TRAFD1 (1.7)	PARP10 (1.7)	TRIB1 (1.6)
ENSG00000186298	PPP1CC PPI subnetwork	0.18	> 0.20	PSRC1 (4.6)	FEN1 (3.8)	USP1 (3.0)	POC5 (2.9)	ENSG00000226645 (1.9)	ZHX3 (1.5)	ILF3 (1.5)	GATAD2A (1.4)	TOP1 (1.3)	CARM1 (1.3)
GO:0002761	regulation of myeloid leukocyte differentiation	0.18	> 0.20	ITGB3 (2.8)	DNAH11 (2.6)	PBX4 (2.2)	RHCE (2.1)	RHD (2.0)	ENSG00000235545 (2.0)	ST3GAL4 (1.9)	C1orf63 (1.6)	GCNT4 (1.5)	ENSG00000238078 (1.4)
REACTOME_PROSTANOID_METABOLISM	REACTOME_PROSTANOID_METABOLISM	0.18	> 0.20	ALDH2 (3.7)	GMPR (2.7)	HLX (2.1)	NT5DC1 (2.1)	BCAM (2.0)	NYNRIN (2.0)	ADAM1 (2.0)	PLEKHH2 (1.9)	ITGB3 (1.9)	C12orf43 (1.7)
ENSG00000157191	NECAP2 PPI subnetwork	0.18	> 0.20	USP24 (4.3)	PARP10 (3.9)	OASL (3.6)	PPP1R37 (3.2)	HNF1A (2.7)	GRINA (2.7)	CLPTM1 (2.3)	RELB (1.7)	TXNL4B (1.7)	DHX38 (1.6)
MP:0004722	abnormal platelet dense granule number	0.18	> 0.20	ZNF101 (3.2)	BLOC1S3 (3.0)	GMPR (2.6)	ENSG00000228044 (2.3)	GMIP (2.1)	CYB561D1 (2.0)	ITGB3 (1.9)	ZNF180 (1.9)	COL4A3BP (1.8)	MARK4 (1.8)
MP:0005616	decreased susceptibility to type IV hypersensitivity reaction	0.18	> 0.20	BCL3 (4.2)	RELB (3.5)	HLX (3.0)	MAFB (2.7)	PVR (1.9)	ZNF101 (1.9)	OASL (1.9)	TRAFD1 (1.7)	TIMD4 (1.7)	TRIB1 (1.6)
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	0.18	> 0.20	SH2B3 (3.2)	HLX (3.1)	TRIB1 (3.1)	PVR (2.4)	MARK4 (2.1)	CARM1 (1.8)	ENSG00000228044 (1.5)	COL4A3BP (1.4)	MAPKAPK5 (1.3)	BLOC1S3 (1.2)
ENSG00000119535	CSF3R PPI subnetwork	0.18	> 0.20	BCL3 (3.7)	COL4A3BP (2.3)	HLX (1.8)	C17orf57 (1.6)	RELB (1.6)	PVR (1.5)	CYP7A1 (1.5)	ZNF101 (1.4)	HP (1.2)	SH2B3 (1.1)
ENSG00000182004	SNRPE PPI subnetwork	0.18	> 0.20	ILF3 (3.8)	TOP1 (3.0)	BUD13 (2.9)	C1orf63 (2.8)	USP1 (2.8)	SMARCA4 (2.6)	DHX38 (2.6)	FEN1 (2.5)	QTRT1 (2.3)	SUGP1 (2.0)
GO:0060419	heart growth	0.18	> 0.20	CEACAM19 (2.7)	C11orf9 (2.5)	BLOC1S3 (2.1)	PLEKHH2 (1.9)	ENSG00000235545 (1.6)	GCNT4 (1.5)	NYNRIN (1.5)	ALDH2 (1.5)	C19orf52 (1.4)	HLX (1.4)
MP:0005030	absent amnion	0.18	> 0.20	MAPKAPK5 (2.2)	HNF1A (1.8)	BUD13 (1.8)	SH2B3 (1.7)	MYLIP (1.6)	TM6SF2 (1.6)	ANGPTL3 (1.5)	PLG (1.5)	ST3GAL4 (1.4)	ENSG00000226648 (1.4)
ENSG00000123124	WWP1 PPI subnetwork	0.18	> 0.20	SLC44A2 (4.7)	GRINA (3.1)	HAVCR1 (2.6)	AP1M2 (2.5)	SH2B3 (2.2)	TXNL4B (1.8)	PPP1R37 (1.5)	HNF1A (1.5)	CBLC (1.5)	C1orf63 (1.4)
MP:0004068	dilated dorsal aorta	0.18	> 0.20	CETP (2.2)	SH2B3 (2.2)	BCAM (2.2)	RHD (2.0)	PVR (1.8)	BLOC1S3 (1.6)	ZNF180 (1.6)	HLX (1.6)	SLC44A2 (1.6)	NYNRIN (1.5)
REACTOME_G1S_DNA_DAMAGE_CHECKPOINTS	REACTOME_G1S_DNA_DAMAGE_CHECKPOINTS	0.18	> 0.20	PSMA5 (5.9)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	PARP10 (1.9)	TOMM40 (1.7)	FEN1 (1.6)	DDX56 (1.5)	SUGP1 (1.5)	SARS (1.4)
ENSG00000162702	ZNF281 PPI subnetwork	0.18	> 0.20	ATP13A1 (3.0)	ATXN2 (2.4)	CYB561D1 (2.2)	C12orf43 (2.2)	USP1 (1.9)	DHX38 (1.9)	QTRT1 (1.7)	TOMM40 (1.7)	ILF3 (1.6)	POLK (1.6)
MP:0001731	abnormal postnatal growth	0.18	> 0.20	APOC1 (3.0)	ALDH2 (2.8)	MOSC1 (2.3)	USP24 (2.3)	NKPD1 (2.1)	NYNRIN (2.0)	KIAA1324 (1.7)	LPA (1.5)	BLOC1S3 (1.5)	GEMIN7 (1.4)
GO:0017017	MAP kinase tyrosine/serine/threonine phosphatase activity	0.18	> 0.20	TRIB1 (7.7)	TSSK6 (2.5)	ENSG00000226645 (1.9)	LDLR (1.9)	PVR (1.8)	ENSG00000235545 (1.7)	SH2B3 (1.6)	SYPL2 (1.6)	DNAH11 (1.4)	POLK (1.4)
MP:0001606	impaired hematopoiesis	0.18	> 0.20	RHCE (4.3)	RHD (3.7)	SH2B3 (2.8)	KANK2 (2.5)	GMPR (2.5)	ITGB3 (2.4)	HLX (1.9)	FADS1 (1.7)	SLC44A2 (1.7)	PARP10 (1.7)
GO:0045787	positive regulation of cell cycle	0.18	> 0.20	ANKRD31 (2.8)	DNAH11 (2.7)	ENSG00000228044 (2.4)	PSRC1 (2.0)	TMED4 (1.9)	ENSG00000238078 (1.7)	ATXN2 (1.5)	PTPN11 (1.5)	RHD (1.3)	RHCE (1.3)
MP:0000195	hypocalcemia	0.18	> 0.20	TMEM116 (3.6)	AP1M2 (2.6)	BCAM (2.3)	TXNL4B (1.9)	SLC22A1 (1.9)	TOP1 (1.7)	KIAA1324 (1.7)	C17orf57 (1.7)	ENSG00000226648 (1.5)	FRK (1.5)
ENSG00000205937	RNPS1 PPI subnetwork	0.18	> 0.20	TOP1 (4.5)	ILF3 (4.0)	C1orf63 (3.8)	DHX38 (3.1)	SMARCA4 (3.1)	BUD13 (3.0)	SUGP1 (2.8)	USP1 (2.7)	GATAD2A (2.4)	PTPN11 (2.1)
MP:0005362	abnormal Langerhans cell physiology	0.18	> 0.20	MAFB (3.5)	HLX (2.3)	MYLIP (2.2)	BCL3 (2.2)	TRAFD1 (2.2)	CETP (1.8)	TIMD4 (1.7)	TRIB1 (1.5)	ENSG00000238078 (1.5)	PLEKHH2 (1.4)
GO:0002573	myeloid leukocyte differentiation	0.18	> 0.20	ITGB3 (2.9)	ST3GAL4 (2.5)	SH2B3 (2.4)	RHCE (2.2)	RHD (2.1)	DNAH11 (2.0)	ENSG00000235545 (2.0)	TMEM57 (1.6)	GCNT4 (1.6)	TMEM50A (1.6)
ENSG00000129521	EGLN3 PPI subnetwork	0.18	> 0.20	GRINA (4.3)	BCL3 (2.2)	TSSK6 (2.2)	CETP (2.1)	GOT2P1 (1.9)	PVRL2 (1.9)	TMEM57 (1.8)	C1orf63 (1.4)	BCAM (1.4)	GATAD2A (1.4)
ENSG00000113649	TCERG1 PPI subnetwork	0.18	> 0.20	DHX38 (3.0)	ILF3 (2.8)	SMARCA4 (2.8)	NYNRIN (2.4)	SUGP1 (2.4)	ERP29 (2.2)	ATP13A1 (2.1)	DNM2 (2.0)	CARM1 (1.9)	TOP1 (1.9)
MP:0002896	abnormal bone mineralization	0.18	> 0.20	CILP2 (4.4)	MAFB (2.5)	KIAA1324 (2.4)	MYLIP (1.7)	APOE (1.6)	HLX (1.6)	YIPF2 (1.5)	FRK (1.5)	TMEM116 (1.5)	ANKRD31 (1.4)
ENSG00000104969	SGTA PPI subnetwork	0.18	> 0.20	ST3GAL4 (3.1)	AMIGO1 (2.0)	CLPTM1 (2.0)	PPP1R37 (2.0)	TMED4 (1.9)	APOE (1.8)	TMEM57 (1.8)	PARP10 (1.7)	ATP13A1 (1.6)	CYP7A1 (1.6)
ENSG00000108518	PFN1 PPI subnetwork	0.18	> 0.20	NPC1L1 (3.4)	GMIP (3.2)	FADS2 (2.4)	PLEC (2.3)	C11orf9 (2.3)	LDLR (2.3)	HMGCR (2.0)	AP1M2 (1.9)	ST3GAL4 (1.9)	HNF1A (1.7)
MP:0010876	decreased bone volume	0.18	> 0.20	CILP2 (2.8)	KANK2 (2.5)	PLEKHH2 (2.1)	ADAM1 (2.1)	YIPF2 (1.6)	LDLR (1.5)	PTPN11 (1.5)	ENSG00000238078 (1.5)	CBLC (1.4)	ST3GAL4 (1.4)
ENSG00000136813	KIAA0368 PPI subnetwork	0.18	> 0.20	PSMA5 (5.1)	NAA25 (4.3)	SARS (4.0)	DDX56 (3.0)	PTPN11 (2.6)	TOMM40 (2.3)	NT5DC1 (2.1)	SMARCA4 (2.1)	CLPTM1 (2.0)	ZNF259 (1.9)
GO:0034968	histone lysine methylation	0.18	> 0.20	C12orf51 (3.4)	MAU2 (2.5)	ZNF180 (2.4)	ATXN2 (2.2)	USP24 (2.1)	ANKRD31 (2.0)	C19orf52 (1.8)	C1orf63 (1.7)	GOT2P1 (1.6)	BUD13 (1.6)
MP:0005189	abnormal anogenital distance	0.18	> 0.20	LPAR2 (2.6)	PBX4 (2.5)	ALDH2 (1.9)	ATXN7L2 (1.9)	CYP7A1 (1.8)	TMED4 (1.8)	PVRL2 (1.6)	KIAA1324 (1.6)	YIPF2 (1.5)	MARK4 (1.5)
GO:0060525	prostate glandular acinus development	0.18	> 0.20	ENSG00000254235 (3.1)	GOT2P1 (2.9)	DNAH11 (2.5)	AMIGO1 (2.2)	ANKRD31 (2.1)	ADAM1 (1.9)	KIAA1324 (1.8)	C19orf52 (1.6)	CBLC (1.6)	GCNT4 (1.5)
GO:0031268	pseudopodium organization	0.18	> 0.20	CBLC (4.9)	AP1M2 (3.9)	ENSG00000235545 (3.6)	PVRL2 (3.0)	SLC44A2 (2.6)	CETP (2.4)	BRAP (2.0)	LPIN3 (2.0)	BLOC1S3 (1.9)	SYPL2 (1.6)
GO:0000096	sulfur amino acid metabolic process	0.18	> 0.20	SLC22A1 (2.9)	GOT2P1 (2.2)	LPA (2.2)	DNAH11 (2.0)	APOA5 (1.8)	CYP7A1 (1.8)	NT5DC1 (1.7)	APOC4 (1.7)	ABCG8 (1.7)	UBXN2B (1.7)
ENSG00000165525	NEMF PPI subnetwork	0.18	> 0.20	NAA25 (3.3)	ZNF259 (3.2)	SARS (2.5)	DDX56 (2.5)	QTRT1 (2.3)	GATAD2A (2.1)	DNAH11 (2.0)	TOMM40 (1.9)	TOP1 (1.8)	TMEM57 (1.7)
GO:0016782	transferase activity, transferring sulfur-containing groups	0.18	> 0.20	ABCG5 (2.5)	APOB (2.0)	ZHX3 (1.9)	ABCG8 (1.9)	ST3GAL4 (1.8)	GCNT4 (1.7)	DYNC2LI1 (1.7)	MARK4 (1.6)	C12orf47 (1.6)	TXNL4B (1.6)
ENSG00000144218	AFF3 PPI subnetwork	0.18	> 0.20	NAA25 (3.0)	ST3GAL4 (2.5)	ITGB3 (2.3)	SORT1 (2.2)	GOT2P1 (2.0)	MAFB (1.8)	SARS (1.8)	GATAD2A (1.8)	ILF3 (1.7)	GRINA (1.6)
ENSG00000080815	PSEN1 PPI subnetwork	0.18	> 0.20	DNM2 (3.4)	NYNRIN (2.6)	CELSR2 (2.6)	CLPTM1 (2.3)	PLEC (2.3)	ENSG00000226645 (2.1)	GRINA (2.0)	YIPF2 (2.0)	NCAN (2.0)	DNAH11 (2.0)
GO:0042445	hormone metabolic process	0.19	> 0.20	CYP7A1 (2.6)	NKPD1 (2.5)	ABCG5 (2.4)	LPA (2.3)	SLC22A1 (2.1)	CYB561D1 (2.1)	ST3GAL4 (2.0)	ABCG8 (2.0)	PMFBP1 (1.9)	TM6SF2 (1.6)
GO:0035254	glutamate receptor binding	0.19	> 0.20	KIAA1324 (2.8)	RPH3A (2.5)	GCNT4 (2.4)	CELSR2 (2.3)	GOT2P1 (2.2)	HAPLN4 (2.1)	HNF1A (1.9)	ENSG00000238078 (1.8)	FRK (1.7)	SORT1 (1.6)
MP:0005165	increased susceptibility to injury	0.19	> 0.20	KIAA1324 (2.4)	BCAM (2.1)	CETP (2.0)	C11orf9 (2.0)	ITGB3 (1.8)	PVRL2 (1.7)	TMED4 (1.6)	TM6SF2 (1.6)	C17orf57 (1.6)	HAPLN4 (1.3)
MP:0002223	lymphoid hypoplasia	0.19	> 0.20	FADS1 (6.1)	BLOC1S3 (2.8)	LDLR (2.8)	HMGCR (2.5)	UBXN2B (2.2)	GMIP (2.0)	LPIN3 (1.9)	OGDH (1.7)	SYPL2 (1.7)	ABCG8 (1.7)
GO:0060334	regulation of interferon-gamma-mediated signaling pathway	0.19	> 0.20	TRAFD1 (3.5)	PBX4 (2.7)	ADAM1 (2.6)	ENSG00000228044 (2.6)	ZNF101 (2.1)	NKPD1 (2.0)	ENSG00000238078 (2.0)	GEMIN7 (1.9)	ST3GAL4 (1.8)	PARP10 (1.8)
GO:0060330	regulation of response to interferon-gamma	0.19	> 0.20	TRAFD1 (3.5)	PBX4 (2.7)	ADAM1 (2.6)	ENSG00000228044 (2.6)	ZNF101 (2.1)	NKPD1 (2.0)	ENSG00000238078 (2.0)	GEMIN7 (1.9)	ST3GAL4 (1.8)	PARP10 (1.8)
ENSG00000182054	IDH2 PPI subnetwork	0.19	> 0.20	PSMA5 (2.5)	ABCG5 (2.2)	TM6SF2 (2.1)	CEACAM19 (1.9)	ENSG00000235545 (1.9)	TOMM40 (1.9)	HAPLN4 (1.6)	DDX56 (1.5)	PVR (1.4)	CARM1 (1.4)
ENSG00000100038	TOP3B PPI subnetwork	0.19	> 0.20	HNF1A (3.3)	BRAP (3.1)	TRAPPC6A (2.7)	ATP13A1 (2.6)	ERP29 (2.5)	CLPTM1 (2.3)	C19orf52 (2.1)	ANKRD31 (2.0)	SLC44A2 (1.9)	PLEKHH2 (1.9)
ENSG00000119541	VPS4B PPI subnetwork	0.19	> 0.20	TXNL4B (3.9)	GEMIN7 (2.7)	SUGP1 (2.6)	MARK4 (2.1)	DHODH (2.0)	C12orf43 (2.0)	MAU2 (1.8)	BLOC1S3 (1.8)	TRAPPC6A (1.8)	FRK (1.7)
GO:0010288	response to lead ion	0.19	> 0.20	RHD (3.2)	RHCE (3.0)	ENSG00000235545 (2.1)	DHODH (2.0)	NPC1L1 (1.9)	DNAH11 (1.9)	GOT2P1 (1.9)	ANGPTL3 (1.9)	FADS2 (1.7)	FADS1 (1.6)
ENSG00000134109	EDEM1 PPI subnetwork	0.19	> 0.20	C19orf52 (3.2)	SARS (3.1)	ST3GAL4 (2.2)	ERP29 (2.1)	NCAN (2.0)	DHODH (1.8)	RPH3A (1.7)	ENSG00000238078 (1.6)	TIMD4 (1.6)	PMFBP1 (1.6)
ENSG00000167258	CDK12 PPI subnetwork	0.19	> 0.20	TOP1 (3.2)	SMARCA4 (3.0)	GEMIN7 (3.0)	GATAD2A (2.8)	SUGP1 (2.5)	BUD13 (2.2)	TRAFD1 (1.8)	MAU2 (1.8)	NYNRIN (1.7)	PPP1R37 (1.7)
ENSG00000120333	MRPS14 PPI subnetwork	0.19	> 0.20	OASL (3.5)	TMED4 (3.2)	PARP10 (3.2)	ZNF101 (2.3)	USP24 (1.9)	MAPKAPK5 (1.7)	NAA25 (1.6)	DHX38 (1.5)	SUGP1 (1.4)	PLEC (1.4)
GO:0014743	regulation of muscle hypertrophy	0.19	> 0.20	CEACAM19 (4.2)	HNF1A (2.8)	ENSG00000235545 (2.4)	ANKRD31 (2.4)	TRAPPC6A (2.0)	SYPL2 (1.8)	DNAH11 (1.8)	HAVCR1 (1.8)	ENSG00000254235 (1.7)	AMIGO1 (1.6)
ENSG00000126001	CEP250 PPI subnetwork	0.19	> 0.20	DNM2 (3.3)	GPAM (3.1)	PLEC (3.0)	COL4A3BP (2.9)	C11orf9 (2.7)	ZHX3 (2.6)	LPAR2 (2.6)	CARM1 (2.5)	KANK2 (2.3)	OGDH (2.3)
ENSG00000178896	EXOSC4 PPI subnetwork	0.19	> 0.20	SUGP1 (3.7)	DHODH (3.1)	USP24 (2.9)	DDX56 (2.9)	SMARCA4 (2.3)	ZNF259 (2.3)	TOMM40 (2.1)	C12orf43 (2.0)	DHX38 (1.9)	QTRT1 (1.9)
MP:0002123	abnormal hematopoiesis	0.19	> 0.20	ITGB3 (3.7)	SH2B3 (2.7)	RHCE (2.6)	GMIP (2.4)	CETP (2.3)	PTPN11 (2.0)	BCL3 (2.0)	RHD (2.0)	HLX (1.8)	USP24 (1.8)
GO:0045136	development of secondary sexual characteristics	0.19	> 0.20	BLOC1S3 (3.1)	ST3GAL4 (2.9)	DNAH11 (2.5)	C17orf57 (2.3)	COL4A3BP (1.9)	NT5DC1 (1.8)	ZNF180 (1.8)	ABO (1.7)	NKPD1 (1.6)	SH2B3 (1.5)
MP:0004510	myositis	0.19	> 0.20	BCL3 (5.0)	SH2B3 (3.4)	GRINA (2.9)	ST3GAL4 (2.4)	LPIN3 (2.3)	CLPTM1 (2.3)	PARP10 (2.2)	SYPL2 (2.2)	PLEC (1.9)	GMIP (1.8)
ENSG00000163629	PTPN13 PPI subnetwork	0.19	> 0.20	SLC44A2 (3.3)	BCAM (2.6)	PLEC (2.5)	PBX4 (2.3)	ENSG00000238078 (2.0)	ENSG00000235545 (1.9)	NYNRIN (1.9)	CBLC (1.8)	LPAR2 (1.7)	UBXN2B (1.6)
ENSG00000170917	NUDT6 PPI subnetwork	0.19	> 0.20	C1orf63 (2.5)	TXNL4B (2.1)	GRINA (1.8)	ENSG00000254235 (1.8)	PLEKHH2 (1.8)	MYLIP (1.7)	DNM2 (1.6)	CLPTM1 (1.6)	UBXN2B (1.5)	C12orf47 (1.5)
MP:0001313	increased incidence of corneal inflammation	0.19	> 0.20	AMIGO1 (2.5)	DNAH11 (2.4)	C17orf57 (1.8)	LPIN3 (1.8)	NKPD1 (1.5)	OASL (1.4)	ST3GAL4 (1.4)	CELSR2 (1.3)	LPAR2 (1.3)	PVR (1.2)
ENSG00000105379	ETFB PPI subnetwork	0.19	> 0.20	TRAPPC6A (3.3)	PSMA5 (3.0)	APOC4 (2.1)	ACAD10 (2.0)	APOC1 (1.9)	ATXN7L2 (1.7)	DYNC2LI1 (1.6)	OGDH (1.5)	HNF1A (1.5)	APOA5 (1.4)
ENSG00000114854	TNNC1 PPI subnetwork	0.19	> 0.20	SYPL2 (5.0)	GMPR (2.5)	TMEM50A (2.1)	ACAD10 (1.8)	C12orf47 (1.5)	OGDH (1.4)	BCAM (1.2)	RHCE (1.1)	FADS1 (1.0)	C1orf63 (1.0)
ENSG00000113272	THG1L PPI subnetwork	0.19	> 0.20	USP24 (2.9)	PSMA5 (2.2)	POLK (2.0)	TMEM57 (2.0)	CYP7A1 (2.0)	UBXN2B (1.9)	HNF1A (1.7)	PBX4 (1.7)	ERP29 (1.5)	ENSG00000254235 (1.4)
GO:0046434	organophosphate catabolic process	0.19	> 0.20	CYP7A1 (2.9)	TSSK6 (2.2)	ZNF180 (2.1)	SLC22A1 (2.0)	UBXN2B (2.0)	AMIGO1 (1.9)	HAPLN4 (1.8)	MOSC1 (1.8)	ANKRD31 (1.7)	DNAH11 (1.7)
GO:0030055	cell-substrate junction	0.19	> 0.20	PLEC (4.6)	ITGB3 (3.3)	KANK2 (2.5)	BCAM (2.2)	GMIP (2.2)	PVRL2 (2.0)	DNM2 (1.9)	C11orf9 (1.5)	SH2B3 (1.5)	GPAM (1.4)
GO:0042594	response to starvation	0.19	> 0.20	BRAP (3.5)	ACAD10 (3.4)	NPC1L1 (2.3)	ABCG8 (2.3)	HNF1A (2.2)	TXNL4B (2.2)	SARS (2.2)	FADS2 (2.1)	ABCG5 (2.0)	TM6SF2 (1.9)
ENSG00000108296	CWC25 PPI subnetwork	0.19	> 0.20	BRAP (3.8)	SUGP1 (3.2)	BUD13 (3.1)	ZNF259 (2.6)	C12orf43 (2.5)	ENSG00000226645 (2.4)	TOP1 (2.4)	POC5 (2.3)	SARS (2.3)	QTRT1 (2.1)
ENSG00000165280	VCP PPI subnetwork	0.19	> 0.20	TMEM57 (2.5)	RELB (2.1)	ABO (2.0)	GRINA (1.8)	TRIB1 (1.7)	TMEM50A (1.6)	FEN1 (1.4)	PVR (1.4)	TRAFD1 (1.3)	NT5DC1 (1.3)
ENSG00000204217	BMPR2 PPI subnetwork	0.19	> 0.20	LPIN3 (2.5)	APOA5 (2.3)	NYNRIN (2.0)	PLEKHH2 (2.0)	ENSG00000228044 (1.9)	CARM1 (1.8)	DOCK7 (1.7)	FRK (1.7)	C11orf9 (1.7)	ABCG8 (1.6)
ENSG00000144895	EIF2A PPI subnetwork	0.19	> 0.20	DDX56 (3.8)	ZNF259 (3.4)	NAA25 (3.1)	ATP13A1 (2.6)	QTRT1 (2.4)	TOMM40 (2.4)	DHX38 (2.2)	DHODH (2.1)	GATAD2A (2.0)	SUGP1 (2.0)
ENSG00000123728	RAP2C PPI subnetwork	0.19	> 0.20	HLX (2.8)	HNF1A (2.8)	PARP10 (2.3)	GPAM (2.2)	LPIN3 (1.8)	ANKRD31 (1.8)	TIMD4 (1.7)	ATXN7L2 (1.7)	C12orf51 (1.7)	CYB561D1 (1.7)
ENSG00000206298	PSMB8 PPI subnetwork	0.19	> 0.20	PSMA5 (6.1)	TRAFD1 (4.6)	PARP10 (2.5)	NT5DC1 (2.4)	NAA25 (2.4)	TMEM50A (2.0)	SUGP1 (1.8)	DHX38 (1.8)	TOMM40 (1.6)	TXNL4B (1.4)
ENSG00000206234	ENSG00000206234 PPI subnetwork	0.19	> 0.20	PSMA5 (6.1)	TRAFD1 (4.6)	PARP10 (2.5)	NT5DC1 (2.4)	NAA25 (2.4)	TMEM50A (2.0)	SUGP1 (1.8)	DHX38 (1.8)	TOMM40 (1.6)	TXNL4B (1.4)
ENSG00000204264	PSMB8 PPI subnetwork	0.19	> 0.20	PSMA5 (6.1)	TRAFD1 (4.6)	PARP10 (2.5)	NT5DC1 (2.4)	NAA25 (2.4)	TMEM50A (2.0)	SUGP1 (1.8)	DHX38 (1.8)	TOMM40 (1.6)	TXNL4B (1.4)
MP:0000217	abnormal leukocyte cell number	0.19	> 0.20	MAFB (4.9)	RHCE (3.7)	RHD (3.4)	TIMD4 (3.0)	CETP (2.9)	SH2B3 (2.6)	TRIB1 (2.6)	GMIP (2.1)	RELB (2.1)	ZNF101 (1.7)
ENSG00000116678	LEPR PPI subnetwork	0.19	> 0.20	BCL3 (3.4)	COL4A3BP (2.7)	C17orf57 (1.8)	TRAFD1 (1.5)	BCAM (1.5)	PVR (1.4)	RELB (1.4)	TIMD4 (1.3)	POLK (1.3)	ENSG00000238078 (1.3)
GO:0031960	response to corticosteroid stimulus	0.19	> 0.20	LPA (3.3)	SLC22A1 (2.5)	ABCG5 (2.3)	APOC4 (2.0)	APOA5 (1.9)	ATXN7L2 (1.9)	ABCG8 (1.8)	HP (1.7)	CBLC (1.7)	PLG (1.7)
ENSG00000168807	SNTB2 PPI subnetwork	0.19	> 0.20	KANK2 (3.5)	PPP1R37 (3.0)	SYPL2 (2.7)	BCAM (2.5)	COL4A3BP (2.4)	ATXN7L2 (2.2)	ZHX3 (2.1)	GPAM (2.1)	C12orf51 (2.1)	NKPD1 (2.0)
ENSG00000198265	HELZ PPI subnetwork	0.19	> 0.20	MAPKAPK5 (3.2)	SMARCA4 (2.9)	BRAP (2.8)	C12orf43 (2.4)	C12orf51 (2.3)	C19orf52 (2.2)	NAA25 (2.1)	TRAFD1 (2.1)	PCSK9 (2.0)	ATXN2 (2.0)
REACTOME_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS	REACTOME_REMOVAL_OF_LICENSING_FACTORS_FROM_ORIGINS	0.19	> 0.20	PSMA5 (5.3)	FEN1 (3.3)	NT5DC1 (2.9)	TRAFD1 (2.7)	NAA25 (2.0)	TOMM40 (1.9)	SUGP1 (1.8)	USP1 (1.6)	DDX56 (1.5)	PARP10 (1.5)
MP:0004042	decreased susceptibility to kidney reperfusion injury	0.19	> 0.20	MAFB (4.0)	PMFBP1 (2.2)	PSRC1 (1.8)	NCAN (1.7)	AP1M2 (1.5)	BLOC1S3 (1.5)	PLEKHH2 (1.5)	POLK (1.4)	RHCE (1.4)	ENSG00000238078 (1.3)
GO:0030544	Hsp70 protein binding	0.19	> 0.20	HMGCR (5.2)	LDLR (4.1)	FADS2 (3.9)	PCSK9 (3.8)	FADS1 (3.6)	GRINA (3.0)	RHD (2.9)	RHCE (2.8)	CARM1 (2.7)	CYP7A1 (2.6)
MP:0005154	increased B cell proliferation	0.19	> 0.20	RELB (4.9)	GMIP (4.1)	SH2B3 (2.8)	TIMD4 (2.5)	SLC44A2 (2.4)	BCL3 (2.2)	CETP (2.1)	GCNT4 (1.8)	MAFB (1.5)	RHCE (1.5)
MP:0001862	interstitial pneumonia	0.19	> 0.20	RHCE (4.8)	RHD (4.7)	DNM2 (3.3)	TMEM57 (2.3)	APOC1 (2.2)	CLPTM1 (2.1)	GMIP (2.1)	TOP1 (2.1)	PLEC (2.0)	RELB (2.0)
GO:0009635	response to herbicide	0.19	> 0.20	PMFBP1 (2.6)	DNAH11 (2.5)	GOT2P1 (2.4)	ST3GAL4 (2.3)	FRK (1.9)	COL4A3BP (1.5)	ABCG8 (1.5)	HP (1.4)	TXNL4B (1.4)	TMED4 (1.4)
GO:0009067	aspartate family amino acid biosynthetic process	0.19	> 0.20	ENSG00000254235 (3.0)	GOT2P1 (2.6)	SARS (2.3)	DNAH11 (2.0)	TXNL4B (1.9)	TMED4 (1.8)	DHODH (1.7)	TMEM116 (1.7)	NT5DC1 (1.6)	CYP7A1 (1.5)
ENSG00000076321	KLHL20 PPI subnetwork	0.19	> 0.20	LDLR (3.1)	PCSK9 (2.9)	FADS1 (2.4)	NPC1L1 (2.4)	FADS2 (2.4)	HMGCR (2.3)	TRAFD1 (2.2)	ENSG00000254235 (2.0)	UBXN2B (1.8)	TMEM50A (1.7)
MP:0006319	abnormal epididymal fat pad morphology	0.19	> 0.20	APOC1 (3.6)	USP24 (2.9)	SORT1 (2.4)	LDLR (2.1)	POLK (1.9)	PSRC1 (1.9)	MOSC1 (1.7)	HP (1.5)	GCNT4 (1.5)	PVR (1.4)
ENSG00000136634	IL10 PPI subnetwork	0.19	> 0.20	BCL3 (4.2)	HLX (3.3)	TIMD4 (2.9)	CETP (2.7)	RELB (2.6)	GMIP (2.0)	TRIB1 (1.6)	LPA (1.5)	ZNF101 (1.5)	PARP10 (1.4)
ENSG00000166402	TUB PPI subnetwork	0.19	> 0.20	ZHX3 (3.9)	COL4A3BP (2.9)	ZNF101 (2.2)	ABCG8 (2.1)	DNM2 (1.9)	GMIP (1.8)	ALDH2 (1.7)	MAFB (1.6)	LPAR2 (1.6)	PLCG1 (1.6)
ENSG00000100028	SNRPD3 PPI subnetwork	0.19	> 0.20	ILF3 (3.5)	DHX38 (3.4)	BUD13 (3.3)	TOP1 (3.1)	SUGP1 (2.8)	C1orf63 (2.6)	SMARCA4 (2.5)	QTRT1 (2.4)	FEN1 (2.4)	USP1 (2.4)
ENSG00000112335	SNX3 PPI subnetwork	0.19	> 0.20	ZNF101 (2.0)	TXNL4B (1.9)	TMEM50A (1.9)	RELB (1.8)	NYNRIN (1.8)	POC5 (1.7)	MOSC1 (1.7)	ABO (1.6)	GMIP (1.5)	DNM2 (1.5)
GO:0019400	alditol metabolic process	0.19	> 0.20	TM6SF2 (3.6)	ENSG00000254235 (2.7)	GCNT4 (2.7)	ABCG8 (2.6)	ENSG00000226645 (2.5)	MOSC1 (2.2)	NPC1L1 (1.9)	PMFBP1 (1.9)	ABCG5 (1.8)	GPAM (1.8)
GO:0051353	positive regulation of oxidoreductase activity	0.19	> 0.20	ENSG00000235545 (4.1)	TRAPPC6A (1.9)	ENSG00000228044 (1.9)	ENSG00000226645 (1.7)	COL4A3BP (1.6)	AMIGO1 (1.6)	ST3GAL4 (1.3)	FADS2 (1.3)	ATXN7L2 (1.3)	TXNL4B (1.2)
ENSG00000204673	AKT1S1 PPI subnetwork	0.19	> 0.20	DNM2 (3.3)	PLEC (3.2)	ZHX3 (3.2)	GPAM (2.8)	PTPN11 (2.7)	C11orf9 (2.7)	CARM1 (2.7)	KANK2 (2.4)	COL4A3BP (2.4)	USP24 (2.3)
MP:0004560	abnormal chorionic plate morphology	0.19	> 0.20	CBLC (3.3)	CETP (2.7)	YIPF2 (2.6)	AP1M2 (2.6)	DNM2 (2.3)	TRIB1 (2.1)	ATP13A1 (2.0)	LDLR (1.9)	GMIP (1.8)	DYNC2LI1 (1.8)
ENSG00000146535	GNA12 PPI subnetwork	0.19	> 0.20	DNM2 (2.8)	CLPTM1 (2.6)	HLX (1.9)	ITGB3 (1.9)	TOMM40 (1.9)	MARK4 (1.9)	MAFB (1.7)	TOP1 (1.6)	PTPN11 (1.5)	SLC44A2 (1.5)
ENSG00000196975	ANXA4 PPI subnetwork	0.19	> 0.20	HNF1A (4.2)	KIAA1324 (3.3)	NPC1L1 (3.1)	TMEM50A (2.9)	C11orf9 (2.8)	PCSK9 (2.7)	OGDH (2.5)	TMED4 (2.2)	TM6SF2 (2.1)	HMGCR (1.7)
ENSG00000175029	CTBP2 PPI subnetwork	0.19	> 0.20	TMEM57 (3.2)	CARM1 (3.0)	USP24 (2.2)	NYNRIN (2.2)	ILF3 (1.9)	TRAFD1 (1.9)	TOP1 (1.9)	ATXN7L2 (1.8)	DHX38 (1.6)	DNM2 (1.6)
ENSG00000169180	XPO6 PPI subnetwork	0.19	> 0.20	GATAD2A (2.4)	BUD13 (2.2)	SUGP1 (2.2)	BRAP (2.0)	MAPKAPK5 (2.0)	ADAM1 (1.8)	DNAH11 (1.8)	HAVCR1 (1.7)	TXNL4B (1.7)	GMIP (1.6)
GO:0015026	coreceptor activity	0.19	> 0.20	PLCG1 (3.1)	MAFB (2.6)	NYNRIN (2.4)	HLX (2.3)	BCAM (2.1)	ZNF101 (2.1)	APOE (2.1)	MARK4 (2.0)	APOC1 (1.9)	TIMD4 (1.7)
ENSG00000110721	CHKA PPI subnetwork	0.19	> 0.20	CETP (2.9)	TIMD4 (2.8)	OASL (2.7)	PLEKHH2 (2.0)	TMEM57 (1.7)	CEACAM19 (1.6)	TMEM50A (1.6)	C1orf63 (1.6)	POLK (1.6)	SYPL2 (1.5)
REACTOME_SEMA3A:PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	REACTOME_SEMA3A:PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	0.19	> 0.20	PVRL2 (3.1)	NYNRIN (2.9)	PVR (2.8)	HLX (2.8)	SH2B3 (2.7)	PLEC (2.5)	ENSG00000254235 (2.3)	MARK4 (1.9)	OGDH (1.8)	ENSG00000226645 (1.8)
ENSG00000140396	NCOA2 PPI subnetwork	0.19	> 0.20	TRIB1 (3.3)	MAU2 (2.8)	UBXN2B (2.5)	MAFB (2.4)	MYLIP (2.3)	BCL3 (1.7)	KANK2 (1.7)	OASL (1.5)	ATXN2 (1.4)	COL4A3BP (1.3)
GO:0072531	pyrimidine-containing compound transmembrane transport	0.19	> 0.20	GCNT4 (4.6)	GOT2P1 (3.0)	TMED4 (2.5)	ADAM1 (2.3)	NKPD1 (2.3)	PMFBP1 (2.3)	TMEM57 (2.0)	CILP2 (1.8)	SLC44A2 (1.8)	SLC22A1 (1.7)
ENSG00000114520	SNX4 PPI subnetwork	0.19	> 0.20	TMEM50A (3.1)	NYNRIN (2.9)	HAVCR1 (2.6)	MYLIP (2.2)	USP24 (1.9)	ENSG00000235545 (1.8)	ZNF259 (1.8)	POLK (1.8)	SYPL2 (1.7)	TRAFD1 (1.7)
ENSG00000143520	FLG2 PPI subnetwork	0.19	> 0.20	ATP13A1 (4.4)	ILF3 (4.0)	CARM1 (3.1)	TOMM40 (3.0)	DDX56 (3.0)	SMARCA4 (2.9)	ANKRD31 (2.9)	GATAD2A (2.6)	QTRT1 (2.1)	ENSG00000238078 (2.0)
GO:0007159	leukocyte cell-cell adhesion	0.19	> 0.20	TIMD4 (2.6)	SLC44A2 (2.5)	GMIP (2.1)	GCNT4 (2.0)	TMEM116 (2.0)	CETP (1.9)	CEACAM19 (1.9)	LPA (1.7)	CILP2 (1.6)	ENSG00000228044 (1.6)
GO:0019210	kinase inhibitor activity	0.19	> 0.20	BCL3 (2.3)	APOB (2.1)	MYLIP (2.1)	NCAN (2.0)	ABCG5 (1.8)	ZNF101 (1.8)	LDLR (1.7)	TRIB1 (1.7)	SLC44A2 (1.6)	MAFB (1.6)
ENSG00000079950	STX7 PPI subnetwork	0.19	> 0.20	BLOC1S3 (3.5)	ZNF259 (3.2)	BRAP (2.9)	SLC44A2 (2.3)	TRAPPC6A (2.2)	LPIN3 (2.1)	PPP1R37 (2.0)	ENSG00000228044 (1.8)	HNF1A (1.8)	ENSG00000226645 (1.7)
GO:0009071	serine family amino acid catabolic process	0.19	> 0.20	ENSG00000254235 (3.5)	TXNL4B (3.2)	PMFBP1 (3.1)	UBXN2B (2.9)	LPIN3 (2.8)	SLC22A1 (2.5)	ANGPTL3 (2.4)	LPA (2.4)	ATXN7L2 (2.4)	DHODH (2.4)
MP:0001548	hyperlipidemia	0.19	> 0.20	APOC1 (5.5)	TIMD4 (3.3)	COL4A3BP (2.5)	GPAM (2.4)	CETP (2.3)	MOSC1 (2.1)	TRAPPC6A (2.0)	UBXN2B (1.6)	USP24 (1.6)	POLK (1.4)
ENSG00000187109	NAP1L1 PPI subnetwork	0.19	> 0.20	SMARCA4 (3.5)	DDX56 (2.9)	ZNF259 (2.5)	QTRT1 (2.4)	ILF3 (2.3)	TOMM40 (2.1)	NAA25 (1.9)	BUD13 (1.9)	ENSG00000226645 (1.8)	GATAD2A (1.8)
ENSG00000100811	YY1 PPI subnetwork	0.19	> 0.20	PARP10 (2.8)	PSRC1 (2.6)	GMIP (2.6)	USP24 (2.5)	BCL3 (2.4)	POLK (2.3)	ATXN7L2 (2.1)	ATXN2 (1.9)	TOP1 (1.7)	PLCG1 (1.7)
ENSG00000134697	GNL2 PPI subnetwork	0.19	> 0.20	ZNF259 (4.9)	NAA25 (4.5)	DDX56 (4.1)	DHX38 (3.2)	TOMM40 (3.1)	QTRT1 (2.8)	DHODH (2.7)	ATP13A1 (2.4)	ENSG00000226645 (2.3)	SUGP1 (2.2)
ENSG00000150991	UBC PPI subnetwork	0.19	> 0.20	SMARCA4 (2.4)	TOP1 (2.3)	FEN1 (2.3)	PSMA5 (2.3)	GRINA (2.1)	PTPN11 (2.0)	TMEM57 (2.0)	TRIB1 (1.9)	C1orf63 (1.8)	GATAD2A (1.8)
ENSG00000171148	TADA3 PPI subnetwork	0.19	> 0.20	ATXN7L2 (3.3)	DHODH (2.5)	UBXN2B (2.5)	ILF3 (2.3)	CLPTM1 (2.1)	C19orf52 (2.1)	BUD13 (2.0)	DDX56 (1.8)	SMARCA4 (1.8)	DHX38 (1.7)
ENSG00000069702	TGFBR3 PPI subnetwork	0.19	> 0.20	DNM2 (2.9)	ENSG00000235545 (2.5)	PVR (2.2)	AMIGO1 (2.2)	SLC44A2 (2.0)	GPAM (2.0)	ITGB3 (1.9)	KANK2 (1.8)	ZNF180 (1.8)	HLX (1.8)
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES	0.19	> 0.20	ERP29 (3.4)	ENSG00000254235 (2.3)	PVRL2 (2.2)	CYB561D1 (2.1)	PCSK9 (2.1)	LPIN3 (2.0)	CBLC (2.0)	TMEM50A (1.9)	NYNRIN (1.8)	RHCE (1.8)
ENSG00000070193	FGF10 PPI subnetwork	0.19	> 0.20	HAVCR1 (4.4)	HAPLN4 (3.5)	C11orf9 (3.4)	PLEKHH2 (3.4)	CBLC (2.6)	ZHX3 (2.4)	NYNRIN (2.3)	C17orf57 (2.3)	CEACAM19 (1.9)	MYLIP (1.7)
REACTOME_POST:TRANSLATIONAL_PROTEIN_MODIFICATION	REACTOME_POST:TRANSLATIONAL_PROTEIN_MODIFICATION	0.19	> 0.20	YIPF2 (4.4)	ERP29 (3.7)	TMED4 (3.6)	ATP13A1 (3.1)	ST3GAL4 (2.4)	CLPTM1 (2.3)	TMEM57 (2.3)	KIAA1324 (2.2)	TMEM50A (2.2)	PVRL2 (1.8)
GO:0051099	positive regulation of binding	0.19	> 0.20	ANKRD31 (2.0)	HLX (1.9)	DNAH11 (1.8)	MARK4 (1.7)	SH2B3 (1.7)	C17orf57 (1.7)	ENSG00000238078 (1.6)	SARS (1.4)	MAFB (1.4)	C1orf63 (1.3)
MP:0002499	chronic inflammation	0.19	> 0.20	MAFB (3.9)	TIMD4 (3.1)	CETP (2.7)	GMIP (2.6)	BCL3 (2.5)	ZNF101 (2.4)	ENSG00000254235 (2.4)	TRIB1 (2.0)	PBX4 (2.0)	HLX (1.8)
GO:0002253	activation of immune response	0.19	> 0.20	TIMD4 (3.7)	LPA (3.2)	GMIP (3.1)	ZNF101 (3.1)	MAFB (2.9)	CYB561D1 (2.4)	CETP (2.1)	SH2B3 (1.9)	LPAR2 (1.8)	APOC4 (1.6)
ENSG00000173530	TNFRSF10D PPI subnetwork	0.19	> 0.20	ATP13A1 (3.4)	SARS (3.3)	TOMM40 (3.3)	NAA25 (2.8)	FADS2 (2.7)	SMARCA4 (2.6)	FADS1 (2.5)	OGDH (2.3)	LDLR (2.3)	DHODH (2.2)
GO:0001525	angiogenesis	0.19	> 0.20	PVR (3.2)	HLX (3.1)	C17orf57 (2.3)	SH2B3 (2.2)	PVRL2 (2.1)	MAFB (1.7)	BCAM (1.7)	SLC44A2 (1.6)	CEACAM19 (1.6)	ENSG00000226648 (1.4)
ENSG00000100815	TRIP11 PPI subnetwork	0.19	> 0.20	DNM2 (3.6)	PTPN11 (3.2)	ZHX3 (3.1)	KANK2 (3.0)	CARM1 (2.9)	C11orf9 (2.9)	PLEC (2.8)	COL4A3BP (2.4)	LPAR2 (2.4)	USP24 (2.3)
ENSG00000188130	MAPK12 PPI subnetwork	0.19	> 0.20	TRIB1 (6.4)	SH2B3 (2.7)	PLCG1 (1.7)	HLX (1.6)	MYLIP (1.6)	PPP1R37 (1.6)	MAFB (1.5)	ENSG00000226645 (1.5)	SYPL2 (1.4)	ZHX3 (1.4)
GO:0008629	induction of apoptosis by intracellular signals	0.19	> 0.20	POLK (3.0)	BLOC1S3 (2.9)	C17orf57 (2.2)	ZNF101 (2.1)	ZNF259 (2.1)	BRAP (2.0)	BUD13 (1.9)	LPIN3 (1.8)	ST3GAL4 (1.5)	TRAFD1 (1.5)
GO:0001772	immunological synapse	0.19	> 0.20	ZNF101 (3.1)	BCL3 (3.0)	RELB (2.9)	ITGB3 (2.0)	C11orf9 (2.0)	HAVCR1 (2.0)	PBX4 (1.9)	CYB561D1 (1.8)	ENSG00000228044 (1.6)	SLC44A2 (1.5)
GO:0005849	mRNA cleavage factor complex	0.19	> 0.20	PTPN11 (3.1)	DHX38 (3.1)	SUGP1 (2.3)	TOP1 (2.0)	MAPKAPK5 (2.0)	NKPD1 (1.9)	ENSG00000226645 (1.8)	GATAD2A (1.7)	TXNL4B (1.7)	NT5DC1 (1.6)
ENSG00000184634	MED12 PPI subnetwork	0.19	> 0.20	BRAP (2.9)	OASL (2.8)	BUD13 (2.3)	TIMD4 (2.2)	GEMIN7 (2.2)	BLOC1S3 (2.1)	C19orf52 (2.0)	C12orf51 (2.0)	TXNL4B (2.0)	POC5 (1.8)
GO:0050839	cell adhesion molecule binding	0.19	> 0.20	HAVCR1 (2.5)	NCAN (2.5)	GCNT4 (2.4)	TIMD4 (2.1)	C11orf9 (2.1)	BCAM (2.1)	SLC44A2 (1.9)	APOE (1.9)	PVRL2 (1.9)	TRIB1 (1.9)
ENSG00000082516	GEMIN5 PPI subnetwork	0.19	> 0.20	BLOC1S3 (2.2)	C12orf43 (2.1)	GEMIN7 (1.8)	TIMD4 (1.8)	ILF3 (1.7)	TOMM40 (1.7)	DYNC2LI1 (1.6)	ZNF180 (1.5)	MAPKAPK5 (1.5)	C19orf52 (1.4)
GO:0009988	cell-cell recognition	0.19	> 0.20	TSSK6 (4.6)	ENSG00000228044 (4.0)	CETP (3.1)	PMFBP1 (3.0)	GCNT4 (3.0)	ENSG00000238078 (2.3)	C17orf57 (1.5)	TIMD4 (1.4)	PBX4 (1.4)	LPA (1.3)
ENSG00000130402	ACTN4 PPI subnetwork	0.19	> 0.20	OGDH (3.6)	PLEC (3.1)	SYPL2 (3.1)	GMPR (3.0)	BCAM (2.6)	NPC1L1 (2.4)	CARM1 (1.9)	KANK2 (1.8)	PVRL2 (1.8)	ITGB3 (1.8)
KEGG_GNRH_SIGNALING_PATHWAY	KEGG_GNRH_SIGNALING_PATHWAY	0.19	> 0.20	KIAA1324 (3.1)	CEACAM19 (2.1)	MARK4 (2.0)	PVR (2.0)	CYB561D1 (1.7)	ST3GAL4 (1.6)	ENSG00000238078 (1.6)	GATAD2A (1.6)	PLCG1 (1.5)	MOSC1 (1.5)
GO:0006760	folic acid-containing compound metabolic process	0.19	> 0.20	TXNL4B (2.8)	GOT2P1 (2.8)	CYP7A1 (2.7)	ENSG00000238078 (2.5)	ENSG00000254235 (2.4)	DHODH (2.4)	ABCG8 (2.3)	CEACAM19 (1.9)	LPA (1.8)	HNF1A (1.7)
ENSG00000135845	PIGC PPI subnetwork	0.19	> 0.20	HMGCR (5.2)	LDLR (4.8)	ATP13A1 (4.0)	FADS1 (4.0)	FADS2 (3.8)	CLPTM1 (2.4)	ERP29 (2.1)	TMED4 (2.1)	SORT1 (2.0)	TMEM57 (2.0)
GO:0042168	heme metabolic process	0.19	> 0.20	RHCE (7.6)	RHD (7.1)	ADAM1 (2.9)	C12orf51 (2.7)	GMPR (2.1)	TRAPPC6A (2.1)	BLOC1S3 (1.9)	NT5DC1 (1.9)	ACAD10 (1.8)	DHODH (1.8)
ENSG00000165025	SYK PPI subnetwork	0.19	> 0.20	GMIP (5.2)	DNM2 (3.3)	MAFB (2.8)	SLC44A2 (2.6)	SH2B3 (2.4)	APOE (2.3)	OGDH (1.8)	CYB561D1 (1.8)	MAU2 (1.7)	TIMD4 (1.6)
GO:0046942	carboxylic acid transport	0.19	> 0.20	TM6SF2 (3.5)	ABCG8 (3.3)	HAPLN4 (2.2)	TMEM116 (2.1)	GCNT4 (2.0)	ABCG5 (1.9)	CLPTM1 (1.7)	LPAR2 (1.6)	NPC1L1 (1.5)	PBX4 (1.5)
ENSG00000145555	MYO10 PPI subnetwork	0.19	> 0.20	GOT2P1 (2.6)	ILF3 (2.3)	PBX4 (2.1)	PVR (2.0)	BCAM (1.8)	CILP2 (1.8)	FRK (1.7)	TMED4 (1.4)	PTPN11 (1.4)	TMEM50A (1.4)
ENSG00000166986	MARS PPI subnetwork	0.19	> 0.20	SARS (5.2)	DNM2 (3.0)	ATP13A1 (2.9)	PVRL2 (2.8)	CARM1 (2.5)	SUGP1 (2.4)	QTRT1 (2.4)	RHCE (2.1)	POLK (2.1)	YIPF2 (2.0)
ENSG00000141956	PRDM15 PPI subnetwork	0.19	> 0.20	OASL (3.0)	TIMD4 (2.9)	CETP (2.7)	PLEKHH2 (2.1)	TMEM57 (1.8)	DNAH11 (1.6)	C1orf63 (1.5)	CEACAM19 (1.3)	SYPL2 (1.3)	TSSK6 (1.3)
GO:0009116	nucleoside metabolic process	0.19	> 0.20	DHODH (2.9)	TXNL4B (2.8)	LPA (2.3)	NT5DC1 (2.1)	TRAPPC6A (2.1)	TSSK6 (1.7)	CYP7A1 (1.7)	SLC22A1 (1.6)	ENSG00000228044 (1.5)	ANKRD31 (1.5)
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	0.19	> 0.20	PSMA5 (6.0)	TRAFD1 (3.5)	NAA25 (2.4)	NT5DC1 (2.4)	SUGP1 (1.7)	TOMM40 (1.7)	PARP10 (1.6)	DDX56 (1.5)	TMEM50A (1.2)	DHX38 (1.2)
GO:0060351	cartilage development involved in endochondral bone morphogenesis	0.20	> 0.20	CILP2 (7.2)	PLEKHH2 (2.0)	YIPF2 (2.0)	NYNRIN (1.9)	ATXN7L2 (1.9)	ANKRD31 (1.8)	PMFBP1 (1.4)	QTRT1 (1.4)	SLC44A2 (1.2)	UBXN2B (1.1)
ENSG00000112448	ENSG00000112448 PPI subnetwork	0.20	> 0.20	MAU2 (3.2)	ATP13A1 (2.7)	MAFB (2.6)	GRINA (2.5)	C1orf63 (2.3)	UBXN2B (2.2)	KANK2 (2.0)	ITGB3 (2.0)	ILF3 (1.8)	C19orf52 (1.8)
ENSG00000215641	TRIM27 PPI subnetwork	0.20	> 0.20	MAU2 (3.2)	ATP13A1 (2.7)	MAFB (2.6)	GRINA (2.5)	C1orf63 (2.3)	UBXN2B (2.2)	KANK2 (2.0)	ITGB3 (2.0)	ILF3 (1.8)	C19orf52 (1.8)
ENSG00000204713	TRIM27 PPI subnetwork	0.20	> 0.20	MAU2 (3.2)	ATP13A1 (2.7)	MAFB (2.6)	GRINA (2.5)	C1orf63 (2.3)	UBXN2B (2.2)	KANK2 (2.0)	ITGB3 (2.0)	ILF3 (1.8)	C19orf52 (1.8)
ENSG00000099956	SMARCB1 PPI subnetwork	0.20	> 0.20	BUD13 (3.0)	SMARCA4 (2.9)	GATAD2A (2.6)	TRIB1 (2.6)	ATXN2 (2.4)	TOP1 (2.3)	CARM1 (2.2)	USP1 (2.2)	C12orf51 (1.9)	ENSG00000238078 (1.8)
ENSG00000044115	CTNNA1 PPI subnetwork	0.20	> 0.20	DOCK7 (3.2)	BCAM (3.2)	C11orf9 (3.0)	PVRL2 (3.0)	PLEC (2.8)	APOE (2.1)	PVR (2.1)	GMPR (1.9)	POLK (1.6)	OGDH (1.5)
ENSG00000182199	SHMT2 PPI subnetwork	0.20	> 0.20	C12orf43 (3.1)	BRAP (3.0)	HAPLN4 (3.0)	TM6SF2 (2.6)	ZHX3 (2.6)	SH2B3 (2.3)	SARS (2.1)	PTPN11 (2.1)	PVR (2.1)	NPC1L1 (2.1)
ENSG00000173801	JUP PPI subnetwork	0.20	> 0.20	PVRL2 (3.5)	AP1M2 (3.0)	CEACAM19 (2.8)	C11orf9 (2.5)	CELSR2 (2.4)	LPIN3 (2.2)	DOCK7 (2.1)	CBLC (2.1)	CLPTM1 (1.8)	BCAM (1.7)
MP:0000477	abnormal intestine morphology	0.20	> 0.20	C11orf9 (4.2)	KANK2 (2.7)	MOSC1 (2.6)	PVRL2 (2.3)	HLX (2.1)	CETP (1.9)	NYNRIN (1.8)	MYLIP (1.8)	OGDH (1.6)	CBLC (1.6)
ENSG00000100485	SOS2 PPI subnetwork	0.20	> 0.20	ZHX3 (3.7)	PLEKHH2 (3.0)	HAVCR1 (2.5)	C11orf9 (2.3)	SLC44A2 (2.3)	CBLC (2.2)	ABO (2.1)	KANK2 (2.1)	ITGB3 (2.1)	C17orf57 (2.1)
MP:0000823	abnormal lateral ventricle morphology	0.20	> 0.20	NYNRIN (3.7)	LPA (1.9)	ABCG5 (1.9)	CELSR2 (1.8)	SMARCA4 (1.8)	MARK4 (1.8)	TM6SF2 (1.5)	APOE (1.4)	FRK (1.4)	ATP13A1 (1.4)
GO:0008028	monocarboxylic acid transmembrane transporter activity	0.20	> 0.20	TM6SF2 (3.9)	APOC4 (2.9)	CYP7A1 (2.7)	APOA5 (2.6)	ABCG8 (2.5)	ANGPTL3 (2.3)	HP (2.2)	PLEC (2.1)	CILP2 (2.0)	CLPTM1 (1.9)
ENSG00000118965	WDR35 PPI subnetwork	0.20	> 0.20	MAU2 (3.0)	USP24 (2.9)	PARP10 (2.8)	MARK4 (2.4)	ATXN2 (2.4)	BCL3 (2.3)	GMIP (2.1)	SMARCA4 (1.9)	DHX38 (1.9)	ZNF180 (1.6)
ENSG00000065559	MAP2K4 PPI subnetwork	0.20	> 0.20	PLCG1 (2.7)	PARP10 (2.5)	HLX (2.5)	BCL3 (2.3)	TRIB1 (2.0)	LPAR2 (2.0)	PVR (1.9)	SH2B3 (1.9)	ZNF180 (1.9)	COL4A3BP (1.9)
ENSG00000215412	ENSG00000215412 PPI subnetwork	0.20	> 0.20	TOP1 (3.8)	QTRT1 (3.4)	ILF3 (3.3)	C19orf52 (2.5)	TRAFD1 (2.4)	GATAD2A (2.4)	ZNF180 (2.2)	ADAM1 (1.9)	TXNL4B (1.8)	CLPTM1 (1.8)
ENSG00000198563	DDX39B PPI subnetwork	0.20	> 0.20	TOP1 (3.8)	QTRT1 (3.4)	ILF3 (3.3)	C19orf52 (2.5)	TRAFD1 (2.4)	GATAD2A (2.4)	ZNF180 (2.2)	ADAM1 (1.9)	TXNL4B (1.8)	CLPTM1 (1.8)
ENSG00000215425	DDX39B PPI subnetwork	0.20	> 0.20	TOP1 (3.8)	QTRT1 (3.4)	ILF3 (3.3)	C19orf52 (2.5)	TRAFD1 (2.4)	GATAD2A (2.4)	ZNF180 (2.2)	ADAM1 (1.9)	TXNL4B (1.8)	CLPTM1 (1.8)
ENSG00000163558	PRKCI PPI subnetwork	0.20	> 0.20	DNM2 (2.8)	COL4A3BP (2.6)	CELSR2 (2.6)	UBXN2B (2.5)	PLEC (2.5)	C11orf9 (2.4)	GRINA (2.2)	POLK (2.0)	AP1M2 (1.9)	C12orf51 (1.9)
ENSG00000062038	CDH3 PPI subnetwork	0.20	> 0.20	AP1M2 (4.2)	PVRL2 (3.8)	BCAM (3.5)	CBLC (2.8)	LPAR2 (2.5)	DOCK7 (2.3)	FRK (2.1)	ENSG00000226648 (2.0)	C11orf9 (2.0)	MAFB (1.9)
MP:0003915	increased left ventricle weight	0.20	> 0.20	SYPL2 (3.4)	MOSC1 (2.6)	TM6SF2 (2.0)	TMEM50A (2.0)	PLEKHH2 (1.9)	GMPR (1.9)	NPC1L1 (1.8)	ABCG8 (1.4)	SORT1 (1.4)	ACAD10 (1.4)
MP:0005216	abnormal pancreatic alpha cell morphology	0.20	> 0.20	KIAA1324 (3.6)	TRIB1 (2.5)	HAPLN4 (2.0)	ABCG8 (1.7)	MARK4 (1.7)	TMEM57 (1.7)	PVR (1.6)	C11orf9 (1.5)	NPC1L1 (1.4)	TM6SF2 (1.3)
ENSG00000169398	PTK2 PPI subnetwork	0.20	> 0.20	SLC44A2 (4.5)	PLEC (3.2)	DNM2 (3.1)	SH2B3 (2.9)	GMIP (2.8)	PVRL2 (2.3)	ZNF101 (2.0)	ITGB3 (1.9)	USP24 (1.8)	C1orf63 (1.8)
ENSG00000149084	HSD17B12 PPI subnetwork	0.20	> 0.20	LDLR (7.1)	FADS1 (6.6)	FADS2 (5.3)	HMGCR (5.3)	ERP29 (4.6)	ATP13A1 (4.0)	PCSK9 (4.0)	TMEM50A (3.2)	SORT1 (3.1)	TMEM57 (2.4)
ENSG00000127831	VIL1 PPI subnetwork	0.20	> 0.20	TM6SF2 (5.5)	NPC1L1 (5.3)	ABCG5 (4.6)	ABCG8 (3.1)	PVRL2 (2.7)	TMEM116 (2.3)	APOB (2.3)	LPIN3 (2.3)	PLEC (2.0)	TMEM57 (2.0)
GO:0050750	low-density lipoprotein particle receptor binding	0.20	> 0.20	APOC1 (3.7)	ERP29 (3.0)	ABCG5 (2.9)	TMED4 (2.6)	NPC1L1 (2.5)	HNF1A (2.4)	PLG (2.2)	APOC4 (2.1)	FRK (2.0)	HP (1.9)
ENSG00000004660	CAMKK1 PPI subnetwork	0.20	> 0.20	LDLR (2.9)	CYP7A1 (2.4)	FADS1 (2.3)	HMGCR (2.0)	MAPKAPK5 (2.0)	CARM1 (1.8)	PLCG1 (1.7)	NPC1L1 (1.7)	MAFB (1.6)	HLX (1.6)
GO:0005161	platelet-derived growth factor receptor binding	0.20	> 0.20	C17orf57 (3.7)	ITGB3 (3.3)	KANK2 (2.6)	HLX (2.4)	LDLR (1.9)	SH2B3 (1.9)	AP1M2 (1.4)	BCL3 (1.3)	C11orf9 (1.2)	MAPKAPK5 (1.2)
ENSG00000137807	KIF23 PPI subnetwork	0.20	> 0.20	ZHX3 (3.2)	DNM2 (3.1)	CARM1 (3.1)	LPAR2 (2.4)	UBXN2B (2.3)	PLEC (2.2)	PTPN11 (2.2)	MARK4 (2.0)	COL4A3BP (2.0)	ATXN2 (1.9)
MP:0004024	aneuploidy	0.20	> 0.20	PSRC1 (4.1)	FEN1 (3.4)	USP1 (2.7)	POC5 (2.5)	ATXN7L2 (1.9)	ENSG00000226648 (1.7)	RHD (1.6)	CBLC (1.4)	GOT2P1 (1.4)	DHX38 (1.4)
MP:0005536	Leydig cell hypoplasia	0.20	> 0.20	GCNT4 (3.3)	DOCK7 (2.6)	UBXN2B (2.1)	ATXN7L2 (2.0)	LPIN3 (2.0)	C12orf47 (2.0)	DNAH11 (2.0)	COL4A3BP (1.8)	AMIGO1 (1.5)	PMFBP1 (1.5)
GO:0010812	negative regulation of cell-substrate adhesion	0.20	> 0.20	ENSG00000254235 (3.3)	ANKRD31 (2.8)	DNAH11 (2.5)	GCNT4 (2.1)	SLC44A2 (1.8)	BLOC1S3 (1.8)	UBXN2B (1.8)	HLX (1.6)	PPP1R37 (1.6)	ITGB3 (1.5)
GO:0009108	coenzyme biosynthetic process	0.20	> 0.20	GPAM (3.3)	PCSK9 (3.2)	NT5DC1 (3.2)	FADS1 (3.0)	DHODH (3.0)	FADS2 (3.0)	ACAD10 (2.9)	OGDH (2.7)	HMGCR (2.7)	TXNL4B (2.5)
ENSG00000146904	EPHA1 PPI subnetwork	0.20	> 0.20	PLEKHH2 (3.5)	PARP10 (3.0)	BCL3 (2.5)	LPAR2 (2.3)	OASL (2.3)	NT5DC1 (2.1)	TRAFD1 (2.0)	GMIP (2.0)	TRIB1 (2.0)	PLCG1 (1.9)
ENSG00000177463	NR2C2 PPI subnetwork	0.20	> 0.20	HNF1A (2.9)	ZHX3 (2.9)	UBXN2B (2.2)	PTPN11 (2.1)	CYP7A1 (2.1)	KIAA1324 (2.0)	BRAP (1.9)	USP24 (1.8)	MAU2 (1.8)	NAA25 (1.8)
MP:0004771	increased anti-single stranded DNA antibody level	0.20	> 0.20	ZNF101 (3.9)	C17orf57 (2.9)	POLK (2.7)	PVR (2.6)	ITGB3 (2.5)	TRIB1 (2.4)	GRINA (2.4)	ENSG00000226648 (2.2)	FRK (2.0)	BCL3 (2.0)
GO:0016604	nuclear body	0.20	> 0.20	BUD13 (4.0)	TOP1 (3.6)	USP1 (3.6)	C1orf63 (3.2)	BRAP (2.5)	DHX38 (2.4)	ILF3 (2.3)	FEN1 (2.3)	ATXN2 (2.0)	GATAD2A (1.9)
MP:0003638	abnormal response/metabolism to endogenous compounds	0.20	> 0.20	ABCG5 (2.3)	NCAN (1.9)	CBLC (1.9)	BCAM (1.8)	CYP7A1 (1.8)	DNAH11 (1.8)	ABCG8 (1.7)	AP1M2 (1.7)	ERP29 (1.7)	POLK (1.7)
ENSG00000170860	LSM3 PPI subnetwork	0.20	> 0.20	POC5 (3.1)	DHX38 (2.7)	MAU2 (2.6)	QTRT1 (2.3)	DHODH (2.2)	BUD13 (2.0)	SUGP1 (2.0)	ADAM1 (1.9)	ZNF259 (1.9)	TRAFD1 (1.8)
GO:0022613	ribonucleoprotein complex biogenesis	0.20	> 0.20	ZNF259 (3.9)	C12orf43 (3.5)	DDX56 (3.3)	QTRT1 (3.3)	NAA25 (3.1)	TOMM40 (2.8)	DHODH (2.8)	MAPKAPK5 (2.6)	SUGP1 (2.5)	BRAP (2.3)
GO:0043903	regulation of symbiosis, encompassing mutualism through parasitism	0.20	> 0.20	DNAH11 (2.5)	HP (2.4)	RHD (2.3)	TIMD4 (2.1)	RHCE (1.9)	ENSG00000238078 (1.8)	GOT2P1 (1.8)	ENSG00000228044 (1.8)	CETP (1.7)	ANKRD31 (1.6)
ENSG00000142539	SPIB PPI subnetwork	0.20	> 0.20	TRIB1 (3.9)	ATXN7L2 (2.9)	GOT2P1 (2.8)	CARM1 (2.6)	GRINA (2.5)	MAFB (2.3)	RELB (2.3)	MAPKAPK5 (2.0)	BCL3 (1.9)	HLX (1.7)
MP:0001045	abnormal enteric ganglia morphology	0.20	> 0.20	HLX (3.7)	TRIB1 (2.1)	ENSG00000254235 (1.8)	MYLIP (1.7)	AMIGO1 (1.7)	KANK2 (1.6)	ENSG00000238078 (1.6)	ABCG5 (1.5)	C17orf57 (1.4)	ABO (1.4)
GO:0035383	thioester metabolic process	0.20	> 0.20	FADS2 (4.1)	FADS1 (4.1)	PCSK9 (3.9)	HMGCR (3.9)	GPAM (3.6)	LDLR (3.2)	BLOC1S3 (3.0)	TRAPPC6A (2.4)	MOSC1 (2.3)	CYP7A1 (2.2)
GO:0006637	acyl-CoA metabolic process	0.20	> 0.20	FADS2 (4.1)	FADS1 (4.1)	PCSK9 (3.9)	HMGCR (3.9)	GPAM (3.6)	LDLR (3.2)	BLOC1S3 (3.0)	TRAPPC6A (2.4)	MOSC1 (2.3)	CYP7A1 (2.2)
ENSG00000032514	ENSG00000032514 PPI subnetwork	0.20	> 0.20	SUGP1 (3.1)	MARK4 (3.1)	MAPKAPK5 (2.7)	TOMM40 (2.6)	ATXN2 (2.5)	BUD13 (2.2)	POC5 (1.9)	CBLC (1.8)	CLPTM1 (1.7)	NT5DC1 (1.6)
ENSG00000126456	IRF3 PPI subnetwork	0.20	> 0.20	OASL (7.2)	TRAFD1 (6.5)	PARP10 (4.5)	RELB (2.6)	ATP13A1 (2.5)	GRINA (2.4)	CYP7A1 (2.1)	TOP1 (1.8)	PSMA5 (1.6)	GMIP (1.5)
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	0.20	> 0.20	PSMA5 (5.4)	NT5DC1 (3.0)	FEN1 (3.0)	TRAFD1 (2.8)	NAA25 (2.1)	TOMM40 (2.0)	SUGP1 (1.8)	DDX56 (1.6)	PARP10 (1.6)	USP1 (1.3)
REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST:REPLICATIVE_STATE	REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST:REPLICATIVE_STATE	0.20	> 0.20	PSMA5 (5.4)	NT5DC1 (3.0)	FEN1 (3.0)	TRAFD1 (2.8)	NAA25 (2.1)	TOMM40 (2.0)	SUGP1 (1.8)	DDX56 (1.6)	PARP10 (1.6)	USP1 (1.3)
MP:0002467	impaired neutrophil phagocytosis	0.20	> 0.20	CEACAM19 (2.9)	GMIP (2.8)	SH2B3 (2.7)	HP (2.2)	BCL3 (2.2)	MAFB (2.1)	GRINA (1.8)	ALDH2 (1.7)	ADAM1 (1.6)	UBXN2B (1.4)
MP:0002490	abnormal immunoglobulin level	0.20	> 0.20	RELB (5.0)	CETP (3.2)	BCL3 (2.9)	GMIP (2.3)	PARP10 (2.2)	PBX4 (2.2)	TRAFD1 (2.0)	SLC44A2 (1.8)	TIMD4 (1.8)	LPAR2 (1.6)
REACTOME_STABILIZATION_OF_P53	REACTOME_STABILIZATION_OF_P53	0.20	> 0.20	PSMA5 (6.2)	TRAFD1 (3.7)	NAA25 (2.6)	NT5DC1 (2.5)	PARP10 (2.2)	SARS (1.7)	DDX56 (1.7)	SUGP1 (1.7)	TOMM40 (1.7)	ZNF259 (1.3)
GO:0032592	integral to mitochondrial membrane	0.20	> 0.20	RHD (3.0)	OGDH (3.0)	GEMIN7 (2.7)	TRAPPC6A (2.5)	RHCE (2.4)	ALDH2 (2.3)	C19orf52 (2.2)	ACAD10 (2.1)	GOT2P1 (2.0)	TOMM40 (2.0)
GO:0043277	apoptotic cell clearance	0.20	> 0.20	APOE (2.5)	GRINA (2.3)	TMED4 (2.2)	HAVCR1 (2.2)	ALDH2 (2.0)	TIMD4 (2.0)	MAFB (1.9)	CILP2 (1.8)	PVRL2 (1.7)	PMFBP1 (1.7)
GO:0009072	aromatic amino acid family metabolic process	0.20	> 0.20	ENSG00000254235 (4.0)	SLC22A1 (3.6)	LPA (3.0)	ANGPTL3 (2.8)	CYP7A1 (2.7)	APOA5 (2.7)	APOC4 (2.3)	PLG (2.3)	ATXN7L2 (1.8)	HNF1A (1.8)
ENSG00000118260	CREB1 PPI subnetwork	0.20	> 0.20	DNM2 (3.0)	GOT2P1 (3.0)	CARM1 (2.8)	LDLR (2.5)	PLEC (2.4)	DHX38 (2.4)	ABO (2.1)	CYB561D1 (2.0)	HLX (1.9)	HMGCR (1.9)
ENSG00000066336	SPI1 PPI subnetwork	0.20	> 0.20	MAFB (3.7)	TRIB1 (3.5)	SH2B3 (3.3)	PTPN11 (2.1)	BUD13 (1.9)	BCL3 (1.9)	HLX (1.9)	RELB (1.9)	MYLIP (1.9)	KANK2 (1.8)
GO:0043548	phosphatidylinositol 3-kinase binding	0.20	> 0.20	DNAH11 (2.4)	ZNF180 (2.3)	MYLIP (2.3)	SLC44A2 (2.1)	PBX4 (2.1)	COL4A3BP (1.9)	HLX (1.8)	ZNF101 (1.7)	CELSR2 (1.7)	FRK (1.6)
GO:0046519	sphingoid metabolic process	0.20	> 0.20	NKPD1 (4.9)	COL4A3BP (3.4)	HAVCR1 (3.3)	CYB561D1 (3.2)	TMEM50A (3.0)	TMED4 (2.6)	ERP29 (2.3)	POLK (2.2)	ATP13A1 (2.1)	GCNT4 (1.8)
ENSG00000068654	POLR1A PPI subnetwork	0.20	> 0.20	ZNF259 (3.3)	C12orf43 (3.2)	MAPKAPK5 (3.1)	BUD13 (3.1)	BRAP (3.0)	DDX56 (2.9)	ILF3 (2.9)	DHX38 (2.8)	GEMIN7 (2.8)	SUGP1 (2.7)
REACTOME_METABOLISM_OF_MRNA	REACTOME_METABOLISM_OF_MRNA	0.20	> 0.20	PSMA5 (3.0)	TRAFD1 (2.8)	NAA25 (2.6)	TXNL4B (2.5)	DHX38 (2.3)	TOMM40 (2.0)	SUGP1 (1.9)	BRAP (1.8)	DDX56 (1.8)	ZNF259 (1.7)
ENSG00000026025	VIM PPI subnetwork	0.20	> 0.20	PLEC (2.8)	ILF3 (2.3)	SMARCA4 (2.1)	C1orf63 (1.8)	CARM1 (1.7)	NYNRIN (1.7)	ST3GAL4 (1.6)	SH2B3 (1.6)	TRAFD1 (1.6)	DNM2 (1.6)
GO:0019901	protein kinase binding	0.20	> 0.20	RELB (2.5)	PLCG1 (2.4)	DNM2 (2.2)	C11orf9 (2.1)	TRIB1 (2.1)	GMIP (2.1)	PTPN11 (2.0)	NCAN (1.9)	PLEC (1.8)	BCL3 (1.8)
MP:0000642	enlarged adrenal glands	0.20	> 0.20	FADS1 (3.6)	ST3GAL4 (2.7)	FADS2 (2.6)	HAVCR1 (2.3)	GPAM (1.9)	APOC1 (1.9)	MYLIP (1.8)	KANK2 (1.7)	APOC4 (1.6)	DNAH11 (1.5)
GO:0033137	negative regulation of peptidyl-serine phosphorylation	0.20	> 0.20	DNAH11 (2.9)	CYB561D1 (2.6)	PPP1R37 (2.3)	ABO (2.2)	BLOC1S3 (2.2)	LPAR2 (2.0)	ENSG00000254235 (1.8)	TSSK6 (1.8)	TRAPPC6A (1.7)	YIPF2 (1.6)
ENSG00000109846	CRYAB PPI subnetwork	0.20	> 0.20	SYPL2 (2.3)	HAPLN4 (2.0)	GMPR (2.0)	PVR (1.7)	ERP29 (1.7)	GRINA (1.6)	RPH3A (1.6)	ENSG00000254235 (1.6)	C11orf9 (1.6)	APOA5 (1.5)
ENSG00000111775	COX6A1 PPI subnetwork	0.20	> 0.20	TRAPPC6A (3.1)	TOMM40 (2.7)	GOT2P1 (2.5)	ATP13A1 (2.3)	CEACAM19 (2.0)	MAU2 (1.9)	ZNF180 (1.9)	HNF1A (1.8)	FRK (1.8)	ACAD10 (1.6)
ENSG00000087365	SF3B2 PPI subnetwork	0.20	> 0.20	ILF3 (3.9)	SUGP1 (3.4)	C1orf63 (3.4)	DHX38 (3.2)	BUD13 (3.1)	SMARCA4 (2.7)	QTRT1 (2.7)	TOP1 (2.6)	USP1 (2.5)	FEN1 (2.4)
ENSG00000145901	TNIP1 PPI subnetwork	0.20	> 0.20	RELB (7.1)	BCL3 (3.6)	SH2B3 (2.1)	ENSG00000228044 (2.0)	SYPL2 (2.0)	CEACAM19 (1.7)	MYLIP (1.6)	CILP2 (1.4)	FRK (1.3)	MAPKAPK5 (1.3)
GO:0048514	blood vessel morphogenesis	0.20	> 0.20	PVR (2.9)	HLX (2.8)	PVRL2 (2.6)	NYNRIN (2.1)	BCAM (2.1)	SH2B3 (2.0)	KANK2 (1.8)	C17orf57 (1.8)	CEACAM19 (1.7)	MAFB (1.7)
ENSG00000093000	NUP50 PPI subnetwork	0.20	> 0.20	POC5 (3.3)	USP24 (3.2)	DDX56 (3.2)	NAA25 (3.1)	USP1 (3.0)	DOCK7 (2.8)	BUD13 (2.7)	ILF3 (2.2)	MAPKAPK5 (2.0)	ENSG00000226648 (1.9)
GO:0071843	cellular component biogenesis at cellular level	0.20	> 0.20	ZNF259 (3.8)	C12orf43 (3.5)	DDX56 (3.3)	QTRT1 (3.1)	NAA25 (3.0)	DHODH (2.9)	TOMM40 (2.9)	SUGP1 (2.5)	MAPKAPK5 (2.5)	BRAP (2.2)
ENSG00000149187	CELF1 PPI subnetwork	0.20	> 0.20	ITGB3 (3.7)	TMED4 (2.2)	C1orf63 (2.2)	UBXN2B (2.1)	ENSG00000226645 (2.0)	CELSR2 (1.8)	FADS1 (1.4)	CYP7A1 (1.4)	TIMD4 (1.3)	MAFB (1.3)
ENSG00000197369	ENSG00000197369 PPI subnetwork	0.20	> 0.20	SLC44A2 (2.5)	TMEM50A (2.2)	SMARCA4 (2.2)	DNM2 (2.0)	KIAA1324 (1.8)	TRIB1 (1.7)	C11orf9 (1.6)	ENSG00000238078 (1.6)	MARK4 (1.5)	LPAR2 (1.5)
ENSG00000197003	ENSG00000197003 PPI subnetwork	0.20	> 0.20	SLC44A2 (2.5)	TMEM50A (2.2)	SMARCA4 (2.2)	DNM2 (2.0)	KIAA1324 (1.8)	TRIB1 (1.7)	C11orf9 (1.6)	ENSG00000238078 (1.6)	MARK4 (1.5)	LPAR2 (1.5)
ENSG00000136997	MYC PPI subnetwork	0.20	> 0.20	ATXN2 (3.5)	ILF3 (3.1)	SMARCA4 (2.8)	DHX38 (2.8)	C12orf51 (2.4)	MAU2 (2.4)	DNM2 (2.4)	MAPKAPK5 (2.3)	BRAP (2.1)	BUD13 (2.1)
ENSG00000133101	CCNA1 PPI subnetwork	0.20	> 0.20	FEN1 (4.3)	FADS1 (3.3)	USP1 (3.3)	FADS2 (2.5)	HMGCR (2.3)	ILF3 (2.0)	GATAD2A (1.8)	LDLR (1.8)	GOT2P1 (1.7)	PSRC1 (1.4)
GO:0051403	stress-activated MAPK cascade	0.20	> 0.20	HLX (2.4)	ENSG00000228044 (2.0)	PVR (1.9)	MAU2 (1.8)	SH2B3 (1.8)	ENSG00000226645 (1.6)	POLK (1.6)	ZNF180 (1.5)	TRIB1 (1.5)	MARK4 (1.4)
MP:0005491	pancreatic islet hyperplasia	0.20	> 0.20	MOSC1 (3.0)	ALDH2 (2.9)	KIAA1324 (2.8)	GPAM (2.8)	CELSR2 (2.3)	POLK (1.9)	PLEKHH2 (1.7)	GCNT4 (1.7)	LPIN3 (1.7)	NAA25 (1.6)
ENSG00000077063	CTTNBP2 PPI subnetwork	0.20	> 0.20	ZNF180 (2.9)	MARK4 (2.6)	PSMA5 (2.5)	C11orf9 (2.5)	NAA25 (2.3)	CLPTM1 (2.3)	PVRL2 (2.2)	PVR (2.1)	TOMM40 (2.0)	ITGB3 (1.7)
ENSG00000181222	POLR2A PPI subnetwork	0.20	> 0.20	ILF3 (3.5)	SUGP1 (3.5)	SMARCA4 (3.4)	TOP1 (3.4)	DHX38 (3.2)	USP1 (2.9)	BUD13 (2.8)	GATAD2A (2.2)	MAPKAPK5 (2.0)	FEN1 (1.9)
ENSG00000164346	NSA2 PPI subnetwork	0.20	> 0.20	ZNF259 (5.0)	NAA25 (4.7)	DDX56 (4.2)	TOMM40 (3.9)	QTRT1 (3.1)	DHODH (2.6)	ATP13A1 (2.2)	DHX38 (2.2)	SARS (2.2)	SUGP1 (2.1)
ENSG00000113070	HBEGF PPI subnetwork	0.20	> 0.20	ZHX3 (2.9)	SLC44A2 (2.8)	ENSG00000226648 (2.6)	TMED4 (2.3)	PLEC (2.0)	ITGB3 (2.0)	CELSR2 (1.9)	CILP2 (1.9)	MAPKAPK5 (1.9)	BCAM (1.8)
ENSG00000087111	PIGS PPI subnetwork	0.20	> 0.20	ATP13A1 (3.8)	CYB561D1 (3.1)	HAVCR1 (3.0)	ERP29 (2.9)	SORT1 (2.5)	CLPTM1 (2.4)	YIPF2 (2.2)	C12orf51 (2.1)	NT5DC1 (2.1)	ATXN7L2 (2.0)
ENSG00000072274	TFRC PPI subnetwork	0.20	> 0.20	GRINA (3.5)	ZNF101 (3.1)	ENSG00000254235 (2.7)	PARP10 (2.5)	GMIP (2.4)	ITGB3 (1.9)	BCL3 (1.9)	PVR (1.8)	CETP (1.8)	CYB561D1 (1.7)
MP:0003934	abnormal pancreas development	0.20	> 0.20	KIAA1324 (2.4)	TRIB1 (1.7)	ENSG00000254235 (1.7)	ENSG00000238078 (1.5)	ABCG8 (1.4)	TRAFD1 (1.3)	TIMD4 (1.3)	DNAH11 (1.3)	POLK (1.2)	C17orf57 (1.2)
GO:0043021	ribonucleoprotein complex binding	0.20	> 0.20	ZNF259 (3.4)	SUGP1 (2.9)	SARS (2.8)	TOMM40 (2.7)	CLPTM1 (2.6)	DHODH (2.3)	ATP13A1 (2.2)	DDX56 (2.1)	PSMA5 (2.0)	DHX38 (2.0)
ENSG00000169682	SPNS1 PPI subnetwork	0.20	> 0.20	ZNF101 (3.8)	GMIP (3.3)	LPAR2 (2.6)	ZHX3 (2.5)	PLCG1 (2.1)	ITGB3 (2.1)	TOP1 (2.1)	MAFB (2.0)	PBX4 (1.7)	ENSG00000226645 (1.7)
ENSG00000215440	NPEPL1 PPI subnetwork	0.20	> 0.20	MAU2 (2.8)	C19orf52 (2.6)	CLPTM1 (2.4)	GRINA (2.3)	YIPF2 (2.3)	ENSG00000238078 (2.3)	SLC44A2 (2.2)	TMED4 (2.1)	CYB561D1 (2.1)	ATP13A1 (2.1)
ENSG00000185630	PBX1 PPI subnetwork	0.20	> 0.20	ANKRD31 (3.2)	ATXN7L2 (2.7)	HLX (2.6)	ENSG00000228044 (2.5)	SYPL2 (2.0)	C19orf52 (1.4)	PSRC1 (1.4)	OGDH (1.3)	C11orf9 (1.3)	PLCG1 (1.3)
ENSG00000143375	CGN PPI subnetwork	0.20	> 0.20	CBLC (4.9)	AP1M2 (4.2)	DNM2 (3.1)	LPAR2 (2.9)	PLEC (2.6)	BCAM (2.3)	KANK2 (2.1)	CELSR2 (1.9)	DOCK7 (1.9)	CARM1 (1.9)
MP:0011260	abnormal head mesenchyme morphology	0.20	> 0.20	GATAD2A (3.6)	ATP13A1 (3.2)	C17orf57 (3.1)	DOCK7 (2.9)	QTRT1 (2.7)	ITGB3 (2.7)	ABO (2.4)	CLPTM1 (2.2)	ANKRD31 (2.1)	PLCG1 (1.8)
GO:0016620	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	0.20	> 0.20	ALDH2 (3.1)	TRAPPC6A (3.0)	ABCG8 (2.8)	CYP7A1 (2.7)	MOSC1 (2.7)	PLG (2.6)	GPAM (2.5)	KIAA1324 (2.5)	APOC4 (2.4)	ANGPTL3 (2.1)
KEGG_SULFUR_METABOLISM	KEGG_SULFUR_METABOLISM	0.20	> 0.20	ALDH2 (2.7)	TM6SF2 (2.6)	ENSG00000254235 (2.5)	ABCG5 (2.2)	HAPLN4 (2.1)	ABCG8 (2.1)	CYP7A1 (2.0)	NKPD1 (1.8)	TMED4 (1.7)	APOB (1.7)
MP:0005350	increased susceptibility to autoimmune disorder	0.20	> 0.20	GOT2P1 (2.4)	GCNT4 (2.1)	PBX4 (2.0)	RELB (2.0)	C12orf47 (1.5)	CELSR2 (1.5)	SLC22A1 (1.4)	TRAFD1 (1.3)	ENSG00000254235 (1.3)	PPP1R37 (1.3)
ENSG00000170653	ATF7 PPI subnetwork	0.20	> 0.20	TRIB1 (6.2)	BCL3 (3.7)	MAFB (3.2)	PARP10 (3.0)	PVR (2.9)	POLK (2.1)	MAPKAPK5 (1.8)	OASL (1.7)	SARS (1.7)	ATXN2 (1.5)
GO:0090316	positive regulation of intracellular protein transport	0.20	> 0.20	ENSG00000238078 (3.9)	TMEM116 (2.7)	PLEKHH2 (2.5)	OASL (2.5)	AP1M2 (2.4)	GCNT4 (1.8)	ENSG00000254235 (1.8)	MYLIP (1.7)	ZNF101 (1.7)	SLC44A2 (1.6)
GO:0045309	protein phosphorylated amino acid binding	0.20	> 0.20	C17orf57 (3.9)	C1orf63 (2.8)	CLPTM1 (2.7)	SLC44A2 (2.6)	MARK4 (2.5)	CARM1 (2.3)	ENSG00000226645 (1.9)	PVRL2 (1.9)	ATXN2 (1.8)	PLEKHH2 (1.8)
ENSG00000135597	REPS1 PPI subnetwork	0.20	> 0.20	KIAA1324 (2.8)	GMIP (2.5)	LPAR2 (2.5)	PLEC (2.2)	GATAD2A (2.1)	ABO (1.9)	AP1M2 (1.8)	ST3GAL4 (1.7)	ANKRD31 (1.7)	COL4A3BP (1.7)
ENSG00000129757	CDKN1C PPI subnetwork	0.20	> 0.20	FEN1 (3.5)	USP1 (3.3)	LPIN3 (2.1)	AMIGO1 (1.9)	GCNT4 (1.9)	PSRC1 (1.9)	GATAD2A (1.8)	HLX (1.7)	HAPLN4 (1.6)	CETP (1.5)
MP:0009400	decreased skeletal muscle fiber size	0.20	> 0.20	SYPL2 (5.5)	USP24 (3.2)	TRIB1 (3.0)	PLEC (2.2)	AMIGO1 (2.1)	C1orf63 (1.9)	GRINA (1.6)	UBXN2B (1.6)	OGDH (1.5)	TMEM50A (1.5)
ENSG00000105376	ICAM5 PPI subnetwork	0.20	> 0.20	GMIP (3.4)	DNM2 (3.3)	USP24 (2.9)	PLEC (2.6)	PVR (2.4)	POLK (2.3)	ALDH2 (2.2)	COL4A3BP (2.0)	SORT1 (1.8)	MAU2 (1.7)
MP:0002590	increased mean corpuscular volume	0.20	> 0.20	RHCE (5.4)	RHD (5.0)	TRAPPC6A (2.8)	C12orf51 (2.7)	GMPR (2.2)	TMEM57 (1.9)	ZNF180 (1.7)	TOP1 (1.6)	PLEC (1.5)	GOT2P1 (1.4)
GO:0005164	tumor necrosis factor receptor binding	0.20	> 0.20	RELB (2.7)	DNAH11 (2.2)	GCNT4 (1.9)	PARP10 (1.9)	TIMD4 (1.9)	CETP (1.9)	HAVCR1 (1.9)	SH2B3 (1.8)	TRAPPC6A (1.7)	ENSG00000228044 (1.6)
GO:0033002	muscle cell proliferation	0.20	> 0.20	PVR (3.1)	PLEKHH2 (2.3)	ALDH2 (2.2)	CEACAM19 (2.1)	HLX (2.0)	NYNRIN (1.9)	ENSG00000254235 (1.8)	MAFB (1.5)	ENSG00000228044 (1.3)	ZNF101 (1.3)
ENSG00000206353	SKIV2L PPI subnetwork	0.20	> 0.20	TOMM40 (4.5)	DDX56 (4.3)	NAA25 (3.9)	ZNF259 (3.7)	USP24 (3.7)	DHODH (3.4)	QTRT1 (2.8)	DHX38 (2.6)	ATP13A1 (2.5)	SUGP1 (1.8)
GO:0032606	type I interferon production	0.20	> 0.20	OASL (6.3)	PARP10 (6.0)	TRAFD1 (3.0)	CYB561D1 (2.9)	ADAM1 (2.7)	FRK (2.5)	MAU2 (2.4)	BRAP (2.2)	C12orf43 (2.1)	ENSG00000226645 (1.9)
GO:0033574	response to testosterone stimulus	0.20	> 0.20	TMED4 (2.4)	C19orf52 (2.3)	C17orf57 (2.3)	CEACAM19 (1.9)	ENSG00000226648 (1.8)	POLK (1.7)	PCSK9 (1.7)	NT5DC1 (1.7)	NKPD1 (1.6)	ATXN7L2 (1.6)
ENSG00000112742	TTK PPI subnetwork	0.20	> 0.20	NYNRIN (2.9)	FRK (2.8)	ITGB3 (2.1)	MAFB (2.0)	PSRC1 (1.9)	C19orf52 (1.8)	ENSG00000226648 (1.8)	AMIGO1 (1.8)	C1orf63 (1.7)	TMEM57 (1.6)
GO:0010596	negative regulation of endothelial cell migration	0.20	> 0.20	DNAH11 (3.1)	GCNT4 (2.9)	ADAM1 (2.6)	APOC1 (2.1)	TRAPPC6A (1.9)	PMFBP1 (1.9)	CETP (1.7)	HNF1A (1.6)	CEACAM19 (1.6)	HLX (1.6)
MP:0006050	pulmonary fibrosis	0.21	> 0.20	RHD (2.9)	APOE (2.8)	ANGPTL3 (2.8)	APOC4 (2.6)	HP (2.4)	TRIB1 (2.3)	APOC1 (2.3)	BCL3 (2.2)	KANK2 (2.0)	APOA5 (1.9)
ENSG00000164708	PGAM2 PPI subnetwork	0.21	> 0.20	SARS (2.7)	ALDH2 (2.3)	COL4A3BP (2.1)	FRK (2.0)	CYP7A1 (1.9)	PLEC (1.8)	SYPL2 (1.8)	OGDH (1.7)	GMPR (1.7)	BRAP (1.6)
ENSG00000146232	NFKBIE PPI subnetwork	0.21	> 0.20	RELB (5.3)	SARS (3.7)	BCL3 (3.4)	GRINA (2.2)	CLPTM1 (2.0)	PLEC (1.8)	CYP7A1 (1.7)	ENSG00000235545 (1.7)	USP24 (1.6)	PSMA5 (1.6)
ENSG00000138442	WDR12 PPI subnetwork	0.21	> 0.20	NAA25 (4.9)	ZNF259 (4.7)	TOMM40 (4.2)	DDX56 (4.1)	DHX38 (3.4)	QTRT1 (3.3)	DHODH (3.0)	ATP13A1 (2.7)	C12orf43 (2.5)	MAPKAPK5 (2.1)
ENSG00000161513	FDXR PPI subnetwork	0.21	> 0.20	TRAPPC6A (3.7)	ACAD10 (3.0)	APOC1 (2.6)	GOT2P1 (2.0)	ATXN2 (2.0)	APOC4 (1.7)	APOE (1.7)	GPAM (1.7)	ADAM1 (1.6)	COL4A3BP (1.6)
ENSG00000118402	ELOVL4 PPI subnetwork	0.21	> 0.20	LDLR (7.1)	HMGCR (6.2)	FADS1 (6.1)	FADS2 (5.1)	PCSK9 (4.6)	TMEM50A (3.8)	ERP29 (3.3)	SORT1 (3.2)	ATP13A1 (2.7)	CLPTM1 (2.6)
GO:0043566	structure-specific DNA binding	0.21	> 0.20	USP1 (3.9)	TRIB1 (2.6)	FEN1 (2.6)	ZNF101 (1.9)	NYNRIN (1.5)	KANK2 (1.3)	ANKRD31 (1.2)	GATAD2A (1.2)	ILF3 (1.2)	DHODH (1.2)
MP:0001730	embryonic growth arrest	0.21	> 0.20	ATXN2 (3.9)	ATP13A1 (2.9)	GATAD2A (2.8)	C12orf51 (2.4)	C17orf57 (2.3)	SMARCA4 (2.2)	USP1 (2.1)	BRAP (1.9)	DHX38 (1.8)	CLPTM1 (1.8)
ENSG00000119729	RHOQ PPI subnetwork	0.21	> 0.20	SLC44A2 (3.5)	PVRL2 (3.3)	CLPTM1 (2.2)	SORT1 (2.1)	PVR (2.1)	BCAM (2.1)	PLEC (2.0)	GMIP (1.9)	SARS (1.9)	DNM2 (1.9)
GO:0005759	mitochondrial matrix	0.21	> 0.20	ACAD10 (4.5)	OGDH (3.0)	DHODH (2.8)	ALDH2 (2.6)	TOMM40 (2.4)	NT5DC1 (2.3)	C19orf52 (2.2)	TRAPPC6A (2.1)	GPAM (2.0)	QTRT1 (1.8)
ENSG00000125740	FOSB PPI subnetwork	0.21	> 0.20	TRIB1 (6.8)	BCL3 (3.2)	MYLIP (2.7)	MAPKAPK5 (2.7)	POLK (2.2)	SARS (1.9)	TMED4 (1.8)	ATXN2 (1.8)	GRINA (1.7)	MAU2 (1.6)
MP:0002667	decreased circulating aldosterone level	0.21	> 0.20	ST3GAL4 (4.5)	DNAH11 (3.5)	FADS2 (3.2)	ZHX3 (2.6)	LPIN3 (2.5)	SYPL2 (2.5)	FADS1 (2.2)	APOC1 (1.9)	CYB561D1 (1.7)	GOT2P1 (1.6)
GO:0006555	methionine metabolic process	0.21	> 0.20	ENSG00000254235 (3.8)	DNAH11 (3.0)	UBXN2B (2.3)	SLC22A1 (2.2)	DHODH (2.0)	C1orf63 (2.0)	LPA (1.9)	ANGPTL3 (1.8)	NT5DC1 (1.8)	APOA5 (1.7)
REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	0.21	> 0.20	ITGB3 (3.0)	ST3GAL4 (2.9)	SH2B3 (2.7)	SORT1 (2.6)	AMIGO1 (1.8)	PMFBP1 (1.8)	ENSG00000228044 (1.8)	GMPR (1.7)	KANK2 (1.7)	ENSG00000238078 (1.7)
ENSG00000107882	SUFU PPI subnetwork	0.21	> 0.20	NYNRIN (3.1)	TRIB1 (2.4)	PPP1R37 (2.2)	FADS2 (2.1)	BLOC1S3 (2.0)	COL4A3BP (1.8)	MARK4 (1.7)	PLEKHH2 (1.6)	PLCG1 (1.6)	ENSG00000235545 (1.5)
GO:0000228	nuclear chromosome	0.21	> 0.20	USP1 (4.5)	FEN1 (4.5)	PSRC1 (2.3)	POC5 (2.1)	NYNRIN (2.1)	ILF3 (1.8)	SMARCA4 (1.6)	TOP1 (1.5)	BUD13 (1.5)	ANKRD31 (1.2)
MP:0002209	decreased germ cell number	0.21	> 0.20	LPAR2 (3.0)	TSSK6 (2.5)	C11orf9 (2.2)	ABO (2.2)	PMFBP1 (2.0)	PLEKHH2 (1.5)	FRK (1.5)	HAPLN4 (1.4)	KIAA1324 (1.3)	TXNL4B (1.2)
MP:0008721	abnormal chemokine level	0.21	> 0.20	HP (3.5)	MAFB (3.2)	BCL3 (2.7)	TRIB1 (2.6)	RELB (2.3)	TIMD4 (2.3)	CETP (2.2)	HLX (2.0)	PMFBP1 (1.8)	GMIP (1.6)
ENSG00000114978	MOB1A PPI subnetwork	0.21	> 0.20	ZNF180 (2.6)	CYB561D1 (2.5)	SLC44A2 (1.8)	GEMIN7 (1.8)	NCAN (1.8)	ZHX3 (1.6)	ATP13A1 (1.6)	GCNT4 (1.6)	QTRT1 (1.6)	POC5 (1.5)
ENSG00000174371	EXO1 PPI subnetwork	0.21	> 0.20	ENSG00000235545 (2.7)	ANKRD31 (2.7)	USP1 (2.5)	FEN1 (2.5)	DOCK7 (2.1)	NPC1L1 (1.9)	ERP29 (1.8)	DNAH11 (1.6)	ZNF180 (1.6)	AP1M2 (1.5)
GO:0005178	integrin binding	0.21	> 0.20	SLC44A2 (2.9)	CILP2 (2.8)	APOE (2.6)	BCAM (2.5)	ITGB3 (2.5)	ENSG00000238078 (2.5)	KANK2 (2.1)	PVRL2 (2.1)	PVR (1.9)	CLPTM1 (1.7)
GO:0005811	lipid particle	0.21	> 0.20	GPAM (5.5)	MOSC1 (4.8)	COL4A3BP (2.7)	NKPD1 (2.2)	CLPTM1 (1.7)	GRINA (1.7)	OGDH (1.6)	HP (1.6)	SORT1 (1.5)	PARP10 (1.5)
ENSG00000115524	SF3B1 PPI subnetwork	0.21	> 0.20	ILF3 (3.8)	C1orf63 (3.5)	BUD13 (3.3)	SUGP1 (3.2)	DHX38 (3.1)	TOP1 (2.9)	SMARCA4 (2.9)	QTRT1 (2.6)	USP1 (2.6)	FEN1 (2.5)
MP:0002389	abnormal Peyer's patch follicle morphology	0.21	> 0.20	RELB (6.7)	KIAA1324 (3.4)	BCL3 (2.8)	GMIP (2.4)	ST3GAL4 (2.3)	PLEC (2.0)	PVR (1.5)	HNF1A (1.5)	HAVCR1 (1.5)	PVRL2 (1.4)
MP:0009115	abnormal fat cell morphology	0.21	> 0.20	MOSC1 (3.9)	APOC1 (3.0)	SORT1 (2.8)	GPAM (2.7)	GCNT4 (2.7)	PPP1R37 (2.4)	TMEM57 (1.9)	ST3GAL4 (1.8)	MYLIP (1.8)	HP (1.8)
ENSG00000168811	IL12A PPI subnetwork	0.21	> 0.20	BCL3 (4.7)	RELB (4.5)	HLX (3.1)	TRIB1 (2.7)	TIMD4 (2.5)	CETP (2.4)	GMIP (1.9)	PVR (1.8)	ALDH2 (1.8)	GRINA (1.6)
ENSG00000184226	PCDH9 PPI subnetwork	0.21	> 0.20	USP24 (2.9)	PARP10 (2.8)	MAU2 (2.7)	MARK4 (2.6)	BCL3 (2.4)	ATXN2 (2.3)	SMARCA4 (2.3)	GMIP (2.0)	DHX38 (1.8)	C12orf51 (1.7)
GO:0001501	skeletal system development	0.21	> 0.20	CILP2 (5.6)	PLEKHH2 (2.5)	NYNRIN (2.2)	MAFB (2.1)	MYLIP (1.6)	CEACAM19 (1.4)	ABO (1.4)	TMEM57 (1.4)	ATXN7L2 (1.2)	HLX (1.2)
ENSG00000105851	PIK3CG PPI subnetwork	0.21	> 0.20	HLX (3.5)	SLC44A2 (3.0)	GMIP (2.6)	MYLIP (2.5)	C1orf63 (2.3)	DOCK7 (2.2)	DNM2 (2.0)	PLEC (2.0)	SH2B3 (1.8)	C17orf57 (1.8)
ENSG00000198001	IRAK4 PPI subnetwork	0.21	> 0.20	MAFB (3.1)	TRIB1 (2.2)	SH2B3 (2.1)	UBXN2B (2.0)	PMFBP1 (1.9)	OASL (1.8)	FRK (1.8)	MYLIP (1.7)	GMIP (1.6)	NYNRIN (1.6)
REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY	REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY	0.21	> 0.20	AP1M2 (3.4)	YIPF2 (3.0)	ERP29 (2.6)	QTRT1 (2.3)	ENSG00000228044 (2.2)	LPAR2 (2.0)	PMFBP1 (1.9)	ST3GAL4 (1.8)	LPIN3 (1.8)	GATAD2A (1.7)
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	0.21	> 0.20	RELB (8.4)	BCL3 (4.9)	GRINA (2.2)	ENSG00000228044 (2.1)	PVR (2.0)	BLOC1S3 (1.9)	PARP10 (1.9)	GMIP (1.9)	PTPN11 (1.7)	UBXN2B (1.7)
MP:0005156	bradykinesia	0.21	> 0.20	C12orf51 (2.4)	ERP29 (2.3)	USP24 (2.1)	ACAD10 (2.1)	ST3GAL4 (2.1)	GEMIN7 (1.8)	PLEC (1.8)	COL4A3BP (1.8)	GOT2P1 (1.8)	GMPR (1.7)
GO:0005643	nuclear pore	0.21	> 0.20	NAA25 (3.4)	POC5 (3.0)	DDX56 (2.9)	USP24 (2.9)	USP1 (2.6)	ILF3 (2.4)	CARM1 (2.4)	FEN1 (2.2)	MAPKAPK5 (2.1)	DHX38 (2.1)
MP:0002074	abnormal hair texture	0.21	> 0.20	BLOC1S3 (2.2)	PBX4 (1.8)	ENSG00000235545 (1.8)	AMIGO1 (1.6)	GCNT4 (1.6)	DNAH11 (1.6)	ZNF101 (1.5)	ZNF180 (1.3)	POLK (1.3)	ANKRD31 (1.3)
ENSG00000103275	UBE2I PPI subnetwork	0.21	> 0.20	MYLIP (2.8)	BUD13 (2.6)	BCL3 (2.6)	RELB (2.4)	TRIB1 (2.3)	CELSR2 (2.2)	GATAD2A (2.0)	TRAPPC6A (1.9)	SMARCA4 (1.7)	PLCG1 (1.6)
ENSG00000130520	LSM4 PPI subnetwork	0.21	> 0.20	DHX38 (5.1)	SUGP1 (3.4)	SMARCA4 (2.9)	MAU2 (2.9)	BUD13 (2.7)	TOP1 (2.4)	ATP13A1 (2.4)	ILF3 (2.3)	DHODH (2.2)	FEN1 (2.1)
MP:0003140	dilated heart atrium	0.21	> 0.20	GMPR (2.5)	ATXN7L2 (1.8)	GRINA (1.8)	BLOC1S3 (1.8)	OGDH (1.7)	BCAM (1.7)	PLEC (1.6)	NYNRIN (1.6)	ENSG00000226648 (1.6)	SLC22A1 (1.5)
GO:0044259	multicellular organismal macromolecule metabolic process	0.21	> 0.20	CEACAM19 (3.4)	FRK (3.1)	PLEKHH2 (2.1)	NPC1L1 (1.8)	ENSG00000228044 (1.7)	CILP2 (1.6)	ENSG00000226645 (1.6)	C11orf9 (1.5)	PVRL2 (1.5)	ENSG00000238078 (1.2)
ENSG00000130159	ECSIT PPI subnetwork	0.21	> 0.20	TMEM116 (3.1)	MAPKAPK5 (2.3)	SH2B3 (2.2)	TRIB1 (2.0)	ENSG00000226648 (2.0)	BRAP (1.9)	MAU2 (1.8)	ZNF101 (1.8)	ATXN2 (1.7)	C12orf43 (1.6)
ENSG00000109046	WSB1 PPI subnetwork	0.21	> 0.20	ST3GAL4 (2.2)	GRINA (2.1)	TRAPPC6A (2.0)	ANKRD31 (1.9)	ZNF101 (1.8)	CBLC (1.8)	SORT1 (1.7)	CLPTM1 (1.7)	ZHX3 (1.5)	FRK (1.4)
ENSG00000172977	KAT5 PPI subnetwork	0.21	> 0.20	BUD13 (2.7)	USP1 (2.4)	MYLIP (1.9)	GEMIN7 (1.8)	TRAFD1 (1.7)	PSRC1 (1.7)	ZNF180 (1.6)	BCL3 (1.4)	DNAH11 (1.4)	C12orf47 (1.4)
ENSG00000183791	TCEB3C PPI subnetwork	0.21	> 0.20	OASL (3.1)	TIMD4 (3.0)	CETP (2.7)	PLEKHH2 (1.9)	C1orf63 (1.8)	DNAH11 (1.8)	TMEM57 (1.8)	POLK (1.7)	CEACAM19 (1.5)	SLC44A2 (1.4)
ENSG00000112033	PPARD PPI subnetwork	0.21	> 0.20	C12orf51 (3.5)	TRIB1 (3.3)	USP24 (3.1)	SMARCA4 (2.4)	TOP1 (2.2)	ATXN2 (2.1)	BCL3 (2.0)	CELSR2 (2.0)	PVR (2.0)	TSSK6 (1.9)
ENSG00000169891	REPS2 PPI subnetwork	0.21	> 0.20	MARK4 (3.2)	LPAR2 (2.7)	PPP1R37 (2.7)	HLX (2.6)	GMIP (2.6)	PSRC1 (2.4)	GEMIN7 (2.2)	PVRL2 (1.9)	DNM2 (1.8)	TMEM116 (1.8)
GO:0045649	regulation of macrophage differentiation	0.21	> 0.20	ITGB3 (3.7)	ST3GAL4 (2.3)	TMED4 (1.8)	CILP2 (1.7)	ENSG00000228044 (1.6)	CEACAM19 (1.6)	GOT2P1 (1.5)	ABO (1.5)	CYB561D1 (1.5)	TIMD4 (1.4)
GO:0034130	toll-like receptor 1 signaling pathway	0.21	> 0.20	SH2B3 (2.7)	BLOC1S3 (2.3)	TRIB1 (2.2)	ENSG00000226645 (2.0)	CYB561D1 (1.9)	HLX (1.9)	RELB (1.8)	ENSG00000228044 (1.8)	LPAR2 (1.7)	BUD13 (1.6)
KEGG_HISTIDINE_METABOLISM	KEGG_HISTIDINE_METABOLISM	0.21	> 0.20	TM6SF2 (3.8)	MOSC1 (3.7)	ALDH2 (3.2)	PLG (3.1)	ABCG8 (3.1)	ANGPTL3 (2.9)	HNF1A (2.4)	ABCG5 (2.3)	C11orf9 (2.1)	ABO (2.1)
GO:0051015	actin filament binding	0.21	> 0.20	RHCE (4.0)	RHD (3.6)	PLEC (2.5)	PCSK9 (2.5)	NPC1L1 (2.3)	DOCK7 (2.3)	ENSG00000235545 (2.2)	ITGB3 (2.1)	AP1M2 (2.1)	SORT1 (2.0)
ENSG00000163541	SUCLG1 PPI subnetwork	0.21	> 0.20	ATP13A1 (3.2)	QTRT1 (2.7)	GPAM (2.6)	OGDH (2.2)	TOMM40 (2.1)	POC5 (2.0)	PSMA5 (1.9)	NT5DC1 (1.9)	SARS (1.7)	ENSG00000226648 (1.7)
GO:0045814	negative regulation of gene expression, epigenetic	0.21	> 0.20	TSSK6 (3.8)	GCNT4 (2.5)	MAU2 (2.4)	MAPKAPK5 (2.0)	SUGP1 (1.8)	FRK (1.8)	C19orf52 (1.8)	NT5DC1 (1.5)	TMEM116 (1.5)	ILF3 (1.3)
GO:0006397	mRNA processing	0.21	> 0.20	BUD13 (3.3)	TOP1 (3.3)	C1orf63 (3.1)	DHX38 (2.9)	SUGP1 (2.8)	ILF3 (2.7)	C12orf43 (2.4)	MAPKAPK5 (2.4)	QTRT1 (1.8)	SMARCA4 (1.7)
REACTOME_P53:DEPENDENT_G1_DNA_DAMAGE_RESPONSE	REACTOME_P53:DEPENDENT_G1_DNA_DAMAGE_RESPONSE	0.21	> 0.20	PSMA5 (6.1)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.5)	PARP10 (2.0)	TOMM40 (1.7)	SARS (1.7)	DDX56 (1.5)	SUGP1 (1.5)	ENSG00000254235 (1.0)
REACTOME_P53:DEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	REACTOME_P53:DEPENDENT_G1S_DNA_DAMAGE_CHECKPOINT	0.21	> 0.20	PSMA5 (6.1)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.5)	PARP10 (2.0)	TOMM40 (1.7)	SARS (1.7)	DDX56 (1.5)	SUGP1 (1.5)	ENSG00000254235 (1.0)
GO:0050920	regulation of chemotaxis	0.21	> 0.20	GCNT4 (2.6)	CETP (2.4)	PLEKHH2 (2.3)	TIMD4 (2.2)	ZNF101 (2.1)	PVR (2.0)	MAFB (1.7)	YIPF2 (1.7)	APOE (1.6)	HLX (1.6)
ENSG00000197303	ENSG00000197303 PPI subnetwork	0.21	> 0.20	DDX56 (2.9)	NAA25 (2.9)	ILF3 (2.7)	NKPD1 (2.6)	QTRT1 (2.6)	DHX38 (2.5)	ZNF259 (2.4)	SARS (2.3)	C12orf43 (2.2)	ANKRD31 (2.2)
ENSG00000135486	HNRNPA1 PPI subnetwork	0.21	> 0.20	ILF3 (3.5)	C1orf63 (3.3)	TOP1 (3.2)	SMARCA4 (3.0)	QTRT1 (2.8)	DHX38 (2.6)	USP1 (2.5)	SUGP1 (2.1)	GATAD2A (2.0)	TOMM40 (2.0)
GO:0033014	tetrapyrrole biosynthetic process	0.21	> 0.20	RHCE (7.4)	RHD (7.3)	ADAM1 (3.2)	C12orf51 (2.8)	NT5DC1 (2.5)	GMPR (2.1)	ABO (1.9)	ACAD10 (1.9)	TRAPPC6A (1.5)	TMEM116 (1.4)
GO:0006779	porphyrin-containing compound biosynthetic process	0.21	> 0.20	RHCE (7.4)	RHD (7.3)	ADAM1 (3.2)	C12orf51 (2.8)	NT5DC1 (2.5)	GMPR (2.1)	ABO (1.9)	ACAD10 (1.9)	TRAPPC6A (1.5)	TMEM116 (1.4)
ENSG00000142892	PIGK PPI subnetwork	0.21	> 0.20	CLPTM1 (5.6)	ATP13A1 (4.6)	TMEM50A (4.2)	ERP29 (3.0)	CYB561D1 (2.9)	TMED4 (2.8)	TMEM57 (2.7)	SORT1 (2.4)	HMGCR (2.1)	FADS1 (1.9)
GO:0030674	protein binding, bridging	0.21	> 0.20	PLEC (2.6)	GMIP (2.2)	ITGB3 (1.9)	C11orf9 (1.8)	LPAR2 (1.7)	MAFB (1.6)	COL4A3BP (1.6)	ST3GAL4 (1.6)	APOC1 (1.5)	ZNF101 (1.4)
MP:0003883	enlarged stomach	0.21	> 0.20	C11orf9 (3.1)	CETP (2.2)	ABO (2.2)	ITGB3 (1.9)	SLC44A2 (1.8)	CLPTM1 (1.7)	OASL (1.6)	C12orf47 (1.5)	HLX (1.5)	PPP1R37 (1.4)
GO:0071549	cellular response to dexamethasone stimulus	0.21	> 0.20	RHCE (4.1)	RHD (3.3)	GMPR (2.4)	TXNL4B (2.3)	ENSG00000226645 (2.0)	LPIN3 (2.0)	TMEM57 (1.9)	ABCG8 (1.8)	CEACAM19 (1.7)	C19orf52 (1.7)
MP:0000062	increased bone mineral density	0.21	> 0.20	APOC1 (3.6)	APOE (3.3)	MAFB (2.8)	ITGB3 (2.5)	SH2B3 (2.5)	KIAA1324 (2.3)	GMIP (2.2)	ENSG00000226645 (2.0)	CETP (1.9)	MYLIP (1.8)
GO:0016445	somatic diversification of immunoglobulins	0.21	> 0.20	GCNT4 (3.1)	ZNF101 (2.5)	NT5DC1 (2.3)	C17orf57 (2.1)	ANKRD31 (2.0)	DYNC2LI1 (1.9)	ENSG00000226648 (1.9)	UBXN2B (1.6)	PBX4 (1.6)	MAPKAPK5 (1.5)
ENSG00000109339	MAPK10 PPI subnetwork	0.21	> 0.20	TRIB1 (7.0)	POLK (2.4)	LDLR (2.0)	ENSG00000226645 (1.9)	PBX4 (1.8)	PLCG1 (1.6)	MYLIP (1.6)	LPAR2 (1.5)	SH2B3 (1.5)	SORT1 (1.4)
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	0.21	> 0.20	PTPN11 (2.1)	HLX (2.0)	CARM1 (2.0)	DNM2 (1.9)	CYB561D1 (1.9)	TMEM50A (1.8)	ZHX3 (1.8)	SLC44A2 (1.8)	MARK4 (1.7)	DHX38 (1.7)
ENSG00000171863	RPS7 PPI subnetwork	0.21	> 0.20	DDX56 (3.7)	QTRT1 (3.3)	NAA25 (3.1)	C12orf43 (2.9)	DHX38 (2.7)	ZNF259 (2.7)	SARS (2.6)	ILF3 (2.3)	SUGP1 (2.3)	PTPN11 (2.2)
MP:0003659	abnormal lymph circulation	0.21	> 0.20	CETP (6.1)	TIMD4 (3.7)	PVRL2 (3.4)	BCAM (2.5)	SH2B3 (2.5)	C11orf9 (2.1)	HLX (1.8)	SLC44A2 (1.8)	ATXN7L2 (1.7)	ZNF180 (1.5)
ENSG00000068394	GPKOW PPI subnetwork	0.21	> 0.20	OASL (4.2)	PARP10 (2.3)	FRK (1.7)	BRAP (1.6)	TMED4 (1.6)	DYNC2LI1 (1.6)	POLK (1.5)	C1orf63 (1.5)	MAPKAPK5 (1.4)	NT5DC1 (1.4)
ENSG00000143850	PLEKHA6 PPI subnetwork	0.21	> 0.20	HNF1A (2.7)	ST3GAL4 (2.7)	DNM2 (2.5)	AP1M2 (2.2)	CETP (2.0)	CBLC (1.8)	CYB561D1 (1.8)	NT5DC1 (1.7)	ITGB3 (1.7)	POLK (1.7)
MP:0002842	increased systemic arterial blood pressure	0.21	> 0.20	HLX (2.9)	POLK (2.3)	BCAM (2.0)	RPH3A (1.4)	PLEKHH2 (1.3)	MAFB (1.3)	AMIGO1 (1.3)	NPC1L1 (1.2)	DNAH11 (1.2)	KANK2 (1.1)
ENSG00000173757	STAT5B PPI subnetwork	0.21	> 0.20	BCL3 (3.0)	PARP10 (2.9)	HLX (2.5)	PBX4 (2.5)	PLCG1 (2.3)	DNM2 (2.2)	MAU2 (2.2)	TRIB1 (2.0)	USP24 (1.9)	TRAFD1 (1.9)
ENSG00000179889	PDXDC1 PPI subnetwork	0.21	> 0.20	SORT1 (2.2)	MYLIP (1.9)	TRIB1 (1.9)	GMPR (1.9)	POLK (1.8)	DNM2 (1.6)	BCAM (1.5)	TRAPPC6A (1.5)	C11orf9 (1.5)	TOMM40 (1.5)
MP:0003828	pulmonary edema	0.21	> 0.20	MAFB (4.5)	TRIB1 (4.0)	MYLIP (2.9)	GPAM (2.8)	PBX4 (2.0)	C12orf47 (2.0)	ATXN7L2 (2.0)	POLK (1.9)	AMIGO1 (1.9)	FRK (1.8)
ENSG00000165516	KLHDC2 PPI subnetwork	0.21	> 0.20	CBLC (5.3)	AP1M2 (2.9)	LPAR2 (2.7)	PVRL2 (2.2)	DHX38 (2.1)	PSRC1 (2.0)	DOCK7 (1.9)	CELSR2 (1.9)	ZNF180 (1.6)	MARK4 (1.6)
ENSG00000135679	MDM2 PPI subnetwork	0.21	> 0.20	POLK (2.0)	CELSR2 (1.9)	TMEM50A (1.7)	HMGCR (1.6)	PSRC1 (1.5)	GMPR (1.4)	TRIB1 (1.4)	BLOC1S3 (1.4)	C12orf51 (1.2)	USP1 (1.2)
ENSG00000127666	TICAM1 PPI subnetwork	0.21	> 0.20	PARP10 (3.6)	TRAFD1 (3.1)	FRK (2.8)	OASL (2.6)	RELB (2.5)	NT5DC1 (2.5)	CYB561D1 (2.0)	LPAR2 (1.9)	TSSK6 (1.9)	ZNF101 (1.8)
GO:0009886	post-embryonic morphogenesis	0.21	> 0.20	GEMIN7 (3.3)	DNAH11 (3.2)	LPAR2 (2.8)	PPP1R37 (2.4)	C12orf43 (2.0)	NPC1L1 (1.9)	GOT2P1 (1.7)	BRAP (1.7)	MAFB (1.6)	QTRT1 (1.5)
ENSG00000162402	USP24 PPI subnetwork	0.21	> 0.20	ENSG00000228044 (2.4)	GPAM (2.0)	KANK2 (1.9)	SORT1 (1.8)	ST3GAL4 (1.7)	FADS2 (1.6)	PSRC1 (1.6)	CEACAM19 (1.5)	RPH3A (1.5)	FADS1 (1.4)
MP:0009703	decreased birth body size	0.21	> 0.20	ATXN2 (3.5)	C12orf51 (2.2)	ALDH2 (2.1)	C11orf9 (1.9)	LDLR (1.8)	NYNRIN (1.7)	PVRL2 (1.7)	TOP1 (1.7)	SORT1 (1.7)	TMEM50A (1.6)
ENSG00000184486	POU3F2 PPI subnetwork	0.21	> 0.20	NCAN (3.2)	CELSR2 (2.4)	BUD13 (1.6)	SORT1 (1.6)	TRIB1 (1.5)	APOE (1.5)	TOP1 (1.4)	DOCK7 (1.4)	C12orf51 (1.4)	CYP7A1 (1.3)
ENSG00000149948	HMGA2 PPI subnetwork	0.21	> 0.20	RELB (4.4)	SH2B3 (2.5)	ATXN2 (2.4)	GMIP (2.4)	MARK4 (2.4)	BCL3 (2.3)	DNM2 (2.2)	BLOC1S3 (2.0)	PSRC1 (2.0)	CYB561D1 (2.0)
KEGG_PENTOSE_PHOSPHATE_PATHWAY	KEGG_PENTOSE_PHOSPHATE_PATHWAY	0.21	> 0.20	NT5DC1 (3.5)	TRAPPC6A (3.3)	NPC1L1 (3.0)	FADS1 (2.7)	FADS2 (2.5)	LPA (2.0)	TM6SF2 (1.9)	ENSG00000228044 (1.8)	SYPL2 (1.7)	DHODH (1.7)
GO:0048255	mRNA stabilization	0.21	> 0.20	ENSG00000238078 (4.1)	ENSG00000226648 (2.9)	TOP1 (2.5)	ADAM1 (2.5)	ILF3 (2.4)	NT5DC1 (2.3)	ENSG00000226645 (2.0)	ENSG00000228044 (1.8)	ENSG00000235545 (1.7)	SUGP1 (1.5)
GO:0043489	RNA stabilization	0.21	> 0.20	ENSG00000238078 (4.1)	ENSG00000226648 (2.9)	TOP1 (2.5)	ADAM1 (2.5)	ILF3 (2.4)	NT5DC1 (2.3)	ENSG00000226645 (2.0)	ENSG00000228044 (1.8)	ENSG00000235545 (1.7)	SUGP1 (1.5)
ENSG00000126351	THRA PPI subnetwork	0.21	> 0.20	C12orf51 (4.0)	ATXN2 (2.3)	TOP1 (2.1)	SMARCA4 (2.0)	OASL (1.9)	MAU2 (1.8)	OGDH (1.6)	PPP1R37 (1.6)	C17orf57 (1.6)	CEACAM19 (1.6)
MP:0000259	abnormal vascular development	0.21	> 0.20	HLX (4.1)	PVR (2.8)	SH2B3 (2.5)	PLCG1 (2.2)	NYNRIN (2.2)	PLEC (2.2)	CETP (2.1)	TRIB1 (2.1)	BCAM (1.9)	ENSG00000226648 (1.8)
ENSG00000095002	MSH2 PPI subnetwork	0.21	> 0.20	FEN1 (4.1)	USP1 (3.4)	ZNF180 (2.8)	BUD13 (2.5)	POC5 (2.1)	POLK (2.1)	SMARCA4 (2.0)	ENSG00000226648 (2.0)	ILF3 (1.8)	ZNF101 (1.8)
MP:0011506	glomerular crescent	0.21	> 0.20	MAFB (5.2)	TIMD4 (3.8)	CETP (2.9)	APOE (2.5)	PVR (2.2)	GCNT4 (2.0)	ACAD10 (1.9)	TRIB1 (1.7)	C11orf9 (1.4)	APOC1 (1.4)
GO:0043202	lysosomal lumen	0.21	> 0.20	MAFB (4.2)	APOE (4.1)	ERP29 (3.8)	ATP13A1 (2.9)	GRINA (2.4)	HNF1A (2.3)	CLPTM1 (2.2)	TMEM50A (1.9)	TMED4 (1.8)	PMFBP1 (1.7)
ENSG00000137752	CASP1 PPI subnetwork	0.21	> 0.20	GRINA (2.5)	NT5DC1 (2.3)	ST3GAL4 (2.2)	ENSG00000228044 (2.1)	BCL3 (2.1)	PLEC (1.9)	UBXN2B (1.7)	ABO (1.3)	POLK (1.3)	DOCK7 (1.3)
ENSG00000205250	E2F4 PPI subnetwork	0.21	> 0.20	ATXN2 (3.8)	C12orf51 (2.9)	FEN1 (2.7)	USP1 (2.7)	KANK2 (2.5)	MAPKAPK5 (2.2)	GOT2P1 (2.0)	USP24 (1.6)	SMARCA4 (1.6)	DNM2 (1.5)
ENSG00000149743	TRPT1 PPI subnetwork	0.21	> 0.20	QTRT1 (3.3)	TOMM40 (2.7)	TRAPPC6A (2.4)	CBLC (2.3)	SARS (2.3)	ST3GAL4 (2.1)	DDX56 (2.0)	ZNF259 (2.0)	NT5DC1 (1.9)	RELB (1.7)
ENSG00000136488	CSH1 PPI subnetwork	0.21	> 0.20	BCL3 (4.1)	RELB (2.9)	HLX (2.7)	ALDH2 (2.2)	TIMD4 (2.1)	GMIP (2.1)	CETP (1.8)	SH2B3 (1.6)	LPA (1.4)	TRIB1 (1.4)
MP:0008501	increased IgG2b level	0.21	> 0.20	CETP (5.2)	RELB (4.1)	GMIP (2.8)	BCL3 (2.6)	TIMD4 (2.3)	SH2B3 (1.6)	HAVCR1 (1.6)	POLK (1.4)	PBX4 (1.4)	COL4A3BP (1.3)
GO:0004702	receptor signaling protein serine/threonine kinase activity	0.21	> 0.20	PVR (2.9)	PLCG1 (2.3)	BCL3 (2.3)	ZHX3 (2.1)	SH2B3 (2.1)	GCNT4 (1.9)	MARK4 (1.9)	LPAR2 (1.8)	CYB561D1 (1.8)	RELB (1.7)
ENSG00000065485	PDIA5 PPI subnetwork	0.21	> 0.20	ACAD10 (3.8)	HNF1A (3.0)	NT5DC1 (2.8)	TMED4 (2.4)	C1orf63 (1.8)	TRAPPC6A (1.8)	ATXN7L2 (1.5)	OGDH (1.4)	PLEKHH2 (1.3)	CETP (1.3)
MP:0001011	abnormal superior cervical ganglion morphology	0.21	> 0.20	TRIB1 (3.3)	KANK2 (2.4)	POLK (2.4)	YIPF2 (2.2)	KIAA1324 (2.2)	AMIGO1 (2.2)	TSSK6 (2.1)	ADAM1 (2.0)	CELSR2 (1.9)	CBLC (1.9)
MP:0009288	increased epididymal fat pad weight	0.21	> 0.20	GCNT4 (3.9)	KIAA1324 (2.5)	GOT2P1 (2.1)	CELSR2 (2.1)	ABO (1.8)	C12orf47 (1.7)	ABCG5 (1.7)	NT5DC1 (1.6)	FRK (1.6)	TM6SF2 (1.5)
MP:0005408	hypopigmentation	0.21	> 0.20	DOCK7 (3.3)	ACAD10 (2.6)	COL4A3BP (2.5)	LPA (2.2)	PLG (2.0)	ENSG00000235545 (1.8)	C12orf47 (1.7)	APOA5 (1.6)	ANGPTL3 (1.6)	PLEKHH2 (1.6)
ENSG00000102753	KPNA3 PPI subnetwork	0.21	> 0.20	C12orf43 (3.2)	USP1 (2.7)	TXNL4B (2.4)	ZNF180 (2.4)	FEN1 (1.9)	FADS2 (1.8)	PSRC1 (1.7)	PTPN11 (1.7)	DHX38 (1.7)	RELB (1.7)
MP:0001120	abnormal uterus morphology	0.21	> 0.20	ST3GAL4 (3.9)	PLEKHH2 (2.2)	GPAM (2.1)	PVRL2 (2.0)	HAPLN4 (1.7)	FRK (1.6)	KIAA1324 (1.5)	ABCG8 (1.4)	KANK2 (1.3)	GCNT4 (1.1)
ENSG00000094914	AAAS PPI subnetwork	0.21	> 0.20	USP1 (3.7)	NAA25 (3.6)	POC5 (2.8)	DOCK7 (2.8)	USP24 (2.5)	FEN1 (2.4)	BUD13 (2.2)	ILF3 (2.0)	DDX56 (1.9)	MOSC1 (1.9)
MP:0004091	abnormal Z lines	0.21	> 0.20	SYPL2 (6.1)	GMPR (2.5)	C12orf47 (2.3)	LPAR2 (1.8)	PVRL2 (1.8)	ERP29 (1.7)	BCAM (1.5)	PCSK9 (1.5)	TM6SF2 (1.5)	C11orf9 (1.4)
ENSG00000142798	HSPG2 PPI subnetwork	0.21	> 0.20	ITGB3 (2.9)	KANK2 (2.8)	CILP2 (2.7)	APOE (2.3)	BCAM (2.1)	SLC44A2 (1.9)	C17orf57 (1.8)	SH2B3 (1.6)	ST3GAL4 (1.6)	PVRL2 (1.3)
ENSG00000129473	BCL2L2 PPI subnetwork	0.21	> 0.20	FRK (3.3)	PARP10 (2.9)	TRAPPC6A (2.8)	OASL (2.2)	RELB (2.2)	TOMM40 (1.9)	CBLC (1.8)	PTPN11 (1.8)	CLPTM1 (1.7)	ZNF180 (1.7)
ENSG00000106803	SEC61B PPI subnetwork	0.21	> 0.20	NPC1L1 (3.6)	TMEM50A (3.1)	ATP13A1 (3.1)	TMEM57 (2.4)	ERP29 (2.3)	GRINA (2.2)	TMED4 (2.2)	ABCG5 (2.1)	TIMD4 (2.1)	FRK (1.7)
GO:0014074	response to purine-containing compound	0.21	> 0.20	HMGCR (2.8)	CYP7A1 (2.5)	LDLR (2.4)	AMIGO1 (2.2)	FADS1 (2.0)	ANKRD31 (1.9)	SYPL2 (1.8)	C17orf57 (1.7)	PCSK9 (1.6)	GCNT4 (1.6)
MP:0011086	partial postnatal lethality	0.21	> 0.20	NYNRIN (3.3)	HLX (2.9)	LDLR (2.7)	PCSK9 (2.0)	BCAM (1.8)	PLEC (1.8)	APOE (1.8)	USP24 (1.7)	KANK2 (1.6)	PLEKHH2 (1.5)
ENSG00000077312	SNRPA PPI subnetwork	0.22	> 0.20	ILF3 (4.0)	DHX38 (3.7)	SUGP1 (3.4)	BUD13 (3.3)	SMARCA4 (3.2)	TOP1 (2.9)	QTRT1 (2.6)	DDX56 (2.4)	C1orf63 (2.3)	FEN1 (2.2)
ENSG00000134460	IL2RA PPI subnetwork	0.22	> 0.20	BCL3 (4.0)	RELB (2.4)	COL4A3BP (2.0)	PVR (1.8)	ZNF101 (1.6)	C17orf57 (1.5)	CYP7A1 (1.5)	SLC22A1 (1.5)	CETP (1.4)	HLX (1.3)
MP:0004136	abnormal tongue muscle morphology	0.22	> 0.20	CEACAM19 (2.6)	ZHX3 (2.3)	PVR (2.0)	HAVCR1 (1.9)	ST3GAL4 (1.5)	ATXN7L2 (1.5)	CILP2 (1.4)	ENSG00000226648 (1.4)	PSRC1 (1.4)	HLX (1.2)
GO:0071333	cellular response to glucose stimulus	0.22	> 0.20	ENSG00000254235 (2.6)	ST3GAL4 (2.4)	GEMIN7 (2.2)	ADAM1 (1.9)	ENSG00000238078 (1.9)	UBXN2B (1.7)	DNAH11 (1.3)	NT5DC1 (1.2)	PCSK9 (1.2)	DYNC2LI1 (1.2)
GO:0071331	cellular response to hexose stimulus	0.22	> 0.20	ENSG00000254235 (2.6)	ST3GAL4 (2.4)	GEMIN7 (2.2)	ADAM1 (1.9)	ENSG00000238078 (1.9)	UBXN2B (1.7)	DNAH11 (1.3)	NT5DC1 (1.2)	PCSK9 (1.2)	DYNC2LI1 (1.2)
GO:0071326	cellular response to monosaccharide stimulus	0.22	> 0.20	ENSG00000254235 (2.6)	ST3GAL4 (2.4)	GEMIN7 (2.2)	ADAM1 (1.9)	ENSG00000238078 (1.9)	UBXN2B (1.7)	DNAH11 (1.3)	NT5DC1 (1.2)	PCSK9 (1.2)	DYNC2LI1 (1.2)
GO:0051896	regulation of protein kinase B signaling cascade	0.22	> 0.20	TSSK6 (2.3)	CETP (2.3)	TIMD4 (2.1)	CILP2 (2.0)	NKPD1 (1.9)	SORT1 (1.8)	ZNF180 (1.7)	PTPN11 (1.7)	PVRL2 (1.7)	PVR (1.7)
GO:0010740	positive regulation of intracellular protein kinase cascade	0.22	> 0.20	SH2B3 (2.3)	ST3GAL4 (2.3)	PVR (2.1)	POLK (2.0)	PARP10 (1.9)	GEMIN7 (1.8)	GRINA (1.8)	HLX (1.7)	RELB (1.4)	PVRL2 (1.4)
ENSG00000090339	ICAM1 PPI subnetwork	0.22	> 0.20	CEACAM19 (2.2)	APOE (2.1)	AP1M2 (2.0)	APOB (1.9)	OGDH (1.9)	PCSK9 (1.9)	SARS (1.9)	HP (1.8)	PLEC (1.8)	HAVCR1 (1.8)
GO:0006979	response to oxidative stress	0.22	> 0.20	ALDH2 (3.3)	ACAD10 (3.1)	GOT2P1 (2.2)	LPIN3 (2.0)	RHD (1.9)	PVR (1.6)	RHCE (1.6)	C17orf57 (1.6)	TRAPPC6A (1.5)	LPA (1.4)
ENSG00000197711	ENSG00000197711 PPI subnetwork	0.22	> 0.20	TIMD4 (2.9)	MAFB (2.8)	ZNF180 (2.8)	ENSG00000228044 (2.2)	HP (2.0)	PCSK9 (1.7)	APOC1 (1.6)	APOE (1.6)	ST3GAL4 (1.4)	ALDH2 (1.4)
ENSG00000132694	ARHGEF11 PPI subnetwork	0.22	> 0.20	KANK2 (4.1)	PTPN11 (3.1)	APOE (3.0)	ZHX3 (2.8)	PBX4 (2.1)	MYLIP (2.1)	PMFBP1 (1.9)	SLC44A2 (1.9)	DOCK7 (1.9)	FADS2 (1.7)
ENSG00000135775	COG2 PPI subnetwork	0.22	> 0.20	MAU2 (4.4)	SUGP1 (3.2)	YIPF2 (3.2)	DHX38 (2.9)	CYB561D1 (2.8)	ENSG00000228044 (2.4)	DNM2 (2.2)	TXNL4B (2.1)	MAPKAPK5 (2.0)	TRAFD1 (1.9)
GO:0002762	negative regulation of myeloid leukocyte differentiation	0.22	> 0.20	ST3GAL4 (3.5)	GCNT4 (3.2)	DNAH11 (2.2)	LPIN3 (2.1)	DYNC2LI1 (1.9)	ENSG00000235545 (1.5)	GPAM (1.5)	ENSG00000226645 (1.4)	ATXN7L2 (1.4)	C19orf52 (1.4)
GO:0032869	cellular response to insulin stimulus	0.22	> 0.20	COL4A3BP (3.0)	SORT1 (2.5)	PTPN11 (2.4)	TMEM57 (2.3)	BRAP (1.8)	GPAM (1.8)	C11orf9 (1.8)	PPP1R37 (1.8)	MOSC1 (1.7)	USP24 (1.6)
ENSG00000111802	TDP2 PPI subnetwork	0.22	> 0.20	RELB (3.7)	ZNF180 (3.4)	PBX4 (3.2)	MYLIP (2.4)	BCL3 (2.0)	GEMIN7 (2.0)	LPA (1.8)	ABCG8 (1.8)	UBXN2B (1.8)	C19orf52 (1.8)
ENSG00000147852	VLDLR PPI subnetwork	0.22	> 0.20	APOC1 (4.4)	CETP (2.8)	GPAM (2.7)	TIMD4 (2.5)	ENSG00000254235 (2.4)	SYPL2 (2.3)	TMED4 (2.1)	APOE (1.9)	ERP29 (1.7)	RHD (1.7)
GO:0016835	carbon-oxygen lyase activity	0.22	> 0.20	RHD (4.6)	RHCE (3.5)	DHODH (3.3)	MOSC1 (3.2)	ACAD10 (3.1)	ALDH2 (2.7)	GPAM (2.7)	NT5DC1 (2.4)	ENSG00000235545 (2.1)	DOCK7 (2.0)
ENSG00000143106	PSMA5 PPI subnetwork	0.22	> 0.20	PSMA5 (6.3)	TRAFD1 (2.8)	NT5DC1 (2.5)	NAA25 (2.5)	TOMM40 (1.8)	C19orf52 (1.8)	ENSG00000254235 (1.7)	DDX56 (1.5)	PARP10 (1.3)	SUGP1 (1.3)
KEGG_JAK_STAT_SIGNALING_PATHWAY	KEGG_JAK_STAT_SIGNALING_PATHWAY	0.22	> 0.20	BCL3 (4.0)	HLX (2.8)	COL4A3BP (2.6)	RELB (2.0)	SH2B3 (1.7)	CETP (1.6)	ZNF101 (1.6)	TRIB1 (1.5)	PARP10 (1.5)	TRAFD1 (1.5)
GO:0030275	LRR domain binding	0.22	> 0.20	BRAP (2.9)	CEACAM19 (2.5)	PLEC (2.0)	PVRL2 (1.7)	ZNF259 (1.7)	RELB (1.7)	TRAPPC6A (1.5)	TMEM57 (1.5)	C12orf51 (1.4)	TRIB1 (1.4)
GO:0007160	cell-matrix adhesion	0.22	> 0.20	SLC44A2 (4.2)	ITGB3 (3.9)	C17orf57 (2.9)	GCNT4 (2.7)	ENSG00000226648 (2.4)	KANK2 (2.4)	PLEKHH2 (2.2)	SORT1 (2.0)	CETP (2.0)	PLEC (1.9)
GO:0044272	sulfur compound biosynthetic process	0.22	> 0.20	TXNL4B (2.2)	ENSG00000254235 (1.9)	ZHX3 (1.9)	ST3GAL4 (1.7)	NT5DC1 (1.6)	DYNC2LI1 (1.6)	TMED4 (1.6)	SLC22A1 (1.5)	CYP7A1 (1.5)	TM6SF2 (1.5)
GO:0032462	regulation of protein homooligomerization	0.22	> 0.20	C12orf47 (3.7)	TMEM116 (2.3)	ANKRD31 (2.2)	C19orf52 (2.0)	ZNF101 (1.9)	TXNL4B (1.8)	HAVCR1 (1.7)	ENSG00000226645 (1.6)	ALDH2 (1.5)	BRAP (1.4)
ENSG00000100567	PSMA3 PPI subnetwork	0.22	> 0.20	PSMA5 (5.1)	TRAFD1 (2.5)	TOMM40 (2.1)	NAA25 (2.0)	NT5DC1 (1.7)	DDX56 (1.6)	TRIB1 (1.5)	SARS (1.5)	ENSG00000254235 (1.5)	CLPTM1 (1.4)
GO:0031060	regulation of histone methylation	0.22	> 0.20	ZNF180 (3.4)	USP24 (2.0)	C1orf63 (1.9)	C12orf51 (1.9)	ITGB3 (1.7)	CILP2 (1.6)	ENSG00000254235 (1.6)	TMEM57 (1.6)	C19orf52 (1.5)	ANKRD31 (1.4)
GO:0045089	positive regulation of innate immune response	0.22	> 0.20	OASL (2.3)	SH2B3 (2.3)	CYB561D1 (2.2)	ZNF101 (2.0)	ENSG00000228044 (2.0)	GMIP (1.9)	PVR (1.9)	RELB (1.8)	PARP10 (1.8)	HLX (1.7)
MP:0004991	decreased bone strength	0.22	> 0.20	OASL (6.1)	MAFB (4.2)	PARP10 (2.6)	CILP2 (2.2)	CETP (2.1)	KANK2 (2.0)	TRIB1 (2.0)	MYLIP (1.9)	ZNF101 (1.8)	APOE (1.7)
REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS	0.22	> 0.20	TM6SF2 (3.1)	PLG (3.0)	RHD (2.8)	RHCE (2.6)	TMEM116 (2.3)	ANGPTL3 (2.1)	SORT1 (2.0)	ABO (1.8)	ABCG8 (1.8)	SYPL2 (1.7)
ENSG00000132341	RAN PPI subnetwork	0.22	> 0.20	NAA25 (3.6)	CARM1 (3.2)	ILF3 (3.1)	DDX56 (3.0)	DOCK7 (2.9)	TOMM40 (2.7)	USP1 (2.6)	USP24 (2.1)	DHX38 (2.1)	POC5 (2.0)
ENSG00000169679	BUB1 PPI subnetwork	0.22	> 0.20	PSRC1 (5.0)	POC5 (3.4)	ZHX3 (2.7)	CLPTM1 (2.5)	GEMIN7 (2.3)	FEN1 (2.1)	PLCG1 (2.0)	ACAD10 (1.9)	USP1 (1.7)	DNM2 (1.7)
ENSG00000131931	THAP1 PPI subnetwork	0.22	> 0.20	BLOC1S3 (4.0)	C19orf52 (3.5)	CLPTM1 (2.9)	PPP1R37 (2.8)	ZNF180 (2.5)	UBXN2B (2.2)	DNM2 (1.8)	ANKRD31 (1.6)	MARK4 (1.6)	TOMM40 (1.6)
ENSG00000139505	MTMR6 PPI subnetwork	0.22	> 0.20	PARP10 (2.8)	MAU2 (2.8)	USP24 (2.8)	ATXN2 (2.5)	SMARCA4 (2.5)	MARK4 (2.5)	BCL3 (2.3)	GMIP (2.1)	DHX38 (1.9)	C12orf51 (1.8)
GO:0051445	regulation of meiotic cell cycle	0.22	> 0.20	ENSG00000228044 (2.9)	TMED4 (2.3)	PLEKHH2 (1.8)	CEACAM19 (1.6)	NKPD1 (1.5)	PMFBP1 (1.5)	ATXN7L2 (1.5)	C1orf63 (1.4)	GOT2P1 (1.4)	HAPLN4 (1.3)
GO:0050995	negative regulation of lipid catabolic process	0.22	> 0.20	ENSG00000228044 (4.1)	MOSC1 (2.8)	GPAM (2.2)	CETP (2.1)	APOB (1.7)	CBLC (1.6)	APOA5 (1.5)	AMIGO1 (1.5)	APOE (1.5)	APOC4 (1.4)
ENSG00000123143	PKN1 PPI subnetwork	0.22	> 0.20	ST3GAL4 (2.6)	SYPL2 (2.5)	ZNF180 (2.3)	ZNF101 (1.8)	CEACAM19 (1.8)	PCSK9 (1.6)	GOT2P1 (1.5)	C12orf51 (1.4)	GCNT4 (1.4)	PMFBP1 (1.2)
GO:0034134	toll-like receptor 2 signaling pathway	0.22	> 0.20	SH2B3 (2.7)	TRIB1 (2.3)	BLOC1S3 (2.1)	ENSG00000226645 (2.0)	RELB (2.0)	ENSG00000228044 (1.9)	CYB561D1 (1.8)	HLX (1.7)	MAPKAPK5 (1.6)	BUD13 (1.6)
MP:0001674	abnormal triploblastic development	0.22	> 0.20	TMEM50A (2.2)	C17orf57 (1.9)	FRK (1.9)	PSMA5 (1.9)	ENSG00000238078 (1.8)	CETP (1.6)	C1orf63 (1.6)	HMGCR (1.4)	PVR (1.4)	SARS (1.3)
REACTOME_VPR:MEDIATED_NUCLEAR_IMPORT_OF_PICS	REACTOME_VPR:MEDIATED_NUCLEAR_IMPORT_OF_PICS	0.22	> 0.20	POC5 (3.3)	NAA25 (3.2)	USP1 (2.9)	USP24 (2.8)	DOCK7 (2.7)	BUD13 (2.7)	DDX56 (2.6)	ILF3 (2.2)	FEN1 (2.1)	MAPKAPK5 (1.9)
GO:0009896	positive regulation of catabolic process	0.22	> 0.20	ZNF180 (2.3)	BLOC1S3 (2.1)	POLK (1.9)	MAU2 (1.8)	GRINA (1.7)	TRIB1 (1.6)	CLPTM1 (1.6)	GPAM (1.4)	ENSG00000235545 (1.3)	MYLIP (1.3)
MP:0005466	abnormal T-helper 2 physiology	0.22	> 0.20	BCL3 (4.0)	TRIB1 (3.0)	RELB (3.0)	MAFB (3.0)	PARP10 (1.8)	PBX4 (1.8)	PVR (1.6)	GMIP (1.6)	PLCG1 (1.6)	ZNF101 (1.5)
MP:0009640	abnormal renal tubule epithelium morphology	0.22	> 0.20	TM6SF2 (2.9)	TRAPPC6A (2.8)	APOC4 (2.6)	SLC22A1 (2.1)	PLG (2.0)	LPA (2.0)	HNF1A (1.9)	ENSG00000235545 (1.9)	CARM1 (1.9)	AP1M2 (1.8)
GO:0002755	MyD88-dependent toll-like receptor signaling pathway	0.22	> 0.20	SH2B3 (2.7)	BLOC1S3 (2.1)	TRIB1 (2.1)	LPAR2 (1.8)	RELB (1.7)	HLX (1.7)	ENSG00000226645 (1.6)	CYB561D1 (1.6)	BUD13 (1.6)	BCL3 (1.5)
ENSG00000110492	MDK PPI subnetwork	0.22	> 0.20	HAVCR1 (2.9)	TRAFD1 (2.6)	USP24 (2.6)	APOE (2.4)	CELSR2 (2.4)	NKPD1 (1.8)	DOCK7 (1.8)	OASL (1.8)	MAFB (1.7)	TMEM50A (1.7)
ENSG00000184489	PTP4A3 PPI subnetwork	0.22	> 0.20	ATP13A1 (4.2)	NAA25 (3.2)	DHX38 (2.8)	DDX56 (2.6)	FEN1 (2.5)	SARS (2.2)	TMEM57 (2.1)	ILF3 (2.1)	CLPTM1 (2.0)	HAVCR1 (2.0)
ENSG00000106638	TBL2 PPI subnetwork	0.22	> 0.20	CARM1 (3.6)	ILF3 (3.1)	TRAFD1 (3.1)	BRAP (2.7)	ATP13A1 (2.4)	MAPKAPK5 (2.2)	TOMM40 (2.2)	DDX56 (2.1)	C12orf43 (2.1)	SMARCA4 (2.0)
ENSG00000100644	HIF1A PPI subnetwork	0.22	> 0.20	PLCG1 (3.0)	TRIB1 (2.2)	UBXN2B (2.2)	GRINA (2.1)	BCL3 (1.6)	MARK4 (1.6)	GOT2P1 (1.6)	HLX (1.6)	ATXN2 (1.5)	MAU2 (1.4)
ENSG00000136273	HUS1 PPI subnetwork	0.22	> 0.20	USP1 (4.4)	FEN1 (4.4)	PPP1R37 (2.8)	ZNF180 (2.4)	TXNL4B (2.2)	ERP29 (2.1)	CLPTM1 (2.0)	ANGPTL3 (1.9)	PSMA5 (1.8)	TMED4 (1.7)
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6ORCORIGIN_COMPLEX	REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6ORCORIGIN_COMPLEX	0.22	> 0.20	PSMA5 (6.2)	TRAFD1 (3.1)	NT5DC1 (3.1)	NAA25 (2.4)	SUGP1 (2.0)	PARP10 (1.8)	DDX56 (1.7)	TOMM40 (1.7)	TXNL4B (1.5)	FEN1 (1.4)
MP:0005669	increased circulating leptin level	0.22	> 0.20	GPAM (4.2)	MOSC1 (2.9)	PLEKHH2 (2.7)	ABCG5 (2.6)	KIAA1324 (2.4)	ABCG8 (1.9)	TIMD4 (1.9)	C12orf47 (1.8)	DYNC2LI1 (1.7)	CETP (1.7)
MP:0010249	lactation failure	0.22	> 0.20	KIAA1324 (4.2)	GEMIN7 (2.6)	SH2B3 (2.3)	NKPD1 (1.9)	DNAH11 (1.8)	PARP10 (1.6)	NPC1L1 (1.5)	PMFBP1 (1.5)	TIMD4 (1.4)	PPP1R37 (1.4)
MP:0003945	abnormal lymphocyte physiology	0.22	> 0.20	BCL3 (3.7)	RELB (3.1)	GMIP (3.0)	TRAFD1 (2.5)	PARP10 (2.4)	PBX4 (1.7)	SLC44A2 (1.5)	MYLIP (1.5)	DNM2 (1.4)	GCNT4 (1.3)
ENSG00000198755	RPL10A PPI subnetwork	0.22	> 0.20	NAA25 (3.6)	ZNF259 (3.2)	DDX56 (3.1)	NKPD1 (2.5)	DHX38 (2.4)	SUGP1 (2.3)	SARS (2.2)	ATP13A1 (2.0)	QTRT1 (1.9)	C12orf43 (1.9)
REACTOME_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR	REACTOME_ACTIVATION_OF_DNA_FRAGMENTATION_FACTOR	0.22	> 0.20	ZNF101 (2.1)	ABO (1.8)	ENSG00000254235 (1.6)	FADS1 (1.6)	FADS2 (1.6)	C19orf52 (1.5)	TMEM57 (1.5)	CBLC (1.5)	DNAH11 (1.4)	ABCG8 (1.4)
REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION	0.22	> 0.20	ZNF101 (2.1)	ABO (1.8)	ENSG00000254235 (1.6)	FADS1 (1.6)	FADS2 (1.6)	C19orf52 (1.5)	TMEM57 (1.5)	CBLC (1.5)	DNAH11 (1.4)	ABCG8 (1.4)
ENSG00000144021	CIAO1 PPI subnetwork	0.22	> 0.20	DHX38 (3.3)	ATP13A1 (2.7)	OGDH (2.6)	ILF3 (2.1)	DDX56 (1.9)	GMPR (1.8)	SMARCA4 (1.7)	PSMA5 (1.7)	SARS (1.7)	DNM2 (1.6)
MP:0002696	decreased circulating glucagon level	0.22	> 0.20	KIAA1324 (5.1)	SH2B3 (2.3)	ZHX3 (2.1)	ENSG00000254235 (2.1)	GCNT4 (2.1)	C12orf47 (1.7)	MOSC1 (1.7)	C1orf63 (1.6)	HLX (1.6)	C12orf43 (1.6)
MP:0004989	decreased osteoblast cell number	0.22	> 0.20	KIAA1324 (2.7)	MYLIP (2.7)	CBLC (2.4)	CILP2 (1.9)	TMEM116 (1.5)	HNF1A (1.5)	CELSR2 (1.5)	PLEKHH2 (1.5)	ALDH2 (1.5)	YIPF2 (1.5)
ENSG00000179271	GADD45GIP1 PPI subnetwork	0.22	> 0.20	TRIB1 (4.3)	BCL3 (2.0)	RHCE (1.7)	PVR (1.7)	GMPR (1.6)	TRAFD1 (1.5)	UBXN2B (1.5)	LPA (1.4)	TOP1 (1.4)	TSSK6 (1.4)
ENSG00000169194	IL13 PPI subnetwork	0.22	> 0.20	BCL3 (4.0)	TIMD4 (3.7)	CETP (3.1)	RELB (3.0)	HLX (2.9)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.8)	TRIB1 (1.2)	GRINA (1.1)
GO:0016684	oxidoreductase activity, acting on peroxide as acceptor	0.22	> 0.20	MOSC1 (3.9)	ALDH2 (3.6)	RHD (3.1)	NYNRIN (3.0)	HLX (2.5)	HP (2.4)	PSMA5 (2.1)	RHCE (2.0)	AP1M2 (1.9)	GOT2P1 (1.9)
GO:0004601	peroxidase activity	0.22	> 0.20	MOSC1 (3.9)	ALDH2 (3.6)	RHD (3.1)	NYNRIN (3.0)	HLX (2.5)	HP (2.4)	PSMA5 (2.1)	RHCE (2.0)	AP1M2 (1.9)	GOT2P1 (1.9)
ENSG00000162688	AGL PPI subnetwork	0.22	> 0.20	C12orf43 (2.4)	PLEKHH2 (2.1)	BRAP (1.9)	C12orf47 (1.9)	DYNC2LI1 (1.9)	MYLIP (1.9)	GEMIN7 (1.8)	ABO (1.6)	ZHX3 (1.5)	CEACAM19 (1.4)
ENSG00000092529	CAPN3 PPI subnetwork	0.22	> 0.20	SYPL2 (2.9)	PLEC (2.8)	TMEM50A (2.3)	PVR (2.2)	ENSG00000235545 (1.8)	UBXN2B (1.7)	CYP7A1 (1.7)	SLC22A1 (1.6)	PLCG1 (1.4)	PBX4 (1.4)
ENSG00000185532	PRKG1 PPI subnetwork	0.22	> 0.20	ITGB3 (3.1)	KANK2 (2.6)	HLX (2.6)	PLEKHH2 (2.5)	BCAM (2.0)	AP1M2 (1.9)	ABO (1.9)	NPC1L1 (1.8)	SYPL2 (1.7)	ANKRD31 (1.6)
MP:0001750	increased circulating follicle stimulating hormone level	0.22	> 0.20	ST3GAL4 (3.2)	BLOC1S3 (2.4)	LDLR (2.2)	MARK4 (1.9)	APOB (1.6)	TMED4 (1.4)	PVRL2 (1.3)	TRIB1 (1.3)	GPAM (1.2)	DNAH11 (1.2)
ENSG00000075785	RAB7A PPI subnetwork	0.22	> 0.20	TMEM50A (3.2)	GEMIN7 (2.8)	C12orf43 (2.8)	SARS (2.4)	COL4A3BP (2.3)	GOT2P1 (2.1)	SUGP1 (2.1)	CLPTM1 (2.0)	TRAPPC6A (1.7)	HAPLN4 (1.7)
REACTOME_SYNTHESIS_OF_DNA	REACTOME_SYNTHESIS_OF_DNA	0.22	> 0.20	FEN1 (5.2)	PSMA5 (4.1)	USP1 (3.6)	NT5DC1 (2.6)	TRAFD1 (2.0)	TOMM40 (1.7)	ZNF180 (1.5)	NAA25 (1.4)	DDX56 (1.3)	PARP10 (1.3)
KEGG_TYPE_II_DIABETES_MELLITUS	KEGG_TYPE_II_DIABETES_MELLITUS	0.22	> 0.20	HLX (2.8)	KIAA1324 (2.4)	COL4A3BP (2.3)	HAPLN4 (2.2)	SORT1 (2.0)	MYLIP (1.9)	TMEM57 (1.9)	BCL3 (1.9)	GMIP (1.8)	GPAM (1.7)
GO:0016836	hydro-lyase activity	0.22	> 0.20	RHD (5.0)	RHCE (3.7)	MOSC1 (3.5)	ALDH2 (3.0)	ACAD10 (2.9)	DHODH (2.6)	GPAM (2.5)	UBXN2B (2.5)	NT5DC1 (2.2)	DOCK7 (2.0)
MP:0008388	hypochromic microcytic anemia	0.22	> 0.20	RHD (8.6)	RHCE (6.6)	USP24 (2.3)	APOC1 (2.1)	PCSK9 (1.9)	GPAM (1.8)	APOE (1.7)	PARP10 (1.5)	C12orf47 (1.4)	PPP1R37 (1.4)
MP:0001340	abnormal eyelid morphology	0.22	> 0.20	AP1M2 (2.2)	LPIN3 (2.2)	PLEC (1.9)	TRIB1 (1.8)	PCSK9 (1.6)	CBLC (1.6)	PLCG1 (1.6)	GCNT4 (1.6)	MYLIP (1.5)	ENSG00000254235 (1.4)
GO:0046474	glycerophospholipid biosynthetic process	0.22	> 0.20	TSSK6 (2.7)	BLOC1S3 (2.2)	ATP13A1 (2.1)	TRAPPC6A (1.9)	CYB561D1 (1.8)	NKPD1 (1.7)	UBXN2B (1.6)	TMED4 (1.5)	NPC1L1 (1.5)	TMEM50A (1.5)
GO:0006111	regulation of gluconeogenesis	0.22	> 0.20	ENSG00000226645 (2.8)	ENSG00000254235 (2.6)	ZNF180 (2.4)	MOSC1 (2.3)	CYP7A1 (2.3)	GPAM (2.2)	HNF1A (1.8)	GCNT4 (1.5)	ACAD10 (1.5)	LPA (1.4)
ENSG00000198909	MAP3K3 PPI subnetwork	0.22	> 0.20	SARS (4.3)	PLEC (3.0)	SMARCA4 (2.8)	OGDH (2.7)	TOMM40 (2.5)	PSMA5 (2.4)	PVR (2.3)	ATXN2 (1.9)	GATAD2A (1.8)	ATP13A1 (1.8)
MP:0000280	thin ventricular wall	0.22	> 0.20	BCAM (2.8)	TRIB1 (2.7)	PLEC (2.0)	MARK4 (1.8)	ENSG00000228044 (1.6)	ATXN7L2 (1.5)	SH2B3 (1.4)	HLX (1.4)	MAFB (1.4)	BCL3 (1.3)
ENSG00000131462	TUBG1 PPI subnetwork	0.22	> 0.20	PSRC1 (3.1)	POC5 (2.7)	POLK (2.7)	LPAR2 (2.5)	GATAD2A (2.0)	LDLR (2.0)	ATXN7L2 (2.0)	DNM2 (1.9)	FADS2 (1.8)	C11orf9 (1.8)
ENSG00000137275	RIPK1 PPI subnetwork	0.22	> 0.20	RELB (6.2)	BCL3 (3.7)	PVR (3.1)	PARP10 (3.0)	TRAFD1 (2.5)	FRK (2.2)	POLK (1.8)	SH2B3 (1.6)	PBX4 (1.6)	OASL (1.5)
ENSG00000077380	DYNC1I2 PPI subnetwork	0.22	> 0.20	CILP2 (4.5)	TMEM50A (2.4)	NPC1L1 (2.0)	GMPR (1.9)	GOT2P1 (1.7)	C12orf43 (1.6)	COL4A3BP (1.5)	MAFB (1.4)	TXNL4B (1.4)	ZNF180 (1.4)
ENSG00000008838	MED24 PPI subnetwork	0.22	> 0.20	GEMIN7 (3.0)	C12orf51 (2.9)	BUD13 (2.6)	BRAP (2.5)	TXNL4B (2.4)	ATXN2 (2.4)	MAPKAPK5 (2.2)	TOP1 (2.1)	ZHX3 (1.8)	BLOC1S3 (1.7)
GO:0015909	long-chain fatty acid transport	0.22	> 0.20	CYB561D1 (3.1)	NKPD1 (3.0)	TM6SF2 (2.5)	ACAD10 (2.5)	ENSG00000235545 (2.3)	AMIGO1 (2.0)	ABCG8 (1.9)	GCNT4 (1.9)	ABO (1.7)	TMEM116 (1.6)
GO:0010869	regulation of receptor biosynthetic process	0.22	> 0.20	PMFBP1 (2.5)	CEACAM19 (2.4)	FRK (2.2)	TIMD4 (2.0)	LPIN3 (1.9)	ATXN2 (1.8)	ENSG00000226648 (1.8)	ENSG00000235545 (1.8)	MOSC1 (1.7)	C17orf57 (1.5)
ENSG00000131051	RBM39 PPI subnetwork	0.22	> 0.20	C1orf63 (3.4)	HNF1A (3.3)	ACAD10 (3.1)	ABO (2.6)	KIAA1324 (2.2)	TRIB1 (2.1)	NYNRIN (2.0)	CBLC (2.0)	ATXN7L2 (2.0)	BUD13 (1.7)
MP:0002573	behavioral despair	0.22	> 0.20	GCNT4 (2.5)	PCSK9 (2.5)	TMEM50A (1.9)	C11orf9 (1.8)	CETP (1.7)	HAPLN4 (1.6)	DNAH11 (1.4)	APOB (1.4)	AMIGO1 (1.4)	RPH3A (1.2)
ENSG00000124535	WRNIP1 PPI subnetwork	0.22	> 0.20	FRK (3.0)	ZNF180 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	C19orf52 (2.4)	USP1 (2.2)	BLOC1S3 (2.2)	GEMIN7 (2.2)	TRAPPC6A (1.9)	GATAD2A (1.8)
MP:0009293	decreased inguinal fat pad weight	0.22	> 0.20	GPAM (5.0)	MOSC1 (4.5)	HP (2.4)	SYPL2 (2.1)	ALDH2 (2.0)	GEMIN7 (1.9)	APOC1 (1.7)	TRAFD1 (1.7)	SORT1 (1.6)	KIAA1324 (1.5)
GO:0010888	negative regulation of lipid storage	0.22	> 0.20	ENSG00000238078 (2.7)	TIMD4 (2.4)	CETP (2.2)	MYLIP (2.2)	MOSC1 (1.8)	GEMIN7 (1.7)	APOC1 (1.7)	APOE (1.7)	COL4A3BP (1.6)	PVR (1.6)
ENSG00000075413	MARK3 PPI subnetwork	0.22	> 0.20	CBLC (3.8)	AP1M2 (3.0)	CELSR2 (2.3)	BCAM (2.2)	UBXN2B (2.1)	PVRL2 (2.1)	LPIN3 (2.0)	CARM1 (1.9)	BUD13 (1.9)	ZNF259 (1.9)
MP:0004025	polyploidy	0.22	> 0.20	RHD (3.1)	RHCE (3.1)	MARK4 (2.6)	NKPD1 (2.5)	PVR (2.4)	PSRC1 (2.3)	PTPN11 (1.7)	ENSG00000226648 (1.7)	PVRL2 (1.7)	GATAD2A (1.5)
ENSG00000206427	PRRC2A PPI subnetwork	0.22	> 0.20	C19orf52 (2.4)	QTRT1 (2.3)	PLEC (2.2)	ERP29 (2.1)	ACAD10 (1.9)	ATXN7L2 (1.9)	PSMA5 (1.8)	ILF3 (1.8)	CLPTM1 (1.7)	ALDH2 (1.7)
ENSG00000206318	ENSG00000206318 PPI subnetwork	0.22	> 0.20	C19orf52 (2.4)	QTRT1 (2.3)	PLEC (2.2)	ERP29 (2.1)	ACAD10 (1.9)	ATXN7L2 (1.9)	PSMA5 (1.8)	ILF3 (1.8)	CLPTM1 (1.7)	ALDH2 (1.7)
GO:0005765	lysosomal membrane	0.22	> 0.20	ATP13A1 (3.5)	GRINA (3.5)	ERP29 (3.4)	CLPTM1 (3.2)	SORT1 (3.1)	TMEM50A (2.9)	COL4A3BP (2.2)	YIPF2 (2.0)	SLC44A2 (1.9)	APOE (1.8)
GO:0008380	RNA splicing	0.22	> 0.20	C1orf63 (4.5)	TOP1 (3.3)	BUD13 (3.3)	SUGP1 (2.8)	DHX38 (2.8)	ILF3 (2.7)	QTRT1 (2.4)	C12orf43 (2.1)	MAPKAPK5 (2.0)	MAU2 (1.9)
GO:0046148	pigment biosynthetic process	0.22	> 0.20	RHCE (4.5)	RHD (4.4)	ADAM1 (2.6)	GMPR (2.4)	NT5DC1 (2.4)	DHODH (2.1)	ENSG00000235545 (1.9)	TRAPPC6A (1.6)	ANKRD31 (1.4)	ACAD10 (1.3)
ENSG00000182195	LDOC1 PPI subnetwork	0.22	> 0.20	UBXN2B (3.3)	ATP13A1 (2.2)	DNAH11 (2.1)	C12orf43 (2.0)	ATXN7L2 (1.9)	QTRT1 (1.8)	CEACAM19 (1.7)	GRINA (1.7)	TMEM57 (1.6)	HAPLN4 (1.6)
ENSG00000140564	FURIN PPI subnetwork	0.22	> 0.20	DNAH11 (2.5)	PLEC (2.4)	ITGB3 (2.3)	ADAM1 (2.0)	CELSR2 (1.8)	HAPLN4 (1.7)	SLC44A2 (1.6)	CYB561D1 (1.6)	PVR (1.5)	ERP29 (1.4)
MP:0010868	increased bone trabecula number	0.22	> 0.20	APOC1 (3.8)	MAFB (3.3)	PPP1R37 (2.4)	CETP (2.4)	TRIB1 (2.0)	ITGB3 (1.9)	ENSG00000228044 (1.9)	POC5 (1.7)	CLPTM1 (1.5)	SH2B3 (1.5)
GO:0043405	regulation of MAP kinase activity	0.22	> 0.20	ENSG00000226645 (3.6)	TRIB1 (2.9)	HLX (2.8)	LPAR2 (2.3)	PVR (2.2)	CEACAM19 (1.9)	ENSG00000238078 (1.7)	AMIGO1 (1.5)	ENSG00000228044 (1.4)	SH2B3 (1.3)
ENSG00000196924	FLNA PPI subnetwork	0.22	> 0.20	PLEC (4.1)	PVRL2 (2.1)	PVR (2.1)	ITGB3 (2.0)	DNM2 (1.9)	DOCK7 (1.9)	OGDH (1.8)	GATAD2A (1.7)	KANK2 (1.7)	GMIP (1.6)
ENSG00000146457	WTAP PPI subnetwork	0.22	> 0.20	C11orf9 (3.1)	NYNRIN (2.5)	UBXN2B (2.3)	PVRL2 (2.1)	ENSG00000235545 (2.1)	USP24 (1.8)	MARK4 (1.8)	TOP1 (1.5)	CEACAM19 (1.4)	BCAM (1.4)
MP:0010379	decreased respiratory quotient	0.22	> 0.20	GPAM (3.0)	MOSC1 (3.0)	ACAD10 (2.2)	ALDH2 (2.1)	PLEKHH2 (2.1)	CILP2 (2.0)	AMIGO1 (1.9)	TM6SF2 (1.7)	KANK2 (1.5)	DHODH (1.5)
ENSG00000125731	SH2D3A PPI subnetwork	0.22	> 0.20	CBLC (6.1)	AP1M2 (4.3)	LPIN3 (2.5)	CELSR2 (2.4)	LPAR2 (2.4)	PVRL2 (2.0)	ST3GAL4 (1.7)	PPP1R37 (1.7)	DOCK7 (1.6)	DNM2 (1.6)
ENSG00000106554	CHCHD3 PPI subnetwork	0.22	> 0.20	SYPL2 (3.0)	OGDH (2.9)	GMPR (2.7)	ACAD10 (2.7)	TMEM50A (2.0)	APOE (1.8)	BCAM (1.8)	RHD (1.3)	PSMA5 (1.3)	C1orf63 (1.2)
GO:0050778	positive regulation of immune response	0.22	> 0.20	TIMD4 (3.7)	ZNF101 (3.3)	GMIP (2.8)	LPA (2.5)	CETP (2.2)	MAFB (2.1)	CYB561D1 (2.1)	SLC22A1 (1.7)	PARP10 (1.7)	APOE (1.6)
GO:0005640	nuclear outer membrane	0.22	> 0.20	LDLR (4.1)	FADS1 (3.4)	FADS2 (3.3)	KIAA1324 (2.8)	HAVCR1 (2.6)	YIPF2 (2.5)	LPIN3 (2.5)	HMGCR (2.1)	NKPD1 (2.0)	LPAR2 (2.0)
GO:0055072	iron ion homeostasis	0.22	> 0.20	RHD (3.4)	RHCE (3.3)	TMEM116 (2.6)	FRK (2.6)	GRINA (2.3)	ENSG00000228044 (2.0)	DHODH (1.7)	GMPR (1.5)	PMFBP1 (1.3)	HP (1.3)
MP:0002461	increased immunoglobulin level	0.22	> 0.20	GMIP (3.9)	RELB (3.9)	SH2B3 (3.1)	MYLIP (2.6)	LPAR2 (2.2)	MAFB (2.2)	BCL3 (2.1)	APOC1 (2.1)	COL4A3BP (1.9)	PARP10 (1.9)
ENSG00000103507	BCKDK PPI subnetwork	0.22	> 0.20	C19orf52 (3.0)	QTRT1 (2.1)	USP24 (2.1)	SORT1 (2.0)	ZNF180 (1.9)	GRINA (1.9)	BRAP (1.7)	OASL (1.7)	AMIGO1 (1.6)	DOCK7 (1.5)
GO:0002690	positive regulation of leukocyte chemotaxis	0.22	> 0.20	TIMD4 (2.5)	ENSG00000228044 (2.4)	ZNF101 (2.1)	CETP (2.1)	MAFB (2.0)	PVR (1.9)	ST3GAL4 (1.9)	APOE (1.9)	ENSG00000238078 (1.5)	RELB (1.4)
GO:0048568	embryonic organ development	0.22	> 0.20	PVRL2 (1.9)	CEACAM19 (1.7)	ABO (1.7)	PLEKHH2 (1.7)	ATXN2 (1.7)	ENSG00000238078 (1.7)	ATXN7L2 (1.6)	NYNRIN (1.5)	MARK4 (1.4)	HLX (1.4)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION	0.22	> 0.20	C12orf43 (3.4)	GEMIN7 (3.1)	DDX56 (2.5)	POC5 (2.4)	ATXN2 (2.4)	ZNF259 (2.3)	C19orf52 (2.3)	SUGP1 (2.2)	ENSG00000226645 (2.0)	MAPKAPK5 (1.9)
REACTOME_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION	REACTOME_RNA_POLYMERASE_III_ABORTIVE_AND_RETRACTIVE_INITIATION	0.22	> 0.20	C12orf43 (3.4)	GEMIN7 (3.1)	DDX56 (2.5)	POC5 (2.4)	ATXN2 (2.4)	ZNF259 (2.3)	C19orf52 (2.3)	SUGP1 (2.2)	ENSG00000226645 (2.0)	MAPKAPK5 (1.9)
ENSG00000106366	SERPINE1 PPI subnetwork	0.22	> 0.20	ANGPTL3 (3.5)	HP (3.1)	PVR (3.1)	CEACAM19 (2.9)	PVRL2 (2.8)	APOC4 (2.5)	PLG (2.4)	SLC22A1 (2.4)	LPIN3 (2.3)	APOA5 (2.0)
ENSG00000183072	NKX2-5 PPI subnetwork	0.23	> 0.20	ATXN7L2 (2.9)	CARM1 (2.6)	PTPN11 (2.6)	HLX (2.4)	C11orf9 (2.2)	ZHX3 (1.8)	NPC1L1 (1.7)	SORT1 (1.7)	MARK4 (1.7)	CYB561D1 (1.7)
GO:0007031	peroxisome organization	0.23	> 0.20	NT5DC1 (3.7)	YIPF2 (2.3)	C19orf52 (2.3)	AMIGO1 (2.2)	ACAD10 (2.0)	TRAPPC6A (1.9)	GPAM (1.8)	TSSK6 (1.8)	CYP7A1 (1.6)	TMED4 (1.5)
ENSG00000108465	CDK5RAP3 PPI subnetwork	0.23	> 0.20	ACAD10 (3.3)	HNF1A (3.3)	BRAP (2.8)	ERP29 (2.4)	TMED4 (2.3)	PLCG1 (2.0)	NT5DC1 (1.6)	BLOC1S3 (1.6)	KIAA1324 (1.6)	ENSG00000254235 (1.5)
ENSG00000067533	RRP15 PPI subnetwork	0.23	> 0.20	ZNF259 (4.5)	QTRT1 (3.3)	TOMM40 (3.2)	NAA25 (3.1)	DDX56 (2.9)	DHODH (2.5)	SARS (2.4)	GATAD2A (2.1)	MAPKAPK5 (2.0)	ATP13A1 (1.9)
MP:0004809	increased hematopoietic stem cell number	0.23	> 0.20	ITGB3 (4.8)	HLX (3.2)	GMIP (2.5)	ATXN2 (2.2)	HAVCR1 (2.0)	NYNRIN (1.9)	SH2B3 (1.9)	POLK (1.8)	C12orf51 (1.7)	SLC44A2 (1.6)
ENSG00000131475	VPS25 PPI subnetwork	0.23	> 0.20	POLK (2.8)	DYNC2LI1 (2.4)	GRINA (2.2)	C12orf43 (2.2)	HAVCR1 (2.2)	TRAPPC6A (2.2)	UBXN2B (2.2)	SARS (1.9)	GEMIN7 (1.7)	SUGP1 (1.6)
KEGG_SMALL_CELL_LUNG_CANCER	KEGG_SMALL_CELL_LUNG_CANCER	0.23	> 0.20	RELB (4.2)	ITGB3 (3.0)	KANK2 (2.4)	MAU2 (1.9)	ST3GAL4 (1.9)	BCL3 (1.8)	GATAD2A (1.7)	PVRL2 (1.7)	PLEC (1.7)	GMIP (1.6)
GO:0046620	regulation of organ growth	0.23	> 0.20	GCNT4 (2.7)	CEACAM19 (2.1)	BLOC1S3 (2.0)	C11orf9 (1.9)	HAPLN4 (1.8)	ENSG00000226648 (1.8)	ANKRD31 (1.5)	DNAH11 (1.4)	ENSG00000238078 (1.2)	PLEKHH2 (1.2)
GO:0010038	response to metal ion	0.23	> 0.20	TM6SF2 (3.0)	ABCG5 (2.7)	NPC1L1 (2.6)	RHD (2.5)	ANGPTL3 (2.1)	RHCE (2.0)	HP (2.0)	APOB (2.0)	SLC22A1 (1.9)	ABCG8 (1.8)
ENSG00000144028	SNRNP200 PPI subnetwork	0.23	> 0.20	ILF3 (3.8)	SUGP1 (3.7)	SMARCA4 (3.3)	C1orf63 (3.3)	DHX38 (3.3)	TOP1 (3.2)	FEN1 (2.5)	BUD13 (2.5)	DDX56 (2.5)	USP1 (2.3)
ENSG00000092621	PHGDH PPI subnetwork	0.23	> 0.20	RHD (3.8)	RHCE (3.4)	HMGCR (2.7)	ADAM1 (2.6)	FADS1 (2.4)	LDLR (2.4)	ENSG00000226645 (2.2)	NT5DC1 (1.9)	SLC44A2 (1.8)	SARS (1.7)
ENSG00000211614	ENSG00000211614 PPI subnetwork	0.23	> 0.20	TIMD4 (5.5)	MAFB (2.9)	APOE (2.9)	PTPN11 (2.0)	DOCK7 (2.0)	ENSG00000238078 (2.0)	CETP (1.8)	APOC1 (1.7)	NKPD1 (1.6)	GRINA (1.6)
ENSG00000115307	AUP1 PPI subnetwork	0.23	> 0.20	ITGB3 (6.2)	C1orf63 (2.1)	PVR (2.0)	PTPN11 (1.9)	TXNL4B (1.8)	ALDH2 (1.7)	LDLR (1.7)	SH2B3 (1.6)	MOSC1 (1.4)	COL4A3BP (1.3)
ENSG00000121858	TNFSF10 PPI subnetwork	0.23	> 0.20	FRK (2.6)	LPAR2 (2.4)	BCL3 (2.0)	POLK (1.9)	PVR (1.8)	ZNF101 (1.8)	TRIB1 (1.8)	RELB (1.8)	ENSG00000235545 (1.6)	ITGB3 (1.4)
ENSG00000121274	PAPD5 PPI subnetwork	0.23	> 0.20	DHODH (4.0)	USP24 (2.8)	NT5DC1 (2.6)	USP1 (2.6)	QTRT1 (2.3)	DHX38 (2.1)	GPAM (2.0)	DDX56 (2.0)	ATXN7L2 (2.0)	MAPKAPK5 (1.9)
MP:0008593	increased circulating interleukin-10 level	0.23	> 0.20	TRIB1 (5.2)	PVR (2.6)	BCL3 (2.6)	POC5 (2.3)	GMIP (2.1)	MAFB (1.8)	ENSG00000228044 (1.8)	OASL (1.8)	TSSK6 (1.5)	PARP10 (1.5)
ENSG00000132139	GAS2L2 PPI subnetwork	0.23	> 0.20	TIMD4 (3.1)	OASL (3.0)	CETP (2.5)	PLEKHH2 (1.9)	TMEM57 (1.8)	C1orf63 (1.6)	SLC44A2 (1.5)	HNF1A (1.4)	POLK (1.3)	GOT2P1 (1.3)
ENSG00000166793	YPEL4 PPI subnetwork	0.23	> 0.20	NAA25 (3.4)	TOP1 (3.2)	TOMM40 (3.1)	QTRT1 (2.9)	ZNF259 (2.8)	DDX56 (2.6)	ANKRD31 (2.3)	ADAM1 (2.1)	RHD (2.0)	TMEM57 (2.0)
ENSG00000173418	NAA20 PPI subnetwork	0.23	> 0.20	PVR (3.0)	TRAFD1 (2.5)	PSMA5 (2.5)	TOMM40 (2.2)	POC5 (2.0)	MAPKAPK5 (1.9)	PVRL2 (1.9)	NAA25 (1.7)	HMGCR (1.5)	ADAM1 (1.5)
ENSG00000197043	ANXA6 PPI subnetwork	0.23	> 0.20	PLEC (3.6)	C1orf63 (3.3)	OGDH (3.0)	ENSG00000238078 (2.4)	APOE (2.2)	CLPTM1 (1.8)	PVR (1.6)	HAVCR1 (1.6)	PARP10 (1.5)	MOSC1 (1.3)
ENSG00000158792	SPATA2L PPI subnetwork	0.23	> 0.20	ENSG00000228044 (3.0)	NAA25 (2.2)	OASL (2.1)	BUD13 (1.9)	ZNF180 (1.6)	ENSG00000254235 (1.6)	DDX56 (1.6)	SH2B3 (1.5)	DOCK7 (1.5)	C11orf9 (1.4)
MP:0001967	deafness	0.23	> 0.20	HNF1A (2.8)	ANKRD31 (2.1)	ABO (1.8)	ZHX3 (1.7)	ENSG00000226648 (1.7)	LPAR2 (1.6)	NCAN (1.5)	APOC1 (1.5)	GCNT4 (1.5)	AP1M2 (1.5)
GO:0051651	maintenance of location in cell	0.23	> 0.20	C17orf57 (2.8)	RHD (2.1)	ZNF101 (2.0)	GOT2P1 (1.8)	RHCE (1.7)	CBLC (1.7)	PSRC1 (1.7)	CLPTM1 (1.6)	C12orf51 (1.6)	PBX4 (1.6)
MP:0001805	decreased IgG level	0.23	> 0.20	RELB (3.6)	BCL3 (2.6)	CETP (2.6)	TIMD4 (2.5)	ZNF101 (2.2)	GMIP (2.0)	HAVCR1 (1.9)	MAFB (1.9)	PARP10 (1.7)	APOE (1.6)
ENSG00000161634	DCD PPI subnetwork	0.23	> 0.20	PLEC (2.6)	PTPN11 (2.6)	ANGPTL3 (2.2)	HP (2.1)	ABO (2.0)	CEACAM19 (2.0)	ADAM1 (1.9)	ILF3 (1.9)	APOA5 (1.9)	SLC22A1 (1.9)
MP:0000292	distended pericardium	0.23	> 0.20	GATAD2A (2.7)	NYNRIN (2.5)	PLCG1 (2.5)	ENSG00000238078 (2.4)	MARK4 (2.3)	KANK2 (2.3)	ATXN2 (2.2)	ENSG00000226648 (2.2)	C17orf57 (1.9)	ENSG00000235545 (1.8)
ENSG00000163399	ATP1A1 PPI subnetwork	0.23	> 0.20	NPC1L1 (6.3)	TM6SF2 (5.1)	ABCG5 (4.6)	ABCG8 (3.3)	GCNT4 (2.9)	FRK (2.9)	APOB (2.8)	C11orf9 (2.5)	OGDH (2.4)	AP1M2 (2.1)
MP:0004028	chromosome breakage	0.23	> 0.20	FEN1 (3.3)	USP1 (2.5)	PTPN11 (2.3)	POC5 (2.2)	ADAM1 (2.1)	BUD13 (2.0)	PVR (1.7)	PSRC1 (1.6)	POLK (1.5)	UBXN2B (1.4)
ENSG00000109193	SULT1E1 PPI subnetwork	0.23	> 0.20	PCSK9 (2.2)	FADS1 (2.1)	C12orf47 (2.0)	FEN1 (2.0)	BLOC1S3 (1.9)	FADS2 (1.8)	USP1 (1.8)	MYLIP (1.7)	C11orf9 (1.6)	GMIP (1.6)
GO:0042826	histone deacetylase binding	0.23	> 0.20	HLX (2.9)	CARM1 (2.0)	MAU2 (1.9)	C12orf51 (1.8)	SH2B3 (1.6)	KANK2 (1.5)	DNM2 (1.5)	MARK4 (1.5)	MAFB (1.5)	TMEM57 (1.5)
GO:0044452	nucleolar part	0.23	> 0.20	ZNF259 (3.2)	NAA25 (3.2)	QTRT1 (2.8)	DDX56 (2.7)	DHODH (2.7)	TOMM40 (2.5)	C12orf43 (2.5)	TXNL4B (2.4)	MAPKAPK5 (2.4)	ZNF180 (2.2)
GO:0002922	positive regulation of humoral immune response	0.23	> 0.20	ENSG00000235545 (2.9)	ENSG00000228044 (2.7)	TIMD4 (2.5)	DYNC2LI1 (2.3)	HAVCR1 (2.2)	AMIGO1 (2.1)	ZNF101 (1.9)	LPAR2 (1.7)	CEACAM19 (1.6)	SLC44A2 (1.6)
GO:0032784	regulation of transcription elongation, DNA-dependent	0.23	> 0.20	BLOC1S3 (2.9)	C12orf47 (2.6)	MAU2 (2.2)	TRAPPC6A (2.0)	PMFBP1 (1.8)	BUD13 (1.6)	GCNT4 (1.6)	PBX4 (1.6)	ENSG00000254235 (1.6)	DNM2 (1.5)
ENSG00000137996	RTCD1 PPI subnetwork	0.23	> 0.20	BLOC1S3 (4.8)	ZNF180 (3.0)	GATAD2A (2.9)	GEMIN7 (2.8)	TOMM40 (2.3)	USP1 (2.3)	PVRL2 (1.8)	TRAPPC6A (1.8)	SUGP1 (1.8)	ABCG8 (1.7)
ENSG00000162924	REL PPI subnetwork	0.23	> 0.20	RELB (7.1)	BCL3 (5.9)	GRINA (2.5)	ABO (2.1)	PVRL2 (2.0)	PVR (2.0)	TOP1 (1.7)	PLEC (1.7)	MYLIP (1.6)	GMIP (1.6)
ENSG00000140750	ARHGAP17 PPI subnetwork	0.23	> 0.20	C11orf9 (2.7)	COL4A3BP (2.4)	KANK2 (2.2)	SH2B3 (1.9)	DNM2 (1.9)	ALDH2 (1.8)	DNAH11 (1.7)	ITGB3 (1.7)	PTPN11 (1.5)	CARM1 (1.5)
MP:0002401	abnormal lymphopoiesis	0.23	> 0.20	GMIP (3.7)	ZNF101 (3.3)	GCNT4 (2.7)	SMARCA4 (2.5)	PBX4 (2.4)	TRIB1 (2.1)	PLCG1 (1.8)	MAU2 (1.8)	MAFB (1.8)	CYB561D1 (1.7)
ENSG00000105289	TJP3 PPI subnetwork	0.23	> 0.20	APOB (3.1)	AP1M2 (2.9)	FRK (2.8)	CBLC (2.5)	APOC1 (2.3)	SORT1 (1.7)	APOC4 (1.6)	C17orf57 (1.5)	PVRL2 (1.5)	TRAPPC6A (1.4)
MP:0001179	thick pulmonary interalveolar septum	0.23	> 0.20	MAFB (2.5)	TRIB1 (2.4)	HLX (2.4)	CLPTM1 (1.8)	CETP (1.7)	PPP1R37 (1.6)	PVR (1.6)	GPAM (1.6)	BCAM (1.6)	UBXN2B (1.3)
GO:0022407	regulation of cell-cell adhesion	0.23	> 0.20	ANKRD31 (3.7)	GCNT4 (2.5)	FRK (2.1)	ENSG00000228044 (1.6)	ENSG00000238078 (1.6)	SLC44A2 (1.4)	CYB561D1 (1.4)	PLEKHH2 (1.4)	AP1M2 (1.4)	TMEM50A (1.2)
GO:0042742	defense response to bacterium	0.23	> 0.20	PMFBP1 (2.2)	HP (2.2)	TIMD4 (1.9)	ENSG00000235545 (1.7)	MOSC1 (1.6)	HLX (1.5)	ABCG5 (1.5)	ADAM1 (1.4)	ABCG8 (1.3)	RHCE (1.2)
GO:0010460	positive regulation of heart rate	0.23	> 0.20	LPIN3 (3.4)	CEACAM19 (3.0)	FRK (2.3)	GCNT4 (2.3)	ENSG00000254235 (2.3)	ENSG00000226648 (2.2)	NKPD1 (1.8)	TM6SF2 (1.8)	HAPLN4 (1.5)	ITGB3 (1.4)
GO:0009306	protein secretion	0.23	> 0.20	GEMIN7 (1.9)	KIAA1324 (1.9)	DNAH11 (1.5)	C17orf57 (1.5)	C12orf43 (1.4)	APOE (1.4)	HAVCR1 (1.3)	ENSG00000228044 (1.2)	ST3GAL4 (1.2)	AMIGO1 (1.2)
ENSG00000074319	TSG101 PPI subnetwork	0.23	> 0.20	POLK (4.3)	MYLIP (2.1)	PLEC (2.1)	GMIP (2.1)	MAPKAPK5 (2.1)	CARM1 (2.0)	UBXN2B (1.9)	C12orf43 (1.8)	BRAP (1.8)	SUGP1 (1.7)
GO:0009065	glutamine family amino acid catabolic process	0.23	> 0.20	COL4A3BP (2.5)	ANGPTL3 (2.0)	DYNC2LI1 (1.8)	UBXN2B (1.8)	ENSG00000226648 (1.8)	ZHX3 (1.8)	C17orf57 (1.7)	PCSK9 (1.6)	ACAD10 (1.5)	DHODH (1.5)
GO:0019199	transmembrane receptor protein kinase activity	0.23	> 0.20	PVRL2 (3.6)	NYNRIN (2.7)	PLEKHH2 (2.6)	MYLIP (2.2)	BCAM (2.2)	LPAR2 (2.2)	SLC44A2 (2.1)	MAFB (1.7)	PLCG1 (1.7)	CLPTM1 (1.6)
MP:0006309	decreased retinal ganglion cell number	0.23	> 0.20	ENSG00000238078 (1.9)	APOE (1.8)	APOC1 (1.8)	LPAR2 (1.7)	DNAH11 (1.7)	ENSG00000226645 (1.6)	ZHX3 (1.5)	MOSC1 (1.5)	HAVCR1 (1.5)	LPIN3 (1.4)
MP:0002750	exophthalmos	0.23	> 0.20	KANK2 (3.4)	HAPLN4 (2.0)	COL4A3BP (2.0)	ENSG00000235545 (1.9)	POLK (1.9)	ENSG00000228044 (1.8)	ST3GAL4 (1.7)	CYB561D1 (1.7)	PBX4 (1.6)	DYNC2LI1 (1.5)
ENSG00000116478	HDAC1 PPI subnetwork	0.23	> 0.20	ATXN2 (3.0)	MYLIP (2.9)	BUD13 (2.8)	MAU2 (2.8)	GATAD2A (2.7)	USP1 (2.6)	SMARCA4 (2.4)	TOP1 (2.3)	CARM1 (2.3)	ILF3 (2.2)
ENSG00000183431	SF3A3 PPI subnetwork	0.23	> 0.20	ILF3 (3.9)	SUGP1 (3.6)	DHX38 (3.6)	TOP1 (3.3)	C1orf63 (3.2)	BUD13 (3.1)	SMARCA4 (2.9)	FEN1 (2.5)	USP1 (2.4)	QTRT1 (2.2)
GO:2000379	positive regulation of reactive oxygen species metabolic process	0.23	> 0.20	ENSG00000226645 (2.9)	ANKRD31 (2.8)	PVR (2.1)	POLK (2.0)	FRK (1.9)	CYB561D1 (1.9)	ALDH2 (1.9)	HAVCR1 (1.8)	BRAP (1.8)	LPIN3 (1.4)
MP:0001245	thick dermal layer	0.23	> 0.20	BCL3 (3.4)	TRIB1 (3.1)	HLX (2.8)	CETP (2.5)	CILP2 (2.2)	PVRL2 (2.2)	SH2B3 (2.0)	C11orf9 (1.9)	RELB (1.9)	ZNF101 (1.7)
ENSG00000102981	PARD6A PPI subnetwork	0.23	> 0.20	PVRL2 (3.8)	AP1M2 (3.2)	CBLC (2.8)	PSRC1 (2.1)	FRK (1.9)	C11orf9 (1.8)	ZNF180 (1.7)	BCAM (1.5)	PVR (1.5)	PLCG1 (1.5)
GO:0060669	embryonic placenta morphogenesis	0.23	> 0.20	ENSG00000228044 (2.9)	CETP (2.5)	CBLC (2.2)	TIMD4 (2.1)	ENSG00000226645 (2.0)	BCL3 (2.0)	HAVCR1 (1.9)	ZNF101 (1.5)	MYLIP (1.5)	ENSG00000238078 (1.4)
ENSG00000138095	LRPPRC PPI subnetwork	0.23	> 0.20	TMEM50A (2.7)	HLX (2.3)	TRAPPC6A (1.9)	CYB561D1 (1.9)	TRIB1 (1.8)	POLK (1.8)	C1orf63 (1.8)	NYNRIN (1.8)	ENSG00000226648 (1.6)	QTRT1 (1.6)
GO:0060761	negative regulation of response to cytokine stimulus	0.23	> 0.20	ANKRD31 (3.6)	CEACAM19 (2.7)	PBX4 (2.6)	MOSC1 (2.2)	MAU2 (2.0)	ENSG00000238078 (1.9)	TMEM116 (1.9)	NKPD1 (1.7)	TRAPPC6A (1.5)	DYNC2LI1 (1.5)
MP:0000161	scoliosis	0.23	> 0.20	KANK2 (2.6)	HMGCR (2.2)	TRIB1 (2.0)	HAPLN4 (1.9)	PCSK9 (1.8)	LDLR (1.7)	PLEC (1.7)	ZNF101 (1.7)	KIAA1324 (1.7)	ENSG00000226648 (1.5)
ENSG00000166135	HIF1AN PPI subnetwork	0.23	> 0.20	PLCG1 (3.4)	NT5DC1 (3.3)	PCSK9 (2.5)	HNF1A (2.2)	FRK (2.1)	DOCK7 (1.9)	ENSG00000226645 (1.6)	POLK (1.5)	TOP1 (1.5)	USP24 (1.4)
ENSG00000088038	CNOT3 PPI subnetwork	0.23	> 0.20	TXNL4B (2.7)	ADAM1 (2.3)	DDX56 (2.2)	BUD13 (2.1)	DHX38 (1.8)	BRAP (1.8)	TMED4 (1.7)	ATXN7L2 (1.6)	ATXN2 (1.6)	ENSG00000254235 (1.6)
ENSG00000117450	PRDX1 PPI subnetwork	0.23	> 0.20	ADAM1 (2.5)	PVRL2 (2.3)	UBXN2B (2.1)	PLG (1.9)	ANGPTL3 (1.8)	TMEM50A (1.7)	PARP10 (1.7)	PLEC (1.7)	OGDH (1.6)	APOC4 (1.6)
MP:0002812	spherocytosis	0.23	> 0.20	RHCE (13.0)	RHD (11.6)	C12orf51 (4.9)	GMPR (4.7)	GRINA (1.7)	ENSG00000238078 (1.7)	TOP1 (1.5)	USP24 (1.5)	FADS2 (1.5)	SLC44A2 (1.5)
GO:0051100	negative regulation of binding	0.23	> 0.20	OASL (2.6)	GATAD2A (2.5)	ENSG00000238078 (2.4)	PLCG1 (2.3)	LPAR2 (2.2)	MARK4 (2.0)	TMEM57 (1.9)	ABO (1.9)	MAFB (1.9)	ENSG00000226645 (1.7)
ENSG00000125630	POLR1B PPI subnetwork	0.23	> 0.20	ZNF259 (3.8)	DDX56 (3.7)	NAA25 (3.1)	C12orf43 (3.1)	QTRT1 (3.0)	BUD13 (2.6)	MAPKAPK5 (2.3)	PSMA5 (2.2)	TOMM40 (2.2)	SUGP1 (2.2)
GO:0002685	regulation of leukocyte migration	0.23	> 0.20	ENSG00000228044 (3.6)	TIMD4 (3.4)	CETP (2.4)	MAFB (2.2)	PVR (2.1)	ZNF101 (2.0)	RELB (1.7)	ENSG00000238078 (1.7)	APOE (1.5)	NKPD1 (1.4)
MP:0000267	abnormal heart development	0.23	> 0.20	C11orf9 (3.3)	NYNRIN (2.8)	ATXN2 (2.8)	PVRL2 (2.7)	KANK2 (2.6)	MARK4 (2.5)	SH2B3 (2.4)	BCAM (2.3)	HLX (2.0)	TRIB1 (1.8)
MP:0008146	asymmetric rib-sternum attachment	0.23	> 0.20	TRIB1 (3.6)	DOCK7 (2.2)	ENSG00000238078 (2.0)	FRK (2.0)	NYNRIN (1.8)	C11orf9 (1.5)	TMEM57 (1.4)	TMED4 (1.3)	PVRL2 (1.3)	BCAM (1.3)
ENSG00000135316	SYNCRIP PPI subnetwork	0.23	> 0.20	C12orf43 (3.2)	ILF3 (3.1)	BRAP (3.0)	SMARCA4 (2.9)	ABO (2.8)	SARS (2.7)	CARM1 (2.7)	GATAD2A (2.6)	HAPLN4 (2.6)	PSMA5 (2.5)
ENSG00000075415	SLC25A3 PPI subnetwork	0.23	> 0.20	QTRT1 (3.2)	ILF3 (3.1)	ENSG00000226645 (2.3)	TOP1 (2.0)	SARS (2.0)	SMARCA4 (1.9)	PBX4 (1.9)	DHX38 (1.8)	DDX56 (1.7)	NKPD1 (1.7)
ENSG00000126005	ENSG00000126005 PPI subnetwork	0.23	> 0.20	ZNF259 (4.8)	TOMM40 (4.1)	QTRT1 (3.7)	NAA25 (3.7)	SARS (3.4)	DDX56 (3.2)	PSMA5 (2.8)	C12orf43 (2.6)	DHODH (2.4)	TOP1 (2.3)
MP:0005070	impaired NK cell cytolysis	0.23	> 0.20	TRAFD1 (3.3)	PARP10 (2.1)	BCL3 (1.9)	RELB (1.9)	USP24 (1.6)	ST3GAL4 (1.4)	PSMA5 (1.3)	ADAM1 (1.1)	MYLIP (1.1)	ANKRD31 (1.1)
ENSG00000180008	SOCS4 PPI subnetwork	0.23	> 0.20	BCL3 (4.4)	RELB (3.2)	HLX (3.1)	GMIP (2.6)	CETP (2.3)	TIMD4 (2.2)	ALDH2 (1.9)	PARP10 (1.6)	GRINA (1.5)	LPA (1.5)
ENSG00000114739	ACVR2B PPI subnetwork	0.23	> 0.20	MARK4 (2.4)	ABO (2.3)	PVR (2.0)	PVRL2 (2.0)	POLK (1.8)	SLC22A1 (1.8)	ENSG00000226645 (1.7)	SLC44A2 (1.7)	PTPN11 (1.7)	KANK2 (1.5)
ENSG00000130702	LAMA5 PPI subnetwork	0.23	> 0.20	BCAM (3.3)	GPAM (2.6)	PLEC (2.5)	PVRL2 (2.4)	KANK2 (2.3)	CELSR2 (2.2)	CBLC (1.9)	SLC44A2 (1.7)	ST3GAL4 (1.6)	DOCK7 (1.5)
REACTOME_MRNA_PROCESSING	REACTOME_MRNA_PROCESSING	0.23	> 0.20	ILF3 (4.2)	BUD13 (3.0)	TOP1 (2.9)	DHX38 (2.8)	C1orf63 (2.8)	USP1 (2.8)	SMARCA4 (2.5)	FEN1 (2.4)	DDX56 (2.4)	SUGP1 (2.3)
MP:0000371	diluted coat color	0.23	> 0.20	DOCK7 (2.5)	ST3GAL4 (2.3)	GMPR (2.1)	ENSG00000235545 (1.8)	PPP1R37 (1.7)	DNM2 (1.6)	CELSR2 (1.5)	MYLIP (1.4)	ZNF259 (1.4)	GPAM (1.4)
ENSG00000112208	BAG2 PPI subnetwork	0.23	> 0.20	RELB (6.2)	BCL3 (3.4)	BLOC1S3 (3.0)	CYB561D1 (2.8)	PVR (2.1)	GRINA (2.1)	CLPTM1 (2.1)	CELSR2 (1.9)	AMIGO1 (1.9)	ZNF180 (1.8)
ENSG00000166164	BRD7 PPI subnetwork	0.23	> 0.20	CARM1 (4.3)	GRINA (2.9)	MARK4 (2.4)	ZNF180 (2.4)	SMARCA4 (2.1)	GOT2P1 (1.9)	NYNRIN (1.9)	BUD13 (1.9)	BCL3 (1.8)	ILF3 (1.7)
ENSG00000205302	SNX2 PPI subnetwork	0.23	> 0.20	HAVCR1 (3.8)	TMEM50A (3.3)	USP24 (2.3)	CEACAM19 (2.2)	DOCK7 (1.8)	TMEM57 (1.8)	HNF1A (1.8)	PTPN11 (1.7)	C17orf57 (1.5)	CETP (1.5)
MP:0000592	short tail	0.23	> 0.20	PLCG1 (2.7)	LDLR (2.3)	CILP2 (2.0)	NYNRIN (1.8)	HMGCR (1.7)	HAPLN4 (1.7)	APOB (1.7)	TMEM50A (1.5)	TMEM57 (1.4)	ABO (1.4)
MP:0010551	abnormal coronary vessel morphology	0.23	> 0.20	C11orf9 (3.5)	BCAM (3.1)	ENSG00000238078 (2.4)	NYNRIN (2.3)	CETP (2.0)	TMED4 (1.9)	GMPR (1.8)	TMEM57 (1.7)	APOB (1.7)	HLX (1.6)
ENSG00000187266	EPOR PPI subnetwork	0.23	> 0.20	BCL3 (3.0)	COL4A3BP (2.2)	HLX (2.2)	C17orf57 (1.6)	CETP (1.5)	CYP7A1 (1.4)	GMIP (1.4)	PVR (1.3)	TIMD4 (1.3)	RELB (1.3)
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	0.23	> 0.20	PSMA5 (6.1)	TRAFD1 (3.6)	NAA25 (2.6)	NT5DC1 (2.6)	PARP10 (1.9)	DDX56 (1.9)	SUGP1 (1.8)	TOMM40 (1.7)	BRAP (1.4)	SARS (1.4)
GO:0060249	anatomical structure homeostasis	0.23	> 0.20	POLK (2.8)	TMEM116 (2.3)	ZNF180 (2.0)	SLC44A2 (1.8)	ZNF101 (1.7)	ENSG00000235545 (1.7)	DNAH11 (1.6)	USP1 (1.5)	ENSG00000228044 (1.4)	ENSG00000226648 (1.3)
ENSG00000158092	NCK1 PPI subnetwork	0.23	> 0.20	GMIP (2.4)	USP24 (2.4)	SLC44A2 (2.4)	CARM1 (2.4)	MARK4 (2.2)	ATXN2 (2.1)	DNM2 (2.0)	GATAD2A (1.8)	SH2B3 (1.7)	ATXN7L2 (1.7)
MP:0005517	decreased liver regeneration	0.23	> 0.20	TRIB1 (4.3)	HP (3.0)	MAFB (2.7)	BCL3 (2.4)	APOB (2.4)	APOE (2.4)	C11orf9 (2.3)	APOC1 (2.2)	HNF1A (2.0)	LDLR (1.7)
GO:0016790	thiolester hydrolase activity	0.23	> 0.20	USP24 (3.9)	TMEM57 (2.6)	OASL (2.2)	BRAP (2.0)	ACAD10 (1.8)	CARM1 (1.8)	COL4A3BP (1.7)	NT5DC1 (1.6)	CYP7A1 (1.6)	C12orf51 (1.5)
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	0.23	> 0.20	PSMA5 (6.4)	TRAFD1 (3.6)	NAA25 (2.6)	NT5DC1 (2.5)	PARP10 (2.0)	SUGP1 (1.8)	TOMM40 (1.7)	DDX56 (1.7)	SARS (1.7)	ZNF259 (1.3)
REACTOME_SYNTHESIS_OF_VERY_LONG:CHAIN_FATTY_ACYL:COAS	REACTOME_SYNTHESIS_OF_VERY_LONG:CHAIN_FATTY_ACYL:COAS	0.23	> 0.20	HMGCR (7.2)	FADS1 (6.9)	FADS2 (6.1)	LDLR (5.4)	PCSK9 (3.8)	GPAM (3.3)	MOSC1 (1.9)	SORT1 (1.9)	NKPD1 (1.9)	SYPL2 (1.8)
KEGG_ECM_RECEPTOR_INTERACTION	KEGG_ECM_RECEPTOR_INTERACTION	0.23	> 0.20	ITGB3 (5.4)	CILP2 (4.9)	BCAM (2.8)	APOE (2.6)	PLEC (2.6)	KANK2 (2.4)	C17orf57 (2.0)	CBLC (1.8)	PLEKHH2 (1.8)	CELSR2 (1.7)
MP:0001156	abnormal spermatogenesis	0.23	> 0.20	TSSK6 (2.7)	PBX4 (2.4)	GATAD2A (2.3)	ST3GAL4 (2.1)	LPAR2 (2.1)	LDLR (1.7)	FADS1 (1.7)	FADS2 (1.6)	GMPR (1.6)	PCSK9 (1.5)
MP:0001131	abnormal ovarian follicle morphology	0.23	> 0.20	FADS1 (4.2)	ST3GAL4 (2.4)	TRAPPC6A (2.4)	FADS2 (2.2)	LDLR (2.1)	HMGCR (2.1)	NCAN (2.0)	CELSR2 (1.9)	ABO (1.8)	KIAA1324 (1.8)
ENSG00000108671	PSMD11 PPI subnetwork	0.24	> 0.20	PSMA5 (5.2)	NAA25 (2.6)	NT5DC1 (2.3)	TRAFD1 (2.3)	TOMM40 (2.1)	DDX56 (1.5)	TOP1 (1.4)	SARS (1.3)	ENSG00000254235 (1.2)	SMARCA4 (1.2)
MP:0003944	abnormal T cell subpopulation ratio	0.24	> 0.20	PLCG1 (4.2)	GMIP (3.9)	TIMD4 (2.9)	RELB (2.3)	GRINA (2.0)	ZNF101 (1.8)	BCL3 (1.6)	NPC1L1 (1.5)	C19orf52 (1.4)	APOC1 (1.4)
GO:0016575	histone deacetylation	0.24	> 0.20	TMEM57 (2.7)	ATXN7L2 (2.6)	C17orf57 (2.1)	PLCG1 (2.0)	FADS2 (1.7)	HNF1A (1.6)	NT5DC1 (1.6)	C1orf63 (1.5)	USP24 (1.5)	PPP1R37 (1.5)
ENSG00000123131	PRDX4 PPI subnetwork	0.24	> 0.20	ADAM1 (3.8)	PSMA5 (3.3)	RHD (2.7)	RHCE (2.4)	ALDH2 (2.2)	CYP7A1 (2.0)	ACAD10 (1.9)	C1orf63 (1.9)	SLC44A2 (1.8)	PVRL2 (1.7)
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	0.24	> 0.20	YIPF2 (3.4)	ENSG00000235545 (2.1)	ABCG8 (2.1)	TMED4 (2.1)	NPC1L1 (1.9)	TMEM57 (1.9)	TM6SF2 (1.8)	LPIN3 (1.7)	ABCG5 (1.7)	ERP29 (1.5)
ENSG00000166197	NOLC1 PPI subnetwork	0.24	> 0.20	ILF3 (3.0)	TOP1 (2.7)	QTRT1 (2.7)	C12orf43 (2.6)	SMARCA4 (2.6)	NAA25 (2.5)	GATAD2A (2.0)	PLEC (2.0)	SARS (1.9)	TRIB1 (1.9)
ENSG00000117335	CD46 PPI subnetwork	0.24	> 0.20	PVRL2 (2.9)	ITGB3 (2.7)	TMEM50A (2.7)	PLEC (2.7)	APOE (2.6)	POLK (2.5)	PTPN11 (2.5)	BCAM (2.4)	APOC1 (2.2)	NCAN (2.2)
REACTOME_SCF:BETA:TRCP_MEDIATED_DEGRADATION_OF_EMI1	REACTOME_SCF:BETA:TRCP_MEDIATED_DEGRADATION_OF_EMI1	0.24	> 0.20	PSMA5 (6.5)	TRAFD1 (3.3)	NT5DC1 (2.3)	NAA25 (2.3)	SUGP1 (1.8)	DDX56 (1.7)	TOMM40 (1.6)	PARP10 (1.5)	SARS (1.5)	TMEM50A (1.3)
MP:0005223	abnormal anterior-posterior polarity of the somites	0.24	> 0.20	PLEC (3.2)	ABO (2.9)	ATXN2 (2.7)	MAU2 (2.6)	SLC44A2 (2.5)	GMIP (2.3)	LPAR2 (1.7)	HNF1A (1.6)	USP24 (1.6)	PLCG1 (1.5)
GO:0008217	regulation of blood pressure	0.24	> 0.20	ABO (3.7)	C12orf47 (2.6)	CEACAM19 (2.2)	KIAA1324 (2.2)	TSSK6 (2.0)	ACAD10 (1.9)	TMED4 (1.7)	NKPD1 (1.5)	COL4A3BP (1.4)	HAVCR1 (1.4)
ENSG00000094916	CBX5 PPI subnetwork	0.24	> 0.20	FEN1 (3.3)	PSRC1 (3.2)	USP1 (3.1)	BUD13 (2.2)	ZNF101 (2.1)	SMARCA4 (1.8)	ZNF180 (1.8)	MAU2 (1.6)	C19orf52 (1.6)	ZHX3 (1.5)
ENSG00000187514	PTMA PPI subnetwork	0.24	> 0.20	USP1 (2.5)	PSRC1 (2.4)	MYLIP (1.9)	FEN1 (1.7)	TXNL4B (1.7)	BUD13 (1.7)	HLX (1.5)	ABO (1.4)	TMEM50A (1.4)	TRIB1 (1.4)
ENSG00000101017	CD40 PPI subnetwork	0.24	> 0.20	RELB (4.5)	BCL3 (3.6)	PSMA5 (3.0)	NT5DC1 (2.8)	PBX4 (2.5)	PARP10 (2.4)	TRAFD1 (2.4)	UBXN2B (1.8)	ZNF180 (1.7)	ZNF101 (1.6)
GO:0090003	regulation of establishment of protein localization in plasma membrane	0.24	> 0.20	ENSG00000226645 (3.0)	PTPN11 (2.6)	ZHX3 (1.9)	ENSG00000238078 (1.9)	AP1M2 (1.8)	CBLC (1.5)	COL4A3BP (1.5)	HAVCR1 (1.5)	ANKRD31 (1.4)	PLEKHH2 (1.4)
GO:0006342	chromatin silencing	0.24	> 0.20	TSSK6 (3.5)	MAU2 (2.3)	GCNT4 (2.2)	MAPKAPK5 (1.9)	SUGP1 (1.9)	FRK (1.9)	C17orf57 (1.7)	C19orf52 (1.7)	TMEM116 (1.7)	NT5DC1 (1.6)
GO:0045765	regulation of angiogenesis	0.24	> 0.20	PVR (2.6)	ENSG00000226648 (2.6)	C17orf57 (2.5)	CEACAM19 (2.4)	ENSG00000235545 (2.3)	CILP2 (2.3)	MAFB (2.1)	TRIB1 (1.6)	PVRL2 (1.5)	SH2B3 (1.4)
ENSG00000125912	NCLN PPI subnetwork	0.24	> 0.20	HNF1A (2.8)	MAPKAPK5 (2.7)	LPA (2.3)	TRAPPC6A (2.2)	ATP13A1 (2.0)	PTPN11 (2.0)	CEACAM19 (2.0)	ANKRD31 (1.9)	BRAP (1.8)	USP24 (1.8)
GO:0003727	single-stranded RNA binding	0.24	> 0.20	NT5DC1 (2.7)	TRIB1 (2.4)	DHODH (2.4)	C1orf63 (2.3)	UBXN2B (2.2)	PARP10 (2.1)	MYLIP (1.9)	ILF3 (1.9)	PPP1R37 (1.8)	CYB561D1 (1.7)
GO:0005912	adherens junction	0.24	> 0.20	PLEC (4.3)	PVRL2 (3.9)	BCAM (3.9)	KANK2 (2.5)	ITGB3 (2.4)	AP1M2 (2.2)	PVR (2.0)	C11orf9 (1.9)	CBLC (1.8)	DNM2 (1.6)
ENSG00000132676	DAP3 PPI subnetwork	0.24	> 0.20	FRK (2.6)	RELB (2.2)	BCL3 (2.2)	PARP10 (2.0)	GOT2P1 (2.0)	AMIGO1 (1.9)	ZNF101 (1.9)	KIAA1324 (1.8)	PLEC (1.7)	DHODH (1.6)
GO:0060674	placenta blood vessel development	0.24	> 0.20	CBLC (3.3)	ENSG00000235545 (2.9)	AP1M2 (2.2)	ZNF101 (2.0)	PVR (1.9)	LDLR (1.8)	MAPKAPK5 (1.8)	DYNC2LI1 (1.7)	PVRL2 (1.6)	ENSG00000228044 (1.5)
ENSG00000115008	IL1A PPI subnetwork	0.24	> 0.20	BCL3 (3.4)	RELB (2.8)	ST3GAL4 (2.8)	CBLC (2.4)	NYNRIN (1.8)	ENSG00000254235 (1.5)	ANKRD31 (1.5)	CYB561D1 (1.5)	GRINA (1.4)	HP (1.3)
ENSG00000123094	RASSF8 PPI subnetwork	0.24	> 0.20	LPAR2 (3.3)	ZHX3 (2.9)	UBXN2B (2.9)	KANK2 (2.9)	CBLC (2.9)	GPAM (2.5)	COL4A3BP (2.4)	PLEC (2.4)	CARM1 (2.4)	C11orf9 (2.2)
ENSG00000105997	HOXA3 PPI subnetwork	0.24	> 0.20	OASL (2.9)	TIMD4 (2.9)	CETP (2.4)	TMEM57 (1.8)	C1orf63 (1.7)	CELSR2 (1.6)	POLK (1.6)	DNAH11 (1.5)	PLEKHH2 (1.5)	SLC44A2 (1.5)
REACTOME_APOPTOTIC_EXECUTION__PHASE	REACTOME_APOPTOTIC_EXECUTION__PHASE	0.24	> 0.20	PLEC (2.6)	DOCK7 (2.2)	CBLC (2.1)	ZNF101 (2.0)	AP1M2 (1.9)	COL4A3BP (1.9)	ENSG00000226645 (1.6)	DHX38 (1.6)	ABO (1.5)	SMARCA4 (1.3)
MP:0003427	parakeratosis	0.24	> 0.20	CBLC (3.0)	CELSR2 (2.9)	KIAA1324 (2.5)	PLEC (2.4)	NKPD1 (2.1)	MAFB (2.0)	CEACAM19 (2.0)	AP1M2 (1.9)	CYB561D1 (1.7)	ENSG00000226648 (1.4)
GO:0071901	negative regulation of protein serine/threonine kinase activity	0.24	> 0.20	ENSG00000226645 (4.3)	TRIB1 (3.8)	ENSG00000238078 (2.4)	C17orf57 (2.0)	HLX (1.8)	MYLIP (1.6)	ZNF180 (1.6)	KANK2 (1.5)	ENSG00000226648 (1.4)	ZHX3 (1.4)
GO:0071377	cellular response to glucagon stimulus	0.24	> 0.20	ST3GAL4 (2.7)	ITGB3 (2.7)	ENSG00000254235 (2.4)	PMFBP1 (2.3)	TM6SF2 (2.1)	GCNT4 (1.9)	ABCG8 (1.8)	CYP7A1 (1.5)	LPA (1.3)	ABCG5 (1.3)
ENSG00000100029	PES1 PPI subnetwork	0.24	> 0.20	NAA25 (5.0)	ZNF259 (4.5)	DDX56 (4.3)	TOMM40 (4.0)	QTRT1 (3.6)	C12orf43 (2.7)	DHODH (2.7)	ATP13A1 (2.6)	TOP1 (2.3)	DHX38 (2.1)
ENSG00000143753	DEGS1 PPI subnetwork	0.24	> 0.20	SARS (3.2)	TXNL4B (2.8)	LPAR2 (2.6)	CARM1 (2.3)	C19orf52 (2.1)	ANKRD31 (2.0)	NT5DC1 (1.8)	ADAM1 (1.8)	DHX38 (1.7)	YIPF2 (1.6)
ENSG00000164867	NOS3 PPI subnetwork	0.24	> 0.20	TIMD4 (2.5)	PPP1R37 (2.4)	ENSG00000228044 (2.4)	C17orf57 (2.2)	BCAM (2.2)	TXNL4B (2.0)	PLEKHH2 (2.0)	GOT2P1 (1.8)	SYPL2 (1.8)	HLX (1.8)
MP:0001704	abnormal dorsal-ventral axis patterning	0.24	> 0.20	AP1M2 (2.5)	NYNRIN (2.1)	BCAM (1.9)	CARM1 (1.5)	KANK2 (1.5)	LPAR2 (1.5)	SLC44A2 (1.4)	PVRL2 (1.3)	CLPTM1 (1.3)	ENSG00000254235 (1.2)
ENSG00000204628	GNB2L1 PPI subnetwork	0.24	> 0.20	NAA25 (4.5)	QTRT1 (4.1)	DDX56 (4.1)	PTPN11 (3.4)	ZNF259 (3.3)	TOP1 (3.3)	C12orf43 (3.1)	DHODH (2.8)	DHX38 (2.6)	GATAD2A (2.6)
GO:0071565	nBAF complex	0.24	> 0.20	CARM1 (5.1)	NYNRIN (3.7)	NCAN (3.4)	C12orf51 (3.0)	GRINA (2.7)	MARK4 (2.7)	SMARCA4 (2.6)	MAU2 (2.2)	ATXN2 (2.1)	TMEM57 (2.0)
KEGG_RENIN_ANGIOTENSIN_SYSTEM	KEGG_RENIN_ANGIOTENSIN_SYSTEM	0.24	> 0.20	TM6SF2 (4.0)	NPC1L1 (3.7)	ANKRD31 (2.7)	ABCG5 (2.1)	TMED4 (2.0)	PMFBP1 (1.9)	ZHX3 (1.8)	ATXN7L2 (1.8)	ABCG8 (1.4)	GOT2P1 (1.4)
ENSG00000138069	RAB1A PPI subnetwork	0.24	> 0.20	SARS (3.3)	YIPF2 (3.3)	TMEM50A (3.0)	CYB561D1 (2.9)	PSMA5 (2.8)	GEMIN7 (2.7)	CLPTM1 (2.6)	ZNF259 (1.8)	AP1M2 (1.8)	PPP1R37 (1.5)
ENSG00000182944	EWSR1 PPI subnetwork	0.24	> 0.20	FADS2 (2.8)	RHD (2.7)	GATAD2A (2.7)	SUGP1 (2.3)	ILF3 (2.2)	UBXN2B (2.1)	SLC44A2 (2.1)	FADS1 (2.1)	SMARCA4 (2.1)	C1orf63 (2.1)
GO:0046332	SMAD binding	0.24	> 0.20	KANK2 (4.7)	TRIB1 (2.9)	GATAD2A (2.5)	ATXN2 (2.3)	ENSG00000226645 (2.1)	DOCK7 (2.1)	SH2B3 (2.0)	MYLIP (1.9)	NYNRIN (1.8)	PLEC (1.5)
MP:0001125	abnormal oocyte morphology	0.24	> 0.20	FADS1 (3.6)	PCSK9 (2.6)	CELSR2 (2.4)	GMPR (2.1)	LDLR (2.0)	APOA5 (1.8)	RHCE (1.7)	ABCG5 (1.7)	ZHX3 (1.6)	LPIN3 (1.5)
GO:0051320	S phase	0.24	> 0.20	PSMA5 (2.6)	NT5DC1 (2.3)	USP1 (2.3)	ENSG00000235545 (2.1)	ZNF180 (2.1)	FEN1 (2.1)	TXNL4B (1.7)	ENSG00000228044 (1.5)	TRAFD1 (1.4)	BRAP (1.4)
ENSG00000011422	PLAUR PPI subnetwork	0.24	> 0.20	MAFB (3.6)	APOE (2.8)	SLC22A1 (2.3)	PLG (2.2)	SH2B3 (2.2)	FRK (1.9)	LPA (1.9)	ANGPTL3 (1.7)	CEACAM19 (1.5)	RELB (1.5)
GO:0035145	exon-exon junction complex	0.24	> 0.20	TXNL4B (4.8)	C1orf63 (2.9)	ILF3 (2.7)	MAU2 (2.5)	CYB561D1 (2.2)	SUGP1 (2.1)	BRAP (2.1)	KIAA1324 (2.0)	USP1 (1.8)	TOP1 (1.6)
GO:0015849	organic acid transport	0.24	> 0.20	TM6SF2 (3.5)	ABCG8 (3.2)	TMEM116 (2.2)	HAPLN4 (2.1)	GCNT4 (1.8)	ABCG5 (1.8)	CLPTM1 (1.7)	LPAR2 (1.6)	GRINA (1.5)	PBX4 (1.5)
ENSG00000134014	ELP3 PPI subnetwork	0.24	> 0.20	MYLIP (3.1)	GEMIN7 (2.6)	MAPKAPK5 (2.4)	TMEM50A (2.3)	COL4A3BP (2.0)	ATXN2 (1.9)	SUGP1 (1.8)	TMED4 (1.8)	C17orf57 (1.6)	ZNF180 (1.5)
GO:0006476	protein deacetylation	0.24	> 0.20	ATXN7L2 (2.4)	TMEM57 (2.3)	C1orf63 (2.3)	C17orf57 (2.1)	HNF1A (1.9)	MYLIP (1.5)	PLCG1 (1.3)	UBXN2B (1.3)	TXNL4B (1.3)	BUD13 (1.3)
ENSG00000137193	PIM1 PPI subnetwork	0.24	> 0.20	TRAFD1 (2.9)	POLK (2.1)	MAFB (1.9)	HLX (1.8)	OGDH (1.5)	ACAD10 (1.4)	ABCG8 (1.2)	GRINA (1.2)	TM6SF2 (1.2)	GOT2P1 (1.2)
ENSG00000170260	ZNF212 PPI subnetwork	0.24	> 0.20	TRIB1 (4.8)	HNF1A (2.4)	BUD13 (2.3)	PVR (2.2)	RELB (2.2)	ACAD10 (2.1)	ST3GAL4 (1.9)	TRAFD1 (1.9)	SUGP1 (1.9)	BCL3 (1.7)
MP:0008190	decreased transitional stage B cell number	0.24	> 0.20	GMIP (2.7)	TIMD4 (2.7)	RELB (2.5)	GPAM (2.2)	NT5DC1 (2.0)	MAFB (2.0)	CETP (1.8)	C17orf57 (1.6)	FRK (1.5)	CILP2 (1.5)
ENSG00000170608	FOXA3 PPI subnetwork	0.24	> 0.20	DHODH (3.9)	DHX38 (3.7)	ATP13A1 (2.4)	PLCG1 (1.8)	ENSG00000238078 (1.7)	ABO (1.7)	ZHX3 (1.6)	LPA (1.6)	GOT2P1 (1.4)	PLEKHH2 (1.4)
ENSG00000143947	RPS27A PPI subnetwork	0.24	> 0.20	TOP1 (2.5)	PSMA5 (2.4)	SMARCA4 (2.4)	PTPN11 (2.3)	FEN1 (2.1)	DHX38 (2.0)	NAA25 (1.9)	ILF3 (1.9)	GRINA (1.8)	MAU2 (1.8)
ENSG00000162517	PEF1 PPI subnetwork	0.24	> 0.20	PBX4 (3.3)	MAU2 (3.2)	SYPL2 (2.6)	BLOC1S3 (2.4)	KANK2 (2.1)	TMED4 (1.9)	YIPF2 (1.9)	ZNF259 (1.8)	C19orf52 (1.8)	QTRT1 (1.7)
ENSG00000083750	RRAGB PPI subnetwork	0.24	> 0.20	QTRT1 (2.8)	YIPF2 (2.4)	GEMIN7 (2.4)	PPP1R37 (2.0)	ILF3 (1.9)	C19orf52 (1.8)	ZNF259 (1.5)	COL4A3BP (1.5)	GRINA (1.4)	DHX38 (1.3)
MP:0000230	abnormal systemic arterial blood pressure	0.24	> 0.20	BCAM (3.2)	ITGB3 (2.8)	CETP (2.3)	ANKRD31 (1.8)	ENSG00000235545 (1.8)	GOT2P1 (1.7)	C17orf57 (1.7)	C12orf47 (1.6)	LDLR (1.6)	POLK (1.4)
MP:0008539	decreased susceptibility to induced colitis	0.24	> 0.20	RELB (4.2)	BCL3 (3.9)	TRAFD1 (2.6)	ST3GAL4 (2.4)	TRIB1 (2.0)	KIAA1324 (2.0)	PVR (1.7)	PBX4 (1.5)	GRINA (1.5)	LDLR (1.3)
ENSG00000142676	RPL11 PPI subnetwork	0.24	> 0.20	DDX56 (3.9)	NAA25 (3.9)	ZNF259 (3.2)	TOMM40 (2.9)	QTRT1 (2.7)	C12orf43 (2.6)	DHX38 (2.4)	TOP1 (2.1)	DHODH (2.1)	ATP13A1 (2.1)
ENSG00000168438	CDC40 PPI subnetwork	0.24	> 0.20	ILF3 (3.6)	C1orf63 (3.5)	DHX38 (3.3)	TOP1 (3.1)	SUGP1 (3.0)	BUD13 (2.8)	SMARCA4 (2.7)	USP1 (2.6)	FEN1 (2.4)	MAU2 (2.3)
ENSG00000139496	NUPL1 PPI subnetwork	0.24	> 0.20	NAA25 (3.9)	POC5 (3.6)	DDX56 (3.0)	USP1 (2.9)	CARM1 (2.8)	POLK (2.6)	USP24 (2.6)	DOCK7 (2.5)	ILF3 (2.4)	BUD13 (2.2)
GO:0030225	macrophage differentiation	0.24	> 0.20	ITGB3 (3.1)	ST3GAL4 (2.5)	GEMIN7 (1.8)	ENSG00000228044 (1.8)	ABO (1.7)	TIMD4 (1.7)	DNAH11 (1.5)	CYB561D1 (1.5)	GMIP (1.4)	BLOC1S3 (1.3)
ENSG00000170515	PA2G4 PPI subnetwork	0.24	> 0.20	MYLIP (3.3)	BRAP (2.7)	APOC1 (2.6)	TRAPPC6A (2.2)	C1orf63 (2.0)	ADAM1 (2.0)	C12orf43 (1.9)	ZHX3 (1.8)	FEN1 (1.6)	POC5 (1.4)
GO:0008565	protein transporter activity	0.24	> 0.20	ATXN2 (2.6)	DDX56 (2.6)	DNM2 (2.4)	CLPTM1 (2.2)	CARM1 (2.2)	OGDH (2.1)	ERP29 (2.0)	ILF3 (2.0)	POLK (2.0)	USP24 (2.0)
ENSG00000117400	MPL PPI subnetwork	0.24	> 0.20	BCL3 (3.3)	COL4A3BP (1.8)	C17orf57 (1.8)	PVR (1.7)	RELB (1.5)	SLC22A1 (1.5)	CYP7A1 (1.5)	BCAM (1.4)	ZNF101 (1.3)	HLX (1.2)
MP:0001648	abnormal apoptosis	0.24	> 0.20	GRINA (3.0)	PSRC1 (2.6)	CLPTM1 (2.1)	PARP10 (1.9)	FEN1 (1.9)	MAFB (1.8)	TRIB1 (1.7)	LPAR2 (1.5)	USP1 (1.5)	APOE (1.3)
MP:0001219	thick epidermis	0.24	> 0.20	CBLC (6.5)	AP1M2 (3.7)	PMFBP1 (2.4)	PLEC (2.1)	CELSR2 (2.0)	NKPD1 (1.9)	CEACAM19 (1.8)	BCAM (1.8)	ZNF101 (1.6)	DNM2 (1.6)
MP:0002136	abnormal kidney physiology	0.24	> 0.20	PLG (3.2)	ANGPTL3 (3.1)	SLC22A1 (2.0)	UBXN2B (2.0)	GRINA (1.9)	BCAM (1.8)	TMEM116 (1.7)	MAFB (1.7)	TM6SF2 (1.5)	CEACAM19 (1.5)
ENSG00000054523	KIF1B PPI subnetwork	0.24	> 0.20	C11orf9 (3.4)	OGDH (3.0)	ZHX3 (3.0)	LDLR (2.8)	COL4A3BP (2.8)	PLEC (2.4)	CBLC (2.4)	SORT1 (2.3)	AP1M2 (2.2)	DNM2 (2.2)
MP:0008466	enlarged mesenteric lymph nodes	0.24	> 0.20	SH2B3 (2.9)	RELB (2.5)	MAFB (1.9)	SLC44A2 (1.9)	RHD (1.9)	DNAH11 (1.8)	PLEKHH2 (1.7)	HAVCR1 (1.6)	MAPKAPK5 (1.6)	PBX4 (1.4)
GO:0070307	lens fiber cell development	0.24	> 0.20	CEACAM19 (1.8)	CILP2 (1.7)	ABO (1.5)	GOT2P1 (1.5)	TMED4 (1.5)	ENSG00000226645 (1.3)	TMEM57 (1.2)	NCAN (1.2)	PBX4 (1.2)	C19orf52 (1.1)
MP:0000492	abnormal rectum morphology	0.24	> 0.20	ANGPTL3 (3.0)	LPA (2.4)	ATXN7L2 (1.9)	LDLR (1.7)	APOC4 (1.6)	MOSC1 (1.5)	ENSG00000238078 (1.5)	PLEKHH2 (1.5)	GOT2P1 (1.5)	UBXN2B (1.4)
MP:0004374	bowed radius	0.24	> 0.20	C11orf9 (2.7)	HMGCR (2.6)	LDLR (2.2)	ALDH2 (2.1)	PCSK9 (2.0)	FADS1 (1.9)	TRAFD1 (1.9)	ENSG00000254235 (1.8)	FADS2 (1.8)	NYNRIN (1.8)
GO:0032757	positive regulation of interleukin-8 production	0.24	> 0.20	ZNF180 (2.6)	FRK (2.0)	PMFBP1 (1.9)	DNAH11 (1.8)	OASL (1.5)	C17orf57 (1.5)	PVR (1.4)	ENSG00000228044 (1.4)	POLK (1.3)	GOT2P1 (1.2)
GO:0000146	microfilament motor activity	0.24	> 0.20	SYPL2 (4.0)	ANKRD31 (1.7)	LDLR (1.6)	AP1M2 (1.5)	BCAM (1.5)	CBLC (1.3)	ENSG00000238078 (1.3)	NPC1L1 (1.2)	C11orf9 (1.2)	FADS2 (1.2)
ENSG00000198242	RPL23A PPI subnetwork	0.24	> 0.20	ZNF259 (3.6)	NAA25 (3.5)	DDX56 (2.8)	QTRT1 (2.7)	GATAD2A (2.6)	SUGP1 (2.0)	TOMM40 (1.9)	C12orf43 (1.8)	ILF3 (1.8)	SARS (1.7)
ENSG00000167996	FTH1 PPI subnetwork	0.24	> 0.20	ALDH2 (2.5)	NCAN (1.8)	ABO (1.8)	ENSG00000226645 (1.8)	FADS2 (1.7)	MARK4 (1.6)	HAPLN4 (1.4)	MAFB (1.3)	TXNL4B (1.3)	TOMM40 (1.3)
ENSG00000110422	HIPK3 PPI subnetwork	0.24	> 0.20	TRAFD1 (2.5)	GOT2P1 (2.3)	FADS2 (1.8)	TSSK6 (1.8)	HNF1A (1.6)	ENSG00000228044 (1.5)	LPIN3 (1.5)	NYNRIN (1.5)	BRAP (1.5)	BLOC1S3 (1.5)
ENSG00000118491	C6orf94 PPI subnetwork	0.24	> 0.20	BCAM (2.9)	SLC44A2 (2.2)	TSSK6 (1.9)	HMGCR (1.9)	ZHX3 (1.8)	FADS1 (1.7)	CBLC (1.7)	FADS2 (1.7)	AP1M2 (1.6)	HAPLN4 (1.3)
ENSG00000169375	SIN3A PPI subnetwork	0.24	> 0.20	CARM1 (4.7)	ATXN2 (3.1)	BRAP (3.1)	DHX38 (3.0)	MAU2 (2.8)	SMARCA4 (2.7)	ILF3 (2.7)	MARK4 (2.2)	GATAD2A (2.2)	DNM2 (2.2)
ENSG00000101665	SMAD7 PPI subnetwork	0.24	> 0.20	PLCG1 (2.9)	POLK (2.3)	ENSG00000226645 (2.2)	ATXN2 (2.2)	MYLIP (2.1)	PLEC (1.9)	MARK4 (1.9)	SH2B3 (1.9)	BUD13 (1.8)	DOCK7 (1.7)
ENSG00000125691	RPL23 PPI subnetwork	0.24	> 0.20	NAA25 (3.1)	ZNF259 (2.7)	DHX38 (2.2)	QTRT1 (2.2)	TOP1 (2.1)	PTPN11 (2.1)	ATP13A1 (2.1)	DDX56 (1.9)	C12orf43 (1.8)	ADAM1 (1.8)
REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS	0.24	> 0.20	CLPTM1 (2.7)	GATAD2A (2.5)	CYB561D1 (2.3)	PVR (2.2)	TMEM50A (2.2)	ANKRD31 (2.0)	MAU2 (1.9)	TMED4 (1.9)	TMEM57 (1.9)	ZNF101 (1.8)
MP:0002442	abnormal leukocyte physiology	0.24	> 0.20	GMIP (4.1)	HLX (3.0)	BCL3 (2.2)	SH2B3 (2.1)	HAVCR1 (2.0)	LPA (2.0)	PARP10 (2.0)	MYLIP (1.8)	RELB (1.7)	CYB561D1 (1.6)
GO:0035821	modification of morphology or physiology of other organism	0.24	> 0.20	HP (2.3)	KANK2 (2.1)	ANKRD31 (2.0)	RHD (2.0)	C1orf63 (1.9)	ENSG00000235545 (1.8)	ENSG00000226645 (1.7)	LPA (1.6)	DHODH (1.5)	ANGPTL3 (1.5)
GO:0051817	modification of morphology or physiology of other organism involved in symbiotic interaction	0.24	> 0.20	HP (2.3)	KANK2 (2.1)	ANKRD31 (2.0)	RHD (2.0)	C1orf63 (1.9)	ENSG00000235545 (1.8)	ENSG00000226645 (1.7)	LPA (1.6)	DHODH (1.5)	ANGPTL3 (1.5)
ENSG00000050748	MAPK9 PPI subnetwork	0.24	> 0.20	TRIB1 (5.9)	PVR (3.0)	SH2B3 (2.9)	POLK (2.2)	LDLR (2.1)	MARK4 (2.0)	ATXN2 (2.0)	MAU2 (2.0)	GATAD2A (1.9)	PLCG1 (1.9)
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.24	> 0.20	KANK2 (3.8)	ITGB3 (3.1)	HLX (2.4)	PLEKHH2 (2.3)	ZHX3 (2.0)	SORT1 (1.8)	BCAM (1.7)	SH2B3 (1.7)	KIAA1324 (1.6)	PTPN11 (1.5)
MP:0008664	decreased interleukin-12 secretion	0.24	> 0.20	RELB (5.3)	BCL3 (3.3)	PVR (2.8)	HLX (2.7)	GMIP (2.6)	TRIB1 (2.2)	HAVCR1 (2.0)	CETP (2.0)	SH2B3 (1.9)	PARP10 (1.7)
GO:0002688	regulation of leukocyte chemotaxis	0.24	> 0.20	TIMD4 (2.5)	ENSG00000228044 (2.3)	ENSG00000238078 (2.0)	ZNF101 (2.0)	MAFB (1.9)	ST3GAL4 (1.8)	APOE (1.8)	CETP (1.8)	PVR (1.7)	TMEM116 (1.6)
GO:0071345	cellular response to cytokine stimulus	0.24	> 0.20	OASL (5.9)	PARP10 (5.5)	TRAFD1 (3.9)	CYB561D1 (2.6)	BCL3 (2.4)	RELB (2.0)	GRINA (1.7)	GMIP (1.6)	CEACAM19 (1.5)	ATP13A1 (1.4)
GO:0070161	anchoring junction	0.24	> 0.20	PLEC (4.2)	BCAM (4.0)	PVRL2 (3.8)	AP1M2 (2.5)	CBLC (2.4)	ITGB3 (2.2)	KANK2 (2.0)	C11orf9 (1.9)	PVR (1.7)	DNM2 (1.7)
MP:0000554	abnormal carpal bone morphology	0.24	> 0.20	PLEKHH2 (3.6)	NYNRIN (2.7)	DNAH11 (2.6)	DYNC2LI1 (2.6)	KANK2 (2.3)	PLCG1 (2.0)	MYLIP (1.9)	GCNT4 (1.4)	CILP2 (1.4)	ATXN7L2 (1.3)
ENSG00000123737	EXOSC9 PPI subnetwork	0.24	> 0.20	DDX56 (4.0)	DHODH (3.3)	QTRT1 (3.3)	ZNF259 (3.2)	NAA25 (2.8)	SUGP1 (2.8)	USP24 (2.7)	TOMM40 (2.6)	DHX38 (2.5)	MAPKAPK5 (2.1)
ENSG00000165782	TMEM55B PPI subnetwork	0.24	> 0.20	ST3GAL4 (2.2)	DNM2 (2.1)	GMIP (2.0)	PMFBP1 (1.9)	ATP13A1 (1.8)	TOP1 (1.7)	RELB (1.7)	NCAN (1.6)	BCL3 (1.5)	CYB561D1 (1.5)
GO:0003705	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	0.24	> 0.20	TRIB1 (3.1)	HNF1A (2.9)	HLX (2.7)	KANK2 (2.4)	ALDH2 (2.0)	ST3GAL4 (1.8)	PVR (1.7)	LPIN3 (1.6)	C11orf9 (1.5)	COL4A3BP (1.5)
ENSG00000102054	RBBP7 PPI subnetwork	0.24	> 0.20	OASL (4.9)	BUD13 (2.6)	GATAD2A (2.4)	SMARCA4 (2.2)	SUGP1 (2.2)	DHX38 (2.2)	ATP13A1 (2.2)	CARM1 (2.0)	ATXN7L2 (2.0)	C19orf52 (1.9)
MP:0002932	abnormal joint morphology	0.24	> 0.20	CILP2 (5.3)	PLEKHH2 (2.2)	PLEC (2.1)	PVR (1.8)	TM6SF2 (1.7)	LPA (1.6)	PLG (1.6)	APOA5 (1.5)	CLPTM1 (1.5)	NPC1L1 (1.4)
MP:0001651	necrosis	0.24	> 0.20	APOB (3.6)	RHD (3.1)	SH2B3 (3.1)	RHCE (3.1)	HLX (3.0)	APOA5 (2.2)	ITGB3 (2.0)	ABCG5 (2.0)	APOC4 (1.6)	TM6SF2 (1.5)
ENSG00000198223	CSF2RA PPI subnetwork	0.24	> 0.20	BCL3 (3.0)	COL4A3BP (1.9)	CYP7A1 (1.9)	HLX (1.8)	C17orf57 (1.6)	PVR (1.6)	SLC22A1 (1.5)	ZNF101 (1.5)	RELB (1.3)	TIMD4 (1.1)
ENSG00000164105	SAP30 PPI subnetwork	0.24	> 0.20	OASL (5.0)	SMARCA4 (3.0)	GATAD2A (2.8)	MAU2 (2.4)	TOP1 (2.4)	SUGP1 (2.3)	BUD13 (2.2)	DNM2 (2.2)	PARP10 (2.1)	ATP13A1 (2.0)
GO:0030099	myeloid cell differentiation	0.24	> 0.20	RHCE (4.3)	RHD (4.2)	SH2B3 (2.3)	HLX (1.9)	ITGB3 (1.7)	TMEM57 (1.6)	DNM2 (1.5)	ZNF101 (1.4)	GEMIN7 (1.3)	C12orf51 (1.3)
ENSG00000126561	STAT5A PPI subnetwork	0.24	> 0.20	PARP10 (2.7)	BCL3 (2.5)	TMEM50A (2.2)	DNM2 (2.1)	USP24 (2.1)	MAU2 (1.8)	HLX (1.7)	RHD (1.7)	PLCG1 (1.6)	SLC44A2 (1.6)
GO:0008210	estrogen metabolic process	0.24	> 0.20	ST3GAL4 (3.2)	NKPD1 (2.0)	FRK (1.9)	TM6SF2 (1.8)	CYB561D1 (1.8)	ABCG5 (1.8)	ABCG8 (1.7)	PMFBP1 (1.7)	CBLC (1.7)	TRAPPC6A (1.7)
MP:0006400	decreased molar number	0.24	> 0.20	ENSG00000235545 (3.0)	GCNT4 (2.8)	MYLIP (2.6)	DNAH11 (2.2)	ABO (1.7)	ENSG00000238078 (1.6)	C19orf52 (1.5)	MAFB (1.3)	ZNF101 (1.2)	ACAD10 (1.1)
GO:0006879	cellular iron ion homeostasis	0.24	> 0.20	TMEM116 (2.8)	RHD (2.5)	RHCE (2.0)	FRK (2.0)	GRINA (1.9)	ERP29 (1.7)	BLOC1S3 (1.5)	MAFB (1.5)	TMEM57 (1.4)	ADAM1 (1.4)
ENSG00000114127	XRN1 PPI subnetwork	0.24	> 0.20	DDX56 (3.2)	SUGP1 (2.9)	TOMM40 (2.9)	GATAD2A (2.9)	DHX38 (2.8)	ILF3 (2.8)	TOP1 (2.6)	SMARCA4 (2.6)	ZNF259 (2.4)	USP24 (2.3)
MP:0009336	increased splenocyte proliferation	0.25	> 0.20	CETP (5.2)	PBX4 (1.9)	RHD (1.9)	HAVCR1 (1.8)	APOC1 (1.8)	DNM2 (1.4)	RHCE (1.4)	FEN1 (1.3)	TOMM40 (1.3)	COL4A3BP (1.3)
ENSG00000137843	PAK6 PPI subnetwork	0.25	> 0.20	TIMD4 (2.8)	CETP (2.7)	OASL (2.6)	KIAA1324 (1.9)	SYPL2 (1.8)	BCAM (1.8)	TMEM50A (1.8)	ANKRD31 (1.8)	ENSG00000238078 (1.7)	C1orf63 (1.7)
MP:0000652	enlarged sebaceous gland	0.25	> 0.20	NKPD1 (2.6)	APOC1 (2.2)	AMIGO1 (2.2)	BLOC1S3 (2.2)	CELSR2 (2.0)	APOE (1.9)	ENSG00000235545 (1.9)	SYPL2 (1.7)	CYB561D1 (1.7)	BCAM (1.6)
ENSG00000060138	CSDA PPI subnetwork	0.25	> 0.20	ADAM1 (3.9)	GOT2P1 (2.6)	BRAP (2.5)	MAPKAPK5 (2.4)	COL4A3BP (2.4)	PTPN11 (2.1)	PCSK9 (2.0)	C12orf47 (1.9)	C11orf9 (1.8)	DNAH11 (1.8)
ENSG00000186193	C9orf140 PPI subnetwork	0.25	> 0.20	MYLIP (3.2)	GCNT4 (2.4)	PLCG1 (2.1)	OGDH (1.8)	GEMIN7 (1.7)	ACAD10 (1.7)	GOT2P1 (1.5)	FRK (1.5)	MAPKAPK5 (1.4)	DNAH11 (1.2)
GO:0030139	endocytic vesicle	0.25	> 0.20	CLPTM1 (3.5)	C11orf9 (2.4)	PPP1R37 (2.3)	NCAN (1.8)	GRINA (1.8)	APOE (1.7)	NPC1L1 (1.7)	YIPF2 (1.7)	SLC44A2 (1.6)	SARS (1.5)
ENSG00000138771	SHROOM3 PPI subnetwork	0.25	> 0.20	CBLC (6.9)	AP1M2 (3.9)	LPAR2 (2.8)	ST3GAL4 (2.2)	HNF1A (1.8)	PVRL2 (1.7)	CELSR2 (1.5)	ALDH2 (1.4)	DNM2 (1.3)	DOCK7 (1.3)
MP:0002989	small kidney	0.25	> 0.20	BCAM (4.7)	PLEKHH2 (3.8)	PVRL2 (3.7)	NYNRIN (3.6)	C11orf9 (2.3)	KANK2 (1.9)	MYLIP (1.8)	TRIB1 (1.7)	MAFB (1.6)	AP1M2 (1.5)
GO:0035265	organ growth	0.25	> 0.20	GCNT4 (2.8)	HAPLN4 (2.0)	ENSG00000235545 (1.9)	NYNRIN (1.9)	PLEKHH2 (1.8)	CEACAM19 (1.8)	DNAH11 (1.7)	ENSG00000226648 (1.6)	LPA (1.4)	C19orf52 (1.4)
GO:0046677	response to antibiotic	0.25	> 0.20	ENSG00000254235 (3.1)	DNAH11 (2.7)	PMFBP1 (2.3)	ZNF180 (2.3)	FRK (2.1)	ZNF101 (2.0)	CEACAM19 (1.8)	ST3GAL4 (1.6)	ENSG00000235545 (1.4)	GCNT4 (1.4)
ENSG00000021488	SLC7A9 PPI subnetwork	0.25	> 0.20	ABO (2.9)	NPC1L1 (2.4)	ZNF180 (2.2)	TM6SF2 (1.8)	COL4A3BP (1.7)	ABCG5 (1.6)	TOP1 (1.6)	PSMA5 (1.4)	ANGPTL3 (1.4)	CYB561D1 (1.3)
ENSG00000130589	RP4-697K14.7 PPI subnetwork	0.25	> 0.20	USP24 (2.8)	MARK4 (2.7)	ATXN2 (2.6)	MAU2 (2.6)	SMARCA4 (2.3)	PARP10 (2.1)	BCL3 (2.1)	DHX38 (1.9)	GMIP (1.8)	C12orf51 (1.7)
MP:0000783	abnormal forebrain morphology	0.25	> 0.20	NYNRIN (2.1)	PLCG1 (2.1)	GATAD2A (1.9)	NCAN (1.8)	DHX38 (1.8)	DOCK7 (1.6)	PBX4 (1.5)	DHODH (1.5)	TMEM57 (1.4)	CILP2 (1.3)
ENSG00000083312	TNPO1 PPI subnetwork	0.25	> 0.20	NAA25 (2.3)	DDX56 (2.2)	GMPR (2.2)	GATAD2A (1.8)	ILF3 (1.8)	QTRT1 (1.8)	ERP29 (1.7)	TOMM40 (1.7)	AP1M2 (1.6)	KIAA1324 (1.5)
ENSG00000135829	DHX9 PPI subnetwork	0.25	> 0.20	ILF3 (4.0)	C1orf63 (3.6)	SMARCA4 (3.1)	TOP1 (3.1)	USP1 (3.0)	QTRT1 (2.6)	FEN1 (2.4)	DHX38 (2.3)	SUGP1 (2.2)	GATAD2A (2.2)
ENSG00000078900	TP73 PPI subnetwork	0.25	> 0.20	ATXN2 (3.9)	C12orf51 (3.2)	C12orf43 (3.2)	C11orf9 (2.6)	MAPKAPK5 (2.5)	POLK (2.5)	PTPN11 (2.4)	NYNRIN (2.2)	PVRL2 (2.1)	ADAM1 (2.0)
ENSG00000065526	SPEN PPI subnetwork	0.25	> 0.20	GMIP (3.2)	GATAD2A (2.9)	MAFB (2.5)	TOP1 (2.3)	MARK4 (2.3)	OASL (2.2)	PSRC1 (2.2)	BCL3 (2.2)	USP24 (2.1)	CARM1 (1.8)
REACTOME_CDK:MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	REACTOME_CDK:MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	0.25	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.4)	PARP10 (1.9)	DDX56 (1.8)	SUGP1 (1.8)	TOMM40 (1.6)	SARS (1.4)	TMEM50A (1.2)
MP:0000157	abnormal sternum morphology	0.25	> 0.20	NYNRIN (4.7)	PVRL2 (2.9)	TRIB1 (2.7)	PLEKHH2 (2.2)	PVR (2.2)	C11orf9 (1.6)	LDLR (1.5)	DOCK7 (1.5)	SYPL2 (1.4)	GOT2P1 (1.3)
MP:0002703	abnormal renal tubule morphology	0.25	> 0.20	NYNRIN (2.8)	PLEKHH2 (2.5)	TMEM116 (1.7)	MAFB (1.6)	DYNC2LI1 (1.6)	BCAM (1.6)	KANK2 (1.5)	TRIB1 (1.5)	FRK (1.4)	ABCG5 (1.4)
MP:0003009	abnormal cytokine secretion	0.25	> 0.20	RELB (4.5)	BCL3 (3.4)	PARP10 (3.2)	TRIB1 (3.0)	GMIP (2.9)	TRAFD1 (2.6)	MAFB (2.3)	OASL (1.9)	TIMD4 (1.4)	SH2B3 (1.3)
REACTOME_MUSCLE_CONTRACTION	REACTOME_MUSCLE_CONTRACTION	0.25	> 0.20	SYPL2 (6.1)	GMPR (2.8)	KANK2 (2.7)	ITGB3 (1.5)	PVRL2 (1.5)	SORT1 (1.4)	UBXN2B (1.3)	C17orf57 (1.2)	TMEM50A (1.2)	HNF1A (1.1)
GO:0042430	indole-containing compound metabolic process	0.25	> 0.20	ENSG00000254235 (4.0)	CYP7A1 (2.4)	LPA (2.3)	CYB561D1 (2.2)	SLC22A1 (2.2)	GOT2P1 (2.1)	FRK (2.1)	APOA5 (1.7)	DYNC2LI1 (1.7)	ATXN7L2 (1.5)
GO:0006586	indolalkylamine metabolic process	0.25	> 0.20	ENSG00000254235 (4.0)	CYP7A1 (2.4)	LPA (2.3)	CYB561D1 (2.2)	SLC22A1 (2.2)	GOT2P1 (2.1)	FRK (2.1)	APOA5 (1.7)	DYNC2LI1 (1.7)	ATXN7L2 (1.5)
ENSG00000089693	MLF2 PPI subnetwork	0.25	> 0.20	HAVCR1 (2.5)	PSMA5 (2.2)	OGDH (2.1)	HMGCR (2.1)	GPAM (1.9)	GMPR (1.9)	FADS1 (1.8)	TMEM116 (1.6)	USP24 (1.6)	LDLR (1.6)
ENSG00000075151	EIF4G3 PPI subnetwork	0.25	> 0.20	NAA25 (4.5)	TOP1 (3.8)	ZNF259 (3.8)	QTRT1 (3.5)	DDX56 (3.3)	TOMM40 (3.0)	CARM1 (2.9)	GATAD2A (2.7)	DHODH (2.6)	ILF3 (2.5)
ENSG00000136936	XPA PPI subnetwork	0.25	> 0.20	FEN1 (3.3)	NT5DC1 (2.6)	SUGP1 (2.4)	POC5 (2.3)	POLK (1.8)	USP1 (1.7)	DHODH (1.6)	NYNRIN (1.6)	MAPKAPK5 (1.6)	BUD13 (1.5)
ENSG00000172053	QARS PPI subnetwork	0.25	> 0.20	SARS (5.4)	NAA25 (3.8)	QTRT1 (3.4)	DDX56 (2.4)	PLEC (2.2)	ATP13A1 (2.2)	ZNF259 (2.2)	PSMA5 (2.1)	RELB (2.1)	GCNT4 (1.8)
ENSG00000159346	ADIPOR1 PPI subnetwork	0.25	> 0.20	TIMD4 (3.6)	OASL (2.6)	CETP (2.4)	MOSC1 (2.1)	SYPL2 (2.0)	C1orf63 (1.4)	ATXN7L2 (1.4)	TMEM50A (1.3)	DNAH11 (1.3)	ANKRD31 (1.3)
REACTOME_INTERFERON_GAMMA_SIGNALING	REACTOME_INTERFERON_GAMMA_SIGNALING	0.25	> 0.20	TRAFD1 (6.6)	PARP10 (6.2)	OASL (4.9)	BCL3 (3.6)	RELB (3.3)	SH2B3 (1.8)	ADAM1 (1.7)	GRINA (1.6)	APOE (1.5)	ALDH2 (1.4)
GO:0005544	calcium-dependent phospholipid binding	0.25	> 0.20	PLEC (3.5)	HAPLN4 (2.7)	RPH3A (2.7)	HLX (2.5)	ALDH2 (2.4)	C11orf9 (2.1)	PVR (1.9)	DYNC2LI1 (1.7)	AMIGO1 (1.7)	NPC1L1 (1.6)
GO:0016765	transferase activity, transferring alkyl or aryl (other than methyl) groups	0.25	> 0.20	HMGCR (4.0)	PCSK9 (3.5)	LDLR (3.5)	FADS1 (3.0)	FADS2 (2.1)	NT5DC1 (2.1)	ALDH2 (1.9)	GPAM (1.8)	YIPF2 (1.8)	PSMA5 (1.7)
GO:0006518	peptide metabolic process	0.25	> 0.20	GOT2P1 (3.4)	KIAA1324 (3.1)	ERP29 (2.7)	TM6SF2 (2.4)	NT5DC1 (2.2)	NPC1L1 (2.1)	ALDH2 (2.0)	TMED4 (2.0)	ABCG8 (1.9)	AMIGO1 (1.9)
GO:0016577	histone demethylation	0.25	> 0.20	TMEM57 (3.0)	ATXN7L2 (2.5)	BLOC1S3 (2.4)	ENSG00000254235 (2.3)	C12orf47 (2.1)	LPAR2 (2.1)	GCNT4 (1.9)	C12orf51 (1.8)	TOP1 (1.7)	LPA (1.7)
GO:0006109	regulation of carbohydrate metabolic process	0.25	> 0.20	ENSG00000254235 (3.9)	HNF1A (2.5)	GPAM (2.4)	CYP7A1 (2.3)	ENSG00000238078 (2.3)	LPA (2.3)	PCSK9 (2.1)	TMEM116 (1.8)	KANK2 (1.7)	ZHX3 (1.7)
GO:0032844	regulation of homeostatic process	0.25	> 0.20	ENSG00000226648 (3.4)	RHCE (2.3)	ENSG00000235545 (2.2)	ABO (2.0)	HAVCR1 (1.9)	RHD (1.7)	PLCG1 (1.7)	MARK4 (1.6)	MYLIP (1.5)	NYNRIN (1.5)
ENSG00000138642	HERC6 PPI subnetwork	0.25	> 0.20	GOT2P1 (2.7)	BLOC1S3 (2.6)	TMEM57 (2.4)	CLPTM1 (2.1)	AMIGO1 (1.9)	ENSG00000238078 (1.9)	GRINA (1.9)	ERP29 (1.8)	OGDH (1.8)	NKPD1 (1.8)
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	0.25	> 0.20	FRK (2.9)	TSSK6 (2.6)	MAU2 (2.2)	RELB (2.1)	SH2B3 (2.1)	GMIP (1.9)	LPAR2 (1.8)	OASL (1.8)	UBXN2B (1.7)	ENSG00000226645 (1.7)
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX	REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX	0.25	> 0.20	FRK (2.9)	TSSK6 (2.6)	MAU2 (2.2)	RELB (2.1)	SH2B3 (2.1)	GMIP (1.9)	LPAR2 (1.8)	OASL (1.8)	UBXN2B (1.7)	ENSG00000226645 (1.7)
MP:0010909	pulmonary alveolar hemorrhage	0.25	> 0.20	PVRL2 (2.6)	PVR (2.3)	BCL3 (2.3)	PBX4 (2.2)	ENSG00000238078 (1.9)	CYB561D1 (1.8)	KIAA1324 (1.7)	BCAM (1.6)	AMIGO1 (1.6)	SORT1 (1.5)
ENSG00000197045	GMFB PPI subnetwork	0.25	> 0.20	KANK2 (2.7)	TRAFD1 (2.4)	PLEC (2.2)	TM6SF2 (2.1)	PVRL2 (2.0)	GATAD2A (1.9)	HLX (1.8)	CARM1 (1.8)	ABO (1.8)	DNM2 (1.7)
KEGG_SPHINGOLIPID_METABOLISM	KEGG_SPHINGOLIPID_METABOLISM	0.25	> 0.20	NKPD1 (5.7)	HNF1A (3.6)	COL4A3BP (3.0)	TMEM50A (2.9)	HAPLN4 (2.6)	LPIN3 (2.5)	ABCG8 (2.4)	TM6SF2 (2.4)	TMED4 (2.3)	ABCG5 (2.1)
ENSG00000136807	CDK9 PPI subnetwork	0.25	> 0.20	BUD13 (2.8)	DNM2 (2.8)	DHX38 (2.3)	CARM1 (2.1)	ATXN2 (2.1)	SMARCA4 (2.1)	GEMIN7 (2.0)	SUGP1 (2.0)	TOP1 (1.8)	PSMA5 (1.8)
ENSG00000112357	PEX7 PPI subnetwork	0.25	> 0.20	NT5DC1 (3.8)	MAPKAPK5 (2.1)	ACAD10 (1.9)	FRK (1.9)	LPAR2 (1.8)	PSMA5 (1.8)	DYNC2LI1 (1.6)	DHX38 (1.6)	OGDH (1.6)	TRAFD1 (1.6)
GO:0050766	positive regulation of phagocytosis	0.25	> 0.20	PMFBP1 (2.3)	UBXN2B (2.2)	HP (2.2)	GOT2P1 (1.9)	TMED4 (1.9)	CILP2 (1.9)	MAFB (1.8)	LPA (1.7)	ENSG00000235545 (1.7)	CEACAM19 (1.6)
GO:0051918	negative regulation of fibrinolysis	0.25	> 0.20	ANGPTL3 (4.7)	PLG (3.6)	APOC4 (3.4)	APOA5 (3.4)	PCSK9 (3.3)	HP (3.0)	SLC22A1 (2.7)	CEACAM19 (2.3)	APOB (2.3)	APOC1 (2.0)
ENSG00000138592	USP8 PPI subnetwork	0.25	> 0.20	CBLC (5.1)	AP1M2 (3.8)	LPAR2 (3.5)	DNM2 (3.3)	PLEC (2.4)	SLC44A2 (2.1)	C12orf51 (2.1)	PVRL2 (2.0)	MARK4 (2.0)	CELSR2 (1.8)
ENSG00000171862	PTEN PPI subnetwork	0.25	> 0.20	KIAA1324 (2.9)	PLEC (2.7)	CARM1 (2.2)	BCAM (2.2)	SH2B3 (2.1)	PPP1R37 (2.0)	KANK2 (1.8)	DNM2 (1.7)	MYLIP (1.7)	GATAD2A (1.5)
ENSG00000001167	NFYA PPI subnetwork	0.25	> 0.20	PPP1R37 (2.9)	TRIB1 (2.5)	AMIGO1 (2.5)	USP1 (2.3)	ADAM1 (2.2)	PVR (2.2)	PTPN11 (2.0)	HNF1A (1.8)	PSRC1 (1.7)	BLOC1S3 (1.7)
ENSG00000111537	IFNG PPI subnetwork	0.25	> 0.20	BCL3 (3.4)	HLX (2.9)	ALDH2 (2.6)	TIMD4 (2.5)	CETP (2.5)	RELB (2.2)	GMIP (1.5)	ST3GAL4 (1.3)	PARP10 (1.3)	LPA (1.3)
MP:0002691	small stomach	0.25	> 0.20	RELB (3.1)	ABO (2.6)	LDLR (2.1)	C11orf9 (2.1)	YIPF2 (2.0)	SMARCA4 (2.0)	LPAR2 (1.9)	CBLC (1.8)	ALDH2 (1.8)	C19orf52 (1.8)
ENSG00000118495	PLAGL1 PPI subnetwork	0.25	> 0.20	CYP7A1 (3.0)	UBXN2B (2.9)	KIAA1324 (2.7)	MYLIP (2.2)	LPA (2.1)	MOSC1 (2.0)	ATXN2 (1.8)	TRIB1 (1.8)	BCL3 (1.7)	GPAM (1.7)
ENSG00000165309	ARMC3 PPI subnetwork	0.25	> 0.20	GCNT4 (2.4)	SLC22A1 (2.3)	GOT2P1 (2.3)	PVR (2.0)	DNAH11 (2.0)	LPA (1.9)	DDX56 (1.7)	NT5DC1 (1.6)	ENSG00000226648 (1.6)	NPC1L1 (1.6)
ENSG00000006468	ETV1 PPI subnetwork	0.25	> 0.20	GMIP (3.4)	OGDH (2.6)	YIPF2 (2.6)	DNM2 (2.5)	TOP1 (2.5)	GRINA (2.4)	BCL3 (2.3)	ZHX3 (2.1)	C1orf63 (1.9)	SH2B3 (1.9)
ENSG00000119689	DLST PPI subnetwork	0.25	> 0.20	ZHX3 (2.4)	PLEC (2.4)	GATAD2A (2.2)	ATXN2 (2.2)	ENSG00000238078 (2.1)	USP24 (2.1)	OGDH (2.1)	NAA25 (1.9)	DDX56 (1.8)	SH2B3 (1.7)
MP:0003324	increased liver adenoma incidence	0.25	> 0.20	TMEM57 (2.9)	ZNF180 (2.7)	MYLIP (2.2)	ANGPTL3 (2.1)	CYP7A1 (2.1)	AMIGO1 (1.9)	PARP10 (1.8)	NT5DC1 (1.7)	BRAP (1.5)	TSSK6 (1.4)
ENSG00000075914	EXOSC7 PPI subnetwork	0.25	> 0.20	SUGP1 (3.5)	DHODH (2.9)	DDX56 (2.8)	GRINA (2.3)	TRAPPC6A (2.3)	ZNF259 (2.2)	POC5 (2.1)	TMEM57 (1.9)	CEACAM19 (1.8)	SARS (1.6)
GO:0051879	Hsp90 protein binding	0.25	> 0.20	HLX (2.8)	C1orf63 (2.0)	ENSG00000228044 (1.9)	TMEM50A (1.9)	FRK (1.7)	OGDH (1.4)	ITGB3 (1.4)	CLPTM1 (1.3)	CETP (1.2)	PLEKHH2 (1.2)
ENSG00000107371	EXOSC3 PPI subnetwork	0.25	> 0.20	DDX56 (4.5)	SUGP1 (3.6)	DHODH (3.6)	NAA25 (3.3)	C12orf43 (3.1)	ZNF259 (2.8)	USP24 (2.8)	DHX38 (2.6)	QTRT1 (2.5)	BRAP (2.4)
ENSG00000044446	PHKA2 PPI subnetwork	0.25	> 0.20	ZNF180 (2.6)	ENSG00000238078 (2.3)	SORT1 (1.8)	NYNRIN (1.6)	MOSC1 (1.6)	TXNL4B (1.5)	ZHX3 (1.5)	MYLIP (1.4)	GMPR (1.4)	KIAA1324 (1.3)
ENSG00000105726	ATP13A1 PPI subnetwork	0.25	> 0.20	TMEM57 (3.8)	CYB561D1 (2.9)	TMEM50A (2.8)	TMED4 (2.5)	YIPF2 (2.3)	TSSK6 (2.1)	CLPTM1 (1.7)	QTRT1 (1.6)	NT5DC1 (1.6)	TXNL4B (1.5)
ENSG00000204256	BRD2 PPI subnetwork	0.25	> 0.20	BUD13 (3.4)	SMARCA4 (2.9)	ATXN2 (2.4)	TXNL4B (2.3)	USP1 (2.3)	PSRC1 (1.8)	TMED4 (1.7)	TMEM116 (1.6)	MAPKAPK5 (1.5)	DHX38 (1.5)
ENSG00000215077	BRD2 PPI subnetwork	0.25	> 0.20	BUD13 (3.4)	SMARCA4 (2.9)	ATXN2 (2.4)	TXNL4B (2.3)	USP1 (2.3)	PSRC1 (1.8)	TMED4 (1.7)	TMEM116 (1.6)	MAPKAPK5 (1.5)	DHX38 (1.5)
ENSG00000112526	ENSG00000112526 PPI subnetwork	0.25	> 0.20	BUD13 (3.4)	SMARCA4 (2.9)	ATXN2 (2.4)	TXNL4B (2.3)	USP1 (2.3)	PSRC1 (1.8)	TMED4 (1.7)	TMEM116 (1.6)	MAPKAPK5 (1.5)	DHX38 (1.5)
MP:0003453	abnormal keratinocyte physiology	0.25	> 0.20	CBLC (3.8)	PLEC (3.4)	BCL3 (2.9)	PVRL2 (2.6)	CEACAM19 (2.1)	HNF1A (2.1)	BCAM (2.0)	OASL (1.7)	NKPD1 (1.6)	LDLR (1.5)
ENSG00000155926	SLA PPI subnetwork	0.25	> 0.20	PLCG1 (3.0)	HAVCR1 (2.6)	SLC44A2 (2.2)	ZNF101 (2.0)	BUD13 (1.8)	LPAR2 (1.7)	C19orf52 (1.6)	PVR (1.6)	ENSG00000226645 (1.6)	GMIP (1.5)
ENSG00000134058	CDK7 PPI subnetwork	0.25	> 0.20	BUD13 (2.5)	ZNF259 (2.3)	FEN1 (2.1)	POC5 (2.0)	SUGP1 (2.0)	USP1 (1.9)	MAPKAPK5 (1.9)	SMARCA4 (1.7)	CARM1 (1.7)	POLK (1.6)
GO:0046966	thyroid hormone receptor binding	0.25	> 0.20	C12orf51 (2.8)	TRAFD1 (2.7)	USP24 (2.1)	SMARCA4 (2.0)	ATXN2 (1.9)	MAPKAPK5 (1.9)	DHX38 (1.8)	DOCK7 (1.6)	PSMA5 (1.6)	GMIP (1.5)
ENSG00000088356	PDRG1 PPI subnetwork	0.25	> 0.20	DYNC2LI1 (3.2)	DHODH (2.6)	POC5 (2.4)	ATXN2 (2.3)	BLOC1S3 (2.2)	QTRT1 (2.2)	MARK4 (2.2)	TOMM40 (2.1)	ZNF180 (2.1)	GEMIN7 (2.1)
GO:0006917	induction of apoptosis	0.25	> 0.20	ENSG00000238078 (2.8)	ZNF101 (2.7)	POLK (2.4)	BLOC1S3 (2.1)	PARP10 (2.0)	MARK4 (1.9)	CYB561D1 (1.9)	C12orf43 (1.6)	TRAFD1 (1.6)	CEACAM19 (1.5)
ENSG00000143153	ATP1B1 PPI subnetwork	0.25	> 0.20	NPC1L1 (5.3)	TM6SF2 (3.8)	ABCG5 (3.2)	AP1M2 (2.7)	ABCG8 (2.6)	APOB (2.4)	SARS (2.2)	TMEM50A (2.0)	MAFB (1.9)	FRK (1.9)
MP:0002398	abnormal bone marrow cell morphology/development	0.25	> 0.20	BCL3 (2.8)	PVR (2.6)	RHD (2.5)	GMIP (2.4)	RELB (2.4)	PARP10 (2.3)	CETP (2.0)	HP (2.0)	TOP1 (1.9)	HLX (1.8)
GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	0.25	> 0.20	KANK2 (2.9)	ENSG00000226645 (2.4)	GCNT4 (2.3)	TMED4 (2.2)	ENSG00000254235 (2.0)	NYNRIN (1.9)	C19orf52 (1.9)	DNM2 (1.6)	GATAD2A (1.5)	SLC44A2 (1.5)
ENSG00000128408	RIBC2 PPI subnetwork	0.25	> 0.20	LPAR2 (3.4)	CELSR2 (3.3)	YIPF2 (2.6)	TSSK6 (2.4)	UBXN2B (2.3)	PLCG1 (2.3)	C17orf57 (2.3)	SUGP1 (2.1)	RELB (2.1)	ANKRD31 (2.0)
ENSG00000106992	AK1 PPI subnetwork	0.25	> 0.20	USP24 (3.9)	DNM2 (3.6)	PLEC (3.1)	GMIP (2.7)	COL4A3BP (2.6)	POLK (2.0)	SORT1 (1.9)	CELSR2 (1.8)	ALDH2 (1.8)	C12orf51 (1.7)
ENSG00000124575	HIST1H1D PPI subnetwork	0.25	> 0.20	SYPL2 (3.5)	GMPR (3.1)	TMEM50A (2.1)	BCAM (2.0)	ACAD10 (1.7)	OGDH (1.7)	PSMA5 (1.6)	C1orf63 (1.5)	KANK2 (1.5)	RHD (1.5)
GO:0003281	ventricular septum development	0.25	> 0.20	ENSG00000238078 (3.7)	ATXN7L2 (3.2)	NYNRIN (2.5)	ZNF180 (2.0)	PVRL2 (2.0)	C19orf52 (1.8)	C11orf9 (1.6)	PBX4 (1.6)	BLOC1S3 (1.5)	C17orf57 (1.4)
ENSG00000007174	DNAH9 PPI subnetwork	0.25	> 0.20	USP24 (2.8)	MAU2 (2.7)	PARP10 (2.7)	MARK4 (2.6)	BCL3 (2.4)	SMARCA4 (2.3)	ATXN2 (2.2)	GMIP (2.1)	DHX38 (1.9)	C12orf51 (1.8)
ENSG00000028839	TBPL1 PPI subnetwork	0.25	> 0.20	OGDH (3.3)	C19orf52 (2.6)	CLPTM1 (2.6)	ST3GAL4 (2.2)	TXNL4B (2.1)	ERP29 (2.0)	LDLR (1.8)	ENSG00000226648 (1.8)	ACAD10 (1.7)	C17orf57 (1.7)
MP:0002095	abnormal skin pigmentation	0.25	> 0.20	RHCE (3.4)	RHD (3.2)	PLEKHH2 (2.8)	GMPR (2.5)	ENSG00000235545 (2.1)	HAVCR1 (2.1)	DOCK7 (2.0)	MYLIP (1.8)	CEACAM19 (1.6)	CELSR2 (1.4)
GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	0.25	> 0.20	ENSG00000235545 (3.1)	TMED4 (2.4)	AMIGO1 (2.2)	C12orf47 (2.2)	GOT2P1 (2.0)	LPIN3 (1.8)	C17orf57 (1.8)	ZHX3 (1.7)	ENSG00000228044 (1.7)	TM6SF2 (1.6)
ENSG00000122566	HNRNPA2B1 PPI subnetwork	0.25	> 0.20	ILF3 (3.8)	C1orf63 (3.8)	SMARCA4 (3.0)	TOP1 (2.9)	TOMM40 (2.3)	USP1 (2.1)	QTRT1 (2.0)	BUD13 (2.0)	SUGP1 (1.9)	DHX38 (1.9)
ENSG00000106070	GRB10 PPI subnetwork	0.25	> 0.20	HLX (2.9)	CETP (2.5)	SH2B3 (2.4)	GPAM (2.0)	ANKRD31 (1.7)	LPIN3 (1.7)	NPC1L1 (1.6)	LPA (1.4)	USP24 (1.4)	FADS2 (1.3)
ENSG00000074201	CLNS1A PPI subnetwork	0.25	> 0.20	ITGB3 (3.0)	NYNRIN (2.6)	BUD13 (2.5)	GOT2P1 (2.3)	ZNF259 (2.3)	PSMA5 (2.2)	SARS (2.2)	ILF3 (2.2)	TOMM40 (1.8)	USP1 (1.8)
GO:0044144	modulation of growth of symbiont involved in interaction with host	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044126	regulation of growth of symbiont in host	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044110	growth involved in symbiotic interaction	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044117	growth of symbiont in host	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044146	negative regulation of growth of symbiont involved in interaction with host	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044130	negative regulation of growth of symbiont in host	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
GO:0044116	growth of symbiont involved in interaction with host	0.25	> 0.20	DNAH11 (2.9)	HP (2.7)	RHD (2.6)	TIMD4 (2.2)	RHCE (2.2)	GOT2P1 (1.8)	CETP (1.8)	MOSC1 (1.5)	TRAFD1 (1.5)	SLC22A1 (1.4)
ENSG00000131876	SNRPA1 PPI subnetwork	0.25	> 0.20	ILF3 (3.8)	SUGP1 (3.4)	C1orf63 (3.3)	DHX38 (3.3)	BUD13 (3.3)	TOP1 (2.8)	SMARCA4 (2.7)	USP1 (2.5)	FEN1 (2.5)	QTRT1 (2.2)
ENSG00000160633	SAFB PPI subnetwork	0.25	> 0.20	C1orf63 (5.0)	TOP1 (3.2)	GATAD2A (3.0)	QTRT1 (2.9)	ATXN2 (2.6)	ILF3 (2.6)	ADAM1 (2.0)	ACAD10 (2.0)	AP1M2 (1.9)	BRAP (1.9)
MP:0005036	diarrhea	0.25	> 0.20	BCL3 (3.6)	RELB (2.7)	PARP10 (2.3)	NPC1L1 (2.3)	UBXN2B (2.3)	ST3GAL4 (2.2)	ABCG5 (1.8)	KIAA1324 (1.8)	TM6SF2 (1.7)	ABO (1.6)
MP:0005029	abnormal amnion morphology	0.25	> 0.20	C17orf57 (2.7)	HLX (2.3)	GEMIN7 (2.3)	TRAPPC6A (2.0)	KANK2 (2.0)	PTPN11 (1.8)	PSRC1 (1.7)	UBXN2B (1.6)	HNF1A (1.6)	POLK (1.5)
GO:0005665	DNA-directed RNA polymerase II, core complex	0.25	> 0.20	GEMIN7 (4.9)	TOMM40 (3.1)	CLPTM1 (2.5)	QTRT1 (2.3)	MARK4 (1.9)	DHX38 (1.7)	PVRL2 (1.5)	UBXN2B (1.5)	SUGP1 (1.5)	TRAPPC6A (1.4)
MP:0001541	abnormal osteoclast physiology	0.25	> 0.20	ITGB3 (2.7)	MAFB (2.7)	CILP2 (2.5)	MYLIP (2.2)	TRIB1 (2.1)	C17orf57 (1.9)	APOE (1.8)	GMIP (1.8)	SH2B3 (1.6)	BCL3 (1.5)
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	0.25	> 0.20	GMIP (4.4)	SH2B3 (3.1)	RELB (3.0)	GATAD2A (2.4)	MYLIP (2.3)	GEMIN7 (2.0)	MAFB (1.7)	ENSG00000226645 (1.6)	SLC44A2 (1.5)	CARM1 (1.4)
GO:0048659	smooth muscle cell proliferation	0.25	> 0.20	PVR (2.6)	HLX (2.0)	ENSG00000228044 (1.9)	MAFB (1.8)	TRIB1 (1.7)	ZNF101 (1.7)	ALDH2 (1.6)	PLEKHH2 (1.5)	NYNRIN (1.4)	ENSG00000254235 (1.4)
ENSG00000117594	HSD11B1 PPI subnetwork	0.25	> 0.20	DHX38 (4.5)	USP24 (3.4)	DDX56 (3.4)	SUGP1 (3.3)	C12orf43 (2.9)	DHODH (2.6)	NAA25 (2.2)	ZNF259 (2.0)	SARS (2.0)	TMEM57 (1.8)
ENSG00000184900	SUMO3 PPI subnetwork	0.25	> 0.20	SMARCA4 (2.5)	ENSG00000238078 (2.4)	CETP (2.2)	PPP1R37 (2.1)	NCAN (1.8)	MAPKAPK5 (1.8)	TRIB1 (1.8)	PLCG1 (1.6)	RHD (1.6)	ADAM1 (1.5)
GO:0060412	ventricular septum morphogenesis	0.25	> 0.20	ENSG00000238078 (3.4)	C19orf52 (2.7)	ABO (2.5)	ATXN7L2 (2.2)	C11orf9 (2.0)	ENSG00000235545 (1.9)	ZNF180 (1.8)	C17orf57 (1.7)	ABCG8 (1.7)	NYNRIN (1.6)
ENSG00000147885	IFNA16 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000188379	IFNA2 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000137080	IFNA21 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000120247	ENSG00000120247 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000186803	IFNA10 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000120242	IFNA8 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000186809	ENSG00000186809 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000147873	IFNA5 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000147877	ENSG00000147877 PPI subnetwork	0.25	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	GMIP (2.1)	CETP (2.1)	ALDH2 (1.8)	LPA (1.6)	PARP10 (1.5)	PVRL2 (1.4)
ENSG00000120500	ARR3 PPI subnetwork	0.25	> 0.20	LPA (2.9)	MARK4 (2.5)	SH2B3 (2.0)	FADS2 (2.0)	ENSG00000228044 (1.8)	COL4A3BP (1.8)	PPP1R37 (1.8)	CARM1 (1.7)	OGDH (1.5)	GOT2P1 (1.3)
MP:0008115	abnormal dendritic cell differentiation	0.25	> 0.20	BCL3 (3.3)	HLX (2.2)	GMIP (2.1)	C12orf47 (2.1)	ENSG00000228044 (2.1)	PARP10 (2.0)	NYNRIN (1.8)	TRAFD1 (1.6)	LPA (1.6)	RELB (1.6)
MP:0008181	increased marginal zone B cell number	0.25	> 0.20	TIMD4 (3.7)	RELB (3.3)	CETP (3.1)	GMIP (3.1)	APOC1 (3.0)	SH2B3 (2.9)	MAFB (2.5)	APOE (1.6)	TRAPPC6A (1.5)	ZNF101 (1.5)
ENSG00000117395	EBNA1BP2 PPI subnetwork	0.25	> 0.20	NAA25 (4.7)	ZNF259 (4.7)	DDX56 (3.9)	TOMM40 (3.7)	QTRT1 (3.6)	DHODH (3.1)	DHX38 (2.4)	C12orf43 (2.4)	ILF3 (2.3)	ATP13A1 (2.2)
ENSG00000177105	RHOG PPI subnetwork	0.25	> 0.20	OGDH (1.9)	MARK4 (1.9)	CLPTM1 (1.8)	GOT2P1 (1.8)	BCL3 (1.8)	DNM2 (1.8)	POC5 (1.6)	GATAD2A (1.5)	PVRL2 (1.4)	C11orf9 (1.3)
MP:0001931	abnormal oogenesis	0.25	> 0.20	GOT2P1 (2.1)	LPIN3 (1.9)	TMEM116 (1.6)	NPC1L1 (1.5)	HAVCR1 (1.4)	NKPD1 (1.4)	CEACAM19 (1.4)	TIMD4 (1.2)	ENSG00000226645 (1.2)	ANKRD31 (1.1)
ENSG00000028528	SNX1 PPI subnetwork	0.25	> 0.20	HAVCR1 (3.0)	ENSG00000235545 (2.3)	SARS (2.3)	ABO (1.8)	DHODH (1.8)	POC5 (1.7)	TMEM50A (1.7)	DOCK7 (1.7)	COL4A3BP (1.6)	TOP1 (1.6)
ENSG00000120071	KIAA1267 PPI subnetwork	0.25	> 0.20	OGDH (2.6)	C12orf43 (2.5)	GEMIN7 (2.5)	ATXN2 (2.3)	BUD13 (2.2)	QTRT1 (2.1)	GOT2P1 (2.0)	SUGP1 (1.9)	MAPKAPK5 (1.7)	C19orf52 (1.7)
ENSG00000101146	RAE1 PPI subnetwork	0.25	> 0.20	NAA25 (4.1)	DOCK7 (2.9)	USP24 (2.8)	DDX56 (2.8)	USP1 (2.8)	BUD13 (2.6)	POC5 (2.5)	TOP1 (2.4)	DHX38 (2.1)	ZNF259 (2.1)
GO:0006071	glycerol metabolic process	0.25	> 0.20	TM6SF2 (3.5)	ENSG00000254235 (3.0)	ENSG00000226645 (2.7)	GCNT4 (2.6)	ABCG8 (2.4)	MOSC1 (2.3)	HAPLN4 (1.9)	PMFBP1 (1.9)	GPAM (1.9)	CBLC (1.8)
ENSG00000070882	OSBPL3 PPI subnetwork	0.25	> 0.20	ZHX3 (3.9)	CARM1 (3.5)	DNM2 (3.4)	PLEC (3.2)	LPAR2 (2.8)	GPAM (2.7)	USP24 (2.6)	OGDH (2.6)	AP1M2 (2.4)	CBLC (2.4)
REACTOME_PYRIMIDINE_CATABOLISM	REACTOME_PYRIMIDINE_CATABOLISM	0.25	> 0.20	PLG (5.4)	APOC4 (4.8)	ANGPTL3 (4.8)	SLC22A1 (3.8)	APOA5 (3.1)	LPA (3.0)	CYP7A1 (2.9)	HP (1.7)	GEMIN7 (1.5)	TRAPPC6A (1.5)
ENSG00000100453	GZMB PPI subnetwork	0.25	> 0.20	ENSG00000228044 (2.7)	UBXN2B (2.1)	ABCG8 (2.0)	TMEM57 (1.9)	FRK (1.9)	TMEM50A (1.6)	TRAFD1 (1.6)	RPH3A (1.4)	TXNL4B (1.4)	BUD13 (1.4)
GO:0044236	multicellular organismal metabolic process	0.25	> 0.20	FRK (3.3)	CEACAM19 (3.0)	ENSG00000228044 (2.4)	NPC1L1 (1.9)	ENSG00000226645 (1.8)	PLEKHH2 (1.7)	C11orf9 (1.6)	MAFB (1.3)	ENSG00000238078 (1.2)	PVRL2 (1.2)
MP:0005358	abnormal incisor morphology	0.25	> 0.20	MYLIP (2.7)	PLCG1 (2.3)	KANK2 (2.2)	CILP2 (2.0)	PLEC (1.7)	MAFB (1.7)	CELSR2 (1.6)	PLEKHH2 (1.5)	BCAM (1.5)	HNF1A (1.4)
ENSG00000213949	ITGA1 PPI subnetwork	0.25	> 0.20	PVR (3.0)	C17orf57 (2.7)	OGDH (2.6)	ITGB3 (1.9)	ST3GAL4 (1.9)	APOE (1.9)	ATP13A1 (1.8)	PLEKHH2 (1.8)	FADS1 (1.7)	SYPL2 (1.7)
ENSG00000116750	UCHL5 PPI subnetwork	0.25	> 0.20	PSMA5 (6.0)	TRAFD1 (2.6)	NAA25 (2.2)	TOMM40 (2.1)	SUGP1 (2.0)	NT5DC1 (1.9)	DDX56 (1.8)	SARS (1.7)	TXNL4B (1.5)	CELSR2 (1.4)
ENSG00000215021	PHB2 PPI subnetwork	0.25	> 0.20	SARS (3.2)	ATP13A1 (2.7)	C12orf51 (2.7)	DNM2 (2.1)	ENSG00000226648 (2.0)	PLCG1 (1.9)	ILF3 (1.9)	PSMA5 (1.7)	DDX56 (1.7)	ST3GAL4 (1.7)
MP:0005153	abnormal B cell proliferation	0.25	> 0.20	GMIP (3.8)	C17orf57 (2.7)	CYB561D1 (2.5)	SLC44A2 (1.8)	BCL3 (1.7)	RELB (1.6)	TIMD4 (1.4)	SH2B3 (1.3)	CETP (1.3)	PARP10 (1.3)
MP:0000364	abnormal vascular regression	0.25	> 0.20	HLX (3.6)	FRK (2.4)	POLK (2.1)	TRAPPC6A (2.1)	SH2B3 (1.8)	ENSG00000238078 (1.7)	DNAH11 (1.7)	PCSK9 (1.6)	KANK2 (1.6)	PLCG1 (1.6)
ENSG00000188229	TUBB4B PPI subnetwork	0.25	> 0.20	GATAD2A (2.5)	SARS (2.1)	SMARCA4 (2.0)	DOCK7 (1.9)	FADS1 (1.8)	TOMM40 (1.7)	DDX56 (1.4)	NAA25 (1.4)	GMPR (1.4)	PSMA5 (1.4)
ENSG00000150768	DLAT PPI subnetwork	0.26	> 0.20	OGDH (3.6)	GPAM (2.6)	TSSK6 (2.4)	HAPLN4 (2.1)	DOCK7 (2.0)	TOMM40 (1.7)	GMPR (1.7)	QTRT1 (1.5)	CLPTM1 (1.5)	TIMD4 (1.4)
ENSG00000140285	FGF7 PPI subnetwork	0.26	> 0.20	HAVCR1 (3.4)	PLEKHH2 (3.3)	HAPLN4 (2.8)	C17orf57 (2.8)	C11orf9 (2.7)	NYNRIN (2.6)	APOE (2.4)	CILP2 (2.2)	BCAM (1.9)	CBLC (1.9)
REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D	REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D	0.26	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	TOMM40 (1.9)	PARP10 (1.8)	SUGP1 (1.7)	DDX56 (1.7)	SARS (1.6)	TMEM50A (1.1)
REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D1	REACTOME_UBIQUITIN:DEPENDENT_DEGRADATION_OF_CYCLIN_D1	0.26	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	TOMM40 (1.9)	PARP10 (1.8)	SUGP1 (1.7)	DDX56 (1.7)	SARS (1.6)	TMEM50A (1.1)
ENSG00000162374	ELAVL4 PPI subnetwork	0.26	> 0.20	ATXN2 (3.1)	UBXN2B (2.8)	COL4A3BP (2.7)	PTPN11 (2.1)	DHX38 (2.1)	C1orf63 (2.1)	ENSG00000238078 (1.9)	ATP13A1 (1.9)	C12orf47 (1.9)	TOP1 (1.7)
ENSG00000189079	ARID2 PPI subnetwork	0.26	> 0.20	CARM1 (4.4)	SMARCA4 (2.5)	GATAD2A (2.5)	GOT2P1 (2.4)	TRAFD1 (2.1)	PMFBP1 (2.0)	SUGP1 (1.9)	MARK4 (1.9)	MAPKAPK5 (1.7)	C12orf47 (1.6)
ENSG00000141837	CACNA1A PPI subnetwork	0.26	> 0.20	USP24 (2.4)	MAU2 (2.3)	MARK4 (2.3)	HAPLN4 (2.3)	SMARCA4 (2.2)	GMIP (2.1)	PPP1R37 (2.0)	CARM1 (1.6)	BCL3 (1.6)	POLK (1.5)
GO:0072202	cell differentiation involved in metanephros development	0.26	> 0.20	HAVCR1 (3.3)	PLEKHH2 (2.7)	BCAM (2.6)	TSSK6 (2.6)	DYNC2LI1 (1.9)	HNF1A (1.7)	CELSR2 (1.6)	ENSG00000228044 (1.4)	ST3GAL4 (1.4)	AMIGO1 (1.3)
REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	0.26	> 0.20	SH2B3 (3.7)	MARK4 (2.7)	HLX (2.5)	COL4A3BP (2.0)	CLPTM1 (1.9)	TRIB1 (1.7)	OGDH (1.7)	TOMM40 (1.6)	DNM2 (1.6)	CARM1 (1.6)
GO:0016327	apicolateral plasma membrane	0.26	> 0.20	AP1M2 (6.3)	CBLC (4.5)	PVRL2 (4.1)	BCAM (3.6)	FRK (3.2)	DYNC2LI1 (2.4)	PVR (2.1)	LPAR2 (2.0)	PLEKHH2 (1.9)	C11orf9 (1.9)
GO:0004843	ubiquitin-specific protease activity	0.26	> 0.20	ZNF180 (4.0)	USP24 (3.9)	OASL (3.7)	CARM1 (2.6)	TRAFD1 (2.3)	PARP10 (2.1)	NAA25 (1.9)	MAU2 (1.5)	ATXN7L2 (1.5)	TMEM57 (1.4)
MP:0002075	abnormal coat/hair pigmentation	0.26	> 0.20	DOCK7 (2.7)	ST3GAL4 (2.3)	CELSR2 (2.3)	MYLIP (2.2)	GMPR (1.5)	GPAM (1.5)	FRK (1.4)	FEN1 (1.3)	APOE (1.3)	TRIB1 (1.2)
MP:0008500	increased IgG2a level	0.26	> 0.20	RELB (4.1)	BCL3 (3.0)	CETP (2.9)	GMIP (2.8)	TIMD4 (2.8)	C17orf57 (1.9)	PBX4 (1.5)	MAFB (1.4)	SH2B3 (1.3)	POLK (1.2)
MP:0010299	increased mammary gland tumor incidence	0.26	> 0.20	FEN1 (3.3)	BLOC1S3 (3.0)	UBXN2B (2.5)	POC5 (2.2)	MAU2 (2.0)	GOT2P1 (2.0)	BCL3 (1.6)	MARK4 (1.5)	PTPN11 (1.5)	USP1 (1.5)
GO:0034374	low-density lipoprotein particle remodeling	0.26	> 0.20	APOC1 (4.2)	TIMD4 (3.7)	HAVCR1 (2.5)	CETP (2.3)	APOE (2.3)	APOB (2.1)	ANGPTL3 (2.1)	APOC4 (2.1)	ENSG00000228044 (2.1)	APOA5 (2.1)
MP:0000069	kyphoscoliosis	0.26	> 0.20	PLEC (3.8)	ST3GAL4 (2.6)	ATP13A1 (2.4)	LDLR (2.2)	ERP29 (2.1)	SYPL2 (2.0)	ABO (1.8)	PVR (1.7)	CLPTM1 (1.7)	C11orf9 (1.5)
ENSG00000120235	IFNA6 PPI subnetwork	0.26	> 0.20	BCL3 (3.8)	HLX (3.1)	RELB (2.9)	TIMD4 (2.3)	CETP (2.2)	GMIP (2.1)	PARP10 (1.6)	ALDH2 (1.5)	LPA (1.5)	GRINA (1.4)
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	0.26	> 0.20	DHODH (2.6)	SORT1 (2.2)	TM6SF2 (2.1)	KIAA1324 (2.1)	NPC1L1 (2.0)	GOT2P1 (2.0)	TRAPPC6A (1.9)	PBX4 (1.5)	ALDH2 (1.5)	ABCG5 (1.4)
ENSG00000105173	CCNE1 PPI subnetwork	0.26	> 0.20	MAU2 (3.5)	MARK4 (2.4)	SMARCA4 (2.2)	USP1 (2.1)	C12orf51 (2.1)	MAFB (2.0)	BUD13 (2.0)	NYNRIN (1.9)	ENSG00000254235 (1.9)	CARM1 (1.9)
GO:0015101	organic cation transmembrane transporter activity	0.26	> 0.20	RHD (5.1)	PLG (4.1)	RHCE (3.8)	MOSC1 (2.9)	ENSG00000238078 (2.8)	ANGPTL3 (2.7)	TM6SF2 (2.0)	TMEM116 (1.9)	CEACAM19 (1.5)	PBX4 (1.5)
MP:0001658	increased mortality induced by gamma-irradiation	0.26	> 0.20	BUD13 (3.6)	PSRC1 (3.3)	POLK (3.2)	UBXN2B (2.6)	FEN1 (2.6)	ILF3 (2.2)	SMARCA4 (2.2)	ATXN7L2 (2.0)	KANK2 (1.8)	ZNF180 (1.6)
MP:0010308	decreased tumor latency	0.26	> 0.20	TRIB1 (4.0)	ENSG00000226648 (2.9)	NYNRIN (2.1)	AMIGO1 (2.1)	TOP1 (2.0)	POC5 (1.9)	TRAFD1 (1.9)	ENSG00000228044 (1.8)	PVR (1.8)	PSRC1 (1.7)
MP:0001666	abnormal intestinal absorption	0.26	> 0.20	TM6SF2 (4.8)	NPC1L1 (4.2)	ABCG5 (3.2)	ABCG8 (3.1)	TMED4 (2.9)	CBLC (2.0)	APOB (1.9)	FRK (1.9)	ABO (1.8)	HNF1A (1.7)
ENSG00000116171	SCP2 PPI subnetwork	0.26	> 0.20	TM6SF2 (2.4)	GPAM (1.8)	MOSC1 (1.7)	COL4A3BP (1.7)	ANGPTL3 (1.7)	APOB (1.6)	ACAD10 (1.6)	PLEC (1.5)	KANK2 (1.5)	NPC1L1 (1.4)
ENSG00000107789	MINPP1 PPI subnetwork	0.26	> 0.20	NYNRIN (2.6)	GRINA (2.3)	HNF1A (2.2)	GEMIN7 (2.2)	ALDH2 (2.1)	NKPD1 (2.0)	RHCE (2.0)	RHD (1.9)	ACAD10 (1.8)	ANKRD31 (1.7)
ENSG00000139117	CPNE8 PPI subnetwork	0.26	> 0.20	GPAM (2.8)	ENSG00000228044 (2.5)	FADS2 (2.3)	HMGCR (2.2)	AMIGO1 (2.2)	LDLR (2.2)	C12orf51 (2.1)	MOSC1 (2.1)	HAVCR1 (2.0)	CETP (1.9)
ENSG00000119392	GLE1 PPI subnetwork	0.26	> 0.20	DDX56 (4.1)	ZNF259 (3.9)	NAA25 (3.5)	DHX38 (2.8)	DHODH (2.7)	QTRT1 (2.6)	PTPN11 (2.4)	ILF3 (2.3)	TOP1 (2.3)	SUGP1 (2.3)
ENSG00000180855	ZNF443 PPI subnetwork	0.26	> 0.20	USP24 (2.8)	MAU2 (2.8)	PARP10 (2.7)	MARK4 (2.5)	BCL3 (2.3)	ATXN2 (2.3)	SMARCA4 (2.3)	GMIP (2.1)	DHX38 (1.9)	C12orf51 (1.8)
GO:0006898	receptor-mediated endocytosis	0.26	> 0.20	TIMD4 (2.2)	APOE (1.8)	CETP (1.8)	NPC1L1 (1.6)	USP24 (1.6)	PCSK9 (1.5)	CILP2 (1.4)	ACAD10 (1.3)	MAFB (1.3)	YIPF2 (1.3)
ENSG00000105221	AKT2 PPI subnetwork	0.26	> 0.20	RELB (2.7)	MOSC1 (2.4)	DNM2 (2.3)	GPAM (2.0)	GMIP (1.9)	PLEC (1.9)	GRINA (1.9)	SLC22A1 (1.9)	ZNF180 (1.9)	HLX (1.8)
GO:0055007	cardiac muscle cell differentiation	0.26	> 0.20	HNF1A (2.7)	ANKRD31 (2.6)	CEACAM19 (2.2)	SYPL2 (2.1)	NYNRIN (2.0)	C11orf9 (1.9)	GCNT4 (1.9)	ST3GAL4 (1.8)	GMPR (1.6)	ABO (1.5)
ENSG00000111875	ASF1A PPI subnetwork	0.26	> 0.20	FEN1 (2.5)	GATAD2A (2.3)	C19orf52 (2.3)	USP1 (2.2)	DNAH11 (1.9)	LPAR2 (1.9)	BUD13 (1.7)	TRAPPC6A (1.7)	ZNF101 (1.7)	TMEM57 (1.5)
ENSG00000142864	SERBP1 PPI subnetwork	0.26	> 0.20	C1orf63 (2.9)	ST3GAL4 (2.4)	UBXN2B (2.2)	SUGP1 (2.0)	TMEM57 (2.0)	PBX4 (1.9)	ZNF180 (1.7)	MYLIP (1.4)	BUD13 (1.4)	HMGCR (1.4)
ENSG00000148175	STOM PPI subnetwork	0.26	> 0.20	QTRT1 (2.3)	BRAP (2.2)	GRINA (2.1)	YIPF2 (2.1)	C19orf52 (2.0)	BLOC1S3 (1.9)	AMIGO1 (1.8)	PPP1R37 (1.7)	ATP13A1 (1.6)	DNAH11 (1.5)
ENSG00000145777	TSLP PPI subnetwork	0.26	> 0.20	BCL3 (4.3)	RELB (3.1)	HLX (2.9)	CETP (2.2)	ALDH2 (2.1)	TIMD4 (2.1)	GMIP (1.9)	PARP10 (1.6)	LPA (1.3)	ANKRD31 (1.3)
GO:0050710	negative regulation of cytokine secretion	0.26	> 0.20	MOSC1 (2.2)	DNAH11 (2.2)	ENSG00000238078 (2.2)	ADAM1 (2.1)	APOB (1.8)	NPC1L1 (1.7)	COL4A3BP (1.5)	ENSG00000228044 (1.4)	C12orf47 (1.4)	HLX (1.3)
MP:0004946	abnormal regulatory T cell physiology	0.26	> 0.20	TIMD4 (2.8)	ZNF101 (2.7)	PLCG1 (2.7)	PBX4 (1.6)	SLC44A2 (1.4)	SLC22A1 (1.4)	CETP (1.3)	TRIB1 (1.2)	MAFB (1.1)	GMIP (1.1)
GO:0031331	positive regulation of cellular catabolic process	0.26	> 0.20	BLOC1S3 (2.6)	BRAP (1.9)	TRAFD1 (1.9)	CLPTM1 (1.8)	GRINA (1.5)	MAPKAPK5 (1.5)	GPAM (1.5)	TRIB1 (1.4)	ST3GAL4 (1.3)	ZNF180 (1.3)
ENSG00000184185	KCNJ12 PPI subnetwork	0.26	> 0.20	ZHX3 (3.3)	PPP1R37 (2.8)	FRK (2.4)	ALDH2 (2.2)	SYPL2 (2.0)	RPH3A (1.9)	PTPN11 (1.9)	HNF1A (1.7)	COL4A3BP (1.7)	PLCG1 (1.6)
ENSG00000073921	PICALM PPI subnetwork	0.26	> 0.20	ZHX3 (2.9)	SARS (2.5)	PPP1R37 (2.2)	GRINA (2.2)	C1orf63 (2.1)	CEACAM19 (2.1)	ENSG00000226648 (2.0)	C12orf47 (2.0)	BLOC1S3 (1.9)	HAPLN4 (1.7)
GO:0006801	superoxide metabolic process	0.26	> 0.20	ALDH2 (2.9)	TRAPPC6A (2.3)	RHD (2.3)	ENSG00000235545 (2.0)	RHCE (1.8)	ERP29 (1.7)	PMFBP1 (1.6)	LPIN3 (1.5)	HNF1A (1.4)	CILP2 (1.4)
ENSG00000110700	RPS13 PPI subnetwork	0.26	> 0.20	QTRT1 (3.8)	DDX56 (3.7)	NAA25 (3.6)	ZNF259 (2.9)	C12orf43 (2.6)	SARS (2.6)	TOP1 (2.5)	ILF3 (2.5)	ATP13A1 (2.5)	TOMM40 (2.4)
ENSG00000102225	CDK16 PPI subnetwork	0.26	> 0.20	CARM1 (3.2)	GATAD2A (2.3)	OGDH (2.3)	GRINA (2.1)	GOT2P1 (2.0)	SMARCA4 (1.7)	ENSG00000238078 (1.7)	HNF1A (1.7)	ZNF101 (1.6)	YIPF2 (1.6)
GO:0001784	phosphotyrosine binding	0.26	> 0.20	C17orf57 (3.8)	SLC44A2 (2.7)	CYB561D1 (2.4)	GMIP (2.2)	PLEKHH2 (2.2)	PVRL2 (2.1)	PBX4 (2.0)	AMIGO1 (2.0)	MAFB (1.9)	C1orf63 (1.8)
ENSG00000131023	LATS1 PPI subnetwork	0.26	> 0.20	PBX4 (3.3)	RHD (2.1)	LPAR2 (2.0)	SLC44A2 (1.9)	ST3GAL4 (1.8)	KANK2 (1.7)	RHCE (1.7)	PVRL2 (1.7)	CETP (1.6)	SH2B3 (1.6)
MP:0005122	increased circulating thyroid-stimulating hormone level	0.26	> 0.20	C17orf57 (3.5)	ZHX3 (3.1)	PBX4 (2.7)	COL4A3BP (2.3)	MOSC1 (2.2)	CELSR2 (2.0)	BCAM (1.9)	NKPD1 (1.8)	TRIB1 (1.8)	MYLIP (1.7)
ENSG00000072849	DERL2 PPI subnetwork	0.26	> 0.20	SARS (2.7)	TMED4 (2.5)	BLOC1S3 (2.1)	BRAP (2.0)	YIPF2 (1.9)	ERP29 (1.8)	TMEM57 (1.6)	APOB (1.5)	GOT2P1 (1.4)	PLEC (1.4)
ENSG00000164330	EBF1 PPI subnetwork	0.26	> 0.20	PLCG1 (2.4)	GMIP (2.3)	PBX4 (2.0)	USP24 (2.0)	LPAR2 (1.9)	MAU2 (1.9)	NYNRIN (1.9)	DHX38 (1.8)	ALDH2 (1.7)	SMARCA4 (1.7)
ENSG00000105647	PIK3R2 PPI subnetwork	0.26	> 0.20	DOCK7 (3.0)	GMIP (2.9)	SH2B3 (2.6)	USP24 (2.4)	SLC44A2 (2.3)	PLEC (2.2)	DNM2 (2.1)	PLEKHH2 (2.0)	C1orf63 (1.9)	PVRL2 (1.7)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION	0.26	> 0.20	C1orf63 (5.4)	TOP1 (3.1)	ILF3 (2.9)	USP1 (2.8)	BUD13 (2.6)	ENSG00000226645 (2.4)	DHODH (2.2)	FEN1 (2.2)	C12orf47 (1.9)	ADAM1 (1.8)
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION	0.26	> 0.20	C1orf63 (5.4)	TOP1 (3.1)	ILF3 (2.9)	USP1 (2.8)	BUD13 (2.6)	ENSG00000226645 (2.4)	DHODH (2.2)	FEN1 (2.2)	C12orf47 (1.9)	ADAM1 (1.8)
REACTOME_POST:ELONGATION_PROCESSING_OF_THE_TRANSCRIPT	REACTOME_POST:ELONGATION_PROCESSING_OF_THE_TRANSCRIPT	0.26	> 0.20	C1orf63 (5.4)	TOP1 (3.1)	ILF3 (2.9)	USP1 (2.8)	BUD13 (2.6)	ENSG00000226645 (2.4)	DHODH (2.2)	FEN1 (2.2)	C12orf47 (1.9)	ADAM1 (1.8)
ENSG00000114867	EIF4G1 PPI subnetwork	0.26	> 0.20	TOP1 (3.7)	QTRT1 (3.6)	GATAD2A (3.5)	NAA25 (3.5)	ZNF259 (3.2)	DDX56 (3.2)	ILF3 (2.8)	CARM1 (2.6)	TOMM40 (2.4)	DHX38 (2.3)
ENSG00000124789	NUP153 PPI subnetwork	0.26	> 0.20	USP1 (3.2)	NAA25 (3.2)	POC5 (2.8)	DOCK7 (2.7)	ILF3 (2.5)	BUD13 (2.4)	CARM1 (2.3)	DDX56 (2.2)	USP24 (2.1)	FEN1 (1.8)
MP:0002834	decreased heart weight	0.26	> 0.20	PVR (2.4)	BCL3 (2.2)	BCAM (2.0)	KIAA1324 (1.8)	AMIGO1 (1.7)	PPP1R37 (1.7)	LDLR (1.7)	GRINA (1.4)	HP (1.4)	OASL (1.4)
GO:0032432	actin filament bundle	0.26	> 0.20	PVRL2 (3.5)	KANK2 (3.3)	PLEC (3.2)	ITGB3 (2.3)	AP1M2 (2.2)	NPC1L1 (2.2)	CBLC (1.9)	DNM2 (1.9)	PLEKHH2 (1.6)	POLK (1.6)
GO:0033135	regulation of peptidyl-serine phosphorylation	0.26	> 0.20	C17orf57 (3.1)	ENSG00000238078 (2.1)	DNAH11 (2.1)	ENSG00000228044 (1.8)	MYLIP (1.6)	TMEM57 (1.5)	ST3GAL4 (1.4)	ENSG00000254235 (1.3)	PLEKHH2 (1.3)	GCNT4 (1.1)
GO:0012502	induction of programmed cell death	0.26	> 0.20	ENSG00000238078 (2.7)	ZNF101 (2.6)	POLK (2.5)	BLOC1S3 (2.0)	PARP10 (1.9)	MARK4 (1.9)	CYB561D1 (1.9)	TRAFD1 (1.6)	CEACAM19 (1.6)	HAVCR1 (1.6)
GO:0004860	protein kinase inhibitor activity	0.26	> 0.20	BCL3 (2.3)	APOB (2.1)	NCAN (2.1)	ABCG5 (1.9)	MYLIP (1.7)	TRIB1 (1.7)	LDLR (1.6)	ZNF101 (1.6)	TRAFD1 (1.6)	HLX (1.6)
ENSG00000154143	PANX3 PPI subnetwork	0.26	> 0.20	USP24 (3.0)	PARP10 (2.7)	MAU2 (2.6)	MARK4 (2.5)	ATXN2 (2.4)	BCL3 (2.4)	SMARCA4 (2.3)	GMIP (1.9)	C12orf51 (1.8)	DHX38 (1.8)
GO:0051130	positive regulation of cellular component organization	0.26	> 0.20	PLEC (2.4)	POLK (2.0)	PVRL2 (1.8)	SH2B3 (1.7)	PBX4 (1.7)	NYNRIN (1.6)	ANKRD31 (1.6)	LPIN3 (1.6)	TMEM50A (1.4)	KANK2 (1.4)
ENSG00000071794	HLTF PPI subnetwork	0.26	> 0.20	FEN1 (3.9)	PSRC1 (2.4)	DNAH11 (2.4)	USP1 (2.1)	POLK (1.9)	BRAP (1.8)	ATXN2 (1.8)	RHCE (1.7)	ZNF180 (1.7)	SUGP1 (1.6)
ENSG00000091592	NLRP1 PPI subnetwork	0.26	> 0.20	TRAFD1 (2.4)	BLOC1S3 (2.3)	TIMD4 (2.2)	ST3GAL4 (2.0)	DNAH11 (1.9)	POLK (1.7)	APOE (1.6)	GCNT4 (1.6)	ALDH2 (1.6)	NT5DC1 (1.5)
MP:0003014	abnormal kidney medulla morphology	0.26	> 0.20	NYNRIN (3.5)	CBLC (2.9)	NPC1L1 (2.8)	AP1M2 (2.8)	BCAM (2.5)	APOB (2.1)	C12orf47 (2.0)	TRAPPC6A (2.0)	PLG (1.9)	C11orf9 (1.7)
ENSG00000114416	FXR1 PPI subnetwork	0.26	> 0.20	OASL (3.2)	FADS1 (3.0)	ENSG00000226645 (2.5)	USP24 (2.4)	NPC1L1 (2.4)	FADS2 (2.3)	LDLR (2.0)	TRAFD1 (1.8)	CYB561D1 (1.7)	HMGCR (1.6)
ENSG00000127824	TUBA4A PPI subnetwork	0.26	> 0.20	PSMA5 (3.9)	SARS (3.4)	OGDH (3.0)	SMARCA4 (3.0)	TOMM40 (2.6)	CLPTM1 (2.6)	TOP1 (2.4)	NAA25 (2.3)	TMEM50A (2.2)	GRINA (2.0)
MP:0003077	abnormal cell cycle	0.26	> 0.20	PSRC1 (3.6)	USP1 (3.4)	FEN1 (3.4)	TRIB1 (2.6)	ILF3 (2.2)	ATXN7L2 (2.0)	ADAM1 (1.7)	OASL (1.4)	BCL3 (1.3)	ENSG00000254235 (1.3)
ENSG00000168924	LETM1 PPI subnetwork	0.26	> 0.20	GEMIN7 (2.8)	TOMM40 (2.4)	QTRT1 (2.1)	TRIB1 (2.0)	HAVCR1 (1.8)	C12orf47 (1.8)	ENSG00000254235 (1.7)	CARM1 (1.7)	AP1M2 (1.7)	OGDH (1.3)
GO:0006479	protein methylation	0.26	> 0.20	C12orf51 (2.7)	ZNF180 (2.5)	C19orf52 (2.4)	QTRT1 (2.0)	DHODH (2.0)	USP24 (1.8)	ILF3 (1.7)	BUD13 (1.7)	ATXN2 (1.6)	SMARCA4 (1.4)
GO:0008213	protein alkylation	0.26	> 0.20	C12orf51 (2.7)	ZNF180 (2.5)	C19orf52 (2.4)	QTRT1 (2.0)	DHODH (2.0)	USP24 (1.8)	ILF3 (1.7)	BUD13 (1.7)	ATXN2 (1.6)	SMARCA4 (1.4)
MP:0011092	complete embryonic lethality	0.26	> 0.20	ENSG00000226648 (3.2)	USP24 (2.9)	SMARCA4 (2.6)	MAU2 (2.6)	HLX (2.6)	ATXN2 (2.6)	KANK2 (2.5)	ILF3 (2.4)	DHX38 (2.3)	PTPN11 (2.2)
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	0.26	> 0.20	PSMA5 (5.1)	NAA25 (3.2)	DDX56 (2.8)	TOMM40 (2.3)	CLPTM1 (2.1)	DHX38 (2.0)	SMARCA4 (2.0)	TRAFD1 (1.8)	NT5DC1 (1.7)	SARS (1.6)
MP:0005591	decreased vasodilation	0.26	> 0.20	HLX (3.0)	APOC1 (2.9)	MYLIP (2.7)	C17orf57 (2.6)	TRIB1 (1.8)	C12orf47 (1.6)	MAFB (1.4)	ST3GAL4 (1.4)	ENSG00000235545 (1.3)	TRAPPC6A (1.3)
ENSG00000168685	IL7R PPI subnetwork	0.26	> 0.20	BCL3 (3.2)	COL4A3BP (2.4)	C17orf57 (1.7)	CYP7A1 (1.6)	RELB (1.5)	SLC22A1 (1.4)	HLX (1.4)	ZNF101 (1.3)	PVR (1.2)	CETP (1.2)
ENSG00000145604	SKP2 PPI subnetwork	0.26	> 0.20	FEN1 (2.7)	TOMM40 (2.7)	TRIB1 (2.1)	PSRC1 (2.1)	POLK (2.1)	USP1 (2.0)	PVR (1.8)	ENSG00000226645 (1.7)	GCNT4 (1.4)	KANK2 (1.4)
GO:0045860	positive regulation of protein kinase activity	0.26	> 0.20	ENSG00000228044 (3.7)	AMIGO1 (2.4)	PTPN11 (2.1)	PVR (2.1)	SLC44A2 (2.1)	HLX (2.0)	ST3GAL4 (1.8)	SH2B3 (1.7)	CYB561D1 (1.4)	ENSG00000235545 (1.4)
MP:0001382	abnormal nursing	0.26	> 0.20	APOC1 (3.9)	CELSR2 (2.9)	TRIB1 (2.6)	NCAN (2.3)	NPC1L1 (1.7)	DOCK7 (1.5)	MYLIP (1.5)	CBLC (1.5)	NYNRIN (1.4)	PSRC1 (1.3)
GO:0034483	heparan sulfate sulfotransferase activity	0.26	> 0.20	ST3GAL4 (3.8)	CETP (3.0)	PMFBP1 (2.6)	ANKRD31 (2.4)	MAFB (2.3)	GCNT4 (2.2)	PCSK9 (2.0)	DOCK7 (1.8)	SH2B3 (1.7)	APOE (1.6)
ENSG00000167601	AXL PPI subnetwork	0.26	> 0.20	ZHX3 (3.4)	ZNF101 (2.4)	PLEKHH2 (2.3)	MYLIP (2.1)	TRAFD1 (1.9)	COL4A3BP (1.8)	MARK4 (1.8)	PARP10 (1.8)	TOP1 (1.7)	DNAH11 (1.7)
GO:0001819	positive regulation of cytokine production	0.26	> 0.20	OASL (2.4)	SH2B3 (2.3)	ZNF101 (2.2)	ST3GAL4 (2.0)	PARP10 (1.9)	POLK (1.8)	RELB (1.7)	COL4A3BP (1.6)	CYB561D1 (1.5)	BCL3 (1.4)
ENSG00000113594	LIFR PPI subnetwork	0.26	> 0.20	BCL3 (2.8)	COL4A3BP (2.1)	PVR (1.8)	C17orf57 (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	SLC22A1 (1.4)	HLX (1.3)	RELB (1.3)	BCAM (1.2)
REACTOME_PKA_ACTIVATION	REACTOME_PKA_ACTIVATION	0.26	> 0.20	ITGB3 (3.0)	ST3GAL4 (3.0)	SH2B3 (2.6)	SORT1 (2.5)	ENSG00000228044 (2.0)	GMPR (1.9)	KANK2 (1.9)	MYLIP (1.6)	PMFBP1 (1.6)	GOT2P1 (1.6)
MP:0008114	abnormal Kupffer cell morphology	0.26	> 0.20	PARP10 (2.7)	ACAD10 (2.2)	BCAM (2.1)	CYB561D1 (2.0)	ATP13A1 (1.8)	PCSK9 (1.7)	SLC22A1 (1.7)	RELB (1.7)	HP (1.6)	ERP29 (1.6)
GO:0015093	ferrous iron transmembrane transporter activity	0.26	> 0.20	C12orf43 (3.6)	TOMM40 (3.3)	ZNF259 (2.4)	TMED4 (2.4)	MAPKAPK5 (2.1)	DDX56 (2.0)	ENSG00000226645 (1.9)	PBX4 (1.9)	PVR (1.7)	CLPTM1 (1.7)
ENSG00000102606	ARHGEF7 PPI subnetwork	0.26	> 0.20	MARK4 (3.1)	GMIP (2.7)	SH2B3 (2.7)	ATXN2 (2.6)	ENSG00000226645 (2.0)	TMEM116 (1.8)	CLPTM1 (1.7)	CARM1 (1.6)	OGDH (1.6)	C12orf43 (1.6)
ENSG00000179222	MAGED1 PPI subnetwork	0.26	> 0.20	ATP13A1 (3.6)	SARS (3.0)	DDX56 (2.9)	PLEC (2.4)	QTRT1 (2.2)	DHX38 (2.1)	ZNF259 (2.0)	DNM2 (1.8)	SMARCA4 (1.8)	ILF3 (1.7)
ENSG00000183386	FHL3 PPI subnetwork	0.26	> 0.20	CEACAM19 (3.5)	PVRL2 (2.9)	CARM1 (2.9)	CBLC (2.2)	ATXN7L2 (2.2)	PVR (2.1)	LPIN3 (1.9)	PLEC (1.9)	C11orf9 (1.8)	GCNT4 (1.7)
GO:0071359	cellular response to dsRNA	0.26	> 0.20	OASL (3.0)	ADAM1 (2.6)	MAPKAPK5 (2.5)	PARP10 (2.5)	MYLIP (2.3)	C12orf43 (1.9)	ENSG00000228044 (1.8)	GOT2P1 (1.8)	GCNT4 (1.7)	CYB561D1 (1.6)
MP:0000932	absent notochord	0.26	> 0.20	ATXN7L2 (2.4)	ENSG00000254235 (2.4)	APOE (2.3)	APOC4 (2.2)	ADAM1 (2.1)	PMFBP1 (2.0)	ZNF101 (2.0)	HNF1A (1.9)	BCAM (1.9)	HAVCR1 (1.7)
ENSG00000105663	ENSG00000105663 PPI subnetwork	0.26	> 0.20	GMIP (3.2)	MAU2 (2.6)	ZHX3 (2.5)	PARP10 (2.3)	MAFB (2.1)	USP24 (2.0)	DHX38 (1.8)	PLEKHH2 (1.7)	OASL (1.6)	MYLIP (1.6)
ENSG00000130713	EXOSC2 PPI subnetwork	0.26	> 0.20	USP24 (4.0)	SUGP1 (3.5)	DHX38 (2.7)	DHODH (2.5)	BRAP (2.5)	CARM1 (2.3)	ZNF259 (2.2)	C12orf43 (2.2)	TOMM40 (2.2)	DDX56 (2.1)
ENSG00000141279	NPEPPS PPI subnetwork	0.26	> 0.20	C19orf52 (3.5)	OASL (3.4)	MYLIP (2.9)	PARP10 (2.4)	ZHX3 (1.8)	GMPR (1.8)	KANK2 (1.6)	NT5DC1 (1.5)	COL4A3BP (1.4)	BLOC1S3 (1.4)
ENSG00000110713	NUP98 PPI subnetwork	0.26	> 0.20	PSRC1 (4.8)	FEN1 (4.2)	USP1 (4.0)	POC5 (3.6)	USP24 (2.0)	ILF3 (2.0)	NAA25 (1.7)	DDX56 (1.5)	DHX38 (1.2)	CARM1 (1.2)
MP:0005182	increased circulating estradiol level	0.26	> 0.20	APOC1 (2.8)	ST3GAL4 (2.5)	LPIN3 (2.4)	CETP (2.3)	MARK4 (2.2)	ABCG5 (1.9)	APOE (1.9)	DNAH11 (1.6)	APOA5 (1.5)	ENSG00000228044 (1.5)
ENSG00000140829	DHX38 PPI subnetwork	0.26	> 0.20	C1orf63 (4.0)	ILF3 (3.9)	TOP1 (3.3)	DHX38 (3.2)	USP1 (2.7)	SMARCA4 (2.6)	BUD13 (2.5)	QTRT1 (2.5)	SUGP1 (2.2)	ATP13A1 (2.1)
GO:0000122	negative regulation of transcription from RNA polymerase II promoter	0.26	> 0.20	MYLIP (2.7)	ATXN7L2 (2.3)	NYNRIN (1.9)	TRIB1 (1.7)	ATXN2 (1.7)	PPP1R37 (1.6)	KANK2 (1.6)	ENSG00000254235 (1.5)	ABO (1.5)	ENSG00000226648 (1.5)
GO:0050663	cytokine secretion	0.26	> 0.20	HAVCR1 (2.6)	DNAH11 (2.1)	ZNF101 (1.8)	C17orf57 (1.5)	ENSG00000238078 (1.5)	GOT2P1 (1.4)	APOE (1.3)	HLX (1.3)	ENSG00000228044 (1.2)	CYB561D1 (1.2)
MP:0001044	abnormal enteric nervous system morphology	0.26	> 0.20	HLX (3.0)	AMIGO1 (2.6)	ENSG00000228044 (2.2)	ENSG00000254235 (2.0)	ZNF101 (2.0)	TRIB1 (1.8)	TMED4 (1.6)	DOCK7 (1.4)	FRK (1.2)	CELSR2 (1.2)
GO:0005057	receptor signaling protein activity	0.26	> 0.20	PVR (3.0)	SH2B3 (2.7)	MARK4 (2.5)	NYNRIN (2.1)	GMIP (2.1)	LPAR2 (1.9)	ENSG00000228044 (1.9)	MAPKAPK5 (1.8)	LPIN3 (1.8)	GATAD2A (1.7)
GO:0006767	water-soluble vitamin metabolic process	0.26	> 0.20	NT5DC1 (2.9)	ABCG8 (2.3)	DHODH (2.1)	ACAD10 (2.1)	ENSG00000226645 (2.0)	TM6SF2 (2.0)	UBXN2B (1.9)	C19orf52 (1.9)	MOSC1 (1.8)	TMEM116 (1.8)
GO:0030880	RNA polymerase complex	0.26	> 0.20	GEMIN7 (4.7)	ZNF259 (3.5)	TOMM40 (3.4)	QTRT1 (2.4)	MAPKAPK5 (2.0)	DDX56 (1.9)	BLOC1S3 (1.8)	PVR (1.8)	BUD13 (1.7)	NAA25 (1.6)
ENSG00000175334	BANF1 PPI subnetwork	0.26	> 0.20	USP1 (3.3)	POC5 (3.0)	NAA25 (2.8)	BUD13 (2.8)	MAPKAPK5 (2.6)	FEN1 (2.3)	DDX56 (2.3)	DOCK7 (2.1)	ILF3 (2.1)	DHX38 (2.0)
GO:0005775	vacuolar lumen	0.26	> 0.20	APOE (3.8)	MAFB (3.7)	ERP29 (3.7)	ATP13A1 (2.8)	GRINA (2.4)	CLPTM1 (2.1)	HNF1A (1.9)	TMEM50A (1.8)	TMED4 (1.7)	PMFBP1 (1.6)
MP:0006011	abnormal endolymphatic duct morphology	0.26	> 0.20	MYLIP (3.1)	GCNT4 (2.0)	ENSG00000238078 (1.9)	ENSG00000226645 (1.8)	LPA (1.7)	PPP1R37 (1.7)	TMEM116 (1.6)	CILP2 (1.5)	PVRL2 (1.4)	BCAM (1.4)
ENSG00000076604	TRAF4 PPI subnetwork	0.26	> 0.20	PVRL2 (3.1)	KANK2 (3.0)	ITGB3 (2.7)	PLCG1 (2.2)	ENSG00000254235 (2.0)	FADS1 (1.9)	CARM1 (1.9)	KIAA1324 (1.5)	GEMIN7 (1.5)	CETP (1.5)
ENSG00000118503	TNFAIP3 PPI subnetwork	0.26	> 0.20	RELB (5.8)	BCL3 (3.7)	PVR (2.6)	GRINA (2.3)	FRK (2.2)	TMEM50A (1.9)	ZNF259 (1.8)	BUD13 (1.5)	C1orf63 (1.5)	GMIP (1.4)
ENSG00000113282	CLINT1 PPI subnetwork	0.26	> 0.20	AP1M2 (3.9)	KIAA1324 (3.2)	ST3GAL4 (2.6)	DOCK7 (2.0)	ERP29 (2.0)	CETP (2.0)	PLCG1 (2.0)	C1orf63 (1.9)	DNM2 (1.8)	CLPTM1 (1.8)
GO:0070302	regulation of stress-activated protein kinase signaling cascade	0.27	> 0.20	ST3GAL4 (3.0)	LPAR2 (2.5)	UBXN2B (2.4)	POLK (1.9)	C11orf9 (1.9)	FRK (1.8)	ENSG00000226645 (1.7)	ENSG00000235545 (1.6)	TRAFD1 (1.5)	ZNF180 (1.5)
MP:0000377	abnormal hair follicle morphology	0.27	> 0.20	CELSR2 (2.6)	BCAM (2.4)	CBLC (2.2)	AP1M2 (1.9)	MAFB (1.8)	CYB561D1 (1.8)	NYNRIN (1.7)	LPIN3 (1.7)	PLEC (1.6)	APOC1 (1.6)
ENSG00000110324	IL10RA PPI subnetwork	0.27	> 0.20	BCL3 (3.4)	COL4A3BP (2.1)	C17orf57 (1.8)	PVR (1.6)	RELB (1.5)	ZNF101 (1.5)	CYP7A1 (1.5)	SLC22A1 (1.4)	HLX (1.3)	BCAM (1.3)
ENSG00000096968	JAK2 PPI subnetwork	0.27	> 0.20	GMIP (3.7)	BCL3 (3.5)	DNM2 (2.7)	RELB (2.7)	TRIB1 (2.2)	HLX (2.2)	CYB561D1 (2.1)	ALDH2 (2.1)	PBX4 (1.9)	PARP10 (1.9)
GO:0005979	regulation of glycogen biosynthetic process	0.27	> 0.20	CYB561D1 (2.0)	ZHX3 (1.9)	LPA (1.8)	KANK2 (1.8)	ZNF180 (1.7)	AMIGO1 (1.7)	MYLIP (1.7)	GPAM (1.6)	PCSK9 (1.3)	FRK (1.3)
GO:0032885	regulation of polysaccharide biosynthetic process	0.27	> 0.20	CYB561D1 (2.0)	ZHX3 (1.9)	LPA (1.8)	KANK2 (1.8)	ZNF180 (1.7)	AMIGO1 (1.7)	MYLIP (1.7)	GPAM (1.6)	PCSK9 (1.3)	FRK (1.3)
GO:0010962	regulation of glucan biosynthetic process	0.27	> 0.20	CYB561D1 (2.0)	ZHX3 (1.9)	LPA (1.8)	KANK2 (1.8)	ZNF180 (1.7)	AMIGO1 (1.7)	MYLIP (1.7)	GPAM (1.6)	PCSK9 (1.3)	FRK (1.3)
GO:0032091	negative regulation of protein binding	0.27	> 0.20	OASL (2.8)	TMEM57 (2.7)	SLC44A2 (2.4)	GCNT4 (2.3)	GATAD2A (2.1)	BLOC1S3 (2.1)	LPAR2 (2.1)	PLCG1 (2.0)	MARK4 (1.9)	AMIGO1 (1.8)
ENSG00000058262	SEC61A1 PPI subnetwork	0.27	> 0.20	POLK (2.9)	YIPF2 (2.9)	ATP13A1 (2.8)	PSMA5 (2.1)	ERP29 (2.0)	DOCK7 (1.9)	TMED4 (1.9)	CLPTM1 (1.8)	OGDH (1.7)	SARS (1.7)
GO:0006766	vitamin metabolic process	0.27	> 0.20	TM6SF2 (2.8)	ABCG8 (2.7)	GPAM (2.1)	ALDH2 (2.0)	ENSG00000235545 (1.9)	CYP7A1 (1.8)	LPAR2 (1.8)	ACAD10 (1.8)	ANGPTL3 (1.7)	ABCG5 (1.6)
ENSG00000119408	NEK6 PPI subnetwork	0.27	> 0.20	ILF3 (3.6)	SARS (2.8)	DHX38 (2.7)	QTRT1 (2.4)	DDX56 (2.4)	ATP13A1 (2.4)	FEN1 (2.2)	CARM1 (2.0)	PTPN11 (2.0)	NAA25 (2.0)
GO:0016624	oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor	0.27	> 0.20	ACAD10 (3.1)	MOSC1 (2.4)	GPAM (2.3)	NT5DC1 (2.1)	TRAPPC6A (1.8)	LPA (1.7)	DHODH (1.6)	OGDH (1.5)	PLG (1.5)	GOT2P1 (1.4)
ENSG00000213625	LEPROT PPI subnetwork	0.27	> 0.20	BCL3 (5.2)	TRAFD1 (3.3)	TRIB1 (2.4)	USP24 (2.2)	DOCK7 (1.8)	HAVCR1 (1.8)	GRINA (1.8)	COL4A3BP (1.7)	BRAP (1.6)	GPAM (1.4)
ENSG00000108504	ENSG00000108504 PPI subnetwork	0.27	> 0.20	FEN1 (2.8)	USP1 (2.7)	PSRC1 (2.6)	MAU2 (2.1)	TMEM57 (2.0)	PTPN11 (1.8)	C19orf52 (1.6)	POC5 (1.6)	OGDH (1.5)	DOCK7 (1.5)
MP:0000470	abnormal stomach morphology	0.27	> 0.20	C12orf47 (2.9)	KIAA1324 (2.6)	ANGPTL3 (2.3)	C11orf9 (2.0)	LDLR (1.8)	PPP1R37 (1.7)	OASL (1.5)	NCAN (1.4)	CETP (1.3)	ATXN7L2 (1.3)
GO:0043331	response to dsRNA	0.27	> 0.20	OASL (3.2)	PARP10 (3.1)	MYLIP (2.7)	ADAM1 (2.4)	MAPKAPK5 (2.2)	TRAFD1 (2.0)	ENSG00000228044 (1.8)	C12orf43 (1.7)	ENSG00000226648 (1.7)	GOT2P1 (1.6)
REACTOME_ERKMAPK_TARGETS	REACTOME_ERKMAPK_TARGETS	0.27	> 0.20	SH2B3 (3.6)	MARK4 (3.1)	HLX (2.5)	CLPTM1 (2.1)	COL4A3BP (2.1)	TRIB1 (1.7)	DNM2 (1.7)	ENSG00000226648 (1.6)	TMEM57 (1.6)	ENSG00000226645 (1.6)
ENSG00000170296	GABARAP PPI subnetwork	0.27	> 0.20	COL4A3BP (2.6)	C12orf51 (2.6)	GRINA (2.5)	SARS (2.2)	TRAPPC6A (2.2)	C12orf43 (2.1)	SUGP1 (1.9)	CLPTM1 (1.9)	BRAP (1.8)	ENSG00000228044 (1.7)
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	REACTOME_SIGNALING_BY_EGFR_IN_CANCER	0.27	> 0.20	DNM2 (3.4)	CLPTM1 (3.2)	MARK4 (3.1)	ZHX3 (3.0)	SH2B3 (2.9)	PLEC (2.8)	SMARCA4 (2.5)	CARM1 (2.4)	MAU2 (2.1)	HLX (2.0)
GO:0003009	skeletal muscle contraction	0.27	> 0.20	SYPL2 (6.6)	C17orf57 (2.3)	GMPR (2.3)	CYB561D1 (2.0)	UBXN2B (1.5)	C12orf43 (1.4)	POC5 (1.4)	C12orf47 (1.3)	ANKRD31 (1.3)	ENSG00000228044 (1.3)
GO:0007162	negative regulation of cell adhesion	0.27	> 0.20	ANKRD31 (3.5)	ENSG00000238078 (2.7)	HLX (2.7)	ENSG00000254235 (2.3)	ST3GAL4 (1.9)	SLC44A2 (1.9)	GCNT4 (1.5)	SH2B3 (1.3)	SORT1 (1.2)	APOE (1.2)
ENSG00000173744	AGFG1 PPI subnetwork	0.27	> 0.20	NT5DC1 (3.8)	MAU2 (3.4)	UBXN2B (2.4)	PBX4 (2.4)	C12orf51 (2.3)	LPAR2 (2.3)	NAA25 (2.2)	BRAP (2.0)	CARM1 (1.9)	USP24 (1.8)
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	0.27	> 0.20	SARS (3.3)	NAA25 (2.5)	GOT2P1 (2.4)	GPAM (2.3)	QTRT1 (2.2)	USP24 (2.1)	DHODH (2.0)	TOMM40 (2.0)	ACAD10 (2.0)	CARM1 (1.9)
GO:0032461	positive regulation of protein oligomerization	0.27	> 0.20	C12orf47 (2.9)	ENSG00000226648 (2.4)	FRK (2.4)	ANKRD31 (2.1)	ZNF101 (2.0)	BRAP (1.9)	LPIN3 (1.8)	POLK (1.5)	TMEM116 (1.4)	SH2B3 (1.4)
MP:0005410	abnormal fertilization	0.27	> 0.20	PMFBP1 (3.6)	TSSK6 (3.4)	NKPD1 (2.1)	ENSG00000228044 (2.0)	C12orf47 (1.9)	CEACAM19 (1.9)	PVRL2 (1.9)	CYB561D1 (1.3)	PCSK9 (1.3)	ST3GAL4 (1.1)
ENSG00000160224	AIRE PPI subnetwork	0.27	> 0.20	ZHX3 (3.4)	MYLIP (2.2)	PMFBP1 (1.9)	GATAD2A (1.9)	C19orf52 (1.8)	C12orf47 (1.6)	ZNF101 (1.6)	PPP1R37 (1.6)	MAFB (1.5)	TMEM57 (1.4)
GO:0006278	RNA-dependent DNA replication	0.27	> 0.20	TXNL4B (3.5)	GOT2P1 (2.9)	POLK (2.8)	ENSG00000235545 (2.5)	DHODH (2.4)	POC5 (2.3)	DHX38 (1.8)	UBXN2B (1.7)	GCNT4 (1.6)	C12orf43 (1.6)
REACTOME_FANCONI_ANEMIA_PATHWAY	REACTOME_FANCONI_ANEMIA_PATHWAY	0.27	> 0.20	FEN1 (3.9)	ZNF180 (2.8)	USP1 (2.5)	POC5 (2.2)	PSRC1 (2.1)	C17orf57 (1.6)	TMEM116 (1.6)	NKPD1 (1.5)	MAU2 (1.4)	DHODH (1.2)
GO:0021545	cranial nerve development	0.27	> 0.20	TSSK6 (2.7)	PMFBP1 (2.7)	ANKRD31 (2.3)	HAVCR1 (2.3)	ENSG00000238078 (2.3)	NKPD1 (2.2)	ABO (2.0)	DNAH11 (1.6)	BLOC1S3 (1.5)	C17orf57 (1.5)
ENSG00000185624	P4HB PPI subnetwork	0.27	> 0.20	ERP29 (2.8)	PARP10 (2.7)	NPC1L1 (2.3)	SARS (2.1)	HNF1A (2.1)	TRAFD1 (1.9)	TMED4 (1.8)	TM6SF2 (1.8)	ITGB3 (1.7)	CILP2 (1.7)
ENSG00000114126	TFDP2 PPI subnetwork	0.27	> 0.20	GOT2P1 (3.5)	GATAD2A (2.8)	USP1 (2.8)	MAPKAPK5 (2.6)	FEN1 (2.5)	RHD (2.5)	ATXN2 (2.4)	CLPTM1 (2.1)	RHCE (2.0)	ADAM1 (2.0)
MP:0008174	decreased follicular B cell number	0.27	> 0.20	RELB (3.8)	TIMD4 (3.0)	SH2B3 (2.7)	GMIP (2.4)	APOC1 (2.3)	MAFB (2.2)	CETP (1.5)	BCL3 (1.5)	GPAM (1.4)	ALDH2 (1.4)
ENSG00000145241	CENPC1 PPI subnetwork	0.27	> 0.20	PSRC1 (5.7)	FEN1 (4.0)	USP1 (3.5)	POC5 (3.3)	OASL (1.7)	TIMD4 (1.7)	ENSG00000228044 (1.7)	CETP (1.6)	ENSG00000226648 (1.2)	ZNF180 (1.2)
ENSG00000026508	CD44 PPI subnetwork	0.27	> 0.20	SLC44A2 (3.1)	SH2B3 (2.7)	APOE (2.4)	ITGB3 (2.2)	PVR (2.2)	ENSG00000226648 (2.1)	GMIP (2.0)	PLEC (1.9)	GATAD2A (1.9)	HAVCR1 (1.5)
ENSG00000140451	PIF1 PPI subnetwork	0.27	> 0.20	CBLC (3.4)	TRAPPC6A (2.8)	ABCG8 (2.8)	ABCG5 (2.7)	FEN1 (2.4)	POLK (1.9)	POC5 (1.8)	SUGP1 (1.7)	DHODH (1.6)	TM6SF2 (1.6)
GO:0042542	response to hydrogen peroxide	0.27	> 0.20	DNAH11 (3.0)	ENSG00000226648 (2.6)	CYB561D1 (2.1)	ACAD10 (2.1)	C12orf47 (2.1)	ALDH2 (2.0)	GOT2P1 (1.9)	TRIB1 (1.8)	MOSC1 (1.8)	CEACAM19 (1.8)
GO:0032479	regulation of type I interferon production	0.27	> 0.20	OASL (6.4)	PARP10 (5.7)	TRAFD1 (3.2)	ADAM1 (2.9)	CYB561D1 (2.7)	MAU2 (2.5)	FRK (2.3)	BRAP (2.3)	ENSG00000226645 (2.2)	C12orf43 (2.1)
ENSG00000159113	ENSG00000159113 PPI subnetwork	0.27	> 0.20	BCL3 (3.1)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	ZNF101 (1.5)	RELB (1.4)	HLX (1.4)	PVR (1.4)	SLC22A1 (1.4)	BCAM (1.2)
ENSG00000186468	RPS23 PPI subnetwork	0.27	> 0.20	NKPD1 (2.6)	PLEC (1.9)	TOP1 (1.9)	ILF3 (1.8)	NAA25 (1.8)	ATP13A1 (1.8)	MYLIP (1.7)	SARS (1.6)	QTRT1 (1.6)	ANKRD31 (1.5)
ENSG00000129514	FOXA1 PPI subnetwork	0.27	> 0.20	DHODH (3.8)	DHX38 (3.6)	ABO (2.2)	ATP13A1 (1.9)	GOT2P1 (1.7)	ENSG00000238078 (1.7)	LPAR2 (1.7)	ENSG00000254235 (1.6)	TXNL4B (1.5)	UBXN2B (1.5)
GO:0030673	axolemma	0.27	> 0.20	NCAN (4.0)	RPH3A (3.3)	HAPLN4 (3.2)	FRK (2.6)	CYP7A1 (2.4)	ABCG8 (2.3)	ABO (1.8)	C17orf57 (1.6)	PPP1R37 (1.6)	GCNT4 (1.6)
GO:0004004	ATP-dependent RNA helicase activity	0.27	> 0.20	SUGP1 (3.1)	ATP13A1 (2.7)	DHX38 (2.6)	TOP1 (2.6)	NAA25 (2.1)	ZNF259 (2.1)	ILF3 (2.1)	BUD13 (2.1)	SMARCA4 (2.1)	NT5DC1 (1.7)
ENSG00000003400	CASP10 PPI subnetwork	0.27	> 0.20	FRK (3.5)	RELB (2.9)	TRAFD1 (2.8)	BCL3 (2.2)	LPAR2 (1.9)	ST3GAL4 (1.9)	ENSG00000228044 (1.8)	UBXN2B (1.8)	CEACAM19 (1.6)	PVR (1.5)
GO:0031903	microbody membrane	0.27	> 0.20	GPAM (4.3)	MOSC1 (4.2)	FADS2 (2.2)	CLPTM1 (2.1)	ALDH2 (2.1)	YIPF2 (2.0)	GRINA (1.8)	TRAPPC6A (1.8)	ACAD10 (1.7)	SORT1 (1.7)
GO:0005778	peroxisomal membrane	0.27	> 0.20	GPAM (4.3)	MOSC1 (4.2)	FADS2 (2.2)	CLPTM1 (2.1)	ALDH2 (2.1)	YIPF2 (2.0)	GRINA (1.8)	TRAPPC6A (1.8)	ACAD10 (1.7)	SORT1 (1.7)
MP:0004247	small pancreas	0.27	> 0.20	DYNC2LI1 (3.9)	C11orf9 (2.3)	PLEKHH2 (2.2)	SLC22A1 (1.9)	CEACAM19 (1.8)	ANKRD31 (1.6)	CYP7A1 (1.6)	ENSG00000235545 (1.6)	KIAA1324 (1.5)	DHODH (1.2)
ENSG00000137070	IL11RA PPI subnetwork	0.27	> 0.20	BCL3 (3.1)	COL4A3BP (2.2)	C17orf57 (1.7)	PVR (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	RELB (1.5)	SLC22A1 (1.4)	HLX (1.4)	BCAM (1.3)
ENSG00000145623	OSMR PPI subnetwork	0.27	> 0.20	BCL3 (3.1)	COL4A3BP (2.2)	C17orf57 (1.7)	PVR (1.6)	ZNF101 (1.5)	CYP7A1 (1.5)	RELB (1.5)	SLC22A1 (1.4)	HLX (1.4)	BCAM (1.3)
ENSG00000167658	EEF2 PPI subnetwork	0.27	> 0.20	TOMM40 (3.3)	NAA25 (3.2)	SARS (3.1)	ILF3 (2.6)	SMARCA4 (2.6)	PSMA5 (2.5)	ADAM1 (2.3)	CARM1 (2.1)	ATP13A1 (2.0)	DDX56 (2.0)
ENSG00000110680	CALCA PPI subnetwork	0.27	> 0.20	ABO (3.6)	FADS1 (2.4)	CELSR2 (2.0)	ALDH2 (2.0)	NYNRIN (1.9)	LPIN3 (1.9)	OGDH (1.9)	ATXN7L2 (1.7)	TMEM50A (1.7)	PMFBP1 (1.7)
ENSG00000112818	MEP1A PPI subnetwork	0.27	> 0.20	TM6SF2 (4.4)	ABCG5 (3.7)	NPC1L1 (3.7)	APOB (3.4)	ABCG8 (2.5)	KIAA1324 (2.4)	PLEKHH2 (2.0)	CYP7A1 (1.8)	HLX (1.8)	TSSK6 (1.8)
ENSG00000099783	HNRNPM PPI subnetwork	0.27	> 0.20	ILF3 (4.1)	TOP1 (3.2)	C1orf63 (3.1)	QTRT1 (3.1)	DHX38 (3.0)	SMARCA4 (2.7)	PTPN11 (2.6)	SUGP1 (2.6)	GATAD2A (2.5)	USP1 (2.5)
ENSG00000148334	PTGES2 PPI subnetwork	0.27	> 0.20	ATP13A1 (3.6)	QTRT1 (2.6)	YIPF2 (2.5)	ILF3 (2.4)	DNM2 (2.2)	SARS (2.2)	OGDH (2.0)	C19orf52 (1.7)	LDLR (1.6)	DOCK7 (1.5)
ENSG00000170348	TMED10 PPI subnetwork	0.27	> 0.20	YIPF2 (4.0)	TMED4 (3.6)	C19orf52 (2.7)	CLPTM1 (2.7)	TMEM50A (2.5)	ABCG8 (2.2)	ATP13A1 (1.8)	FADS2 (1.8)	PVR (1.8)	TXNL4B (1.7)
MP:0001246	mixed cellular infiltration to dermis	0.27	> 0.20	DNM2 (3.2)	GMIP (3.1)	RHCE (2.4)	RHD (2.3)	TM6SF2 (2.3)	ILF3 (2.2)	YIPF2 (2.1)	CBLC (2.1)	PARP10 (2.0)	LPAR2 (2.0)
MP:0003643	spleen atrophy	0.27	> 0.20	RELB (5.6)	HNF1A (3.4)	ENSG00000226645 (2.9)	PBX4 (2.6)	BCL3 (2.4)	C12orf47 (2.1)	PARP10 (1.6)	TOMM40 (1.5)	AMIGO1 (1.5)	GEMIN7 (1.4)
ENSG00000120948	TARDBP PPI subnetwork	0.27	> 0.20	CLPTM1 (4.6)	QTRT1 (3.8)	SUGP1 (3.1)	ILF3 (3.1)	GATAD2A (2.8)	PPP1R37 (2.4)	PLCG1 (2.3)	TOP1 (2.1)	DHX38 (2.1)	SMARCA4 (1.9)
ENSG00000130222	GADD45G PPI subnetwork	0.27	> 0.20	PSRC1 (3.0)	TXNL4B (2.8)	TRIB1 (2.2)	BUD13 (2.0)	POC5 (1.9)	LPA (1.8)	ATXN7L2 (1.6)	FEN1 (1.5)	MYLIP (1.4)	HLX (1.3)
GO:0071357	cellular response to type I interferon	0.27	> 0.20	OASL (8.7)	PARP10 (6.5)	TRAFD1 (4.4)	GMPR (1.8)	ATP13A1 (1.8)	ENSG00000228044 (1.8)	ADAM1 (1.7)	CYB561D1 (1.6)	TMEM50A (1.5)	FRK (1.5)
GO:0060337	type I interferon-mediated signaling pathway	0.27	> 0.20	OASL (8.7)	PARP10 (6.5)	TRAFD1 (4.4)	GMPR (1.8)	ATP13A1 (1.8)	ENSG00000228044 (1.8)	ADAM1 (1.7)	CYB561D1 (1.6)	TMEM50A (1.5)	FRK (1.5)
MP:0008474	absent spleen germinal center	0.27	> 0.20	RELB (8.1)	BCL3 (4.1)	GRINA (4.0)	GMIP (3.0)	PARP10 (2.8)	HAVCR1 (2.1)	PLEC (2.0)	TRAFD1 (2.0)	PBX4 (1.6)	LPAR2 (1.6)
ENSG00000111676	ATN1 PPI subnetwork	0.27	> 0.20	BCAM (3.8)	NYNRIN (3.6)	ATXN2 (2.5)	MARK4 (2.4)	PPP1R37 (2.3)	GRINA (2.3)	ENSG00000238078 (2.1)	SMARCA4 (2.1)	CELSR2 (2.0)	PLEC (2.0)
GO:0017134	fibroblast growth factor binding	0.27	> 0.20	PLEKHH2 (3.9)	PCSK9 (3.5)	CELSR2 (2.5)	NCAN (2.2)	LDLR (2.0)	SLC44A2 (1.9)	BCAM (1.8)	FADS1 (1.8)	GPAM (1.8)	ZNF101 (1.7)
MP:0002780	decreased circulating testosterone level	0.27	> 0.20	MOSC1 (3.2)	GPAM (2.8)	PMFBP1 (2.1)	KIAA1324 (1.5)	GCNT4 (1.4)	MYLIP (1.3)	APOB (1.3)	ALDH2 (1.3)	HLX (1.2)	APOC1 (1.2)
GO:0043406	positive regulation of MAP kinase activity	0.27	> 0.20	LPAR2 (2.8)	ENSG00000226645 (2.6)	ENSG00000228044 (2.4)	ABO (2.3)	HLX (2.1)	SLC44A2 (2.0)	PTPN11 (2.0)	GCNT4 (1.8)	CYB561D1 (1.6)	ST3GAL4 (1.5)
GO:0002218	activation of innate immune response	0.27	> 0.20	SH2B3 (2.9)	CYB561D1 (2.6)	GMIP (2.2)	RELB (2.2)	PARP10 (2.0)	MAFB (2.0)	HLX (1.9)	MYLIP (1.8)	TRIB1 (1.8)	BCL3 (1.8)
ENSG00000131979	GCH1 PPI subnetwork	0.27	> 0.20	TMEM57 (2.6)	ALDH2 (2.3)	LPIN3 (2.2)	HAPLN4 (2.0)	HNF1A (1.9)	PPP1R37 (1.9)	TXNL4B (1.6)	BLOC1S3 (1.5)	UBXN2B (1.4)	CYP7A1 (1.4)
ENSG00000100784	RPS6KA5 PPI subnetwork	0.27	> 0.20	TSSK6 (2.8)	SH2B3 (2.7)	PARP10 (2.5)	BCL3 (2.2)	TRIB1 (1.9)	HLX (1.7)	MYLIP (1.7)	PLEC (1.6)	GEMIN7 (1.6)	GMPR (1.5)
GO:0043011	myeloid dendritic cell differentiation	0.27	> 0.20	SH2B3 (2.7)	GEMIN7 (2.6)	ZNF180 (2.5)	ZNF101 (2.5)	GCNT4 (1.6)	C12orf47 (1.6)	GOT2P1 (1.6)	PBX4 (1.5)	CLPTM1 (1.3)	ABCG8 (1.3)
ENSG00000011275	RNF216 PPI subnetwork	0.27	> 0.20	PARP10 (3.9)	OASL (3.8)	GMPR (3.6)	RHCE (2.8)	FRK (2.7)	LPIN3 (2.5)	DYNC2LI1 (2.2)	RHD (2.1)	MYLIP (1.8)	ZNF180 (1.8)
ENSG00000112576	CCND3 PPI subnetwork	0.27	> 0.20	TRIB1 (2.6)	NYNRIN (2.6)	MAU2 (2.4)	GRINA (2.0)	MYLIP (1.7)	BLOC1S3 (1.7)	PPP1R37 (1.7)	KANK2 (1.6)	TRAPPC6A (1.6)	TMED4 (1.6)
ENSG00000100603	SNW1 PPI subnetwork	0.27	> 0.20	DHX38 (4.3)	SMARCA4 (3.6)	USP24 (2.8)	BUD13 (2.3)	CARM1 (2.3)	SARS (2.0)	SUGP1 (1.9)	USP1 (1.7)	MAU2 (1.7)	BRAP (1.7)
ENSG00000115392	FANCL PPI subnetwork	0.27	> 0.20	POC5 (3.1)	C17orf57 (2.2)	DHODH (2.0)	ENSG00000254235 (2.0)	UBXN2B (1.9)	ZNF180 (1.8)	ST3GAL4 (1.6)	LPA (1.6)	ABO (1.4)	DOCK7 (1.3)
REACTOME_STRIATED_MUSCLE_CONTRACTION	REACTOME_STRIATED_MUSCLE_CONTRACTION	0.27	> 0.20	SYPL2 (6.9)	GMPR (2.8)	RHCE (1.3)	TMEM50A (1.2)	UBXN2B (0.9)	HMGCR (0.9)	RPH3A (0.9)	PLEC (0.9)	RHD (0.9)	LPAR2 (0.8)
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES	0.27	> 0.20	TMED4 (3.3)	ERP29 (2.9)	ST3GAL4 (2.5)	GRINA (1.9)	ITGB3 (1.9)	YIPF2 (1.8)	SH2B3 (1.8)	RHCE (1.6)	ENSG00000254235 (1.6)	COL4A3BP (1.6)
GO:0002274	myeloid leukocyte activation	0.27	> 0.20	C17orf57 (3.4)	GMIP (2.3)	ZNF101 (1.9)	ANKRD31 (1.8)	MAFB (1.5)	C12orf47 (1.5)	GEMIN7 (1.5)	ITGB3 (1.4)	SH2B3 (1.3)	BCL3 (1.3)
GO:0034340	response to type I interferon	0.27	> 0.20	OASL (8.6)	PARP10 (6.7)	TRAFD1 (4.4)	GMPR (1.8)	ENSG00000228044 (1.8)	ATP13A1 (1.8)	ADAM1 (1.7)	CYB561D1 (1.7)	FRK (1.5)	TMEM50A (1.5)
GO:0060644	mammary gland epithelial cell differentiation	0.27	> 0.20	ENSG00000226648 (2.8)	BLOC1S3 (2.7)	NKPD1 (2.5)	HLX (2.0)	ENSG00000254235 (1.8)	GOT2P1 (1.8)	TRAPPC6A (1.8)	HAVCR1 (1.6)	DYNC2LI1 (1.6)	PLEKHH2 (1.5)
MP:0000747	muscle weakness	0.27	> 0.20	SYPL2 (5.9)	COL4A3BP (2.4)	RPH3A (1.9)	HAPLN4 (1.8)	C12orf47 (1.8)	GMPR (1.7)	CARM1 (1.6)	GRINA (1.6)	NPC1L1 (1.5)	ATXN7L2 (1.4)
ENSG00000100985	MMP9 PPI subnetwork	0.27	> 0.20	ITGB3 (2.8)	PVR (2.5)	SLC22A1 (2.5)	FRK (2.4)	PLEKHH2 (1.9)	PVRL2 (1.8)	ABCG5 (1.7)	HP (1.7)	DYNC2LI1 (1.7)	ANGPTL3 (1.7)
ENSG00000110367	DDX6 PPI subnetwork	0.27	> 0.20	DHX38 (3.5)	ZNF259 (3.3)	MAU2 (2.8)	SARS (2.7)	DDX56 (2.6)	GEMIN7 (2.6)	NAA25 (2.6)	SUGP1 (2.5)	PSMA5 (2.4)	ATP13A1 (2.4)
GO:0008146	sulfotransferase activity	0.27	> 0.20	ABCG5 (3.1)	SH2B3 (2.2)	ST3GAL4 (2.1)	ABCG8 (2.1)	APOB (2.1)	MARK4 (2.0)	NPC1L1 (2.0)	GCNT4 (1.9)	TM6SF2 (1.7)	APOE (1.6)
MP:0008750	abnormal interferon level	0.27	> 0.20	OASL (10.2)	PARP10 (7.0)	TRAFD1 (3.8)	BCL3 (3.2)	GMIP (2.2)	SH2B3 (2.2)	FRK (2.1)	RELB (2.0)	PVR (1.9)	CEACAM19 (1.5)
GO:0016569	covalent chromatin modification	0.27	> 0.20	ATXN7L2 (3.9)	BUD13 (2.7)	ILF3 (2.7)	C12orf51 (2.3)	MAU2 (2.0)	SMARCA4 (1.9)	ATXN2 (1.9)	TMEM57 (1.9)	TOP1 (1.8)	USP24 (1.8)
MP:0004704	short vertebral column	0.27	> 0.20	CILP2 (5.8)	FADS2 (3.5)	FADS1 (3.5)	HMGCR (3.3)	PLEKHH2 (2.6)	NPC1L1 (2.1)	PCSK9 (2.0)	LDLR (2.0)	CEACAM19 (1.6)	HAVCR1 (1.5)
ENSG00000133997	MED6 PPI subnetwork	0.27	> 0.20	GEMIN7 (4.0)	BLOC1S3 (2.6)	C12orf51 (2.3)	BUD13 (2.2)	MAPKAPK5 (2.1)	POC5 (2.1)	ATXN7L2 (2.1)	C12orf47 (2.0)	HMGCR (1.8)	FADS2 (1.7)
GO:0002718	regulation of cytokine production involved in immune response	0.27	> 0.20	ZNF101 (2.7)	GCNT4 (2.7)	HAVCR1 (1.8)	NPC1L1 (1.7)	CETP (1.7)	MAFB (1.7)	TIMD4 (1.7)	SH2B3 (1.4)	PVR (1.3)	BCL3 (1.3)
ENSG00000103365	GGA2 PPI subnetwork	0.27	> 0.20	COL4A3BP (3.3)	ENSG00000226645 (3.2)	CYB561D1 (2.3)	BLOC1S3 (2.2)	YIPF2 (2.2)	C19orf52 (2.0)	PTPN11 (1.8)	POLK (1.7)	MYLIP (1.7)	PLEKHH2 (1.6)
MP:0004030	induced chromosome breakage	0.27	> 0.20	ZNF180 (2.6)	FEN1 (2.4)	GEMIN7 (2.2)	BUD13 (1.9)	DHODH (1.7)	POC5 (1.7)	UBXN2B (1.5)	DOCK7 (1.4)	ZNF101 (1.4)	ENSG00000254235 (1.3)
ENSG00000096746	HNRNPH3 PPI subnetwork	0.27	> 0.20	LDLR (3.1)	ABO (2.6)	HMGCR (2.3)	FADS2 (2.2)	CARM1 (2.2)	PCSK9 (2.1)	FADS1 (2.1)	CYB561D1 (2.0)	ITGB3 (1.8)	ANGPTL3 (1.8)
ENSG00000148303	RPL7A PPI subnetwork	0.27	> 0.20	NAA25 (3.9)	ZNF259 (3.5)	QTRT1 (3.4)	DDX56 (3.3)	TOMM40 (2.7)	DHX38 (2.3)	TOP1 (2.2)	PTPN11 (2.1)	ATP13A1 (1.9)	ILF3 (1.8)
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	0.27	> 0.20	PLEC (2.9)	DOCK7 (1.8)	AP1M2 (1.8)	COL4A3BP (1.8)	DHX38 (1.7)	UBXN2B (1.6)	TRAFD1 (1.5)	ST3GAL4 (1.5)	SMARCA4 (1.4)	ENSG00000226645 (1.3)
MP:0000116	abnormal tooth development	0.27	> 0.20	CILP2 (4.2)	PLEKHH2 (2.9)	MAFB (2.2)	ST3GAL4 (2.1)	BCAM (2.0)	KANK2 (1.8)	GCNT4 (1.8)	NKPD1 (1.7)	MYLIP (1.7)	PPP1R37 (1.6)
GO:0048608	reproductive structure development	0.27	> 0.20	LPAR2 (2.6)	DNAH11 (2.5)	ABO (2.4)	ST3GAL4 (2.4)	NYNRIN (2.0)	PVRL2 (1.7)	AMIGO1 (1.5)	CELSR2 (1.4)	YIPF2 (1.3)	AP1M2 (1.3)
MP:0000690	absent spleen	0.27	> 0.20	NYNRIN (4.1)	C11orf9 (3.5)	PVRL2 (2.8)	PLEKHH2 (2.6)	GCNT4 (2.5)	DYNC2LI1 (2.4)	HLX (2.1)	TMED4 (1.7)	ABO (1.7)	DOCK7 (1.6)
GO:0035336	long-chain fatty-acyl-CoA metabolic process	0.27	> 0.20	FADS1 (5.5)	FADS2 (5.3)	HMGCR (5.3)	LDLR (4.6)	PCSK9 (4.5)	GPAM (3.3)	BLOC1S3 (3.0)	NKPD1 (2.6)	MOSC1 (1.9)	DOCK7 (1.8)
GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	0.27	> 0.20	FADS1 (5.5)	FADS2 (5.3)	HMGCR (5.3)	LDLR (4.6)	PCSK9 (4.5)	GPAM (3.3)	BLOC1S3 (3.0)	NKPD1 (2.6)	MOSC1 (1.9)	DOCK7 (1.8)
GO:0007004	telomere maintenance via telomerase	0.27	> 0.20	TXNL4B (3.6)	POLK (3.0)	GOT2P1 (2.6)	DHODH (2.5)	POC5 (2.2)	ENSG00000235545 (2.1)	DHX38 (1.8)	UBXN2B (1.7)	TMEM57 (1.6)	GCNT4 (1.6)
ENSG00000162734	PEA15 PPI subnetwork	0.27	> 0.20	ENSG00000238078 (3.4)	TMEM50A (2.7)	C1orf63 (2.4)	ST3GAL4 (2.1)	USP24 (2.0)	NPC1L1 (2.0)	GOT2P1 (1.8)	POLK (1.7)	PVRL2 (1.6)	DHODH (1.3)
ENSG00000069275	NUCKS1 PPI subnetwork	0.27	> 0.20	ACAD10 (4.0)	HNF1A (3.3)	NT5DC1 (3.1)	TMED4 (2.4)	C1orf63 (2.4)	KIAA1324 (1.8)	TRAPPC6A (1.8)	ATXN7L2 (1.6)	PLEKHH2 (1.6)	TMEM50A (1.5)
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	0.27	> 0.20	TIMD4 (4.1)	RELB (3.5)	MAFB (3.0)	BCL3 (2.6)	CETP (2.5)	OASL (2.3)	ZNF101 (2.1)	ENSG00000228044 (1.4)	GMIP (1.3)	TRAFD1 (1.3)
ENSG00000152455	SUV39H2 PPI subnetwork	0.27	> 0.20	TOP1 (2.4)	MYLIP (2.3)	GATAD2A (2.1)	PTPN11 (2.1)	ZHX3 (2.0)	CYP7A1 (1.8)	ENSG00000226645 (1.6)	SMARCA4 (1.6)	NYNRIN (1.5)	C19orf52 (1.5)
GO:0009314	response to radiation	0.27	> 0.20	ZNF180 (2.2)	POLK (2.0)	ATXN7L2 (1.9)	BLOC1S3 (1.9)	TRIB1 (1.8)	TRAPPC6A (1.4)	ENSG00000235545 (1.3)	BUD13 (1.3)	DNAH11 (1.3)	PVR (1.3)
ENSG00000167978	SRRM2 PPI subnetwork	0.27	> 0.20	GATAD2A (3.2)	C1orf63 (3.1)	TOP1 (2.8)	SMARCA4 (2.3)	DOCK7 (2.1)	CARM1 (2.0)	LPAR2 (1.9)	FRK (1.8)	ILF3 (1.8)	USP1 (1.7)
ENSG00000187735	TCEA1 PPI subnetwork	0.27	> 0.20	SUGP1 (4.6)	DHX38 (2.7)	DNM2 (2.5)	MAPKAPK5 (2.4)	ZNF259 (2.4)	SMARCA4 (2.2)	TXNL4B (2.2)	MAU2 (2.1)	CLPTM1 (2.1)	BUD13 (2.1)
MP:0008663	increased interleukin-12 secretion	0.27	> 0.20	MAFB (3.8)	GMIP (2.6)	APOC1 (2.5)	APOE (2.5)	ERP29 (2.3)	ADAM1 (2.2)	C12orf43 (2.1)	UBXN2B (1.9)	POLK (1.7)	ATP13A1 (1.6)
ENSG00000067082	KLF6 PPI subnetwork	0.27	> 0.20	SARS (2.8)	PSRC1 (2.3)	SORT1 (2.3)	PSMA5 (2.2)	GEMIN7 (2.1)	CYB561D1 (1.9)	POLK (1.8)	LPIN3 (1.8)	MAFB (1.8)	ENSG00000235545 (1.7)
REACTOME_PROTEIN_FOLDING	REACTOME_PROTEIN_FOLDING	0.27	> 0.20	ENSG00000238078 (2.6)	SMARCA4 (2.0)	SUGP1 (2.0)	QTRT1 (2.0)	LPIN3 (1.9)	C12orf47 (1.9)	ZNF259 (1.8)	TOMM40 (1.6)	ITGB3 (1.6)	ZHX3 (1.5)
ENSG00000101161	PRPF6 PPI subnetwork	0.27	> 0.20	DHX38 (3.8)	ILF3 (3.6)	TOP1 (3.2)	SUGP1 (3.1)	SMARCA4 (2.7)	C1orf63 (2.5)	FEN1 (2.5)	MAU2 (2.4)	QTRT1 (2.4)	USP1 (2.4)
ENSG00000113161	HMGCR PPI subnetwork	0.27	> 0.20	LDLR (9.4)	FADS1 (7.9)	HMGCR (7.3)	FADS2 (6.5)	PCSK9 (4.2)	OGDH (2.2)	SORT1 (1.8)	ATP13A1 (1.6)	TMED4 (1.3)	HNF1A (1.3)
ENSG00000162594	IL23R PPI subnetwork	0.28	> 0.20	BCL3 (3.4)	COL4A3BP (2.0)	C17orf57 (1.7)	ZNF101 (1.5)	RELB (1.5)	PVR (1.4)	CYP7A1 (1.4)	SLC22A1 (1.3)	HLX (1.3)	BCAM (1.2)
ENSG00000110075	PPP6R3 PPI subnetwork	0.28	> 0.20	TOMM40 (2.9)	C19orf52 (2.4)	PPP1R37 (1.9)	RELB (1.9)	USP24 (1.9)	ENSG00000226648 (1.8)	TXNL4B (1.8)	SMARCA4 (1.8)	ZNF101 (1.7)	BUD13 (1.6)
ENSG00000139514	SLC7A1 PPI subnetwork	0.28	> 0.20	USP24 (2.7)	DNM2 (2.7)	GMIP (2.4)	ALDH2 (2.3)	COL4A3BP (2.1)	PLEC (1.8)	SORT1 (1.8)	TMEM50A (1.7)	POLK (1.6)	LDLR (1.5)
ENSG00000066427	ATXN3 PPI subnetwork	0.28	> 0.20	MAU2 (2.8)	PSMA5 (2.4)	C19orf52 (2.1)	ENSG00000238078 (2.0)	TOMM40 (1.9)	NKPD1 (1.9)	TXNL4B (1.8)	DHX38 (1.6)	CARM1 (1.5)	CYP7A1 (1.5)
GO:0032964	collagen biosynthetic process	0.28	> 0.20	GEMIN7 (2.1)	FRK (2.1)	HNF1A (2.1)	ST3GAL4 (1.9)	ENSG00000226645 (1.7)	CEACAM19 (1.7)	C11orf9 (1.4)	C17orf57 (1.4)	PVRL2 (1.4)	APOE (1.2)
GO:0015850	organic alcohol transport	0.28	> 0.20	ABO (2.8)	AMIGO1 (1.9)	GOT2P1 (1.8)	GMPR (1.7)	TSSK6 (1.7)	ST3GAL4 (1.5)	YIPF2 (1.4)	ZHX3 (1.4)	C19orf52 (1.4)	MOSC1 (1.3)
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	0.28	> 0.20	GMIP (4.5)	SH2B3 (3.3)	GATAD2A (3.0)	DNM2 (2.9)	ITGB3 (2.3)	DOCK7 (2.3)	PPP1R37 (2.1)	CYB561D1 (1.8)	ZHX3 (1.8)	SMARCA4 (1.7)
MP:0000120	malocclusion	0.28	> 0.20	NYNRIN (2.4)	KANK2 (2.3)	CILP2 (2.1)	PLEC (2.0)	PBX4 (1.8)	ATXN2 (1.5)	HNF1A (1.5)	ZHX3 (1.5)	TMEM116 (1.4)	LDLR (1.4)
GO:0055017	cardiac muscle tissue growth	0.28	> 0.20	CEACAM19 (2.9)	BLOC1S3 (2.3)	C19orf52 (2.1)	PLEKHH2 (1.9)	GCNT4 (1.4)	C11orf9 (1.4)	ALDH2 (1.3)	PVR (1.3)	NYNRIN (1.3)	ZNF180 (1.2)
GO:0044427	chromosomal part	0.28	> 0.20	USP1 (5.0)	FEN1 (4.8)	PSRC1 (4.0)	POC5 (2.9)	BUD13 (1.7)	ILF3 (1.3)	ZNF180 (1.3)	SMARCA4 (1.2)	DHX38 (1.1)	KANK2 (1.0)
ENSG00000104824	HNRNPL PPI subnetwork	0.28	> 0.20	ILF3 (4.2)	C1orf63 (3.7)	QTRT1 (2.8)	SMARCA4 (2.8)	TOP1 (2.7)	DHX38 (2.6)	BUD13 (2.2)	ATP13A1 (2.1)	MAU2 (2.1)	USP1 (2.1)
GO:0008173	RNA methyltransferase activity	0.28	> 0.20	QTRT1 (5.2)	NAA25 (3.3)	DDX56 (2.9)	MAPKAPK5 (2.9)	C19orf52 (2.8)	DHODH (2.5)	C12orf43 (2.4)	TOMM40 (2.2)	ZNF259 (2.1)	YIPF2 (2.0)
MP:0009814	increased prostaglandin level	0.28	> 0.20	APOC1 (3.8)	TRIB1 (3.1)	ALDH2 (2.7)	GMPR (2.2)	UBXN2B (2.1)	ITGB3 (1.7)	C11orf9 (1.7)	TMEM57 (1.6)	ENSG00000238078 (1.4)	ANGPTL3 (1.4)
MP:0003658	abnormal capillary morphology	0.28	> 0.20	DNAH11 (2.8)	GPAM (1.8)	BCL3 (1.8)	PVR (1.7)	ST3GAL4 (1.6)	SLC44A2 (1.5)	ACAD10 (1.5)	ITGB3 (1.4)	HLX (1.4)	PARP10 (1.3)
GO:0032856	activation of Ras GTPase activity	0.28	> 0.20	ENSG00000238078 (2.9)	CEACAM19 (2.8)	AP1M2 (2.7)	CETP (2.7)	PBX4 (2.5)	HNF1A (2.1)	TIMD4 (2.0)	ENSG00000228044 (1.8)	LPIN3 (1.7)	UBXN2B (1.7)
ENSG00000168135	KCNJ4 PPI subnetwork	0.28	> 0.20	PPP1R37 (2.8)	ALDH2 (2.6)	CYB561D1 (2.1)	POLK (2.1)	ENSG00000238078 (2.0)	MAPKAPK5 (1.7)	RPH3A (1.7)	DNAH11 (1.6)	TMEM116 (1.5)	HLX (1.4)
ENSG00000077238	IL4R PPI subnetwork	0.28	> 0.20	BCL3 (3.1)	COL4A3BP (2.0)	RELB (1.9)	CYP7A1 (1.8)	C17orf57 (1.6)	SLC22A1 (1.5)	PVR (1.5)	HLX (1.5)	BCAM (1.3)	CETP (1.2)
GO:0008584	male gonad development	0.28	> 0.20	LPAR2 (3.1)	DNAH11 (2.7)	ST3GAL4 (2.5)	ABO (2.3)	C11orf9 (2.0)	FRK (1.9)	GCNT4 (1.6)	PLEKHH2 (1.6)	PVRL2 (1.6)	YIPF2 (1.6)
ENSG00000157933	SKI PPI subnetwork	0.28	> 0.20	TRIB1 (3.1)	NYNRIN (2.6)	KANK2 (2.5)	ZHX3 (2.4)	DOCK7 (2.4)	PLEC (2.1)	ATXN2 (1.9)	TMEM57 (1.7)	GCNT4 (1.6)	ENSG00000235545 (1.4)
GO:0006000	fructose metabolic process	0.28	> 0.20	NPC1L1 (2.8)	PBX4 (2.7)	GOT2P1 (2.4)	TM6SF2 (2.2)	ENSG00000228044 (2.2)	LPA (1.9)	ACAD10 (1.7)	ENSG00000238078 (1.5)	ENSG00000254235 (1.5)	TRAFD1 (1.5)
ENSG00000020426	MNAT1 PPI subnetwork	0.28	> 0.20	BUD13 (3.3)	SUGP1 (2.8)	ZNF259 (2.5)	POC5 (2.2)	TXNL4B (2.1)	FEN1 (2.0)	POLK (1.9)	PSMA5 (1.8)	ILF3 (1.7)	DHX38 (1.7)
ENSG00000130726	TRIM28 PPI subnetwork	0.28	> 0.20	ZNF180 (2.8)	ACAD10 (2.3)	POLK (1.9)	DHX38 (1.9)	USP1 (1.8)	SH2B3 (1.7)	PLCG1 (1.6)	C19orf52 (1.6)	FADS1 (1.6)	ENSG00000238078 (1.6)
ENSG00000143344	RGL1 PPI subnetwork	0.28	> 0.20	CYB561D1 (3.1)	ST3GAL4 (2.9)	LPAR2 (2.4)	USP24 (2.2)	MAPKAPK5 (2.1)	SLC44A2 (2.1)	ATXN7L2 (2.0)	CETP (1.7)	PSMA5 (1.6)	SARS (1.5)
ENSG00000126067	PSMB2 PPI subnetwork	0.28	> 0.20	PSMA5 (4.7)	TRAFD1 (2.2)	NAA25 (2.2)	DDX56 (1.9)	NT5DC1 (1.8)	TMEM57 (1.8)	SUGP1 (1.6)	TOP1 (1.4)	DHX38 (1.4)	TOMM40 (1.4)
MP:0003419	delayed endochondral bone ossification	0.28	> 0.20	CILP2 (3.3)	MAFB (3.3)	KANK2 (2.6)	PLCG1 (2.2)	NYNRIN (1.7)	PLEKHH2 (1.6)	CEACAM19 (1.4)	PPP1R37 (1.3)	ENSG00000254235 (1.2)	TMEM57 (1.2)
GO:0031301	integral to organelle membrane	0.28	> 0.20	CLPTM1 (4.1)	TMED4 (3.3)	YIPF2 (3.3)	ATP13A1 (3.2)	GRINA (3.0)	ERP29 (2.7)	CYB561D1 (2.2)	TMEM50A (2.2)	AMIGO1 (2.2)	TMEM57 (1.8)
ENSG00000196776	CD47 PPI subnetwork	0.28	> 0.20	RHD (6.1)	RHCE (5.0)	ITGB3 (3.6)	FADS1 (2.0)	LDLR (1.9)	CETP (1.9)	GMPR (1.9)	DOCK7 (1.8)	ALDH2 (1.7)	TMED4 (1.7)
ENSG00000049759	NEDD4L PPI subnetwork	0.28	> 0.20	SMARCA4 (3.1)	DNM2 (3.0)	TMEM50A (2.5)	PSMA5 (2.1)	USP24 (2.1)	C1orf63 (2.0)	ATP13A1 (1.9)	COL4A3BP (1.9)	CBLC (1.8)	NKPD1 (1.8)
ENSG00000156873	PHKG2 PPI subnetwork	0.28	> 0.20	SYPL2 (2.4)	DHODH (2.1)	ZNF180 (2.1)	PPP1R37 (2.0)	HP (2.0)	TXNL4B (1.9)	GPAM (1.7)	FADS2 (1.5)	ZHX3 (1.4)	ST3GAL4 (1.4)
ENSG00000100836	PABPN1 PPI subnetwork	0.28	> 0.20	ILF3 (4.3)	TOP1 (3.2)	DHX38 (3.2)	SMARCA4 (3.1)	C1orf63 (3.0)	SUGP1 (2.4)	USP1 (2.4)	DHODH (2.1)	BUD13 (2.1)	PTPN11 (2.0)
ENSG00000110955	ATP5B PPI subnetwork	0.28	> 0.20	PSMA5 (2.7)	ACAD10 (2.2)	OGDH (2.1)	TOMM40 (2.0)	NAA25 (1.9)	GMPR (1.9)	TMED4 (1.9)	PLEC (1.7)	TOP1 (1.6)	ENSG00000238078 (1.5)
GO:0008514	organic anion transmembrane transporter activity	0.28	> 0.20	PLG (6.5)	ANGPTL3 (6.4)	SLC22A1 (5.2)	APOA5 (3.1)	APOC4 (3.0)	CYP7A1 (2.9)	TIMD4 (2.2)	APOE (2.0)	APOC1 (1.7)	HNF1A (1.7)
ENSG00000152518	ZFP36L2 PPI subnetwork	0.28	> 0.20	PLEC (3.4)	CARM1 (3.0)	ZHX3 (3.0)	DNM2 (2.9)	C11orf9 (2.9)	COL4A3BP (2.6)	C12orf51 (2.5)	USP24 (2.4)	LPAR2 (2.3)	PTPN11 (2.2)
ENSG00000178573	MAF PPI subnetwork	0.28	> 0.20	TRIB1 (6.6)	MAFB (2.9)	PLCG1 (2.8)	DNAH11 (2.0)	CELSR2 (1.9)	ATXN2 (1.9)	HLX (1.9)	ABCG8 (1.8)	ATXN7L2 (1.6)	NPC1L1 (1.5)
GO:0002687	positive regulation of leukocyte migration	0.28	> 0.20	ENSG00000228044 (3.4)	TIMD4 (2.7)	ZNF101 (2.2)	PVR (2.1)	CETP (2.1)	RELB (2.0)	MAFB (1.9)	APOE (1.5)	BCL3 (1.5)	GMIP (1.3)
GO:0032102	negative regulation of response to external stimulus	0.28	> 0.20	GCNT4 (3.6)	ANKRD31 (3.6)	DNAH11 (2.6)	HLX (1.8)	NKPD1 (1.5)	PPP1R37 (1.5)	APOC1 (1.3)	LPIN3 (1.3)	SH2B3 (1.2)	ABO (1.2)
GO:0050821	protein stabilization	0.28	> 0.20	ENSG00000238078 (2.3)	ADAM1 (2.2)	ZNF259 (2.1)	POLK (2.1)	NPC1L1 (1.8)	MYLIP (1.7)	ABCG5 (1.6)	DYNC2LI1 (1.6)	BRAP (1.6)	C19orf52 (1.6)
MP:0005435	hemoperitoneum	0.28	> 0.20	HP (5.2)	APOB (3.9)	ANGPTL3 (3.4)	PLG (2.9)	PVR (2.3)	APOA5 (2.3)	APOC4 (2.2)	HNF1A (2.1)	ENSG00000226648 (2.1)	HLX (1.7)
MP:0002038	carcinoma	0.28	> 0.20	SARS (2.3)	LPIN3 (2.2)	AP1M2 (2.2)	POLK (1.8)	ATXN7L2 (1.7)	PLEKHH2 (1.7)	C17orf57 (1.7)	PSRC1 (1.6)	KANK2 (1.6)	GMIP (1.6)
ENSG00000159128	IFNGR2 PPI subnetwork	0.28	> 0.20	BCL3 (3.0)	COL4A3BP (2.3)	C17orf57 (1.7)	PVR (1.6)	CYP7A1 (1.6)	HLX (1.5)	RELB (1.5)	BCAM (1.4)	POLK (1.3)	ZNF101 (1.3)
ENSG00000055732	MCOLN3 PPI subnetwork	0.28	> 0.20	PTPN11 (3.3)	PARP10 (2.9)	FRK (2.7)	ADAM1 (2.2)	ZNF180 (2.0)	HNF1A (1.9)	BRAP (1.8)	C17orf57 (1.8)	C12orf43 (1.8)	ENSG00000254235 (1.8)
GO:0002714	positive regulation of B cell mediated immunity	0.28	> 0.20	ENSG00000235545 (3.3)	GEMIN7 (2.6)	AMIGO1 (2.2)	GOT2P1 (1.9)	ENSG00000228044 (1.7)	ZNF101 (1.6)	HAVCR1 (1.4)	DYNC2LI1 (1.3)	PMFBP1 (1.3)	TRAPPC6A (1.3)
GO:0002891	positive regulation of immunoglobulin mediated immune response	0.28	> 0.20	ENSG00000235545 (3.3)	GEMIN7 (2.6)	AMIGO1 (2.2)	GOT2P1 (1.9)	ENSG00000228044 (1.7)	ZNF101 (1.6)	HAVCR1 (1.4)	DYNC2LI1 (1.3)	PMFBP1 (1.3)	TRAPPC6A (1.3)
GO:0030865	cortical cytoskeleton organization	0.28	> 0.20	ABO (3.7)	NYNRIN (2.1)	GRINA (1.7)	GATAD2A (1.6)	ENSG00000254235 (1.6)	OGDH (1.5)	YIPF2 (1.5)	ERP29 (1.2)	MYLIP (1.2)	ZNF101 (1.2)
MP:0003795	abnormal bone structure	0.28	> 0.20	CILP2 (3.3)	MAFB (2.6)	PLEC (2.2)	MAU2 (2.1)	MYLIP (2.1)	TMEM116 (1.7)	FRK (1.6)	PLEKHH2 (1.4)	TIMD4 (1.3)	GMIP (1.3)
GO:0016894	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters	0.28	> 0.20	PMFBP1 (2.9)	YIPF2 (2.6)	APOC1 (2.6)	TIMD4 (2.4)	HP (2.3)	CEACAM19 (2.1)	TMEM116 (2.0)	ERP29 (2.0)	MOSC1 (1.7)	APOE (1.5)
MP:0009285	increased gonadal fat pad weight	0.28	> 0.20	ST3GAL4 (2.7)	C12orf47 (2.6)	GPAM (2.0)	C12orf51 (1.8)	BRAP (1.8)	DYNC2LI1 (1.7)	MAPKAPK5 (1.5)	PLEKHH2 (1.4)	MOSC1 (1.4)	APOA5 (1.4)
MP:0003215	renal interstitial fibrosis	0.28	> 0.20	BCAM (4.4)	HNF1A (2.6)	TMED4 (2.5)	PLEKHH2 (2.0)	PVR (1.9)	ANKRD31 (1.8)	C11orf9 (1.8)	PCSK9 (1.7)	C17orf57 (1.6)	ERP29 (1.6)
ENSG00000147010	SH3KBP1 PPI subnetwork	0.28	> 0.20	ATXN2 (3.9)	DNM2 (3.9)	SH2B3 (3.0)	USP24 (2.7)	CARM1 (2.7)	C17orf57 (2.6)	PPP1R37 (2.4)	MARK4 (2.3)	SMARCA4 (2.2)	GMIP (2.1)
GO:0006260	DNA replication	0.28	> 0.20	USP1 (3.2)	FEN1 (2.6)	ENSG00000228044 (2.5)	ZNF180 (2.4)	TXNL4B (2.2)	BUD13 (1.8)	POLK (1.8)	DHODH (1.8)	POC5 (1.7)	GOT2P1 (1.4)
ENSG00000184779	RPS17 PPI subnetwork	0.28	> 0.20	NAA25 (3.9)	DDX56 (3.7)	QTRT1 (3.1)	ZNF259 (2.5)	ATP13A1 (2.4)	DHX38 (2.3)	C12orf43 (2.3)	NKPD1 (2.2)	SARS (2.2)	TOMM40 (2.1)
ENSG00000182774	RPS17L PPI subnetwork	0.28	> 0.20	NAA25 (3.9)	DDX56 (3.7)	QTRT1 (3.1)	ZNF259 (2.5)	ATP13A1 (2.4)	DHX38 (2.3)	C12orf43 (2.3)	NKPD1 (2.2)	SARS (2.2)	TOMM40 (2.1)
ENSG00000120437	ACAT2 PPI subnetwork	0.28	> 0.20	FADS1 (4.2)	FADS2 (3.9)	LDLR (3.8)	HMGCR (3.2)	PCSK9 (3.1)	HAPLN4 (2.5)	PBX4 (1.9)	MAPKAPK5 (1.8)	BRAP (1.8)	SH2B3 (1.8)
GO:0020027	hemoglobin metabolic process	0.28	> 0.20	RHCE (7.1)	RHD (4.9)	GMPR (3.0)	ADAM1 (2.4)	BLOC1S3 (1.9)	CEACAM19 (1.8)	C12orf51 (1.7)	ATXN7L2 (1.6)	LPIN3 (1.5)	GRINA (1.2)
ENSG00000182481	KPNA2 PPI subnetwork	0.28	> 0.20	OASL (3.1)	NAA25 (2.6)	PARP10 (2.6)	USP1 (2.2)	SMARCA4 (2.2)	TOP1 (2.0)	ILF3 (1.6)	DHX38 (1.5)	ABCG5 (1.5)	TOMM40 (1.4)
ENSG00000215769	ENSG00000215769 PPI subnetwork	0.28	> 0.20	OASL (3.1)	NAA25 (2.6)	PARP10 (2.6)	USP1 (2.2)	SMARCA4 (2.2)	TOP1 (2.0)	ILF3 (1.6)	DHX38 (1.5)	ABCG5 (1.5)	TOMM40 (1.4)
MP:0001134	absent corpus luteum	0.28	> 0.20	GPAM (2.8)	GCNT4 (2.6)	KIAA1324 (2.4)	LDLR (2.0)	MOSC1 (1.9)	PMFBP1 (1.8)	CELSR2 (1.8)	TRIB1 (1.8)	AMIGO1 (1.8)	APOE (1.7)
GO:0051222	positive regulation of protein transport	0.28	> 0.20	ENSG00000238078 (2.4)	PLEKHH2 (2.0)	OASL (1.7)	ENSG00000228044 (1.6)	AP1M2 (1.5)	KIAA1324 (1.5)	POLK (1.5)	GEMIN7 (1.4)	MAFB (1.3)	HLX (1.3)
GO:0048732	gland development	0.28	> 0.20	KIAA1324 (2.5)	BCAM (2.1)	PPP1R37 (2.0)	AP1M2 (1.9)	ATXN7L2 (1.8)	MYLIP (1.7)	PVRL2 (1.7)	ENSG00000238078 (1.7)	ANKRD31 (1.6)	GOT2P1 (1.5)
ENSG00000142684	ZNF593 PPI subnetwork	0.28	> 0.20	ZNF259 (4.7)	NAA25 (4.2)	DDX56 (3.7)	TOMM40 (3.6)	QTRT1 (2.8)	DHODH (2.5)	SUGP1 (2.0)	BRAP (1.7)	ENSG00000226645 (1.6)	BUD13 (1.6)
GO:0090004	positive regulation of establishment of protein localization in plasma membrane	0.28	> 0.20	ENSG00000226645 (3.0)	HAVCR1 (1.6)	PTPN11 (1.6)	ENSG00000238078 (1.5)	ZHX3 (1.5)	AP1M2 (1.4)	TMEM57 (1.3)	C11orf9 (1.2)	ST3GAL4 (1.1)	ANKRD31 (1.1)
MP:0000786	abnormal embryonic neuroepithelial layer differentiation	0.28	> 0.20	ABCG8 (2.3)	C11orf9 (1.8)	ACAD10 (1.7)	HNF1A (1.7)	LPIN3 (1.5)	CYB561D1 (1.4)	GOT2P1 (1.4)	POLK (1.4)	YIPF2 (1.3)	MOSC1 (1.3)
MP:0003924	herniated diaphragm	0.28	> 0.20	C11orf9 (5.5)	PLEKHH2 (4.2)	LPAR2 (2.6)	DYNC2LI1 (2.3)	NYNRIN (2.2)	YIPF2 (2.1)	MYLIP (1.9)	HP (1.7)	MOSC1 (1.6)	PVRL2 (1.4)
ENSG00000138768	USO1 PPI subnetwork	0.28	> 0.20	SUGP1 (3.6)	SARS (2.4)	ATXN2 (2.2)	ENSG00000226648 (2.2)	TMEM57 (2.1)	BRAP (2.1)	DHX38 (2.1)	TRAFD1 (2.1)	PBX4 (2.0)	YIPF2 (1.9)
ENSG00000111653	ING4 PPI subnetwork	0.28	> 0.20	SMARCA4 (3.1)	BUD13 (2.7)	USP1 (2.4)	TXNL4B (2.1)	ILF3 (1.8)	ZNF259 (1.7)	ATXN2 (1.6)	PSRC1 (1.6)	UBXN2B (1.3)	BCAM (1.3)
ENSG00000206452	HLA-C PPI subnetwork	0.28	> 0.20	PSMA5 (3.9)	PLCG1 (2.8)	HAVCR1 (2.7)	AMIGO1 (2.4)	CLPTM1 (2.3)	ENSG00000228044 (1.8)	PARP10 (1.6)	TMED4 (1.6)	QTRT1 (1.5)	ERP29 (1.4)
ENSG00000069345	DNAJA2 PPI subnetwork	0.28	> 0.20	SARS (3.1)	PSMA5 (2.4)	DDX56 (2.3)	HMGCR (2.1)	OASL (2.1)	ANGPTL3 (2.0)	NAA25 (1.9)	TOMM40 (1.9)	OGDH (1.9)	TOP1 (1.8)
GO:0007140	male meiosis	0.28	> 0.20	ANKRD31 (3.3)	ENSG00000238078 (3.0)	PBX4 (2.1)	TMEM116 (1.7)	POC5 (1.3)	CILP2 (1.3)	NKPD1 (1.2)	ADAM1 (1.1)	PLEKHH2 (1.1)	MAPKAPK5 (1.1)
ENSG00000136485	DCAF7 PPI subnetwork	0.28	> 0.20	CARM1 (3.6)	BRAP (2.6)	LPAR2 (2.5)	COL4A3BP (2.3)	MARK4 (2.3)	GATAD2A (2.1)	TRIB1 (2.1)	PLEC (1.9)	AP1M2 (1.9)	CBLC (1.8)
ENSG00000095380	NANS PPI subnetwork	0.28	> 0.20	SARS (4.3)	ERP29 (3.7)	ALDH2 (3.1)	TMEM116 (2.9)	RHD (2.0)	GMPR (2.0)	DOCK7 (1.9)	HAVCR1 (1.9)	RHCE (1.7)	UBXN2B (1.5)
MP:0000030	abnormal tympanic ring morphology	0.28	> 0.20	NYNRIN (2.5)	CILP2 (2.1)	ATXN7L2 (1.8)	OGDH (1.6)	TSSK6 (1.5)	ZHX3 (1.5)	ENSG00000254235 (1.5)	BCAM (1.2)	MAFB (1.2)	ANKRD31 (1.2)
ENSG00000170017	ALCAM PPI subnetwork	0.28	> 0.20	AP1M2 (2.8)	SARS (2.5)	PCSK9 (2.3)	FRK (2.3)	CEACAM19 (1.9)	SLC44A2 (1.9)	ERP29 (1.8)	CELSR2 (1.8)	COL4A3BP (1.7)	SORT1 (1.6)
GO:0046717	acid secretion	0.28	> 0.20	NKPD1 (3.1)	TMEM116 (2.0)	ADAM1 (1.9)	LPIN3 (1.7)	C17orf57 (1.7)	ENSG00000226648 (1.6)	CEACAM19 (1.6)	FRK (1.6)	ABO (1.6)	CYB561D1 (1.5)
MP:0005458	increased percent body fat	0.28	> 0.20	GPAM (2.8)	LPA (2.6)	C12orf47 (2.4)	MOSC1 (2.4)	TIMD4 (2.1)	HP (2.0)	C11orf9 (2.0)	FRK (1.8)	MAFB (1.8)	TRIB1 (1.7)
GO:0015926	glucosidase activity	0.28	> 0.20	SORT1 (3.8)	ABCG5 (2.6)	ACAD10 (2.5)	TM6SF2 (2.3)	SYPL2 (2.3)	OGDH (2.3)	TMED4 (2.1)	ZNF101 (2.0)	YIPF2 (2.0)	ABCG8 (2.0)
GO:0043235	receptor complex	0.28	> 0.20	SLC44A2 (2.7)	PLCG1 (2.2)	RELB (2.2)	PVR (2.1)	TIMD4 (2.0)	SH2B3 (1.9)	PLEC (1.8)	ZNF101 (1.8)	LDLR (1.7)	GMIP (1.7)
ENSG00000108669	CYTH1 PPI subnetwork	0.28	> 0.20	CYB561D1 (4.1)	GMIP (3.0)	C19orf52 (2.7)	TRAPPC6A (2.3)	LPIN3 (2.0)	COL4A3BP (2.0)	C1orf63 (1.8)	OASL (1.8)	PLEC (1.7)	PSMA5 (1.7)
GO:0033613	activating transcription factor binding	0.28	> 0.20	MARK4 (2.6)	ATXN2 (2.5)	SH2B3 (2.2)	ENSG00000226648 (2.0)	ATXN7L2 (1.9)	KANK2 (1.8)	DNM2 (1.7)	TRIB1 (1.7)	C1orf63 (1.6)	PCSK9 (1.6)
GO:0061099	negative regulation of protein tyrosine kinase activity	0.28	> 0.20	ABO (2.9)	NT5DC1 (2.2)	NKPD1 (1.9)	GCNT4 (1.7)	DDX56 (1.5)	LPA (1.4)	TMEM116 (1.4)	DNAH11 (1.4)	TSSK6 (1.4)	TM6SF2 (1.4)
ENSG00000121390	PSPC1 PPI subnetwork	0.28	> 0.20	ATXN2 (2.8)	GMIP (2.7)	C1orf63 (2.4)	ABO (2.3)	BUD13 (2.1)	CYP7A1 (2.0)	SMARCA4 (1.8)	C12orf47 (1.8)	ILF3 (1.8)	FADS2 (1.7)
ENSG00000163882	POLR2H PPI subnetwork	0.28	> 0.20	BUD13 (3.8)	DHX38 (3.4)	ILF3 (3.2)	SUGP1 (3.1)	TOP1 (2.6)	MAPKAPK5 (2.5)	C1orf63 (2.2)	DDX56 (2.2)	C12orf43 (2.2)	SMARCA4 (2.2)
MP:0002843	decreased systemic arterial blood pressure	0.28	> 0.20	ITGB3 (4.3)	PMFBP1 (2.8)	HLX (2.4)	TIMD4 (2.1)	PLG (2.1)	ANGPTL3 (2.1)	SORT1 (2.0)	HP (2.0)	ZHX3 (1.8)	HAVCR1 (1.8)
ENSG00000206439	TNF PPI subnetwork	0.28	> 0.20	RELB (3.0)	PARP10 (2.9)	ST3GAL4 (2.3)	PPP1R37 (2.2)	TRAFD1 (2.0)	BCL3 (2.0)	FRK (2.0)	ZNF180 (2.0)	TOMM40 (1.9)	PVR (1.8)
ENSG00000206328	ENSG00000206328 PPI subnetwork	0.28	> 0.20	RELB (3.0)	PARP10 (2.9)	ST3GAL4 (2.3)	PPP1R37 (2.2)	TRAFD1 (2.0)	BCL3 (2.0)	FRK (2.0)	ZNF180 (2.0)	TOMM40 (1.9)	PVR (1.8)
ENSG00000204490	TNF PPI subnetwork	0.28	> 0.20	RELB (3.0)	PARP10 (2.9)	ST3GAL4 (2.3)	PPP1R37 (2.2)	TRAFD1 (2.0)	BCL3 (2.0)	FRK (2.0)	ZNF180 (2.0)	TOMM40 (1.9)	PVR (1.8)
GO:0016558	protein import into peroxisome matrix	0.28	> 0.20	C19orf52 (3.5)	YIPF2 (2.9)	NT5DC1 (2.6)	BLOC1S3 (2.1)	BRAP (2.1)	QTRT1 (2.0)	AMIGO1 (2.0)	ACAD10 (1.9)	TRAPPC6A (1.8)	PPP1R37 (1.7)
ENSG00000173267	SNCG PPI subnetwork	0.28	> 0.20	TMEM50A (2.7)	C1orf63 (2.6)	PLCG1 (2.1)	PVR (2.1)	PSRC1 (1.7)	FEN1 (1.6)	NKPD1 (1.6)	GCNT4 (1.6)	ITGB3 (1.6)	ST3GAL4 (1.5)
MP:0003409	decreased width of hypertrophic chondrocyte zone	0.28	> 0.20	PLEKHH2 (3.7)	ZHX3 (3.1)	CILP2 (2.9)	C11orf9 (2.8)	DYNC2LI1 (2.0)	CEACAM19 (1.8)	MAFB (1.8)	NYNRIN (1.7)	PPP1R37 (1.6)	PLCG1 (1.5)
ENSG00000196083	IL1RAP PPI subnetwork	0.28	> 0.20	BCL3 (4.1)	HP (2.5)	GPAM (2.1)	ENSG00000235545 (1.9)	OASL (1.8)	COL4A3BP (1.7)	MAFB (1.6)	PMFBP1 (1.5)	PLEKHH2 (1.5)	SLC22A1 (1.4)
ENSG00000108826	MRPL27 PPI subnetwork	0.28	> 0.20	QTRT1 (3.8)	TOMM40 (3.4)	DDX56 (3.3)	GEMIN7 (2.2)	DHODH (2.2)	NAA25 (2.2)	TOP1 (2.1)	ATP13A1 (2.0)	ZNF259 (2.0)	BUD13 (2.0)
GO:0016208	AMP binding	0.28	> 0.20	PCSK9 (2.9)	MOSC1 (2.8)	OGDH (2.6)	NCAN (2.4)	FADS1 (1.7)	ST3GAL4 (1.7)	GMPR (1.7)	ABO (1.7)	SYPL2 (1.6)	ENSG00000254235 (1.4)
ENSG00000147507	ENSG00000147507 PPI subnetwork	0.28	> 0.20	GMIP (4.5)	DNM2 (2.9)	ITGB3 (2.5)	SLC44A2 (2.5)	MAFB (2.5)	SH2B3 (2.3)	CETP (2.3)	TIMD4 (1.9)	LPAR2 (1.6)	GATAD2A (1.5)
ENSG00000174748	RPL15 PPI subnetwork	0.28	> 0.20	NAA25 (3.1)	ZNF259 (2.8)	QTRT1 (2.7)	DDX56 (2.5)	ILF3 (2.1)	TOP1 (2.0)	ATP13A1 (2.0)	C12orf43 (2.0)	SUGP1 (2.0)	TOMM40 (1.9)
ENSG00000099381	SETD1A PPI subnetwork	0.28	> 0.20	C19orf52 (3.0)	KIAA1324 (3.0)	BUD13 (2.9)	C1orf63 (2.6)	PSMA5 (2.1)	BRAP (1.8)	USP1 (1.8)	ACAD10 (1.7)	CARM1 (1.7)	NAA25 (1.5)
REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION	0.28	> 0.20	CYP7A1 (3.2)	RPH3A (3.0)	HAPLN4 (2.8)	NCAN (2.8)	ABCG8 (2.3)	C12orf51 (2.2)	APOC4 (2.2)	AMIGO1 (1.9)	PLG (1.8)	MARK4 (1.8)
ENSG00000119401	TRIM32 PPI subnetwork	0.28	> 0.20	CBLC (5.7)	AP1M2 (3.2)	LPAR2 (2.4)	PSRC1 (2.4)	DOCK7 (1.8)	PVRL2 (1.8)	LPIN3 (1.7)	KANK2 (1.7)	FRK (1.6)	CELSR2 (1.4)
MP:0004016	decreased bone mass	0.28	> 0.20	KIAA1324 (3.3)	CILP2 (3.0)	MOSC1 (2.8)	AP1M2 (2.8)	TMED4 (2.3)	NT5DC1 (2.0)	ERP29 (2.0)	SH2B3 (1.7)	PCSK9 (1.7)	YIPF2 (1.7)
MP:0001923	reduced female fertility	0.28	> 0.20	KANK2 (2.8)	LDLR (2.5)	RHD (2.2)	TRIB1 (2.2)	PLEC (1.9)	APOB (1.9)	RHCE (1.8)	ANGPTL3 (1.8)	C11orf9 (1.8)	TOP1 (1.7)
MP:0008682	decreased interleukin-17 secretion	0.28	> 0.20	PBX4 (4.0)	MYLIP (1.9)	SLC22A1 (1.8)	BCL3 (1.7)	HLX (1.7)	ENSG00000235545 (1.6)	TRAFD1 (1.6)	COL4A3BP (1.5)	RELB (1.4)	PVR (1.4)
ENSG00000179295	PTPN11 PPI subnetwork	0.28	> 0.20	ITGB3 (3.4)	HLX (2.7)	CETP (2.5)	TRIB1 (2.2)	BCL3 (2.1)	SLC44A2 (1.9)	SH2B3 (1.9)	USP24 (1.8)	DNM2 (1.8)	SORT1 (1.8)
GO:0005741	mitochondrial outer membrane	0.28	> 0.20	GMPR (2.7)	MOSC1 (2.7)	TRAFD1 (2.7)	ALDH2 (2.7)	GPAM (2.4)	BRAP (2.4)	PARP10 (2.4)	ACAD10 (2.2)	GRINA (2.1)	PTPN11 (1.9)
ENSG00000157227	MMP14 PPI subnetwork	0.28	> 0.20	FRK (3.2)	MAFB (3.2)	CILP2 (3.0)	C11orf9 (2.0)	KANK2 (1.7)	SLC22A1 (1.6)	GPAM (1.5)	APOA5 (1.3)	C12orf47 (1.2)	APOE (1.1)
GO:0043255	regulation of carbohydrate biosynthetic process	0.28	> 0.20	GPAM (2.8)	ZNF180 (2.7)	ENSG00000254235 (2.3)	ENSG00000238078 (2.0)	MOSC1 (1.9)	GCNT4 (1.7)	CYP7A1 (1.7)	ENSG00000226645 (1.7)	GMPR (1.6)	LPA (1.5)
REACTOME_NEPHRIN_INTERACTIONS	REACTOME_NEPHRIN_INTERACTIONS	0.28	> 0.20	DOCK7 (2.6)	GCNT4 (2.5)	PVRL2 (2.4)	TMEM50A (2.4)	ZNF101 (2.4)	SYPL2 (2.3)	HAVCR1 (2.1)	FRK (2.1)	ZNF180 (1.8)	ITGB3 (1.6)
ENSG00000156508	EEF1A1 PPI subnetwork	0.28	> 0.20	SARS (3.5)	SMARCA4 (3.1)	ILF3 (3.1)	TOMM40 (2.6)	NAA25 (2.5)	ZNF259 (2.4)	QTRT1 (2.2)	TOP1 (2.2)	PSMA5 (2.1)	DHX38 (2.1)
GO:0032355	response to estradiol stimulus	0.28	> 0.20	POLK (2.9)	GEMIN7 (2.6)	KIAA1324 (2.0)	PLEKHH2 (1.5)	ABO (1.4)	ZNF101 (1.3)	TMEM57 (1.3)	BLOC1S3 (1.3)	CBLC (1.2)	TSSK6 (1.2)
ENSG00000174231	PRPF8 PPI subnetwork	0.28	> 0.20	DHX38 (3.9)	ILF3 (3.6)	SUGP1 (3.5)	TOP1 (3.3)	SMARCA4 (3.3)	BUD13 (2.9)	FEN1 (2.7)	MAU2 (2.6)	C1orf63 (2.5)	USP1 (2.5)
ENSG00000138293	NCOA4 PPI subnetwork	0.28	> 0.20	C12orf51 (2.8)	MOSC1 (2.4)	COL4A3BP (2.4)	CYP7A1 (2.3)	PLEC (2.3)	RHD (2.1)	POLK (2.0)	RHCE (1.9)	DOCK7 (1.7)	PPP1R37 (1.6)
ENSG00000113013	HSPA9 PPI subnetwork	0.28	> 0.20	RELB (3.6)	BCL3 (3.3)	C12orf43 (2.4)	TOMM40 (2.3)	NAA25 (2.0)	SARS (1.9)	GRINA (1.9)	NT5DC1 (1.9)	DDX56 (1.5)	PSMA5 (1.5)
ENSG00000120802	TMPO PPI subnetwork	0.28	> 0.20	NAA25 (2.8)	ILF3 (2.6)	TOMM40 (2.2)	TOP1 (2.1)	SMARCA4 (2.0)	DHX38 (2.0)	DDX56 (2.0)	C19orf52 (1.7)	USP1 (1.7)	PBX4 (1.6)
ENSG00000157764	BRAF PPI subnetwork	0.28	> 0.20	CARM1 (3.7)	DNM2 (3.2)	MARK4 (3.0)	PLEC (2.5)	GATAD2A (2.5)	SMARCA4 (2.3)	TOP1 (2.2)	CBLC (2.1)	MAU2 (2.1)	PPP1R37 (2.0)
MP:0003085	abnormal egg cylinder morphology	0.28	> 0.20	USP24 (2.6)	C17orf57 (2.2)	ZHX3 (2.2)	UBXN2B (2.0)	DOCK7 (1.9)	ITGB3 (1.9)	ABO (1.9)	HAVCR1 (1.8)	PLCG1 (1.7)	GPAM (1.6)
GO:0050829	defense response to Gram-negative bacterium	0.28	> 0.20	PVR (2.8)	DNAH11 (2.8)	PBX4 (2.1)	HP (2.0)	SLC22A1 (1.8)	FRK (1.7)	TXNL4B (1.6)	UBXN2B (1.5)	RHCE (1.4)	RHD (1.3)
MP:0009746	enhanced behavioral response to xenobiotic	0.28	> 0.20	LPA (3.8)	CYP7A1 (3.7)	SLC22A1 (3.3)	APOC4 (3.1)	RPH3A (2.7)	APOA5 (2.6)	PLG (2.1)	ANGPTL3 (2.0)	TM6SF2 (1.8)	HP (1.8)
ENSG00000092199	HNRNPC PPI subnetwork	0.28	> 0.20	ILF3 (4.6)	SMARCA4 (3.4)	C1orf63 (3.3)	TOP1 (3.3)	QTRT1 (2.8)	DHX38 (2.7)	USP1 (2.5)	SUGP1 (2.3)	BUD13 (2.2)	TOMM40 (2.2)
MP:0003156	abnormal leukocyte migration	0.28	> 0.20	SH2B3 (3.4)	GMIP (3.0)	HLX (2.8)	TIMD4 (2.4)	ITGB3 (2.2)	CETP (1.8)	RELB (1.8)	BCL3 (1.6)	SLC44A2 (1.6)	OGDH (1.5)
MP:0004910	decreased seminal vesicle weight	0.29	> 0.20	DNAH11 (2.7)	GPAM (2.2)	LDLR (1.7)	MYLIP (1.6)	PMFBP1 (1.6)	POLK (1.6)	LPA (1.5)	KANK2 (1.5)	ALDH2 (1.2)	ENSG00000228044 (1.2)
ENSG00000213416	KRTAP4-12 PPI subnetwork	0.29	> 0.20	ZNF101 (2.8)	CBLC (1.7)	CEACAM19 (1.6)	SUGP1 (1.6)	TSSK6 (1.4)	PSRC1 (1.4)	PPP1R37 (1.3)	CILP2 (1.3)	DDX56 (1.3)	PVRL2 (1.3)
ENSG00000212908	ENSG00000212908 PPI subnetwork	0.29	> 0.20	ZNF101 (2.8)	CBLC (1.7)	CEACAM19 (1.6)	SUGP1 (1.6)	TSSK6 (1.4)	PSRC1 (1.4)	PPP1R37 (1.3)	CILP2 (1.3)	DDX56 (1.3)	PVRL2 (1.3)
GO:0051569	regulation of histone H3-K4 methylation	0.29	> 0.20	ZNF180 (2.8)	C1orf63 (2.0)	ANKRD31 (2.0)	USP24 (2.0)	ITGB3 (1.9)	C12orf51 (1.7)	ENSG00000254235 (1.7)	HNF1A (1.5)	RHD (1.4)	CILP2 (1.4)
ENSG00000014138	POLA2 PPI subnetwork	0.29	> 0.20	USP1 (5.3)	FEN1 (5.3)	ENSG00000228044 (2.5)	ERP29 (1.9)	TXNL4B (1.8)	AMIGO1 (1.8)	PSRC1 (1.6)	ZNF180 (1.5)	ENSG00000235545 (1.4)	POC5 (1.2)
ENSG00000142453	CARM1 PPI subnetwork	0.29	> 0.20	MYLIP (2.4)	C12orf51 (2.0)	TRIB1 (2.0)	ILF3 (1.7)	MARK4 (1.6)	SMARCA4 (1.6)	GATAD2A (1.6)	TOP1 (1.6)	GMIP (1.5)	CARM1 (1.5)
MP:0008844	decreased subcutaneous adipose tissue amount	0.29	> 0.20	GPAM (4.6)	MOSC1 (3.8)	POLK (2.3)	PVR (1.6)	SH2B3 (1.6)	PCSK9 (1.5)	FADS1 (1.5)	PLEC (1.5)	PSRC1 (1.5)	LDLR (1.4)
ENSG00000166441	RPL27A PPI subnetwork	0.29	> 0.20	NKPD1 (3.1)	ZNF259 (3.0)	NAA25 (2.8)	TOP1 (2.3)	C12orf43 (2.3)	DDX56 (2.2)	DHX38 (2.1)	SUGP1 (2.0)	ANKRD31 (1.9)	QTRT1 (1.9)
ENSG00000137709	POU2F3 PPI subnetwork	0.29	> 0.20	USP24 (2.9)	MAU2 (2.8)	PARP10 (2.6)	SMARCA4 (2.5)	ATXN2 (2.5)	MARK4 (2.4)	BCL3 (2.3)	C12orf51 (2.2)	DHX38 (2.0)	GMIP (1.9)
ENSG00000205609	EIF3CL PPI subnetwork	0.29	> 0.20	ZNF259 (4.1)	QTRT1 (3.8)	TOMM40 (3.8)	NAA25 (3.8)	DDX56 (3.6)	DHX38 (3.5)	SARS (3.4)	ATP13A1 (2.6)	TOP1 (2.6)	ILF3 (2.3)
ENSG00000150907	FOXO1 PPI subnetwork	0.29	> 0.20	UBXN2B (3.2)	GCNT4 (2.3)	PLEC (2.2)	GOT2P1 (1.8)	ENSG00000226648 (1.8)	ALDH2 (1.6)	ENSG00000238078 (1.6)	APOA5 (1.5)	ATXN2 (1.4)	DOCK7 (1.3)
ENSG00000117118	SDHB PPI subnetwork	0.29	> 0.20	SYPL2 (3.5)	GMPR (3.2)	ACAD10 (2.3)	RHD (1.9)	OGDH (1.7)	C12orf47 (1.6)	BCAM (1.5)	LPAR2 (1.3)	PMFBP1 (1.3)	SLC44A2 (1.2)
MP:0005277	abnormal brainstem morphology	0.29	> 0.20	HAPLN4 (2.9)	ATP13A1 (2.7)	RPH3A (2.5)	CYP7A1 (2.5)	ENSG00000235545 (2.2)	CELSR2 (1.9)	GRINA (1.7)	AMIGO1 (1.6)	C1orf63 (1.5)	CEACAM19 (1.5)
MP:0000358	abnormal cell morphology	0.29	> 0.20	BLOC1S3 (2.8)	DYNC2LI1 (2.8)	CLPTM1 (2.6)	DOCK7 (2.4)	TMEM50A (2.2)	DNM2 (2.2)	POC5 (2.0)	ATP13A1 (2.0)	POLK (1.7)	MARK4 (1.7)
ENSG00000184575	XPOT PPI subnetwork	0.29	> 0.20	DDX56 (2.8)	TOMM40 (2.7)	NAA25 (2.6)	GOT2P1 (2.2)	QTRT1 (2.2)	ILF3 (2.0)	USP1 (2.0)	PSMA5 (1.8)	SARS (1.8)	ATXN2 (1.5)
ENSG00000133226	SRRM1 PPI subnetwork	0.29	> 0.20	ILF3 (4.0)	C1orf63 (3.7)	TOP1 (3.4)	DHX38 (3.1)	SMARCA4 (3.0)	USP1 (2.9)	SUGP1 (2.6)	BUD13 (2.4)	FEN1 (2.4)	GATAD2A (1.9)
MP:0005028	abnormal trophectoderm morphology	0.29	> 0.20	BUD13 (2.8)	MAPKAPK5 (2.3)	ENSG00000226645 (2.3)	USP1 (2.3)	COL4A3BP (2.3)	BLOC1S3 (2.1)	DHX38 (1.9)	HNF1A (1.9)	ALDH2 (1.7)	ENSG00000228044 (1.7)
ENSG00000174197	MGA PPI subnetwork	0.29	> 0.20	ATXN7L2 (2.6)	BUD13 (2.6)	C19orf52 (2.6)	ATXN2 (2.4)	TRAFD1 (2.1)	GATAD2A (2.0)	TMEM57 (1.9)	QTRT1 (1.9)	MARK4 (1.8)	NAA25 (1.7)
MP:0001828	abnormal T cell activation	0.29	> 0.20	RELB (2.6)	GMIP (2.3)	PBX4 (2.1)	PARP10 (2.0)	PLCG1 (2.0)	CETP (1.9)	POLK (1.8)	SH2B3 (1.8)	TIMD4 (1.7)	SLC44A2 (1.6)
ENSG00000173465	SSSCA1 PPI subnetwork	0.29	> 0.20	DNAH11 (2.5)	CLPTM1 (2.1)	BCAM (2.1)	DDX56 (2.1)	TOMM40 (1.9)	MARK4 (1.7)	PMFBP1 (1.6)	TM6SF2 (1.6)	CBLC (1.5)	SUGP1 (1.5)
ENSG00000065548	ZC3H15 PPI subnetwork	0.29	> 0.20	ZNF259 (4.3)	NAA25 (4.1)	DDX56 (3.6)	TOMM40 (3.0)	QTRT1 (2.8)	TOP1 (2.8)	DHODH (2.8)	DHX38 (2.3)	BUD13 (2.2)	MAPKAPK5 (2.1)
ENSG00000131437	KIF3A PPI subnetwork	0.29	> 0.20	DYNC2LI1 (3.0)	POC5 (2.6)	TOP1 (2.3)	DOCK7 (2.3)	PLCG1 (1.6)	ENSG00000226645 (1.5)	TSSK6 (1.4)	CETP (1.4)	UBXN2B (1.3)	BCAM (1.2)
ENSG00000115875	SRSF7 PPI subnetwork	0.29	> 0.20	ILF3 (3.8)	C1orf63 (3.6)	TOP1 (2.8)	BUD13 (2.8)	DHX38 (2.8)	USP1 (2.6)	SMARCA4 (2.5)	FEN1 (2.3)	QTRT1 (2.2)	MAU2 (2.2)
GO:0051345	positive regulation of hydrolase activity	0.29	> 0.20	ST3GAL4 (2.3)	CBLC (1.8)	PLEKHH2 (1.5)	POLK (1.5)	LPIN3 (1.4)	HAVCR1 (1.3)	ZNF101 (1.3)	SH2B3 (1.2)	MARK4 (1.2)	GOT2P1 (1.1)
ENSG00000197279	ZNF165 PPI subnetwork	0.29	> 0.20	PBX4 (2.9)	BLOC1S3 (2.7)	BRAP (1.9)	PARP10 (1.9)	GRINA (1.8)	SUGP1 (1.7)	ZNF180 (1.6)	PPP1R37 (1.6)	PTPN11 (1.6)	UBXN2B (1.5)
REACTOME_PROCESSING_OF_CAPPED_INTRON:CONTAINING_PRE:MRNA	REACTOME_PROCESSING_OF_CAPPED_INTRON:CONTAINING_PRE:MRNA	0.29	> 0.20	ILF3 (4.2)	C1orf63 (3.2)	USP1 (3.0)	TOP1 (2.9)	BUD13 (2.9)	DHX38 (2.9)	FEN1 (2.5)	SMARCA4 (2.4)	DDX56 (2.2)	SUGP1 (2.1)
ENSG00000151292	CSNK1G3 PPI subnetwork	0.29	> 0.20	C12orf43 (2.7)	MAPKAPK5 (2.3)	NAA25 (2.0)	TOMM40 (1.8)	CEACAM19 (1.6)	CYP7A1 (1.5)	POLK (1.5)	HLX (1.5)	NT5DC1 (1.4)	ENSG00000254235 (1.4)
ENSG00000112715	VEGFA PPI subnetwork	0.29	> 0.20	HLX (3.2)	MYLIP (3.1)	C1orf63 (2.3)	PVRL2 (2.3)	ENSG00000254235 (2.3)	ALDH2 (2.0)	MOSC1 (1.9)	LPA (1.9)	DNAH11 (1.9)	ENSG00000238078 (1.9)
ENSG00000090382	LYZ PPI subnetwork	0.29	> 0.20	RELB (3.5)	ALDH2 (2.8)	GEMIN7 (2.4)	TM6SF2 (2.2)	CYB561D1 (2.1)	BCAM (2.0)	BCL3 (2.0)	APOE (1.8)	BLOC1S3 (1.7)	CBLC (1.7)
GO:0042228	interleukin-8 biosynthetic process	0.29	> 0.20	C17orf57 (2.8)	BLOC1S3 (1.9)	NT5DC1 (1.9)	HP (1.8)	HLX (1.8)	POC5 (1.5)	C12orf47 (1.4)	RHCE (1.4)	CEACAM19 (1.3)	RHD (1.3)
ENSG00000070501	POLB PPI subnetwork	0.29	> 0.20	BLOC1S3 (5.5)	BUD13 (2.7)	PLEKHH2 (2.3)	AP1M2 (2.2)	ZNF180 (2.1)	SMARCA4 (1.9)	CBLC (1.9)	AMIGO1 (1.9)	FEN1 (1.8)	QTRT1 (1.8)
GO:0042226	interleukin-6 biosynthetic process	0.29	> 0.20	HLX (2.5)	ENSG00000254235 (2.3)	ENSG00000228044 (2.3)	ENSG00000235545 (1.9)	BUD13 (1.8)	ENSG00000226645 (1.8)	HNF1A (1.8)	ENSG00000238078 (1.6)	BLOC1S3 (1.5)	TRIB1 (1.5)
ENSG00000164403	SHROOM1 PPI subnetwork	0.29	> 0.20	CBLC (4.4)	AP1M2 (3.9)	MARK4 (2.5)	FRK (2.5)	LPIN3 (2.3)	CELSR2 (2.3)	PSRC1 (2.2)	PVRL2 (1.9)	DHX38 (1.6)	DOCK7 (1.6)
GO:0032388	positive regulation of intracellular transport	0.29	> 0.20	ENSG00000238078 (3.6)	PLEKHH2 (2.5)	OASL (2.4)	AP1M2 (2.3)	TMEM116 (2.3)	ENSG00000254235 (2.0)	GCNT4 (1.7)	KANK2 (1.6)	FRK (1.5)	ENSG00000228044 (1.4)
ENSG00000139083	ETV6 PPI subnetwork	0.29	> 0.20	C19orf52 (3.1)	BUD13 (2.8)	DHX38 (2.6)	SH2B3 (2.5)	SMARCA4 (2.3)	LPA (2.3)	GEMIN7 (2.3)	POC5 (2.1)	GATAD2A (1.8)	COL4A3BP (1.7)
ENSG00000179950	PUF60 PPI subnetwork	0.29	> 0.20	CARM1 (2.9)	DDX56 (2.5)	TOP1 (2.2)	PTPN11 (2.1)	DOCK7 (2.0)	ILF3 (2.0)	SMARCA4 (2.0)	TOMM40 (2.0)	NAA25 (1.9)	PPP1R37 (1.9)
ENSG00000185129	PURA PPI subnetwork	0.29	> 0.20	OASL (2.7)	FADS1 (2.6)	ENSG00000226648 (2.2)	NT5DC1 (2.2)	SORT1 (2.2)	PARP10 (2.2)	FADS2 (2.0)	DOCK7 (1.9)	MOSC1 (1.8)	C17orf57 (1.8)
ENSG00000007372	PAX6 PPI subnetwork	0.29	> 0.20	CARM1 (2.9)	CELSR2 (2.7)	DOCK7 (2.4)	ATXN2 (2.3)	TMED4 (2.0)	PLCG1 (1.9)	ST3GAL4 (1.9)	C11orf9 (1.9)	DHX38 (1.9)	NCAN (1.8)
ENSG00000156675	RAB11FIP1 PPI subnetwork	0.29	> 0.20	PLEC (3.8)	COL4A3BP (3.2)	DNM2 (3.2)	ZHX3 (3.2)	C11orf9 (3.0)	LPAR2 (2.8)	CARM1 (2.7)	C12orf51 (2.5)	PTPN11 (2.5)	USP24 (2.4)
MP:0008720	impaired neutrophil chemotaxis	0.29	> 0.20	GMIP (3.6)	HLX (3.6)	MYLIP (2.6)	ST3GAL4 (1.8)	OGDH (1.7)	DNM2 (1.6)	BCL3 (1.6)	TRAFD1 (1.4)	ALDH2 (1.4)	SORT1 (1.3)
ENSG00000134001	EIF2S1 PPI subnetwork	0.29	> 0.20	ILF3 (2.6)	ZNF259 (2.6)	QTRT1 (2.6)	TXNL4B (2.5)	DDX56 (2.4)	ATP13A1 (2.3)	TOP1 (2.3)	DHX38 (2.2)	NKPD1 (2.2)	PTPN11 (2.2)
ENSG00000111679	PTPN6 PPI subnetwork	0.29	> 0.20	GMIP (3.8)	CETP (2.4)	HLX (2.4)	BCL3 (2.3)	TIMD4 (2.1)	RELB (2.1)	SH2B3 (1.9)	ZNF101 (1.5)	MAFB (1.5)	CYB561D1 (1.5)
REACTOME_SCFSKP2:MEDIATED_DEGRADATION_OF_P27P21	REACTOME_SCFSKP2:MEDIATED_DEGRADATION_OF_P27P21	0.29	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.3)	NT5DC1 (2.0)	TOMM40 (1.8)	DDX56 (1.7)	SUGP1 (1.6)	PARP10 (1.5)	SARS (1.4)	BRAP (1.2)
ENSG00000175505	CLCF1 PPI subnetwork	0.29	> 0.20	BCL3 (3.9)	HLX (3.0)	RELB (2.6)	TIMD4 (2.5)	CETP (2.0)	ALDH2 (2.0)	GMIP (1.9)	PVR (1.5)	LPA (1.4)	SH2B3 (1.4)
ENSG00000118523	CTGF PPI subnetwork	0.29	> 0.20	QTRT1 (2.4)	PLEC (1.9)	CILP2 (1.7)	BCAM (1.7)	UBXN2B (1.6)	C1orf63 (1.6)	DNM2 (1.6)	SMARCA4 (1.4)	LDLR (1.3)	C12orf51 (1.3)
ENSG00000076984	MAP2K7 PPI subnetwork	0.29	> 0.20	PARP10 (3.3)	TRIB1 (3.2)	BCL3 (2.5)	OASL (2.4)	ATXN7L2 (2.4)	HLX (2.3)	LPAR2 (2.2)	PLEKHH2 (2.1)	ABCG8 (2.1)	SARS (2.0)
ENSG00000035403	VCL PPI subnetwork	0.29	> 0.20	GATAD2A (3.4)	PLEC (2.8)	ADAM1 (2.7)	BCAM (2.6)	PVRL2 (2.3)	CLPTM1 (2.2)	C1orf63 (2.0)	OGDH (2.0)	PTPN11 (1.8)	SMARCA4 (1.7)
ENSG00000114686	MRPL3 PPI subnetwork	0.29	> 0.20	GEMIN7 (3.0)	QTRT1 (2.9)	CARM1 (2.7)	ATP13A1 (2.7)	C12orf47 (2.2)	MAU2 (2.1)	ABO (1.9)	DDX56 (1.8)	NAA25 (1.8)	TOMM40 (1.7)
MP:0002233	abnormal nose morphology	0.29	> 0.20	NYNRIN (2.6)	LDLR (2.3)	FADS2 (1.7)	MYLIP (1.7)	HMGCR (1.6)	APOB (1.6)	TMEM116 (1.5)	AP1M2 (1.4)	AMIGO1 (1.3)	DYNC2LI1 (1.2)
GO:0008238	exopeptidase activity	0.29	> 0.20	NPC1L1 (3.9)	ERP29 (3.3)	TM6SF2 (3.0)	PMFBP1 (2.7)	TMED4 (2.0)	APOB (2.0)	FRK (2.0)	HAPLN4 (1.9)	ALDH2 (1.8)	HNF1A (1.7)
ENSG00000160007	ARHGAP35 PPI subnetwork	0.29	> 0.20	GMIP (3.2)	PARP10 (2.8)	ATXN2 (2.5)	USP24 (2.5)	MARK4 (2.4)	MAU2 (2.2)	MAFB (2.1)	C17orf57 (1.9)	SMARCA4 (1.8)	POLK (1.7)
MP:0005202	lethargy	0.29	> 0.20	BCAM (2.3)	ALDH2 (2.1)	HAVCR1 (2.1)	TMEM116 (1.8)	ZHX3 (1.8)	CILP2 (1.8)	PTPN11 (1.6)	ERP29 (1.6)	SLC44A2 (1.5)	GRINA (1.5)
MP:0002786	abnormal Leydig cell morphology	0.29	> 0.20	TRIB1 (2.5)	ABO (2.5)	ATXN7L2 (2.2)	ST3GAL4 (2.2)	DNAH11 (2.2)	FADS2 (2.0)	GCNT4 (2.0)	ABCG8 (1.8)	ALDH2 (1.7)	HAPLN4 (1.6)
ENSG00000108272	DHRS11 PPI subnetwork	0.29	> 0.20	PSMA5 (2.7)	NAA25 (2.4)	ENSG00000235545 (2.3)	HMGCR (2.2)	CARM1 (2.2)	ABCG5 (1.8)	USP24 (1.7)	SUGP1 (1.7)	PLCG1 (1.6)	TMEM57 (1.5)
MP:0000709	enlarged thymus	0.29	> 0.20	PLCG1 (3.0)	ST3GAL4 (2.1)	GOT2P1 (2.0)	HAPLN4 (2.0)	NT5DC1 (1.9)	PBX4 (1.8)	ATXN7L2 (1.6)	LPAR2 (1.6)	GCNT4 (1.5)	MOSC1 (1.5)
GO:0071845	cellular component disassembly at cellular level	0.29	> 0.20	ENSG00000226645 (2.4)	UBXN2B (2.1)	C1orf63 (2.0)	CBLC (1.7)	TSSK6 (1.7)	SLC44A2 (1.7)	DOCK7 (1.7)	ABO (1.6)	GATAD2A (1.6)	ANKRD31 (1.6)
ENSG00000120907	ADRA1A PPI subnetwork	0.29	> 0.20	ST3GAL4 (3.2)	HLX (2.5)	SH2B3 (2.5)	PVR (2.2)	PLEC (2.2)	KANK2 (2.1)	ZHX3 (1.8)	PPP1R37 (1.6)	ALDH2 (1.4)	DOCK7 (1.4)
ENSG00000133706	LARS PPI subnetwork	0.29	> 0.20	SARS (4.4)	NAA25 (3.1)	HMGCR (2.8)	PSMA5 (2.4)	ZNF259 (2.4)	DDX56 (2.2)	QTRT1 (1.8)	RHCE (1.6)	SMARCA4 (1.5)	HP (1.5)
GO:0016854	racemase and epimerase activity	0.29	> 0.20	PMFBP1 (2.9)	FADS1 (2.6)	NT5DC1 (2.4)	TRAPPC6A (2.3)	ST3GAL4 (2.1)	SLC22A1 (2.1)	DYNC2LI1 (1.9)	NYNRIN (1.7)	APOC4 (1.5)	FADS2 (1.5)
ENSG00000169217	CD2BP2 PPI subnetwork	0.29	> 0.20	ILF3 (4.3)	C1orf63 (4.0)	TOP1 (2.8)	USP1 (2.7)	SMARCA4 (2.6)	BUD13 (2.5)	DHX38 (2.5)	SUGP1 (2.5)	PTPN11 (2.2)	FEN1 (2.1)
GO:0030176	integral to endoplasmic reticulum membrane	0.29	> 0.20	CLPTM1 (4.5)	ATP13A1 (4.4)	ERP29 (3.5)	YIPF2 (3.5)	GRINA (3.1)	TMEM50A (3.0)	TMED4 (3.0)	CYB561D1 (2.8)	HMGCR (2.5)	SORT1 (2.3)
ENSG00000181163	NPM1 PPI subnetwork	0.29	> 0.20	ILF3 (3.8)	SMARCA4 (3.3)	TOP1 (3.0)	GATAD2A (2.6)	USP1 (2.4)	C1orf63 (1.9)	DDX56 (1.8)	QTRT1 (1.8)	NAA25 (1.7)	TOMM40 (1.6)
GO:0016538	cyclin-dependent protein kinase regulator activity	0.29	> 0.20	MYLIP (2.6)	FEN1 (2.1)	TMEM57 (2.1)	KANK2 (2.1)	ENSG00000254235 (2.0)	USP1 (1.9)	TMED4 (1.8)	C1orf63 (1.7)	HLX (1.7)	SLC44A2 (1.7)
ENSG00000056558	TRAF1 PPI subnetwork	0.29	> 0.20	RELB (4.4)	BCL3 (3.4)	PBX4 (2.6)	ENSG00000238078 (2.1)	C12orf43 (2.1)	PARP10 (2.0)	TRAFD1 (2.0)	LPAR2 (2.0)	FRK (1.8)	PVR (1.7)
REACTOME_INTERLEUKIN:1_SIGNALING	REACTOME_INTERLEUKIN:1_SIGNALING	0.29	> 0.20	BCL3 (3.8)	RELB (3.3)	HLX (2.5)	ENSG00000235545 (2.2)	BLOC1S3 (2.2)	OASL (2.1)	MYLIP (2.1)	CYB561D1 (1.8)	GRINA (1.5)	PVR (1.3)
GO:0010675	regulation of cellular carbohydrate metabolic process	0.29	> 0.20	ENSG00000254235 (4.2)	LPA (2.4)	GPAM (2.4)	HNF1A (2.3)	CYP7A1 (2.3)	ENSG00000238078 (2.2)	PCSK9 (1.9)	KANK2 (1.8)	TMEM116 (1.7)	ZHX3 (1.6)
ENSG00000106683	LIMK1 PPI subnetwork	0.29	> 0.20	GMIP (2.9)	DNM2 (2.6)	PLEC (2.2)	ST3GAL4 (2.1)	CARM1 (2.1)	BCL3 (2.1)	NYNRIN (1.9)	PTPN11 (1.9)	MARK4 (1.8)	PVRL2 (1.8)
GO:0009408	response to heat	0.29	> 0.20	ENSG00000235545 (3.3)	AMIGO1 (2.1)	ENSG00000226645 (2.1)	SYPL2 (1.9)	C12orf51 (1.8)	NAA25 (1.8)	TMEM57 (1.7)	DDX56 (1.4)	BCL3 (1.3)	C17orf57 (1.3)
ENSG00000113196	HAND1 PPI subnetwork	0.29	> 0.20	CARM1 (3.4)	DNM2 (2.1)	KANK2 (1.8)	SYPL2 (1.8)	OGDH (1.7)	CEACAM19 (1.7)	ENSG00000238078 (1.7)	RHCE (1.5)	MARK4 (1.5)	FRK (1.5)
ENSG00000144061	NPHP1 PPI subnetwork	0.29	> 0.20	PLEC (4.4)	KANK2 (2.9)	PVR (2.8)	C11orf9 (2.1)	C17orf57 (2.1)	POLK (1.7)	HAVCR1 (1.6)	PVRL2 (1.6)	LPIN3 (1.5)	DYNC2LI1 (1.5)
MP:0000571	interdigital webbing	0.29	> 0.20	MOSC1 (2.4)	MAFB (2.4)	LPIN3 (1.7)	UBXN2B (1.7)	NYNRIN (1.6)	ZHX3 (1.5)	ABCG5 (1.5)	ITGB3 (1.5)	POLK (1.3)	GOT2P1 (1.3)
GO:0000097	sulfur amino acid biosynthetic process	0.29	> 0.20	DNAH11 (2.1)	SARS (1.9)	DHODH (1.8)	UBXN2B (1.7)	SLC22A1 (1.6)	ANGPTL3 (1.6)	CYP7A1 (1.5)	GOT2P1 (1.5)	APOA5 (1.5)	C17orf57 (1.5)
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE:NUCLEOTIDE_REPLACEMENT_PATHWAY	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE:NUCLEOTIDE_REPLACEMENT_PATHWAY	0.29	> 0.20	POC5 (2.5)	ANKRD31 (2.0)	TMEM57 (2.0)	TRAPPC6A (1.8)	C17orf57 (1.7)	C12orf43 (1.6)	MAPKAPK5 (1.6)	CEACAM19 (1.6)	DHODH (1.6)	LPIN3 (1.5)
ENSG00000120697	ALG5 PPI subnetwork	0.29	> 0.20	HMGCR (5.2)	LDLR (4.9)	TMED4 (3.4)	FADS1 (3.2)	ERP29 (3.2)	TMEM50A (3.1)	FADS2 (2.8)	CLPTM1 (2.5)	TMEM57 (2.5)	ATP13A1 (2.5)
GO:0032799	low-density lipoprotein receptor particle metabolic process	0.29	> 0.20	MOSC1 (3.1)	ENSG00000235545 (3.1)	C17orf57 (2.6)	APOC1 (2.5)	GPAM (2.4)	HAVCR1 (2.4)	FRK (2.3)	ANKRD31 (2.1)	ENSG00000238078 (1.7)	LPIN3 (1.7)
ENSG00000141738	GRB7 PPI subnetwork	0.29	> 0.20	KANK2 (2.4)	AP1M2 (2.3)	TRIB1 (2.2)	LDLR (2.2)	PBX4 (1.9)	PSRC1 (1.7)	BCAM (1.6)	HAPLN4 (1.5)	GATAD2A (1.5)	SH2B3 (1.5)
ENSG00000107863	ARHGAP21 PPI subnetwork	0.29	> 0.20	AP1M2 (2.1)	NT5DC1 (2.1)	MYLIP (1.9)	GATAD2A (1.8)	TOP1 (1.8)	PLEC (1.8)	C1orf63 (1.7)	DOCK7 (1.5)	HAVCR1 (1.5)	C19orf52 (1.4)
REACTOME_CHAPERONIN:MEDIATED_PROTEIN_FOLDING	REACTOME_CHAPERONIN:MEDIATED_PROTEIN_FOLDING	0.29	> 0.20	ENSG00000238078 (2.6)	QTRT1 (2.0)	SMARCA4 (2.0)	ZNF259 (1.9)	ZHX3 (1.9)	LPIN3 (1.9)	DDX56 (1.7)	GMPR (1.7)	RHD (1.7)	ITGB3 (1.6)
ENSG00000104177	MYEF2 PPI subnetwork	0.29	> 0.20	NAA25 (2.6)	DOCK7 (2.4)	NT5DC1 (2.1)	OASL (1.9)	PSMA5 (1.9)	MOSC1 (1.8)	GPAM (1.8)	PARP10 (1.6)	CYP7A1 (1.6)	ENSG00000235545 (1.6)
GO:0030166	proteoglycan biosynthetic process	0.29	> 0.20	GCNT4 (4.4)	CILP2 (4.4)	ST3GAL4 (3.0)	ANKRD31 (2.6)	ENSG00000226645 (2.1)	GEMIN7 (2.1)	C12orf47 (1.9)	ZHX3 (1.7)	ENSG00000235545 (1.7)	ENSG00000254235 (1.6)
GO:0014061	regulation of norepinephrine secretion	0.29	> 0.20	ANKRD31 (2.7)	ZHX3 (2.4)	GMPR (2.3)	ABO (2.0)	GEMIN7 (1.8)	DNAH11 (1.6)	GOT2P1 (1.5)	PMFBP1 (1.5)	ITGB3 (1.4)	CEACAM19 (1.4)
MP:0001929	abnormal gametogenesis	0.29	> 0.20	PLEKHH2 (2.6)	FADS1 (2.3)	PCSK9 (2.3)	PBX4 (2.2)	ALDH2 (2.0)	TMEM116 (1.7)	PLCG1 (1.6)	UBXN2B (1.6)	PLG (1.5)	ANKRD31 (1.4)
REACTOME_TIGHT_JUNCTION_INTERACTIONS	REACTOME_TIGHT_JUNCTION_INTERACTIONS	0.29	> 0.20	AP1M2 (6.9)	FRK (5.0)	CBLC (3.7)	BCAM (3.3)	PVRL2 (2.9)	YIPF2 (2.4)	DYNC2LI1 (2.3)	CYP7A1 (2.0)	PVR (1.9)	HAVCR1 (1.9)
ENSG00000134602	ENSG00000134602 PPI subnetwork	0.29	> 0.20	ZNF180 (3.6)	C11orf9 (2.2)	PVRL2 (2.2)	PLEKHH2 (2.0)	MARK4 (2.0)	CYB561D1 (1.9)	DNM2 (1.7)	GEMIN7 (1.7)	PVR (1.5)	ATXN7L2 (1.5)
KEGG_SPLICEOSOME	KEGG_SPLICEOSOME	0.29	> 0.20	DHX38 (3.8)	SUGP1 (3.4)	BUD13 (3.3)	ILF3 (3.2)	TOP1 (2.9)	USP1 (2.5)	SMARCA4 (2.4)	C1orf63 (2.2)	DDX56 (2.2)	MAPKAPK5 (2.1)
ENSG00000090863	GLG1 PPI subnetwork	0.29	> 0.20	RELB (8.0)	BCL3 (6.5)	GRINA (2.3)	ENSG00000254235 (2.2)	C12orf43 (1.9)	PVR (1.8)	ENSG00000228044 (1.8)	CLPTM1 (1.7)	ZNF259 (1.7)	PBX4 (1.6)
GO:0007260	tyrosine phosphorylation of STAT protein	0.29	> 0.20	ENSG00000228044 (2.2)	TRAFD1 (1.9)	TIMD4 (1.9)	PBX4 (1.9)	ENSG00000254235 (1.8)	GEMIN7 (1.6)	ENSG00000238078 (1.6)	PARP10 (1.6)	COL4A3BP (1.6)	PVR (1.5)
ENSG00000134363	FST PPI subnetwork	0.29	> 0.20	SLC22A1 (2.6)	ST3GAL4 (2.6)	APOA5 (2.5)	CYP7A1 (2.5)	PVR (2.5)	ABCG8 (2.1)	APOB (1.7)	APOC4 (1.6)	LPA (1.5)	ABO (1.5)
ENSG00000087338	GMCL1 PPI subnetwork	0.29	> 0.20	TMED4 (2.6)	TMEM57 (2.2)	ENSG00000238078 (2.1)	CYP7A1 (2.1)	AMIGO1 (2.0)	GATAD2A (1.8)	RHCE (1.8)	POC5 (1.8)	GEMIN7 (1.7)	ZNF259 (1.6)
GO:0019221	cytokine-mediated signaling pathway	0.29	> 0.20	OASL (6.1)	PARP10 (5.6)	TRAFD1 (3.8)	BCL3 (2.5)	CYB561D1 (2.5)	RELB (2.1)	GRINA (1.8)	GMIP (1.7)	TMEM50A (1.5)	CEACAM19 (1.4)
ENSG00000055609	MLL3 PPI subnetwork	0.29	> 0.20	PLEC (2.2)	C12orf51 (2.1)	ZHX3 (1.8)	MAU2 (1.7)	KANK2 (1.7)	ITGB3 (1.7)	C19orf52 (1.6)	GMIP (1.6)	ENSG00000226648 (1.5)	HNF1A (1.5)
ENSG00000157344	ENSG00000157344 PPI subnetwork	0.29	> 0.20	POC5 (3.7)	MAPKAPK5 (2.9)	DHODH (2.1)	TOP1 (2.0)	GEMIN7 (1.8)	POLK (1.7)	C19orf52 (1.7)	USP24 (1.6)	NT5DC1 (1.6)	GCNT4 (1.3)
MP:0003403	absent placental labyrinth	0.29	> 0.20	BCAM (4.5)	CBLC (3.2)	CLPTM1 (2.6)	CARM1 (2.4)	SORT1 (2.2)	ATXN2 (2.2)	LDLR (2.1)	AP1M2 (2.0)	GATAD2A (2.0)	TMEM116 (1.7)
ENSG00000133265	HSPBP1 PPI subnetwork	0.29	> 0.20	PARP10 (3.3)	PVR (2.0)	FRK (2.0)	PPP1R37 (1.9)	TRIB1 (1.8)	BRAP (1.7)	CELSR2 (1.6)	C1orf63 (1.5)	POLK (1.2)	OGDH (1.2)
GO:0035601	protein deacylation	0.29	> 0.20	C1orf63 (2.3)	ATXN7L2 (2.3)	TMEM57 (2.2)	HNF1A (2.2)	C17orf57 (2.0)	UBXN2B (1.7)	MYLIP (1.7)	PLCG1 (1.5)	TXNL4B (1.4)	BUD13 (1.2)
ENSG00000134470	IL15RA PPI subnetwork	0.29	> 0.20	BCL3 (3.0)	COL4A3BP (2.0)	RELB (1.8)	C17orf57 (1.6)	CYP7A1 (1.6)	TIMD4 (1.5)	PVR (1.5)	ZNF101 (1.5)	SLC22A1 (1.4)	HLX (1.3)
MP:0008042	abnormal NK T cell physiology	0.29	> 0.20	PARP10 (2.5)	MAFB (2.3)	SH2B3 (1.9)	C17orf57 (1.8)	GCNT4 (1.7)	GMIP (1.6)	GATAD2A (1.6)	NKPD1 (1.5)	ZNF101 (1.4)	DNAH11 (1.3)
GO:0045177	apical part of cell	0.29	> 0.20	AP1M2 (3.6)	TMEM116 (3.4)	FRK (3.4)	TM6SF2 (3.2)	BCAM (2.6)	NPC1L1 (2.3)	SORT1 (2.2)	TMED4 (2.1)	CELSR2 (2.0)	SLC22A1 (1.8)
GO:0030878	thyroid gland development	0.29	> 0.20	C17orf57 (4.7)	PMFBP1 (2.7)	TSSK6 (2.6)	ANKRD31 (2.5)	ABO (2.1)	PBX4 (2.0)	NKPD1 (1.7)	BCAM (1.7)	BLOC1S3 (1.6)	HLX (1.4)
ENSG00000197892	KIF13B PPI subnetwork	0.29	> 0.20	USP24 (2.9)	PARP10 (2.9)	MAU2 (2.6)	BCL3 (2.2)	ATXN2 (2.2)	MARK4 (2.1)	GMIP (2.0)	SMARCA4 (2.0)	ZNF180 (1.7)	C12orf51 (1.6)
REACTOME_ARMS:MEDIATED_ACTIVATION	REACTOME_ARMS:MEDIATED_ACTIVATION	0.29	> 0.20	CARM1 (2.2)	DNM2 (2.2)	TMEM50A (2.1)	CYB561D1 (2.1)	HLX (1.9)	MARK4 (1.7)	MAPKAPK5 (1.7)	SH2B3 (1.6)	SLC44A2 (1.6)	AMIGO1 (1.6)
MP:0002739	abnormal olfactory bulb development	0.29	> 0.20	NCAN (3.0)	RPH3A (2.7)	APOE (2.0)	MAFB (1.9)	CETP (1.7)	BLOC1S3 (1.7)	HLX (1.6)	ENSG00000238078 (1.5)	DNAH11 (1.4)	GCNT4 (1.4)
ENSG00000132688	NES PPI subnetwork	0.29	> 0.20	HMGCR (4.2)	LDLR (2.7)	CELSR2 (2.6)	PCSK9 (2.4)	FADS2 (2.0)	HAPLN4 (1.8)	FADS1 (1.8)	COL4A3BP (1.7)	NCAN (1.7)	RPH3A (1.7)
GO:0015238	drug transmembrane transporter activity	0.29	> 0.20	ANGPTL3 (3.2)	HAVCR1 (2.8)	TM6SF2 (2.5)	ATP13A1 (2.0)	TMED4 (1.8)	PLG (1.8)	SLC22A1 (1.7)	HMGCR (1.6)	BCAM (1.5)	SYPL2 (1.4)
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	0.29	> 0.20	ABCG5 (5.1)	TM6SF2 (4.5)	ABCG8 (3.4)	HAPLN4 (2.8)	APOB (2.7)	CYP7A1 (2.6)	APOC4 (2.5)	SLC22A1 (2.5)	APOA5 (2.1)	NKPD1 (1.9)
ENSG00000099139	PCSK5 PPI subnetwork	0.30	> 0.20	C12orf47 (2.0)	OGDH (1.9)	ST3GAL4 (1.9)	ZNF101 (1.9)	MARK4 (1.9)	ADAM1 (1.6)	DDX56 (1.5)	MYLIP (1.5)	HNF1A (1.5)	C12orf43 (1.4)
ENSG00000186081	KRT5 PPI subnetwork	0.30	> 0.20	NKPD1 (2.2)	ANGPTL3 (2.1)	CELSR2 (2.1)	GMPR (2.0)	C11orf9 (1.8)	NT5DC1 (1.8)	APOC1 (1.7)	PCSK9 (1.7)	LPAR2 (1.6)	ALDH2 (1.6)
GO:0002889	regulation of immunoglobulin mediated immune response	0.30	> 0.20	HAVCR1 (2.0)	ENSG00000235545 (2.0)	GEMIN7 (1.3)	AMIGO1 (1.2)	ENSG00000228044 (1.2)	LPAR2 (1.2)	DNAH11 (1.2)	GCNT4 (1.1)	GMIP (1.1)	SLC22A1 (1.1)
MP:0009503	abnormal mammary gland duct morphology	0.30	> 0.20	TRIB1 (2.6)	CELSR2 (2.4)	PLEKHH2 (2.3)	UBXN2B (2.1)	MAFB (2.1)	RELB (1.9)	C17orf57 (1.8)	GOT2P1 (1.8)	NKPD1 (1.4)	PVR (1.4)
GO:0005605	basal lamina	0.30	> 0.20	BCAM (5.5)	CBLC (4.3)	CELSR2 (2.6)	AP1M2 (2.6)	PVRL2 (2.4)	APOE (2.1)	PLEC (1.9)	SLC44A2 (1.9)	KANK2 (1.8)	OGDH (1.7)
ENSG00000130762	ARHGEF16 PPI subnetwork	0.30	> 0.20	CBLC (4.2)	AP1M2 (3.1)	MARK4 (2.7)	LPIN3 (2.3)	FRK (2.2)	PSRC1 (2.2)	CELSR2 (2.1)	PVRL2 (1.7)	C12orf51 (1.7)	ST3GAL4 (1.6)
GO:0090305	nucleic acid phosphodiester bond hydrolysis	0.30	> 0.20	POLK (3.6)	AMIGO1 (1.8)	ST3GAL4 (1.6)	BLOC1S3 (1.6)	TRAPPC6A (1.6)	QTRT1 (1.6)	TXNL4B (1.5)	ENSG00000226645 (1.5)	ENSG00000226648 (1.4)	TSSK6 (1.4)
MP:0001422	abnormal drinking behavior	0.30	> 0.20	ABO (3.9)	BCAM (3.3)	ALDH2 (2.9)	CBLC (2.5)	PLEKHH2 (2.1)	HNF1A (2.1)	GMPR (2.0)	NPC1L1 (2.0)	HLX (2.0)	YIPF2 (1.8)
GO:0008536	Ran GTPase binding	0.30	> 0.20	ILF3 (2.5)	USP1 (2.1)	USP24 (2.0)	TOP1 (2.0)	KANK2 (2.0)	CEACAM19 (1.7)	ENSG00000226648 (1.7)	FEN1 (1.7)	CARM1 (1.5)	SMARCA4 (1.5)
MP:0003722	absent ureter	0.30	> 0.20	ZHX3 (3.1)	KANK2 (3.1)	FADS1 (2.3)	ITGB3 (2.0)	PVRL2 (2.0)	ENSG00000238078 (2.0)	CELSR2 (1.9)	FADS2 (1.8)	SORT1 (1.8)	BCAM (1.7)
GO:0009113	purine base biosynthetic process	0.30	> 0.20	DHODH (3.4)	ENSG00000228044 (2.9)	ENSG00000226648 (2.7)	TXNL4B (2.4)	ANKRD31 (2.2)	TRAPPC6A (2.1)	NKPD1 (1.8)	DNAH11 (1.8)	NT5DC1 (1.6)	QTRT1 (1.5)
ENSG00000176095	IP6K1 PPI subnetwork	0.30	> 0.20	ABO (3.2)	TSSK6 (2.7)	GOT2P1 (2.7)	GRINA (2.0)	DYNC2LI1 (1.7)	CARM1 (1.6)	NKPD1 (1.6)	MYLIP (1.4)	DHODH (1.3)	SYPL2 (1.3)
MP:0000813	abnormal hippocampus layer morphology	0.30	> 0.20	RPH3A (2.9)	CETP (2.4)	PBX4 (2.4)	ST3GAL4 (2.2)	C17orf57 (2.1)	HMGCR (1.8)	ABCG5 (1.8)	ZNF101 (1.7)	MOSC1 (1.7)	TSSK6 (1.7)
ENSG00000198034	RPS4X PPI subnetwork	0.30	> 0.20	DDX56 (3.9)	ZNF259 (3.6)	NAA25 (3.6)	QTRT1 (3.2)	SARS (2.7)	DHX38 (2.7)	TOMM40 (2.4)	ATP13A1 (2.3)	SUGP1 (2.1)	ILF3 (2.1)
ENSG00000055208	TAB2 PPI subnetwork	0.30	> 0.20	PARP10 (4.2)	PTPN11 (3.0)	TOMM40 (2.5)	RELB (2.4)	SARS (2.1)	HAVCR1 (2.0)	PSMA5 (1.9)	PLEC (1.9)	FRK (1.7)	DOCK7 (1.6)
ENSG00000113140	SPARC PPI subnetwork	0.30	> 0.20	APOE (2.9)	ITGB3 (2.9)	CILP2 (2.7)	PVRL2 (2.5)	SH2B3 (2.2)	KANK2 (2.1)	BCAM (1.9)	APOC1 (1.9)	ANGPTL3 (1.9)	C17orf57 (1.8)
GO:0045638	negative regulation of myeloid cell differentiation	0.30	> 0.20	GCNT4 (2.3)	C19orf52 (2.3)	ST3GAL4 (1.9)	DNAH11 (1.8)	ZHX3 (1.8)	ABO (1.6)	ZNF180 (1.6)	HLX (1.5)	MAU2 (1.5)	ITGB3 (1.5)
GO:0001704	formation of primary germ layer	0.30	> 0.20	ENSG00000226648 (3.3)	ENSG00000238078 (3.1)	ENSG00000254235 (3.0)	TRIB1 (2.2)	NYNRIN (1.8)	ATXN7L2 (1.7)	CILP2 (1.5)	ABO (1.5)	ANKRD31 (1.5)	PVR (1.4)
GO:0051897	positive regulation of protein kinase B signaling cascade	0.30	> 0.20	CETP (2.8)	TIMD4 (2.5)	PTPN11 (1.8)	CILP2 (1.6)	SORT1 (1.6)	TSSK6 (1.6)	ENSG00000228044 (1.5)	NKPD1 (1.4)	SLC22A1 (1.4)	ITGB3 (1.3)
GO:0050777	negative regulation of immune response	0.30	> 0.20	ADAM1 (2.2)	CYB561D1 (2.0)	GMIP (1.8)	ENSG00000235545 (1.7)	OASL (1.6)	PARP10 (1.5)	HAVCR1 (1.5)	PBX4 (1.2)	ABO (1.2)	HNF1A (1.2)
ENSG00000100934	SEC23A PPI subnetwork	0.30	> 0.20	YIPF2 (3.2)	PSMA5 (2.4)	ABCG8 (2.3)	SUGP1 (2.0)	USP24 (2.0)	ATXN2 (2.0)	TMEM57 (2.0)	DDX56 (1.8)	PLCG1 (1.8)	OGDH (1.8)
MP:0001272	increased metastatic potential	0.30	> 0.20	POLK (2.3)	CETP (1.8)	TRAFD1 (1.7)	RELB (1.7)	ITGB3 (1.6)	PVR (1.5)	MOSC1 (1.4)	ALDH2 (1.3)	LPIN3 (1.2)	CILP2 (1.1)
GO:0051348	negative regulation of transferase activity	0.30	> 0.20	TRIB1 (3.8)	ENSG00000226645 (3.6)	PVR (2.0)	KANK2 (1.8)	HLX (1.4)	POC5 (1.4)	ENSG00000238078 (1.3)	GPAM (1.3)	GCNT4 (1.3)	ENSG00000254235 (1.3)
KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY	0.30	> 0.20	GMIP (3.1)	TMEM57 (2.3)	GATAD2A (2.3)	SH2B3 (2.2)	GCNT4 (2.2)	MYLIP (2.0)	MARK4 (1.9)	DNM2 (1.9)	PLEKHH2 (1.5)	ABCG8 (1.5)
GO:0003724	RNA helicase activity	0.30	> 0.20	SUGP1 (3.3)	ZNF259 (3.1)	TOP1 (2.6)	BUD13 (2.6)	DDX56 (2.4)	NAA25 (2.4)	DHX38 (2.4)	DHODH (2.3)	ILF3 (2.2)	ATP13A1 (1.9)
ENSG00000164134	NAA15 PPI subnetwork	0.30	> 0.20	DDX56 (3.5)	TOMM40 (3.0)	NAA25 (2.7)	PSMA5 (2.6)	SUGP1 (2.6)	SMARCA4 (2.5)	ZNF259 (2.3)	OGDH (2.2)	MAPKAPK5 (2.2)	DHODH (2.1)
REACTOME_TIE2_SIGNALING	REACTOME_TIE2_SIGNALING	0.30	> 0.20	COL4A3BP (3.0)	USP24 (2.2)	ITGB3 (2.1)	LPIN3 (2.0)	ZHX3 (1.7)	DNAH11 (1.6)	TMEM57 (1.5)	DNM2 (1.5)	MAPKAPK5 (1.3)	NCAN (1.1)
GO:0016289	CoA hydrolase activity	0.30	> 0.20	ANGPTL3 (3.4)	SLC22A1 (3.3)	PLG (3.1)	ABCG8 (2.6)	ACAD10 (2.6)	CYP7A1 (2.5)	PCSK9 (2.1)	TM6SF2 (1.9)	APOC4 (1.8)	NT5DC1 (1.7)
GO:0031349	positive regulation of defense response	0.30	> 0.20	ENSG00000228044 (2.9)	SH2B3 (2.4)	PVR (2.0)	HLX (2.0)	RELB (1.9)	OASL (1.9)	ZNF101 (1.9)	BCL3 (1.8)	PARP10 (1.7)	GMIP (1.6)
ENSG00000177455	CD19 PPI subnetwork	0.30	> 0.20	SLC44A2 (3.3)	TIMD4 (3.3)	GMIP (2.9)	APOE (2.6)	CETP (2.1)	C19orf52 (1.9)	ITGB3 (1.8)	TMED4 (1.7)	PTPN11 (1.7)	PMFBP1 (1.7)
GO:0042177	negative regulation of protein catabolic process	0.30	> 0.20	PBX4 (2.9)	ENSG00000226648 (2.4)	CYB561D1 (2.3)	GOT2P1 (1.9)	GEMIN7 (1.7)	PLEKHH2 (1.7)	ENSG00000238078 (1.6)	GCNT4 (1.4)	ZNF101 (1.3)	ST3GAL4 (1.2)
ENSG00000072310	SREBF1 PPI subnetwork	0.30	> 0.20	MYLIP (3.2)	PLEC (2.8)	UBXN2B (2.7)	C12orf51 (2.2)	ATXN2 (2.0)	ENSG00000254235 (1.9)	NT5DC1 (1.5)	COL4A3BP (1.5)	LDLR (1.5)	KANK2 (1.3)
ENSG00000172172	MRPL13 PPI subnetwork	0.30	> 0.20	CARM1 (3.5)	QTRT1 (3.2)	TOMM40 (2.8)	MAU2 (2.4)	ATP13A1 (2.0)	DDX56 (2.0)	DHODH (2.0)	YIPF2 (2.0)	BUD13 (1.9)	NAA25 (1.8)
ENSG00000131469	RPL27 PPI subnetwork	0.30	> 0.20	ZNF259 (3.3)	NAA25 (2.9)	DHX38 (2.8)	DDX56 (2.6)	SUGP1 (2.4)	NKPD1 (2.4)	GATAD2A (2.3)	QTRT1 (2.3)	MAPKAPK5 (1.9)	ADAM1 (1.8)
ENSG00000143333	RGS16 PPI subnetwork	0.30	> 0.20	HAVCR1 (3.3)	NCAN (3.1)	MARK4 (2.0)	ZHX3 (1.9)	TMEM50A (1.8)	ITGB3 (1.8)	CLPTM1 (1.8)	PPP1R37 (1.7)	DNM2 (1.7)	CARM1 (1.6)
ENSG00000118985	ELL2 PPI subnetwork	0.30	> 0.20	TXNL4B (4.4)	BLOC1S3 (3.0)	TOP1 (2.5)	ZNF180 (2.2)	DHX38 (2.2)	BRAP (2.1)	ENSG00000226648 (2.1)	TRAPPC6A (2.0)	C19orf52 (2.0)	TRAFD1 (1.6)
MP:0008688	decreased interleukin-2 secretion	0.30	> 0.20	RELB (3.3)	GMIP (2.4)	CETP (2.4)	SH2B3 (1.9)	BCL3 (1.9)	TIMD4 (1.5)	HAVCR1 (1.5)	ZNF101 (1.3)	PBX4 (1.3)	PARP10 (1.2)
MP:0002032	sarcoma	0.30	> 0.20	PLEKHH2 (2.1)	FEN1 (2.0)	POC5 (2.0)	KANK2 (1.9)	SLC44A2 (1.9)	POLK (1.8)	PSRC1 (1.7)	ZHX3 (1.7)	ADAM1 (1.6)	USP1 (1.6)
ENSG00000213588	ZBTB9 PPI subnetwork	0.30	> 0.20	GEMIN7 (3.6)	TXNL4B (3.0)	TOP1 (2.3)	ZNF180 (2.2)	NKPD1 (2.0)	MAPKAPK5 (2.0)	BUD13 (1.9)	BRAP (1.9)	C12orf43 (1.7)	POC5 (1.7)
GO:0002440	production of molecular mediator of immune response	0.30	> 0.20	ZNF101 (3.1)	GCNT4 (2.3)	C17orf57 (2.3)	HAVCR1 (1.9)	PBX4 (1.9)	POC5 (1.8)	DYNC2LI1 (1.6)	NT5DC1 (1.6)	C12orf43 (1.3)	ADAM1 (1.3)
GO:0042474	middle ear morphogenesis	0.30	> 0.20	NYNRIN (2.3)	NKPD1 (2.2)	CEACAM19 (2.0)	ENSG00000228044 (1.9)	AMIGO1 (1.9)	MYLIP (1.8)	CILP2 (1.7)	HMGCR (1.5)	FADS1 (1.5)	ATXN7L2 (1.5)
ENSG00000196084	ENSG00000196084 PPI subnetwork	0.30	> 0.20	FEN1 (2.3)	PTPN11 (2.3)	TOP1 (2.2)	PSMA5 (2.1)	SMARCA4 (1.9)	GRINA (1.8)	TMEM57 (1.8)	DHX38 (1.7)	NAA25 (1.6)	GATAD2A (1.6)
MP:0001304	cataracts	0.30	> 0.20	HMGCR (2.5)	LDLR (2.0)	UBXN2B (1.6)	USP24 (1.6)	TMEM116 (1.6)	FADS1 (1.5)	PCSK9 (1.4)	TRIB1 (1.3)	TMED4 (1.3)	CILP2 (1.3)
MP:0002494	increased IgM level	0.30	> 0.20	RELB (5.2)	GMIP (4.0)	CETP (2.9)	SH2B3 (2.9)	TIMD4 (2.9)	BCL3 (2.7)	GRINA (2.1)	HAVCR1 (1.6)	ALDH2 (1.3)	C17orf57 (1.3)
MP:0004014	abnormal uterine environment	0.30	> 0.20	ANGPTL3 (2.5)	GRINA (2.4)	PLG (2.0)	MOSC1 (2.0)	KIAA1324 (1.8)	APOC4 (1.8)	TOMM40 (1.7)	CBLC (1.7)	APOA5 (1.7)	APOB (1.7)
GO:0042537	benzene-containing compound metabolic process	0.30	> 0.20	DNAH11 (3.7)	TSSK6 (2.2)	ENSG00000254235 (2.1)	ANKRD31 (1.9)	PMFBP1 (1.7)	GCNT4 (1.6)	ST3GAL4 (1.5)	CYP7A1 (1.5)	ENSG00000235545 (1.5)	ABO (1.4)
GO:0002027	regulation of heart rate	0.30	> 0.20	PPP1R37 (2.4)	ABO (2.2)	KIAA1324 (2.1)	ENSG00000226648 (2.0)	C12orf47 (1.6)	ENSG00000254235 (1.6)	ZNF101 (1.4)	TMEM116 (1.4)	CEACAM19 (1.4)	MYLIP (1.4)
REACTOME_REMOVAL_OF_DNA_PATCH_CONTAINING_ABASIC_RESIDUE	REACTOME_REMOVAL_OF_DNA_PATCH_CONTAINING_ABASIC_RESIDUE	0.30	> 0.20	USP1 (3.4)	FEN1 (3.0)	TRAPPC6A (1.9)	BUD13 (1.8)	POC5 (1.8)	LPIN3 (1.7)	TMEM57 (1.6)	ABO (1.6)	DHODH (1.6)	ERP29 (1.6)
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE:NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE:NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	0.30	> 0.20	USP1 (3.4)	FEN1 (3.0)	TRAPPC6A (1.9)	BUD13 (1.8)	POC5 (1.8)	LPIN3 (1.7)	TMEM57 (1.6)	ABO (1.6)	DHODH (1.6)	ERP29 (1.6)
ENSG00000113494	PRLR PPI subnetwork	0.30	> 0.20	BCL3 (3.2)	COL4A3BP (2.4)	CYP7A1 (1.8)	C17orf57 (1.7)	PVR (1.7)	ZNF101 (1.6)	RELB (1.5)	SLC22A1 (1.3)	TIMD4 (1.2)	BCAM (1.2)
MP:0002884	abnormal branchial arch morphology	0.30	> 0.20	PLCG1 (2.2)	DOCK7 (2.1)	PVR (1.8)	UBXN2B (1.7)	PTPN11 (1.7)	HLX (1.6)	CEACAM19 (1.6)	COL4A3BP (1.6)	DNAH11 (1.5)	BCAM (1.5)
ENSG00000072134	EPN2 PPI subnetwork	0.30	> 0.20	DHX38 (2.3)	COL4A3BP (2.2)	TXNL4B (2.1)	MYLIP (2.1)	USP24 (2.1)	ENSG00000235545 (2.0)	GOT2P1 (1.6)	APOE (1.6)	CLPTM1 (1.6)	FRK (1.5)
ENSG00000129991	TNNI3 PPI subnetwork	0.30	> 0.20	SYPL2 (4.3)	TMEM50A (3.4)	GMPR (2.8)	ACAD10 (2.3)	C1orf63 (1.9)	APOE (1.6)	C12orf47 (1.1)	LPIN3 (1.1)	NKPD1 (1.1)	HNF1A (1.1)
ENSG00000119041	GTF3C3 PPI subnetwork	0.30	> 0.20	DDX56 (2.8)	GEMIN7 (2.8)	ENSG00000226645 (2.7)	ATXN2 (2.6)	ATP13A1 (2.5)	BUD13 (2.5)	TOMM40 (2.3)	MAU2 (2.2)	POC5 (2.0)	C12orf43 (1.9)
ENSG00000162434	JAK1 PPI subnetwork	0.30	> 0.20	BCL3 (3.8)	GMIP (3.5)	HLX (2.8)	PARP10 (2.7)	RELB (2.4)	TRIB1 (2.0)	DNM2 (1.8)	ZNF101 (1.6)	MYLIP (1.5)	LPA (1.5)
KEGG_NON_SMALL_CELL_LUNG_CANCER	KEGG_NON_SMALL_CELL_LUNG_CANCER	0.30	> 0.20	DNM2 (2.9)	SLC44A2 (2.3)	MAU2 (2.2)	SORT1 (2.2)	TRAPPC6A (2.1)	GMIP (2.1)	ZHX3 (2.1)	GATAD2A (2.1)	PPP1R37 (2.0)	PTPN11 (1.9)
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	0.30	> 0.20	ACAD10 (5.2)	ALDH2 (3.7)	TRAPPC6A (3.1)	FADS2 (2.9)	MOSC1 (2.8)	NT5DC1 (2.7)	FADS1 (2.5)	GPAM (2.5)	PLG (2.4)	OGDH (2.2)
ENSG00000113643	RARS PPI subnetwork	0.30	> 0.20	SARS (4.6)	RELB (4.4)	NAA25 (3.4)	QTRT1 (2.4)	DDX56 (2.2)	ST3GAL4 (2.1)	DHODH (2.0)	GOT2P1 (2.0)	PVRL2 (1.7)	BCL3 (1.7)
ENSG00000148218	ALAD PPI subnetwork	0.30	> 0.20	BRAP (2.9)	RHCE (2.6)	RHD (2.6)	ADAM1 (2.5)	CYP7A1 (2.4)	ERP29 (2.2)	ALDH2 (1.8)	YIPF2 (1.7)	NAA25 (1.6)	C19orf52 (1.6)
KEGG_PROTEASOME	KEGG_PROTEASOME	0.30	> 0.20	PSMA5 (6.7)	TRAFD1 (4.3)	NAA25 (2.5)	NT5DC1 (2.0)	TOMM40 (1.8)	PARP10 (1.8)	SUGP1 (1.6)	DDX56 (1.4)	SARS (1.3)	TMEM50A (1.3)
GO:0051270	regulation of cellular component movement	0.30	> 0.20	PVR (3.2)	PVRL2 (3.2)	ENSG00000254235 (2.5)	HLX (2.4)	MAFB (2.1)	KANK2 (1.9)	CETP (1.9)	APOE (1.8)	SLC44A2 (1.8)	PTPN11 (1.7)
ENSG00000136937	NCBP1 PPI subnetwork	0.30	> 0.20	ILF3 (4.1)	TOP1 (3.5)	SMARCA4 (3.1)	C1orf63 (2.7)	DHX38 (2.7)	GATAD2A (2.7)	USP1 (2.6)	SUGP1 (2.3)	BUD13 (2.3)	PTPN11 (2.2)
ENSG00000181991	MRPS11 PPI subnetwork	0.30	> 0.20	OASL (3.5)	PARP10 (2.6)	TMED4 (2.2)	ZNF180 (2.1)	NAA25 (2.0)	MAPKAPK5 (1.8)	C12orf43 (1.5)	BUD13 (1.5)	FRK (1.4)	USP24 (1.3)
MP:0003037	increased infarction size	0.30	> 0.20	TIMD4 (3.2)	PVR (3.0)	CETP (2.5)	PLEKHH2 (2.3)	PARP10 (1.9)	C17orf57 (1.9)	BCL3 (1.7)	CEACAM19 (1.7)	ALDH2 (1.6)	OASL (1.5)
GO:0032393	MHC class I receptor activity	0.30	> 0.20	FRK (2.4)	POLK (1.9)	ENSG00000228044 (1.9)	OASL (1.7)	PLEKHH2 (1.7)	ADAM1 (1.4)	PARP10 (1.3)	YIPF2 (1.3)	LPIN3 (1.3)	SH2B3 (1.3)
GO:0048660	regulation of smooth muscle cell proliferation	0.30	> 0.20	PVR (2.6)	HLX (2.1)	MAFB (1.8)	TRIB1 (1.8)	ALDH2 (1.6)	ENSG00000228044 (1.5)	ZNF101 (1.5)	NYNRIN (1.5)	ENSG00000254235 (1.5)	TIMD4 (1.5)
MP:0000351	increased cell proliferation	0.30	> 0.20	POLK (3.1)	ZNF101 (2.1)	C17orf57 (2.0)	MAFB (1.9)	GATAD2A (1.8)	BCL3 (1.7)	MAPKAPK5 (1.7)	KANK2 (1.5)	RELB (1.5)	MYLIP (1.3)
ENSG00000090006	LTBP4 PPI subnetwork	0.30	> 0.20	RHD (2.9)	MAPKAPK5 (2.1)	RHCE (2.1)	ATP13A1 (1.9)	TMEM57 (1.8)	ITGB3 (1.8)	GPAM (1.8)	NT5DC1 (1.7)	FADS2 (1.6)	RPH3A (1.5)
MP:0009146	abnormal pancreatic acinar cell morphology	0.30	> 0.20	DYNC2LI1 (2.5)	ATP13A1 (2.4)	CYB561D1 (2.0)	TMEM57 (2.0)	C11orf9 (1.9)	KIAA1324 (1.8)	NPC1L1 (1.8)	ENSG00000254235 (1.7)	SLC22A1 (1.6)	PLG (1.6)
ENSG00000147082	CCNB3 PPI subnetwork	0.30	> 0.20	PSRC1 (4.1)	PVR (2.6)	FEN1 (2.6)	ACAD10 (2.6)	TRIB1 (2.5)	POC5 (2.1)	TXNL4B (1.9)	USP1 (1.9)	ENSG00000226648 (1.7)	CETP (1.5)
MP:0009404	centrally nucleated skeletal muscle fibers	0.30	> 0.20	SYPL2 (5.1)	PLEC (3.3)	PVR (2.6)	BCAM (2.5)	SLC44A2 (2.5)	OGDH (2.4)	KANK2 (2.4)	CLPTM1 (2.4)	CILP2 (2.0)	AMIGO1 (2.0)
GO:0005516	calmodulin binding	0.30	> 0.20	SYPL2 (3.9)	RPH3A (2.5)	C12orf51 (2.2)	HLX (1.9)	NCAN (1.7)	KANK2 (1.7)	ENSG00000226648 (1.6)	CEACAM19 (1.6)	AMIGO1 (1.6)	PLEC (1.5)
MP:0000383	abnormal hair follicle orientation	0.30	> 0.20	CELSR2 (3.4)	CBLC (3.0)	AP1M2 (2.7)	PVR (2.7)	BCAM (2.5)	CEACAM19 (2.3)	LPIN3 (1.8)	PLEC (1.6)	OASL (1.6)	PVRL2 (1.5)
GO:0031293	membrane protein intracellular domain proteolysis	0.30	> 0.20	ANKRD31 (3.0)	GCNT4 (2.6)	CYB561D1 (2.6)	CLPTM1 (2.4)	TMED4 (2.0)	ENSG00000254235 (2.0)	TMEM50A (2.0)	BLOC1S3 (1.9)	TRAPPC6A (1.8)	MAU2 (1.7)
GO:0032231	regulation of actin filament bundle assembly	0.30	> 0.20	C17orf57 (2.9)	USP24 (2.5)	HNF1A (2.2)	ENSG00000226645 (1.8)	NYNRIN (1.8)	GCNT4 (1.8)	C11orf9 (1.7)	ABO (1.6)	ITGB3 (1.6)	PBX4 (1.6)
GO:0045806	negative regulation of endocytosis	0.30	> 0.20	ANKRD31 (2.4)	GEMIN7 (2.3)	APOE (2.3)	TIMD4 (2.2)	ST3GAL4 (2.1)	CETP (1.8)	ENSG00000226645 (1.7)	TM6SF2 (1.6)	ENSG00000228044 (1.6)	CLPTM1 (1.5)
MP:0003036	vertebral transformation	0.30	> 0.20	NYNRIN (3.2)	UBXN2B (2.4)	PLCG1 (1.9)	POLK (1.6)	ATXN7L2 (1.5)	TRIB1 (1.4)	ENSG00000254235 (1.3)	CARM1 (1.3)	PCSK9 (1.2)	CILP2 (1.2)
MP:0001260	increased body weight	0.30	> 0.20	KIAA1324 (2.9)	ABCG8 (2.4)	GPAM (2.3)	ABO (2.1)	SORT1 (1.9)	MOSC1 (1.9)	CBLC (1.9)	TRIB1 (1.7)	ABCG5 (1.6)	C12orf47 (1.5)
GO:0046459	short-chain fatty acid metabolic process	0.31	> 0.20	ACAD10 (4.3)	TRAPPC6A (2.8)	CYP7A1 (2.7)	BLOC1S3 (1.9)	TMEM116 (1.9)	AMIGO1 (1.8)	PBX4 (1.8)	BRAP (1.6)	ZNF101 (1.6)	ANGPTL3 (1.6)
ENSG00000106636	YKT6 PPI subnetwork	0.31	> 0.20	SUGP1 (3.6)	YIPF2 (2.8)	ZNF259 (2.8)	SARS (2.7)	PSMA5 (2.5)	DDX56 (2.5)	TRAFD1 (2.3)	CYB561D1 (2.1)	C19orf52 (2.1)	DHX38 (2.0)
GO:0032469	endoplasmic reticulum calcium ion homeostasis	0.31	> 0.20	PPP1R37 (3.0)	CLPTM1 (2.7)	BLOC1S3 (2.5)	YIPF2 (2.4)	CYB561D1 (2.2)	C17orf57 (1.9)	BRAP (1.9)	GATAD2A (1.8)	ANKRD31 (1.8)	ERP29 (1.8)
MP:0000462	abnormal digestive system morphology	0.31	> 0.20	CBLC (3.3)	KANK2 (3.1)	PLEKHH2 (2.6)	AP1M2 (2.3)	KIAA1324 (2.1)	ENSG00000254235 (2.1)	CILP2 (2.0)	FRK (1.8)	HNF1A (1.8)	CYP7A1 (1.7)
MP:0009660	abnormal induced retinal neovascularization	0.31	> 0.20	DNAH11 (3.3)	CBLC (2.7)	PVRL2 (2.2)	PVR (2.2)	KIAA1324 (1.9)	NCAN (1.7)	BCL3 (1.5)	TRIB1 (1.5)	BCAM (1.5)	C17orf57 (1.4)
ENSG00000153395	LPCAT1 PPI subnetwork	0.31	> 0.20	OASL (7.8)	PARP10 (3.7)	USP1 (2.3)	ATP13A1 (2.2)	TXNL4B (1.8)	MAU2 (1.7)	PSMA5 (1.6)	SUGP1 (1.6)	TOP1 (1.6)	GATAD2A (1.6)
MP:0002731	megacolon	0.31	> 0.20	HLX (3.7)	ABO (3.5)	KANK2 (2.1)	ENSG00000254235 (1.6)	MOSC1 (1.6)	MAU2 (1.5)	ST3GAL4 (1.3)	LPAR2 (1.3)	CEACAM19 (1.3)	KIAA1324 (1.1)
ENSG00000164329	PAPD4 PPI subnetwork	0.31	> 0.20	ENSG00000226648 (2.8)	ANGPTL3 (2.7)	TSSK6 (2.0)	GMPR (2.0)	MOSC1 (1.9)	ACAD10 (1.8)	PLG (1.8)	DOCK7 (1.5)	TMEM116 (1.4)	MYLIP (1.4)
ENSG00000104825	NFKBIB PPI subnetwork	0.31	> 0.20	PVR (2.8)	SARS (2.7)	RELB (2.7)	PLEC (1.7)	TIMD4 (1.7)	ZNF259 (1.6)	ILF3 (1.5)	TXNL4B (1.5)	PSMA5 (1.4)	TMEM57 (1.4)
ENSG00000152804	HHEX PPI subnetwork	0.31	> 0.20	PPP1R37 (3.1)	TSSK6 (2.5)	TRIB1 (2.5)	C11orf9 (2.4)	SLC44A2 (2.1)	GOT2P1 (2.0)	PVRL2 (1.6)	PVR (1.6)	ANKRD31 (1.6)	BCAM (1.5)
MP:0003420	delayed intramembranous bone ossification	0.31	> 0.20	C11orf9 (2.4)	CLPTM1 (2.1)	ANKRD31 (2.0)	BCAM (1.9)	TRAFD1 (1.8)	MAU2 (1.7)	NT5DC1 (1.6)	TRAPPC6A (1.5)	TMEM116 (1.5)	C17orf57 (1.5)
ENSG00000183117	CSMD1 PPI subnetwork	0.31	> 0.20	MAU2 (2.8)	PARP10 (2.8)	USP24 (2.8)	MARK4 (2.6)	BCL3 (2.4)	ATXN2 (2.3)	SMARCA4 (2.2)	GMIP (2.0)	DHX38 (1.9)	C12orf51 (1.7)
MP:0000198	hypophosphatemia	0.31	> 0.20	AP1M2 (3.8)	TMEM116 (2.7)	FRK (2.6)	SLC22A1 (2.0)	C19orf52 (1.8)	SYPL2 (1.8)	PLG (1.7)	CILP2 (1.6)	TM6SF2 (1.6)	ZNF101 (1.6)
GO:0015932	nucleobase-containing compound transmembrane transporter activity	0.31	> 0.20	GCNT4 (2.4)	TM6SF2 (2.4)	ABCG8 (2.4)	ABCG5 (2.1)	TOMM40 (2.1)	HAPLN4 (2.1)	SLC44A2 (2.1)	CEACAM19 (2.0)	TMEM57 (1.9)	GOT2P1 (1.8)
GO:0030867	rough endoplasmic reticulum membrane	0.31	> 0.20	ERP29 (3.2)	FRK (2.5)	TMED4 (2.4)	YIPF2 (1.9)	TMEM57 (1.9)	BUD13 (1.9)	ST3GAL4 (1.6)	SLC22A1 (1.5)	ENSG00000226645 (1.5)	PLG (1.4)
ENSG00000138798	EGF PPI subnetwork	0.31	> 0.20	MYLIP (4.7)	HLX (3.2)	PPP1R37 (2.9)	C1orf63 (2.9)	PLEKHH2 (2.5)	C17orf57 (2.4)	DNM2 (2.4)	COL4A3BP (2.2)	DOCK7 (2.1)	C12orf51 (2.1)
GO:0016805	dipeptidase activity	0.31	> 0.20	NPC1L1 (4.7)	TM6SF2 (4.0)	HNF1A (2.6)	NT5DC1 (2.5)	PMFBP1 (2.2)	ABCG8 (2.1)	BLOC1S3 (2.0)	MOSC1 (2.0)	ABCG5 (1.9)	AP1M2 (1.8)
ENSG00000120094	HOXB1 PPI subnetwork	0.31	> 0.20	DHODH (2.2)	ZHX3 (2.0)	ENSG00000228044 (2.0)	TMEM50A (1.7)	NYNRIN (1.5)	C12orf51 (1.5)	DOCK7 (1.4)	BRAP (1.4)	C1orf63 (1.4)	UBXN2B (1.4)
ENSG00000143556	S100A7 PPI subnetwork	0.31	> 0.20	CARM1 (2.8)	DYNC2LI1 (2.4)	MAU2 (2.2)	NYNRIN (2.1)	YIPF2 (1.9)	PVR (1.9)	PLEC (1.9)	TXNL4B (1.8)	HAVCR1 (1.8)	GRINA (1.8)
ENSG00000078902	TOLLIP PPI subnetwork	0.31	> 0.20	UBXN2B (3.8)	ZHX3 (3.0)	MAFB (2.5)	PLEKHH2 (2.0)	PARP10 (1.9)	GRINA (1.9)	GMPR (1.8)	PTPN11 (1.7)	GPAM (1.5)	MYLIP (1.5)
ENSG00000147145	LPAR4 PPI subnetwork	0.31	> 0.20	USP24 (2.9)	MAU2 (2.7)	MARK4 (2.6)	PARP10 (2.6)	SMARCA4 (2.4)	ATXN2 (2.3)	BCL3 (2.3)	GMIP (2.2)	DHX38 (1.9)	ZNF180 (1.6)
GO:0043046	DNA methylation involved in gamete generation	0.31	> 0.20	ANKRD31 (4.0)	ENSG00000238078 (2.7)	DNAH11 (2.0)	CEACAM19 (2.0)	PBX4 (1.8)	FRK (1.8)	LPAR2 (1.6)	C17orf57 (1.3)	CILP2 (1.2)	ADAM1 (1.2)
GO:0048753	pigment granule organization	0.31	> 0.20	ZNF101 (2.8)	C19orf52 (2.2)	NKPD1 (2.2)	ZNF180 (2.1)	GMPR (1.9)	BLOC1S3 (1.9)	ST3GAL4 (1.8)	TSSK6 (1.6)	PMFBP1 (1.6)	PPP1R37 (1.6)
ENSG00000117632	STMN1 PPI subnetwork	0.31	> 0.20	UBXN2B (3.3)	BCL3 (2.7)	ZNF101 (1.8)	NCAN (1.8)	BLOC1S3 (1.7)	PVRL2 (1.7)	MAU2 (1.5)	MYLIP (1.5)	RPH3A (1.5)	C11orf9 (1.4)
ENSG00000039650	PNKP PPI subnetwork	0.31	> 0.20	SYPL2 (3.6)	SMARCA4 (3.2)	AMIGO1 (2.4)	POC5 (2.2)	SUGP1 (2.0)	DYNC2LI1 (1.9)	DHX38 (1.8)	DHODH (1.8)	CEACAM19 (1.7)	BLOC1S3 (1.7)
GO:0031640	killing of cells of other organism	0.31	> 0.20	LPA (3.7)	HP (2.9)	ABCG5 (2.8)	CEACAM19 (2.1)	APOA5 (2.0)	C17orf57 (1.9)	APOC4 (1.9)	MOSC1 (1.9)	RHD (1.8)	ANGPTL3 (1.6)
ENSG00000103266	STUB1 PPI subnetwork	0.31	> 0.20	RELB (2.4)	MYLIP (2.4)	LDLR (2.3)	CYP7A1 (2.2)	TRIB1 (2.2)	ST3GAL4 (2.1)	TRAFD1 (2.1)	BCL3 (2.1)	AMIGO1 (2.1)	C1orf63 (1.9)
MP:0002674	abnormal sperm motility	0.31	> 0.20	TSSK6 (4.6)	PMFBP1 (4.2)	ABCG8 (2.4)	ABCG5 (1.4)	GRINA (1.3)	ENSG00000254235 (1.2)	AP1M2 (1.2)	BRAP (1.1)	DHODH (1.1)	MYLIP (1.0)
MP:0000125	absent incisors	0.31	> 0.20	ENSG00000238078 (2.2)	PLCG1 (2.0)	CILP2 (1.7)	ANKRD31 (1.5)	ZNF101 (1.4)	ITGB3 (1.4)	ABO (1.4)	FRK (1.4)	CELSR2 (1.3)	AMIGO1 (1.2)
ENSG00000171885	AQP4 PPI subnetwork	0.31	> 0.20	HMGCR (7.0)	FADS1 (5.9)	LDLR (5.6)	FADS2 (5.6)	PCSK9 (3.4)	BLOC1S3 (3.3)	SYPL2 (2.8)	TXNL4B (2.6)	SORT1 (2.3)	CEACAM19 (2.2)
GO:0060347	heart trabecula formation	0.31	> 0.20	CEACAM19 (3.3)	CARM1 (2.7)	HAVCR1 (2.5)	ATXN7L2 (2.1)	GOT2P1 (1.8)	TMEM116 (1.8)	AP1M2 (1.7)	ZNF101 (1.6)	ENSG00000254235 (1.6)	TSSK6 (1.4)
GO:0022011	myelination in peripheral nervous system	0.31	> 0.20	ENSG00000226645 (3.7)	DNAH11 (2.6)	PBX4 (2.2)	ENSG00000226648 (2.1)	AMIGO1 (1.7)	ZHX3 (1.7)	COL4A3BP (1.5)	PLEC (1.4)	ANKRD31 (1.4)	GCNT4 (1.4)
GO:0032292	peripheral nervous system axon ensheathment	0.31	> 0.20	ENSG00000226645 (3.7)	DNAH11 (2.6)	PBX4 (2.2)	ENSG00000226648 (2.1)	AMIGO1 (1.7)	ZHX3 (1.7)	COL4A3BP (1.5)	PLEC (1.4)	ANKRD31 (1.4)	GCNT4 (1.4)
ENSG00000104221	BRF2 PPI subnetwork	0.31	> 0.20	TOMM40 (3.4)	ATP13A1 (3.4)	ZNF259 (3.1)	POC5 (3.0)	DDX56 (2.9)	DHX38 (2.9)	NAA25 (2.7)	PSMA5 (2.3)	SARS (2.2)	ATXN2 (2.1)
ENSG00000100299	ARSA PPI subnetwork	0.31	> 0.20	C11orf9 (4.0)	HAVCR1 (3.1)	APOA5 (2.6)	ABCG5 (2.2)	APOC1 (2.0)	FRK (2.0)	FEN1 (1.8)	TMEM50A (1.7)	APOC4 (1.6)	HAPLN4 (1.6)
ENSG00000118689	FOXO3 PPI subnetwork	0.31	> 0.20	PLEC (2.7)	UBXN2B (2.6)	OGDH (2.3)	C11orf9 (2.3)	SLC44A2 (2.2)	DNM2 (2.1)	AP1M2 (2.0)	GMIP (1.9)	ATXN7L2 (1.9)	ZHX3 (1.7)
MP:0002855	abnormal cochlear ganglion morphology	0.31	> 0.20	TM6SF2 (2.8)	HNF1A (2.7)	KIAA1324 (2.5)	MAU2 (2.1)	TRAPPC6A (2.0)	AP1M2 (2.0)	CYP7A1 (1.9)	LPAR2 (1.9)	BCAM (1.8)	PCSK9 (1.8)
MP:0008236	decreased susceptibility to neuronal excitotoxicity	0.31	> 0.20	TRIB1 (3.6)	OASL (3.2)	PVR (2.8)	ANGPTL3 (2.5)	PARP10 (2.4)	AMIGO1 (2.1)	BCL3 (1.9)	GRINA (1.7)	PPP1R37 (1.7)	APOC4 (1.7)
MP:0002679	abnormal corpus luteum morphology	0.31	> 0.20	APOC1 (3.0)	NYNRIN (2.9)	MOSC1 (2.6)	KIAA1324 (2.1)	MYLIP (2.0)	ALDH2 (1.9)	BCAM (1.8)	AP1M2 (1.8)	PLEKHH2 (1.7)	APOE (1.7)
ENSG00000065150	IPO5 PPI subnetwork	0.31	> 0.20	PSMA5 (2.6)	BUD13 (2.5)	NAA25 (2.5)	TOMM40 (2.4)	GMPR (2.4)	C19orf52 (1.9)	GATAD2A (1.8)	ZNF259 (1.7)	CLPTM1 (1.7)	NT5DC1 (1.6)
GO:0060055	angiogenesis involved in wound healing	0.31	> 0.20	ST3GAL4 (3.2)	ENSG00000254235 (2.9)	PPP1R37 (2.4)	NKPD1 (2.3)	ENSG00000238078 (2.3)	PVR (2.2)	CEACAM19 (2.2)	ENSG00000226648 (2.1)	FRK (2.1)	TMEM116 (1.7)
ENSG00000104164	PLDN PPI subnetwork	0.31	> 0.20	COL4A3BP (2.9)	ENSG00000226645 (2.8)	GMPR (2.5)	TXNL4B (2.4)	TRAPPC6A (2.3)	C12orf43 (2.3)	POC5 (2.3)	CYB561D1 (2.0)	C17orf57 (1.8)	BRAP (1.6)
ENSG00000147274	RBMX PPI subnetwork	0.31	> 0.20	ILF3 (4.0)	C1orf63 (3.3)	SMARCA4 (2.9)	SUGP1 (2.8)	TOP1 (2.8)	DHX38 (2.5)	USP1 (2.4)	QTRT1 (2.4)	BUD13 (2.3)	FEN1 (2.0)
MP:0001259	abnormal body weight	0.31	> 0.20	ANGPTL3 (2.6)	GPAM (2.5)	TRIB1 (2.3)	MOSC1 (2.0)	ZHX3 (1.7)	PVR (1.6)	GCNT4 (1.6)	LPIN3 (1.6)	PCSK9 (1.5)	POC5 (1.5)
GO:0051010	microtubule plus-end binding	0.31	> 0.20	USP24 (2.8)	PTPN11 (2.7)	C12orf51 (2.7)	NCAN (2.6)	PSRC1 (2.5)	POLK (2.3)	ACAD10 (1.9)	POC5 (1.8)	CEACAM19 (1.8)	ATXN2 (1.6)
MP:0002774	small prostate gland	0.31	> 0.20	LPIN3 (2.2)	TRIB1 (2.2)	ST3GAL4 (2.2)	ATXN7L2 (1.9)	ENSG00000254235 (1.9)	LPA (1.8)	CYP7A1 (1.6)	DNAH11 (1.5)	DHODH (1.5)	COL4A3BP (1.5)
ENSG00000100345	MYH9 PPI subnetwork	0.31	> 0.20	KANK2 (3.3)	PLEC (3.1)	OGDH (2.7)	ITGB3 (2.4)	AP1M2 (2.3)	SLC44A2 (2.0)	TMEM50A (2.0)	ILF3 (1.6)	POLK (1.4)	GMIP (1.3)
KEGG_BLADDER_CANCER	KEGG_BLADDER_CANCER	0.31	> 0.20	GRINA (2.5)	ENSG00000228044 (2.2)	CBLC (2.1)	ATXN7L2 (1.9)	PVR (1.6)	DNM2 (1.4)	SARS (1.4)	MAPKAPK5 (1.4)	CARM1 (1.3)	CELSR2 (1.3)
MP:0002463	abnormal neutrophil physiology	0.31	> 0.20	HP (5.3)	GMIP (3.1)	HLX (2.7)	BCL3 (2.4)	MAFB (2.0)	CEACAM19 (1.3)	DNM2 (1.3)	ITGB3 (1.2)	TIMD4 (1.2)	TRIB1 (1.1)
ENSG00000016402	IL20RA PPI subnetwork	0.31	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	CYP7A1 (1.5)	C17orf57 (1.5)	PVR (1.5)	ZNF101 (1.4)	HLX (1.4)	RELB (1.4)	SLC22A1 (1.3)	BCAM (1.2)
ENSG00000111530	CAND1 PPI subnetwork	0.31	> 0.20	NAA25 (2.6)	GRINA (2.5)	ITGB3 (2.1)	ATXN2 (2.0)	OASL (1.8)	PARP10 (1.8)	GATAD2A (1.7)	PVRL2 (1.7)	C12orf47 (1.7)	CLPTM1 (1.6)
GO:0030168	platelet activation	0.31	> 0.20	ITGB3 (8.4)	CETP (2.9)	GMPR (2.3)	TIMD4 (1.9)	SORT1 (1.6)	PTPN11 (1.6)	APOE (1.5)	SH2B3 (1.4)	TMEM50A (1.3)	ZNF101 (1.3)
ENSG00000178921	PFAS PPI subnetwork	0.31	> 0.20	ZNF101 (2.2)	FRK (2.2)	ZNF180 (2.1)	HAPLN4 (2.1)	ATP13A1 (2.0)	GPAM (2.0)	TRIB1 (2.0)	RELB (1.7)	HNF1A (1.7)	MAU2 (1.6)
ENSG00000122691	TWIST1 PPI subnetwork	0.31	> 0.20	HLX (2.9)	TSSK6 (2.0)	RELB (2.0)	TMED4 (2.0)	CARM1 (2.0)	BCL3 (1.9)	MYLIP (1.8)	C11orf9 (1.7)	MAFB (1.7)	LDLR (1.6)
MP:0001732	postnatal growth retardation	0.31	> 0.20	LDLR (2.2)	TRIB1 (2.1)	PLEC (1.8)	CELSR2 (1.8)	CLPTM1 (1.7)	CARM1 (1.6)	KANK2 (1.5)	NYNRIN (1.4)	BCL3 (1.4)	ATXN2 (1.3)
ENSG00000142677	IL22RA1 PPI subnetwork	0.31	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.5)	PVR (1.5)	RELB (1.4)	ZNF101 (1.4)	SLC22A1 (1.4)	OASL (1.4)	HLX (1.3)
ENSG00000123612	ACVR1C PPI subnetwork	0.31	> 0.20	SH2B3 (4.2)	PVR (3.2)	KANK2 (2.9)	SLC44A2 (2.6)	BRAP (2.3)	POLK (2.2)	GEMIN7 (2.2)	PTPN11 (2.0)	MYLIP (2.0)	MARK4 (1.9)
ENSG00000111300	NAA25 PPI subnetwork	0.31	> 0.20	MAPKAPK5 (3.0)	ATP13A1 (2.3)	LPA (2.2)	FRK (1.9)	HNF1A (1.8)	TOMM40 (1.8)	BRAP (1.7)	DHODH (1.7)	USP24 (1.6)	ADAM1 (1.6)
GO:0016447	somatic recombination of immunoglobulin gene segments	0.31	> 0.20	NT5DC1 (2.3)	ZNF101 (2.1)	GCNT4 (2.0)	C17orf57 (2.0)	DYNC2LI1 (1.7)	GOT2P1 (1.5)	POC5 (1.5)	ENSG00000226648 (1.4)	UBXN2B (1.4)	ZNF180 (1.3)
GO:0042108	positive regulation of cytokine biosynthetic process	0.31	> 0.20	TIMD4 (2.1)	HLX (1.6)	CYB561D1 (1.6)	ENSG00000226645 (1.6)	GMIP (1.5)	RELB (1.5)	ENSG00000228044 (1.3)	BCL3 (1.2)	TM6SF2 (1.2)	TRAFD1 (1.1)
ENSG00000197555	SIPA1L1 PPI subnetwork	0.31	> 0.20	CBLC (6.4)	AP1M2 (4.4)	ST3GAL4 (2.5)	CELSR2 (2.3)	LPAR2 (2.1)	LPIN3 (1.8)	PPP1R37 (1.6)	HNF1A (1.6)	PLEC (1.5)	DNM2 (1.4)
REACTOME_DNA_REPLICATION	REACTOME_DNA_REPLICATION	0.31	> 0.20	FEN1 (5.8)	USP1 (4.5)	PSRC1 (4.2)	POC5 (2.5)	PSMA5 (2.2)	ZNF180 (1.6)	ENSG00000228044 (0.9)	ENSG00000226648 (0.9)	LPIN3 (0.8)	BUD13 (0.8)
MP:0002907	abnormal parturition	0.31	> 0.20	ATXN7L2 (2.6)	CYB561D1 (2.2)	MYLIP (1.8)	ABCG8 (1.6)	BLOC1S3 (1.6)	GMPR (1.6)	DNM2 (1.5)	GEMIN7 (1.5)	DNAH11 (1.5)	FADS1 (1.5)
MP:0001807	decreased IgA level	0.31	> 0.20	RELB (6.1)	BCL3 (4.1)	GMIP (2.5)	GRINA (2.3)	TIMD4 (2.2)	ZNF101 (2.2)	CETP (2.0)	TRAFD1 (1.8)	PBX4 (1.8)	ENSG00000235545 (1.6)
REACTOME_SIGNALING_BY_EGFR	REACTOME_SIGNALING_BY_EGFR	0.31	> 0.20	CLPTM1 (3.2)	MARK4 (3.1)	ZHX3 (3.1)	SH2B3 (3.0)	DNM2 (3.0)	PLEC (2.7)	SMARCA4 (2.2)	CARM1 (2.1)	MAU2 (2.0)	C12orf51 (2.0)
ENSG00000105639	JAK3 PPI subnetwork	0.31	> 0.20	BCL3 (4.5)	PARP10 (4.1)	GMIP (3.5)	RELB (2.8)	HLX (2.4)	PBX4 (2.0)	TRAFD1 (2.0)	TRIB1 (1.9)	ZNF101 (1.9)	PLEKHH2 (1.8)
GO:0001773	myeloid dendritic cell activation	0.31	> 0.20	ZNF101 (4.6)	ZNF180 (2.2)	PBX4 (2.1)	GEMIN7 (1.9)	SH2B3 (1.8)	CYB561D1 (1.7)	ENSG00000238078 (1.5)	C12orf47 (1.4)	C17orf57 (1.3)	ANKRD31 (1.2)
ENSG00000175445	LPL PPI subnetwork	0.31	> 0.20	TIMD4 (4.4)	CILP2 (2.3)	BCAM (2.3)	TMEM116 (2.1)	KIAA1324 (2.0)	CLPTM1 (1.9)	MOSC1 (1.8)	ERP29 (1.8)	PPP1R37 (1.8)	DNAH11 (1.7)
GO:0033157	regulation of intracellular protein transport	0.31	> 0.20	ZNF101 (2.8)	ENSG00000238078 (2.6)	OASL (2.0)	ENSG00000254235 (1.8)	MYLIP (1.6)	TMEM116 (1.5)	LPAR2 (1.5)	GRINA (1.4)	SH2B3 (1.3)	ABO (1.3)
ENSG00000137699	TRIM29 PPI subnetwork	0.31	> 0.20	C19orf52 (1.9)	NYNRIN (1.8)	POC5 (1.8)	DNM2 (1.7)	BLOC1S3 (1.7)	TMED4 (1.7)	SH2B3 (1.6)	PPP1R37 (1.6)	ENSG00000226648 (1.5)	PSRC1 (1.5)
GO:0008013	beta-catenin binding	0.31	> 0.20	PLCG1 (3.0)	PVRL2 (2.8)	MARK4 (2.7)	C11orf9 (2.7)	KANK2 (2.1)	BCAM (2.1)	TRIB1 (2.1)	AP1M2 (2.1)	CELSR2 (2.1)	PLEC (2.0)
ENSG00000126581	BECN1 PPI subnetwork	0.31	> 0.20	POC5 (2.9)	RHCE (2.5)	RHD (2.5)	ITGB3 (2.4)	ERP29 (1.9)	GMPR (1.7)	NT5DC1 (1.6)	COL4A3BP (1.5)	SH2B3 (1.5)	TSSK6 (1.4)
ENSG00000143384	MCL1 PPI subnetwork	0.31	> 0.20	TRAPPC6A (2.9)	TRIB1 (2.9)	CBLC (2.2)	GEMIN7 (2.0)	SH2B3 (2.0)	RELB (2.0)	TMEM50A (1.8)	LPIN3 (1.6)	FEN1 (1.3)	BCL3 (1.3)
MP:0003054	spina bifida	0.31	> 0.20	NYNRIN (2.4)	KANK2 (2.0)	SLC44A2 (2.0)	LPAR2 (2.0)	DOCK7 (1.9)	PLCG1 (1.9)	ENSG00000254235 (1.8)	GMPR (1.7)	MYLIP (1.6)	ST3GAL4 (1.5)
ENSG00000185420	SMYD3 PPI subnetwork	0.31	> 0.20	NYNRIN (4.5)	C12orf47 (2.7)	ATXN2 (2.7)	UBXN2B (2.3)	PPP1R37 (1.8)	C17orf57 (1.7)	OGDH (1.7)	TOP1 (1.7)	GRINA (1.6)	PLEC (1.5)
GO:0006359	regulation of transcription from RNA polymerase III promoter	0.31	> 0.20	BRAP (2.6)	AMIGO1 (2.4)	ADAM1 (2.0)	COL4A3BP (1.9)	CYP7A1 (1.7)	ABCG8 (1.5)	CEACAM19 (1.4)	ATXN7L2 (1.3)	HNF1A (1.3)	C12orf47 (1.3)
GO:0055093	response to hyperoxia	0.31	> 0.20	C17orf57 (3.2)	TMEM116 (3.1)	LPIN3 (3.0)	ENSG00000228044 (2.6)	ANKRD31 (2.3)	GOT2P1 (2.2)	C11orf9 (1.5)	CEACAM19 (1.4)	FRK (1.3)	BLOC1S3 (1.2)
GO:0009451	RNA modification	0.31	> 0.20	DHODH (3.8)	QTRT1 (3.6)	ZNF259 (3.2)	NAA25 (3.1)	C12orf43 (2.6)	TXNL4B (2.5)	DDX56 (2.4)	TOMM40 (2.1)	MAPKAPK5 (2.1)	GOT2P1 (2.0)
GO:0031570	DNA integrity checkpoint	0.31	> 0.20	PSMA5 (2.6)	NT5DC1 (2.4)	ZNF180 (2.1)	POLK (2.0)	SUGP1 (1.8)	NAA25 (1.7)	TRAFD1 (1.7)	C12orf47 (1.6)	BRAP (1.6)	PSRC1 (1.6)
MP:0000825	dilated lateral ventricles	0.31	> 0.20	NYNRIN (2.4)	C12orf51 (2.3)	MARK4 (2.3)	GRINA (2.3)	ATP13A1 (2.2)	DYNC2LI1 (2.2)	CELSR2 (2.1)	HMGCR (1.9)	PCSK9 (1.9)	ATXN7L2 (1.9)
ENSG00000163207	IVL PPI subnetwork	0.31	> 0.20	NKPD1 (3.7)	PMFBP1 (2.3)	LPIN3 (1.9)	UBXN2B (1.7)	BRAP (1.6)	DHX38 (1.4)	CBLC (1.4)	PVRL2 (1.2)	TOMM40 (1.2)	COL4A3BP (1.2)
ENSG00000099875	MKNK2 PPI subnetwork	0.31	> 0.20	ALDH2 (2.2)	PLEC (2.2)	USP24 (2.1)	ENSG00000226648 (1.9)	POLK (1.8)	NKPD1 (1.8)	PARP10 (1.8)	MARK4 (1.8)	DNM2 (1.7)	TMEM50A (1.7)
GO:0044437	vacuolar part	0.31	> 0.20	GRINA (4.2)	CLPTM1 (3.4)	ERP29 (3.3)	ATP13A1 (3.3)	TMEM50A (3.0)	SORT1 (2.9)	YIPF2 (2.1)	APOE (2.1)	COL4A3BP (1.8)	TMED4 (1.8)
ENSG00000169372	CRADD PPI subnetwork	0.31	> 0.20	HMGCR (3.6)	FADS2 (2.6)	ZNF180 (2.4)	ST3GAL4 (2.3)	PCSK9 (2.2)	LDLR (2.1)	FADS1 (2.1)	ZNF101 (2.1)	BLOC1S3 (2.0)	ANKRD31 (1.6)
ENSG00000117245	KIF17 PPI subnetwork	0.31	> 0.20	PPP1R37 (4.7)	GEMIN7 (2.8)	C11orf9 (2.4)	TSSK6 (2.3)	NKPD1 (2.0)	TXNL4B (1.9)	ZNF180 (1.9)	ENSG00000226648 (1.7)	BCAM (1.7)	CILP2 (1.7)
ENSG00000196911	KPNA5 PPI subnetwork	0.31	> 0.20	TOMM40 (4.3)	DDX56 (3.1)	NAA25 (2.9)	ILF3 (2.7)	FEN1 (2.6)	GATAD2A (2.6)	TOP1 (2.5)	DHODH (2.5)	DHX38 (2.4)	ZNF259 (2.3)
ENSG00000214869	ENSG00000214869 PPI subnetwork	0.31	> 0.20	PLEC (3.1)	ST3GAL4 (2.5)	AP1M2 (2.0)	HNF1A (1.8)	KANK2 (1.7)	NPC1L1 (1.6)	GMPR (1.5)	LDLR (1.4)	SORT1 (1.4)	BCL3 (1.3)
GO:0060713	labyrinthine layer morphogenesis	0.31	> 0.20	ENSG00000228044 (3.5)	CBLC (3.0)	CETP (2.7)	ENSG00000238078 (2.6)	ENSG00000226645 (1.9)	AMIGO1 (1.7)	ZNF101 (1.6)	TIMD4 (1.6)	HAVCR1 (1.5)	ANKRD31 (1.5)
GO:0032321	positive regulation of Rho GTPase activity	0.31	> 0.20	ENSG00000226645 (2.7)	CBLC (2.5)	PPP1R37 (2.4)	ST3GAL4 (2.2)	AP1M2 (2.1)	PLEKHH2 (2.0)	HNF1A (2.0)	LPIN3 (1.9)	BUD13 (1.7)	LPAR2 (1.6)
REACTOME_VPU_MEDIATED_DEGRADATION_OF_CD4	REACTOME_VPU_MEDIATED_DEGRADATION_OF_CD4	0.31	> 0.20	PSMA5 (6.4)	TRAFD1 (3.4)	NT5DC1 (2.4)	NAA25 (2.3)	SUGP1 (1.9)	PARP10 (1.8)	DDX56 (1.7)	TOMM40 (1.6)	SARS (1.5)	TMEM50A (1.3)
ENSG00000158042	MRPL17 PPI subnetwork	0.31	> 0.20	GEMIN7 (3.0)	MAPKAPK5 (2.9)	TOMM40 (2.8)	QTRT1 (2.6)	DHX38 (2.2)	MAU2 (2.1)	ST3GAL4 (2.0)	DDX56 (1.9)	SMARCA4 (1.9)	SUGP1 (1.8)
GO:0000502	proteasome complex	0.31	> 0.20	PSMA5 (6.0)	TRAFD1 (3.2)	NAA25 (2.7)	NT5DC1 (2.6)	TOMM40 (1.7)	SUGP1 (1.7)	DDX56 (1.6)	SARS (1.5)	DHX38 (1.4)	SMARCA4 (1.3)
MP:0002375	abnormal thymus medulla morphology	0.31	> 0.20	BCL3 (4.5)	RELB (3.6)	ZNF101 (3.4)	PLEC (2.7)	PARP10 (2.5)	PLCG1 (2.5)	GMIP (2.3)	PBX4 (2.3)	CYB561D1 (2.0)	PVR (1.8)
ENSG00000171793	CTPS PPI subnetwork	0.31	> 0.20	DDX56 (3.1)	SARS (2.9)	PSMA5 (2.7)	TOMM40 (2.5)	SUGP1 (2.3)	NAA25 (2.2)	OGDH (2.1)	ENSG00000235545 (1.7)	GPAM (1.7)	SMARCA4 (1.7)
ENSG00000198712	MT-CO2 PPI subnetwork	0.32	> 0.20	TRAPPC6A (3.9)	GOT2P1 (2.5)	HAVCR1 (2.1)	OGDH (2.1)	C12orf47 (2.1)	ACAD10 (1.9)	C19orf52 (1.8)	ZNF180 (1.6)	PVRL2 (1.5)	TOMM40 (1.4)
ENSG00000212874	ENSG00000212874 PPI subnetwork	0.32	> 0.20	TRAPPC6A (3.9)	GOT2P1 (2.5)	HAVCR1 (2.1)	OGDH (2.1)	C12orf47 (2.1)	ACAD10 (1.9)	C19orf52 (1.8)	ZNF180 (1.6)	PVRL2 (1.5)	TOMM40 (1.4)
ENSG00000148377	IDI2 PPI subnetwork	0.32	> 0.20	MAU2 (2.8)	USP24 (2.8)	PARP10 (2.7)	MARK4 (2.6)	ATXN2 (2.4)	BCL3 (2.4)	SMARCA4 (2.3)	GMIP (2.0)	DHX38 (1.9)	C12orf51 (1.8)
MP:0002745	abnormal atrioventricular valve morphology	0.32	> 0.20	MYLIP (3.2)	PVR (2.5)	SORT1 (2.5)	TMEM57 (2.3)	CEACAM19 (1.6)	ENSG00000226648 (1.6)	SYPL2 (1.6)	TRIB1 (1.6)	TM6SF2 (1.6)	HLX (1.5)
ENSG00000105011	ASF1B PPI subnetwork	0.32	> 0.20	USP1 (4.3)	FEN1 (4.2)	C19orf52 (2.1)	BUD13 (1.9)	GATAD2A (1.9)	TMEM116 (1.6)	ILF3 (1.5)	SMARCA4 (1.5)	C12orf51 (1.5)	ATXN2 (1.4)
MP:0008495	decreased IgG1 level	0.32	> 0.20	RELB (5.4)	GMIP (4.0)	BCL3 (3.3)	CETP (3.0)	TIMD4 (2.9)	SH2B3 (2.1)	PARP10 (1.8)	OASL (1.6)	MAFB (1.5)	PLCG1 (1.5)
ENSG00000169567	HINT1 PPI subnetwork	0.32	> 0.20	GOT2P1 (3.1)	ABCG8 (2.7)	C12orf51 (2.6)	HMGCR (2.6)	POC5 (2.5)	MAU2 (2.1)	ABCG5 (2.1)	BUD13 (1.9)	ERP29 (1.7)	ZNF101 (1.5)
ENSG00000186654	PRR5 PPI subnetwork	0.32	> 0.20	DHX38 (3.9)	MAU2 (2.9)	ILF3 (2.3)	SMARCA4 (2.3)	DNM2 (2.2)	MARK4 (2.1)	CARM1 (2.1)	USP24 (2.1)	TMEM50A (2.0)	ATP13A1 (1.9)
ENSG00000123496	IL13RA2 PPI subnetwork	0.32	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	PVR (1.5)	ZNF101 (1.4)	RELB (1.4)	HLX (1.4)	SLC22A1 (1.4)	BCAM (1.3)
ENSG00000103522	IL21R PPI subnetwork	0.32	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	PVR (1.5)	ZNF101 (1.4)	RELB (1.4)	HLX (1.4)	SLC22A1 (1.4)	BCAM (1.3)
ENSG00000164485	IL22RA2 PPI subnetwork	0.32	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.6)	PVR (1.5)	ZNF101 (1.4)	RELB (1.4)	HLX (1.4)	SLC22A1 (1.4)	BCAM (1.3)
GO:0034764	positive regulation of transmembrane transport	0.32	> 0.20	GCNT4 (2.6)	AP1M2 (2.4)	OASL (2.4)	TMEM116 (2.2)	FRK (2.1)	ENSG00000238078 (2.0)	ENSG00000235545 (2.0)	PLEKHH2 (1.9)	MYLIP (1.8)	ENSG00000228044 (1.7)
MP:0000172	abnormal bone marrow cell number	0.32	> 0.20	RHCE (6.4)	RHD (5.3)	KIAA1324 (2.1)	GRINA (1.7)	BCAM (1.6)	ENSG00000226645 (1.5)	ABO (1.4)	NYNRIN (1.4)	YIPF2 (1.3)	GMPR (1.3)
GO:0050840	extracellular matrix binding	0.32	> 0.20	BCAM (4.3)	CILP2 (3.5)	PVRL2 (3.0)	APOE (2.2)	ITGB3 (2.2)	KANK2 (2.1)	SLC44A2 (2.0)	PBX4 (1.9)	ST3GAL4 (1.9)	MAFB (1.8)
GO:0042446	hormone biosynthetic process	0.32	> 0.20	ST3GAL4 (3.2)	GOT2P1 (2.6)	ABO (2.2)	PMFBP1 (1.8)	BLOC1S3 (1.7)	CYB561D1 (1.7)	CYP7A1 (1.7)	LPIN3 (1.7)	ATXN7L2 (1.7)	FADS2 (1.7)
ENSG00000170027	YWHAG PPI subnetwork	0.32	> 0.20	TOP1 (3.3)	SMARCA4 (3.3)	PLEC (2.9)	C1orf63 (2.8)	C12orf51 (2.6)	ATXN2 (2.2)	PTPN11 (2.1)	ILF3 (1.9)	DNM2 (1.9)	DOCK7 (1.9)
MP:0010380	inner cell mass apoptosis	0.32	> 0.20	USP1 (2.9)	UBXN2B (2.7)	HAVCR1 (2.7)	POC5 (1.7)	CETP (1.6)	DDX56 (1.6)	TOP1 (1.5)	PSRC1 (1.4)	TOMM40 (1.4)	AMIGO1 (1.3)
GO:0010243	response to organic nitrogen	0.32	> 0.20	C17orf57 (3.4)	C12orf51 (2.2)	ABCG5 (1.7)	ENSG00000235545 (1.5)	DNAH11 (1.4)	ABCG8 (1.4)	NPC1L1 (1.3)	TSSK6 (1.3)	GMPR (1.3)	AP1M2 (1.3)
ENSG00000071626	DAZAP1 PPI subnetwork	0.32	> 0.20	HAVCR1 (2.1)	DYNC2LI1 (2.0)	GATAD2A (1.9)	SUGP1 (1.8)	RPH3A (1.8)	NT5DC1 (1.7)	HAPLN4 (1.7)	CEACAM19 (1.7)	AP1M2 (1.6)	TRAFD1 (1.4)
ENSG00000196591	HDAC2 PPI subnetwork	0.32	> 0.20	SMARCA4 (3.9)	ILF3 (2.8)	USP1 (2.8)	DNM2 (2.7)	BUD13 (2.7)	CARM1 (2.7)	DHX38 (2.5)	BRAP (2.5)	MAU2 (2.4)	PLCG1 (2.4)
REACTOME_S_PHASE	REACTOME_S_PHASE	0.32	> 0.20	FEN1 (5.3)	PSMA5 (4.0)	USP1 (3.9)	NT5DC1 (1.9)	TOMM40 (1.8)	TRAFD1 (1.5)	ENSG00000235545 (1.4)	DDX56 (1.3)	ZNF180 (1.2)	NAA25 (1.2)
ENSG00000118058	MLL PPI subnetwork	0.32	> 0.20	BUD13 (3.5)	C12orf43 (3.0)	ATXN7L2 (2.7)	ATXN2 (2.4)	POC5 (2.0)	ILF3 (1.9)	UBXN2B (1.8)	ZNF259 (1.7)	C12orf47 (1.7)	GOT2P1 (1.7)
GO:0006349	regulation of gene expression by genetic imprinting	0.32	> 0.20	ZNF180 (2.9)	GOT2P1 (2.9)	TXNL4B (2.6)	NYNRIN (2.5)	DHODH (2.3)	ATXN7L2 (2.3)	COL4A3BP (2.2)	LPAR2 (1.7)	ENSG00000254235 (1.4)	HAVCR1 (1.4)
ENSG00000117360	PRPF3 PPI subnetwork	0.32	> 0.20	DHX38 (4.5)	SUGP1 (3.4)	MAU2 (3.2)	BUD13 (3.1)	ATP13A1 (3.1)	ILF3 (3.1)	SMARCA4 (3.0)	DDX56 (2.4)	C12orf43 (2.4)	FEN1 (2.3)
GO:0016045	detection of bacterium	0.32	> 0.20	CEACAM19 (4.3)	C17orf57 (2.5)	PMFBP1 (2.1)	GOT2P1 (1.8)	SORT1 (1.7)	DNAH11 (1.7)	LPAR2 (1.5)	BLOC1S3 (1.3)	HP (1.2)	NKPD1 (1.2)
ENSG00000101349	PAK7 PPI subnetwork	0.32	> 0.20	PTPN11 (2.2)	DNM2 (2.0)	RHCE (2.0)	CLPTM1 (2.0)	ATXN2 (2.0)	SYPL2 (1.8)	MARK4 (1.7)	TXNL4B (1.6)	GEMIN7 (1.5)	HLX (1.5)
MP:0003920	abnormal heart right ventricle morphology	0.32	> 0.20	C11orf9 (3.6)	HLX (2.2)	C17orf57 (1.9)	MOSC1 (1.7)	ANKRD31 (1.6)	NYNRIN (1.5)	TRAFD1 (1.5)	C12orf43 (1.4)	NCAN (1.4)	SYPL2 (1.4)
GO:0032438	melanosome organization	0.32	> 0.20	ZNF101 (2.4)	NKPD1 (2.3)	BLOC1S3 (2.1)	ZNF180 (2.1)	GMPR (1.9)	ST3GAL4 (1.8)	C19orf52 (1.8)	C11orf9 (1.8)	PMFBP1 (1.7)	PPP1R37 (1.6)
GO:0031669	cellular response to nutrient levels	0.32	> 0.20	BLOC1S3 (3.6)	BRAP (2.6)	TXNL4B (2.4)	LPIN3 (2.2)	AP1M2 (2.0)	MAPKAPK5 (1.7)	HNF1A (1.6)	POLK (1.4)	FADS2 (1.4)	TRAPPC6A (1.3)
GO:0045453	bone resorption	0.32	> 0.20	ENSG00000226645 (3.0)	ENSG00000235545 (2.2)	ENSG00000226648 (1.8)	TMEM116 (1.7)	ENSG00000254235 (1.6)	POLK (1.4)	RHCE (1.4)	ITGB3 (1.4)	FRK (1.3)	CETP (1.3)
REACTOME_INFLUENZA_INFECTION	REACTOME_INFLUENZA_INFECTION	0.32	> 0.20	ILF3 (2.8)	DOCK7 (2.0)	NAA25 (1.9)	MOSC1 (1.9)	NKPD1 (1.8)	DDX56 (1.7)	GATAD2A (1.6)	USP1 (1.5)	DHX38 (1.4)	ANKRD31 (1.4)
GO:0001776	leukocyte homeostasis	0.32	> 0.20	GEMIN7 (2.2)	ENSG00000226645 (2.1)	SH2B3 (2.0)	TRAPPC6A (1.8)	GCNT4 (1.8)	GMIP (1.6)	CYB561D1 (1.6)	PBX4 (1.5)	POLK (1.4)	FRK (1.4)
MP:0009790	decreased susceptibility to viral infection induced morbidity/mortality	0.32	> 0.20	OASL (4.3)	RELB (3.1)	TRAFD1 (3.0)	PARP10 (2.5)	BCL3 (2.2)	GMIP (2.0)	FRK (1.8)	POLK (1.8)	C12orf43 (1.6)	NAA25 (1.6)
GO:0022411	cellular component disassembly	0.32	> 0.20	ENSG00000226645 (2.4)	UBXN2B (2.1)	C1orf63 (2.0)	CBLC (1.8)	SLC44A2 (1.8)	ABO (1.8)	TSSK6 (1.7)	GATAD2A (1.6)	ENSG00000238078 (1.5)	TMEM50A (1.4)
GO:0033119	negative regulation of RNA splicing	0.32	> 0.20	ADAM1 (3.6)	C1orf63 (3.5)	ATXN2 (3.0)	C12orf43 (2.8)	C17orf57 (2.7)	MAPKAPK5 (2.7)	BRAP (2.6)	MAU2 (1.9)	PPP1R37 (1.8)	ENSG00000226648 (1.8)
ENSG00000185615	PDIA2 PPI subnetwork	0.32	> 0.20	ZHX3 (4.0)	COL4A3BP (2.4)	DNM2 (2.4)	MAFB (2.3)	OGDH (2.2)	PMFBP1 (2.1)	POC5 (2.0)	C12orf47 (1.8)	MOSC1 (1.7)	ABO (1.6)
GO:0045335	phagocytic vesicle	0.32	> 0.20	MAFB (2.0)	HLX (1.9)	ENSG00000238078 (1.8)	OASL (1.7)	PMFBP1 (1.6)	APOE (1.5)	HAPLN4 (1.5)	GMIP (1.5)	PARP10 (1.5)	UBXN2B (1.4)
ENSG00000091181	IL5RA PPI subnetwork	0.32	> 0.20	BCL3 (3.2)	COL4A3BP (2.2)	RELB (1.6)	CYP7A1 (1.6)	HLX (1.4)	C17orf57 (1.4)	ZNF101 (1.4)	SLC22A1 (1.3)	BCAM (1.2)	TRAFD1 (1.2)
ENSG00000065978	YBX1 PPI subnetwork	0.32	> 0.20	ILF3 (3.9)	C1orf63 (3.5)	TOP1 (3.0)	SMARCA4 (2.9)	USP1 (2.6)	DHX38 (2.6)	PTPN11 (2.5)	QTRT1 (2.4)	GATAD2A (2.3)	BUD13 (2.2)
ENSG00000105141	CASP14 PPI subnetwork	0.32	> 0.20	FRK (2.9)	UBXN2B (2.4)	MARK4 (2.2)	LPAR2 (2.1)	ENSG00000228044 (2.1)	ST3GAL4 (2.1)	BCL3 (2.1)	NYNRIN (2.0)	CYB561D1 (1.8)	BLOC1S3 (1.6)
ENSG00000164506	STXBP5 PPI subnetwork	0.32	> 0.20	HAVCR1 (2.7)	ENSG00000228044 (2.5)	LDLR (2.3)	C12orf51 (2.0)	CETP (1.9)	PVR (1.7)	FADS2 (1.7)	RPH3A (1.7)	PSMA5 (1.7)	PVRL2 (1.7)
MP:0000079	abnormal basioccipital bone morphology	0.32	> 0.20	CILP2 (3.1)	PLEC (2.2)	ENSG00000254235 (2.1)	MAFB (2.1)	NYNRIN (1.6)	LPIN3 (1.5)	CEACAM19 (1.2)	ACAD10 (1.2)	PLEKHH2 (1.1)	RHCE (1.0)
GO:0000049	tRNA binding	0.32	> 0.20	SARS (6.9)	ZNF259 (3.9)	DHODH (3.7)	DDX56 (3.3)	QTRT1 (3.2)	POC5 (2.7)	TXNL4B (2.6)	C12orf43 (2.5)	TOMM40 (2.4)	NAA25 (2.4)
MP:0009409	abnormal skeletal muscle fiber type ratio	0.32	> 0.20	SYPL2 (6.8)	MOSC1 (2.8)	BCAM (2.2)	GMPR (1.9)	HNF1A (1.8)	GPAM (1.4)	GOT2P1 (1.4)	TMEM50A (1.3)	CELSR2 (1.2)	ST3GAL4 (1.1)
GO:0060349	bone morphogenesis	0.32	> 0.20	CILP2 (6.3)	PLEKHH2 (2.7)	YIPF2 (2.4)	NYNRIN (2.3)	MYLIP (1.7)	ATXN2 (1.5)	MAFB (1.4)	ALDH2 (1.3)	PCSK9 (1.3)	PMFBP1 (1.2)
GO:0030159	receptor signaling complex scaffold activity	0.32	> 0.20	PLCG1 (3.9)	CBLC (2.4)	ZNF180 (2.2)	MARK4 (2.1)	C17orf57 (1.9)	AMIGO1 (1.8)	KIAA1324 (1.7)	LPAR2 (1.7)	ZNF101 (1.6)	POLK (1.5)
ENSG00000099964	ENSG00000099964 PPI subnetwork	0.32	> 0.20	GEMIN7 (2.4)	PVRL2 (2.2)	RELB (2.2)	NYNRIN (2.1)	ABO (2.0)	SH2B3 (2.0)	GRINA (1.9)	ZNF101 (1.7)	TRAPPC6A (1.7)	C12orf43 (1.6)
ENSG00000131323	TRAF3 PPI subnetwork	0.32	> 0.20	RELB (5.2)	BCL3 (3.8)	PBX4 (3.6)	LPAR2 (2.6)	PVR (2.6)	ZNF180 (2.2)	TRAFD1 (2.0)	BLOC1S3 (1.7)	PVRL2 (1.5)	GMIP (1.5)
ENSG00000186660	ZFP91 PPI subnetwork	0.32	> 0.20	CETP (3.3)	BCL3 (3.3)	RELB (3.1)	HLX (3.1)	TIMD4 (2.9)	ALDH2 (2.1)	PARP10 (1.7)	GMIP (1.7)	PVRL2 (1.6)	PLEKHH2 (1.6)
ENSG00000003756	RBM5 PPI subnetwork	0.32	> 0.20	ILF3 (4.1)	C1orf63 (3.5)	TOP1 (3.0)	USP1 (2.9)	DHX38 (2.6)	BUD13 (2.6)	SMARCA4 (2.6)	FEN1 (2.3)	SUGP1 (2.2)	PTPN11 (2.0)
REACTOME_CROSS:PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	REACTOME_CROSS:PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	0.32	> 0.20	PSMA5 (6.3)	TRAFD1 (3.9)	NAA25 (2.5)	NT5DC1 (2.4)	PARP10 (1.9)	TOMM40 (1.8)	SUGP1 (1.7)	DDX56 (1.6)	TMEM50A (1.4)	SARS (1.3)
GO:0008214	protein dealkylation	0.32	> 0.20	TMEM57 (3.2)	BLOC1S3 (2.9)	ATXN7L2 (2.8)	C12orf51 (2.2)	ENSG00000254235 (2.1)	TOP1 (1.9)	GCNT4 (1.9)	LPA (1.6)	CYB561D1 (1.6)	LPAR2 (1.6)
GO:0006482	protein demethylation	0.32	> 0.20	TMEM57 (3.2)	BLOC1S3 (2.9)	ATXN7L2 (2.8)	C12orf51 (2.2)	ENSG00000254235 (2.1)	TOP1 (1.9)	GCNT4 (1.9)	LPA (1.6)	CYB561D1 (1.6)	LPAR2 (1.6)
REACTOME_REGULATION_OF_ACTIVATED_PAK:2P34_BY_PROTEASOME_MEDIATED_DEGRADATION	REACTOME_REGULATION_OF_ACTIVATED_PAK:2P34_BY_PROTEASOME_MEDIATED_DEGRADATION	0.32	> 0.20	PSMA5 (6.4)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.5)	SUGP1 (1.8)	PARP10 (1.8)	DDX56 (1.7)	TOMM40 (1.6)	SARS (1.4)	ZNF259 (1.1)
ENSG00000108829	LRRC59 PPI subnetwork	0.32	> 0.20	ERP29 (3.2)	C12orf43 (2.7)	NT5DC1 (2.6)	ITGB3 (2.6)	ENSG00000226648 (2.4)	SH2B3 (2.2)	FADS1 (1.6)	PVRL2 (1.5)	BRAP (1.5)	ST3GAL4 (1.5)
GO:0001569	patterning of blood vessels	0.32	> 0.20	ABO (2.3)	TSSK6 (1.8)	ENSG00000254235 (1.8)	MYLIP (1.7)	NKPD1 (1.6)	HNF1A (1.6)	CEACAM19 (1.6)	HLX (1.6)	NYNRIN (1.5)	CYB561D1 (1.5)
GO:0008630	DNA damage response, signal transduction resulting in induction of apoptosis	0.32	> 0.20	C17orf57 (2.4)	BLOC1S3 (2.2)	C12orf47 (2.0)	ZNF101 (1.8)	ZNF180 (1.8)	BUD13 (1.7)	POLK (1.5)	DOCK7 (1.4)	AMIGO1 (1.3)	NYNRIN (1.2)
ENSG00000143393	PI4KB PPI subnetwork	0.32	> 0.20	CBLC (5.7)	AP1M2 (2.9)	TSSK6 (2.5)	HNF1A (2.2)	LPAR2 (2.0)	DOCK7 (1.8)	FRK (1.7)	CELSR2 (1.7)	LPIN3 (1.7)	BCAM (1.6)
GO:0035270	endocrine system development	0.32	> 0.20	ANKRD31 (2.4)	C11orf9 (2.4)	KIAA1324 (2.3)	ABO (2.1)	ATXN7L2 (1.6)	TSSK6 (1.6)	NKPD1 (1.4)	CEACAM19 (1.4)	HNF1A (1.4)	CYP7A1 (1.3)
ENSG00000079435	LIPE PPI subnetwork	0.32	> 0.20	ST3GAL4 (3.9)	GPAM (2.2)	SH2B3 (2.2)	APOC1 (2.2)	ENSG00000226645 (2.1)	SYPL2 (1.8)	CYB561D1 (1.7)	ITGB3 (1.6)	GMPR (1.5)	DYNC2LI1 (1.4)
MP:0004956	decreased thymus weight	0.32	> 0.20	CILP2 (3.8)	C17orf57 (2.3)	POLK (2.1)	UBXN2B (2.0)	ZNF101 (1.7)	FRK (1.4)	SYPL2 (1.4)	PLEC (1.3)	AP1M2 (1.2)	SLC22A1 (1.2)
GO:0031941	filamentous actin	0.32	> 0.20	PVRL2 (3.0)	TM6SF2 (2.2)	POLK (2.2)	PVR (2.1)	ENSG00000228044 (2.0)	NPC1L1 (1.9)	CBLC (1.8)	ABO (1.7)	PMFBP1 (1.4)	LPAR2 (1.4)
GO:0060090	binding, bridging	0.32	> 0.20	PLEC (2.8)	GMIP (2.2)	C11orf9 (1.7)	CBLC (1.6)	COL4A3BP (1.6)	ST3GAL4 (1.5)	LPAR2 (1.5)	ITGB3 (1.5)	APOC1 (1.4)	FRK (1.4)
GO:0019395	fatty acid oxidation	0.32	> 0.20	ACAD10 (4.6)	NT5DC1 (3.1)	MOSC1 (2.6)	OGDH (2.4)	AMIGO1 (2.1)	TMEM116 (1.9)	ALDH2 (1.8)	C19orf52 (1.8)	TRAPPC6A (1.8)	ENSG00000238078 (1.8)
GO:0002712	regulation of B cell mediated immunity	0.32	> 0.20	HAVCR1 (2.1)	ENSG00000235545 (2.0)	GEMIN7 (1.4)	DNAH11 (1.4)	GMIP (1.2)	AMIGO1 (1.2)	ENSG00000228044 (1.1)	ADAM1 (1.1)	C17orf57 (1.1)	ZNF101 (1.1)
ENSG00000121691	CAT PPI subnetwork	0.32	> 0.20	GPAM (3.3)	TMEM57 (3.2)	CYP7A1 (2.5)	ZHX3 (2.3)	NAA25 (1.8)	USP24 (1.7)	ENSG00000254235 (1.7)	PVR (1.6)	BRAP (1.6)	KANK2 (1.5)
REACTOME_MITOTIC_M:MG1_PHASES	REACTOME_MITOTIC_M:MG1_PHASES	0.32	> 0.20	FEN1 (5.4)	PSRC1 (4.1)	USP1 (4.1)	POC5 (2.7)	PSMA5 (2.6)	ZNF180 (1.4)	ENSG00000228044 (1.0)	TRAFD1 (1.0)	LPIN3 (0.8)	DDX56 (0.8)
ENSG00000095637	SORBS1 PPI subnetwork	0.32	> 0.20	PLEC (3.4)	GMIP (3.2)	DNM2 (3.1)	GRINA (2.5)	SORT1 (2.4)	PVRL2 (2.4)	OGDH (2.2)	ACAD10 (2.1)	CEACAM19 (1.9)	SH2B3 (1.7)
ENSG00000185621	LMLN PPI subnetwork	0.32	> 0.20	BRAP (2.5)	PLG (2.1)	ANGPTL3 (1.9)	GATAD2A (1.6)	TRAFD1 (1.5)	KANK2 (1.5)	SUGP1 (1.4)	SYPL2 (1.4)	MARK4 (1.4)	BLOC1S3 (1.4)
GO:0006672	ceramide metabolic process	0.32	> 0.20	NKPD1 (4.4)	COL4A3BP (3.5)	CYB561D1 (3.1)	HAVCR1 (3.0)	TMEM50A (3.0)	TMED4 (2.9)	ERP29 (2.4)	POLK (2.1)	PMFBP1 (2.1)	ATP13A1 (2.0)
GO:0007351	tripartite regional subdivision	0.32	> 0.20	CEACAM19 (2.8)	ENSG00000238078 (2.7)	ANKRD31 (2.5)	PVRL2 (2.4)	ENSG00000254235 (2.1)	ABO (1.8)	C11orf9 (1.8)	FRK (1.4)	MOSC1 (1.3)	NKPD1 (1.2)
GO:0008595	anterior/posterior axis specification, embryo	0.32	> 0.20	CEACAM19 (2.8)	ENSG00000238078 (2.7)	ANKRD31 (2.5)	PVRL2 (2.4)	ENSG00000254235 (2.1)	ABO (1.8)	C11orf9 (1.8)	FRK (1.4)	MOSC1 (1.3)	NKPD1 (1.2)
REACTOME_SIGNALING_BY_WNT	REACTOME_SIGNALING_BY_WNT	0.32	> 0.20	PSMA5 (6.4)	TRAFD1 (3.2)	NAA25 (2.4)	NT5DC1 (1.9)	SUGP1 (1.8)	DDX56 (1.7)	SARS (1.7)	PARP10 (1.6)	TOMM40 (1.5)	COL4A3BP (1.4)
REACTOME_DEGRADATION_OF_BETA:CATENIN_BY_THE_DESTRUCTION_COMPLEX	REACTOME_DEGRADATION_OF_BETA:CATENIN_BY_THE_DESTRUCTION_COMPLEX	0.32	> 0.20	PSMA5 (6.4)	TRAFD1 (3.2)	NAA25 (2.4)	NT5DC1 (1.9)	SUGP1 (1.8)	DDX56 (1.7)	SARS (1.7)	PARP10 (1.6)	TOMM40 (1.5)	COL4A3BP (1.4)
ENSG00000184557	SOCS3 PPI subnetwork	0.32	> 0.20	HLX (3.8)	BCL3 (3.7)	RELB (2.9)	TRIB1 (2.2)	TIMD4 (2.2)	GMIP (1.9)	ALDH2 (1.8)	CETP (1.8)	SLC44A2 (1.7)	LPA (1.5)
MP:0001240	abnormal epidermis stratum corneum morphology	0.32	> 0.20	NKPD1 (4.9)	CBLC (3.7)	AP1M2 (2.4)	CEACAM19 (2.4)	MAFB (2.3)	PMFBP1 (1.8)	CELSR2 (1.8)	LPIN3 (1.8)	PLEC (1.5)	C17orf57 (1.4)
GO:0044246	regulation of multicellular organismal metabolic process	0.32	> 0.20	ENSG00000226645 (2.3)	ST3GAL4 (2.2)	GEMIN7 (2.1)	ENSG00000228044 (2.0)	FRK (2.0)	ALDH2 (1.9)	NKPD1 (1.6)	BLOC1S3 (1.6)	GMPR (1.5)	ENSG00000254235 (1.5)
ENSG00000007237	GAS7 PPI subnetwork	0.32	> 0.20	ATXN2 (2.4)	GMIP (2.3)	TMEM50A (2.3)	ENSG00000235545 (2.2)	NPC1L1 (2.0)	C1orf63 (2.0)	ABCG5 (1.9)	DOCK7 (1.8)	HAVCR1 (1.8)	ABO (1.7)
ENSG00000138794	CASP6 PPI subnetwork	0.32	> 0.20	BCL3 (2.8)	FRK (2.5)	RELB (2.3)	PVRL2 (2.0)	PLEC (1.8)	GRINA (1.7)	GMIP (1.7)	UBXN2B (1.6)	ST3GAL4 (1.5)	ABO (1.5)
MP:0004783	abnormal cardinal vein morphology	0.32	> 0.20	BCAM (3.5)	CETP (3.2)	SLC44A2 (2.7)	PVRL2 (2.4)	SH2B3 (2.0)	NYNRIN (1.9)	PVR (1.8)	LPA (1.8)	MARK4 (1.6)	HLX (1.5)
ENSG00000044524	EPHA3 PPI subnetwork	0.32	> 0.20	ITGB3 (2.7)	TMEM50A (2.6)	HMGCR (2.3)	FADS1 (2.3)	ILF3 (2.0)	GCNT4 (1.7)	USP1 (1.7)	LDLR (1.7)	FADS2 (1.6)	SLC44A2 (1.6)
ENSG00000132300	PTCD3 PPI subnetwork	0.32	> 0.20	SUGP1 (3.0)	GMPR (3.0)	LPAR2 (2.8)	NT5DC1 (2.8)	TMEM116 (2.7)	PBX4 (2.3)	GATAD2A (2.1)	HAPLN4 (1.9)	GOT2P1 (1.8)	TRAPPC6A (1.7)
ENSG00000072501	SMC1A PPI subnetwork	0.32	> 0.20	ILF3 (4.4)	USP1 (4.3)	DHX38 (3.6)	FEN1 (3.3)	SMARCA4 (3.1)	TOP1 (3.1)	PTPN11 (2.7)	C1orf63 (2.4)	SUGP1 (2.4)	BUD13 (2.0)
ENSG00000068354	TBC1D25 PPI subnetwork	0.32	> 0.20	BUD13 (3.0)	GOT2P1 (2.7)	DHODH (2.2)	TXNL4B (2.1)	ZNF259 (2.1)	SUGP1 (1.8)	SLC44A2 (1.6)	APOC1 (1.6)	PLEKHH2 (1.6)	QTRT1 (1.5)
ENSG00000104897	SF3A2 PPI subnetwork	0.32	> 0.20	ILF3 (3.9)	DHX38 (3.6)	C1orf63 (3.6)	BUD13 (3.6)	TOP1 (3.5)	SUGP1 (3.5)	SMARCA4 (3.3)	USP1 (2.8)	QTRT1 (2.6)	FEN1 (2.3)
GO:0051043	regulation of membrane protein ectodomain proteolysis	0.32	> 0.20	ENSG00000235545 (3.2)	ENSG00000228044 (2.8)	ST3GAL4 (2.2)	CETP (2.0)	GEMIN7 (1.9)	ENSG00000254235 (1.7)	DYNC2LI1 (1.5)	TRAFD1 (1.4)	ENSG00000238078 (1.4)	SUGP1 (1.3)
GO:0017069	snRNA binding	0.32	> 0.20	MYLIP (3.1)	C1orf63 (2.7)	C17orf57 (2.3)	ITGB3 (2.3)	TMED4 (1.8)	PARP10 (1.8)	ZHX3 (1.6)	GCNT4 (1.4)	PLEKHH2 (1.3)	HLX (1.2)
MP:0009305	decreased retroperitoneal fat pad weight	0.32	> 0.20	MOSC1 (6.3)	GPAM (3.5)	HP (2.7)	SORT1 (2.7)	GEMIN7 (2.2)	APOA5 (2.1)	TM6SF2 (2.1)	HAPLN4 (2.0)	LPA (2.0)	C12orf47 (1.9)
GO:0019059	initiation of viral infection	0.32	> 0.20	ZNF101 (4.2)	GCNT4 (3.4)	ENSG00000254235 (2.9)	CETP (2.7)	ENSG00000228044 (2.5)	TMEM116 (2.2)	DYNC2LI1 (2.2)	LPA (2.0)	PVR (2.0)	MAPKAPK5 (1.8)
ENSG00000140022	STON2 PPI subnetwork	0.32	> 0.20	HAPLN4 (3.3)	ENSG00000235545 (2.7)	TIMD4 (2.5)	SARS (2.4)	ABO (2.1)	ATXN2 (2.1)	USP24 (1.9)	PBX4 (1.8)	CETP (1.8)	CARM1 (1.7)
ENSG00000146701	MDH2 PPI subnetwork	0.32	> 0.20	SARS (2.9)	ACAD10 (2.7)	ZNF259 (2.6)	NAA25 (2.6)	DHODH (2.5)	TRAPPC6A (2.3)	GOT2P1 (2.1)	FADS2 (2.1)	DOCK7 (2.0)	TOMM40 (1.8)
GO:0002446	neutrophil mediated immunity	0.32	> 0.20	UBXN2B (3.3)	CYB561D1 (2.6)	LPAR2 (1.9)	ENSG00000238078 (1.7)	ANKRD31 (1.7)	CEACAM19 (1.7)	GMIP (1.6)	HLX (1.6)	HP (1.5)	C19orf52 (1.5)
ENSG00000171855	IFNB1 PPI subnetwork	0.32	> 0.20	BCL3 (3.6)	HLX (2.9)	RELB (2.8)	TIMD4 (2.5)	CETP (2.2)	ALDH2 (1.9)	GMIP (1.8)	LPA (1.6)	PARP10 (1.3)	PVRL2 (1.3)
GO:0050921	positive regulation of chemotaxis	0.32	> 0.20	ZNF101 (2.6)	TIMD4 (2.3)	PVR (2.1)	TMEM116 (1.9)	CETP (1.9)	PLEKHH2 (1.8)	APOE (1.8)	ENSG00000228044 (1.8)	AP1M2 (1.6)	KIAA1324 (1.4)
MP:0002128	abnormal blood circulation	0.32	> 0.20	PVR (2.8)	PVRL2 (2.6)	TMEM116 (2.3)	NYNRIN (2.3)	ALDH2 (2.1)	ENSG00000226648 (2.0)	C11orf9 (2.0)	BCAM (2.0)	FRK (1.6)	MAFB (1.5)
REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS	0.32	> 0.20	NKPD1 (2.7)	TMEM50A (2.6)	ZHX3 (2.2)	COL4A3BP (2.2)	LDLR (2.2)	POLK (2.1)	HMGCR (2.1)	CYB561D1 (2.0)	PVR (2.0)	ABCG8 (1.9)
GO:0002467	germinal center formation	0.32	> 0.20	RELB (2.7)	ENSG00000228044 (2.4)	GMIP (1.9)	DNAH11 (1.9)	GCNT4 (1.7)	PBX4 (1.7)	GRINA (1.4)	DYNC2LI1 (1.4)	TIMD4 (1.3)	TXNL4B (1.3)
ENSG00000167553	TUBA1C PPI subnetwork	0.32	> 0.20	OGDH (3.1)	PLEC (2.2)	KANK2 (2.1)	SARS (2.0)	POLK (1.9)	SMARCA4 (1.8)	CARM1 (1.7)	NYNRIN (1.7)	C1orf63 (1.7)	ITGB3 (1.5)
ENSG00000115705	TPO PPI subnetwork	0.32	> 0.20	BCL3 (3.6)	HLX (3.2)	RELB (2.5)	TIMD4 (2.2)	ALDH2 (2.0)	CETP (2.0)	GMIP (1.7)	LPA (1.7)	TRIB1 (1.3)	ST3GAL4 (1.2)
ENSG00000138029	HADHB PPI subnetwork	0.32	> 0.20	TOMM40 (3.1)	OGDH (2.9)	ACAD10 (2.2)	POLK (1.8)	TOP1 (1.8)	PSMA5 (1.8)	CLPTM1 (1.6)	ENSG00000226648 (1.5)	GCNT4 (1.5)	PLEC (1.4)
REACTOME_METABOLISM_OF_PROTEINS	REACTOME_METABOLISM_OF_PROTEINS	0.32	> 0.20	ERP29 (4.4)	YIPF2 (4.0)	ATP13A1 (3.8)	TMED4 (2.9)	TMEM57 (2.6)	TMEM50A (2.4)	KIAA1324 (2.3)	CLPTM1 (2.1)	ST3GAL4 (1.9)	QTRT1 (1.6)
GO:0031641	regulation of myelination	0.32	> 0.20	NKPD1 (2.8)	ANKRD31 (2.7)	PBX4 (2.4)	C12orf43 (2.1)	BLOC1S3 (2.1)	TRAFD1 (1.9)	DNAH11 (1.8)	CEACAM19 (1.4)	PPP1R37 (1.4)	GOT2P1 (1.4)
ENSG00000168497	SDPR PPI subnetwork	0.32	> 0.20	NAA25 (2.3)	SARS (2.2)	SORT1 (2.2)	ST3GAL4 (2.1)	BUD13 (1.9)	ERP29 (1.8)	GATAD2A (1.8)	GRINA (1.6)	ENSG00000238078 (1.6)	HAVCR1 (1.5)
ENSG00000136068	FLNB PPI subnetwork	0.32	> 0.20	PLEC (4.1)	ITGB3 (3.0)	ZHX3 (2.6)	PLCG1 (2.6)	DNM2 (2.5)	PVR (2.5)	NPC1L1 (2.0)	SH2B3 (1.8)	POLK (1.7)	PTPN11 (1.7)
MP:0001297	microphthalmia	0.32	> 0.20	ATXN2 (1.9)	TMED4 (1.8)	DYNC2LI1 (1.8)	UBXN2B (1.8)	NYNRIN (1.7)	ABO (1.6)	PVRL2 (1.5)	PLG (1.4)	PBX4 (1.4)	TRIB1 (1.4)
GO:0033059	cellular pigmentation	0.32	> 0.20	C12orf43 (2.7)	POLK (2.0)	PPP1R37 (1.9)	DYNC2LI1 (1.8)	C19orf52 (1.7)	BLOC1S3 (1.7)	ZNF101 (1.6)	C12orf47 (1.5)	GMPR (1.5)	ENSG00000228044 (1.5)
ENSG00000110786	PTPN5 PPI subnetwork	0.32	> 0.20	PBX4 (2.7)	MOSC1 (2.5)	APOE (2.2)	NPC1L1 (2.1)	MAFB (2.0)	ENSG00000226645 (2.0)	SH2B3 (2.0)	AMIGO1 (2.0)	RPH3A (1.8)	MARK4 (1.6)
ENSG00000117266	CDK18 PPI subnetwork	0.32	> 0.20	CARM1 (3.6)	PLEC (3.4)	DNM2 (3.0)	ZHX3 (2.9)	COL4A3BP (2.4)	PTPN11 (2.4)	USP24 (2.3)	C12orf51 (2.2)	LPAR2 (2.2)	KANK2 (2.2)
MP:0004875	increased mean systemic arterial blood pressure	0.32	> 0.20	ITGB3 (2.6)	KIAA1324 (2.2)	SLC44A2 (1.9)	ZHX3 (1.7)	BCAM (1.6)	TMEM50A (1.6)	ERP29 (1.5)	C12orf47 (1.5)	ZNF180 (1.5)	GMPR (1.5)
ENSG00000119138	KLF9 PPI subnetwork	0.32	> 0.20	TMEM57 (3.0)	SMARCA4 (2.5)	MAU2 (2.5)	BUD13 (2.4)	CARM1 (2.2)	KIAA1324 (2.1)	ATXN2 (2.0)	C12orf51 (1.9)	TMEM116 (1.8)	C19orf52 (1.8)
ENSG00000146143	ENSG00000146143 PPI subnetwork	0.32	> 0.20	FEN1 (5.7)	USP1 (5.6)	ZNF180 (2.4)	ENSG00000228044 (2.2)	GOT2P1 (1.8)	TXNL4B (1.4)	FADS1 (1.4)	DHODH (1.3)	PSRC1 (1.3)	POLK (1.2)
ENSG00000129515	SNX6 PPI subnetwork	0.32	> 0.20	TMEM50A (3.0)	ABO (3.0)	DOCK7 (2.8)	AMIGO1 (2.6)	COL4A3BP (2.1)	NYNRIN (2.0)	C12orf47 (2.0)	ZHX3 (1.7)	HLX (1.6)	GCNT4 (1.5)
ENSG00000100097	LGALS1 PPI subnetwork	0.32	> 0.20	PLEC (3.2)	SLC44A2 (3.1)	APOE (2.4)	AP1M2 (2.0)	PVR (2.0)	APOC1 (1.9)	ST3GAL4 (1.9)	ITGB3 (1.5)	BCAM (1.5)	ZNF101 (1.5)
KEGG_LEISHMANIA_INFECTION	KEGG_LEISHMANIA_INFECTION	0.32	> 0.20	BCL3 (3.7)	RELB (3.3)	SH2B3 (2.5)	TRIB1 (2.5)	GMIP (2.3)	MAFB (2.0)	MYLIP (1.9)	APOE (1.8)	TRAFD1 (1.8)	GEMIN7 (1.7)
ENSG00000130332	LSM7 PPI subnetwork	0.32	> 0.20	DHX38 (2.9)	BUD13 (2.8)	SUGP1 (2.6)	FEN1 (2.6)	MAU2 (2.5)	TOP1 (2.3)	BRAP (2.3)	ILF3 (2.2)	DDX56 (1.9)	POC5 (1.9)
ENSG00000122122	SASH3 PPI subnetwork	0.32	> 0.20	YIPF2 (2.5)	TMEM57 (2.3)	ENSG00000228044 (2.2)	TM6SF2 (1.8)	DNM2 (1.7)	GRINA (1.7)	ABCG8 (1.5)	MAU2 (1.5)	CLPTM1 (1.4)	BLOC1S3 (1.4)
GO:0031647	regulation of protein stability	0.33	> 0.20	YIPF2 (2.8)	BRAP (2.5)	POLK (2.4)	MYLIP (2.2)	POC5 (1.9)	ZNF259 (1.7)	ENSG00000238078 (1.7)	ADAM1 (1.7)	MAU2 (1.6)	RHCE (1.6)
REACTOME_TRANSCRIPTION	REACTOME_TRANSCRIPTION	0.33	> 0.20	BUD13 (3.2)	SUGP1 (2.6)	TOP1 (2.4)	ZNF259 (2.2)	ENSG00000226645 (2.2)	DDX56 (2.1)	C1orf63 (2.1)	C19orf52 (2.1)	GEMIN7 (2.0)	ILF3 (2.0)
ENSG00000070367	EXOC5 PPI subnetwork	0.33	> 0.20	SARS (2.7)	COL4A3BP (2.6)	OGDH (2.3)	USP24 (2.2)	ENSG00000238078 (1.7)	GOT2P1 (1.7)	DNM2 (1.7)	PSMA5 (1.7)	ACAD10 (1.6)	FRK (1.5)
ENSG00000105887	MTPN PPI subnetwork	0.33	> 0.20	RELB (5.1)	CYB561D1 (3.0)	BCL3 (3.0)	SH2B3 (2.5)	C12orf43 (2.4)	RHD (2.1)	GEMIN7 (1.9)	MAU2 (1.9)	TMEM50A (1.8)	DNM2 (1.7)
ENSG00000186879	ENSG00000186879 PPI subnetwork	0.33	> 0.20	FRK (3.6)	PARP10 (3.0)	ZNF180 (2.4)	PTPN11 (2.4)	DOCK7 (2.1)	OASL (1.9)	TOMM40 (1.6)	PVR (1.3)	ENSG00000254235 (1.3)	C1orf63 (1.3)
GO:0005923	tight junction	0.33	> 0.20	AP1M2 (6.1)	CBLC (4.2)	FRK (3.7)	PVRL2 (3.6)	DYNC2LI1 (2.5)	BCAM (2.5)	PVR (2.1)	PLEKHH2 (2.0)	CYP7A1 (1.9)	LPAR2 (1.6)
GO:0070160	occluding junction	0.33	> 0.20	AP1M2 (6.1)	CBLC (4.2)	FRK (3.7)	PVRL2 (3.6)	DYNC2LI1 (2.5)	BCAM (2.5)	PVR (2.1)	PLEKHH2 (2.0)	CYP7A1 (1.9)	LPAR2 (1.6)
GO:0000428	DNA-directed RNA polymerase complex	0.33	> 0.20	GEMIN7 (4.8)	ZNF259 (3.5)	TOMM40 (3.4)	QTRT1 (2.3)	MAPKAPK5 (2.0)	DDX56 (1.9)	BUD13 (1.8)	PVR (1.7)	BLOC1S3 (1.6)	NAA25 (1.6)
GO:0055029	nuclear DNA-directed RNA polymerase complex	0.33	> 0.20	GEMIN7 (4.8)	ZNF259 (3.5)	TOMM40 (3.4)	QTRT1 (2.3)	MAPKAPK5 (2.0)	DDX56 (1.9)	BUD13 (1.8)	PVR (1.7)	BLOC1S3 (1.6)	NAA25 (1.6)
ENSG00000115919	KYNU PPI subnetwork	0.33	> 0.20	QTRT1 (2.7)	PMFBP1 (2.3)	TOMM40 (2.0)	C19orf52 (2.0)	ILF3 (1.9)	C12orf43 (1.9)	ENSG00000238078 (1.8)	CYP7A1 (1.5)	ST3GAL4 (1.4)	GATAD2A (1.4)
GO:0001570	vasculogenesis	0.33	> 0.20	BCAM (2.3)	NYNRIN (2.3)	ENSG00000238078 (2.3)	ATXN7L2 (2.0)	HLX (1.7)	KANK2 (1.7)	CYB561D1 (1.6)	SH2B3 (1.6)	PVRL2 (1.6)	PVR (1.4)
GO:0007350	blastoderm segmentation	0.33	> 0.20	DYNC2LI1 (2.5)	CEACAM19 (2.4)	ABO (2.3)	ANKRD31 (2.2)	ENSG00000254235 (2.2)	ENSG00000238078 (2.2)	PVRL2 (1.5)	DNAH11 (1.5)	NKPD1 (1.5)	KANK2 (1.4)
GO:0002285	lymphocyte activation involved in immune response	0.33	> 0.20	NT5DC1 (2.4)	ZNF101 (2.0)	ENSG00000235545 (1.8)	GMIP (1.7)	ANKRD31 (1.7)	BCL3 (1.3)	RELB (1.3)	CYB561D1 (1.3)	DNAH11 (1.2)	PVR (1.2)
ENSG00000109501	WFS1 PPI subnetwork	0.33	> 0.20	APOB (2.8)	TRAPPC6A (2.8)	CBLC (2.7)	AP1M2 (2.7)	DOCK7 (2.1)	APOC1 (2.0)	SORT1 (1.9)	ANKRD31 (1.8)	KIAA1324 (1.8)	APOC4 (1.6)
ENSG00000066379	ZNRD1 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.7)	C12orf43 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	DDX56 (2.5)	TOMM40 (2.3)	ADAM1 (2.2)	ANKRD31 (2.1)	GMPR (2.0)	NAA25 (1.8)
ENSG00000206429	ENSG00000206429 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.7)	C12orf43 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	DDX56 (2.5)	TOMM40 (2.3)	ADAM1 (2.2)	ANKRD31 (2.1)	GMPR (2.0)	NAA25 (1.8)
ENSG00000206502	ZNRD1 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.7)	C12orf43 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	DDX56 (2.5)	TOMM40 (2.3)	ADAM1 (2.2)	ANKRD31 (2.1)	GMPR (2.0)	NAA25 (1.8)
MP:0003049	abnormal lumbar vertebrae morphology	0.33	> 0.20	NYNRIN (3.9)	LPAR2 (1.9)	CILP2 (1.7)	CLPTM1 (1.6)	PPP1R37 (1.5)	PLCG1 (1.4)	CEACAM19 (1.4)	MARK4 (1.3)	NCAN (1.3)	PCSK9 (1.3)
ENSG00000095066	HOOK2 PPI subnetwork	0.33	> 0.20	UBXN2B (3.1)	ZNF180 (2.7)	GRINA (2.4)	MYLIP (2.3)	AP1M2 (2.3)	ZHX3 (2.2)	TMEM57 (2.2)	GMPR (2.0)	DNAH11 (1.9)	USP1 (1.8)
MP:0003149	abnormal tectorial membrane morphology	0.33	> 0.20	TMEM116 (2.9)	HNF1A (2.7)	APOC1 (2.7)	AP1M2 (2.5)	MYLIP (2.0)	PBX4 (1.9)	CETP (1.6)	ZHX3 (1.5)	SLC22A1 (1.5)	MAFB (1.5)
ENSG00000137673	MMP7 PPI subnetwork	0.33	> 0.20	ABCG5 (2.2)	APOB (2.1)	SLC22A1 (2.0)	PVR (1.9)	APOE (1.8)	ENSG00000228044 (1.8)	APOA5 (1.7)	APOC1 (1.7)	C11orf9 (1.6)	NCAN (1.6)
ENSG00000011243	AKAP8L PPI subnetwork	0.33	> 0.20	ATP13A1 (3.2)	DNM2 (2.6)	MAU2 (2.4)	C19orf52 (2.1)	SLC44A2 (2.1)	YIPF2 (2.0)	QTRT1 (1.9)	OGDH (1.8)	ILF3 (1.7)	DHODH (1.6)
ENSG00000186810	CXCR3 PPI subnetwork	0.33	> 0.20	OASL (4.4)	TRAFD1 (3.6)	TIMD4 (2.6)	RELB (2.4)	MAFB (2.3)	PARP10 (2.2)	APOE (1.9)	APOC1 (1.3)	ZNF101 (1.3)	PVR (1.2)
ENSG00000138439	FAM117B PPI subnetwork	0.33	> 0.20	CBLC (4.5)	AP1M2 (3.5)	PSRC1 (2.4)	LPIN3 (2.3)	FRK (1.9)	CELSR2 (1.9)	MARK4 (1.8)	ANKRD31 (1.7)	DOCK7 (1.7)	ST3GAL4 (1.7)
ENSG00000162552	WNT4 PPI subnetwork	0.33	> 0.20	CILP2 (3.9)	OASL (2.9)	TMEM116 (2.1)	MOSC1 (1.9)	ATP13A1 (1.8)	PLEKHH2 (1.7)	CELSR2 (1.7)	KIAA1324 (1.6)	TXNL4B (1.6)	AMIGO1 (1.5)
REACTOME_METABOLISM_OF_NITRIC_OXIDE	REACTOME_METABOLISM_OF_NITRIC_OXIDE	0.33	> 0.20	NT5DC1 (2.6)	PPP1R37 (2.6)	SH2B3 (2.0)	TOMM40 (2.0)	C1orf63 (1.9)	ST3GAL4 (1.6)	TRAPPC6A (1.5)	APOA5 (1.4)	HLX (1.3)	BCAM (1.2)
REACTOME_ENOS_ACTIVATION_AND_REGULATION	REACTOME_ENOS_ACTIVATION_AND_REGULATION	0.33	> 0.20	NT5DC1 (2.6)	PPP1R37 (2.6)	SH2B3 (2.0)	TOMM40 (2.0)	C1orf63 (1.9)	ST3GAL4 (1.6)	TRAPPC6A (1.5)	APOA5 (1.4)	HLX (1.3)	BCAM (1.2)
ENSG00000095752	IL11 PPI subnetwork	0.33	> 0.20	BCL3 (3.6)	HLX (3.2)	RELB (2.7)	TIMD4 (2.3)	CETP (2.2)	GMIP (1.9)	ALDH2 (1.9)	LPA (1.6)	PARP10 (1.2)	TRIB1 (1.1)
ENSG00000185745	IFIT1 PPI subnetwork	0.33	> 0.20	OASL (5.3)	PARP10 (3.0)	USP1 (2.3)	TOP1 (2.1)	ATP13A1 (2.0)	PSMA5 (1.9)	LPAR2 (1.9)	GCNT4 (1.8)	ENSG00000226648 (1.8)	SARS (1.7)
GO:0002697	regulation of immune effector process	0.33	> 0.20	PARP10 (2.2)	GEMIN7 (2.2)	GMIP (1.8)	TIMD4 (1.8)	SH2B3 (1.7)	OASL (1.7)	ZNF101 (1.7)	GRINA (1.6)	RELB (1.6)	C17orf57 (1.5)
GO:2001251	negative regulation of chromosome organization	0.33	> 0.20	RHCE (2.6)	TXNL4B (2.5)	BLOC1S3 (2.4)	ENSG00000235545 (2.0)	ZNF180 (1.9)	ENSG00000226648 (1.7)	MAU2 (1.6)	RHD (1.6)	GOT2P1 (1.4)	C17orf57 (1.4)
ENSG00000173011	TADA2B PPI subnetwork	0.33	> 0.20	ATXN7L2 (4.1)	BUD13 (3.6)	ATXN2 (2.5)	POC5 (2.4)	MAU2 (2.2)	MAPKAPK5 (2.1)	CARM1 (1.7)	SUGP1 (1.7)	DDX56 (1.4)	TMEM57 (1.3)
ENSG00000069431	ABCC9 PPI subnetwork	0.33	> 0.20	C12orf51 (3.9)	UBXN2B (3.2)	ZHX3 (3.0)	ATXN2 (2.6)	OGDH (1.9)	NPC1L1 (1.8)	USP24 (1.7)	SMARCA4 (1.7)	ABCG8 (1.6)	CYP7A1 (1.5)
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES	0.33	> 0.20	PVR (2.9)	GATAD2A (2.3)	PARP10 (2.3)	RELB (2.2)	CYB561D1 (1.8)	ANKRD31 (1.7)	NKPD1 (1.7)	BCL3 (1.5)	SLC22A1 (1.5)	BRAP (1.5)
GO:0010469	regulation of receptor activity	0.33	> 0.20	ENSG00000226645 (3.4)	GCNT4 (3.1)	ABO (2.6)	RPH3A (2.4)	ANKRD31 (2.2)	PPP1R37 (1.6)	CELSR2 (1.5)	SLC44A2 (1.5)	NCAN (1.5)	ENSG00000228044 (1.5)
ENSG00000178188	SH2B1 PPI subnetwork	0.33	> 0.20	C17orf57 (3.1)	TRAFD1 (2.4)	NYNRIN (2.4)	ABO (2.2)	CBLC (1.9)	PLEKHH2 (1.9)	ZHX3 (1.9)	GPAM (1.8)	NPC1L1 (1.8)	AMIGO1 (1.7)
ENSG00000161920	MED11 PPI subnetwork	0.33	> 0.20	TXNL4B (3.7)	GEMIN7 (3.6)	BRAP (2.5)	MAPKAPK5 (2.4)	BUD13 (2.3)	BLOC1S3 (2.1)	DHX38 (2.0)	ZNF180 (2.0)	POC5 (1.9)	TOP1 (1.7)
ENSG00000100227	POLDIP3 PPI subnetwork	0.33	> 0.20	NAA25 (3.0)	DDX56 (2.4)	SORT1 (2.2)	ILF3 (2.2)	FEN1 (1.9)	SARS (1.9)	DHODH (1.8)	C12orf43 (1.6)	ST3GAL4 (1.6)	ENSG00000238078 (1.5)
GO:0005487	nucleocytoplasmic transporter activity	0.33	> 0.20	C1orf63 (3.1)	POC5 (2.5)	USP1 (2.1)	BUD13 (2.0)	DOCK7 (1.8)	FEN1 (1.7)	TMED4 (1.5)	POLK (1.5)	DDX56 (1.5)	ILF3 (1.4)
MP:0001672	abnormal embryogenesis/ development	0.33	> 0.20	GATAD2A (1.9)	PVRL2 (1.7)	LDLR (1.6)	NYNRIN (1.5)	PSRC1 (1.4)	DOCK7 (1.3)	ABO (1.3)	APOB (1.3)	ATXN2 (1.3)	USP1 (1.3)
GO:0051321	meiotic cell cycle	0.33	> 0.20	ANKRD31 (3.9)	ENSG00000228044 (2.4)	POC5 (1.9)	USP1 (1.4)	PSRC1 (1.3)	ZHX3 (1.3)	TMEM116 (1.2)	ENSG00000238078 (1.1)	PLEKHH2 (1.1)	FEN1 (1.1)
ENSG00000113141	IK PPI subnetwork	0.33	> 0.20	COL4A3BP (3.6)	CLPTM1 (3.3)	PPP1R37 (2.7)	CYB561D1 (2.5)	POC5 (2.4)	LPA (2.3)	DHX38 (2.3)	GEMIN7 (2.1)	SUGP1 (2.0)	TRAPPC6A (1.8)
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON:CONTAINING_TRANSCRIPT	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRON:CONTAINING_TRANSCRIPT	0.33	> 0.20	TOP1 (3.5)	USP1 (3.4)	ILF3 (3.3)	BUD13 (3.1)	C1orf63 (3.1)	DDX56 (2.8)	NAA25 (2.7)	DHODH (2.5)	DOCK7 (2.4)	ADAM1 (2.2)
GO:0050709	negative regulation of protein secretion	0.33	> 0.20	ADAM1 (2.1)	MOSC1 (1.9)	CETP (1.6)	ENSG00000238078 (1.6)	NKPD1 (1.6)	DNAH11 (1.5)	COL4A3BP (1.5)	APOE (1.4)	APOC1 (1.3)	NPC1L1 (1.3)
ENSG00000164400	CSF2 PPI subnetwork	0.33	> 0.20	BCL3 (3.4)	HLX (3.3)	RELB (2.9)	TIMD4 (2.6)	CETP (1.9)	ALDH2 (1.8)	LPA (1.8)	GMIP (1.6)	PLEKHH2 (1.5)	PARP10 (1.2)
GO:0001725	stress fiber	0.33	> 0.20	PVRL2 (3.4)	KANK2 (3.4)	PLEC (3.4)	ITGB3 (2.2)	AP1M2 (2.0)	CARM1 (1.8)	DNM2 (1.8)	CBLC (1.4)	GMIP (1.4)	PLEKHH2 (1.4)
ENSG00000092010	PSME1 PPI subnetwork	0.33	> 0.20	PSMA5 (5.8)	TRAFD1 (2.9)	NT5DC1 (2.6)	NAA25 (2.1)	TOMM40 (2.0)	TMEM50A (1.6)	DHX38 (1.5)	DDX56 (1.5)	SUGP1 (1.3)	SARS (1.2)
GO:0071322	cellular response to carbohydrate stimulus	0.33	> 0.20	ENSG00000254235 (2.4)	ADAM1 (2.0)	GEMIN7 (1.9)	ST3GAL4 (1.9)	NT5DC1 (1.6)	UBXN2B (1.3)	ERP29 (1.3)	PCSK9 (1.2)	ENSG00000238078 (1.2)	KIAA1324 (1.1)
MP:0003718	maternal effect	0.33	> 0.20	AP1M2 (2.8)	ABCG8 (2.8)	TM6SF2 (2.5)	ABCG5 (2.3)	CBLC (2.1)	HMGCR (1.9)	FADS2 (1.8)	APOB (1.6)	GOT2P1 (1.6)	CYP7A1 (1.5)
ENSG00000126945	HNRNPH2 PPI subnetwork	0.33	> 0.20	C1orf63 (4.3)	ILF3 (3.9)	SMARCA4 (3.0)	TOP1 (2.8)	PTPN11 (2.7)	SUGP1 (2.7)	USP1 (2.4)	DHX38 (2.4)	QTRT1 (2.1)	BUD13 (1.9)
GO:0034061	DNA polymerase activity	0.33	> 0.20	FEN1 (3.6)	USP1 (3.1)	PARP10 (2.6)	DNAH11 (2.1)	DDX56 (2.1)	ILF3 (2.0)	MAPKAPK5 (1.7)	USP24 (1.5)	PSRC1 (1.5)	ACAD10 (1.4)
KEGG_LONG_TERM_DEPRESSION	KEGG_LONG_TERM_DEPRESSION	0.33	> 0.20	TMEM50A (2.3)	ABCG8 (2.2)	LPIN3 (2.2)	GCNT4 (2.0)	NCAN (2.0)	HLX (1.9)	PLEKHH2 (1.8)	BLOC1S3 (1.7)	MARK4 (1.7)	ABCG5 (1.6)
ENSG00000149503	INCENP PPI subnetwork	0.33	> 0.20	PSRC1 (5.4)	FEN1 (4.9)	USP1 (3.9)	POC5 (3.3)	DHX38 (2.0)	ILF3 (1.5)	ZNF180 (1.4)	DDX56 (1.2)	SUGP1 (1.2)	BUD13 (1.1)
ENSG00000155561	NUP205 PPI subnetwork	0.33	> 0.20	POC5 (3.0)	USP1 (2.9)	BUD13 (2.8)	DDX56 (2.7)	NAA25 (2.7)	CARM1 (2.3)	DOCK7 (2.3)	ENSG00000226648 (2.2)	ADAM1 (2.1)	ILF3 (2.0)
MP:0008082	increased single-positive T cell number	0.33	> 0.20	CILP2 (3.5)	RELB (2.5)	CETP (2.4)	TIMD4 (1.9)	KANK2 (1.9)	LPAR2 (1.9)	ENSG00000238078 (1.9)	PBX4 (1.9)	CARM1 (1.7)	PLEKHH2 (1.6)
GO:0030855	epithelial cell differentiation	0.33	> 0.20	AP1M2 (3.0)	ENSG00000226648 (2.8)	NKPD1 (2.8)	CBLC (2.4)	CEACAM19 (2.3)	PMFBP1 (1.8)	BCAM (1.7)	CELSR2 (1.5)	C17orf57 (1.5)	LPIN3 (1.4)
ENSG00000116106	EPHA4 PPI subnetwork	0.33	> 0.20	PLEKHH2 (3.3)	PLCG1 (2.7)	C11orf9 (2.5)	PBX4 (2.5)	CILP2 (2.1)	HNF1A (2.0)	ABO (1.9)	PVRL2 (1.8)	MARK4 (1.8)	BCAM (1.7)
ENSG00000109471	IL2 PPI subnetwork	0.33	> 0.20	BCL3 (3.1)	TIMD4 (2.9)	RELB (2.7)	HLX (2.6)	CETP (2.1)	SH2B3 (1.9)	LPA (1.7)	GMIP (1.7)	ALDH2 (1.3)	PBX4 (1.3)
GO:0050869	negative regulation of B cell activation	0.33	> 0.20	ZNF101 (3.1)	ENSG00000238078 (2.7)	PBX4 (2.2)	GOT2P1 (1.8)	GCNT4 (1.7)	ENSG00000254235 (1.6)	NT5DC1 (1.6)	CEACAM19 (1.6)	ENSG00000228044 (1.6)	ENSG00000226645 (1.5)
ENSG00000107404	DVL1 PPI subnetwork	0.33	> 0.20	MARK4 (2.9)	ABO (2.0)	PVRL2 (2.0)	PLEC (1.9)	CELSR2 (1.9)	DOCK7 (1.8)	CARM1 (1.8)	SORT1 (1.7)	LPAR2 (1.6)	SLC44A2 (1.6)
GO:0016570	histone modification	0.33	> 0.20	ATXN7L2 (3.9)	BUD13 (2.8)	ILF3 (2.6)	C12orf51 (2.3)	TMEM57 (2.2)	SMARCA4 (2.0)	MAU2 (1.9)	ATXN2 (1.9)	C1orf63 (1.9)	USP24 (1.9)
MP:0006414	decreased T cell apoptosis	0.33	> 0.20	PARP10 (2.8)	PBX4 (2.3)	MYLIP (1.8)	SYPL2 (1.8)	CYP7A1 (1.7)	ST3GAL4 (1.7)	ZNF101 (1.6)	PLCG1 (1.6)	MAFB (1.4)	POC5 (1.3)
ENSG00000055130	CUL1 PPI subnetwork	0.33	> 0.20	PTPN11 (2.6)	GMPR (2.2)	BRAP (2.1)	OASL (2.0)	FEN1 (2.0)	SUGP1 (1.9)	ZNF180 (1.8)	GRINA (1.5)	RELB (1.4)	ENSG00000226645 (1.3)
MP:0000042	abnormal organ of Corti morphology	0.33	> 0.20	CILP2 (3.1)	HNF1A (3.1)	BCAM (2.6)	PLEKHH2 (2.5)	TRIB1 (2.4)	ZHX3 (2.4)	C11orf9 (2.4)	ANKRD31 (2.3)	PLCG1 (2.0)	LPA (1.7)
ENSG00000035115	SH3YL1 PPI subnetwork	0.33	> 0.20	ATXN2 (4.3)	HAVCR1 (2.8)	NCAN (2.8)	APOE (2.5)	APOC1 (2.2)	CLPTM1 (2.1)	TOMM40 (2.0)	C12orf43 (2.0)	ENSG00000235545 (2.0)	LPIN3 (1.8)
ENSG00000099810	MTAP PPI subnetwork	0.33	> 0.20	C1orf63 (2.6)	PPP1R37 (2.3)	GMPR (2.3)	PLCG1 (2.1)	KANK2 (1.9)	MAU2 (1.8)	TRAFD1 (1.7)	GCNT4 (1.5)	FRK (1.4)	ITGB3 (1.3)
ENSG00000135547	HEY2 PPI subnetwork	0.33	> 0.20	BLOC1S3 (1.9)	ITGB3 (1.7)	LDLR (1.5)	CBLC (1.5)	POLK (1.4)	PVRL2 (1.3)	C11orf9 (1.3)	CETP (1.3)	DNAH11 (1.3)	TRIB1 (1.3)
GO:0030917	midbrain-hindbrain boundary development	0.33	> 0.20	ANKRD31 (4.5)	DNAH11 (3.0)	C12orf47 (2.4)	AMIGO1 (2.1)	ENSG00000238078 (1.9)	CARM1 (1.7)	TSSK6 (1.7)	PMFBP1 (1.6)	ENSG00000254235 (1.5)	PBX4 (1.5)
MP:0004696	abnormal thyroid follicle morphology	0.33	> 0.20	MOSC1 (3.4)	PBX4 (3.1)	C17orf57 (3.0)	GOT2P1 (2.7)	NKPD1 (1.8)	ZHX3 (1.8)	YIPF2 (1.5)	PLCG1 (1.3)	GCNT4 (1.3)	PMFBP1 (1.1)
GO:0034101	erythrocyte homeostasis	0.33	> 0.20	RHCE (6.2)	RHD (5.8)	C12orf51 (2.5)	TMEM57 (2.4)	C19orf52 (2.2)	BLOC1S3 (2.1)	DNM2 (1.8)	UBXN2B (1.6)	ZNF180 (1.5)	GMPR (1.5)
MP:0004207	squamous cell carcinoma	0.33	> 0.20	PSRC1 (2.3)	FEN1 (2.2)	ENSG00000226648 (2.2)	PBX4 (1.8)	C12orf51 (1.7)	LDLR (1.6)	CBLC (1.6)	HAVCR1 (1.5)	POLK (1.4)	TSSK6 (1.4)
GO:0002366	leukocyte activation involved in immune response	0.33	> 0.20	GMIP (2.5)	C17orf57 (2.2)	DNAH11 (2.1)	ZNF101 (1.9)	CYB561D1 (1.9)	SH2B3 (1.7)	NT5DC1 (1.5)	ANKRD31 (1.5)	BCL3 (1.4)	PARP10 (1.3)
GO:0002263	cell activation involved in immune response	0.33	> 0.20	GMIP (2.5)	C17orf57 (2.2)	DNAH11 (2.1)	ZNF101 (1.9)	CYB561D1 (1.9)	SH2B3 (1.7)	NT5DC1 (1.5)	ANKRD31 (1.5)	BCL3 (1.4)	PARP10 (1.3)
GO:0043467	regulation of generation of precursor metabolites and energy	0.33	> 0.20	ZHX3 (2.6)	ENSG00000254235 (2.1)	HNF1A (2.1)	PCSK9 (1.8)	KANK2 (1.7)	LPA (1.7)	NT5DC1 (1.5)	GPAM (1.4)	TSSK6 (1.4)	SORT1 (1.4)
GO:0005952	cAMP-dependent protein kinase complex	0.33	> 0.20	ITGB3 (3.4)	TSSK6 (2.9)	GPAM (2.4)	PTPN11 (2.2)	ADAM1 (2.1)	GMPR (2.0)	SH2B3 (1.9)	C19orf52 (1.9)	SORT1 (1.9)	BCAM (1.9)
ENSG00000152944	MED21 PPI subnetwork	0.33	> 0.20	GEMIN7 (3.0)	BRAP (2.8)	TXNL4B (2.7)	POC5 (2.5)	BUD13 (2.5)	SMARCA4 (2.1)	C12orf51 (2.0)	TMEM57 (2.0)	C17orf57 (1.9)	MAPKAPK5 (1.8)
ENSG00000114030	KPNA1 PPI subnetwork	0.33	> 0.20	USP1 (3.1)	BCL3 (2.8)	TOP1 (2.6)	PSMA5 (2.5)	PARP10 (2.4)	ILF3 (2.2)	PSRC1 (2.2)	ENSG00000238078 (1.9)	RELB (1.9)	SMARCA4 (1.8)
GO:0070076	histone lysine demethylation	0.33	> 0.20	TMEM57 (2.9)	ATXN7L2 (2.8)	GCNT4 (2.2)	BLOC1S3 (2.2)	LPAR2 (2.0)	ENSG00000254235 (1.9)	C12orf47 (1.9)	ZNF180 (1.9)	MAU2 (1.9)	CYB561D1 (1.9)
GO:0006643	membrane lipid metabolic process	0.33	> 0.20	NKPD1 (5.6)	HAVCR1 (3.5)	TMEM50A (3.5)	CYB561D1 (3.3)	ERP29 (2.9)	COL4A3BP (2.5)	CLPTM1 (2.2)	LPIN3 (2.1)	TMED4 (2.1)	PPP1R37 (2.1)
GO:0030879	mammary gland development	0.33	> 0.20	KIAA1324 (3.8)	PPP1R37 (2.3)	AP1M2 (2.0)	PLEKHH2 (2.0)	TRAPPC6A (1.9)	MYLIP (1.7)	ANKRD31 (1.6)	CELSR2 (1.6)	ENSG00000226648 (1.5)	NKPD1 (1.4)
GO:0008637	apoptotic mitochondrial changes	0.33	> 0.20	ENSG00000226645 (2.4)	TRAPPC6A (2.1)	ENSG00000235545 (1.7)	BRAP (1.6)	C12orf47 (1.6)	BLOC1S3 (1.5)	ERP29 (1.4)	C12orf43 (1.4)	CBLC (1.3)	ST3GAL4 (1.3)
GO:0005283	sodium:amino acid symporter activity	0.33	> 0.20	NCAN (4.6)	ABCG8 (3.1)	CYP7A1 (3.0)	APOC4 (2.8)	HAPLN4 (2.5)	GEMIN7 (2.2)	APOA5 (2.2)	ENSG00000235545 (1.9)	ABCG5 (1.9)	ZHX3 (1.7)
GO:0019207	kinase regulator activity	0.33	> 0.20	NCAN (2.4)	SH2B3 (2.2)	MYLIP (2.1)	ITGB3 (1.8)	TOP1 (1.8)	TRAFD1 (1.8)	DYNC2LI1 (1.8)	TRIB1 (1.7)	MAFB (1.6)	COL4A3BP (1.5)
ENSG00000008294	SPAG9 PPI subnetwork	0.33	> 0.20	RELB (6.2)	BCL3 (2.8)	MAPKAPK5 (2.5)	GEMIN7 (2.4)	TMEM57 (2.3)	MYLIP (2.1)	BLOC1S3 (2.0)	PBX4 (1.9)	C12orf43 (1.9)	SH2B3 (1.9)
GO:0005528	FK506 binding	0.33	> 0.20	YIPF2 (4.1)	CLPTM1 (2.5)	GATAD2A (2.4)	OGDH (2.4)	ERP29 (2.3)	TOMM40 (2.2)	ZHX3 (2.1)	GRINA (1.9)	QTRT1 (1.8)	PPP1R37 (1.7)
GO:0005527	macrolide binding	0.33	> 0.20	YIPF2 (4.1)	CLPTM1 (2.5)	GATAD2A (2.4)	OGDH (2.4)	ERP29 (2.3)	TOMM40 (2.2)	ZHX3 (2.1)	GRINA (1.9)	QTRT1 (1.8)	PPP1R37 (1.7)
MP:0010869	decreased bone trabecula number	0.33	> 0.20	MAFB (3.4)	TMEM57 (2.2)	CILP2 (1.8)	APOE (1.8)	ANKRD31 (1.7)	BCL3 (1.7)	TRIB1 (1.6)	ATXN7L2 (1.5)	LPAR2 (1.4)	LDLR (1.4)
ENSG00000175592	FOSL1 PPI subnetwork	0.33	> 0.20	TRIB1 (7.5)	SARS (3.1)	TMED4 (2.1)	BLOC1S3 (2.1)	GRINA (2.0)	BCL3 (2.0)	MAPKAPK5 (1.8)	CARM1 (1.6)	MAU2 (1.6)	MYLIP (1.6)
GO:0002521	leukocyte differentiation	0.33	> 0.20	ZNF101 (4.6)	PBX4 (3.0)	PLCG1 (2.4)	GMIP (2.0)	DNAH11 (1.7)	SH2B3 (1.6)	TRIB1 (1.6)	TIMD4 (1.5)	HLX (1.4)	LPAR2 (1.4)
ENSG00000167552	TUBA1A PPI subnetwork	0.33	> 0.20	SMARCA4 (3.2)	PLEC (3.0)	CLPTM1 (2.7)	CARM1 (2.3)	TOMM40 (2.2)	ILF3 (2.0)	TOP1 (1.9)	PVR (1.8)	RPH3A (1.8)	C1orf63 (1.5)
GO:0051272	positive regulation of cellular component movement	0.33	> 0.20	PVR (3.6)	PVRL2 (2.6)	MAFB (2.4)	AP1M2 (2.1)	APOE (1.9)	ENSG00000228044 (1.9)	CETP (1.8)	ENSG00000254235 (1.8)	PTPN11 (1.8)	ITGB3 (1.6)
MP:0004543	abnormal sperm physiology	0.33	> 0.20	PMFBP1 (3.8)	TSSK6 (3.7)	FADS2 (1.6)	PBX4 (1.5)	BRAP (1.5)	LDLR (1.4)	HP (1.3)	AP1M2 (1.3)	ST3GAL4 (1.3)	TMED4 (1.2)
MP:0009171	enlarged pancreatic islets	0.33	> 0.20	GPAM (4.5)	MOSC1 (4.5)	GCNT4 (2.9)	ALDH2 (2.7)	CBLC (2.0)	AP1M2 (1.9)	KANK2 (1.6)	LPAR2 (1.5)	PLEC (1.4)	YIPF2 (1.4)
ENSG00000074054	CLASP1 PPI subnetwork	0.33	> 0.20	PSRC1 (6.0)	FEN1 (3.8)	USP1 (3.3)	POC5 (3.2)	ZHX3 (2.0)	ENSG00000228044 (1.7)	C11orf9 (1.5)	DNM2 (1.4)	USP24 (1.3)	PLEC (1.3)
GO:0005179	hormone activity	0.33	> 0.20	KIAA1324 (4.9)	NPC1L1 (3.7)	TM6SF2 (2.1)	APOB (2.0)	C12orf47 (1.9)	ABCG5 (1.6)	YIPF2 (1.5)	PMFBP1 (1.4)	ABO (1.4)	HAPLN4 (1.4)
ENSG00000023191	RNH1 PPI subnetwork	0.33	> 0.20	ATP13A1 (3.0)	ILF3 (2.0)	YIPF2 (1.9)	DNM2 (1.9)	OGDH (1.8)	ENSG00000235545 (1.6)	ACAD10 (1.5)	LDLR (1.5)	DOCK7 (1.4)	DHODH (1.4)
ENSG00000171497	PPID PPI subnetwork	0.33	> 0.20	TOMM40 (4.5)	PSMA5 (3.0)	NAA25 (2.9)	CLPTM1 (2.8)	DDX56 (2.5)	OGDH (2.4)	GOT2P1 (1.7)	ZNF259 (1.6)	SARS (1.6)	CARM1 (1.5)
ENSG00000172850	LSM2 PPI subnetwork	0.33	> 0.20	TOP1 (3.4)	ILF3 (3.2)	BUD13 (2.9)	SUGP1 (2.8)	DHX38 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	QTRT1 (2.5)	USP1 (2.3)	DDX56 (2.2)
ENSG00000204392	LSM2 PPI subnetwork	0.33	> 0.20	TOP1 (3.4)	ILF3 (3.2)	BUD13 (2.9)	SUGP1 (2.8)	DHX38 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	QTRT1 (2.5)	USP1 (2.3)	DDX56 (2.2)
ENSG00000111987	ENSG00000111987 PPI subnetwork	0.33	> 0.20	TOP1 (3.4)	ILF3 (3.2)	BUD13 (2.9)	SUGP1 (2.8)	DHX38 (2.8)	SMARCA4 (2.7)	FEN1 (2.5)	QTRT1 (2.5)	USP1 (2.3)	DDX56 (2.2)
GO:0043687	post-translational protein modification	0.33	> 0.20	YIPF2 (4.8)	ERP29 (3.8)	TMED4 (3.6)	ATP13A1 (3.1)	TMEM57 (2.4)	CLPTM1 (2.3)	CYB561D1 (2.1)	TMEM50A (1.8)	C19orf52 (1.6)	TSSK6 (1.4)
GO:0043507	positive regulation of JUN kinase activity	0.33	> 0.20	LPAR2 (3.1)	ENSG00000235545 (2.2)	ENSG00000226645 (2.1)	ST3GAL4 (2.1)	CYB561D1 (1.7)	GMIP (1.6)	BRAP (1.6)	GCNT4 (1.6)	PPP1R37 (1.5)	FRK (1.3)
GO:0010770	positive regulation of cell morphogenesis involved in differentiation	0.33	> 0.20	ENSG00000226648 (2.8)	MYLIP (2.6)	ITGB3 (2.4)	SH2B3 (2.3)	ENSG00000254235 (2.3)	ABO (2.2)	GCNT4 (2.0)	PLEKHH2 (1.9)	ANKRD31 (1.8)	KANK2 (1.8)
ENSG00000099817	POLR2E PPI subnetwork	0.33	> 0.20	ILF3 (3.2)	SUGP1 (3.0)	DHX38 (3.0)	TOP1 (2.9)	BUD13 (2.9)	DDX56 (2.6)	SMARCA4 (2.3)	QTRT1 (2.2)	C1orf63 (2.1)	TOMM40 (2.1)
ENSG00000073711	PPP2R3A PPI subnetwork	0.33	> 0.20	SYPL2 (2.7)	TOMM40 (2.7)	CLPTM1 (2.1)	LPIN3 (2.0)	GOT2P1 (1.9)	ADAM1 (1.8)	ZNF180 (1.6)	SLC44A2 (1.6)	AMIGO1 (1.6)	CELSR2 (1.5)
ENSG00000122756	CNTFR PPI subnetwork	0.33	> 0.20	BCL3 (3.1)	COL4A3BP (2.3)	C17orf57 (1.8)	ZNF101 (1.7)	TIMD4 (1.4)	CYP7A1 (1.4)	RELB (1.4)	HLX (1.3)	CETP (1.3)	PVR (1.3)
MP:0002132	abnormal respiratory system morphology	0.33	> 0.20	PLEKHH2 (3.3)	ENSG00000226648 (2.6)	HLX (2.5)	TIMD4 (2.2)	GCNT4 (2.2)	DNAH11 (1.9)	ALDH2 (1.7)	MOSC1 (1.6)	ENSG00000228044 (1.6)	GPAM (1.6)
MP:0002282	abnormal trachea morphology	0.33	> 0.20	APOC4 (2.8)	KIAA1324 (2.6)	HLX (2.3)	LPA (2.1)	CBLC (2.1)	ALDH2 (2.0)	PMFBP1 (1.9)	DNAH11 (1.9)	CYP7A1 (1.8)	ANGPTL3 (1.7)
ENSG00000102898	NUTF2 PPI subnetwork	0.33	> 0.20	USP1 (2.5)	CARM1 (2.3)	FEN1 (2.1)	ILF3 (2.0)	TOMM40 (2.0)	C12orf43 (2.0)	PSRC1 (1.8)	NAA25 (1.7)	MAU2 (1.6)	ENSG00000226645 (1.5)
ENSG00000159217	IGF2BP1 PPI subnetwork	0.33	> 0.20	ILF3 (3.6)	SMARCA4 (3.4)	DDX56 (3.4)	QTRT1 (3.2)	SARS (3.1)	ATP13A1 (2.7)	ZNF259 (2.4)	C12orf43 (2.3)	TOMM40 (2.3)	GATAD2A (2.3)
GO:0042306	regulation of protein import into nucleus	0.33	> 0.20	OASL (2.2)	MYLIP (1.9)	ENSG00000238078 (1.8)	ZNF101 (1.7)	SH2B3 (1.6)	GRINA (1.6)	ENSG00000235545 (1.5)	TMEM116 (1.5)	DOCK7 (1.5)	GCNT4 (1.4)
GO:0051928	positive regulation of calcium ion transport	0.33	> 0.20	ABO (3.3)	DNAH11 (1.8)	CYB561D1 (1.6)	C12orf47 (1.5)	C12orf43 (1.5)	ST3GAL4 (1.4)	GRINA (1.3)	PLCG1 (1.3)	YIPF2 (1.3)	ENSG00000228044 (1.2)
GO:0034097	response to cytokine stimulus	0.34	> 0.20	OASL (5.4)	PARP10 (4.9)	TRAFD1 (3.3)	BCL3 (2.5)	RELB (1.9)	PVR (1.7)	CYB561D1 (1.7)	TRIB1 (1.7)	GMIP (1.6)	GRINA (1.4)
ENSG00000005884	ITGA3 PPI subnetwork	0.34	> 0.20	BCAM (3.9)	ST3GAL4 (3.2)	PVRL2 (3.0)	APOE (3.0)	PLEC (2.7)	GRINA (2.6)	CLPTM1 (2.3)	KANK2 (2.1)	PMFBP1 (1.8)	ITGB3 (1.8)
GO:0015012	heparan sulfate proteoglycan biosynthetic process	0.34	> 0.20	GCNT4 (4.0)	ANKRD31 (3.6)	ST3GAL4 (2.5)	GEMIN7 (2.3)	ZNF180 (2.2)	NKPD1 (1.8)	ZHX3 (1.7)	DYNC2LI1 (1.5)	AMIGO1 (1.4)	LPIN3 (1.3)
MP:0001685	abnormal endoderm development	0.34	> 0.20	APOE (2.6)	ABO (2.1)	LPAR2 (2.1)	COL4A3BP (2.0)	KIAA1324 (1.9)	ERP29 (1.8)	HNF1A (1.8)	PVRL2 (1.8)	UBXN2B (1.8)	PLCG1 (1.8)
ENSG00000174123	TLR10 PPI subnetwork	0.34	> 0.20	GMIP (3.3)	PARP10 (2.4)	HLX (2.2)	BCL3 (2.0)	OASL (1.9)	PCSK9 (1.8)	UBXN2B (1.7)	MAFB (1.5)	CYB561D1 (1.5)	NCAN (1.4)
ENSG00000204843	DCTN1 PPI subnetwork	0.34	> 0.20	C12orf51 (3.7)	MAU2 (3.5)	SMARCA4 (2.5)	ENSG00000238078 (2.4)	PBX4 (2.0)	PLCG1 (2.0)	CARM1 (2.0)	DHX38 (1.9)	PLEC (1.7)	SUGP1 (1.7)
GO:0016328	lateral plasma membrane	0.34	> 0.20	AP1M2 (6.4)	CBLC (5.0)	CELSR2 (2.8)	BCAM (2.8)	PVRL2 (2.4)	LPIN3 (2.4)	ABCG5 (2.0)	TRAPPC6A (2.0)	NYNRIN (1.9)	FRK (1.7)
ENSG00000136875	PRPF4 PPI subnetwork	0.34	> 0.20	TOP1 (3.8)	ILF3 (3.7)	DHX38 (3.5)	C1orf63 (3.3)	SMARCA4 (3.0)	SUGP1 (2.9)	QTRT1 (2.8)	BUD13 (2.7)	FEN1 (2.5)	USP1 (2.3)
ENSG00000115738	ID2 PPI subnetwork	0.34	> 0.20	NCAN (2.5)	HLX (2.2)	SYPL2 (2.2)	TSSK6 (2.1)	DNM2 (1.8)	LPIN3 (1.7)	TRAPPC6A (1.6)	ABO (1.5)	BUD13 (1.2)	MYLIP (1.2)
ENSG00000110711	AIP PPI subnetwork	0.34	> 0.20	CYP7A1 (2.4)	OGDH (2.1)	MYLIP (1.9)	ABCG8 (1.9)	GPAM (1.9)	MAFB (1.8)	PTPN11 (1.7)	TIMD4 (1.5)	PBX4 (1.5)	FRK (1.5)
ENSG00000010818	HIVEP2 PPI subnetwork	0.34	> 0.20	FRK (2.9)	PTPN11 (2.5)	PARP10 (2.4)	C17orf57 (2.2)	KANK2 (1.9)	HNF1A (1.9)	ZNF180 (1.9)	ENSG00000254235 (1.8)	ADAM1 (1.8)	TOMM40 (1.7)
GO:0022408	negative regulation of cell-cell adhesion	0.34	> 0.20	ANKRD31 (5.5)	ENSG00000238078 (2.4)	ENSG00000254235 (2.4)	GOT2P1 (2.3)	ENSG00000226645 (1.8)	TRAPPC6A (1.7)	AP1M2 (1.7)	MOSC1 (1.6)	C19orf52 (1.3)	CILP2 (1.3)
REACTOME_IRON_UPTAKE_AND_TRANSPORT	REACTOME_IRON_UPTAKE_AND_TRANSPORT	0.34	> 0.20	GRINA (3.0)	TMEM116 (3.0)	APOE (2.7)	SORT1 (2.7)	RHD (2.2)	MAFB (2.2)	FRK (2.0)	ERP29 (1.8)	TIMD4 (1.7)	TMEM50A (1.7)
MP:0002410	decreased susceptibility to viral infection	0.34	> 0.20	OASL (6.8)	GMIP (3.4)	PARP10 (3.2)	TRAFD1 (2.5)	FRK (2.5)	MAFB (1.9)	TRIB1 (1.6)	LPAR2 (1.4)	C12orf43 (1.3)	SH2B3 (1.2)
MP:0000750	abnormal muscle regeneration	0.34	> 0.20	SYPL2 (5.2)	LPIN3 (3.0)	PVR (2.9)	AMIGO1 (2.4)	TRIB1 (2.0)	BCAM (1.9)	MAFB (1.8)	TSSK6 (1.7)	GOT2P1 (1.4)	SLC44A2 (1.4)
ENSG00000096696	DSP PPI subnetwork	0.34	> 0.20	CBLC (3.7)	AP1M2 (2.7)	BCL3 (2.2)	BCAM (2.0)	CEACAM19 (1.9)	TRAPPC6A (1.8)	LPIN3 (1.7)	RELB (1.7)	CELSR2 (1.5)	GEMIN7 (1.4)
MP:0004402	decreased cochlear outer hair cell number	0.34	> 0.20	MOSC1 (2.4)	C12orf47 (2.1)	CELSR2 (1.9)	BCAM (1.8)	HNF1A (1.7)	SORT1 (1.5)	TRIB1 (1.5)	LPAR2 (1.5)	ANKRD31 (1.5)	ENSG00000226648 (1.4)
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	0.34	> 0.20	ITGB3 (4.0)	ST3GAL4 (2.7)	ENSG00000254235 (2.1)	KIAA1324 (1.9)	TM6SF2 (1.9)	SH2B3 (1.8)	KANK2 (1.7)	PMFBP1 (1.6)	ABCG8 (1.4)	GCNT4 (1.4)
REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	0.34	> 0.20	TXNL4B (3.5)	CARM1 (2.5)	SH2B3 (2.3)	GATAD2A (2.0)	CLPTM1 (2.0)	MAU2 (1.9)	YIPF2 (1.9)	LPAR2 (1.8)	PBX4 (1.7)	DHX38 (1.7)
ENSG00000160789	LMNA PPI subnetwork	0.34	> 0.20	OGDH (2.4)	ILF3 (2.1)	TOP1 (1.8)	ITGB3 (1.8)	TOMM40 (1.6)	SARS (1.5)	NAA25 (1.5)	PSMA5 (1.5)	KANK2 (1.3)	ENSG00000238078 (1.3)
MP:0002824	abnormal chorioallantoic fusion	0.34	> 0.20	TIMD4 (3.8)	CETP (2.6)	TMED4 (2.5)	ENSG00000235545 (2.3)	HAVCR1 (2.1)	ENSG00000228044 (1.9)	PVRL2 (1.8)	TMEM50A (1.8)	FRK (1.7)	TRAFD1 (1.7)
MP:0002663	failure to form blastocele	0.34	> 0.20	CBLC (3.3)	BRAP (2.8)	PLEKHH2 (2.7)	AP1M2 (2.2)	LPAR2 (1.9)	PVRL2 (1.8)	ABCG5 (1.5)	DOCK7 (1.2)	ABO (1.2)	FEN1 (1.2)
ENSG00000183625	CCR3 PPI subnetwork	0.34	> 0.20	OASL (5.0)	MAFB (3.6)	TRAFD1 (3.0)	PARP10 (2.0)	TIMD4 (2.0)	RELB (1.9)	PMFBP1 (1.8)	ST3GAL4 (1.3)	APOE (1.2)	ABO (1.2)
GO:0046822	regulation of nucleocytoplasmic transport	0.34	> 0.20	ENSG00000238078 (2.8)	ZNF101 (2.2)	OASL (2.1)	GRINA (1.9)	MYLIP (1.8)	ENSG00000235545 (1.7)	GCNT4 (1.6)	TRAFD1 (1.6)	ENSG00000254235 (1.6)	TMEM116 (1.6)
ENSG00000103490	PYCARD PPI subnetwork	0.34	> 0.20	ST3GAL4 (2.8)	SORT1 (1.9)	GMPR (1.7)	ENSG00000238078 (1.7)	MOSC1 (1.6)	BCAM (1.5)	TOP1 (1.4)	AP1M2 (1.3)	TRAPPC6A (1.3)	GRINA (1.2)
ENSG00000107562	CXCL12 PPI subnetwork	0.34	> 0.20	TIMD4 (3.8)	HP (2.6)	CETP (2.4)	HLX (2.4)	CILP2 (2.0)	APOE (2.0)	RHD (1.9)	MAFB (1.8)	MOSC1 (1.8)	C12orf47 (1.8)
ENSG00000113739	STC2 PPI subnetwork	0.34	> 0.20	TXNL4B (2.8)	C12orf47 (2.7)	GCNT4 (2.4)	MAPKAPK5 (2.3)	QTRT1 (2.2)	KANK2 (1.8)	BRAP (1.7)	C12orf43 (1.6)	USP1 (1.5)	TMED4 (1.5)
GO:0070491	repressing transcription factor binding	0.34	> 0.20	HLX (2.6)	ALDH2 (2.4)	BUD13 (2.2)	TRIB1 (2.1)	RELB (1.7)	SMARCA4 (1.6)	ENSG00000226645 (1.6)	HNF1A (1.6)	FADS1 (1.6)	PCSK9 (1.5)
ENSG00000072803	FBXW11 PPI subnetwork	0.34	> 0.20	RELB (5.1)	TMEM57 (2.3)	PLEC (2.0)	USP24 (2.0)	ENSG00000235545 (1.7)	TRIB1 (1.5)	BUD13 (1.5)	PBX4 (1.5)	BCL3 (1.5)	LDLR (1.4)
ENSG00000124160	NCOA5 PPI subnetwork	0.34	> 0.20	HMGCR (3.5)	LDLR (3.0)	BRAP (2.6)	TMEM116 (2.1)	ENSG00000228044 (1.9)	MAU2 (1.9)	SYPL2 (1.7)	C12orf51 (1.7)	DHX38 (1.7)	ATXN2 (1.6)
GO:0032881	regulation of polysaccharide metabolic process	0.34	> 0.20	LPA (2.2)	ZHX3 (2.1)	MYLIP (1.8)	AMIGO1 (1.7)	CYB561D1 (1.7)	ZNF180 (1.7)	GPAM (1.6)	KANK2 (1.5)	PCSK9 (1.4)	CYP7A1 (1.3)
GO:0070873	regulation of glycogen metabolic process	0.34	> 0.20	LPA (2.2)	ZHX3 (2.1)	MYLIP (1.8)	AMIGO1 (1.7)	CYB561D1 (1.7)	ZNF180 (1.7)	GPAM (1.6)	KANK2 (1.5)	PCSK9 (1.4)	CYP7A1 (1.3)
MP:0004180	failure of initiation of embryo turning	0.34	> 0.20	ATXN2 (3.3)	MAPKAPK5 (2.8)	TOP1 (2.1)	C12orf51 (2.0)	PLEKHH2 (2.0)	HAVCR1 (2.0)	MAU2 (1.9)	NAA25 (1.9)	BCL3 (1.9)	DOCK7 (1.7)
MP:0002619	abnormal lymphocyte morphology	0.34	> 0.20	SLC44A2 (3.5)	PARP10 (3.2)	RELB (3.0)	GMIP (2.8)	OASL (2.8)	ZNF101 (1.8)	CETP (1.7)	PBX4 (1.7)	SH2B3 (1.6)	TRAFD1 (1.6)
MP:0005631	decreased lung weight	0.34	> 0.20	LDLR (4.1)	HMGCR (3.7)	FADS2 (3.5)	FADS1 (3.2)	GPAM (2.2)	ENSG00000226648 (2.0)	PCSK9 (2.0)	LPIN3 (1.9)	GOT2P1 (1.8)	GEMIN7 (1.6)
MP:0002631	abnormal epididymis morphology	0.34	> 0.20	ST3GAL4 (2.9)	TMED4 (2.8)	NT5DC1 (2.4)	ERP29 (2.1)	TSSK6 (2.1)	FRK (2.0)	NKPD1 (1.7)	PVRL2 (1.5)	OGDH (1.5)	ABO (1.3)
MP:0001008	abnormal sympathetic ganglion morphology	0.34	> 0.20	CELSR2 (3.0)	AMIGO1 (2.5)	AP1M2 (2.1)	FADS2 (2.1)	ANKRD31 (1.9)	LPIN3 (1.8)	KIAA1324 (1.8)	NPC1L1 (1.6)	BCAM (1.6)	PMFBP1 (1.5)
ENSG00000130024	PHF10 PPI subnetwork	0.34	> 0.20	CARM1 (3.2)	GOT2P1 (2.6)	MARK4 (2.6)	SMARCA4 (2.3)	ATXN2 (2.2)	NYNRIN (2.1)	MAU2 (1.9)	ADAM1 (1.8)	GRINA (1.7)	SORT1 (1.7)
ENSG00000144642	RBMS3 PPI subnetwork	0.34	> 0.20	DOCK7 (2.4)	NAA25 (2.1)	OASL (2.0)	FADS1 (1.9)	MOSC1 (1.9)	GPAM (1.9)	PARP10 (1.8)	FADS2 (1.8)	PSMA5 (1.8)	OGDH (1.8)
GO:0040014	regulation of multicellular organism growth	0.34	> 0.20	KIAA1324 (2.6)	C12orf51 (2.5)	C12orf47 (2.3)	USP24 (2.0)	AMIGO1 (1.9)	ACAD10 (1.8)	CETP (1.7)	ANKRD31 (1.7)	ENSG00000228044 (1.2)	PLCG1 (1.2)
GO:0005326	neurotransmitter transporter activity	0.34	> 0.20	TM6SF2 (4.1)	HAPLN4 (3.3)	ABCG5 (3.2)	ABCG8 (3.0)	NPC1L1 (2.5)	APOC4 (2.2)	CYP7A1 (2.1)	RPH3A (2.1)	LPA (2.0)	GEMIN7 (1.8)
ENSG00000125870	SNRPB2 PPI subnetwork	0.34	> 0.20	ILF3 (3.9)	C1orf63 (3.7)	BUD13 (2.8)	SMARCA4 (2.7)	DHX38 (2.7)	USP1 (2.7)	SUGP1 (2.6)	TOP1 (2.6)	QTRT1 (2.2)	FEN1 (2.1)
MP:0006269	abnormal mammary gland growth during pregnancy	0.34	> 0.20	GEMIN7 (2.6)	CELSR2 (2.4)	SH2B3 (2.2)	RELB (2.0)	KIAA1324 (1.9)	POLK (1.9)	PARP10 (1.8)	TIMD4 (1.7)	ABO (1.5)	C19orf52 (1.4)
GO:0032233	positive regulation of actin filament bundle assembly	0.34	> 0.20	HNF1A (2.6)	PBX4 (2.5)	C17orf57 (2.5)	HAVCR1 (2.2)	ABO (1.9)	NYNRIN (1.9)	C11orf9 (1.8)	AMIGO1 (1.7)	ENSG00000226645 (1.6)	ADAM1 (1.6)
MP:0001303	abnormal lens morphology	0.34	> 0.20	ATXN2 (1.6)	CETP (1.4)	MYLIP (1.4)	OASL (1.3)	CELSR2 (1.3)	SYPL2 (1.2)	GOT2P1 (1.2)	TIMD4 (1.2)	SORT1 (1.2)	NPC1L1 (1.2)
GO:0051785	positive regulation of nuclear division	0.34	> 0.20	ENSG00000228044 (2.3)	TMED4 (2.3)	POLK (2.0)	POC5 (1.8)	PSRC1 (1.6)	ANKRD31 (1.6)	KANK2 (1.5)	YIPF2 (1.5)	GCNT4 (1.4)	DNAH11 (1.3)
GO:0045840	positive regulation of mitosis	0.34	> 0.20	ENSG00000228044 (2.3)	TMED4 (2.3)	POLK (2.0)	POC5 (1.8)	PSRC1 (1.6)	ANKRD31 (1.6)	KANK2 (1.5)	YIPF2 (1.5)	GCNT4 (1.4)	DNAH11 (1.3)
ENSG00000122679	RAMP3 PPI subnetwork	0.34	> 0.20	CETP (4.0)	LPIN3 (2.7)	TIMD4 (2.7)	ENSG00000254235 (2.7)	PPP1R37 (1.9)	SYPL2 (1.8)	BLOC1S3 (1.8)	MAFB (1.8)	DNAH11 (1.4)	ERP29 (1.4)
ENSG00000100650	SRSF5 PPI subnetwork	0.34	> 0.20	ILF3 (4.2)	C1orf63 (3.8)	TOP1 (3.1)	DHX38 (2.9)	SMARCA4 (2.8)	USP1 (2.7)	BUD13 (2.4)	PTPN11 (2.4)	SUGP1 (2.2)	QTRT1 (2.2)
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING__PRESENTATION	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING__PRESENTATION	0.34	> 0.20	TRAFD1 (4.8)	PSMA5 (3.9)	PARP10 (3.0)	NAA25 (1.9)	CARM1 (1.7)	SUGP1 (1.6)	BRAP (1.6)	C12orf51 (1.5)	GEMIN7 (1.5)	ATXN2 (1.5)
ENSG00000163464	CXCR1 PPI subnetwork	0.34	> 0.20	ITGB3 (3.2)	BCL3 (2.7)	MAFB (2.1)	ENSG00000254235 (1.8)	UBXN2B (1.7)	SLC22A1 (1.7)	ANGPTL3 (1.7)	RELB (1.6)	HP (1.5)	TIMD4 (1.5)
ENSG00000116095	PLEKHA3 PPI subnetwork	0.34	> 0.20	PARP10 (2.7)	C17orf57 (2.5)	PTPN11 (2.4)	FRK (2.3)	HNF1A (2.0)	KANK2 (1.7)	DHX38 (1.6)	OGDH (1.6)	ADAM1 (1.6)	ZNF180 (1.5)
ENSG00000131724	IL13RA1 PPI subnetwork	0.34	> 0.20	BCL3 (3.1)	COL4A3BP (2.1)	C17orf57 (1.8)	CYP7A1 (1.6)	PVR (1.6)	HLX (1.6)	RELB (1.5)	ZNF101 (1.5)	SLC22A1 (1.3)	ENSG00000226645 (1.1)
GO:0048532	anatomical structure arrangement	0.34	> 0.20	ANKRD31 (2.5)	TMED4 (2.3)	DYNC2LI1 (1.9)	DOCK7 (1.7)	ENSG00000254235 (1.6)	FRK (1.4)	HAVCR1 (1.3)	UBXN2B (1.1)	CEACAM19 (1.1)	SYPL2 (1.1)
ENSG00000096063	SRPK1 PPI subnetwork	0.34	> 0.20	TOP1 (4.2)	ILF3 (3.6)	C1orf63 (3.3)	USP1 (3.0)	QTRT1 (2.6)	SMARCA4 (2.3)	SUGP1 (2.2)	BUD13 (2.2)	TMEM57 (2.1)	TOMM40 (1.8)
GO:0009295	nucleoid	0.34	> 0.20	ACAD10 (4.1)	DHODH (3.4)	C19orf52 (2.6)	TMEM116 (2.5)	ABCG5 (2.5)	ABCG8 (2.5)	NAA25 (2.4)	SARS (2.2)	OGDH (2.2)	BRAP (2.0)
ENSG00000053918	KCNQ1 PPI subnetwork	0.34	> 0.20	ZNF101 (2.2)	MAU2 (1.8)	SLC44A2 (1.7)	C19orf52 (1.7)	GATAD2A (1.6)	DNAH11 (1.5)	ZHX3 (1.5)	TM6SF2 (1.5)	GMIP (1.4)	KANK2 (1.4)
MP:0001073	abnormal glossopharyngeal nerve morphology	0.34	> 0.20	BCAM (3.2)	CEACAM19 (2.4)	HAVCR1 (2.1)	MARK4 (2.0)	PVRL2 (1.9)	ANKRD31 (1.8)	PPP1R37 (1.7)	TSSK6 (1.7)	ENSG00000226648 (1.4)	UBXN2B (1.4)
MP:0000060	delayed bone ossification	0.34	> 0.20	MAFB (3.0)	CILP2 (2.8)	NYNRIN (2.2)	FADS2 (1.6)	BCAM (1.6)	MYLIP (1.6)	PVRL2 (1.4)	PLCG1 (1.4)	PLEKHH2 (1.4)	FRK (1.3)
KEGG_CHRONIC_MYELOID_LEUKEMIA	KEGG_CHRONIC_MYELOID_LEUKEMIA	0.34	> 0.20	GATAD2A (3.1)	SLC44A2 (3.0)	DNM2 (2.8)	RELB (2.5)	PTPN11 (2.4)	PVR (2.1)	SORT1 (2.1)	SH2B3 (2.0)	GMIP (2.0)	MAU2 (1.9)
GO:0046943	carboxylic acid transmembrane transporter activity	0.34	> 0.20	TM6SF2 (3.8)	ABCG8 (3.6)	ABCG5 (2.4)	GRINA (2.3)	HAPLN4 (2.3)	ATP13A1 (2.3)	NPC1L1 (2.2)	PLG (2.1)	SARS (2.1)	TMEM116 (2.0)
ENSG00000011405	PIK3C2A PPI subnetwork	0.34	> 0.20	BCL3 (3.0)	DNM2 (2.3)	ALDH2 (2.2)	DOCK7 (2.1)	SLC44A2 (2.1)	GATAD2A (2.0)	C12orf47 (2.0)	PLEC (2.0)	PVRL2 (1.8)	MARK4 (1.7)
GO:0008180	signalosome	0.34	> 0.20	SARS (2.2)	OGDH (2.2)	TXNL4B (2.1)	MAFB (1.9)	PSMA5 (1.8)	GMPR (1.8)	C12orf43 (1.8)	C12orf51 (1.4)	TMED4 (1.3)	SYPL2 (1.3)
MP:0002408	abnormal double-positive T cell morphology	0.34	> 0.20	TIMD4 (4.9)	CETP (3.3)	MAFB (3.1)	GMIP (2.8)	PLCG1 (2.5)	SLC44A2 (2.0)	APOC1 (1.8)	GCNT4 (1.7)	LPA (1.6)	APOE (1.5)
MP:0004256	abnormal maternal decidual layer morphology	0.34	> 0.20	NCAN (3.1)	APOE (2.9)	APOC1 (2.6)	DNM2 (1.9)	ST3GAL4 (1.6)	RHD (1.6)	TIMD4 (1.6)	SLC22A1 (1.6)	APOA5 (1.5)	TRAFD1 (1.5)
ENSG00000111142	METAP2 PPI subnetwork	0.34	> 0.20	OASL (3.5)	C12orf47 (2.4)	FEN1 (2.3)	PLG (2.1)	APOA5 (2.0)	ATXN2 (2.0)	APOB (1.9)	TMEM50A (1.9)	ANGPTL3 (1.9)	PARP10 (1.8)
ENSG00000124614	RPS10 PPI subnetwork	0.34	> 0.20	NKPD1 (3.0)	ERP29 (1.8)	ILF3 (1.5)	ANKRD31 (1.5)	SARS (1.5)	TRAPPC6A (1.4)	ADAM1 (1.2)	LPAR2 (1.2)	COL4A3BP (1.1)	ATP13A1 (1.1)
ENSG00000204592	HLA-E PPI subnetwork	0.34	> 0.20	PARP10 (4.5)	HNF1A (2.1)	TMED4 (2.0)	YIPF2 (2.0)	ENSG00000228044 (1.9)	LPIN3 (1.7)	PPP1R37 (1.7)	ERP29 (1.6)	ABCG8 (1.5)	SLC22A1 (1.5)
REACTOME_VIF:MEDIATED_DEGRADATION_OF_APOBEC3G	REACTOME_VIF:MEDIATED_DEGRADATION_OF_APOBEC3G	0.34	> 0.20	PSMA5 (6.3)	TRAFD1 (3.5)	NAA25 (2.5)	NT5DC1 (2.3)	PARP10 (1.9)	SUGP1 (1.8)	TOMM40 (1.8)	DDX56 (1.6)	SARS (1.4)	ZNF259 (1.2)
MP:0003157	impaired muscle relaxation	0.34	> 0.20	SYPL2 (5.0)	APOC1 (2.9)	GOT2P1 (2.4)	GMPR (2.1)	SLC22A1 (1.9)	COL4A3BP (1.7)	RPH3A (1.6)	ALDH2 (1.4)	ENSG00000238078 (1.4)	KANK2 (1.4)
GO:0005774	vacuolar membrane	0.34	> 0.20	GRINA (4.3)	CLPTM1 (3.4)	ATP13A1 (3.2)	SORT1 (3.1)	ERP29 (3.1)	TMEM50A (2.9)	YIPF2 (2.4)	COL4A3BP (2.1)	SLC44A2 (1.9)	TMED4 (1.9)
ENSG00000131149	KIAA0182 PPI subnetwork	0.34	> 0.20	SMARCA4 (2.8)	NT5DC1 (2.4)	BUD13 (2.3)	MARK4 (2.2)	KIAA1324 (2.0)	C19orf52 (2.0)	PLCG1 (1.9)	KANK2 (1.8)	ACAD10 (1.6)	DNM2 (1.6)
GO:0003382	epithelial cell morphogenesis	0.34	> 0.20	CILP2 (3.7)	HNF1A (3.0)	ENSG00000238078 (2.6)	NYNRIN (2.6)	ABO (2.5)	ENSG00000254235 (2.3)	ENSG00000226645 (2.3)	BCAM (1.9)	C11orf9 (1.8)	PVRL2 (1.7)
ENSG00000169083	AR PPI subnetwork	0.34	> 0.20	ATXN2 (3.7)	TOP1 (2.5)	MAU2 (2.4)	BCL3 (2.3)	PLCG1 (2.3)	TRIB1 (2.1)	TRAFD1 (2.1)	SMARCA4 (2.0)	GATAD2A (1.9)	KIAA1324 (1.8)
GO:0042588	zymogen granule	0.34	> 0.20	KIAA1324 (4.2)	C12orf47 (2.3)	SORT1 (1.9)	YIPF2 (1.8)	ADAM1 (1.8)	ZNF180 (1.8)	ITGB3 (1.7)	TMED4 (1.7)	TMEM50A (1.6)	TSSK6 (1.6)
ENSG00000169439	SDC2 PPI subnetwork	0.34	> 0.20	APOE (3.4)	ITGB3 (3.1)	TIMD4 (2.6)	APOC1 (2.4)	CILP2 (2.2)	CYP7A1 (2.1)	ALDH2 (2.1)	PLEKHH2 (2.1)	APOC4 (2.0)	ABCG5 (2.0)
GO:0043534	blood vessel endothelial cell migration	0.34	> 0.20	ENSG00000226645 (2.4)	PVR (2.2)	ENSG00000228044 (2.1)	HLX (1.7)	ENSG00000226648 (1.6)	CEACAM19 (1.5)	ATXN7L2 (1.4)	CETP (1.4)	SH2B3 (1.4)	BCAM (1.4)
MP:0003071	decreased vascular permeability	0.34	> 0.20	HLX (3.7)	BCAM (2.1)	C17orf57 (2.1)	NYNRIN (1.7)	ITGB3 (1.6)	GMPR (1.5)	POLK (1.3)	CELSR2 (1.2)	DNAH11 (1.2)	ENSG00000228044 (1.2)
GO:0051495	positive regulation of cytoskeleton organization	0.34	> 0.20	PBX4 (2.5)	HNF1A (2.2)	DOCK7 (2.0)	ZNF101 (1.9)	ANKRD31 (1.6)	C17orf57 (1.6)	PLEC (1.6)	PLCG1 (1.5)	PVRL2 (1.5)	POLK (1.5)
GO:0051953	negative regulation of amine transport	0.34	> 0.20	MOSC1 (2.5)	TSSK6 (2.3)	ABO (2.3)	ENSG00000235545 (2.0)	GMPR (1.9)	GCNT4 (1.8)	PCSK9 (1.6)	ITGB3 (1.4)	HNF1A (1.2)	PLEKHH2 (1.1)
MP:0008497	decreased IgG2b level	0.34	> 0.20	RELB (4.4)	CETP (3.9)	TIMD4 (3.5)	GMIP (3.1)	BCL3 (2.5)	SH2B3 (1.9)	MAFB (1.8)	ZNF101 (1.7)	GCNT4 (1.7)	PLCG1 (1.1)
GO:0002204	somatic recombination of immunoglobulin genes involved in immune response	0.34	> 0.20	GCNT4 (2.4)	DYNC2LI1 (2.0)	NT5DC1 (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ZNF180 (1.6)	C17orf57 (1.5)	ANKRD31 (1.4)	PBX4 (1.3)	POC5 (1.2)
GO:0002208	somatic diversification of immunoglobulins involved in immune response	0.34	> 0.20	GCNT4 (2.4)	DYNC2LI1 (2.0)	NT5DC1 (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ZNF180 (1.6)	C17orf57 (1.5)	ANKRD31 (1.4)	PBX4 (1.3)	POC5 (1.2)
GO:0045190	isotype switching	0.34	> 0.20	GCNT4 (2.4)	DYNC2LI1 (2.0)	NT5DC1 (2.0)	ZNF101 (1.8)	HAVCR1 (1.7)	ZNF180 (1.6)	C17orf57 (1.5)	ANKRD31 (1.4)	PBX4 (1.3)	POC5 (1.2)
ENSG00000204261	ENSG00000204261 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (4.4)	NAA25 (2.6)	PARP10 (2.4)	NT5DC1 (2.1)	TOMM40 (1.7)	TMEM50A (1.6)	SARS (1.4)	DDX56 (1.4)	DHX38 (1.3)
ENSG00000206296	ENSG00000206296 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (4.4)	NAA25 (2.6)	PARP10 (2.4)	NT5DC1 (2.1)	TOMM40 (1.7)	TMEM50A (1.6)	SARS (1.4)	DDX56 (1.4)	DHX38 (1.3)
ENSG00000206232	ENSG00000206232 PPI subnetwork	0.34	> 0.20	PSMA5 (6.6)	TRAFD1 (4.4)	NAA25 (2.6)	PARP10 (2.4)	NT5DC1 (2.1)	TOMM40 (1.7)	TMEM50A (1.6)	SARS (1.4)	DDX56 (1.4)	DHX38 (1.3)
GO:0060411	cardiac septum morphogenesis	0.34	> 0.20	ABO (3.4)	C11orf9 (3.0)	ENSG00000238078 (2.7)	C19orf52 (2.5)	NYNRIN (2.2)	ATXN7L2 (2.1)	PVRL2 (1.8)	ENSG00000235545 (1.6)	C17orf57 (1.4)	ABCG8 (1.3)
MP:0000538	abnormal urinary bladder morphology	0.34	> 0.20	ABCG5 (3.9)	TM6SF2 (3.4)	NPC1L1 (2.5)	HLX (2.3)	FRK (1.9)	ABCG8 (1.8)	CBLC (1.8)	APOB (1.6)	ZHX3 (1.6)	ITGB3 (1.5)
ENSG00000177733	HNRNPA0 PPI subnetwork	0.34	> 0.20	ILF3 (3.6)	C1orf63 (3.2)	TOP1 (3.1)	SMARCA4 (3.0)	DHX38 (2.6)	USP1 (2.4)	SUGP1 (2.2)	TOMM40 (2.0)	FEN1 (1.9)	PTPN11 (1.9)
GO:0017046	peptide hormone binding	0.34	> 0.20	GPAM (2.7)	CETP (2.6)	C12orf47 (2.4)	KIAA1324 (2.1)	PLEKHH2 (2.0)	SYPL2 (1.7)	MYLIP (1.7)	SLC44A2 (1.6)	ANGPTL3 (1.6)	CEACAM19 (1.6)
GO:0001952	regulation of cell-matrix adhesion	0.34	> 0.20	SLC44A2 (4.2)	GCNT4 (3.6)	ITGB3 (3.3)	PLEKHH2 (2.6)	USP24 (2.0)	PBX4 (2.0)	ZHX3 (1.8)	YIPF2 (1.8)	C17orf57 (1.7)	AP1M2 (1.6)
ENSG00000174547	MRPL11 PPI subnetwork	0.34	> 0.20	QTRT1 (4.3)	ATP13A1 (3.4)	C19orf52 (3.1)	CARM1 (2.7)	TOMM40 (2.5)	GEMIN7 (2.4)	MAU2 (2.1)	OGDH (1.6)	PBX4 (1.6)	ENSG00000235545 (1.6)
MP:0009414	skeletal muscle fiber necrosis	0.34	> 0.20	SYPL2 (6.9)	PVR (2.7)	KANK2 (2.5)	SLC44A2 (2.3)	CYB561D1 (2.0)	GMPR (1.7)	TSSK6 (1.7)	RPH3A (1.5)	HAVCR1 (1.5)	MAU2 (1.5)
ENSG00000179094	PER1 PPI subnetwork	0.34	> 0.20	ZHX3 (2.6)	TMEM57 (2.5)	KANK2 (2.4)	ENSG00000254235 (2.3)	PVRL2 (2.0)	C17orf57 (1.8)	ATXN2 (1.7)	GPAM (1.7)	COL4A3BP (1.5)	PBX4 (1.4)
MP:0002754	dilated heart right ventricle	0.34	> 0.20	BCAM (3.4)	SYPL2 (3.0)	CEACAM19 (2.7)	KANK2 (2.7)	PVR (2.2)	MAFB (1.8)	GMPR (1.7)	ENSG00000228044 (1.7)	ENSG00000226645 (1.7)	HNF1A (1.7)
ENSG00000083168	KAT6A PPI subnetwork	0.34	> 0.20	C1orf63 (3.0)	MYLIP (2.9)	GMIP (1.9)	C17orf57 (1.9)	PPP1R37 (1.9)	SUGP1 (1.8)	CLPTM1 (1.6)	DYNC2LI1 (1.6)	ATXN7L2 (1.5)	GRINA (1.4)
GO:0010827	regulation of glucose transport	0.35	> 0.20	NPC1L1 (3.0)	POC5 (2.9)	DOCK7 (2.7)	ABCG8 (2.3)	GPAM (2.0)	NAA25 (2.0)	ENSG00000235545 (1.8)	MOSC1 (1.8)	ABCG5 (1.8)	GCNT4 (1.7)
ENSG00000095261	PSMD5 PPI subnetwork	0.35	> 0.20	PSMA5 (6.6)	TRAFD1 (3.5)	NT5DC1 (2.3)	NAA25 (2.2)	PARP10 (1.9)	TOMM40 (1.8)	TMEM50A (1.7)	SUGP1 (1.7)	DDX56 (1.6)	SARS (1.4)
ENSG00000125818	PSMF1 PPI subnetwork	0.35	> 0.20	PSMA5 (6.4)	TRAFD1 (4.2)	NAA25 (2.3)	NT5DC1 (2.3)	TOMM40 (1.9)	SUGP1 (1.9)	DHX38 (1.6)	SARS (1.6)	PARP10 (1.5)	TXNL4B (1.4)
ENSG00000164118	CEP44 PPI subnetwork	0.35	> 0.20	ITGB3 (3.2)	GMPR (2.8)	TMEM57 (2.5)	TMEM50A (2.3)	APOC1 (2.2)	HAVCR1 (1.8)	LPIN3 (1.7)	POC5 (1.7)	BRAP (1.6)	PLCG1 (1.5)
ENSG00000105939	ZC3HAV1 PPI subnetwork	0.35	> 0.20	OASL (7.0)	PARP10 (2.7)	USP1 (2.4)	ATP13A1 (2.2)	ENSG00000226648 (1.9)	ENSG00000235545 (1.9)	TOP1 (1.8)	PSMA5 (1.7)	SUGP1 (1.6)	ILF3 (1.6)
GO:0001101	response to acid	0.35	> 0.20	C17orf57 (4.3)	C11orf9 (2.2)	ANKRD31 (2.2)	SARS (2.0)	COL4A3BP (1.7)	NPC1L1 (1.7)	FRK (1.7)	ABCG5 (1.6)	YIPF2 (1.6)	AP1M2 (1.5)
GO:0044253	positive regulation of multicellular organismal metabolic process	0.35	> 0.20	NKPD1 (2.1)	ST3GAL4 (2.0)	HNF1A (1.7)	GEMIN7 (1.6)	C17orf57 (1.6)	ENSG00000226645 (1.6)	FRK (1.6)	ENSG00000235545 (1.5)	BLOC1S3 (1.4)	POLK (1.4)
GO:0060348	bone development	0.35	> 0.20	CILP2 (5.6)	PLEKHH2 (2.2)	NYNRIN (2.2)	YIPF2 (2.1)	MAFB (1.7)	PCSK9 (1.6)	ALDH2 (1.6)	MYLIP (1.4)	MAPKAPK5 (1.1)	SLC22A1 (1.1)
MP:0002769	abnormal vas deferens morphology	0.35	> 0.20	LPAR2 (3.0)	KANK2 (2.2)	GCNT4 (2.0)	GMPR (1.8)	FADS1 (1.8)	YIPF2 (1.7)	FADS2 (1.5)	SYPL2 (1.4)	FRK (1.4)	KIAA1324 (1.4)
ENSG00000170759	KIF5B PPI subnetwork	0.35	> 0.20	CBLC (4.8)	DNM2 (3.6)	PLEC (3.2)	AP1M2 (3.1)	LPAR2 (2.8)	MARK4 (2.7)	HNF1A (2.2)	C12orf51 (2.0)	ATXN2 (1.9)	CARM1 (1.8)
ENSG00000184371	CSF1 PPI subnetwork	0.35	> 0.20	POLK (2.8)	GMIP (2.6)	DNM2 (2.6)	CELSR2 (2.4)	BCL3 (2.4)	NCAN (2.4)	MARK4 (2.3)	PLEC (2.3)	TSSK6 (2.3)	PARP10 (2.1)
ENSG00000149532	CPSF7 PPI subnetwork	0.35	> 0.20	ILF3 (4.2)	C1orf63 (3.9)	SMARCA4 (3.2)	DHX38 (3.1)	SUGP1 (3.0)	TOP1 (2.7)	BUD13 (2.6)	USP1 (2.2)	MAU2 (2.0)	FEN1 (2.0)
MP:0008025	brain vacuoles	0.35	> 0.20	ZHX3 (3.0)	ABO (2.8)	GRINA (2.5)	HNF1A (2.3)	PTPN11 (2.3)	ACAD10 (2.3)	MAPKAPK5 (2.1)	CEACAM19 (2.1)	COL4A3BP (2.0)	ST3GAL4 (1.7)
GO:0042455	ribonucleoside biosynthetic process	0.35	> 0.20	DHODH (3.0)	TXNL4B (2.9)	NKPD1 (2.0)	YIPF2 (1.8)	ENSG00000238078 (1.7)	C12orf47 (1.5)	C17orf57 (1.5)	PSMA5 (1.4)	DDX56 (1.4)	ENSG00000226648 (1.4)
GO:0046129	purine ribonucleoside biosynthetic process	0.35	> 0.20	DHODH (3.0)	TXNL4B (2.9)	NKPD1 (2.0)	YIPF2 (1.8)	ENSG00000238078 (1.7)	C12orf47 (1.5)	C17orf57 (1.5)	PSMA5 (1.4)	DDX56 (1.4)	ENSG00000226648 (1.4)
GO:0042451	purine nucleoside biosynthetic process	0.35	> 0.20	DHODH (3.0)	TXNL4B (2.9)	NKPD1 (2.0)	YIPF2 (1.8)	ENSG00000238078 (1.7)	C12orf47 (1.5)	C17orf57 (1.5)	PSMA5 (1.4)	DDX56 (1.4)	ENSG00000226648 (1.4)
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	0.35	> 0.20	POC5 (3.3)	NAA25 (2.9)	BUD13 (2.7)	USP1 (2.7)	DOCK7 (2.6)	USP24 (2.3)	ILF3 (2.3)	DDX56 (2.2)	FEN1 (2.1)	MAPKAPK5 (2.0)
ENSG00000104814	MAP4K1 PPI subnetwork	0.35	> 0.20	PLCG1 (2.6)	SH2B3 (2.3)	TRAFD1 (1.9)	FRK (1.7)	C1orf63 (1.7)	PPP1R37 (1.6)	GMIP (1.6)	ITGB3 (1.5)	OGDH (1.5)	BLOC1S3 (1.4)
ENSG00000153187	HNRNPU PPI subnetwork	0.35	> 0.20	ILF3 (4.0)	TOP1 (3.6)	C1orf63 (3.3)	SMARCA4 (2.8)	DHX38 (2.8)	USP1 (2.6)	QTRT1 (2.6)	BUD13 (2.3)	GATAD2A (2.1)	TOMM40 (2.0)
MP:0000188	abnormal circulating glucose level	0.35	> 0.20	MOSC1 (3.3)	SORT1 (2.3)	GPAM (2.3)	PLEKHH2 (1.7)	HLX (1.4)	GRINA (1.4)	DOCK7 (1.4)	MAFB (1.4)	AMIGO1 (1.4)	LPIN3 (1.3)
ENSG00000138668	HNRNPD PPI subnetwork	0.35	> 0.20	ILF3 (4.3)	C1orf63 (3.7)	SMARCA4 (3.3)	TOP1 (3.2)	DHX38 (2.4)	BUD13 (2.4)	USP1 (2.3)	QTRT1 (2.3)	GATAD2A (2.3)	SUGP1 (2.1)
ENSG00000133121	STARD13 PPI subnetwork	0.35	> 0.20	LDLR (4.4)	FADS1 (3.7)	COL4A3BP (3.0)	GMPR (2.5)	PCSK9 (2.4)	FADS2 (2.4)	C11orf9 (2.0)	SORT1 (1.9)	ENSG00000238078 (1.7)	RPH3A (1.5)
MP:0001154	seminiferous tubule degeneration	0.35	> 0.20	ATXN7L2 (2.3)	ABO (2.2)	LDLR (1.8)	ST3GAL4 (1.8)	PVRL2 (1.5)	HNF1A (1.5)	FEN1 (1.4)	USP1 (1.4)	PBX4 (1.3)	FADS1 (1.3)
MP:0001847	brain inflammation	0.35	> 0.20	MAFB (3.4)	APOE (2.0)	RELB (1.9)	TMEM50A (1.8)	BCL3 (1.8)	GMIP (1.5)	SLC44A2 (1.5)	MYLIP (1.3)	ST3GAL4 (1.2)	ENSG00000228044 (1.2)
MP:0004220	abnormal peripheral nervous system regeneration	0.35	> 0.20	HP (3.0)	CELSR2 (2.5)	CETP (2.1)	ST3GAL4 (1.9)	GPAM (1.7)	TXNL4B (1.5)	APOE (1.5)	BCAM (1.4)	PCSK9 (1.3)	TIMD4 (1.3)
ENSG00000141759	TXNL4A PPI subnetwork	0.35	> 0.20	ILF3 (3.9)	DHX38 (3.6)	TOP1 (3.3)	SUGP1 (3.1)	C1orf63 (3.0)	SMARCA4 (3.0)	FEN1 (2.7)	QTRT1 (2.6)	BUD13 (2.5)	USP1 (2.4)
MP:0005168	abnormal female meiosis	0.35	> 0.20	ANKRD31 (2.9)	TMEM116 (2.6)	USP1 (1.9)	NYNRIN (1.8)	PCSK9 (1.7)	PSRC1 (1.5)	C17orf57 (1.5)	AP1M2 (1.4)	CEACAM19 (1.4)	ATXN7L2 (1.4)
ENSG00000025293	PHF20 PPI subnetwork	0.35	> 0.20	BUD13 (3.8)	C19orf52 (3.6)	GEMIN7 (2.0)	GCNT4 (2.0)	GATAD2A (1.8)	ATXN2 (1.8)	DHX38 (1.7)	C12orf43 (1.7)	SUGP1 (1.6)	ZNF259 (1.5)
GO:0033673	negative regulation of kinase activity	0.35	> 0.20	ENSG00000226645 (4.2)	TRIB1 (3.9)	PVR (2.0)	ENSG00000238078 (1.8)	KANK2 (1.7)	HLX (1.6)	MYLIP (1.5)	BCAM (1.4)	GPAM (1.3)	LDLR (1.3)
MP:0002621	delayed neural tube closure	0.35	> 0.20	NYNRIN (4.5)	PVRL2 (3.3)	HAVCR1 (2.4)	CBLC (2.4)	BCAM (2.1)	SLC44A2 (1.5)	TMEM116 (1.4)	CELSR2 (1.4)	PLEKHH2 (1.3)	MARK4 (1.3)
MP:0000748	progressive muscle weakness	0.35	> 0.20	SYPL2 (2.7)	BCAM (2.2)	HAPLN4 (2.1)	DOCK7 (2.1)	PLEC (2.0)	ENSG00000235545 (1.5)	RPH3A (1.5)	HMGCR (1.5)	SORT1 (1.5)	CYP7A1 (1.4)
ENSG00000100206	DMC1 PPI subnetwork	0.35	> 0.20	ANKRD31 (2.7)	FEN1 (2.5)	NAA25 (2.0)	USP1 (2.0)	C17orf57 (1.9)	TOMM40 (1.9)	SUGP1 (1.8)	GOT2P1 (1.6)	POLK (1.5)	TMEM57 (1.5)
REACTOME_SIGNALING_BY_ERBB4	REACTOME_SIGNALING_BY_ERBB4	0.35	> 0.20	CLPTM1 (3.4)	CELSR2 (2.7)	MARK4 (2.5)	ATXN2 (2.2)	ENSG00000226645 (2.2)	PLEC (2.1)	SARS (1.7)	ZHX3 (1.6)	DNM2 (1.6)	PVR (1.5)
ENSG00000126267	COX6B1 PPI subnetwork	0.35	> 0.20	GOT2P1 (3.2)	TRAPPC6A (2.9)	RHD (2.2)	SARS (1.6)	OGDH (1.6)	RHCE (1.5)	C1orf63 (1.4)	ACAD10 (1.4)	TMED4 (1.3)	CLPTM1 (1.3)
GO:0048246	macrophage chemotaxis	0.35	> 0.20	TMEM116 (3.5)	ZNF101 (2.7)	HAVCR1 (2.4)	ST3GAL4 (2.3)	AMIGO1 (2.0)	C17orf57 (1.9)	MAFB (1.9)	TMED4 (1.4)	KIAA1324 (1.3)	ENSG00000238078 (1.3)
ENSG00000017260	ATP2C1 PPI subnetwork	0.35	> 0.20	CLPTM1 (3.6)	YIPF2 (3.0)	TMEM50A (2.7)	TMEM57 (2.5)	TMED4 (2.4)	ERP29 (2.4)	ATP13A1 (2.3)	MAU2 (1.7)	SLC44A2 (1.6)	CYB561D1 (1.6)
REACTOME_PKA:MEDIATED_PHOSPHORYLATION_OF_CREB	REACTOME_PKA:MEDIATED_PHOSPHORYLATION_OF_CREB	0.35	> 0.20	ST3GAL4 (3.0)	ITGB3 (2.8)	SH2B3 (2.7)	SORT1 (2.3)	KANK2 (2.0)	ENSG00000228044 (1.8)	PMFBP1 (1.8)	OGDH (1.7)	ENSG00000238078 (1.5)	GOT2P1 (1.4)
GO:0031650	regulation of heat generation	0.35	> 0.20	ENSG00000235545 (3.4)	ENSG00000228044 (2.7)	DNAH11 (2.3)	BLOC1S3 (2.0)	ZNF180 (1.7)	CETP (1.6)	HLX (1.6)	OASL (1.5)	ENSG00000226645 (1.4)	TSSK6 (1.3)
GO:0031652	positive regulation of heat generation	0.35	> 0.20	ENSG00000235545 (3.4)	ENSG00000228044 (2.7)	DNAH11 (2.3)	BLOC1S3 (2.0)	ZNF180 (1.7)	CETP (1.6)	HLX (1.6)	OASL (1.5)	ENSG00000226645 (1.4)	TSSK6 (1.3)
ENSG00000089022	MAPKAPK5 PPI subnetwork	0.35	> 0.20	PVR (2.4)	MARK4 (2.1)	AMIGO1 (1.9)	HLX (1.7)	MYLIP (1.6)	CARM1 (1.5)	NYNRIN (1.4)	SARS (1.4)	CBLC (1.3)	NPC1L1 (1.3)
ENSG00000101109	STK4 PPI subnetwork	0.35	> 0.20	UBXN2B (2.8)	PARP10 (2.6)	TRAFD1 (2.0)	C19orf52 (1.9)	NKPD1 (1.8)	GCNT4 (1.7)	CBLC (1.6)	CEACAM19 (1.6)	DNAH11 (1.6)	MYLIP (1.5)
GO:0019783	small conjugating protein-specific protease activity	0.35	> 0.20	USP24 (3.8)	ZNF180 (3.7)	OASL (3.4)	CARM1 (2.8)	TRAFD1 (2.1)	PARP10 (2.0)	NAA25 (1.7)	ATXN7L2 (1.6)	BRAP (1.5)	TMEM57 (1.3)
MP:0001728	failure of embryo implantation	0.35	> 0.20	PVR (2.8)	BLOC1S3 (2.6)	ENSG00000254235 (1.9)	PLEKHH2 (1.7)	MOSC1 (1.6)	SUGP1 (1.5)	CBLC (1.5)	HLX (1.4)	TXNL4B (1.4)	HAVCR1 (1.4)
ENSG00000169188	APEX2 PPI subnetwork	0.35	> 0.20	TRAPPC6A (3.1)	CELSR2 (2.2)	PBX4 (2.2)	YIPF2 (2.2)	PVRL2 (2.1)	QTRT1 (2.1)	NT5DC1 (2.0)	SUGP1 (1.8)	ZNF180 (1.7)	DYNC2LI1 (1.7)
GO:0017048	Rho GTPase binding	0.35	> 0.20	PLEC (3.1)	PVRL2 (2.5)	DNM2 (2.3)	AP1M2 (2.2)	MARK4 (2.2)	GMIP (2.2)	CARM1 (2.2)	LPIN3 (2.2)	C11orf9 (2.0)	ENSG00000235545 (2.0)
MP:0006033	abnormal external auditory canal morphology	0.35	> 0.20	MYLIP (2.7)	LPIN3 (2.7)	CEACAM19 (2.4)	BCAM (2.2)	DYNC2LI1 (2.0)	CILP2 (1.9)	HAVCR1 (1.9)	MAFB (1.8)	NKPD1 (1.6)	PLEC (1.6)
ENSG00000130193	C8orf55 PPI subnetwork	0.35	> 0.20	BCAM (3.4)	ENSG00000235545 (2.0)	PLEKHH2 (1.6)	MAFB (1.6)	PBX4 (1.5)	C11orf9 (1.5)	SLC22A1 (1.5)	LPAR2 (1.5)	POC5 (1.5)	C1orf63 (1.3)
ENSG00000146731	CCT6A PPI subnetwork	0.35	> 0.20	DDX56 (3.8)	NAA25 (3.7)	ZNF259 (3.4)	PSMA5 (2.8)	TOMM40 (2.8)	SARS (2.7)	TOP1 (2.1)	NT5DC1 (2.0)	OGDH (1.7)	QTRT1 (1.6)
ENSG00000135862	LAMC1 PPI subnetwork	0.35	> 0.20	BCAM (3.8)	PLEKHH2 (3.2)	KANK2 (3.0)	CELSR2 (2.3)	DOCK7 (2.2)	PVRL2 (2.1)	OGDH (2.0)	PLEC (2.0)	SLC44A2 (2.0)	PLCG1 (1.9)
ENSG00000129250	KIF1C PPI subnetwork	0.35	> 0.20	CARM1 (3.8)	DNM2 (3.5)	PLEC (3.3)	PTPN11 (2.9)	COL4A3BP (2.9)	ZHX3 (2.9)	ATXN2 (2.5)	MARK4 (2.4)	C11orf9 (2.2)	OGDH (2.2)
ENSG00000127318	IL22 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.4)	CETP (2.0)	GMIP (1.9)	ALDH2 (1.8)	LPA (1.6)	SH2B3 (1.1)	PARP10 (1.1)
GO:0050775	positive regulation of dendrite morphogenesis	0.35	> 0.20	DOCK7 (4.1)	ENSG00000235545 (3.8)	ABO (2.9)	GCNT4 (2.5)	ENSG00000226648 (2.3)	TSSK6 (1.8)	ABCG8 (1.6)	LPIN3 (1.5)	C11orf9 (1.5)	GEMIN7 (1.4)
MP:0008566	increased interferon-gamma secretion	0.35	> 0.20	CETP (3.7)	OASL (3.0)	GMIP (3.0)	BCL3 (2.5)	PARP10 (2.1)	RELB (2.1)	TIMD4 (1.8)	MAFB (1.6)	TRAFD1 (1.5)	ZNF101 (1.5)
ENSG00000104626	ERI1 PPI subnetwork	0.35	> 0.20	DOCK7 (2.6)	NT5DC1 (2.4)	NAA25 (2.1)	OASL (2.0)	FADS1 (2.0)	GPAM (1.9)	FADS2 (1.9)	PSMA5 (1.8)	MOSC1 (1.8)	GMPR (1.6)
KEGG_PATHWAYS_IN_CANCER	KEGG_PATHWAYS_IN_CANCER	0.35	> 0.20	RELB (3.2)	BCAM (2.3)	KANK2 (2.2)	PVRL2 (2.2)	MARK4 (2.0)	GATAD2A (1.9)	PTPN11 (1.9)	PVR (1.9)	PLEC (1.8)	LPAR2 (1.7)
MP:0002493	increased IgG level	0.35	> 0.20	RELB (3.4)	GMIP (3.0)	BCL3 (2.9)	MAFB (2.8)	SH2B3 (2.4)	PARP10 (2.0)	HAVCR1 (1.5)	LPAR2 (1.4)	TRIB1 (1.3)	RHD (1.2)
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY:ACID_OXIDATION_IN_MUSCLE	REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY:ACID_OXIDATION_IN_MUSCLE	0.35	> 0.20	BRAP (4.5)	C19orf52 (2.9)	SYPL2 (2.7)	ACAD10 (2.6)	GMPR (2.5)	AMIGO1 (2.2)	OGDH (2.1)	MOSC1 (1.9)	PTPN11 (1.8)	LPAR2 (1.7)
ENSG00000125676	THOC2 PPI subnetwork	0.35	> 0.20	C1orf63 (5.4)	ILF3 (3.3)	ATXN2 (2.7)	QTRT1 (2.7)	TOP1 (2.2)	ADAM1 (2.2)	NAA25 (2.1)	ERP29 (1.8)	PMFBP1 (1.8)	DOCK7 (1.8)
GO:0016579	protein deubiquitination	0.35	> 0.20	ZNF180 (4.3)	USP24 (3.6)	MAU2 (2.5)	TMEM57 (2.2)	BRAP (2.2)	CARM1 (2.1)	ENSG00000226648 (1.9)	ATXN7L2 (1.9)	C12orf51 (1.5)	AMIGO1 (1.4)
ENSG00000174111	SOCS7 PPI subnetwork	0.35	> 0.20	ZHX3 (2.8)	HAVCR1 (2.7)	PLEKHH2 (2.2)	TMEM50A (1.9)	TOP1 (1.8)	ZNF101 (1.6)	FADS2 (1.6)	COL4A3BP (1.5)	ABO (1.5)	RPH3A (1.4)
GO:0007005	mitochondrion organization	0.35	> 0.20	GOT2P1 (3.0)	TOMM40 (2.8)	ACAD10 (2.8)	DHODH (2.7)	TRAPPC6A (2.3)	C19orf52 (2.0)	TMEM116 (2.0)	C12orf43 (1.9)	BLOC1S3 (1.8)	TXNL4B (1.7)
ENSG00000140992	PDPK1 PPI subnetwork	0.35	> 0.20	DNM2 (3.5)	COL4A3BP (2.7)	MARK4 (2.6)	MAU2 (2.2)	CELSR2 (2.2)	SMARCA4 (2.2)	MYLIP (2.1)	CARM1 (2.0)	GRINA (2.0)	PVRL2 (2.0)
MP:0008866	chromosomal instability	0.35	> 0.20	FEN1 (5.6)	USP1 (3.5)	GOT2P1 (2.7)	ZNF180 (2.1)	PSRC1 (2.1)	ANKRD31 (1.7)	ENSG00000228044 (1.5)	BUD13 (1.5)	AMIGO1 (1.3)	POC5 (1.2)
GO:0070646	protein modification by small protein removal	0.35	> 0.20	ZNF180 (4.3)	USP24 (2.9)	ATXN7L2 (2.5)	BRAP (2.3)	ENSG00000226648 (2.3)	CARM1 (2.0)	MAU2 (1.8)	TMEM57 (1.5)	CEACAM19 (1.4)	ANKRD31 (1.3)
MP:0009009	absent estrous cycle	0.35	> 0.20	TOP1 (2.5)	KIAA1324 (2.3)	PMFBP1 (2.1)	PBX4 (1.7)	ENSG00000226648 (1.5)	ABO (1.5)	TRIB1 (1.4)	CYP7A1 (1.4)	LDLR (1.4)	ZHX3 (1.3)
MP:0002654	spongiform encephalopathy	0.35	> 0.20	CLPTM1 (2.5)	DOCK7 (2.4)	OGDH (2.4)	GCNT4 (2.1)	FRK (2.0)	COL4A3BP (2.0)	BCL3 (1.9)	CARM1 (1.8)	GRINA (1.7)	TMEM116 (1.6)
GO:0000060	protein import into nucleus, translocation	0.35	> 0.20	ENSG00000254235 (3.9)	UBXN2B (2.0)	ENSG00000226645 (1.9)	ENSG00000238078 (1.9)	ENSG00000228044 (1.7)	TRAFD1 (1.5)	LPA (1.5)	TXNL4B (1.3)	RELB (1.3)	BCL3 (1.3)
MP:0002273	abnormal pulmonary alveolus epithelial cell morphology	0.35	> 0.20	TMEM116 (2.4)	LPIN3 (2.3)	BCAM (2.3)	KIAA1324 (2.3)	DNAH11 (2.2)	TOP1 (1.8)	ERP29 (1.5)	PLEKHH2 (1.5)	PVR (1.4)	MYLIP (1.3)
ENSG00000135605	TEC PPI subnetwork	0.35	> 0.20	GATAD2A (2.7)	GMIP (2.7)	MYLIP (2.3)	DNM2 (1.9)	LPAR2 (1.9)	GRINA (1.8)	ATXN7L2 (1.7)	ST3GAL4 (1.7)	GMPR (1.6)	CYB561D1 (1.5)
ENSG00000149311	ATM PPI subnetwork	0.35	> 0.20	FEN1 (4.3)	USP1 (3.2)	UBXN2B (2.5)	POC5 (2.5)	SMARCA4 (2.3)	ZNF180 (2.0)	POLK (1.9)	ZNF259 (1.9)	ILF3 (1.4)	CLPTM1 (1.4)
GO:0006281	DNA repair	0.35	> 0.20	ZNF180 (3.2)	POC5 (3.2)	BUD13 (2.6)	SUGP1 (2.4)	USP1 (1.9)	MAPKAPK5 (1.8)	NT5DC1 (1.8)	FEN1 (1.8)	BLOC1S3 (1.8)	UBXN2B (1.8)
REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS	0.35	> 0.20	KIAA1324 (6.2)	ST3GAL4 (2.9)	SLC22A1 (1.9)	CYP7A1 (1.9)	YIPF2 (1.8)	ABCG5 (1.6)	MOSC1 (1.6)	TSSK6 (1.5)	APOA5 (1.5)	ABCG8 (1.5)
ENSG00000100867	DHRS2 PPI subnetwork	0.35	> 0.20	TMEM50A (2.8)	TMEM57 (2.6)	C1orf63 (2.3)	ERP29 (1.9)	PSMA5 (1.9)	SARS (1.8)	ADAM1 (1.7)	QTRT1 (1.6)	MYLIP (1.6)	C19orf52 (1.5)
ENSG00000155897	ADCY8 PPI subnetwork	0.35	> 0.20	AP1M2 (3.0)	CBLC (2.3)	APOC1 (2.3)	SORT1 (2.0)	PLEC (1.8)	APOB (1.8)	FRK (1.5)	TMEM57 (1.5)	CLPTM1 (1.4)	APOE (1.4)
MP:0004189	abnormal alveolar process morphology	0.35	> 0.20	ANKRD31 (2.5)	CILP2 (2.3)	TRAFD1 (1.9)	SLC22A1 (1.8)	ITGB3 (1.7)	PPP1R37 (1.6)	KANK2 (1.6)	ST3GAL4 (1.6)	APOE (1.5)	ENSG00000238078 (1.4)
GO:0016884	carbon-nitrogen ligase activity, with glutamine as amido-N-donor	0.35	> 0.20	DDX56 (3.4)	SARS (3.3)	QTRT1 (2.9)	C12orf43 (2.6)	NT5DC1 (2.6)	ACAD10 (2.1)	ANKRD31 (2.0)	DHODH (1.8)	FRK (1.7)	ATP13A1 (1.6)
GO:0090068	positive regulation of cell cycle process	0.35	> 0.20	PSMA5 (2.6)	TMED4 (2.1)	NAA25 (1.9)	PSRC1 (1.8)	TRAFD1 (1.7)	POLK (1.7)	POC5 (1.7)	TMEM50A (1.6)	DDX56 (1.4)	SUGP1 (1.3)
GO:0043900	regulation of multi-organism process	0.35	> 0.20	OASL (2.7)	ZNF101 (2.5)	MAU2 (2.2)	TIMD4 (2.2)	GEMIN7 (2.1)	ATP13A1 (1.9)	CETP (1.9)	PARP10 (1.8)	PBX4 (1.7)	CYB561D1 (1.7)
ENSG00000006744	ELAC2 PPI subnetwork	0.35	> 0.20	CARM1 (3.5)	DDX56 (2.7)	GMPR (2.4)	SMARCA4 (2.3)	TMEM57 (1.9)	ILF3 (1.8)	TOMM40 (1.7)	GATAD2A (1.7)	ACAD10 (1.7)	QTRT1 (1.6)
MP:0002784	abnormal Sertoli cell morphology	0.35	> 0.20	MARK4 (3.5)	NYNRIN (2.3)	FADS1 (2.2)	ABO (2.1)	LPAR2 (2.0)	TSSK6 (1.9)	CYP7A1 (1.9)	TMED4 (1.6)	ST3GAL4 (1.6)	PVRL2 (1.5)
ENSG00000066777	ARFGEF1 PPI subnetwork	0.35	> 0.20	TRAPPC6A (3.6)	TOMM40 (2.8)	CYB561D1 (2.2)	ST3GAL4 (2.0)	ERP29 (1.8)	RPH3A (1.8)	CLPTM1 (1.8)	UBXN2B (1.7)	QTRT1 (1.7)	PPP1R37 (1.6)
MP:0005011	increased eosinophil cell number	0.35	> 0.20	BCL3 (4.3)	GMIP (3.5)	RELB (3.0)	SH2B3 (2.0)	PLEC (1.9)	PVR (1.9)	ITGB3 (1.6)	PLEKHH2 (1.5)	ABCG8 (1.3)	HP (1.2)
GO:0006809	nitric oxide biosynthetic process	0.35	> 0.20	ENSG00000228044 (1.9)	PVR (1.6)	BCL3 (1.6)	TMEM116 (1.6)	MAFB (1.5)	AMIGO1 (1.5)	TXNL4B (1.5)	GCNT4 (1.5)	C17orf57 (1.4)	PLCG1 (1.2)
GO:0042176	regulation of protein catabolic process	0.35	> 0.20	ENSG00000235545 (3.1)	POLK (2.8)	GEMIN7 (2.1)	ZNF180 (2.0)	CLPTM1 (2.0)	CARM1 (2.0)	ENSG00000238078 (1.9)	SUGP1 (1.9)	GRINA (1.8)	ENSG00000254235 (1.6)
ENSG00000164136	IL15 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000128342	LIF PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000184995	IFNE PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000138684	IL21 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000183709	IL28A PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000145839	IL9 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000162892	IL24 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000147896	IFNK PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000182393	IL29 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000197110	IL28B PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000142224	IL19 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000104432	IL7 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000111536	IL26 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000177047	IFNW1 PPI subnetwork	0.35	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.8)	TIMD4 (2.3)	CETP (2.2)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	TRIB1 (1.2)	PARP10 (1.2)
ENSG00000171365	CLCN5 PPI subnetwork	0.35	> 0.20	TXNL4B (2.8)	UBXN2B (2.6)	C12orf51 (2.5)	ATP13A1 (2.4)	GRINA (2.4)	CLPTM1 (2.4)	CARM1 (2.3)	GOT2P1 (2.3)	SLC44A2 (2.2)	C12orf43 (1.7)
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	0.35	> 0.20	TOP1 (3.4)	USP1 (3.3)	ILF3 (3.3)	BUD13 (3.0)	C1orf63 (2.9)	DDX56 (2.7)	DOCK7 (2.5)	NAA25 (2.5)	DHODH (2.5)	USP24 (2.3)
GO:0006469	negative regulation of protein kinase activity	0.35	> 0.20	ENSG00000226645 (4.1)	TRIB1 (4.0)	PVR (2.2)	ENSG00000238078 (1.8)	MYLIP (1.7)	HLX (1.6)	KANK2 (1.5)	LDLR (1.2)	TOP1 (1.2)	BCAM (1.2)
ENSG00000101138	CSTF1 PPI subnetwork	0.35	> 0.20	ILF3 (4.1)	C1orf63 (3.2)	USP1 (3.0)	TOP1 (2.9)	DHX38 (2.8)	BUD13 (2.8)	SMARCA4 (2.7)	FEN1 (2.6)	SUGP1 (2.4)	QTRT1 (2.0)
GO:0048678	response to axon injury	0.35	> 0.20	ENSG00000228044 (3.7)	ENSG00000235545 (2.6)	ERP29 (1.8)	ALDH2 (1.8)	RHCE (1.5)	NPC1L1 (1.5)	ENSG00000238078 (1.5)	TRAPPC6A (1.4)	LPIN3 (1.4)	COL4A3BP (1.4)
ENSG00000146950	SHROOM2 PPI subnetwork	0.35	> 0.20	DNM2 (3.9)	PLEC (3.8)	COL4A3BP (3.0)	ZHX3 (2.8)	C11orf9 (2.8)	USP24 (2.6)	PTPN11 (2.4)	CARM1 (2.3)	C12orf51 (2.3)	ATXN2 (2.3)
ENSG00000111674	ENO2 PPI subnetwork	0.35	> 0.20	SLC44A2 (2.2)	PLEC (2.1)	ENSG00000228044 (2.0)	RHD (2.0)	RPH3A (1.8)	KANK2 (1.8)	SUGP1 (1.7)	PSRC1 (1.7)	MARK4 (1.7)	CARM1 (1.7)
ENSG00000108342	CSF3 PPI subnetwork	0.35	> 0.20	BCL3 (3.5)	HLX (3.4)	RELB (2.8)	TIMD4 (2.4)	CETP (2.3)	GMIP (2.1)	ALDH2 (2.0)	LPA (1.5)	CEACAM19 (1.3)	HP (1.2)
MP:0004031	insulitis	0.35	> 0.20	MAFB (4.5)	TIMD4 (2.0)	APOC1 (1.9)	GOT2P1 (1.9)	APOE (1.8)	POLK (1.6)	CETP (1.5)	NYNRIN (1.5)	NKPD1 (1.4)	ERP29 (1.2)
ENSG00000071894	CPSF1 PPI subnetwork	0.35	> 0.20	ILF3 (3.8)	SMARCA4 (3.2)	TOP1 (3.1)	DHX38 (2.9)	C1orf63 (2.6)	PTPN11 (2.6)	USP1 (2.2)	BUD13 (2.1)	SUGP1 (2.1)	FEN1 (2.1)
ENSG00000107186	MPDZ PPI subnetwork	0.35	> 0.20	ENSG00000226648 (3.1)	APOE (2.9)	CELSR2 (2.8)	HAVCR1 (2.3)	C17orf57 (2.2)	GCNT4 (1.9)	PVRL2 (1.8)	MYLIP (1.7)	KANK2 (1.7)	GPAM (1.6)
ENSG00000126217	MCF2L PPI subnetwork	0.36	> 0.20	CARM1 (3.9)	TMEM50A (3.3)	GATAD2A (2.8)	DDX56 (2.6)	ILF3 (2.5)	BRAP (2.5)	ATP13A1 (2.5)	PVR (2.3)	QTRT1 (2.2)	C11orf9 (2.1)
GO:0045502	dynein binding	0.36	> 0.20	RHCE (2.8)	DHX38 (2.7)	MAPKAPK5 (2.6)	DYNC2LI1 (2.5)	PBX4 (2.5)	DNAH11 (2.3)	TMEM57 (2.1)	POC5 (2.1)	TOP1 (2.0)	C12orf51 (1.9)
ENSG00000112118	MCM3 PPI subnetwork	0.36	> 0.20	FEN1 (6.3)	USP1 (4.0)	PSRC1 (2.0)	SUGP1 (1.7)	ENSG00000228044 (1.7)	NT5DC1 (1.5)	ENSG00000235545 (1.4)	ZNF180 (1.3)	TMEM50A (1.2)	POC5 (1.1)
GO:0060742	epithelial cell differentiation involved in prostate gland development	0.36	> 0.20	GCNT4 (4.0)	DNAH11 (3.4)	ENSG00000226648 (2.9)	ANKRD31 (2.7)	GOT2P1 (2.6)	AMIGO1 (2.0)	COL4A3BP (1.7)	CBLC (1.5)	TRAPPC6A (1.4)	ALDH2 (1.4)
ENSG00000139144	PIK3C2G PPI subnetwork	0.36	> 0.20	BCL3 (3.6)	DOCK7 (2.7)	RELB (2.6)	DNM2 (2.6)	SLC44A2 (2.5)	SH2B3 (2.3)	MARK4 (2.0)	HLX (2.0)	GMIP (1.9)	GATAD2A (1.9)
MP:0011104	partial embryonic lethality before implantation	0.36	> 0.20	FEN1 (2.7)	PSRC1 (2.7)	USP1 (2.6)	MAFB (1.9)	ENSG00000238078 (1.8)	AMIGO1 (1.6)	ABO (1.5)	MOSC1 (1.5)	CETP (1.4)	APOE (1.3)
KEGG_NITROGEN_METABOLISM	KEGG_NITROGEN_METABOLISM	0.36	> 0.20	RHD (3.7)	RHCE (3.6)	DNAH11 (3.3)	MOSC1 (2.8)	ENSG00000235545 (2.7)	SARS (2.5)	HAPLN4 (2.3)	UBXN2B (2.2)	APOC4 (2.0)	APOE (2.0)
GO:0045429	positive regulation of nitric oxide biosynthetic process	0.36	> 0.20	ENSG00000228044 (3.2)	AMIGO1 (2.5)	BCL3 (1.8)	PVR (1.7)	C12orf43 (1.6)	TXNL4B (1.6)	RELB (1.6)	MAFB (1.4)	ENSG00000254235 (1.4)	DNAH11 (1.4)
ENSG00000115685	PPP1R7 PPI subnetwork	0.36	> 0.20	TOP1 (2.4)	CARM1 (2.2)	KANK2 (2.1)	DHX38 (1.9)	BUD13 (1.8)	DYNC2LI1 (1.7)	DOCK7 (1.6)	TM6SF2 (1.6)	TMEM50A (1.5)	BRAP (1.4)
ENSG00000132970	WASF3 PPI subnetwork	0.36	> 0.20	DYNC2LI1 (3.1)	DNM2 (2.6)	CEACAM19 (2.4)	ATXN7L2 (2.3)	PPP1R37 (2.2)	ENSG00000226648 (2.1)	SUGP1 (2.1)	BLOC1S3 (1.8)	LPIN3 (1.8)	DNAH11 (1.8)
ENSG00000174780	SRP72 PPI subnetwork	0.36	> 0.20	LPIN3 (2.3)	ENSG00000254235 (2.3)	C12orf43 (2.2)	TMEM57 (2.2)	SUGP1 (2.0)	DYNC2LI1 (2.0)	C1orf63 (1.8)	FRK (1.8)	DHX38 (1.6)	YIPF2 (1.6)
ENSG00000132669	RIN2 PPI subnetwork	0.36	> 0.20	PTPN11 (2.8)	TMEM50A (2.2)	GATAD2A (2.1)	ANKRD31 (2.1)	HMGCR (2.0)	PLEKHH2 (1.9)	PPP1R37 (1.9)	FADS2 (1.8)	TMEM57 (1.8)	NPC1L1 (1.8)
MP:0009335	decreased splenocyte proliferation	0.36	> 0.20	PLCG1 (2.9)	RELB (2.4)	PBX4 (2.3)	GMPR (2.2)	LPAR2 (2.1)	ZNF101 (2.1)	TRIB1 (1.9)	OASL (1.8)	PARP10 (1.7)	BCL3 (1.7)
ENSG00000172179	PRL PPI subnetwork	0.36	> 0.20	BCL3 (3.6)	HLX (2.8)	RELB (2.7)	TIMD4 (2.4)	CETP (2.2)	GMIP (1.8)	ALDH2 (1.8)	LPA (1.5)	GRINA (1.1)	CEACAM19 (1.1)
ENSG00000167085	PHB PPI subnetwork	0.36	> 0.20	ERP29 (3.1)	ENSG00000226648 (2.3)	PLCG1 (1.9)	NAA25 (1.9)	USP1 (1.8)	ADAM1 (1.8)	ALDH2 (1.8)	GOT2P1 (1.6)	SARS (1.6)	MAFB (1.5)
MP:0002908	delayed wound healing	0.36	> 0.20	SLC22A1 (2.1)	BCL3 (1.9)	TRIB1 (1.6)	MAFB (1.5)	C11orf9 (1.5)	HP (1.4)	ENSG00000228044 (1.4)	PVR (1.3)	HNF1A (1.2)	ABCG5 (1.1)
ENSG00000196419	XRCC6 PPI subnetwork	0.36	> 0.20	SMARCA4 (3.3)	FEN1 (2.5)	ILF3 (2.5)	DHX38 (2.3)	USP1 (2.2)	TOP1 (2.2)	PLEC (1.9)	MYLIP (1.8)	PSMA5 (1.6)	BUD13 (1.5)
ENSG00000160746	ANO10 PPI subnetwork	0.36	> 0.20	ATP13A1 (2.6)	QTRT1 (2.4)	C19orf52 (2.3)	DDX56 (2.2)	LPAR2 (2.1)	DNM2 (2.1)	ILF3 (2.0)	SUGP1 (1.9)	TMEM57 (1.8)	SARS (1.8)
MP:0005465	abnormal T-helper 1 physiology	0.36	> 0.20	BCL3 (2.4)	MAFB (2.2)	PBX4 (2.1)	RELB (1.8)	TRAFD1 (1.6)	PVR (1.5)	DNAH11 (1.5)	SLC22A1 (1.5)	MAU2 (1.5)	C19orf52 (1.4)
GO:0008023	transcription elongation factor complex	0.36	> 0.20	SUGP1 (2.6)	ZNF259 (2.6)	DDX56 (2.4)	GCNT4 (2.3)	TOP1 (2.0)	ATXN7L2 (2.0)	ZHX3 (1.8)	C19orf52 (1.8)	KIAA1324 (1.8)	BUD13 (1.8)
GO:0000940	condensed chromosome outer kinetochore	0.36	> 0.20	PSRC1 (6.1)	POC5 (3.1)	FEN1 (2.5)	USP1 (2.4)	MAU2 (1.6)	ZHX3 (1.4)	ENSG00000228044 (1.1)	GEMIN7 (1.1)	COL4A3BP (0.9)	DNAH11 (0.7)
GO:2000145	regulation of cell motility	0.36	> 0.20	PVR (3.1)	PVRL2 (3.0)	HLX (2.4)	ENSG00000254235 (2.4)	KANK2 (2.2)	MAFB (2.1)	CETP (1.9)	APOE (1.8)	SLC44A2 (1.7)	PTPN11 (1.6)
ENSG00000148672	GLUD1 PPI subnetwork	0.36	> 0.20	HAVCR1 (2.5)	NCAN (2.5)	BRAP (2.3)	UBXN2B (2.2)	SYPL2 (2.2)	USP24 (2.1)	TRAFD1 (2.0)	GMPR (1.9)	RHD (1.7)	C12orf43 (1.7)
ENSG00000165966	PDZRN4 PPI subnetwork	0.36	> 0.20	ITGB3 (3.3)	APOC1 (3.1)	GMPR (2.6)	TMEM50A (2.5)	ZNF101 (2.3)	LPIN3 (2.0)	GPAM (1.8)	HAVCR1 (1.8)	C1orf63 (1.7)	PLCG1 (1.5)
GO:0015874	norepinephrine transport	0.36	> 0.20	GMPR (2.7)	TSSK6 (2.1)	ZHX3 (2.1)	ABO (2.0)	DNAH11 (1.7)	ITGB3 (1.7)	PMFBP1 (1.5)	ANKRD31 (1.5)	LPIN3 (1.3)	MOSC1 (1.2)
ENSG00000091409	ITGA6 PPI subnetwork	0.36	> 0.20	BCAM (4.9)	PLEC (4.3)	ST3GAL4 (3.1)	PVRL2 (3.0)	CLPTM1 (2.9)	ERP29 (2.6)	GRINA (2.5)	APOE (2.4)	KANK2 (2.0)	OGDH (2.0)
GO:0030163	protein catabolic process	0.36	> 0.20	BRAP (3.1)	TRAFD1 (2.7)	MAU2 (2.5)	USP24 (2.3)	ZNF180 (2.1)	TMEM57 (2.0)	NAA25 (2.0)	DHX38 (1.9)	SUGP1 (1.8)	LPIN3 (1.6)
GO:0009267	cellular response to starvation	0.36	> 0.20	BRAP (3.7)	BLOC1S3 (3.4)	LPIN3 (2.5)	SARS (2.4)	TXNL4B (2.1)	HNF1A (2.0)	C1orf63 (2.0)	ACAD10 (1.9)	FADS2 (1.8)	ERP29 (1.6)
GO:0030334	regulation of cell migration	0.36	> 0.20	PVR (3.2)	PVRL2 (3.1)	HLX (2.3)	ENSG00000254235 (2.3)	MAFB (2.0)	KANK2 (2.0)	CETP (2.0)	APOE (1.9)	SLC44A2 (1.7)	PLEKHH2 (1.5)
ENSG00000212789	ENSG00000212789 PPI subnetwork	0.36	> 0.20	DOCK7 (2.8)	NAA25 (2.1)	GPAM (2.1)	OASL (2.0)	NT5DC1 (1.9)	PSMA5 (1.8)	MOSC1 (1.7)	OGDH (1.7)	FADS1 (1.7)	FADS2 (1.6)
ENSG00000120708	TGFBI PPI subnetwork	0.36	> 0.20	APOE (3.8)	C17orf57 (3.5)	APOC1 (2.5)	PVRL2 (1.9)	CETP (1.8)	SYPL2 (1.5)	CILP2 (1.4)	BCAM (1.3)	SORT1 (1.3)	FADS2 (1.3)
ENSG00000125944	HNRNPR PPI subnetwork	0.36	> 0.20	TOP1 (4.1)	ILF3 (3.5)	SMARCA4 (3.2)	USP1 (2.9)	DHX38 (2.8)	C1orf63 (2.7)	GATAD2A (2.5)	DDX56 (2.4)	SUGP1 (2.4)	FEN1 (2.1)
GO:0005839	proteasome core complex	0.36	> 0.20	PSMA5 (6.0)	TRAFD1 (4.4)	PARP10 (3.4)	NT5DC1 (2.2)	TMEM50A (1.9)	C12orf47 (1.7)	NAA25 (1.5)	ENSG00000254235 (1.5)	LPA (1.1)	CYB561D1 (1.1)
MP:0008225	abnormal anterior commissure morphology	0.36	> 0.20	PLCG1 (3.3)	GRINA (2.7)	C12orf47 (2.6)	PPP1R37 (2.4)	PVRL2 (2.2)	CELSR2 (1.9)	C12orf51 (1.9)	NYNRIN (1.7)	CYP7A1 (1.4)	CLPTM1 (1.3)
MP:0002718	abnormal inner cell mass morphology	0.36	> 0.20	FEN1 (3.0)	USP1 (2.7)	BUD13 (2.6)	ATXN7L2 (1.8)	ENSG00000254235 (1.8)	PPP1R37 (1.7)	GEMIN7 (1.5)	CBLC (1.4)	GATAD2A (1.4)	GOT2P1 (1.2)
ENSG00000196150	ZNF250 PPI subnetwork	0.36	> 0.20	FRK (3.8)	YIPF2 (3.8)	AP1M2 (3.3)	LPAR2 (3.2)	QTRT1 (1.8)	TMED4 (1.8)	MOSC1 (1.8)	SUGP1 (1.7)	HAVCR1 (1.6)	KANK2 (1.5)
ENSG00000186852	ENSG00000186852 PPI subnetwork	0.36	> 0.20	MAU2 (2.7)	TSSK6 (2.4)	ZNF101 (1.8)	BLOC1S3 (1.8)	PMFBP1 (1.6)	CILP2 (1.5)	HAVCR1 (1.4)	C11orf9 (1.4)	BUD13 (1.4)	PVR (1.4)
ENSG00000154310	TNIK PPI subnetwork	0.36	> 0.20	PSMA5 (3.3)	TOMM40 (3.0)	TMEM50A (2.6)	NT5DC1 (2.4)	CLPTM1 (2.4)	HMGCR (2.3)	LDLR (2.1)	FADS1 (1.9)	ST3GAL4 (1.8)	C12orf47 (1.7)
ENSG00000158769	F11R PPI subnetwork	0.36	> 0.20	ITGB3 (4.0)	C11orf9 (2.8)	APOE (2.5)	CBLC (2.4)	ENSG00000238078 (2.3)	AP1M2 (2.2)	CETP (2.1)	FRK (2.1)	PLCG1 (2.0)	PVRL2 (1.8)
MP:0005222	abnormal somite size	0.36	> 0.20	PLCG1 (2.7)	ABO (2.3)	NCAN (2.2)	ATXN2 (2.2)	GATAD2A (2.2)	SLC44A2 (2.1)	ATXN7L2 (2.0)	TOP1 (2.0)	C17orf57 (1.9)	C11orf9 (1.7)
ENSG00000152214	RIT2 PPI subnetwork	0.36	> 0.20	PMFBP1 (3.2)	MARK4 (2.8)	PPP1R37 (2.6)	NKPD1 (2.3)	COL4A3BP (2.3)	PVRL2 (1.8)	TOP1 (1.7)	PLEKHH2 (1.7)	ABO (1.6)	ANKRD31 (1.6)
MP:0004814	reduced linear vestibular evoked potential	0.36	> 0.20	LPIN3 (2.6)	FADS2 (1.9)	TSSK6 (1.8)	PCSK9 (1.6)	CBLC (1.6)	TM6SF2 (1.6)	ABO (1.6)	DNAH11 (1.5)	MOSC1 (1.5)	RPH3A (1.5)
GO:0005548	phospholipid transporter activity	0.36	> 0.20	TIMD4 (2.9)	COL4A3BP (2.4)	MYLIP (2.1)	AMIGO1 (1.9)	KANK2 (1.8)	GATAD2A (1.7)	ATP13A1 (1.6)	C17orf57 (1.6)	SLC44A2 (1.5)	GMIP (1.5)
GO:0005100	Rho GTPase activator activity	0.36	> 0.20	PLEKHH2 (2.9)	NYNRIN (2.7)	GMIP (2.6)	PPP1R37 (2.3)	DNM2 (2.3)	TRIB1 (2.1)	ATXN2 (2.0)	PVRL2 (1.9)	CBLC (1.8)	ENSG00000226645 (1.5)
ENSG00000064961	HMG20B PPI subnetwork	0.36	> 0.20	MARK4 (2.3)	SMARCA4 (2.2)	PSRC1 (2.1)	ACAD10 (1.9)	DHX38 (1.9)	BUD13 (1.7)	ILF3 (1.7)	DNM2 (1.7)	PLCG1 (1.7)	PPP1R37 (1.6)
ENSG00000197943	PLCG2 PPI subnetwork	0.36	> 0.20	SH2B3 (3.7)	MAFB (3.1)	SLC44A2 (2.7)	PLEKHH2 (2.5)	GMIP (2.5)	USP24 (2.4)	APOE (2.3)	MYLIP (2.2)	TIMD4 (2.2)	LPA (2.1)
ENSG00000198569	SLC34A3 PPI subnetwork	0.36	> 0.20	NCAN (2.8)	TMEM57 (2.4)	ADAM1 (2.2)	RPH3A (2.1)	MYLIP (2.1)	APOC1 (1.9)	SUGP1 (1.8)	TRAFD1 (1.7)	ENSG00000238078 (1.7)	ST3GAL4 (1.7)
GO:0002709	regulation of T cell mediated immunity	0.36	> 0.20	ZNF180 (3.1)	NKPD1 (2.1)	PARP10 (1.8)	CEACAM19 (1.7)	OASL (1.6)	CBLC (1.5)	FRK (1.5)	DNAH11 (1.5)	PVR (1.3)	GEMIN7 (1.3)
ENSG00000008018	PSMB1 PPI subnetwork	0.36	> 0.20	PSMA5 (5.7)	TRAFD1 (2.4)	NAA25 (2.3)	NT5DC1 (2.2)	DDX56 (1.6)	COL4A3BP (1.4)	HMGCR (1.4)	TXNL4B (1.4)	SARS (1.4)	ENSG00000254235 (1.3)
GO:0051047	positive regulation of secretion	0.36	> 0.20	KIAA1324 (3.4)	ENSG00000228044 (2.1)	GEMIN7 (1.7)	ENSG00000235545 (1.7)	NPC1L1 (1.6)	YIPF2 (1.5)	COL4A3BP (1.5)	ABO (1.5)	GCNT4 (1.3)	C11orf9 (1.2)
GO:0050433	regulation of catecholamine secretion	0.36	> 0.20	ABO (3.1)	CEACAM19 (2.4)	BLOC1S3 (1.8)	GOT2P1 (1.7)	PMFBP1 (1.6)	CETP (1.6)	PPP1R37 (1.6)	C19orf52 (1.5)	TSSK6 (1.4)	GMPR (1.4)
MP:0003704	abnormal hair follicle development	0.36	> 0.20	MAFB (2.4)	AP1M2 (2.2)	ANKRD31 (2.2)	CELSR2 (2.1)	CBLC (2.1)	CILP2 (2.0)	ZNF101 (1.9)	DNAH11 (1.7)	ENSG00000254235 (1.6)	C19orf52 (1.6)
REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR78_OR_9_STIMULATION	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR78_OR_9_STIMULATION	0.36	> 0.20	FRK (3.8)	TSSK6 (2.7)	OASL (2.4)	RELB (2.3)	MAU2 (2.3)	PARP10 (2.1)	LPAR2 (2.1)	ENSG00000226645 (1.7)	PLEKHH2 (1.5)	TMEM57 (1.5)
ENSG00000143498	TAF1A PPI subnetwork	0.36	> 0.20	C12orf43 (3.7)	ZNF259 (3.0)	MAPKAPK5 (2.7)	NAA25 (2.7)	TXNL4B (2.3)	DDX56 (2.2)	DYNC2LI1 (2.2)	BUD13 (2.2)	GEMIN7 (2.1)	POLK (1.9)
ENSG00000004478	FKBP4 PPI subnetwork	0.36	> 0.20	C17orf57 (2.8)	CARM1 (2.7)	SH2B3 (2.2)	HLX (2.1)	TRIB1 (2.1)	GOT2P1 (2.1)	ZNF259 (1.8)	PLEC (1.8)	GRINA (1.7)	ZNF101 (1.7)
GO:0048643	positive regulation of skeletal muscle tissue development	0.36	> 0.20	COL4A3BP (3.3)	POLK (2.8)	PMFBP1 (2.2)	LDLR (2.0)	DNAH11 (1.9)	CYP7A1 (1.6)	ENSG00000226648 (1.5)	SLC44A2 (1.4)	GMPR (1.3)	FADS1 (1.3)
GO:0031672	A band	0.36	> 0.20	SYPL2 (5.1)	GMPR (3.4)	RHCE (1.5)	ENSG00000238078 (1.3)	RHD (1.3)	POC5 (1.2)	LPAR2 (1.1)	ZNF101 (1.1)	ENSG00000226648 (1.1)	HP (1.1)
ENSG00000085760	MTIF2 PPI subnetwork	0.36	> 0.20	OASL (4.1)	PARP10 (3.3)	PLEKHH2 (2.5)	COL4A3BP (2.1)	ABCG5 (2.1)	PLCG1 (2.1)	PBX4 (2.0)	ABCG8 (1.9)	C12orf43 (1.8)	TM6SF2 (1.8)
GO:0001779	natural killer cell differentiation	0.36	> 0.20	CEACAM19 (2.9)	GEMIN7 (2.3)	C17orf57 (2.3)	CYB561D1 (2.2)	PBX4 (2.0)	ZNF180 (2.0)	TIMD4 (1.6)	C12orf43 (1.6)	BLOC1S3 (1.5)	ENSG00000228044 (1.4)
MP:0000926	absent floor plate	0.36	> 0.20	DYNC2LI1 (8.5)	PLEKHH2 (4.6)	ACAD10 (1.8)	TMEM116 (1.8)	NT5DC1 (1.6)	HAVCR1 (1.5)	DOCK7 (1.5)	C11orf9 (1.4)	DHODH (1.4)	FRK (1.3)
GO:0042345	regulation of NF-kappaB import into nucleus	0.36	> 0.20	ENSG00000228044 (3.2)	ENSG00000235545 (2.7)	ENSG00000238078 (2.5)	ZNF101 (2.3)	MYLIP (2.3)	OASL (1.8)	ZNF180 (1.7)	SH2B3 (1.6)	RELB (1.6)	LPAR2 (1.4)
GO:0042348	NF-kappaB import into nucleus	0.36	> 0.20	ENSG00000228044 (3.2)	ENSG00000235545 (2.7)	ENSG00000238078 (2.5)	ZNF101 (2.3)	MYLIP (2.3)	OASL (1.8)	ZNF180 (1.7)	SH2B3 (1.6)	RELB (1.6)	LPAR2 (1.4)
ENSG00000101400	SNTA1 PPI subnetwork	0.36	> 0.20	AMIGO1 (3.4)	KANK2 (2.7)	SYPL2 (2.5)	PBX4 (2.4)	ZHX3 (2.3)	RPH3A (2.2)	GPAM (2.2)	PLEC (2.2)	SORT1 (1.8)	CELSR2 (1.8)
ENSG00000147382	FAM58A PPI subnetwork	0.36	> 0.20	APOC1 (3.0)	NKPD1 (2.4)	NPC1L1 (2.3)	APOE (2.3)	C19orf52 (2.2)	PBX4 (2.0)	TXNL4B (2.0)	ABO (1.9)	COL4A3BP (1.8)	ABCG8 (1.8)
GO:0071339	MLL1 complex	0.36	> 0.20	C12orf43 (3.0)	BUD13 (3.0)	ATXN2 (2.9)	QTRT1 (2.5)	MAPKAPK5 (2.4)	DHX38 (2.3)	DDX56 (2.1)	OGDH (2.1)	ZNF180 (2.1)	C12orf47 (2.0)
MP:0006144	increased systemic arterial systolic blood pressure	0.36	> 0.20	BCAM (3.4)	AP1M2 (1.8)	POLK (1.6)	ABO (1.6)	ERP29 (1.5)	CILP2 (1.5)	C12orf47 (1.4)	MAFB (1.3)	RHCE (1.3)	HLX (1.3)
ENSG00000120063	GNA13 PPI subnetwork	0.36	> 0.20	DNM2 (3.1)	HLX (2.5)	CETP (2.3)	MARK4 (2.3)	SH2B3 (2.2)	MAFB (2.1)	GATAD2A (2.1)	PBX4 (2.1)	SLC44A2 (1.9)	GMIP (1.8)
GO:0002444	myeloid leukocyte mediated immunity	0.36	> 0.20	CYB561D1 (2.9)	UBXN2B (2.3)	GMIP (2.0)	ALDH2 (2.0)	ST3GAL4 (1.6)	C19orf52 (1.5)	HP (1.4)	BLOC1S3 (1.4)	CEACAM19 (1.3)	CILP2 (1.1)
ENSG00000198793	MTOR PPI subnetwork	0.36	> 0.20	USP24 (3.2)	DNM2 (2.6)	AP1M2 (2.5)	C12orf51 (2.5)	DOCK7 (2.4)	NAA25 (2.2)	PTPN11 (2.2)	SMARCA4 (2.2)	DHX38 (1.9)	GATAD2A (1.8)
GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	0.36	> 0.20	ANKRD31 (3.6)	MYLIP (2.3)	C1orf63 (2.2)	POLK (2.0)	ENSG00000238078 (1.7)	C12orf47 (1.7)	NT5DC1 (1.6)	POC5 (1.5)	DYNC2LI1 (1.5)	PMFBP1 (1.4)
REACTOME_CELL_CYCLE_CHECKPOINTS	REACTOME_CELL_CYCLE_CHECKPOINTS	0.36	> 0.20	FEN1 (5.1)	PSMA5 (4.2)	USP1 (2.9)	PSRC1 (2.2)	TRAFD1 (2.1)	POC5 (2.1)	NAA25 (1.7)	LPIN3 (1.7)	DDX56 (1.6)	NT5DC1 (1.5)
ENSG00000141027	NCOR1 PPI subnetwork	0.36	> 0.20	DHX38 (2.8)	PPP1R37 (2.7)	ATXN2 (2.6)	TMEM57 (2.5)	MYLIP (2.3)	SMARCA4 (2.3)	USP1 (2.2)	USP24 (2.0)	ILF3 (1.9)	MAPKAPK5 (1.8)
ENSG00000166603	MC4R PPI subnetwork	0.36	> 0.20	DNAH11 (2.9)	CETP (2.5)	FRK (2.3)	GMIP (2.3)	TSSK6 (2.0)	FADS2 (1.5)	C12orf47 (1.5)	GOT2P1 (1.5)	SLC44A2 (1.5)	CELSR2 (1.4)
ENSG00000023171	GRAMD1B PPI subnetwork	0.36	> 0.20	NPC1L1 (3.5)	TM6SF2 (2.6)	ENSG00000235545 (2.6)	SYPL2 (2.5)	ABCG8 (2.3)	ZNF101 (2.2)	C12orf47 (2.1)	HAPLN4 (2.0)	AMIGO1 (1.8)	ABCG5 (1.8)
GO:0007126	meiosis	0.36	> 0.20	ANKRD31 (3.8)	ENSG00000228044 (2.3)	POC5 (1.8)	USP1 (1.4)	PSRC1 (1.3)	TMEM116 (1.3)	ZHX3 (1.3)	ENSG00000238078 (1.1)	DYNC2LI1 (1.1)	FEN1 (1.1)
GO:0051327	M phase of meiotic cell cycle	0.36	> 0.20	ANKRD31 (3.8)	ENSG00000228044 (2.3)	POC5 (1.8)	USP1 (1.4)	PSRC1 (1.3)	TMEM116 (1.3)	ZHX3 (1.3)	ENSG00000238078 (1.1)	DYNC2LI1 (1.1)	FEN1 (1.1)
GO:0000084	S phase of mitotic cell cycle	0.36	> 0.20	PSMA5 (2.6)	NT5DC1 (2.3)	ENSG00000235545 (2.1)	USP1 (2.0)	FEN1 (2.0)	ZNF180 (1.9)	ENSG00000228044 (1.7)	TXNL4B (1.6)	TRAFD1 (1.5)	ENSG00000226648 (1.5)
ENSG00000067182	TNFRSF1A PPI subnetwork	0.36	> 0.20	PSMA5 (3.2)	PARP10 (2.8)	ACAD10 (2.4)	SARS (2.4)	TOMM40 (2.4)	RELB (2.3)	ZNF259 (2.1)	HAVCR1 (2.0)	TRAFD1 (2.0)	ATP13A1 (2.0)
ENSG00000140481	CCDC33 PPI subnetwork	0.36	> 0.20	DNM2 (4.0)	LPAR2 (3.0)	YIPF2 (2.9)	MARK4 (2.5)	SUGP1 (2.2)	CARM1 (2.2)	HAVCR1 (2.2)	FADS2 (2.0)	QTRT1 (2.0)	ATP13A1 (2.0)
GO:0002708	positive regulation of lymphocyte mediated immunity	0.36	> 0.20	GEMIN7 (2.0)	ENSG00000235545 (1.9)	POLK (1.6)	PBX4 (1.5)	PARP10 (1.4)	MAU2 (1.3)	SLC22A1 (1.1)	ZNF180 (1.1)	TRAFD1 (1.1)	ZNF101 (1.1)
GO:0002705	positive regulation of leukocyte mediated immunity	0.36	> 0.20	GEMIN7 (2.0)	ENSG00000235545 (1.9)	POLK (1.6)	PBX4 (1.5)	PARP10 (1.4)	MAU2 (1.3)	SLC22A1 (1.1)	ZNF180 (1.1)	TRAFD1 (1.1)	ZNF101 (1.1)
GO:0022603	regulation of anatomical structure morphogenesis	0.36	> 0.20	PVRL2 (2.9)	BCAM (2.3)	PPP1R37 (2.1)	NYNRIN (1.9)	PLEKHH2 (1.9)	ENSG00000235545 (1.8)	C11orf9 (1.8)	SLC44A2 (1.8)	PVR (1.7)	MAFB (1.6)
MP:0006107	abnormal fetal atrioventricular canal morphology	0.36	> 0.20	BCAM (4.3)	C11orf9 (2.1)	GMPR (1.9)	TSSK6 (1.9)	NYNRIN (1.8)	SORT1 (1.4)	UBXN2B (1.4)	PVRL2 (1.3)	MYLIP (1.2)	SYPL2 (1.2)
ENSG00000131746	TNS4 PPI subnetwork	0.36	> 0.20	CBLC (5.6)	AP1M2 (3.8)	CELSR2 (2.5)	FRK (2.3)	LPIN3 (2.1)	ST3GAL4 (2.0)	DNM2 (1.9)	C12orf51 (1.8)	PLEC (1.7)	LPAR2 (1.7)
REACTOME_DOWNREGULATION_OF_ERRB2ERBB3_SIGNALING	REACTOME_DOWNREGULATION_OF_ERRB2ERBB3_SIGNALING	0.36	> 0.20	ANKRD31 (2.6)	PPP1R37 (2.4)	YIPF2 (2.4)	CLPTM1 (2.3)	DOCK7 (2.3)	AMIGO1 (2.2)	ENSG00000238078 (2.0)	BCAM (1.9)	ABCG8 (1.8)	SH2B3 (1.7)
ENSG00000182132	KCNIP1 PPI subnetwork	0.36	> 0.20	ERP29 (2.8)	POC5 (2.5)	C17orf57 (2.1)	ENSG00000226645 (2.0)	GEMIN7 (1.9)	QTRT1 (1.9)	POLK (1.7)	ZNF180 (1.7)	COL4A3BP (1.6)	CLPTM1 (1.6)
ENSG00000140319	SRP14 PPI subnetwork	0.36	> 0.20	FRK (2.9)	QTRT1 (2.8)	GATAD2A (2.6)	ADAM1 (2.5)	C12orf43 (2.2)	ZNF101 (2.1)	OGDH (2.0)	ERP29 (2.0)	TMEM57 (1.9)	ENSG00000226645 (1.9)
GO:0034440	lipid oxidation	0.36	> 0.20	ACAD10 (4.6)	MOSC1 (3.0)	NT5DC1 (3.0)	OGDH (2.2)	AMIGO1 (2.1)	GPAM (1.9)	ENSG00000238078 (1.9)	ALDH2 (1.9)	TMEM116 (1.8)	C19orf52 (1.7)
MP:0009969	abnormal cerebral cortex pyramidal cell morphology	0.36	> 0.20	NCAN (3.5)	ABCG5 (2.7)	ABCG8 (2.3)	NKPD1 (2.3)	PLEKHH2 (2.2)	ITGB3 (2.1)	CYP7A1 (2.1)	DYNC2LI1 (2.1)	APOC4 (2.0)	C17orf57 (2.0)
MP:0002740	heart hypoplasia	0.36	> 0.20	C12orf51 (2.7)	MAFB (2.1)	BCAM (1.8)	ZHX3 (1.8)	USP24 (1.8)	PVR (1.7)	SMARCA4 (1.7)	ACAD10 (1.5)	ENSG00000254235 (1.4)	ATXN7L2 (1.4)
ENSG00000108175	ZMIZ1 PPI subnetwork	0.36	> 0.20	ATXN2 (4.3)	C12orf51 (3.8)	C12orf43 (2.9)	CARM1 (2.8)	BRAP (2.7)	GRINA (2.6)	C19orf52 (2.2)	MAPKAPK5 (2.2)	PLCG1 (2.1)	MYLIP (2.0)
GO:0015278	calcium-release channel activity	0.36	> 0.20	PLEC (2.4)	ITGB3 (2.2)	SH2B3 (2.1)	SLC44A2 (2.0)	LPIN3 (1.9)	SYPL2 (1.9)	MAU2 (1.8)	OGDH (1.8)	RPH3A (1.7)	ANKRD31 (1.7)
ENSG00000198231	DDX42 PPI subnetwork	0.36	> 0.20	DHX38 (2.6)	ATXN7L2 (2.5)	TXNL4B (2.4)	ATP13A1 (2.3)	DHODH (2.3)	LPIN3 (2.3)	SUGP1 (2.2)	ABO (2.0)	PBX4 (1.9)	GOT2P1 (1.8)
ENSG00000163161	ERCC3 PPI subnetwork	0.36	> 0.20	BUD13 (3.1)	SUGP1 (2.7)	ZNF259 (2.6)	PSMA5 (2.2)	POC5 (2.2)	TXNL4B (2.1)	MAPKAPK5 (2.1)	QTRT1 (1.8)	DNM2 (1.7)	DHX38 (1.6)
GO:0071715	icosanoid transport	0.36	> 0.20	NKPD1 (3.0)	DNAH11 (2.7)	CYB561D1 (2.6)	ST3GAL4 (2.2)	ADAM1 (1.9)	PMFBP1 (1.8)	ZNF180 (1.7)	LPIN3 (1.7)	YIPF2 (1.5)	ENSG00000228044 (1.5)
ENSG00000017797	RALBP1 PPI subnetwork	0.36	> 0.20	PPP1R37 (2.9)	FRK (2.4)	OGDH (2.1)	GOT2P1 (2.1)	PVRL2 (2.1)	COL4A3BP (2.1)	RELB (2.0)	BCL3 (2.0)	DDX56 (1.8)	LPAR2 (1.8)
GO:0048332	mesoderm morphogenesis	0.36	> 0.20	ENSG00000238078 (3.0)	ENSG00000254235 (2.6)	ENSG00000226648 (2.5)	NYNRIN (2.4)	ABO (1.6)	ANKRD31 (1.6)	GOT2P1 (1.5)	ATXN7L2 (1.5)	CARM1 (1.5)	CILP2 (1.3)
MP:0000427	abnormal hair cycle	0.36	> 0.20	AMIGO1 (3.6)	CELSR2 (2.4)	PVR (2.3)	ABO (2.1)	CEACAM19 (2.1)	ENSG00000254235 (2.0)	PMFBP1 (1.7)	CYB561D1 (1.6)	NPC1L1 (1.5)	GOT2P1 (1.4)
MP:0009866	abnormal aorta wall morphology	0.37	> 0.20	APOC1 (3.1)	SLC44A2 (1.9)	KANK2 (1.7)	PLEKHH2 (1.6)	NYNRIN (1.5)	ENSG00000226648 (1.5)	DYNC2LI1 (1.3)	ATXN7L2 (1.3)	ST3GAL4 (1.3)	CARM1 (1.1)
ENSG00000175792	RUVBL1 PPI subnetwork	0.37	> 0.20	SMARCA4 (3.0)	DHX38 (2.4)	TOMM40 (2.2)	DDX56 (2.1)	USP1 (2.1)	ILF3 (2.0)	BUD13 (1.9)	TOP1 (1.9)	ZNF180 (1.8)	ATXN2 (1.8)
GO:0006270	DNA-dependent DNA replication initiation	0.37	> 0.20	ZNF180 (3.0)	AMIGO1 (2.5)	USP1 (2.5)	FEN1 (2.5)	ENSG00000235545 (1.9)	TMEM116 (1.9)	ENSG00000228044 (1.7)	ERP29 (1.6)	NT5DC1 (1.6)	GOT2P1 (1.5)
ENSG00000070018	LRP6 PPI subnetwork	0.37	> 0.20	LPAR2 (2.9)	CILP2 (2.2)	DOCK7 (1.8)	PVRL2 (1.7)	KANK2 (1.6)	PLEKHH2 (1.6)	PCSK9 (1.6)	ENSG00000254235 (1.4)	PVR (1.3)	MOSC1 (1.3)
GO:0031047	gene silencing by RNA	0.37	> 0.20	DOCK7 (2.4)	ENSG00000228044 (2.3)	MAPKAPK5 (2.0)	ADAM1 (1.9)	ANKRD31 (1.9)	USP24 (1.8)	C1orf63 (1.7)	ENSG00000238078 (1.6)	ENSG00000226648 (1.5)	GCNT4 (1.4)
GO:0032039	integrator complex	0.37	> 0.20	POC5 (2.9)	GEMIN7 (2.7)	UBXN2B (2.5)	DHX38 (2.5)	ATP13A1 (2.0)	MAU2 (1.9)	NT5DC1 (1.8)	NKPD1 (1.8)	TOP1 (1.7)	BUD13 (1.6)
GO:2001020	regulation of response to DNA damage stimulus	0.37	> 0.20	ANKRD31 (2.3)	BUD13 (2.3)	ENSG00000226645 (2.1)	HAVCR1 (2.0)	NT5DC1 (1.8)	C19orf52 (1.6)	BLOC1S3 (1.6)	TRAPPC6A (1.6)	ZNF259 (1.5)	DYNC2LI1 (1.5)
GO:0006091	generation of precursor metabolites and energy	0.37	> 0.20	OGDH (4.3)	GOT2P1 (3.6)	ACAD10 (3.3)	ENSG00000238078 (2.6)	SYPL2 (2.1)	GMPR (1.9)	HAPLN4 (1.8)	GPAM (1.8)	TRAPPC6A (1.8)	C12orf47 (1.7)
REACTOME_SOS:MEDIATED_SIGNALLING	REACTOME_SOS:MEDIATED_SIGNALLING	0.37	> 0.20	GEMIN7 (2.3)	DNM2 (2.2)	MARK4 (2.2)	CARM1 (2.1)	BLOC1S3 (1.9)	MAPKAPK5 (1.9)	PBX4 (1.9)	ATXN2 (1.6)	ENSG00000238078 (1.6)	MYLIP (1.5)
MP:0008111	abnormal granulocyte differentiation	0.37	> 0.20	GMIP (3.9)	MAU2 (2.4)	DNM2 (2.0)	MYLIP (2.0)	LPAR2 (2.0)	RELB (2.0)	UBXN2B (1.5)	PARP10 (1.5)	KANK2 (1.4)	SLC44A2 (1.3)
ENSG00000167880	EVPL PPI subnetwork	0.37	> 0.20	NKPD1 (3.4)	PMFBP1 (2.7)	CEACAM19 (2.7)	DNAH11 (2.0)	CELSR2 (1.7)	MAFB (1.7)	CBLC (1.6)	C17orf57 (1.4)	ENSG00000226648 (1.4)	GMPR (1.2)
ENSG00000174446	SNAPC5 PPI subnetwork	0.37	> 0.20	C12orf43 (3.6)	ADAM1 (3.4)	GEMIN7 (3.2)	SUGP1 (2.5)	ZNF259 (2.4)	MAPKAPK5 (2.3)	POC5 (2.2)	C19orf52 (2.2)	DDX56 (2.0)	ATXN2 (2.0)
GO:0035051	cardiac cell differentiation	0.37	> 0.20	NYNRIN (2.7)	HNF1A (2.5)	CEACAM19 (2.2)	ANKRD31 (2.2)	GCNT4 (1.9)	C11orf9 (1.8)	BCAM (1.8)	SYPL2 (1.7)	ENSG00000238078 (1.6)	CILP2 (1.6)
ENSG00000155508	CNOT8 PPI subnetwork	0.37	> 0.20	ATXN2 (3.0)	BRAP (3.0)	FEN1 (2.7)	USP1 (2.4)	BUD13 (2.1)	HMGCR (2.0)	DHX38 (1.9)	ILF3 (1.9)	C12orf51 (1.7)	OGDH (1.7)
ENSG00000100304	TTLL12 PPI subnetwork	0.37	> 0.20	OASL (7.8)	PARP10 (3.4)	USP1 (2.3)	ATP13A1 (1.8)	PSRC1 (1.7)	TRAFD1 (1.7)	GCNT4 (1.7)	GATAD2A (1.7)	SUGP1 (1.6)	ENSG00000226648 (1.6)
GO:0000956	nuclear-transcribed mRNA catabolic process	0.37	> 0.20	TXNL4B (4.0)	BUD13 (2.7)	ADAM1 (2.6)	MAPKAPK5 (2.5)	UBXN2B (2.5)	ZNF259 (2.2)	BRAP (2.2)	ENSG00000226645 (2.1)	MAU2 (1.8)	DHX38 (1.7)
ENSG00000144668	ITGA9 PPI subnetwork	0.37	> 0.20	APOE (4.0)	TIMD4 (3.2)	CETP (3.0)	MAFB (3.0)	HLX (2.5)	GMIP (2.4)	SH2B3 (2.4)	APOC1 (2.1)	FRK (1.9)	ITGB3 (1.8)
ENSG00000175104	TRAF6 PPI subnetwork	0.37	> 0.20	PSMA5 (4.4)	TOMM40 (4.1)	NAA25 (3.1)	SARS (2.9)	PTPN11 (2.4)	CLPTM1 (2.4)	CARM1 (2.2)	TMEM50A (2.2)	SMARCA4 (2.1)	OGDH (1.8)
MP:0005566	decreased blood urea nitrogen level	0.37	> 0.20	C19orf52 (2.9)	CYB561D1 (2.2)	BCL3 (1.9)	PBX4 (1.9)	KANK2 (1.5)	BRAP (1.5)	PTPN11 (1.4)	ZHX3 (1.4)	PLEKHH2 (1.4)	DNAH11 (1.3)
KEGG_GLIOMA	KEGG_GLIOMA	0.37	> 0.20	SLC44A2 (2.6)	MARK4 (2.5)	PTPN11 (2.3)	NCAN (2.2)	ITGB3 (2.2)	SMARCA4 (2.1)	ATXN7L2 (2.1)	ZHX3 (2.0)	CELSR2 (1.9)	HLX (1.9)
MP:0004608	abnormal cervical axis morphology	0.37	> 0.20	CILP2 (4.3)	ENSG00000254235 (2.3)	MAFB (2.3)	NYNRIN (2.1)	C17orf57 (1.7)	TMEM50A (1.6)	ENSG00000238078 (1.6)	PLCG1 (1.5)	PCSK9 (1.4)	GMPR (1.4)
ENSG00000168476	REEP4 PPI subnetwork	0.37	> 0.20	CBLC (6.1)	AP1M2 (4.3)	ST3GAL4 (2.4)	LPAR2 (2.0)	CELSR2 (1.9)	FRK (1.7)	DOCK7 (1.6)	LPIN3 (1.5)	HNF1A (1.5)	PPP1R37 (1.4)
ENSG00000096996	IL12RB1 PPI subnetwork	0.37	> 0.20	BCL3 (2.9)	COL4A3BP (2.0)	PVR (1.9)	C17orf57 (1.7)	RELB (1.6)	OASL (1.4)	TIMD4 (1.3)	PARP10 (1.3)	CYP7A1 (1.3)	HLX (1.3)
ENSG00000185436	IL28RA PPI subnetwork	0.37	> 0.20	BCL3 (3.0)	COL4A3BP (2.1)	C17orf57 (1.6)	CYP7A1 (1.5)	PVR (1.5)	RELB (1.4)	HLX (1.4)	ZNF101 (1.3)	BCAM (1.3)	SLC22A1 (1.2)
GO:0050795	regulation of behavior	0.37	> 0.20	GCNT4 (2.4)	CETP (2.3)	ENSG00000226648 (2.3)	HLX (2.1)	ZNF101 (1.8)	MAFB (1.6)	DNAH11 (1.6)	APOE (1.5)	TIMD4 (1.5)	ENSG00000228044 (1.4)
ENSG00000129315	CCNT1 PPI subnetwork	0.37	> 0.20	SUGP1 (3.0)	DHX38 (2.7)	BUD13 (2.2)	SMARCA4 (2.2)	ZNF259 (2.0)	ATXN2 (2.0)	ATP13A1 (1.9)	C12orf43 (1.9)	TOP1 (1.8)	QTRT1 (1.7)
GO:0003678	DNA helicase activity	0.37	> 0.20	BRAP (3.2)	SUGP1 (3.1)	POC5 (2.9)	DHX38 (2.8)	FEN1 (2.6)	MAPKAPK5 (2.4)	ZNF180 (2.4)	DHODH (2.2)	SMARCA4 (2.2)	DDX56 (2.1)
MP:0000827	dilated third ventricle	0.37	> 0.20	DYNC2LI1 (4.2)	FADS1 (3.9)	FADS2 (2.9)	ATXN2 (2.8)	LDLR (2.5)	GRINA (2.5)	UBXN2B (2.4)	CARM1 (2.3)	C12orf51 (2.3)	HMGCR (2.0)
MP:0001726	abnormal allantois morphology	0.37	> 0.20	CETP (3.4)	ATXN2 (2.4)	KANK2 (2.3)	GATAD2A (2.0)	MARK4 (2.0)	ADAM1 (1.9)	PPP1R37 (1.9)	TIMD4 (1.6)	ABO (1.6)	SH2B3 (1.4)
GO:0050922	negative regulation of chemotaxis	0.37	> 0.20	ANKRD31 (3.2)	GCNT4 (3.2)	C17orf57 (2.4)	DNAH11 (2.2)	CEACAM19 (2.1)	TMEM57 (2.0)	PLEKHH2 (2.0)	ATXN7L2 (1.9)	PBX4 (1.8)	ENSG00000226648 (1.8)
ENSG00000138162	TACC2 PPI subnetwork	0.37	> 0.20	PSRC1 (2.6)	USP1 (1.9)	NCAN (1.9)	ZHX3 (1.7)	ENSG00000228044 (1.7)	TOMM40 (1.7)	BUD13 (1.6)	MAPKAPK5 (1.6)	BCL3 (1.5)	DHX38 (1.5)
ENSG00000185432	METTL7A PPI subnetwork	0.37	> 0.20	ACAD10 (3.0)	ABO (2.3)	HNF1A (2.3)	TMED4 (2.0)	TRAPPC6A (2.0)	ATXN7L2 (2.0)	ERP29 (2.0)	BUD13 (1.9)	CBLC (1.7)	NYNRIN (1.6)
ENSG00000166913	YWHAB PPI subnetwork	0.37	> 0.20	C12orf51 (3.5)	TOP1 (3.2)	PLEC (3.0)	SMARCA4 (2.9)	ATXN2 (2.7)	CBLC (2.6)	CELSR2 (2.3)	OGDH (2.3)	TRIB1 (2.1)	CARM1 (2.0)
GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	0.37	> 0.20	ENSG00000254235 (3.4)	CEACAM19 (2.4)	ZNF180 (2.1)	BLOC1S3 (2.1)	ALDH2 (1.7)	TSSK6 (1.7)	HNF1A (1.5)	MAPKAPK5 (1.4)	UBXN2B (1.4)	CILP2 (1.3)
ENSG00000061987	MON2 PPI subnetwork	0.37	> 0.20	TM6SF2 (3.2)	SLC22A1 (3.1)	ACAD10 (2.7)	C12orf43 (2.5)	ADAM1 (2.5)	ABCG8 (2.2)	HNF1A (2.0)	DHODH (1.9)	ANGPTL3 (1.8)	LPA (1.8)
ENSG00000148396	SEC16A PPI subnetwork	0.37	> 0.20	MARK4 (2.6)	HMGCR (2.5)	ENSG00000226648 (2.4)	LDLR (2.2)	ZNF180 (2.2)	GATAD2A (1.8)	C12orf51 (1.8)	USP24 (1.8)	PCSK9 (1.7)	FADS1 (1.7)
ENSG00000100297	MCM5 PPI subnetwork	0.37	> 0.20	FEN1 (5.8)	USP1 (4.7)	HAPLN4 (2.0)	ENSG00000235545 (2.0)	FADS1 (1.9)	PSRC1 (1.8)	BRAP (1.3)	DDX56 (1.2)	GMPR (1.1)	ENSG00000228044 (1.1)
ENSG00000113525	IL5 PPI subnetwork	0.37	> 0.20	BCL3 (3.7)	HLX (3.1)	RELB (2.6)	TIMD4 (2.1)	CETP (2.1)	GMIP (2.0)	ALDH2 (1.8)	LPA (1.7)	PBX4 (1.3)	PARP10 (1.2)
GO:0033044	regulation of chromosome organization	0.37	> 0.20	ENSG00000226648 (2.7)	TMEM57 (2.4)	BLOC1S3 (2.2)	RHD (1.8)	RHCE (1.7)	C12orf51 (1.6)	GOT2P1 (1.6)	PSRC1 (1.5)	ATXN2 (1.5)	ABO (1.4)
ENSG00000196396	PTPN1 PPI subnetwork	0.37	> 0.20	DNM2 (3.6)	C1orf63 (2.3)	PVRL2 (2.3)	PLEC (2.1)	TRAFD1 (2.1)	PLCG1 (2.0)	SLC44A2 (1.9)	CARM1 (1.9)	BLOC1S3 (1.8)	LDLR (1.7)
ENSG00000100823	APEX1 PPI subnetwork	0.37	> 0.20	USP1 (2.6)	PSRC1 (2.4)	HLX (2.0)	CELSR2 (1.9)	MAFB (1.9)	UBXN2B (1.8)	TOMM40 (1.7)	BLOC1S3 (1.6)	GRINA (1.6)	BCAM (1.5)
GO:0042094	interleukin-2 biosynthetic process	0.37	> 0.20	ENSG00000235545 (3.1)	ENSG00000254235 (2.5)	PBX4 (2.1)	CYB561D1 (1.9)	SLC44A2 (1.8)	POLK (1.7)	DYNC2LI1 (1.7)	PLCG1 (1.5)	ST3GAL4 (1.5)	ANKRD31 (1.4)
ENSG00000169045	HNRNPH1 PPI subnetwork	0.37	> 0.20	C1orf63 (3.8)	ILF3 (3.4)	SMARCA4 (3.3)	TOP1 (2.8)	DHX38 (2.4)	QTRT1 (2.3)	GATAD2A (2.3)	SUGP1 (2.2)	BUD13 (2.1)	USP1 (2.0)
MP:0000274	enlarged heart	0.37	> 0.20	BCAM (3.1)	KANK2 (2.6)	PLEC (2.3)	OGDH (2.2)	ATXN2 (2.0)	C11orf9 (2.0)	PVRL2 (1.9)	ACAD10 (1.8)	RHD (1.7)	TMED4 (1.7)
ENSG00000174243	DDX23 PPI subnetwork	0.37	> 0.20	ILF3 (4.1)	C1orf63 (3.6)	TOP1 (3.4)	DHX38 (3.1)	USP1 (2.9)	SMARCA4 (2.9)	SUGP1 (2.6)	BUD13 (2.6)	FEN1 (2.5)	MAU2 (2.1)
GO:2001252	positive regulation of chromosome organization	0.37	> 0.20	TMEM57 (3.1)	ENSG00000226648 (2.7)	SH2B3 (2.1)	FADS1 (2.0)	PCSK9 (2.0)	C12orf51 (1.9)	FADS2 (1.8)	DNM2 (1.8)	MYLIP (1.6)	RHD (1.6)
ENSG00000185291	IL3RA PPI subnetwork	0.37	> 0.20	COL4A3BP (2.8)	BCL3 (2.8)	HLX (1.7)	ZNF101 (1.5)	SH2B3 (1.4)	TIMD4 (1.4)	POLK (1.4)	GMIP (1.3)	RELB (1.3)	CYP7A1 (1.2)
GO:0006665	sphingolipid metabolic process	0.37	> 0.20	NKPD1 (5.8)	TMEM50A (3.6)	CYB561D1 (3.4)	HAVCR1 (3.1)	ERP29 (2.8)	COL4A3BP (2.7)	CLPTM1 (2.2)	TMED4 (2.2)	LPIN3 (2.1)	PPP1R37 (2.1)
GO:0032309	icosanoid secretion	0.37	> 0.20	NKPD1 (3.1)	CYB561D1 (2.4)	DNAH11 (2.4)	ADAM1 (2.3)	ST3GAL4 (2.0)	PMFBP1 (1.8)	LPIN3 (1.7)	ZNF180 (1.6)	ENSG00000235545 (1.5)	YIPF2 (1.5)
GO:0031072	heat shock protein binding	0.37	> 0.20	OGDH (2.8)	TMEM57 (2.7)	CLPTM1 (2.1)	PPP1R37 (2.0)	HMGCR (1.9)	LDLR (1.9)	GATAD2A (1.7)	ENSG00000226645 (1.6)	GOT2P1 (1.5)	CYP7A1 (1.5)
MP:0001714	absent trophoblast giant cells	0.37	> 0.20	ENSG00000228044 (3.2)	PSRC1 (3.0)	PVRL2 (2.2)	ACAD10 (1.9)	ABO (1.8)	CBLC (1.8)	HNF1A (1.5)	USP1 (1.5)	ILF3 (1.3)	CEACAM19 (1.3)
GO:0030866	cortical actin cytoskeleton organization	0.37	> 0.20	ABO (3.0)	NYNRIN (2.1)	GATAD2A (1.8)	GRINA (1.7)	OGDH (1.6)	YIPF2 (1.4)	ENSG00000254235 (1.3)	MYLIP (1.2)	CARM1 (1.1)	TMED4 (1.1)
MP:0000276	heart right ventricle hypertrophy	0.37	> 0.20	BCAM (2.9)	APOE (2.3)	C11orf9 (2.3)	HNF1A (2.2)	PLEKHH2 (2.1)	KANK2 (2.0)	GRINA (1.9)	ENSG00000254235 (1.7)	MYLIP (1.6)	ANKRD31 (1.6)
ENSG00000196655	TRAPPC4 PPI subnetwork	0.37	> 0.20	CLPTM1 (3.4)	YIPF2 (3.3)	BLOC1S3 (3.1)	GEMIN7 (3.1)	TMEM50A (2.8)	ZNF180 (2.3)	QTRT1 (2.0)	MARK4 (1.9)	C19orf52 (1.8)	KIAA1324 (1.8)
ENSG00000178741	COX5A PPI subnetwork	0.37	> 0.20	TRAPPC6A (4.7)	GOT2P1 (3.2)	C19orf52 (2.2)	DDX56 (2.0)	TOMM40 (1.8)	QTRT1 (1.8)	TXNL4B (1.6)	DHODH (1.6)	HAVCR1 (1.5)	ZNF259 (1.5)
MP:0005418	abnormal circulating hormone level	0.37	> 0.20	GPAM (4.6)	MOSC1 (3.6)	KIAA1324 (2.2)	ZHX3 (2.0)	C12orf47 (1.9)	ENSG00000254235 (1.7)	ATXN7L2 (1.5)	SORT1 (1.4)	HLX (1.4)	COL4A3BP (1.4)
GO:0030529	ribonucleoprotein complex	0.37	> 0.20	TOMM40 (2.9)	GEMIN7 (2.8)	DDX56 (2.6)	C12orf43 (2.4)	QTRT1 (2.3)	DHODH (2.3)	PSMA5 (2.2)	ILF3 (2.2)	DHX38 (2.2)	SMARCA4 (2.0)
ENSG00000197976	AKAP17A PPI subnetwork	0.37	> 0.20	C1orf63 (2.2)	ENSG00000228044 (2.0)	AMIGO1 (2.0)	CELSR2 (1.8)	PLCG1 (1.8)	NYNRIN (1.7)	PPP1R37 (1.6)	ERP29 (1.6)	ENSG00000254235 (1.5)	ZHX3 (1.3)
ENSG00000100368	CSF2RB PPI subnetwork	0.37	> 0.20	BCL3 (3.1)	COL4A3BP (2.3)	HLX (2.3)	SH2B3 (2.1)	CETP (1.7)	TIMD4 (1.6)	GMIP (1.6)	ZNF101 (1.5)	RELB (1.3)	ENSG00000238078 (1.3)
ENSG00000135404	CD63 PPI subnetwork	0.37	> 0.20	ST3GAL4 (3.2)	APOE (2.4)	SLC44A2 (2.1)	PMFBP1 (2.0)	TMEM50A (1.9)	ABO (1.8)	CYB561D1 (1.7)	PVR (1.7)	BCAM (1.6)	FADS2 (1.6)
ENSG00000092969	TGFB2 PPI subnetwork	0.37	> 0.20	CILP2 (6.1)	SLC44A2 (2.2)	KANK2 (2.1)	YIPF2 (2.0)	PVR (2.0)	LPA (1.8)	SLC22A1 (1.7)	MAFB (1.6)	ZNF180 (1.5)	APOA5 (1.5)
GO:0031649	heat generation	0.37	> 0.20	ENSG00000235545 (3.7)	ENSG00000228044 (2.5)	ST3GAL4 (2.4)	BLOC1S3 (2.4)	DNAH11 (2.2)	POLK (1.9)	GCNT4 (1.3)	OASL (1.2)	CETP (1.2)	TXNL4B (1.2)
ENSG00000185513	L3MBTL1 PPI subnetwork	0.37	> 0.20	POLK (2.6)	C19orf52 (2.4)	ST3GAL4 (2.1)	TSSK6 (1.8)	ZNF101 (1.7)	DNAH11 (1.7)	ENSG00000226648 (1.7)	BUD13 (1.6)	GCNT4 (1.6)	GEMIN7 (1.5)
ENSG00000012660	ELOVL5 PPI subnetwork	0.37	> 0.20	HMGCR (7.2)	LDLR (6.7)	FADS1 (6.1)	FADS2 (5.1)	PCSK9 (4.2)	SORT1 (3.1)	ERP29 (2.7)	CELSR2 (2.6)	GMPR (2.1)	CYB561D1 (2.1)
ENSG00000108468	CBX1 PPI subnetwork	0.37	> 0.20	USP1 (2.9)	BUD13 (2.1)	PSRC1 (2.0)	FEN1 (1.9)	ZNF180 (1.8)	GATAD2A (1.7)	FADS2 (1.7)	HLX (1.6)	FADS1 (1.6)	TMEM57 (1.5)
ENSG00000119638	NEK9 PPI subnetwork	0.37	> 0.20	ZNF180 (3.7)	PTPN11 (2.8)	C11orf9 (2.5)	USP1 (2.5)	DHX38 (2.4)	FEN1 (2.3)	PSRC1 (2.1)	ENSG00000235545 (1.7)	NYNRIN (1.7)	TRAPPC6A (1.6)
ENSG00000116266	STXBP3 PPI subnetwork	0.37	> 0.20	TSSK6 (2.8)	C12orf43 (2.7)	HNF1A (2.2)	PLEKHH2 (2.1)	POC5 (2.0)	GCNT4 (1.8)	GEMIN7 (1.8)	SH2B3 (1.7)	PVRL2 (1.6)	ENSG00000238078 (1.5)
MP:0001056	abnormal cranial nerve morphology	0.37	> 0.20	BCAM (2.6)	ANKRD31 (2.6)	CELSR2 (2.4)	NCAN (2.2)	HLX (2.1)	TMEM116 (2.1)	ATXN2 (2.0)	SORT1 (1.8)	TSSK6 (1.7)	MAFB (1.6)
KEGG_RENAL_CELL_CARCINOMA	KEGG_RENAL_CELL_CARCINOMA	0.37	> 0.20	DNM2 (3.6)	DOCK7 (2.2)	HLX (2.0)	PLEC (1.9)	MARK4 (1.9)	MYLIP (1.8)	CARM1 (1.8)	PTPN11 (1.8)	COL4A3BP (1.7)	DNAH11 (1.7)
MP:0001116	small gonad	0.37	> 0.20	GCNT4 (2.6)	PBX4 (2.5)	LPAR2 (2.2)	HNF1A (1.9)	C12orf47 (1.7)	TRIB1 (1.6)	ACAD10 (1.6)	DYNC2LI1 (1.5)	USP1 (1.5)	NT5DC1 (1.4)
ENSG00000172572	PDE3A PPI subnetwork	0.37	> 0.20	ST3GAL4 (3.2)	ITGB3 (2.6)	ENSG00000238078 (2.5)	GATAD2A (2.4)	GMPR (2.3)	MARK4 (2.1)	SLC44A2 (2.0)	SYPL2 (1.9)	SH2B3 (1.8)	BLOC1S3 (1.7)
GO:0055038	recycling endosome membrane	0.37	> 0.20	HMGCR (3.7)	FADS2 (3.4)	FADS1 (2.9)	TMEM116 (2.5)	PLEC (1.9)	BLOC1S3 (1.9)	CYB561D1 (1.8)	ENSG00000226645 (1.7)	ZNF259 (1.6)	USP24 (1.6)
REACTOME_UNWINDING_OF_DNA	REACTOME_UNWINDING_OF_DNA	0.37	> 0.20	FEN1 (7.2)	USP1 (4.9)	ZNF180 (2.0)	ENSG00000228044 (1.9)	FADS1 (1.4)	ENSG00000238078 (1.3)	MAU2 (1.2)	DHODH (1.2)	ILF3 (1.1)	HAPLN4 (1.1)
ENSG00000110395	CBL PPI subnetwork	0.37	> 0.20	GMIP (3.9)	SH2B3 (3.6)	DNM2 (3.2)	CETP (2.8)	PBX4 (2.3)	PLEKHH2 (2.2)	TIMD4 (2.2)	SLC44A2 (2.1)	RELB (2.0)	LPAR2 (2.0)
GO:0046520	sphingoid biosynthetic process	0.37	> 0.20	NKPD1 (3.8)	HAVCR1 (3.4)	COL4A3BP (2.7)	POLK (2.2)	CYB561D1 (2.1)	SLC44A2 (2.1)	ATP13A1 (1.7)	PVR (1.7)	TM6SF2 (1.5)	ANKRD31 (1.5)
ENSG00000107554	DNMBP PPI subnetwork	0.37	> 0.20	HAPLN4 (2.6)	PPP1R37 (2.6)	MARK4 (2.0)	PVRL2 (2.0)	LPIN3 (1.9)	GATAD2A (1.9)	PLEC (1.7)	HAVCR1 (1.5)	CYP7A1 (1.5)	C11orf9 (1.4)
ENSG00000182718	ANXA2 PPI subnetwork	0.37	> 0.20	PLEC (3.5)	C1orf63 (2.2)	TMEM50A (2.2)	GATAD2A (2.1)	OGDH (1.8)	TOP1 (1.8)	PVR (1.8)	ADAM1 (1.5)	PTPN11 (1.5)	ENSG00000238078 (1.5)
ENSG00000206271	ENSG00000206271 PPI subnetwork	0.37	> 0.20	CBLC (3.0)	ANKRD31 (2.4)	DOCK7 (2.3)	GRINA (2.2)	PLCG1 (2.1)	AP1M2 (1.9)	KIAA1324 (1.9)	ERP29 (1.8)	C1orf63 (1.7)	DNAH11 (1.5)
ENSG00000206380	C6orf48 PPI subnetwork	0.37	> 0.20	CBLC (3.0)	ANKRD31 (2.4)	DOCK7 (2.3)	GRINA (2.2)	PLCG1 (2.1)	AP1M2 (1.9)	KIAA1324 (1.9)	ERP29 (1.8)	C1orf63 (1.7)	DNAH11 (1.5)
ENSG00000204387	C6orf48 PPI subnetwork	0.37	> 0.20	CBLC (3.0)	ANKRD31 (2.4)	DOCK7 (2.3)	GRINA (2.2)	PLCG1 (2.1)	AP1M2 (1.9)	KIAA1324 (1.9)	ERP29 (1.8)	C1orf63 (1.7)	DNAH11 (1.5)
GO:0008417	fucosyltransferase activity	0.37	> 0.20	CBLC (2.7)	FRK (2.6)	YIPF2 (2.3)	ERP29 (2.0)	HNF1A (1.8)	LPIN3 (1.8)	MYLIP (1.5)	ABO (1.4)	SLC44A2 (1.3)	TMED4 (1.3)
GO:0009615	response to virus	0.37	> 0.20	OASL (7.7)	PARP10 (5.4)	TRAFD1 (4.6)	ENSG00000235545 (3.2)	ATP13A1 (2.3)	CYB561D1 (2.2)	TXNL4B (1.9)	BLOC1S3 (1.7)	GRINA (1.6)	MAU2 (1.6)
MP:0000585	kinked tail	0.37	> 0.20	CILP2 (3.1)	LPAR2 (2.7)	PCSK9 (2.6)	LDLR (2.5)	MAFB (2.3)	HMGCR (1.9)	PVRL2 (1.8)	PLCG1 (1.7)	FADS1 (1.7)	NYNRIN (1.6)
ENSG00000161654	LSM12 PPI subnetwork	0.37	> 0.20	C12orf43 (2.7)	TOMM40 (2.4)	ENSG00000226645 (2.2)	ENSG00000238078 (2.2)	DOCK7 (2.0)	ATXN2 (1.8)	OGDH (1.8)	DDX56 (1.7)	NAA25 (1.7)	ADAM1 (1.6)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	0.37	> 0.20	GEMIN7 (3.5)	C12orf43 (3.4)	ZNF259 (3.2)	POC5 (2.7)	ADAM1 (2.6)	MAPKAPK5 (2.3)	BUD13 (2.2)	DDX56 (2.1)	SUGP1 (2.0)	ENSG00000226645 (1.8)
MP:0002841	impaired skeletal muscle contractility	0.37	> 0.20	SYPL2 (9.0)	GMPR (2.5)	ATXN7L2 (1.5)	PLEC (1.4)	PBX4 (1.3)	AMIGO1 (1.3)	CEACAM19 (1.2)	ENSG00000226645 (1.2)	CYB561D1 (1.0)	NPC1L1 (1.0)
MP:0002795	dilated cardiomyopathy	0.37	> 0.20	SYPL2 (2.9)	KANK2 (2.6)	GMPR (2.4)	ENSG00000226648 (1.7)	SORT1 (1.6)	PLEC (1.5)	BCAM (1.4)	ST3GAL4 (1.4)	TMEM50A (1.4)	MAFB (1.2)
GO:0002367	cytokine production involved in immune response	0.37	> 0.20	GCNT4 (3.0)	MAFB (1.9)	ZNF101 (1.7)	TIMD4 (1.5)	CETP (1.5)	SH2B3 (1.4)	NPC1L1 (1.2)	POLK (1.2)	HAVCR1 (1.2)	POC5 (1.1)
GO:0042158	lipoprotein biosynthetic process	0.37	> 0.20	CYB561D1 (3.2)	ATP13A1 (2.4)	TRAPPC6A (2.2)	TMEM116 (2.2)	TMED4 (2.0)	ERP29 (2.0)	ADAM1 (1.9)	TSSK6 (1.9)	CEACAM19 (1.9)	TXNL4B (1.7)
MP:0000757	herniated abdominal wall	0.37	> 0.20	CILP2 (2.6)	MOSC1 (2.5)	MAFB (2.3)	TM6SF2 (2.3)	ATXN2 (2.2)	MYLIP (2.1)	ABO (1.9)	ENSG00000254235 (1.8)	SLC44A2 (1.7)	AP1M2 (1.7)
MP:0003797	abnormal compact bone morphology	0.37	> 0.20	MAFB (2.5)	ITGB3 (2.4)	APOE (2.4)	CILP2 (1.9)	MYLIP (1.8)	TMEM57 (1.8)	ANKRD31 (1.7)	TRIB1 (1.7)	CETP (1.5)	PCSK9 (1.4)
GO:0007369	gastrulation	0.37	> 0.20	ENSG00000238078 (2.8)	NYNRIN (2.8)	ABO (2.8)	LPAR2 (1.8)	ENSG00000254235 (1.7)	ATXN7L2 (1.7)	TRIB1 (1.6)	C19orf52 (1.5)	PVRL2 (1.2)	CILP2 (1.2)
ENSG00000127688	GAN PPI subnetwork	0.37	> 0.20	CBLC (6.0)	AP1M2 (4.7)	LPAR2 (2.4)	CELSR2 (2.2)	DOCK7 (2.0)	LPIN3 (1.9)	PVRL2 (1.9)	MARK4 (1.6)	DNM2 (1.5)	BCAM (1.5)
MP:0006346	small branchial arch	0.37	> 0.20	LPAR2 (3.3)	CBLC (3.0)	CETP (2.3)	PLEC (2.2)	CYB561D1 (2.1)	AP1M2 (1.8)	GMIP (1.8)	APOE (1.5)	LPIN3 (1.4)	HLX (1.3)
ENSG00000100410	PHF5A PPI subnetwork	0.37	> 0.20	ILF3 (4.0)	C1orf63 (3.8)	TOP1 (3.0)	BUD13 (2.8)	USP1 (2.7)	DHX38 (2.6)	SMARCA4 (2.6)	SUGP1 (2.3)	FEN1 (2.1)	QTRT1 (1.8)
MP:0002022	increased lymphoma incidence	0.37	> 0.20	FEN1 (4.2)	POLK (2.7)	USP1 (2.5)	KANK2 (2.2)	DYNC2LI1 (1.9)	RELB (1.8)	TMEM57 (1.7)	PSRC1 (1.7)	C12orf43 (1.6)	RHD (1.4)
MP:0001299	abnormal eye distance/ position	0.37	> 0.20	ZNF101 (2.4)	GMPR (2.3)	DOCK7 (1.7)	KANK2 (1.6)	GEMIN7 (1.5)	TMED4 (1.5)	NAA25 (1.4)	ENSG00000254235 (1.2)	USP24 (1.2)	ACAD10 (1.2)
GO:0042116	macrophage activation	0.37	> 0.20	C17orf57 (3.1)	ENSG00000226645 (1.9)	DHODH (1.7)	PMFBP1 (1.7)	GCNT4 (1.6)	ANKRD31 (1.4)	ADAM1 (1.4)	AMIGO1 (1.4)	TMED4 (1.3)	DNAH11 (1.2)
MP:0005592	abnormal vascular smooth muscle morphology	0.37	> 0.20	KANK2 (3.5)	PVR (3.2)	SH2B3 (2.7)	HLX (2.5)	BCAM (2.2)	SLC44A2 (2.0)	CYB561D1 (2.0)	PLCG1 (1.8)	PLEC (1.7)	GCNT4 (1.6)
GO:0021675	nerve development	0.37	> 0.20	TSSK6 (3.0)	ENSG00000238078 (2.5)	HAVCR1 (2.4)	CELSR2 (1.7)	PMFBP1 (1.6)	ABO (1.6)	CEACAM19 (1.6)	NKPD1 (1.6)	ACAD10 (1.6)	HNF1A (1.4)
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.37	> 0.20	TIMD4 (2.2)	SH2B3 (2.1)	ABCG8 (1.8)	BCL3 (1.8)	PBX4 (1.7)	RELB (1.7)	CETP (1.7)	TRAFD1 (1.5)	ABCG5 (1.5)	TM6SF2 (1.5)
GO:0006790	sulfur compound metabolic process	0.37	> 0.20	TM6SF2 (2.5)	SLC22A1 (2.5)	ALDH2 (2.3)	ABCG8 (2.2)	LPA (1.9)	NT5DC1 (1.8)	TMEM116 (1.7)	TMED4 (1.6)	CYP7A1 (1.5)	MOSC1 (1.4)
GO:0051646	mitochondrion localization	0.37	> 0.20	CYP7A1 (2.0)	TMEM57 (2.0)	GOT2P1 (1.9)	DNAH11 (1.6)	OGDH (1.5)	ZNF180 (1.5)	COL4A3BP (1.4)	ACAD10 (1.4)	PLEKHH2 (1.3)	GMPR (1.3)
MP:0009417	skeletal muscle atrophy	0.37	> 0.20	BCAM (3.1)	SYPL2 (2.6)	GRINA (2.3)	CELSR2 (2.2)	DYNC2LI1 (2.2)	HAVCR1 (1.8)	BLOC1S3 (1.6)	SLC44A2 (1.5)	HLX (1.2)	PLEC (1.2)
ENSG00000078399	HOXA9 PPI subnetwork	0.37	> 0.20	NYNRIN (2.5)	KANK2 (2.5)	ATXN7L2 (2.3)	MAPKAPK5 (2.3)	ENSG00000228044 (1.9)	ZNF101 (1.7)	TRAFD1 (1.5)	BCL3 (1.5)	MAU2 (1.5)	TXNL4B (1.4)
ENSG00000206509	HLA-F PPI subnetwork	0.37	> 0.20	PARP10 (4.1)	ERP29 (2.4)	ENSG00000228044 (2.2)	YIPF2 (2.0)	TMED4 (2.0)	TRAFD1 (1.8)	DHODH (1.7)	CYB561D1 (1.7)	HNF1A (1.6)	OASL (1.5)
ENSG00000134480	CCNH PPI subnetwork	0.37	> 0.20	SUGP1 (3.2)	ZNF259 (2.9)	BUD13 (2.7)	TXNL4B (2.2)	ILF3 (2.1)	PSMA5 (2.1)	MAPKAPK5 (1.9)	POC5 (1.9)	CARM1 (1.8)	DHX38 (1.8)
GO:0046661	male sex differentiation	0.37	> 0.20	LPAR2 (2.7)	ST3GAL4 (2.6)	ABO (2.6)	DNAH11 (2.5)	PLEKHH2 (2.0)	C11orf9 (1.7)	TSSK6 (1.6)	AP1M2 (1.4)	NYNRIN (1.4)	FRK (1.4)
REACTOME_DARPP:32_EVENTS	REACTOME_DARPP:32_EVENTS	0.37	> 0.20	OGDH (2.0)	ITGB3 (1.8)	CLPTM1 (1.6)	MYLIP (1.6)	SORT1 (1.6)	MOSC1 (1.4)	GMPR (1.4)	GPAM (1.3)	PTPN11 (1.3)	GOT2P1 (1.3)
ENSG00000075884	ARHGAP15 PPI subnetwork	0.37	> 0.20	DDX56 (4.3)	NAA25 (4.1)	ZNF259 (4.0)	DHX38 (3.3)	TOMM40 (3.2)	QTRT1 (3.1)	BRAP (2.5)	TOP1 (2.3)	PTPN11 (2.3)	DHODH (2.3)
GO:0010744	positive regulation of macrophage derived foam cell differentiation	0.37	> 0.20	ENSG00000228044 (2.8)	ITGB3 (2.5)	GOT2P1 (2.2)	TIMD4 (1.9)	PMFBP1 (1.7)	C12orf47 (1.6)	MOSC1 (1.6)	MAPKAPK5 (1.5)	GEMIN7 (1.5)	GCNT4 (1.4)
ENSG00000114503	NCBP2 PPI subnetwork	0.37	> 0.20	ILF3 (3.9)	TOP1 (3.2)	USP1 (2.9)	SMARCA4 (2.9)	C1orf63 (2.7)	DHX38 (2.5)	GATAD2A (2.4)	SUGP1 (2.4)	BUD13 (2.2)	FEN1 (2.1)
ENSG00000197746	PSAP PPI subnetwork	0.38	> 0.20	SORT1 (2.5)	PLCG1 (2.5)	PVR (2.5)	TRAPPC6A (2.3)	CELSR2 (2.3)	PVRL2 (2.1)	SARS (2.0)	ANKRD31 (1.6)	DOCK7 (1.5)	ADAM1 (1.5)
MP:0004984	increased osteoclast cell number	0.38	> 0.20	TRIB1 (3.3)	HAVCR1 (2.8)	ENSG00000228044 (2.2)	ITGB3 (2.2)	SH2B3 (1.9)	FRK (1.8)	MAFB (1.6)	TMEM57 (1.4)	ENSG00000254235 (1.4)	PVR (1.4)
MP:0011106	partial embryonic lethality before somite formation	0.38	> 0.20	FRK (3.8)	APOB (1.9)	PTPN11 (1.8)	CELSR2 (1.7)	HNF1A (1.7)	ABO (1.5)	PVRL2 (1.5)	MAFB (1.2)	YIPF2 (1.2)	DHX38 (1.1)
GO:0016594	glycine binding	0.38	> 0.20	APOC4 (2.8)	LPA (2.5)	GMPR (2.3)	RHD (2.2)	APOA5 (2.1)	RHCE (2.0)	CETP (1.9)	ANGPTL3 (1.9)	PBX4 (1.9)	TM6SF2 (1.8)
MP:0011110	partial preweaning lethality	0.38	> 0.20	MYLIP (3.1)	CETP (2.5)	RHD (2.1)	C12orf51 (2.1)	ITGB3 (2.0)	RHCE (1.9)	C1orf63 (1.8)	TMEM50A (1.8)	BCL3 (1.7)	CELSR2 (1.6)
MP:0002724	enhanced wound healing	0.38	> 0.20	BCL3 (2.9)	PLEC (2.8)	PVRL2 (2.8)	PVR (2.5)	CBLC (2.0)	ENSG00000238078 (1.9)	TRIB1 (1.8)	PTPN11 (1.7)	AP1M2 (1.5)	ITGB3 (1.5)
ENSG00000129465	RIPK3 PPI subnetwork	0.38	> 0.20	SARS (3.5)	DOCK7 (2.8)	HAVCR1 (2.7)	SMARCA4 (2.6)	OGDH (2.4)	PSMA5 (2.3)	PLEC (2.2)	FRK (1.8)	TOMM40 (1.7)	ILF3 (1.6)
MP:0004985	decreased osteoclast cell number	0.38	> 0.20	MAFB (3.7)	CILP2 (2.6)	APOE (2.5)	APOC1 (2.1)	GMIP (2.0)	TMEM116 (2.0)	ITGB3 (1.7)	SH2B3 (1.6)	TRIB1 (1.6)	TIMD4 (1.5)
MP:0010956	abnormal mitochondrial ATP synthesis coupled electron transport	0.38	> 0.20	GOT2P1 (2.9)	POC5 (2.6)	DNAH11 (2.0)	COL4A3BP (2.0)	ACAD10 (2.0)	TXNL4B (2.0)	NT5DC1 (1.9)	ENSG00000226645 (1.6)	GPAM (1.5)	GMPR (1.4)
GO:0072331	signal transduction by p53 class mediator	0.38	> 0.20	PSMA5 (2.7)	NT5DC1 (2.5)	NAA25 (2.4)	TRAFD1 (2.3)	ENSG00000238078 (1.9)	PARP10 (1.8)	TOMM40 (1.6)	BUD13 (1.5)	POC5 (1.5)	ZNF259 (1.5)
GO:0009378	four-way junction helicase activity	0.38	> 0.20	MAPKAPK5 (5.0)	BRAP (3.9)	POC5 (3.8)	SUGP1 (2.8)	DHX38 (2.6)	TXNL4B (2.5)	SARS (2.2)	TOMM40 (2.2)	ZNF180 (2.1)	UBXN2B (1.6)
ENSG00000157540	DYRK1A PPI subnetwork	0.38	> 0.20	CBLC (2.2)	PLCG1 (2.0)	C17orf57 (2.0)	CARM1 (1.9)	MARK4 (1.8)	ZNF101 (1.8)	LPIN3 (1.7)	HAPLN4 (1.7)	PPP1R37 (1.6)	SMARCA4 (1.6)
ENSG00000143878	RHOB PPI subnetwork	0.38	> 0.20	CLPTM1 (2.6)	OGDH (2.4)	PLEC (2.2)	MARK4 (2.2)	SLC44A2 (2.1)	DNM2 (2.0)	GMIP (1.9)	DNAH11 (1.8)	CARM1 (1.6)	CBLC (1.5)
GO:0032612	interleukin-1 production	0.38	> 0.20	ST3GAL4 (2.1)	CYB561D1 (2.1)	ENSG00000238078 (1.7)	C12orf43 (1.3)	HLX (1.3)	OASL (1.3)	PLEKHH2 (1.2)	SH2B3 (1.2)	ENSG00000228044 (1.2)	MAFB (1.2)
ENSG00000130119	GNL3L PPI subnetwork	0.38	> 0.20	OASL (3.5)	PARP10 (2.7)	FRK (2.3)	ZNF180 (2.2)	NAA25 (2.0)	SUGP1 (1.6)	MAPKAPK5 (1.4)	TMED4 (1.4)	C12orf43 (1.3)	PSMA5 (1.2)
REACTOME_PAUSING_AND_RECOVERY_OF_TAT:MEDIATED_HIV:1_ELONGATION	REACTOME_PAUSING_AND_RECOVERY_OF_TAT:MEDIATED_HIV:1_ELONGATION	0.38	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.4)	BUD13 (2.2)	DNM2 (2.2)	ZNF259 (2.0)	GEMIN7 (2.0)	PTPN11 (1.9)	MAPKAPK5 (1.9)	GATAD2A (1.7)
REACTOME_TAT:MEDIATED_HIV:1_ELONGATION_ARREST_AND_RECOVERY	REACTOME_TAT:MEDIATED_HIV:1_ELONGATION_ARREST_AND_RECOVERY	0.38	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.4)	BUD13 (2.2)	DNM2 (2.2)	ZNF259 (2.0)	GEMIN7 (2.0)	PTPN11 (1.9)	MAPKAPK5 (1.9)	GATAD2A (1.7)
ENSG00000134308	YWHAQ PPI subnetwork	0.38	> 0.20	TOP1 (3.0)	BCAM (2.7)	SARS (2.6)	ATXN2 (2.5)	OGDH (2.3)	COL4A3BP (2.2)	SMARCA4 (2.1)	DOCK7 (2.0)	PVRL2 (1.9)	CBLC (1.9)
ENSG00000072195	SPEG PPI subnetwork	0.38	> 0.20	GMIP (3.3)	MARK4 (3.1)	LPAR2 (3.0)	USP24 (2.9)	C12orf51 (2.9)	DNM2 (2.8)	ATXN2 (2.8)	SLC44A2 (2.2)	MAU2 (2.0)	POLK (1.9)
ENSG00000120265	PCMT1 PPI subnetwork	0.38	> 0.20	ABCG5 (2.9)	PLEC (2.8)	NPC1L1 (2.6)	APOB (2.6)	TM6SF2 (2.5)	KANK2 (2.1)	SH2B3 (2.0)	ABCG8 (1.7)	RELB (1.7)	PVR (1.5)
GO:0022884	macromolecule transmembrane transporter activity	0.38	> 0.20	DHODH (2.2)	TXNL4B (2.1)	GEMIN7 (1.9)	YIPF2 (1.9)	ILF3 (1.9)	ERP29 (1.8)	APOA5 (1.7)	QTRT1 (1.7)	GOT2P1 (1.6)	OGDH (1.6)
GO:0008320	protein transmembrane transporter activity	0.38	> 0.20	DHODH (2.2)	TXNL4B (2.1)	GEMIN7 (1.9)	YIPF2 (1.9)	ILF3 (1.9)	ERP29 (1.8)	APOA5 (1.7)	QTRT1 (1.7)	GOT2P1 (1.6)	OGDH (1.6)
MP:0002160	abnormal reproductive system morphology	0.38	> 0.20	TMEM116 (2.9)	PVRL2 (2.0)	ANKRD31 (2.0)	ZHX3 (1.9)	FRK (1.8)	ENSG00000254235 (1.8)	ST3GAL4 (1.8)	TOMM40 (1.7)	KANK2 (1.5)	GOT2P1 (1.5)
ENSG00000166889	PATL1 PPI subnetwork	0.38	> 0.20	DHX38 (3.2)	ILF3 (2.9)	TOP1 (2.9)	DDX56 (2.8)	SMARCA4 (2.6)	SUGP1 (2.5)	FEN1 (2.3)	MAU2 (2.2)	BUD13 (2.0)	ZNF259 (1.8)
ENSG00000153944	MSI2 PPI subnetwork	0.38	> 0.20	PSRC1 (2.9)	GCNT4 (2.3)	TRAPPC6A (2.1)	FEN1 (1.8)	GEMIN7 (1.6)	APOE (1.5)	APOC1 (1.4)	SLC44A2 (1.4)	ENSG00000226645 (1.3)	CETP (1.3)
MP:0003691	abnormal microglial cell physiology	0.38	> 0.20	TRIB1 (3.7)	PVR (3.4)	MAFB (3.2)	OASL (2.8)	GPAM (2.5)	SH2B3 (2.2)	SORT1 (2.0)	ERP29 (1.9)	AMIGO1 (1.6)	NCAN (1.5)
ENSG00000105364	MRPL4 PPI subnetwork	0.38	> 0.20	BUD13 (3.0)	MAPKAPK5 (2.8)	DHX38 (2.7)	MAU2 (2.7)	ATP13A1 (2.7)	DDX56 (2.3)	BRAP (2.1)	ILF3 (2.1)	C12orf51 (2.1)	SUGP1 (2.1)
ENSG00000118972	FGF23 PPI subnetwork	0.38	> 0.20	HAVCR1 (4.7)	PLEKHH2 (3.9)	HAPLN4 (3.5)	C11orf9 (2.5)	ZHX3 (2.3)	NCAN (2.0)	C17orf57 (1.9)	CBLC (1.9)	CEACAM19 (1.8)	ENSG00000235545 (1.7)
GO:0042307	positive regulation of protein import into nucleus	0.38	> 0.20	ENSG00000238078 (2.8)	OASL (2.7)	TMEM116 (2.7)	AP1M2 (2.2)	PLEKHH2 (2.2)	GCNT4 (2.2)	ENSG00000228044 (2.0)	FRK (1.9)	MYLIP (1.8)	ENSG00000235545 (1.6)
MP:0005329	abnormal myocardium layer morphology	0.38	> 0.20	BCAM (3.4)	PVR (2.0)	PVRL2 (2.0)	HP (1.9)	C11orf9 (1.8)	SORT1 (1.7)	APOB (1.6)	ENSG00000228044 (1.6)	CYP7A1 (1.5)	TIMD4 (1.4)
ENSG00000104960	PTOV1 PPI subnetwork	0.38	> 0.20	CBLC (6.1)	AP1M2 (4.1)	LPAR2 (2.9)	CELSR2 (1.9)	PVRL2 (1.7)	FRK (1.6)	LPIN3 (1.5)	PLEC (1.5)	KANK2 (1.5)	ST3GAL4 (1.5)
ENSG00000198700	IPO9 PPI subnetwork	0.38	> 0.20	USP1 (2.5)	FEN1 (2.5)	ERP29 (2.4)	DDX56 (2.3)	PSMA5 (2.1)	ATP13A1 (1.9)	GMPR (1.8)	SMARCA4 (1.7)	BUD13 (1.7)	PSRC1 (1.7)
ENSG00000153201	RANBP2 PPI subnetwork	0.38	> 0.20	PSRC1 (5.7)	FEN1 (4.3)	USP1 (4.0)	POC5 (3.6)	ILF3 (1.3)	ENSG00000228044 (1.3)	ZNF180 (1.2)	ENSG00000226648 (1.0)	USP24 (1.0)	NAA25 (0.9)
ENSG00000150672	DLG2 PPI subnetwork	0.38	> 0.20	RPH3A (3.7)	CELSR2 (2.7)	PPP1R37 (2.6)	GCNT4 (2.6)	AMIGO1 (2.5)	HAVCR1 (2.2)	NCAN (1.7)	MOSC1 (1.6)	MYLIP (1.4)	ABO (1.3)
MP:0009172	small pancreatic islets	0.38	> 0.20	HAPLN4 (2.7)	KIAA1324 (2.7)	DNAH11 (2.5)	TRAPPC6A (2.4)	PLEKHH2 (1.7)	MOSC1 (1.7)	GCNT4 (1.7)	PMFBP1 (1.6)	C11orf9 (1.5)	ABO (1.5)
ENSG00000131467	PSME3 PPI subnetwork	0.38	> 0.20	GMPR (2.5)	MYLIP (2.1)	TMED4 (2.1)	BRAP (1.9)	C12orf43 (1.9)	PARP10 (1.9)	ZNF101 (1.7)	PLCG1 (1.7)	NT5DC1 (1.4)	TRAFD1 (1.4)
MP:0002420	abnormal adaptive immunity	0.38	> 0.20	CETP (3.5)	APOE (2.8)	TIMD4 (2.8)	GCNT4 (2.0)	MAFB (1.6)	APOC1 (1.6)	HNF1A (1.5)	OASL (1.5)	TXNL4B (1.3)	ZNF101 (1.3)
GO:0001664	G-protein coupled receptor binding	0.38	> 0.20	CETP (2.8)	RELB (2.5)	MAFB (2.5)	KIAA1324 (2.1)	BCL3 (2.1)	PVRL2 (2.0)	OASL (2.0)	TIMD4 (2.0)	ENSG00000226645 (1.7)	NPC1L1 (1.6)
ENSG00000168490	PHYHIP PPI subnetwork	0.38	> 0.20	FADS1 (3.3)	APOC1 (3.3)	FADS2 (2.5)	RPH3A (2.2)	ENSG00000226645 (2.1)	NCAN (2.0)	BUD13 (2.0)	TRAPPC6A (1.9)	C12orf43 (1.8)	HAPLN4 (1.6)
ENSG00000160967	ENSG00000160967 PPI subnetwork	0.38	> 0.20	DHX38 (2.5)	POC5 (2.4)	CETP (2.3)	MAFB (2.3)	TOMM40 (2.2)	MAU2 (2.1)	LPIN3 (1.9)	ACAD10 (1.8)	COL4A3BP (1.7)	TIMD4 (1.6)
ENSG00000034713	GABARAPL2 PPI subnetwork	0.38	> 0.20	SARS (3.8)	OGDH (3.5)	NAA25 (2.1)	PSMA5 (2.0)	ATXN2 (2.0)	NT5DC1 (1.8)	HAPLN4 (1.8)	SMARCA4 (1.6)	ILF3 (1.6)	ATP13A1 (1.6)
REACTOME_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_I_RNA_POLYMERASE_III_AND_MITOCHONDRIAL_TRANSCRIPTION	0.38	> 0.20	DDX56 (2.5)	C19orf52 (2.3)	ZNF259 (2.2)	GMPR (2.2)	SUGP1 (2.2)	GEMIN7 (2.2)	BUD13 (2.0)	ATXN2 (1.9)	C12orf43 (1.8)	ENSG00000226645 (1.8)
MP:0008279	arrest of spermiogenesis	0.38	> 0.20	FADS1 (4.9)	LDLR (3.0)	HMGCR (2.5)	BRAP (2.1)	ENSG00000226645 (2.0)	ABCG5 (2.0)	ABCG8 (2.0)	TMED4 (1.8)	NKPD1 (1.7)	TIMD4 (1.5)
GO:0006401	RNA catabolic process	0.38	> 0.20	TXNL4B (3.1)	UBXN2B (3.0)	MAPKAPK5 (2.8)	BUD13 (2.5)	ADAM1 (2.5)	BRAP (2.1)	ZNF259 (2.0)	NT5DC1 (1.9)	USP24 (1.9)	ILF3 (1.8)
MP:0002359	abnormal spleen germinal center morphology	0.38	> 0.20	CETP (3.5)	TIMD4 (3.1)	RELB (2.9)	ZNF101 (2.7)	GMIP (2.6)	BCL3 (2.1)	ENSG00000235545 (1.7)	TMEM116 (1.5)	DNM2 (1.4)	PLEC (1.3)
GO:0008406	gonad development	0.38	> 0.20	ST3GAL4 (2.7)	DNAH11 (2.4)	ABO (2.2)	LPAR2 (2.0)	HNF1A (1.8)	TSSK6 (1.8)	AMIGO1 (1.6)	PVRL2 (1.5)	C11orf9 (1.5)	NYNRIN (1.4)
GO:0032963	collagen metabolic process	0.38	> 0.20	CEACAM19 (3.3)	FRK (3.1)	PLEKHH2 (2.2)	C11orf9 (1.7)	ENSG00000226645 (1.7)	CILP2 (1.7)	ENSG00000228044 (1.7)	PVRL2 (1.6)	ENSG00000238078 (1.4)	HP (1.3)
MP:0001689	incomplete somite formation	0.38	> 0.20	KANK2 (3.0)	SH2B3 (2.8)	DOCK7 (2.1)	USP24 (2.0)	C12orf51 (1.7)	ATXN2 (1.6)	NYNRIN (1.6)	TOP1 (1.5)	HNF1A (1.5)	MAFB (1.5)
ENSG00000172201	ID4 PPI subnetwork	0.38	> 0.20	NCAN (4.1)	ZHX3 (2.5)	MAFB (2.3)	ENSG00000226645 (2.0)	ALDH2 (1.9)	HAPLN4 (1.9)	MYLIP (1.7)	ABO (1.7)	GEMIN7 (1.6)	TOP1 (1.3)
REACTOME_REGULATION_OF_APOPTOSIS	REACTOME_REGULATION_OF_APOPTOSIS	0.38	> 0.20	PSMA5 (6.1)	TRAFD1 (3.9)	NT5DC1 (2.7)	NAA25 (2.2)	SUGP1 (1.9)	PARP10 (1.7)	TOMM40 (1.6)	DDX56 (1.6)	TMEM50A (1.5)	SARS (1.3)
ENSG00000111445	RFC5 PPI subnetwork	0.38	> 0.20	FEN1 (5.0)	USP1 (4.2)	NT5DC1 (2.0)	PSRC1 (1.9)	POC5 (1.9)	PSMA5 (1.7)	ILF3 (1.6)	TMEM116 (1.6)	SMARCA4 (1.6)	ZNF180 (1.5)
ENSG00000164362	TERT PPI subnetwork	0.38	> 0.20	ANKRD31 (2.8)	SMARCA4 (2.7)	TOMM40 (2.5)	PTPN11 (2.4)	ZNF259 (2.0)	DHODH (1.8)	USP24 (1.7)	NPC1L1 (1.5)	DOCK7 (1.5)	LPIN3 (1.5)
ENSG00000205220	PSMB10 PPI subnetwork	0.38	> 0.20	PSMA5 (6.3)	TRAFD1 (3.3)	NAA25 (2.3)	NT5DC1 (2.2)	TOMM40 (1.8)	SUGP1 (1.8)	SARS (1.7)	DDX56 (1.7)	TMEM50A (1.6)	CLPTM1 (1.2)
MP:0002725	abnormal vein morphology	0.38	> 0.20	RHD (2.6)	RHCE (2.1)	DNAH11 (2.0)	GCNT4 (1.9)	HLX (1.7)	NYNRIN (1.6)	TSSK6 (1.5)	MYLIP (1.5)	C11orf9 (1.5)	HAVCR1 (1.3)
ENSG00000198805	PNP PPI subnetwork	0.38	> 0.20	RELB (2.4)	LPA (1.9)	KIAA1324 (1.8)	BLOC1S3 (1.8)	UBXN2B (1.8)	ZNF180 (1.6)	MYLIP (1.6)	ZNF101 (1.6)	GMIP (1.5)	NYNRIN (1.4)
ENSG00000169813	HNRNPF PPI subnetwork	0.38	> 0.20	ILF3 (3.8)	C1orf63 (3.5)	TOP1 (3.1)	SMARCA4 (2.9)	DHX38 (2.4)	QTRT1 (2.4)	TOMM40 (2.3)	PSMA5 (2.2)	USP1 (2.2)	PTPN11 (2.2)
ENSG00000130175	PRKCSH PPI subnetwork	0.38	> 0.20	ST3GAL4 (2.5)	AP1M2 (2.0)	C1orf63 (1.9)	MYLIP (1.9)	ENSG00000226645 (1.8)	LPA (1.8)	UBXN2B (1.7)	KIAA1324 (1.6)	LPIN3 (1.6)	TMED4 (1.5)
REACTOME_SIGNALING_BY_PDGF	REACTOME_SIGNALING_BY_PDGF	0.38	> 0.20	PLEC (2.5)	ITGB3 (2.5)	MYLIP (2.4)	ZHX3 (2.2)	PLEKHH2 (1.7)	SH2B3 (1.7)	CLPTM1 (1.6)	MARK4 (1.6)	OGDH (1.6)	SORT1 (1.6)
GO:2000147	positive regulation of cell motility	0.38	> 0.20	PVR (3.5)	PVRL2 (2.6)	MAFB (2.4)	AP1M2 (2.2)	CETP (1.8)	APOE (1.7)	PTPN11 (1.7)	ENSG00000254235 (1.7)	HLX (1.7)	ENSG00000228044 (1.6)
MP:0000708	thymus hyperplasia	0.38	> 0.20	PARP10 (3.0)	BCL3 (2.5)	ZNF101 (2.3)	RELB (1.9)	CELSR2 (1.7)	PBX4 (1.5)	PMFBP1 (1.5)	TRIB1 (1.4)	GMIP (1.3)	ENSG00000228044 (1.3)
ENSG00000100401	RANGAP1 PPI subnetwork	0.38	> 0.20	PSRC1 (5.1)	FEN1 (4.4)	USP1 (4.0)	POC5 (2.9)	ZNF180 (1.8)	ILF3 (1.8)	ENSG00000226648 (1.2)	ZHX3 (1.1)	DHX38 (1.0)	PTPN11 (0.9)
ENSG00000077721	UBE2A PPI subnetwork	0.38	> 0.20	ENSG00000235545 (1.8)	TMEM57 (1.6)	ENSG00000226645 (1.6)	PBX4 (1.5)	POC5 (1.4)	PSRC1 (1.4)	TOP1 (1.4)	PSMA5 (1.4)	FEN1 (1.4)	USP1 (1.2)
ENSG00000103126	AXIN1 PPI subnetwork	0.38	> 0.20	MARK4 (3.4)	MYLIP (2.6)	ENSG00000226645 (2.4)	ATXN2 (2.0)	DNM2 (1.9)	TMEM57 (1.8)	ATXN7L2 (1.7)	C11orf9 (1.6)	ENSG00000238078 (1.6)	NYNRIN (1.6)
GO:0030100	regulation of endocytosis	0.38	> 0.20	GOT2P1 (2.0)	CLPTM1 (1.9)	ANKRD31 (1.8)	HP (1.7)	HNF1A (1.6)	CILP2 (1.6)	ERP29 (1.6)	APOE (1.4)	ALDH2 (1.4)	CETP (1.4)
ENSG00000124334	IL9R PPI subnetwork	0.38	> 0.20	BCL3 (2.9)	COL4A3BP (2.3)	C17orf57 (1.6)	RELB (1.6)	CYP7A1 (1.5)	PVR (1.5)	ZNF101 (1.4)	SLC22A1 (1.4)	BCAM (1.3)	HLX (1.2)
GO:0060716	labyrinthine layer blood vessel development	0.38	> 0.20	CBLC (2.5)	ENSG00000235545 (2.4)	MAPKAPK5 (2.0)	LDLR (1.9)	SLC44A2 (1.8)	ATXN2 (1.8)	ZNF101 (1.8)	LPAR2 (1.7)	ENSG00000226648 (1.6)	AP1M2 (1.6)
GO:0060706	cell differentiation involved in embryonic placenta development	0.38	> 0.20	ST3GAL4 (2.1)	LPA (2.0)	POC5 (1.9)	AMIGO1 (1.7)	ENSG00000254235 (1.6)	CBLC (1.6)	MARK4 (1.5)	TMEM116 (1.4)	UBXN2B (1.4)	CYB561D1 (1.4)
GO:0003779	actin binding	0.38	> 0.20	SYPL2 (4.5)	PLEC (3.5)	KANK2 (2.5)	GMPR (2.1)	GMIP (2.0)	ITGB3 (1.9)	SH2B3 (1.8)	DNM2 (1.7)	C11orf9 (1.6)	AP1M2 (1.6)
ENSG00000076003	MCM6 PPI subnetwork	0.38	> 0.20	FEN1 (6.1)	USP1 (5.1)	FADS1 (1.9)	TXNL4B (1.8)	MAU2 (1.6)	DHODH (1.5)	PSRC1 (1.4)	ILF3 (1.4)	FADS2 (1.3)	BRAP (1.2)
ENSG00000177426	TGIF1 PPI subnetwork	0.38	> 0.20	DOCK7 (2.4)	ENSG00000226648 (2.0)	GEMIN7 (2.0)	GATAD2A (1.9)	ATXN2 (1.9)	BCAM (1.9)	TRIB1 (1.7)	UBXN2B (1.6)	MYLIP (1.5)	POC5 (1.5)
ENSG00000188620	HMX3 PPI subnetwork	0.38	> 0.20	MYLIP (3.5)	ENSG00000226645 (2.9)	ZNF101 (2.6)	TM6SF2 (2.3)	TRIB1 (2.3)	MAU2 (2.1)	DNAH11 (2.0)	LDLR (1.9)	LPAR2 (1.6)	PBX4 (1.5)
GO:0032611	interleukin-1 beta production	0.38	> 0.20	ST3GAL4 (2.0)	ENSG00000238078 (2.0)	CYB561D1 (1.6)	ENSG00000228044 (1.5)	OASL (1.3)	C12orf43 (1.2)	HLX (1.2)	ALDH2 (1.2)	DOCK7 (1.1)	C11orf9 (1.1)
KEGG_CHEMOKINE_SIGNALING_PATHWAY	KEGG_CHEMOKINE_SIGNALING_PATHWAY	0.38	> 0.20	GMIP (3.9)	RELB (3.8)	BCL3 (3.1)	TIMD4 (2.9)	OASL (2.6)	MAFB (2.4)	SH2B3 (2.1)	CETP (2.1)	GRINA (2.0)	TRAFD1 (1.9)
ENSG00000135604	STX11 PPI subnetwork	0.38	> 0.20	MAU2 (2.4)	ENSG00000228044 (2.3)	NT5DC1 (2.2)	SARS (2.0)	GOT2P1 (1.9)	LDLR (1.8)	RPH3A (1.7)	SUGP1 (1.7)	TSSK6 (1.4)	C12orf47 (1.4)
ENSG00000162891	IL20 PPI subnetwork	0.38	> 0.20	BCL3 (3.6)	HLX (2.9)	RELB (2.7)	TIMD4 (2.1)	CETP (2.1)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	PARP10 (1.3)	TRIB1 (1.2)
ENSG00000169967	MAP3K2 PPI subnetwork	0.38	> 0.20	LPAR2 (3.4)	DNM2 (3.3)	GMIP (2.9)	MARK4 (2.7)	UBXN2B (2.2)	ATXN7L2 (2.1)	CBLC (2.0)	GATAD2A (1.9)	TRIB1 (1.8)	PLEC (1.7)
GO:0005865	striated muscle thin filament	0.38	> 0.20	SYPL2 (5.6)	GMPR (1.9)	PVRL2 (1.8)	ITGB3 (1.2)	LPAR2 (1.2)	C12orf47 (1.1)	RPH3A (1.0)	TMEM50A (1.0)	UBXN2B (1.0)	HMGCR (0.9)
GO:0008195	phosphatidate phosphatase activity	0.38	> 0.20	TMEM57 (3.5)	ZHX3 (3.4)	FADS2 (2.8)	C12orf47 (2.3)	FADS1 (2.2)	HMGCR (2.0)	NCAN (2.0)	LPAR2 (1.9)	LDLR (1.9)	FRK (1.6)
MP:0003447	decreased tumor growth/size	0.38	> 0.20	BCL3 (2.9)	NYNRIN (2.7)	CELSR2 (2.1)	CBLC (2.1)	MAFB (2.0)	HLX (1.7)	PLEC (1.6)	ENSG00000254235 (1.6)	ATXN7L2 (1.5)	ABO (1.5)
ENSG00000027697	IFNGR1 PPI subnetwork	0.38	> 0.20	BCL3 (3.2)	COL4A3BP (2.2)	RELB (1.9)	PVR (1.7)	C17orf57 (1.7)	ZNF101 (1.4)	OASL (1.3)	CYP7A1 (1.3)	BCAM (1.3)	TRAFD1 (1.3)
MP:0008022	dilated heart ventricle	0.38	> 0.20	BCAM (2.6)	ENSG00000235545 (2.6)	PLEKHH2 (2.5)	NYNRIN (2.4)	ALDH2 (2.3)	TSSK6 (2.1)	TRIB1 (2.1)	GEMIN7 (2.0)	LPA (1.8)	TIMD4 (1.8)
GO:0055013	cardiac muscle cell development	0.38	> 0.20	ENSG00000226648 (2.2)	SYPL2 (2.2)	CEACAM19 (1.8)	ANKRD31 (1.7)	DNAH11 (1.7)	ST3GAL4 (1.6)	ENSG00000254235 (1.6)	HNF1A (1.5)	SH2B3 (1.1)	HAPLN4 (1.1)
GO:0055006	cardiac cell development	0.38	> 0.20	ENSG00000226648 (2.2)	SYPL2 (2.2)	CEACAM19 (1.8)	ANKRD31 (1.7)	DNAH11 (1.7)	ST3GAL4 (1.6)	ENSG00000254235 (1.6)	HNF1A (1.5)	SH2B3 (1.1)	HAPLN4 (1.1)
ENSG00000184216	IRAK1 PPI subnetwork	0.38	> 0.20	UBXN2B (2.9)	MYLIP (2.6)	OASL (2.6)	BCL3 (2.4)	RELB (2.3)	PARP10 (2.2)	ST3GAL4 (2.0)	ALDH2 (1.8)	GRINA (1.8)	MAFB (1.7)
MP:0002929	abnormal bile duct development	0.38	> 0.20	DYNC2LI1 (5.4)	TRIB1 (2.6)	ENSG00000254235 (2.2)	MAFB (1.8)	ACAD10 (1.7)	C11orf9 (1.7)	CYP7A1 (1.5)	KIAA1324 (1.5)	BUD13 (1.4)	PVRL2 (1.4)
ENSG00000198951	NAGA PPI subnetwork	0.38	> 0.20	BRAP (2.8)	ST3GAL4 (2.4)	TRAFD1 (2.3)	SLC44A2 (1.9)	PBX4 (1.7)	DYNC2LI1 (1.7)	LPAR2 (1.6)	PMFBP1 (1.6)	ADAM1 (1.6)	ANKRD31 (1.5)
GO:0006913	nucleocytoplasmic transport	0.38	> 0.20	GATAD2A (3.6)	PTPN11 (2.6)	ENSG00000254235 (2.5)	NAA25 (2.2)	C12orf43 (2.2)	ILF3 (1.8)	TRAFD1 (1.7)	MAPKAPK5 (1.7)	ADAM1 (1.7)	ATXN2 (1.7)
ENSG00000114423	CBLB PPI subnetwork	0.38	> 0.20	HLX (3.7)	SH2B3 (3.0)	CETP (2.9)	TIMD4 (2.6)	BCL3 (2.4)	MYLIP (1.9)	RELB (1.8)	GMIP (1.8)	PBX4 (1.6)	ZNF101 (1.6)
MP:0002396	abnormal hematopoietic system morphology/development	0.38	> 0.20	ST3GAL4 (2.8)	HLX (2.7)	TIMD4 (2.3)	ATXN7L2 (2.3)	CETP (2.0)	ENSG00000235545 (2.0)	TOMM40 (1.9)	KANK2 (1.9)	GMIP (1.6)	DNM2 (1.6)
MP:0001300	ocular hypertelorism	0.39	> 0.20	NYNRIN (2.4)	PLEKHH2 (2.3)	GPAM (2.3)	HAPLN4 (2.0)	ZHX3 (1.9)	ATXN2 (1.7)	TMEM116 (1.6)	APOB (1.4)	KANK2 (1.3)	GATAD2A (1.3)
GO:0042310	vasoconstriction	0.39	> 0.20	C12orf47 (2.6)	ITGB3 (2.3)	ENSG00000228044 (1.9)	ABO (1.9)	C17orf57 (1.6)	TSSK6 (1.6)	GMPR (1.5)	ADAM1 (1.4)	PLEKHH2 (1.3)	HAPLN4 (1.1)
ENSG00000131795	RBM8A PPI subnetwork	0.39	> 0.20	ILF3 (3.8)	C1orf63 (3.4)	TOP1 (3.0)	DHX38 (2.9)	USP1 (2.8)	SMARCA4 (2.6)	BUD13 (2.4)	FEN1 (2.3)	SUGP1 (2.2)	PTPN11 (2.1)
GO:0070403	NAD+ binding	0.39	> 0.20	ACAD10 (2.3)	C1orf63 (2.2)	TRAPPC6A (2.0)	SLC22A1 (1.9)	BLOC1S3 (1.8)	UBXN2B (1.8)	LPA (1.7)	TXNL4B (1.6)	C12orf51 (1.6)	DNM2 (1.6)
ENSG00000147536	GINS4 PPI subnetwork	0.39	> 0.20	FEN1 (7.4)	USP1 (4.6)	ZNF180 (2.4)	DHX38 (1.9)	ILF3 (1.8)	DNAH11 (1.7)	DHODH (1.6)	HAPLN4 (1.2)	ENSG00000238078 (1.1)	GOT2P1 (1.1)
GO:0001974	blood vessel remodeling	0.39	> 0.20	PVR (2.8)	CEACAM19 (2.6)	PLEKHH2 (2.3)	BCAM (2.1)	BLOC1S3 (1.9)	ALDH2 (1.7)	PPP1R37 (1.6)	CILP2 (1.5)	TSSK6 (1.5)	CBLC (1.4)
ENSG00000100170	SLC5A1 PPI subnetwork	0.39	> 0.20	AP1M2 (4.7)	CELSR2 (3.3)	PSRC1 (2.5)	FRK (2.4)	NPC1L1 (2.2)	ABCG5 (2.0)	ZHX3 (2.0)	BCAM (1.9)	TXNL4B (1.9)	APOB (1.9)
ENSG00000132906	CASP9 PPI subnetwork	0.39	> 0.20	BCL3 (2.6)	ST3GAL4 (2.4)	TRAFD1 (2.3)	GRINA (2.0)	PTPN11 (1.8)	DNM2 (1.8)	FRK (1.8)	RELB (1.8)	CARM1 (1.7)	HMGCR (1.7)
GO:0003887	DNA-directed DNA polymerase activity	0.39	> 0.20	FEN1 (3.9)	USP1 (3.2)	PARP10 (2.6)	DNAH11 (2.6)	DDX56 (2.0)	ILF3 (1.7)	NT5DC1 (1.5)	PSRC1 (1.5)	USP24 (1.4)	ZNF180 (1.4)
KEGG_DNA_REPLICATION	KEGG_DNA_REPLICATION	0.39	> 0.20	FEN1 (6.9)	USP1 (5.8)	ZNF180 (2.5)	FADS1 (1.6)	ENSG00000235545 (1.5)	ENSG00000228044 (1.5)	DHODH (1.2)	ILF3 (1.2)	TMEM116 (1.2)	AMIGO1 (1.1)
MP:0000662	abnormal branching of the mammary ductal tree	0.39	> 0.20	KIAA1324 (2.1)	GPAM (1.9)	CELSR2 (1.8)	PMFBP1 (1.7)	PLEKHH2 (1.7)	MYLIP (1.7)	MOSC1 (1.6)	AMIGO1 (1.6)	BUD13 (1.5)	TOP1 (1.4)
GO:0004298	threonine-type endopeptidase activity	0.39	> 0.20	PSMA5 (6.1)	TRAFD1 (4.4)	PARP10 (3.3)	TMEM50A (2.4)	NT5DC1 (2.3)	C12orf47 (1.6)	NAA25 (1.6)	LPA (1.2)	C11orf9 (1.1)	CYB561D1 (1.1)
GO:0070003	threonine-type peptidase activity	0.39	> 0.20	PSMA5 (6.1)	TRAFD1 (4.4)	PARP10 (3.3)	TMEM50A (2.4)	NT5DC1 (2.3)	C12orf47 (1.6)	NAA25 (1.6)	LPA (1.2)	C11orf9 (1.1)	CYB561D1 (1.1)
ENSG00000143006	DMRTB1 PPI subnetwork	0.39	> 0.20	NYNRIN (2.6)	PLEC (2.2)	RPH3A (1.9)	PPP1R37 (1.9)	BCAM (1.7)	ST3GAL4 (1.7)	ILF3 (1.7)	CARM1 (1.5)	DHODH (1.4)	SUGP1 (1.3)
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	0.39	> 0.20	MARK4 (3.7)	SH2B3 (2.9)	CLPTM1 (2.7)	ZHX3 (2.7)	OGDH (2.4)	PLEC (2.3)	GRINA (2.2)	PTPN11 (2.1)	PPP1R37 (2.1)	DNM2 (2.1)
ENSG00000105323	HNRNPUL1 PPI subnetwork	0.39	> 0.20	ILF3 (3.7)	C1orf63 (3.6)	TOP1 (2.9)	QTRT1 (2.9)	SUGP1 (2.8)	PTPN11 (2.6)	DHX38 (2.5)	SMARCA4 (2.5)	USP1 (2.5)	GATAD2A (2.3)
ENSG00000167657	DAPK3 PPI subnetwork	0.39	> 0.20	PVR (3.7)	KANK2 (2.8)	PVRL2 (2.7)	BRAP (2.6)	FRK (2.3)	TRAFD1 (1.9)	AP1M2 (1.8)	LPIN3 (1.8)	ITGB3 (1.8)	SLC22A1 (1.8)
GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	0.39	> 0.20	ENSG00000226645 (2.8)	BLOC1S3 (2.4)	RELB (2.3)	GMIP (2.2)	BCL3 (2.0)	OASL (2.0)	PLEKHH2 (1.9)	ATXN7L2 (1.6)	PARP10 (1.6)	SH2B3 (1.5)
MP:0001829	increased activated T cell number	0.39	> 0.20	PARP10 (3.7)	OASL (2.8)	PBX4 (2.6)	TRAFD1 (2.6)	RELB (2.2)	ITGB3 (2.0)	ZNF101 (1.9)	PLCG1 (1.8)	CETP (1.6)	POLK (1.4)
GO:0006664	glycolipid metabolic process	0.39	> 0.20	HAVCR1 (4.0)	COL4A3BP (2.3)	TMEM50A (2.2)	TRAPPC6A (2.2)	ERP29 (2.1)	CYB561D1 (2.1)	ABO (2.0)	HNF1A (1.9)	NKPD1 (1.8)	TMED4 (1.7)
GO:0030330	DNA damage response, signal transduction by p53 class mediator	0.39	> 0.20	PSMA5 (2.8)	TRAFD1 (2.5)	NT5DC1 (2.5)	NAA25 (2.3)	PARP10 (1.8)	ENSG00000238078 (1.6)	BUD13 (1.5)	TOMM40 (1.4)	ZNF180 (1.4)	POC5 (1.4)
ENSG00000206385	ENSG00000206385 PPI subnetwork	0.39	> 0.20	POLK (3.0)	FEN1 (2.9)	NYNRIN (2.3)	UBXN2B (2.2)	BUD13 (2.0)	BLOC1S3 (1.9)	DHODH (1.8)	USP1 (1.6)	DHX38 (1.6)	SMARCA4 (1.5)
ENSG00000137337	MDC1 PPI subnetwork	0.39	> 0.20	POLK (3.0)	FEN1 (2.9)	NYNRIN (2.3)	UBXN2B (2.2)	BUD13 (2.0)	BLOC1S3 (1.9)	DHODH (1.8)	USP1 (1.6)	DHX38 (1.6)	SMARCA4 (1.5)
ENSG00000117322	CR2 PPI subnetwork	0.39	> 0.20	CETP (4.5)	TIMD4 (2.9)	GMIP (2.5)	ZNF101 (2.3)	HP (1.8)	SLC44A2 (1.7)	GCNT4 (1.7)	PVRL2 (1.6)	GATAD2A (1.6)	GEMIN7 (1.6)
GO:0051937	catecholamine transport	0.39	> 0.20	ABO (2.4)	CETP (1.8)	AMIGO1 (1.6)	GMPR (1.6)	LPA (1.5)	RPH3A (1.4)	C19orf52 (1.3)	TSSK6 (1.3)	PMFBP1 (1.3)	GOT2P1 (1.2)
ENSG00000132424	PNISR PPI subnetwork	0.39	> 0.20	C1orf63 (4.9)	C12orf43 (3.2)	MAPKAPK5 (2.6)	C12orf51 (2.4)	ATXN2 (2.1)	USP1 (2.0)	TOP1 (2.0)	C19orf52 (1.9)	ADAM1 (1.9)	BUD13 (1.8)
REACTOME_GAP_JUNCTION_DEGRADATION	REACTOME_GAP_JUNCTION_DEGRADATION	0.39	> 0.20	TIMD4 (2.5)	HAVCR1 (2.2)	CETP (2.1)	C1orf63 (2.1)	FRK (2.1)	APOE (2.0)	CLPTM1 (2.0)	SUGP1 (1.8)	SARS (1.7)	COL4A3BP (1.6)
GO:0031490	chromatin DNA binding	0.39	> 0.20	SH2B3 (3.8)	ABO (2.3)	BLOC1S3 (1.8)	QTRT1 (1.8)	PLCG1 (1.8)	TRIB1 (1.8)	PLEKHH2 (1.7)	PLEC (1.7)	BCL3 (1.6)	GATAD2A (1.5)
GO:0009636	response to toxin	0.39	> 0.20	TM6SF2 (2.5)	ABCG8 (2.3)	ALDH2 (1.9)	ABCG5 (1.9)	DNAH11 (1.9)	CYP7A1 (1.7)	TRAPPC6A (1.7)	RHCE (1.6)	TXNL4B (1.6)	RHD (1.5)
GO:0005911	cell-cell junction	0.39	> 0.20	AP1M2 (5.5)	BCAM (4.6)	CBLC (4.5)	PVRL2 (4.3)	PLEC (2.7)	CELSR2 (2.7)	C11orf9 (2.2)	KANK2 (1.9)	PVR (1.7)	FRK (1.5)
ENSG00000144048	DUSP11 PPI subnetwork	0.39	> 0.20	GPAM (2.6)	ATXN2 (2.4)	OASL (2.4)	FADS1 (2.4)	FADS2 (2.1)	ERP29 (2.1)	PARP10 (2.0)	ENSG00000235545 (1.9)	ALDH2 (1.9)	MOSC1 (1.8)
ENSG00000060339	CCAR1 PPI subnetwork	0.39	> 0.20	ILF3 (4.5)	C1orf63 (3.9)	DHX38 (3.0)	SMARCA4 (2.8)	TOP1 (2.7)	USP1 (2.7)	SUGP1 (2.6)	BUD13 (2.5)	PTPN11 (2.3)	FEN1 (2.2)
GO:0045933	positive regulation of muscle contraction	0.39	> 0.20	CYB561D1 (2.6)	ABO (2.5)	ITGB3 (2.4)	NKPD1 (2.3)	LPIN3 (2.2)	GOT2P1 (2.1)	TXNL4B (1.9)	SYPL2 (1.9)	KIAA1324 (1.7)	ENSG00000226648 (1.6)
MP:0004358	bowed tibia	0.39	> 0.20	HMGCR (3.5)	C11orf9 (2.4)	CILP2 (2.1)	FADS1 (2.1)	FADS2 (1.9)	LDLR (1.8)	C17orf57 (1.8)	ENSG00000254235 (1.8)	GPAM (1.8)	PVR (1.6)
GO:0016757	transferase activity, transferring glycosyl groups	0.39	> 0.20	TMED4 (2.8)	ST3GAL4 (2.8)	YIPF2 (2.8)	ATP13A1 (2.8)	ERP29 (2.4)	OASL (2.1)	TMEM50A (2.1)	SLC44A2 (2.0)	ENSG00000235545 (1.7)	LDLR (1.7)
ENSG00000181090	EHMT1 PPI subnetwork	0.39	> 0.20	USP24 (2.2)	GMIP (2.2)	PARP10 (2.2)	BLOC1S3 (2.0)	BCL3 (1.9)	MARK4 (1.9)	PSRC1 (1.8)	CARM1 (1.6)	ZNF180 (1.6)	GATAD2A (1.6)
ENSG00000169976	SF3B5 PPI subnetwork	0.39	> 0.20	ILF3 (4.2)	C1orf63 (3.4)	TOP1 (3.1)	DHX38 (2.9)	USP1 (2.7)	SMARCA4 (2.7)	BUD13 (2.4)	SUGP1 (2.3)	QTRT1 (2.1)	FEN1 (2.0)
ENSG00000073111	MCM2 PPI subnetwork	0.39	> 0.20	FEN1 (5.9)	USP1 (5.2)	ENSG00000235545 (1.9)	PSRC1 (1.8)	MAU2 (1.5)	POC5 (1.3)	DHODH (1.3)	TMEM116 (1.2)	ILF3 (1.1)	ST3GAL4 (1.1)
GO:0008186	RNA-dependent ATPase activity	0.39	> 0.20	SUGP1 (2.9)	ATP13A1 (2.7)	DHX38 (2.6)	TOP1 (2.5)	NAA25 (2.2)	ILF3 (2.0)	ZNF259 (1.9)	SMARCA4 (1.9)	BUD13 (1.8)	DDX56 (1.7)
ENSG00000104879	CKM PPI subnetwork	0.39	> 0.20	SYPL2 (3.4)	ACAD10 (2.9)	TMEM50A (2.4)	GMPR (2.3)	OGDH (1.9)	BCAM (1.7)	CILP2 (1.4)	C12orf47 (1.3)	TMED4 (1.3)	C1orf63 (1.3)
ENSG00000113300	CNOT6 PPI subnetwork	0.39	> 0.20	MAPKAPK5 (4.2)	ATXN2 (3.9)	BRAP (3.3)	C12orf51 (2.7)	C12orf43 (2.4)	USP24 (2.1)	BUD13 (2.0)	POC5 (2.0)	PSRC1 (1.9)	DNAH11 (1.9)
MP:0000873	thin external granule cell layer	0.39	> 0.20	TIMD4 (3.3)	CETP (3.1)	APOE (2.5)	ATXN7L2 (2.4)	ENSG00000226645 (2.0)	NYNRIN (1.9)	PCSK9 (1.9)	ABO (1.9)	ADAM1 (1.7)	OGDH (1.5)
GO:0061097	regulation of protein tyrosine kinase activity	0.39	> 0.20	ENSG00000228044 (2.9)	ENSG00000226645 (2.2)	TMED4 (2.2)	ANKRD31 (2.1)	CYB561D1 (1.8)	TSSK6 (1.7)	ZNF259 (1.5)	C19orf52 (1.5)	AP1M2 (1.3)	ACAD10 (1.3)
GO:0031998	regulation of fatty acid beta-oxidation	0.39	> 0.20	C17orf57 (2.1)	MARK4 (1.7)	MAU2 (1.7)	OGDH (1.7)	ENSG00000238078 (1.7)	DHX38 (1.6)	ABCG8 (1.6)	AMIGO1 (1.6)	DHODH (1.6)	ACAD10 (1.4)
MP:0010954	abnormal cellular respiration	0.39	> 0.20	ACAD10 (3.4)	C1orf63 (2.6)	BRAP (2.5)	AMIGO1 (2.4)	C12orf47 (2.2)	SYPL2 (2.2)	TRIB1 (2.2)	OGDH (2.0)	PBX4 (1.7)	ERP29 (1.7)
GO:0006090	pyruvate metabolic process	0.39	> 0.20	OGDH (3.2)	ACAD10 (2.8)	GOT2P1 (2.5)	TMEM116 (1.9)	GPAM (1.9)	ENSG00000226648 (1.8)	TXNL4B (1.8)	DHODH (1.7)	PMFBP1 (1.6)	UBXN2B (1.6)
ENSG00000131941	RHPN2 PPI subnetwork	0.39	> 0.20	CBLC (6.6)	AP1M2 (4.5)	LPAR2 (2.3)	PVRL2 (1.9)	HNF1A (1.8)	PCSK9 (1.7)	FRK (1.5)	GEMIN7 (1.4)	PLEC (1.4)	ALDH2 (1.3)
KEGG_RNA_DEGRADATION	KEGG_RNA_DEGRADATION	0.39	> 0.20	DHODH (4.1)	POC5 (3.3)	DHX38 (2.9)	ZNF259 (2.7)	ST3GAL4 (2.3)	TXNL4B (2.2)	MAPKAPK5 (2.0)	DDX56 (2.0)	TOMM40 (2.0)	SUGP1 (1.9)
ENSG00000196782	MAML3 PPI subnetwork	0.39	> 0.20	NYNRIN (2.7)	BCAM (2.5)	PSRC1 (2.4)	NCAN (2.1)	ENSG00000254235 (1.7)	SH2B3 (1.7)	USP24 (1.7)	GATAD2A (1.5)	USP1 (1.5)	BUD13 (1.4)
GO:0045408	regulation of interleukin-6 biosynthetic process	0.39	> 0.20	ENSG00000254235 (2.6)	HLX (2.4)	ENSG00000235545 (2.1)	ENSG00000228044 (2.1)	HNF1A (1.8)	ENSG00000226645 (1.7)	BUD13 (1.6)	ENSG00000238078 (1.5)	PMFBP1 (1.4)	TRIB1 (1.3)
MP:0003809	abnormal hair shaft morphology	0.39	> 0.20	AP1M2 (3.9)	CBLC (2.8)	CYB561D1 (2.2)	CELSR2 (2.1)	HMGCR (2.0)	NKPD1 (1.8)	LDLR (1.8)	BCAM (1.5)	FADS1 (1.5)	MAFB (1.3)
ENSG00000118898	PPL PPI subnetwork	0.39	> 0.20	TMEM57 (3.2)	C1orf63 (2.6)	PLEC (2.5)	C11orf9 (2.1)	NT5DC1 (2.0)	LPIN3 (1.9)	CBLC (1.9)	OGDH (1.6)	ABO (1.5)	CELSR2 (1.4)
ENSG00000163828	ENSG00000163828 PPI subnetwork	0.39	> 0.20	PMFBP1 (2.0)	CEACAM19 (1.9)	LPA (1.5)	BUD13 (1.4)	APOA5 (1.3)	ZNF180 (1.3)	MOSC1 (1.2)	ALDH2 (1.1)	APOC4 (1.0)	YIPF2 (1.0)
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	0.39	> 0.20	RELB (5.8)	BCL3 (4.1)	OASL (2.7)	PARP10 (2.3)	PVR (2.1)	ENSG00000228044 (1.7)	MAFB (1.5)	TRAFD1 (1.4)	GRINA (1.4)	GMIP (1.3)
MP:0004204	absent stapes	0.39	> 0.20	MYLIP (3.2)	CEACAM19 (2.3)	TMEM57 (2.2)	KIAA1324 (2.1)	DYNC2LI1 (2.0)	TMED4 (1.6)	PVRL2 (1.4)	PLCG1 (1.4)	RHCE (1.4)	ENSG00000238078 (1.3)
MP:0000752	dystrophic muscle	0.39	> 0.20	SYPL2 (4.3)	KANK2 (2.9)	SORT1 (2.5)	PVR (2.2)	PLEC (2.1)	ZHX3 (2.1)	ENSG00000238078 (2.0)	SLC44A2 (1.9)	TMEM50A (1.9)	AMIGO1 (1.8)
MP:0008182	decreased marginal zone B cell number	0.39	> 0.20	RELB (5.3)	GMIP (3.5)	BCL3 (2.9)	SH2B3 (2.5)	CETP (1.9)	TIMD4 (1.8)	SLC44A2 (1.8)	MAFB (1.8)	GRINA (1.7)	NT5DC1 (1.7)
ENSG00000011304	PTBP1 PPI subnetwork	0.39	> 0.20	ILF3 (4.5)	C1orf63 (3.9)	TOP1 (3.3)	SMARCA4 (3.3)	PTPN11 (2.7)	USP1 (2.6)	DHX38 (2.6)	QTRT1 (2.6)	GATAD2A (2.3)	SUGP1 (2.2)
GO:0006921	cellular component disassembly involved in apoptotic process	0.39	> 0.20	ENSG00000226645 (2.7)	ST3GAL4 (2.4)	ZNF101 (2.3)	C1orf63 (2.1)	POLK (2.0)	ENSG00000238078 (1.9)	AP1M2 (1.7)	CBLC (1.6)	UBXN2B (1.4)	TRAPPC6A (1.3)
GO:0000077	DNA damage checkpoint	0.39	> 0.20	PSMA5 (2.7)	NT5DC1 (2.3)	POLK (2.1)	SUGP1 (1.8)	NAA25 (1.8)	TRAFD1 (1.8)	BRAP (1.7)	ZNF180 (1.7)	PSRC1 (1.6)	C12orf47 (1.6)
ENSG00000140538	NTRK3 PPI subnetwork	0.39	> 0.20	TRIB1 (3.8)	PBX4 (2.7)	MAFB (2.3)	ZNF101 (2.3)	ENSG00000238078 (1.9)	PSRC1 (1.6)	MARK4 (1.5)	PVR (1.5)	ZHX3 (1.4)	ADAM1 (1.1)
ENSG00000197558	ENSG00000197558 PPI subnetwork	0.39	> 0.20	PARP10 (2.7)	C17orf57 (2.6)	PTPN11 (2.5)	FRK (2.4)	KANK2 (1.8)	ADAM1 (1.8)	HNF1A (1.7)	UBXN2B (1.5)	DHX38 (1.4)	ZNF180 (1.4)
ENSG00000127388	ENSG00000127388 PPI subnetwork	0.39	> 0.20	PARP10 (2.7)	C17orf57 (2.6)	PTPN11 (2.5)	FRK (2.4)	KANK2 (1.8)	ADAM1 (1.8)	HNF1A (1.7)	UBXN2B (1.5)	DHX38 (1.4)	ZNF180 (1.4)
GO:0015629	actin cytoskeleton	0.39	> 0.20	SYPL2 (4.8)	PLEC (2.8)	GMPR (2.4)	KANK2 (2.2)	C11orf9 (2.1)	PVRL2 (1.8)	SH2B3 (1.6)	AP1M2 (1.5)	GMIP (1.4)	SORT1 (1.3)
GO:0010833	telomere maintenance via telomere lengthening	0.39	> 0.20	GOT2P1 (2.6)	USP1 (2.6)	ENSG00000235545 (2.3)	TXNL4B (2.3)	ZNF180 (2.2)	ENSG00000226648 (2.1)	ENSG00000228044 (2.1)	AMIGO1 (2.0)	FEN1 (2.0)	POLK (2.0)
ENSG00000070770	CSNK2A2 PPI subnetwork	0.39	> 0.20	ILF3 (3.5)	SMARCA4 (3.4)	CARM1 (3.3)	TOP1 (3.3)	GATAD2A (3.3)	TOMM40 (2.7)	PTPN11 (2.6)	ZNF259 (2.5)	C12orf43 (2.4)	DHX38 (2.3)
ENSG00000168003	SLC3A2 PPI subnetwork	0.39	> 0.20	ALDH2 (3.1)	C19orf52 (2.5)	HAVCR1 (2.4)	PCSK9 (2.3)	BCAM (2.0)	DDX56 (2.0)	PLEC (1.9)	ENSG00000226648 (1.9)	SARS (1.8)	AP1M2 (1.8)
ENSG00000073584	SMARCE1 PPI subnetwork	0.39	> 0.20	RHCE (3.1)	C12orf51 (2.7)	SMARCA4 (2.6)	ATXN2 (2.6)	CARM1 (2.6)	TOP1 (2.4)	GRINA (2.3)	RHD (2.1)	KANK2 (2.0)	GATAD2A (2.0)
ENSG00000127511	SIN3B PPI subnetwork	0.39	> 0.20	OASL (5.7)	BRAP (3.1)	PARP10 (3.1)	TOP1 (2.8)	CARM1 (2.7)	MAU2 (2.6)	TRAFD1 (2.5)	C12orf51 (2.4)	CELSR2 (2.2)	SMARCA4 (2.1)
GO:0022617	extracellular matrix disassembly	0.39	> 0.20	CEACAM19 (2.8)	HNF1A (2.7)	FRK (2.7)	ENSG00000226645 (2.3)	CBLC (2.3)	PLCG1 (2.1)	ENSG00000254235 (2.0)	ZHX3 (1.7)	CYP7A1 (1.6)	NPC1L1 (1.5)
ENSG00000164818	HEATR2 PPI subnetwork	0.39	> 0.20	SUGP1 (2.7)	TRAPPC6A (2.3)	BCAM (1.7)	HAPLN4 (1.7)	GRINA (1.6)	CBLC (1.6)	GEMIN7 (1.5)	GMPR (1.5)	KANK2 (1.5)	PSRC1 (1.4)
GO:0021782	glial cell development	0.39	> 0.20	NCAN (3.0)	C11orf9 (2.7)	ENSG00000226648 (1.7)	SORT1 (1.7)	CEACAM19 (1.7)	ENSG00000254235 (1.7)	C19orf52 (1.6)	DYNC2LI1 (1.6)	ENSG00000235545 (1.5)	HAPLN4 (1.4)
GO:0090136	epithelial cell-cell adhesion	0.39	> 0.20	HNF1A (3.0)	CBLC (2.8)	ENSG00000254235 (2.2)	AMIGO1 (2.2)	ENSG00000226648 (2.1)	LPIN3 (2.1)	PMFBP1 (2.0)	PBX4 (2.0)	BLOC1S3 (1.7)	CILP2 (1.7)
ENSG00000185989	RASA3 PPI subnetwork	0.39	> 0.20	ENSG00000226648 (4.3)	ZHX3 (4.2)	HLX (3.1)	TRIB1 (2.6)	SH2B3 (2.4)	TOP1 (2.3)	DOCK7 (2.1)	MAFB (2.0)	DHX38 (1.8)	SORT1 (1.7)
ENSG00000107854	TNKS2 PPI subnetwork	0.39	> 0.20	PBX4 (3.6)	UBXN2B (3.4)	TMEM116 (2.2)	ENSG00000226645 (2.1)	HAVCR1 (2.0)	COL4A3BP (2.0)	ABO (1.9)	KIAA1324 (1.8)	ENSG00000226648 (1.7)	AMIGO1 (1.7)
MP:0005010	abnormal CD8-positive T cell morphology	0.39	> 0.20	PLCG1 (4.0)	ZNF101 (2.6)	MYLIP (1.8)	PBX4 (1.4)	GMIP (1.4)	TMEM50A (1.4)	KIAA1324 (1.3)	RELB (1.3)	LPA (1.2)	HAVCR1 (1.2)
ENSG00000056972	TRAF3IP2 PPI subnetwork	0.39	> 0.20	RELB (5.9)	BCL3 (2.8)	CYB561D1 (2.7)	NT5DC1 (2.3)	PBX4 (2.2)	TRAFD1 (2.1)	LPAR2 (2.0)	BLOC1S3 (2.0)	SH2B3 (1.8)	UBXN2B (1.7)
GO:0017148	negative regulation of translation	0.39	> 0.20	HNF1A (2.1)	TMEM57 (2.1)	ANKRD31 (1.9)	NYNRIN (1.8)	GCNT4 (1.8)	USP24 (1.7)	ILF3 (1.7)	RHCE (1.5)	PMFBP1 (1.5)	C12orf51 (1.5)
ENSG00000206476	ENSG00000206476 PPI subnetwork	0.39	> 0.20	SUGP1 (3.1)	TXNL4B (2.7)	BUD13 (2.5)	DHX38 (2.4)	MAPKAPK5 (2.4)	ZNF259 (2.3)	POC5 (2.2)	PSMA5 (2.0)	TOP1 (1.6)	TRAPPC6A (1.6)
ENSG00000213780	GTF2H4 PPI subnetwork	0.39	> 0.20	SUGP1 (3.1)	TXNL4B (2.7)	BUD13 (2.5)	DHX38 (2.4)	MAPKAPK5 (2.4)	ZNF259 (2.3)	POC5 (2.2)	PSMA5 (2.0)	TOP1 (1.6)	TRAPPC6A (1.6)
ENSG00000215476	ENSG00000215476 PPI subnetwork	0.39	> 0.20	SUGP1 (3.1)	TXNL4B (2.7)	BUD13 (2.5)	DHX38 (2.4)	MAPKAPK5 (2.4)	ZNF259 (2.3)	POC5 (2.2)	PSMA5 (2.0)	TOP1 (1.6)	TRAPPC6A (1.6)
ENSG00000108179	PPIF PPI subnetwork	0.39	> 0.20	TSSK6 (2.4)	C19orf52 (2.3)	TRAPPC6A (2.2)	BUD13 (2.1)	TOMM40 (2.1)	CLPTM1 (1.8)	TXNL4B (1.8)	SMARCA4 (1.7)	ZNF180 (1.6)	GEMIN7 (1.4)
ENSG00000112531	QKI PPI subnetwork	0.39	> 0.20	HAVCR1 (3.3)	ACAD10 (2.3)	DNM2 (2.2)	KANK2 (1.9)	CLPTM1 (1.6)	CARM1 (1.6)	HNF1A (1.6)	AMIGO1 (1.4)	C11orf9 (1.4)	ATXN2 (1.4)
ENSG00000089041	P2RX7 PPI subnetwork	0.39	> 0.20	PLEC (3.1)	CYP7A1 (2.6)	OGDH (2.3)	APOE (2.1)	C17orf57 (1.8)	DNM2 (1.6)	GMIP (1.6)	ABCG8 (1.5)	FADS2 (1.5)	APOC1 (1.5)
ENSG00000029363	BCLAF1 PPI subnetwork	0.39	> 0.20	C1orf63 (4.3)	SMARCA4 (2.9)	PLEC (2.8)	TOP1 (2.7)	GATAD2A (2.6)	KANK2 (2.5)	OGDH (2.4)	FRK (2.0)	ADAM1 (1.9)	GCNT4 (1.9)
ENSG00000173599	PC PPI subnetwork	0.39	> 0.20	C19orf52 (3.1)	ENSG00000235545 (2.8)	OASL (2.8)	QTRT1 (2.6)	DOCK7 (2.6)	NT5DC1 (2.6)	YIPF2 (2.3)	OGDH (2.3)	SUGP1 (2.2)	AP1M2 (1.8)
ENSG00000137312	FLOT1 PPI subnetwork	0.39	> 0.20	HP (3.1)	UBXN2B (2.4)	TMED4 (2.4)	DYNC2LI1 (2.2)	TIMD4 (2.2)	LPA (1.9)	PBX4 (1.9)	ENSG00000238078 (1.7)	SLC22A1 (1.6)	C17orf57 (1.6)
ENSG00000206480	FLOT1 PPI subnetwork	0.39	> 0.20	HP (3.1)	UBXN2B (2.4)	TMED4 (2.4)	DYNC2LI1 (2.2)	TIMD4 (2.2)	LPA (1.9)	PBX4 (1.9)	ENSG00000238078 (1.7)	SLC22A1 (1.6)	C17orf57 (1.6)
ENSG00000206379	FLOT1 PPI subnetwork	0.39	> 0.20	HP (3.1)	UBXN2B (2.4)	TMED4 (2.4)	DYNC2LI1 (2.2)	TIMD4 (2.2)	LPA (1.9)	PBX4 (1.9)	ENSG00000238078 (1.7)	SLC22A1 (1.6)	C17orf57 (1.6)
ENSG00000075391	RASAL2 PPI subnetwork	0.39	> 0.20	RELB (5.7)	ZNF259 (3.2)	C12orf43 (2.8)	GEMIN7 (2.4)	BCL3 (2.3)	MAPKAPK5 (2.1)	DDX56 (1.9)	TOMM40 (1.9)	BLOC1S3 (1.8)	CLPTM1 (1.8)
REACTOME_PAUSING_AND_RECOVERY_OF_ELONGATION	REACTOME_PAUSING_AND_RECOVERY_OF_ELONGATION	0.39	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
REACTOME_ELONGATION_ARREST_AND_RECOVERY	REACTOME_ELONGATION_ARREST_AND_RECOVERY	0.39	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
REACTOME_HIV:1_ELONGATION_ARREST_AND_RECOVERY	REACTOME_HIV:1_ELONGATION_ARREST_AND_RECOVERY	0.39	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
REACTOME_PAUSING_AND_RECOVERY_OF_HIV:1_ELONGATION	REACTOME_PAUSING_AND_RECOVERY_OF_HIV:1_ELONGATION	0.39	> 0.20	SUGP1 (2.6)	DHX38 (2.6)	CLPTM1 (2.3)	BUD13 (2.2)	DNM2 (2.1)	GEMIN7 (2.0)	ZNF259 (1.9)	MAPKAPK5 (1.9)	PTPN11 (1.9)	QTRT1 (1.7)
GO:0043500	muscle adaptation	0.39	> 0.20	LPIN3 (3.1)	ENSG00000254235 (2.7)	SYPL2 (2.3)	CEACAM19 (2.2)	TXNL4B (1.9)	ENSG00000235545 (1.8)	CYB561D1 (1.6)	MAFB (1.5)	C17orf57 (1.5)	ATXN7L2 (1.5)
MP:0001759	increased urine glucose level	0.39	> 0.20	ERP29 (2.0)	CEACAM19 (2.0)	MOSC1 (1.8)	COL4A3BP (1.8)	TMED4 (1.6)	HAVCR1 (1.6)	TMEM116 (1.5)	SYPL2 (1.5)	PMFBP1 (1.5)	YIPF2 (1.4)
ENSG00000184363	PKP3 PPI subnetwork	0.39	> 0.20	CBLC (5.1)	AP1M2 (3.5)	CELSR2 (2.7)	PVRL2 (2.2)	ALDH2 (2.1)	LPAR2 (1.9)	ST3GAL4 (1.6)	FRK (1.5)	HNF1A (1.3)	PCSK9 (1.3)
MP:0002944	increased lactate dehydrogenase level	0.39	> 0.20	DYNC2LI1 (3.1)	PVRL2 (2.5)	TMED4 (1.9)	SLC44A2 (1.9)	NPC1L1 (1.8)	ZHX3 (1.7)	TMEM116 (1.6)	NCAN (1.6)	ENSG00000238078 (1.5)	PLEKHH2 (1.5)
GO:0052745	inositol phosphate phosphatase activity	0.39	> 0.20	UBXN2B (2.4)	SH2B3 (2.2)	C12orf51 (2.1)	ZNF180 (2.1)	BLOC1S3 (1.9)	HAPLN4 (1.9)	NT5DC1 (1.8)	MYLIP (1.8)	TSSK6 (1.6)	POC5 (1.6)
GO:0009897	external side of plasma membrane	0.39	> 0.20	CETP (3.5)	TIMD4 (3.5)	APOE (2.7)	PLCG1 (2.3)	RELB (2.2)	APOC1 (1.9)	BCL3 (1.8)	SLC44A2 (1.4)	PBX4 (1.4)	MAFB (1.3)
GO:0016500	protein-hormone receptor activity	0.39	> 0.20	PMFBP1 (2.6)	CELSR2 (2.4)	HAVCR1 (2.4)	PCSK9 (2.2)	DNAH11 (1.9)	MOSC1 (1.9)	HMGCR (1.8)	C17orf57 (1.8)	SORT1 (1.7)	GPAM (1.7)
ENSG00000117461	PIK3R3 PPI subnetwork	0.39	> 0.20	DOCK7 (3.3)	HLX (3.1)	PVRL2 (2.7)	C1orf63 (2.6)	SLC44A2 (2.6)	SH2B3 (2.1)	GMIP (2.1)	MYLIP (2.0)	DNM2 (1.9)	CELSR2 (1.8)
GO:0030335	positive regulation of cell migration	0.39	> 0.20	PVR (3.5)	PVRL2 (2.6)	MAFB (2.3)	AP1M2 (2.2)	CETP (1.9)	APOE (1.8)	ENSG00000228044 (1.7)	ZNF101 (1.6)	HLX (1.6)	PTPN11 (1.6)
ENSG00000166595	FAM96B PPI subnetwork	0.39	> 0.20	TOMM40 (2.6)	PPP1R37 (2.5)	NKPD1 (2.4)	DDX56 (2.2)	POLK (2.2)	ATP13A1 (1.9)	CEACAM19 (1.8)	MOSC1 (1.8)	PSRC1 (1.7)	GCNT4 (1.7)
GO:0001522	pseudouridine synthesis	0.39	> 0.20	ZNF259 (3.5)	DHODH (3.4)	QTRT1 (3.4)	BUD13 (3.1)	NAA25 (2.8)	GOT2P1 (2.4)	DDX56 (2.3)	TOMM40 (2.1)	NKPD1 (2.1)	ANKRD31 (1.9)
GO:0000216	M/G1 transition of mitotic cell cycle	0.39	> 0.20	PSMA5 (3.5)	NT5DC1 (3.2)	ENSG00000235545 (2.3)	ZNF180 (2.1)	NAA25 (1.9)	TXNL4B (1.7)	TRAFD1 (1.7)	FEN1 (1.7)	USP1 (1.5)	SUGP1 (1.4)
GO:0016234	inclusion body	0.39	> 0.20	CILP2 (2.4)	GRINA (2.3)	C1orf63 (2.2)	SYPL2 (1.8)	APOE (1.8)	CYP7A1 (1.7)	RPH3A (1.7)	BCAM (1.6)	GMPR (1.5)	YIPF2 (1.4)
GO:0002377	immunoglobulin production	0.39	> 0.20	ZNF101 (2.6)	PBX4 (2.4)	NT5DC1 (2.0)	POC5 (1.9)	DYNC2LI1 (1.9)	C12orf43 (1.7)	GEMIN7 (1.3)	ADAM1 (1.3)	HAVCR1 (1.3)	C17orf57 (1.2)
GO:0046328	regulation of JNK cascade	0.39	> 0.20	ST3GAL4 (3.4)	LPAR2 (2.6)	UBXN2B (2.5)	FRK (2.2)	C11orf9 (2.0)	ENSG00000235545 (1.9)	ENSG00000226645 (1.8)	POLK (1.6)	CYB561D1 (1.4)	GMIP (1.3)
ENSG00000075945	KIFAP3 PPI subnetwork	0.39	> 0.20	PLCG1 (3.1)	DYNC2LI1 (2.8)	COL4A3BP (2.6)	MARK4 (2.3)	POC5 (2.2)	UBXN2B (2.1)	DOCK7 (2.0)	SLC44A2 (1.8)	ABO (1.7)	SARS (1.7)
GO:0017147	Wnt-protein binding	0.39	> 0.20	CILP2 (4.0)	BCAM (2.5)	PVRL2 (2.2)	LPAR2 (2.1)	DYNC2LI1 (1.8)	CELSR2 (1.7)	PLEKHH2 (1.6)	AMIGO1 (1.5)	NYNRIN (1.3)	MOSC1 (1.3)
ENSG00000122884	P4HA1 PPI subnetwork	0.39	> 0.20	ATP13A1 (3.6)	OGDH (3.2)	YIPF2 (3.1)	ILF3 (3.1)	DNM2 (3.0)	QTRT1 (2.8)	DHX38 (2.3)	ACAD10 (2.2)	FEN1 (1.9)	NT5DC1 (1.7)
GO:0016032	viral reproduction	0.39	> 0.20	BUD13 (2.5)	PSMA5 (2.2)	ZNF101 (2.1)	ZNF180 (2.1)	GEMIN7 (1.9)	SUGP1 (1.9)	NKPD1 (1.8)	BRAP (1.7)	PTPN11 (1.7)	MAU2 (1.7)
GO:0071158	positive regulation of cell cycle arrest	0.40	> 0.20	PSMA5 (3.5)	TRAFD1 (2.5)	NAA25 (2.3)	NT5DC1 (2.2)	ENSG00000254235 (1.9)	SUGP1 (1.6)	SARS (1.4)	ZNF259 (1.3)	C12orf43 (1.3)	ENSG00000226645 (1.3)
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION	0.40	> 0.20	C12orf43 (4.0)	DYNC2LI1 (3.1)	MAPKAPK5 (2.8)	TXNL4B (2.7)	ZNF259 (2.6)	GEMIN7 (2.5)	DHX38 (2.4)	NAA25 (2.3)	POLK (2.2)	ATXN7L2 (2.1)
ENSG00000215467	ENSG00000215467 PPI subnetwork	0.40	> 0.20	ZNF259 (3.4)	NAA25 (3.0)	DDX56 (2.5)	TOMM40 (2.2)	GATAD2A (2.1)	NKPD1 (2.0)	QTRT1 (2.0)	PLEKHH2 (1.8)	C12orf43 (1.8)	TOP1 (1.8)
GO:0051247	positive regulation of protein metabolic process	0.40	> 0.20	GEMIN7 (2.0)	TRAFD1 (2.0)	ENSG00000228044 (1.8)	TIMD4 (1.8)	SH2B3 (1.7)	POC5 (1.7)	PSMA5 (1.7)	PTPN11 (1.6)	COL4A3BP (1.6)	CETP (1.5)
GO:0001676	long-chain fatty acid metabolic process	0.40	> 0.20	ENSG00000254235 (3.7)	CYB561D1 (2.5)	NKPD1 (2.4)	CYP7A1 (2.1)	GMPR (1.8)	AMIGO1 (1.8)	PMFBP1 (1.6)	HAPLN4 (1.5)	ENSG00000238078 (1.5)	FRK (1.5)
MP:0005565	increased blood urea nitrogen level	0.40	> 0.20	BCAM (3.2)	FRK (2.3)	TRIB1 (2.2)	ZHX3 (2.0)	AP1M2 (2.0)	NT5DC1 (1.9)	PLEC (1.9)	SLC22A1 (1.8)	HAVCR1 (1.8)	PVR (1.7)
ENSG00000179151	EDC3 PPI subnetwork	0.40	> 0.20	CBLC (5.4)	AP1M2 (3.5)	LPAR2 (2.7)	CYB561D1 (2.2)	CELSR2 (2.1)	CARM1 (2.1)	PVRL2 (1.9)	PLEC (1.9)	TSSK6 (1.7)	DNM2 (1.5)
ENSG00000135249	RINT1 PPI subnetwork	0.40	> 0.20	RHD (3.9)	RHCE (2.8)	BRAP (2.8)	ITGB3 (2.5)	ZNF259 (2.3)	TRAPPC6A (2.2)	GMPR (2.2)	TMEM57 (2.1)	TXNL4B (2.0)	TMEM116 (2.0)
ENSG00000214655	KIAA0913 PPI subnetwork	0.40	> 0.20	CILP2 (3.6)	ABO (3.4)	PPP1R37 (2.7)	ENSG00000254235 (2.4)	SORT1 (2.3)	CARM1 (2.0)	PSRC1 (2.0)	ENSG00000235545 (2.0)	LPIN3 (2.0)	GCNT4 (1.9)
ENSG00000100842	EFS PPI subnetwork	0.40	> 0.20	PPP1R37 (2.9)	DNM2 (2.8)	ZHX3 (2.5)	GATAD2A (2.1)	C17orf57 (2.1)	SH2B3 (2.0)	PVRL2 (1.9)	ABO (1.8)	SLC44A2 (1.8)	PLEC (1.8)
GO:0034199	activation of protein kinase A activity	0.40	> 0.20	ST3GAL4 (2.7)	ENSG00000228044 (2.6)	GOT2P1 (2.1)	ITGB3 (2.1)	PMFBP1 (2.1)	ENSG00000238078 (1.9)	SORT1 (1.7)	ADAM1 (1.5)	AMIGO1 (1.5)	SH2B3 (1.5)
ENSG00000129219	PLD2 PPI subnetwork	0.40	> 0.20	DNM2 (2.4)	PLEC (2.2)	ITGB3 (1.9)	ZNF101 (1.9)	GATAD2A (1.8)	ENSG00000238078 (1.8)	PLCG1 (1.8)	TOP1 (1.7)	MOSC1 (1.7)	ADAM1 (1.5)
ENSG00000099622	CIRBP PPI subnetwork	0.40	> 0.20	NCAN (2.5)	RPH3A (2.4)	APOC1 (2.0)	QTRT1 (1.7)	ADAM1 (1.5)	CARM1 (1.4)	GPAM (1.4)	MOSC1 (1.3)	NKPD1 (1.3)	GOT2P1 (1.2)
ENSG00000213246	SUPT4H1 PPI subnetwork	0.40	> 0.20	SUGP1 (3.2)	ZNF259 (2.7)	DHX38 (2.6)	MAPKAPK5 (2.5)	BUD13 (2.4)	PTPN11 (2.4)	TOMM40 (2.4)	GEMIN7 (2.4)	TOP1 (2.3)	TXNL4B (2.1)
MP:0004753	abnormal miniature excitatory postsynaptic currents	0.40	> 0.20	RPH3A (4.6)	HAPLN4 (3.1)	PPP1R37 (2.2)	CELSR2 (2.0)	TRIB1 (1.8)	AMIGO1 (1.7)	ENSG00000226648 (1.6)	C12orf51 (1.6)	GRINA (1.3)	NCAN (1.3)
GO:0045351	type I interferon biosynthetic process	0.40	> 0.20	PARP10 (3.8)	OASL (3.5)	TRAFD1 (3.0)	ATP13A1 (1.9)	ZNF180 (1.8)	GEMIN7 (1.8)	CYB561D1 (1.7)	ENSG00000228044 (1.5)	ZNF101 (1.5)	C17orf57 (1.4)
GO:0045909	positive regulation of vasodilation	0.40	> 0.20	TMEM116 (2.8)	LPIN3 (2.7)	ENSG00000226648 (2.4)	C12orf47 (2.3)	TMED4 (1.5)	ENSG00000226645 (1.4)	CETP (1.4)	POLK (1.3)	TXNL4B (1.3)	GEMIN7 (1.3)
GO:2001022	positive regulation of response to DNA damage stimulus	0.40	> 0.20	GCNT4 (2.1)	HAVCR1 (2.1)	TRAPPC6A (2.0)	ENSG00000226645 (2.0)	NT5DC1 (1.9)	DYNC2LI1 (1.8)	C17orf57 (1.6)	QTRT1 (1.5)	BLOC1S3 (1.4)	C12orf43 (1.4)
ENSG00000136715	SAP130 PPI subnetwork	0.40	> 0.20	OASL (7.2)	PARP10 (3.0)	ATXN7L2 (2.8)	QTRT1 (2.0)	GEMIN7 (2.0)	MAU2 (2.0)	ENSG00000226648 (1.9)	BUD13 (1.9)	ILF3 (1.8)	ATXN2 (1.8)
ENSG00000114125	RNF7 PPI subnetwork	0.40	> 0.20	GMPR (2.4)	BUD13 (2.1)	TIMD4 (1.9)	HLX (1.7)	CETP (1.5)	CARM1 (1.4)	CILP2 (1.3)	CEACAM19 (1.3)	BRAP (1.3)	TMED4 (1.2)
ENSG00000143761	ARF1 PPI subnetwork	0.40	> 0.20	YIPF2 (4.0)	CLPTM1 (3.8)	DHX38 (2.4)	MAU2 (2.4)	DNM2 (2.1)	KIAA1324 (2.0)	BLOC1S3 (2.0)	OGDH (2.0)	SUGP1 (1.8)	ATP13A1 (1.7)
ENSG00000148356	LRSAM1 PPI subnetwork	0.40	> 0.20	MAU2 (2.8)	DOCK7 (2.4)	ENSG00000235545 (2.4)	ST3GAL4 (2.1)	GRINA (2.0)	RELB (1.9)	ATXN7L2 (1.6)	CEACAM19 (1.5)	AMIGO1 (1.4)	TMEM50A (1.4)
GO:0002673	regulation of acute inflammatory response	0.40	> 0.20	ENSG00000228044 (3.4)	ENSG00000235545 (3.3)	LPA (1.7)	TIMD4 (1.5)	CETP (1.5)	MOSC1 (1.5)	ST3GAL4 (1.3)	POC5 (1.3)	C12orf47 (1.3)	DNAH11 (1.2)
GO:0045823	positive regulation of heart contraction	0.40	> 0.20	LPIN3 (3.2)	CEACAM19 (2.8)	ENSG00000226648 (2.7)	HAPLN4 (1.9)	FRK (1.9)	GEMIN7 (1.8)	CYB561D1 (1.6)	PPP1R37 (1.5)	RPH3A (1.5)	TMED4 (1.4)
GO:0007339	binding of sperm to zona pellucida	0.40	> 0.20	TSSK6 (4.4)	PMFBP1 (3.7)	ENSG00000228044 (3.1)	ENSG00000238078 (3.1)	GCNT4 (2.3)	PBX4 (1.6)	C17orf57 (1.5)	BRAP (1.0)	ANKRD31 (0.9)	PCSK9 (0.9)
GO:0042169	SH2 domain binding	0.40	> 0.20	PBX4 (3.0)	PLCG1 (2.7)	GPAM (2.6)	ABO (2.1)	PPP1R37 (1.8)	FADS1 (1.5)	ENSG00000238078 (1.5)	TRIB1 (1.4)	GMIP (1.3)	CETP (1.3)
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	0.40	> 0.20	TRAFD1 (3.4)	PSMA5 (3.1)	RELB (2.7)	PARP10 (2.5)	TIMD4 (2.1)	USP24 (1.8)	APOE (1.7)	GEMIN7 (1.4)	BCL3 (1.3)	NAA25 (1.3)
GO:0040012	regulation of locomotion	0.40	> 0.20	PVR (3.0)	PVRL2 (2.9)	HLX (2.6)	ENSG00000254235 (2.5)	CETP (2.2)	MAFB (2.2)	KANK2 (1.8)	APOE (1.7)	SLC44A2 (1.5)	PLEKHH2 (1.5)
ENSG00000126698	DNAJC8 PPI subnetwork	0.40	> 0.20	ILF3 (4.1)	C1orf63 (3.6)	TOP1 (3.1)	DHX38 (2.8)	USP1 (2.7)	BUD13 (2.6)	SMARCA4 (2.6)	SUGP1 (2.2)	FEN1 (2.1)	QTRT1 (2.0)
ENSG00000114054	PCCB PPI subnetwork	0.40	> 0.20	FADS1 (3.2)	FADS2 (2.8)	NT5DC1 (2.4)	COL4A3BP (2.4)	PSMA5 (2.2)	GPAM (2.0)	OASL (1.9)	DOCK7 (1.9)	SARS (1.8)	DYNC2LI1 (1.8)
MP:0001684	abnormal axial mesoderm	0.40	> 0.20	GATAD2A (2.7)	ABO (2.3)	QTRT1 (2.1)	HNF1A (2.0)	ZHX3 (2.0)	COL4A3BP (1.8)	APOE (1.8)	C11orf9 (1.7)	DHX38 (1.6)	LPA (1.4)
GO:0030218	erythrocyte differentiation	0.40	> 0.20	RHCE (6.3)	RHD (5.9)	C12orf51 (2.5)	TMEM57 (2.4)	C19orf52 (2.2)	DNM2 (1.9)	GMPR (1.8)	BLOC1S3 (1.6)	ENSG00000228044 (1.6)	UBXN2B (1.5)
GO:0031589	cell-substrate adhesion	0.40	> 0.20	SLC44A2 (4.2)	ITGB3 (3.1)	KANK2 (2.5)	C17orf57 (2.4)	PLEKHH2 (2.4)	SORT1 (2.2)	GCNT4 (2.0)	CILP2 (1.9)	PLEC (1.9)	ZHX3 (1.8)
GO:0042058	regulation of epidermal growth factor receptor signaling pathway	0.40	> 0.20	PPP1R37 (2.9)	C17orf57 (2.4)	CLPTM1 (2.2)	ABO (1.9)	DOCK7 (1.8)	CETP (1.8)	MARK4 (1.7)	ENSG00000235545 (1.7)	PVRL2 (1.7)	ENSG00000226645 (1.6)
MP:0003026	decreased vasoconstriction	0.40	> 0.20	HLX (3.0)	SYPL2 (2.8)	KANK2 (2.5)	SLC22A1 (1.8)	QTRT1 (1.6)	LPA (1.5)	ITGB3 (1.3)	C17orf57 (1.2)	CETP (1.2)	PLEKHH2 (1.2)
ENSG00000105447	GRWD1 PPI subnetwork	0.40	> 0.20	QTRT1 (2.0)	CEACAM19 (2.0)	BUD13 (1.8)	NKPD1 (1.8)	BCL3 (1.7)	DOCK7 (1.7)	ILF3 (1.6)	GATAD2A (1.5)	KANK2 (1.4)	MYLIP (1.4)
GO:0001933	negative regulation of protein phosphorylation	0.40	> 0.20	DNAH11 (3.3)	ENSG00000238078 (3.1)	ACAD10 (2.7)	GCNT4 (2.5)	PPP1R37 (2.3)	ABO (2.2)	TRIB1 (2.1)	ADAM1 (1.7)	YIPF2 (1.7)	MYLIP (1.6)
MP:0004787	abnormal dorsal aorta morphology	0.40	> 0.20	HLX (4.3)	SH2B3 (3.2)	PVR (2.3)	SLC44A2 (2.1)	KANK2 (2.0)	PVRL2 (1.8)	MAFB (1.8)	PLCG1 (1.6)	BCAM (1.6)	CETP (1.5)
ENSG00000136518	ACTL6A PPI subnetwork	0.40	> 0.20	SMARCA4 (3.5)	BUD13 (3.4)	ILF3 (3.2)	ATXN7L2 (3.0)	BRAP (2.7)	CARM1 (2.6)	NYNRIN (2.6)	ATXN2 (2.3)	DHX38 (2.1)	MAU2 (2.0)
ENSG00000152270	PDE3B PPI subnetwork	0.40	> 0.20	ST3GAL4 (2.9)	MARK4 (2.5)	SH2B3 (2.4)	ENSG00000238078 (2.3)	ITGB3 (2.3)	GMPR (2.2)	GATAD2A (1.9)	ENSG00000226645 (1.8)	SLC44A2 (1.8)	GPAM (1.8)
MP:0008406	increased cellular sensitivity to hydrogen peroxide	0.40	> 0.20	ALDH2 (2.7)	CELSR2 (2.2)	ACAD10 (1.8)	SARS (1.7)	PVRL2 (1.6)	NCAN (1.6)	RHCE (1.5)	HP (1.5)	RHD (1.5)	PSMA5 (1.3)
ENSG00000136244	IL6 PPI subnetwork	0.40	> 0.20	BCL3 (5.4)	RELB (4.6)	TRIB1 (3.3)	HLX (2.5)	PVR (1.9)	GMIP (1.9)	CETP (1.7)	TIMD4 (1.7)	PARP10 (1.7)	GRINA (1.7)
MP:0002993	arthritis	0.40	> 0.20	CILP2 (2.4)	TRIB1 (2.2)	ENSG00000238078 (1.9)	PLCG1 (1.8)	LPIN3 (1.7)	PLEKHH2 (1.7)	CEACAM19 (1.6)	PVR (1.6)	BCL3 (1.5)	MAFB (1.4)
ENSG00000114982	KANSL3 PPI subnetwork	0.40	> 0.20	GEMIN7 (4.4)	BRAP (2.8)	TXNL4B (2.6)	C12orf47 (2.1)	BUD13 (2.1)	MAPKAPK5 (2.1)	POC5 (1.9)	BLOC1S3 (1.9)	C19orf52 (1.7)	MAU2 (1.6)
GO:0030133	transport vesicle	0.40	> 0.20	KIAA1324 (4.8)	YIPF2 (3.2)	LDLR (2.5)	FADS2 (2.1)	COL4A3BP (1.7)	ERP29 (1.6)	POLK (1.6)	CEACAM19 (1.6)	GRINA (1.5)	FRK (1.5)
GO:0046902	regulation of mitochondrial membrane permeability	0.40	> 0.20	GEMIN7 (3.2)	TRAPPC6A (2.6)	ENSG00000226648 (2.5)	POLK (2.2)	C12orf43 (2.2)	PPP1R37 (2.0)	TMEM116 (1.9)	GOT2P1 (1.7)	ZNF259 (1.7)	SLC44A2 (1.6)
GO:0051169	nuclear transport	0.40	> 0.20	GATAD2A (3.6)	PTPN11 (2.6)	ENSG00000254235 (2.5)	C12orf43 (2.2)	NAA25 (2.2)	ILF3 (1.8)	TRAFD1 (1.8)	MAPKAPK5 (1.7)	ADAM1 (1.7)	ATXN2 (1.6)
MP:0000780	abnormal corpus callosum morphology	0.40	> 0.20	NCAN (3.7)	GRINA (3.5)	FADS2 (2.9)	NYNRIN (2.6)	FADS1 (2.3)	PCSK9 (1.9)	HMGCR (1.8)	LDLR (1.8)	CELSR2 (1.8)	PVRL2 (1.7)
MP:0010024	increased total body fat amount	0.40	> 0.20	GPAM (3.3)	MOSC1 (2.5)	CETP (2.4)	AMIGO1 (2.4)	TIMD4 (2.1)	KIAA1324 (2.0)	PLEKHH2 (1.9)	ABCG5 (1.8)	ZHX3 (1.8)	CELSR2 (1.7)
MP:0001074	abnormal vagus nerve morphology	0.40	> 0.20	TMED4 (2.2)	HLX (2.1)	HAVCR1 (1.9)	ABO (1.7)	ANKRD31 (1.6)	MAFB (1.5)	TSSK6 (1.5)	ENSG00000228044 (1.4)	CEACAM19 (1.4)	COL4A3BP (1.3)
GO:0030595	leukocyte chemotaxis	0.40	> 0.20	MAFB (3.2)	ZNF101 (2.8)	TIMD4 (2.2)	ST3GAL4 (2.1)	APOE (1.9)	HLX (1.9)	GMIP (1.7)	ENSG00000228044 (1.7)	TMEM116 (1.6)	AMIGO1 (1.5)
GO:0071478	cellular response to radiation	0.40	> 0.20	NYNRIN (2.8)	BLOC1S3 (2.6)	HAVCR1 (2.6)	GEMIN7 (2.5)	TRAPPC6A (2.3)	C12orf43 (2.2)	C19orf52 (2.1)	DNAH11 (1.9)	CILP2 (1.6)	GATAD2A (1.5)
ENSG00000168495	POLR3D PPI subnetwork	0.40	> 0.20	C12orf43 (3.9)	DDX56 (3.2)	GEMIN7 (3.1)	ZNF259 (2.5)	MAPKAPK5 (2.4)	SUGP1 (2.3)	BUD13 (2.2)	POC5 (2.2)	QTRT1 (2.0)	ADAM1 (1.9)
MP:0002699	abnormal vitreous body morphology	0.40	> 0.20	PVRL2 (3.5)	C11orf9 (2.1)	GMPR (1.7)	ST3GAL4 (1.7)	NYNRIN (1.5)	PLEKHH2 (1.5)	GEMIN7 (1.5)	TMEM116 (1.4)	APOE (1.4)	ABCG5 (1.4)
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	0.40	> 0.20	NAA25 (3.1)	DDX56 (2.9)	DOCK7 (2.8)	POC5 (2.6)	ILF3 (2.4)	MAPKAPK5 (2.4)	USP24 (2.3)	BUD13 (2.2)	DHX38 (2.2)	USP1 (2.1)
MP:0005102	abnormal iris pigmentation	0.40	> 0.20	DOCK7 (2.1)	MYLIP (2.1)	GMPR (2.0)	APOE (2.0)	C19orf52 (1.6)	TMEM116 (1.6)	PPP1R37 (1.6)	ACAD10 (1.5)	COL4A3BP (1.4)	CELSR2 (1.3)
ENSG00000145736	GTF2H2 PPI subnetwork	0.40	> 0.20	SUGP1 (3.1)	BUD13 (2.9)	TXNL4B (2.8)	ZNF259 (2.3)	MAPKAPK5 (2.3)	POC5 (2.3)	DHX38 (2.2)	PSMA5 (2.0)	POLK (1.6)	BRAP (1.5)
MP:0008481	increased spleen germinal center number	0.40	> 0.20	TIMD4 (3.3)	MAFB (3.0)	CETP (2.9)	GMIP (2.5)	C17orf57 (2.2)	SH2B3 (2.2)	TRIB1 (1.7)	ITGB3 (1.5)	KIAA1324 (1.4)	AP1M2 (1.4)
GO:0000375	RNA splicing, via transesterification reactions	0.40	> 0.20	TOP1 (3.4)	BUD13 (3.2)	C1orf63 (3.2)	SUGP1 (3.0)	ILF3 (2.9)	DHX38 (2.9)	QTRT1 (2.3)	C12orf43 (2.0)	MAU2 (2.0)	SMARCA4 (1.8)
GO:0032673	regulation of interleukin-4 production	0.40	> 0.20	ZNF101 (2.3)	GCNT4 (2.1)	ENSG00000254235 (1.9)	TMEM57 (1.8)	ENSG00000226645 (1.7)	ENSG00000235545 (1.6)	POLK (1.5)	DNAH11 (1.4)	HNF1A (1.4)	PLCG1 (1.3)
ENSG00000081985	IL12RB2 PPI subnetwork	0.40	> 0.20	BCL3 (3.0)	COL4A3BP (2.0)	C17orf57 (1.7)	HLX (1.5)	ZNF101 (1.5)	CYP7A1 (1.4)	RELB (1.3)	PVR (1.3)	SLC22A1 (1.2)	POLK (1.1)
ENSG00000101160	CTSZ PPI subnetwork	0.40	> 0.20	OASL (3.7)	PARP10 (2.3)	TOMM40 (1.7)	CLPTM1 (1.7)	OGDH (1.6)	C12orf43 (1.6)	TMED4 (1.6)	ZNF180 (1.5)	PSRC1 (1.4)	C12orf47 (1.4)
ENSG00000100014	SPECC1L PPI subnetwork	0.40	> 0.20	PLEC (3.1)	PVR (2.3)	LPIN3 (2.2)	PVRL2 (2.1)	TRAFD1 (2.0)	SYPL2 (1.9)	ABO (1.8)	PPP1R37 (1.8)	ALDH2 (1.7)	DOCK7 (1.6)
GO:0016514	SWI/SNF complex	0.40	> 0.20	CARM1 (4.8)	SMARCA4 (2.8)	NYNRIN (2.6)	GRINA (2.5)	ATXN2 (2.5)	MAU2 (2.4)	SUGP1 (2.3)	C12orf51 (2.3)	CELSR2 (2.3)	MARK4 (1.9)
ENSG00000144837	PLA1A PPI subnetwork	0.40	> 0.20	ENSG00000228044 (2.6)	GPAM (2.1)	FADS2 (2.0)	CEACAM19 (2.0)	SORT1 (1.8)	LDLR (1.7)	PLEC (1.5)	C12orf51 (1.5)	CARM1 (1.4)	PVR (1.4)
ENSG00000094631	HDAC6 PPI subnetwork	0.40	> 0.20	USP24 (3.0)	PLEC (2.9)	TMEM57 (2.8)	C12orf51 (2.6)	ZNF180 (2.6)	BRAP (2.5)	ATXN2 (2.2)	BCL3 (1.8)	BUD13 (1.8)	SMARCA4 (1.7)
MP:0001216	abnormal epidermal layer morphology	0.40	> 0.20	CBLC (4.9)	AP1M2 (3.7)	CELSR2 (3.5)	PLEC (2.8)	BCAM (2.6)	C17orf57 (1.9)	ABCG8 (1.7)	PMFBP1 (1.6)	NYNRIN (1.5)	MAFB (1.5)
MP:0001284	absent vibrissae	0.40	> 0.20	AP1M2 (4.7)	CBLC (2.5)	BCAM (2.3)	MAFB (1.8)	CELSR2 (1.8)	TRAPPC6A (1.6)	GCNT4 (1.6)	SLC44A2 (1.5)	RHCE (1.5)	NKPD1 (1.5)
MP:0010763	abnormal hematopoietic stem cell physiology	0.40	> 0.20	UBXN2B (2.6)	CEACAM19 (2.2)	NYNRIN (1.9)	SLC44A2 (1.9)	KANK2 (1.7)	HLX (1.6)	PSRC1 (1.4)	GOT2P1 (1.4)	GEMIN7 (1.3)	DOCK7 (1.3)
GO:0016675	oxidoreductase activity, acting on a heme group of donors	0.40	> 0.20	TRAPPC6A (3.4)	C12orf47 (2.7)	TMEM116 (2.4)	GOT2P1 (2.3)	ACAD10 (2.3)	OGDH (2.1)	ABCG8 (1.5)	UBXN2B (1.4)	KANK2 (1.4)	SYPL2 (1.4)
ENSG00000151320	AKAP6 PPI subnetwork	0.40	> 0.20	C17orf57 (2.9)	COL4A3BP (2.6)	MYLIP (2.5)	OGDH (2.4)	ZNF101 (2.2)	DNM2 (2.1)	C19orf52 (1.9)	PPP1R37 (1.7)	POC5 (1.7)	PMFBP1 (1.6)
REACTOME_GPVI:MEDIATED_ACTIVATION_CASCADE	REACTOME_GPVI:MEDIATED_ACTIVATION_CASCADE	0.40	> 0.20	ITGB3 (3.1)	GMIP (3.0)	GATAD2A (2.6)	SH2B3 (2.2)	CETP (2.1)	TMEM57 (2.0)	DNM2 (1.9)	MYLIP (1.8)	SLC44A2 (1.8)	OGDH (1.7)
ENSG00000144744	UBA3 PPI subnetwork	0.40	> 0.20	CARM1 (4.2)	MARK4 (2.4)	ZNF180 (2.2)	GOT2P1 (1.9)	SLC44A2 (1.8)	NYNRIN (1.7)	TOMM40 (1.7)	SARS (1.6)	GMIP (1.5)	LPAR2 (1.5)
ENSG00000022267	FHL1 PPI subnetwork	0.40	> 0.20	SYPL2 (3.1)	TRIB1 (2.8)	BCL3 (2.1)	GMPR (2.0)	RELB (1.9)	CEACAM19 (1.7)	KANK2 (1.7)	RHCE (1.6)	C12orf51 (1.6)	DNM2 (1.6)
GO:0004714	transmembrane receptor protein tyrosine kinase activity	0.40	> 0.20	PVRL2 (3.2)	PLEKHH2 (2.5)	LPAR2 (2.5)	MYLIP (2.2)	NYNRIN (2.1)	CELSR2 (2.0)	APOE (1.9)	BCAM (1.7)	SLC44A2 (1.7)	NKPD1 (1.7)
ENSG00000171431	KRT20 PPI subnetwork	0.40	> 0.20	ENSG00000228044 (2.9)	GEMIN7 (2.6)	TRAPPC6A (2.1)	LPA (2.0)	TMED4 (1.8)	C19orf52 (1.7)	UBXN2B (1.7)	ACAD10 (1.6)	ENSG00000254235 (1.6)	MARK4 (1.5)
GO:0045072	regulation of interferon-gamma biosynthetic process	0.40	> 0.20	DNAH11 (3.1)	GCNT4 (2.9)	ENSG00000226645 (2.4)	ZNF180 (2.2)	ST3GAL4 (2.1)	TMED4 (1.8)	CYB561D1 (1.8)	BLOC1S3 (1.6)	TXNL4B (1.2)	PVR (1.2)
MP:0000606	decreased hepatocyte number	0.40	> 0.20	USP24 (3.3)	MARK4 (2.8)	C12orf51 (2.8)	ALDH2 (2.6)	MAPKAPK5 (2.2)	DOCK7 (2.1)	MAFB (2.0)	PSRC1 (2.0)	APOB (1.9)	TMEM50A (1.9)
ENSG00000143632	ACTA1 PPI subnetwork	0.40	> 0.20	ITGB3 (3.0)	SYPL2 (2.4)	PLEC (2.4)	HNF1A (2.2)	DOCK7 (2.1)	SORT1 (2.1)	C11orf9 (2.0)	KANK2 (2.0)	SH2B3 (1.9)	DNM2 (1.8)
ENSG00000177469	PTRF PPI subnetwork	0.40	> 0.20	C12orf43 (3.7)	DYNC2LI1 (3.2)	POLK (2.9)	TXNL4B (2.6)	ATXN7L2 (2.4)	MAPKAPK5 (2.3)	ZNF259 (2.1)	DHX38 (1.9)	COL4A3BP (1.9)	GEMIN7 (1.8)
GO:0071346	cellular response to interferon-gamma	0.40	> 0.20	TRAFD1 (5.3)	PARP10 (4.6)	OASL (3.5)	ADAM1 (2.7)	CEACAM19 (2.0)	CYB561D1 (1.8)	BCL3 (1.7)	NAA25 (1.7)	FRK (1.7)	C19orf52 (1.6)
ENSG00000104884	ERCC2 PPI subnetwork	0.40	> 0.20	SUGP1 (3.9)	PSMA5 (3.1)	DHX38 (3.1)	TXNL4B (2.7)	POC5 (2.7)	ZNF259 (2.7)	BUD13 (2.6)	MAPKAPK5 (2.5)	DDX56 (2.3)	BRAP (1.8)
MP:0003954	abnormal Reichert's membrane morphology	0.40	> 0.20	ATP13A1 (3.2)	ERP29 (3.1)	PVRL2 (3.1)	CELSR2 (2.5)	KIAA1324 (2.4)	ENSG00000254235 (2.3)	APOE (2.2)	PVR (2.1)	ITGB3 (2.0)	TMEM116 (2.0)
ENSG00000145675	PIK3R1 PPI subnetwork	0.40	> 0.20	GMIP (3.2)	DNM2 (2.5)	PLEC (2.4)	DOCK7 (2.4)	TIMD4 (2.3)	SH2B3 (2.2)	SLC44A2 (2.1)	MAFB (2.0)	PLCG1 (1.9)	ITGB3 (1.9)
ENSG00000171241	SHCBP1 PPI subnetwork	0.40	> 0.20	CBLC (6.1)	AP1M2 (4.5)	CELSR2 (2.3)	LPAR2 (2.0)	PVRL2 (1.9)	ST3GAL4 (1.8)	FRK (1.7)	PSRC1 (1.7)	LPIN3 (1.5)	PLEC (1.5)
ENSG00000183305	MAGEA2B PPI subnetwork	0.40	> 0.20	ATP13A1 (3.1)	OGDH (2.9)	SMARCA4 (2.9)	ILF3 (2.7)	DDX56 (2.6)	CLPTM1 (2.6)	PPP1R37 (2.4)	SARS (2.4)	ACAD10 (2.2)	TMEM57 (2.1)
ENSG00000152942	RAD17 PPI subnetwork	0.40	> 0.20	FEN1 (4.0)	USP1 (3.3)	PARP10 (2.5)	NT5DC1 (2.5)	OASL (2.2)	C12orf43 (2.1)	PLEKHH2 (1.9)	TMEM116 (1.9)	ENSG00000228044 (1.8)	ZNF180 (1.7)
ENSG00000063177	RPL18 PPI subnetwork	0.40	> 0.20	DDX56 (3.1)	NAA25 (2.9)	ZNF259 (2.8)	QTRT1 (2.6)	ERP29 (2.2)	DHX38 (2.2)	SUGP1 (2.2)	SARS (2.1)	TOMM40 (2.0)	ADAM1 (2.0)
ENSG00000165304	MELK PPI subnetwork	0.40	> 0.20	USP1 (2.4)	ZNF180 (2.4)	PMFBP1 (2.3)	ST3GAL4 (2.1)	GATAD2A (2.0)	BUD13 (1.8)	PLCG1 (1.7)	ZNF101 (1.5)	ERP29 (1.4)	OASL (1.3)
ENSG00000130312	MRPL34 PPI subnetwork	0.40	> 0.20	GEMIN7 (3.1)	QTRT1 (2.7)	MAPKAPK5 (2.2)	TOMM40 (2.1)	ATXN7L2 (1.9)	NAA25 (1.8)	PSMA5 (1.7)	CARM1 (1.6)	BUD13 (1.5)	HAVCR1 (1.4)
GO:0006677	glycosylceramide metabolic process	0.40	> 0.20	NKPD1 (3.6)	HAVCR1 (2.7)	DNAH11 (2.3)	CYB561D1 (2.2)	COL4A3BP (2.1)	LPIN3 (2.0)	ATP13A1 (1.9)	BLOC1S3 (1.6)	C1orf63 (1.5)	UBXN2B (1.5)
ENSG00000142937	RPS8 PPI subnetwork	0.40	> 0.20	DDX56 (4.2)	QTRT1 (3.2)	NAA25 (3.1)	ZNF259 (2.7)	TOMM40 (2.5)	TOP1 (2.4)	SARS (2.3)	DHX38 (2.3)	SUGP1 (2.1)	DHODH (2.1)
ENSG00000100142	POLR2F PPI subnetwork	0.40	> 0.20	BUD13 (3.4)	DHX38 (3.1)	ILF3 (3.0)	SUGP1 (3.0)	TOP1 (2.7)	USP1 (2.4)	DDX56 (2.4)	SMARCA4 (2.2)	C1orf63 (2.1)	QTRT1 (2.0)
ENSG00000164944	KIAA1429 PPI subnetwork	0.40	> 0.20	FRK (3.2)	C19orf52 (2.8)	ATXN7L2 (2.6)	SMARCA4 (2.5)	BLOC1S3 (2.4)	BUD13 (2.3)	GEMIN7 (2.3)	ZNF101 (2.2)	ST3GAL4 (2.1)	LPAR2 (2.1)
REACTOME_POST:CHAPERONIN_TUBULIN_FOLDING_PATHWAY	REACTOME_POST:CHAPERONIN_TUBULIN_FOLDING_PATHWAY	0.40	> 0.20	ITGB3 (2.3)	HMGCR (2.1)	C12orf47 (2.0)	BLOC1S3 (2.0)	GMPR (1.8)	ENSG00000226645 (1.6)	PVR (1.5)	RHD (1.4)	SUGP1 (1.4)	SMARCA4 (1.3)
ENSG00000167005	NUDT21 PPI subnetwork	0.40	> 0.20	ILF3 (4.2)	C1orf63 (3.6)	BUD13 (2.9)	TOP1 (2.7)	SMARCA4 (2.5)	QTRT1 (2.2)	DHX38 (2.2)	PTPN11 (2.1)	USP1 (2.1)	SUGP1 (2.1)
ENSG00000137710	RDX PPI subnetwork	0.40	> 0.20	SH2B3 (2.8)	RELB (2.4)	ZHX3 (2.1)	ST3GAL4 (2.0)	CETP (2.0)	HLX (1.9)	DNM2 (1.8)	APOB (1.8)	C11orf9 (1.8)	APOE (1.7)
ENSG00000101452	DHX35 PPI subnetwork	0.40	> 0.20	CLPTM1 (3.6)	PPP1R37 (2.5)	SUGP1 (2.2)	CYB561D1 (2.0)	DNAH11 (2.0)	MOSC1 (1.9)	C17orf57 (1.8)	DNM2 (1.8)	ATXN7L2 (1.7)	SARS (1.7)
MP:0009583	increased keratinocyte proliferation	0.40	> 0.20	CBLC (5.8)	AP1M2 (3.1)	PLEC (2.7)	BCL3 (2.6)	YIPF2 (2.6)	PMFBP1 (2.5)	PVRL2 (2.2)	CEACAM19 (2.0)	PARP10 (1.7)	LPIN3 (1.7)
GO:0006289	nucleotide-excision repair	0.40	> 0.20	NT5DC1 (2.8)	ZNF180 (2.4)	SUGP1 (2.2)	GEMIN7 (2.2)	BLOC1S3 (2.1)	TRAPPC6A (2.0)	DYNC2LI1 (1.9)	TXNL4B (1.9)	UBXN2B (1.8)	GOT2P1 (1.6)
MP:0003799	impaired macrophage chemotaxis	0.40	> 0.20	BCL3 (3.1)	GMIP (2.9)	RELB (2.7)	POLK (2.4)	ITGB3 (2.3)	SH2B3 (2.2)	DNM2 (2.0)	PVR (2.0)	DNAH11 (1.9)	C17orf57 (1.9)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION	0.40	> 0.20	GEMIN7 (3.2)	ZNF259 (3.1)	QTRT1 (2.4)	ZHX3 (2.3)	CARM1 (2.1)	GMPR (2.0)	C12orf43 (1.9)	ENSG00000226645 (1.9)	DDX56 (1.8)	ADAM1 (1.7)
ENSG00000130956	HABP4 PPI subnetwork	0.40	> 0.20	BUD13 (2.3)	C11orf9 (2.3)	MYLIP (2.1)	NYNRIN (2.0)	RELB (1.8)	ZNF259 (1.7)	PLCG1 (1.6)	ATXN7L2 (1.6)	SMARCA4 (1.5)	C12orf43 (1.5)
GO:0014911	positive regulation of smooth muscle cell migration	0.40	> 0.20	C19orf52 (2.6)	NKPD1 (2.5)	ZNF101 (2.3)	AMIGO1 (2.1)	ST3GAL4 (2.0)	MYLIP (2.0)	TMEM116 (1.7)	C12orf47 (1.6)	HLX (1.3)	DNAH11 (1.2)
GO:0035036	sperm-egg recognition	0.41	> 0.20	TSSK6 (4.5)	PMFBP1 (4.2)	ENSG00000228044 (3.8)	ENSG00000238078 (3.0)	GCNT4 (2.6)	PBX4 (1.8)	C17orf57 (1.7)	PCSK9 (1.1)	HNF1A (1.0)	BRAP (1.0)
obsolete_molecular_function	obsolete_molecular_function	0.41	> 0.20	SLC44A2 (2.4)	DNM2 (2.4)	GMIP (2.2)	PPP1R37 (2.1)	BLOC1S3 (2.0)	MARK4 (1.9)	C11orf9 (1.8)	SH2B3 (1.8)	POC5 (1.7)	CYB561D1 (1.6)
ENSG00000160299	PCNT PPI subnetwork	0.41	> 0.20	ZNF180 (2.5)	POC5 (2.3)	ABCG5 (2.3)	USP1 (1.7)	PSRC1 (1.7)	RPH3A (1.7)	SMARCA4 (1.7)	TM6SF2 (1.5)	NPC1L1 (1.4)	FEN1 (1.4)
MP:0002828	abnormal renal glomerular capsule morphology	0.41	> 0.20	ACAD10 (2.1)	C17orf57 (2.0)	POC5 (2.0)	POLK (2.0)	TMED4 (1.9)	PVRL2 (1.8)	YIPF2 (1.7)	BCAM (1.5)	PLEKHH2 (1.5)	PVR (1.5)
ENSG00000119203	CPSF3 PPI subnetwork	0.41	> 0.20	ILF3 (3.7)	BUD13 (3.3)	SMARCA4 (3.2)	DHX38 (3.0)	TOP1 (2.7)	C1orf63 (2.7)	GATAD2A (2.4)	SUGP1 (2.3)	QTRT1 (2.3)	USP1 (2.2)
ENSG00000141480	ARRB2 PPI subnetwork	0.41	> 0.20	PTPN11 (3.6)	CLPTM1 (2.7)	TOMM40 (2.5)	C17orf57 (2.3)	HLX (2.1)	BLOC1S3 (2.0)	MYLIP (1.9)	CARM1 (1.8)	DHX38 (1.7)	DNM2 (1.7)
GO:0060039	pericardium development	0.41	> 0.20	C11orf9 (3.2)	SLC44A2 (2.5)	ENSG00000238078 (2.1)	ATXN2 (2.0)	ENSG00000226645 (1.9)	MAPKAPK5 (1.8)	ATXN7L2 (1.7)	CILP2 (1.6)	ZNF180 (1.6)	PLEKHH2 (1.6)
GO:0031102	neuron projection regeneration	0.41	> 0.20	ENSG00000228044 (3.0)	ENSG00000238078 (3.0)	ENSG00000235545 (2.5)	GCNT4 (2.3)	LPIN3 (2.1)	HAPLN4 (2.0)	ANKRD31 (1.7)	MAFB (1.3)	FRK (1.3)	NCAN (1.3)
GO:0007176	regulation of epidermal growth factor-activated receptor activity	0.41	> 0.20	ENSG00000228044 (2.6)	TMED4 (2.1)	CYB561D1 (2.0)	GCNT4 (2.0)	TSSK6 (1.8)	ABO (1.6)	C17orf57 (1.6)	CETP (1.5)	ENSG00000226645 (1.5)	C19orf52 (1.5)
MP:0005463	abnormal CD4-positive T cell physiology	0.41	> 0.20	RELB (2.8)	GMIP (2.2)	SH2B3 (2.1)	PBX4 (2.0)	TIMD4 (1.9)	BCL3 (1.7)	SLC22A1 (1.7)	ENSG00000235545 (1.6)	SLC44A2 (1.4)	ZNF101 (1.3)
REACTOME_MRNA_SPLICING_:_MAJOR_PATHWAY	REACTOME_MRNA_SPLICING_:_MAJOR_PATHWAY	0.41	> 0.20	ILF3 (4.2)	C1orf63 (3.6)	TOP1 (2.9)	USP1 (2.7)	DHX38 (2.7)	SMARCA4 (2.7)	BUD13 (2.5)	SUGP1 (2.5)	FEN1 (2.2)	QTRT1 (2.1)
REACTOME_MRNA_SPLICING	REACTOME_MRNA_SPLICING	0.41	> 0.20	ILF3 (4.2)	C1orf63 (3.6)	TOP1 (2.9)	USP1 (2.7)	DHX38 (2.7)	SMARCA4 (2.7)	BUD13 (2.5)	SUGP1 (2.5)	FEN1 (2.2)	QTRT1 (2.1)
ENSG00000116741	RGS2 PPI subnetwork	0.41	> 0.20	GCNT4 (2.9)	GOT2P1 (2.9)	TOP1 (2.2)	MARK4 (1.9)	YIPF2 (1.9)	C19orf52 (1.9)	AMIGO1 (1.8)	FADS1 (1.8)	SORT1 (1.8)	C11orf9 (1.6)
GO:0043496	regulation of protein homodimerization activity	0.41	> 0.20	POLK (3.3)	GEMIN7 (3.2)	DNAH11 (2.7)	PPP1R37 (2.7)	ENSG00000226648 (2.6)	ABO (2.3)	PMFBP1 (2.2)	COL4A3BP (2.1)	QTRT1 (2.1)	ST3GAL4 (2.0)
ENSG00000100813	ACIN1 PPI subnetwork	0.41	> 0.20	C1orf63 (3.0)	TOP1 (2.9)	ZNF180 (2.5)	POC5 (2.3)	BLOC1S3 (2.2)	BUD13 (2.1)	CARM1 (2.0)	TXNL4B (1.7)	GEMIN7 (1.3)	DDX56 (1.3)
ENSG00000130669	PAK4 PPI subnetwork	0.41	> 0.20	DNM2 (3.8)	GATAD2A (3.4)	LPAR2 (2.6)	CBLC (2.5)	GMIP (2.2)	CLPTM1 (2.1)	ILF3 (1.8)	SH2B3 (1.6)	TOP1 (1.6)	UBXN2B (1.6)
ENSG00000126803	HSPA2 PPI subnetwork	0.41	> 0.20	MYLIP (2.8)	CLPTM1 (2.4)	ATXN2 (2.1)	HLX (2.0)	BRAP (1.9)	ENSG00000235545 (1.8)	BLOC1S3 (1.8)	CYP7A1 (1.8)	TOMM40 (1.8)	TRAPPC6A (1.7)
GO:0045121	membrane raft	0.41	> 0.20	MAFB (2.5)	PLEC (2.5)	SH2B3 (2.4)	SLC44A2 (2.2)	TMEM50A (2.1)	COL4A3BP (2.0)	BCAM (1.7)	PVRL2 (1.6)	RELB (1.5)	GMPR (1.5)
GO:0002700	regulation of production of molecular mediator of immune response	0.41	> 0.20	GCNT4 (2.3)	C17orf57 (2.1)	HAVCR1 (2.0)	ZNF101 (1.7)	SH2B3 (1.5)	TIMD4 (1.4)	MOSC1 (1.3)	CETP (1.3)	BCL3 (1.2)	POC5 (1.2)
ENSG00000132016	C19orf57 PPI subnetwork	0.41	> 0.20	MAU2 (3.0)	DDX56 (2.9)	SARS (2.3)	TMEM57 (2.3)	PBX4 (2.0)	AP1M2 (2.0)	GMPR (1.9)	TMED4 (1.8)	GEMIN7 (1.8)	QTRT1 (1.6)
ENSG00000117560	FASLG PPI subnetwork	0.41	> 0.20	FRK (2.7)	OGDH (2.7)	GATAD2A (2.6)	PLCG1 (2.5)	ITGB3 (2.5)	DNM2 (2.4)	LPAR2 (1.9)	TMEM50A (1.9)	ZNF101 (1.9)	PBX4 (1.8)
MP:0009254	disorganized pancreatic islets	0.41	> 0.20	DNAH11 (3.2)	NCAN (2.9)	C11orf9 (2.7)	HAPLN4 (2.2)	ENSG00000226648 (1.6)	ENSG00000226645 (1.4)	COL4A3BP (1.4)	TRIB1 (1.3)	RPH3A (1.2)	ABCG8 (1.2)
GO:0042626	ATPase activity, coupled to transmembrane movement of substances	0.41	> 0.20	CLPTM1 (3.4)	ATP13A1 (3.4)	GRINA (2.9)	TMEM116 (2.8)	SORT1 (2.6)	HAPLN4 (2.2)	COL4A3BP (2.1)	C12orf51 (2.0)	GMPR (2.0)	USP24 (1.9)
ENSG00000188687	SLC4A5 PPI subnetwork	0.41	> 0.20	HMGCR (4.7)	LDLR (4.3)	FADS1 (3.9)	PCSK9 (2.8)	ILF3 (2.5)	FADS2 (2.5)	QTRT1 (2.4)	ZNF259 (2.0)	ATP13A1 (1.9)	NAA25 (1.8)
ENSG00000150281	CTF1 PPI subnetwork	0.41	> 0.20	BCL3 (3.6)	HLX (3.2)	RELB (2.8)	TIMD4 (2.2)	CETP (2.1)	GMIP (1.9)	ALDH2 (1.7)	LPA (1.5)	TRIB1 (1.3)	PARP10 (1.3)
ENSG00000081052	COL4A4 PPI subnetwork	0.41	> 0.20	APOE (2.3)	ATXN7L2 (2.2)	TXNL4B (1.7)	C17orf57 (1.6)	KANK2 (1.5)	C11orf9 (1.5)	ZHX3 (1.4)	APOB (1.4)	ANGPTL3 (1.3)	TMED4 (1.3)
GO:0045637	regulation of myeloid cell differentiation	0.41	> 0.20	RHCE (2.7)	ITGB3 (2.3)	RHD (2.1)	PBX4 (2.0)	ENSG00000226648 (2.0)	ENSG00000226645 (2.0)	ENSG00000235545 (1.9)	MYLIP (1.9)	DNAH11 (1.7)	MAFB (1.6)
GO:0010719	negative regulation of epithelial to mesenchymal transition	0.41	> 0.20	ENSG00000254235 (2.5)	NT5DC1 (2.5)	PLEKHH2 (2.4)	DNAH11 (2.4)	TMEM116 (2.4)	ABO (2.1)	ENSG00000226645 (2.0)	KANK2 (1.6)	NYNRIN (1.6)	AP1M2 (1.5)
GO:0045907	positive regulation of vasoconstriction	0.41	> 0.20	C17orf57 (3.4)	ENSG00000254235 (3.0)	C12orf47 (2.6)	ITGB3 (2.5)	GCNT4 (2.0)	POLK (2.0)	GMPR (1.9)	SYPL2 (1.8)	TSSK6 (1.7)	CETP (1.7)
GO:0005732	small nucleolar ribonucleoprotein complex	0.41	> 0.20	QTRT1 (3.8)	TOMM40 (3.6)	DHODH (3.1)	DDX56 (3.0)	TRAPPC6A (2.5)	ZNF259 (2.4)	GEMIN7 (2.4)	GATAD2A (1.9)	PVR (1.8)	FEN1 (1.5)
MP:0005602	decreased angiogenesis	0.41	> 0.20	PVR (4.0)	SH2B3 (3.5)	BCAM (2.5)	HLX (2.2)	KANK2 (2.2)	BCL3 (2.2)	TOP1 (2.1)	PVRL2 (2.0)	ENSG00000254235 (1.8)	PLEC (1.6)
ENSG00000196586	MYO6 PPI subnetwork	0.41	> 0.20	FRK (2.8)	SH2B3 (2.3)	NPC1L1 (2.2)	KANK2 (2.1)	PVR (2.1)	PTPN11 (1.9)	ADAM1 (1.8)	HLX (1.8)	TMEM116 (1.7)	BRAP (1.7)
ENSG00000163902	RPN1 PPI subnetwork	0.41	> 0.20	ATP13A1 (3.7)	PSMA5 (3.3)	QTRT1 (2.9)	YIPF2 (2.8)	OGDH (2.6)	DDX56 (2.5)	SARS (2.2)	NAA25 (2.1)	AP1M2 (2.1)	TMED4 (2.0)
MP:0009593	absent chorion	0.41	> 0.20	ST3GAL4 (2.3)	PLG (2.1)	ANGPTL3 (1.9)	ATXN7L2 (1.8)	DOCK7 (1.7)	MYLIP (1.7)	CEACAM19 (1.7)	SH2B3 (1.7)	ATXN2 (1.7)	PVR (1.6)
MP:0008078	increased CD8-positive T cell number	0.41	> 0.20	TIMD4 (4.6)	CETP (3.9)	PLCG1 (2.6)	MAFB (2.5)	RELB (2.3)	RHD (2.3)	APOC1 (2.2)	GMIP (2.1)	RHCE (2.0)	SLC44A2 (1.9)
ENSG00000132326	PER2 PPI subnetwork	0.41	> 0.20	C17orf57 (2.7)	ZHX3 (2.5)	GPAM (2.2)	TMEM57 (2.1)	CILP2 (1.6)	MYLIP (1.6)	KANK2 (1.5)	PBX4 (1.4)	ENSG00000254235 (1.4)	MAPKAPK5 (1.4)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION	0.41	> 0.20	C12orf43 (3.9)	GEMIN7 (3.4)	POC5 (2.8)	ZNF259 (2.6)	DDX56 (2.6)	MAPKAPK5 (2.5)	SUGP1 (2.3)	BUD13 (2.1)	ENSG00000226645 (2.0)	ADAM1 (1.9)
GO:0033238	regulation of cellular amine metabolic process	0.41	> 0.20	PSMA5 (4.1)	TRAFD1 (2.4)	NT5DC1 (2.1)	NAA25 (2.1)	C12orf47 (2.1)	TXNL4B (1.6)	ENSG00000254235 (1.5)	TOMM40 (1.4)	SUGP1 (1.4)	TMEM50A (1.1)
GO:0009070	serine family amino acid biosynthetic process	0.41	> 0.20	SARS (4.5)	TMEM116 (2.7)	DNAH11 (2.3)	CYP7A1 (2.1)	ERP29 (2.1)	TXNL4B (2.0)	PMFBP1 (1.9)	TM6SF2 (1.9)	ABCG8 (1.8)	LPA (1.8)
MP:0004362	cochlear hair cell degeneration	0.41	> 0.20	GPAM (2.5)	PBX4 (2.4)	ZNF101 (2.3)	CYP7A1 (1.9)	CELSR2 (1.9)	SLC44A2 (1.8)	APOE (1.7)	LPAR2 (1.6)	LPA (1.5)	FRK (1.5)
MP:0004047	abnormal milk composition	0.41	> 0.20	KIAA1324 (3.2)	NPC1L1 (2.2)	MAFB (1.9)	HAVCR1 (1.7)	LPA (1.7)	PPP1R37 (1.5)	GPAM (1.5)	ZNF101 (1.3)	TMED4 (1.3)	FADS1 (1.3)
GO:0015980	energy derivation by oxidation of organic compounds	0.41	> 0.20	OGDH (4.5)	ACAD10 (3.8)	GOT2P1 (3.1)	ENSG00000238078 (2.5)	HAPLN4 (2.2)	C12orf47 (2.1)	GMPR (2.0)	SYPL2 (1.8)	GPAM (1.6)	SORT1 (1.6)
REACTOME_PLC:GAMMA1_SIGNALLING	REACTOME_PLC:GAMMA1_SIGNALLING	0.41	> 0.20	ZHX3 (2.6)	SH2B3 (2.6)	SORT1 (2.6)	AMIGO1 (2.3)	ST3GAL4 (2.1)	ITGB3 (1.9)	GOT2P1 (1.8)	KANK2 (1.7)	ENSG00000238078 (1.7)	ZNF101 (1.7)
ENSG00000175073	VCPIP1 PPI subnetwork	0.41	> 0.20	TMEM57 (4.2)	BRAP (2.9)	GRINA (2.6)	YIPF2 (2.6)	SUGP1 (2.3)	DNM2 (2.1)	SARS (2.0)	C19orf52 (1.9)	ALDH2 (1.7)	TOMM40 (1.6)
GO:0048384	retinoic acid receptor signaling pathway	0.41	> 0.20	ST3GAL4 (2.3)	BLOC1S3 (2.2)	CILP2 (2.1)	PMFBP1 (2.1)	CYP7A1 (1.9)	ENSG00000228044 (1.8)	ENSG00000235545 (1.8)	PPP1R37 (1.4)	TSSK6 (1.4)	MAU2 (1.4)
MP:0001077	abnormal spinal nerve morphology	0.41	> 0.20	PLEKHH2 (2.5)	FADS1 (2.4)	DYNC2LI1 (2.1)	PVR (1.8)	PMFBP1 (1.7)	KANK2 (1.7)	BCAM (1.7)	TRIB1 (1.7)	PVRL2 (1.5)	FADS2 (1.5)
MP:0003845	abnormal decidualization	0.41	> 0.20	KIAA1324 (2.9)	FRK (2.7)	CELSR2 (2.2)	ENSG00000228044 (2.1)	ENSG00000238078 (2.0)	PLEKHH2 (2.0)	CBLC (2.0)	CEACAM19 (1.9)	HAPLN4 (1.8)	PVRL2 (1.8)
ENSG00000145321	GC PPI subnetwork	0.41	> 0.20	ANGPTL3 (3.9)	PLG (3.5)	HP (2.3)	PCSK9 (2.1)	TMEM116 (1.9)	SYPL2 (1.9)	HNF1A (1.8)	APOB (1.8)	APOC1 (1.7)	GOT2P1 (1.7)
ENSG00000165030	NFIL3 PPI subnetwork	0.41	> 0.20	SARS (5.1)	PVRL2 (2.8)	PVR (2.7)	BCL3 (2.6)	TM6SF2 (2.6)	MAPKAPK5 (2.5)	TXNL4B (2.4)	TRAFD1 (2.1)	HLX (1.9)	KIAA1324 (1.9)
MP:0004261	abnormal embryonic neuroepithelium morphology	0.41	> 0.20	GATAD2A (3.8)	DOCK7 (3.0)	ATXN2 (2.9)	CLPTM1 (2.6)	MARK4 (2.6)	COL4A3BP (2.3)	DYNC2LI1 (2.3)	ABO (1.8)	MAPKAPK5 (1.8)	SLC44A2 (1.6)
ENSG00000178913	TAF7 PPI subnetwork	0.41	> 0.20	MAPKAPK5 (3.8)	ATXN2 (2.4)	BUD13 (2.2)	SUGP1 (2.1)	GATAD2A (1.9)	TMED4 (1.8)	TOP1 (1.8)	ADAM1 (1.7)	POC5 (1.6)	ZNF259 (1.6)
ENSG00000139269	INHBE PPI subnetwork	0.41	> 0.20	OASL (3.0)	TIMD4 (2.3)	TMEM57 (2.0)	CETP (2.0)	BCAM (1.9)	POLK (1.6)	PLEKHH2 (1.6)	PVRL2 (1.5)	SYPL2 (1.5)	CILP2 (1.5)
ENSG00000119917	IFIT3 PPI subnetwork	0.41	> 0.20	OASL (10.1)	PARP10 (3.7)	TRAFD1 (2.7)	USP1 (2.4)	TXNL4B (2.2)	ATP13A1 (2.0)	DHODH (2.0)	SUGP1 (1.7)	LPAR2 (1.7)	ENSG00000226648 (1.7)
ENSG00000125351	UPF3B PPI subnetwork	0.41	> 0.20	ILF3 (4.1)	TOP1 (3.7)	C1orf63 (3.4)	DHX38 (2.9)	USP1 (2.8)	SMARCA4 (2.8)	SUGP1 (2.6)	BUD13 (2.3)	FEN1 (2.1)	PTPN11 (2.0)
ENSG00000150093	ITGB1 PPI subnetwork	0.41	> 0.20	KANK2 (3.6)	APOE (3.2)	ITGB3 (3.2)	PVRL2 (2.8)	PLEC (2.6)	BCAM (2.4)	ST3GAL4 (2.4)	PLEKHH2 (2.2)	SH2B3 (2.1)	CETP (2.0)
ENSG00000136021	SCYL2 PPI subnetwork	0.41	> 0.20	SMARCA4 (3.8)	GATAD2A (3.4)	QTRT1 (3.3)	ILF3 (2.4)	TMEM57 (2.4)	ATP13A1 (2.2)	ERP29 (2.2)	CARM1 (2.1)	TOP1 (2.0)	SARS (2.0)
ENSG00000155229	MMS19 PPI subnetwork	0.41	> 0.20	TOMM40 (2.9)	PSMA5 (2.7)	NAA25 (2.4)	NT5DC1 (2.1)	DHX38 (2.1)	FEN1 (2.0)	CLPTM1 (1.7)	ENSG00000235545 (1.7)	OGDH (1.7)	ALDH2 (1.6)
ENSG00000198176	TFDP1 PPI subnetwork	0.41	> 0.20	ATXN2 (3.5)	USP1 (3.1)	C12orf51 (2.4)	MAPKAPK5 (2.4)	TMEM57 (2.4)	GATAD2A (2.3)	MARK4 (2.2)	FEN1 (2.2)	RHD (1.9)	KANK2 (1.8)
REACTOME_INFLUENZA_LIFE_CYCLE	REACTOME_INFLUENZA_LIFE_CYCLE	0.41	> 0.20	ILF3 (2.6)	DOCK7 (2.3)	NAA25 (2.0)	DDX56 (1.9)	MOSC1 (1.8)	NKPD1 (1.8)	USP24 (1.6)	USP1 (1.6)	GATAD2A (1.5)	DHX38 (1.4)
ENSG00000121774	KHDRBS1 PPI subnetwork	0.41	> 0.20	GMIP (4.2)	PPP1R37 (3.2)	ITGB3 (2.9)	OGDH (2.5)	ZNF101 (2.3)	ATXN2 (2.2)	SMARCA4 (2.2)	MAFB (2.2)	C1orf63 (2.0)	COL4A3BP (1.7)
ENSG00000154001	PPP2R5E PPI subnetwork	0.41	> 0.20	OASL (2.6)	PSRC1 (2.3)	COL4A3BP (2.3)	PARP10 (2.3)	NT5DC1 (2.2)	PLCG1 (2.1)	LPAR2 (2.1)	ADAM1 (2.0)	PLEKHH2 (2.0)	ERP29 (1.7)
ENSG00000142494	SLC47A1 PPI subnetwork	0.41	> 0.20	TM6SF2 (3.2)	DNAH11 (2.3)	MYLIP (2.3)	ST3GAL4 (2.2)	ENSG00000226645 (2.2)	NPC1L1 (2.1)	LPIN3 (2.0)	ZNF101 (1.9)	ABCG8 (1.8)	HAPLN4 (1.7)
ENSG00000165476	REEP3 PPI subnetwork	0.41	> 0.20	CBLC (5.9)	AP1M2 (4.3)	ST3GAL4 (2.5)	PPP1R37 (2.0)	CELSR2 (1.9)	LPAR2 (1.9)	LPIN3 (1.8)	PSRC1 (1.7)	PLEC (1.7)	DOCK7 (1.6)
MP:0001433	polyphagia	0.41	> 0.20	MOSC1 (2.7)	KIAA1324 (2.5)	ST3GAL4 (2.5)	SORT1 (2.4)	GPAM (2.4)	DYNC2LI1 (2.1)	PMFBP1 (1.9)	CELSR2 (1.8)	ABO (1.8)	TIMD4 (1.7)
ENSG00000105701	FKBP8 PPI subnetwork	0.41	> 0.20	GRINA (3.0)	CYB561D1 (2.1)	DNAH11 (2.0)	FRK (1.9)	MYLIP (1.9)	BCAM (1.8)	DNM2 (1.8)	TRAPPC6A (1.7)	TXNL4B (1.6)	C12orf43 (1.6)
GO:0004713	protein tyrosine kinase activity	0.41	> 0.20	MARK4 (3.3)	LPIN3 (2.2)	PTPN11 (2.2)	DNM2 (2.2)	GMIP (2.2)	NKPD1 (2.1)	LPAR2 (2.1)	SH2B3 (2.1)	CARM1 (2.0)	PVRL2 (2.0)
ENSG00000023287	RB1CC1 PPI subnetwork	0.41	> 0.20	OASL (2.6)	PARP10 (2.4)	TRAFD1 (2.4)	ZNF180 (2.3)	NT5DC1 (2.1)	CYB561D1 (2.0)	CETP (1.8)	ENSG00000238078 (1.8)	TXNL4B (1.6)	FRK (1.5)
ENSG00000134248	HBXIP PPI subnetwork	0.41	> 0.20	HNF1A (2.7)	ZHX3 (2.5)	ZNF180 (2.4)	BLOC1S3 (2.1)	MAFB (1.9)	UBXN2B (1.8)	PLEC (1.8)	POC5 (1.6)	C17orf57 (1.5)	CYB561D1 (1.4)
GO:0005342	organic acid transmembrane transporter activity	0.41	> 0.20	TM6SF2 (3.7)	ABCG8 (3.5)	GRINA (2.4)	PLG (2.3)	ATP13A1 (2.3)	HAPLN4 (2.2)	ABCG5 (2.2)	TMEM116 (2.1)	SARS (2.1)	NCAN (2.0)
ENSG00000164442	CITED2 PPI subnetwork	0.41	> 0.20	CELSR2 (2.2)	KIAA1324 (1.9)	ANKRD31 (1.8)	LPAR2 (1.7)	ATXN2 (1.7)	C17orf57 (1.7)	ENSG00000226645 (1.3)	TSSK6 (1.3)	BUD13 (1.3)	APOC4 (1.2)
REACTOME_SIGNALLING_BY_NGF	REACTOME_SIGNALLING_BY_NGF	0.41	> 0.20	MARK4 (3.7)	CLPTM1 (3.3)	PLEC (3.1)	SH2B3 (3.1)	DNM2 (2.7)	GATAD2A (2.6)	GRINA (2.4)	GMIP (2.2)	RELB (1.9)	CELSR2 (1.8)
ENSG00000066933	MYO9A PPI subnetwork	0.41	> 0.20	ATP13A1 (3.3)	QTRT1 (3.0)	ILF3 (2.9)	YIPF2 (2.7)	DNM2 (2.6)	OGDH (2.5)	DHX38 (1.7)	ACAD10 (1.7)	SARS (1.6)	DHODH (1.5)
GO:0009062	fatty acid catabolic process	0.41	> 0.20	ACAD10 (5.2)	NT5DC1 (3.1)	MOSC1 (2.4)	TRAPPC6A (2.0)	OGDH (1.9)	GPAM (1.9)	ALDH2 (1.8)	LPA (1.7)	ABCG8 (1.6)	SLC22A1 (1.6)
ENSG00000070366	SMG6 PPI subnetwork	0.41	> 0.20	MAU2 (3.0)	SUGP1 (2.6)	BRAP (2.5)	HNF1A (2.2)	GATAD2A (2.1)	C1orf63 (2.1)	ENSG00000238078 (2.0)	ATXN2 (2.0)	SMARCA4 (1.9)	LPIN3 (1.9)
GO:0019934	cGMP-mediated signaling	0.41	> 0.20	HAVCR1 (3.0)	TMED4 (2.5)	TMEM116 (2.0)	SORT1 (1.7)	ATXN7L2 (1.6)	CELSR2 (1.6)	AMIGO1 (1.6)	C12orf47 (1.5)	DYNC2LI1 (1.5)	ACAD10 (1.4)
ENSG00000168040	FADD PPI subnetwork	0.41	> 0.20	RELB (4.9)	PARP10 (3.5)	BCL3 (3.1)	PVR (2.3)	OASL (2.3)	SH2B3 (1.9)	HAVCR1 (1.9)	ADAM1 (1.9)	ZNF180 (1.9)	TRAFD1 (1.8)
MP:0002953	thick ventricular wall	0.41	> 0.20	KANK2 (2.5)	GMPR (2.2)	OGDH (1.8)	NKPD1 (1.6)	SYPL2 (1.5)	SH2B3 (1.5)	CEACAM19 (1.4)	ACAD10 (1.4)	TMED4 (1.3)	TSSK6 (1.3)
GO:0015643	toxin binding	0.41	> 0.20	ANGPTL3 (2.8)	ALDH2 (2.8)	APOB (2.7)	PLG (2.5)	HP (2.4)	PBX4 (2.2)	CEACAM19 (2.0)	ATXN7L2 (1.8)	APOA5 (1.8)	APOC4 (1.7)
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	0.41	> 0.20	FEN1 (5.5)	USP1 (5.3)	ZNF180 (2.3)	AMIGO1 (2.3)	TOMM40 (1.5)	GOT2P1 (1.5)	ENSG00000235545 (1.5)	KIAA1324 (1.5)	FADS1 (1.4)	ENSG00000228044 (1.3)
ENSG00000140600	SH3GL3 PPI subnetwork	0.41	> 0.20	DNM2 (4.1)	PPP1R37 (2.7)	OASL (2.3)	ERP29 (2.2)	YIPF2 (2.2)	CLPTM1 (2.0)	SARS (2.0)	COL4A3BP (2.0)	NT5DC1 (1.9)	PARP10 (1.8)
GO:0022624	proteasome accessory complex	0.41	> 0.20	PSMA5 (5.0)	TOMM40 (2.5)	NT5DC1 (2.3)	TRAFD1 (2.3)	NAA25 (1.8)	SUGP1 (1.7)	ENSG00000235545 (1.6)	TXNL4B (1.5)	SARS (1.5)	PTPN11 (1.4)
ENSG00000151743	AMN1 PPI subnetwork	0.41	> 0.20	COL4A3BP (2.6)	SLC44A2 (2.5)	PSRC1 (2.4)	DOCK7 (2.0)	TMEM50A (1.9)	ENSG00000226645 (1.9)	USP1 (1.9)	ILF3 (1.8)	POC5 (1.8)	DHX38 (1.8)
GO:0040020	regulation of meiosis	0.41	> 0.20	ENSG00000228044 (2.7)	TMED4 (2.4)	CEACAM19 (1.9)	C1orf63 (1.7)	PLEKHH2 (1.6)	ENSG00000226645 (1.5)	ATXN7L2 (1.5)	ZNF180 (1.4)	CYB561D1 (1.3)	PMFBP1 (1.3)
ENSG00000168496	FEN1 PPI subnetwork	0.41	> 0.20	FEN1 (5.0)	USP1 (4.1)	PSRC1 (1.8)	DHODH (1.7)	ZNF180 (1.6)	POC5 (1.4)	BLOC1S3 (1.4)	RHD (1.4)	ENSG00000226648 (1.2)	TXNL4B (1.2)
MP:0008477	decreased spleen red pulp amount	0.41	> 0.20	CILP2 (3.5)	RHD (2.8)	GMIP (2.5)	RHCE (2.4)	MAFB (2.4)	BCL3 (2.1)	GMPR (1.6)	TRAPPC6A (1.5)	HLX (1.3)	AMIGO1 (1.3)
GO:0002260	lymphocyte homeostasis	0.41	> 0.20	GEMIN7 (2.1)	SH2B3 (2.0)	TRAPPC6A (2.0)	CYB561D1 (1.8)	GCNT4 (1.8)	POLK (1.8)	PBX4 (1.7)	GMIP (1.7)	FRK (1.4)	ENSG00000226645 (1.3)
MP:0003271	abnormal duodenum morphology	0.42	> 0.20	HNF1A (3.2)	C11orf9 (2.7)	HLX (1.9)	RHCE (1.7)	NPC1L1 (1.7)	COL4A3BP (1.7)	PCSK9 (1.7)	DOCK7 (1.6)	AP1M2 (1.6)	HAVCR1 (1.4)
ENSG00000164494	PDSS2 PPI subnetwork	0.42	> 0.20	GCNT4 (2.8)	ENSG00000235545 (2.7)	RPH3A (2.7)	GPAM (1.9)	COL4A3BP (1.8)	PPP1R37 (1.8)	PTPN11 (1.8)	C12orf43 (1.7)	ENSG00000226645 (1.6)	C17orf57 (1.6)
REACTOME_A_THIRD_PROTEOLYTIC_CLEAVAGE_RELEASES_NICD	REACTOME_A_THIRD_PROTEOLYTIC_CLEAVAGE_RELEASES_NICD	0.42	> 0.20	CLPTM1 (3.7)	NYNRIN (3.1)	ENSG00000254235 (2.6)	MAU2 (2.4)	TMEM50A (2.3)	SLC44A2 (2.2)	SORT1 (2.0)	CYB561D1 (2.0)	CELSR2 (1.9)	GATAD2A (1.9)
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1APCC	REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1APCC	0.42	> 0.20	PSMA5 (6.1)	TRAFD1 (3.7)	NAA25 (2.6)	SUGP1 (2.4)	DDX56 (2.0)	PARP10 (1.6)	POC5 (1.5)	DHX38 (1.4)	NT5DC1 (1.4)	SARS (1.4)
KEGG_HEMATOPOIETIC_CELL_LINEAGE	KEGG_HEMATOPOIETIC_CELL_LINEAGE	0.42	> 0.20	ITGB3 (3.2)	TIMD4 (3.1)	CETP (2.8)	RHD (2.6)	ZNF101 (2.2)	GMIP (2.0)	BCL3 (2.0)	RHCE (2.0)	PLCG1 (2.0)	MAFB (1.8)
ENSG00000136842	TMOD1 PPI subnetwork	0.42	> 0.20	SYPL2 (4.9)	TMEM50A (2.6)	GMPR (2.2)	C12orf47 (1.7)	OGDH (1.7)	ACAD10 (1.7)	C1orf63 (1.5)	PSMA5 (1.2)	ADAM1 (1.1)	TIMD4 (1.1)
ENSG00000188986	COBRA1 PPI subnetwork	0.42	> 0.20	SUGP1 (2.6)	BUD13 (2.5)	MAPKAPK5 (2.4)	TOP1 (2.1)	ENSG00000226645 (1.9)	DHX38 (1.9)	ZNF259 (1.7)	C12orf47 (1.6)	GATAD2A (1.6)	COL4A3BP (1.6)
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C:STRAND_OF_THE_TELOMERE	REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C:STRAND_OF_THE_TELOMERE	0.42	> 0.20	USP1 (5.2)	FEN1 (4.8)	ZNF180 (2.2)	GOT2P1 (2.1)	AMIGO1 (1.8)	KIAA1324 (1.6)	BLOC1S3 (1.6)	TOMM40 (1.6)	OGDH (1.6)	TMED4 (1.4)
GO:0016324	apical plasma membrane	0.42	> 0.20	TM6SF2 (3.5)	AP1M2 (3.3)	TMEM116 (3.1)	FRK (3.0)	BCAM (2.6)	NPC1L1 (2.5)	TMED4 (2.1)	SORT1 (2.1)	ABCG5 (1.9)	ANGPTL3 (1.7)
REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS	REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS	0.42	> 0.20	GMIP (4.0)	APOC1 (2.2)	ITGB3 (2.2)	ADAM1 (2.1)	MAFB (1.9)	APOE (1.8)	ALDH2 (1.8)	C11orf9 (1.7)	SLC44A2 (1.6)	PARP10 (1.5)
GO:0071108	protein K48-linked deubiquitination	0.42	> 0.20	ZNF180 (3.3)	NKPD1 (2.6)	GCNT4 (2.3)	ENSG00000238078 (2.3)	USP24 (2.2)	AMIGO1 (1.9)	CYB561D1 (1.7)	HAVCR1 (1.7)	CEACAM19 (1.7)	YIPF2 (1.6)
ENSG00000101096	NFATC2 PPI subnetwork	0.42	> 0.20	TRIB1 (5.9)	PVR (2.5)	ANKRD31 (2.5)	TMEM50A (2.4)	GEMIN7 (2.0)	POC5 (1.9)	ENSG00000228044 (1.8)	RPH3A (1.7)	COL4A3BP (1.6)	BCL3 (1.5)
GO:0046638	positive regulation of alpha-beta T cell differentiation	0.42	> 0.20	ZNF101 (2.7)	NT5DC1 (2.1)	HLX (1.7)	MYLIP (1.7)	ENSG00000254235 (1.6)	NKPD1 (1.5)	ENSG00000235545 (1.4)	GOT2P1 (1.4)	ANKRD31 (1.3)	TSSK6 (1.3)
MP:0010123	increased bone mineral content	0.42	> 0.20	MAFB (3.3)	PVR (2.8)	KIAA1324 (2.7)	AMIGO1 (2.4)	TIMD4 (2.4)	DHODH (2.3)	APOC1 (2.3)	APOE (2.2)	ENSG00000226648 (2.0)	CYB561D1 (1.9)
GO:0032092	positive regulation of protein binding	0.42	> 0.20	TMEM57 (3.0)	ENSG00000226648 (2.2)	C12orf51 (1.8)	DNAH11 (1.8)	TMEM116 (1.6)	SARS (1.6)	GRINA (1.6)	HLX (1.5)	HAVCR1 (1.5)	SH2B3 (1.5)
MP:0008133	decreased Peyer's patch number	0.42	> 0.20	RELB (4.4)	BCL3 (3.3)	GMIP (3.3)	PARP10 (3.0)	TIMD4 (2.6)	PVRL2 (2.6)	KIAA1324 (2.5)	OASL (2.5)	PVR (2.0)	CETP (1.8)
ENSG00000107485	GATA3 PPI subnetwork	0.42	> 0.20	HLX (4.3)	RHD (2.9)	GMPR (2.5)	MYLIP (2.2)	USP24 (2.2)	SH2B3 (2.2)	MAFB (1.8)	NCAN (1.8)	RHCE (1.5)	ITGB3 (1.2)
GO:0042744	hydrogen peroxide catabolic process	0.42	> 0.20	GOT2P1 (2.9)	MOSC1 (2.6)	DNAH11 (2.6)	PBX4 (2.4)	C19orf52 (2.2)	ADAM1 (2.1)	RHCE (1.9)	AMIGO1 (1.9)	LPIN3 (1.8)	RHD (1.8)
ENSG00000092094	OSGEP PPI subnetwork	0.42	> 0.20	ITGB3 (3.4)	PPP1R37 (2.6)	CLPTM1 (2.0)	CETP (1.8)	GATAD2A (1.7)	HNF1A (1.7)	GEMIN7 (1.5)	TIMD4 (1.5)	BLOC1S3 (1.4)	C17orf57 (1.4)
MP:0002651	abnormal sciatic nerve morphology	0.42	> 0.20	DOCK7 (2.7)	TIMD4 (2.6)	APOC1 (2.5)	SARS (2.3)	USP24 (2.1)	FADS1 (2.0)	CETP (1.9)	LDLR (1.9)	HMGCR (1.8)	PCSK9 (1.8)
REACTOME_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA	REACTOME_TRANSPORT_OF_THE_SLBP_INDEPENDENT_MATURE_MRNA	0.42	> 0.20	NAA25 (3.1)	DDX56 (3.0)	POC5 (2.8)	DOCK7 (2.7)	BUD13 (2.5)	ILF3 (2.4)	USP1 (2.3)	MAPKAPK5 (2.1)	FEN1 (2.0)	USP24 (2.0)
ENSG00000104964	AES PPI subnetwork	0.42	> 0.20	FADS2 (2.7)	GRINA (2.3)	RHCE (1.9)	KIAA1324 (1.8)	RHD (1.7)	DYNC2LI1 (1.5)	BCL3 (1.5)	ANKRD31 (1.5)	ENSG00000238078 (1.4)	ALDH2 (1.4)
GO:0004812	aminoacyl-tRNA ligase activity	0.42	> 0.20	SARS (8.6)	ZNF259 (3.4)	NAA25 (3.3)	DHODH (3.1)	DDX56 (3.1)	QTRT1 (3.0)	PSMA5 (2.5)	MAPKAPK5 (2.4)	USP24 (2.3)	POC5 (2.2)
GO:0016875	ligase activity, forming carbon-oxygen bonds	0.42	> 0.20	SARS (8.6)	ZNF259 (3.4)	NAA25 (3.3)	DHODH (3.1)	DDX56 (3.1)	QTRT1 (3.0)	PSMA5 (2.5)	MAPKAPK5 (2.4)	USP24 (2.3)	POC5 (2.2)
GO:0016876	ligase activity, forming aminoacyl-tRNA and related compounds	0.42	> 0.20	SARS (8.6)	ZNF259 (3.4)	NAA25 (3.3)	DHODH (3.1)	DDX56 (3.1)	QTRT1 (3.0)	PSMA5 (2.5)	MAPKAPK5 (2.4)	USP24 (2.3)	POC5 (2.2)
ENSG00000165178	ENSG00000165178 PPI subnetwork	0.42	> 0.20	GMIP (3.9)	NCAN (2.5)	RELB (2.5)	DNM2 (2.0)	TMEM50A (1.7)	SH2B3 (1.7)	PMFBP1 (1.7)	ATP13A1 (1.6)	TRAPPC6A (1.6)	ZNF259 (1.5)
ENSG00000110944	IL23A PPI subnetwork	0.42	> 0.20	BCL3 (3.5)	RELB (3.0)	HLX (3.0)	TIMD4 (2.3)	CETP (2.1)	ALDH2 (2.0)	GMIP (1.9)	LPA (1.6)	SH2B3 (1.4)	PBX4 (1.3)
GO:0006417	regulation of translation	0.42	> 0.20	BRAP (2.9)	C12orf43 (2.7)	PTPN11 (2.5)	C12orf51 (2.4)	MAPKAPK5 (2.1)	ILF3 (2.0)	ANKRD31 (2.0)	TXNL4B (1.8)	ADAM1 (1.8)	MYLIP (1.8)
GO:0031098	stress-activated protein kinase signaling cascade	0.42	> 0.20	ST3GAL4 (2.7)	LPAR2 (2.3)	POLK (2.3)	HLX (1.7)	UBXN2B (1.7)	SH2B3 (1.7)	MARK4 (1.6)	FRK (1.5)	YIPF2 (1.4)	ZNF180 (1.4)
MP:0005595	abnormal vascular smooth muscle physiology	0.42	> 0.20	GCNT4 (2.1)	ENSG00000235545 (2.0)	ERP29 (1.9)	NCAN (1.9)	AMIGO1 (1.7)	DNAH11 (1.6)	KANK2 (1.6)	MYLIP (1.6)	SLC44A2 (1.5)	KIAA1324 (1.5)
GO:0051117	ATPase binding	0.42	> 0.20	ST3GAL4 (3.2)	ENSG00000254235 (2.3)	BCAM (2.1)	C1orf63 (2.0)	SORT1 (1.8)	TMEM116 (1.7)	TMED4 (1.6)	AP1M2 (1.6)	TMEM50A (1.5)	PLG (1.5)
GO:0040017	positive regulation of locomotion	0.42	> 0.20	PVR (3.3)	PVRL2 (2.5)	AP1M2 (2.3)	MAFB (2.3)	HLX (2.0)	CETP (1.8)	ZNF101 (1.8)	APOE (1.7)	PTPN11 (1.7)	ENSG00000228044 (1.6)
ENSG00000168439	STIP1 PPI subnetwork	0.42	> 0.20	TOMM40 (3.8)	DDX56 (2.5)	OGDH (2.5)	PSMA5 (2.4)	CLPTM1 (2.4)	NAA25 (2.4)	DHX38 (1.9)	QTRT1 (1.9)	TXNL4B (1.6)	SARS (1.6)
MP:0002069	abnormal eating/drinking behavior	0.42	> 0.20	APOC1 (3.5)	ZHX3 (1.6)	FADS1 (1.6)	BLOC1S3 (1.6)	PMFBP1 (1.5)	RHD (1.5)	RPH3A (1.4)	USP24 (1.4)	KIAA1324 (1.4)	FADS2 (1.3)
ENSG00000213658	LAT PPI subnetwork	0.42	> 0.20	LPAR2 (3.2)	GMIP (3.1)	ZNF101 (2.6)	MAFB (2.0)	PBX4 (2.0)	PLCG1 (1.9)	ZHX3 (1.9)	TOP1 (1.6)	ITGB3 (1.6)	ABCG8 (1.5)
ENSG00000162419	GMEB1 PPI subnetwork	0.42	> 0.20	MAU2 (2.9)	UBXN2B (2.0)	TRIB1 (1.8)	SYPL2 (1.7)	SH2B3 (1.6)	KANK2 (1.6)	DOCK7 (1.5)	HNF1A (1.4)	ENSG00000226648 (1.4)	TOP1 (1.4)
ENSG00000122140	MRPS2 PPI subnetwork	0.42	> 0.20	TOMM40 (4.9)	DHODH (4.6)	CARM1 (3.4)	QTRT1 (2.9)	DDX56 (2.8)	ATP13A1 (2.7)	NAA25 (2.6)	ATXN2 (2.5)	HAVCR1 (2.0)	GPAM (1.9)
ENSG00000133961	NUMB PPI subnetwork	0.42	> 0.20	GATAD2A (2.6)	MYLIP (2.4)	KANK2 (2.4)	HLX (2.3)	USP24 (1.9)	MAFB (1.9)	PLEC (1.8)	TSSK6 (1.7)	LPIN3 (1.6)	CILP2 (1.6)
ENSG00000171747	LGALS4 PPI subnetwork	0.42	> 0.20	KIAA1324 (3.9)	AP1M2 (2.6)	C11orf9 (2.5)	HNF1A (2.4)	NPC1L1 (2.3)	ST3GAL4 (2.0)	DNAH11 (2.0)	PCSK9 (1.7)	PLEC (1.7)	TMEM50A (1.6)
ENSG00000139372	TDG PPI subnetwork	0.42	> 0.20	TRIB1 (3.7)	KIAA1324 (2.6)	BUD13 (2.5)	TMEM50A (2.1)	CELSR2 (2.1)	BCL3 (1.8)	UBXN2B (1.6)	TRAFD1 (1.6)	NYNRIN (1.6)	BCAM (1.5)
ENSG00000185811	IKZF1 PPI subnetwork	0.42	> 0.20	ATXN7L2 (4.6)	CARM1 (3.1)	MARK4 (3.1)	ATXN2 (3.0)	ADAM1 (2.6)	SMARCA4 (2.4)	DNM2 (2.0)	MAU2 (1.9)	PPP1R37 (1.9)	PLCG1 (1.8)
MP:0005044	sepsis	0.42	> 0.20	CETP (4.0)	TIMD4 (3.0)	HP (2.7)	RHD (2.7)	HLX (2.3)	ALDH2 (2.3)	C17orf57 (2.3)	TMEM57 (2.0)	AP1M2 (2.0)	GMIP (1.9)
ENSG00000124356	STAMBP PPI subnetwork	0.42	> 0.20	ADAM1 (3.1)	GMIP (2.4)	ITGB3 (2.2)	DOCK7 (2.1)	MAPKAPK5 (2.1)	ENSG00000226645 (2.0)	TMEM57 (1.9)	COL4A3BP (1.7)	PLCG1 (1.5)	GCNT4 (1.4)
GO:0005793	endoplasmic reticulum-Golgi intermediate compartment	0.42	> 0.20	YIPF2 (6.5)	ERP29 (4.7)	TMED4 (3.4)	TMEM50A (2.4)	CLPTM1 (2.3)	ATP13A1 (2.2)	PVRL2 (1.9)	KIAA1324 (1.9)	TSSK6 (1.1)	ADAM1 (1.1)
ENSG00000204175	GPRIN2 PPI subnetwork	0.42	> 0.20	CBLC (6.7)	AP1M2 (2.9)	LPAR2 (2.4)	PVRL2 (2.3)	PSRC1 (2.1)	ST3GAL4 (2.1)	BCAM (1.9)	PPP1R37 (1.7)	FRK (1.6)	CELSR2 (1.6)
ENSG00000110931	CAMKK2 PPI subnetwork	0.42	> 0.20	MAPKAPK5 (3.2)	CARM1 (1.9)	ALDH2 (1.9)	DNM2 (1.9)	MARK4 (1.9)	LDLR (1.8)	HMGCR (1.8)	NKPD1 (1.7)	GMIP (1.7)	SLC44A2 (1.5)
ENSG00000171873	ADRA1D PPI subnetwork	0.42	> 0.20	ZHX3 (3.4)	COL4A3BP (3.1)	ENSG00000235545 (2.5)	KANK2 (2.4)	ITGB3 (2.0)	RHCE (1.9)	SH2B3 (1.8)	PPP1R37 (1.8)	SYPL2 (1.7)	FADS2 (1.5)
ENSG00000153391	INO80C PPI subnetwork	0.42	> 0.20	BUD13 (3.2)	C12orf43 (2.5)	ATXN2 (2.5)	QTRT1 (2.4)	GOT2P1 (2.4)	DDX56 (2.1)	ZNF180 (2.1)	SUGP1 (2.0)	ANKRD31 (2.0)	ZNF259 (1.9)
ENSG00000108953	YWHAE PPI subnetwork	0.42	> 0.20	SMARCA4 (3.6)	TRIB1 (2.8)	GATAD2A (2.5)	TOP1 (2.2)	PLEC (2.0)	DNM2 (2.0)	OGDH (2.0)	PLCG1 (1.8)	ENSG00000238078 (1.6)	SARS (1.6)
GO:0016874	ligase activity	0.42	> 0.20	SARS (4.2)	BRAP (3.1)	ATXN2 (3.1)	USP24 (2.5)	MAPKAPK5 (2.3)	NT5DC1 (2.2)	TRAFD1 (2.1)	NAA25 (1.9)	C12orf51 (1.9)	C19orf52 (1.8)
REACTOME_REGULATION_OF_IFNG_SIGNALING	REACTOME_REGULATION_OF_IFNG_SIGNALING	0.42	> 0.20	TRAFD1 (6.0)	BCL3 (4.8)	RELB (3.2)	PARP10 (3.2)	ENSG00000228044 (2.6)	TRIB1 (2.2)	COL4A3BP (2.0)	NAA25 (2.0)	GRINA (2.0)	TMEM50A (1.5)
ENSG00000102362	SYTL4 PPI subnetwork	0.42	> 0.20	ITGB3 (3.4)	KIAA1324 (2.9)	ST3GAL4 (2.8)	PBX4 (2.6)	GATAD2A (2.3)	GMPR (2.3)	TMEM57 (2.3)	CELSR2 (1.9)	CYB561D1 (1.9)	YIPF2 (1.7)
ENSG00000112081	SRSF3 PPI subnetwork	0.42	> 0.20	C1orf63 (4.9)	TOP1 (4.0)	ILF3 (3.7)	USP1 (2.6)	SMARCA4 (2.6)	DHX38 (2.5)	BUD13 (2.4)	FEN1 (1.9)	QTRT1 (1.9)	SUGP1 (1.8)
ENSG00000176986	SEC24C PPI subnetwork	0.42	> 0.20	YIPF2 (4.6)	CLPTM1 (3.1)	GEMIN7 (2.2)	DNM2 (2.0)	SUGP1 (1.8)	TOP1 (1.8)	ENSG00000226648 (1.5)	MARK4 (1.5)	C19orf52 (1.1)	TMED4 (1.1)
ENSG00000215120	ENSG00000215120 PPI subnetwork	0.42	> 0.20	TOP1 (2.8)	MAPKAPK5 (2.8)	C1orf63 (2.5)	TRIB1 (2.3)	BUD13 (2.2)	ZNF101 (2.2)	POC5 (2.0)	MAU2 (1.9)	USP1 (1.9)	TMED4 (1.7)
GO:0031400	negative regulation of protein modification process	0.42	> 0.20	PSMA5 (2.9)	TRAFD1 (2.6)	NAA25 (2.1)	TMEM57 (1.8)	TMEM50A (1.8)	NT5DC1 (1.7)	C12orf43 (1.7)	DNAH11 (1.5)	PARP10 (1.5)	DDX56 (1.5)
GO:0016226	iron-sulfur cluster assembly	0.42	> 0.20	C12orf43 (3.3)	GEMIN7 (3.1)	C12orf47 (2.4)	TMEM116 (2.2)	C19orf52 (2.1)	NT5DC1 (1.7)	PBX4 (1.7)	BRAP (1.6)	ZNF180 (1.6)	RHCE (1.5)
GO:0031163	metallo-sulfur cluster assembly	0.42	> 0.20	C12orf43 (3.3)	GEMIN7 (3.1)	C12orf47 (2.4)	TMEM116 (2.2)	C19orf52 (2.1)	NT5DC1 (1.7)	PBX4 (1.7)	BRAP (1.6)	ZNF180 (1.6)	RHCE (1.5)
ENSG00000121989	ACVR2A PPI subnetwork	0.42	> 0.20	PVRL2 (3.3)	SLC22A1 (2.4)	MYLIP (2.0)	ENSG00000226645 (1.9)	NYNRIN (1.8)	PVR (1.8)	ALDH2 (1.6)	ABO (1.6)	MARK4 (1.3)	TMEM57 (1.3)
MP:0005300	abnormal corneal stroma morphology	0.42	> 0.20	CILP2 (4.4)	MAFB (3.6)	APOE (2.7)	PLCG1 (2.4)	ANGPTL3 (2.3)	APOA5 (2.0)	APOC1 (1.8)	LPA (1.7)	SLC22A1 (1.7)	MOSC1 (1.5)
GO:0010564	regulation of cell cycle process	0.42	> 0.20	PSRC1 (3.2)	POC5 (3.0)	FEN1 (2.5)	USP1 (2.5)	ENSG00000228044 (2.3)	POLK (1.8)	ZNF180 (1.7)	MAU2 (1.6)	BUD13 (1.5)	SUGP1 (1.5)
ENSG00000125450	NUP85 PPI subnetwork	0.42	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (4.1)	POC5 (3.9)	ZNF180 (1.5)	ENSG00000226648 (1.5)	ENSG00000228044 (1.3)	ENSG00000238078 (1.0)	USP24 (0.8)	CEACAM19 (0.8)
ENSG00000189091	SF3B3 PPI subnetwork	0.42	> 0.20	ILF3 (4.1)	C1orf63 (3.5)	DHX38 (3.4)	TOP1 (3.2)	SUGP1 (3.2)	SMARCA4 (3.1)	BUD13 (3.0)	USP1 (2.3)	QTRT1 (2.2)	FEN1 (2.2)
ENSG00000145349	CAMK2D PPI subnetwork	0.42	> 0.20	PLEC (2.9)	PVR (2.6)	OGDH (2.6)	C1orf63 (2.3)	HAVCR1 (2.3)	GOT2P1 (2.0)	HMGCR (2.0)	KANK2 (1.9)	LDLR (1.8)	KIAA1324 (1.8)
ENSG00000086598	TMED2 PPI subnetwork	0.42	> 0.20	YIPF2 (4.2)	HMGCR (3.6)	LDLR (3.3)	TMED4 (3.2)	FADS2 (2.9)	ATP13A1 (2.3)	ABCG8 (2.2)	FADS1 (2.2)	SARS (2.1)	TMEM50A (2.0)
ENSG00000156273	BACH1 PPI subnetwork	0.42	> 0.20	MAFB (2.7)	TMEM116 (2.2)	TIMD4 (2.1)	TRIB1 (1.9)	NPC1L1 (1.9)	BCAM (1.9)	ATXN2 (1.7)	DOCK7 (1.7)	POLK (1.7)	BRAP (1.6)
GO:0042393	histone binding	0.42	> 0.20	USP1 (4.6)	ILF3 (3.0)	FEN1 (2.8)	SMARCA4 (2.6)	BUD13 (2.4)	C19orf52 (2.2)	GATAD2A (2.2)	TOP1 (1.8)	C1orf63 (1.8)	COL4A3BP (1.8)
MP:0000474	abnormal foregut morphology	0.42	> 0.20	C11orf9 (3.2)	PVRL2 (3.1)	ABO (3.0)	BCAM (2.4)	LPAR2 (2.4)	PLEKHH2 (2.3)	KANK2 (2.1)	AP1M2 (2.0)	NYNRIN (2.0)	ENSG00000226648 (1.8)
GO:0090066	regulation of anatomical structure size	0.42	> 0.20	ABO (3.2)	TSSK6 (2.2)	CETP (1.9)	C17orf57 (1.9)	TMEM50A (1.7)	ENSG00000226645 (1.7)	HAVCR1 (1.5)	HAPLN4 (1.4)	C12orf47 (1.4)	LPIN3 (1.4)
ENSG00000124208	TMEM189-UBE2V1 PPI subnetwork	0.42	> 0.20	ZNF101 (4.9)	ENSG00000238078 (2.6)	NCAN (2.1)	PTPN11 (1.8)	OGDH (1.8)	GRINA (1.7)	TMEM116 (1.7)	HNF1A (1.6)	TRAPPC6A (1.5)	ACAD10 (1.5)
ENSG00000196411	EPHB4 PPI subnetwork	0.42	> 0.20	FRK (3.3)	CETP (3.1)	PSRC1 (2.9)	OASL (2.4)	TIMD4 (2.3)	GRINA (2.1)	HAPLN4 (2.0)	C11orf9 (1.9)	MARK4 (1.9)	ABO (1.9)
GO:0071241	cellular response to inorganic substance	0.42	> 0.20	KANK2 (2.3)	TSSK6 (1.9)	HAVCR1 (1.8)	RHD (1.6)	DYNC2LI1 (1.6)	C1orf63 (1.5)	POLK (1.4)	C19orf52 (1.3)	GCNT4 (1.3)	ANKRD31 (1.3)
GO:0004003	ATP-dependent DNA helicase activity	0.42	> 0.20	FEN1 (3.0)	USP1 (2.3)	ILF3 (2.3)	SUGP1 (2.3)	TRAPPC6A (1.9)	DHX38 (1.9)	ZNF180 (1.8)	GCNT4 (1.7)	NT5DC1 (1.6)	SMARCA4 (1.6)
ENSG00000211455	STK38L PPI subnetwork	0.42	> 0.20	TOP1 (2.4)	GATAD2A (2.3)	ZNF101 (2.3)	ATP13A1 (1.9)	MARK4 (1.7)	CILP2 (1.7)	MYLIP (1.6)	ABO (1.6)	BRAP (1.5)	PTPN11 (1.5)
GO:0060420	regulation of heart growth	0.42	> 0.20	C11orf9 (3.4)	GCNT4 (2.2)	PLEKHH2 (1.8)	ENSG00000254235 (1.7)	ANKRD31 (1.6)	ALDH2 (1.5)	TXNL4B (1.5)	HAPLN4 (1.4)	CEACAM19 (1.4)	BLOC1S3 (1.3)
GO:0050708	regulation of protein secretion	0.42	> 0.20	GEMIN7 (2.3)	ENSG00000228044 (2.1)	KIAA1324 (1.9)	ST3GAL4 (1.8)	PBX4 (1.3)	HLX (1.3)	MOSC1 (1.2)	NT5DC1 (1.2)	CYP7A1 (1.2)	ZNF180 (1.1)
GO:0016918	retinal binding	0.42	> 0.20	C11orf9 (3.6)	APOB (3.5)	ABCG5 (3.3)	TM6SF2 (3.3)	NKPD1 (2.7)	NYNRIN (2.2)	LPAR2 (2.1)	APOC4 (1.8)	APOA5 (1.8)	ABCG8 (1.8)
ENSG00000099308	MAST3 PPI subnetwork	0.42	> 0.20	PLEC (3.6)	DNM2 (3.1)	ZHX3 (3.1)	COL4A3BP (3.1)	C11orf9 (3.0)	CARM1 (2.7)	USP24 (2.6)	LPAR2 (2.4)	C12orf51 (2.4)	PTPN11 (2.3)
ENSG00000126522	ASL PPI subnetwork	0.42	> 0.20	ZNF259 (3.3)	DDX56 (3.2)	GEMIN7 (3.0)	QTRT1 (2.8)	C12orf43 (2.2)	BUD13 (2.1)	MAPKAPK5 (2.0)	ADAM1 (1.9)	ACAD10 (1.9)	NAA25 (1.8)
ENSG00000108294	PSMB3 PPI subnetwork	0.42	> 0.20	PSMA5 (5.5)	TRAFD1 (2.5)	NAA25 (2.3)	NT5DC1 (2.3)	SARS (1.9)	C19orf52 (1.9)	DDX56 (1.6)	SMARCA4 (1.4)	SUGP1 (1.3)	ENSG00000254235 (1.2)
GO:0006182	cGMP biosynthetic process	0.42	> 0.20	TSSK6 (3.4)	HAVCR1 (3.0)	C12orf47 (2.2)	ENSG00000226648 (2.0)	NKPD1 (2.0)	ANKRD31 (1.6)	POC5 (1.5)	TMEM116 (1.5)	PMFBP1 (1.4)	MYLIP (1.3)
ENSG00000083896	YTHDC1 PPI subnetwork	0.42	> 0.20	ADAM1 (4.0)	ITGB3 (2.9)	GATAD2A (2.6)	TRIB1 (1.9)	PPP1R37 (1.8)	TIMD4 (1.8)	SH2B3 (1.6)	ILF3 (1.6)	CETP (1.5)	FADS1 (1.3)
MP:0003222	increased cardiomyocyte apoptosis	0.42	> 0.20	C1orf63 (2.4)	MAFB (2.3)	UBXN2B (2.2)	BCL3 (1.8)	C17orf57 (1.8)	SORT1 (1.7)	HP (1.7)	PLCG1 (1.6)	ACAD10 (1.5)	OGDH (1.4)
MP:0001851	eye inflammation	0.42	> 0.20	ITGB3 (4.1)	CYP7A1 (2.8)	ANGPTL3 (2.3)	BCL3 (2.2)	TXNL4B (2.1)	RELB (2.0)	APOC4 (1.9)	ENSG00000254235 (1.8)	ENSG00000228044 (1.7)	LPA (1.7)
ENSG00000122565	CBX3 PPI subnetwork	0.42	> 0.20	USP1 (3.3)	TMEM57 (2.7)	PSRC1 (2.6)	BUD13 (2.4)	ZNF180 (1.9)	TOP1 (1.8)	C19orf52 (1.8)	FEN1 (1.6)	TRAFD1 (1.6)	KANK2 (1.3)
ENSG00000012124	CD22 PPI subnetwork	0.42	> 0.20	GMIP (3.7)	MAFB (2.8)	ZHX3 (2.3)	OGDH (2.3)	GPAM (2.2)	SH2B3 (2.0)	ENSG00000226645 (1.9)	KANK2 (1.8)	MARK4 (1.7)	NYNRIN (1.7)
REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING	0.42	> 0.20	TMEM50A (2.9)	CLPTM1 (2.9)	SORT1 (2.8)	SLC44A2 (2.4)	DNM2 (2.0)	ATXN7L2 (1.9)	COL4A3BP (1.8)	CYB561D1 (1.8)	AMIGO1 (1.7)	ST3GAL4 (1.7)
MP:0001222	epidermal hyperplasia	0.42	> 0.20	CBLC (6.1)	PLEC (3.4)	AP1M2 (3.1)	BCAM (2.2)	APOC1 (2.1)	GMIP (2.0)	DNM2 (1.9)	BCL3 (1.7)	LPIN3 (1.6)	CYB561D1 (1.6)
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	0.42	> 0.20	GMIP (2.2)	RELB (2.2)	SH2B3 (2.2)	CYP7A1 (2.0)	ENSG00000228044 (1.9)	COL4A3BP (1.6)	GOT2P1 (1.6)	GATAD2A (1.6)	NCAN (1.5)	MYLIP (1.4)
ENSG00000105176	URI1 PPI subnetwork	0.42	> 0.20	BLOC1S3 (3.1)	ATXN2 (2.6)	GMPR (2.5)	TRAPPC6A (2.5)	POC5 (2.2)	GATAD2A (2.0)	DDX56 (2.0)	MAPKAPK5 (1.9)	SUGP1 (1.9)	TOMM40 (1.9)
MP:0010879	decreased trabecular bone volume	0.42	> 0.20	OASL (6.3)	TRIB1 (3.0)	MAFB (2.7)	PARP10 (2.5)	TRAFD1 (2.3)	CYB561D1 (2.1)	MOSC1 (1.9)	CILP2 (1.6)	TSSK6 (1.5)	ERP29 (1.4)
MP:0005599	increased cardiac muscle contractility	0.42	> 0.20	ST3GAL4 (2.2)	ANKRD31 (1.5)	ENSG00000238078 (1.4)	OASL (1.4)	CILP2 (1.4)	UBXN2B (1.3)	GPAM (1.3)	GMPR (1.3)	NKPD1 (1.3)	DNAH11 (1.3)
GO:0045069	regulation of viral genome replication	0.42	> 0.20	OASL (6.0)	MAU2 (3.1)	FRK (2.8)	GCNT4 (2.5)	PARP10 (2.1)	ENSG00000228044 (1.8)	ENSG00000235545 (1.6)	ATP13A1 (1.4)	HAVCR1 (1.3)	PLCG1 (1.2)
MP:0008088	abnormal T-helper 1 cell differentiation	0.42	> 0.20	RELB (3.3)	TRAFD1 (2.8)	ABO (2.0)	PARP10 (2.0)	PBX4 (1.9)	BCL3 (1.8)	GMIP (1.6)	C12orf47 (1.5)	TRIB1 (1.5)	PPP1R37 (1.3)
GO:0045844	positive regulation of striated muscle tissue development	0.42	> 0.20	DNAH11 (2.7)	POLK (2.6)	COL4A3BP (2.5)	LDLR (1.9)	PMFBP1 (1.8)	PLEKHH2 (1.8)	TMEM116 (1.6)	GMPR (1.5)	CYP7A1 (1.1)	NKPD1 (1.1)
GO:0048636	positive regulation of muscle organ development	0.42	> 0.20	DNAH11 (2.7)	POLK (2.6)	COL4A3BP (2.5)	LDLR (1.9)	PMFBP1 (1.8)	PLEKHH2 (1.8)	TMEM116 (1.6)	GMPR (1.5)	CYP7A1 (1.1)	NKPD1 (1.1)
ENSG00000206557	TRIM71 PPI subnetwork	0.42	> 0.20	OASL (3.6)	PARP10 (3.1)	TMED4 (2.1)	ZNF180 (1.8)	NAA25 (1.8)	FRK (1.5)	SUGP1 (1.5)	C12orf43 (1.3)	BUD13 (1.3)	MAPKAPK5 (1.3)
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	REACTOME_ACTIVATION_OF_GENES_BY_ATF4	0.42	> 0.20	SARS (5.0)	PVR (3.4)	TXNL4B (3.0)	POC5 (2.8)	TRIB1 (2.7)	DHODH (2.7)	MAPKAPK5 (2.6)	PMFBP1 (1.8)	TRAPPC6A (1.7)	TMEM116 (1.6)
GO:0048243	norepinephrine secretion	0.42	> 0.20	ZHX3 (2.5)	ANKRD31 (2.4)	GMPR (2.1)	ABO (2.1)	TSSK6 (1.6)	DNAH11 (1.5)	ITGB3 (1.4)	LPIN3 (1.4)	PMFBP1 (1.3)	GOT2P1 (1.3)
ENSG00000127616	SMARCA4 PPI subnetwork	0.42	> 0.20	SMARCA4 (3.1)	USP1 (2.8)	TOP1 (2.8)	ATXN2 (2.7)	GATAD2A (2.5)	CARM1 (2.5)	C12orf51 (1.8)	C12orf47 (1.8)	TRIB1 (1.6)	MAU2 (1.6)
ENSG00000105397	TYK2 PPI subnetwork	0.42	> 0.20	BCL3 (4.0)	GMIP (2.9)	PARP10 (2.5)	RELB (2.4)	HLX (2.3)	SLC44A2 (2.0)	DNM2 (1.9)	CYB561D1 (1.8)	PBX4 (1.6)	TRAFD1 (1.6)
ENSG00000108055	SMC3 PPI subnetwork	0.42	> 0.20	ILF3 (2.8)	USP1 (2.5)	SMARCA4 (2.5)	POC5 (2.4)	ACAD10 (2.1)	SUGP1 (1.7)	FEN1 (1.6)	BRAP (1.6)	ATXN2 (1.6)	TOP1 (1.6)
ENSG00000168827	GFM1 PPI subnetwork	0.42	> 0.20	TOMM40 (2.7)	CYP7A1 (2.3)	ATP13A1 (2.1)	TXNL4B (2.1)	UBXN2B (2.0)	PLEC (1.8)	TOP1 (1.8)	DHODH (1.8)	TRAPPC6A (1.7)	ENSG00000228044 (1.7)
MP:0001236	abnormal epidermis stratum spinosum morphology	0.42	> 0.20	CBLC (4.3)	CELSR2 (3.8)	AP1M2 (3.8)	C17orf57 (2.7)	BCAM (2.5)	NKPD1 (2.4)	PLEC (2.3)	YIPF2 (1.7)	DNM2 (1.7)	TM6SF2 (1.6)
GO:0006284	base-excision repair	0.42	> 0.20	ZNF180 (2.4)	BUD13 (2.0)	ADAM1 (1.9)	TRAPPC6A (1.8)	LPIN3 (1.7)	AMIGO1 (1.4)	USP1 (1.4)	ANKRD31 (1.3)	DHODH (1.2)	FEN1 (1.2)
ENSG00000173894	CBX2 PPI subnetwork	0.42	> 0.20	TMEM57 (2.5)	USP1 (2.0)	TOP1 (2.0)	HLX (1.9)	MARK4 (1.9)	ATXN2 (1.9)	GATAD2A (1.8)	NT5DC1 (1.8)	TRIB1 (1.7)	NAA25 (1.6)
GO:0046686	response to cadmium ion	0.42	> 0.20	ZHX3 (2.6)	CYP7A1 (2.0)	ENSG00000238078 (2.0)	ABO (2.0)	PMFBP1 (1.8)	HNF1A (1.6)	DNAH11 (1.6)	ITGB3 (1.5)	PBX4 (1.5)	C1orf63 (1.4)
MP:0006138	congestive heart failure	0.42	> 0.20	BCAM (2.7)	GPAM (2.4)	SORT1 (2.2)	ANKRD31 (1.7)	UBXN2B (1.6)	POLK (1.5)	PLEC (1.4)	OGDH (1.3)	ACAD10 (1.2)	CEACAM19 (1.0)
GO:0031334	positive regulation of protein complex assembly	0.42	> 0.20	ANKRD31 (2.9)	ENSG00000254235 (2.2)	CETP (1.6)	LPIN3 (1.6)	HAVCR1 (1.6)	ZNF101 (1.4)	HNF1A (1.4)	ENSG00000226648 (1.4)	PLCG1 (1.3)	ZHX3 (1.3)
ENSG00000168765	GSTM4 PPI subnetwork	0.42	> 0.20	PSRC1 (2.7)	GEMIN7 (2.4)	BCAM (2.4)	ATXN7L2 (2.2)	BLOC1S3 (2.0)	SLC44A2 (1.9)	ZHX3 (1.8)	AMIGO1 (1.8)	SORT1 (1.7)	C17orf57 (1.7)
ENSG00000039319	ZFYVE16 PPI subnetwork	0.42	> 0.20	DOCK7 (3.3)	AMIGO1 (2.1)	CYB561D1 (2.0)	LPIN3 (1.9)	MAFB (1.9)	ENSG00000226648 (1.7)	ENSG00000228044 (1.5)	BRAP (1.5)	ATXN2 (1.4)	POC5 (1.3)
ENSG00000183093	ENSG00000183093 PPI subnetwork	0.42	> 0.20	ZNF259 (3.9)	NAA25 (3.7)	TOMM40 (3.3)	DDX56 (2.8)	QTRT1 (2.8)	CARM1 (2.5)	DHODH (1.8)	ADAM1 (1.6)	MAPKAPK5 (1.5)	C12orf43 (1.5)
ENSG00000081026	MAGI3 PPI subnetwork	0.42	> 0.20	CELSR2 (3.0)	ST3GAL4 (2.9)	CEACAM19 (2.5)	NCAN (2.2)	PVRL2 (2.2)	TIMD4 (2.0)	ANKRD31 (1.9)	ENSG00000238078 (1.9)	AMIGO1 (1.8)	PVR (1.6)
GO:0071156	regulation of cell cycle arrest	0.42	> 0.20	PSRC1 (2.7)	POC5 (2.5)	FEN1 (2.3)	USP1 (2.2)	ZNF180 (2.1)	SUGP1 (1.9)	PSMA5 (1.8)	ENSG00000228044 (1.7)	POLK (1.7)	MAU2 (1.7)
ENSG00000087250	MT3 PPI subnetwork	0.42	> 0.20	PARP10 (2.7)	C17orf57 (2.6)	PTPN11 (2.5)	FRK (2.3)	HNF1A (1.8)	KANK2 (1.8)	ADAM1 (1.6)	DHX38 (1.5)	UBXN2B (1.5)	ZNF180 (1.4)
ENSG00000073910	FRY PPI subnetwork	0.42	> 0.20	CARM1 (3.0)	GATAD2A (2.9)	TOP1 (2.8)	BRAP (2.7)	TOMM40 (2.4)	ENSG00000226645 (2.2)	DHX38 (2.2)	ALDH2 (2.1)	PTPN11 (2.0)	USP24 (1.6)
ENSG00000090470	PDCD7 PPI subnetwork	0.42	> 0.20	PMFBP1 (2.3)	TOP1 (2.3)	TIMD4 (2.0)	ADAM1 (2.0)	C12orf47 (1.7)	USP1 (1.7)	GEMIN7 (1.7)	ILF3 (1.6)	ENSG00000238078 (1.6)	ZNF180 (1.4)
ENSG00000163486	SRGAP2 PPI subnetwork	0.42	> 0.20	PLEC (4.2)	DNM2 (3.3)	COL4A3BP (3.1)	C11orf9 (2.9)	CARM1 (2.8)	LPAR2 (2.6)	ZHX3 (2.5)	USP24 (2.4)	MAU2 (2.3)	PTPN11 (2.3)
ENSG00000104081	BMF PPI subnetwork	0.42	> 0.20	C11orf9 (3.4)	TRIB1 (3.0)	GMPR (2.3)	ENSG00000226645 (1.9)	GCNT4 (1.9)	PLEKHH2 (1.8)	PPP1R37 (1.7)	TXNL4B (1.6)	TMEM57 (1.5)	BCAM (1.2)
ENSG00000105705	SUGP1 PPI subnetwork	0.42	> 0.20	ILF3 (3.8)	C1orf63 (3.7)	TOP1 (3.0)	USP1 (2.8)	DHX38 (2.5)	BUD13 (2.4)	SMARCA4 (2.4)	SUGP1 (2.2)	FEN1 (2.1)	PTPN11 (1.9)
REACTOME_POST:ELONGATION_PROCESSING_OF_INTRON:CONTAINING_PRE:MRNA	REACTOME_POST:ELONGATION_PROCESSING_OF_INTRON:CONTAINING_PRE:MRNA	0.43	> 0.20	C1orf63 (6.0)	TOP1 (3.4)	ILF3 (2.9)	BUD13 (2.5)	USP1 (2.5)	DHODH (2.5)	ENSG00000226645 (2.0)	FEN1 (2.0)	SUGP1 (1.7)	ENSG00000226648 (1.6)
REACTOME_MRNA_3:END_PROCESSING	REACTOME_MRNA_3:END_PROCESSING	0.43	> 0.20	C1orf63 (6.0)	TOP1 (3.4)	ILF3 (2.9)	BUD13 (2.5)	USP1 (2.5)	DHODH (2.5)	ENSG00000226645 (2.0)	FEN1 (2.0)	SUGP1 (1.7)	ENSG00000226648 (1.6)
MP:0000435	shortened head	0.43	> 0.20	CILP2 (3.4)	MYLIP (3.0)	PLEKHH2 (2.6)	ANKRD31 (2.1)	USP1 (1.7)	PLCG1 (1.7)	KANK2 (1.5)	NPC1L1 (1.5)	ALDH2 (1.3)	GATAD2A (1.1)
GO:0051052	regulation of DNA metabolic process	0.43	> 0.20	POLK (3.4)	HAVCR1 (2.5)	C17orf57 (2.1)	POC5 (2.0)	BUD13 (2.0)	ENSG00000226645 (1.9)	GCNT4 (1.8)	GEMIN7 (1.8)	BLOC1S3 (1.7)	USP1 (1.3)
ENSG00000160200	CBS PPI subnetwork	0.43	> 0.20	TOMM40 (3.2)	NAA25 (2.8)	ZNF259 (2.7)	MAPKAPK5 (2.6)	QTRT1 (2.3)	SARS (2.2)	DHODH (2.2)	DHX38 (2.0)	TXNL4B (1.9)	DDX56 (1.8)
GO:0015844	monoamine transport	0.43	> 0.20	ABO (2.6)	GMPR (2.4)	PMFBP1 (1.7)	TSSK6 (1.5)	ABCG8 (1.5)	CETP (1.4)	MOSC1 (1.3)	GOT2P1 (1.2)	LPA (1.1)	RPH3A (1.1)
GO:0007127	meiosis I	0.43	> 0.20	ANKRD31 (3.9)	ENSG00000238078 (2.5)	ENSG00000228044 (1.9)	C17orf57 (1.5)	LPIN3 (1.5)	POC5 (1.4)	TSSK6 (1.3)	ZHX3 (1.2)	DYNC2LI1 (1.1)	HAVCR1 (1.0)
GO:0004437	inositol or phosphatidylinositol phosphatase activity	0.43	> 0.20	C12orf51 (2.5)	SH2B3 (1.9)	TM6SF2 (1.9)	UBXN2B (1.7)	PBX4 (1.7)	POC5 (1.6)	HAPLN4 (1.6)	AMIGO1 (1.5)	BLOC1S3 (1.5)	ST3GAL4 (1.4)
GO:0055123	digestive system development	0.43	> 0.20	C11orf9 (4.5)	TM6SF2 (2.7)	PLEKHH2 (2.6)	NPC1L1 (2.3)	ABCG8 (2.1)	ABCG5 (2.0)	NYNRIN (1.9)	LPAR2 (1.9)	ENSG00000235545 (1.7)	HLX (1.7)
MP:0008217	abnormal B cell activation	0.43	> 0.20	ZNF101 (3.0)	TIMD4 (2.9)	CETP (2.6)	SLC44A2 (2.0)	GMIP (1.9)	GEMIN7 (1.5)	HAVCR1 (1.5)	RELB (1.4)	CYB561D1 (1.3)	GCNT4 (1.2)
MP:0003690	abnormal glial cell physiology	0.43	> 0.20	APOC1 (3.8)	MYLIP (3.1)	GPAM (2.8)	AMIGO1 (1.9)	POC5 (1.8)	OASL (1.7)	PVR (1.6)	ALDH2 (1.5)	ZHX3 (1.4)	RPH3A (1.3)
GO:0035255	ionotropic glutamate receptor binding	0.43	> 0.20	GCNT4 (2.2)	HNF1A (2.1)	KIAA1324 (1.8)	ANKRD31 (1.7)	PCSK9 (1.7)	RPH3A (1.6)	AMIGO1 (1.6)	GOT2P1 (1.5)	PTPN11 (1.5)	DOCK7 (1.5)
ENSG00000006715	VPS41 PPI subnetwork	0.43	> 0.20	BRAP (3.2)	ATP13A1 (2.9)	ZNF259 (2.8)	MAU2 (2.5)	DDX56 (2.4)	DNM2 (2.4)	SUGP1 (2.3)	C1orf63 (2.2)	ERP29 (2.1)	DHX38 (1.7)
MP:0004179	transmission ratio distortion	0.43	> 0.20	KIAA1324 (3.3)	PMFBP1 (3.2)	LDLR (2.6)	ABCG8 (1.8)	TSSK6 (1.7)	POC5 (1.6)	BUD13 (1.6)	ITGB3 (1.5)	HMGCR (1.5)	CYP7A1 (1.4)
ENSG00000189037	DUSP21 PPI subnetwork	0.43	> 0.20	MYLIP (3.5)	TM6SF2 (2.5)	ZNF101 (2.5)	ENSG00000226645 (2.4)	MAU2 (2.4)	TRIB1 (2.1)	PBX4 (2.0)	LPAR2 (2.0)	LDLR (2.0)	LPIN3 (1.8)
GO:0005545	1-phosphatidylinositol binding	0.43	> 0.20	DOCK7 (3.8)	PTPN11 (3.1)	COL4A3BP (2.9)	BRAP (2.2)	ENSG00000254235 (2.2)	C12orf51 (1.9)	PMFBP1 (1.7)	SH2B3 (1.7)	MYLIP (1.6)	TRAFD1 (1.6)
REACTOME_PYRIMIDINE_METABOLISM	REACTOME_PYRIMIDINE_METABOLISM	0.43	> 0.20	PLG (3.7)	SLC22A1 (3.4)	ANGPTL3 (3.4)	LPA (3.2)	APOC4 (3.2)	DHODH (2.3)	APOA5 (2.3)	TXNL4B (2.2)	CYP7A1 (1.9)	HP (1.9)
GO:0051053	negative regulation of DNA metabolic process	0.43	> 0.20	POLK (3.3)	BLOC1S3 (3.2)	POC5 (2.7)	SUGP1 (2.2)	ENSG00000235545 (1.9)	C17orf57 (1.6)	GOT2P1 (1.6)	ENSG00000228044 (1.5)	USP1 (1.4)	BUD13 (1.3)
GO:0009914	hormone transport	0.43	> 0.20	KIAA1324 (4.8)	ANKRD31 (2.8)	ABO (2.2)	MOSC1 (1.9)	HNF1A (1.9)	AMIGO1 (1.8)	ENSG00000228044 (1.7)	GPAM (1.6)	TMED4 (1.5)	HAPLN4 (1.5)
ENSG00000163605	PPP4R2 PPI subnetwork	0.43	> 0.20	PARP10 (3.0)	OASL (2.9)	USP1 (1.9)	BUD13 (1.8)	ZNF180 (1.8)	TMED4 (1.7)	TOMM40 (1.4)	PSMA5 (1.4)	ZNF101 (1.4)	C12orf43 (1.3)
GO:0002706	regulation of lymphocyte mediated immunity	0.43	> 0.20	DNAH11 (1.5)	PARP10 (1.5)	HAVCR1 (1.4)	ZNF101 (1.4)	GEMIN7 (1.4)	ENSG00000235545 (1.4)	TRAFD1 (1.3)	C12orf43 (1.2)	PBX4 (1.2)	AMIGO1 (1.2)
GO:0016338	calcium-independent cell-cell adhesion	0.43	> 0.20	AP1M2 (5.3)	FRK (3.8)	CBLC (2.5)	ENSG00000228044 (2.3)	YIPF2 (2.1)	CYP7A1 (2.1)	DYNC2LI1 (2.1)	ENSG00000226648 (1.8)	ENSG00000254235 (1.7)	BCAM (1.7)
MP:0004275	abnormal postnatal subventricular zone morphology	0.43	> 0.20	CELSR2 (3.4)	NCAN (2.6)	ST3GAL4 (2.2)	ATP13A1 (1.8)	CYB561D1 (1.8)	ENSG00000254235 (1.7)	FRK (1.6)	FADS2 (1.5)	RPH3A (1.5)	SORT1 (1.5)
ENSG00000111596	CNOT2 PPI subnetwork	0.43	> 0.20	ATXN2 (2.7)	SARS (2.2)	TXNL4B (2.1)	TMEM57 (2.0)	C1orf63 (1.9)	DNAH11 (1.8)	BUD13 (1.7)	TRAPPC6A (1.6)	C17orf57 (1.6)	BLOC1S3 (1.6)
GO:0031011	Ino80 complex	0.43	> 0.20	SUGP1 (4.1)	MAPKAPK5 (3.7)	TOMM40 (3.2)	ZNF259 (3.0)	ZNF180 (2.8)	C12orf43 (2.6)	POC5 (2.6)	DDX56 (1.8)	DYNC2LI1 (1.7)	MARK4 (1.6)
GO:0033202	DNA helicase complex	0.43	> 0.20	SUGP1 (4.1)	MAPKAPK5 (3.7)	TOMM40 (3.2)	ZNF259 (3.0)	ZNF180 (2.8)	C12orf43 (2.6)	POC5 (2.6)	DDX56 (1.8)	DYNC2LI1 (1.7)	MARK4 (1.6)
GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	0.43	> 0.20	ENSG00000226645 (3.1)	BLOC1S3 (2.4)	KANK2 (1.9)	RELB (1.9)	BCL3 (1.8)	ENSG00000254235 (1.7)	GMIP (1.6)	PVR (1.5)	OASL (1.5)	ATXN7L2 (1.4)
GO:0000413	protein peptidyl-prolyl isomerization	0.43	> 0.20	YIPF2 (4.2)	QTRT1 (2.3)	ERP29 (2.3)	TOMM40 (2.2)	TRAPPC6A (2.0)	CEACAM19 (1.9)	TXNL4B (1.7)	DHODH (1.6)	OGDH (1.6)	CLPTM1 (1.5)
GO:0018105	peptidyl-serine phosphorylation	0.43	> 0.20	C1orf63 (2.1)	ZHX3 (1.9)	PLEKHH2 (1.8)	USP24 (1.8)	PLCG1 (1.8)	C17orf57 (1.7)	GCNT4 (1.7)	PTPN11 (1.5)	DOCK7 (1.4)	CYB561D1 (1.4)
ENSG00000111642	CHD4 PPI subnetwork	0.43	> 0.20	CARM1 (4.2)	ATXN2 (4.0)	SMARCA4 (3.4)	DNM2 (2.9)	ATP13A1 (2.6)	ATXN7L2 (2.6)	PPP1R37 (2.6)	TOP1 (2.4)	ILF3 (2.4)	MARK4 (2.3)
ENSG00000147669	POLR2K PPI subnetwork	0.43	> 0.20	BUD13 (3.5)	ILF3 (3.3)	DHX38 (3.2)	SUGP1 (2.9)	TOP1 (2.6)	C1orf63 (2.3)	MAPKAPK5 (2.3)	SMARCA4 (2.3)	DDX56 (2.2)	USP1 (2.1)
ENSG00000166855	CLPX PPI subnetwork	0.43	> 0.20	GMPR (3.0)	SARS (2.8)	C19orf52 (2.2)	TXNL4B (2.2)	QTRT1 (2.0)	DDX56 (1.8)	ZNF259 (1.6)	HAVCR1 (1.5)	DHODH (1.5)	CEACAM19 (1.4)
GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	0.43	> 0.20	TRAPPC6A (2.5)	GEMIN7 (2.4)	POLK (2.3)	TRAFD1 (2.3)	ENSG00000226648 (2.0)	BLOC1S3 (2.0)	GOT2P1 (2.0)	CYB561D1 (1.8)	BRAP (1.7)	ST3GAL4 (1.6)
GO:0030291	protein serine/threonine kinase inhibitor activity	0.43	> 0.20	KANK2 (2.3)	ENSG00000254235 (2.1)	TRAFD1 (1.9)	AP1M2 (1.9)	TMED4 (1.8)	GMPR (1.7)	MYLIP (1.6)	ITGB3 (1.5)	SORT1 (1.5)	SLC44A2 (1.4)
GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	0.43	> 0.20	NYNRIN (3.2)	BUD13 (2.3)	DHODH (2.3)	SH2B3 (2.0)	PSRC1 (1.7)	KANK2 (1.5)	ABO (1.5)	ANKRD31 (1.3)	PLEKHH2 (1.1)	BLOC1S3 (1.1)
MP:0008699	increased interleukin-4 secretion	0.43	> 0.20	OASL (2.9)	C11orf9 (2.3)	RELB (2.1)	TRIB1 (2.1)	ZNF101 (2.0)	GCNT4 (2.0)	HAVCR1 (1.9)	BCL3 (1.9)	COL4A3BP (1.8)	GMIP (1.8)
MP:0000754	paresis	0.43	> 0.20	TMEM116 (2.1)	APOC4 (2.0)	TMED4 (1.9)	CELSR2 (1.9)	MAFB (1.9)	OGDH (1.9)	ALDH2 (1.8)	GCNT4 (1.8)	ENSG00000235545 (1.5)	LPA (1.3)
ENSG00000142856	ITGB3BP PPI subnetwork	0.43	> 0.20	PSRC1 (5.2)	FEN1 (4.5)	USP1 (3.8)	POC5 (3.6)	ACAD10 (1.2)	AMIGO1 (1.0)	ZNF180 (0.9)	SORT1 (0.8)	TXNL4B (0.8)	BUD13 (0.8)
GO:0002711	positive regulation of T cell mediated immunity	0.43	> 0.20	ZNF180 (2.6)	PARP10 (1.9)	ENSG00000226645 (1.7)	PBX4 (1.6)	NKPD1 (1.6)	NAA25 (1.5)	MAU2 (1.4)	HNF1A (1.2)	LPIN3 (1.2)	GEMIN7 (1.1)
GO:0033598	mammary gland epithelial cell proliferation	0.43	> 0.20	ENSG00000254235 (2.1)	DNAH11 (2.1)	C17orf57 (2.0)	ENSG00000226645 (2.0)	NKPD1 (1.7)	PPP1R37 (1.7)	BLOC1S3 (1.5)	HLX (1.5)	ST3GAL4 (1.3)	SH2B3 (1.3)
GO:0001891	phagocytic cup	0.43	> 0.20	CETP (3.0)	ENSG00000228044 (2.2)	SH2B3 (2.2)	TIMD4 (1.9)	TSSK6 (1.8)	HAVCR1 (1.8)	ENSG00000254235 (1.7)	RELB (1.6)	GMIP (1.6)	PLCG1 (1.6)
ENSG00000130427	EPO PPI subnetwork	0.43	> 0.20	BCL3 (3.6)	HLX (2.9)	RELB (2.7)	TIMD4 (2.5)	CETP (2.2)	GMIP (2.1)	ALDH2 (1.9)	LPA (1.7)	SH2B3 (1.3)	ANKRD31 (1.2)
MP:0006387	abnormal T cell number	0.43	> 0.20	RELB (5.8)	BCL3 (4.8)	PARP10 (4.1)	GMIP (3.3)	GRINA (2.6)	APOC1 (2.6)	C12orf47 (2.0)	MAFB (2.0)	LPAR2 (1.7)	FRK (1.7)
ENSG00000107290	SETX PPI subnetwork	0.43	> 0.20	BRAP (3.4)	LPIN3 (2.7)	C1orf63 (2.5)	NYNRIN (2.5)	POLK (2.2)	ZNF101 (2.1)	NPC1L1 (1.8)	FRK (1.8)	ATXN7L2 (1.8)	TRAFD1 (1.6)
ENSG00000165934	CPSF2 PPI subnetwork	0.43	> 0.20	ILF3 (3.8)	DHX38 (3.6)	SMARCA4 (3.0)	TOP1 (3.0)	BUD13 (2.9)	C1orf63 (2.7)	SUGP1 (2.5)	USP1 (2.4)	GATAD2A (2.3)	TOMM40 (2.3)
ENSG00000078579	FGF20 PPI subnetwork	0.43	> 0.20	HAVCR1 (2.7)	HAPLN4 (2.6)	PLEKHH2 (2.3)	TOMM40 (2.0)	CBLC (1.9)	SARS (1.9)	DOCK7 (1.8)	AP1M2 (1.5)	HNF1A (1.4)	ZHX3 (1.4)
GO:0005416	cation:amino acid symporter activity	0.43	> 0.20	NCAN (4.7)	ABCG8 (3.2)	HAPLN4 (2.7)	CYP7A1 (2.6)	APOC4 (2.3)	RPH3A (2.0)	C12orf51 (2.0)	APOA5 (1.9)	ABCG5 (1.9)	GEMIN7 (1.8)
ENSG00000197386	HTT PPI subnetwork	0.43	> 0.20	PPP1R37 (3.7)	SMARCA4 (2.9)	CARM1 (2.6)	C12orf51 (2.3)	PLCG1 (2.3)	ATXN2 (2.1)	SARS (2.0)	MARK4 (1.9)	FADS1 (1.5)	ATXN7L2 (1.4)
ENSG00000156261	CCT8 PPI subnetwork	0.43	> 0.20	SARS (3.4)	NAA25 (3.2)	PSMA5 (3.1)	DDX56 (3.0)	SMARCA4 (2.2)	ZNF259 (1.9)	TOMM40 (1.9)	TOP1 (1.8)	OGDH (1.8)	PTPN11 (1.8)
GO:0042095	interferon-gamma biosynthetic process	0.43	> 0.20	DNAH11 (2.9)	GCNT4 (2.7)	ST3GAL4 (2.5)	ENSG00000226645 (2.2)	CYB561D1 (1.9)	ZNF180 (1.8)	TMED4 (1.4)	BLOC1S3 (1.3)	DYNC2LI1 (1.3)	PVR (1.3)
MP:0000841	abnormal hindbrain morphology	0.43	> 0.20	PLCG1 (2.3)	CARM1 (2.0)	ADAM1 (2.0)	PVRL2 (1.9)	ZHX3 (1.9)	OGDH (1.7)	ATXN2 (1.6)	PCSK9 (1.5)	PTPN11 (1.4)	MARK4 (1.3)
MP:0004992	increased bone resorption	0.43	> 0.20	PARP10 (2.9)	OASL (2.7)	BCL3 (2.7)	ZHX3 (2.4)	TRIB1 (2.1)	ENSG00000228044 (2.0)	ENSG00000254235 (1.8)	HNF1A (1.8)	ST3GAL4 (1.8)	LPA (1.4)
GO:0002026	regulation of the force of heart contraction	0.43	> 0.20	ENSG00000226648 (2.7)	ACAD10 (2.6)	PPP1R37 (2.2)	TXNL4B (2.1)	ENSG00000235545 (2.0)	ST3GAL4 (1.7)	TMEM116 (1.7)	HAPLN4 (1.7)	C12orf47 (1.5)	ERP29 (1.5)
GO:0019887	protein kinase regulator activity	0.43	> 0.20	ITGB3 (2.4)	NCAN (2.3)	MYLIP (1.9)	TRAFD1 (1.9)	TRIB1 (1.7)	DYNC2LI1 (1.6)	TSSK6 (1.6)	APOB (1.4)	ST3GAL4 (1.4)	SORT1 (1.4)
ENSG00000173546	CSPG4 PPI subnetwork	0.43	> 0.20	TIMD4 (3.9)	APOE (3.6)	CETP (3.6)	MAFB (2.7)	APOC1 (2.6)	USP24 (2.6)	CEACAM19 (1.6)	ENSG00000238078 (1.5)	NCAN (1.5)	PVRL2 (1.5)
MP:0009133	decreased white fat cell size	0.43	> 0.20	MOSC1 (4.0)	GPAM (3.6)	HP (2.6)	ZNF101 (2.2)	APOA5 (2.0)	SYPL2 (1.9)	SORT1 (1.9)	MAU2 (1.9)	AMIGO1 (1.8)	POLK (1.7)
ENSG00000113558	SKP1 PPI subnetwork	0.43	> 0.20	MYLIP (2.1)	FEN1 (1.8)	PSMA5 (1.8)	PTPN11 (1.8)	PSRC1 (1.7)	ZNF180 (1.6)	SARS (1.6)	GATAD2A (1.5)	DOCK7 (1.5)	TRIB1 (1.4)
ENSG00000099995	SF3A1 PPI subnetwork	0.43	> 0.20	ILF3 (4.0)	DHX38 (3.6)	SUGP1 (3.3)	C1orf63 (3.2)	BUD13 (3.1)	SMARCA4 (3.0)	MAU2 (2.8)	TOP1 (2.7)	PTPN11 (2.4)	USP1 (2.2)
ENSG00000188419	CHM PPI subnetwork	0.43	> 0.20	CEACAM19 (2.9)	AP1M2 (2.5)	ENSG00000238078 (2.2)	COL4A3BP (1.9)	C19orf52 (1.9)	YIPF2 (1.8)	ATXN2 (1.6)	GOT2P1 (1.5)	AMIGO1 (1.5)	CILP2 (1.5)
GO:0017053	transcriptional repressor complex	0.43	> 0.20	CARM1 (3.9)	SMARCA4 (2.3)	SH2B3 (2.2)	PLCG1 (2.1)	ENSG00000238078 (1.9)	USP1 (1.9)	ENSG00000226645 (1.9)	MYLIP (1.8)	HNF1A (1.7)	PPP1R37 (1.7)
MP:0006108	abnormal hindbrain development	0.43	> 0.20	PLCG1 (3.0)	GATAD2A (2.7)	TRIB1 (2.4)	PPP1R37 (1.9)	MARK4 (1.8)	GEMIN7 (1.7)	ZHX3 (1.7)	DNAH11 (1.7)	DYNC2LI1 (1.7)	CILP2 (1.5)
GO:0016578	histone deubiquitination	0.43	> 0.20	ATXN7L2 (4.3)	ZNF180 (3.2)	UBXN2B (2.6)	TMEM57 (2.1)	MAPKAPK5 (1.8)	C17orf57 (1.8)	GEMIN7 (1.7)	ATP13A1 (1.6)	ENSG00000226648 (1.6)	LPIN3 (1.6)
ENSG00000104312	RIPK2 PPI subnetwork	0.43	> 0.20	C1orf63 (2.7)	PARP10 (2.3)	RELB (2.2)	HAVCR1 (2.0)	FRK (1.9)	GRINA (1.9)	ENSG00000238078 (1.7)	PBX4 (1.6)	NT5DC1 (1.4)	ZNF101 (1.4)
GO:0006004	fucose metabolic process	0.43	> 0.20	FRK (3.9)	CYB561D1 (2.8)	CBLC (2.5)	LPIN3 (2.3)	ERP29 (1.8)	NT5DC1 (1.7)	TMEM57 (1.7)	YIPF2 (1.6)	ZNF180 (1.6)	TMEM50A (1.6)
ENSG00000154889	MPPE1 PPI subnetwork	0.43	> 0.20	MAFB (3.0)	CYB561D1 (2.2)	C11orf9 (2.1)	GCNT4 (1.9)	ENSG00000228044 (1.7)	RHCE (1.7)	ANKRD31 (1.6)	TRAFD1 (1.6)	NPC1L1 (1.5)	BLOC1S3 (1.5)
ENSG00000156313	RPGR PPI subnetwork	0.43	> 0.20	DYNC2LI1 (2.8)	MARK4 (2.4)	SARS (2.3)	DNM2 (1.8)	DOCK7 (1.8)	SMARCA4 (1.8)	CLPTM1 (1.8)	ANKRD31 (1.7)	TOP1 (1.6)	TMEM57 (1.2)
GO:0048520	positive regulation of behavior	0.43	> 0.20	ZNF101 (2.7)	ENSG00000228044 (2.4)	TMEM116 (2.0)	CETP (2.0)	TIMD4 (1.8)	PLEKHH2 (1.7)	APOE (1.5)	PVR (1.5)	KIAA1324 (1.5)	RELB (1.3)
GO:0006521	regulation of cellular amino acid metabolic process	0.43	> 0.20	PSMA5 (4.2)	NT5DC1 (2.6)	TRAFD1 (2.4)	NAA25 (2.3)	C17orf57 (1.6)	TXNL4B (1.6)	SUGP1 (1.5)	ZNF180 (1.5)	CYB561D1 (1.5)	ENSG00000254235 (1.5)
REACTOME_TELOMERE_C:STRAND_LAGGING_STRAND_SYNTHESIS	REACTOME_TELOMERE_C:STRAND_LAGGING_STRAND_SYNTHESIS	0.43	> 0.20	FEN1 (6.2)	USP1 (5.7)	ZNF180 (2.6)	ENSG00000235545 (1.8)	ENSG00000228044 (1.7)	AMIGO1 (1.6)	ERP29 (1.5)	FADS1 (1.5)	GOT2P1 (1.4)	NT5DC1 (1.3)
ENSG00000088035	ALG6 PPI subnetwork	0.43	> 0.20	ACAD10 (3.4)	ERP29 (2.4)	YIPF2 (2.3)	CLPTM1 (2.3)	MAU2 (2.2)	TMEM50A (2.1)	ENSG00000235545 (2.0)	KIAA1324 (2.0)	QTRT1 (2.0)	TSSK6 (1.9)
ENSG00000142168	SOD1 PPI subnetwork	0.43	> 0.20	KIAA1324 (4.2)	AP1M2 (2.6)	C19orf52 (2.3)	ENSG00000235545 (2.2)	TXNL4B (2.0)	C1orf63 (1.9)	MYLIP (1.9)	HAPLN4 (1.6)	RPH3A (1.5)	CYP7A1 (1.4)
REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION	0.43	> 0.20	C12orf43 (3.5)	DHX38 (3.0)	TXNL4B (2.9)	ZNF259 (2.8)	DYNC2LI1 (2.6)	MAPKAPK5 (2.3)	NAA25 (2.1)	DDX56 (2.0)	ZNF180 (1.9)	POLK (1.7)
MP:0003564	abnormal insulin secretion	0.43	> 0.20	KIAA1324 (3.5)	MOSC1 (3.3)	HAPLN4 (2.8)	GPAM (2.4)	HNF1A (2.2)	NPC1L1 (2.2)	CYP7A1 (1.7)	PLEKHH2 (1.6)	COL4A3BP (1.5)	TM6SF2 (1.5)
GO:0046887	positive regulation of hormone secretion	0.43	> 0.20	KIAA1324 (3.1)	LPIN3 (2.4)	ABO (2.4)	GCNT4 (2.4)	ENSG00000254235 (2.4)	NPC1L1 (2.3)	ANKRD31 (2.1)	GPAM (1.8)	COL4A3BP (1.7)	HNF1A (1.6)
ENSG00000111786	SRSF9 PPI subnetwork	0.43	> 0.20	C1orf63 (4.1)	ILF3 (3.9)	TOP1 (3.0)	DHX38 (2.9)	SMARCA4 (2.6)	USP1 (2.6)	SUGP1 (2.4)	FEN1 (2.2)	QTRT1 (2.2)	BUD13 (2.2)
GO:0003684	damaged DNA binding	0.43	> 0.20	FEN1 (3.3)	ZNF180 (2.7)	SUGP1 (2.6)	BUD13 (2.4)	DYNC2LI1 (2.2)	TRAPPC6A (2.0)	USP1 (2.0)	POC5 (1.7)	ILF3 (1.7)	PSRC1 (1.5)
GO:0001659	temperature homeostasis	0.43	> 0.20	ENSG00000235545 (2.9)	POLK (2.0)	AMIGO1 (1.9)	BLOC1S3 (1.8)	ENSG00000228044 (1.6)	RPH3A (1.6)	ZNF180 (1.5)	CETP (1.4)	ST3GAL4 (1.4)	ACAD10 (1.3)
MP:0002332	abnormal exercise endurance	0.43	> 0.20	SYPL2 (6.7)	GMPR (3.0)	TRIB1 (2.8)	HLX (2.3)	OGDH (2.2)	ATXN7L2 (1.6)	SH2B3 (1.4)	NPC1L1 (1.4)	PVR (1.3)	POC5 (1.2)
ENSG00000080503	SMARCA2 PPI subnetwork	0.43	> 0.20	SMARCA4 (2.9)	TOP1 (2.6)	BUD13 (2.5)	TRIB1 (2.4)	USP1 (2.4)	TMEM57 (2.3)	CARM1 (2.2)	ATXN2 (2.1)	GATAD2A (1.9)	FEN1 (1.7)
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	0.43	> 0.20	PVRL2 (3.5)	BCAM (3.1)	SLC44A2 (2.9)	PLEC (2.7)	KANK2 (2.2)	PVR (2.0)	C11orf9 (1.9)	GEMIN7 (1.9)	PPP1R37 (1.9)	CBLC (1.8)
ENSG00000155363	MOV10 PPI subnetwork	0.43	> 0.20	ILF3 (3.8)	CARM1 (3.5)	BRAP (3.0)	DDX56 (2.7)	ATP13A1 (2.7)	SUGP1 (2.2)	SMARCA4 (2.2)	C19orf52 (2.1)	MAPKAPK5 (2.0)	TOMM40 (2.0)
ENSG00000171208	NETO2 PPI subnetwork	0.43	> 0.20	POLK (2.4)	C12orf43 (2.3)	CARM1 (1.9)	PPP1R37 (1.6)	C1orf63 (1.5)	NKPD1 (1.5)	COL4A3BP (1.5)	DNAH11 (1.4)	GCNT4 (1.3)	APOC1 (1.3)
GO:0030130	clathrin coat of trans-Golgi network vesicle	0.43	> 0.20	COL4A3BP (2.9)	POLK (2.5)	GRINA (2.5)	AMIGO1 (2.3)	GEMIN7 (2.1)	KIAA1324 (1.9)	ERP29 (1.9)	ZNF101 (1.8)	CLPTM1 (1.7)	TMEM57 (1.7)
GO:0048617	embryonic foregut morphogenesis	0.43	> 0.20	LPAR2 (4.2)	ABO (2.8)	ENSG00000226648 (2.7)	LPIN3 (2.3)	TMEM116 (2.1)	C11orf9 (2.0)	UBXN2B (1.9)	HNF1A (1.9)	PVRL2 (1.8)	BCAM (1.6)
GO:0004180	carboxypeptidase activity	0.43	> 0.20	ERP29 (3.7)	NPC1L1 (2.8)	TMED4 (2.3)	APOB (2.1)	FRK (2.0)	NKPD1 (2.0)	TM6SF2 (2.0)	ALDH2 (1.9)	PMFBP1 (1.9)	HAPLN4 (1.8)
ENSG00000137992	DBT PPI subnetwork	0.43	> 0.20	FRK (2.9)	PARP10 (2.4)	ZNF180 (2.2)	PTPN11 (2.2)	ABO (1.8)	UBXN2B (1.7)	TOMM40 (1.7)	ENSG00000254235 (1.7)	TRAPPC6A (1.4)	DOCK7 (1.4)
ENSG00000145220	LYAR PPI subnetwork	0.43	> 0.20	ZNF259 (3.6)	QTRT1 (3.4)	TOMM40 (3.3)	NAA25 (3.0)	PTPN11 (3.0)	DDX56 (2.8)	ILF3 (2.7)	TOP1 (2.7)	SMARCA4 (2.5)	SUGP1 (2.4)
GO:0043492	ATPase activity, coupled to movement of substances	0.43	> 0.20	CLPTM1 (3.4)	ATP13A1 (3.3)	GRINA (2.8)	TMEM116 (2.7)	SORT1 (2.5)	C12orf51 (2.1)	COL4A3BP (2.1)	HAPLN4 (2.1)	GMPR (2.1)	USP24 (2.0)
MP:0000067	osteopetrosis	0.43	> 0.20	GMIP (3.7)	APOE (3.5)	ITGB3 (3.0)	APOC1 (2.9)	SORT1 (2.5)	MAFB (2.4)	SH2B3 (2.2)	DNM2 (1.7)	PARP10 (1.7)	TOMM40 (1.7)
MP:0006413	increased T cell apoptosis	0.43	> 0.20	ZNF101 (2.9)	PLCG1 (2.8)	APOC4 (2.7)	PBX4 (2.3)	TIMD4 (2.3)	LPA (2.1)	MAFB (2.0)	SLC44A2 (1.8)	ABCG8 (1.6)	SLC22A1 (1.6)
GO:0070830	tight junction assembly	0.43	> 0.20	FRK (4.2)	AP1M2 (2.9)	GCNT4 (2.6)	ENSG00000254235 (2.6)	TMEM116 (2.4)	LPAR2 (2.3)	TSSK6 (2.0)	YIPF2 (1.9)	C17orf57 (1.7)	PTPN11 (1.7)
ENSG00000152256	PDK1 PPI subnetwork	0.43	> 0.20	GPAM (3.7)	OGDH (3.5)	CLPTM1 (2.6)	DOCK7 (2.2)	KANK2 (2.0)	USP24 (1.8)	FADS1 (1.7)	MARK4 (1.5)	BCL3 (1.1)	MOSC1 (1.1)
ENSG00000004864	SLC25A13 PPI subnetwork	0.43	> 0.20	PSMA5 (3.8)	TOMM40 (3.2)	ATP13A1 (3.1)	ATXN2 (2.8)	NYNRIN (2.6)	BRAP (2.1)	NAA25 (1.9)	DDX56 (1.9)	AMIGO1 (1.9)	QTRT1 (1.9)
ENSG00000154429	C1orf96 PPI subnetwork	0.44	> 0.20	NCAN (2.8)	TMEM57 (2.5)	MYLIP (2.2)	ADAM1 (2.1)	APOC1 (1.8)	RPH3A (1.8)	SUGP1 (1.8)	ENSG00000238078 (1.6)	TRAFD1 (1.6)	C1orf63 (1.6)
MP:0000121	failure of tooth eruption	0.44	> 0.20	FRK (3.3)	GMIP (2.8)	GRINA (2.7)	HLX (2.6)	MAFB (2.1)	CLPTM1 (2.1)	TRIB1 (2.1)	DNM2 (1.9)	APOE (1.8)	TIMD4 (1.7)
MP:0000848	abnormal pons morphology	0.44	> 0.20	PBX4 (1.9)	PMFBP1 (1.9)	APOC1 (1.9)	HMGCR (1.8)	ITGB3 (1.8)	DHODH (1.8)	OGDH (1.8)	COL4A3BP (1.8)	FADS1 (1.5)	MAPKAPK5 (1.5)
REACTOME_EXTENSION_OF_TELOMERES	REACTOME_EXTENSION_OF_TELOMERES	0.44	> 0.20	FEN1 (5.8)	USP1 (5.4)	ZNF180 (2.5)	TOMM40 (1.7)	DHODH (1.7)	AMIGO1 (1.6)	ENSG00000235545 (1.4)	ENSG00000228044 (1.4)	GOT2P1 (1.3)	ERP29 (1.3)
GO:0031231	intrinsic to peroxisomal membrane	0.44	> 0.20	NT5DC1 (3.0)	YIPF2 (2.8)	BLOC1S3 (2.7)	GPAM (2.6)	GRINA (1.9)	TRAPPC6A (1.8)	AMIGO1 (1.8)	LPAR2 (1.7)	C19orf52 (1.5)	ACAD10 (1.5)
GO:0005779	integral to peroxisomal membrane	0.44	> 0.20	NT5DC1 (3.0)	YIPF2 (2.8)	BLOC1S3 (2.7)	GPAM (2.6)	GRINA (1.9)	TRAPPC6A (1.8)	AMIGO1 (1.8)	LPAR2 (1.7)	C19orf52 (1.5)	ACAD10 (1.5)
ENSG00000215104	ENSG00000215104 PPI subnetwork	0.44	> 0.20	TRAPPC6A (3.4)	TXNL4B (3.0)	C1orf63 (2.9)	KIAA1324 (2.7)	TMEM50A (1.9)	CYB561D1 (1.8)	CBLC (1.7)	ZNF180 (1.7)	C12orf43 (1.6)	DHX38 (1.6)
ENSG00000174953	DHX36 PPI subnetwork	0.44	> 0.20	QTRT1 (2.5)	DDX56 (2.5)	TXNL4B (2.1)	SUGP1 (2.1)	CARM1 (1.8)	ENSG00000226645 (1.8)	SLC22A1 (1.7)	TRAPPC6A (1.7)	C12orf43 (1.6)	C19orf52 (1.5)
MP:0002127	abnormal cardiovascular system morphology	0.44	> 0.20	HLX (2.3)	NYNRIN (2.2)	PVRL2 (1.9)	BCAM (1.9)	SYPL2 (1.7)	HNF1A (1.5)	COL4A3BP (1.4)	TM6SF2 (1.3)	KANK2 (1.2)	DYNC2LI1 (1.2)
GO:0048661	positive regulation of smooth muscle cell proliferation	0.44	> 0.20	PVR (2.8)	ZNF101 (2.2)	MAFB (2.2)	TRIB1 (2.0)	ENSG00000228044 (1.9)	HLX (1.5)	C19orf52 (1.4)	TSSK6 (1.3)	ADAM1 (1.3)	PLEKHH2 (1.1)
GO:0007266	Rho protein signal transduction	0.44	> 0.20	ENSG00000235545 (3.3)	CBLC (3.1)	AP1M2 (2.4)	PVRL2 (2.3)	LPIN3 (2.3)	LPAR2 (2.1)	PLCG1 (2.1)	GATAD2A (2.0)	SLC44A2 (1.9)	PBX4 (1.7)
MP:0010769	abnormal survival	0.44	> 0.20	ZNF180 (2.6)	TRAPPC6A (2.5)	ENSG00000254235 (1.7)	DYNC2LI1 (1.6)	MYLIP (1.5)	NYNRIN (1.5)	C11orf9 (1.3)	NT5DC1 (1.3)	NKPD1 (1.3)	C1orf63 (1.3)
GO:0051324	prophase	0.44	> 0.20	ANKRD31 (4.3)	C17orf57 (2.3)	TSSK6 (1.9)	ENSG00000238078 (1.7)	NKPD1 (1.7)	ENSG00000228044 (1.5)	LPIN3 (1.4)	GOT2P1 (1.3)	AP1M2 (1.3)	TMEM116 (1.3)
GO:0015833	peptide transport	0.44	> 0.20	KIAA1324 (4.7)	HNF1A (2.7)	ANKRD31 (2.5)	ENSG00000228044 (2.2)	COL4A3BP (2.0)	HAPLN4 (2.0)	ABO (1.8)	ENSG00000254235 (1.8)	PLEKHH2 (1.8)	NPC1L1 (1.8)
GO:0010761	fibroblast migration	0.44	> 0.20	TMEM116 (3.2)	GCNT4 (2.9)	ENSG00000226648 (2.6)	KANK2 (2.4)	PMFBP1 (2.1)	CYB561D1 (2.0)	DOCK7 (1.8)	AMIGO1 (1.7)	ZNF101 (1.6)	NKPD1 (1.5)
ENSG00000163931	TKT PPI subnetwork	0.44	> 0.20	OASL (2.9)	QTRT1 (2.4)	CEACAM19 (2.2)	COL4A3BP (2.1)	ANGPTL3 (2.1)	PARP10 (1.9)	MAU2 (1.9)	TXNL4B (1.9)	GPAM (1.8)	TMEM50A (1.7)
MP:0004139	abnormal gastric parietal cell morphology	0.44	> 0.20	C11orf9 (2.6)	OASL (2.4)	ABO (2.2)	GCNT4 (2.0)	KIAA1324 (1.9)	HNF1A (1.8)	TMED4 (1.6)	KANK2 (1.5)	SLC44A2 (1.5)	DOCK7 (1.5)
ENSG00000178252	WDR6 PPI subnetwork	0.44	> 0.20	CELSR2 (3.9)	PSRC1 (2.9)	TOP1 (2.8)	PLCG1 (2.5)	CARM1 (2.2)	FADS1 (2.2)	BCAM (2.1)	AP1M2 (1.9)	GRINA (1.9)	POLK (1.8)
ENSG00000004897	CDC27 PPI subnetwork	0.44	> 0.20	PSRC1 (5.4)	POC5 (3.6)	FEN1 (3.3)	USP1 (2.5)	SUGP1 (1.5)	LPIN3 (1.4)	BRAP (1.4)	ILF3 (1.3)	C1orf63 (1.3)	GEMIN7 (1.3)
ENSG00000168148	HIST3H3 PPI subnetwork	0.44	> 0.20	USP1 (3.8)	FEN1 (3.2)	TXNL4B (2.1)	BUD13 (1.8)	TOP1 (1.8)	UBXN2B (1.7)	DHX38 (1.7)	MAU2 (1.7)	C19orf52 (1.6)	NT5DC1 (1.5)
ENSG00000163599	CTLA4 PPI subnetwork	0.44	> 0.20	PBX4 (3.3)	TRAFD1 (2.6)	COL4A3BP (2.4)	GRINA (2.1)	ZNF101 (2.0)	GPAM (1.9)	TIMD4 (1.9)	MOSC1 (1.8)	PLCG1 (1.8)	SLC44A2 (1.6)
GO:0045821	positive regulation of glycolysis	0.44	> 0.20	PMFBP1 (3.3)	HNF1A (3.0)	ENSG00000254235 (2.3)	TSSK6 (1.8)	GPAM (1.7)	CYP7A1 (1.6)	ENSG00000228044 (1.6)	FRK (1.6)	PCSK9 (1.3)	HAPLN4 (1.3)
GO:0006360	transcription from RNA polymerase I promoter	0.44	> 0.20	C12orf43 (2.9)	TXNL4B (2.6)	ANKRD31 (2.0)	ZNF259 (1.9)	GEMIN7 (1.9)	DYNC2LI1 (1.9)	MAPKAPK5 (1.7)	POLK (1.6)	DHX38 (1.5)	NAA25 (1.5)
MP:0002260	abnormal thyroid cartilage morphology	0.44	> 0.20	CILP2 (2.4)	CEACAM19 (1.6)	ENSG00000238078 (1.6)	MYLIP (1.6)	FRK (1.6)	KIAA1324 (1.5)	PLCG1 (1.4)	DYNC2LI1 (1.4)	HLX (1.4)	SORT1 (1.3)
GO:0002347	response to tumor cell	0.44	> 0.20	DNAH11 (4.0)	ADAM1 (2.5)	ZNF180 (2.1)	ZNF101 (1.9)	LPIN3 (1.9)	CYB561D1 (1.8)	BLOC1S3 (1.8)	CEACAM19 (1.6)	GEMIN7 (1.5)	HAVCR1 (1.3)
GO:0030826	regulation of cGMP biosynthetic process	0.44	> 0.20	ANKRD31 (3.4)	C12orf47 (2.6)	TSSK6 (2.3)	ENSG00000228044 (2.3)	PMFBP1 (2.1)	MYLIP (1.9)	ZNF180 (1.8)	HAVCR1 (1.6)	ST3GAL4 (1.5)	NKPD1 (1.4)
REACTOME_ACTIVATION_OF_THE_PRE:REPLICATIVE_COMPLEX	REACTOME_ACTIVATION_OF_THE_PRE:REPLICATIVE_COMPLEX	0.44	> 0.20	FEN1 (6.7)	USP1 (5.1)	NT5DC1 (1.9)	ENSG00000228044 (1.9)	TMEM116 (1.7)	DHODH (1.7)	ENSG00000235545 (1.6)	AMIGO1 (1.4)	ZNF180 (1.3)	FADS1 (1.0)
GO:0048871	multicellular organismal homeostasis	0.44	> 0.20	ENSG00000235545 (2.2)	DNAH11 (2.2)	POLK (2.0)	CILP2 (1.8)	SLC44A2 (1.8)	KIAA1324 (1.7)	TMEM116 (1.5)	TSSK6 (1.2)	MAFB (1.1)	RHCE (1.1)
MP:0000279	ventricular hypoplasia	0.44	> 0.20	C12orf51 (2.8)	RHD (2.0)	NYNRIN (1.9)	ACAD10 (1.8)	SMARCA4 (1.8)	LPA (1.8)	SYPL2 (1.6)	ENSG00000235545 (1.6)	COL4A3BP (1.5)	ENSG00000226648 (1.5)
ENSG00000099940	SNAP29 PPI subnetwork	0.44	> 0.20	TRAPPC6A (2.6)	ENSG00000226645 (2.5)	TMEM57 (2.3)	SLC44A2 (2.3)	C1orf63 (2.1)	DNM2 (2.0)	TMEM50A (2.0)	CLPTM1 (1.7)	PVRL2 (1.6)	UBXN2B (1.6)
ENSG00000067334	DNTTIP2 PPI subnetwork	0.44	> 0.20	C19orf52 (2.6)	ZNF259 (1.7)	BUD13 (1.7)	HNF1A (1.6)	CBLC (1.6)	GPAM (1.6)	ENSG00000226648 (1.6)	NAA25 (1.5)	NKPD1 (1.5)	TIMD4 (1.4)
MP:0008049	increased memory T cell number	0.44	> 0.20	PARP10 (3.3)	BCL3 (3.2)	GMIP (3.0)	ZNF101 (2.9)	RELB (2.7)	OASL (2.6)	TRIB1 (2.3)	TRAFD1 (2.0)	UBXN2B (1.4)	POLK (1.3)
ENSG00000189319	FAM53B PPI subnetwork	0.44	> 0.20	CBLC (5.5)	AP1M2 (4.1)	CELSR2 (2.5)	LPAR2 (2.0)	ST3GAL4 (1.9)	LPIN3 (1.8)	DOCK7 (1.7)	FRK (1.6)	PLEC (1.6)	PVRL2 (1.6)
REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	0.44	> 0.20	TRIB1 (4.4)	SH2B3 (3.0)	HLX (2.5)	MARK4 (2.3)	PVR (2.1)	COL4A3BP (1.6)	MAPKAPK5 (1.6)	CLPTM1 (1.4)	TOMM40 (1.4)	MAFB (1.4)
ENSG00000166411	IDH3A PPI subnetwork	0.44	> 0.20	TOMM40 (3.5)	NAA25 (3.2)	PSMA5 (3.1)	SARS (3.0)	CLPTM1 (2.5)	DDX56 (2.3)	DHX38 (2.2)	OGDH (2.1)	SUGP1 (2.1)	NT5DC1 (2.0)
MP:0005306	abnormal phalanx morphology	0.44	> 0.20	NYNRIN (4.5)	FADS1 (1.9)	MAFB (1.7)	PCSK9 (1.5)	MARK4 (1.5)	LDLR (1.5)	CILP2 (1.4)	CBLC (1.4)	DYNC2LI1 (1.4)	GOT2P1 (1.4)
GO:0048487	beta-tubulin binding	0.44	> 0.20	RHCE (2.6)	C12orf51 (2.2)	GMPR (2.1)	PPP1R37 (2.0)	GATAD2A (2.0)	ILF3 (1.9)	COL4A3BP (1.8)	RHD (1.7)	MAU2 (1.7)	SLC22A1 (1.7)
ENSG00000133026	MYH10 PPI subnetwork	0.44	> 0.20	PLEC (3.3)	TMEM50A (3.1)	PVR (2.7)	KANK2 (2.6)	ITGB3 (2.3)	HAVCR1 (2.1)	DNM2 (2.0)	SLC44A2 (1.8)	GMIP (1.8)	GATAD2A (1.8)
GO:0051412	response to corticosterone stimulus	0.44	> 0.20	DNAH11 (2.9)	TSSK6 (2.2)	GMPR (2.1)	ZHX3 (1.8)	POLK (1.8)	PMFBP1 (1.7)	GOT2P1 (1.7)	LPA (1.6)	ENSG00000254235 (1.4)	ABCG5 (1.3)
MP:0005455	increased susceptibility to weight gain	0.44	> 0.20	APOC1 (3.1)	C12orf47 (3.1)	ATP13A1 (2.2)	ST3GAL4 (1.9)	HMGCR (1.9)	PCSK9 (1.8)	MAPKAPK5 (1.8)	ENSG00000228044 (1.7)	GMPR (1.5)	GPAM (1.3)
ENSG00000116918	TSNAX PPI subnetwork	0.44	> 0.20	MAPKAPK5 (2.9)	RHCE (2.6)	C12orf51 (2.6)	POC5 (2.4)	RHD (2.2)	ENSG00000226645 (2.2)	SYPL2 (2.0)	SUGP1 (1.9)	SMARCA4 (1.8)	ZNF101 (1.5)
ENSG00000136279	DBNL PPI subnetwork	0.44	> 0.20	PARP10 (3.0)	UBXN2B (2.6)	TRAFD1 (2.4)	LPIN3 (2.4)	DNM2 (2.0)	LPAR2 (1.8)	GMIP (1.8)	FRK (1.8)	OASL (1.7)	CYP7A1 (1.7)
MP:0001916	intracerebral hemorrhage	0.44	> 0.20	OASL (5.8)	FRK (3.3)	PARP10 (2.9)	NCAN (2.6)	PVRL2 (2.4)	TMED4 (2.4)	ENSG00000235545 (1.7)	POC5 (1.7)	GMIP (1.6)	GOT2P1 (1.5)
MP:0008531	increased chemical nociceptive threshold	0.44	> 0.20	BCAM (3.4)	GMPR (2.4)	ENSG00000226648 (2.3)	PBX4 (2.1)	AMIGO1 (2.0)	TMEM116 (2.0)	HLX (1.8)	ITGB3 (1.7)	ENSG00000226645 (1.7)	TRIB1 (1.6)
MP:0002836	abnormal chorion morphology	0.44	> 0.20	PVRL2 (2.5)	ATXN2 (2.0)	ABO (1.9)	TSSK6 (1.8)	BCAM (1.7)	HLX (1.6)	CLPTM1 (1.6)	PPP1R37 (1.6)	LDLR (1.6)	TRIB1 (1.5)
ENSG00000134453	RBM17 PPI subnetwork	0.44	> 0.20	CARM1 (2.8)	ABO (2.6)	SMARCA4 (2.3)	ILF3 (2.2)	ZNF259 (2.1)	C12orf47 (2.1)	ATP13A1 (2.0)	SUGP1 (1.8)	GATAD2A (1.8)	DHX38 (1.7)
GO:0005159	insulin-like growth factor receptor binding	0.44	> 0.20	KANK2 (2.8)	MYLIP (2.0)	LDLR (2.0)	TRIB1 (1.8)	HLX (1.8)	PVRL2 (1.5)	PLG (1.5)	C12orf47 (1.4)	SLC22A1 (1.4)	HNF1A (1.3)
ENSG00000161203	AP2M1 PPI subnetwork	0.44	> 0.20	CETP (3.8)	CLPTM1 (3.4)	TIMD4 (3.1)	MARK4 (3.1)	OGDH (2.6)	PPP1R37 (2.3)	DNM2 (2.1)	GRINA (2.1)	TRAPPC6A (1.9)	SLC44A2 (1.9)
ENSG00000188342	GTF2F2 PPI subnetwork	0.44	> 0.20	ILF3 (3.2)	BUD13 (3.1)	TOP1 (2.9)	SUGP1 (2.9)	USP1 (2.8)	C1orf63 (2.8)	DHX38 (2.5)	SMARCA4 (2.2)	PTPN11 (2.0)	FEN1 (1.9)
ENSG00000171421	MRPL36 PPI subnetwork	0.44	> 0.20	QTRT1 (3.8)	NAA25 (2.6)	CARM1 (2.6)	MAU2 (2.5)	ATP13A1 (2.5)	GEMIN7 (2.1)	MAPKAPK5 (1.8)	SMARCA4 (1.7)	DDX56 (1.6)	TMEM116 (1.6)
MP:0000711	thymus cortex hypoplasia	0.44	> 0.20	ATP13A1 (2.5)	CYB561D1 (2.5)	DNM2 (2.5)	GMIP (2.3)	BCL3 (2.2)	PBX4 (2.2)	PARP10 (2.0)	RELB (2.0)	PLEC (1.9)	KANK2 (1.8)
GO:0006783	heme biosynthetic process	0.44	> 0.20	RHCE (7.8)	RHD (7.2)	ADAM1 (3.6)	C12orf51 (3.0)	NT5DC1 (2.2)	ABO (2.2)	C19orf52 (2.1)	GMPR (1.8)	TMEM116 (1.6)	ACAD10 (1.6)
KEGG_RNA_POLYMERASE	KEGG_RNA_POLYMERASE	0.44	> 0.20	GEMIN7 (4.1)	ZNF259 (3.3)	DHODH (2.5)	QTRT1 (2.5)	DDX56 (2.2)	ENSG00000226645 (2.1)	C12orf43 (2.0)	TXNL4B (1.9)	TOMM40 (1.9)	DNAH11 (1.9)
ENSG00000168502	CCDC165 PPI subnetwork	0.44	> 0.20	ZNF101 (3.3)	ATXN2 (3.2)	DOCK7 (2.9)	GATAD2A (2.9)	CEACAM19 (2.7)	ENSG00000235545 (2.6)	ILF3 (2.6)	CARM1 (2.5)	SORT1 (2.0)	CELSR2 (1.9)
MP:0004097	abnormal cerebellar cortex morphology	0.44	> 0.20	ATP13A1 (2.7)	ERP29 (2.5)	ALDH2 (2.1)	CETP (2.0)	SORT1 (1.9)	APOE (1.9)	GRINA (1.8)	HAVCR1 (1.8)	PARP10 (1.8)	APOC4 (1.7)
ENSG00000115170	ACVR1 PPI subnetwork	0.44	> 0.20	AP1M2 (3.0)	MYLIP (2.6)	CELSR2 (2.6)	CBLC (2.2)	MOSC1 (2.1)	SLC22A1 (2.0)	LPIN3 (2.0)	BLOC1S3 (2.0)	ZNF101 (1.6)	PVRL2 (1.5)
ENSG00000198000	NOL8 PPI subnetwork	0.44	> 0.20	ZNF180 (2.7)	GEMIN7 (2.6)	DHX38 (2.5)	TXNL4B (2.5)	TOP1 (2.3)	BUD13 (2.2)	C19orf52 (2.1)	C1orf63 (2.0)	BRAP (1.9)	BLOC1S3 (1.9)
MP:0004837	abnormal neural fold formation	0.44	> 0.20	NYNRIN (3.0)	HAPLN4 (2.0)	CARM1 (1.9)	ATP13A1 (1.8)	ABO (1.7)	MARK4 (1.7)	PVRL2 (1.6)	TRIB1 (1.6)	PLCG1 (1.5)	APOE (1.4)
REACTOME_PROCESSING_OF_INTRONLESS_PRE:MRNAS	REACTOME_PROCESSING_OF_INTRONLESS_PRE:MRNAS	0.44	> 0.20	C1orf63 (3.8)	ENSG00000226645 (2.6)	UBXN2B (2.5)	ENSG00000235545 (2.0)	TXNL4B (1.7)	FEN1 (1.7)	NYNRIN (1.5)	ZNF259 (1.4)	NKPD1 (1.3)	FADS1 (1.3)
MP:0008498	decreased IgG3 level	0.44	> 0.20	RELB (4.1)	GMIP (3.8)	TIMD4 (3.2)	CETP (3.2)	SH2B3 (2.1)	BCL3 (1.9)	MAFB (1.6)	ZNF101 (1.1)	HAVCR1 (1.0)	GEMIN7 (1.0)
GO:0000722	telomere maintenance via recombination	0.44	> 0.20	ZNF180 (3.1)	USP1 (3.0)	ENSG00000228044 (2.6)	FEN1 (2.4)	AMIGO1 (2.4)	GOT2P1 (2.2)	ENSG00000235545 (2.1)	ERP29 (1.8)	ENSG00000226648 (1.8)	TMEM116 (1.8)
ENSG00000164109	MAD2L1 PPI subnetwork	0.44	> 0.20	PSRC1 (5.3)	FEN1 (4.3)	POC5 (3.8)	USP1 (2.9)	ILF3 (1.0)	DHX38 (0.9)	ENSG00000228044 (0.8)	HMGCR (0.7)	CBLC (0.7)	LDLR (0.6)
GO:0001818	negative regulation of cytokine production	0.44	> 0.20	OASL (4.7)	PARP10 (3.5)	TIMD4 (2.5)	MAU2 (2.1)	TRAFD1 (2.0)	ZNF101 (1.9)	GRINA (1.8)	ADAM1 (1.7)	GMIP (1.7)	RELB (1.5)
ENSG00000137267	TUBB2A PPI subnetwork	0.44	> 0.20	GEMIN7 (3.4)	GATAD2A (2.8)	TMEM50A (2.7)	CLPTM1 (2.1)	QTRT1 (1.9)	ABO (1.8)	TMEM57 (1.7)	ENSG00000228044 (1.6)	KANK2 (1.6)	NCAN (1.5)
ENSG00000047621	C12orf4 PPI subnetwork	0.44	> 0.20	YIPF2 (3.6)	COL4A3BP (3.4)	ERP29 (3.3)	C19orf52 (2.9)	BRAP (2.3)	C12orf43 (2.2)	DDX56 (2.1)	HNF1A (2.1)	CLPTM1 (2.0)	ATP13A1 (2.0)
ENSG00000177700	POLR2L PPI subnetwork	0.44	> 0.20	BUD13 (3.4)	SUGP1 (3.1)	DHX38 (3.0)	ILF3 (3.0)	TOP1 (2.6)	C12orf43 (2.3)	DDX56 (2.3)	SMARCA4 (2.3)	USP1 (2.2)	MAPKAPK5 (2.1)
ENSG00000181061	HIGD1A PPI subnetwork	0.44	> 0.20	ATP13A1 (3.0)	OGDH (2.4)	ILF3 (2.3)	YIPF2 (2.0)	DNM2 (1.7)	LDLR (1.7)	ACAD10 (1.7)	TMEM116 (1.6)	QTRT1 (1.5)	PCSK9 (1.4)
ENSG00000111961	SASH1 PPI subnetwork	0.44	> 0.20	CBLC (6.4)	AP1M2 (4.3)	ST3GAL4 (2.3)	LPAR2 (2.2)	FRK (2.2)	CELSR2 (2.2)	LPIN3 (1.7)	PVRL2 (1.7)	PLEC (1.7)	PSRC1 (1.4)
GO:0048610	cellular process involved in reproduction	0.44	> 0.20	TSSK6 (3.9)	PMFBP1 (2.6)	ANKRD31 (2.4)	ENSG00000228044 (1.7)	NKPD1 (1.2)	PLEKHH2 (1.1)	ABO (1.0)	UBXN2B (0.9)	USP1 (0.9)	ATXN7L2 (0.8)
ENSG00000156711	MAPK13 PPI subnetwork	0.44	> 0.20	TRIB1 (7.1)	PVR (2.1)	SH2B3 (1.9)	POLK (1.7)	MYLIP (1.6)	RPH3A (1.3)	ERP29 (1.3)	MAPKAPK5 (1.2)	MAFB (1.2)	NPC1L1 (1.1)
MP:0002027	lung adenocarcinoma	0.44	> 0.20	FEN1 (2.4)	NYNRIN (2.3)	USP1 (2.0)	UBXN2B (2.0)	LPIN3 (1.9)	GMIP (1.8)	MAFB (1.6)	ZNF101 (1.5)	KANK2 (1.4)	CETP (1.3)
MP:0002168	other aberrant phenotype	0.44	> 0.20	ANGPTL3 (3.4)	PVR (2.9)	APOC4 (2.5)	HP (2.4)	PLG (2.2)	PLEC (2.1)	APOA5 (2.0)	KANK2 (1.9)	TRIB1 (1.8)	NYNRIN (1.6)
ENSG00000159063	ALG8 PPI subnetwork	0.44	> 0.20	LDLR (2.6)	KIAA1324 (2.6)	HMGCR (2.6)	FADS2 (2.4)	CYP7A1 (2.2)	ATP13A1 (1.9)	COL4A3BP (1.8)	TMED4 (1.7)	TMEM50A (1.6)	SLC44A2 (1.6)
ENSG00000145723	GIN1 PPI subnetwork	0.44	> 0.20	OASL (3.7)	PARP10 (2.7)	TMED4 (2.2)	ZNF180 (1.6)	C12orf43 (1.6)	MAPKAPK5 (1.6)	USP24 (1.5)	NAA25 (1.3)	USP1 (1.3)	ENSG00000228044 (1.2)
ENSG00000151498	ACAD8 PPI subnetwork	0.44	> 0.20	DHX38 (2.8)	BUD13 (2.5)	USP24 (2.2)	ATXN7L2 (2.1)	C17orf57 (2.1)	CEACAM19 (2.0)	ANKRD31 (1.8)	MAPKAPK5 (1.7)	POC5 (1.7)	ATXN2 (1.7)
ENSG00000108813	DLX4 PPI subnetwork	0.44	> 0.20	ZHX3 (2.6)	GATAD2A (2.4)	TMED4 (2.3)	TOP1 (1.8)	ERP29 (1.8)	SH2B3 (1.6)	TMEM57 (1.6)	PMFBP1 (1.5)	MAFB (1.4)	DNM2 (1.4)
ENSG00000008130	NADK PPI subnetwork	0.44	> 0.20	DNM2 (3.4)	CARM1 (3.4)	ZHX3 (3.2)	LPAR2 (3.1)	PLEC (3.1)	GPAM (2.7)	COL4A3BP (2.4)	AP1M2 (2.2)	OGDH (2.2)	C11orf9 (2.1)
GO:0050907	detection of chemical stimulus involved in sensory perception	0.44	> 0.20	ENSG00000228044 (3.8)	ENSG00000235545 (3.7)	GOT2P1 (2.2)	DNAH11 (2.0)	PMFBP1 (1.6)	ADAM1 (1.4)	C17orf57 (1.3)	ANKRD31 (1.3)	GCNT4 (1.3)	CYP7A1 (1.1)
ENSG00000031544	ENSG00000031544 PPI subnetwork	0.44	> 0.20	ATXN7L2 (2.6)	DHODH (2.4)	DHX38 (2.4)	TOMM40 (2.3)	SUGP1 (1.9)	ENSG00000238078 (1.8)	BUD13 (1.8)	LPIN3 (1.6)	USP1 (1.5)	MARK4 (1.5)
GO:0008171	O-methyltransferase activity	0.44	> 0.20	TRAPPC6A (2.5)	NT5DC1 (2.4)	GEMIN7 (2.2)	NKPD1 (1.9)	C19orf52 (1.9)	TMEM50A (1.7)	ZHX3 (1.6)	AMIGO1 (1.4)	PVRL2 (1.3)	GOT2P1 (1.3)
ENSG00000105223	PLD3 PPI subnetwork	0.44	> 0.20	MAFB (2.9)	APOE (2.7)	APOC1 (2.3)	C19orf52 (2.2)	ST3GAL4 (2.1)	LPIN3 (1.8)	GEMIN7 (1.7)	TIMD4 (1.7)	NPC1L1 (1.7)	GCNT4 (1.4)
MP:0002211	abnormal primary sex determination	0.44	> 0.20	ST3GAL4 (3.1)	C11orf9 (2.9)	DYNC2LI1 (2.0)	GCNT4 (1.3)	GPAM (1.3)	OGDH (1.2)	NYNRIN (1.2)	FRK (1.0)	TSSK6 (1.0)	ENSG00000254235 (0.9)
ENSG00000111252	SH2B3 PPI subnetwork	0.44	> 0.20	ZHX3 (2.7)	ZNF101 (2.7)	PLCG1 (2.5)	PLEKHH2 (2.1)	DNM2 (1.9)	LPAR2 (1.9)	ADAM1 (1.9)	OGDH (1.7)	PLEC (1.6)	GATAD2A (1.6)
ENSG00000187391	MAGI2 PPI subnetwork	0.44	> 0.20	CELSR2 (3.5)	NCAN (3.1)	MARK4 (2.8)	PPP1R37 (2.5)	RPH3A (2.5)	LPIN3 (1.7)	PVRL2 (1.6)	ENSG00000238078 (1.6)	BCAM (1.6)	PLCG1 (1.5)
GO:0032770	positive regulation of monooxygenase activity	0.44	> 0.20	ST3GAL4 (3.2)	ENSG00000235545 (2.8)	ATXN7L2 (2.1)	COL4A3BP (2.0)	ENSG00000226645 (1.8)	TMEM116 (1.7)	ENSG00000228044 (1.7)	TXNL4B (1.5)	MAFB (1.2)	HMGCR (1.1)
MP:0004148	increased compact bone thickness	0.44	> 0.20	BCAM (2.6)	FRK (2.5)	APOC1 (2.4)	KIAA1324 (2.3)	PLEC (1.9)	MYLIP (1.9)	CBLC (1.8)	ENSG00000228044 (1.8)	PARP10 (1.8)	CILP2 (1.5)
KEGG_PANCREATIC_CANCER	KEGG_PANCREATIC_CANCER	0.44	> 0.20	RELB (3.3)	DNM2 (2.6)	SLC44A2 (2.5)	GATAD2A (2.4)	TMEM57 (2.3)	TMEM50A (2.2)	SH2B3 (2.1)	PARP10 (2.0)	BCL3 (1.9)	GRINA (1.8)
ENSG00000140575	IQGAP1 PPI subnetwork	0.44	> 0.20	PLEC (3.2)	PVR (3.2)	SH2B3 (2.6)	TMEM50A (2.5)	TOP1 (1.8)	OGDH (1.8)	DNM2 (1.7)	KANK2 (1.7)	PVRL2 (1.6)	PTPN11 (1.6)
GO:0004016	adenylate cyclase activity	0.44	> 0.20	PMFBP1 (2.1)	ENSG00000228044 (2.0)	C12orf51 (1.9)	CYP7A1 (1.8)	ZNF180 (1.8)	ABCG8 (1.6)	GOT2P1 (1.5)	PVR (1.4)	ST3GAL4 (1.4)	ENSG00000226645 (1.4)
ENSG00000197958	RPL12 PPI subnetwork	0.44	> 0.20	NAA25 (3.3)	ZNF259 (3.1)	DDX56 (2.7)	TOP1 (2.4)	QTRT1 (2.4)	ILF3 (2.2)	NKPD1 (2.2)	ANKRD31 (2.2)	TOMM40 (1.9)	DHODH (1.8)
GO:0008360	regulation of cell shape	0.44	> 0.20	PVRL2 (2.6)	C11orf9 (2.3)	SLC44A2 (2.2)	ENSG00000254235 (1.8)	BCAM (1.6)	SH2B3 (1.6)	ENSG00000235545 (1.5)	RHCE (1.5)	KANK2 (1.5)	AP1M2 (1.5)
ENSG00000129625	REEP5 PPI subnetwork	0.44	> 0.20	HMGCR (5.5)	LDLR (5.0)	TMEM50A (3.8)	FADS1 (3.5)	FADS2 (2.9)	PCSK9 (2.7)	CLPTM1 (2.5)	TRAPPC6A (2.0)	CEACAM19 (1.8)	MOSC1 (1.8)
GO:0043297	apical junction assembly	0.44	> 0.20	FRK (3.6)	AP1M2 (3.1)	GCNT4 (2.6)	TMEM116 (2.3)	LPAR2 (2.1)	PTPN11 (2.1)	TSSK6 (1.9)	ENSG00000254235 (1.9)	CEACAM19 (1.9)	YIPF2 (1.9)
GO:0032635	interleukin-6 production	0.44	> 0.20	HLX (2.3)	C17orf57 (2.2)	TRIB1 (1.8)	ENSG00000228044 (1.8)	MAFB (1.6)	OASL (1.4)	POC5 (1.4)	SH2B3 (1.3)	PMFBP1 (1.3)	ZNF101 (1.3)
MP:0002968	increased circulating alkaline phosphatase level	0.44	> 0.20	PLG (3.1)	ANGPTL3 (2.9)	SLC22A1 (2.6)	RHCE (2.4)	TMEM116 (2.3)	ZHX3 (2.1)	GMPR (2.0)	DYNC2LI1 (1.9)	KIAA1324 (1.9)	RHD (1.5)
ENSG00000092841	MYL6 PPI subnetwork	0.44	> 0.20	TMEM50A (3.2)	KANK2 (2.7)	ADAM1 (2.5)	ENSG00000238078 (2.4)	PLEC (2.1)	C1orf63 (1.9)	PVR (1.9)	ITGB3 (1.9)	ILF3 (1.6)	MYLIP (1.5)
GO:0033158	regulation of protein import into nucleus, translocation	0.44	> 0.20	ENSG00000238078 (2.5)	HNF1A (1.6)	TRIB1 (1.6)	CILP2 (1.4)	ATXN2 (1.3)	TSSK6 (1.2)	GRINA (1.1)	BCL3 (1.1)	PBX4 (1.1)	PVR (1.1)
GO:0004364	glutathione transferase activity	0.44	> 0.20	ALDH2 (3.8)	TM6SF2 (2.3)	TRAPPC6A (2.0)	PSRC1 (1.9)	C11orf9 (1.6)	ACAD10 (1.5)	PSMA5 (1.5)	GPAM (1.5)	AMIGO1 (1.5)	ABCG8 (1.4)
ENSG00000015475	BID PPI subnetwork	0.44	> 0.20	MARK4 (2.5)	C11orf9 (2.4)	GOT2P1 (2.3)	BLOC1S3 (2.3)	PPP1R37 (2.0)	PVR (2.0)	FRK (1.7)	PTPN11 (1.6)	OGDH (1.6)	RELB (1.5)
GO:0006275	regulation of DNA replication	0.44	> 0.20	POLK (3.6)	ENSG00000228044 (2.4)	BLOC1S3 (1.9)	BUD13 (1.8)	USP1 (1.4)	C17orf57 (1.3)	POC5 (1.3)	PSRC1 (1.3)	PLEKHH2 (1.1)	TOP1 (1.1)
MP:0001273	decreased metastatic potential	0.44	> 0.20	ST3GAL4 (3.1)	HLX (1.8)	SLC44A2 (1.8)	OASL (1.7)	MAFB (1.4)	GMIP (1.2)	TRIB1 (1.2)	CYB561D1 (1.2)	DOCK7 (1.1)	SH2B3 (1.1)
MP:0004181	abnormal carotid artery morphology	0.44	> 0.20	PLCG1 (2.4)	C12orf43 (2.4)	PVRL2 (1.8)	BRAP (1.6)	KIAA1324 (1.6)	PCSK9 (1.4)	MYLIP (1.4)	C12orf47 (1.4)	ADAM1 (1.4)	PVR (1.3)
ENSG00000097046	CDC7 PPI subnetwork	0.44	> 0.20	FEN1 (6.1)	USP1 (4.4)	ENSG00000235545 (1.5)	NT5DC1 (1.4)	APOC4 (1.1)	TXNL4B (1.0)	ERP29 (1.0)	CYP7A1 (1.0)	SLC22A1 (0.9)	DDX56 (0.9)
MP:0000223	decreased monocyte cell number	0.44	> 0.20	MAFB (2.4)	SH2B3 (2.4)	CYP7A1 (2.4)	LPA (2.1)	TIMD4 (1.9)	NCAN (1.8)	HLX (1.8)	MYLIP (1.6)	PVR (1.6)	RHCE (1.4)
MP:0004830	short incisors	0.44	> 0.20	CILP2 (3.1)	MYLIP (2.8)	GCNT4 (2.2)	PLEC (2.1)	FRK (2.0)	MAFB (2.0)	DNAH11 (1.8)	HNF1A (1.6)	ABO (1.5)	APOE (1.3)
MP:0001106	abnormal Schwann cell morphology	0.45	> 0.20	RPH3A (2.4)	CELSR2 (2.4)	TSSK6 (2.3)	GRINA (2.3)	FADS1 (2.2)	LDLR (1.8)	PLEC (1.8)	SORT1 (1.8)	C12orf47 (1.8)	TMED4 (1.6)
ENSG00000164399	IL3 PPI subnetwork	0.45	> 0.20	BCL3 (3.4)	HLX (3.3)	RELB (3.0)	TIMD4 (2.4)	GMIP (2.2)	CETP (2.0)	SH2B3 (1.5)	GRINA (1.3)	LPA (1.2)	PARP10 (1.2)
ENSG00000105048	TNNT1 PPI subnetwork	0.45	> 0.20	SYPL2 (4.9)	ENSG00000228044 (2.4)	GMPR (2.3)	PVRL2 (1.7)	PTPN11 (1.6)	ENSG00000226648 (1.4)	KANK2 (1.3)	BRAP (1.2)	POC5 (1.2)	LPIN3 (1.2)
ENSG00000110237	ARHGEF17 PPI subnetwork	0.45	> 0.20	CBLC (5.7)	AP1M2 (3.9)	CELSR2 (2.3)	LPAR2 (2.1)	ST3GAL4 (2.1)	PSRC1 (1.7)	DOCK7 (1.6)	LPIN3 (1.6)	DNM2 (1.6)	FRK (1.5)
REACTOME_DNA_STRAND_ELONGATION	REACTOME_DNA_STRAND_ELONGATION	0.45	> 0.20	FEN1 (7.1)	USP1 (5.9)	ZNF180 (2.6)	ENSG00000228044 (1.7)	FADS1 (1.5)	ENSG00000235545 (1.3)	AMIGO1 (1.2)	GOT2P1 (1.2)	DHODH (1.1)	ERP29 (1.0)
MP:0004174	abnormal spine curvature	0.45	> 0.20	NYNRIN (5.5)	SYPL2 (3.6)	CARM1 (2.5)	PLEC (2.3)	NCAN (2.2)	ENSG00000235545 (2.1)	DOCK7 (2.0)	PCSK9 (1.5)	KANK2 (1.5)	ENSG00000226648 (1.4)
REACTOME_ERKS_ARE_INACTIVATED	REACTOME_ERKS_ARE_INACTIVATED	0.45	> 0.20	MARK4 (3.3)	TRIB1 (2.6)	CLPTM1 (2.1)	SH2B3 (1.9)	PBX4 (1.7)	SORT1 (1.7)	COL4A3BP (1.6)	PVRL2 (1.6)	TOMM40 (1.6)	PVR (1.4)
MP:0008280	male germ cell apoptosis	0.45	> 0.20	ANKRD31 (2.7)	PBX4 (2.5)	BRAP (1.6)	OASL (1.2)	GATAD2A (1.2)	MYLIP (1.0)	PLEKHH2 (1.0)	KANK2 (1.0)	KIAA1324 (0.9)	SH2B3 (0.9)
GO:0042509	regulation of tyrosine phosphorylation of STAT protein	0.45	> 0.20	ENSG00000228044 (2.3)	TIMD4 (2.0)	ENSG00000238078 (2.0)	ENSG00000254235 (1.9)	GEMIN7 (1.9)	PBX4 (1.8)	COL4A3BP (1.6)	TRAFD1 (1.5)	DNAH11 (1.4)	PVR (1.4)
MP:0001377	abnormal mating frequency	0.45	> 0.20	GCNT4 (3.5)	ST3GAL4 (2.5)	C17orf57 (2.4)	ENSG00000238078 (2.1)	PCSK9 (2.0)	ANKRD31 (1.9)	NKPD1 (1.8)	ITGB3 (1.7)	SLC44A2 (1.7)	TMED4 (1.6)
GO:0016581	NuRD complex	0.45	> 0.20	CARM1 (4.1)	PLCG1 (3.2)	SMARCA4 (2.9)	PPP1R37 (2.7)	ILF3 (2.3)	KANK2 (2.2)	PTPN11 (1.9)	MARK4 (1.9)	DNM2 (1.9)	ATXN7L2 (1.8)
MP:0003051	curly tail	0.45	> 0.20	NYNRIN (4.9)	FADS2 (2.8)	LPAR2 (2.5)	FADS1 (2.4)	MARK4 (2.3)	PCSK9 (2.2)	LDLR (2.1)	NCAN (2.0)	HMGCR (1.7)	ABO (1.6)
ENSG00000173273	TNKS PPI subnetwork	0.45	> 0.20	GOT2P1 (2.7)	UBXN2B (2.6)	POC5 (2.0)	SH2B3 (2.0)	QTRT1 (2.0)	PTPN11 (1.9)	ACAD10 (1.9)	COL4A3BP (1.8)	POLK (1.8)	PLEC (1.7)
ENSG00000115904	SOS1 PPI subnetwork	0.45	> 0.20	SLC44A2 (4.2)	ZHX3 (3.5)	ITGB3 (2.7)	PLCG1 (2.6)	MAFB (2.5)	KANK2 (2.2)	C11orf9 (2.2)	MYLIP (2.0)	CBLC (2.0)	DNM2 (2.0)
GO:0051923	sulfation	0.45	> 0.20	ABCG5 (2.8)	C17orf57 (2.8)	GCNT4 (2.2)	ABCG8 (2.2)	TM6SF2 (2.1)	FRK (1.8)	SLC22A1 (1.7)	ZNF180 (1.7)	ANKRD31 (1.5)	ENSG00000228044 (1.5)
ENSG00000101811	CSTF2 PPI subnetwork	0.45	> 0.20	ILF3 (3.9)	SMARCA4 (3.3)	DHX38 (3.0)	BUD13 (3.0)	SUGP1 (2.7)	C1orf63 (2.6)	USP1 (2.5)	TOP1 (2.5)	CLPTM1 (2.2)	FEN1 (2.0)
GO:0005721	centromeric heterochromatin	0.45	> 0.20	FEN1 (3.5)	USP1 (3.3)	SMARCA4 (2.8)	ILF3 (2.8)	KANK2 (2.6)	FADS1 (2.0)	PTPN11 (1.9)	C12orf51 (1.8)	DNM2 (1.8)	SLC44A2 (1.7)
GO:0051283	negative regulation of sequestering of calcium ion	0.45	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	ZNF180 (1.9)	TRAPPC6A (1.8)	ABO (1.7)	APOE (1.4)	TSSK6 (1.3)	C1orf63 (1.3)	RPH3A (1.3)	LPIN3 (1.2)
GO:0051282	regulation of sequestering of calcium ion	0.45	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	ZNF180 (1.9)	TRAPPC6A (1.8)	ABO (1.7)	APOE (1.4)	TSSK6 (1.3)	C1orf63 (1.3)	RPH3A (1.3)	LPIN3 (1.2)
GO:0051209	release of sequestered calcium ion into cytosol	0.45	> 0.20	SYPL2 (2.1)	HAVCR1 (2.0)	ZNF180 (1.9)	TRAPPC6A (1.8)	ABO (1.7)	APOE (1.4)	TSSK6 (1.3)	C1orf63 (1.3)	RPH3A (1.3)	LPIN3 (1.2)
KEGG_N_GLYCAN_BIOSYNTHESIS	KEGG_N_GLYCAN_BIOSYNTHESIS	0.45	> 0.20	ERP29 (4.5)	ATP13A1 (4.1)	CLPTM1 (3.9)	YIPF2 (3.6)	TMEM50A (3.2)	TMED4 (2.9)	CYB561D1 (2.1)	SORT1 (2.0)	TMEM57 (1.9)	SLC44A2 (1.7)
ENSG00000135218	CD36 PPI subnetwork	0.45	> 0.20	ITGB3 (5.8)	FADS2 (4.0)	FADS1 (2.6)	PLEC (2.6)	ENSG00000238078 (2.6)	CILP2 (2.6)	APOE (2.5)	HMGCR (2.5)	APOC1 (1.7)	SLC44A2 (1.7)
MP:0010819	primary atelectasis	0.45	> 0.20	PVRL2 (3.2)	C11orf9 (3.0)	ABO (2.8)	HNF1A (2.6)	ENSG00000238078 (2.2)	BCAM (2.0)	ENSG00000254235 (1.8)	KIAA1324 (1.7)	COL4A3BP (1.7)	PVR (1.7)
ENSG00000198130	HIBCH PPI subnetwork	0.45	> 0.20	TOMM40 (3.7)	NAA25 (3.3)	QTRT1 (3.1)	ZNF259 (3.1)	DHODH (3.0)	MAPKAPK5 (2.8)	CARM1 (2.5)	DDX56 (2.4)	ADAM1 (2.1)	C12orf43 (1.8)
ENSG00000166228	PCBD1 PPI subnetwork	0.45	> 0.20	ANGPTL3 (3.4)	PLG (3.1)	GRINA (2.5)	PCSK9 (2.2)	CARM1 (2.0)	TMED4 (1.9)	ENSG00000226645 (1.7)	YIPF2 (1.6)	MARK4 (1.5)	APOC4 (1.5)
MP:0000547	short limbs	0.45	> 0.20	CILP2 (5.6)	MAFB (3.3)	PLEKHH2 (3.0)	HMGCR (2.3)	PCSK9 (2.2)	PLCG1 (1.5)	LDLR (1.5)	NPC1L1 (1.4)	YIPF2 (1.2)	FADS1 (1.2)
GO:0051082	unfolded protein binding	0.45	> 0.20	TMED4 (3.2)	TMEM57 (2.9)	ERP29 (2.6)	CYP7A1 (1.8)	DHODH (1.8)	OGDH (1.6)	TXNL4B (1.6)	NAA25 (1.6)	SARS (1.5)	PSMA5 (1.5)
MP:0008908	increased total fat pad weight	0.45	> 0.20	TIMD4 (2.8)	GPAM (2.4)	APOC1 (2.0)	PVR (2.0)	ALDH2 (2.0)	CETP (1.9)	HP (1.9)	OASL (1.9)	LPIN3 (1.7)	APOE (1.6)
MP:0005167	abnormal blood-brain barrier function	0.45	> 0.20	APOC1 (2.6)	NCAN (2.6)	HLX (2.4)	GPAM (2.2)	BCAM (2.0)	PLCG1 (2.0)	CLPTM1 (1.8)	NYNRIN (1.7)	ENSG00000235545 (1.7)	ZHX3 (1.6)
MP:0000135	decreased compact bone thickness	0.45	> 0.20	OASL (2.8)	MAFB (2.5)	KIAA1324 (2.1)	TMEM57 (2.1)	TRIB1 (2.0)	CYB561D1 (1.9)	ENSG00000254235 (1.9)	FRK (1.8)	TRAFD1 (1.6)	YIPF2 (1.5)
ENSG00000113520	IL4 PPI subnetwork	0.45	> 0.20	BCL3 (3.5)	HLX (3.0)	RELB (2.8)	GMIP (2.5)	TIMD4 (2.4)	CETP (2.1)	ALDH2 (1.7)	LPA (1.6)	SH2B3 (1.3)	PARP10 (1.1)
ENSG00000100280	AP1B1 PPI subnetwork	0.45	> 0.20	AP1M2 (2.5)	MYLIP (2.4)	DHX38 (2.2)	SH2B3 (1.9)	C12orf51 (1.7)	DNM2 (1.7)	MAU2 (1.6)	KIAA1324 (1.6)	GMIP (1.6)	ZNF101 (1.5)
GO:0010893	positive regulation of steroid biosynthetic process	0.45	> 0.20	MYLIP (3.1)	ENSG00000238078 (2.9)	SLC44A2 (2.8)	COL4A3BP (2.4)	TMEM57 (2.3)	POC5 (2.1)	ST3GAL4 (2.0)	ENSG00000228044 (1.6)	TMED4 (1.6)	POLK (1.5)
MP:0002893	ketoaciduria	0.45	> 0.20	TRAPPC6A (3.0)	KIAA1324 (2.6)	DYNC2LI1 (2.5)	QTRT1 (2.2)	TOMM40 (2.1)	KANK2 (2.1)	HNF1A (2.0)	ANGPTL3 (1.8)	ALDH2 (1.7)	TMEM116 (1.6)
GO:0004659	prenyltransferase activity	0.45	> 0.20	HMGCR (4.7)	LDLR (3.8)	FADS1 (3.7)	FADS2 (2.8)	UBXN2B (2.6)	PCSK9 (2.5)	ATXN7L2 (2.2)	NAA25 (1.9)	USP24 (1.9)	PVR (1.8)
ENSG00000138802	SEC24B PPI subnetwork	0.45	> 0.20	YIPF2 (4.1)	TMED4 (2.9)	CLPTM1 (2.5)	LPIN3 (2.4)	ZHX3 (2.1)	NPC1L1 (2.1)	ADAM1 (2.0)	SUGP1 (1.9)	ABCG8 (1.9)	KIAA1324 (1.8)
REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	0.45	> 0.20	NAA25 (2.9)	DDX56 (2.8)	DOCK7 (2.7)	ILF3 (2.4)	POC5 (2.3)	USP1 (2.3)	BUD13 (2.3)	MAPKAPK5 (2.2)	USP24 (2.2)	FEN1 (2.1)
ENSG00000104313	EYA1 PPI subnetwork	0.45	> 0.20	TRAFD1 (2.5)	NYNRIN (2.4)	TXNL4B (2.1)	GOT2P1 (1.9)	MOSC1 (1.8)	GATAD2A (1.7)	ENSG00000238078 (1.5)	MAPKAPK5 (1.5)	FRK (1.4)	COL4A3BP (1.4)
ENSG00000124762	CDKN1A PPI subnetwork	0.45	> 0.20	FEN1 (4.3)	USP1 (3.4)	HLX (2.3)	TRIB1 (2.2)	PSRC1 (2.2)	GMPR (1.6)	PSMA5 (1.6)	MAFB (1.4)	RHD (1.4)	TOMM40 (1.3)
ENSG00000001497	LAS1L PPI subnetwork	0.45	> 0.20	C19orf52 (3.0)	C12orf43 (2.7)	ZNF259 (2.5)	DDX56 (2.5)	GATAD2A (2.5)	BUD13 (2.1)	GOT2P1 (1.9)	ILF3 (1.8)	ANKRD31 (1.8)	ATXN7L2 (1.6)
MP:0008642	decreased circulating interleukin-1 beta level	0.45	> 0.20	HLX (2.3)	RPH3A (2.1)	BCL3 (2.0)	RELB (2.0)	PMFBP1 (1.7)	OASL (1.5)	PVR (1.5)	PSRC1 (1.5)	ATXN7L2 (1.5)	MAFB (1.5)
GO:0002698	negative regulation of immune effector process	0.45	> 0.20	PARP10 (1.9)	GCNT4 (1.7)	BLOC1S3 (1.5)	OASL (1.4)	ENSG00000235545 (1.4)	DNAH11 (1.3)	GMIP (1.3)	ZNF101 (1.3)	TRAFD1 (1.3)	C12orf47 (1.2)
ENSG00000091483	FH PPI subnetwork	0.45	> 0.20	OGDH (2.1)	KIAA1324 (2.0)	GOT2P1 (1.8)	PMFBP1 (1.6)	ACAD10 (1.5)	RELB (1.5)	NT5DC1 (1.4)	QTRT1 (1.4)	SH2B3 (1.4)	PBX4 (1.2)
ENSG00000169062	UPF3A PPI subnetwork	0.45	> 0.20	TXNL4B (3.4)	C1orf63 (3.3)	MAU2 (3.2)	BRAP (2.7)	TOP1 (2.5)	SUGP1 (2.5)	UBXN2B (2.4)	ATP13A1 (2.3)	USP24 (2.0)	C19orf52 (1.9)
ENSG00000177606	JUN PPI subnetwork	0.45	> 0.20	TRIB1 (5.8)	BCL3 (3.7)	HLX (3.1)	ATXN2 (2.8)	MAFB (1.8)	CARM1 (1.8)	RELB (1.7)	MAU2 (1.6)	SMARCA4 (1.5)	GRINA (1.5)
GO:0030684	preribosome	0.45	> 0.20	DDX56 (3.8)	QTRT1 (3.7)	NAA25 (3.2)	TOMM40 (2.7)	SUGP1 (2.7)	ZNF259 (2.6)	C12orf43 (2.4)	POC5 (2.0)	TOP1 (1.9)	ENSG00000235545 (1.8)
GO:0005740	mitochondrial envelope	0.45	> 0.20	ACAD10 (4.4)	OGDH (4.0)	ALDH2 (2.7)	GMPR (2.5)	GPAM (2.3)	TRAPPC6A (2.2)	TOMM40 (2.1)	MOSC1 (1.8)	C19orf52 (1.7)	ABCG8 (1.6)
ENSG00000158169	FANCC PPI subnetwork	0.45	> 0.20	OASL (2.6)	RHD (2.6)	TRAFD1 (2.5)	C1orf63 (2.5)	PARP10 (2.3)	HMGCR (2.1)	RHCE (1.8)	TOP1 (1.8)	TRIB1 (1.6)	USP1 (1.3)
GO:0035411	catenin import into nucleus	0.45	> 0.20	CILP2 (2.2)	DOCK7 (2.0)	TMEM116 (1.8)	NKPD1 (1.7)	ENSG00000226648 (1.7)	DNAH11 (1.6)	ST3GAL4 (1.6)	GEMIN7 (1.6)	ZHX3 (1.5)	HAVCR1 (1.5)
MP:0001182	lung hemorrhage	0.45	> 0.20	PVRL2 (3.5)	HLX (3.5)	BCAM (3.0)	BCL3 (1.9)	KANK2 (1.9)	APOE (1.6)	ABO (1.6)	C11orf9 (1.5)	MYLIP (1.4)	ST3GAL4 (1.4)
ENSG00000101745	ANKRD12 PPI subnetwork	0.45	> 0.20	ATXN2 (3.5)	C19orf52 (2.9)	USP24 (2.6)	NAA25 (2.3)	TMEM57 (2.2)	BRAP (1.8)	ILF3 (1.7)	PCSK9 (1.6)	GCNT4 (1.5)	MAU2 (1.5)
GO:0005540	hyaluronic acid binding	0.45	> 0.20	CILP2 (3.7)	CETP (3.2)	TIMD4 (3.2)	MAFB (2.7)	NCAN (2.6)	PSRC1 (2.1)	ENSG00000254235 (2.0)	LPA (1.9)	NKPD1 (1.9)	HAPLN4 (1.7)
GO:0045026	plasma membrane fusion	0.45	> 0.20	GCNT4 (4.0)	PMFBP1 (3.9)	ENSG00000238078 (2.5)	CEACAM19 (2.4)	TSSK6 (2.3)	ENSG00000228044 (2.1)	DNAH11 (2.0)	NKPD1 (1.5)	ANKRD31 (1.2)	POLK (1.2)
ENSG00000069667	RORA PPI subnetwork	0.45	> 0.20	COL4A3BP (3.1)	UBXN2B (2.8)	C17orf57 (2.2)	DNAH11 (1.8)	TMED4 (1.6)	PBX4 (1.4)	ALDH2 (1.4)	PLEC (1.3)	MAFB (1.3)	TOP1 (1.2)
ENSG00000213123	TCTEX1D2 PPI subnetwork	0.45	> 0.20	GCNT4 (2.2)	BLOC1S3 (2.2)	GPAM (2.0)	NKPD1 (1.8)	POC5 (1.6)	SLC22A1 (1.6)	OGDH (1.6)	TOP1 (1.5)	ENSG00000238078 (1.4)	ZHX3 (1.3)
ENSG00000162188	GNG3 PPI subnetwork	0.45	> 0.20	ITGB3 (3.8)	TM6SF2 (1.9)	TMEM50A (1.9)	CETP (1.7)	TXNL4B (1.5)	DNM2 (1.4)	ENSG00000235545 (1.4)	CYP7A1 (1.4)	HLX (1.3)	GCNT4 (1.3)
MP:0000167	decreased chondrocyte cell number	0.45	> 0.20	NYNRIN (2.6)	ALDH2 (1.7)	KIAA1324 (1.7)	PLEKHH2 (1.6)	YIPF2 (1.6)	ENSG00000254235 (1.6)	FRK (1.6)	GOT2P1 (1.5)	KANK2 (1.5)	PLEC (1.4)
GO:0000377	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	0.45	> 0.20	C1orf63 (3.3)	BUD13 (3.2)	TOP1 (3.2)	SUGP1 (3.1)	ILF3 (3.0)	DHX38 (2.9)	QTRT1 (2.4)	C12orf43 (2.1)	MAU2 (1.9)	SMARCA4 (1.9)
GO:0000398	nuclear mRNA splicing, via spliceosome	0.45	> 0.20	C1orf63 (3.3)	BUD13 (3.2)	TOP1 (3.2)	SUGP1 (3.1)	ILF3 (3.0)	DHX38 (2.9)	QTRT1 (2.4)	C12orf43 (2.1)	MAU2 (1.9)	SMARCA4 (1.9)
REACTOME_CYCLIN_ACDK2:ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	REACTOME_CYCLIN_ACDK2:ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY	0.45	> 0.20	PSMA5 (6.2)	TRAFD1 (2.8)	TOMM40 (2.1)	NAA25 (1.9)	DDX56 (1.7)	NT5DC1 (1.5)	FEN1 (1.4)	SUGP1 (1.4)	SARS (1.3)	TMEM50A (1.1)
MP:0004087	abnormal muscle fiber morphology	0.45	> 0.20	SYPL2 (5.2)	CILP2 (2.4)	ATXN7L2 (1.9)	CEACAM19 (1.9)	USP24 (1.9)	CYB561D1 (1.7)	MYLIP (1.6)	HP (1.5)	AMIGO1 (1.4)	RHD (1.2)
MP:0002768	small adrenal glands	0.45	> 0.20	GCNT4 (2.6)	FADS1 (2.4)	NYNRIN (2.2)	YIPF2 (2.1)	FADS2 (2.1)	ST3GAL4 (2.0)	MOSC1 (1.8)	DNAH11 (1.7)	TSSK6 (1.5)	GPAM (1.4)
ENSG00000211895	ENSG00000211895 PPI subnetwork	0.45	> 0.20	DYNC2LI1 (2.5)	MAFB (2.4)	PLEC (2.2)	POLK (2.0)	TRIB1 (1.8)	OGDH (1.8)	BCAM (1.8)	C11orf9 (1.7)	AP1M2 (1.5)	MYLIP (1.4)
GO:0032587	ruffle membrane	0.45	> 0.20	PVR (3.7)	SLC44A2 (3.3)	SH2B3 (3.3)	C11orf9 (3.2)	NCAN (3.2)	ITGB3 (2.4)	PVRL2 (2.2)	PLEC (2.1)	AP1M2 (1.9)	GATAD2A (1.7)
REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	0.45	> 0.20	DHODH (3.8)	ACAD10 (3.1)	NT5DC1 (3.0)	MAPKAPK5 (2.1)	SARS (2.1)	NAA25 (2.0)	C19orf52 (1.9)	DOCK7 (1.8)	DDX56 (1.7)	SMARCA4 (1.7)
ENSG00000143190	POU2F1 PPI subnetwork	0.45	> 0.20	BUD13 (2.5)	ATXN2 (2.2)	C12orf43 (2.1)	POLK (1.8)	ADAM1 (1.7)	TRIB1 (1.6)	DHODH (1.6)	ACAD10 (1.6)	ENSG00000226645 (1.5)	ZNF259 (1.5)
ENSG00000024048	UBR2 PPI subnetwork	0.45	> 0.20	POC5 (2.1)	PSMA5 (2.0)	SMARCA4 (2.0)	COL4A3BP (2.0)	BRAP (1.9)	NAA25 (1.9)	ATXN2 (1.9)	NT5DC1 (1.8)	USP24 (1.7)	TOMM40 (1.5)
ENSG00000154188	ANGPT1 PPI subnetwork	0.45	> 0.20	ITGB3 (2.3)	GCNT4 (2.3)	DNAH11 (2.1)	COL4A3BP (2.1)	SH2B3 (2.0)	DNM2 (1.9)	NYNRIN (1.8)	TMEM57 (1.8)	ZHX3 (1.6)	GATAD2A (1.5)
GO:0022409	positive regulation of cell-cell adhesion	0.45	> 0.20	ENSG00000228044 (2.9)	TSSK6 (2.2)	GCNT4 (2.1)	KANK2 (1.9)	ENSG00000238078 (1.8)	C1orf63 (1.4)	FRK (1.4)	TMEM116 (1.3)	ZNF101 (1.3)	SLC44A2 (1.3)
MP:0002837	dystrophic cardiac calcinosis	0.45	> 0.20	KANK2 (2.5)	COL4A3BP (2.2)	TSSK6 (2.1)	GMPR (2.0)	KIAA1324 (2.0)	ACAD10 (2.0)	SLC22A1 (1.7)	ENSG00000254235 (1.5)	CYB561D1 (1.5)	DNM2 (1.4)
MP:0008578	decreased circulating interferon-gamma level	0.45	> 0.20	OASL (5.7)	PARP10 (4.4)	TRAFD1 (3.7)	TIMD4 (3.2)	ZNF101 (2.2)	RELB (2.0)	BCL3 (1.7)	ATP13A1 (1.7)	HLX (1.6)	PBX4 (1.5)
GO:0051219	phosphoprotein binding	0.45	> 0.20	C17orf57 (2.6)	MARK4 (2.6)	TMEM50A (2.2)	PPP1R37 (1.8)	GRINA (1.8)	TSSK6 (1.8)	COL4A3BP (1.6)	CARM1 (1.5)	DHODH (1.5)	CLPTM1 (1.5)
ENSG00000105664	COMP PPI subnetwork	0.45	> 0.20	CILP2 (5.6)	SYPL2 (3.3)	GRINA (2.3)	PLEKHH2 (2.1)	MARK4 (1.8)	LPAR2 (1.7)	ITGB3 (1.6)	PLEC (1.4)	GEMIN7 (1.4)	PVR (1.4)
MP:0001802	arrested B cell differentiation	0.45	> 0.20	GMIP (2.9)	SMARCA4 (2.8)	ZNF101 (2.5)	HLX (2.1)	CYB561D1 (1.8)	GPAM (1.7)	GCNT4 (1.6)	GRINA (1.4)	TIMD4 (1.3)	RELB (1.3)
ENSG00000137054	POLR1E PPI subnetwork	0.45	> 0.20	ZNF259 (3.8)	TOMM40 (3.2)	DDX56 (3.1)	C12orf43 (3.0)	QTRT1 (3.0)	PVR (2.9)	GEMIN7 (2.8)	DHX38 (2.5)	ILF3 (2.3)	SUGP1 (2.0)
ENSG00000033327	GAB2 PPI subnetwork	0.45	> 0.20	SLC44A2 (2.8)	ITGB3 (2.7)	DNM2 (2.6)	PLCG1 (2.5)	GMIP (2.3)	MARK4 (2.1)	DHX38 (1.6)	ZHX3 (1.6)	OGDH (1.5)	PTPN11 (1.5)
MP:0008246	abnormal leukocyte morphology	0.45	> 0.20	ZNF101 (3.4)	TIMD4 (2.8)	GMIP (2.3)	TRIB1 (2.1)	MYLIP (2.1)	CETP (1.8)	HAVCR1 (1.7)	APOC1 (1.7)	BCL3 (1.7)	APOE (1.3)
GO:0044003	modification by symbiont of host morphology or physiology	0.45	> 0.20	ANKRD31 (2.4)	ST3GAL4 (2.0)	DNAH11 (1.9)	OASL (1.9)	ANGPTL3 (1.7)	POLK (1.6)	LPA (1.5)	SLC22A1 (1.5)	GMPR (1.5)	C1orf63 (1.4)
GO:0002703	regulation of leukocyte mediated immunity	0.45	> 0.20	DNAH11 (1.9)	GEMIN7 (1.6)	GMIP (1.5)	ENSG00000235545 (1.5)	PARP10 (1.4)	ZNF101 (1.3)	LPAR2 (1.3)	NKPD1 (1.2)	TRAFD1 (1.2)	TIMD4 (1.0)
GO:0014897	striated muscle hypertrophy	0.45	> 0.20	ENSG00000226648 (3.2)	CEACAM19 (3.0)	HNF1A (2.6)	GCNT4 (2.4)	DNAH11 (2.1)	ENSG00000254235 (1.9)	TXNL4B (1.7)	ENSG00000235545 (1.4)	NPC1L1 (1.4)	C12orf51 (1.3)
GO:0003300	cardiac muscle hypertrophy	0.45	> 0.20	ENSG00000226648 (3.2)	CEACAM19 (3.0)	HNF1A (2.6)	GCNT4 (2.4)	DNAH11 (2.1)	ENSG00000254235 (1.9)	TXNL4B (1.7)	ENSG00000235545 (1.4)	NPC1L1 (1.4)	C12orf51 (1.3)
GO:0051044	positive regulation of membrane protein ectodomain proteolysis	0.45	> 0.20	ENSG00000235545 (4.2)	ENSG00000228044 (3.5)	ENSG00000254235 (2.2)	GEMIN7 (2.1)	CBLC (1.9)	TRAFD1 (1.7)	SUGP1 (1.5)	CETP (1.5)	SLC44A2 (1.4)	LPAR2 (1.4)
ENSG00000150867	PIP4K2A PPI subnetwork	0.45	> 0.20	CARM1 (3.6)	ALDH2 (3.1)	POLK (2.5)	PVRL2 (2.3)	ITGB3 (2.2)	TOMM40 (2.1)	ATXN2 (2.1)	SORT1 (1.9)	PLEC (1.7)	ANKRD31 (1.7)
GO:0003417	growth plate cartilage development	0.45	> 0.20	CILP2 (7.4)	UBXN2B (2.5)	YIPF2 (2.2)	ANKRD31 (2.0)	SLC44A2 (1.9)	TSSK6 (1.9)	QTRT1 (1.6)	ABO (1.5)	PBX4 (1.2)	GMPR (1.2)
ENSG00000079102	RUNX1T1 PPI subnetwork	0.45	> 0.20	ATXN2 (2.8)	SMARCA4 (2.4)	CARM1 (2.2)	PLCG1 (2.1)	PTPN11 (2.1)	ZHX3 (2.1)	C12orf47 (1.9)	KANK2 (1.7)	GATAD2A (1.7)	UBXN2B (1.5)
ENSG00000014216	CAPN1 PPI subnetwork	0.45	> 0.20	PVR (3.1)	SYPL2 (2.4)	TMEM50A (2.3)	PLG (2.3)	CEACAM19 (2.0)	PLEC (1.7)	APOE (1.5)	UBXN2B (1.5)	ANGPTL3 (1.4)	ACAD10 (1.3)
MP:0008965	increased basal metabolism	0.45	> 0.20	CELSR2 (2.6)	CETP (2.4)	SH2B3 (2.2)	TIMD4 (2.1)	TRIB1 (2.0)	LPA (1.8)	ZNF101 (1.7)	TSSK6 (1.7)	COL4A3BP (1.6)	MAFB (1.5)
ENSG00000102871	TRADD PPI subnetwork	0.45	> 0.20	HAVCR1 (3.7)	TRAFD1 (3.6)	RELB (2.7)	PTPN11 (2.5)	PARP10 (2.4)	PSMA5 (2.2)	C11orf9 (2.2)	BCL3 (2.1)	GRINA (1.8)	ZNF101 (1.7)
MP:0004819	decreased skeletal muscle mass	0.45	> 0.20	SYPL2 (5.5)	AMIGO1 (2.5)	PVR (2.4)	CARM1 (2.4)	PLEC (2.0)	SLC44A2 (1.7)	BCAM (1.7)	KIAA1324 (1.6)	PVRL2 (1.3)	GPAM (1.3)
ENSG00000140307	GTF2A2 PPI subnetwork	0.45	> 0.20	MAPKAPK5 (3.4)	PSMA5 (2.6)	SUGP1 (2.5)	POC5 (2.5)	ATXN2 (2.4)	GEMIN7 (2.4)	TOP1 (2.3)	MARK4 (1.8)	ZNF259 (1.7)	ILF3 (1.6)
MP:0001614	abnormal blood vessel morphology	0.45	> 0.20	HLX (3.4)	KANK2 (3.1)	SH2B3 (2.9)	ITGB3 (2.7)	BCAM (2.2)	PLEC (2.1)	MYLIP (1.6)	GATAD2A (1.6)	LPA (1.4)	MAFB (1.4)
ENSG00000198324	FAM109A PPI subnetwork	0.45	> 0.20	BRAP (2.5)	ZNF101 (2.4)	ENSG00000254235 (2.3)	TIMD4 (2.1)	CETP (1.9)	PLCG1 (1.8)	MAFB (1.8)	TOP1 (1.7)	APOE (1.7)	TMED4 (1.7)
GO:0007623	circadian rhythm	0.45	> 0.20	ENSG00000226648 (2.9)	HNF1A (2.2)	ENSG00000228044 (2.1)	HAPLN4 (2.1)	ENSG00000235545 (1.9)	ENSG00000254235 (1.8)	TRIB1 (1.7)	ABO (1.4)	DNAH11 (1.4)	ZHX3 (1.3)
GO:0007129	synapsis	0.45	> 0.20	ANKRD31 (2.9)	ENSG00000238078 (2.7)	DNAH11 (2.0)	LPIN3 (1.9)	GCNT4 (1.3)	ADAM1 (1.2)	PBX4 (1.2)	ATP13A1 (1.0)	C17orf57 (1.0)	MAPKAPK5 (0.9)
GO:0034104	negative regulation of tissue remodeling	0.45	> 0.20	HNF1A (2.8)	ENSG00000228044 (2.4)	CEACAM19 (2.1)	ANKRD31 (2.0)	GOT2P1 (1.9)	ABO (1.5)	ENSG00000235545 (1.5)	HAPLN4 (1.5)	ERP29 (1.2)	ENSG00000226645 (1.2)
GO:0005581	collagen	0.45	> 0.20	CILP2 (6.3)	APOE (3.1)	APOC1 (2.3)	LPA (2.2)	MYLIP (2.0)	PLEKHH2 (1.9)	MAFB (1.8)	TIMD4 (1.6)	CETP (1.6)	AP1M2 (1.5)
MP:0009504	abnormal mammary gland epithelium morphology	0.45	> 0.20	CELSR2 (2.9)	PSRC1 (2.1)	POLK (1.8)	KANK2 (1.7)	FRK (1.6)	UBXN2B (1.6)	ABO (1.6)	AP1M2 (1.5)	KIAA1324 (1.4)	ACAD10 (1.3)
GO:0032958	inositol phosphate biosynthetic process	0.45	> 0.20	GMPR (3.1)	CEACAM19 (2.2)	ZHX3 (2.2)	ENSG00000235545 (2.2)	FRK (1.9)	ENSG00000238078 (1.8)	ITGB3 (1.5)	TMEM57 (1.4)	KIAA1324 (1.3)	GCNT4 (1.3)
GO:0090407	organophosphate biosynthetic process	0.45	> 0.20	GMPR (3.1)	CEACAM19 (2.2)	ZHX3 (2.2)	ENSG00000235545 (2.2)	FRK (1.9)	ENSG00000238078 (1.8)	ITGB3 (1.5)	TMEM57 (1.4)	KIAA1324 (1.3)	GCNT4 (1.3)
ENSG00000182319	SGK223 PPI subnetwork	0.45	> 0.20	CBLC (5.8)	AP1M2 (3.6)	ST3GAL4 (2.8)	CELSR2 (2.4)	FRK (2.3)	LPIN3 (2.2)	DNM2 (1.8)	C12orf51 (1.8)	LPAR2 (1.8)	PLEC (1.6)
MP:0000933	abnormal rhombomere morphology	0.45	> 0.20	PLCG1 (1.8)	ENSG00000254235 (1.6)	CILP2 (1.6)	HLX (1.5)	ANKRD31 (1.5)	APOE (1.2)	MAFB (1.1)	ENSG00000228044 (1.1)	PMFBP1 (1.1)	CYP7A1 (1.0)
ENSG00000101413	RPRD1B PPI subnetwork	0.45	> 0.20	USP24 (4.1)	SUGP1 (2.9)	SMARCA4 (2.9)	CARM1 (2.4)	POLK (2.3)	ATXN2 (1.9)	C12orf43 (1.8)	TMEM57 (1.7)	C1orf63 (1.6)	NT5DC1 (1.6)
ENSG00000113318	MSH3 PPI subnetwork	0.45	> 0.20	FEN1 (4.0)	USP1 (2.9)	POLK (2.5)	ZNF180 (2.3)	ATP13A1 (1.8)	TMEM116 (1.8)	ENSG00000226645 (1.7)	BRAP (1.5)	BUD13 (1.5)	POC5 (1.2)
GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	0.45	> 0.20	CELSR2 (3.4)	TRAFD1 (2.9)	PARP10 (2.3)	CYB561D1 (1.9)	MYLIP (1.7)	HAVCR1 (1.7)	SORT1 (1.7)	TSSK6 (1.6)	FRK (1.5)	GRINA (1.4)
ENSG00000214026	MRPL23 PPI subnetwork	0.45	> 0.20	QTRT1 (3.7)	MAU2 (3.2)	GEMIN7 (2.8)	ATP13A1 (2.2)	C19orf52 (2.2)	CARM1 (2.1)	TOMM40 (2.0)	DDX56 (2.0)	NAA25 (1.9)	C12orf47 (1.8)
MP:0001196	shiny skin	0.45	> 0.20	NKPD1 (5.1)	CBLC (4.7)	AP1M2 (3.3)	CEACAM19 (2.8)	BCAM (2.3)	LPIN3 (2.3)	CELSR2 (2.2)	C17orf57 (2.0)	ERP29 (1.7)	PLEC (1.4)
MP:0005095	decreased T cell proliferation	0.45	> 0.20	RELB (3.5)	GMIP (3.2)	BCL3 (2.7)	SH2B3 (1.8)	ZNF101 (1.7)	PARP10 (1.6)	PBX4 (1.6)	CETP (1.2)	MAFB (1.2)	HAVCR1 (1.2)
ENSG00000057657	PRDM1 PPI subnetwork	0.46	> 0.20	TM6SF2 (3.1)	HAPLN4 (2.7)	DNAH11 (2.4)	MYLIP (2.2)	ABCG8 (2.2)	LDLR (1.9)	ABCG5 (1.8)	ZNF101 (1.8)	PPP1R37 (1.7)	SYPL2 (1.7)
ENSG00000176658	MYO1D PPI subnetwork	0.46	> 0.20	POLK (3.1)	POC5 (2.4)	ITGB3 (2.3)	GEMIN7 (1.8)	HAVCR1 (1.6)	PPP1R37 (1.6)	HLX (1.6)	RELB (1.5)	TMEM50A (1.5)	MOSC1 (1.4)
GO:0010717	regulation of epithelial to mesenchymal transition	0.46	> 0.20	KANK2 (2.8)	ENSG00000254235 (2.5)	SLC44A2 (2.4)	ANKRD31 (2.1)	PLEKHH2 (2.1)	ENSG00000226648 (2.0)	ABO (1.9)	MYLIP (1.8)	SH2B3 (1.8)	TMEM116 (1.5)
GO:0030522	intracellular receptor mediated signaling pathway	0.46	> 0.20	ENSG00000226648 (2.8)	ATXN2 (2.6)	MAPKAPK5 (2.3)	CYP7A1 (1.9)	FRK (1.8)	MAU2 (1.7)	COL4A3BP (1.5)	TRIB1 (1.5)	C1orf63 (1.3)	SH2B3 (1.3)
GO:0014823	response to activity	0.46	> 0.20	SYPL2 (4.1)	DNAH11 (2.4)	TXNL4B (2.1)	FRK (1.9)	ZNF101 (1.8)	ZHX3 (1.7)	ENSG00000226645 (1.7)	AMIGO1 (1.6)	C17orf57 (1.5)	MAFB (1.3)
ENSG00000157985	AGAP1 PPI subnetwork	0.46	> 0.20	MAU2 (2.6)	CETP (2.5)	ITGB3 (2.4)	PLEKHH2 (2.4)	ABO (2.2)	MYLIP (2.2)	BLOC1S3 (2.1)	C12orf51 (2.0)	YIPF2 (1.4)	CBLC (1.4)
GO:0046135	pyrimidine nucleoside catabolic process	0.46	> 0.20	C17orf57 (2.6)	TSSK6 (2.3)	SYPL2 (2.2)	SLC22A1 (1.9)	DNAH11 (1.8)	GEMIN7 (1.7)	LPA (1.6)	ABO (1.5)	APOC4 (1.5)	ANGPTL3 (1.5)
ENSG00000137074	APTX PPI subnetwork	0.46	> 0.20	PBX4 (2.7)	MARK4 (1.9)	TRAPPC6A (1.7)	RPH3A (1.7)	DNAH11 (1.7)	PSRC1 (1.4)	TRAFD1 (1.3)	SLC44A2 (1.3)	PVRL2 (1.3)	HAPLN4 (1.3)
ENSG00000206258	TNXB PPI subnetwork	0.46	> 0.20	PARP10 (2.6)	PTPN11 (2.5)	C17orf57 (2.4)	FRK (2.3)	KANK2 (1.8)	ADAM1 (1.6)	UBXN2B (1.5)	ZNF180 (1.4)	DHX38 (1.4)	OGDH (1.4)
GO:0003690	double-stranded DNA binding	0.46	> 0.20	TRIB1 (3.4)	USP1 (2.9)	ANKRD31 (1.9)	ENSG00000226645 (1.8)	ZNF101 (1.8)	KANK2 (1.8)	HLX (1.5)	HNF1A (1.5)	NYNRIN (1.5)	MAPKAPK5 (1.4)
GO:0051048	negative regulation of secretion	0.46	> 0.20	KIAA1324 (4.1)	GPAM (2.8)	MOSC1 (2.6)	ANKRD31 (2.3)	AMIGO1 (1.8)	CELSR2 (1.7)	ENSG00000228044 (1.6)	LPIN3 (1.4)	NPC1L1 (1.3)	HNF1A (1.3)
MP:0003634	abnormal glial cell morphology	0.46	> 0.20	BCL3 (2.2)	ENSG00000254235 (2.0)	TSSK6 (1.9)	CELSR2 (1.7)	LPAR2 (1.7)	PLEKHH2 (1.6)	TRIB1 (1.6)	RELB (1.5)	ENSG00000226645 (1.5)	ITGB3 (1.5)
GO:0046068	cGMP metabolic process	0.46	> 0.20	TSSK6 (2.6)	CEACAM19 (2.3)	C12orf47 (2.1)	ENSG00000226648 (2.0)	HAVCR1 (2.0)	ZNF180 (1.9)	NKPD1 (1.8)	TMEM116 (1.6)	LPIN3 (1.4)	POC5 (1.3)
MP:0002258	abnormal cricoid cartilage morphology	0.46	> 0.20	HLX (2.8)	HAPLN4 (2.3)	ABCG8 (2.0)	PLEKHH2 (1.8)	NYNRIN (1.7)	BLOC1S3 (1.7)	MARK4 (1.5)	MYLIP (1.4)	CEACAM19 (1.3)	MAFB (1.3)
GO:0000723	telomere maintenance	0.46	> 0.20	POLK (3.2)	ZNF180 (2.6)	ENSG00000226648 (2.4)	USP1 (2.3)	TXNL4B (2.1)	POC5 (2.1)	AMIGO1 (1.9)	BLOC1S3 (1.9)	NKPD1 (1.8)	FEN1 (1.7)
GO:0033327	Leydig cell differentiation	0.46	> 0.20	DNAH11 (4.7)	ST3GAL4 (2.5)	TSSK6 (2.2)	ABO (2.2)	PMFBP1 (2.1)	FRK (2.0)	SLC44A2 (1.6)	LPAR2 (1.6)	TMED4 (1.4)	FADS1 (1.2)
ENSG00000153317	ASAP1 PPI subnetwork	0.46	> 0.20	ITGB3 (3.1)	SH2B3 (2.8)	PMFBP1 (2.8)	ZHX3 (2.6)	SLC44A2 (2.4)	GMIP (2.3)	DNM2 (2.2)	GATAD2A (2.0)	ABO (1.9)	ADAM1 (1.8)
ENSG00000213380	COG8 PPI subnetwork	0.46	> 0.20	PSMA5 (2.7)	ENSG00000226648 (2.6)	SUGP1 (2.6)	DOCK7 (2.5)	CYB561D1 (2.5)	ATXN7L2 (2.5)	MAPKAPK5 (2.1)	DNM2 (2.0)	POC5 (2.0)	NT5DC1 (2.0)
ENSG00000122778	KIAA1549 PPI subnetwork	0.46	> 0.20	ZHX3 (3.5)	HNF1A (3.5)	CBLC (1.8)	SLC22A1 (1.8)	ST3GAL4 (1.7)	HAVCR1 (1.7)	C12orf51 (1.7)	TMED4 (1.6)	KIAA1324 (1.6)	BCL3 (1.5)
GO:0045931	positive regulation of mitotic cell cycle	0.46	> 0.20	DNAH11 (2.4)	CEACAM19 (1.9)	RHD (1.8)	RHCE (1.7)	UBXN2B (1.7)	PSRC1 (1.7)	ENSG00000228044 (1.5)	PMFBP1 (1.5)	ZNF101 (1.5)	BLOC1S3 (1.5)
ENSG00000116604	MEF2D PPI subnetwork	0.46	> 0.20	HLX (2.5)	ANKRD31 (2.4)	ENSG00000226648 (2.2)	SH2B3 (2.2)	DOCK7 (2.1)	CARM1 (2.1)	C12orf51 (2.0)	TRIB1 (1.7)	C17orf57 (1.6)	CEACAM19 (1.5)
ENSG00000064995	TAF11 PPI subnetwork	0.46	> 0.20	MAPKAPK5 (3.2)	PSMA5 (2.9)	TXNL4B (2.4)	SUGP1 (2.3)	POC5 (2.1)	MAU2 (2.0)	COL4A3BP (2.0)	ATXN2 (2.0)	TOP1 (1.7)	USP1 (1.7)
ENSG00000117877	CD3EAP PPI subnetwork	0.46	> 0.20	QTRT1 (2.6)	ZNF259 (2.5)	ZNF180 (2.4)	C12orf43 (2.4)	BUD13 (2.3)	DHODH (2.1)	GEMIN7 (1.9)	MOSC1 (1.8)	DHX38 (1.8)	DYNC2LI1 (1.5)
REACTOME_CALCITONIN:LIKE_LIGAND_RECEPTORS	REACTOME_CALCITONIN:LIKE_LIGAND_RECEPTORS	0.46	> 0.20	LPIN3 (2.7)	ABO (2.6)	HLX (2.2)	PVRL2 (1.8)	ERP29 (1.7)	RPH3A (1.5)	CETP (1.4)	BCAM (1.4)	GEMIN7 (1.3)	NKPD1 (1.2)
GO:0033146	regulation of intracellular estrogen receptor signaling pathway	0.46	> 0.20	GCNT4 (3.3)	AP1M2 (2.1)	QTRT1 (2.0)	ENSG00000254235 (1.7)	YIPF2 (1.7)	COL4A3BP (1.6)	ENSG00000238078 (1.6)	ATXN2 (1.5)	HAVCR1 (1.5)	C19orf52 (1.5)
REACTOME_APCCCDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APCCCDH1_TARGETED_PROTEINS_IN_LATE_MITOSISEARLY_G1	REACTOME_APCCCDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APCCCDH1_TARGETED_PROTEINS_IN_LATE_MITOSISEARLY_G1	0.46	> 0.20	PSMA5 (5.8)	TRAFD1 (3.7)	NAA25 (2.2)	SUGP1 (2.2)	DDX56 (1.9)	POC5 (1.8)	PSRC1 (1.8)	FEN1 (1.5)	LPIN3 (1.4)	TOMM40 (1.3)
GO:0003158	endothelium development	0.46	> 0.20	DNAH11 (3.1)	CILP2 (2.7)	ENSG00000226645 (2.4)	CETP (2.2)	HLX (2.1)	BCAM (2.0)	HNF1A (1.9)	PLCG1 (1.8)	ANKRD31 (1.7)	SLC44A2 (1.7)
GO:0007062	sister chromatid cohesion	0.46	> 0.20	ABO (2.7)	ANKRD31 (2.5)	POC5 (2.1)	USP1 (1.8)	C19orf52 (1.6)	ENSG00000226648 (1.5)	C12orf47 (1.4)	BUD13 (1.4)	ILF3 (1.3)	PSRC1 (1.3)
ENSG00000120699	EXOSC8 PPI subnetwork	0.46	> 0.20	DHODH (3.4)	SUGP1 (3.1)	MAPKAPK5 (3.0)	POC5 (2.7)	USP24 (2.5)	DDX56 (2.3)	POLK (2.1)	DHX38 (2.0)	GRINA (1.5)	KANK2 (1.5)
GO:0031966	mitochondrial membrane	0.46	> 0.20	ACAD10 (4.3)	OGDH (4.1)	ALDH2 (2.6)	GMPR (2.5)	GPAM (2.2)	TRAPPC6A (2.2)	TOMM40 (2.1)	ABCG8 (1.7)	C19orf52 (1.7)	PSMA5 (1.6)
ENSG00000183155	RABIF PPI subnetwork	0.46	> 0.20	CYB561D1 (3.3)	PSMA5 (2.8)	TMED4 (2.7)	SARS (2.7)	TMEM50A (2.3)	DNAH11 (2.3)	AMIGO1 (2.3)	ABO (2.3)	PSRC1 (1.9)	TRAFD1 (1.8)
GO:0001836	release of cytochrome c from mitochondria	0.46	> 0.20	TRAPPC6A (2.3)	BLOC1S3 (2.2)	ENSG00000235545 (2.2)	C12orf43 (2.0)	FRK (2.0)	BRAP (1.8)	TRAFD1 (1.7)	CBLC (1.7)	ERP29 (1.6)	CILP2 (1.5)
MP:0006341	small first branchial arch	0.46	> 0.20	GATAD2A (3.5)	PLCG1 (2.7)	SLC44A2 (2.5)	RHCE (1.9)	MARK4 (1.8)	ANKRD31 (1.7)	ATXN2 (1.6)	ATP13A1 (1.6)	ENSG00000226648 (1.6)	KANK2 (1.6)
GO:2000242	negative regulation of reproductive process	0.46	> 0.20	OASL (4.8)	ENSG00000235545 (3.3)	C11orf9 (2.5)	GCNT4 (1.9)	ZNF101 (1.8)	GMPR (1.8)	PARP10 (1.7)	ENSG00000226645 (1.6)	C1orf63 (1.5)	MAU2 (1.4)
GO:0030730	sequestering of triglyceride	0.46	> 0.20	MOSC1 (3.4)	GPAM (2.4)	CYP7A1 (2.0)	SORT1 (1.9)	GCNT4 (1.7)	TIMD4 (1.5)	ENSG00000228044 (1.5)	AMIGO1 (1.4)	TXNL4B (1.4)	ABCG8 (1.4)
GO:0030552	cAMP binding	0.46	> 0.20	MOSC1 (2.7)	ENSG00000254235 (2.2)	ITGB3 (2.2)	ABO (2.0)	PCSK9 (1.9)	SORT1 (1.6)	CEACAM19 (1.6)	RPH3A (1.5)	CETP (1.4)	CYP7A1 (1.4)
MP:0003243	abnormal dopaminergic neuron morphology	0.46	> 0.20	GMPR (3.4)	RHCE (2.2)	ABO (2.1)	ENSG00000254235 (2.0)	BLOC1S3 (1.8)	HNF1A (1.5)	DNAH11 (1.5)	PMFBP1 (1.4)	TMEM50A (1.4)	RHD (1.3)
GO:0030286	dynein complex	0.46	> 0.20	DNAH11 (5.7)	DYNC2LI1 (1.7)	KIAA1324 (1.6)	C1orf63 (1.3)	MARK4 (1.1)	CEACAM19 (1.1)	PLCG1 (1.0)	COL4A3BP (1.0)	PLEC (0.9)	C12orf51 (0.9)
GO:0042401	cellular biogenic amine biosynthetic process	0.46	> 0.20	BLOC1S3 (2.9)	HNF1A (2.4)	TSSK6 (2.2)	C12orf47 (2.1)	PMFBP1 (1.9)	CILP2 (1.9)	GMPR (1.7)	TRAPPC6A (1.7)	QTRT1 (1.6)	GEMIN7 (1.6)
ENSG00000110880	CORO1C PPI subnetwork	0.46	> 0.20	PLEC (4.3)	PVR (2.4)	LPIN3 (2.4)	ABCG8 (2.2)	KANK2 (2.1)	GATAD2A (2.0)	TM6SF2 (1.9)	DOCK7 (1.8)	PLCG1 (1.7)	BRAP (1.6)
ENSG00000101306	MYLK2 PPI subnetwork	0.46	> 0.20	UBXN2B (3.1)	SYPL2 (3.0)	ZNF180 (2.5)	CEACAM19 (2.1)	TMEM50A (2.0)	PPP1R37 (1.6)	PBX4 (1.6)	KIAA1324 (1.5)	BCL3 (1.4)	C1orf63 (1.3)
ENSG00000178209	PLEC PPI subnetwork	0.46	> 0.20	PLEC (4.5)	KANK2 (2.8)	GATAD2A (2.7)	OGDH (2.4)	RHD (2.3)	PLCG1 (2.0)	HLX (1.9)	BCAM (1.8)	C12orf51 (1.7)	HAPLN4 (1.6)
REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6:ALPHA	REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6:ALPHA	0.46	> 0.20	TMED4 (3.7)	ERP29 (3.1)	SARS (2.7)	ADAM1 (2.7)	C12orf47 (2.7)	POC5 (2.3)	MAPKAPK5 (2.3)	DHODH (2.2)	TXNL4B (2.1)	PMFBP1 (2.0)
GO:0001541	ovarian follicle development	0.46	> 0.20	ST3GAL4 (2.8)	ABO (2.6)	YIPF2 (2.2)	CEACAM19 (2.1)	ENSG00000235545 (2.0)	FRK (1.6)	AMIGO1 (1.5)	RHCE (1.4)	GEMIN7 (1.4)	NYNRIN (1.3)
MP:0004568	fusion of glossopharyngeal and vagus nerve	0.46	> 0.20	TSSK6 (3.3)	HLX (2.8)	CEACAM19 (2.4)	BLOC1S3 (2.2)	C11orf9 (1.9)	DYNC2LI1 (1.8)	ANKRD31 (1.7)	SORT1 (1.7)	UBXN2B (1.3)	POC5 (1.3)
GO:0090398	cellular senescence	0.46	> 0.20	POLK (2.5)	TMED4 (1.9)	NAA25 (1.8)	GOT2P1 (1.8)	ZNF259 (1.7)	PBX4 (1.7)	ENSG00000254235 (1.6)	AMIGO1 (1.6)	DHODH (1.5)	PMFBP1 (1.5)
ENSG00000135744	AGT PPI subnetwork	0.46	> 0.20	PMFBP1 (2.9)	TM6SF2 (2.9)	PLG (2.6)	FRK (2.4)	NPC1L1 (2.3)	ABCG5 (2.1)	APOB (2.1)	ANGPTL3 (2.0)	HAVCR1 (1.9)	TRAFD1 (1.9)
GO:0019079	viral genome replication	0.46	> 0.20	OASL (5.0)	MAU2 (2.3)	ENSG00000228044 (2.0)	ENSG00000235545 (1.9)	FRK (1.8)	NKPD1 (1.7)	ATP13A1 (1.6)	GCNT4 (1.4)	PARP10 (1.4)	TIMD4 (1.4)
GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	0.46	> 0.20	KANK2 (2.8)	C19orf52 (2.5)	ENSG00000226645 (2.2)	TMED4 (2.0)	ZNF180 (2.0)	GCNT4 (1.6)	ENSG00000254235 (1.5)	CYP7A1 (1.4)	TMEM50A (1.4)	DNM2 (1.2)
ENSG00000177169	ULK1 PPI subnetwork	0.46	> 0.20	ILF3 (3.7)	CARM1 (3.5)	GATAD2A (3.4)	MAU2 (3.4)	GOT2P1 (2.9)	YIPF2 (2.7)	AP1M2 (2.6)	DNM2 (2.6)	SLC44A2 (2.2)	GRINA (2.2)
MP:0005348	increased T cell proliferation	0.46	> 0.20	RELB (3.0)	PBX4 (2.6)	GMIP (2.2)	RHCE (2.1)	RHD (2.0)	CETP (2.0)	BCL3 (1.9)	SLC44A2 (1.9)	TRAFD1 (1.8)	PARP10 (1.6)
REACTOME_UNFOLDED_PROTEIN_RESPONSE	REACTOME_UNFOLDED_PROTEIN_RESPONSE	0.46	> 0.20	YIPF2 (4.6)	ERP29 (3.5)	SARS (3.5)	TMED4 (2.4)	DHODH (1.9)	GRINA (1.7)	PVR (1.7)	ATP13A1 (1.6)	DHX38 (1.5)	PCSK9 (1.5)
KEGG_RIBOFLAVIN_METABOLISM	KEGG_RIBOFLAVIN_METABOLISM	0.46	> 0.20	ST3GAL4 (3.0)	SORT1 (2.1)	CYB561D1 (1.9)	APOE (1.8)	ZNF101 (1.7)	APOC1 (1.7)	ABO (1.6)	TM6SF2 (1.5)	YIPF2 (1.4)	CILP2 (1.4)
MP:0008725	enlarged heart atrium	0.46	> 0.20	BCAM (3.0)	GMPR (2.0)	DHODH (2.0)	ABCG5 (1.8)	PVRL2 (1.8)	POC5 (1.7)	C11orf9 (1.5)	ABCG8 (1.5)	NPC1L1 (1.5)	NYNRIN (1.4)
KEGG_ENDOMETRIAL_CANCER	KEGG_ENDOMETRIAL_CANCER	0.46	> 0.20	DNM2 (3.1)	UBXN2B (2.6)	AP1M2 (2.4)	DOCK7 (2.3)	PLEC (2.2)	SORT1 (2.1)	PTPN11 (2.0)	SLC44A2 (1.9)	GATAD2A (1.9)	BLOC1S3 (1.7)
ENSG00000104973	MED25 PPI subnetwork	0.46	> 0.20	TXNL4B (3.0)	GEMIN7 (2.8)	BRAP (2.7)	BUD13 (2.3)	POC5 (2.0)	MAPKAPK5 (1.8)	DHX38 (1.8)	BLOC1S3 (1.7)	C17orf57 (1.7)	TMEM57 (1.7)
ENSG00000108883	EFTUD2 PPI subnetwork	0.46	> 0.20	ILF3 (3.8)	SMARCA4 (3.2)	TOP1 (3.1)	C1orf63 (3.1)	USP1 (2.9)	DHX38 (2.6)	TOMM40 (2.2)	FEN1 (2.2)	SUGP1 (2.0)	BUD13 (2.0)
MP:0005590	increased vasodilation	0.46	> 0.20	PVR (2.4)	SYPL2 (1.7)	PLEC (1.6)	LPIN3 (1.6)	PVRL2 (1.5)	TRIB1 (1.4)	SH2B3 (1.3)	PSRC1 (1.3)	ATP13A1 (1.2)	ENSG00000254235 (1.2)
ENSG00000077514	POLD3 PPI subnetwork	0.46	> 0.20	FEN1 (5.2)	USP1 (4.8)	AMIGO1 (2.4)	ZNF180 (2.2)	ENSG00000235545 (2.0)	DHODH (1.7)	FADS1 (1.6)	ENSG00000228044 (1.5)	TOMM40 (1.3)	LPA (1.3)
GO:0030119	AP-type membrane coat adaptor complex	0.46	> 0.20	CLPTM1 (3.4)	PPP1R37 (2.9)	YIPF2 (2.4)	DNM2 (2.4)	COL4A3BP (2.2)	OGDH (2.1)	C1orf63 (2.1)	GRINA (1.9)	CYB561D1 (1.8)	BLOC1S3 (1.6)
MP:0002161	abnormal fertility/fecundity	0.46	> 0.20	GMPR (1.7)	NYNRIN (1.5)	ANKRD31 (1.4)	HLX (1.3)	MYLIP (1.3)	PLCG1 (1.2)	TIMD4 (1.2)	POC5 (1.2)	PPP1R37 (1.2)	POLK (1.2)
ENSG00000129682	FGF13 PPI subnetwork	0.46	> 0.20	CBLC (4.0)	PLEKHH2 (3.7)	C11orf9 (2.9)	KIAA1324 (2.4)	HAPLN4 (2.3)	APOE (2.3)	HAVCR1 (2.3)	MYLIP (2.2)	AP1M2 (2.2)	NCAN (2.1)
ENSG00000186446	ZNF501 PPI subnetwork	0.46	> 0.20	TM6SF2 (2.9)	ENSG00000226645 (2.7)	MYLIP (2.5)	TRIB1 (2.4)	LDLR (2.2)	ABCG5 (1.8)	MAU2 (1.8)	ABCG8 (1.8)	NPC1L1 (1.8)	DNAH11 (1.7)
GO:0046131	pyrimidine ribonucleoside metabolic process	0.46	> 0.20	DYNC2LI1 (2.7)	C12orf43 (2.4)	TSSK6 (2.4)	ANKRD31 (2.3)	PBX4 (2.1)	PMFBP1 (2.0)	SYPL2 (1.7)	ACAD10 (1.5)	GOT2P1 (1.4)	LPA (1.4)
ENSG00000095585	BLNK PPI subnetwork	0.46	> 0.20	GMIP (3.7)	COL4A3BP (3.1)	SH2B3 (2.5)	GATAD2A (2.4)	DNM2 (2.2)	MAFB (1.9)	APOE (1.9)	SLC44A2 (1.7)	ENSG00000226645 (1.6)	MYLIP (1.6)
ENSG00000187840	EIF4EBP1 PPI subnetwork	0.46	> 0.20	HMGCR (3.5)	DHX38 (3.2)	PTPN11 (3.0)	LDLR (2.6)	C12orf43 (2.4)	FADS2 (2.3)	ATXN2 (2.3)	SMARCA4 (2.3)	CLPTM1 (2.0)	MAU2 (2.0)
ENSG00000115138	POMC PPI subnetwork	0.46	> 0.20	ENSG00000228044 (3.0)	PMFBP1 (2.9)	ENSG00000254235 (1.9)	C12orf47 (1.9)	FRK (1.7)	COL4A3BP (1.7)	NKPD1 (1.6)	NPC1L1 (1.5)	LPIN3 (1.5)	HP (1.5)
ENSG00000166206	GABRB3 PPI subnetwork	0.46	> 0.20	C11orf9 (2.3)	ANKRD31 (2.0)	ABO (1.7)	RPH3A (1.6)	GCNT4 (1.4)	ATP13A1 (1.2)	MYLIP (1.1)	ERP29 (1.1)	GOT2P1 (1.1)	KIAA1324 (1.1)
ENSG00000163362	C1orf106 PPI subnetwork	0.46	> 0.20	CBLC (5.0)	AP1M2 (3.6)	CELSR2 (2.2)	ST3GAL4 (2.0)	LPIN3 (1.8)	PSRC1 (1.8)	C12orf51 (1.8)	DOCK7 (1.7)	LPAR2 (1.7)	PLEC (1.4)
MP:0002111	abnormal tail morphology	0.46	> 0.20	CILP2 (4.2)	PCSK9 (3.0)	PLCG1 (1.9)	HAPLN4 (1.9)	ALDH2 (1.8)	TRIB1 (1.7)	ENSG00000254235 (1.6)	PLEKHH2 (1.5)	LDLR (1.4)	MAFB (1.4)
ENSG00000138376	BARD1 PPI subnetwork	0.46	> 0.20	FEN1 (3.7)	RELB (2.8)	USP1 (2.4)	ILF3 (2.2)	CLPTM1 (2.1)	SMARCA4 (2.1)	BUD13 (2.0)	ATXN2 (1.9)	ZNF180 (1.9)	ENSG00000228044 (1.7)
ENSG00000182247	UBE2E2 PPI subnetwork	0.46	> 0.20	USP24 (3.0)	TMEM57 (2.9)	BRAP (2.6)	C19orf52 (2.3)	DHX38 (2.2)	CETP (2.2)	PPP1R37 (2.2)	BLOC1S3 (2.1)	CLPTM1 (2.1)	DOCK7 (2.0)
GO:0032386	regulation of intracellular transport	0.46	> 0.20	ENSG00000238078 (3.3)	ZNF101 (2.6)	GRINA (2.3)	OASL (1.9)	TRAFD1 (1.7)	MYLIP (1.6)	GCNT4 (1.5)	TMEM116 (1.5)	KANK2 (1.4)	PBX4 (1.4)
ENSG00000133112	TPT1 PPI subnetwork	0.46	> 0.20	PTPN11 (3.4)	POC5 (2.7)	BRAP (2.7)	NCAN (2.5)	TRAFD1 (2.1)	GPAM (2.1)	FADS2 (2.0)	TMEM50A (2.0)	DOCK7 (1.9)	GCNT4 (1.8)
GO:0033189	response to vitamin A	0.46	> 0.20	ENSG00000235545 (2.2)	TSSK6 (1.9)	AP1M2 (1.8)	NPC1L1 (1.7)	TM6SF2 (1.6)	LPAR2 (1.6)	C11orf9 (1.6)	HAPLN4 (1.6)	ATXN7L2 (1.5)	MOSC1 (1.4)
REACTOME_ACTIVATION_OF_BH3:ONLY_PROTEINS	REACTOME_ACTIVATION_OF_BH3:ONLY_PROTEINS	0.46	> 0.20	MYLIP (3.3)	RELB (2.0)	FEN1 (1.8)	TRAPPC6A (1.7)	GATAD2A (1.7)	PBX4 (1.6)	PLCG1 (1.5)	ENSG00000254235 (1.5)	LPIN3 (1.5)	MARK4 (1.5)
GO:0016072	rRNA metabolic process	0.46	> 0.20	ZNF259 (3.8)	DDX56 (3.5)	TOMM40 (3.2)	DHODH (3.0)	QTRT1 (3.0)	NAA25 (3.0)	C12orf43 (2.6)	POC5 (2.4)	C19orf52 (2.4)	MAPKAPK5 (2.4)
ENSG00000080845	DLGAP4 PPI subnetwork	0.46	> 0.20	ENSG00000238078 (2.6)	POLK (2.4)	ENSG00000254235 (2.4)	LPIN3 (2.4)	FRK (2.3)	NCAN (2.2)	RPH3A (2.2)	COL4A3BP (2.1)	PPP1R37 (2.1)	POC5 (1.6)
GO:0033605	positive regulation of catecholamine secretion	0.46	> 0.20	ABO (2.6)	BLOC1S3 (2.4)	CEACAM19 (2.3)	ERP29 (2.2)	GOT2P1 (2.0)	NKPD1 (1.9)	KIAA1324 (1.9)	CETP (1.8)	PPP1R37 (1.6)	ZHX3 (1.5)
GO:0061039	ovum-producing ovary development	0.47	> 0.20	ST3GAL4 (2.2)	DNAH11 (2.1)	ABO (2.1)	ENSG00000235545 (1.7)	AMIGO1 (1.6)	YIPF2 (1.6)	CEACAM19 (1.5)	NYNRIN (1.5)	FRK (1.4)	TSSK6 (1.4)
ENSG00000130340	SNX9 PPI subnetwork	0.47	> 0.20	AP1M2 (3.9)	PLEC (2.1)	GMIP (2.0)	KIAA1324 (1.9)	PTPN11 (1.9)	DNM2 (1.9)	ENSG00000238078 (1.8)	CETP (1.7)	YIPF2 (1.5)	HNF1A (1.5)
ENSG00000182934	SRPR PPI subnetwork	0.47	> 0.20	YIPF2 (3.7)	FRK (3.2)	CLPTM1 (2.6)	POC5 (2.4)	SLC44A2 (2.2)	KIAA1324 (2.0)	ENSG00000228044 (2.0)	ERP29 (1.9)	C12orf47 (1.8)	ST3GAL4 (1.7)
GO:0018208	peptidyl-proline modification	0.47	> 0.20	YIPF2 (3.6)	ERP29 (2.9)	TRAPPC6A (2.4)	TOMM40 (2.2)	CEACAM19 (2.1)	TXNL4B (2.0)	DHODH (2.0)	QTRT1 (2.0)	HNF1A (1.6)	TMED4 (1.5)
GO:0003006	developmental process involved in reproduction	0.47	> 0.20	TSSK6 (3.4)	ABO (2.0)	PMFBP1 (2.0)	DNAH11 (2.0)	LPAR2 (1.6)	PLEKHH2 (1.5)	NYNRIN (1.3)	CELSR2 (1.3)	MARK4 (1.2)	ST3GAL4 (1.2)
GO:0060191	regulation of lipase activity	0.47	> 0.20	AMIGO1 (3.1)	PMFBP1 (2.3)	ST3GAL4 (1.9)	PLEKHH2 (1.9)	ZHX3 (1.7)	GOT2P1 (1.6)	ENSG00000235545 (1.4)	APOE (1.3)	ITGB3 (1.3)	COL4A3BP (1.3)
ENSG00000101843	PSMD10 PPI subnetwork	0.47	> 0.20	PSMA5 (5.5)	TRAFD1 (2.7)	NAA25 (2.3)	NT5DC1 (2.1)	TOMM40 (2.0)	DDX56 (1.5)	SARS (1.5)	DHX38 (1.5)	PARP10 (1.4)	TMEM50A (1.3)
GO:0031529	ruffle organization	0.47	> 0.20	ENSG00000228044 (3.4)	ZNF101 (2.7)	DOCK7 (2.3)	CETP (2.0)	HAVCR1 (1.8)	TIMD4 (1.5)	AP1M2 (1.4)	TMEM57 (1.3)	FADS1 (1.2)	PCSK9 (1.2)
GO:0022412	cellular process involved in reproduction in multicellular organism	0.47	> 0.20	GCNT4 (3.9)	PMFBP1 (3.9)	CEACAM19 (3.0)	ENSG00000226645 (2.9)	TSSK6 (2.3)	ENSG00000228044 (2.2)	DNAH11 (1.7)	ANKRD31 (1.5)	POLK (1.2)	NKPD1 (1.1)
GO:0010799	regulation of peptidyl-threonine phosphorylation	0.47	> 0.20	FRK (3.0)	ENSG00000226645 (2.8)	DNAH11 (2.1)	CYB561D1 (1.8)	MAPKAPK5 (1.5)	C19orf52 (1.4)	GCNT4 (1.3)	C17orf57 (1.3)	ENSG00000238078 (1.3)	ENSG00000254235 (1.1)
ENSG00000103089	FA2H PPI subnetwork	0.47	> 0.20	TMEM57 (3.5)	TMEM50A (2.9)	CYB561D1 (2.8)	CLPTM1 (2.6)	TMED4 (2.3)	PVR (2.3)	ERP29 (2.2)	ATP13A1 (2.1)	C19orf52 (2.0)	CYP7A1 (1.8)
GO:0035091	phosphatidylinositol binding	0.47	> 0.20	COL4A3BP (3.0)	CYB561D1 (2.4)	HLX (2.1)	DOCK7 (2.0)	SH2B3 (2.0)	UBXN2B (1.9)	MAFB (1.7)	ZHX3 (1.6)	PPP1R37 (1.6)	LPIN3 (1.5)
GO:0032507	maintenance of protein location in cell	0.47	> 0.20	GOT2P1 (2.1)	ZNF101 (2.0)	CBLC (1.8)	RHD (1.8)	PBX4 (1.8)	CEACAM19 (1.7)	C17orf57 (1.7)	PSRC1 (1.7)	PLEC (1.7)	CLPTM1 (1.6)
GO:0048705	skeletal system morphogenesis	0.47	> 0.20	CILP2 (5.0)	PLEKHH2 (2.5)	NYNRIN (2.5)	CEACAM19 (1.7)	MYLIP (1.6)	ATXN7L2 (1.5)	ANKRD31 (1.3)	MAFB (1.1)	PMFBP1 (1.0)	BCAM (1.0)
GO:0051020	GTPase binding	0.47	> 0.20	DNM2 (2.7)	SH2B3 (2.5)	COL4A3BP (2.4)	GMIP (2.4)	KANK2 (2.2)	PLEC (2.1)	PTPN11 (2.0)	USP24 (2.0)	CARM1 (2.0)	ABO (1.9)
ENSG00000152137	HSPB8 PPI subnetwork	0.47	> 0.20	SYPL2 (4.5)	ZNF101 (2.8)	PLEKHH2 (2.6)	ZHX3 (2.5)	PLEC (1.8)	PTPN11 (1.7)	CARM1 (1.5)	KANK2 (1.5)	PVR (1.4)	CEACAM19 (1.0)
MP:0000296	absent trabeculae carneae	0.47	> 0.20	TSSK6 (2.5)	ABCG8 (2.0)	BCAM (2.0)	ENSG00000226648 (1.9)	SLC44A2 (1.8)	ATXN7L2 (1.7)	APOE (1.6)	PVR (1.6)	TMEM50A (1.5)	ANKRD31 (1.4)
ENSG00000077454	LRCH4 PPI subnetwork	0.47	> 0.20	OASL (7.3)	PARP10 (3.1)	ATP13A1 (2.1)	USP1 (2.0)	ENSG00000235545 (1.7)	LPAR2 (1.7)	PLCG1 (1.7)	GATAD2A (1.7)	GCNT4 (1.6)	TOP1 (1.6)
ENSG00000205307	SAP25 PPI subnetwork	0.47	> 0.20	OASL (7.3)	PARP10 (3.1)	ATP13A1 (2.1)	USP1 (2.0)	ENSG00000235545 (1.7)	LPAR2 (1.7)	PLCG1 (1.7)	GATAD2A (1.7)	GCNT4 (1.6)	TOP1 (1.6)
ENSG00000136504	KAT7 PPI subnetwork	0.47	> 0.20	UBXN2B (3.1)	DYNC2LI1 (1.9)	FRK (1.9)	C17orf57 (1.9)	HNF1A (1.8)	PSRC1 (1.6)	LPAR2 (1.6)	ZNF180 (1.5)	AP1M2 (1.4)	HAVCR1 (1.4)
ENSG00000170315	UBB PPI subnetwork	0.47	> 0.20	FEN1 (2.4)	PTPN11 (2.2)	GRINA (2.0)	MYLIP (2.0)	MAU2 (2.0)	SMARCA4 (1.9)	TOP1 (1.9)	RELB (1.9)	PSMA5 (1.8)	TRIB1 (1.7)
ENSG00000141968	VAV1 PPI subnetwork	0.47	> 0.20	GMIP (3.4)	GATAD2A (2.6)	DNM2 (2.5)	SLC44A2 (2.5)	SMARCA4 (2.4)	SH2B3 (2.2)	PLCG1 (2.1)	C1orf63 (1.9)	ZNF101 (1.8)	MAFB (1.8)
GO:0032965	regulation of collagen biosynthetic process	0.47	> 0.20	HNF1A (2.9)	FRK (2.1)	ST3GAL4 (2.0)	GEMIN7 (1.9)	ENSG00000226645 (1.9)	ENSG00000228044 (1.6)	C11orf9 (1.6)	ALDH2 (1.5)	NKPD1 (1.3)	PMFBP1 (1.2)
GO:0000781	chromosome, telomeric region	0.47	> 0.20	POLK (4.3)	DHODH (3.0)	POC5 (2.7)	FEN1 (2.6)	PSRC1 (2.1)	BUD13 (2.0)	NYNRIN (1.8)	USP1 (1.8)	DOCK7 (1.7)	SARS (1.7)
GO:0030131	clathrin adaptor complex	0.47	> 0.20	CLPTM1 (3.5)	PPP1R37 (2.9)	DNM2 (2.6)	YIPF2 (2.6)	OGDH (2.3)	CYB561D1 (2.1)	GRINA (2.0)	C1orf63 (1.9)	COL4A3BP (1.7)	ZHX3 (1.7)
MP:0002432	abnormal CD4-positive T cell morphology	0.47	> 0.20	GMIP (3.2)	ITGB3 (2.9)	PLCG1 (2.3)	BCL3 (2.2)	CETP (2.0)	DNM2 (1.7)	ZNF101 (1.7)	SLC44A2 (1.6)	POLK (1.5)	CYB561D1 (1.5)
MP:0008000	increased ovary tumor incidence	0.47	> 0.20	NT5DC1 (2.1)	BLOC1S3 (1.9)	ST3GAL4 (1.8)	ABO (1.8)	LPIN3 (1.6)	POC5 (1.4)	ZHX3 (1.3)	ENSG00000226648 (1.3)	PLEC (1.3)	NYNRIN (1.2)
ENSG00000169564	PCBP1 PPI subnetwork	0.47	> 0.20	ILF3 (4.2)	C1orf63 (3.3)	TOP1 (3.0)	DHX38 (2.7)	PTPN11 (2.6)	SMARCA4 (2.5)	BUD13 (2.4)	USP1 (2.3)	SUGP1 (2.1)	QTRT1 (2.0)
ENSG00000099901	RANBP1 PPI subnetwork	0.47	> 0.20	GATAD2A (2.2)	C12orf47 (2.1)	C19orf52 (2.1)	PVR (2.0)	TMEM50A (1.6)	CARM1 (1.6)	ERP29 (1.5)	C12orf43 (1.5)	TMEM57 (1.5)	GEMIN7 (1.4)
ENSG00000065268	WDR18 PPI subnetwork	0.47	> 0.20	ILF3 (3.5)	ATP13A1 (2.7)	MAPKAPK5 (2.4)	DDX56 (2.4)	CARM1 (2.3)	BRAP (2.2)	GATAD2A (2.1)	BUD13 (2.0)	NAA25 (2.0)	TRAFD1 (1.9)
REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	0.47	> 0.20	NAA25 (2.9)	DDX56 (2.8)	DOCK7 (2.7)	USP1 (2.6)	BUD13 (2.5)	POC5 (2.5)	ILF3 (2.4)	FEN1 (2.2)	MAPKAPK5 (2.0)	USP24 (1.9)
GO:0045880	positive regulation of smoothened signaling pathway	0.47	> 0.20	NYNRIN (2.8)	CYB561D1 (2.1)	ENSG00000235545 (1.9)	ENSG00000228044 (1.9)	LPAR2 (1.7)	PLEKHH2 (1.6)	AMIGO1 (1.6)	LPIN3 (1.5)	ATXN7L2 (1.5)	TMEM116 (1.5)
MP:0003871	abnormal myelin sheath morphology	0.47	> 0.20	APOC1 (3.5)	C11orf9 (2.9)	RPH3A (2.4)	APOE (2.4)	SORT1 (2.3)	NT5DC1 (2.0)	TMEM116 (1.8)	HAPLN4 (1.6)	FADS1 (1.6)	HMGCR (1.6)
ENSG00000105991	HOXA1 PPI subnetwork	0.47	> 0.20	NYNRIN (2.6)	MARK4 (2.4)	LPIN3 (2.2)	TRAPPC6A (1.9)	ERP29 (1.9)	GATAD2A (1.7)	APOE (1.6)	SMARCA4 (1.5)	CLPTM1 (1.5)	PVRL2 (1.5)
ENSG00000138193	PLCE1 PPI subnetwork	0.47	> 0.20	PARP10 (2.9)	CYB561D1 (2.4)	FRK (2.2)	PTPN11 (2.1)	OASL (2.0)	ZNF180 (1.9)	TOMM40 (1.8)	PVR (1.6)	DOCK7 (1.6)	USP24 (1.5)
ENSG00000188612	SUMO2 PPI subnetwork	0.47	> 0.20	TMED4 (2.5)	TRIB1 (2.2)	MAFB (1.9)	TMEM57 (1.9)	PVRL2 (1.9)	PPP1R37 (1.9)	PVR (1.8)	USP1 (1.8)	PARP10 (1.7)	SMARCA4 (1.6)
GO:0010042	response to manganese ion	0.47	> 0.20	ABO (2.4)	PBX4 (2.1)	BLOC1S3 (2.0)	C12orf51 (1.9)	HNF1A (1.7)	ENSG00000254235 (1.6)	TSSK6 (1.5)	ALDH2 (1.4)	ENSG00000228044 (1.4)	HP (1.3)
GO:0051378	serotonin binding	0.47	> 0.20	RPH3A (2.7)	ABO (2.2)	GOT2P1 (2.1)	ABCG8 (2.1)	DNAH11 (1.8)	ABCG5 (1.8)	GPAM (1.7)	GCNT4 (1.7)	ENSG00000226648 (1.4)	MYLIP (1.4)
MP:0006410	abnormal common myeloid progenitor cell morphology	0.47	> 0.20	RHD (3.4)	HLX (3.2)	PARP10 (2.8)	TRAFD1 (2.8)	BCL3 (2.8)	GMIP (2.7)	RHCE (2.6)	C12orf51 (2.4)	PBX4 (1.9)	DNM2 (1.8)
MP:0001952	increased airway responsiveness	0.47	> 0.20	C17orf57 (3.2)	SLC44A2 (2.1)	ENSG00000226648 (1.9)	ST3GAL4 (1.8)	APOB (1.6)	TMEM116 (1.6)	KIAA1324 (1.5)	NPC1L1 (1.5)	LPAR2 (1.4)	PMFBP1 (1.3)
ENSG00000138594	TMOD3 PPI subnetwork	0.47	> 0.20	PLEC (3.5)	KANK2 (3.1)	ADAM1 (2.6)	SMARCA4 (2.4)	C1orf63 (2.0)	OGDH (2.0)	DOCK7 (1.9)	TRAFD1 (1.8)	ITGB3 (1.7)	PVR (1.7)
GO:0042645	mitochondrial nucleoid	0.47	> 0.20	ACAD10 (4.0)	DHODH (3.2)	C19orf52 (2.7)	NAA25 (2.4)	OGDH (2.4)	BRAP (2.4)	TMEM116 (2.3)	ABCG5 (2.2)	ABCG8 (2.2)	TOMM40 (2.1)
ENSG00000126756	UXT PPI subnetwork	0.47	> 0.20	TRAPPC6A (3.8)	BLOC1S3 (3.7)	ANKRD31 (2.7)	PVR (2.3)	ATXN2 (2.1)	POC5 (1.7)	PSMA5 (1.7)	TOMM40 (1.7)	GMPR (1.6)	TXNL4B (1.6)
REACTOME_PERK_REGULATED_GENE_EXPRESSION	REACTOME_PERK_REGULATED_GENE_EXPRESSION	0.47	> 0.20	SARS (5.2)	PVR (3.4)	TXNL4B (2.9)	TRIB1 (2.8)	MAPKAPK5 (2.6)	DHODH (2.6)	POC5 (2.4)	PMFBP1 (2.0)	ERP29 (2.0)	TMED4 (1.7)
GO:0002507	tolerance induction	0.47	> 0.20	GCNT4 (3.3)	C12orf47 (2.7)	PBX4 (2.5)	ENSG00000228044 (1.8)	PMFBP1 (1.6)	TSSK6 (1.4)	POLK (1.3)	HNF1A (1.2)	GMIP (1.2)	FRK (1.1)
REACTOME_SMOOTH_MUSCLE_CONTRACTION	REACTOME_SMOOTH_MUSCLE_CONTRACTION	0.47	> 0.20	KANK2 (4.7)	ITGB3 (3.6)	PVRL2 (2.4)	SORT1 (2.0)	HLX (1.9)	ADAM1 (1.9)	HNF1A (1.9)	PLEKHH2 (1.7)	C17orf57 (1.5)	ZNF101 (1.5)
ENSG00000158710	TAGLN2 PPI subnetwork	0.47	> 0.20	ZNF101 (3.3)	C19orf52 (2.0)	HLX (2.0)	FRK (1.8)	NYNRIN (1.7)	ENSG00000226648 (1.6)	C12orf43 (1.5)	CETP (1.3)	NT5DC1 (1.3)	NCAN (1.3)
GO:0048662	negative regulation of smooth muscle cell proliferation	0.47	> 0.20	ENSG00000254235 (2.7)	TIMD4 (2.4)	POC5 (1.6)	CEACAM19 (1.6)	ST3GAL4 (1.4)	MOSC1 (1.3)	PMFBP1 (1.3)	TRAFD1 (1.2)	PPP1R37 (1.2)	NYNRIN (1.1)
GO:0000287	magnesium ion binding	0.47	> 0.20	TSSK6 (3.2)	NT5DC1 (2.6)	ALDH2 (2.1)	PMFBP1 (2.0)	HAPLN4 (1.9)	ENSG00000228044 (1.8)	OGDH (1.6)	LDLR (1.5)	USP1 (1.4)	HMGCR (1.4)
MP:0001431	abnormal eating behavior	0.47	> 0.20	C11orf9 (3.5)	PMFBP1 (2.2)	CBLC (2.1)	FRK (2.0)	TM6SF2 (1.8)	MARK4 (1.6)	ABO (1.5)	C17orf57 (1.4)	GCNT4 (1.4)	TSSK6 (1.3)
GO:0015399	primary active transmembrane transporter activity	0.47	> 0.20	ATP13A1 (3.6)	CLPTM1 (3.4)	TMEM116 (2.9)	GRINA (2.8)	SORT1 (2.5)	HAPLN4 (2.2)	MAU2 (2.0)	OGDH (1.9)	GMPR (1.8)	DNM2 (1.8)
GO:0015405	P-P-bond-hydrolysis-driven transmembrane transporter activity	0.47	> 0.20	ATP13A1 (3.6)	CLPTM1 (3.4)	TMEM116 (2.9)	GRINA (2.8)	SORT1 (2.5)	HAPLN4 (2.2)	MAU2 (2.0)	OGDH (1.9)	GMPR (1.8)	DNM2 (1.8)
GO:0007076	mitotic chromosome condensation	0.47	> 0.20	ENSG00000226648 (3.3)	C19orf52 (3.3)	DNAH11 (3.2)	PSRC1 (3.0)	ENSG00000228044 (2.5)	MAU2 (2.3)	BLOC1S3 (2.1)	ILF3 (1.8)	PMFBP1 (1.8)	CYB561D1 (1.7)
ENSG00000090060	PAPOLA PPI subnetwork	0.47	> 0.20	ILF3 (3.6)	DHX38 (3.4)	BUD13 (3.2)	SMARCA4 (3.0)	TOP1 (2.6)	SUGP1 (2.6)	C1orf63 (2.4)	GATAD2A (2.4)	USP1 (2.4)	PTPN11 (2.1)
ENSG00000100612	DHRS7 PPI subnetwork	0.47	> 0.20	DHX38 (2.9)	SMARCA4 (2.7)	ILF3 (2.5)	USP24 (2.5)	CARM1 (2.2)	TOMM40 (2.2)	CLPTM1 (2.1)	C12orf51 (1.9)	ATP13A1 (1.6)	DNM2 (1.6)
GO:0060326	cell chemotaxis	0.47	> 0.20	MAFB (3.4)	HLX (2.9)	ZNF101 (2.7)	TIMD4 (2.5)	APOE (2.2)	ST3GAL4 (2.1)	TMEM116 (2.0)	ADAM1 (1.7)	AMIGO1 (1.7)	CETP (1.4)
ENSG00000153233	PTPRR PPI subnetwork	0.47	> 0.20	GATAD2A (2.9)	CBLC (2.7)	MARK4 (2.1)	MYLIP (1.7)	AMIGO1 (1.6)	CARM1 (1.5)	MAPKAPK5 (1.5)	PBX4 (1.4)	GCNT4 (1.3)	SLC44A2 (1.2)
ENSG00000099985	OSM PPI subnetwork	0.47	> 0.20	BCL3 (3.7)	CETP (2.7)	RELB (2.6)	HLX (2.6)	TIMD4 (2.2)	PVR (1.9)	GMIP (1.9)	PVRL2 (1.6)	PLEKHH2 (1.5)	TRIB1 (1.5)
ENSG00000155966	AFF2 PPI subnetwork	0.47	> 0.20	MAFB (3.3)	LPIN3 (2.9)	GATAD2A (2.5)	FRK (2.0)	ENSG00000226648 (1.8)	MYLIP (1.8)	GCNT4 (1.7)	HAPLN4 (1.6)	TOP1 (1.5)	ZHX3 (1.5)
GO:0003995	acyl-CoA dehydrogenase activity	0.47	> 0.20	ALDH2 (4.8)	ACAD10 (4.6)	GPAM (3.0)	MOSC1 (2.8)	ABCG8 (2.0)	NT5DC1 (1.9)	APOA5 (1.9)	OGDH (1.8)	TRAPPC6A (1.7)	APOC1 (1.6)
GO:0045428	regulation of nitric oxide biosynthetic process	0.47	> 0.20	ENSG00000228044 (2.4)	AMIGO1 (1.8)	BCL3 (1.8)	PVR (1.7)	GCNT4 (1.6)	ENSG00000226645 (1.6)	MAFB (1.4)	TRIB1 (1.3)	RELB (1.3)	TXNL4B (1.3)
MP:0002672	abnormal branchial arch artery morphology	0.47	> 0.20	MYLIP (3.1)	HLX (2.9)	MAFB (2.8)	BCAM (2.2)	SLC44A2 (2.2)	CEACAM19 (2.0)	PLCG1 (1.7)	SH2B3 (1.6)	PVRL2 (1.5)	ANKRD31 (1.4)
GO:0060341	regulation of cellular localization	0.47	> 0.20	KIAA1324 (3.2)	ABO (2.2)	COL4A3BP (2.0)	PLEKHH2 (1.9)	AP1M2 (1.7)	AMIGO1 (1.7)	HLX (1.5)	C11orf9 (1.4)	HNF1A (1.4)	C12orf47 (1.3)
GO:0090150	establishment of protein localization in membrane	0.47	> 0.20	PTPN11 (3.0)	BCAM (2.4)	C11orf9 (2.2)	C12orf47 (2.0)	AP1M2 (2.0)	ZHX3 (1.7)	CBLC (1.6)	ENSG00000226645 (1.6)	TSSK6 (1.4)	CELSR2 (1.4)
ENSG00000163162	RNF149 PPI subnetwork	0.47	> 0.20	HMGCR (4.5)	FADS1 (3.8)	LDLR (3.8)	ILF3 (2.6)	FADS2 (2.4)	NAA25 (2.4)	QTRT1 (2.2)	ZNF259 (2.2)	PBX4 (2.0)	PCSK9 (2.0)
GO:0002544	chronic inflammatory response	0.47	> 0.20	ENSG00000228044 (3.9)	TIMD4 (2.1)	CETP (1.8)	DYNC2LI1 (1.7)	FRK (1.5)	GCNT4 (1.4)	BCL3 (1.3)	GMIP (1.2)	ENSG00000238078 (1.1)	ST3GAL4 (1.0)
ENSG00000204086	RPA4 PPI subnetwork	0.47	> 0.20	FEN1 (6.0)	USP1 (5.3)	NT5DC1 (2.6)	MAU2 (1.6)	TMEM116 (1.6)	ENSG00000228044 (1.5)	AMIGO1 (1.4)	DHODH (1.4)	ENSG00000235545 (1.3)	ZNF180 (1.3)
ENSG00000016490	CLCA1 PPI subnetwork	0.47	> 0.20	CBLC (2.7)	AP1M2 (2.7)	HNF1A (2.6)	APOC1 (2.4)	SORT1 (2.4)	TRAPPC6A (2.3)	APOB (2.1)	ERP29 (1.8)	GOT2P1 (1.8)	FRK (1.8)
ENSG00000117758	STX12 PPI subnetwork	0.47	> 0.20	SARS (3.1)	TRAFD1 (3.0)	AP1M2 (2.7)	SUGP1 (2.7)	BRAP (2.6)	GRINA (2.6)	ENSG00000228044 (2.2)	COL4A3BP (2.1)	C12orf43 (2.1)	ABO (2.0)
GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development	0.47	> 0.20	C19orf52 (2.2)	AMIGO1 (2.0)	C1orf63 (1.9)	GOT2P1 (1.7)	CYB561D1 (1.6)	BLOC1S3 (1.5)	LPIN3 (1.5)	UBXN2B (1.4)	HNF1A (1.4)	PSMA5 (1.3)
GO:0032608	interferon-beta production	0.47	> 0.20	DNAH11 (3.7)	PARP10 (3.4)	OASL (3.3)	CYB561D1 (2.7)	GEMIN7 (2.7)	FRK (2.0)	C12orf43 (2.0)	MAU2 (2.0)	ZNF180 (1.9)	ADAM1 (1.8)
GO:0035102	PRC1 complex	0.47	> 0.20	MARK4 (2.4)	ENSG00000235545 (1.9)	ATXN7L2 (1.9)	TMEM116 (1.8)	GRINA (1.7)	PPP1R37 (1.6)	ENSG00000254235 (1.5)	BCAM (1.4)	C12orf47 (1.4)	LPAR2 (1.3)
ENSG00000135409	AMHR2 PPI subnetwork	0.47	> 0.20	OASL (2.5)	TMEM57 (2.3)	PLEKHH2 (2.3)	TIMD4 (2.1)	CETP (1.7)	ATP13A1 (1.6)	CILP2 (1.5)	SLC22A1 (1.5)	ABO (1.5)	POLK (1.5)
ENSG00000177963	RIC8A PPI subnetwork	0.47	> 0.20	MARK4 (2.3)	HAVCR1 (1.9)	SH2B3 (1.7)	CARM1 (1.7)	DNM2 (1.7)	NCAN (1.4)	C12orf43 (1.4)	TMEM57 (1.4)	POLK (1.3)	RPH3A (1.3)
ENSG00000184787	UBE2G2 PPI subnetwork	0.47	> 0.20	TMED4 (3.1)	COL4A3BP (2.3)	YIPF2 (2.2)	POLK (2.1)	ABCG8 (2.0)	ABCG5 (1.9)	ATP13A1 (1.8)	C12orf51 (1.7)	ATXN2 (1.7)	GRINA (1.7)
GO:0010712	regulation of collagen metabolic process	0.47	> 0.20	HNF1A (3.2)	ENSG00000226645 (2.2)	FRK (2.2)	CEACAM19 (2.1)	GEMIN7 (2.0)	ALDH2 (1.8)	ENSG00000228044 (1.8)	ST3GAL4 (1.7)	C11orf9 (1.6)	GMPR (1.5)
ENSG00000182533	CAV3 PPI subnetwork	0.47	> 0.20	MAFB (2.4)	SYPL2 (2.2)	PLEC (2.0)	SLC44A2 (2.0)	OGDH (1.9)	BCAM (1.8)	ENSG00000238078 (1.7)	PVR (1.7)	TIMD4 (1.7)	PTPN11 (1.5)
ENSG00000107201	DDX58 PPI subnetwork	0.47	> 0.20	OASL (2.6)	GPAM (2.4)	FADS1 (2.3)	PARP10 (2.2)	FADS2 (2.1)	C17orf57 (1.9)	ATXN2 (1.8)	MOSC1 (1.6)	ENSG00000235545 (1.5)	NAA25 (1.4)
GO:0048011	nerve growth factor receptor signaling pathway	0.47	> 0.20	MARK4 (3.0)	DNM2 (2.3)	ZHX3 (2.2)	CLPTM1 (2.2)	CYB561D1 (2.1)	SH2B3 (2.0)	ADAM1 (2.0)	MAU2 (1.9)	GATAD2A (1.9)	PLEC (1.7)
ENSG00000164815	ORC5 PPI subnetwork	0.47	> 0.20	FEN1 (6.6)	USP1 (5.2)	PSRC1 (2.2)	ENSG00000235545 (1.5)	POC5 (1.4)	TMEM116 (1.3)	LPAR2 (1.1)	TXNL4B (1.1)	RHD (1.0)	SLC44A2 (1.0)
ENSG00000168487	BMP1 PPI subnetwork	0.47	> 0.20	CBLC (3.9)	BCAM (3.4)	AP1M2 (3.0)	PLEC (2.8)	ENSG00000254235 (2.1)	KANK2 (1.9)	HAVCR1 (1.8)	APOE (1.8)	C17orf57 (1.7)	CYP7A1 (1.5)
ENSG00000133627	ACTR3B PPI subnetwork	0.47	> 0.20	CARM1 (2.7)	NPC1L1 (2.4)	SMARCA4 (2.3)	GMIP (2.3)	ENSG00000235545 (2.0)	GATAD2A (2.0)	ATP13A1 (1.8)	ERP29 (1.7)	FRK (1.6)	LPIN3 (1.6)
ENSG00000130724	CHMP2A PPI subnetwork	0.47	> 0.20	TRAPPC6A (2.5)	FRK (2.4)	TRAFD1 (2.2)	UBXN2B (2.0)	LDLR (1.8)	FADS2 (1.8)	HMGCR (1.6)	TXNL4B (1.6)	DHODH (1.6)	YIPF2 (1.5)
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	0.47	> 0.20	AP1M2 (4.3)	SLC44A2 (3.4)	DNM2 (3.4)	GMIP (2.9)	SH2B3 (2.9)	PVRL2 (2.9)	ITGB3 (2.4)	BCAM (2.2)	GATAD2A (2.1)	CYP7A1 (2.1)
MP:0002544	brachydactyly	0.47	> 0.20	CILP2 (4.9)	HMGCR (2.8)	PLEKHH2 (2.5)	NYNRIN (2.5)	FADS2 (2.4)	LDLR (2.2)	PCSK9 (2.0)	FADS1 (2.0)	ALDH2 (1.8)	NKPD1 (1.6)
GO:0002861	regulation of inflammatory response to antigenic stimulus	0.47	> 0.20	ENSG00000235545 (3.3)	ZNF101 (2.0)	TRAPPC6A (2.0)	DNAH11 (1.7)	ANKRD31 (1.5)	TIMD4 (1.3)	ENSG00000228044 (1.3)	GOT2P1 (1.2)	HAVCR1 (1.2)	ADAM1 (1.1)
MP:0010124	decreased bone mineral content	0.48	> 0.20	MAFB (3.1)	KANK2 (2.7)	AP1M2 (2.7)	BCAM (2.5)	TRIB1 (2.5)	CILP2 (2.4)	CETP (2.0)	TIMD4 (1.7)	CBLC (1.7)	CELSR2 (1.7)
GO:0002369	T cell cytokine production	0.48	> 0.20	GCNT4 (3.0)	NKPD1 (2.2)	LPAR2 (1.6)	COL4A3BP (1.6)	POLK (1.6)	TRAPPC6A (1.6)	GOT2P1 (1.5)	BRAP (1.5)	PBX4 (1.4)	ZNF180 (1.4)
MP:0008522	abnormal lymph node germinal center morphology	0.48	> 0.20	RELB (3.1)	GMIP (2.5)	ZNF101 (2.3)	SH2B3 (2.0)	SLC44A2 (2.0)	APOE (1.9)	CETP (1.8)	TIMD4 (1.7)	PVRL2 (1.4)	ALDH2 (1.4)
GO:0006364	rRNA processing	0.48	> 0.20	ZNF259 (3.6)	DDX56 (3.5)	TOMM40 (3.2)	DHODH (3.1)	QTRT1 (3.1)	NAA25 (2.9)	C12orf43 (2.5)	MAPKAPK5 (2.4)	C19orf52 (2.4)	POC5 (2.3)
ENSG00000100084	HIRA PPI subnetwork	0.48	> 0.20	MAU2 (3.7)	FEN1 (3.3)	USP1 (3.0)	C19orf52 (2.6)	GATAD2A (2.5)	KANK2 (2.2)	SUGP1 (2.2)	QTRT1 (2.0)	ATP13A1 (1.9)	TMEM50A (1.8)
ENSG00000134259	NGF PPI subnetwork	0.48	> 0.20	BRAP (2.4)	DOCK7 (2.3)	GRINA (2.0)	SARS (1.9)	GATAD2A (1.8)	CELSR2 (1.8)	PTPN11 (1.7)	KANK2 (1.4)	C12orf43 (1.4)	PCSK9 (1.3)
GO:0060045	positive regulation of cardiac muscle cell proliferation	0.48	> 0.20	GCNT4 (3.2)	ENSG00000226648 (2.8)	C11orf9 (2.5)	HAPLN4 (2.0)	DYNC2LI1 (1.6)	CEACAM19 (1.5)	ABCG8 (1.5)	NYNRIN (1.4)	POC5 (1.4)	TM6SF2 (1.4)
ENSG00000015479	MATR3 PPI subnetwork	0.48	> 0.20	ILF3 (3.4)	PTPN11 (2.4)	RELB (2.3)	SMARCA4 (2.2)	DHX38 (2.1)	PLEC (2.0)	NAA25 (1.8)	C1orf63 (1.7)	DOCK7 (1.6)	SARS (1.6)
GO:0004715	non-membrane spanning protein tyrosine kinase activity	0.48	> 0.20	GMIP (3.7)	OASL (2.6)	PARP10 (2.3)	LPIN3 (2.0)	ZNF101 (1.9)	FRK (1.8)	DNM2 (1.7)	ALDH2 (1.6)	TRAFD1 (1.6)	GATAD2A (1.6)
ENSG00000163918	RFC4 PPI subnetwork	0.48	> 0.20	FEN1 (6.0)	USP1 (5.1)	BLOC1S3 (2.0)	ZNF180 (1.8)	ILF3 (1.7)	TMEM116 (1.7)	ENSG00000228044 (1.7)	AMIGO1 (1.6)	NT5DC1 (1.2)	SMARCA4 (1.2)
ENSG00000136149	ENSG00000136149 PPI subnetwork	0.48	> 0.20	ZNF259 (3.3)	NAA25 (3.3)	DDX56 (3.0)	TOMM40 (3.0)	GATAD2A (2.5)	QTRT1 (2.3)	DHODH (2.2)	ILF3 (2.0)	DHX38 (1.9)	SUGP1 (1.7)
ENSG00000080819	CPOX PPI subnetwork	0.48	> 0.20	RHCE (3.2)	CARM1 (2.9)	TMEM57 (2.8)	SARS (2.6)	ATXN2 (2.4)	SUGP1 (2.2)	ILF3 (2.1)	ATP13A1 (2.1)	C12orf51 (2.0)	RHD (2.0)
MP:0009887	abnormal palatal shelf fusion at midline	0.48	> 0.20	PLEC (3.0)	KANK2 (2.8)	GATAD2A (2.5)	ATXN2 (2.3)	MYLIP (1.7)	DNM2 (1.6)	MARK4 (1.6)	MAFB (1.5)	PLCG1 (1.4)	ENSG00000226648 (1.4)
ENSG00000103510	KAT8 PPI subnetwork	0.48	> 0.20	BUD13 (3.5)	ATXN2 (2.9)	QTRT1 (2.8)	ATXN7L2 (2.7)	GOT2P1 (2.6)	OGDH (2.5)	C12orf43 (2.4)	DHX38 (2.3)	MAPKAPK5 (2.3)	ZNF259 (1.9)
GO:0043270	positive regulation of ion transport	0.48	> 0.20	ABO (2.5)	KIAA1324 (2.2)	DNAH11 (1.8)	YIPF2 (1.6)	CYB561D1 (1.6)	SLC44A2 (1.4)	MARK4 (1.3)	CETP (1.3)	RPH3A (1.3)	PLCG1 (1.2)
REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	0.48	> 0.20	RPH3A (3.0)	GRINA (2.4)	MARK4 (1.9)	FRK (1.7)	HNF1A (1.6)	POC5 (1.4)	C12orf51 (1.3)	HAPLN4 (1.3)	CEACAM19 (1.2)	C12orf43 (1.2)
MP:0004841	abnormal small intestine crypts of Lieberkuhn morphology	0.48	> 0.20	HNF1A (3.1)	ABCG8 (3.0)	C11orf9 (2.4)	HLX (2.4)	ABCG5 (2.4)	PLEKHH2 (2.3)	DNAH11 (2.2)	ENSG00000235545 (2.1)	GMPR (1.8)	TM6SF2 (1.7)
GO:0019866	organelle inner membrane	0.48	> 0.20	OGDH (4.2)	ACAD10 (3.9)	TOMM40 (2.3)	ALDH2 (2.2)	TRAPPC6A (2.1)	GMPR (2.1)	C19orf52 (2.0)	ABCG8 (2.0)	GPAM (1.8)	SYPL2 (1.8)
MP:0002954	abnormal aerobic energy metabolism	0.48	> 0.20	GPAM (3.1)	OGDH (2.7)	SYPL2 (2.5)	MOSC1 (2.4)	ACAD10 (2.2)	HAVCR1 (2.1)	NT5DC1 (2.0)	HP (2.0)	ALDH2 (1.7)	TMEM116 (1.6)
MP:0011495	abnormal head shape	0.48	> 0.20	NYNRIN (3.4)	DOCK7 (3.1)	CILP2 (3.0)	ALDH2 (2.5)	UBXN2B (2.5)	GOT2P1 (2.1)	PLEKHH2 (1.9)	MARK4 (1.9)	PVRL2 (1.9)	NPC1L1 (1.8)
GO:0071248	cellular response to metal ion	0.48	> 0.20	KANK2 (2.2)	TSSK6 (1.9)	HAVCR1 (1.8)	POLK (1.6)	ANKRD31 (1.6)	POC5 (1.5)	GCNT4 (1.5)	UBXN2B (1.5)	DYNC2LI1 (1.4)	ATXN7L2 (1.4)
GO:0030838	positive regulation of actin filament polymerization	0.48	> 0.20	HNF1A (2.8)	ENSG00000226648 (2.7)	ANKRD31 (2.5)	ZNF101 (2.1)	ZHX3 (2.1)	ST3GAL4 (1.8)	HAVCR1 (1.8)	DOCK7 (1.7)	PMFBP1 (1.5)	CBLC (1.5)
GO:0032480	negative regulation of type I interferon production	0.48	> 0.20	OASL (6.1)	PARP10 (5.7)	TRAFD1 (3.2)	MAU2 (2.7)	CYB561D1 (2.4)	C19orf52 (2.3)	FRK (2.0)	ADAM1 (2.0)	ZNF180 (2.0)	ZNF101 (1.9)
ENSG00000172845	SP3 PPI subnetwork	0.48	> 0.20	SYPL2 (3.0)	CELSR2 (2.6)	MAU2 (2.5)	ATXN7L2 (2.3)	ADAM1 (1.9)	NT5DC1 (1.9)	CARM1 (1.9)	UBXN2B (1.9)	C1orf63 (1.8)	BRAP (1.6)
ENSG00000161939	C17orf49 PPI subnetwork	0.48	> 0.20	BUD13 (3.0)	C12orf43 (3.0)	ATXN2 (2.5)	C19orf52 (2.3)	OGDH (2.3)	GOT2P1 (2.2)	QTRT1 (2.2)	MAPKAPK5 (2.0)	DHX38 (2.0)	DDX56 (1.8)
ENSG00000184009	ACTG1 PPI subnetwork	0.48	> 0.20	PLEC (2.7)	ITGB3 (2.2)	SMARCA4 (1.7)	RELB (1.7)	CBLC (1.7)	OGDH (1.6)	TMEM50A (1.6)	CLPTM1 (1.6)	DOCK7 (1.5)	TOMM40 (1.4)
ENSG00000115844	DLX2 PPI subnetwork	0.48	> 0.20	MAFB (2.7)	MYLIP (2.4)	GCNT4 (2.3)	ACAD10 (1.6)	KIAA1324 (1.5)	ENSG00000238078 (1.5)	CYP7A1 (1.4)	CETP (1.3)	DNAH11 (1.1)	GPAM (1.1)
MP:0002500	granulomatous inflammation	0.48	> 0.20	BCL3 (3.0)	C17orf57 (2.3)	MAFB (2.2)	HLX (2.2)	RELB (1.6)	ABO (1.5)	GMIP (1.4)	C12orf47 (1.4)	PBX4 (1.4)	SH2B3 (1.2)
ENSG00000143614	GATAD2B PPI subnetwork	0.48	> 0.20	C19orf52 (2.2)	GMPR (2.1)	TMEM57 (1.8)	MYLIP (1.6)	USP1 (1.5)	ZNF180 (1.3)	PMFBP1 (1.3)	BUD13 (1.1)	NT5DC1 (1.1)	ENSG00000226648 (1.0)
ENSG00000125965	GDF5 PPI subnetwork	0.48	> 0.20	AMIGO1 (3.5)	ENSG00000228044 (2.5)	PVRL2 (2.2)	DOCK7 (2.1)	ZNF101 (1.9)	LPAR2 (1.9)	LPIN3 (1.8)	MAFB (1.6)	ATP13A1 (1.6)	ATXN2 (1.5)
REACTOME_NEF:MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	REACTOME_NEF:MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	0.48	> 0.20	CLPTM1 (3.8)	GRINA (3.5)	PPP1R37 (2.8)	PLCG1 (2.7)	TXNL4B (2.4)	OGDH (2.1)	CETP (2.0)	APOE (1.8)	MARK4 (1.8)	DNM2 (1.7)
ENSG00000106588	PSMA2 PPI subnetwork	0.48	> 0.20	PSMA5 (6.1)	NT5DC1 (2.8)	NAA25 (2.5)	TRAFD1 (2.0)	DDX56 (2.0)	TOMM40 (1.9)	ENSG00000254235 (1.6)	C19orf52 (1.4)	SARS (1.3)	ITGB3 (1.2)
GO:0000976	transcription regulatory region sequence-specific DNA binding	0.48	> 0.20	MARK4 (2.2)	RHD (2.2)	ENSG00000226648 (2.0)	CELSR2 (1.8)	C19orf52 (1.5)	MYLIP (1.5)	TRIB1 (1.4)	GMPR (1.4)	HLX (1.3)	PARP10 (1.2)
ENSG00000171992	SYNPO PPI subnetwork	0.48	> 0.20	PLEC (4.3)	GATAD2A (3.0)	LPIN3 (2.6)	PVR (2.3)	DOCK7 (2.1)	PLCG1 (2.0)	ABCG8 (2.0)	OGDH (1.9)	SARS (1.8)	LDLR (1.7)
GO:0000922	spindle pole	0.48	> 0.20	PSRC1 (5.3)	POC5 (4.8)	USP1 (3.5)	FEN1 (3.4)	BUD13 (1.9)	ENSG00000228044 (1.7)	DYNC2LI1 (1.5)	ZNF180 (1.5)	PBX4 (1.4)	POLK (1.4)
GO:0008624	induction of apoptosis by extracellular signals	0.48	> 0.20	LPAR2 (2.9)	CYB561D1 (2.4)	ADAM1 (2.1)	FRK (2.1)	ENSG00000238078 (2.0)	HAVCR1 (1.9)	LPIN3 (1.7)	GMIP (1.6)	ANKRD31 (1.5)	TRAFD1 (1.4)
GO:0046546	development of primary male sexual characteristics	0.48	> 0.20	DNAH11 (2.6)	LPAR2 (2.6)	ST3GAL4 (2.6)	ABO (2.3)	PLEKHH2 (1.8)	C11orf9 (1.6)	TSSK6 (1.6)	AP1M2 (1.5)	FRK (1.5)	PVRL2 (1.4)
ENSG00000109670	FBXW7 PPI subnetwork	0.48	> 0.20	LDLR (3.6)	ATXN2 (2.7)	HMGCR (2.6)	BLOC1S3 (2.6)	TRIB1 (2.4)	ATXN7L2 (2.3)	ACAD10 (2.1)	FADS2 (1.9)	PPP1R37 (1.8)	PSRC1 (1.7)
ENSG00000135940	COX5B PPI subnetwork	0.48	> 0.20	TRAPPC6A (3.2)	GOT2P1 (3.2)	GRINA (2.2)	UBXN2B (1.9)	GMPR (1.8)	ACAD10 (1.8)	C19orf52 (1.8)	KANK2 (1.6)	OGDH (1.5)	KIAA1324 (1.5)
ENSG00000115091	ACTR3 PPI subnetwork	0.48	> 0.20	TMEM50A (3.0)	ITGB3 (2.8)	AP1M2 (2.3)	C1orf63 (2.2)	FRK (2.2)	ERP29 (1.7)	MYLIP (1.7)	SH2B3 (1.6)	GATAD2A (1.5)	TOP1 (1.4)
REACTOME_DNA_REPAIR	REACTOME_DNA_REPAIR	0.48	> 0.20	FEN1 (4.6)	USP1 (3.6)	POC5 (2.9)	ZNF180 (2.2)	POLK (2.2)	BUD13 (2.1)	NT5DC1 (1.8)	PSRC1 (1.7)	DHODH (1.6)	SUGP1 (1.6)
MP:0003207	decreased cellular sensitivity to gamma-irradiation	0.48	> 0.20	POLK (3.5)	PCSK9 (2.7)	UBXN2B (2.2)	TMEM116 (1.9)	ABCG8 (1.7)	LPAR2 (1.6)	DNAH11 (1.6)	ERP29 (1.4)	GMIP (1.3)	PARP10 (1.3)
MP:0005399	increased susceptibility to fungal infection	0.48	> 0.20	MAFB (2.9)	HLX (2.5)	GOT2P1 (2.3)	PMFBP1 (2.1)	HP (2.1)	TRIB1 (1.9)	BCL3 (1.7)	SH2B3 (1.5)	CYP7A1 (1.4)	ADAM1 (1.3)
GO:0051539	4 iron, 4 sulfur cluster binding	0.48	> 0.20	ACAD10 (4.1)	LPIN3 (2.2)	DHODH (2.1)	NT5DC1 (2.0)	ALDH2 (2.0)	PBX4 (1.8)	GOT2P1 (1.8)	SARS (1.8)	C12orf47 (1.6)	OGDH (1.5)
MP:0001957	apnea	0.48	> 0.20	FADS1 (3.9)	HMGCR (3.4)	LDLR (3.2)	FADS2 (2.9)	PBX4 (2.4)	CILP2 (2.2)	PCSK9 (2.0)	ATXN2 (1.9)	LPA (1.9)	CEACAM19 (1.8)
MP:0001244	thin dermal layer	0.48	> 0.20	LPA (3.6)	APOC4 (2.8)	SLC22A1 (2.3)	AP1M2 (2.2)	ENSG00000254235 (2.0)	NYNRIN (1.9)	KIAA1324 (1.8)	APOA5 (1.7)	HAPLN4 (1.5)	ABCG8 (1.4)
ENSG00000165699	TSC1 PPI subnetwork	0.48	> 0.20	PLEC (2.9)	KANK2 (2.8)	GATAD2A (2.5)	DNM2 (2.1)	PTPN11 (2.1)	COL4A3BP (2.0)	SMARCA4 (2.0)	AP1M2 (2.0)	SLC44A2 (1.9)	PVRL2 (1.9)
REACTOME_NOD12_SIGNALING_PATHWAY	REACTOME_NOD12_SIGNALING_PATHWAY	0.48	> 0.20	RELB (4.4)	PARP10 (2.5)	BCL3 (2.3)	ZNF101 (2.2)	ST3GAL4 (1.8)	TRAFD1 (1.8)	ENSG00000228044 (1.7)	ENSG00000226645 (1.7)	FRK (1.7)	ZNF259 (1.6)
ENSG00000197111	PCBP2 PPI subnetwork	0.48	> 0.20	ILF3 (4.4)	C1orf63 (3.4)	TOP1 (3.3)	SMARCA4 (2.9)	DHX38 (2.7)	USP1 (2.6)	SUGP1 (2.5)	BUD13 (2.4)	MAU2 (2.3)	PTPN11 (2.2)
GO:0050432	catecholamine secretion	0.48	> 0.20	ABO (3.2)	TSSK6 (2.0)	CEACAM19 (1.8)	C19orf52 (1.7)	PPP1R37 (1.6)	GMPR (1.6)	CETP (1.4)	ZHX3 (1.4)	RPH3A (1.2)	PMFBP1 (1.2)
ENSG00000151693	ASAP2 PPI subnetwork	0.48	> 0.20	OGDH (3.7)	COL4A3BP (3.0)	ADAM1 (2.7)	ZHX3 (2.5)	SLC44A2 (2.5)	GATAD2A (2.5)	PBX4 (2.3)	PMFBP1 (2.3)	C12orf47 (2.0)	DDX56 (2.0)
ENSG00000160917	CPSF4 PPI subnetwork	0.48	> 0.20	DHX38 (2.9)	SMARCA4 (2.4)	USP24 (2.4)	NT5DC1 (2.3)	DHODH (2.2)	PTPN11 (2.2)	MAPKAPK5 (2.2)	TOP1 (1.9)	C1orf63 (1.9)	ATXN2 (1.9)
ENSG00000078668	VDAC3 PPI subnetwork	0.48	> 0.20	PSMA5 (3.3)	DDX56 (3.2)	NAA25 (2.8)	TOMM40 (2.6)	SARS (2.3)	ENSG00000235545 (2.2)	ZNF259 (2.2)	CLPTM1 (1.9)	OASL (1.8)	LPIN3 (1.6)
MP:0003878	abnormal ear physiology	0.48	> 0.20	BCAM (3.2)	HNF1A (2.4)	LPIN3 (2.0)	AP1M2 (1.7)	POLK (1.7)	C12orf47 (1.6)	PVRL2 (1.6)	HAPLN4 (1.5)	NPC1L1 (1.5)	PBX4 (1.5)
ENSG00000079785	DDX1 PPI subnetwork	0.48	> 0.20	PLCG1 (3.1)	ILF3 (2.7)	TOP1 (2.6)	GATAD2A (2.6)	SMARCA4 (2.4)	SARS (2.1)	C1orf63 (1.9)	CLPTM1 (1.9)	QTRT1 (1.8)	ADAM1 (1.8)
MP:0009543	abnormal thymus corticomedullary boundary morphology	0.48	> 0.20	RELB (4.0)	BCL3 (3.2)	PLEC (2.6)	ATP13A1 (2.1)	PBX4 (2.0)	GRINA (2.0)	ENSG00000226648 (1.9)	CLPTM1 (1.9)	GMIP (1.9)	PARP10 (1.8)
REACTOME_CALNEXINCALRETICULIN_CYCLE	REACTOME_CALNEXINCALRETICULIN_CYCLE	0.48	> 0.20	ERP29 (5.6)	YIPF2 (3.6)	ATP13A1 (3.5)	CLPTM1 (3.3)	TMED4 (2.5)	OGDH (2.1)	TMEM57 (2.0)	PVRL2 (1.5)	TRAPPC6A (1.4)	ST3GAL4 (1.4)
GO:0032103	positive regulation of response to external stimulus	0.48	> 0.20	ENSG00000228044 (3.3)	TIMD4 (2.3)	PLEKHH2 (2.0)	CETP (1.9)	KIAA1324 (1.8)	PVR (1.6)	HLX (1.6)	APOE (1.5)	ST3GAL4 (1.3)	PMFBP1 (1.2)
MP:0008034	enhanced lipolysis	0.48	> 0.20	MOSC1 (6.6)	GPAM (5.7)	HAPLN4 (2.6)	HP (2.4)	SORT1 (2.2)	SYPL2 (2.0)	AMIGO1 (1.9)	NT5DC1 (1.6)	PVRL2 (1.5)	TM6SF2 (1.4)
GO:0051567	histone H3-K9 methylation	0.48	> 0.20	ZNF180 (2.3)	SLC44A2 (1.9)	TMEM57 (1.8)	KANK2 (1.8)	TSSK6 (1.7)	SMARCA4 (1.6)	ABO (1.5)	ILF3 (1.3)	C12orf51 (1.3)	DNM2 (1.2)
ENSG00000113522	RAD50 PPI subnetwork	0.48	> 0.20	FEN1 (4.2)	USP1 (3.3)	POLK (2.0)	DHODH (1.8)	BUD13 (1.8)	SMARCA4 (1.8)	DHX38 (1.7)	C1orf63 (1.6)	PLCG1 (1.5)	ANKRD31 (1.4)
MP:0008092	abnormal T-helper 2 cell differentiation	0.48	> 0.20	OASL (6.3)	PARP10 (3.6)	GMIP (3.1)	SH2B3 (1.9)	CYB561D1 (1.7)	DNM2 (1.7)	MAFB (1.3)	TRAFD1 (1.2)	GOT2P1 (1.1)	POC5 (1.0)
MP:0001065	abnormal trigeminal nerve morphology	0.48	> 0.20	PVR (2.5)	PVRL2 (2.1)	LPA (2.1)	SLC22A1 (2.1)	CELSR2 (2.1)	SARS (1.9)	TSSK6 (1.9)	APOE (1.9)	TMED4 (1.8)	PPP1R37 (1.8)
ENSG00000135365	PHF21A PPI subnetwork	0.48	> 0.20	TOP1 (2.6)	KIAA1324 (2.5)	NT5DC1 (2.5)	ACAD10 (2.4)	SMARCA4 (2.4)	ATXN2 (2.3)	PLCG1 (2.2)	CELSR2 (2.0)	ENSG00000238078 (1.9)	ILF3 (1.7)
REACTOME_SIGNALING_BY_NOTCH	REACTOME_SIGNALING_BY_NOTCH	0.48	> 0.20	CELSR2 (2.8)	NYNRIN (2.3)	TRAPPC6A (2.3)	PLEC (2.2)	BCAM (2.1)	GRINA (2.0)	MAU2 (2.0)	CLPTM1 (1.8)	GATAD2A (1.8)	TMEM50A (1.8)
ENSG00000087460	GNAS PPI subnetwork	0.48	> 0.20	ST3GAL4 (2.8)	SH2B3 (2.3)	RPH3A (2.2)	HLX (2.1)	MOSC1 (2.1)	ABCG8 (1.8)	ENSG00000254235 (1.7)	ENSG00000226648 (1.7)	CYP7A1 (1.7)	HMGCR (1.6)
MP:0011368	increased kidney apoptosis	0.48	> 0.20	CELSR2 (4.1)	BCAM (3.8)	TMEM116 (2.9)	AP1M2 (2.4)	NYNRIN (2.3)	HAVCR1 (2.3)	MYLIP (2.1)	PLEC (2.0)	PLEKHH2 (1.8)	SLC22A1 (1.8)
ENSG00000213699	C2orf18 PPI subnetwork	0.48	> 0.20	APOE (3.1)	ERP29 (2.6)	APOC1 (2.2)	C19orf52 (2.1)	NYNRIN (2.0)	ALDH2 (1.9)	TMEM57 (1.7)	CYB561D1 (1.7)	ANKRD31 (1.6)	UBXN2B (1.6)
GO:0016441	posttranscriptional gene silencing	0.48	> 0.20	DOCK7 (3.2)	ENSG00000226648 (2.7)	USP24 (2.6)	MAPKAPK5 (2.4)	UBXN2B (2.0)	ENSG00000235545 (1.9)	ADAM1 (1.6)	GOT2P1 (1.6)	C1orf63 (1.5)	BUD13 (1.4)
GO:0035194	posttranscriptional gene silencing by RNA	0.48	> 0.20	DOCK7 (3.2)	ENSG00000226648 (2.7)	USP24 (2.6)	MAPKAPK5 (2.4)	UBXN2B (2.0)	ENSG00000235545 (1.9)	ADAM1 (1.6)	GOT2P1 (1.6)	C1orf63 (1.5)	BUD13 (1.4)
GO:0009566	fertilization	0.48	> 0.20	PMFBP1 (5.2)	TSSK6 (4.2)	ENSG00000238078 (3.4)	ENSG00000228044 (2.9)	GCNT4 (1.7)	PBX4 (1.1)	HNF1A (1.0)	NPC1L1 (1.0)	POLK (1.0)	CILP2 (0.9)
GO:0002456	T cell mediated immunity	0.48	> 0.20	ZNF180 (2.5)	NKPD1 (1.9)	LPAR2 (1.6)	PARP10 (1.6)	POLK (1.5)	PBX4 (1.5)	GCNT4 (1.4)	OASL (1.3)	CBLC (1.2)	PVR (1.2)
ENSG00000213397	HAUS7 PPI subnetwork	0.48	> 0.20	GEMIN7 (2.6)	C19orf52 (2.4)	BLOC1S3 (2.4)	TXNL4B (2.1)	TRAPPC6A (2.0)	KIAA1324 (1.8)	C1orf63 (1.7)	BRAP (1.6)	POC5 (1.6)	C12orf51 (1.6)
MP:0002110	abnormal digit morphology	0.48	> 0.20	PCSK9 (2.3)	NYNRIN (2.2)	PLEKHH2 (2.2)	ZHX3 (2.1)	HMGCR (2.1)	LDLR (1.9)	CBLC (1.9)	MAFB (1.8)	FADS1 (1.6)	KANK2 (1.6)
MP:0000920	abnormal myelination	0.48	> 0.20	C11orf9 (3.3)	APOE (3.0)	RPH3A (2.1)	ST3GAL4 (1.9)	HAPLN4 (1.7)	NCAN (1.7)	APOC1 (1.6)	FADS1 (1.6)	HNF1A (1.4)	DNM2 (1.3)
GO:0043403	skeletal muscle tissue regeneration	0.48	> 0.20	SYPL2 (3.9)	LPIN3 (2.9)	ENSG00000235545 (2.7)	CILP2 (1.9)	CBLC (1.8)	TMEM116 (1.8)	GCNT4 (1.8)	GOT2P1 (1.6)	ENSG00000226645 (1.5)	AMIGO1 (1.4)
GO:0045932	negative regulation of muscle contraction	0.48	> 0.20	C17orf57 (2.8)	ENSG00000226648 (2.5)	C12orf51 (2.1)	TXNL4B (2.1)	SYPL2 (2.1)	ANKRD31 (2.0)	GMPR (1.9)	BLOC1S3 (1.8)	ERP29 (1.7)	TMEM116 (1.5)
GO:0050691	regulation of defense response to virus by host	0.48	> 0.20	OASL (4.4)	PARP10 (4.2)	ENSG00000235545 (2.9)	FRK (2.5)	MAU2 (2.5)	CYB561D1 (2.4)	GEMIN7 (2.1)	TRAFD1 (1.9)	POLK (1.6)	MYLIP (1.4)
GO:0007128	meiotic prophase I	0.48	> 0.20	ANKRD31 (4.5)	C17orf57 (2.4)	ENSG00000238078 (2.3)	ENSG00000228044 (1.9)	TSSK6 (1.7)	NKPD1 (1.7)	TMEM116 (1.3)	LPIN3 (1.3)	PBX4 (1.3)	HAVCR1 (1.2)
ENSG00000163635	ATXN7 PPI subnetwork	0.48	> 0.20	TMEM57 (2.6)	PMFBP1 (2.2)	ATP13A1 (1.7)	C19orf52 (1.6)	C12orf51 (1.6)	ATXN7L2 (1.6)	GMPR (1.6)	SMARCA4 (1.3)	ATXN2 (1.2)	ANGPTL3 (1.2)
ENSG00000160916	ENSG00000160916 PPI subnetwork	0.48	> 0.20	ACAD10 (4.1)	AP1M2 (2.8)	TOMM40 (2.6)	TRAPPC6A (2.6)	ERP29 (2.3)	PSMA5 (2.2)	OGDH (2.1)	TMED4 (2.0)	ATP13A1 (2.0)	BRAP (1.9)
MP:0001680	abnormal mesoderm development	0.48	> 0.20	PVRL2 (2.6)	NYNRIN (2.1)	APOB (2.0)	LDLR (1.9)	APOE (1.9)	ITGB3 (1.5)	PLCG1 (1.5)	MARK4 (1.4)	PVR (1.4)	DOCK7 (1.2)
GO:0043001	Golgi to plasma membrane protein transport	0.48	> 0.20	FRK (2.7)	USP24 (2.5)	C17orf57 (2.2)	ENSG00000228044 (1.9)	AP1M2 (1.6)	NKPD1 (1.6)	C11orf9 (1.5)	ZNF180 (1.5)	C12orf51 (1.5)	TMEM57 (1.5)
GO:0001562	response to protozoan	0.48	> 0.20	ENSG00000235545 (2.7)	ST3GAL4 (2.0)	ENSG00000254235 (1.9)	ADAM1 (1.7)	DNAH11 (1.7)	PVR (1.6)	CEACAM19 (1.6)	C17orf57 (1.4)	POC5 (1.3)	DOCK7 (1.3)
GO:0046824	positive regulation of nucleocytoplasmic transport	0.48	> 0.20	ENSG00000238078 (2.7)	TMEM116 (2.6)	PLEKHH2 (2.4)	OASL (2.4)	AP1M2 (2.3)	GCNT4 (1.9)	SLC44A2 (1.8)	MYLIP (1.6)	KANK2 (1.6)	ENSG00000254235 (1.5)
ENSG00000120438	TCP1 PPI subnetwork	0.48	> 0.20	NAA25 (3.2)	PSMA5 (2.9)	DDX56 (2.6)	SARS (2.0)	ZNF180 (1.9)	POLK (1.9)	TOMM40 (1.9)	POC5 (1.6)	ZNF101 (1.6)	OGDH (1.4)
GO:0018298	protein-chromophore linkage	0.48	> 0.20	HNF1A (2.1)	ENSG00000235545 (2.0)	BLOC1S3 (1.7)	MAPKAPK5 (1.6)	ABO (1.6)	C12orf47 (1.4)	CEACAM19 (1.4)	DNAH11 (1.3)	GOT2P1 (1.2)	HAVCR1 (1.2)
ENSG00000148848	ADAM12 PPI subnetwork	0.48	> 0.20	SYPL2 (3.6)	TMEM116 (2.8)	CETP (2.8)	ST3GAL4 (2.8)	ITGB3 (2.7)	C19orf52 (2.3)	LPAR2 (2.1)	TIMD4 (2.0)	PLCG1 (2.0)	FRK (1.9)
ENSG00000179262	RAD23A PPI subnetwork	0.48	> 0.20	TMEM57 (3.0)	BRAP (2.7)	TRAFD1 (2.6)	SUGP1 (2.4)	NAA25 (2.0)	PSMA5 (1.9)	NT5DC1 (1.7)	RPH3A (1.6)	SARS (1.6)	TMEM50A (1.6)
ENSG00000171219	CDC42BPG PPI subnetwork	0.48	> 0.20	CBLC (6.4)	AP1M2 (4.2)	ST3GAL4 (2.4)	LPAR2 (2.1)	CELSR2 (2.1)	PVRL2 (1.7)	DOCK7 (1.7)	FRK (1.6)	ALDH2 (1.5)	PSRC1 (1.5)
ENSG00000130254	SAFB2 PPI subnetwork	0.48	> 0.20	NPC1L1 (2.5)	FRK (2.4)	PLCG1 (2.3)	ZHX3 (2.3)	BRAP (2.2)	TM6SF2 (2.0)	SH2B3 (1.7)	PLEC (1.7)	HAPLN4 (1.7)	KANK2 (1.6)
GO:0016799	hydrolase activity, hydrolyzing N-glycosyl compounds	0.48	> 0.20	AMIGO1 (2.3)	TRIB1 (2.0)	DHODH (1.7)	MOSC1 (1.7)	FEN1 (1.6)	MYLIP (1.5)	TRAPPC6A (1.4)	TMEM50A (1.3)	ENSG00000235545 (1.3)	ABCG5 (1.3)
GO:0032200	telomere organization	0.48	> 0.20	POLK (3.4)	ZNF180 (2.5)	USP1 (2.2)	ENSG00000226648 (2.2)	TXNL4B (2.1)	POC5 (2.1)	AMIGO1 (1.8)	BLOC1S3 (1.8)	DHODH (1.8)	NKPD1 (1.8)
ENSG00000162616	DNAJB4 PPI subnetwork	0.48	> 0.20	TOMM40 (2.4)	ZNF180 (2.4)	BLOC1S3 (2.3)	PVR (2.1)	PTPN11 (2.1)	DOCK7 (2.0)	FRK (1.7)	TRAPPC6A (1.7)	CEACAM19 (1.6)	C19orf52 (1.5)
ENSG00000188191	PRKAR1B PPI subnetwork	0.48	> 0.20	TRIB1 (2.8)	PLEKHH2 (2.5)	TOP1 (2.4)	OGDH (2.2)	C1orf63 (2.2)	MOSC1 (2.1)	PMFBP1 (2.0)	SORT1 (1.9)	POLK (1.9)	KIAA1324 (1.7)
GO:0006337	nucleosome disassembly	0.48	> 0.20	CARM1 (4.2)	TSSK6 (2.4)	C12orf47 (2.3)	GOT2P1 (2.3)	BRAP (2.2)	NYNRIN (2.1)	BUD13 (2.0)	TMEM57 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.7)
GO:0032986	protein-DNA complex disassembly	0.48	> 0.20	CARM1 (4.2)	TSSK6 (2.4)	C12orf47 (2.3)	GOT2P1 (2.3)	BRAP (2.2)	NYNRIN (2.1)	BUD13 (2.0)	TMEM57 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.7)
GO:0031498	chromatin disassembly	0.48	> 0.20	CARM1 (4.2)	TSSK6 (2.4)	C12orf47 (2.3)	GOT2P1 (2.3)	BRAP (2.2)	NYNRIN (2.1)	BUD13 (2.0)	TMEM57 (1.9)	PMFBP1 (1.8)	ANKRD31 (1.7)
GO:0006402	mRNA catabolic process	0.48	> 0.20	TXNL4B (4.0)	UBXN2B (2.8)	MAPKAPK5 (2.6)	BUD13 (2.5)	BRAP (2.4)	ADAM1 (2.3)	ZNF259 (1.9)	ILF3 (1.7)	DHX38 (1.7)	DHODH (1.6)
ENSG00000010030	ETV7 PPI subnetwork	0.48	> 0.20	TOP1 (3.3)	TRIB1 (2.9)	PLEC (2.2)	ATXN2 (2.2)	ZHX3 (2.2)	PSRC1 (2.1)	TSSK6 (2.0)	ANKRD31 (1.8)	C17orf57 (1.7)	RHCE (1.6)
MP:0004158	right aortic arch	0.48	> 0.20	ANKRD31 (3.2)	PVRL2 (2.9)	CEACAM19 (2.7)	TRIB1 (2.6)	PLCG1 (2.0)	PVR (2.0)	BCAM (2.0)	HLX (1.8)	TRAPPC6A (1.8)	DOCK7 (1.7)
ENSG00000100266	PACSIN2 PPI subnetwork	0.48	> 0.20	PPP1R37 (3.1)	SH2B3 (2.6)	LPIN3 (2.6)	PLEC (2.1)	GATAD2A (2.0)	COL4A3BP (1.9)	HAVCR1 (1.7)	DNM2 (1.6)	BLOC1S3 (1.6)	ST3GAL4 (1.5)
MP:0010878	increased trabecular bone volume	0.48	> 0.20	ITGB3 (3.7)	PARP10 (3.0)	RHD (2.5)	RHCE (2.4)	CEACAM19 (2.3)	GMIP (2.1)	GMPR (1.9)	MAFB (1.9)	TRAFD1 (1.6)	OASL (1.5)
ENSG00000196998	WDR45 PPI subnetwork	0.48	> 0.20	PPP1R37 (2.5)	TXNL4B (2.4)	GEMIN7 (2.0)	HAPLN4 (2.0)	PLCG1 (1.9)	MOSC1 (1.9)	GATAD2A (1.8)	AMIGO1 (1.7)	SARS (1.7)	APOC4 (1.7)
GO:0003416	endochondral bone growth	0.48	> 0.20	CILP2 (6.9)	YIPF2 (2.3)	UBXN2B (2.2)	ABO (2.0)	TSSK6 (1.6)	PBX4 (1.5)	NYNRIN (1.5)	PLEC (1.4)	QTRT1 (1.4)	SLC44A2 (1.3)
ENSG00000114391	RPL24 PPI subnetwork	0.48	> 0.20	NKPD1 (2.9)	GATAD2A (1.9)	ANKRD31 (1.9)	ZNF259 (1.9)	NAA25 (1.6)	PTPN11 (1.5)	C1orf63 (1.5)	SUGP1 (1.5)	SARS (1.5)	TOMM40 (1.4)
GO:0030325	adrenal gland development	0.48	> 0.20	GCNT4 (2.8)	C11orf9 (2.6)	NYNRIN (2.3)	ST3GAL4 (2.3)	ATXN7L2 (1.8)	TSSK6 (1.6)	FRK (1.6)	DYNC2LI1 (1.5)	ENSG00000226645 (1.3)	MYLIP (1.1)
ENSG00000206313	ENSG00000206313 PPI subnetwork	0.49	> 0.20	YIPF2 (3.7)	TMEM57 (2.9)	TMEM50A (2.9)	ST3GAL4 (2.7)	PPP1R37 (2.5)	ERP29 (2.2)	CLPTM1 (2.1)	ENSG00000235545 (1.6)	SARS (1.6)	PVR (1.5)
ENSG00000204463	BAG6 PPI subnetwork	0.49	> 0.20	YIPF2 (3.7)	TMEM57 (2.9)	TMEM50A (2.9)	ST3GAL4 (2.7)	PPP1R37 (2.5)	ERP29 (2.2)	CLPTM1 (2.1)	ENSG00000235545 (1.6)	SARS (1.6)	PVR (1.5)
ENSG00000096155	BAG6 PPI subnetwork	0.49	> 0.20	YIPF2 (3.7)	TMEM57 (2.9)	TMEM50A (2.9)	ST3GAL4 (2.7)	PPP1R37 (2.5)	ERP29 (2.2)	CLPTM1 (2.1)	ENSG00000235545 (1.6)	SARS (1.6)	PVR (1.5)
ENSG00000152894	PTPRK PPI subnetwork	0.49	> 0.20	OASL (2.9)	PARP10 (2.7)	LPAR2 (2.6)	TRIB1 (2.5)	ABCG8 (2.3)	PLEKHH2 (2.0)	PBX4 (2.0)	ABCG5 (1.8)	COL4A3BP (1.8)	SLC22A1 (1.6)
ENSG00000180818	HOXC10 PPI subnetwork	0.49	> 0.20	SARS (3.6)	AP1M2 (2.9)	ERP29 (2.5)	YIPF2 (2.4)	SUGP1 (2.1)	COL4A3BP (2.1)	PSRC1 (2.0)	POC5 (1.9)	C19orf52 (1.8)	FRK (1.7)
GO:2000241	regulation of reproductive process	0.49	> 0.20	OASL (2.7)	SUGP1 (2.6)	BUD13 (2.6)	TXNL4B (2.4)	MAU2 (2.2)	QTRT1 (1.7)	MAPKAPK5 (1.7)	C1orf63 (1.7)	NKPD1 (1.6)	PTPN11 (1.6)
ENSG00000196367	TRRAP PPI subnetwork	0.49	> 0.20	SMARCA4 (2.9)	BUD13 (2.3)	USP1 (2.2)	ATXN2 (1.9)	SUGP1 (1.9)	GMPR (1.8)	ILF3 (1.8)	POC5 (1.8)	DHX38 (1.7)	ZNF180 (1.7)
ENSG00000155366	RHOC PPI subnetwork	0.49	> 0.20	OGDH (2.2)	AP1M2 (2.0)	NYNRIN (1.9)	GMIP (1.8)	CBLC (1.6)	SLC44A2 (1.6)	DNM2 (1.5)	ENSG00000254235 (1.4)	TMED4 (1.3)	ZNF101 (1.3)
GO:0030823	regulation of cGMP metabolic process	0.49	> 0.20	C12orf47 (2.9)	PMFBP1 (2.3)	ANKRD31 (2.3)	TSSK6 (2.2)	CEACAM19 (1.9)	ZHX3 (1.9)	ZNF180 (1.8)	ENSG00000228044 (1.7)	MYLIP (1.6)	NYNRIN (1.6)
REACTOME_LAGGING_STRAND_SYNTHESIS	REACTOME_LAGGING_STRAND_SYNTHESIS	0.49	> 0.20	FEN1 (6.1)	USP1 (5.8)	ZNF180 (2.7)	ENSG00000235545 (1.9)	AMIGO1 (1.8)	ERP29 (1.4)	FADS1 (1.4)	GOT2P1 (1.4)	ENSG00000228044 (1.4)	KIAA1324 (1.2)
ENSG00000116455	WDR77 PPI subnetwork	0.49	> 0.20	TOMM40 (3.1)	ILF3 (2.4)	PSMA5 (2.4)	C12orf43 (2.3)	DHX38 (2.1)	SMARCA4 (2.0)	CLPTM1 (1.7)	GATAD2A (1.7)	MAPKAPK5 (1.7)	FEN1 (1.6)
GO:0003682	chromatin binding	0.49	> 0.20	USP1 (3.0)	PLCG1 (2.7)	GATAD2A (2.5)	SMARCA4 (2.5)	ILF3 (2.3)	CARM1 (2.1)	MARK4 (2.1)	SH2B3 (1.9)	NYNRIN (1.9)	ATXN2 (1.9)
GO:0061384	heart trabecula morphogenesis	0.49	> 0.20	CEACAM19 (3.0)	GOT2P1 (2.3)	CARM1 (2.2)	ATXN7L2 (2.1)	ENSG00000254235 (2.0)	ENSG00000238078 (1.9)	KIAA1324 (1.9)	C19orf52 (1.9)	TMEM116 (1.6)	UBXN2B (1.5)
MP:0004200	decreased fetal size	0.49	> 0.20	NYNRIN (1.9)	GATAD2A (1.8)	PLEKHH2 (1.7)	BCAM (1.7)	MAFB (1.6)	KANK2 (1.5)	SMARCA4 (1.5)	KIAA1324 (1.5)	ATP13A1 (1.4)	TRIB1 (1.4)
ENSG00000124193	SRSF6 PPI subnetwork	0.49	> 0.20	C1orf63 (4.6)	ILF3 (4.0)	TOP1 (3.1)	USP1 (2.6)	DHX38 (2.5)	SMARCA4 (2.4)	QTRT1 (2.3)	BUD13 (2.3)	FEN1 (2.1)	SUGP1 (2.0)
GO:0016820	hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances	0.49	> 0.20	ATP13A1 (3.4)	CLPTM1 (3.3)	GRINA (2.8)	TMEM116 (2.7)	SORT1 (2.5)	HAPLN4 (2.3)	COL4A3BP (2.1)	C12orf51 (2.0)	TMEM50A (1.9)	GMPR (1.8)
ENSG00000069011	PITX1 PPI subnetwork	0.49	> 0.20	TRIB1 (3.5)	HNF1A (2.7)	DYNC2LI1 (2.4)	GCNT4 (2.2)	RHD (1.8)	ATXN2 (1.8)	ATXN7L2 (1.8)	CYB561D1 (1.6)	LDLR (1.6)	AMIGO1 (1.5)
MP:0003710	abnormal physiological neovascularization	0.49	> 0.20	BCL3 (3.2)	PVR (3.1)	GRINA (2.2)	C17orf57 (2.0)	CEACAM19 (1.9)	LDLR (1.8)	HAVCR1 (1.6)	YIPF2 (1.6)	ITGB3 (1.5)	RELB (1.5)
MP:0009331	absent primitive node	0.49	> 0.20	AP1M2 (3.3)	HNF1A (2.0)	MAPKAPK5 (1.9)	HAVCR1 (1.8)	PMFBP1 (1.8)	APOE (1.7)	CEACAM19 (1.7)	PARP10 (1.7)	YIPF2 (1.7)	PVRL2 (1.6)
ENSG00000115128	ENSG00000115128 PPI subnetwork	0.49	> 0.20	ILF3 (4.0)	C1orf63 (3.4)	TOP1 (2.8)	SMARCA4 (2.7)	BUD13 (2.6)	DHX38 (2.5)	USP1 (2.5)	SUGP1 (2.5)	PTPN11 (2.2)	FEN1 (2.1)
ENSG00000107242	PIP5K1B PPI subnetwork	0.49	> 0.20	ITGB3 (3.5)	KANK2 (2.8)	ALDH2 (2.7)	ATXN2 (2.3)	PTPN11 (2.3)	TRAFD1 (2.2)	FADS1 (2.1)	C1orf63 (1.9)	SARS (1.8)	TXNL4B (1.7)
ENSG00000170542	SERPINB9 PPI subnetwork	0.49	> 0.20	FADS2 (2.6)	FADS1 (2.2)	TRAPPC6A (2.0)	CEACAM19 (1.9)	ATXN7L2 (1.8)	SLC44A2 (1.6)	HMGCR (1.4)	NT5DC1 (1.3)	ANKRD31 (1.3)	PCSK9 (1.3)
GO:0051017	actin filament bundle assembly	0.49	> 0.20	HNF1A (2.8)	HAVCR1 (2.4)	CARM1 (2.0)	USP24 (2.0)	C11orf9 (1.9)	C17orf57 (1.9)	ITGB3 (1.7)	POLK (1.4)	ABO (1.3)	ENSG00000235545 (1.3)
GO:0042641	actomyosin	0.49	> 0.20	PLEC (3.7)	KANK2 (3.7)	PVRL2 (2.8)	ITGB3 (2.2)	CARM1 (1.8)	DNM2 (1.7)	PLCG1 (1.6)	ENSG00000238078 (1.5)	PTPN11 (1.5)	NPC1L1 (1.4)
ENSG00000206315	PBX2 PPI subnetwork	0.49	> 0.20	COL4A3BP (2.8)	C12orf43 (2.6)	DHODH (2.3)	ALDH2 (2.0)	SUGP1 (2.0)	ATXN7L2 (1.7)	CYB561D1 (1.6)	DHX38 (1.5)	SMARCA4 (1.5)	POLK (1.4)
ENSG00000204304	PBX2 PPI subnetwork	0.49	> 0.20	COL4A3BP (2.8)	C12orf43 (2.6)	DHODH (2.3)	ALDH2 (2.0)	SUGP1 (2.0)	ATXN7L2 (1.7)	CYB561D1 (1.6)	DHX38 (1.5)	SMARCA4 (1.5)	POLK (1.4)
ENSG00000206247	ENSG00000206247 PPI subnetwork	0.49	> 0.20	COL4A3BP (2.8)	C12orf43 (2.6)	DHODH (2.3)	ALDH2 (2.0)	SUGP1 (2.0)	ATXN7L2 (1.7)	CYB561D1 (1.6)	DHX38 (1.5)	SMARCA4 (1.5)	POLK (1.4)
ENSG00000101868	POLA1 PPI subnetwork	0.49	> 0.20	FEN1 (6.2)	USP1 (5.1)	PSRC1 (2.4)	ILF3 (1.8)	ZNF180 (1.5)	ENSG00000235545 (1.4)	ENSG00000228044 (1.2)	GOT2P1 (1.2)	DHODH (1.1)	BUD13 (1.0)
ENSG00000182923	CEP63 PPI subnetwork	0.49	> 0.20	MAU2 (3.9)	GATAD2A (2.3)	C12orf47 (1.9)	RPH3A (1.9)	DNAH11 (1.9)	NT5DC1 (1.8)	KANK2 (1.8)	CYB561D1 (1.7)	SMARCA4 (1.7)	ATXN2 (1.6)
MP:0000288	abnormal pericardium morphology	0.49	> 0.20	BCAM (3.2)	MAFB (2.5)	TSSK6 (2.2)	NYNRIN (2.1)	BLOC1S3 (2.1)	LPAR2 (1.5)	MOSC1 (1.5)	CEACAM19 (1.4)	HAPLN4 (1.3)	PVRL2 (1.3)
GO:0007292	female gamete generation	0.49	> 0.20	CEACAM19 (4.0)	ANKRD31 (2.8)	NKPD1 (2.2)	AP1M2 (2.0)	HNF1A (1.8)	CBLC (1.8)	TSSK6 (1.6)	LPIN3 (1.4)	NYNRIN (1.2)	AMIGO1 (1.1)
ENSG00000099246	RAB18 PPI subnetwork	0.49	> 0.20	COL4A3BP (3.9)	TMEM50A (3.0)	PSMA5 (2.6)	DYNC2LI1 (1.8)	SLC44A2 (1.8)	MARK4 (1.8)	POLK (1.7)	OGDH (1.6)	KANK2 (1.6)	DNAH11 (1.4)
REACTOME_SHC:MEDIATED_SIGNALLING	REACTOME_SHC:MEDIATED_SIGNALLING	0.49	> 0.20	MARK4 (3.1)	GEMIN7 (2.3)	PBX4 (2.2)	BLOC1S3 (2.0)	MAPKAPK5 (1.9)	CARM1 (1.9)	DNM2 (1.9)	ENSG00000238078 (1.8)	PSRC1 (1.7)	PVRL2 (1.7)
MP:0001435	no suckling reflex	0.49	> 0.20	LDLR (4.0)	CELSR2 (3.3)	HMGCR (3.3)	FADS1 (3.0)	PLCG1 (2.7)	FADS2 (2.5)	C11orf9 (2.4)	NCAN (2.1)	C17orf57 (2.0)	ATP13A1 (1.8)
ENSG00000026103	FAS PPI subnetwork	0.49	> 0.20	TMEM50A (2.3)	FRK (2.3)	GMIP (2.2)	PARP10 (2.1)	OGDH (2.0)	LDLR (2.0)	ENSG00000238078 (2.0)	SH2B3 (1.9)	ZNF180 (1.9)	TRAFD1 (1.8)
ENSG00000079739	PGM1 PPI subnetwork	0.49	> 0.20	SARS (3.2)	PSMA5 (2.8)	SUGP1 (2.6)	ZNF259 (2.4)	ZNF101 (2.2)	ENSG00000238078 (2.1)	QTRT1 (2.1)	NT5DC1 (2.0)	NAA25 (2.0)	ENSG00000254235 (1.9)
GO:0050805	negative regulation of synaptic transmission	0.49	> 0.20	ENSG00000254235 (2.7)	ENSG00000226648 (2.2)	CETP (2.2)	RPH3A (2.1)	ABO (2.1)	BLOC1S3 (1.7)	ABCG8 (1.4)	CEACAM19 (1.3)	GOT2P1 (1.3)	C12orf51 (1.2)
MP:0009230	abnormal sperm head morphology	0.49	> 0.20	TSSK6 (4.7)	BRAP (2.8)	ADAM1 (2.5)	GCNT4 (2.2)	PMFBP1 (2.1)	TMEM116 (2.1)	MAPKAPK5 (1.9)	LPAR2 (1.8)	MARK4 (1.7)	TXNL4B (1.6)
GO:0002819	regulation of adaptive immune response	0.49	> 0.20	DNAH11 (1.9)	ENSG00000235545 (1.9)	POLK (1.7)	PARP10 (1.7)	HAVCR1 (1.5)	PBX4 (1.4)	RELB (1.4)	GEMIN7 (1.2)	ZNF101 (1.2)	NKPD1 (1.2)
ENSG00000100505	TRIM9 PPI subnetwork	0.49	> 0.20	HAVCR1 (2.8)	CYB561D1 (2.4)	NCAN (2.1)	KIAA1324 (2.1)	TRAPPC6A (1.6)	LDLR (1.6)	PMFBP1 (1.6)	AMIGO1 (1.6)	POC5 (1.6)	HMGCR (1.5)
ENSG00000126457	PRMT1 PPI subnetwork	0.49	> 0.20	QTRT1 (4.1)	GATAD2A (2.8)	SMARCA4 (2.8)	ILF3 (2.2)	TOMM40 (1.9)	TRIB1 (1.7)	GEMIN7 (1.6)	C19orf52 (1.6)	PTPN11 (1.6)	HAVCR1 (1.3)
MP:0002636	delayed vaginal opening	0.49	> 0.20	PLEKHH2 (2.4)	ATXN7L2 (2.3)	PBX4 (2.3)	PMFBP1 (1.6)	GCNT4 (1.6)	TOP1 (1.6)	ANKRD31 (1.6)	KIAA1324 (1.4)	NT5DC1 (1.4)	CILP2 (1.3)
ENSG00000110651	CD81 PPI subnetwork	0.49	> 0.20	TIMD4 (3.3)	APOE (3.2)	GRINA (3.0)	CETP (2.8)	TMEM50A (2.6)	CYB561D1 (2.4)	BCAM (2.3)	SLC44A2 (2.3)	CILP2 (2.1)	ADAM1 (1.8)
GO:0060038	cardiac muscle cell proliferation	0.49	> 0.20	CEACAM19 (2.8)	BLOC1S3 (2.4)	C19orf52 (2.2)	PLEKHH2 (2.0)	TXNL4B (1.4)	NYNRIN (1.4)	ALDH2 (1.3)	C11orf9 (1.3)	ZNF180 (1.3)	LPA (1.3)
GO:0014075	response to amine stimulus	0.49	> 0.20	C17orf57 (3.7)	C12orf51 (2.3)	SARS (1.8)	ABCG5 (1.7)	COL4A3BP (1.6)	NPC1L1 (1.5)	C11orf9 (1.5)	TSSK6 (1.4)	ABCG8 (1.4)	DNAH11 (1.3)
ENSG00000121552	CSTA PPI subnetwork	0.49	> 0.20	MAFB (2.9)	NKPD1 (2.8)	APOE (2.5)	PMFBP1 (2.0)	TMEM116 (1.7)	ALDH2 (1.7)	APOC1 (1.5)	CEACAM19 (1.5)	GMPR (1.4)	ENSG00000226648 (1.3)
MP:0003866	abnormal defecation	0.49	> 0.20	PMFBP1 (2.2)	NYNRIN (2.0)	LPIN3 (1.7)	NKPD1 (1.6)	CILP2 (1.6)	HNF1A (1.5)	AMIGO1 (1.4)	YIPF2 (1.4)	LPAR2 (1.4)	KANK2 (1.3)
ENSG00000134899	ERCC5 PPI subnetwork	0.49	> 0.20	PARP10 (2.6)	MAU2 (2.3)	SUGP1 (2.2)	ZNF180 (2.0)	GMIP (1.8)	POLK (1.8)	POC5 (1.6)	TXNL4B (1.6)	CBLC (1.4)	BCL3 (1.4)
MP:0002188	small heart	0.49	> 0.20	NYNRIN (3.4)	C11orf9 (2.3)	BCAM (2.2)	PVRL2 (2.2)	COL4A3BP (1.9)	GCNT4 (1.4)	PCSK9 (1.4)	OGDH (1.3)	ACAD10 (1.3)	CARM1 (1.2)
ENSG00000160791	CCR5 PPI subnetwork	0.49	> 0.20	OASL (3.5)	RELB (3.0)	TRAFD1 (2.7)	GRINA (2.5)	PARP10 (2.4)	GMIP (2.3)	MAFB (2.3)	TMEM50A (2.2)	BCL3 (2.2)	USP24 (1.9)
ENSG00000215778	ENSG00000215778 PPI subnetwork	0.49	> 0.20	OASL (3.5)	RELB (3.0)	TRAFD1 (2.7)	GRINA (2.5)	PARP10 (2.4)	GMIP (2.3)	MAFB (2.3)	TMEM50A (2.2)	BCL3 (2.2)	USP24 (1.9)
REACTOME_PEROXISOMAL_LIPID_METABOLISM	REACTOME_PEROXISOMAL_LIPID_METABOLISM	0.49	> 0.20	MOSC1 (4.1)	GPAM (2.7)	UBXN2B (2.5)	APOA5 (2.4)	ACAD10 (2.3)	ALDH2 (2.3)	NT5DC1 (2.3)	TM6SF2 (2.2)	ABCG8 (2.1)	ABCG5 (2.0)
ENSG00000167965	MLST8 PPI subnetwork	0.49	> 0.20	DHX38 (2.6)	AP1M2 (2.5)	COL4A3BP (2.3)	MAPKAPK5 (2.1)	CLPTM1 (2.0)	ATP13A1 (1.9)	PCSK9 (1.8)	ANKRD31 (1.7)	ENSG00000228044 (1.6)	YIPF2 (1.5)
MP:0011100	complete preweaning lethality	0.49	> 0.20	PTPN11 (2.4)	C11orf9 (2.3)	CETP (2.1)	ATP13A1 (2.1)	CLPTM1 (2.1)	UBXN2B (1.9)	RHD (1.8)	SLC44A2 (1.8)	ILF3 (1.8)	TMEM50A (1.8)
ENSG00000160201	U2AF1 PPI subnetwork	0.49	> 0.20	C1orf63 (4.2)	ILF3 (4.1)	TOP1 (3.2)	SMARCA4 (2.9)	DHX38 (2.6)	USP1 (2.5)	SUGP1 (2.4)	BUD13 (2.4)	PTPN11 (2.3)	QTRT1 (2.2)
ENSG00000159692	CTBP1 PPI subnetwork	0.49	> 0.20	ATXN2 (3.7)	ATXN7L2 (3.4)	C12orf51 (3.1)	PPP1R37 (2.4)	SMARCA4 (2.3)	USP24 (2.2)	KANK2 (1.9)	CELSR2 (1.9)	CARM1 (1.8)	APOC4 (1.8)
GO:0071384	cellular response to corticosteroid stimulus	0.49	> 0.20	RHCE (2.9)	TXNL4B (2.5)	RHD (2.4)	ENSG00000226645 (2.4)	TMEM57 (2.1)	ATXN7L2 (2.1)	LPIN3 (2.1)	GMPR (2.1)	ABCG8 (2.0)	FRK (2.0)
GO:0071385	cellular response to glucocorticoid stimulus	0.49	> 0.20	RHCE (2.9)	TXNL4B (2.5)	RHD (2.4)	ENSG00000226645 (2.4)	TMEM57 (2.1)	ATXN7L2 (2.1)	LPIN3 (2.1)	GMPR (2.1)	ABCG8 (2.0)	FRK (2.0)
ENSG00000139618	BRCA2 PPI subnetwork	0.49	> 0.20	FEN1 (3.6)	PSRC1 (2.5)	DNM2 (2.2)	USP1 (1.9)	ILF3 (1.9)	PBX4 (1.6)	POC5 (1.4)	SLC44A2 (1.4)	ITGB3 (1.4)	MAU2 (1.4)
GO:0008252	nucleotidase activity	0.49	> 0.20	TMED4 (2.8)	UBXN2B (2.7)	FRK (2.3)	ITGB3 (2.0)	NT5DC1 (1.8)	GMPR (1.7)	CEACAM19 (1.6)	TXNL4B (1.5)	DDX56 (1.4)	SARS (1.3)
ENSG00000136011	STAB2 PPI subnetwork	0.49	> 0.20	OASL (3.2)	TMEM57 (2.2)	POLK (1.8)	PLEKHH2 (1.8)	TMEM50A (1.6)	C1orf63 (1.5)	BCAM (1.5)	CEACAM19 (1.4)	PVRL2 (1.3)	SLC44A2 (1.2)
ENSG00000109472	CPE PPI subnetwork	0.49	> 0.20	ERP29 (3.2)	TMED4 (2.6)	NCAN (2.2)	CELSR2 (2.2)	HAPLN4 (2.1)	PCSK9 (2.0)	CLPTM1 (2.0)	BCAM (1.9)	TIMD4 (1.8)	YIPF2 (1.7)
GO:0010543	regulation of platelet activation	0.49	> 0.20	ITGB3 (5.6)	CETP (2.7)	GMPR (2.1)	CYP7A1 (2.1)	ANGPTL3 (1.7)	PMFBP1 (1.6)	PVR (1.5)	SLC22A1 (1.5)	TIMD4 (1.5)	TXNL4B (1.4)
MP:0003055	abnormal long bone epiphyseal plate morphology	0.49	> 0.20	CILP2 (6.9)	PLEKHH2 (2.8)	MAFB (2.8)	GOT2P1 (1.6)	YIPF2 (1.3)	ALDH2 (1.2)	PLCG1 (1.2)	MYLIP (1.1)	TIMD4 (1.1)	KANK2 (1.0)
MP:0002762	ectopic cerebellar granule cells	0.49	> 0.20	NCAN (2.2)	DOCK7 (2.1)	PVR (1.6)	AMIGO1 (1.5)	MAFB (1.5)	CEACAM19 (1.4)	TMED4 (1.3)	TMEM116 (1.3)	ZHX3 (1.3)	ALDH2 (1.2)
GO:0032680	regulation of tumor necrosis factor production	0.49	> 0.20	GRINA (2.1)	MAFB (2.0)	PVR (1.7)	HLX (1.7)	ALDH2 (1.7)	TIMD4 (1.6)	GMIP (1.6)	ZNF101 (1.5)	ST3GAL4 (1.5)	FRK (1.4)
GO:0032640	tumor necrosis factor production	0.49	> 0.20	GRINA (2.1)	MAFB (2.0)	PVR (1.7)	HLX (1.7)	ALDH2 (1.7)	TIMD4 (1.6)	GMIP (1.6)	ZNF101 (1.5)	ST3GAL4 (1.5)	FRK (1.4)
GO:0050707	regulation of cytokine secretion	0.49	> 0.20	ZNF101 (1.9)	ENSG00000228044 (1.9)	DNAH11 (1.7)	HAVCR1 (1.7)	HLX (1.6)	MOSC1 (1.2)	CYP7A1 (1.2)	NKPD1 (1.2)	ZNF180 (1.2)	ST3GAL4 (1.1)
MP:0005272	abnormal temporal bone morphology	0.49	> 0.20	MYLIP (2.2)	CEACAM19 (1.9)	MAFB (1.7)	ENSG00000254235 (1.6)	ST3GAL4 (1.4)	TMEM57 (1.4)	PLEC (1.4)	GPAM (1.3)	C19orf52 (1.2)	TMEM116 (1.2)
MP:0001891	hydroencephaly	0.49	> 0.20	DYNC2LI1 (2.6)	OASL (2.6)	PVRL2 (2.3)	ENSG00000235545 (1.9)	TRAFD1 (1.9)	CELSR2 (1.5)	DOCK7 (1.5)	ABCG5 (1.5)	CILP2 (1.4)	ANKRD31 (1.4)
REACTOME_E2F:ENABLED_INHIBITION_OF_PRE:REPLICATION_COMPLEX_FORMATION	REACTOME_E2F:ENABLED_INHIBITION_OF_PRE:REPLICATION_COMPLEX_FORMATION	0.49	> 0.20	POC5 (3.4)	FEN1 (3.2)	USP1 (2.2)	NT5DC1 (2.2)	TMEM116 (2.0)	MAU2 (1.8)	PSRC1 (1.7)	RHD (1.6)	TXNL4B (1.3)	ENSG00000226645 (1.2)
MP:0008097	increased plasma cell number	0.49	> 0.20	RELB (3.3)	TIMD4 (2.5)	ZNF101 (2.4)	GMIP (2.4)	PBX4 (2.2)	SLC44A2 (1.8)	BCL3 (1.8)	COL4A3BP (1.3)	NT5DC1 (1.3)	PLCG1 (1.3)
GO:0043330	response to exogenous dsRNA	0.49	> 0.20	OASL (4.3)	PARP10 (4.0)	MYLIP (2.0)	CYB561D1 (1.8)	TRAFD1 (1.8)	TSSK6 (1.8)	TMEM50A (1.7)	AMIGO1 (1.5)	GEMIN7 (1.4)	FRK (1.3)
ENSG00000132849	INADL PPI subnetwork	0.49	> 0.20	NCAN (3.2)	RPH3A (3.2)	CELSR2 (1.9)	GCNT4 (1.9)	AP1M2 (1.7)	FRK (1.7)	LPA (1.7)	ENSG00000228044 (1.7)	ENSG00000226648 (1.6)	HAPLN4 (1.5)
KEGG_P53_SIGNALING_PATHWAY	KEGG_P53_SIGNALING_PATHWAY	0.49	> 0.20	POLK (4.5)	PSRC1 (3.3)	FEN1 (2.1)	PARP10 (1.4)	TRAFD1 (1.4)	CETP (1.2)	MYLIP (1.2)	ENSG00000228044 (1.1)	KANK2 (1.0)	AP1M2 (1.0)
ENSG00000146733	PSPH PPI subnetwork	0.49	> 0.20	TRAPPC6A (4.8)	QTRT1 (2.4)	GATAD2A (2.0)	NT5DC1 (2.0)	YIPF2 (1.6)	BLOC1S3 (1.6)	LPAR2 (1.5)	TRAFD1 (1.4)	SUGP1 (1.3)	TMEM50A (1.3)
GO:0070192	chromosome organization involved in meiosis	0.49	> 0.20	ANKRD31 (3.2)	ENSG00000238078 (2.4)	DNAH11 (1.5)	LPIN3 (1.4)	POC5 (1.3)	GCNT4 (1.3)	C17orf57 (1.2)	PBX4 (1.2)	DYNC2LI1 (1.1)	ADAM1 (1.0)
GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	0.49	> 0.20	ABO (2.6)	ST3GAL4 (2.1)	TRAPPC6A (2.0)	C12orf43 (1.8)	BLOC1S3 (1.8)	PCSK9 (1.4)	C17orf57 (1.3)	LPIN3 (1.3)	HNF1A (1.2)	ENSG00000254235 (1.2)
KEGG_MAPK_SIGNALING_PATHWAY	KEGG_MAPK_SIGNALING_PATHWAY	0.49	> 0.20	PVR (4.2)	TRIB1 (4.1)	RELB (3.0)	BCL3 (3.0)	PTPN11 (2.6)	LDLR (2.1)	SH2B3 (2.0)	PLEKHH2 (2.0)	MARK4 (1.8)	HLX (1.8)
GO:0043408	regulation of MAPK cascade	0.49	> 0.20	TRIB1 (2.4)	PVR (2.3)	C11orf9 (2.3)	ENSG00000226645 (2.2)	PLEKHH2 (1.9)	HLX (1.7)	POLK (1.5)	ST3GAL4 (1.4)	PTPN11 (1.3)	KANK2 (1.1)
ENSG00000101654	RNMT PPI subnetwork	0.49	> 0.20	SUGP1 (3.4)	GEMIN7 (3.0)	C12orf43 (3.0)	TRAPPC6A (2.9)	ZNF259 (2.3)	DHX38 (1.8)	DYNC2LI1 (1.8)	SARS (1.8)	TXNL4B (1.7)	MARK4 (1.6)
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	0.49	> 0.20	MAPKAPK5 (3.3)	POC5 (2.9)	PSMA5 (2.9)	BUD13 (2.7)	DDX56 (2.5)	DHX38 (2.1)	ILF3 (2.0)	USP1 (2.0)	TOP1 (1.8)	ZNF259 (1.7)
ENSG00000147044	CASK PPI subnetwork	0.49	> 0.20	RPH3A (3.1)	CETP (2.7)	BCAM (2.4)	CELSR2 (2.3)	C11orf9 (1.6)	FRK (1.6)	PPP1R37 (1.5)	CYP7A1 (1.3)	APOE (1.3)	MARK4 (1.3)
ENSG00000161547	SRSF2 PPI subnetwork	0.49	> 0.20	C1orf63 (4.6)	ILF3 (3.9)	TOP1 (3.3)	USP1 (3.0)	DHX38 (2.7)	BUD13 (2.7)	SMARCA4 (2.3)	SUGP1 (2.3)	FEN1 (2.2)	QTRT1 (2.0)
ENSG00000065883	CDK13 PPI subnetwork	0.49	> 0.20	ANKRD31 (2.4)	PPP1R37 (2.0)	SMARCA4 (1.9)	PMFBP1 (1.9)	PBX4 (1.9)	USP24 (1.7)	ZNF180 (1.7)	POLK (1.4)	NCAN (1.4)	ILF3 (1.3)
GO:0003229	ventricular cardiac muscle tissue development	0.49	> 0.20	ENSG00000254235 (2.5)	ENSG00000238078 (2.5)	CEACAM19 (2.1)	TSSK6 (2.1)	CILP2 (2.0)	ACAD10 (1.7)	GMPR (1.7)	NKPD1 (1.5)	TRAPPC6A (1.4)	BLOC1S3 (1.3)
REACTOME_G2M_CHECKPOINTS	REACTOME_G2M_CHECKPOINTS	0.49	> 0.20	FEN1 (6.6)	USP1 (4.8)	PSRC1 (2.2)	TMEM116 (2.1)	POC5 (2.1)	ENSG00000226645 (1.5)	LPIN3 (1.2)	ENSG00000228044 (1.1)	NT5DC1 (1.0)	DNAH11 (1.0)
ENSG00000111667	USP5 PPI subnetwork	0.49	> 0.20	DHX38 (3.1)	SARS (2.7)	HAVCR1 (2.3)	PPP1R37 (2.3)	PTPN11 (2.3)	TXNL4B (2.3)	QTRT1 (1.9)	DOCK7 (1.6)	C12orf47 (1.6)	YIPF2 (1.6)
ENSG00000125651	GTF2F1 PPI subnetwork	0.49	> 0.20	ILF3 (3.3)	BUD13 (3.3)	TOP1 (3.0)	C1orf63 (2.7)	USP1 (2.7)	DHX38 (2.7)	SUGP1 (2.5)	SMARCA4 (2.4)	FEN1 (2.0)	PTPN11 (1.8)
GO:0045070	positive regulation of viral genome replication	0.49	> 0.20	GCNT4 (3.1)	OASL (3.0)	YIPF2 (2.3)	MAU2 (2.3)	ENSG00000226645 (1.9)	C12orf43 (1.7)	NKPD1 (1.7)	ADAM1 (1.5)	ANKRD31 (1.4)	ATP13A1 (1.4)
ENSG00000101557	USP14 PPI subnetwork	0.49	> 0.20	PSMA5 (5.3)	TRAFD1 (2.6)	NAA25 (2.6)	SARS (1.7)	DDX56 (1.7)	TOMM40 (1.6)	NT5DC1 (1.6)	SUGP1 (1.5)	TMEM57 (1.4)	BRAP (1.2)
REACTOME_ASPARAGINE_N:LINKED_GLYCOSYLATION	REACTOME_ASPARAGINE_N:LINKED_GLYCOSYLATION	0.49	> 0.20	YIPF2 (4.9)	ERP29 (4.0)	TMED4 (3.0)	ATP13A1 (2.9)	CLPTM1 (2.8)	TMEM57 (2.0)	TMEM50A (1.7)	ENSG00000235545 (1.1)	TOP1 (1.1)	C19orf52 (1.1)
ENSG00000004487	KDM1A PPI subnetwork	0.49	> 0.20	MARK4 (2.6)	SMARCA4 (2.2)	NT5DC1 (2.0)	ATXN2 (1.9)	TMEM57 (1.9)	DOCK7 (1.9)	ATXN7L2 (1.9)	TRAFD1 (1.8)	TOP1 (1.7)	PLCG1 (1.6)
GO:0005770	late endosome	0.49	> 0.20	TMEM50A (3.5)	COL4A3BP (2.7)	ERP29 (2.3)	TRAFD1 (2.3)	GRINA (2.2)	MAFB (2.1)	APOC1 (1.9)	APOE (1.7)	CETP (1.6)	ATP13A1 (1.3)
MP:0001675	abnormal ectoderm development	0.50	> 0.20	APOE (2.9)	NAA25 (2.6)	GEMIN7 (2.2)	C17orf57 (2.1)	ENSG00000254235 (2.0)	DOCK7 (2.0)	APOB (1.6)	COL4A3BP (1.6)	HNF1A (1.5)	ABO (1.4)
ENSG00000133398	MED10 PPI subnetwork	0.50	> 0.20	GEMIN7 (4.0)	MAPKAPK5 (2.7)	TRAPPC6A (2.4)	TXNL4B (2.3)	BRAP (2.2)	BUD13 (1.9)	BLOC1S3 (1.8)	C12orf51 (1.8)	DHX38 (1.7)	ATXN7L2 (1.7)
GO:0001707	mesoderm formation	0.50	> 0.20	ENSG00000226648 (2.7)	ENSG00000238078 (2.7)	ENSG00000254235 (2.7)	NYNRIN (2.2)	GOT2P1 (2.0)	ATXN7L2 (1.7)	ABO (1.5)	CILP2 (1.5)	C19orf52 (1.5)	CARM1 (1.4)
ENSG00000107175	CREB3 PPI subnetwork	0.50	> 0.20	SARS (3.9)	PVRL2 (3.4)	ZNF259 (3.1)	PVR (3.0)	KIAA1324 (2.1)	MAPKAPK5 (2.1)	MAFB (2.0)	BCL3 (2.0)	HLX (1.9)	TM6SF2 (1.9)
KEGG_CITRATE_CYCLE_TCA_CYCLE	KEGG_CITRATE_CYCLE_TCA_CYCLE	0.50	> 0.20	OGDH (4.3)	ACAD10 (4.1)	GPAM (2.6)	GMPR (2.1)	ALDH2 (1.9)	FADS1 (1.9)	FADS2 (1.9)	MOSC1 (1.8)	CLPTM1 (1.7)	HAPLN4 (1.6)
ENSG00000033011	ALG1 PPI subnetwork	0.50	> 0.20	HMGCR (5.6)	LDLR (5.1)	FADS1 (4.6)	FADS2 (4.5)	TMEM50A (3.3)	PCSK9 (3.1)	ERP29 (3.0)	SORT1 (2.7)	CYB561D1 (2.1)	AMIGO1 (1.9)
MP:0000065	abnormal bone marrow cavity morphology	0.50	> 0.20	CILP2 (6.6)	NPC1L1 (2.4)	NYNRIN (2.1)	PLEC (2.0)	RHCE (1.8)	PVRL2 (1.8)	BCAM (1.6)	ANKRD31 (1.6)	GOT2P1 (1.6)	TRIB1 (1.6)
GO:0007044	cell-substrate junction assembly	0.50	> 0.20	C17orf57 (3.8)	PLEC (3.0)	CBLC (2.8)	BCAM (2.7)	ITGB3 (2.0)	SLC44A2 (1.9)	AP1M2 (1.8)	GCNT4 (1.7)	KANK2 (1.7)	PVRL2 (1.6)
ENSG00000105655	ISYNA1 PPI subnetwork	0.50	> 0.20	PSMA5 (3.0)	TMEM50A (2.6)	SARS (2.4)	QTRT1 (2.2)	NYNRIN (2.0)	TSSK6 (1.8)	SUGP1 (1.7)	ENSG00000235545 (1.7)	ATP13A1 (1.4)	OGDH (1.4)
REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG:NER	REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG:NER	0.50	> 0.20	FEN1 (5.9)	USP1 (5.8)	ZNF180 (2.5)	GOT2P1 (1.8)	ENSG00000235545 (1.7)	ERP29 (1.6)	ENSG00000228044 (1.6)	NT5DC1 (1.3)	FADS1 (1.2)	TMEM116 (1.2)
REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC:NER	REACTOME_GAP:FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_TC:NER	0.50	> 0.20	FEN1 (5.9)	USP1 (5.8)	ZNF180 (2.5)	GOT2P1 (1.8)	ENSG00000235545 (1.7)	ERP29 (1.6)	ENSG00000228044 (1.6)	NT5DC1 (1.3)	FADS1 (1.2)	TMEM116 (1.2)
MP:0002722	abnormal immune system organ morphology	0.50	> 0.20	GMIP (3.1)	MAFB (2.6)	ZNF101 (2.5)	TMEM57 (2.5)	C17orf57 (2.2)	PBX4 (2.1)	BCL3 (2.1)	CETP (1.9)	PLEC (1.8)	PLCG1 (1.8)
ENSG00000105327	BBC3 PPI subnetwork	0.50	> 0.20	ITGB3 (3.3)	GMPR (2.6)	BCAM (2.5)	PLCG1 (2.2)	LPAR2 (1.8)	ZNF101 (1.7)	C11orf9 (1.7)	RHCE (1.7)	PBX4 (1.5)	QTRT1 (1.4)
MP:0008918	microgliosis	0.50	> 0.20	NCAN (3.2)	CYB561D1 (2.5)	ERP29 (2.4)	TMEM116 (2.3)	POLK (2.0)	SORT1 (1.9)	ATXN7L2 (1.9)	GCNT4 (1.8)	PCSK9 (1.8)	SLC44A2 (1.8)
GO:0000075	cell cycle checkpoint	0.50	> 0.20	PSRC1 (2.6)	POC5 (2.5)	FEN1 (2.3)	USP1 (2.1)	ZNF180 (2.1)	PSMA5 (1.9)	SUGP1 (1.8)	BRAP (1.7)	POLK (1.7)	BUD13 (1.7)
ENSG00000103423	DNAJA3 PPI subnetwork	0.50	> 0.20	SARS (3.2)	NAA25 (2.9)	DDX56 (2.3)	C12orf43 (2.2)	RELB (2.1)	ENSG00000226648 (2.0)	OGDH (1.9)	TOMM40 (1.8)	TOP1 (1.8)	PLEC (1.7)
MP:0000737	abnormal myotome development	0.50	> 0.20	MYLIP (2.9)	TMEM116 (2.4)	FRK (2.2)	SYPL2 (2.1)	TRAPPC6A (2.0)	C17orf57 (1.8)	TMED4 (1.6)	ENSG00000228044 (1.5)	TM6SF2 (1.5)	HLX (1.4)
ENSG00000138346	DNA2 PPI subnetwork	0.50	> 0.20	USP1 (4.8)	FEN1 (4.7)	FADS1 (2.5)	POC5 (2.2)	ENSG00000235545 (1.8)	ZNF180 (1.6)	DHODH (1.5)	FADS2 (1.5)	AMIGO1 (1.1)	FRK (1.1)
MP:0004937	dilated heart	0.50	> 0.20	LPIN3 (2.6)	C1orf63 (2.3)	C11orf9 (1.9)	ITGB3 (1.8)	NPC1L1 (1.8)	OGDH (1.8)	C17orf57 (1.8)	UBXN2B (1.8)	CARM1 (1.7)	ADAM1 (1.6)
GO:0022612	gland morphogenesis	0.50	> 0.20	PLEKHH2 (2.3)	CELSR2 (2.1)	BCAM (2.1)	PPP1R37 (2.0)	AP1M2 (1.9)	ENSG00000254235 (1.8)	AMIGO1 (1.8)	ST3GAL4 (1.7)	CBLC (1.7)	PLEC (1.6)
KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	0.50	> 0.20	SARS (8.7)	DHODH (3.3)	NAA25 (3.1)	ZNF259 (2.8)	SUGP1 (2.6)	DDX56 (2.6)	QTRT1 (2.3)	MAPKAPK5 (2.2)	POC5 (2.2)	PSMA5 (2.1)
MP:0008826	abnormal splenic cell ratio	0.50	> 0.20	TIMD4 (5.1)	RHD (3.4)	ZNF101 (3.2)	RHCE (2.7)	CETP (2.6)	GMIP (2.4)	BCL3 (2.0)	RELB (1.9)	HAVCR1 (1.8)	SLC44A2 (1.8)
ENSG00000039123	SKIV2L2 PPI subnetwork	0.50	> 0.20	MAPKAPK5 (3.5)	SUGP1 (3.0)	BRAP (2.9)	C12orf43 (2.6)	DHODH (2.5)	DDX56 (2.4)	USP24 (2.3)	TOMM40 (2.3)	PLEKHH2 (2.2)	DHX38 (2.1)
MP:0003662	abnormal long bone epiphyseal plate proliferative zone	0.50	> 0.20	CILP2 (7.9)	PLEKHH2 (3.6)	MAFB (2.3)	APOE (1.8)	GPAM (1.7)	PLCG1 (1.6)	YIPF2 (1.6)	NPC1L1 (1.6)	HNF1A (1.3)	ACAD10 (1.2)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	0.50	> 0.20	GEMIN7 (3.7)	C12orf43 (3.1)	DDX56 (2.8)	ZNF259 (2.6)	ENSG00000226645 (2.2)	MAPKAPK5 (1.9)	POC5 (1.8)	BUD13 (1.7)	TOMM40 (1.7)	C19orf52 (1.6)
GO:0048008	platelet-derived growth factor receptor signaling pathway	0.50	> 0.20	ABO (2.6)	GCNT4 (2.5)	FRK (2.4)	ENSG00000226645 (2.3)	DOCK7 (2.2)	C11orf9 (2.1)	C17orf57 (2.0)	DNAH11 (1.7)	KANK2 (1.4)	TSSK6 (1.4)
ENSG00000136931	NR5A1 PPI subnetwork	0.50	> 0.20	COL4A3BP (2.5)	APOB (2.4)	GCNT4 (1.8)	APOE (1.8)	C19orf52 (1.6)	TMED4 (1.6)	ABCG5 (1.5)	ALDH2 (1.4)	ENSG00000235545 (1.3)	APOC1 (1.2)
GO:0032456	endocytic recycling	0.50	> 0.20	GCNT4 (2.5)	ENSG00000226645 (2.2)	ZHX3 (1.6)	USP24 (1.4)	DOCK7 (1.4)	PBX4 (1.3)	TMEM57 (1.2)	SH2B3 (1.2)	ST3GAL4 (1.2)	GEMIN7 (1.1)
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	REACTOME_REGULATION_OF_SIGNALING_BY_CBL	0.50	> 0.20	GMIP (3.0)	SH2B3 (2.9)	MAFB (2.6)	DNM2 (2.5)	GATAD2A (2.4)	TIMD4 (2.0)	ERP29 (2.0)	MAU2 (2.0)	UBXN2B (1.7)	C19orf52 (1.5)
MP:0000260	abnormal angiogenesis	0.50	> 0.20	HLX (3.2)	KANK2 (2.8)	PLEC (2.7)	PVRL2 (2.3)	GATAD2A (2.3)	SH2B3 (2.2)	NYNRIN (1.8)	PLCG1 (1.8)	BCAM (1.7)	MAFB (1.6)
GO:0014896	muscle hypertrophy	0.50	> 0.20	ENSG00000226648 (3.0)	CEACAM19 (2.7)	ENSG00000235545 (2.6)	HNF1A (2.4)	ENSG00000254235 (2.0)	TRAPPC6A (1.8)	DNAH11 (1.7)	TXNL4B (1.6)	GCNT4 (1.6)	SYPL2 (1.4)
GO:0022625	cytosolic large ribosomal subunit	0.50	> 0.20	ENSG00000226645 (2.2)	DNAH11 (1.9)	CEACAM19 (1.8)	C1orf63 (1.7)	MARK4 (1.6)	ERP29 (1.6)	UBXN2B (1.5)	TMEM57 (1.5)	AMIGO1 (1.5)	NKPD1 (1.5)
GO:0000079	regulation of cyclin-dependent protein kinase activity	0.50	> 0.20	C1orf63 (3.2)	ANKRD31 (3.0)	ENSG00000226648 (2.5)	TXNL4B (2.3)	PSRC1 (2.1)	PBX4 (2.1)	ENSG00000226645 (1.8)	TOP1 (1.6)	ENSG00000254235 (1.6)	BLOC1S3 (1.5)
MP:0003628	abnormal leukocyte adhesion	0.50	> 0.20	BCL3 (2.7)	PVR (2.7)	GMIP (2.3)	PLEC (1.9)	TIMD4 (1.9)	RELB (1.7)	HLX (1.7)	TMEM116 (1.6)	SH2B3 (1.6)	LDLR (1.5)
ENSG00000145782	ATG12 PPI subnetwork	0.50	> 0.20	ANKRD31 (2.6)	DDX56 (2.5)	GATAD2A (2.5)	USP1 (1.8)	C19orf52 (1.8)	DHX38 (1.7)	TOP1 (1.6)	SMARCA4 (1.6)	NKPD1 (1.5)	SUGP1 (1.5)
ENSG00000125970	RALY PPI subnetwork	0.50	> 0.20	ILF3 (3.9)	QTRT1 (3.6)	PPP1R37 (3.2)	DHX38 (3.0)	SMARCA4 (2.8)	SUGP1 (2.6)	PLCG1 (2.3)	GATAD2A (2.2)	C1orf63 (2.0)	CLPTM1 (1.9)
MP:0003719	abnormal pericyte morphology	0.50	> 0.20	ITGB3 (2.6)	PLEC (2.4)	PVRL2 (2.2)	KIAA1324 (2.1)	HLX (2.0)	ZNF101 (1.8)	C17orf57 (1.5)	HAPLN4 (1.5)	AMIGO1 (1.5)	MAFB (1.4)
MP:0003503	decreased activity of thyroid	0.50	> 0.20	MOSC1 (5.0)	PBX4 (2.5)	KIAA1324 (2.3)	GPAM (2.2)	AMIGO1 (1.8)	HP (1.8)	HNF1A (1.7)	ANGPTL3 (1.7)	MYLIP (1.6)	USP24 (1.4)
ENSG00000152484	USP12 PPI subnetwork	0.50	> 0.20	BRAP (3.3)	DDX56 (2.8)	ATP13A1 (2.4)	HNF1A (2.1)	PTPN11 (2.0)	C12orf47 (1.9)	GPAM (1.8)	CEACAM19 (1.8)	MAU2 (1.7)	MAPKAPK5 (1.6)
ENSG00000155868	MED7 PPI subnetwork	0.50	> 0.20	GEMIN7 (4.1)	MAPKAPK5 (3.2)	BRAP (2.8)	BUD13 (2.4)	BLOC1S3 (2.2)	C19orf52 (2.1)	C12orf51 (2.0)	TXNL4B (1.9)	C12orf43 (1.7)	POC5 (1.6)
GO:0005604	basement membrane	0.50	> 0.20	BCAM (4.8)	APOE (2.7)	PLEKHH2 (2.5)	CBLC (2.3)	CELSR2 (2.3)	AP1M2 (2.2)	PVR (2.2)	CILP2 (2.1)	PLEC (1.9)	KANK2 (1.9)
GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	0.50	> 0.20	TXNL4B (3.7)	GEMIN7 (3.1)	DHODH (2.9)	ST3GAL4 (2.9)	TRAPPC6A (2.4)	C19orf52 (2.3)	ZNF259 (2.3)	UBXN2B (2.2)	SUGP1 (2.1)	DDX56 (2.0)
GO:0000291	nuclear-transcribed mRNA catabolic process, exonucleolytic	0.50	> 0.20	TXNL4B (3.7)	GEMIN7 (3.1)	DHODH (2.9)	ST3GAL4 (2.9)	TRAPPC6A (2.4)	C19orf52 (2.3)	ZNF259 (2.3)	UBXN2B (2.2)	SUGP1 (2.1)	DDX56 (2.0)
GO:0002821	positive regulation of adaptive immune response	0.50	> 0.20	NKPD1 (2.3)	ENSG00000235545 (2.0)	CEACAM19 (1.6)	GEMIN7 (1.6)	PBX4 (1.5)	MAU2 (1.3)	DNAH11 (1.3)	TRAPPC6A (1.3)	ZNF180 (1.3)	PARP10 (1.2)
MP:0008482	decreased spleen germinal center number	0.50	> 0.20	RELB (3.2)	GMIP (2.5)	ZNF101 (2.4)	CETP (2.2)	TIMD4 (1.9)	CLPTM1 (1.8)	PBX4 (1.6)	USP24 (1.6)	TMED4 (1.5)	PLCG1 (1.4)
ENSG00000105258	POLR2I PPI subnetwork	0.50	> 0.20	ILF3 (3.5)	BUD13 (3.2)	TOP1 (3.1)	SUGP1 (2.9)	DHX38 (2.8)	C1orf63 (2.7)	USP1 (2.5)	SMARCA4 (2.4)	MAPKAPK5 (2.2)	PTPN11 (2.2)
GO:0032633	interleukin-4 production	0.50	> 0.20	ZNF101 (3.7)	PLCG1 (2.1)	ENSG00000254235 (1.9)	PBX4 (1.8)	ENSG00000238078 (1.7)	TMEM57 (1.6)	POLK (1.6)	GRINA (1.4)	ENSG00000226645 (1.4)	HNF1A (1.3)
MP:0001596	hypotension	0.50	> 0.20	ZHX3 (2.8)	TM6SF2 (2.6)	ABO (2.4)	NPC1L1 (2.3)	PLEKHH2 (1.7)	CBLC (1.7)	PVR (1.6)	APOB (1.5)	HNF1A (1.4)	KANK2 (1.3)
MP:0001925	male infertility	0.50	> 0.20	TSSK6 (3.4)	PMFBP1 (2.7)	FADS1 (1.8)	PLEKHH2 (1.8)	PBX4 (1.7)	ANKRD31 (1.4)	PCSK9 (1.4)	FADS2 (1.4)	TMEM57 (1.3)	GATAD2A (1.3)
ENSG00000116954	RRAGC PPI subnetwork	0.50	> 0.20	COL4A3BP (2.8)	QTRT1 (2.6)	BLOC1S3 (2.6)	TOMM40 (2.1)	ILF3 (2.1)	ZNF180 (2.0)	POC5 (2.0)	BRAP (1.8)	MAU2 (1.6)	DOCK7 (1.6)
GO:0032768	regulation of monooxygenase activity	0.50	> 0.20	ENSG00000235545 (2.7)	TXNL4B (2.1)	ENSG00000228044 (2.0)	ZNF101 (1.9)	ATXN7L2 (1.9)	ENSG00000226645 (1.7)	FRK (1.7)	TMEM50A (1.7)	TMEM116 (1.7)	COL4A3BP (1.4)
ENSG00000129245	FXR2 PPI subnetwork	0.50	> 0.20	C17orf57 (2.6)	GMPR (2.1)	UBXN2B (2.0)	SUGP1 (1.9)	ILF3 (1.9)	C12orf43 (1.8)	PVRL2 (1.7)	AP1M2 (1.7)	TRAPPC6A (1.5)	SARS (1.5)
ENSG00000204361	FAM55B PPI subnetwork	0.50	> 0.20	PLEC (4.5)	GATAD2A (2.8)	SARS (2.4)	AP1M2 (2.1)	DOCK7 (2.1)	KANK2 (2.0)	ABCG8 (1.9)	QTRT1 (1.8)	KIAA1324 (1.8)	LPIN3 (1.8)
REACTOME_MICRORNA_MIRNA_BIOGENESIS	REACTOME_MICRORNA_MIRNA_BIOGENESIS	0.50	> 0.20	GEMIN7 (3.4)	C12orf51 (2.6)	USP24 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.1)	C12orf47 (2.1)	ATXN2 (1.9)	TOMM40 (1.8)	TXNL4B (1.8)	UBXN2B (1.7)
REACTOME_REGULATORY_RNA_PATHWAYS	REACTOME_REGULATORY_RNA_PATHWAYS	0.50	> 0.20	GEMIN7 (3.4)	C12orf51 (2.6)	USP24 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.1)	C12orf47 (2.1)	ATXN2 (1.9)	TOMM40 (1.8)	TXNL4B (1.8)	UBXN2B (1.7)
GO:0006261	DNA-dependent DNA replication	0.50	> 0.20	USP1 (3.2)	ZNF180 (2.9)	FEN1 (2.7)	AMIGO1 (2.0)	TXNL4B (2.0)	DHODH (2.0)	ENSG00000228044 (1.9)	NT5DC1 (1.6)	GOT2P1 (1.6)	ENSG00000235545 (1.6)
MP:0001625	cardiac hypertrophy	0.50	> 0.20	SYPL2 (4.4)	RHD (2.6)	GMPR (2.6)	NYNRIN (2.5)	RHCE (2.1)	BCAM (1.7)	ACAD10 (1.7)	HP (1.6)	CBLC (1.5)	AP1M2 (1.5)
MP:0000333	decreased bone marrow cell number	0.50	> 0.20	GMIP (2.8)	BCL3 (2.8)	ZNF101 (2.6)	MAFB (2.5)	MAU2 (2.3)	PBX4 (2.1)	SMARCA4 (2.1)	HLX (1.6)	RELB (1.5)	ZHX3 (1.5)
GO:0042383	sarcolemma	0.50	> 0.20	SYPL2 (3.6)	KANK2 (3.2)	GMPR (3.0)	SORT1 (2.7)	PLEC (2.6)	BCAM (1.9)	AMIGO1 (1.9)	COL4A3BP (1.6)	OGDH (1.3)	RPH3A (1.2)
ENSG00000144029	MRPS5 PPI subnetwork	0.50	> 0.20	TOMM40 (4.5)	C12orf43 (3.5)	ERP29 (3.2)	NAA25 (3.1)	GEMIN7 (2.8)	OGDH (2.8)	MAPKAPK5 (2.5)	ADAM1 (2.4)	ZNF259 (2.3)	C12orf47 (2.2)
ENSG00000138398	PPIG PPI subnetwork	0.50	> 0.20	C1orf63 (4.7)	TOP1 (2.6)	TXNL4B (2.4)	ZNF180 (2.2)	GEMIN7 (2.1)	BUD13 (1.9)	FEN1 (1.8)	DHX38 (1.7)	C12orf51 (1.6)	MAU2 (1.5)
REACTOME_GLUTATHIONE_CONJUGATION	REACTOME_GLUTATHIONE_CONJUGATION	0.50	> 0.20	TM6SF2 (3.2)	ALDH2 (3.0)	ACAD10 (2.5)	RHD (2.1)	AP1M2 (2.1)	NT5DC1 (2.0)	TXNL4B (2.0)	KIAA1324 (2.0)	NPC1L1 (2.0)	GRINA (2.0)
ENSG00000196628	TCF4 PPI subnetwork	0.50	> 0.20	HLX (4.1)	MYLIP (3.3)	GMPR (2.2)	RHD (2.0)	TMEM57 (2.0)	PLCG1 (1.8)	RHCE (1.7)	CILP2 (1.6)	LPIN3 (1.5)	KANK2 (1.4)
GO:0042254	ribosome biogenesis	0.50	> 0.20	ZNF259 (4.0)	DDX56 (3.4)	DHODH (3.2)	TOMM40 (3.1)	NAA25 (3.1)	C12orf43 (3.0)	QTRT1 (3.0)	MAPKAPK5 (2.4)	SUGP1 (2.0)	POC5 (1.9)
GO:0042119	neutrophil activation	0.50	> 0.20	UBXN2B (3.0)	CYB561D1 (2.5)	GMIP (2.3)	ANKRD31 (2.2)	LPAR2 (2.1)	C17orf57 (1.8)	HLX (1.8)	AMIGO1 (1.6)	ENSG00000226645 (1.6)	NT5DC1 (1.4)
ENSG00000100804	PSMB5 PPI subnetwork	0.50	> 0.20	PSMA5 (5.7)	TRAFD1 (2.8)	NT5DC1 (2.7)	NAA25 (2.3)	SARS (2.0)	TOMM40 (1.5)	HMGCR (1.3)	DDX56 (1.3)	COL4A3BP (1.3)	TMEM50A (1.1)
REACTOME_N:GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXINCALRETICULIN_CYCLE	REACTOME_N:GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXINCALRETICULIN_CYCLE	0.50	> 0.20	ERP29 (6.1)	YIPF2 (4.4)	CLPTM1 (3.7)	ATP13A1 (3.7)	TMED4 (2.7)	OGDH (1.8)	TMEM57 (1.7)	SORT1 (1.5)	HNF1A (1.4)	ACAD10 (1.3)
GO:0034341	response to interferon-gamma	0.50	> 0.20	TRAFD1 (5.1)	PARP10 (4.5)	OASL (3.5)	ADAM1 (2.4)	GRINA (1.7)	C12orf43 (1.7)	PBX4 (1.6)	BCL3 (1.6)	RELB (1.6)	MAU2 (1.5)
ENSG00000213741	RPS29 PPI subnetwork	0.50	> 0.20	NKPD1 (2.4)	SARS (1.9)	ANKRD31 (1.7)	ILF3 (1.6)	ENSG00000226645 (1.6)	PTPN11 (1.5)	DDX56 (1.4)	C19orf52 (1.4)	SUGP1 (1.4)	GATAD2A (1.4)
ENSG00000160741	CRTC2 PPI subnetwork	0.50	> 0.20	CBLC (4.4)	AP1M2 (2.8)	MARK4 (2.8)	PVRL2 (2.2)	ATXN2 (2.0)	CELSR2 (1.8)	ANKRD31 (1.8)	ZHX3 (1.7)	LPIN3 (1.7)	GEMIN7 (1.7)
ENSG00000196405	EVL PPI subnetwork	0.50	> 0.20	GMIP (3.9)	ATXN2 (3.0)	DNM2 (2.7)	RHD (2.5)	SMARCA4 (2.4)	HAVCR1 (2.4)	PLEC (2.1)	MARK4 (2.1)	C12orf51 (2.1)	GATAD2A (2.0)
GO:0014829	vascular smooth muscle contraction	0.50	> 0.20	ENSG00000228044 (2.6)	LPIN3 (2.2)	HNF1A (2.0)	ABO (1.9)	C12orf47 (1.8)	BLOC1S3 (1.8)	HAPLN4 (1.7)	NKPD1 (1.6)	AMIGO1 (1.5)	ADAM1 (1.5)
MP:0000792	abnormal cortical marginal zone morphology	0.50	> 0.20	GRINA (2.5)	NPC1L1 (2.3)	CLPTM1 (2.2)	C1orf63 (2.1)	RPH3A (1.9)	APOB (1.8)	ABCG8 (1.8)	HAVCR1 (1.8)	ABCG5 (1.7)	C12orf51 (1.7)
ENSG00000116161	CACYBP PPI subnetwork	0.50	> 0.20	ST3GAL4 (3.5)	BCL3 (2.1)	RELB (1.8)	PTPN11 (1.7)	NCAN (1.6)	BUD13 (1.5)	ITGB3 (1.5)	HAPLN4 (1.5)	ABO (1.5)	PLEC (1.4)
GO:0051340	regulation of ligase activity	0.50	> 0.20	PSMA5 (3.6)	POC5 (2.7)	TRAFD1 (2.2)	SUGP1 (2.1)	NAA25 (1.9)	BRAP (1.8)	NT5DC1 (1.7)	DDX56 (1.6)	C19orf52 (1.6)	ENSG00000226645 (1.4)
ENSG00000125952	MAX PPI subnetwork	0.50	> 0.20	BUD13 (2.8)	MAPKAPK5 (2.4)	ILF3 (2.3)	QTRT1 (2.0)	ATXN7L2 (1.9)	BRAP (1.8)	C12orf43 (1.6)	GATAD2A (1.5)	ZNF101 (1.4)	DYNC2LI1 (1.3)
ENSG00000198961	PJA2 PPI subnetwork	0.50	> 0.20	USP24 (4.9)	GRINA (2.2)	ATXN2 (2.2)	DOCK7 (2.1)	C12orf51 (2.1)	COL4A3BP (2.0)	TMEM57 (2.0)	CARM1 (2.0)	SUGP1 (1.5)	NKPD1 (1.3)
ENSG00000112592	TBP PPI subnetwork	0.50	> 0.20	BUD13 (3.0)	ATXN2 (2.7)	SUGP1 (2.3)	MAPKAPK5 (2.2)	TOP1 (2.1)	DHX38 (1.9)	DDX56 (1.7)	ILF3 (1.7)	POC5 (1.7)	TOMM40 (1.7)
MP:0002151	abnormal neural tube morphology/development	0.50	> 0.20	DOCK7 (3.4)	NYNRIN (3.0)	DYNC2LI1 (2.7)	ATXN2 (2.6)	ATXN7L2 (2.1)	PVRL2 (1.9)	KANK2 (1.9)	GATAD2A (1.9)	ABO (1.6)	PLCG1 (1.6)
ENSG00000138018	EPT1 PPI subnetwork	0.50	> 0.20	LDLR (6.9)	HMGCR (6.6)	FADS1 (5.6)	FADS2 (5.4)	PCSK9 (2.9)	TMEM50A (2.2)	YIPF2 (2.2)	TMED4 (2.1)	ERP29 (2.0)	MAPKAPK5 (1.9)
MP:0000703	abnormal thymus morphology	0.50	> 0.20	ZNF101 (4.1)	PLCG1 (3.4)	APOE (2.3)	HAVCR1 (2.0)	BCL3 (2.0)	SLC44A2 (1.8)	RELB (1.6)	MAFB (1.6)	PBX4 (1.5)	GMIP (1.5)
ENSG00000182866	LCK PPI subnetwork	0.50	> 0.20	PLCG1 (3.5)	GMIP (3.4)	ZNF101 (2.4)	TIMD4 (2.2)	SLC44A2 (2.2)	PBX4 (2.0)	CETP (1.9)	DNM2 (1.9)	MAFB (1.7)	PLEC (1.7)
ENSG00000206281	TAPBP PPI subnetwork	0.50	> 0.20	PARP10 (4.6)	YIPF2 (3.2)	TMED4 (2.7)	TRAFD1 (2.2)	ERP29 (2.0)	HAPLN4 (1.7)	CYB561D1 (1.7)	CLPTM1 (1.5)	BLOC1S3 (1.4)	OASL (1.4)
ENSG00000112493	TAPBP PPI subnetwork	0.50	> 0.20	PARP10 (4.6)	YIPF2 (3.2)	TMED4 (2.7)	TRAFD1 (2.2)	ERP29 (2.0)	HAPLN4 (1.7)	CYB561D1 (1.7)	CLPTM1 (1.5)	BLOC1S3 (1.4)	OASL (1.4)
ENSG00000206208	TAPBP PPI subnetwork	0.50	> 0.20	PARP10 (4.6)	YIPF2 (3.2)	TMED4 (2.7)	TRAFD1 (2.2)	ERP29 (2.0)	HAPLN4 (1.7)	CYB561D1 (1.7)	CLPTM1 (1.5)	BLOC1S3 (1.4)	OASL (1.4)
ENSG00000100941	PNN PPI subnetwork	0.50	> 0.20	C1orf63 (3.8)	TOP1 (3.6)	USP1 (2.6)	C17orf57 (1.9)	SMARCA4 (1.9)	BUD13 (1.8)	TMEM57 (1.7)	ENSG00000238078 (1.6)	NAA25 (1.5)	ILF3 (1.3)
ENSG00000162227	TAF6L PPI subnetwork	0.50	> 0.20	ATXN2 (3.4)	ATXN7L2 (2.7)	MAPKAPK5 (2.3)	TOP1 (2.2)	C12orf51 (2.2)	ZHX3 (1.9)	C17orf57 (1.8)	GEMIN7 (1.8)	TXNL4B (1.7)	BUD13 (1.7)
ENSG00000128513	POT1 PPI subnetwork	0.50	> 0.20	TXNL4B (3.6)	NKPD1 (2.4)	POLK (2.2)	TSSK6 (2.2)	DHX38 (2.1)	KANK2 (2.1)	PBX4 (2.0)	SUGP1 (1.8)	NYNRIN (1.7)	C19orf52 (1.7)
ENSG00000178950	GAK PPI subnetwork	0.50	> 0.20	LPAR2 (2.6)	COL4A3BP (2.4)	PMFBP1 (2.2)	ILF3 (2.0)	YIPF2 (2.0)	GMIP (1.8)	DHX38 (1.7)	GRINA (1.7)	NYNRIN (1.7)	ZNF101 (1.6)
MP:0003339	decreased pancreatic beta cell number	0.50	> 0.20	KIAA1324 (3.6)	HAPLN4 (2.2)	MOSC1 (2.1)	C11orf9 (2.0)	NPC1L1 (2.0)	PCSK9 (1.8)	SORT1 (1.5)	AMIGO1 (1.5)	DNAH11 (1.4)	FRK (1.4)
MP:0008658	decreased interleukin-1 beta secretion	0.50	> 0.20	OASL (5.4)	MAFB (3.4)	PARP10 (2.8)	BCL3 (2.8)	TRIB1 (1.6)	RELB (1.5)	GMIP (1.3)	TRAFD1 (1.2)	NKPD1 (1.2)	TIMD4 (1.1)
GO:0043186	P granule	0.50	> 0.20	ANKRD31 (3.3)	TRAFD1 (1.9)	ENSG00000238078 (1.8)	PCSK9 (1.4)	YIPF2 (1.4)	ERP29 (1.3)	RHD (1.3)	OASL (1.1)	ENSG00000228044 (1.1)	CEACAM19 (1.0)
GO:0045495	pole plasm	0.50	> 0.20	ANKRD31 (3.3)	TRAFD1 (1.9)	ENSG00000238078 (1.8)	PCSK9 (1.4)	YIPF2 (1.4)	ERP29 (1.3)	RHD (1.3)	OASL (1.1)	ENSG00000228044 (1.1)	CEACAM19 (1.0)
GO:0060293	germ plasm	0.50	> 0.20	ANKRD31 (3.3)	TRAFD1 (1.9)	ENSG00000238078 (1.8)	PCSK9 (1.4)	YIPF2 (1.4)	ERP29 (1.3)	RHD (1.3)	OASL (1.1)	ENSG00000228044 (1.1)	CEACAM19 (1.0)
ENSG00000189229	ENSG00000189229 PPI subnetwork	0.50	> 0.20	UBXN2B (2.9)	DYNC2LI1 (2.6)	ENSG00000238078 (2.4)	C1orf63 (2.3)	TOP1 (2.0)	PARP10 (1.9)	TRAPPC6A (1.5)	PVRL2 (1.4)	C12orf47 (1.2)	LPIN3 (1.1)
ENSG00000173598	NUDT4 PPI subnetwork	0.50	> 0.20	NCAN (2.7)	TMEM57 (2.4)	APOC1 (1.9)	RPH3A (1.9)	ADAM1 (1.7)	ENSG00000238078 (1.6)	SUGP1 (1.6)	C1orf63 (1.6)	TMEM50A (1.5)	DHODH (1.5)
GO:0000151	ubiquitin ligase complex	0.51	> 0.20	BRAP (2.8)	SUGP1 (2.7)	GRINA (2.6)	TRAFD1 (2.5)	CARM1 (2.5)	MAU2 (2.4)	BUD13 (2.2)	POC5 (2.1)	LPIN3 (2.0)	TMEM116 (1.7)
MP:0002085	abnormal embryonic tissue morphology	0.51	> 0.20	NYNRIN (3.1)	PSRC1 (2.6)	PVRL2 (2.1)	SMARCA4 (2.0)	SLC44A2 (1.9)	ATXN2 (1.7)	LPAR2 (1.7)	LDLR (1.6)	AP1M2 (1.6)	ILF3 (1.6)
MP:0005042	abnormal level of surface class II molecules	0.51	> 0.20	PARP10 (4.0)	TRAFD1 (2.9)	GMIP (2.2)	SH2B3 (2.1)	RELB (1.8)	USP24 (1.8)	MAFB (1.7)	HLX (1.6)	OASL (1.6)	BCL3 (1.5)
GO:0009593	detection of chemical stimulus	0.51	> 0.20	ENSG00000228044 (4.8)	PMFBP1 (2.7)	DNAH11 (1.8)	ENSG00000235545 (1.8)	GOT2P1 (1.8)	CYB561D1 (1.8)	FRK (1.2)	ANKRD31 (1.2)	ADAM1 (1.2)	CYP7A1 (1.1)
ENSG00000187778	MCRS1 PPI subnetwork	0.51	> 0.20	C12orf43 (3.5)	QTRT1 (2.5)	BUD13 (2.4)	C19orf52 (2.3)	TRAFD1 (2.1)	DHX38 (2.0)	ATXN7L2 (2.0)	GATAD2A (2.0)	MAPKAPK5 (1.8)	GEMIN7 (1.7)
ENSG00000196236	XPNPEP3 PPI subnetwork	0.51	> 0.20	C1orf63 (2.7)	CBLC (2.4)	DOCK7 (2.0)	ABCG5 (1.9)	ENSG00000226648 (1.8)	AP1M2 (1.8)	ZNF180 (1.7)	NPC1L1 (1.7)	PLCG1 (1.6)	TM6SF2 (1.5)
ENSG00000058600	POLR3E PPI subnetwork	0.51	> 0.20	C12orf43 (4.1)	GEMIN7 (2.9)	POC5 (2.8)	ATXN2 (2.5)	SUGP1 (2.5)	DDX56 (2.4)	MAPKAPK5 (2.3)	ADAM1 (2.2)	C19orf52 (2.2)	DHX38 (1.6)
ENSG00000121486	TRMT1L PPI subnetwork	0.51	> 0.20	ATP13A1 (3.2)	OGDH (2.8)	SARS (2.5)	SMARCA4 (2.5)	ILF3 (2.4)	FEN1 (2.3)	NAA25 (2.1)	QTRT1 (2.0)	PSMA5 (1.9)	YIPF2 (1.8)
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	0.51	> 0.20	BLOC1S3 (2.5)	CYB561D1 (2.3)	MAPKAPK5 (2.1)	TMEM50A (2.0)	CARM1 (1.9)	HLX (1.9)	TXNL4B (1.7)	DNM2 (1.6)	LPIN3 (1.5)	PMFBP1 (1.5)
ENSG00000076944	STXBP2 PPI subnetwork	0.51	> 0.20	CARM1 (2.5)	TSSK6 (2.4)	DNM2 (2.2)	ABO (2.0)	C17orf57 (1.9)	SARS (1.9)	TOMM40 (1.7)	QTRT1 (1.7)	MAPKAPK5 (1.7)	GEMIN7 (1.6)
MP:0005107	abnormal stapes morphology	0.51	> 0.20	NCAN (2.6)	MYLIP (2.3)	DYNC2LI1 (2.0)	BCAM (1.7)	CEACAM19 (1.4)	C19orf52 (1.2)	SLC44A2 (1.2)	TRAFD1 (1.1)	AMIGO1 (1.1)	ABO (1.1)
ENSG00000131238	PPT1 PPI subnetwork	0.51	> 0.20	ATP13A1 (3.2)	ILF3 (3.1)	YIPF2 (3.0)	DNM2 (2.6)	QTRT1 (2.6)	OGDH (2.6)	ACAD10 (2.2)	SARS (2.1)	DHX38 (2.0)	SMARCA4 (1.7)
ENSG00000166477	LEO1 PPI subnetwork	0.51	> 0.20	SMARCA4 (3.5)	SUGP1 (3.3)	ILF3 (3.0)	C19orf52 (2.6)	BUD13 (2.5)	DHX38 (2.5)	PTPN11 (2.3)	TOMM40 (2.3)	COL4A3BP (2.3)	BRAP (2.2)
REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	0.51	> 0.20	BUD13 (3.2)	C1orf63 (3.0)	TOP1 (2.9)	USP1 (2.4)	MAPKAPK5 (2.4)	SUGP1 (2.3)	ILF3 (2.3)	TXNL4B (2.3)	PSMA5 (2.1)	PTPN11 (1.8)
ENSG00000168028	RPSA PPI subnetwork	0.51	> 0.20	NAA25 (4.1)	SARS (3.3)	DDX56 (3.2)	QTRT1 (2.5)	ZNF259 (2.4)	TOMM40 (2.3)	DHX38 (1.8)	C12orf43 (1.7)	SUGP1 (1.6)	PSMA5 (1.6)
ENSG00000117906	RCN2 PPI subnetwork	0.51	> 0.20	ERP29 (3.5)	RPH3A (3.0)	NCAN (2.1)	AMIGO1 (2.0)	GRINA (1.9)	YIPF2 (1.9)	ENSG00000226645 (1.8)	MYLIP (1.8)	TMED4 (1.8)	BCAM (1.8)
GO:0005372	water transmembrane transporter activity	0.51	> 0.20	NCAN (3.2)	ENSG00000228044 (2.4)	ST3GAL4 (2.4)	HP (2.3)	RHD (2.1)	PLEC (2.1)	RHCE (1.9)	TSSK6 (1.8)	NYNRIN (1.7)	PLG (1.7)
ENSG00000197757	HOXC6 PPI subnetwork	0.51	> 0.20	NYNRIN (3.3)	MAU2 (2.6)	BCAM (2.6)	C12orf51 (2.2)	CELSR2 (2.1)	CBLC (2.0)	SLC44A2 (1.8)	MOSC1 (1.7)	GRINA (1.7)	PSRC1 (1.7)
ENSG00000110321	EIF4G2 PPI subnetwork	0.51	> 0.20	TMEM57 (2.7)	C1orf63 (2.7)	TOP1 (2.6)	TRIB1 (2.1)	C12orf43 (1.9)	POLK (1.7)	GATAD2A (1.7)	ENSG00000226645 (1.6)	ENSG00000254235 (1.5)	TXNL4B (1.5)
ENSG00000214114	MYCBP PPI subnetwork	0.51	> 0.20	NCAN (2.9)	ENSG00000235545 (2.6)	ABO (2.1)	NYNRIN (2.0)	ZNF101 (1.7)	NPC1L1 (1.6)	MYLIP (1.4)	HLX (1.4)	PMFBP1 (1.4)	RPH3A (1.4)
MP:0005269	abnormal occipital bone morphology	0.51	> 0.20	NYNRIN (2.9)	CILP2 (2.9)	ALDH2 (2.5)	C19orf52 (2.3)	PLEKHH2 (2.0)	NCAN (1.6)	PLCG1 (1.6)	CEACAM19 (1.6)	TMEM57 (1.5)	MAFB (1.5)
GO:0072404	signal transduction involved in G1/S transition checkpoint	0.51	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.4)	NAA25 (2.2)	ENSG00000254235 (1.6)	C12orf47 (1.5)	SUGP1 (1.4)	BRAP (1.4)	ZNF180 (1.3)	PARP10 (1.2)
GO:0072395	signal transduction involved in cell cycle checkpoint	0.51	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.4)	NAA25 (2.2)	ENSG00000254235 (1.6)	C12orf47 (1.5)	SUGP1 (1.4)	BRAP (1.4)	ZNF180 (1.3)	PARP10 (1.2)
ENSG00000187098	MITF PPI subnetwork	0.51	> 0.20	ATXN2 (2.2)	GMIP (2.2)	LPAR2 (2.2)	PLEC (2.2)	MAFB (2.1)	UBXN2B (2.0)	CARM1 (1.9)	C19orf52 (1.8)	TRIB1 (1.7)	GRINA (1.5)
ENSG00000168078	PBK PPI subnetwork	0.51	> 0.20	PSRC1 (3.4)	POC5 (3.2)	MAU2 (2.4)	DNAH11 (2.0)	GMPR (1.7)	FEN1 (1.6)	PCSK9 (1.5)	DNM2 (1.4)	KIAA1324 (1.3)	DDX56 (1.2)
GO:0006826	iron ion transport	0.51	> 0.20	TMEM116 (3.2)	BLOC1S3 (2.3)	GRINA (2.0)	FRK (1.9)	AP1M2 (1.7)	LPIN3 (1.7)	TMED4 (1.6)	CLPTM1 (1.6)	RHD (1.4)	SARS (1.4)
GO:0030175	filopodium	0.51	> 0.20	NCAN (3.6)	C11orf9 (3.2)	PLEC (2.5)	ST3GAL4 (2.2)	OGDH (2.1)	SLC44A2 (2.0)	TIMD4 (1.9)	ENSG00000235545 (1.8)	APOE (1.8)	LPAR2 (1.8)
MP:0000273	overriding aorta	0.51	> 0.20	CEACAM19 (2.3)	TRIB1 (2.1)	BCAM (1.7)	GMPR (1.6)	MYLIP (1.6)	PVRL2 (1.4)	SLC44A2 (1.3)	C1orf63 (1.3)	PLCG1 (1.3)	C17orf57 (1.3)
MP:0004521	abnormal cochlear hair cell stereociliary bundle morphology	0.51	> 0.20	HAVCR1 (3.5)	CELSR2 (2.4)	HNF1A (2.1)	DNAH11 (1.8)	TM6SF2 (1.7)	TIMD4 (1.7)	BCAM (1.6)	NT5DC1 (1.5)	LPIN3 (1.4)	SORT1 (1.2)
GO:0000982	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity	0.51	> 0.20	TRIB1 (5.7)	SH2B3 (2.4)	NYNRIN (2.3)	PVRL2 (1.7)	MAFB (1.6)	CELSR2 (1.5)	BCL3 (1.5)	PSRC1 (1.5)	ENSG00000254235 (1.5)	ENSG00000226648 (1.4)
ENSG00000177602	GSG2 PPI subnetwork	0.51	> 0.20	ATP13A1 (3.3)	OGDH (2.7)	SMARCA4 (2.5)	SARS (2.5)	ILF3 (2.5)	FEN1 (2.2)	NAA25 (2.1)	QTRT1 (2.0)	ATXN2 (1.9)	PSMA5 (1.8)
REACTOME_DEADENYLATION:DEPENDENT_MRNA_DECAY	REACTOME_DEADENYLATION:DEPENDENT_MRNA_DECAY	0.51	> 0.20	TXNL4B (3.3)	BUD13 (2.9)	MAPKAPK5 (2.9)	DHODH (2.6)	DHX38 (2.4)	ST3GAL4 (2.3)	DDX56 (2.1)	ZNF259 (2.1)	GEMIN7 (1.9)	C12orf43 (1.8)
ENSG00000100697	DICER1 PPI subnetwork	0.51	> 0.20	RHD (2.5)	ACAD10 (2.3)	PLCG1 (2.2)	ATXN2 (2.1)	LPAR2 (2.0)	ADAM1 (1.9)	BRAP (1.9)	MAPKAPK5 (1.8)	ENSG00000235545 (1.5)	ERP29 (1.5)
ENSG00000042429	MED17 PPI subnetwork	0.51	> 0.20	GEMIN7 (2.9)	BRAP (2.7)	C12orf51 (2.4)	BUD13 (2.3)	CARM1 (2.2)	MAU2 (2.1)	BLOC1S3 (1.9)	DHX38 (1.8)	ATXN2 (1.7)	C17orf57 (1.7)
ENSG00000198730	CTR9 PPI subnetwork	0.51	> 0.20	SUGP1 (2.6)	TOP1 (2.6)	ILF3 (2.4)	TOMM40 (2.1)	DDX56 (2.1)	BRAP (1.8)	PTPN11 (1.8)	TMEM57 (1.8)	ZNF259 (1.7)	SMARCA4 (1.6)
GO:0070509	calcium ion import	0.51	> 0.20	ENSG00000226645 (3.1)	DNAH11 (2.3)	ST3GAL4 (2.0)	ITGB3 (1.9)	KIAA1324 (1.7)	NKPD1 (1.7)	AP1M2 (1.7)	GCNT4 (1.5)	FRK (1.5)	C19orf52 (1.5)
ENSG00000160999	SH2B2 PPI subnetwork	0.51	> 0.20	SH2B3 (3.8)	USP24 (3.2)	C17orf57 (2.7)	PBX4 (2.7)	GMIP (2.5)	DNM2 (2.0)	MARK4 (1.9)	SLC44A2 (1.8)	RHD (1.6)	GMPR (1.5)
ENSG00000176102	CSTF3 PPI subnetwork	0.51	> 0.20	ILF3 (4.0)	SMARCA4 (3.3)	BUD13 (3.1)	DHX38 (3.0)	TOP1 (2.8)	USP1 (2.6)	GATAD2A (2.5)	SUGP1 (2.5)	C1orf63 (2.2)	ATP13A1 (2.1)
ENSG00000198286	CARD11 PPI subnetwork	0.51	> 0.20	ZNF101 (3.0)	RELB (2.2)	PBX4 (2.1)	CYB561D1 (2.0)	PTPN11 (1.9)	SH2B3 (1.9)	NT5DC1 (1.9)	PLEKHH2 (1.8)	HAVCR1 (1.6)	PLCG1 (1.5)
ENSG00000113263	ITK PPI subnetwork	0.51	> 0.20	PLCG1 (3.6)	GMIP (3.3)	PLEKHH2 (2.4)	PARP10 (2.4)	PBX4 (2.2)	ABCG8 (2.1)	COL4A3BP (2.1)	LPAR2 (2.0)	ZNF101 (1.9)	ABCG5 (1.9)
MP:0010792	abnormal stomach mucosa morphology	0.51	> 0.20	KIAA1324 (3.3)	SLC44A2 (2.3)	C11orf9 (2.2)	GCNT4 (1.9)	OASL (1.9)	ZNF101 (1.6)	AP1M2 (1.3)	DNAH11 (1.3)	HNF1A (1.3)	NPC1L1 (1.3)
ENSG00000173163	COMMD1 PPI subnetwork	0.51	> 0.20	RELB (6.7)	BCL3 (4.8)	GEMIN7 (3.3)	C12orf43 (3.0)	GRINA (2.5)	PARP10 (2.0)	GMIP (1.9)	PSMA5 (1.9)	CLPTM1 (1.8)	C12orf47 (1.6)
GO:0032675	regulation of interleukin-6 production	0.51	> 0.20	HLX (2.2)	C17orf57 (2.1)	TRIB1 (1.7)	ENSG00000228044 (1.7)	MAFB (1.7)	PMFBP1 (1.5)	OASL (1.5)	POC5 (1.3)	GMIP (1.3)	SH2B3 (1.2)
ENSG00000153827	TRIP12 PPI subnetwork	0.51	> 0.20	OGDH (3.8)	ZHX3 (3.0)	PLCG1 (2.4)	QTRT1 (2.1)	GATAD2A (2.1)	TOMM40 (2.0)	CLPTM1 (1.9)	NAA25 (1.7)	TOP1 (1.7)	ENSG00000226645 (1.6)
MP:0000717	abnormal lymphocyte cell number	0.51	> 0.20	RELB (3.6)	TIMD4 (3.0)	BCL3 (2.8)	GMIP (2.8)	PBX4 (2.5)	ENSG00000228044 (2.2)	MAFB (2.2)	CETP (1.9)	PLCG1 (1.6)	ZNF101 (1.6)
GO:0016791	phosphatase activity	0.51	> 0.20	TRIB1 (2.9)	SH2B3 (2.3)	AMIGO1 (2.3)	PVR (2.3)	GMPR (1.9)	ZHX3 (1.9)	SORT1 (1.7)	SYPL2 (1.6)	PTPN11 (1.5)	LDLR (1.2)
GO:0000041	transition metal ion transport	0.51	> 0.20	TMEM116 (2.8)	BLOC1S3 (2.7)	ATP13A1 (2.1)	GRINA (2.0)	TMED4 (2.0)	FRK (1.9)	RHD (1.8)	AP1M2 (1.7)	TMEM57 (1.7)	LPIN3 (1.6)
GO:0003729	mRNA binding	0.51	> 0.20	C1orf63 (5.2)	ANKRD31 (1.9)	TRAFD1 (1.8)	TOP1 (1.8)	ILF3 (1.8)	ADAM1 (1.7)	APOB (1.7)	ENSG00000238078 (1.5)	AP1M2 (1.5)	DHODH (1.4)
ENSG00000128692	ENSG00000128692 PPI subnetwork	0.51	> 0.20	DDX56 (4.7)	QTRT1 (3.7)	TOMM40 (3.1)	NAA25 (3.0)	SARS (2.7)	SUGP1 (2.7)	ZNF259 (2.6)	DHX38 (2.5)	TXNL4B (2.4)	PTPN11 (2.3)
GO:0001960	negative regulation of cytokine-mediated signaling pathway	0.51	> 0.20	ANKRD31 (3.5)	PBX4 (2.8)	CEACAM19 (2.6)	MOSC1 (2.1)	NKPD1 (1.8)	MAU2 (1.8)	TMEM116 (1.8)	ENSG00000238078 (1.8)	DYNC2LI1 (1.4)	TRAPPC6A (1.4)
GO:0050879	multicellular organismal movement	0.51	> 0.20	SYPL2 (5.7)	C17orf57 (3.1)	ANKRD31 (2.6)	CYB561D1 (2.0)	GMPR (1.9)	UBXN2B (1.8)	ZHX3 (1.3)	HAPLN4 (1.3)	COL4A3BP (1.1)	LPIN3 (1.1)
GO:0050881	musculoskeletal movement	0.51	> 0.20	SYPL2 (5.7)	C17orf57 (3.1)	ANKRD31 (2.6)	CYB561D1 (2.0)	GMPR (1.9)	UBXN2B (1.8)	ZHX3 (1.3)	HAPLN4 (1.3)	COL4A3BP (1.1)	LPIN3 (1.1)
GO:0048407	platelet-derived growth factor binding	0.51	> 0.20	APOE (3.2)	C17orf57 (2.6)	AP1M2 (2.1)	HLX (1.9)	MYLIP (1.9)	CILP2 (1.6)	KANK2 (1.6)	NPC1L1 (1.5)	KIAA1324 (1.5)	ITGB3 (1.4)
ENSG00000105085	MED26 PPI subnetwork	0.51	> 0.20	GEMIN7 (4.4)	TXNL4B (2.9)	BUD13 (2.3)	MAPKAPK5 (2.1)	POC5 (1.9)	BLOC1S3 (1.8)	BRAP (1.7)	C12orf47 (1.7)	DHX38 (1.6)	TOP1 (1.4)
ENSG00000166478	ZNF143 PPI subnetwork	0.51	> 0.20	GEMIN7 (3.6)	C12orf43 (3.3)	POC5 (3.1)	ADAM1 (2.7)	C19orf52 (2.2)	TOMM40 (2.2)	ZNF259 (2.2)	SUGP1 (2.1)	DDX56 (2.1)	MAPKAPK5 (2.1)
MP:0001922	reduced male fertility	0.51	> 0.20	PMFBP1 (3.0)	TSSK6 (2.2)	UBXN2B (1.8)	NCAN (1.7)	ALDH2 (1.5)	MYLIP (1.5)	USP24 (1.4)	MAFB (1.4)	TOP1 (1.4)	MOSC1 (1.3)
ENSG00000170365	SMAD1 PPI subnetwork	0.51	> 0.20	ATXN2 (3.1)	ATXN7L2 (2.4)	CARM1 (2.2)	PLCG1 (2.1)	DHX38 (1.9)	C19orf52 (1.9)	ZNF101 (1.9)	MARK4 (1.8)	MAU2 (1.8)	DOCK7 (1.8)
MP:0005409	darkened coat color	0.51	> 0.20	SH2B3 (2.4)	CELSR2 (2.3)	POLK (1.9)	ENSG00000254235 (1.8)	BCAM (1.8)	ATXN2 (1.8)	MARK4 (1.5)	RPH3A (1.5)	PLCG1 (1.4)	CEACAM19 (1.4)
MP:0002018	malignant tumors	0.51	> 0.20	AP1M2 (2.3)	CYB561D1 (2.2)	C12orf51 (2.2)	NYNRIN (2.0)	C17orf57 (1.6)	NAA25 (1.6)	UBXN2B (1.5)	ZNF180 (1.5)	CARM1 (1.4)	LPIN3 (1.3)
GO:0005768	endosome	0.51	> 0.20	COL4A3BP (3.1)	TMEM50A (2.5)	GRINA (2.5)	BLOC1S3 (1.8)	FRK (1.8)	GMIP (1.8)	PTPN11 (1.7)	TRAFD1 (1.7)	CLPTM1 (1.7)	MAU2 (1.6)
ENSG00000196235	SUPT5H PPI subnetwork	0.51	> 0.20	ZNF259 (4.1)	SUGP1 (3.8)	DDX56 (3.6)	TOP1 (3.3)	QTRT1 (3.3)	DHX38 (3.2)	ILF3 (3.1)	TOMM40 (3.1)	PTPN11 (2.9)	SMARCA4 (2.8)
GO:0030027	lamellipodium	0.51	> 0.20	DOCK7 (3.7)	GMIP (3.1)	OGDH (2.6)	PVRL2 (2.5)	KANK2 (2.4)	SLC44A2 (2.3)	ST3GAL4 (2.1)	PPP1R37 (2.1)	SH2B3 (2.0)	PLCG1 (1.9)
ENSG00000205022	PABPN1L PPI subnetwork	0.51	> 0.20	DNM2 (3.9)	ILF3 (3.7)	CARM1 (3.1)	SMARCA4 (3.1)	ATXN2 (2.9)	BRAP (2.8)	DHX38 (2.6)	YIPF2 (2.6)	USP24 (2.5)	DOCK7 (2.4)
MP:0002886	abnormal glutamate-mediated receptor currents	0.51	> 0.20	FADS2 (5.1)	FADS1 (4.3)	HMGCR (4.2)	LDLR (4.0)	RPH3A (3.6)	PCSK9 (3.2)	ENSG00000226648 (2.7)	MARK4 (2.3)	HAPLN4 (2.2)	ITGB3 (1.8)
GO:0070742	C2H2 zinc finger domain binding	0.51	> 0.20	ENSG00000238078 (2.6)	ABO (2.3)	RHD (2.0)	GMPR (2.0)	NYNRIN (2.0)	SH2B3 (1.9)	ITGB3 (1.8)	SLC44A2 (1.6)	RHCE (1.5)	BLOC1S3 (1.5)
ENSG00000170604	IRF2BP1 PPI subnetwork	0.51	> 0.20	SH2B3 (3.0)	DOCK7 (2.9)	HLX (2.7)	BUD13 (2.6)	ENSG00000254235 (2.1)	TRAFD1 (1.6)	POC5 (1.6)	ENSG00000226648 (1.6)	C1orf63 (1.5)	C17orf57 (1.5)
ENSG00000185247	MAGEA11 PPI subnetwork	0.51	> 0.20	C12orf43 (2.4)	PBX4 (2.2)	RELB (1.9)	DYNC2LI1 (1.8)	ZNF259 (1.8)	GCNT4 (1.7)	ACAD10 (1.5)	PSRC1 (1.4)	SUGP1 (1.4)	YIPF2 (1.3)
GO:0005858	axonemal dynein complex	0.51	> 0.20	DNAH11 (4.5)	DYNC2LI1 (1.8)	PBX4 (1.7)	CEACAM19 (1.2)	ST3GAL4 (1.2)	KIAA1324 (1.2)	YIPF2 (1.2)	ABO (0.9)	NKPD1 (0.8)	RHCE (0.7)
ENSG00000110768	GTF2H1 PPI subnetwork	0.51	> 0.20	SUGP1 (3.4)	BUD13 (2.8)	DHX38 (2.4)	TXNL4B (2.3)	PSMA5 (2.2)	ZNF259 (2.1)	POC5 (2.0)	FEN1 (2.0)	MAPKAPK5 (1.9)	TOP1 (1.7)
ENSG00000106399	RPA3 PPI subnetwork	0.51	> 0.20	FEN1 (6.3)	USP1 (4.6)	POC5 (2.0)	TMEM116 (2.0)	ZNF180 (1.9)	ENSG00000235545 (1.3)	TXNL4B (1.3)	PSRC1 (1.3)	AMIGO1 (1.2)	FADS1 (1.2)
ENSG00000166226	CCT2 PPI subnetwork	0.51	> 0.20	TOMM40 (3.4)	DDX56 (2.7)	SARS (2.4)	PSMA5 (2.3)	OGDH (2.0)	NAA25 (2.0)	ZNF259 (1.9)	NT5DC1 (1.9)	C19orf52 (1.7)	QTRT1 (1.6)
ENSG00000148200	NR6A1 PPI subnetwork	0.51	> 0.20	PPP1R37 (2.4)	ATXN2 (2.4)	POLK (2.0)	MARK4 (1.9)	SH2B3 (1.8)	C12orf51 (1.7)	PSRC1 (1.7)	ST3GAL4 (1.7)	PLEKHH2 (1.5)	SMARCA4 (1.4)
GO:0002053	positive regulation of mesenchymal cell proliferation	0.51	> 0.20	ENSG00000238078 (2.9)	NYNRIN (1.7)	MYLIP (1.7)	PPP1R37 (1.5)	CBLC (1.5)	DYNC2LI1 (1.5)	NKPD1 (1.4)	ENSG00000254235 (1.4)	TMEM116 (1.3)	ENSG00000226648 (1.2)
GO:0044420	extracellular matrix part	0.51	> 0.20	CILP2 (4.9)	APOE (3.2)	BCAM (2.8)	PLEKHH2 (2.7)	AP1M2 (2.1)	APOC1 (1.8)	KANK2 (1.7)	MAFB (1.7)	CBLC (1.4)	MYLIP (1.3)
GO:0006200	ATP catabolic process	0.51	> 0.20	NKPD1 (3.3)	PSMA5 (2.3)	OGDH (2.1)	HAPLN4 (2.1)	BRAP (2.0)	ENSG00000238078 (1.9)	SARS (1.7)	USP24 (1.7)	ACAD10 (1.7)	CLPTM1 (1.6)
ENSG00000016082	ISL1 PPI subnetwork	0.51	> 0.20	C19orf52 (2.4)	GMPR (1.9)	COL4A3BP (1.7)	TMEM57 (1.6)	BCAM (1.6)	MARK4 (1.5)	RHD (1.5)	RPH3A (1.4)	FADS2 (1.4)	C12orf43 (1.3)
ENSG00000152234	ATP5A1 PPI subnetwork	0.51	> 0.20	OGDH (3.9)	C1orf63 (2.7)	TMEM50A (2.6)	PSMA5 (2.5)	PLEC (2.4)	ADAM1 (2.2)	ACAD10 (2.0)	TOMM40 (1.8)	ENSG00000238078 (1.7)	SARS (1.7)
ENSG00000108823	SGCA PPI subnetwork	0.51	> 0.20	SYPL2 (3.5)	KANK2 (3.0)	ST3GAL4 (2.6)	SLC44A2 (2.3)	NPC1L1 (2.1)	TMED4 (2.0)	CBLC (1.6)	FRK (1.6)	GPAM (1.5)	GMPR (1.5)
ENSG00000135069	PSAT1 PPI subnetwork	0.51	> 0.20	PSMA5 (2.8)	SARS (2.6)	SMARCA4 (2.2)	ALDH2 (2.2)	COL4A3BP (2.1)	PTPN11 (2.0)	ERP29 (1.8)	PVR (1.8)	OGDH (1.7)	PLEKHH2 (1.6)
GO:0051087	chaperone binding	0.51	> 0.20	ERP29 (3.2)	CYP7A1 (2.5)	TOMM40 (2.1)	ZNF259 (2.0)	BRAP (1.9)	ANGPTL3 (1.9)	APOC4 (1.9)	GATAD2A (1.9)	GOT2P1 (1.7)	APOB (1.7)
GO:0032201	telomere maintenance via semi-conservative replication	0.51	> 0.20	ZNF180 (3.6)	USP1 (3.1)	ENSG00000235545 (2.6)	GOT2P1 (2.4)	FEN1 (2.3)	ENSG00000228044 (2.2)	TMEM116 (1.9)	AMIGO1 (1.8)	NT5DC1 (1.6)	ERP29 (1.5)
ENSG00000172809	RPL38 PPI subnetwork	0.51	> 0.20	NKPD1 (2.8)	ZNF259 (1.6)	HAVCR1 (1.6)	ANKRD31 (1.6)	BCL3 (1.5)	ADAM1 (1.5)	PTPN11 (1.5)	MOSC1 (1.4)	NAA25 (1.4)	ZNF101 (1.4)
ENSG00000130699	TAF4 PPI subnetwork	0.51	> 0.20	MAPKAPK5 (3.4)	ATXN2 (3.4)	BUD13 (2.9)	SUGP1 (2.5)	C12orf43 (2.4)	TXNL4B (2.4)	DHX38 (2.4)	ATXN7L2 (1.9)	TOP1 (1.9)	GEMIN7 (1.9)
GO:0001824	blastocyst development	0.51	> 0.20	SUGP1 (3.1)	QTRT1 (2.3)	ATP13A1 (2.2)	MAU2 (2.0)	ATXN7L2 (2.0)	DHX38 (1.7)	UBXN2B (1.7)	CARM1 (1.6)	LPIN3 (1.6)	YIPF2 (1.6)
GO:0002200	somatic diversification of immune receptors	0.51	> 0.20	ZNF101 (3.9)	GCNT4 (2.9)	ANKRD31 (2.7)	NT5DC1 (2.5)	PLCG1 (2.1)	PBX4 (2.0)	C17orf57 (1.8)	ENSG00000226648 (1.6)	UBXN2B (1.5)	DYNC2LI1 (1.4)
MP:0002090	abnormal vision	0.51	> 0.20	SORT1 (3.1)	TRIB1 (2.6)	COL4A3BP (2.5)	GMPR (2.4)	APOE (2.3)	APOC4 (2.2)	APOC1 (2.0)	PMFBP1 (1.9)	HNF1A (1.8)	APOA5 (1.6)
MP:0000822	abnormal brain ventricle morphology	0.51	> 0.20	DYNC2LI1 (2.9)	ATXN2 (2.4)	CELSR2 (2.3)	FADS2 (2.3)	FADS1 (2.2)	NYNRIN (2.1)	GRINA (2.0)	PBX4 (2.0)	SORT1 (2.0)	DHODH (2.0)
GO:0050909	sensory perception of taste	0.51	> 0.20	GOT2P1 (3.2)	ENSG00000228044 (2.2)	DNAH11 (2.0)	PMFBP1 (2.0)	ABO (1.9)	CYB561D1 (1.5)	ADAM1 (1.3)	ANKRD31 (1.0)	GCNT4 (1.0)	OASL (0.9)
GO:0032845	negative regulation of homeostatic process	0.51	> 0.20	ENSG00000235545 (3.2)	BLOC1S3 (2.5)	POLK (2.4)	ENSG00000228044 (2.2)	TXNL4B (2.1)	ENSG00000226648 (2.0)	CEACAM19 (1.7)	GOT2P1 (1.6)	SUGP1 (1.6)	MARK4 (1.5)
ENSG00000162368	CMPK1 PPI subnetwork	0.51	> 0.20	TXNL4B (2.4)	MAPKAPK5 (2.4)	C19orf52 (2.1)	BRAP (2.1)	ADAM1 (1.8)	POC5 (1.8)	TMEM57 (1.8)	PTPN11 (1.7)	GMPR (1.5)	GATAD2A (1.5)
GO:0048306	calcium-dependent protein binding	0.51	> 0.20	LPA (4.0)	PLEC (3.1)	ST3GAL4 (2.8)	CILP2 (2.8)	RPH3A (2.8)	TMEM50A (2.7)	APOC4 (2.2)	APOA5 (1.9)	TMEM57 (1.9)	ABCG5 (1.8)
GO:0032024	positive regulation of insulin secretion	0.51	> 0.20	ANKRD31 (2.7)	KIAA1324 (2.5)	NPC1L1 (2.1)	ABCG8 (1.9)	ENSG00000254235 (1.9)	HNF1A (1.8)	COL4A3BP (1.8)	HAPLN4 (1.8)	GCNT4 (1.5)	NCAN (1.4)
ENSG00000138101	DTNB PPI subnetwork	0.51	> 0.20	ENSG00000238078 (2.5)	PLCG1 (2.4)	DOCK7 (2.3)	AMIGO1 (2.1)	KANK2 (2.0)	MOSC1 (1.9)	PVRL2 (1.9)	SYPL2 (1.9)	ENSG00000228044 (1.7)	TSSK6 (1.7)
MP:0001515	abnormal grip strength	0.52	> 0.20	MAU2 (2.4)	CYB561D1 (2.3)	USP24 (2.3)	GPAM (2.2)	TMED4 (2.0)	ATP13A1 (2.0)	DOCK7 (1.9)	PTPN11 (1.8)	PCSK9 (1.7)	PVR (1.7)
GO:0030183	B cell differentiation	0.52	> 0.20	GMIP (2.4)	ERP29 (2.3)	ENSG00000254235 (2.2)	PBX4 (2.0)	CYB561D1 (1.9)	GEMIN7 (1.8)	ZNF101 (1.8)	CEACAM19 (1.6)	TIMD4 (1.4)	DYNC2LI1 (1.2)
ENSG00000088833	NSFL1C PPI subnetwork	0.52	> 0.20	TMEM57 (2.4)	SUGP1 (1.9)	SMARCA4 (1.8)	CLPTM1 (1.8)	C19orf52 (1.7)	SARS (1.6)	TOMM40 (1.5)	PSMA5 (1.4)	NKPD1 (1.2)	TOP1 (1.2)
ENSG00000167986	DDB1 PPI subnetwork	0.52	> 0.20	BUD13 (3.0)	TXNL4B (2.4)	USP24 (2.3)	BLOC1S3 (2.2)	ILF3 (2.1)	SUGP1 (2.1)	USP1 (2.0)	BRAP (1.9)	TRAPPC6A (1.8)	ZNF180 (1.8)
GO:0006081	cellular aldehyde metabolic process	0.52	> 0.20	TRAPPC6A (3.5)	SLC22A1 (3.3)	ALDH2 (2.7)	CYP7A1 (2.5)	ANGPTL3 (2.2)	LPA (2.2)	C11orf9 (2.1)	ABCG8 (2.1)	APOA5 (1.9)	PLG (1.9)
ENSG00000076641	PAG1 PPI subnetwork	0.52	> 0.20	GMIP (3.4)	SH2B3 (3.2)	ENSG00000226645 (2.1)	COL4A3BP (1.7)	CETP (1.7)	LPA (1.5)	ZHX3 (1.5)	SLC44A2 (1.5)	ABO (1.4)	ZNF101 (1.4)
MP:0003270	intestinal obstruction	0.52	> 0.20	NCAN (2.2)	TMEM57 (1.8)	MYLIP (1.8)	HAVCR1 (1.7)	KANK2 (1.7)	TRIB1 (1.7)	ATXN2 (1.6)	HLX (1.6)	ZHX3 (1.6)	LPAR2 (1.5)
GO:0070410	co-SMAD binding	0.52	> 0.20	DOCK7 (3.8)	ATXN2 (1.8)	TRIB1 (1.8)	ATXN7L2 (1.6)	ENSG00000226648 (1.6)	MYLIP (1.6)	KANK2 (1.5)	GMPR (1.4)	BCL3 (1.4)	TSSK6 (1.3)
GO:0008373	sialyltransferase activity	0.52	> 0.20	ENSG00000254235 (2.4)	FADS2 (2.2)	TMEM57 (2.1)	ITGB3 (2.1)	TRIB1 (1.9)	SH2B3 (1.8)	ABO (1.7)	PPP1R37 (1.6)	GMPR (1.5)	PVRL2 (1.4)
ENSG00000138835	RGS3 PPI subnetwork	0.52	> 0.20	BCAM (2.9)	CETP (2.4)	SLC22A1 (2.0)	NYNRIN (1.9)	CYP7A1 (1.9)	PCSK9 (1.8)	CELSR2 (1.5)	CARM1 (1.5)	TSSK6 (1.4)	AMIGO1 (1.4)
MP:0001326	retinal degeneration	0.52	> 0.20	NCAN (2.2)	DYNC2LI1 (2.2)	ST3GAL4 (2.2)	SORT1 (1.7)	HAVCR1 (1.6)	PSRC1 (1.5)	ENSG00000235545 (1.5)	CLPTM1 (1.5)	MYLIP (1.3)	PMFBP1 (1.2)
ENSG00000158161	EYA3 PPI subnetwork	0.52	> 0.20	MYLIP (2.6)	LPA (2.4)	KIAA1324 (2.3)	PPP1R37 (2.2)	FRK (2.1)	HAPLN4 (1.9)	ENSG00000254235 (1.7)	PVRL2 (1.5)	ATXN2 (1.4)	ENSG00000238078 (1.4)
ENSG00000174485	DENND4A PPI subnetwork	0.52	> 0.20	PLEC (3.3)	DNM2 (3.3)	C11orf9 (2.8)	ZHX3 (2.8)	CARM1 (2.8)	LPAR2 (2.6)	PTPN11 (2.6)	COL4A3BP (2.4)	GPAM (2.2)	BCAM (2.2)
ENSG00000117713	ARID1A PPI subnetwork	0.52	> 0.20	SMARCA4 (3.5)	CARM1 (3.1)	GMIP (2.9)	RHCE (2.7)	RHD (2.7)	MAU2 (2.4)	ILF3 (2.3)	BCL3 (2.2)	HAPLN4 (2.1)	DHX38 (1.9)
GO:0046883	regulation of hormone secretion	0.52	> 0.20	KIAA1324 (4.8)	ABO (2.4)	ANKRD31 (2.3)	HAPLN4 (2.1)	HNF1A (2.0)	ENSG00000254235 (1.8)	GPAM (1.8)	TMED4 (1.7)	ENSG00000228044 (1.7)	MOSC1 (1.7)
ENSG00000089597	GANAB PPI subnetwork	0.52	> 0.20	CLPTM1 (2.8)	MYLIP (1.9)	SLC44A2 (1.9)	ZNF101 (1.8)	AP1M2 (1.7)	TMED4 (1.6)	BUD13 (1.4)	RPH3A (1.4)	ATP13A1 (1.4)	ZHX3 (1.3)
MP:0008584	photoreceptor outer segment degeneration	0.52	> 0.20	HMGCR (4.4)	ENSG00000235545 (2.9)	FADS1 (2.8)	FADS2 (2.7)	NCAN (2.7)	PMFBP1 (1.8)	GCNT4 (1.8)	DYNC2LI1 (1.6)	SORT1 (1.4)	KIAA1324 (1.4)
ENSG00000128591	FLNC PPI subnetwork	0.52	> 0.20	SYPL2 (6.3)	ZHX3 (2.6)	PPP1R37 (2.4)	LPA (2.3)	ENSG00000226645 (1.9)	COL4A3BP (1.7)	SH2B3 (1.5)	FRK (1.5)	ENSG00000254235 (1.3)	LPIN3 (1.3)
MP:0001302	eyelids open at birth	0.52	> 0.20	MYLIP (3.4)	TRIB1 (2.5)	NYNRIN (2.0)	PLCG1 (1.9)	ST3GAL4 (1.7)	ENSG00000238078 (1.6)	BLOC1S3 (1.5)	MARK4 (1.4)	ENSG00000235545 (1.4)	PPP1R37 (1.2)
ENSG00000162337	LRP5 PPI subnetwork	0.52	> 0.20	CILP2 (2.5)	SORT1 (2.4)	LPAR2 (2.1)	PVRL2 (2.0)	PLEKHH2 (1.8)	MOSC1 (1.7)	CELSR2 (1.7)	TMED4 (1.7)	HAVCR1 (1.7)	AMIGO1 (1.4)
ENSG00000103723	AP3B2 PPI subnetwork	0.52	> 0.20	C17orf57 (2.3)	ENSG00000228044 (2.0)	RHD (2.0)	DYNC2LI1 (1.9)	C12orf51 (1.6)	PLEC (1.6)	PARP10 (1.6)	ST3GAL4 (1.5)	ZNF259 (1.3)	HNF1A (1.3)
GO:0005791	rough endoplasmic reticulum	0.52	> 0.20	ERP29 (4.8)	TMED4 (2.5)	PCSK9 (2.5)	LDLR (2.3)	YIPF2 (2.2)	FADS1 (2.2)	PLG (2.2)	TSSK6 (1.9)	FADS2 (1.9)	TMEM57 (1.8)
ENSG00000134046	MBD2 PPI subnetwork	0.52	> 0.20	SMARCA4 (5.0)	BUD13 (3.6)	ILF3 (3.2)	PLCG1 (2.8)	KANK2 (2.7)	USP1 (2.5)	TOP1 (2.5)	DNM2 (2.5)	FRK (1.8)	ATXN2 (1.8)
ENSG00000106459	NRF1 PPI subnetwork	0.52	> 0.20	TRIB1 (3.3)	DOCK7 (2.4)	PVR (2.2)	ADAM1 (1.6)	OGDH (1.5)	CEACAM19 (1.5)	USP1 (1.5)	ZNF259 (1.4)	GMPR (1.4)	ILF3 (1.4)
REACTOME_G1S_TRANSITION	REACTOME_G1S_TRANSITION	0.52	> 0.20	FEN1 (5.4)	PSMA5 (4.3)	USP1 (3.4)	NT5DC1 (1.9)	TOMM40 (1.6)	TRAFD1 (1.5)	ENSG00000235545 (1.5)	TXNL4B (1.4)	PSRC1 (1.4)	DDX56 (1.3)
ENSG00000079462	PAFAH1B3 PPI subnetwork	0.52	> 0.20	TRAPPC6A (2.3)	ATXN7L2 (2.3)	ZNF259 (2.2)	ZNF180 (1.9)	TOP1 (1.7)	C17orf57 (1.6)	FADS1 (1.5)	BUD13 (1.4)	FADS2 (1.4)	NKPD1 (1.4)
GO:0002831	regulation of response to biotic stimulus	0.52	> 0.20	ZNF101 (2.6)	BLOC1S3 (2.6)	OASL (2.6)	ATP13A1 (2.4)	GEMIN7 (2.2)	PBX4 (2.2)	CLPTM1 (2.1)	MAU2 (2.1)	ENSG00000235545 (2.1)	PARP10 (1.9)
GO:0032352	positive regulation of hormone metabolic process	0.52	> 0.20	ATXN7L2 (2.0)	DNAH11 (1.9)	BCAM (1.9)	ENSG00000226645 (1.9)	TMED4 (1.9)	BLOC1S3 (1.8)	TMEM57 (1.5)	PMFBP1 (1.5)	CYB561D1 (1.4)	CEACAM19 (1.4)
ENSG00000166794	PPIB PPI subnetwork	0.52	> 0.20	CLPTM1 (3.9)	GRINA (3.3)	ERP29 (3.1)	RPH3A (3.1)	ATP13A1 (2.7)	YIPF2 (2.6)	CELSR2 (2.4)	PCSK9 (2.2)	TMED4 (2.1)	ZNF101 (2.0)
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION__PROTEASOME_DEGRADATION	REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION__PROTEASOME_DEGRADATION	0.52	> 0.20	TRAFD1 (4.6)	PSMA5 (3.9)	SUGP1 (2.2)	NAA25 (2.2)	BRAP (2.0)	C12orf43 (2.0)	GEMIN7 (2.0)	CARM1 (1.9)	ATXN2 (1.9)	PARP10 (1.7)
ENSG00000100632	ERH PPI subnetwork	0.52	> 0.20	C19orf52 (3.0)	TXNL4B (3.0)	BUD13 (2.7)	GEMIN7 (2.7)	SARS (2.0)	GATAD2A (1.9)	MYLIP (1.7)	QTRT1 (1.6)	DDX56 (1.6)	POC5 (1.5)
GO:0035267	NuA4 histone acetyltransferase complex	0.52	> 0.20	ADAM1 (3.0)	BUD13 (2.7)	USP24 (2.7)	SUGP1 (2.7)	QTRT1 (2.4)	C12orf43 (2.3)	MAPKAPK5 (2.2)	SMARCA4 (2.1)	BRAP (2.0)	ZNF180 (1.8)
GO:0022829	wide pore channel activity	0.52	> 0.20	CBLC (2.7)	NKPD1 (2.6)	C11orf9 (2.2)	CLPTM1 (2.1)	CYP7A1 (2.0)	ANGPTL3 (1.8)	CEACAM19 (1.7)	DNAH11 (1.7)	GOT2P1 (1.5)	PLG (1.5)
ENSG00000163950	SLBP PPI subnetwork	0.52	> 0.20	UBXN2B (2.5)	ZNF180 (2.0)	CYB561D1 (2.0)	PVR (2.0)	TXNL4B (2.0)	TOP1 (2.0)	ENSG00000235545 (1.9)	C12orf47 (1.9)	MYLIP (1.5)	BLOC1S3 (1.4)
ENSG00000203811	HIST2H3C PPI subnetwork	0.52	> 0.20	C19orf52 (2.8)	SMARCA4 (2.5)	ATXN2 (2.2)	USP1 (2.2)	GATAD2A (2.2)	PSRC1 (2.0)	FEN1 (1.9)	TOP1 (1.8)	PLCG1 (1.7)	ILF3 (1.5)
ENSG00000183598	HIST2H3D PPI subnetwork	0.52	> 0.20	C19orf52 (2.8)	SMARCA4 (2.5)	ATXN2 (2.2)	USP1 (2.2)	GATAD2A (2.2)	PSRC1 (2.0)	FEN1 (1.9)	TOP1 (1.8)	PLCG1 (1.7)	ILF3 (1.5)
ENSG00000142627	EPHA2 PPI subnetwork	0.52	> 0.20	PVRL2 (3.4)	CBLC (2.2)	LPAR2 (2.2)	MAFB (2.1)	ST3GAL4 (1.9)	SLC44A2 (1.7)	SH2B3 (1.7)	LPIN3 (1.6)	NAA25 (1.5)	TRAFD1 (1.4)
ENSG00000175602	CCDC85B PPI subnetwork	0.52	> 0.20	BUD13 (2.7)	GMPR (2.6)	PSRC1 (2.3)	POC5 (2.3)	MYLIP (2.2)	ENSG00000226648 (1.9)	BRAP (1.9)	BLOC1S3 (1.6)	POLK (1.5)	USP1 (1.5)
MP:0008489	slow postnatal weight gain	0.52	> 0.20	KIAA1324 (3.6)	TRIB1 (3.4)	APOE (2.5)	DOCK7 (2.4)	TIMD4 (2.3)	CETP (2.2)	SYPL2 (2.1)	MAFB (1.9)	TOP1 (1.8)	ATXN2 (1.8)
ENSG00000131269	ABCB7 PPI subnetwork	0.52	> 0.20	ATP13A1 (3.0)	RHD (2.0)	OGDH (2.0)	RHCE (1.9)	DNM2 (1.8)	ACAD10 (1.8)	YIPF2 (1.7)	ILF3 (1.7)	ENSG00000235545 (1.7)	QTRT1 (1.7)
GO:0048738	cardiac muscle tissue development	0.52	> 0.20	CEACAM19 (2.8)	SYPL2 (2.1)	C11orf9 (2.1)	ENSG00000238078 (2.0)	GMPR (1.7)	C17orf57 (1.5)	C19orf52 (1.4)	CILP2 (1.3)	BCAM (1.3)	NYNRIN (1.3)
ENSG00000161202	DVL3 PPI subnetwork	0.52	> 0.20	CARM1 (3.3)	LPAR2 (2.8)	MARK4 (2.8)	PLCG1 (2.5)	CELSR2 (2.5)	ABO (2.3)	ENSG00000254235 (2.0)	PPP1R37 (2.0)	ATXN2 (1.7)	MAPKAPK5 (1.6)
ENSG00000149091	DGKZ PPI subnetwork	0.52	> 0.20	ZHX3 (4.4)	PLEKHH2 (3.5)	PLCG1 (2.6)	TMEM50A (2.1)	CELSR2 (2.1)	NCAN (2.1)	USP24 (2.0)	LPIN3 (1.8)	ZNF101 (1.7)	TOP1 (1.7)
ENSG00000180871	CXCR2 PPI subnetwork	0.52	> 0.20	ITGB3 (4.0)	NYNRIN (2.5)	BCL3 (2.4)	GRINA (2.4)	MAFB (2.2)	UBXN2B (1.9)	CYP7A1 (1.9)	PVRL2 (1.4)	ANGPTL3 (1.4)	ENSG00000254235 (1.4)
GO:0022415	viral reproductive process	0.52	> 0.20	NKPD1 (3.2)	MAU2 (2.3)	OASL (2.2)	MAPKAPK5 (1.8)	ENSG00000226645 (1.7)	GATAD2A (1.7)	ILF3 (1.6)	SUGP1 (1.6)	PTPN11 (1.6)	GEMIN7 (1.4)
MP:0003172	abnormal lysosome physiology	0.52	> 0.20	ERP29 (3.0)	COL4A3BP (2.8)	UBXN2B (2.2)	NKPD1 (2.1)	PPP1R37 (2.1)	CYB561D1 (1.8)	NT5DC1 (1.7)	ACAD10 (1.6)	GRINA (1.6)	ATP13A1 (1.6)
GO:0032722	positive regulation of chemokine production	0.52	> 0.20	ST3GAL4 (3.2)	PMFBP1 (1.9)	OASL (1.7)	FRK (1.6)	POLK (1.6)	BCL3 (1.5)	PVR (1.4)	GMIP (1.3)	CYB561D1 (1.3)	HP (1.1)
ENSG00000029534	ANK1 PPI subnetwork	0.52	> 0.20	RHD (8.1)	RHCE (6.6)	GMPR (3.4)	PLEC (2.8)	SYPL2 (2.7)	CELSR2 (2.6)	LPIN3 (2.0)	AMIGO1 (1.9)	CYB561D1 (1.6)	C12orf51 (1.6)
ENSG00000138663	COPS4 PPI subnetwork	0.52	> 0.20	ATXN7L2 (3.2)	C19orf52 (2.1)	C12orf47 (1.9)	BUD13 (1.8)	QTRT1 (1.8)	OASL (1.8)	UBXN2B (1.6)	NT5DC1 (1.5)	NAA25 (1.5)	OGDH (1.4)
ENSG00000213905	ENSG00000213905 PPI subnetwork	0.52	> 0.20	ITGB3 (3.2)	GMPR (3.0)	APOC1 (2.6)	TMEM50A (2.3)	TMEM57 (1.9)	ZNF101 (1.9)	LPIN3 (1.8)	LPAR2 (1.4)	GPAM (1.4)	PLCG1 (1.4)
ENSG00000104689	TNFRSF10A PPI subnetwork	0.52	> 0.20	PVR (3.1)	HAVCR1 (3.1)	CILP2 (2.6)	FRK (2.4)	ZNF101 (2.1)	ERP29 (2.0)	PVRL2 (1.9)	OASL (1.8)	GMIP (1.7)	TRAFD1 (1.7)
MP:0004803	increased susceptibility to autoimmune diabetes	0.52	> 0.20	KIAA1324 (2.5)	TIMD4 (2.3)	RELB (1.7)	TRAFD1 (1.6)	POLK (1.6)	NYNRIN (1.3)	MAFB (1.3)	NAA25 (1.1)	ALDH2 (1.0)	DNAH11 (1.0)
ENSG00000108424	KPNB1 PPI subnetwork	0.52	> 0.20	NAA25 (3.1)	DDX56 (3.1)	ILF3 (3.0)	TOP1 (2.7)	USP1 (2.5)	DOCK7 (2.5)	ATXN2 (2.2)	USP24 (2.2)	TOMM40 (2.1)	SARS (2.1)
GO:0042165	neurotransmitter binding	0.52	> 0.20	ANKRD31 (2.7)	GEMIN7 (2.7)	SYPL2 (2.7)	RPH3A (2.5)	GOT2P1 (2.5)	ATXN7L2 (2.3)	CILP2 (1.9)	ABO (1.7)	SORT1 (1.7)	PMFBP1 (1.6)
ENSG00000136754	ABI1 PPI subnetwork	0.52	> 0.20	ATXN2 (3.9)	PPP1R37 (2.3)	ZHX3 (2.2)	MARK4 (2.2)	GATAD2A (2.0)	ABO (2.0)	CBLC (1.9)	USP24 (1.8)	ITGB3 (1.7)	SYPL2 (1.6)
ENSG00000135052	GOLM1 PPI subnetwork	0.52	> 0.20	C1orf63 (3.4)	C12orf47 (2.4)	TMEM57 (2.3)	TXNL4B (2.3)	SARS (2.2)	APOE (2.1)	ACAD10 (1.6)	DDX56 (1.5)	MYLIP (1.5)	USP24 (1.5)
MP:0004000	impaired passive avoidance behavior	0.52	> 0.20	ABCG5 (2.8)	ABO (2.7)	HAPLN4 (2.5)	NPC1L1 (2.3)	RPH3A (2.2)	C17orf57 (2.1)	CYP7A1 (2.1)	CELSR2 (1.9)	LPA (1.9)	ABCG8 (1.8)
GO:0043551	regulation of phosphatidylinositol 3-kinase activity	0.52	> 0.20	HAVCR1 (2.8)	DOCK7 (2.4)	CETP (2.1)	ZNF101 (2.1)	CYB561D1 (2.0)	ANKRD31 (1.9)	PBX4 (1.9)	ENSG00000228044 (1.6)	HLX (1.3)	ENSG00000226645 (1.2)
ENSG00000167491	GATAD2A PPI subnetwork	0.52	> 0.20	GMPR (2.1)	C19orf52 (2.0)	TMEM57 (1.9)	ZNF180 (1.6)	C11orf9 (1.3)	BUD13 (1.3)	MYLIP (1.2)	DNAH11 (1.1)	PMFBP1 (1.1)	FADS1 (1.1)
GO:0090218	positive regulation of lipid kinase activity	0.52	> 0.20	HAVCR1 (2.7)	CETP (2.6)	DOCK7 (2.5)	CYB561D1 (2.1)	ANKRD31 (2.0)	ENSG00000228044 (2.0)	ZNF101 (1.9)	PBX4 (1.6)	TIMD4 (1.5)	CELSR2 (1.5)
GO:0014910	regulation of smooth muscle cell migration	0.52	> 0.20	ZNF101 (2.1)	NKPD1 (1.7)	ST3GAL4 (1.7)	PMFBP1 (1.6)	ANKRD31 (1.6)	AMIGO1 (1.5)	KIAA1324 (1.5)	ADAM1 (1.5)	LPIN3 (1.5)	HLX (1.4)
GO:0001046	core promoter sequence-specific DNA binding	0.52	> 0.20	CELSR2 (3.3)	TRAFD1 (2.8)	HAVCR1 (2.0)	PARP10 (1.7)	TRIB1 (1.7)	MYLIP (1.7)	NCAN (1.6)	TRAPPC6A (1.5)	SORT1 (1.5)	FRK (1.5)
ENSG00000133740	E2F5 PPI subnetwork	0.52	> 0.20	USP1 (3.3)	KANK2 (2.6)	FEN1 (2.5)	RHD (2.3)	C12orf51 (2.1)	RHCE (2.1)	PTPN11 (2.0)	TMEM50A (2.0)	PLCG1 (1.9)	ATXN2 (1.9)
GO:0048521	negative regulation of behavior	0.52	> 0.20	ENSG00000226648 (3.5)	ANKRD31 (3.2)	GCNT4 (2.9)	LPIN3 (2.8)	PPP1R37 (2.2)	HLX (1.8)	TMED4 (1.7)	DNAH11 (1.6)	PVRL2 (1.4)	PLEKHH2 (1.3)
ENSG00000177380	PPFIA3 PPI subnetwork	0.52	> 0.20	C11orf9 (2.5)	LPA (2.3)	MYLIP (2.3)	TMEM57 (2.2)	CILP2 (2.2)	PPP1R37 (2.2)	POC5 (1.8)	TSSK6 (1.8)	LPAR2 (1.7)	MAFB (1.7)
ENSG00000167193	CRK PPI subnetwork	0.52	> 0.20	SLC44A2 (3.5)	DOCK7 (2.2)	NT5DC1 (2.1)	ABO (2.1)	MARK4 (2.1)	USP24 (2.0)	RPH3A (1.9)	SORT1 (1.8)	CARM1 (1.7)	MYLIP (1.6)
GO:0007494	midgut development	0.52	> 0.20	ABCG5 (3.5)	TM6SF2 (2.9)	CYP7A1 (2.9)	ABCG8 (2.9)	LPIN3 (2.5)	ANKRD31 (2.2)	NPC1L1 (2.1)	ENSG00000238078 (2.0)	LPA (1.8)	AMIGO1 (1.7)
ENSG00000090621	PABPC4 PPI subnetwork	0.52	> 0.20	PVR (2.9)	TMEM57 (1.8)	BRAP (1.8)	AMIGO1 (1.7)	SARS (1.5)	GRINA (1.5)	TRAPPC6A (1.4)	PVRL2 (1.4)	PTPN11 (1.4)	SUGP1 (1.3)
ENSG00000168395	ING5 PPI subnetwork	0.52	> 0.20	MAU2 (3.5)	UBXN2B (3.1)	CELSR2 (2.2)	KIAA1324 (2.2)	CARM1 (2.0)	C11orf9 (2.0)	GATAD2A (1.6)	GMIP (1.5)	PLEC (1.4)	BCL3 (1.3)
ENSG00000215693	ENSG00000215693 PPI subnetwork	0.52	> 0.20	MAU2 (3.5)	UBXN2B (3.1)	CELSR2 (2.2)	KIAA1324 (2.2)	CARM1 (2.0)	C11orf9 (2.0)	GATAD2A (1.6)	GMIP (1.5)	PLEC (1.4)	BCL3 (1.3)
MP:0005449	abnormal food intake	0.52	> 0.20	CETP (4.2)	TIMD4 (3.0)	GPAM (2.7)	PMFBP1 (2.0)	C12orf47 (2.0)	TSSK6 (1.9)	MOSC1 (1.7)	COL4A3BP (1.5)	MAFB (1.4)	SYPL2 (1.4)
GO:0045078	positive regulation of interferon-gamma biosynthetic process	0.52	> 0.20	GCNT4 (2.6)	DNAH11 (2.6)	DOCK7 (1.9)	ZNF180 (1.9)	TRAFD1 (1.6)	TMED4 (1.5)	ENSG00000226645 (1.5)	TM6SF2 (1.4)	DYNC2LI1 (1.3)	CYB561D1 (1.3)
ENSG00000182979	MTA1 PPI subnetwork	0.52	> 0.20	TOP1 (3.1)	MARK4 (2.5)	PSRC1 (2.2)	ILF3 (2.1)	CARM1 (2.1)	DDX56 (2.0)	SMARCA4 (1.7)	NT5DC1 (1.7)	DNM2 (1.6)	PVRL2 (1.5)
ENSG00000184916	JAG2 PPI subnetwork	0.52	> 0.20	NCAN (2.8)	SLC44A2 (2.8)	BCAM (2.2)	USP24 (2.2)	CELSR2 (2.2)	NYNRIN (2.0)	TSSK6 (2.0)	C12orf47 (1.9)	ENSG00000254235 (1.8)	GRINA (1.6)
MP:0008006	increased stomach pH	0.52	> 0.20	OASL (2.3)	ABO (2.1)	GCNT4 (2.0)	C11orf9 (1.9)	SLC44A2 (1.8)	TMEM116 (1.7)	KIAA1324 (1.7)	TMED4 (1.4)	DOCK7 (1.4)	COL4A3BP (1.4)
GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	0.52	> 0.20	ATXN2 (3.8)	MAU2 (3.3)	SMARCA4 (3.1)	CARM1 (2.6)	OGDH (2.5)	C12orf51 (2.5)	GMPR (2.2)	BUD13 (2.1)	ATXN7L2 (2.0)	TRIB1 (1.9)
MP:0009546	absent gastric milk in neonates	0.52	> 0.20	PCSK9 (2.8)	HMGCR (2.7)	FADS2 (2.5)	FADS1 (2.4)	ALDH2 (2.3)	LDLR (2.2)	DNAH11 (1.9)	LPA (1.8)	ABO (1.8)	PLCG1 (1.7)
ENSG00000130204	TOMM40 PPI subnetwork	0.52	> 0.20	GEMIN7 (4.4)	DDX56 (3.1)	TOMM40 (3.1)	TRAPPC6A (2.7)	CLPTM1 (2.5)	MARK4 (2.2)	DHODH (2.2)	QTRT1 (2.0)	CBLC (1.9)	ZNF259 (1.6)
MP:0002059	abnormal seminal vesicle morphology	0.52	> 0.20	MAFB (1.9)	NYNRIN (1.8)	BRAP (1.8)	MYLIP (1.6)	ALDH2 (1.6)	PCSK9 (1.6)	CELSR2 (1.5)	GMPR (1.3)	ATXN7L2 (1.2)	COL4A3BP (0.9)
ENSG00000117000	RLF PPI subnetwork	0.52	> 0.20	ATXN2 (2.4)	PCSK9 (2.3)	C19orf52 (2.2)	TXNL4B (1.9)	ENSG00000226648 (1.9)	NYNRIN (1.9)	KANK2 (1.9)	OGDH (1.9)	DNAH11 (1.7)	BRAP (1.6)
GO:0072524	pyridine-containing compound metabolic process	0.52	> 0.20	ACAD10 (3.0)	TRAPPC6A (3.0)	NT5DC1 (2.2)	OGDH (2.1)	DNAH11 (2.0)	LPIN3 (2.0)	FRK (1.9)	ALDH2 (1.9)	BLOC1S3 (1.9)	SYPL2 (1.8)
GO:0019362	pyridine nucleotide metabolic process	0.52	> 0.20	ACAD10 (3.0)	TRAPPC6A (3.0)	NT5DC1 (2.2)	OGDH (2.1)	DNAH11 (2.0)	LPIN3 (2.0)	FRK (1.9)	ALDH2 (1.9)	BLOC1S3 (1.9)	SYPL2 (1.8)
MP:0001806	decreased IgM level	0.52	> 0.20	RELB (4.0)	GMIP (3.7)	SH2B3 (2.5)	TIMD4 (2.3)	CETP (2.3)	BCL3 (2.1)	ACAD10 (1.8)	GCNT4 (1.8)	ZNF101 (1.4)	PLCG1 (1.3)
ENSG00000134138	MEIS2 PPI subnetwork	0.52	> 0.20	TMED4 (2.6)	HLX (2.2)	ENSG00000254235 (2.0)	FADS2 (2.0)	DYNC2LI1 (1.8)	PCSK9 (1.5)	MARK4 (1.5)	ACAD10 (1.4)	LPA (1.4)	ZNF101 (1.4)
MP:0002835	abnormal cranial suture morphology	0.52	> 0.20	CILP2 (3.4)	NYNRIN (3.3)	NCAN (1.7)	PLCG1 (1.7)	C11orf9 (1.7)	ENSG00000235545 (1.6)	PLEC (1.6)	BCAM (1.5)	DOCK7 (1.4)	PPP1R37 (1.4)
REACTOME_CD28_DEPENDENT_PI3KAKT_SIGNALING	REACTOME_CD28_DEPENDENT_PI3KAKT_SIGNALING	0.52	> 0.20	OGDH (2.2)	ZHX3 (2.0)	TMEM57 (1.9)	USP24 (1.8)	POC5 (1.7)	UBXN2B (1.6)	SARS (1.6)	MYLIP (1.6)	MAFB (1.5)	POLK (1.5)
ENSG00000166908	PIP4K2C PPI subnetwork	0.52	> 0.20	MARK4 (3.6)	ATXN2 (3.2)	PVRL2 (3.1)	C12orf51 (2.9)	USP24 (2.0)	GMIP (1.9)	SORT1 (1.9)	GATAD2A (1.8)	POLK (1.7)	ENSG00000226648 (1.7)
ENSG00000165912	PACSIN3 PPI subnetwork	0.52	> 0.20	PPP1R37 (3.7)	CLPTM1 (2.6)	ATXN2 (2.4)	GATAD2A (2.2)	PTPN11 (2.1)	PLEC (1.9)	ST3GAL4 (1.6)	RPH3A (1.6)	HAPLN4 (1.4)	PLEKHH2 (1.3)
ENSG00000075388	FGF4 PPI subnetwork	0.52	> 0.20	HAVCR1 (4.6)	HAPLN4 (3.4)	PLEKHH2 (2.7)	NCAN (2.6)	C11orf9 (2.4)	C17orf57 (2.4)	PPP1R37 (2.1)	ZHX3 (2.0)	CBLC (2.0)	APOE (2.0)
GO:0007259	JAK-STAT cascade	0.52	> 0.20	TRAFD1 (2.6)	PARP10 (2.3)	ENSG00000254235 (1.7)	PVR (1.7)	BCL3 (1.6)	DYNC2LI1 (1.5)	ZNF101 (1.5)	HLX (1.4)	GEMIN7 (1.3)	PBX4 (1.3)
REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE	REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE	0.52	> 0.20	USP1 (5.3)	FEN1 (5.2)	AMIGO1 (2.3)	ZNF180 (2.0)	ENSG00000235545 (1.8)	FADS1 (1.5)	ENSG00000228044 (1.4)	KIAA1324 (1.4)	FRK (1.4)	TOMM40 (1.3)
MP:0004566	myocardial fiber degeneration	0.52	> 0.20	SYPL2 (3.1)	PLEC (2.4)	GMPR (2.1)	GOT2P1 (2.1)	HAPLN4 (2.0)	OGDH (2.0)	ATXN2 (1.9)	AMIGO1 (1.9)	KANK2 (1.9)	ENSG00000235545 (1.6)
GO:0046580	negative regulation of Ras protein signal transduction	0.52	> 0.20	ENSG00000238078 (2.6)	C17orf57 (2.5)	PPP1R37 (2.4)	MAU2 (2.3)	ENSG00000254235 (2.3)	COL4A3BP (1.9)	DNAH11 (1.5)	CYB561D1 (1.4)	RPH3A (1.4)	SH2B3 (1.3)
ENSG00000182901	RGS7 PPI subnetwork	0.52	> 0.20	ZHX3 (4.1)	ITGB3 (3.1)	PSMA5 (1.7)	ENSG00000226648 (1.7)	C11orf9 (1.7)	TXNL4B (1.6)	PTPN11 (1.6)	TMEM50A (1.6)	PSRC1 (1.5)	DOCK7 (1.5)
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	0.52	> 0.20	ST3GAL4 (2.8)	CILP2 (2.4)	HLX (2.3)	ERP29 (2.2)	NCAN (2.1)	TMED4 (1.6)	MARK4 (1.5)	ZHX3 (1.4)	YIPF2 (1.4)	GCNT4 (1.4)
GO:0004221	ubiquitin thiolesterase activity	0.52	> 0.20	USP24 (4.5)	ZNF180 (2.9)	BRAP (2.8)	NAA25 (2.8)	TMEM57 (2.7)	OASL (2.6)	MAU2 (2.1)	PTPN11 (1.9)	TRAFD1 (1.6)	CARM1 (1.6)
ENSG00000162889	MAPKAPK2 PPI subnetwork	0.52	> 0.20	GATAD2A (3.1)	TRIB1 (2.9)	SH2B3 (2.6)	SYPL2 (2.4)	CARM1 (2.3)	ATXN7L2 (2.0)	HLX (2.0)	MARK4 (1.9)	PLEC (1.9)	BCL3 (1.8)
ENSG00000153922	CHD1 PPI subnetwork	0.52	> 0.20	TOP1 (3.5)	ATXN2 (3.1)	SMARCA4 (2.9)	SUGP1 (2.8)	COL4A3BP (2.7)	ILF3 (2.7)	BUD13 (2.6)	C19orf52 (2.4)	POC5 (2.1)	USP1 (1.9)
GO:0032589	neuron projection membrane	0.52	> 0.20	CELSR2 (3.3)	RPH3A (3.2)	AMIGO1 (3.0)	NCAN (2.1)	HAVCR1 (2.0)	SORT1 (1.9)	LPAR2 (1.8)	ENSG00000226648 (1.8)	PBX4 (1.6)	PCSK9 (1.6)
ENSG00000105287	PRKD2 PPI subnetwork	0.52	> 0.20	MARK4 (2.4)	PTPN11 (2.2)	DOCK7 (2.0)	ATXN2 (1.9)	SORT1 (1.7)	BUD13 (1.7)	ZNF180 (1.6)	ENSG00000226648 (1.6)	POLK (1.6)	PVRL2 (1.5)
GO:0060992	response to fungicide	0.52	> 0.20	DNAH11 (4.6)	HNF1A (2.2)	ABO (2.0)	HAPLN4 (1.6)	CEACAM19 (1.5)	ZNF180 (1.5)	ENSG00000254235 (1.4)	ENSG00000235545 (1.3)	NCAN (1.2)	ZHX3 (1.2)
ENSG00000106615	RHEB PPI subnetwork	0.52	> 0.20	USP24 (3.2)	MAPKAPK5 (3.0)	C12orf51 (3.0)	DOCK7 (2.0)	SMARCA4 (1.9)	C12orf43 (1.8)	DHX38 (1.8)	ATXN2 (1.7)	MARK4 (1.6)	GEMIN7 (1.6)
ENSG00000171357	C1orf190 PPI subnetwork	0.52	> 0.20	ABO (2.6)	BLOC1S3 (2.1)	CYB561D1 (1.9)	MARK4 (1.7)	CLPTM1 (1.6)	TMEM116 (1.6)	CARM1 (1.5)	PPP1R37 (1.4)	MYLIP (1.4)	NT5DC1 (1.3)
GO:0033559	unsaturated fatty acid metabolic process	0.52	> 0.20	NKPD1 (4.5)	CYB561D1 (3.6)	ALDH2 (2.9)	FADS2 (1.8)	GMPR (1.7)	CEACAM19 (1.7)	PMFBP1 (1.7)	C11orf9 (1.6)	ITGB3 (1.6)	HNF1A (1.5)
ENSG00000136930	PSMB7 PPI subnetwork	0.53	> 0.20	PSMA5 (6.3)	TRAFD1 (3.1)	NAA25 (2.2)	NT5DC1 (2.0)	TOMM40 (1.7)	DDX56 (1.6)	SARS (1.5)	ENSG00000254235 (1.3)	DHX38 (1.3)	SUGP1 (1.3)
ENSG00000124486	USP9X PPI subnetwork	0.53	> 0.20	BCL3 (3.9)	RELB (3.1)	LPAR2 (2.3)	PSMA5 (2.0)	LDLR (2.0)	AMIGO1 (1.7)	CEACAM19 (1.6)	TRIB1 (1.6)	BCAM (1.6)	C12orf47 (1.6)
MP:0004597	increased susceptibility to noise-induced hearing loss	0.53	> 0.20	RPH3A (3.0)	RELB (3.0)	CYP7A1 (2.4)	NCAN (2.1)	APOE (1.9)	SLC22A1 (1.9)	APOC1 (1.6)	HAPLN4 (1.6)	APOC4 (1.5)	LPAR2 (1.5)
ENSG00000138413	IDH1 PPI subnetwork	0.53	> 0.20	PSMA5 (2.2)	TM6SF2 (2.1)	ABCG5 (1.9)	C17orf57 (1.8)	NAA25 (1.7)	HAPLN4 (1.6)	TOMM40 (1.5)	CEACAM19 (1.5)	NYNRIN (1.4)	TOP1 (1.4)
MP:0003864	abnormal midbrain development	0.53	> 0.20	GMPR (2.1)	NYNRIN (2.0)	CARM1 (2.0)	PSRC1 (1.9)	DOCK7 (1.7)	DYNC2LI1 (1.7)	TRIB1 (1.7)	MARK4 (1.7)	OASL (1.6)	PPP1R37 (1.5)
GO:0034062	RNA polymerase activity	0.53	> 0.20	GEMIN7 (4.7)	ZNF259 (3.4)	DDX56 (2.8)	MAPKAPK5 (2.5)	DHODH (2.5)	QTRT1 (2.4)	C12orf43 (2.2)	TXNL4B (2.2)	TOMM40 (1.8)	C12orf47 (1.5)
GO:0003899	DNA-directed RNA polymerase activity	0.53	> 0.20	GEMIN7 (4.7)	ZNF259 (3.4)	DDX56 (2.8)	MAPKAPK5 (2.5)	DHODH (2.5)	QTRT1 (2.4)	C12orf43 (2.2)	TXNL4B (2.2)	TOMM40 (1.8)	C12orf47 (1.5)
ENSG00000170421	KRT8 PPI subnetwork	0.53	> 0.20	PLEC (4.5)	PVR (3.3)	BCAM (2.3)	KANK2 (2.2)	CEACAM19 (2.0)	SORT1 (2.0)	SARS (1.7)	GATAD2A (1.6)	PVRL2 (1.5)	TRAFD1 (1.5)
GO:0072525	pyridine-containing compound biosynthetic process	0.53	> 0.20	LPIN3 (2.7)	PMFBP1 (2.6)	TM6SF2 (2.3)	ACAD10 (2.0)	TSSK6 (1.8)	TRAPPC6A (1.7)	SYPL2 (1.6)	TMEM116 (1.6)	NT5DC1 (1.6)	CYP7A1 (1.5)
GO:0019363	pyridine nucleotide biosynthetic process	0.53	> 0.20	LPIN3 (2.7)	PMFBP1 (2.6)	TM6SF2 (2.3)	ACAD10 (2.0)	TSSK6 (1.8)	TRAPPC6A (1.7)	SYPL2 (1.6)	TMEM116 (1.6)	NT5DC1 (1.6)	CYP7A1 (1.5)
ENSG00000114302	PRKAR2A PPI subnetwork	0.53	> 0.20	OGDH (3.2)	KANK2 (2.8)	DNM2 (2.7)	GMPR (2.6)	GPAM (2.5)	QTRT1 (2.3)	PTPN11 (2.3)	C19orf52 (2.2)	USP24 (2.2)	MAU2 (2.1)
GO:0005310	dicarboxylic acid transmembrane transporter activity	0.53	> 0.20	ENSG00000228044 (2.7)	TMEM116 (2.1)	GCNT4 (2.0)	SYPL2 (2.0)	TM6SF2 (2.0)	PLG (1.9)	NCAN (1.9)	HNF1A (1.8)	GRINA (1.5)	PPP1R37 (1.5)
GO:0055021	regulation of cardiac muscle tissue growth	0.53	> 0.20	C11orf9 (2.2)	GCNT4 (2.2)	PLEKHH2 (1.8)	C19orf52 (1.6)	GEMIN7 (1.6)	HAPLN4 (1.5)	ALDH2 (1.5)	KIAA1324 (1.4)	DYNC2LI1 (1.4)	ENSG00000254235 (1.4)
GO:0006310	DNA recombination	0.53	> 0.20	POC5 (2.3)	MAPKAPK5 (2.1)	USP1 (2.0)	ZNF180 (2.0)	FEN1 (1.9)	ZNF101 (1.9)	BUD13 (1.8)	C17orf57 (1.7)	C12orf43 (1.6)	ANKRD31 (1.3)
ENSG00000128833	MYO5C PPI subnetwork	0.53	> 0.20	ATP13A1 (3.2)	OGDH (2.7)	SARS (2.5)	SMARCA4 (2.4)	ILF3 (2.4)	FEN1 (2.2)	NAA25 (2.1)	ATXN2 (1.9)	QTRT1 (1.9)	USP24 (1.8)
GO:0045321	leukocyte activation	0.53	> 0.20	ZNF101 (4.0)	TIMD4 (2.5)	PLCG1 (2.2)	GMIP (2.2)	CYB561D1 (1.9)	POLK (1.9)	PBX4 (1.8)	CETP (1.8)	MAFB (1.6)	SH2B3 (1.6)
ENSG00000189283	FHIT PPI subnetwork	0.53	> 0.20	TRAPPC6A (2.9)	ABO (2.7)	PLCG1 (1.9)	APOC1 (1.8)	ZNF101 (1.8)	ADAM1 (1.7)	NKPD1 (1.7)	ACAD10 (1.7)	LPAR2 (1.7)	GOT2P1 (1.6)
GO:0050999	regulation of nitric-oxide synthase activity	0.53	> 0.20	FRK (2.5)	ZNF180 (2.2)	CYB561D1 (2.1)	ENSG00000226645 (2.1)	PPP1R37 (2.0)	ATXN7L2 (2.0)	TXNL4B (1.8)	ENSG00000235545 (1.7)	AMIGO1 (1.7)	C17orf57 (1.6)
GO:0009100	glycoprotein metabolic process	0.53	> 0.20	YIPF2 (4.1)	TMED4 (3.2)	ERP29 (3.2)	TMEM57 (3.0)	TMEM50A (2.8)	CILP2 (2.6)	ATP13A1 (2.3)	CLPTM1 (2.3)	ST3GAL4 (2.3)	SLC44A2 (2.2)
GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	0.53	> 0.20	BUD13 (2.6)	TXNL4B (2.5)	MAPKAPK5 (2.5)	GEMIN7 (2.4)	UBXN2B (2.3)	DHODH (2.0)	ADAM1 (1.9)	ST3GAL4 (1.8)	ENSG00000226645 (1.7)	MAU2 (1.7)
ENSG00000102572	STK24 PPI subnetwork	0.53	> 0.20	NT5DC1 (2.5)	FRK (2.1)	PSMA5 (1.8)	TRAFD1 (1.8)	CEACAM19 (1.7)	ZNF180 (1.7)	TOP1 (1.5)	ZNF101 (1.5)	NAA25 (1.4)	PVR (1.4)
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1S_TRANSITION	REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1S_TRANSITION	0.53	> 0.20	PSMA5 (6.2)	TRAFD1 (2.9)	TOMM40 (2.1)	NAA25 (2.0)	DDX56 (1.7)	FEN1 (1.6)	NT5DC1 (1.5)	SUGP1 (1.4)	SARS (1.3)	TXNL4B (1.2)
MP:0002182	abnormal astrocyte morphology	0.53	> 0.20	FADS1 (2.9)	APOE (2.7)	HAVCR1 (2.2)	GRINA (1.9)	HAPLN4 (1.8)	RELB (1.8)	BCL3 (1.8)	PARP10 (1.8)	NCAN (1.5)	CELSR2 (1.5)
GO:0000775	chromosome, centromeric region	0.53	> 0.20	PSRC1 (5.6)	FEN1 (4.5)	USP1 (4.2)	POC5 (3.8)	ZNF180 (1.4)	DHX38 (1.1)	BUD13 (1.1)	ILF3 (0.8)	COL4A3BP (0.6)	KANK2 (0.6)
MP:0002339	abnormal lymph node morphology	0.53	> 0.20	RELB (3.7)	BCL3 (3.3)	GMIP (3.2)	PBX4 (2.9)	GCNT4 (2.6)	CYB561D1 (2.5)	PLEC (2.4)	CETP (2.2)	TIMD4 (1.8)	RHCE (1.8)
KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	KEGG_ASCORBATE_AND_ALDARATE_METABOLISM	0.53	> 0.20	ABCG8 (4.4)	ABCG5 (3.7)	ANGPTL3 (3.6)	CYP7A1 (3.5)	MOSC1 (2.8)	APOC4 (2.5)	APOB (2.4)	SLC22A1 (2.3)	PLG (2.2)	TM6SF2 (2.2)
GO:0008301	DNA binding, bending	0.53	> 0.20	HNF1A (2.7)	KANK2 (2.4)	CEACAM19 (2.3)	TRIB1 (2.1)	ANKRD31 (1.6)	RHCE (1.6)	HLX (1.6)	ALDH2 (1.3)	MOSC1 (1.3)	PLEKHH2 (1.3)
GO:0071514	genetic imprinting	0.53	> 0.20	GOT2P1 (3.7)	ATXN7L2 (2.8)	ZNF180 (2.6)	NYNRIN (2.5)	COL4A3BP (2.1)	TXNL4B (1.9)	LPAR2 (1.9)	DHODH (1.9)	GEMIN7 (1.8)	MAPKAPK5 (1.4)
ENSG00000011465	DCN PPI subnetwork	0.53	> 0.20	APOE (2.7)	BCAM (2.1)	CILP2 (2.1)	AP1M2 (2.0)	HP (1.8)	PLEKHH2 (1.7)	APOC1 (1.6)	APOB (1.4)	ABCG5 (1.4)	APOA5 (1.3)
GO:0031526	brush border membrane	0.53	> 0.20	TM6SF2 (3.8)	PLG (3.6)	TMEM116 (3.3)	AP1M2 (3.1)	NPC1L1 (2.9)	ANGPTL3 (2.5)	KIAA1324 (2.2)	APOB (1.8)	ENSG00000226648 (1.6)	FRK (1.5)
GO:0051851	modification by host of symbiont morphology or physiology	0.53	> 0.20	ENSG00000235545 (2.9)	RHD (2.5)	HP (2.2)	CEACAM19 (2.0)	BUD13 (1.8)	RHCE (1.7)	C1orf63 (1.6)	GOT2P1 (1.5)	PBX4 (1.5)	ENSG00000226645 (1.4)
ENSG00000058404	CAMK2B PPI subnetwork	0.53	> 0.20	KIAA1324 (2.2)	RPH3A (2.1)	CYB561D1 (2.0)	SORT1 (2.0)	ZNF180 (1.9)	PVR (1.8)	ENSG00000226648 (1.7)	HAVCR1 (1.6)	ATXN7L2 (1.6)	C1orf63 (1.6)
ENSG00000005007	UPF1 PPI subnetwork	0.53	> 0.20	TOP1 (3.5)	GATAD2A (2.8)	ZNF259 (2.6)	SUGP1 (2.6)	DHX38 (2.2)	TXNL4B (2.1)	ATXN7L2 (2.1)	ADAM1 (2.1)	TRAFD1 (2.1)	ATP13A1 (2.1)
ENSG00000172466	ZNF24 PPI subnetwork	0.53	> 0.20	ZNF180 (2.9)	POC5 (2.2)	FADS2 (2.2)	TRAPPC6A (2.0)	GEMIN7 (1.9)	SLC44A2 (1.8)	ATXN7L2 (1.7)	QTRT1 (1.7)	FADS1 (1.6)	PBX4 (1.5)
GO:0006354	transcription elongation, DNA-dependent	0.53	> 0.20	TXNL4B (2.9)	MAPKAPK5 (2.9)	ATXN7L2 (2.7)	ZNF259 (2.6)	BUD13 (2.5)	C12orf43 (2.1)	SUGP1 (2.0)	GEMIN7 (1.9)	DHX38 (1.8)	C19orf52 (1.8)
REACTOME_CHROMOSOME_MAINTENANCE	REACTOME_CHROMOSOME_MAINTENANCE	0.53	> 0.20	USP1 (5.3)	FEN1 (4.9)	PSRC1 (2.5)	POC5 (1.6)	ZNF180 (1.5)	DHODH (1.1)	TXNL4B (1.1)	KANK2 (1.1)	AMIGO1 (1.0)	FADS1 (0.9)
MP:0010144	abnormal tumor vascularization	0.53	> 0.20	BCL3 (3.0)	RELB (2.8)	GRINA (2.3)	TSSK6 (2.3)	ENSG00000235545 (2.0)	CBLC (1.9)	KANK2 (1.9)	PVR (1.5)	ATXN7L2 (1.4)	CELSR2 (1.3)
MP:0001927	abnormal estrous cycle	0.53	> 0.20	ABO (2.8)	APOB (2.6)	NYNRIN (2.4)	KIAA1324 (1.7)	TMEM116 (1.6)	LPIN3 (1.6)	ZHX3 (1.6)	NT5DC1 (1.4)	ZNF180 (1.2)	APOC4 (1.2)
MP:0005075	abnormal melanosome morphology	0.53	> 0.20	DOCK7 (2.5)	NKPD1 (2.2)	PPP1R37 (2.0)	ACAD10 (1.9)	GMPR (1.9)	MYLIP (1.8)	ST3GAL4 (1.7)	TMEM116 (1.6)	BRAP (1.6)	BLOC1S3 (1.5)
ENSG00000166925	TSC22D4 PPI subnetwork	0.53	> 0.20	GEMIN7 (2.8)	ILF3 (2.3)	PBX4 (2.1)	C19orf52 (2.1)	DYNC2LI1 (2.0)	QTRT1 (2.0)	ANKRD31 (2.0)	ATP13A1 (1.9)	NKPD1 (1.8)	TOMM40 (1.8)
MP:0002796	impaired skin barrier function	0.53	> 0.20	NKPD1 (5.2)	CEACAM19 (2.9)	CELSR2 (2.2)	AP1M2 (2.0)	CBLC (1.9)	BLOC1S3 (1.6)	BCAM (1.2)	ENSG00000226648 (1.2)	C17orf57 (1.2)	PLCG1 (1.1)
MP:0010402	ventricular septal defect	0.53	> 0.20	NYNRIN (3.5)	TRIB1 (3.2)	PVRL2 (3.0)	ATXN2 (2.3)	HLX (1.9)	DOCK7 (1.9)	PLCG1 (1.8)	APOB (1.7)	C11orf9 (1.7)	PVR (1.5)
GO:0007548	sex differentiation	0.53	> 0.20	DNAH11 (2.5)	ABO (2.3)	ST3GAL4 (2.2)	LPAR2 (1.9)	NYNRIN (1.8)	TSSK6 (1.6)	ENSG00000238078 (1.5)	AP1M2 (1.4)	PVRL2 (1.4)	ALDH2 (1.4)
GO:0043550	regulation of lipid kinase activity	0.53	> 0.20	HAVCR1 (3.1)	CETP (2.2)	ENSG00000228044 (2.0)	CYB561D1 (1.9)	ZHX3 (1.8)	DOCK7 (1.6)	CELSR2 (1.5)	ZNF101 (1.5)	PBX4 (1.4)	TIMD4 (1.3)
REACTOME_SIGNALING_BY_ERBB2	REACTOME_SIGNALING_BY_ERBB2	0.53	> 0.20	ZHX3 (2.9)	PLEC (2.6)	MARK4 (2.4)	SH2B3 (2.3)	DNM2 (2.1)	CLPTM1 (2.0)	TRIB1 (2.0)	ZNF101 (1.9)	PTPN11 (1.7)	POLK (1.7)
GO:0034644	cellular response to UV	0.53	> 0.20	GEMIN7 (2.5)	HAVCR1 (2.2)	DNAH11 (2.2)	BLOC1S3 (2.2)	CBLC (2.1)	MAU2 (2.1)	PPP1R37 (2.0)	GATAD2A (1.9)	GOT2P1 (1.8)	TRAPPC6A (1.7)
ENSG00000187555	USP7 PPI subnetwork	0.53	> 0.20	DHX38 (3.0)	SARS (3.0)	LPAR2 (2.4)	SUGP1 (2.3)	MAPKAPK5 (2.2)	TRAFD1 (2.1)	ATP13A1 (1.9)	C12orf43 (1.8)	TXNL4B (1.7)	TOMM40 (1.6)
GO:0000803	sex chromosome	0.53	> 0.20	LPAR2 (3.5)	ENSG00000238078 (2.3)	NYNRIN (2.2)	ILF3 (2.0)	PBX4 (2.0)	USP1 (1.9)	CARM1 (1.8)	TOP1 (1.7)	MARK4 (1.5)	FEN1 (1.4)
GO:0051168	nuclear export	0.53	> 0.20	ADAM1 (4.6)	C1orf63 (3.5)	BRAP (3.3)	TOP1 (3.1)	MAPKAPK5 (3.0)	ILF3 (2.8)	ATXN7L2 (2.4)	ENSG00000254235 (2.4)	GATAD2A (2.1)	TXNL4B (2.0)
GO:0070498	interleukin-1-mediated signaling pathway	0.53	> 0.20	ENSG00000228044 (3.0)	ZNF180 (2.5)	ANKRD31 (2.3)	UBXN2B (2.3)	CYB561D1 (2.1)	BLOC1S3 (2.0)	NKPD1 (1.7)	ZNF101 (1.7)	PMFBP1 (1.6)	PLEKHH2 (1.5)
ENSG00000112144	ICK PPI subnetwork	0.53	> 0.20	HMGCR (3.1)	PCSK9 (3.0)	BLOC1S3 (2.9)	LDLR (2.6)	TXNL4B (2.5)	TMEM57 (2.3)	FEN1 (2.2)	FADS1 (2.1)	POC5 (2.0)	FADS2 (1.9)
ENSG00000172534	HCFC1 PPI subnetwork	0.53	> 0.20	ATXN2 (3.2)	BUD13 (3.2)	ATP13A1 (2.7)	ILF3 (2.6)	BRAP (2.5)	USP1 (2.4)	POC5 (2.2)	SUGP1 (2.0)	C19orf52 (2.0)	TOMM40 (1.9)
GO:0048511	rhythmic process	0.53	> 0.20	ABO (3.1)	CEACAM19 (2.2)	ENSG00000226648 (2.1)	ENSG00000235545 (1.9)	GPAM (1.8)	HNF1A (1.7)	TRIB1 (1.7)	KIAA1324 (1.6)	DNAH11 (1.5)	ENSG00000228044 (1.4)
GO:0007173	epidermal growth factor receptor signaling pathway	0.53	> 0.20	PPP1R37 (3.1)	ABO (2.3)	DOCK7 (2.3)	COL4A3BP (2.2)	C17orf57 (2.0)	MARK4 (2.0)	DNM2 (1.9)	PVRL2 (1.9)	ATXN2 (1.8)	ENSG00000235545 (1.8)
ENSG00000141543	EIF4A3 PPI subnetwork	0.53	> 0.20	ILF3 (3.3)	PTPN11 (3.2)	C12orf43 (2.9)	QTRT1 (2.6)	SUGP1 (2.4)	TOP1 (2.3)	ENSG00000226645 (2.1)	SMARCA4 (2.0)	BRAP (2.0)	TXNL4B (1.9)
GO:0046886	positive regulation of hormone biosynthetic process	0.53	> 0.20	ST3GAL4 (2.4)	TMED4 (2.1)	ATXN7L2 (2.1)	BLOC1S3 (2.0)	ENSG00000226645 (1.7)	CEACAM19 (1.6)	TMEM57 (1.5)	DNAH11 (1.5)	HNF1A (1.4)	BUD13 (1.2)
GO:0006369	termination of RNA polymerase II transcription	0.53	> 0.20	C1orf63 (5.5)	ENSG00000226645 (3.7)	ADAM1 (2.6)	TOP1 (2.4)	BUD13 (2.4)	ILF3 (2.1)	C12orf47 (2.1)	TXNL4B (2.0)	ENSG00000226648 (2.0)	ENSG00000235545 (1.8)
ENSG00000111049	MYF5 PPI subnetwork	0.53	> 0.20	MAPKAPK5 (2.6)	CYB561D1 (1.8)	BUD13 (1.7)	HLX (1.7)	TSSK6 (1.6)	PPP1R37 (1.6)	MYLIP (1.6)	PLCG1 (1.6)	DYNC2LI1 (1.5)	ATXN7L2 (1.5)
GO:0003697	single-stranded DNA binding	0.53	> 0.20	FEN1 (4.0)	USP1 (3.4)	C1orf63 (2.3)	ENSG00000235545 (2.0)	DYNC2LI1 (2.0)	ILF3 (1.8)	DHODH (1.8)	POLK (1.7)	NT5DC1 (1.7)	CARM1 (1.6)
GO:0051654	establishment of mitochondrion localization	0.53	> 0.20	GEMIN7 (2.0)	ACAD10 (1.8)	LPAR2 (1.7)	C19orf52 (1.5)	CYB561D1 (1.4)	C12orf47 (1.4)	GCNT4 (1.3)	POLK (1.3)	OGDH (1.2)	ENSG00000226648 (1.2)
ENSG00000135424	ITGA7 PPI subnetwork	0.53	> 0.20	BCAM (3.9)	KANK2 (2.6)	ENSG00000226648 (2.4)	PLEC (2.2)	SORT1 (2.0)	TSSK6 (1.9)	SLC44A2 (1.8)	PVR (1.7)	CILP2 (1.7)	CELSR2 (1.6)
ENSG00000169727	GPS1 PPI subnetwork	0.53	> 0.20	ATXN7L2 (2.9)	ENSG00000226648 (2.1)	BUD13 (2.0)	CARM1 (1.8)	SUGP1 (1.5)	ZNF180 (1.4)	NT5DC1 (1.4)	TXNL4B (1.4)	MYLIP (1.3)	DYNC2LI1 (1.3)
MP:0003998	decreased thermal nociceptive threshold	0.53	> 0.20	RPH3A (4.9)	NYNRIN (2.0)	C12orf47 (1.9)	HAPLN4 (1.8)	GOT2P1 (1.8)	AMIGO1 (1.6)	PCSK9 (1.6)	FRK (1.5)	NCAN (1.5)	CEACAM19 (1.5)
ENSG00000197930	ERO1L PPI subnetwork	0.53	> 0.20	ERP29 (4.8)	TRAPPC6A (3.3)	DHODH (2.5)	TMED4 (2.4)	YIPF2 (2.3)	PVR (1.9)	PMFBP1 (1.7)	ADAM1 (1.5)	HNF1A (1.4)	QTRT1 (1.4)
GO:0008307	structural constituent of muscle	0.53	> 0.20	SYPL2 (7.3)	GMPR (2.6)	KANK2 (1.4)	PVRL2 (1.0)	UBXN2B (0.9)	TMEM50A (0.9)	LPAR2 (0.9)	ITGB3 (0.9)	C12orf47 (0.8)	HNF1A (0.8)
GO:0046879	hormone secretion	0.53	> 0.20	KIAA1324 (5.0)	ANKRD31 (2.6)	ABO (2.4)	HNF1A (2.2)	MOSC1 (2.0)	ENSG00000228044 (1.8)	GPAM (1.7)	AMIGO1 (1.7)	COL4A3BP (1.7)	AP1M2 (1.6)
ENSG00000169621	APLF PPI subnetwork	0.53	> 0.20	SMARCA4 (3.6)	ZNF101 (3.3)	NT5DC1 (2.8)	GCNT4 (2.2)	ENSG00000228044 (2.0)	ANKRD31 (2.0)	PLCG1 (2.0)	POLK (1.7)	GMPR (1.7)	FEN1 (1.7)
ENSG00000101856	PGRMC1 PPI subnetwork	0.53	> 0.20	TMEM50A (3.4)	ZNF101 (3.1)	ERP29 (2.4)	PSMA5 (2.1)	HNF1A (2.1)	BLOC1S3 (1.9)	TMED4 (1.9)	CYB561D1 (1.7)	ATP13A1 (1.6)	NPC1L1 (1.6)
REACTOME_RAFMAP_KINASE_CASCADE	REACTOME_RAFMAP_KINASE_CASCADE	0.53	> 0.20	MAPKAPK5 (2.6)	BLOC1S3 (2.5)	CARM1 (2.2)	DNM2 (2.2)	CYB561D1 (2.1)	PBX4 (1.9)	GEMIN7 (1.7)	TMEM50A (1.4)	HLX (1.4)	SMARCA4 (1.4)
GO:0009101	glycoprotein biosynthetic process	0.53	> 0.20	YIPF2 (4.0)	TMED4 (3.3)	ERP29 (3.1)	TMEM57 (3.0)	ST3GAL4 (2.5)	ATP13A1 (2.4)	TMEM50A (2.3)	CYB561D1 (2.3)	CLPTM1 (2.1)	ABO (2.0)
GO:0019058	viral infectious cycle	0.53	> 0.20	NKPD1 (3.4)	OASL (2.3)	MAU2 (2.1)	GATAD2A (2.0)	MAPKAPK5 (2.0)	ANKRD31 (2.0)	ENSG00000226645 (1.8)	SUGP1 (1.7)	GEMIN7 (1.6)	ZNF101 (1.6)
GO:0043240	Fanconi anaemia nuclear complex	0.53	> 0.20	ZNF180 (3.7)	DHODH (3.0)	NKPD1 (2.7)	BLOC1S3 (2.5)	USP1 (2.0)	FEN1 (1.9)	ABO (1.7)	TXNL4B (1.7)	POC5 (1.6)	ENSG00000254235 (1.6)
GO:0009409	response to cold	0.53	> 0.20	DNAH11 (3.7)	ENSG00000228044 (2.7)	ENSG00000226648 (2.2)	ACAD10 (2.0)	NCAN (1.9)	PMFBP1 (1.8)	MAU2 (1.6)	OASL (1.6)	TRIB1 (1.5)	HAPLN4 (1.4)
ENSG00000162521	RBBP4 PPI subnetwork	0.53	> 0.20	USP1 (3.5)	BUD13 (3.0)	SMARCA4 (2.9)	GATAD2A (2.9)	ATXN2 (2.6)	PSRC1 (2.3)	DHX38 (2.2)	CARM1 (2.1)	MARK4 (1.8)	CELSR2 (1.7)
GO:0045910	negative regulation of DNA recombination	0.53	> 0.20	POC5 (3.2)	ZNF101 (2.9)	ENSG00000235545 (2.7)	TXNL4B (2.1)	TMEM116 (1.9)	ENSG00000226648 (1.8)	C17orf57 (1.8)	DYNC2LI1 (1.7)	POLK (1.6)	ENSG00000226645 (1.6)
ENSG00000197961	ZNF121 PPI subnetwork	0.53	> 0.20	ATP13A1 (3.2)	OGDH (2.7)	SARS (2.5)	SMARCA4 (2.4)	ILF3 (2.4)	FEN1 (2.3)	NAA25 (2.1)	QTRT1 (2.0)	ATXN2 (1.9)	PSMA5 (1.8)
MP:0002275	abnormal type II pneumocyte morphology	0.53	> 0.20	BCAM (3.0)	YIPF2 (2.8)	CYP7A1 (2.3)	TMEM116 (2.1)	DOCK7 (2.1)	PVRL2 (2.0)	AMIGO1 (1.9)	ERP29 (1.9)	KANK2 (1.7)	KIAA1324 (1.6)
ENSG00000106263	EIF3B PPI subnetwork	0.53	> 0.20	ZNF259 (3.8)	DDX56 (3.2)	NAA25 (2.8)	DHX38 (2.7)	SARS (2.5)	QTRT1 (2.5)	TOP1 (2.4)	ILF3 (2.3)	TMEM57 (2.1)	TOMM40 (2.1)
KEGG_PYRIMIDINE_METABOLISM	KEGG_PYRIMIDINE_METABOLISM	0.53	> 0.20	FEN1 (3.0)	GEMIN7 (2.9)	DHODH (2.9)	DDX56 (2.4)	LPA (2.3)	USP1 (2.3)	TXNL4B (2.0)	QTRT1 (1.9)	PARP10 (1.7)	TOMM40 (1.7)
GO:0045739	positive regulation of DNA repair	0.53	> 0.20	HAVCR1 (2.5)	TRAPPC6A (2.4)	NT5DC1 (2.1)	UBXN2B (2.0)	GCNT4 (1.9)	BLOC1S3 (1.9)	BUD13 (1.8)	SUGP1 (1.6)	C19orf52 (1.6)	DYNC2LI1 (1.5)
GO:0045987	positive regulation of smooth muscle contraction	0.53	> 0.20	ABO (3.2)	ITGB3 (2.7)	NKPD1 (2.7)	LPIN3 (2.0)	TXNL4B (1.9)	CYB561D1 (1.9)	BLOC1S3 (1.8)	CBLC (1.8)	C17orf57 (1.7)	ENSG00000226648 (1.7)
ENSG00000132383	RPA1 PPI subnetwork	0.53	> 0.20	FEN1 (5.8)	USP1 (4.2)	ZNF180 (1.8)	TMEM116 (1.5)	DHODH (1.5)	POLK (1.4)	NT5DC1 (1.3)	ENSG00000235545 (1.3)	POC5 (1.3)	ILF3 (1.3)
ENSG00000087586	AURKA PPI subnetwork	0.53	> 0.20	PSRC1 (3.7)	FEN1 (2.6)	POC5 (2.6)	GMPR (2.1)	SUGP1 (1.9)	ATP13A1 (1.8)	C1orf63 (1.8)	MYLIP (1.8)	USP1 (1.6)	ENSG00000226648 (1.6)
GO:0046851	negative regulation of bone remodeling	0.53	> 0.20	ENSG00000228044 (2.2)	HNF1A (2.0)	GOT2P1 (1.8)	ENSG00000254235 (1.8)	KIAA1324 (1.7)	ANKRD31 (1.7)	ABO (1.5)	POLK (1.3)	ENSG00000226645 (1.2)	CEACAM19 (1.1)
GO:0061138	morphogenesis of a branching epithelium	0.53	> 0.20	PLEKHH2 (2.9)	PVRL2 (2.6)	BCAM (2.4)	MYLIP (2.0)	NYNRIN (2.0)	ENSG00000254235 (1.9)	KANK2 (1.8)	AP1M2 (1.7)	HNF1A (1.7)	CBLC (1.5)
ENSG00000179364	PACS2 PPI subnetwork	0.53	> 0.20	CBLC (6.0)	AP1M2 (4.2)	LPAR2 (2.1)	LPIN3 (2.0)	ST3GAL4 (2.0)	CELSR2 (1.9)	PSRC1 (1.7)	C12orf51 (1.7)	DOCK7 (1.6)	PVRL2 (1.6)
GO:0072401	signal transduction involved in DNA integrity checkpoint	0.53	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072422	signal transduction involved in DNA damage checkpoint	0.53	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072474	signal transduction involved in mitotic cell cycle G1/S checkpoint	0.53	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072413	signal transduction involved in mitotic cell cycle checkpoint	0.53	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0072431	signal transduction involved in mitotic cell cycle G1/S transition DNA damage checkpoint	0.53	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	0.53	> 0.20	PSMA5 (3.8)	TRAFD1 (2.7)	NT5DC1 (2.5)	NAA25 (2.3)	SUGP1 (1.6)	ENSG00000254235 (1.5)	C12orf47 (1.4)	PARP10 (1.4)	BRAP (1.3)	ZNF180 (1.2)
GO:0034405	response to fluid shear stress	0.53	> 0.20	GCNT4 (2.5)	TMEM57 (2.5)	MYLIP (2.4)	MAFB (2.2)	SLC44A2 (1.8)	ADAM1 (1.6)	TMEM50A (1.5)	KANK2 (1.5)	TRAPPC6A (1.5)	TRIB1 (1.4)
GO:0005743	mitochondrial inner membrane	0.53	> 0.20	OGDH (4.2)	ACAD10 (4.1)	TRAPPC6A (2.2)	GMPR (2.2)	ALDH2 (2.2)	TOMM40 (2.2)	GPAM (1.9)	ABCG8 (1.9)	C19orf52 (1.8)	PSMA5 (1.8)
ENSG00000131196	NFATC1 PPI subnetwork	0.53	> 0.20	BCL3 (2.5)	TOP1 (2.1)	GRINA (2.0)	PLEC (2.0)	DNM2 (1.7)	CARM1 (1.6)	GMIP (1.5)	PCSK9 (1.5)	C1orf63 (1.4)	TRIB1 (1.4)
GO:0015108	chloride transmembrane transporter activity	0.53	> 0.20	HNF1A (3.2)	PLG (2.6)	TMEM116 (2.5)	PBX4 (2.3)	NT5DC1 (2.2)	ANGPTL3 (2.1)	CLPTM1 (2.1)	ATP13A1 (2.0)	GRINA (1.8)	HLX (1.7)
MP:0002267	abnormal bronchiole morphology	0.53	> 0.20	ITGB3 (2.7)	PLEKHH2 (2.6)	RHCE (2.5)	SLC44A2 (2.2)	ENSG00000235545 (2.0)	FADS2 (1.7)	ENSG00000228044 (1.7)	APOE (1.7)	RHD (1.4)	APOC1 (1.3)
GO:0016568	chromatin modification	0.53	> 0.20	ATXN7L2 (2.7)	ILF3 (2.5)	MAU2 (2.5)	SMARCA4 (2.4)	ATXN2 (2.4)	C12orf51 (2.4)	BUD13 (2.3)	TOP1 (2.2)	TMEM57 (1.8)	ENSG00000226648 (1.6)
ENSG00000134255	CEPT1 PPI subnetwork	0.53	> 0.20	ATP13A1 (3.1)	OGDH (2.7)	SMARCA4 (2.5)	ILF3 (2.5)	FEN1 (2.3)	SARS (2.3)	NAA25 (2.0)	ATXN2 (1.9)	QTRT1 (1.9)	DNM2 (1.8)
ENSG00000159459	UBR1 PPI subnetwork	0.53	> 0.20	COL4A3BP (4.0)	USP24 (2.2)	KANK2 (1.8)	TMEM57 (1.8)	TMEM50A (1.8)	SUGP1 (1.6)	C17orf57 (1.4)	CARM1 (1.3)	GRINA (1.2)	HMGCR (1.2)
GO:0006363	termination of RNA polymerase I transcription	0.53	> 0.20	C12orf43 (3.9)	TXNL4B (2.9)	DYNC2LI1 (2.8)	GEMIN7 (2.7)	MAPKAPK5 (2.5)	ZNF259 (2.3)	ATXN7L2 (2.3)	POLK (2.2)	DHX38 (1.8)	NAA25 (1.8)
GO:0060444	branching involved in mammary gland duct morphogenesis	0.53	> 0.20	KIAA1324 (2.7)	PVRL2 (1.9)	AP1M2 (1.9)	TOP1 (1.7)	PPP1R37 (1.5)	PLEKHH2 (1.4)	BCAM (1.4)	PLEC (1.4)	CBLC (1.3)	FRK (1.2)
GO:0007040	lysosome organization	0.53	> 0.20	ERP29 (4.4)	LPAR2 (3.0)	NKPD1 (2.5)	ENSG00000228044 (2.5)	YIPF2 (2.4)	ATP13A1 (2.3)	TMED4 (2.0)	TRAPPC6A (1.9)	QTRT1 (1.8)	ENSG00000238078 (1.8)
ENSG00000163468	CCT3 PPI subnetwork	0.53	> 0.20	NAA25 (3.4)	PSMA5 (3.2)	C12orf43 (2.8)	BRAP (2.7)	ZNF259 (2.6)	SARS (2.4)	DDX56 (2.4)	NT5DC1 (2.2)	DYNC2LI1 (1.8)	ZNF180 (1.6)
ENSG00000122367	LDB3 PPI subnetwork	0.53	> 0.20	SYPL2 (5.4)	GMPR (2.7)	TMEM50A (2.0)	SH2B3 (1.9)	UBXN2B (1.7)	RHD (1.6)	PLEC (1.6)	RHCE (1.6)	LPIN3 (1.4)	C1orf63 (1.4)
MP:0004982	abnormal osteoclast morphology	0.54	> 0.20	PLEKHH2 (3.2)	CETP (2.4)	FRK (2.3)	COL4A3BP (2.2)	TIMD4 (2.2)	ENSG00000228044 (2.1)	CELSR2 (1.9)	MYLIP (1.8)	TMEM116 (1.8)	MAFB (1.7)
ENSG00000215902	ENSG00000215902 PPI subnetwork	0.54	> 0.20	ABO (2.6)	DHX38 (2.6)	ILF3 (2.2)	ATP13A1 (2.2)	TOMM40 (2.2)	ANKRD31 (2.1)	BCAM (1.9)	TOP1 (1.8)	DDX56 (1.7)	ENSG00000238078 (1.7)
ENSG00000145147	SLIT2 PPI subnetwork	0.54	> 0.20	CETP (4.7)	TIMD4 (3.9)	OASL (2.6)	TMEM116 (2.1)	DNAH11 (2.1)	ATP13A1 (2.0)	PLEKHH2 (1.8)	YIPF2 (1.7)	ACAD10 (1.7)	PVRL2 (1.6)
ENSG00000166971	AKTIP PPI subnetwork	0.54	> 0.20	SARS (2.9)	SMARCA4 (2.5)	OGDH (2.0)	PTPN11 (1.9)	QTRT1 (1.7)	TOMM40 (1.7)	ZNF180 (1.7)	C12orf43 (1.6)	ATP13A1 (1.6)	AP1M2 (1.6)
MP:0008189	increased transitional stage B cell number	0.54	> 0.20	RELB (4.1)	SH2B3 (2.6)	GMIP (2.6)	CETP (2.4)	GPAM (2.0)	TIMD4 (1.7)	BCL3 (1.7)	MAFB (1.7)	C12orf47 (1.6)	ALDH2 (1.4)
MP:0000084	abnormal fontanelle morphology	0.54	> 0.20	MYLIP (2.4)	NPC1L1 (2.4)	APOE (2.0)	ITGB3 (1.9)	CILP2 (1.7)	ABO (1.6)	GCNT4 (1.5)	PPP1R37 (1.4)	GPAM (1.4)	FRK (1.3)
GO:0071855	neuropeptide receptor binding	0.54	> 0.20	KIAA1324 (2.3)	ABO (1.9)	LPIN3 (1.9)	ENSG00000254235 (1.8)	PMFBP1 (1.5)	DNAH11 (1.5)	YIPF2 (1.5)	TSSK6 (1.4)	NKPD1 (1.4)	HAPLN4 (1.3)
ENSG00000197785	ATAD3A PPI subnetwork	0.54	> 0.20	TRAFD1 (3.4)	FRK (2.4)	TXNL4B (2.3)	ITGB3 (2.1)	NPC1L1 (1.9)	PLEC (1.9)	BRAP (1.8)	C19orf52 (1.7)	NT5DC1 (1.7)	ANKRD31 (1.6)
ENSG00000206503	HLA-A PPI subnetwork	0.54	> 0.20	PLCG1 (4.3)	ZNF101 (3.1)	PPP1R37 (2.0)	CLPTM1 (1.9)	HAVCR1 (1.8)	TXNL4B (1.8)	ENSG00000235545 (1.7)	YIPF2 (1.7)	GATAD2A (1.6)	DNM2 (1.6)
MP:0006126	abnormal outflow tract development	0.54	> 0.20	PVRL2 (1.9)	HLX (1.8)	GEMIN7 (1.7)	PLEC (1.6)	NYNRIN (1.6)	ATXN2 (1.5)	BCAM (1.5)	LPIN3 (1.5)	PVR (1.4)	APOB (1.4)
GO:0043502	regulation of muscle adaptation	0.54	> 0.20	CEACAM19 (2.4)	HNF1A (2.1)	ENSG00000254235 (2.0)	LPIN3 (1.9)	SYPL2 (1.7)	TRAPPC6A (1.6)	C12orf43 (1.5)	TXNL4B (1.5)	GCNT4 (1.5)	HAVCR1 (1.5)
MP:0004804	decreased susceptibility to autoimmune diabetes	0.54	> 0.20	MAFB (4.1)	RELB (3.6)	BCL3 (2.3)	APOE (2.1)	TIMD4 (1.9)	GRINA (1.8)	TRAFD1 (1.7)	GMIP (1.5)	TMEM57 (1.4)	APOC1 (1.4)
ENSG00000172315	TP53RK PPI subnetwork	0.54	> 0.20	ENSG00000235545 (2.8)	TM6SF2 (2.1)	PSMA5 (2.1)	HMGCR (1.9)	CARM1 (1.8)	NYNRIN (1.7)	ABCG5 (1.6)	TOMM40 (1.6)	PLCG1 (1.4)	DDX56 (1.4)
GO:0016459	myosin complex	0.54	> 0.20	SYPL2 (5.4)	GMPR (1.9)	AP1M2 (1.7)	LPAR2 (1.4)	NPC1L1 (1.4)	KANK2 (1.2)	HNF1A (1.1)	CBLC (0.9)	PCSK9 (0.8)	TRAPPC6A (0.8)
ENSG00000116711	PLA2G4A PPI subnetwork	0.54	> 0.20	SORT1 (2.9)	NCAN (2.3)	TRAFD1 (2.1)	C1orf63 (2.0)	RPH3A (1.9)	ABCG5 (1.6)	TMEM50A (1.6)	CLPTM1 (1.6)	CYB561D1 (1.5)	UBXN2B (1.5)
KEGG_GLUTATHIONE_METABOLISM	KEGG_GLUTATHIONE_METABOLISM	0.54	> 0.20	ALDH2 (4.1)	KIAA1324 (2.5)	ACAD10 (2.5)	FADS1 (2.4)	TM6SF2 (2.3)	LPIN3 (2.3)	ABCG8 (2.0)	FADS2 (2.0)	PSMA5 (2.0)	RHD (1.9)
ENSG00000065609	SNAP91 PPI subnetwork	0.54	> 0.20	PPP1R37 (3.2)	ENSG00000226648 (2.6)	DOCK7 (2.5)	FRK (2.3)	USP24 (2.3)	C1orf63 (2.3)	PARP10 (2.2)	HNF1A (2.1)	KANK2 (1.9)	C12orf51 (1.7)
GO:0048589	developmental growth	0.54	> 0.20	PPP1R37 (2.6)	CILP2 (2.6)	NYNRIN (1.7)	CELSR2 (1.6)	GOT2P1 (1.5)	ATXN7L2 (1.4)	ENSG00000228044 (1.3)	ATXN2 (1.3)	GCNT4 (1.3)	MAFB (1.2)
ENSG00000184110	EIF3C PPI subnetwork	0.54	> 0.20	ZNF259 (3.5)	SARS (3.4)	DDX56 (3.3)	NAA25 (3.0)	TOMM40 (2.8)	DHX38 (2.7)	QTRT1 (2.6)	TOP1 (2.4)	ATP13A1 (2.3)	PTPN11 (2.2)
GO:0060442	branching involved in prostate gland morphogenesis	0.54	> 0.20	GOT2P1 (2.5)	C19orf52 (2.3)	ENSG00000254235 (2.1)	AMIGO1 (1.9)	BLOC1S3 (1.5)	DNAH11 (1.5)	PMFBP1 (1.5)	TRAPPC6A (1.5)	SLC22A1 (1.4)	KIAA1324 (1.2)
ENSG00000133119	RFC3 PPI subnetwork	0.54	> 0.20	FEN1 (5.3)	USP1 (4.2)	PSRC1 (1.9)	ERP29 (1.9)	ATP13A1 (1.8)	ILF3 (1.7)	PSMA5 (1.6)	SMARCA4 (1.4)	AMIGO1 (1.4)	CLPTM1 (1.4)
ENSG00000137403	HLA-F PPI subnetwork	0.54	> 0.20	PARP10 (2.9)	ENSG00000228044 (2.0)	OASL (1.8)	TMED4 (1.7)	DHODH (1.7)	YIPF2 (1.6)	ERP29 (1.6)	MARK4 (1.4)	HNF1A (1.2)	TMEM50A (1.2)
GO:0001709	cell fate determination	0.54	> 0.20	ENSG00000226648 (2.8)	ABO (2.4)	CEACAM19 (2.3)	DNAH11 (2.1)	ANKRD31 (2.0)	PBX4 (1.9)	HNF1A (1.9)	ATXN7L2 (1.6)	ENSG00000254235 (1.5)	PMFBP1 (1.4)
MP:0002270	abnormal pulmonary alveolus morphology	0.54	> 0.20	APOC1 (2.4)	CLPTM1 (2.4)	HLX (2.2)	TMEM116 (2.2)	BCAM (1.8)	GPAM (1.6)	PLEKHH2 (1.6)	TIMD4 (1.6)	NYNRIN (1.5)	ANKRD31 (1.5)
ENSG00000092847	EIF2C1 PPI subnetwork	0.54	> 0.20	ATXN2 (3.3)	C12orf51 (2.8)	C12orf43 (2.3)	COL4A3BP (2.2)	NAA25 (2.1)	OASL (2.1)	USP24 (1.9)	TMED4 (1.9)	ERP29 (1.8)	NKPD1 (1.7)
MP:0008395	abnormal osteoblast differentiation	0.54	> 0.20	OASL (2.7)	POLK (2.5)	MAFB (2.4)	PARP10 (2.1)	BCL3 (1.9)	HLX (1.9)	CILP2 (1.7)	PLEKHH2 (1.6)	PVRL2 (1.6)	BCAM (1.5)
ENSG00000146425	DYNLT1 PPI subnetwork	0.54	> 0.20	GOT2P1 (2.9)	CYP7A1 (2.5)	DOCK7 (2.4)	TSSK6 (2.4)	NPC1L1 (1.9)	CARM1 (1.8)	MOSC1 (1.7)	ENSG00000238078 (1.7)	LPIN3 (1.7)	PSRC1 (1.7)
MP:0002230	abnormal primitive streak formation	0.54	> 0.20	ABO (2.6)	ATXN7L2 (2.6)	PVRL2 (1.7)	APOB (1.6)	DOCK7 (1.5)	HNF1A (1.5)	APOE (1.4)	MARK4 (1.4)	FADS2 (1.3)	ADAM1 (1.3)
ENSG00000198467	TPM2 PPI subnetwork	0.54	> 0.20	KANK2 (3.3)	PLEC (2.6)	PVR (2.5)	ABO (1.7)	ITGB3 (1.7)	PVRL2 (1.6)	GATAD2A (1.6)	LPIN3 (1.3)	TM6SF2 (1.3)	BRAP (1.2)
GO:0090329	regulation of DNA-dependent DNA replication	0.54	> 0.20	BUD13 (2.5)	POC5 (2.1)	BLOC1S3 (1.9)	ZNF180 (1.8)	TMEM57 (1.8)	USP1 (1.7)	UBXN2B (1.5)	NKPD1 (1.4)	AMIGO1 (1.4)	DHX38 (1.4)
REACTOME_SEROTONIN_RECEPTORS	REACTOME_SEROTONIN_RECEPTORS	0.54	> 0.20	GOT2P1 (4.5)	ABO (3.2)	RPH3A (2.6)	ANKRD31 (2.5)	ENSG00000226648 (1.8)	HAPLN4 (1.7)	GCNT4 (1.6)	DNAH11 (1.6)	PMFBP1 (1.3)	ABCG8 (1.3)
GO:0061035	regulation of cartilage development	0.54	> 0.20	CILP2 (2.5)	PLEKHH2 (2.5)	MAFB (2.0)	LPIN3 (1.7)	LPAR2 (1.6)	NYNRIN (1.4)	ABO (1.3)	KANK2 (1.2)	YIPF2 (1.1)	PVRL2 (1.1)
ENSG00000141404	GNAL PPI subnetwork	0.54	> 0.20	ST3GAL4 (3.1)	SH2B3 (2.4)	GOT2P1 (2.1)	C12orf51 (1.9)	ENSG00000226645 (1.9)	BLOC1S3 (1.8)	ANKRD31 (1.8)	ABO (1.6)	AMIGO1 (1.6)	GCNT4 (1.6)
ENSG00000037965	HOXC8 PPI subnetwork	0.54	> 0.20	ENSG00000238078 (3.1)	TRIB1 (2.8)	MAFB (2.6)	ADAM1 (2.2)	POC5 (2.1)	TMED4 (2.1)	POLK (2.0)	PLCG1 (1.7)	MYLIP (1.6)	TRAFD1 (1.6)
MP:0000432	abnormal head morphology	0.54	> 0.20	CILP2 (2.6)	AP1M2 (2.4)	DOCK7 (2.2)	MARK4 (2.2)	PLEKHH2 (2.1)	GATAD2A (1.7)	C17orf57 (1.6)	UBXN2B (1.6)	NCAN (1.6)	LPAR2 (1.5)
REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER	REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER	0.54	> 0.20	GEMIN7 (3.7)	C12orf43 (3.2)	ZNF259 (2.8)	DDX56 (2.7)	MAPKAPK5 (2.2)	ENSG00000226645 (2.1)	POC5 (1.8)	BUD13 (1.8)	TOMM40 (1.8)	QTRT1 (1.5)
ENSG00000198742	SMURF1 PPI subnetwork	0.54	> 0.20	GATAD2A (2.1)	ENSG00000226645 (1.9)	TMEM57 (1.8)	KANK2 (1.8)	C19orf52 (1.7)	FRK (1.6)	ITGB3 (1.6)	ZNF180 (1.6)	ENSG00000226648 (1.4)	ATXN7L2 (1.3)
MP:0001824	abnormal thymus involution	0.54	> 0.20	PLCG1 (2.5)	ENSG00000235545 (2.4)	RELB (2.3)	PBX4 (2.0)	GCNT4 (1.8)	ZHX3 (1.7)	C12orf47 (1.7)	CYB561D1 (1.5)	BCL3 (1.5)	DNAH11 (1.5)
ENSG00000111199	TRPV4 PPI subnetwork	0.54	> 0.20	LPIN3 (2.9)	PPP1R37 (2.6)	ST3GAL4 (2.1)	PLEKHH2 (2.0)	SH2B3 (1.9)	MAPKAPK5 (1.8)	SLC44A2 (1.7)	NT5DC1 (1.7)	ABCG8 (1.6)	TMEM116 (1.6)
ENSG00000168374	ARF4 PPI subnetwork	0.54	> 0.20	ATP13A1 (3.2)	ILF3 (3.1)	QTRT1 (2.8)	OGDH (2.7)	YIPF2 (2.6)	DNM2 (2.5)	ACAD10 (2.1)	SARS (2.0)	DHX38 (1.8)	SMARCA4 (1.8)
ENSG00000135801	TAF5L PPI subnetwork	0.54	> 0.20	ATXN2 (3.5)	ATXN7L2 (2.4)	C17orf57 (2.4)	C12orf51 (2.3)	ACAD10 (2.0)	BUD13 (1.9)	ZNF101 (1.9)	TOP1 (1.9)	MAPKAPK5 (1.8)	ZHX3 (1.8)
GO:0006283	transcription-coupled nucleotide-excision repair	0.54	> 0.20	ZNF180 (2.8)	POC5 (2.3)	TXNL4B (2.2)	POLK (2.2)	ENSG00000235545 (2.1)	GEMIN7 (2.1)	GOT2P1 (2.1)	MAPKAPK5 (2.0)	USP1 (2.0)	BLOC1S3 (1.9)
MP:0000018	small ears	0.54	> 0.20	AP1M2 (2.4)	C17orf57 (2.4)	PLEKHH2 (2.4)	CELSR2 (2.2)	ZHX3 (2.1)	HAPLN4 (1.8)	NYNRIN (1.7)	PLCG1 (1.7)	HAVCR1 (1.6)	TSSK6 (1.5)
ENSG00000132002	DNAJB1 PPI subnetwork	0.54	> 0.20	TRIB1 (2.6)	PLEC (2.3)	TOP1 (1.9)	ATP13A1 (1.9)	GATAD2A (1.8)	GOT2P1 (1.7)	POLK (1.5)	SARS (1.4)	TXNL4B (1.4)	PBX4 (1.3)
ENSG00000198523	PLN PPI subnetwork	0.54	> 0.20	SYPL2 (2.5)	GMPR (2.2)	KIAA1324 (2.0)	OGDH (1.8)	SORT1 (1.8)	ACAD10 (1.6)	BCAM (1.5)	ENSG00000226645 (1.4)	ADAM1 (1.4)	ZNF101 (1.4)
ENSG00000068878	PSME4 PPI subnetwork	0.54	> 0.20	PSMA5 (5.9)	NAA25 (3.0)	TOMM40 (2.9)	DDX56 (2.5)	ZNF259 (2.0)	SARS (2.0)	NT5DC1 (1.8)	QTRT1 (1.7)	TRAFD1 (1.5)	SMARCA4 (1.3)
GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.54	> 0.20	NKPD1 (2.4)	ENSG00000235545 (2.2)	GEMIN7 (1.6)	PBX4 (1.5)	CEACAM19 (1.5)	MAU2 (1.4)	DNAH11 (1.4)	TRAPPC6A (1.4)	ZNF180 (1.3)	PARP10 (1.3)
GO:0032720	negative regulation of tumor necrosis factor production	0.54	> 0.20	GRINA (2.9)	ABO (2.2)	ALDH2 (1.9)	MOSC1 (1.6)	UBXN2B (1.4)	ZNF259 (1.4)	HP (1.3)	TSSK6 (1.3)	GMIP (1.3)	LPAR2 (1.3)
REACTOME_N:GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIALTRANS:GOLGI	REACTOME_N:GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIALTRANS:GOLGI	0.54	> 0.20	ENSG00000235545 (2.1)	FADS2 (2.0)	ERP29 (2.0)	PCSK9 (1.9)	C12orf47 (1.9)	DOCK7 (1.9)	PVRL2 (1.8)	SLC44A2 (1.8)	ITGB3 (1.7)	FRK (1.7)
ENSG00000006638	TBXA2R PPI subnetwork	0.54	> 0.20	C17orf57 (2.9)	ITGB3 (2.9)	GATAD2A (2.1)	SH2B3 (2.0)	PMFBP1 (1.8)	CETP (1.8)	TMEM50A (1.7)	LDLR (1.6)	ST3GAL4 (1.6)	BLOC1S3 (1.6)
GO:0018022	peptidyl-lysine methylation	0.54	> 0.20	ENSG00000228044 (3.4)	MAU2 (1.9)	TXNL4B (1.7)	C12orf51 (1.7)	C1orf63 (1.7)	ENSG00000238078 (1.5)	DNAH11 (1.5)	ATXN2 (1.4)	USP24 (1.4)	BUD13 (1.3)
GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	0.54	> 0.20	ENSG00000254235 (2.3)	GEMIN7 (1.9)	PBX4 (1.7)	SH2B3 (1.6)	ENSG00000228044 (1.6)	SLC22A1 (1.4)	DNAH11 (1.4)	TIMD4 (1.3)	NKPD1 (1.3)	MOSC1 (1.2)
ENSG00000100479	POLE2 PPI subnetwork	0.54	> 0.20	FEN1 (5.0)	USP1 (3.8)	ZHX3 (2.4)	FADS2 (1.9)	BRAP (1.7)	USP24 (1.7)	DNAH11 (1.6)	FADS1 (1.6)	DHODH (1.6)	ZNF180 (1.4)
ENSG00000116833	NR5A2 PPI subnetwork	0.54	> 0.20	APOB (2.6)	ABCG5 (2.3)	HNF1A (2.0)	TSSK6 (1.8)	MARK4 (1.7)	MAPKAPK5 (1.7)	BCL3 (1.6)	ABCG8 (1.6)	NPC1L1 (1.5)	APOA5 (1.5)
GO:0006383	transcription from RNA polymerase III promoter	0.54	> 0.20	ADAM1 (3.4)	C12orf43 (2.7)	GEMIN7 (2.5)	POC5 (2.4)	MAPKAPK5 (2.4)	BRAP (2.3)	ATXN2 (2.0)	DHX38 (1.9)	SUGP1 (1.8)	DDX56 (1.6)
REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION	REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION	0.54	> 0.20	NKPD1 (3.1)	UBXN2B (1.9)	GATAD2A (1.6)	MOSC1 (1.5)	ERP29 (1.3)	ANKRD31 (1.3)	DNAH11 (1.2)	GPAM (1.2)	CEACAM19 (1.2)	ILF3 (1.1)
GO:0072594	establishment of protein localization to organelle	0.54	> 0.20	BRAP (2.4)	ZNF259 (2.2)	YIPF2 (2.0)	ACAD10 (2.0)	GOT2P1 (1.9)	TRAPPC6A (1.9)	DHODH (1.7)	QTRT1 (1.7)	NT5DC1 (1.6)	ENSG00000226645 (1.5)
ENSG00000005075	POLR2J PPI subnetwork	0.54	> 0.20	ILF3 (3.4)	BUD13 (3.3)	TOP1 (3.1)	DHX38 (2.8)	SUGP1 (2.7)	USP1 (2.6)	C1orf63 (2.4)	SMARCA4 (2.2)	FEN1 (2.1)	MAPKAPK5 (2.0)
ENSG00000105088	OLFM2 PPI subnetwork	0.54	> 0.20	ENSG00000228044 (3.0)	OGDH (2.6)	GRINA (2.3)	SARS (1.9)	ENSG00000235545 (1.9)	LPAR2 (1.9)	FRK (1.8)	QTRT1 (1.6)	PBX4 (1.5)	ST3GAL4 (1.2)
ENSG00000172175	MALT1 PPI subnetwork	0.54	> 0.20	RELB (3.3)	CYB561D1 (3.1)	PTPN11 (2.2)	ZNF101 (2.2)	HAVCR1 (2.1)	SH2B3 (2.1)	PVR (1.9)	BRAP (1.8)	FRK (1.7)	NAA25 (1.6)
REACTOME_N:GLYCAN_ANTENNAE_ELONGATION	REACTOME_N:GLYCAN_ANTENNAE_ELONGATION	0.54	> 0.20	ST3GAL4 (2.6)	DOCK7 (2.0)	PVRL2 (1.9)	ERP29 (1.7)	FADS2 (1.7)	ITGB3 (1.6)	LPIN3 (1.6)	ENSG00000235545 (1.6)	PPP1R37 (1.6)	SLC44A2 (1.4)
GO:0043200	response to amino acid stimulus	0.54	> 0.20	C17orf57 (3.4)	AP1M2 (2.0)	ABCG5 (2.0)	SARS (1.9)	NPC1L1 (1.8)	COL4A3BP (1.7)	C11orf9 (1.7)	C12orf51 (1.6)	DNAH11 (1.6)	ANKRD31 (1.5)
ENSG00000177688	SUMO4 PPI subnetwork	0.54	> 0.20	TOMM40 (2.4)	PSMA5 (2.3)	SARS (2.3)	OGDH (2.1)	CLPTM1 (1.8)	ERP29 (1.7)	PARP10 (1.7)	ADAM1 (1.6)	FEN1 (1.6)	NAA25 (1.5)
ENSG00000173581	CCDC106 PPI subnetwork	0.54	> 0.20	FADS1 (3.2)	FADS2 (3.2)	HMGCR (3.0)	PCSK9 (2.6)	SARS (2.4)	LDLR (2.3)	SLC44A2 (2.0)	GEMIN7 (2.0)	ATXN7L2 (1.8)	BUD13 (1.8)
GO:0070555	response to interleukin-1	0.54	> 0.20	ENSG00000228044 (2.9)	GCNT4 (2.2)	BCL3 (2.2)	ANKRD31 (1.9)	PVR (1.8)	RELB (1.8)	TRIB1 (1.7)	ENSG00000254235 (1.7)	PMFBP1 (1.4)	ZNF101 (1.3)
GO:0032760	positive regulation of tumor necrosis factor production	0.54	> 0.20	ST3GAL4 (2.6)	MAFB (2.5)	FRK (2.3)	TRAFD1 (2.0)	MYLIP (1.8)	ZNF101 (1.7)	HLX (1.6)	PARP10 (1.5)	ENSG00000235545 (1.5)	C19orf52 (1.3)
GO:0014068	positive regulation of phosphatidylinositol 3-kinase cascade	0.54	> 0.20	ANKRD31 (2.3)	ENSG00000226645 (2.0)	NPC1L1 (2.0)	C17orf57 (1.8)	NKPD1 (1.4)	ENSG00000226648 (1.3)	GEMIN7 (1.2)	LPIN3 (1.1)	DOCK7 (1.1)	PBX4 (1.1)
GO:0072595	maintenance of protein localization to organelle	0.54	> 0.20	CEACAM19 (3.3)	GOT2P1 (2.4)	TMED4 (2.3)	YIPF2 (2.2)	BLOC1S3 (2.0)	CLPTM1 (2.0)	CYB561D1 (1.9)	TMEM50A (1.6)	ENSG00000254235 (1.5)	ZNF101 (1.3)
GO:0001741	XY body	0.54	> 0.20	LPAR2 (3.8)	MAU2 (3.2)	CARM1 (2.2)	C12orf47 (1.8)	SUGP1 (1.7)	DNAH11 (1.7)	ZNF101 (1.6)	DNM2 (1.5)	ENSG00000238078 (1.5)	ENSG00000226645 (1.5)
ENSG00000164171	ITGA2 PPI subnetwork	0.54	> 0.20	CILP2 (3.5)	TMEM50A (3.4)	ITGB3 (2.5)	BCAM (2.3)	LPIN3 (1.7)	CELSR2 (1.6)	PVRL2 (1.6)	CEACAM19 (1.6)	KANK2 (1.5)	GMPR (1.5)
ENSG00000105404	RABAC1 PPI subnetwork	0.54	> 0.20	BLOC1S3 (3.4)	CYB561D1 (2.7)	YIPF2 (2.7)	TMEM50A (2.4)	LDLR (2.3)	CLPTM1 (2.3)	TRAPPC6A (1.8)	HNF1A (1.7)	FADS1 (1.7)	PBX4 (1.7)
GO:0001990	regulation of systemic arterial blood pressure by hormone	0.54	> 0.20	TMED4 (2.9)	C12orf47 (2.4)	ADAM1 (2.4)	HNF1A (2.4)	LPIN3 (2.4)	PMFBP1 (2.0)	ZHX3 (2.0)	TM6SF2 (1.8)	AMIGO1 (1.8)	ENSG00000235545 (1.6)
REACTOME_SIGNALLING_TO_RAS	REACTOME_SIGNALLING_TO_RAS	0.54	> 0.20	MARK4 (3.9)	PVRL2 (2.4)	MAPKAPK5 (2.3)	GATAD2A (2.2)	LPAR2 (2.1)	CARM1 (1.9)	LPIN3 (1.9)	PLEC (1.9)	DNM2 (1.8)	COL4A3BP (1.7)
GO:0002089	lens morphogenesis in camera-type eye	0.54	> 0.20	ANKRD31 (3.3)	C11orf9 (2.5)	COL4A3BP (1.8)	HNF1A (1.7)	C19orf52 (1.4)	ZHX3 (1.3)	C17orf57 (1.2)	UBXN2B (1.0)	PPP1R37 (1.0)	TMED4 (1.0)
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	0.54	> 0.20	FEN1 (6.5)	USP1 (4.9)	TMEM116 (2.3)	POC5 (1.8)	NT5DC1 (1.6)	ZNF180 (1.5)	PSRC1 (1.3)	ENSG00000226645 (1.2)	DHODH (1.1)	TXNL4B (1.0)
ENSG00000151923	TIAL1 PPI subnetwork	0.54	> 0.20	SYPL2 (2.7)	TMEM50A (2.2)	ILF3 (2.1)	SMARCA4 (1.7)	GMPR (1.7)	CARM1 (1.6)	ENSG00000238078 (1.6)	OGDH (1.6)	PTPN11 (1.5)	DYNC2LI1 (1.4)
ENSG00000137601	NEK1 PPI subnetwork	0.54	> 0.20	KANK2 (2.1)	ATXN2 (1.9)	DYNC2LI1 (1.9)	ZNF259 (1.8)	CETP (1.6)	PLEKHH2 (1.5)	ENSG00000235545 (1.3)	COL4A3BP (1.2)	ANKRD31 (1.1)	GOT2P1 (1.1)
ENSG00000188985	ENSG00000188985 PPI subnetwork	0.54	> 0.20	ANGPTL3 (3.2)	CYP7A1 (2.3)	RPH3A (2.3)	HP (2.3)	APOA5 (2.2)	APOC4 (2.1)	PLG (1.9)	TMEM50A (1.8)	ALDH2 (1.7)	SLC22A1 (1.7)
ENSG00000005022	SLC25A5 PPI subnetwork	0.54	> 0.20	SARS (2.8)	OGDH (2.8)	PSMA5 (2.8)	C12orf43 (2.7)	QTRT1 (2.3)	ADAM1 (2.2)	NAA25 (2.2)	ACAD10 (2.1)	RELB (2.1)	C1orf63 (2.0)
ENSG00000182180	MRPS16 PPI subnetwork	0.54	> 0.20	TOMM40 (3.6)	NAA25 (3.2)	MAPKAPK5 (3.1)	ZNF259 (2.8)	DHODH (2.7)	DDX56 (2.6)	C12orf43 (2.5)	QTRT1 (2.5)	BRAP (2.3)	ATXN2 (2.3)
REACTOME_CELL_CYCLE	REACTOME_CELL_CYCLE	0.54	> 0.20	FEN1 (5.5)	PSRC1 (4.3)	USP1 (4.3)	POC5 (3.0)	PSMA5 (1.5)	BUD13 (1.2)	SMARCA4 (1.1)	RHD (1.0)	ZNF180 (0.9)	RHCE (0.9)
MP:0003545	increased alcohol consumption	0.54	> 0.20	CYP7A1 (2.1)	TRIB1 (2.0)	ENSG00000254235 (2.0)	TSSK6 (1.9)	FRK (1.8)	PVR (1.7)	LPA (1.7)	AMIGO1 (1.4)	CEACAM19 (1.3)	HAVCR1 (1.3)
GO:0043292	contractile fiber	0.54	> 0.20	SYPL2 (7.2)	GMPR (2.5)	TMEM50A (1.2)	KANK2 (1.2)	PLEC (1.1)	NPC1L1 (1.1)	PVRL2 (1.1)	RPH3A (0.9)	PVR (0.8)	ENSG00000226648 (0.7)
ENSG00000185499	MUC1 PPI subnetwork	0.54	> 0.20	LPIN3 (2.9)	DNM2 (2.8)	PVRL2 (2.7)	SLC44A2 (2.5)	ALDH2 (2.3)	PLEC (2.2)	COL4A3BP (2.2)	NYNRIN (2.1)	GMIP (2.0)	TMED4 (2.0)
ENSG00000068323	TFE3 PPI subnetwork	0.54	> 0.20	SARS (2.9)	NAA25 (2.8)	PSMA5 (2.7)	DOCK7 (2.6)	FADS1 (2.4)	GOT2P1 (2.1)	ATXN2 (2.1)	TOMM40 (2.0)	FADS2 (1.9)	PLEKHH2 (1.9)
ENSG00000167325	RRM1 PPI subnetwork	0.54	> 0.20	POC5 (2.7)	TMEM57 (2.3)	HAPLN4 (1.8)	GMPR (1.7)	C12orf43 (1.7)	NT5DC1 (1.6)	ENSG00000226645 (1.6)	TXNL4B (1.5)	BRAP (1.5)	SUGP1 (1.3)
ENSG00000215727	ENSG00000215727 PPI subnetwork	0.54	> 0.20	ACAD10 (4.1)	TRAPPC6A (3.1)	OGDH (3.1)	C12orf47 (2.4)	HNF1A (1.7)	TMED4 (1.6)	GMPR (1.6)	C1orf63 (1.6)	NT5DC1 (1.4)	PTPN11 (1.4)
ENSG00000065518	NDUFB4 PPI subnetwork	0.54	> 0.20	ACAD10 (4.1)	TRAPPC6A (3.1)	OGDH (3.1)	C12orf47 (2.4)	HNF1A (1.7)	TMED4 (1.6)	GMPR (1.6)	C1orf63 (1.6)	NT5DC1 (1.4)	PTPN11 (1.4)
GO:0090189	regulation of branching involved in ureteric bud morphogenesis	0.54	> 0.20	HAVCR1 (3.4)	ENSG00000228044 (3.4)	HNF1A (2.2)	AMIGO1 (1.8)	DNAH11 (1.7)	TSSK6 (1.6)	TMED4 (1.5)	ENSG00000235545 (1.3)	DYNC2LI1 (1.2)	ENSG00000254235 (1.2)
ENSG00000163288	GABRB1 PPI subnetwork	0.54	> 0.20	GCNT4 (2.6)	ENSG00000235545 (2.3)	ZNF101 (2.0)	ABO (1.9)	ENSG00000226648 (1.8)	LPIN3 (1.7)	HAVCR1 (1.7)	ANKRD31 (1.6)	ERP29 (1.5)	MYLIP (1.3)
GO:0007179	transforming growth factor beta receptor signaling pathway	0.54	> 0.20	KANK2 (3.4)	ENSG00000226645 (2.8)	CEACAM19 (2.5)	NYNRIN (1.8)	TMED4 (1.8)	PVR (1.7)	GATAD2A (1.6)	CILP2 (1.4)	MAPKAPK5 (1.4)	AMIGO1 (1.3)
GO:0014855	striated muscle cell proliferation	0.54	> 0.20	CEACAM19 (2.6)	C19orf52 (2.4)	BLOC1S3 (2.4)	PLEKHH2 (2.1)	TXNL4B (1.5)	C11orf9 (1.4)	ENSG00000254235 (1.4)	LPA (1.3)	ALDH2 (1.3)	PVR (1.2)
ENSG00000179041	RRS1 PPI subnetwork	0.54	> 0.20	ZNF259 (4.5)	NAA25 (4.3)	DDX56 (3.3)	TOMM40 (3.0)	TOP1 (2.2)	MAPKAPK5 (2.2)	GATAD2A (2.1)	DYNC2LI1 (2.0)	POC5 (1.9)	DHODH (1.8)
GO:0006312	mitotic recombination	0.54	> 0.20	ZNF180 (3.3)	ENSG00000235545 (2.9)	USP1 (2.8)	ENSG00000228044 (2.5)	FEN1 (2.3)	ENSG00000226648 (2.1)	AMIGO1 (1.9)	TMEM116 (1.9)	POC5 (1.7)	POLK (1.6)
MP:0001290	delayed eyelid opening	0.54	> 0.20	APOC4 (3.4)	ENSG00000254235 (3.1)	COL4A3BP (2.5)	ABCG8 (2.4)	HLX (2.1)	APOA5 (2.1)	CEACAM19 (1.9)	FADS2 (1.8)	LPA (1.8)	ABCG5 (1.7)
ENSG00000100292	HMOX1 PPI subnetwork	0.54	> 0.20	SYPL2 (2.6)	GRINA (2.2)	MAFB (1.9)	ALDH2 (1.9)	TIMD4 (1.8)	TOMM40 (1.6)	RHD (1.6)	HP (1.5)	PVR (1.5)	BLOC1S3 (1.4)
MP:0000897	abnormal midbrain morphology	0.54	> 0.20	CARM1 (2.6)	ATXN2 (2.4)	CLPTM1 (2.1)	C17orf57 (2.0)	PPP1R37 (1.8)	ABO (1.6)	COL4A3BP (1.6)	HAVCR1 (1.6)	ZHX3 (1.5)	AMIGO1 (1.5)
ENSG00000122490	PQLC1 PPI subnetwork	0.54	> 0.20	TMED4 (3.3)	YIPF2 (3.2)	BUD13 (2.7)	C19orf52 (2.5)	ZNF259 (2.4)	MAU2 (2.3)	PMFBP1 (1.9)	TRAFD1 (1.8)	BRAP (1.7)	ERP29 (1.7)
ENSG00000070159	PTPN3 PPI subnetwork	0.54	> 0.20	CBLC (6.4)	AP1M2 (3.1)	LPAR2 (3.0)	PLCG1 (2.5)	PLEC (2.4)	PVRL2 (2.2)	DNM2 (1.8)	LPIN3 (1.7)	PPP1R37 (1.7)	GMIP (1.6)
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION__PROTEINS	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION__PROTEINS	0.54	> 0.20	AP1M2 (3.4)	FRK (2.0)	PVRL2 (1.9)	CELSR2 (1.8)	CBLC (1.7)	ABCG8 (1.5)	TMEM116 (1.5)	HMGCR (1.4)	APOC1 (1.4)	TM6SF2 (1.3)
REACTOME_REGULATION_OF_APCC_ACTIVATORS_BETWEEN_G1S_AND_EARLY_ANAPHASE	REACTOME_REGULATION_OF_APCC_ACTIVATORS_BETWEEN_G1S_AND_EARLY_ANAPHASE	0.54	> 0.20	PSMA5 (5.6)	TRAFD1 (3.3)	NAA25 (2.2)	SUGP1 (2.2)	POC5 (2.0)	PSRC1 (1.9)	FEN1 (1.9)	DDX56 (1.8)	LPIN3 (1.5)	BRAP (1.0)
ENSG00000107438	PDLIM1 PPI subnetwork	0.54	> 0.20	HAVCR1 (2.3)	ENSG00000238078 (2.3)	UBXN2B (2.2)	C11orf9 (1.9)	SORT1 (1.8)	NYNRIN (1.7)	CARM1 (1.6)	PVR (1.6)	C1orf63 (1.6)	GEMIN7 (1.5)
GO:0032270	positive regulation of cellular protein metabolic process	0.54	> 0.20	TRAFD1 (2.0)	PTPN11 (1.9)	GEMIN7 (1.9)	POC5 (1.7)	TMEM57 (1.6)	PSMA5 (1.6)	SH2B3 (1.5)	ENSG00000228044 (1.4)	SMARCA4 (1.4)	TMEM50A (1.4)
ENSG00000120253	NUP43 PPI subnetwork	0.54	> 0.20	PSRC1 (5.6)	FEN1 (4.4)	POC5 (4.0)	USP1 (4.0)	ZNF180 (1.4)	ILF3 (1.2)	USP24 (1.2)	ENSG00000228044 (1.2)	ENSG00000226648 (1.2)	BUD13 (1.0)
ENSG00000162992	NEUROD1 PPI subnetwork	0.54	> 0.20	PPP1R37 (2.3)	TMED4 (2.0)	PBX4 (2.0)	CELSR2 (1.9)	DNAH11 (1.8)	PMFBP1 (1.8)	USP24 (1.7)	ZNF101 (1.6)	AMIGO1 (1.5)	KANK2 (1.4)
MP:0008947	increased neuron number	0.54	> 0.20	CELSR2 (2.5)	ATXN7L2 (1.7)	PMFBP1 (1.6)	GOT2P1 (1.5)	TMED4 (1.4)	PVR (1.4)	NPC1L1 (1.4)	FADS1 (1.3)	POLK (1.3)	CILP2 (1.3)
MP:0002106	abnormal muscle physiology	0.54	> 0.20	SYPL2 (7.5)	GMPR (2.3)	COL4A3BP (1.7)	SORT1 (1.7)	ZHX3 (1.6)	NPC1L1 (1.5)	ENSG00000226645 (1.5)	BCAM (1.4)	SLC44A2 (1.2)	PLEC (1.2)
MP:0000471	abnormal stomach epithelium morphology	0.55	> 0.20	GRINA (2.6)	PLEC (2.1)	SLC44A2 (1.8)	MYLIP (1.7)	BCAM (1.6)	PPP1R37 (1.5)	DNAH11 (1.5)	CLPTM1 (1.3)	ADAM1 (1.2)	DNM2 (1.1)
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	0.55	> 0.20	RELB (3.6)	GATAD2A (3.0)	GMIP (2.8)	SLC44A2 (2.7)	DNM2 (2.5)	MARK4 (2.4)	PTPN11 (2.1)	BCL3 (2.0)	ZHX3 (2.0)	GRINA (1.8)
ENSG00000084623	EIF3I PPI subnetwork	0.55	> 0.20	TMEM57 (2.7)	MYLIP (2.6)	NKPD1 (2.3)	DDX56 (2.2)	GATAD2A (1.9)	SARS (1.9)	TRIB1 (1.7)	ZNF259 (1.6)	TOP1 (1.6)	ILF3 (1.6)
GO:0000784	nuclear chromosome, telomeric region	0.55	> 0.20	POLK (4.0)	DHODH (2.7)	UBXN2B (2.6)	TXNL4B (2.5)	POC5 (2.2)	SARS (2.1)	ENSG00000235545 (1.8)	NYNRIN (1.8)	SUGP1 (1.7)	DHX38 (1.7)
GO:0017025	TBP-class protein binding	0.55	> 0.20	NYNRIN (2.8)	C1orf63 (2.3)	SH2B3 (2.3)	ATXN2 (2.1)	ERP29 (2.0)	ACAD10 (2.0)	DOCK7 (1.7)	MAPKAPK5 (1.7)	TRAFD1 (1.7)	C17orf57 (1.7)
GO:0070207	protein homotrimerization	0.55	> 0.20	ENSG00000226648 (2.7)	C1orf63 (2.6)	CYP7A1 (2.4)	LPAR2 (2.3)	HP (2.0)	PBX4 (1.9)	ANKRD31 (1.8)	UBXN2B (1.7)	TM6SF2 (1.6)	C17orf57 (1.6)
GO:0034103	regulation of tissue remodeling	0.55	> 0.20	ENSG00000235545 (2.7)	DNAH11 (2.1)	C11orf9 (1.8)	CETP (1.7)	C17orf57 (1.6)	RHCE (1.5)	TMED4 (1.5)	ENSG00000226645 (1.4)	YIPF2 (1.3)	HNF1A (1.2)
ENSG00000002745	WNT16 PPI subnetwork	0.55	> 0.20	CELSR2 (2.5)	CILP2 (2.4)	MAU2 (2.3)	SMARCA4 (2.0)	MARK4 (1.9)	ATXN2 (1.9)	ZNF180 (1.9)	MAFB (1.8)	USP24 (1.8)	PARP10 (1.8)
ENSG00000154710	RABGEF1 PPI subnetwork	0.55	> 0.20	ANKRD31 (2.7)	TXNL4B (2.2)	PTPN11 (2.2)	LPAR2 (2.0)	MAU2 (2.0)	POLK (1.9)	COL4A3BP (1.9)	SUGP1 (1.6)	BRAP (1.6)	DHX38 (1.5)
GO:0004520	endodeoxyribonuclease activity	0.55	> 0.20	POLK (3.0)	ZNF180 (2.8)	POC5 (2.1)	LPAR2 (2.0)	TMEM116 (2.0)	SH2B3 (1.6)	CETP (1.6)	GATAD2A (1.4)	NT5DC1 (1.3)	GMIP (1.3)
ENSG00000116761	CTH PPI subnetwork	0.55	> 0.20	NT5DC1 (3.1)	SARS (2.7)	GATAD2A (1.8)	PSMA5 (1.7)	ENSG00000235545 (1.7)	C12orf43 (1.6)	OGDH (1.5)	ZNF259 (1.5)	SLC22A1 (1.5)	ABCG5 (1.4)
GO:0042359	vitamin D metabolic process	0.55	> 0.20	ENSG00000228044 (3.7)	ANGPTL3 (2.0)	ANKRD31 (1.7)	GCNT4 (1.6)	ATXN7L2 (1.6)	TM6SF2 (1.6)	LPAR2 (1.5)	TRAFD1 (1.4)	POC5 (1.3)	GEMIN7 (1.2)
GO:0070633	transepithelial transport	0.55	> 0.20	TMEM116 (2.8)	TXNL4B (2.6)	PMFBP1 (2.6)	CEACAM19 (2.3)	GCNT4 (2.0)	TSSK6 (1.9)	ANKRD31 (1.6)	C12orf47 (1.6)	CYP7A1 (1.5)	NKPD1 (1.4)
GO:0070252	actin-mediated cell contraction	0.55	> 0.20	SYPL2 (6.5)	GMPR (2.7)	HNF1A (2.0)	C17orf57 (1.9)	UBXN2B (1.6)	ENSG00000226648 (1.4)	NKPD1 (1.3)	TMEM50A (1.3)	LPAR2 (1.2)	CEACAM19 (1.2)
MP:0000035	abnormal membranous labyrinth morphology	0.55	> 0.20	LPA (2.1)	PLCG1 (1.9)	C17orf57 (1.9)	CEACAM19 (1.9)	TSSK6 (1.8)	ENSG00000228044 (1.8)	OGDH (1.7)	PMFBP1 (1.6)	KIAA1324 (1.6)	LPAR2 (1.2)
ENSG00000134057	CCNB1 PPI subnetwork	0.55	> 0.20	PSRC1 (3.3)	FEN1 (3.1)	POC5 (2.8)	MAU2 (2.2)	SUGP1 (2.0)	USP1 (1.9)	TXNL4B (1.8)	MYLIP (1.7)	BRAP (1.6)	HLX (1.6)
ENSG00000204967	PCDHA4 PPI subnetwork	0.55	> 0.20	FADS2 (2.2)	ATXN7L2 (1.9)	PCSK9 (1.8)	GMIP (1.8)	CEACAM19 (1.5)	FADS1 (1.5)	HMGCR (1.5)	RPH3A (1.5)	CYP7A1 (1.4)	TRAPPC6A (1.3)
GO:0022616	DNA strand elongation	0.55	> 0.20	ZNF180 (3.3)	USP1 (3.2)	FEN1 (2.8)	ENSG00000228044 (2.4)	GOT2P1 (2.1)	AMIGO1 (2.0)	ENSG00000235545 (1.9)	TMEM116 (1.5)	ENSG00000226648 (1.2)	DNAH11 (1.2)
ENSG00000130147	SH3BP4 PPI subnetwork	0.55	> 0.20	CBLC (6.0)	AP1M2 (3.9)	LPAR2 (2.5)	ST3GAL4 (2.3)	CELSR2 (2.2)	MARK4 (1.9)	DNM2 (1.9)	LPIN3 (1.8)	DOCK7 (1.8)	PVRL2 (1.7)
ENSG00000129993	CBFA2T3 PPI subnetwork	0.55	> 0.20	PLCG1 (4.2)	RHD (3.5)	SMARCA4 (2.6)	RHCE (2.2)	ILF3 (2.1)	ATXN7L2 (2.1)	TMEM57 (2.0)	ENSG00000228044 (1.8)	ZHX3 (1.8)	HNF1A (1.8)
ENSG00000175324	LSM1 PPI subnetwork	0.55	> 0.20	ZNF259 (3.1)	DHX38 (2.6)	BUD13 (2.3)	TRAFD1 (2.3)	SUGP1 (2.2)	GEMIN7 (2.2)	SARS (2.0)	TOP1 (1.8)	MAU2 (1.8)	PTPN11 (1.7)
ENSG00000054118	THRAP3 PPI subnetwork	0.55	> 0.20	SMARCA4 (3.7)	FRK (2.8)	TRAFD1 (2.7)	KANK2 (2.7)	C1orf63 (2.2)	PTPN11 (2.1)	GATAD2A (2.0)	ILF3 (2.0)	ITGB3 (1.9)	TOP1 (1.9)
MP:0002113	abnormal skeleton development	0.55	> 0.20	CILP2 (3.7)	MYLIP (2.7)	NYNRIN (2.7)	MAFB (2.4)	PLEKHH2 (2.3)	ANGPTL3 (1.8)	ALDH2 (1.6)	BCAM (1.4)	PVRL2 (1.4)	SYPL2 (1.3)
KEGG_DORSO_VENTRAL_AXIS_FORMATION	KEGG_DORSO_VENTRAL_AXIS_FORMATION	0.55	> 0.20	CBLC (2.4)	CEACAM19 (2.0)	PBX4 (1.9)	GATAD2A (1.8)	TRAFD1 (1.7)	MARK4 (1.6)	GCNT4 (1.5)	NCAN (1.4)	NKPD1 (1.4)	ENSG00000254235 (1.4)
ENSG00000188170	ENSG00000188170 PPI subnetwork	0.55	> 0.20	RHD (3.6)	ERP29 (2.9)	ALDH2 (2.7)	RHCE (2.6)	PSMA5 (2.5)	C12orf51 (2.0)	HAVCR1 (2.0)	UBXN2B (1.9)	DOCK7 (1.9)	MYLIP (1.8)
ENSG00000116350	SRSF4 PPI subnetwork	0.55	> 0.20	C1orf63 (4.8)	ILF3 (4.0)	TOP1 (3.2)	USP1 (2.6)	DHX38 (2.5)	QTRT1 (2.3)	SMARCA4 (2.3)	BUD13 (2.2)	FEN1 (2.2)	PTPN11 (2.0)
ENSG00000106392	C1GALT1 PPI subnetwork	0.55	> 0.20	UBXN2B (3.8)	MAPKAPK5 (2.2)	C19orf52 (2.1)	GRINA (2.1)	SUGP1 (2.0)	MARK4 (2.0)	CARM1 (1.9)	MAU2 (1.8)	TIMD4 (1.7)	ATXN2 (1.7)
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	REACTOME_NUCLEOTIDE_EXCISION_REPAIR	0.55	> 0.20	FEN1 (4.3)	USP1 (3.9)	NT5DC1 (2.4)	SUGP1 (2.4)	ZNF180 (2.2)	TRAPPC6A (2.1)	POC5 (1.7)	CLPTM1 (1.6)	TXNL4B (1.6)	GOT2P1 (1.6)
GO:0032892	positive regulation of organic acid transport	0.55	> 0.20	C12orf43 (2.4)	CBLC (2.2)	HAPLN4 (1.8)	ERP29 (1.7)	PMFBP1 (1.5)	CETP (1.4)	GEMIN7 (1.4)	NCAN (1.3)	ADAM1 (1.3)	C12orf47 (1.2)
GO:0004683	calmodulin-dependent protein kinase activity	0.55	> 0.20	RPH3A (3.2)	SYPL2 (2.9)	AMIGO1 (2.8)	SORT1 (2.1)	C12orf43 (2.1)	DNAH11 (2.0)	ABCG8 (2.0)	DHODH (1.8)	MOSC1 (1.8)	CEACAM19 (1.8)
MP:0001663	abnormal digestive system physiology	0.55	> 0.20	KIAA1324 (5.6)	MOSC1 (1.8)	CBLC (1.7)	DOCK7 (1.6)	PMFBP1 (1.5)	HLX (1.5)	SORT1 (1.4)	HNF1A (1.4)	ABO (1.3)	PPP1R37 (1.2)
GO:0006024	glycosaminoglycan biosynthetic process	0.55	> 0.20	ST3GAL4 (2.8)	HAVCR1 (2.1)	CILP2 (2.1)	ENSG00000254235 (2.0)	GCNT4 (1.9)	FRK (1.7)	LPIN3 (1.6)	TMEM57 (1.6)	ZNF180 (1.5)	CYB561D1 (1.5)
REACTOME_TRANSCRIPTION:COUPLED_NER_TC:NER	REACTOME_TRANSCRIPTION:COUPLED_NER_TC:NER	0.55	> 0.20	FEN1 (4.2)	USP1 (4.1)	ZNF180 (2.3)	POC5 (2.3)	POLK (2.1)	SUGP1 (1.9)	MAPKAPK5 (1.9)	TXNL4B (1.7)	ENSG00000235545 (1.7)	TRAPPC6A (1.7)
MP:0000925	abnormal floor plate morphology	0.55	> 0.20	NYNRIN (4.0)	DYNC2LI1 (3.6)	ATXN7L2 (3.3)	ENSG00000235545 (3.0)	PLEKHH2 (3.0)	PLCG1 (2.5)	DHX38 (2.3)	NCAN (2.1)	AMIGO1 (2.0)	DNAH11 (1.9)
ENSG00000115694	STK25 PPI subnetwork	0.55	> 0.20	MARK4 (2.9)	ZNF180 (2.7)	UBXN2B (2.3)	DNM2 (2.0)	TMEM50A (1.9)	PVRL2 (1.8)	C11orf9 (1.8)	PSMA5 (1.7)	C17orf57 (1.7)	CLPTM1 (1.6)
ENSG00000124207	CSE1L PPI subnetwork	0.55	> 0.20	NAA25 (3.2)	SARS (3.1)	OGDH (2.6)	TOP1 (2.6)	ATXN2 (2.2)	DDX56 (2.1)	GRINA (2.0)	HMGCR (2.0)	USP24 (2.0)	DHX38 (2.0)
ENSG00000186184	POLR1D PPI subnetwork	0.55	> 0.20	GEMIN7 (3.9)	C12orf43 (3.6)	ZNF259 (3.5)	MAPKAPK5 (3.0)	BUD13 (2.8)	QTRT1 (2.8)	DDX56 (2.5)	NAA25 (2.4)	TXNL4B (2.0)	BRAP (2.0)
GO:0032890	regulation of organic acid transport	0.55	> 0.20	C12orf43 (1.9)	MOSC1 (1.5)	CBLC (1.5)	C12orf51 (1.5)	ERP29 (1.5)	CETP (1.5)	PMFBP1 (1.4)	NCAN (1.2)	TXNL4B (1.2)	GEMIN7 (1.1)
MP:0001129	impaired ovarian folliculogenesis	0.55	> 0.20	KIAA1324 (3.1)	ST3GAL4 (2.9)	NT5DC1 (2.2)	FADS1 (2.1)	ENSG00000226648 (1.8)	LDLR (1.6)	CEACAM19 (1.5)	LPA (1.4)	PARP10 (1.4)	MOSC1 (1.3)
ENSG00000168002	POLR2G PPI subnetwork	0.55	> 0.20	ILF3 (3.5)	BUD13 (3.3)	SUGP1 (3.0)	TOP1 (2.9)	DHX38 (2.9)	USP1 (2.6)	C1orf63 (2.4)	SMARCA4 (2.2)	FEN1 (2.1)	PTPN11 (2.0)
GO:0051208	sequestering of calcium ion	0.55	> 0.20	NKPD1 (3.0)	SYPL2 (2.1)	ADAM1 (2.0)	TIMD4 (1.9)	ZNF101 (1.9)	HAVCR1 (1.6)	ANKRD31 (1.4)	TRAFD1 (1.4)	ABO (1.3)	C1orf63 (1.2)
GO:0030728	ovulation	0.55	> 0.20	HNF1A (2.2)	FRK (1.7)	GPAM (1.6)	PVR (1.4)	MOSC1 (1.4)	HAVCR1 (1.3)	GCNT4 (1.3)	ST3GAL4 (1.2)	TRIB1 (1.2)	TMEM57 (1.1)
MP:0001701	incomplete embryo turning	0.55	> 0.20	DOCK7 (2.5)	LPIN3 (1.9)	NYNRIN (1.8)	DHX38 (1.7)	ENSG00000254235 (1.6)	ATXN2 (1.5)	PLCG1 (1.5)	HLX (1.4)	SMARCA4 (1.3)	GATAD2A (1.3)
GO:0050886	endocrine process	0.55	> 0.20	TMED4 (3.1)	LPIN3 (3.0)	ADAM1 (2.6)	HNF1A (2.5)	ENSG00000235545 (2.3)	AMIGO1 (2.1)	KIAA1324 (2.0)	C12orf47 (1.6)	ABO (1.6)	ENSG00000228044 (1.5)
ENSG00000004059	ARF5 PPI subnetwork	0.55	> 0.20	CLPTM1 (3.9)	PPP1R37 (3.1)	KIAA1324 (3.0)	DNM2 (2.4)	PLCG1 (2.3)	ACAD10 (2.2)	ENSG00000235545 (2.1)	DOCK7 (2.1)	ZHX3 (2.0)	YIPF2 (1.9)
ENSG00000185721	DRG1 PPI subnetwork	0.55	> 0.20	TOMM40 (3.1)	GMPR (2.8)	QTRT1 (2.7)	DDX56 (2.6)	TOP1 (2.6)	TMEM57 (2.4)	TRAPPC6A (2.3)	GATAD2A (2.2)	FRK (2.1)	PLCG1 (2.0)
ENSG00000124813	RUNX2 PPI subnetwork	0.55	> 0.20	TRIB1 (4.4)	PLCG1 (4.1)	MAFB (3.2)	DOCK7 (2.9)	ENSG00000238078 (2.6)	ENSG00000226648 (2.6)	ENSG00000226645 (2.4)	ATXN2 (2.1)	MAPKAPK5 (1.7)	DHX38 (1.5)
ENSG00000095794	CREM PPI subnetwork	0.55	> 0.20	ATXN2 (3.6)	CARM1 (3.1)	HLX (2.9)	BCL3 (2.7)	MARK4 (2.4)	TXNL4B (2.2)	ZHX3 (2.0)	ABO (1.7)	MAPKAPK5 (1.7)	PVRL2 (1.6)
REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_SECURIN	REACTOME_APCCCDC20_MEDIATED_DEGRADATION_OF_SECURIN	0.55	> 0.20	PSMA5 (6.1)	TRAFD1 (3.8)	NAA25 (2.5)	SUGP1 (2.4)	DDX56 (1.9)	PARP10 (1.4)	NT5DC1 (1.4)	POC5 (1.4)	LPIN3 (1.3)	BRAP (1.2)
GO:0060766	negative regulation of androgen receptor signaling pathway	0.55	> 0.20	C19orf52 (2.6)	NT5DC1 (2.4)	KANK2 (2.1)	ENSG00000226648 (1.9)	NKPD1 (1.7)	ENSG00000226645 (1.7)	AMIGO1 (1.7)	TMEM116 (1.6)	C12orf47 (1.5)	PMFBP1 (1.4)
GO:0070536	protein K63-linked deubiquitination	0.55	> 0.20	NKPD1 (3.7)	ZNF180 (3.0)	GCNT4 (2.7)	TMEM57 (2.4)	MAU2 (2.3)	NT5DC1 (2.2)	ZNF101 (2.1)	AMIGO1 (2.0)	YIPF2 (1.6)	ENSG00000228044 (1.6)
ENSG00000111358	GTF2H3 PPI subnetwork	0.55	> 0.20	SUGP1 (3.2)	BUD13 (2.8)	TXNL4B (2.7)	ZNF259 (2.7)	DHX38 (2.2)	MAPKAPK5 (2.0)	PSMA5 (1.9)	POC5 (1.9)	TOP1 (1.7)	QTRT1 (1.6)
GO:0048483	autonomic nervous system development	0.55	> 0.20	ANKRD31 (3.2)	TSSK6 (3.1)	TMED4 (1.8)	CEACAM19 (1.7)	C17orf57 (1.7)	ENSG00000254235 (1.6)	ABO (1.5)	C19orf52 (1.4)	ZNF101 (1.4)	HLX (1.3)
GO:0016101	diterpenoid metabolic process	0.55	> 0.20	ABCG8 (3.0)	NKPD1 (2.8)	TM6SF2 (2.7)	CYP7A1 (2.3)	CYB561D1 (2.1)	C11orf9 (2.0)	ABCG5 (1.9)	LPAR2 (1.9)	NPC1L1 (1.8)	ENSG00000235545 (1.7)
ENSG00000153989	NUS1 PPI subnetwork	0.55	> 0.20	ATP13A1 (3.3)	ADAM1 (3.2)	C12orf43 (2.7)	CLPTM1 (2.5)	C12orf51 (2.4)	TXNL4B (2.4)	MAU2 (2.2)	MOSC1 (2.2)	BRAP (2.2)	ERP29 (2.1)
ENSG00000100129	EIF3L PPI subnetwork	0.55	> 0.20	NKPD1 (2.0)	C1orf63 (1.9)	QTRT1 (1.8)	GEMIN7 (1.7)	ILF3 (1.6)	C19orf52 (1.6)	NAA25 (1.6)	DHX38 (1.6)	ATP13A1 (1.5)	SH2B3 (1.5)
ENSG00000146648	EGFR PPI subnetwork	0.55	> 0.20	TRIB1 (2.5)	DNM2 (2.4)	DOCK7 (2.3)	GMIP (2.3)	AP1M2 (2.1)	COL4A3BP (2.1)	PVRL2 (2.0)	CARM1 (2.0)	PLEC (1.8)	ENSG00000238078 (1.8)
MP:0004852	decreased testis weight	0.55	> 0.20	PBX4 (2.4)	KIAA1324 (1.8)	LDLR (1.6)	ANKRD31 (1.5)	FADS2 (1.5)	FADS1 (1.4)	TSSK6 (1.4)	GATAD2A (1.2)	PCSK9 (1.1)	HMGCR (1.1)
ENSG00000205542	TMSB4X PPI subnetwork	0.55	> 0.20	TIMD4 (3.2)	CETP (3.2)	PVRL2 (2.2)	FADS2 (2.1)	ITGB3 (2.0)	CEACAM19 (1.8)	RHD (1.5)	BCAM (1.5)	GEMIN7 (1.2)	TOMM40 (1.2)
ENSG00000091140	DLD PPI subnetwork	0.55	> 0.20	GPAM (3.3)	QTRT1 (2.5)	CLPTM1 (2.4)	MOSC1 (2.2)	DHODH (2.2)	OGDH (2.2)	DNAH11 (1.9)	DOCK7 (1.8)	FADS1 (1.6)	FADS2 (1.6)
ENSG00000141736	ERBB2 PPI subnetwork	0.55	> 0.20	ITGB3 (3.0)	GMIP (2.3)	DNM2 (2.2)	PARP10 (2.2)	DOCK7 (2.0)	COL4A3BP (1.9)	PLEC (1.7)	PPP1R37 (1.7)	C17orf57 (1.5)	SLC44A2 (1.5)
MP:0003936	abnormal reproductive system development	0.55	> 0.20	LPAR2 (2.6)	LPA (2.4)	HNF1A (2.1)	CYP7A1 (1.8)	ATP13A1 (1.7)	MARK4 (1.5)	CARM1 (1.5)	ENSG00000254235 (1.5)	NYNRIN (1.5)	ABO (1.4)
GO:0015931	nucleobase-containing compound transport	0.55	> 0.20	C1orf63 (3.3)	ADAM1 (2.8)	MAPKAPK5 (2.6)	NAA25 (2.5)	ILF3 (2.5)	TOP1 (2.2)	DHODH (2.1)	USP24 (2.0)	POC5 (2.0)	DDX56 (1.9)
ENSG00000160868	CYP3A4 PPI subnetwork	0.55	> 0.20	MOSC1 (3.4)	NKPD1 (2.7)	DNAH11 (2.5)	SYPL2 (1.9)	PLG (1.9)	ANGPTL3 (1.9)	NT5DC1 (1.8)	ADAM1 (1.7)	ENSG00000228044 (1.7)	ATXN7L2 (1.5)
ENSG00000131263	RLIM PPI subnetwork	0.55	> 0.20	USP24 (3.9)	TMEM57 (2.6)	DHX38 (2.6)	CARM1 (2.5)	COL4A3BP (2.2)	MARK4 (1.7)	BRAP (1.7)	BUD13 (1.5)	ITGB3 (1.5)	PBX4 (1.4)
GO:0048562	embryonic organ morphogenesis	0.55	> 0.20	PLEKHH2 (1.9)	CEACAM19 (1.9)	NYNRIN (1.8)	ABO (1.7)	PLCG1 (1.7)	TMED4 (1.5)	CILP2 (1.4)	C19orf52 (1.3)	NKPD1 (1.3)	TSSK6 (1.3)
GO:0030016	myofibril	0.55	> 0.20	SYPL2 (7.3)	GMPR (2.6)	TMEM50A (1.4)	PLEC (1.3)	NPC1L1 (1.1)	PVRL2 (1.1)	KANK2 (1.0)	PVR (0.9)	RPH3A (0.8)	C17orf57 (0.8)
GO:0031050	dsRNA fragmentation	0.55	> 0.20	ENSG00000226648 (3.4)	DOCK7 (3.3)	MAPKAPK5 (3.0)	GOT2P1 (2.9)	ADAM1 (2.3)	USP24 (2.2)	C12orf43 (1.7)	ENSG00000228044 (1.6)	UBXN2B (1.2)	ATXN2 (1.2)
GO:0070918	production of small RNA involved in gene silencing by RNA	0.55	> 0.20	ENSG00000226648 (3.4)	DOCK7 (3.3)	MAPKAPK5 (3.0)	GOT2P1 (2.9)	ADAM1 (2.3)	USP24 (2.2)	C12orf43 (1.7)	ENSG00000228044 (1.6)	UBXN2B (1.2)	ATXN2 (1.2)
ENSG00000171681	ATF7IP PPI subnetwork	0.55	> 0.20	PVRL2 (3.2)	USP24 (2.7)	PLEC (2.0)	BCAM (2.0)	NYNRIN (1.9)	HNF1A (1.9)	SH2B3 (1.6)	KANK2 (1.6)	PPP1R37 (1.6)	PVR (1.5)
MP:0003132	increased pre-B cell number	0.55	> 0.20	ERP29 (2.5)	GMIP (2.4)	C17orf57 (2.2)	GEMIN7 (2.1)	FRK (1.9)	SH2B3 (1.9)	MAFB (1.9)	RELB (1.7)	NYNRIN (1.6)	CETP (1.3)
GO:0006353	transcription termination, DNA-dependent	0.55	> 0.20	C1orf63 (3.9)	ENSG00000226645 (3.6)	C12orf43 (3.6)	GEMIN7 (2.8)	BUD13 (2.8)	ADAM1 (2.5)	TXNL4B (2.5)	ILF3 (2.4)	MAPKAPK5 (2.3)	TOP1 (2.0)
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	0.55	> 0.20	GRINA (2.7)	PVR (2.5)	RELB (2.4)	TRIB1 (2.2)	TMEM50A (2.1)	ENSG00000228044 (2.1)	TMED4 (2.0)	SORT1 (1.9)	ITGB3 (1.8)	GATAD2A (1.7)
ENSG00000109332	UBE2D3 PPI subnetwork	0.55	> 0.20	BRAP (3.0)	USP24 (2.9)	ATXN2 (2.6)	C12orf51 (2.0)	PSMA5 (1.9)	SARS (1.9)	GATAD2A (1.8)	PTPN11 (1.7)	MYLIP (1.7)	TMEM57 (1.5)
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE	0.55	> 0.20	ST3GAL4 (3.1)	TMEM116 (2.4)	C17orf57 (2.2)	PVRL2 (2.1)	POLK (2.0)	DHODH (1.9)	SH2B3 (1.9)	YIPF2 (1.8)	SLC44A2 (1.7)	ITGB3 (1.7)
MP:0001324	abnormal eye pigmentation	0.55	> 0.20	DOCK7 (3.6)	ST3GAL4 (2.5)	GMPR (2.2)	MYLIP (2.2)	CYB561D1 (1.9)	ZNF101 (1.7)	NYNRIN (1.5)	BRAP (1.5)	CELSR2 (1.5)	SORT1 (1.5)
ENSG00000100150	DEPDC5 PPI subnetwork	0.55	> 0.20	SMARCA4 (3.2)	TOMM40 (2.8)	TOP1 (2.7)	ILF3 (2.6)	CARM1 (2.5)	QTRT1 (2.4)	BUD13 (2.3)	DHX38 (2.2)	PTPN11 (2.0)	COL4A3BP (1.9)
KEGG_CELL_CYCLE	KEGG_CELL_CYCLE	0.55	> 0.20	FEN1 (4.8)	USP1 (4.5)	PSRC1 (4.3)	ILF3 (1.6)	SLC44A2 (1.6)	SMARCA4 (1.5)	POC5 (1.5)	KANK2 (1.4)	RHCE (1.4)	RHD (1.3)
ENSG00000147133	TAF1 PPI subnetwork	0.55	> 0.20	ATXN2 (2.5)	SUGP1 (2.5)	TOP1 (2.3)	DHX38 (2.1)	BUD13 (2.1)	SMARCA4 (1.8)	MAPKAPK5 (1.7)	USP1 (1.6)	PSMA5 (1.5)	FEN1 (1.4)
MP:0003644	thymus atrophy	0.55	> 0.20	RELB (5.0)	BCL3 (3.4)	GRINA (2.2)	PBX4 (2.1)	GEMIN7 (1.8)	SYPL2 (1.7)	CETP (1.6)	HAPLN4 (1.6)	ABO (1.6)	C12orf47 (1.4)
ENSG00000177084	POLE PPI subnetwork	0.55	> 0.20	FEN1 (4.7)	USP1 (4.7)	ZNF180 (2.3)	SMARCA4 (2.0)	PSRC1 (1.5)	GMPR (1.4)	ENSG00000226648 (1.4)	TOMM40 (1.3)	DHODH (1.3)	MYLIP (1.2)
GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	0.55	> 0.20	MYLIP (2.4)	DOCK7 (2.1)	ST3GAL4 (1.9)	MOSC1 (1.8)	SORT1 (1.7)	GMIP (1.6)	POLK (1.6)	MAFB (1.4)	PSRC1 (1.4)	HLX (1.4)
ENSG00000078403	MLLT10 PPI subnetwork	0.55	> 0.20	MAU2 (3.2)	MAPKAPK5 (2.4)	DOCK7 (2.4)	PTPN11 (2.4)	LDLR (2.3)	C12orf43 (1.8)	BRAP (1.6)	DYNC2LI1 (1.6)	FADS2 (1.6)	ACAD10 (1.5)
ENSG00000131374	TBC1D5 PPI subnetwork	0.55	> 0.20	TMEM50A (3.0)	HNF1A (2.8)	C12orf43 (2.6)	LPIN3 (2.6)	GCNT4 (2.3)	ENSG00000235545 (2.3)	TRAFD1 (2.2)	ADAM1 (2.1)	ABO (2.0)	C12orf51 (2.0)
ENSG00000196839	ADA PPI subnetwork	0.55	> 0.20	OASL (5.6)	TOP1 (2.7)	NPC1L1 (2.6)	PARP10 (2.6)	HAVCR1 (2.6)	TMEM50A (2.1)	NCAN (1.7)	TXNL4B (1.7)	DHODH (1.6)	ENSG00000226648 (1.5)
REACTOME_PEPTIDE_CHAIN_ELONGATION	REACTOME_PEPTIDE_CHAIN_ELONGATION	0.55	> 0.20	NKPD1 (3.0)	MOSC1 (1.7)	GATAD2A (1.5)	UBXN2B (1.5)	ANKRD31 (1.4)	ERP29 (1.2)	DNAH11 (1.2)	ILF3 (1.2)	GPAM (1.2)	CEACAM19 (1.1)
MP:0004813	absent linear vestibular evoked potential	0.55	> 0.20	FRK (2.7)	LPIN3 (2.2)	NPC1L1 (1.9)	APOE (1.8)	C11orf9 (1.7)	HNF1A (1.7)	CELSR2 (1.7)	RPH3A (1.6)	NKPD1 (1.4)	ZNF180 (1.4)
REACTOME_HORMONE:SENSITIVE_LIPASE_HSL:MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS	REACTOME_HORMONE:SENSITIVE_LIPASE_HSL:MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS	0.55	> 0.20	GPAM (4.6)	MOSC1 (4.2)	SORT1 (2.3)	TIMD4 (2.1)	PMFBP1 (2.1)	HP (1.9)	ENSG00000238078 (1.4)	MAU2 (1.4)	NKPD1 (1.4)	KIAA1324 (1.4)
ENSG00000168274	HIST1H2AE PPI subnetwork	0.55	> 0.20	ILF3 (2.7)	SMARCA4 (2.2)	BUD13 (2.0)	TOP1 (1.9)	USP1 (1.8)	DDX56 (1.7)	CARM1 (1.6)	ZNF259 (1.5)	TOMM40 (1.4)	NAA25 (1.4)
ENSG00000137259	HIST1H2AB PPI subnetwork	0.55	> 0.20	ILF3 (2.7)	SMARCA4 (2.2)	BUD13 (2.0)	TOP1 (1.9)	USP1 (1.8)	DDX56 (1.7)	CARM1 (1.6)	ZNF259 (1.5)	TOMM40 (1.4)	NAA25 (1.4)
ENSG00000073792	IGF2BP2 PPI subnetwork	0.55	> 0.20	PSMA5 (3.3)	AP1M2 (2.5)	TOP1 (2.2)	QTRT1 (2.1)	SARS (2.1)	SORT1 (2.1)	BCAM (1.9)	ZNF101 (1.6)	C19orf52 (1.6)	ILF3 (1.6)
GO:0031398	positive regulation of protein ubiquitination	0.55	> 0.20	PSMA5 (3.7)	TRAFD1 (2.7)	BRAP (2.1)	POC5 (2.0)	NAA25 (2.0)	NT5DC1 (1.7)	HAVCR1 (1.6)	TXNL4B (1.5)	ZNF180 (1.5)	SUGP1 (1.5)
ENSG00000139626	ITGB7 PPI subnetwork	0.56	> 0.20	TIMD4 (4.3)	CETP (3.9)	SH2B3 (2.4)	HAVCR1 (2.4)	APOE (2.2)	PLEKHH2 (2.0)	C11orf9 (1.9)	KANK2 (1.8)	C12orf47 (1.6)	ITGB3 (1.6)
ENSG00000185963	BICD2 PPI subnetwork	0.56	> 0.20	OGDH (2.4)	DOCK7 (2.3)	ENSG00000235545 (2.3)	DNM2 (2.2)	C12orf51 (2.2)	SMARCA4 (1.9)	MARK4 (1.9)	CLPTM1 (1.8)	PLEC (1.7)	AMIGO1 (1.6)
GO:0015116	sulfate transmembrane transporter activity	0.56	> 0.20	TMEM116 (3.6)	MOSC1 (2.6)	NT5DC1 (2.4)	FRK (2.2)	PBX4 (2.2)	CYB561D1 (1.9)	TM6SF2 (1.5)	ENSG00000228044 (1.5)	MYLIP (1.5)	HMGCR (1.4)
GO:0045185	maintenance of protein location	0.56	> 0.20	C17orf57 (2.3)	PSRC1 (1.8)	CLPTM1 (1.8)	CBLC (1.8)	UBXN2B (1.7)	PLEC (1.7)	TMEM50A (1.7)	RHD (1.6)	GOT2P1 (1.6)	C11orf9 (1.5)
GO:0051861	glycolipid binding	0.56	> 0.20	SH2B3 (2.1)	TSSK6 (2.0)	NYNRIN (2.0)	ENSG00000226645 (1.9)	TMEM116 (1.6)	ABO (1.5)	CELSR2 (1.5)	PLEKHH2 (1.5)	PLEC (1.4)	ST3GAL4 (1.4)
MP:0003648	abnormal radial glial cell morphology	0.56	> 0.20	NYNRIN (3.9)	CELSR2 (2.7)	BCAM (2.2)	NCAN (2.1)	HAVCR1 (2.0)	TMED4 (1.9)	ALDH2 (1.9)	PLEC (1.8)	CYB561D1 (1.7)	BLOC1S3 (1.7)
ENSG00000157110	RBPMS PPI subnetwork	0.56	> 0.20	PPP1R37 (3.0)	GRINA (2.3)	PSRC1 (1.9)	ENSG00000238078 (1.9)	C19orf52 (1.7)	ANKRD31 (1.7)	DNM2 (1.6)	ABO (1.5)	MARK4 (1.5)	ATXN7L2 (1.5)
ENSG00000112242	E2F3 PPI subnetwork	0.56	> 0.20	BCL3 (2.5)	GMIP (2.4)	MAU2 (2.4)	USP24 (2.4)	PARP10 (2.2)	PSRC1 (2.0)	CBLC (1.8)	NYNRIN (1.8)	MAFB (1.8)	C12orf51 (1.7)
GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	0.56	> 0.20	ENSG00000235545 (2.1)	DNAH11 (2.0)	PARP10 (1.7)	HAVCR1 (1.6)	NKPD1 (1.4)	POLK (1.4)	RELB (1.4)	GEMIN7 (1.2)	ZNF101 (1.2)	TRAFD1 (1.2)
MP:0004964	absent inner cell mass	0.56	> 0.20	OGDH (2.2)	BUD13 (2.1)	DNAH11 (1.9)	ABCG5 (1.8)	ATP13A1 (1.8)	DOCK7 (1.8)	ENSG00000235545 (1.7)	ENSG00000226648 (1.7)	ST3GAL4 (1.7)	USP1 (1.6)
ENSG00000156735	BAG4 PPI subnetwork	0.56	> 0.20	CELSR2 (2.3)	PLCG1 (2.0)	NPC1L1 (1.8)	ACAD10 (1.8)	DNAH11 (1.5)	PLEC (1.4)	SLC44A2 (1.4)	MYLIP (1.4)	AMIGO1 (1.4)	AP1M2 (1.4)
GO:0031401	positive regulation of protein modification process	0.56	> 0.20	POC5 (2.5)	ENSG00000226645 (2.5)	TMEM57 (1.7)	TRAFD1 (1.7)	PLEKHH2 (1.7)	SH2B3 (1.7)	PTPN11 (1.6)	PSMA5 (1.6)	TMEM50A (1.4)	NAA25 (1.4)
GO:0001832	blastocyst growth	0.56	> 0.20	PPP1R37 (3.3)	MAU2 (2.8)	SUGP1 (2.6)	UBXN2B (2.5)	QTRT1 (2.5)	BLOC1S3 (2.4)	YIPF2 (2.4)	ENSG00000226648 (2.2)	AMIGO1 (2.1)	GOT2P1 (1.9)
GO:0043279	response to alkaloid	0.56	> 0.20	C12orf47 (2.9)	ADAM1 (2.4)	ANKRD31 (2.1)	ABO (1.6)	ZHX3 (1.4)	GOT2P1 (1.3)	ENSG00000228044 (1.0)	LPIN3 (1.0)	HNF1A (1.0)	CYP7A1 (1.0)
GO:0070373	negative regulation of ERK1 and ERK2 cascade	0.56	> 0.20	PLEKHH2 (2.4)	TRIB1 (2.1)	SORT1 (2.0)	HAVCR1 (1.8)	PVR (1.7)	C17orf57 (1.7)	PMFBP1 (1.5)	DYNC2LI1 (1.4)	COL4A3BP (1.3)	DNAH11 (1.3)
GO:0051018	protein kinase A binding	0.56	> 0.20	TSSK6 (4.4)	C19orf52 (2.6)	MAU2 (2.5)	GCNT4 (1.8)	LPAR2 (1.5)	KIAA1324 (1.5)	KANK2 (1.4)	HNF1A (1.3)	COL4A3BP (1.2)	YIPF2 (1.2)
ENSG00000042980	ADAM28 PPI subnetwork	0.56	> 0.20	MARK4 (3.7)	GMIP (3.1)	C12orf51 (2.9)	USP24 (2.6)	SLC44A2 (2.4)	LPAR2 (2.3)	ATXN2 (2.3)	DNM2 (2.0)	ZNF180 (1.9)	PVRL2 (1.9)
GO:0008239	dipeptidyl-peptidase activity	0.56	> 0.20	HAPLN4 (2.4)	HNF1A (2.1)	NPC1L1 (1.9)	HAVCR1 (1.8)	LPAR2 (1.8)	AP1M2 (1.8)	FRK (1.7)	GCNT4 (1.7)	PMFBP1 (1.7)	NCAN (1.7)
GO:0005523	tropomyosin binding	0.56	> 0.20	SYPL2 (6.4)	KANK2 (2.5)	GMPR (2.1)	CEACAM19 (2.0)	SORT1 (1.6)	C17orf57 (1.5)	RHCE (1.4)	FRK (1.3)	RPH3A (1.3)	PLEC (1.2)
ENSG00000124642	ENSG00000124642 PPI subnetwork	0.56	> 0.20	DDX56 (2.8)	SMARCA4 (2.7)	BUD13 (2.4)	ZNF259 (2.3)	ILF3 (2.3)	QTRT1 (2.2)	NAA25 (2.2)	TOMM40 (2.2)	CARM1 (2.1)	TOP1 (2.0)
ENSG00000184825	HIST1H2AH PPI subnetwork	0.56	> 0.20	DDX56 (2.8)	SMARCA4 (2.7)	BUD13 (2.4)	ZNF259 (2.3)	ILF3 (2.3)	QTRT1 (2.2)	NAA25 (2.2)	TOMM40 (2.2)	CARM1 (2.1)	TOP1 (2.0)
ENSG00000105855	ITGB8 PPI subnetwork	0.56	> 0.20	SH2B3 (3.3)	APOE (3.0)	ITGB3 (2.6)	PLEC (2.6)	CLPTM1 (2.6)	DNM2 (2.0)	KANK2 (1.9)	SYPL2 (1.9)	HAVCR1 (1.8)	FRK (1.8)
ENSG00000115616	SLC9A2 PPI subnetwork	0.56	> 0.20	RHD (3.2)	RHCE (2.6)	GMIP (2.4)	DNM2 (2.3)	COL4A3BP (2.3)	SLC44A2 (2.2)	FRK (2.2)	PLCG1 (2.0)	HMGCR (2.0)	HAVCR1 (1.9)
ENSG00000074266	EED PPI subnetwork	0.56	> 0.20	USP1 (3.1)	C1orf63 (2.5)	PTPN11 (2.4)	TMEM50A (2.4)	TOP1 (2.3)	ZNF180 (2.2)	USP24 (2.0)	SUGP1 (1.9)	CYB561D1 (1.8)	ILF3 (1.7)
GO:0007346	regulation of mitotic cell cycle	0.56	> 0.20	ENSG00000228044 (3.1)	PSRC1 (2.8)	POC5 (2.7)	PSMA5 (2.0)	SUGP1 (1.8)	TRAFD1 (1.8)	FEN1 (1.6)	BRAP (1.5)	PTPN11 (1.5)	NAA25 (1.4)
GO:0006144	purine base metabolic process	0.56	> 0.20	ENSG00000228044 (2.5)	NT5DC1 (2.5)	DHODH (2.5)	LPIN3 (2.4)	TRAPPC6A (2.1)	SYPL2 (2.1)	QTRT1 (2.0)	ENSG00000226648 (1.9)	NKPD1 (1.7)	CEACAM19 (1.6)
ENSG00000119699	TGFB3 PPI subnetwork	0.56	> 0.20	CILP2 (5.5)	SLC44A2 (2.3)	YIPF2 (2.2)	PVR (2.1)	KANK2 (2.0)	GPAM (1.8)	SORT1 (1.7)	TMED4 (1.6)	CYP7A1 (1.6)	AP1M2 (1.4)
MP:0000026	abnormal inner ear morphology	0.56	> 0.20	TMEM116 (2.7)	CILP2 (2.4)	DYNC2LI1 (2.4)	MYLIP (2.1)	PPP1R37 (1.7)	C17orf57 (1.5)	PLCG1 (1.4)	PLEC (1.2)	ST3GAL4 (1.2)	TM6SF2 (1.1)
ENSG00000197223	C1D PPI subnetwork	0.56	> 0.20	DDX56 (3.0)	SUGP1 (2.8)	C19orf52 (2.5)	AP1M2 (2.4)	YIPF2 (2.4)	TOMM40 (2.3)	ENSG00000226645 (2.1)	QTRT1 (2.0)	GRINA (1.9)	TMEM50A (1.9)
GO:0048565	digestive tract development	0.56	> 0.20	C11orf9 (4.6)	PLEKHH2 (3.0)	TM6SF2 (2.3)	LPAR2 (2.0)	NYNRIN (1.9)	HLX (1.8)	CEACAM19 (1.8)	DYNC2LI1 (1.8)	ABCG8 (1.7)	ENSG00000235545 (1.7)
ENSG00000009413	REV3L PPI subnetwork	0.56	> 0.20	TMEM57 (3.0)	FEN1 (2.5)	ZNF180 (2.3)	GEMIN7 (2.1)	PBX4 (2.1)	POLK (2.0)	HNF1A (1.8)	USP1 (1.7)	ZNF101 (1.5)	DYNC2LI1 (1.4)
ENSG00000131183	SLC34A1 PPI subnetwork	0.56	> 0.20	PVRL2 (2.1)	BCAM (2.0)	TMED4 (1.9)	C11orf9 (1.8)	MYLIP (1.7)	TMEM116 (1.6)	AP1M2 (1.5)	KIAA1324 (1.5)	POLK (1.5)	FRK (1.4)
ENSG00000094804	CDC6 PPI subnetwork	0.56	> 0.20	FEN1 (4.4)	PSMA5 (3.7)	USP1 (3.2)	MAU2 (2.2)	NT5DC1 (1.8)	ENSG00000235545 (1.8)	TXNL4B (1.8)	TOMM40 (1.8)	PSRC1 (1.6)	DDX56 (1.6)
GO:0042771	DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis	0.56	> 0.20	AMIGO1 (2.4)	BLOC1S3 (2.3)	PPP1R37 (2.0)	MARK4 (1.9)	PARP10 (1.6)	ZNF101 (1.5)	GOT2P1 (1.3)	ZNF180 (1.3)	BUD13 (1.3)	CARM1 (1.3)
GO:0019438	aromatic compound biosynthetic process	0.56	> 0.20	HNF1A (3.6)	GOT2P1 (3.5)	NT5DC1 (2.7)	TXNL4B (2.7)	TRAPPC6A (1.9)	DHODH (1.9)	PMFBP1 (1.8)	ACAD10 (1.6)	ENSG00000254235 (1.5)	CYP7A1 (1.3)
MP:0010301	increased stomach tumor incidence	0.56	> 0.20	COL4A3BP (2.2)	BLOC1S3 (2.0)	PLCG1 (1.9)	TM6SF2 (1.9)	PLEC (1.9)	POLK (1.8)	ENSG00000226648 (1.7)	KANK2 (1.5)	TMED4 (1.5)	SH2B3 (1.5)
REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION	0.56	> 0.20	NT5DC1 (2.7)	HLX (2.0)	APOA5 (1.9)	MOSC1 (1.7)	SH2B3 (1.7)	TM6SF2 (1.7)	C1orf63 (1.6)	ABCG8 (1.6)	SLC22A1 (1.5)	ZNF259 (1.5)
GO:0090002	establishment of protein localization in plasma membrane	0.56	> 0.20	PTPN11 (3.0)	BCAM (2.6)	C11orf9 (2.5)	AP1M2 (2.0)	ZHX3 (1.8)	ENSG00000226645 (1.8)	C12orf47 (1.7)	TSSK6 (1.6)	CBLC (1.5)	TMEM57 (1.4)
MP:0003892	abnormal gastric gland morphology	0.56	> 0.20	C11orf9 (3.4)	ABO (2.3)	OASL (2.3)	DOCK7 (2.3)	GCNT4 (2.2)	HNF1A (2.2)	KIAA1324 (2.1)	C12orf47 (1.5)	NPC1L1 (1.5)	TMEM116 (1.4)
GO:0042130	negative regulation of T cell proliferation	0.56	> 0.20	ENSG00000228044 (2.3)	ENSG00000254235 (1.9)	DNAH11 (1.9)	HNF1A (1.9)	COL4A3BP (1.6)	TRAFD1 (1.6)	ABO (1.3)	CYB561D1 (1.3)	GCNT4 (1.3)	C17orf57 (1.3)
ENSG00000149257	SERPINH1 PPI subnetwork	0.56	> 0.20	PLEC (3.4)	KANK2 (3.2)	ITGB3 (3.1)	BRAP (2.7)	PVR (2.6)	ADAM1 (2.4)	GATAD2A (2.1)	PTPN11 (2.1)	SLC44A2 (1.8)	CEACAM19 (1.7)
ENSG00000127191	TRAF2 PPI subnetwork	0.56	> 0.20	PBX4 (4.4)	RELB (4.4)	BCL3 (3.1)	LPAR2 (2.3)	ENSG00000238078 (2.1)	GRINA (1.9)	CARM1 (1.8)	PARP10 (1.8)	PTPN11 (1.7)	NT5DC1 (1.6)
ENSG00000128016	ZFP36 PPI subnetwork	0.56	> 0.20	TXNL4B (4.0)	OASL (3.6)	ENSG00000228044 (2.7)	TRAFD1 (2.6)	ATXN2 (2.6)	DHX38 (2.5)	PARP10 (2.4)	TOP1 (2.2)	UBXN2B (2.1)	C1orf63 (2.1)
GO:0051279	regulation of release of sequestered calcium ion into cytosol	0.56	> 0.20	ABO (2.1)	TRAPPC6A (2.0)	SYPL2 (1.7)	ENSG00000254235 (1.7)	GEMIN7 (1.6)	GCNT4 (1.5)	ZNF180 (1.4)	GMPR (1.4)	C17orf57 (1.4)	TSSK6 (1.3)
MP:0000965	abnormal sensory neuron morphology	0.56	> 0.20	HAPLN4 (2.5)	GMPR (2.5)	CEACAM19 (2.5)	SARS (2.2)	PLEC (1.9)	COL4A3BP (1.7)	ENSG00000238078 (1.7)	ALDH2 (1.5)	PVR (1.5)	ENSG00000228044 (1.4)
GO:0007183	SMAD protein complex assembly	0.56	> 0.20	ENSG00000226648 (2.7)	C19orf52 (2.1)	GCNT4 (2.0)	DOCK7 (2.0)	MAPKAPK5 (1.9)	PTPN11 (1.8)	GOT2P1 (1.7)	ZNF180 (1.7)	LPIN3 (1.6)	TMED4 (1.6)
GO:0031000	response to caffeine	0.56	> 0.20	AMIGO1 (2.3)	ZNF180 (2.3)	FRK (2.0)	SYPL2 (1.9)	ANKRD31 (1.9)	C17orf57 (1.6)	ENSG00000228044 (1.4)	ZNF259 (1.4)	ENSG00000238078 (1.3)	HAVCR1 (1.3)
GO:0006687	glycosphingolipid metabolic process	0.56	> 0.20	HAVCR1 (3.7)	COL4A3BP (2.4)	TMEM50A (2.3)	TRAPPC6A (2.2)	CYB561D1 (2.1)	ERP29 (2.1)	HNF1A (2.1)	NKPD1 (2.0)	TMED4 (2.0)	LPIN3 (1.9)
ENSG00000184708	EIF4ENIF1 PPI subnetwork	0.56	> 0.20	PSRC1 (2.3)	KANK2 (2.3)	MYLIP (2.0)	CARM1 (2.0)	ENSG00000254235 (1.8)	DOCK7 (1.6)	DYNC2LI1 (1.5)	POLK (1.4)	ENSG00000226645 (1.3)	ALDH2 (1.2)
ENSG00000126261	UBA2 PPI subnetwork	0.56	> 0.20	TRAPPC6A (3.8)	ZNF180 (3.2)	TMEM50A (2.9)	MARK4 (2.0)	TOMM40 (1.9)	ZNF101 (1.8)	PVRL2 (1.8)	RELB (1.7)	GOT2P1 (1.7)	GEMIN7 (1.6)
MP:0002582	disorganized extraembryonic tissue	0.56	> 0.20	HAVCR1 (3.1)	CELSR2 (2.8)	ENSG00000254235 (2.6)	TRIB1 (2.4)	PVR (2.0)	LPIN3 (1.9)	SH2B3 (1.8)	TOP1 (1.8)	ZHX3 (1.5)	DOCK7 (1.5)
ENSG00000158417	EIF5B PPI subnetwork	0.56	> 0.20	NAA25 (3.6)	ZNF259 (3.1)	ATP13A1 (3.0)	DDX56 (2.7)	TOMM40 (2.7)	QTRT1 (2.5)	ILF3 (2.3)	GATAD2A (2.3)	DHX38 (2.2)	NKPD1 (2.1)
GO:0030968	endoplasmic reticulum unfolded protein response	0.56	> 0.20	BLOC1S3 (3.4)	GCNT4 (3.3)	SARS (2.8)	TXNL4B (2.7)	C12orf47 (2.1)	YIPF2 (2.1)	TMED4 (1.7)	ERP29 (1.5)	ENSG00000238078 (1.4)	TMEM116 (1.2)
GO:0034620	cellular response to unfolded protein	0.56	> 0.20	BLOC1S3 (3.4)	GCNT4 (3.3)	SARS (2.8)	TXNL4B (2.7)	C12orf47 (2.1)	YIPF2 (2.1)	TMED4 (1.7)	ERP29 (1.5)	ENSG00000238078 (1.4)	TMEM116 (1.2)
GO:0032088	negative regulation of NF-kappaB transcription factor activity	0.56	> 0.20	PMFBP1 (2.5)	PARP10 (2.2)	ZNF180 (1.9)	BLOC1S3 (1.8)	GMIP (1.8)	CEACAM19 (1.8)	GEMIN7 (1.7)	YIPF2 (1.7)	ENSG00000238078 (1.6)	LPAR2 (1.5)
MP:0004110	transposition of great arteries	0.56	> 0.20	NYNRIN (2.9)	HAPLN4 (2.2)	DNAH11 (2.1)	PVRL2 (1.8)	KANK2 (1.8)	BCAM (1.7)	COL4A3BP (1.7)	DOCK7 (1.7)	CEACAM19 (1.6)	MARK4 (1.5)
GO:0048821	erythrocyte development	0.56	> 0.20	RHCE (6.5)	RHD (6.3)	GMPR (3.2)	C12orf51 (2.2)	ENSG00000228044 (2.0)	ERP29 (1.5)	TMEM116 (1.4)	BLOC1S3 (1.3)	GEMIN7 (1.3)	ATXN7L2 (1.0)
ENSG00000068366	ACSL4 PPI subnetwork	0.56	> 0.20	BRAP (2.7)	SARS (2.5)	DDX56 (1.9)	GMPR (1.7)	PLCG1 (1.7)	C19orf52 (1.6)	AMIGO1 (1.6)	PTPN11 (1.6)	ZNF101 (1.6)	NAA25 (1.6)
ENSG00000173636	ENSG00000173636 PPI subnetwork	0.56	> 0.20	FEN1 (2.4)	APOB (2.2)	USP1 (1.9)	GMPR (1.8)	CELSR2 (1.8)	HP (1.8)	ERP29 (1.6)	ALDH2 (1.5)	TMEM50A (1.5)	POC5 (1.4)
GO:2001021	negative regulation of response to DNA damage stimulus	0.56	> 0.20	ANKRD31 (4.6)	POLK (2.5)	MYLIP (2.3)	BLOC1S3 (1.7)	BUD13 (1.5)	SH2B3 (1.5)	C12orf47 (1.3)	NYNRIN (1.3)	NT5DC1 (1.3)	C1orf63 (1.2)
ENSG00000152422	XRCC4 PPI subnetwork	0.56	> 0.20	NT5DC1 (2.6)	UBXN2B (2.5)	MAPKAPK5 (2.1)	ANKRD31 (2.1)	ZNF101 (2.1)	GOT2P1 (1.9)	PLEC (1.8)	ZNF180 (1.8)	CYB561D1 (1.5)	C11orf9 (1.5)
ENSG00000115020	PIKFYVE PPI subnetwork	0.56	> 0.20	PMFBP1 (2.1)	CEACAM19 (2.0)	C17orf57 (1.7)	PTPN11 (1.6)	CARM1 (1.5)	TOMM40 (1.5)	GPAM (1.4)	KANK2 (1.4)	HNF1A (1.3)	USP24 (1.3)
ENSG00000152291	TGOLN2 PPI subnetwork	0.56	> 0.20	OGDH (3.1)	ZHX3 (2.9)	PTPN11 (2.8)	KANK2 (2.5)	SLC44A2 (2.2)	DNM2 (2.1)	COL4A3BP (2.1)	GATAD2A (1.7)	ENSG00000235545 (1.5)	ENSG00000238078 (1.5)
MP:0006279	abnormal limb development	0.56	> 0.20	HMGCR (3.3)	LDLR (3.0)	PLEKHH2 (2.3)	CILP2 (2.2)	DYNC2LI1 (2.0)	GOT2P1 (1.8)	AP1M2 (1.7)	ANKRD31 (1.7)	FADS1 (1.5)	CBLC (1.4)
GO:0042470	melanosome	0.56	> 0.20	ERP29 (5.0)	CLPTM1 (3.5)	APOE (2.9)	SORT1 (2.8)	SARS (2.6)	GRINA (2.2)	ADAM1 (2.1)	CELSR2 (2.1)	PPP1R37 (2.0)	GMPR (2.0)
GO:0048770	pigment granule	0.56	> 0.20	ERP29 (5.0)	CLPTM1 (3.5)	APOE (2.9)	SORT1 (2.8)	SARS (2.6)	GRINA (2.2)	ADAM1 (2.1)	CELSR2 (2.1)	PPP1R37 (2.0)	GMPR (2.0)
GO:0010822	positive regulation of mitochondrion organization	0.56	> 0.20	BRAP (3.1)	C19orf52 (2.3)	LPAR2 (2.0)	TRAFD1 (1.8)	C12orf43 (1.7)	TMEM116 (1.7)	CBLC (1.7)	POLK (1.7)	C12orf47 (1.6)	TXNL4B (1.6)
GO:0048185	activin binding	0.56	> 0.20	PVRL2 (3.4)	MARK4 (2.4)	PVR (2.3)	TMEM116 (1.9)	NYNRIN (1.9)	CARM1 (1.7)	LPIN3 (1.7)	PLEC (1.6)	SH2B3 (1.6)	KANK2 (1.5)
ENSG00000107281	NPDC1 PPI subnetwork	0.56	> 0.20	GATAD2A (2.7)	NYNRIN (2.6)	HLX (2.2)	PVRL2 (2.0)	ST3GAL4 (1.7)	FEN1 (1.6)	KANK2 (1.4)	GOT2P1 (1.4)	USP1 (1.4)	SLC44A2 (1.4)
ENSG00000086102	NFX1 PPI subnetwork	0.56	> 0.20	ILF3 (4.0)	TOP1 (3.4)	C1orf63 (3.3)	SMARCA4 (2.6)	BUD13 (2.5)	USP1 (2.5)	DHX38 (2.5)	SUGP1 (2.1)	FEN1 (2.0)	PTPN11 (1.8)
MP:0002673	abnormal sperm number	0.56	> 0.20	TSSK6 (3.0)	ENSG00000228044 (2.9)	TRAFD1 (2.4)	NCAN (1.9)	PLEKHH2 (1.6)	SLC44A2 (1.4)	TRIB1 (1.3)	PVRL2 (1.3)	GRINA (1.2)	ATXN7L2 (1.1)
MP:0003084	abnormal skeletal muscle fiber morphology	0.56	> 0.20	SYPL2 (6.3)	PVR (2.5)	GMPR (2.1)	KANK2 (1.9)	MAU2 (1.8)	PLEC (1.7)	CYB561D1 (1.6)	AMIGO1 (1.5)	OGDH (1.5)	BCAM (1.4)
GO:0006684	sphingomyelin metabolic process	0.56	> 0.20	NKPD1 (4.8)	FRK (2.8)	BLOC1S3 (2.7)	TMEM57 (2.4)	ANKRD31 (2.1)	GCNT4 (2.1)	LPIN3 (2.0)	POLK (1.9)	NT5DC1 (1.9)	ATP13A1 (1.9)
GO:0031103	axon regeneration	0.56	> 0.20	ENSG00000238078 (2.6)	GCNT4 (2.5)	ENSG00000228044 (2.0)	DNAH11 (1.7)	TMEM50A (1.7)	ALDH2 (1.6)	ANKRD31 (1.5)	HAPLN4 (1.3)	RPH3A (1.2)	COL4A3BP (1.1)
REACTOME_CELL_CYCLE_MITOTIC	REACTOME_CELL_CYCLE_MITOTIC	0.56	> 0.20	FEN1 (5.5)	PSRC1 (4.3)	USP1 (4.2)	POC5 (3.1)	PSMA5 (1.6)	BUD13 (1.0)	RHD (1.0)	SMARCA4 (1.0)	ZNF180 (1.0)	ENSG00000226648 (0.9)
ENSG00000117242	ENSG00000117242 PPI subnetwork	0.56	> 0.20	ATP13A1 (4.1)	TMEM50A (3.7)	YIPF2 (3.4)	TMED4 (3.1)	NT5DC1 (2.2)	ERP29 (2.2)	LDLR (2.2)	TRAPPC6A (2.1)	FADS2 (2.0)	FADS1 (1.9)
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	0.56	> 0.20	PSMA5 (5.4)	TRAFD1 (3.2)	PSRC1 (2.9)	FEN1 (2.3)	POC5 (2.2)	SUGP1 (1.9)	NAA25 (1.9)	DDX56 (1.7)	LPIN3 (1.4)	ABCG8 (1.0)
REACTOME_APCC:MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	REACTOME_APCC:MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS	0.56	> 0.20	PSMA5 (5.4)	TRAFD1 (3.2)	PSRC1 (2.9)	FEN1 (2.3)	POC5 (2.2)	SUGP1 (1.9)	NAA25 (1.9)	DDX56 (1.7)	LPIN3 (1.4)	ABCG8 (1.0)
MP:0002840	abnormal lens fiber morphology	0.56	> 0.20	NPC1L1 (1.4)	HMGCR (1.3)	C19orf52 (1.3)	GOT2P1 (1.1)	FADS2 (1.1)	OASL (1.0)	TIMD4 (1.0)	TRAPPC6A (1.0)	PBX4 (0.9)	LDLR (0.9)
ENSG00000116898	MRPS15 PPI subnetwork	0.56	> 0.20	HNF1A (2.7)	HAPLN4 (2.4)	MAPKAPK5 (2.2)	ADAM1 (2.1)	GPAM (2.0)	NT5DC1 (2.0)	DDX56 (1.9)	BRAP (1.8)	ITGB3 (1.7)	FRK (1.6)
ENSG00000143933	CALM2 PPI subnetwork	0.56	> 0.20	SYPL2 (3.1)	RELB (2.8)	PLEC (2.4)	BCL3 (2.4)	OGDH (1.8)	GRINA (1.7)	COL4A3BP (1.6)	CARM1 (1.6)	ITGB3 (1.6)	C12orf51 (1.5)
ENSG00000160014	CALM3 PPI subnetwork	0.56	> 0.20	SYPL2 (3.1)	RELB (2.8)	PLEC (2.4)	BCL3 (2.4)	OGDH (1.8)	GRINA (1.7)	COL4A3BP (1.6)	CARM1 (1.6)	ITGB3 (1.6)	C12orf51 (1.5)
ENSG00000198668	CALM1 PPI subnetwork	0.56	> 0.20	SYPL2 (3.1)	RELB (2.8)	PLEC (2.4)	BCL3 (2.4)	OGDH (1.8)	GRINA (1.7)	COL4A3BP (1.6)	CARM1 (1.6)	ITGB3 (1.6)	C12orf51 (1.5)
GO:0030666	endocytic vesicle membrane	0.56	> 0.20	CLPTM1 (2.7)	HAPLN4 (2.5)	SORT1 (2.1)	RPH3A (2.0)	PPP1R37 (2.0)	TM6SF2 (1.9)	SARS (1.8)	GRINA (1.8)	HMGCR (1.7)	NCAN (1.6)
ENSG00000167136	ENDOG PPI subnetwork	0.56	> 0.20	GMPR (3.4)	TMEM57 (2.3)	C19orf52 (2.2)	MYLIP (1.4)	TSSK6 (1.2)	PMFBP1 (1.1)	SUGP1 (1.1)	FADS1 (1.0)	ANGPTL3 (1.0)	KIAA1324 (0.9)
ENSG00000168291	PDHB PPI subnetwork	0.56	> 0.20	C19orf52 (2.9)	ACAD10 (2.3)	DNAH11 (1.9)	PSMA5 (1.7)	OGDH